[
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c829c"
    },
    "name": "BRD-K61484514",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c829c.png",
    "lincs": {
      "id": "LSM-12154",
      "name": "BRD-K61484514",
      "pubchemCid": 54649582,
      "chebiId": 100780,
      "inchiParent": "InChI=1S/C23H31N3O5/c1-15-13-25(2)23(28)18-7-5-6-16(12-24)21(18)30-11-10-17-8-9-19(29-4)20(31-17)14-26(3)22(15)27/h5-7,15,17,19-20H,8-11,13-14H2,1-4H3/t15-,17+,19-,20+/m1/s1",
      "inchiKeyParent": "WNHZFTQVONQUSH-VUBSUSDNSA-N",
      "smilesParent": "CO[C@@H]1CC[C@H]2CCOc3c(cccc3C(=O)N(C)C[C@@H](C)C(=O)N(C)C[C@@H]1O2)C#N"
    },
    "unichem": {
      "chebi": "100780",
      "lincs": "LSM-12154",
      "pubchem": "54649582"
    },
    "pubchem": [
      {
        "cid": 54649582,
        "inchi": "InChI=1S/C23H31N3O5/c1-15-13-25(2)23(28)18-7-5-6-16(12-24)21(18)30-11-10-17-8-9-19(29-4)20(31-17)14-26(3)22(15)27/h5-7,15,17,19-20H,8-11,13-14H2,1-4H3/t15-,17+,19-,20+/m1/s1",
        "inchikey": "WNHZFTQVONQUSH-VUBSUSDNSA-N",
        "iupac": {
          "systematic": "(1S,14R,18S,19R)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5,7,9-triene-6-carbonitrile"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=CC=CC(=C2OCCC3CCC(C(O3)CN(C1=O)C)OC)C#N)C"
        },
        "molecularFormula": "C23H31N3O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:13:02Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82ef"
    },
    "name": "BRD-K73871495",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82ef.png",
    "lincs": {
      "id": "LSM-7815",
      "name": "BRD-K73871495",
      "pubchemCid": 54618131,
      "chebiId": 96436,
      "inchiParent": "InChI=1S/C28H42N4O4/c1-5-6-8-11-23-16-24-27(29-17-23)36-25(21(2)18-32(28(24)35)22(3)20-33)19-30(4)26(34)12-15-31-13-9-7-10-14-31/h16-17,21-22,25,33H,5-7,9-10,12-15,18-20H2,1-4H3/t21-,22+,25-/m0/s1",
      "inchiKeyParent": "VKSOWNIUNHUMMN-FBLLAGFSSA-N",
      "smilesParent": "CCCC#Cc1cnc2O[C@@H](CN(C)C(=O)CCN3CCCCC3)[C@@H](C)CN([C@H](C)CO)C(=O)c2c1"
    },
    "unichem": {
      "chebi": "96436",
      "lincs": "LSM-7815",
      "pubchem": "54618131"
    },
    "pubchem": [
      {
        "cid": 54618131,
        "inchi": "InChI=1S/C28H42N4O4/c1-5-6-8-11-23-16-24-27(29-17-23)36-25(21(2)18-32(28(24)35)22(3)20-33)19-30(4)26(34)12-15-31-13-9-7-10-14-31/h16-17,21-22,25,33H,5-7,9-10,12-15,18-20H2,1-4H3/t21-,22+,25-/m0/s1",
        "inchikey": "VKSOWNIUNHUMMN-FBLLAGFSSA-N",
        "iupac": {
          "systematic": "N-[[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-pent-1-ynyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-3-piperidin-1-ylpropanamide"
        },
        "smiles": {
          "canonical": "CCCC#CC1=CC2=C(N=C1)OC(C(CN(C2=O)C(C)CO)C)CN(C)C(=O)CCN3CCCCC3"
        },
        "molecularFormula": "C28H42N4O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:13:04Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8271"
    },
    "name": "BRD-K90205161",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8271.png",
    "lincs": {
      "id": "LSM-42194",
      "name": "BRD-K90205161",
      "pubchemCid": 60190207,
      "chebiId": 130645,
      "inchiParent": "InChI=1S/C22H29N3O2S/c26-14-19-21(18-4-2-1-3-5-18)22(25(19)12-17-6-9-27-10-7-17)15-24(16-22)13-20-23-8-11-28-20/h1-5,8,11,17,19,21,26H,6-7,9-10,12-16H2/t19-,21+/m1/s1",
      "inchiKeyParent": "CLNVEMGQHOOMFT-CTNGQTDRSA-N",
      "smilesParent": "OC[C@@H]1[C@H](c2ccccc2)C3(CN(Cc4nccs4)C3)N1CC5CCOCC5"
    },
    "unichem": {
      "chebi": "130645",
      "lincs": "LSM-42194",
      "pubchem": "60190207"
    },
    "pubchem": [
      {
        "cid": 60190207,
        "inchi": "InChI=1S/C22H29N3O2S/c26-14-19-21(18-4-2-1-3-5-18)22(25(19)12-17-6-9-27-10-7-17)15-24(16-22)13-20-23-8-11-28-20/h1-5,8,11,17,19,21,26H,6-7,9-10,12-16H2/t19-,21+/m1/s1",
        "inchikey": "CLNVEMGQHOOMFT-CTNGQTDRSA-N",
        "iupac": {
          "systematic": "[(2S,3S)-1-(oxan-4-ylmethyl)-3-phenyl-6-(1,3-thiazol-2-ylmethyl)-1,6-diazaspiro[3.3]heptan-2-yl]methanol"
        },
        "smiles": {
          "canonical": "C1COCCC1CN2C(C(C23CN(C3)CC4=NC=CS4)C5=CC=CC=C5)CO"
        },
        "molecularFormula": "C22H29N3O2S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:13:06Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82a2"
    },
    "name": "BRD-K84733605",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82a2.png",
    "lincs": {
      "id": "LSM-13608",
      "name": "BRD-K84733605",
      "pubchemCid": 56835521,
      "chebiId": 102253,
      "inchiParent": "InChI=1S/C32H39N3O4/c1-22-18-35(23(2)20-36)31(37)29-17-11-10-16-28(29)27-15-9-8-14-26(27)21-39-30(22)19-34(4)32(38)33-24(3)25-12-6-5-7-13-25/h5-17,22-24,30,36H,18-21H2,1-4H3,(H,33,38)/t22-,23-,24-,30-/m0/s1",
      "inchiKeyParent": "VBARFQGDBKSOKL-CQUCHYGKSA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@H](C)[C@H](CN(C)C(=O)N[C@@H](C)c2ccccc2)OCc3ccccc3c4ccccc4C1=O"
    },
    "unichem": {
      "chebi": "102253",
      "lincs": "LSM-13608",
      "pubchem": "56835521"
    },
    "pubchem": [
      {
        "cid": 56835521,
        "inchi": "InChI=1S/C32H39N3O4/c1-22-18-35(23(2)20-36)31(37)29-17-11-10-16-28(29)27-15-9-8-14-26(27)21-39-30(22)19-34(4)32(38)33-24(3)25-12-6-5-7-13-25/h5-17,22-24,30,36H,18-21H2,1-4H3,(H,33,38)/t22-,23-,24-,30-/m0/s1",
        "inchikey": "VBARFQGDBKSOKL-CQUCHYGKSA-N",
        "iupac": {
          "systematic": "1-[[(10R,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methyl-3-[(1S)-1-phenylethyl]urea"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=CC=CC=C2C3=CC=CC=C3COC1CN(C)C(=O)NC(C)C4=CC=CC=C4)C(C)CO"
        },
        "molecularFormula": "C32H39N3O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:13:09Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82af"
    },
    "name": "BRD-K97894266",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82af.png",
    "lincs": {
      "id": "LSM-14444",
      "name": "BRD-K97894266",
      "pubchemCid": 54657681,
      "chebiId": 103099,
      "inchiParent": "InChI=1S/C22H34ClN3O6S/c1-25(2)11-3-10-24-22(28)12-18-6-9-20-21(32-18)15-31-14-17(27)13-26(20)33(29,30)19-7-4-16(23)5-8-19/h4-5,7-8,17-18,20-21,27H,3,6,9-15H2,1-2H3,(H,24,28)/t17-,18-,20+,21-/m0/s1",
      "inchiKeyParent": "NJKGITFUOGWCFU-MMKMLUHNSA-N",
      "smilesParent": "CN(C)CCCNC(=O)C[C@@H]1CC[C@@H]2[C@H](COC[C@@H](O)CN2S(=O)(=O)c3ccc(Cl)cc3)O1"
    },
    "unichem": {
      "chebi": "103099",
      "lincs": "LSM-14444",
      "pubchem": "54657681"
    },
    "pubchem": [
      {
        "cid": 54657681,
        "inchi": "InChI=1S/C22H34ClN3O6S/c1-25(2)11-3-10-24-22(28)12-18-6-9-20-21(32-18)15-31-14-17(27)13-26(20)33(29,30)19-7-4-16(23)5-8-19/h4-5,7-8,17-18,20-21,27H,3,6,9-15H2,1-2H3,(H,24,28)/t17-,18-,20+,21-/m0/s1",
        "inchikey": "NJKGITFUOGWCFU-MMKMLUHNSA-N",
        "iupac": {
          "systematic": "2-[(3S,6aR,8S,10aR)-1-(4-chlorophenyl)sulfonyl-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[3-(dimethylamino)propyl]acetamide"
        },
        "smiles": {
          "canonical": "CN(C)CCCNC(=O)CC1CCC2C(O1)COCC(CN2S(=O)(=O)C3=CC=C(C=C3)Cl)O"
        },
        "molecularFormula": "C22H34ClN3O6S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:13:11Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82e1"
    },
    "name": "BRD-K95074209",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82e1.png",
    "lincs": {
      "id": "LSM-42423",
      "name": "BRD-K95074209",
      "pubchemCid": 60191073,
      "chebiId": 130874,
      "inchiParent": "InChI=1S/C26H25N3O3/c1-17-4-2-3-5-21(17)18-6-8-19(9-7-18)25-22-14-28(15-24(31)29(22)23(25)16-30)26(32)20-10-12-27-13-11-20/h2-13,22-23,25,30H,14-16H2,1H3/t22-,23+,25-/m0/s1",
      "inchiKeyParent": "LURUAEVVSCDZBN-ARNLJNQMSA-N",
      "smilesParent": "Cc1ccccc1c2ccc(cc2)[C@@H]3[C@@H](CO)N4[C@H]3CN(CC4=O)C(=O)c5ccncc5"
    },
    "unichem": {
      "chebi": "130874",
      "lincs": "LSM-42423",
      "pubchem": "60191073"
    },
    "pubchem": [
      {
        "cid": 60191073,
        "inchi": "InChI=1S/C26H25N3O3/c1-17-4-2-3-5-21(17)18-6-8-19(9-7-18)25-22-14-28(15-24(31)29(22)23(25)16-30)26(32)20-10-12-27-13-11-20/h2-13,22-23,25,30H,14-16H2,1H3/t22-,23+,25-/m0/s1",
        "inchikey": "LURUAEVVSCDZBN-ARNLJNQMSA-N",
        "iupac": {
          "systematic": "(6R,7S,8S)-8-(hydroxymethyl)-7-[4-(2-methylphenyl)phenyl]-4-(pyridine-4-carbonyl)-1,4-diazabicyclo[4.2.0]octan-2-one"
        },
        "smiles": {
          "canonical": "CC1=CC=CC=C1C2=CC=C(C=C2)C3C4CN(CC(=O)N4C3CO)C(=O)C5=CC=NC=C5"
        },
        "molecularFormula": "C26H25N3O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:13:13Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82e5"
    },
    "name": "SMP2_000081",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82e5.png",
    "lincs": {
      "id": "LSM-43276",
      "name": "SMP2_000081",
      "alternativeNames": [
        "FK506"
      ],
      "pubchemCid": 24140138,
      "inchiParent": "InChI=1S/C45H71NO12/c1-10-13-32-19-26(2)18-27(3)20-33(54-7)24-40-39(56-9)22-29(5)45(53,58-40)42(50)43(51)46-17-12-11-14-34(46)44(52)57-41(30(6)36(48)25-37(32)49)28(4)21-31-15-16-35(47)38(23-31)55-8/h10,19,21,27,29-36,38-41,47-48,53H,1,11-18,20,22-25H2,2-9H3/b26-19-,28-21+/t27-,29+,30+,31-,32+,33-,34-,35+,36-,38+,39-,40+,41+,45+/m0/s1",
      "inchiKeyParent": "KDEJOJSUWQBZSP-JWZPFBAESA-N",
      "smilesParent": "CO[C@H]1C[C@@H](C)C\\C(=C/[C@@H](CC=C)C(=O)C[C@H](O)[C@@H](C)[C@H](OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@]3(O)O[C@H](C1)[C@H](C[C@H]3C)OC)\\C(=C\\[C@@H]4CC[C@@H](O)[C@@H](C4)OC)\\C)\\C"
    },
    "unichem": {
      "lincs": "LSM-43276",
      "pubchem": "24140138"
    },
    "pubchem": [
      {
        "cid": 24140138,
        "inchi": "InChI=1S/C45H71NO12/c1-10-13-32-19-26(2)18-27(3)20-33(54-7)24-40-39(56-9)22-29(5)45(53,58-40)42(50)43(51)46-17-12-11-14-34(46)44(52)57-41(30(6)36(48)25-37(32)49)28(4)21-31-15-16-35(47)38(23-31)55-8/h10,19,21,27,29-36,38-41,47-48,53H,1,11-18,20,22-25H2,2-9H3/b26-19-,28-21+/t27-,29+,30+,31-,32+,33-,34-,35+,36-,38+,39-,40+,41+,45+/m0/s1",
        "inchikey": "KDEJOJSUWQBZSP-JWZPFBAESA-N",
        "iupac": {
          "systematic": "(1R,9S,12S,13R,14S,17R,18Z,21S,23S,25R,26S,28R)-1,14-dihydroxy-12-[(E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl]-23,26-dimethoxy-13,19,21,28-tetramethyl-17-prop-2-enyl-11,29-dioxa-4-azatricyclo[23.3.1.04,9]nonacos-18-ene-2,3,10,16-tetrone"
        },
        "smiles": {
          "canonical": "CC1CC(CC2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC"
        },
        "molecularFormula": "C45H71NO12"
      }
    ],
    "clinicaltrials": [
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01213394",
            "briefTitle": "Mycophenolate Mofetil for Reducing Cardiovascular Risk in Renal Transplant Recipients",
            "officialTitle": "A 6-month, Prospective, Open-label, Randomized, Controlled, Pilot Study Evaluating the Efficacy, Safety and Toxicity of an Optimized Immunosuppressive Regimen of CellCept (Mycophenolate Mofetil, MMF) and Reduced Doses of Both Calcineurin-inhibitors and Prednisone in Renal Transplant Recipients With an Increased 10-year Coronary Heart Disease Risk"
          },
          "statusModule": {
            "overallStatus": "TERMINATED",
            "whyStopped": "Poor recruitment.",
            "studyFirstSubmitDate": "2010-09-28"
          },
          "conditionsModule": {
            "conditions": [
              "Kidney Transplantation",
              "Cardiovascular Diseases"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "The change in the Framingham 10-yr age and gender adjusted score for coronary heart disease from baseline to Month 6",
                "timeFrame": "Baseline to Month 6"
              },
              {
                "measure": "The incidence of a composite of acute rejection (clinically suspected and biopsy-proven), graft loss or patient death.",
                "timeFrame": "Month 6"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Framingham point total"
              },
              {
                "measure": "Day and night blood pressure"
              },
              {
                "measure": "Glucose metabolism"
              },
              {
                "measure": "Lipid metabolism"
              },
              {
                "measure": "Change in renal function"
              },
              {
                "measure": "Adverse cardiovascular events"
              },
              {
                "measure": "Highly-sensitive C-reactive protein (CRP) level"
              },
              {
                "measure": "Change in other biomarkers of cardiovascular risk"
              },
              {
                "measure": "Incidence of MMF-attributable adverse events"
              },
              {
                "measure": "Additional treatment with cardiovascular co-interventions"
              },
              {
                "measure": "Opportunistic infections"
              },
              {
                "measure": "Malignancies"
              },
              {
                "measure": "Adverse events"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00965094",
            "briefTitle": "Efficacy and Safety of Everolimus+EC-MPS After Early CNI Elimination vs EC-MPS +Tacrolimus in Renal Transplant Recipients",
            "officialTitle": "Efficacy and Safety of Certican\u00ae (Everolimus) in Combination With Myfortic\u00ae (EC-MPS, Enteric-coated Mycophenolate Sodium) After Early CNI Elimination Versus Myfortic\u00ae in Combination With Prograf\u00ae in Renal Transplant Recipients"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2009-08-24",
            "resultsFirstSubmitDate": "2014-05-30"
          },
          "conditionsModule": {
            "conditions": [
              "Chronic Renal Failure"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Renal Function Assessed as Glomerula Filtration Rate (GFR) - Nankivell Method - 9 Months After Renal Transplantation (LOCF)",
                "timeFrame": "9 months"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Assessment of GFR by the Cockcroft-Gault Method (LOCF)"
              },
              {
                "measure": "Participants Who Had Occurrence of Biopsy Proven Acute Rejection, Graft Loss or Death."
              },
              {
                "measure": "Participants Who Had Occurrence of Treatment Failure."
              },
              {
                "measure": "Change in Renal Function (Creatinine Slope)"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00240994",
            "briefTitle": "Safety in Immunomodulatory Functions of Alemtuzumab (Campath) in Pediatric Kidney Transplantation Recipients",
            "officialTitle": "A Phase II Exploratory Study to Determine the Safety and Study the Immunomodulatory Functions of Induction Therapy With Campath, Combined With Chronic Immunosuppression With Mycophenolate Mofetil and Sirolimus"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2005-10-14",
            "resultsFirstSubmitDate": "2012-09-13"
          },
          "conditionsModule": {
            "conditions": [
              "Kidney Failure, Chronic",
              "Kidney Transplantation",
              "Immunosuppression"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "The Proportion of Participants With Graft Loss or Death Within 12 Months Post Kidney Transplantation",
                "timeFrame": "Up to one year post kidney transplantation procedure"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01195194",
            "briefTitle": "Selection of Immunosuppression in Kidney Transplant Recipients Depending on Pre-transplant Donor-specific T-cell Reactivity.",
            "officialTitle": "Pilot Study of Selection of Either Calcineurin Inhibitor(CNI)-Based or CNI-free Immunosuppressive Regimen Depending on the Result of Pre-transplantation Donor-specific T-cell Reactivity Measured by Enzyme-linked Immunosorbent Spot(ELISPOT) in Standard-risk Kidney Recipients."
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2010-04-19"
          },
          "conditionsModule": {
            "conditions": [
              "Disorder Related to Renal Transplantation"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Percentage of biopsy-confirmed acute rejection episodes",
                "timeFrame": "6 months"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Percentage of steroid-sensitive acute rejection episodes"
              },
              {
                "measure": "Percentage of acute rejection episodes requiring treatment with antilymphocyte antibodies."
              },
              {
                "measure": "Renal function estimated by Modification of Diet in Renal Disease (MDRD) formula."
              },
              {
                "measure": "Proteinuria measured in g/day"
              },
              {
                "measure": "Histology at month 6 protocol kidney allograft biopsy"
              },
              {
                "measure": "Percentage of patients with negative ELISPOT"
              },
              {
                "measure": "Percentage of patients in group A requiring CNI introduction."
              },
              {
                "measure": "Percentage of patients presenting adverse events requiring study withdrawal"
              },
              {
                "measure": "Percentage of biopsy-confirmed acute rejection episodes"
              },
              {
                "measure": "Percentage of steroid-sensitive acute rejections rejection episodes"
              },
              {
                "measure": "Percentage of acute rejection episodes requiring treatment with antilymphocyte antibodies"
              },
              {
                "measure": "Proteinuria measured in g/day"
              },
              {
                "measure": "Percentage of patients with negative ELISPOT"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01686191",
            "briefTitle": "Genetic Predictors of Renal Dysfunction Following Heart Transplantation",
            "officialTitle": "Pharmacogenomics of Calcineurin Inhibitor Nephrotoxicity in Cardiac Transplantation"
          },
          "statusModule": {
            "overallStatus": "ACTIVE_NOT_RECRUITING",
            "studyFirstSubmitDate": "2012-09-12"
          },
          "conditionsModule": {
            "conditions": [
              "Heart Transplantation",
              "Chronic Renal Insufficiency"
            ]
          },
          "designModule": {
            "studyType": "OBSERVATIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Chronic renal dysfunction",
                "timeFrame": "year 2 post-transplant"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT03978494",
            "briefTitle": "Study to Compare Pharmacokinetics of Tacrolimus Prolonged-release (PR) Capsules and Advagraf\u00ae PR Capsules in Stable Kidney Transplant Patients.",
            "officialTitle": "Randomized, Multicenter, Open-Label, Two-period, Two-sequence Crossover Comparative Pharmacokinetic Study of Generic Tacrolimus (Sandoz) and Advagraf\u00ae in Stable Renal Transplant Patients (TODAY)"
          },
          "statusModule": {
            "overallStatus": "WITHDRAWN",
            "whyStopped": "company decision",
            "studyFirstSubmitDate": "2019-06-05"
          },
          "conditionsModule": {
            "conditions": [
              "Kidney Transplant"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "AUC(0-\u03c4)ss",
                "timeFrame": "Day 21 of each treatment period"
              },
              {
                "measure": "Cmax,ss",
                "timeFrame": "Day 21 of each treatment period"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "AUC(0-\u03c4)ss"
              },
              {
                "measure": "Cmax,ss"
              },
              {
                "measure": "Cmin,ss"
              },
              {
                "measure": "C\u03c4,ss"
              },
              {
                "measure": "Cav"
              },
              {
                "measure": "Tmax,ss"
              },
              {
                "measure": "AUC(0-\u03c4)ss coefficient of variation"
              },
              {
                "measure": "Cmax,ss coefficient of variation"
              },
              {
                "measure": "% Fluctuation"
              },
              {
                "measure": "%Swing"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00134394",
            "briefTitle": "Etanercept With Tacrolimus for Psoriasis",
            "officialTitle": "Double-Blind, Placebo-Controlled, Bilateral Comparison of Topical Tacrolimus 0.1% vs. Placebo Ointment as Adjunctive Therapy for Patients With Moderate to Severe Psoriasis Who Are Candidates for or Poor Responders to Etanercept Therapy"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2005-08-22"
          },
          "conditionsModule": {
            "conditions": [
              "Psoriasis"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Target lesion scoring (on a scale of 0-12) at week 12"
              },
              {
                "measure": "The percentage of lesions having scores of < 2 in the topical tacrolimus and vehicle-treated sites will be assessed."
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Photography of target lesions"
              },
              {
                "measure": "Quarter-body photography"
              },
              {
                "measure": "Static Physician's Global Assessment (PGA) on each side of each subject's body"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02377791",
            "briefTitle": "Impact of CYP3A5 Gene Polymorphisms on Tacrolimus Concentrations and Outcomes in Thai Transplant Recipients",
            "officialTitle": "Impact of CYP3A5 Genetic Polymorphisms on Tacrolimus Concentration and Transplant Outcomes During The Early Stage Post-Transplantation in Thai Kidney Transplant Recipients"
          },
          "statusModule": {
            "overallStatus": "UNKNOWN",
            "studyFirstSubmitDate": "2015-02-26"
          },
          "conditionsModule": {
            "conditions": [
              "Kidney Transplant"
            ]
          },
          "designModule": {
            "studyType": "OBSERVATIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Trough tacrolimus blood concentration to dose ratio",
                "timeFrame": "3 days after transplant"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Proportion achieved the target trough blood concentration within the first week"
              },
              {
                "measure": "Acute rejection rate"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT03360682",
            "briefTitle": "Clinical Trial to Evaluate the Efficacy, Pharmacokinetics (PK) Interactions and Safety of Dolutegravir Plus 2 Nucleoside Reverse Transcriptase Inhibitors (NRTIs) in HIV-1-Infected Solid Organ Transplant Patients",
            "officialTitle": "Pilot Single-Arm Clinical Trial to Evaluate the Efficacy, PK Interactions and Safety of Dolutegravir Plus 2 NRTIs in HIV-1-Infected Solid Organ Transplant Patients"
          },
          "statusModule": {
            "overallStatus": "UNKNOWN",
            "studyFirstSubmitDate": "2017-10-30"
          },
          "conditionsModule": {
            "conditions": [
              "HIV-1-infection",
              "Solid Organ Transplant"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Pharmacokinetic study",
                "timeFrame": "24-hours before the switch and 24-hours 2 weeks after switching"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Viral resistance"
              },
              {
                "measure": "Changes in CD4+ cell"
              },
              {
                "measure": "Lipid profile"
              },
              {
                "measure": "Renal function"
              },
              {
                "measure": "Safety: number AEs and SAEs"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01927120",
            "briefTitle": "In Vivo Treg Expansion and Graft-Versus-Host Disease Prophylaxis",
            "officialTitle": "In Vivo Treg Expansion and Graft-Versus-Host Disease Prophylaxis With IL-2, Sirolimus, and Tacrolimus Following Allogeneic Hematopoietic Cell Transplantation"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2013-08-16",
            "resultsFirstSubmitDate": "2017-04-18"
          },
          "conditionsModule": {
            "conditions": [
              "Graft-Versus-Host-Disease"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Regulatory T Cells (Tregs)/Total CD4+ Cells at Day 30 Post-HCT",
                "timeFrame": "30 days post HCT"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Overall Survival at Day +365"
              },
              {
                "measure": "Cumulative Incidence of Relapse"
              },
              {
                "measure": "Cumulative Incidence of Grade II-IV Acute GVHD by Day +100"
              },
              {
                "measure": "Cumulative Incidence of Chronic GVHD by Day +365"
              },
              {
                "measure": "Incidence of Non-relapse Death"
              },
              {
                "measure": "Incidence of Unexpected or Serious Adverse Events (AEs)"
              },
              {
                "measure": "Proportion of Treg Among Blood CD4+ T Cells at Day +90 After HCT"
              },
              {
                "measure": "STAT3, STAT5 (Y694), and S6 Phosphorylation Among Treg and Non-Treg at Day 30"
              },
              {
                "measure": "STAT3, STAT5 (Y694), and S6 Phosphorylation Among Treg and Non-Treg at Day 90"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00706420",
            "briefTitle": "Islet Transplantation Alone (ITA) in Patients With Difficult to Control Type I Diabetes Mellitus Using a Glucocorticoid-free Immunosuppressive Regimen",
            "officialTitle": "Islet Transplantation Alone (ITA) in Patients With Difficult to Control Type I Diabetes Mellitus Using a Glucocorticoid-free Immunosuppressive Regimen"
          },
          "statusModule": {
            "overallStatus": "ACTIVE_NOT_RECRUITING",
            "studyFirstSubmitDate": "2008-06-25"
          },
          "conditionsModule": {
            "conditions": [
              "Diabetes Mellitus"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Percent of subjects who have achieved insulin independence post transplant.",
                "timeFrame": "3, 6, 12, and 24 months"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Stimulated C-peptide response >0.6 ng/ml"
              },
              {
                "measure": "Insulin use </=0.2units/kg/day"
              },
              {
                "measure": "Reduction/elimination of hypoglycemic episodes"
              },
              {
                "measure": "HgAlc</= 6.5%"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00659620",
            "briefTitle": "Mesenchymal Stem Cell Transplantation in the Treatment of Chronic Allograft Nephropathy",
            "officialTitle": "Mesenchymal Stem Cell Transplantation in the Treatment of Chronic Allograft Nephropathy"
          },
          "statusModule": {
            "overallStatus": "UNKNOWN",
            "studyFirstSubmitDate": "2008-04-14"
          },
          "conditionsModule": {
            "conditions": [
              "Kidney Transplant",
              "Chronic Allograft Nephropathy"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Creatinine and creatinine clearance rate",
                "timeFrame": "5"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Patient and graft survival [ Time Frame: At 1 years post-transplant ]."
              },
              {
                "measure": "The proportion of renal biopsy after 12 months"
              },
              {
                "measure": "The incidence of infectious complications"
              },
              {
                "measure": "Incidence of adverse events associated with MSC and immunosuppression"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02953873",
            "briefTitle": "Dosing Requirements of Astagraf XL\u00ae in African American Kidney Transplant Recipients",
            "officialTitle": "Dosing Requirements of Astagraf XL\u00ae in African American Kidney Transplant Recipients Converted From Twice-daily Tacrolimus"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2016-11-01",
            "resultsFirstSubmitDate": "2019-08-30"
          },
          "conditionsModule": {
            "conditions": [
              "Immunosuppression"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Dose-normalized Trough",
                "timeFrame": "Baseline to 3 months post-conversion"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Total Daily Dose"
              },
              {
                "measure": "Weight-Based Dose Requirement"
              },
              {
                "measure": "Number of Days to Reach Therapeutic Trough Goal"
              },
              {
                "measure": "Dose Modifications"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00970073",
            "briefTitle": "Low Dose Thymoglobulin to Protect Kidney Function After Liver Transplant",
            "officialTitle": "A Randomized Controlled Clinical Trial of Low Dose Thymoglobulin and Extended Delay of Calcineurin Inhibitor Therapy for Renal Protection After Liver Transplantation"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2009-08-31",
            "resultsFirstSubmitDate": "2018-06-12"
          },
          "conditionsModule": {
            "conditions": [
              "Liver Transplantation"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Estimated Glomerular Filtration Rate (eGFR) at 12 Months Post-surgery",
                "timeFrame": "12 Months"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Patient Survival"
              },
              {
                "measure": "Graft Survival"
              },
              {
                "measure": "Allograft Rejection Rates at 30 Days"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00716573",
            "briefTitle": "Efficacy Study of Everolimus on Renal Function in Heart Transplant Recipients With Established Chronic Renal Failure",
            "officialTitle": "COREV : A Multi-center, Randomized, Open-label Study Evaluating the Efficacy on Renal Function of Everolimus in Heart Transplant Recipients With Established Chronic Renal Failure"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2008-07-15"
          },
          "conditionsModule": {
            "conditions": [
              "Cardiac Transplantation",
              "Chronic Renal Insufficiency"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Evaluation of the renal function, at 12 months after everolimus introduction and doses of anticalcineurins decrease.",
                "timeFrame": "12 months"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Evaluation of the benefit of everolimus introduction on renal function at 24 months"
              },
              {
                "measure": "Evaluation of the benefit of everolimus introduction on incidence of Major Adverse Cardiac Events (MACEs)"
              },
              {
                "measure": "Evaluation of the benefit of everolimus introduction on incidence of cardiovascular risk factor (Arterial Tension, diabetes, dyslipidemia, proteinuria)"
              },
              {
                "measure": "Evaluation of the benefit of everolimus introduction on incidence of treatment withdrawals"
              },
              {
                "measure": "Evaluation of the benefit of everolimus introduction on incidence of treated acute rejection"
              },
              {
                "measure": "Evaluation of the benefit of everolimus introduction on safety"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01609673",
            "briefTitle": "Study of Everolimus in de Novo Renal Transplant Recipients",
            "officialTitle": "Evaluation of the Early Conversion From a Calcineurin Inhibitor-based Immunosuppressive Regimen to Everolimus in de Novo Renal Transplant Recipients, a Multicenter Experience"
          },
          "statusModule": {
            "overallStatus": "TERMINATED",
            "whyStopped": "The inclusion of proposed sample turned to be infeasible due to Ethical Non-approval of 2 research sites and another site no transplant activity since 2012.",
            "studyFirstSubmitDate": "2012-05-24"
          },
          "conditionsModule": {
            "conditions": [
              "End Stage Renal Failure With Renal Transplant"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Change in estimated glomerular filtration rate (eGFR)",
                "timeFrame": "4-5 months after transplantation (baseline), and then 6 and 12 months after conversion to everolimus"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "graft acute rejection"
              },
              {
                "measure": "Laboratory results and clinical alterations"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT03234673",
            "briefTitle": "The Effect of Fractional Co2 Laser Either With Tacrolimus, Calcipotriol or NB-UVB in Stable Generalized Vitiligo",
            "officialTitle": "The Effect of Preceding Fractional Co2 Laser Either With Tacrolimus, Calcipotriol or With NB-UVB in the Treatment of Stable Generalized Vitiligo"
          },
          "statusModule": {
            "overallStatus": "UNKNOWN",
            "studyFirstSubmitDate": "2017-07-27"
          },
          "conditionsModule": {
            "conditions": [
              "Vitiligo Vulgaris"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "1- Re-pigmentation : that will be subjectively rated with a previously reported scoring system (Ghiya et al., 2016).",
                "timeFrame": "up to 3 months"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "The VASI percent change"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT06235892",
            "briefTitle": "Tacrolimus Minimization in Kidney Transplant Recipients Selected According to the AGORA Algorithm for Their Low Immunological Risk and Medium-term Graft Failure",
            "officialTitle": "Prospective, Multicenter, Randomized, Open-label, Parallel-group Controlled Phase 3 Study of Tacrolimus Minimization in Kidney Transplant Recipients Selected According to the AGORA Algorithm for Their Low Immunological Risk and Medium-term Graft Failure"
          },
          "statusModule": {
            "overallStatus": "RECRUITING",
            "studyFirstSubmitDate": "2024-01-23"
          },
          "conditionsModule": {
            "conditions": [
              "Organ Grafts"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Improvement of the renal function at 18 months after \"ultra\" minimization of Tacrolimus",
                "timeFrame": "Month 18"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Incidence of biopsy-proven acute rejection (BPAR) according to the 2017 Banff classification (including borderline lesions)"
              },
              {
                "measure": "Type, severity and treatment of biopsy-proven acute rejection ( BPAR)"
              },
              {
                "measure": "Appearance of de novo donor-specific alloantibody (DSA) (4 digits and MFI treshold >500)"
              },
              {
                "measure": "Appearance or worsening of histological lesions of interstitial fibrosis and inflammatory tubular atrophy (IFTA) of study biopsy by considering that only patients with normal histology or with an IFTA-1 or 2will be randomized"
              },
              {
                "measure": "Prevalence of death, and graft loss (dialysis start or retransplantation) at end of study"
              },
              {
                "measure": "Prevalence of metabolic disorders: post-transplant diabetes mellitus (PTDM), dyslipidaemia and hypertension at end of study"
              },
              {
                "measure": "Treatment adherence consisting in monitoring immunosuppression adherence using Trackyourmed\u00ae to monitor individual variability tacrolimus intake"
              },
              {
                "measure": "Change in quality of life estimated using the EQ-5D ( EuroQol instrument - dimensions) questionnaire fulfilled by patients at baseline, Month 3, Month 6, Month 9, Month 12, Month15 and Month18"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT05277792",
            "briefTitle": "Dosage of Tacrolimus Metabolites in Blood and Bile for Prediction of Its Side Effects in Liver Transplant Recipients",
            "officialTitle": "Dosage of Tacrolimus Metabolites in Blood and Bile for Prediction of Its Side Effects in Liver Transplant Recipients"
          },
          "statusModule": {
            "overallStatus": "RECRUITING",
            "studyFirstSubmitDate": "2022-03-03"
          },
          "conditionsModule": {
            "conditions": [
              "Blood Concentration of Tacrolimus Metabolites"
            ]
          },
          "designModule": {
            "studyType": "OBSERVATIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Comparison of blood concentration of TAC metabolites between patients presenting TAC related side effects or not.",
                "timeFrame": "Day 5"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT04384692",
            "briefTitle": "Peritransplant Ruxolitinib for Patients With Primary and Secondary Myelofibrosis",
            "officialTitle": "Peritransplant Ruxolitinib for Patients With Primary and Secondary Myelofibrosis"
          },
          "statusModule": {
            "overallStatus": "RECRUITING",
            "studyFirstSubmitDate": "2020-05-08"
          },
          "conditionsModule": {
            "conditions": [
              "Primary Myelofibrosis",
              "Secondary Myelofibrosis"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Incidence of grade II-IV graft versus host disease (GVHD) in myelofibrosis patients",
                "timeFrame": "Up to day 100"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Incidence of grade III-IV GVHD"
              },
              {
                "measure": "Incidence of chronic GVHD"
              },
              {
                "measure": "Overall survival rate (OS)"
              },
              {
                "measure": "Incidence of primary and secondary graft failure"
              },
              {
                "measure": "Time to neutrophil (ANC > 500) engraftment"
              },
              {
                "measure": "Time to platelet (> 20,000) engraftment"
              },
              {
                "measure": "Incidence of relapse"
              },
              {
                "measure": "Non-relapse mortality (NRM)"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00927992",
            "briefTitle": "Study Evaluating Liver Transplantation in Haemophilia Patients in Spain",
            "officialTitle": "Liver Transplantation in Haemophilia Patients in Spain"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2009-06-24",
            "resultsFirstSubmitDate": "2012-12-20"
          },
          "conditionsModule": {
            "conditions": [
              "Hemophilia",
              "Hemophilia B"
            ]
          },
          "designModule": {
            "studyType": "OBSERVATIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Number of Participants Requiring Immunosuppressive Therapy After Liver Transplantation",
                "timeFrame": "Post liver transplantation up to Month 3"
              },
              {
                "measure": "Number of Participants With Acute Rejection of Liver Transplant",
                "timeFrame": "Post liver transplantation up to Month 3"
              },
              {
                "measure": "Number of Participants With Hepatitis C Viral Infection Recurrence After Liver Transplantation",
                "timeFrame": "Post liver transplantation up to Month 3"
              },
              {
                "measure": "Number of Participants Who Survived After Liver Transplantation",
                "timeFrame": "Post liver transplantation up to Month 3"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Number of Participants Requiring Exogenous Clotting Factor Infusion During Liver Transplantation"
              },
              {
                "measure": "Dose of Exogenous Clotting Factors Used During Liver Transplantation"
              },
              {
                "measure": "Number of Participants With and Without Hemophilia Requiring Immunosuppressive Therapy, Had Acute Rejection, Hepatitis C Viral Infection Recurrence and Who Survived After Liver Transplantation"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02062892",
            "briefTitle": "Differentiating Everolimus Versus Sirolimus in Combination With Calcineurin Inhibitors in Kidney Transplant Patients",
            "officialTitle": "Differentiating Sirolimus and Everolimus in Combination With Calcineurin Inhibitors in Long-term Maintenance of Kidney Transplant Patients - The Effects on Vascular Endothelial and Kidney Function. The DESIRE Study."
          },
          "statusModule": {
            "overallStatus": "WITHDRAWN",
            "whyStopped": "Patients meeting the inclusion/ exclusion criteria did not agree to participate. It became obvious that recruitment goals could not be met.",
            "studyFirstSubmitDate": "2014-02-11"
          },
          "conditionsModule": {
            "conditions": [
              "Kidney Transplantation"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Creatinine Outcome Measure (1)",
                "timeFrame": "1 year"
              },
              {
                "measure": "Calculated Glomerular Filtration Rate (1)",
                "timeFrame": "1 year"
              },
              {
                "measure": "Calculated Glomerular Filtration Rate (2)",
                "timeFrame": "2 years"
              },
              {
                "measure": "Kidney Injury Molecule-1 (1)",
                "timeFrame": "1 year"
              },
              {
                "measure": "Kidney Injury Molecule-1 (2)",
                "timeFrame": "2 years"
              },
              {
                "measure": "S-Adenosylhomocysteine Hydrolase (1)",
                "timeFrame": "1 year"
              },
              {
                "measure": "S-Adenosylhomocysteine Hydrolase (2)",
                "timeFrame": "2 years"
              },
              {
                "measure": "S-Adenosylmethionine (1)",
                "timeFrame": "1 year"
              },
              {
                "measure": "S-Adenosylmethionine (2)",
                "timeFrame": "2 years"
              },
              {
                "measure": "Creatinine Outcome Measure (2)",
                "timeFrame": "2 years"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "12-Hydroxyeicosatetraenoic acid (1)"
              },
              {
                "measure": "12-Hydroxyeicosatetraenoic acid (2)"
              },
              {
                "measure": "20-Hydroxyeicosatetraenoic acid (1)"
              },
              {
                "measure": "20-Hydroxyeicosatetraenoic acid (2)"
              },
              {
                "measure": "18- Hydroxyeicosapentaenoic acid (1)"
              },
              {
                "measure": "18- Hydroxy- eicosapentaenoic acid (2)"
              },
              {
                "measure": "Ornithine (1)"
              },
              {
                "measure": "Ornithine (2)"
              },
              {
                "measure": "Arginine (1)"
              },
              {
                "measure": "Arginine (2)"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT05646992",
            "briefTitle": "Uterus Transplantation to Treat Infertility",
            "officialTitle": "OPRTUNTI: Offering Potential for Reproduction Through Transplantation of Uterus iN the Treatment of Infertility"
          },
          "statusModule": {
            "overallStatus": "RECRUITING",
            "studyFirstSubmitDate": "2022-12-02"
          },
          "conditionsModule": {
            "conditions": [
              "Uterine Factor Infertility"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Successful delivery of viable baby",
                "timeFrame": "Uterus transplantation to 5 years post uterus transplantation"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Number of hazardous drinkers as assessed by Alcohol Use Disorders Identification Test-Concise (AUDIT-C)"
              },
              {
                "measure": "Stress as assessed by the Brief Coping Orientation to Problems Experienced (COPE)"
              },
              {
                "measure": "Resilience as assessed by the Connor Davidson Resilience Scale (CD-RISC)-10"
              },
              {
                "measure": "Relationship quality as assessed by the Dyadic Adjustment Scale (DAS) [if having child with a partner]"
              },
              {
                "measure": "Drug use as assessed by the Drug Abuse Screening Test (DAST) 10 Drug Use Questionnaire"
              },
              {
                "measure": "Depression as assessed by the Patient Health Questionnaire (PHQ-9)"
              },
              {
                "measure": "Overall health status as assessed by the Medical Outcome Study Short Form-36 (SF-36)"
              },
              {
                "measure": "PTSD as assessed by the Posttraumatic Stress Disorder Checklist (PCL-5 PTSD Checklist)"
              },
              {
                "measure": "Anxiety as assessed by the General Anxiety Disorder (GAD)-7"
              },
              {
                "measure": "Positive outcomes as assessed by the Post-Traumatic Growth Inventory (PTGI)"
              },
              {
                "measure": "Life satisfaction as assessed by the Psychological Measures by Satisfaction with Life Scale (SWLS)"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00579592",
            "briefTitle": "Campath, Rituximab, and Myfortic With Short-Course Calcineurin Inhibitor Therapy in Renal Transplanation",
            "officialTitle": "A Pilot Study of Campath-1H Induction Therapy Combined With Rituximab\u00ae, Myfortic\u2122 and a Short Course of Calcineurin Inhibitor Therapy to Allow for a Long Term Calcineurin Inhibitor Free Regimen After Renal Transplantation"
          },
          "statusModule": {
            "overallStatus": "TERMINATED",
            "whyStopped": "Higher than expected rate of acute rejection",
            "studyFirstSubmitDate": "2007-12-17"
          },
          "conditionsModule": {
            "conditions": [
              "Acute Rejection",
              "Renal Transplantation"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "renal function",
                "timeFrame": "2 years"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "hypertension"
              },
              {
                "measure": "drug side effects"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02918292",
            "briefTitle": "Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)",
            "officialTitle": "Optimizing Haploidentical Aplastic Anemia Transplantation (CHAMP) (BMT CTN 1502)"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2016-09-27",
            "resultsFirstSubmitDate": "2022-04-29"
          },
          "conditionsModule": {
            "conditions": [
              "Severe Aplastic Anemia"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Percentage of Participants With Overall Survival (OS)",
                "timeFrame": "1 year"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Percentage of Participants With Neutrophil Recovery"
              },
              {
                "measure": "Percentage of Participants With Platelet Recovery"
              },
              {
                "measure": "Participants Alive With Sustained Engraftment"
              },
              {
                "measure": "Percentage of Participants With Graft-Failure-Free Survival"
              },
              {
                "measure": "Percentage of Participants With Primary Graft Failure"
              },
              {
                "measure": "Percentage of Participants With Secondary Graft Failure"
              },
              {
                "measure": "Participants Alive With Autologous Recovery"
              },
              {
                "measure": "Percentage of Participants With Acute Graft-vs-host-disease (GVHD)"
              },
              {
                "measure": "Participants With Maximum Acute GVHD"
              },
              {
                "measure": "Percentage of Participants With Chronic GVHD"
              },
              {
                "measure": "Number of Participants Experiencing Chronic GVHD With Maximum Severity"
              },
              {
                "measure": "Immune Reconstitution of Flow Cytometry"
              },
              {
                "measure": "Immune Reconstitution of Quantitative Immunoglobulins"
              },
              {
                "measure": "Participants With Infections of Maximum Grade 2 and Grade 3"
              },
              {
                "measure": "Frequencies of Infections Categorized by Infection Type"
              },
              {
                "measure": "Percentage of Participants With Cytomegalovirus (CMV), Epstein Barr Virus (EBV) or Post-Transplant Lymphoproliferative Disease (PTLD)"
              },
              {
                "measure": "Participants With Grade 3-5 Toxicities by SOC"
              },
              {
                "measure": "Health Related Quality of Life (HR-QoL) - Medical Outcomes Study Short Form (MOS SF-36)"
              },
              {
                "measure": "Health Related Quality of Life (HR-QoL) - PedsQL Stem Cell Transplant Module"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT03558373",
            "briefTitle": "The Adherence of Immunosuppressive Therapy Including Tacrolimus Once-daily in Italian Kidney Transplant Recipients",
            "officialTitle": "The Adherence of Immunosuppressive Therapy Including Tacrolimus Once Daily in a Cohort of Kidney Transplant Recipients: an Italian Prospective Observational Study"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2018-05-28"
          },
          "conditionsModule": {
            "conditions": [
              "Kidney Transplant"
            ]
          },
          "designModule": {
            "studyType": "OBSERVATIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Non aderence",
                "timeFrame": "6 months"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "BMQ score"
              },
              {
                "measure": "ACCEPT score"
              },
              {
                "measure": "BAASIS evaluation"
              },
              {
                "measure": "Patients characteristics"
              },
              {
                "measure": "Clinical informations as for clinical practice"
              },
              {
                "measure": "Immunosuppressive treatments"
              },
              {
                "measure": "Rejections"
              },
              {
                "measure": "Graft failure"
              },
              {
                "measure": "Adverse events"
              },
              {
                "measure": "Infections"
              },
              {
                "measure": "Healthcare cost"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02627573",
            "briefTitle": "Trial of GVHD Prophylasxis With PTCy or Thymoglobulin in Unrelated SCT",
            "officialTitle": "Randomized Trial of GVHD Prophylasxis With Post-transplantation Cyclophocphomide (PTCy) or Thymoglobulin in Unrelated SCT Recepients With Chronic Myeloproliferative Neoplasms and Myelodisplatic Syndrome"
          },
          "statusModule": {
            "overallStatus": "TERMINATED",
            "whyStopped": "Poor recruitment",
            "studyFirstSubmitDate": "2015-12-04"
          },
          "conditionsModule": {
            "conditions": [
              "Leukemia, Chronic Myeloid",
              "Myelodysplastic Syndromes",
              "Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Incidence of primary graft failure",
                "timeFrame": "60 days"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Incidence of acute GVHD, grades II-IV"
              },
              {
                "measure": "Incidence of chronic GVHD, moderate and severe (NIH criteria)"
              },
              {
                "measure": "Non-relapse mortality analysis"
              },
              {
                "measure": "Event-free survival analysis"
              },
              {
                "measure": "Overall survival analysis"
              },
              {
                "measure": "Relapse rate analysis"
              },
              {
                "measure": "Toxicity (NCI CTCAE 4.03)"
              },
              {
                "measure": "Infectious complications, including analysis of severe bacterial, fungal and viral infections incidence"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01327573",
            "briefTitle": "Eculizumab Therapy for Chronic Complement-Mediated Injury in Kidney Transplantation",
            "officialTitle": "Eculizumab Therapy for Chronic Complement-Mediated Injury in Kidney Transplantation: A Randomized, Open-Label, Pilot Intervention Trial"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2011-03-30",
            "resultsFirstSubmitDate": "2016-07-20"
          },
          "conditionsModule": {
            "conditions": [
              "Kidney; Complications, Allograft"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Baseline eGFR (Estimated Glomerular Filtration Rate)",
                "timeFrame": "Baseline"
              },
              {
                "measure": "Estimated Glomerular Filtration Rate (eGFR) at Months 2,3,4,5,6",
                "timeFrame": "Months 2,3,4,5,6"
              },
              {
                "measure": "Group Difference Percentage Change in 6-month Estimated Glomerular Filtration Rate (eGFR)",
                "timeFrame": "6 months"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT04963673",
            "briefTitle": "Evaluation of Interaction Between Immunosuppressive Drugs and Protein-bound Uremic Toxins in Renal Transplant Patients",
            "officialTitle": "Evaluation of Interaction Between Immunosuppressive Drugs and Protein-bound Uremic Toxins in Renal Transplant Patients"
          },
          "statusModule": {
            "overallStatus": "WITHDRAWN",
            "whyStopped": "no participants enrolled",
            "studyFirstSubmitDate": "2021-07-06"
          },
          "conditionsModule": {
            "conditions": [
              "Kidney Transplant",
              "Immunosuppression",
              "Uremic; Toxemia"
            ]
          },
          "designModule": {
            "studyType": "OBSERVATIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "plasma tacrolimus concentration without plasma uremic toxin adjustment",
                "timeFrame": "at day 0"
              },
              {
                "measure": "plasma tacrolimus concentration with plasma uremic toxin adjustment",
                "timeFrame": "at day 0"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "plasma ciclosporin concentration without plasma uremic toxin adjustment"
              },
              {
                "measure": "plasma ciclosporin concentration with plasma uremic toxin adjustment"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00615173",
            "briefTitle": "Prospective, Randomized, Multicenter, Control Study to Assess the Efficacy and Safety of Tacrolimus in Induction and Maintenance Phase Treatment in Lupus Nephritis"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2008-02-01"
          },
          "conditionsModule": {
            "conditions": [
              "Kidney Diseases",
              "Lupus Nephritis",
              "Tacrolimus",
              "Induction Phase",
              "Maintenance Phase"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Remission rate",
                "timeFrame": "2006-2008"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Renal function, proteinuria, relapse."
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00525876",
            "briefTitle": "Non-Myeloablative Allogeneic Stem Cell Transplantation",
            "officialTitle": "Allogeneic Stem Cell Transplantation With Rituximab Containing Nonablative Conditioning Regimen for Advanced/Recurrent Mantle Cell Lymphoma"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2007-09-04",
            "resultsFirstSubmitDate": "2011-11-02"
          },
          "conditionsModule": {
            "conditions": [
              "Lymphoma"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Overall Survival at 100 Days Post Transplant (Number of Surviving Participants)",
                "timeFrame": "100 days post transplant"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01754389",
            "briefTitle": "Standard of Care vs. Bortezomib in Graft-Versus Host Disease After Hematopoietic Stem Cell Transplant",
            "officialTitle": "A 3-Arm Randomized Phase II Study of Standard-of-Care vs. Bortezomib Based Graft-Versus-Host Disease Regimen for Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation Patients Lacking HLA-matched Related Donors"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2012-12-13",
            "resultsFirstSubmitDate": "2017-05-22"
          },
          "conditionsModule": {
            "conditions": [
              "Graft Versus Host Disease"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Percentage of Participants With Incidence of Grade II-IV GVHD",
                "timeFrame": "6 months"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Percentage of Participants With Non-relapse Mortality"
              },
              {
                "measure": "Percentage of Participants With Relapse"
              },
              {
                "measure": "Percentage of Participants With Progression-free and Overall Survival"
              },
              {
                "measure": "Percentage of Participants With Chronic Graft Versus Host Disease"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01453192",
            "briefTitle": "Renal Transplantation and Raltegravir in HIV-Infected Patients",
            "officialTitle": "National, Multicenter, Phase III Prospective Trial About Clinical and Immunological Follow-up After Renal Transplantation in HIV-1 Infected Patients With End Stage Chronic Renal Insufficiency"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2011-10-03"
          },
          "conditionsModule": {
            "conditions": [
              "HIV-1 Infection",
              "Chronic Renal Insufficiency"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Incidence of acute clinical renal graft rejection",
                "timeFrame": "6 months"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Incidence of acute clinical and subclinical renal graft rejection"
              },
              {
                "measure": "One year graft survival"
              },
              {
                "measure": "Patients' survival"
              },
              {
                "measure": "Phenotyping of lymphocytic infiltrates in case of acute rejection"
              },
              {
                "measure": "Incidence of AIDS defined diseases and severe morbidity diseases after renal transplantation"
              },
              {
                "measure": "Immunological and virologic status after renal transplantation"
              },
              {
                "measure": "Evaluation of the switch by raltegravir at the time of renal transplantation"
              },
              {
                "measure": "Viral load control after switch by antiretroviral treatment including raltegravir after renal transplantation"
              },
              {
                "measure": "Survival and waiting period of HIV patients registered on French biomedicine agency for renal transplantation"
              },
              {
                "measure": "Measurement of Area under plasma concentration (AUC) variability of immunosuppressive drugs after introduction of antiretroviral regimen containing Raltegravir"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01913392",
            "briefTitle": "Effect of Laparoscopic Sleeve Gastrectomy in the Morbidly Obese, Kidney Transplant Candidate",
            "officialTitle": "Prospective, Clinical Study of the Effect of Bariatric Surgery, Laparoscopic Sleeve Gastrectomy, on the Pharmacokinetics of Immunosuppressive Drugs in the Morbidly Obese, Kidney Transplant Candidate"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2013-07-30"
          },
          "conditionsModule": {
            "conditions": [
              "Obesity, Morbid",
              "Transplant; Failure, Kidney"
            ]
          },
          "designModule": {
            "studyType": "OBSERVATIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "changes in the pharmacokinetics of oral immunosuppressive medications due to bariatric surgery, comparing pre-bariatric surgery to 12 months post-operative",
                "timeFrame": "pre-bariatric surgery and 1 year after surgery"
              },
              {
                "measure": "degree of weight loss achieved after bariatric surgery in the chronic renal failure patient.",
                "timeFrame": "baseline and every 3 months"
              },
              {
                "measure": "Evaluate the change in general quality of life score, SF-36",
                "timeFrame": "Baseline and 1 year after bariatric surgery"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "evaluate changes to residual renal function in the pre-dialysis renal transplant candidate"
              },
              {
                "measure": "evaluate the change in the number and dose of medications required to treat co-morbidities including, hypertension, hyperlipidemia and diabetes mellitus"
              },
              {
                "measure": "the incidence of complications post-bariatric surgery will be evaluated"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT06832189",
            "briefTitle": "EVR and EPO for Liver Transplant Tolerance",
            "officialTitle": "Everolimus and Epoetin for Sustained Liver Transplant Tolerance (EVEREST)(ITN101ST)"
          },
          "statusModule": {
            "overallStatus": "NOT_YET_RECRUITING",
            "studyFirstSubmitDate": "2025-02-12"
          },
          "conditionsModule": {
            "conditions": [
              "Liver Transplant"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "The proportion of subjects free of opportunistic infection attributed to the investigational study regimen",
                "timeFrame": "At 52 weeks post-immunosuppression withdrawal (ISW)"
              },
              {
                "measure": "The proportion of subjects free of malignancy attributed to the investigational study regimen",
                "timeFrame": "At 52 weeks post-immunosuppression withdrawal (ISW)"
              },
              {
                "measure": "The proportion of subjects free of serious adverse events (SAEs) attributed to the investigational study regimen",
                "timeFrame": "At 52 weeks post-immunosuppression withdrawal (ISW)"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Incidence of acute rejection"
              },
              {
                "measure": "Severity of acute rejection"
              },
              {
                "measure": "Timing of acute rejection"
              },
              {
                "measure": "Incidence of chronic rejection"
              },
              {
                "measure": "Severity of chronic rejection"
              },
              {
                "measure": "Timing of chronic rejection"
              },
              {
                "measure": "Incidence of de novo class II donor specific antibody (DSA)"
              },
              {
                "measure": "Incidence of graft loss"
              },
              {
                "measure": "Incidence of all-cause mortality"
              },
              {
                "measure": "Incidence of study-related Serious Adverse Event (SAE)s"
              },
              {
                "measure": "Incidence of opportunistic infections"
              },
              {
                "measure": "Incidence of malignancy"
              },
              {
                "measure": "Incidence of Everolimus (EVR) discontinuation due to Adverse Events (AEs)"
              },
              {
                "measure": "Incidence of polycythemia in the study"
              },
              {
                "measure": "Incidence of thromboembolism in the study"
              },
              {
                "measure": "Proportion of subjects with operational tolerance as defined by no rejection"
              },
              {
                "measure": "Change in estimated glomerular filtration rate (eGFR)"
              },
              {
                "measure": "Proportion of subjects with operational tolerance"
              },
              {
                "measure": "Proportion of subjects who are clinically stable off immunosuppression (IS)"
              },
              {
                "measure": "Proportion of subjects who are clinically stable off immunosuppression (IS)"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT03794492",
            "briefTitle": "Impact of Lymphocyte Anti-metabolite Immunosuppressions on Donor-Specific Anti-HLA Antibody and Kidney Graft Outcome",
            "officialTitle": "Impact of Lymphocyte Anti-metabolite Immunosuppressions on Donor-Specific Anti-HLA Antibody and Kidney Graft Outcome: Open-label, Multi-center, Single Arm, Phase 4 Trial (DoSAKOM)"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2019-01-03"
          },
          "conditionsModule": {
            "conditions": [
              "Kidney Transplant"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "DSA(Donor-specific Anti-HLA Antibody)",
                "timeFrame": "36 months"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Incidence of composite efficacy failure"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02723591",
            "briefTitle": "To Compare the Effects of Immediate-release Tacrolimus and Astagraf XL on Donor-Specific Antibody (DSA) Formation and the Development of Immune Activation (IA) in de Novo Kidney Transplant Recipients",
            "officialTitle": "Astagraf XL\u00ae to Understand the Impact of Immunosuppression on De Novo DSA Development and Chronic Immune Activation in Kidney Transplantation"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2016-03-03",
            "resultsFirstSubmitDate": "2020-06-11"
          },
          "conditionsModule": {
            "conditions": [
              "Kidney Transplantation"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Percentage of Participants Who Were Positive for de Novo DSA (dnDSA) or Immune Activation (IA) Occurrence",
                "timeFrame": "From date of transplant until 1 year"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Percentage of Participants Who Were Positive, Negative or Indeterminate for dnDSA Occurrence"
              },
              {
                "measure": "Peak Mean Fluorescence Intensity (MFI) of DSA Positive Participants"
              },
              {
                "measure": "Percentage of DSA Positive Participants With Weak, Moderate and Strong Antibody Strentgh"
              },
              {
                "measure": "Percentage of DSA Positive Participants With DSA Persistence"
              },
              {
                "measure": "Percentage of Participants Who Were Positive or Negative for Complement Component 1, Q Subcomponent (C1q)-Binding DSA"
              },
              {
                "measure": "Percentage of Participants Who Were Positive or Negative for DSA Immunoglobulin G (IgG3) Isotype"
              },
              {
                "measure": "Percentage of DSA Positive Participants With Human Leukocyte Antigen, Class II, DQ Locus (HLA-DQ)"
              },
              {
                "measure": "Percentage of Participants Who Were Positive for IA Occurrence From Day 1 to Day 365 Visit"
              },
              {
                "measure": "Percentage of Participants Who Were Positive for IA Occurrence From Day 30 to Day 365 Visit"
              },
              {
                "measure": "Percentage of Participants With IA Persistence"
              },
              {
                "measure": "Percentage of Participants With Presence of Transplant Glomerulopathy (TG) on Biopsy"
              },
              {
                "measure": "Percentage of Participants With Presence of Microcirculatory Inflammation (MI) on Biopsy"
              },
              {
                "measure": "Percentage of Participants With Presence of Interstitial Fibrosis and Tubular Atrophy (IFTA) and Inflammation on Biopsy"
              },
              {
                "measure": "Percentage of Participants With Estimated Glomerular Filtration Rate (eGFR) Threshold of <30 Millimetre Per Minute Per 1.73 Meter Square (mL/Min/1.73m^2)"
              },
              {
                "measure": "Percentage of Participants With eGFR Threshold of <40 mL/Min/1.73m^2"
              },
              {
                "measure": "Percentage of Participants With eGFR Threshold of <50 mL/Min/1.73m^2"
              },
              {
                "measure": "Percentage of Participants With a Five-point Decline in eGFR"
              },
              {
                "measure": "eGFR at Day 30, Day 90, Day 180, Day 270 and Day 365"
              },
              {
                "measure": "Percentage of Participants With Graft Loss"
              },
              {
                "measure": "Percentage of Participants Who Died"
              },
              {
                "measure": "Percentage of Participants With Biopsy-Proven Acute Rejection (BPAR)"
              },
              {
                "measure": "Percentage of Participants Who Were Lost to Follow-up"
              },
              {
                "measure": "Percentage of Participants With Either Graft Loss, Death, BPAR or Lost to Follow-up"
              },
              {
                "measure": "Percentage of Participants With Any Antibody-Mediated Rejection (ABMR)"
              },
              {
                "measure": "Percentage of Participants With Normal Biopsy Findings"
              },
              {
                "measure": "Percentage of Participants With C4d Deposition Without Active Rejection"
              },
              {
                "measure": "Percentage of Participants With Acute ABMR"
              },
              {
                "measure": "Percentage of Participants With Grade I, II and III Acute ABMR"
              },
              {
                "measure": "Percentage of Participants With Chronic ABMR"
              },
              {
                "measure": "Percentage of Participants With Borderline Changes"
              },
              {
                "measure": "Percentage of Participants With Acute T-cell Mediated Rejection (TCMR)"
              },
              {
                "measure": "Percentage of Participants With Chronic TCMR"
              },
              {
                "measure": "Percentage of Participants With Grade I, II and III IFTA"
              },
              {
                "measure": "Percentage of Participants With Any Additional Findings"
              },
              {
                "measure": "Percentage of Participants With Glomerulitis (g) Biopsy Score Assessed Using Banff Lesion Scores"
              },
              {
                "measure": "Percentage of Participants With Tubulitis (t) Biopsy Score Assessed Using Banff Lesion Scores"
              },
              {
                "measure": "Percentage of Participants With Intimal Arteritis (v) Biopsy Score Assessed Using Banff Lesion Scores"
              },
              {
                "measure": "Percentage of Participants With Mononuclear Cell Interstitial Inflammation (i) Biopsy Score Assessed Using Banff Lesion Scores"
              },
              {
                "measure": "Percentage of Participants With Glomerular Basement Membrane Double Contours (cg) Biopsy Score Assessed Using Banff Lesion Scores"
              },
              {
                "measure": "Percentage of Participants With Tubular Atrophy (ct) Biopsy Score Assessed Using Banff Lesion Scores"
              },
              {
                "measure": "Percentage of Participants With Interstitial Fibrosis (ci) Biopsy Score Assessed Using Banff Lesion Scores"
              },
              {
                "measure": "Percentage of Participants With Vascular Fibrous Intimal Thickening (cv) Biopsy Score Assessed Using Banff Lesion Scores"
              },
              {
                "measure": "Percentage of Participants With Arteriolar Hyalinosis (ah) Biopsy Score Assessed Using Banff Lesion Scores"
              },
              {
                "measure": "Percentage of Participants With Peritubular Capillaritis (Ptc) Biopsy Score Assessed Using Banff Lesion Scores"
              },
              {
                "measure": "Percentage of Participants With Mesangial Matrix Expansion (mm) Biopsy Score Assessed Using Banff Lesion Scores"
              },
              {
                "measure": "Time to First Occurrence of DSA"
              },
              {
                "measure": "Time to First Occurrence of HLA-DQ DSA"
              },
              {
                "measure": "Time to First Occurrence of C1q-binding DSA"
              },
              {
                "measure": "Time to First Occurrence of DSA IgG3 Isotype"
              },
              {
                "measure": "Time to First Occurrence of IA"
              },
              {
                "measure": "Time to First Occurrence of TG on Biopsy"
              },
              {
                "measure": "Time to Occurrence of Death"
              },
              {
                "measure": "Time to First Occurrence of Local BPAR"
              },
              {
                "measure": "Time to First Occurrence of Acute Forms of ABMR"
              },
              {
                "measure": "Time to First Occurrence of Chronic Forms of ABMR"
              },
              {
                "measure": "Time to First Occurrence of Acute TCMR"
              },
              {
                "measure": "Time to First Occurrence of Chronic TCMR"
              },
              {
                "measure": "Time to First Occurrence of Borderline Changes"
              },
              {
                "measure": "Time to First Occurrence of IFTA"
              },
              {
                "measure": "Percentage of Participants With Treatment-emergent Adverse Event(TEAEs), Related TEAEs, Treatment-emergent Serious Adverse Event (TESAEs), Related TESAEs, TEAEs Leading to Discontinuation of Study Treatment and TEAEs Leading to Death"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00204191",
            "briefTitle": "Comparison of the Two Immunosuppressive Regimens Based on Tacrolimus and Cyclosporine Following Kidney Transplantation",
            "officialTitle": "Open, Prospective, Randomized Study to Compare the Efficacy and Safety of Immunosuppression Regimens Based on Cyclosporine (Neoral\u00ae) and Tacrolimus (Prograf\u00ae) in Renal Transplant Patients"
          },
          "statusModule": {
            "overallStatus": "UNKNOWN",
            "studyFirstSubmitDate": "2005-09-12"
          },
          "conditionsModule": {
            "conditions": [
              "Kidney Transplantation"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "graft survival",
                "timeFrame": "at one year"
              },
              {
                "measure": "patient survival",
                "timeFrame": "at one year"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "renal function measured by serum creatinine (SCr)"
              },
              {
                "measure": "lipid profile"
              },
              {
                "measure": "total cost of the treatment"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02251691",
            "briefTitle": "Influence of Once-daily Versus Twice-daily Immunosuppressant on Renal Transplant",
            "officialTitle": "The Influence of Once-daily Versus Twice-daily Immunosuppressive Regimen on Drug Compliance in Patients After Renal Transplantation"
          },
          "statusModule": {
            "overallStatus": "UNKNOWN",
            "studyFirstSubmitDate": "2014-06-15"
          },
          "conditionsModule": {
            "conditions": [
              "Adherence to Medication Regime"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "basal assessment of adherence with immunosuppressive medication scale",
                "timeFrame": "12 months"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "serum creatinine level"
              },
              {
                "measure": "graft survival"
              },
              {
                "measure": "patient survival"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT05600426",
            "briefTitle": "A Trial Comparing Unrelated Donor BMT With IST for Pediatric and Young Adult Patients With Severe Aplastic Anemia (TransIT, BMT CTN 2202)",
            "officialTitle": "A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation With Immune Suppressive Therapy for Newly Diagnosed Pediatric and Young Adult Patients With Severe Aplastic Anemia (TransIT, BMT CTN 2202)"
          },
          "statusModule": {
            "overallStatus": "RECRUITING",
            "studyFirstSubmitDate": "2022-10-20"
          },
          "conditionsModule": {
            "conditions": [
              "Severe Aplastic Anemia"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "The primary endpoint of this trial is time from randomization to treatment failure or death from any cause.",
                "timeFrame": "Randomization to 2 years post-randomization"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Comparison of subjects with failure of IST or BMT before or at 2 years"
              },
              {
                "measure": "Comparison of subjects with inadequate counts at 2 years among those who have not died or failed treatment."
              },
              {
                "measure": "Comparison of subjects on immune suppression therapy at 2 years among those who have not died or failed treatment."
              },
              {
                "measure": "Estimate the time from randomization to initiation of IST or BMT."
              },
              {
                "measure": "Comparison of the frequency of failure to receive primary assigned therapy (IST or BMT) and reasons for the failure."
              },
              {
                "measure": "Comparison of the incidence of bacteremia, viremia, and invasive fungal infection in the first two years after randomization in the IST and BMT arms."
              },
              {
                "measure": "Estimate the median time to T- and B-cell immune reconstitution the first year for the URD BMT Arm"
              },
              {
                "measure": "Comparison of overall survival at 1 and 2 years from randomization in both arms."
              },
              {
                "measure": "Comparison of treatment-related mortality (TRM) at 1 and 2 years from randomization in both arms."
              },
              {
                "measure": "Comparison of the median time from randomization to and rates of neutrophil recovery on both arms"
              },
              {
                "measure": "Comparison of the median time from randomization to and rate of platelet recovery on both arms"
              },
              {
                "measure": "Comparison of the median time from randomization to and rates of red blood cell recovery on both arms"
              },
              {
                "measure": "Comparison of the median time from initiation of therapy to and rates of neutrophil recovery on both arms"
              },
              {
                "measure": "Comparison of the median time from initiation of therapy to and rate of platelet recovery on both arms"
              },
              {
                "measure": "Comparison of the median time from initiation of therapy to and rates of red blood cell recovery on both arms."
              },
              {
                "measure": "Estimate the rates of engraftment in patients who are randomized to URD BMT."
              },
              {
                "measure": "Estimate the rates of primary graft failure in patients who are randomized to URD BMT ."
              },
              {
                "measure": "Estimate the rates of secondary graft failure in patients who are randomized to URD BMT ."
              },
              {
                "measure": "Estimate the rates of grade II-IV acute GVHD in patients who are randomized to URD BMT ."
              },
              {
                "measure": "Estimate the rates of grade III-IV acute GVHD in patients who are randomized to URD BMT."
              },
              {
                "measure": "Estimate the rates of severe chronic GVHD in patients who are randomized to URD BMT."
              },
              {
                "measure": "Estimate the rates of response of patients randomized to IST"
              },
              {
                "measure": "Estimate the rates of failure of patients randomized to IST"
              },
              {
                "measure": "Describe the secondary therapies given and outcomes achieved for patients failing initial therapy"
              },
              {
                "measure": "Comparison of rates of secondary MDS, AML, other subsequent neoplasms, and development of Paroxysmal Nocturnal Hemoglobinuria in both treatment arms for the duration of the trial."
              },
              {
                "measure": "Comparison of HR-QoL score between patients randomized to both arms"
              },
              {
                "measure": "Comparison of gonadal function values between patients randomized to both arms"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01017757",
            "briefTitle": "Interstitial Lung Abnormalities in Renal Transplant Recipients",
            "officialTitle": "Cross-sectional Analysis of Subclinical Interstitial Lung Abnormalities in Stable Renal Transplant Recipients by High-resolution CT Scan"
          },
          "statusModule": {
            "overallStatus": "UNKNOWN",
            "studyFirstSubmitDate": "2009-11-18"
          },
          "conditionsModule": {
            "conditions": [
              "Renal Transplantation",
              "Kidney-pancreas Transplantation"
            ]
          },
          "designModule": {
            "studyType": "OBSERVATIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Subclinical lung alterations as assessed by high-resolution CT scanning",
                "timeFrame": "CT is performed at study entry and, if abnormalities are found, it is repeated at 3-6 months"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01856257",
            "briefTitle": "Open-Label Phase 2 Trial of a Steroid-Free, CNI-Free, Belatacept-Based Immunosuppressive Regimen",
            "officialTitle": "Steroid and Tacrolimus Avoidance Using NULOJIX\u00ae (Belatacept) in Renal Transplantation (CTOT-16)"
          },
          "statusModule": {
            "overallStatus": "TERMINATED",
            "whyStopped": "Safety: Stopping rule not met.",
            "studyFirstSubmitDate": "2013-05-14",
            "resultsFirstSubmitDate": "2017-06-23"
          },
          "conditionsModule": {
            "conditions": [
              "Primary Renal Allograft Candidate",
              "Kidney Transplantation"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Mean Estimated Glomerular Filtration Rate (eGFR) Calculated for Each Treatment Group Using the CKD-EPI Equation at Wk 52 Post-Transplant",
                "timeFrame": "Week 52"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Count of Participants With Biopsy Proven Acute Rejection By Wk 52 Post-Transplant"
              },
              {
                "measure": "Count of Participants With eGFR < 60 mL/Min/1.73 m^2 Measured by CKD-EPI at Wk 52 Post-Transplant"
              },
              {
                "measure": "Count of Participants by CKD Stage at Wk 52"
              },
              {
                "measure": "Count of Participants With Defined CKD Stage 4 or 5 at Wk 52 Post-Transplant"
              },
              {
                "measure": "Mean Calculated eGFR Using MDRD 4 Variable Model at Wk 52 Post-Transplant"
              },
              {
                "measure": "The Slope of eGFR by CKD-EPI Over Time Based on Serum Creatinine Post-Transplant"
              },
              {
                "measure": "Count of Participants With Delayed Graft Function at Wk 52 Post-Transplant"
              },
              {
                "measure": "Count of Participants With Acute Cellular Rejection Grade \u2265 IA Defined by Banff 2007 Criteria By Wk 52 Post-Transplant"
              },
              {
                "measure": "Count of Participants by Severity of First Acute Cellular Rejection by Wk 52 Post-Transplant"
              },
              {
                "measure": "Count of Participants With Antibody Mediated Rejection by Wk 52 Post-Transplant"
              },
              {
                "measure": "Type of Rejection Classified by Pathologist - For Cause Kidney Biopsies"
              },
              {
                "measure": "Type of Treatment for Detected Graft Rejection"
              },
              {
                "measure": "Count of Participants With De Novo Anti-Donor Histocompatibility Antigen (HLA) Antibodies at Wk 52 Post-Transplant"
              },
              {
                "measure": "Count of Participants With Either New Onset Diabetes After Transplant (NODAT) or Impaired Fasting Glucose (IFG) at Week 52 Post-Transplant -Based on Criteria Specified by the ADA and WHO"
              },
              {
                "measure": "Count of Participants With Treated Diabetes Between Day 14 and Wk 52 Post-Transplant"
              },
              {
                "measure": "Hemoglobin A1c (HbA1c) Measurements Over Time"
              },
              {
                "measure": "Standardized Blood Pressure Measurement at Wk 52 Post-Transplant"
              },
              {
                "measure": "Count of Participants With Use of Anti-hypertensive Medication at Wk 52 Post-Transplant"
              },
              {
                "measure": "Fasting Lipid Profile at Baseline (Pre-Transplant)"
              },
              {
                "measure": "Fasting Lipid Profile at Wk 28 Post-Transplant"
              },
              {
                "measure": "Fasting Lipid Profile at Wk 52 Post-Transplant"
              },
              {
                "measure": "Count of Participants With Use of Lipid Lowering Medications at Baseline and Wk 28 and Wk 52 Post-Transplant"
              },
              {
                "measure": "Total Daily Prescribed Pill Count"
              },
              {
                "measure": "Count of Participant Deaths or Graft Loss by Wk 52 Post-Transplant"
              },
              {
                "measure": "Count of Participants With Graft Rejection by Wk 52 Post-Transplant"
              },
              {
                "measure": "Count of Participants Experiencing \u2265 1 Adverse Event (AEs) or Serious Adverse Events (SAEs) by Wk 52"
              },
              {
                "measure": "Count of Participants With Infections Requiring Hospitalization or Systemic Therapy by Wk 52 Post-Transplant"
              },
              {
                "measure": "Count of Participants With BK Polyoma Virus (BKV) and Cytomegalovirus (CMV) Viremia (Local Center Monitoring) as Adverse Events by Wk 52 Post-Transplant"
              },
              {
                "measure": "Count of Participants With Epstein-Barr Virus (EBV) Infection as Reported on the Case Report Form as Adverse Events"
              },
              {
                "measure": "Count of Participants With Fever > 39 Degrees Celsius and Blood Pressure < 90 mmHg Within 24 Hours of Onset of Transplant Procedure"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02129582",
            "briefTitle": "Targeted Marrow Irradiation, Fludarabine Phosphate, and Busulfan Before Donor Progenitor Cell Transplant in Treating Patients With Hematologic Malignancies",
            "officialTitle": "Phase I Trial of Escalated Doses of Targeted Marrow Irradiation (TMI) Combined With Fludarabine and Busulfan as Conditioning Regimen for Allogeneic Hematopoietic Progenitor Cell Transplantation"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2014-04-30"
          },
          "conditionsModule": {
            "conditions": [
              "Acute Myeloid Leukemia",
              "Hematologic Malignancies",
              "Acute Lymphocytic Leukemia",
              "Non Hodgkin Lymphoma",
              "Hodgkin Lymphoma",
              "Multiple Myeloma",
              "Myelodysplastic Syndrome",
              "Chronic Lymphocytic Leukemia",
              "Chronic Myeloid Leukemia",
              "Myelofibrosis",
              "Myeloproliferative Syndrome"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Maximum tolerated dose of targeted marrow irradiation defined as the dose level immediately below that in which greater than or equal to 2/6 subjects experience a dose limiting toxicity assessed using NCI CTCAE version 4.0",
                "timeFrame": "Up to day 32"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Incidence of toxicities assessed using NCI CTCAE version 4.0"
              },
              {
                "measure": "Patient mortality"
              },
              {
                "measure": "Organ avoidance"
              },
              {
                "measure": "Target coverage"
              },
              {
                "measure": "Planning time"
              },
              {
                "measure": "Treatment delivery time"
              },
              {
                "measure": "Disease response status, assessed by standard criteria for the presence of relapse"
              },
              {
                "measure": "Rates of acute GVHD, graded and staged according to the Blood and Marrow Transplant Clinical Trials Network Manual of Operations"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00369382",
            "briefTitle": "Study Of The Safety And Efficacy Of Conversion From A CNI To Sirolimus In Renally-Impaired Heart Transplant Recipients",
            "officialTitle": "A Randomized Open-Label Study To Compare The Safety And Efficacy Of Conversion From A Calcineurin Inhibitor To Sirolimus Vs Continued Use Of A Calcineurin Inhibitor In Heart Transplant Recipients With Mild-Moderate Impaired Renal Function"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2006-08-25",
            "resultsFirstSubmitDate": "2011-04-26"
          },
          "conditionsModule": {
            "conditions": [
              "Graft Rejection",
              "Kidney Failure"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Change From Baseline in Calculated Creatinine Clearance (Cockcroft-Gault Equation) at 52 Weeks Post-randomization",
                "timeFrame": "Baseline and Week 52"
              },
              {
                "measure": "Calculated Creatinine Clearance (Cockcroft-Gault Equation) at Baseline",
                "timeFrame": "Baseline"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Change From Baseline in Calculated Creatinine Clearance (Cockcroft-Gault Equation) at 4, 16, 24, 32, and 40 Weeks Post-randomization"
              },
              {
                "measure": "Change From Baseline in Calculated Creatinine Clearance (Modification of Diet in Renal Disease [MDRD] Equation) at 4, 16, 24, 32, 40 and 52 Weeks Post-randomization"
              },
              {
                "measure": "Calculated Creatinine Clearance (Modification of Diet in Renal Disease [MDRD] Equation) at Baseline"
              },
              {
                "measure": "Change From Baseline in Serum Creatinine Level at 4, 16, 24, 32, 40, and 52 Weeks Post-randomization"
              },
              {
                "measure": "Serum Creatinine Level at Baseline"
              },
              {
                "measure": "Annual Change in Calculated Creatinine Clearance (Cockcroft-Gault Equation)"
              },
              {
                "measure": "Overall Survival (OS)"
              },
              {
                "measure": "Number of Participants With Acute Rejection"
              },
              {
                "measure": "Number of Participants With Biopsy-confirmed Acute Rejection by Severity"
              },
              {
                "measure": "Time to First Acute Rejection"
              },
              {
                "measure": "Number of Participants Requiring Antibody Use in Treatment of Acute Rejection"
              },
              {
                "measure": "Number of Participants in Sirolimus Treatment Group Requiring Conversion Back to CNI Therapy"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01045382",
            "briefTitle": "MSC and HSC Coinfusion in Mismatched Minitransplants",
            "officialTitle": "Co-transplantation of Mesenchymal Stem Cells and HLA-mismatched Allogeneic Hematopoietic Cells After Nonmyeloablative Conditioning: a Phase II Randomized Double-blind Study"
          },
          "statusModule": {
            "overallStatus": "TERMINATED",
            "whyStopped": "recruitment too slow",
            "studyFirstSubmitDate": "2010-01-08"
          },
          "conditionsModule": {
            "conditions": [
              "Leukemia, Myeloid, Acute",
              "Leukemia, Lymphoblastic, Acute",
              "Leukemia, Myelocytic, Chronic",
              "Myeloproliferative Disorders",
              "Myelodysplastic Syndromes",
              "Multiple Myeloma",
              "Leukemia, Lymphocytic, Chronic",
              "Hodgkin's Disease",
              "Lymphoma, Non-Hodgkin"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "One-year overall survival in the 2 arms.",
                "timeFrame": "One year"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Incidence of grade II-IV and grade III-IV acute GVDH"
              },
              {
                "measure": "Number of absolute donor T cells after HCT in each arm"
              },
              {
                "measure": "Cumulative incidence of non-relapse mortality"
              },
              {
                "measure": "Incidence of extensive chronic GVHD in each arm"
              },
              {
                "measure": "Incidence of graft rejection in each arm."
              },
              {
                "measure": "Quality and timing of immunologic reconstitution in each arm."
              },
              {
                "measure": "Detection of MSC from donor origin in recipient marrow after HCT in patients given MSC"
              },
              {
                "measure": "Proportion of patients with measurable disease at HCT who achieve a complete response in each arm."
              },
              {
                "measure": "Cumulative incidence of relapse"
              },
              {
                "measure": "Incidence of progression-free survival"
              },
              {
                "measure": "Incidence of infections"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00282282",
            "briefTitle": "Tacrolimus and Sirolimus as Prophylaxis After Allogenic Non-myeloablative Peripheral Blood Stem Cell Transplantation",
            "officialTitle": "Tacrolimus and Sirolimus as Graft Versus Host Disease Prophylaxis After Allogeneic Non-myeloablative Peripheral Blood Stem Cell Transplantation"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2006-01-24",
            "resultsFirstSubmitDate": "2013-01-11"
          },
          "conditionsModule": {
            "conditions": [
              "Graft Versus Host Disease",
              "GVHD"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Incidence of Grade II-IV Acute GVHD (aGVHD) Developing by Day 100 Following Non-myeloablative PBSC Transplantation Using Tacrolimus and Sirolimus.",
                "timeFrame": "100 days"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Percentage of Participants With \u226590 Percent Donor-derived Hematopoeisis Around 100 Days Post Transplantation"
              },
              {
                "measure": "Disease Response."
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT03173820",
            "briefTitle": "Clinical Trial in Assigning of Tacrolimus Dosage Regimen According to CYP3A5 Genotype in Kidney Transplant Recipients",
            "officialTitle": "Clinical Trial in Assigning of Tacrolimus Dosage Regimen According to CYP3A5 Genotype in Kidney Transplant Recipients"
          },
          "statusModule": {
            "overallStatus": "UNKNOWN",
            "studyFirstSubmitDate": "2017-05-22"
          },
          "conditionsModule": {
            "conditions": [
              "Kidney Transplantation"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Mean tacrolimus level",
                "timeFrame": "at day 3 after transplantation"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Mean tacrolimus level"
              },
              {
                "measure": "Incidence of delay graft rejection"
              },
              {
                "measure": "Mean GFR level"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02438982",
            "briefTitle": "Efficacy and Safety of Rituximab to That of Calcineurin Inhibitors in Children With Steroid Dependent Nephrotic Syndrome",
            "officialTitle": "Efficacy and Safety of Rituximab to That of Calcineurin Inhibitors in Children With Steroid Dependent Nephrotic Syndrome"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2015-05-06"
          },
          "conditionsModule": {
            "conditions": [
              "Nephrotic Syndrome"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "12-month relapse-free survival",
                "timeFrame": "12-month"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02866682",
            "briefTitle": "Prospective Study Comparing Brand and Generic Immunosuppression on Transplant Outcomes, Adherence, & Immune Response in Kidney Transplant Recipients",
            "officialTitle": "Prospective Study Comparing Brand and Generic Immunosuppression on Transplant Outcomes, Adherence, & Immune Response"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2016-07-26",
            "resultsFirstSubmitDate": "2022-12-09"
          },
          "conditionsModule": {
            "conditions": [
              "Renal Transplant Rejection"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Time to First Occurrence of Acute Rejection, Failure, Death",
                "timeFrame": "1 year post-transplant"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Number of Participants With Graft Rejection at 1 Year"
              },
              {
                "measure": "Number of Participants With Graft Failure at 1 Year"
              },
              {
                "measure": "Number of Participants With Infectious Episodes at 1 Year"
              },
              {
                "measure": "Number of Participants With Malignancy at 1 Year"
              },
              {
                "measure": "Death or Loss-to-follow-up at 1 Year"
              },
              {
                "measure": "Changes in Lymphocyte Subpopulations and Production of Donor Specific HLA Antibodies"
              },
              {
                "measure": "Number of Participants Who Adhered to Medication Regimen"
              },
              {
                "measure": "Quality of Life With Medication Regimen"
              },
              {
                "measure": "Satisfaction With Medication Regimen"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00304720",
            "briefTitle": "Tacrolimus and MMF as Post Grafting Immunosuppression After Conditioning With Flu TBI for HLA Matched Family Donor",
            "officialTitle": "Tacrolimus and Mycophenolate Mofetil as Post-Grafting Immunosuppression After Conditioning With Fludarabine and Low-Dose Total Body Irradiation for Recipients of HLA-Matched Family Donor Hematopoietic Cell Transplants"
          },
          "statusModule": {
            "overallStatus": "UNKNOWN",
            "studyFirstSubmitDate": "2006-03-17"
          },
          "conditionsModule": {
            "conditions": [
              "Multiple Myeloma",
              "Lymphoma",
              "Acute Myelogenous Leukemia",
              "Acute Lymphocytic Leukemia",
              "Myelodysplastic Syndrome"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "The main endpoints are day 100 mortality and acute GVHD."
              }
            ]
          }
        }
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:13:16Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82fc"
    },
    "name": "CHEMBL3183095",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82fc.png",
    "lincs": {
      "id": "LSM-9699",
      "name": "CHEMBL3183095",
      "alternativeNames": [
        "BRD-K20834925"
      ],
      "pubchemCid": 54649383,
      "chebiId": 98320,
      "inchiParent": "InChI=1S/C35H36N4O4S/c1-35(2,3)44(42)39-22-28-19-30(34(41)37-21-23-11-13-29(43-4)14-12-23)38-33(32(28)31(39)15-16-40)27-10-6-9-26(18-27)25-8-5-7-24(17-25)20-36/h5-14,17-19,31,40H,15-16,21-22H2,1-4H3,(H,37,41)/t31-,44-/m0/s1",
      "inchiKeyParent": "NEVKZQRLDPRUMB-JCFUSDQVSA-N",
      "smilesParent": "COc1ccc(CNC(=O)c2cc3CN([C@@H](CCO)c3c(n2)c4cccc(c4)c5cccc(c5)C#N)[S@@](=O)C(C)(C)C)cc1"
    },
    "unichem": {
      "chebi": "98320",
      "chembl": "CHEMBL3183095",
      "lincs": "LSM-9699",
      "pubchem": "54649383"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL3183095",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 608.76,
        "hba": 7,
        "hbd": 2,
        "qedWeighted": 0.23
      }
    },
    "pubchem": [
      {
        "cid": 54649383,
        "inchi": "InChI=1S/C35H36N4O4S/c1-35(2,3)44(42)39-22-28-19-30(34(41)37-21-23-11-13-29(43-4)14-12-23)38-33(32(28)31(39)15-16-40)27-10-6-9-26(18-27)25-8-5-7-24(17-25)20-36/h5-14,17-19,31,40H,15-16,21-22H2,1-4H3,(H,37,41)/t31-,44-/m0/s1",
        "inchikey": "NEVKZQRLDPRUMB-JCFUSDQVSA-N",
        "iupac": {
          "systematic": "(3S)-2-[(S)-tert-butylsulfinyl]-4-[3-(3-cyanophenyl)phenyl]-3-(2-hydroxyethyl)-N-[(4-methoxyphenyl)methyl]-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide"
        },
        "smiles": {
          "canonical": "CC(C)(C)S(=O)N1CC2=CC(=NC(=C2C1CCO)C3=CC=CC(=C3)C4=CC=CC(=C4)C#N)C(=O)NCC5=CC=C(C=C5)OC"
        },
        "molecularFormula": "C35H36N4O4S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:13:27Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8335"
    },
    "name": "BRD-K93754181",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8335.png",
    "lincs": {
      "id": "LSM-14182",
      "name": "BRD-K93754181",
      "pubchemCid": 54654154,
      "chebiId": 102836,
      "inchiParent": "InChI=1S/C27H31N3O7/c1-3-10-28-25(31)13-18-6-7-20-24(37-18)14-34-21-9-5-17(12-19(21)27(33)30(20)2)29-26(32)16-4-8-22-23(11-16)36-15-35-22/h4-5,8-9,11-12,18,20,24H,3,6-7,10,13-15H2,1-2H3,(H,28,31)(H,29,32)/t18-,20-,24+/m0/s1",
      "inchiKeyParent": "OHHWUSSTVAUIQP-VAXXYWNWSA-N",
      "smilesParent": "CCCNC(=O)C[C@@H]1CC[C@H]2[C@@H](COc3ccc(NC(=O)c4ccc5OCOc5c4)cc3C(=O)N2C)O1"
    },
    "unichem": {
      "chebi": "102836",
      "lincs": "LSM-14182",
      "pubchem": "54654154"
    },
    "pubchem": [
      {
        "cid": 54654154,
        "inchi": "InChI=1S/C27H31N3O7/c1-3-10-28-25(31)13-18-6-7-20-24(37-18)14-34-21-9-5-17(12-19(21)27(33)30(20)2)29-26(32)16-4-8-22-23(11-16)36-15-35-22/h4-5,8-9,11-12,18,20,24H,3,6-7,10,13-15H2,1-2H3,(H,28,31)(H,29,32)/t18-,20-,24+/m0/s1",
        "inchikey": "OHHWUSSTVAUIQP-VAXXYWNWSA-N",
        "iupac": {
          "systematic": "N-[(2S,4aS,12aS)-5-methyl-6-oxo-2-[2-oxo-2-(propylamino)ethyl]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-1,3-benzodioxole-5-carboxamide"
        },
        "smiles": {
          "canonical": "CCCNC(=O)CC1CCC2C(O1)COC3=C(C=C(C=C3)NC(=O)C4=CC5=C(C=C4)OCO5)C(=O)N2C"
        },
        "molecularFormula": "C27H31N3O7"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:13:29Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8337"
    },
    "name": "BRD-K85805864",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8337.png",
    "lincs": {
      "id": "LSM-13687",
      "name": "BRD-K85805864",
      "pubchemCid": 54649179,
      "chebiId": 102335,
      "inchiParent": "InChI=1S/C24H33FN2O5S/c1-17-10-12-20(13-11-17)33(30,31)27(19(3)16-28)14-18(2)23(32-5)15-26(4)24(29)21-8-6-7-9-22(21)25/h6-13,18-19,23,28H,14-16H2,1-5H3/t18-,19+,23-/m1/s1",
      "inchiKeyParent": "NDGBDPWBOPYDPZ-SELNLUPBSA-N",
      "smilesParent": "CO[C@H](CN(C)C(=O)c1ccccc1F)[C@H](C)CN([C@@H](C)CO)S(=O)(=O)c2ccc(C)cc2"
    },
    "unichem": {
      "chebi": "102335",
      "lincs": "LSM-13687",
      "pubchem": "54649179"
    },
    "pubchem": [
      {
        "cid": 54649179,
        "inchi": "InChI=1S/C24H33FN2O5S/c1-17-10-12-20(13-11-17)33(30,31)27(19(3)16-28)14-18(2)23(32-5)15-26(4)24(29)21-8-6-7-9-22(21)25/h6-13,18-19,23,28H,14-16H2,1-5H3/t18-,19+,23-/m1/s1",
        "inchikey": "NDGBDPWBOPYDPZ-SELNLUPBSA-N",
        "iupac": {
          "systematic": "2-fluoro-N-[(2S,3R)-4-[[(2S)-1-hydroxypropan-2-yl]-(4-methylphenyl)sulfonylamino]-2-methoxy-3-methylbutyl]-N-methylbenzamide"
        },
        "smiles": {
          "canonical": "CC1=CC=C(C=C1)S(=O)(=O)N(CC(C)C(CN(C)C(=O)C2=CC=CC=C2F)OC)C(C)CO"
        },
        "molecularFormula": "C24H33FN2O5S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:13:32Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8276"
    },
    "name": "BRD-K21453542",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8276.png",
    "lincs": {
      "id": "LSM-38431",
      "name": "BRD-K21453542",
      "pubchemCid": 60191566,
      "chebiId": 126868,
      "inchiParent": "InChI=1S/C20H21N3O3/c1-14(25)23-17(11-24)18(15-7-3-2-4-8-15)20(23)12-22(13-20)19(26)16-9-5-6-10-21-16/h2-10,17-18,24H,11-13H2,1H3/t17-,18+/m0/s1",
      "inchiKeyParent": "VFSMDQOZXWCDPD-ZWKOTPCHSA-N",
      "smilesParent": "CC(=O)N1[C@@H](CO)[C@@H](c2ccccc2)C13CN(C3)C(=O)c4ccccn4"
    },
    "unichem": {
      "chebi": "126868",
      "lincs": "LSM-38431",
      "pubchem": "60191566"
    },
    "pubchem": [
      {
        "cid": 60191566,
        "inchi": "InChI=1S/C20H21N3O3/c1-14(25)23-17(11-24)18(15-7-3-2-4-8-15)20(23)12-22(13-20)19(26)16-9-5-6-10-21-16/h2-10,17-18,24H,11-13H2,1H3/t17-,18+/m0/s1",
        "inchikey": "VFSMDQOZXWCDPD-ZWKOTPCHSA-N",
        "iupac": {
          "systematic": "1-[(2R,3R)-2-(hydroxymethyl)-3-phenyl-6-(pyridine-2-carbonyl)-1,6-diazaspiro[3.3]heptan-1-yl]ethanone"
        },
        "smiles": {
          "canonical": "CC(=O)N1C(C(C12CN(C2)C(=O)C3=CC=CC=N3)C4=CC=CC=C4)CO"
        },
        "molecularFormula": "C20H21N3O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:13:34Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8298"
    },
    "name": "CHEMBL3183425",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8298.png",
    "lincs": {
      "id": "LSM-9420",
      "name": "CHEMBL3183425",
      "alternativeNames": [
        "BRD-K16413530"
      ],
      "pubchemCid": 54649981,
      "chebiId": 98041,
      "inchiParent": "InChI=1S/C25H29N3O3/c1-31-21-13-11-18(12-14-21)17-7-9-19(10-8-17)24-22(15-26)28(23(24)16-29)25(30)27-20-5-3-2-4-6-20/h7-14,20,22-24,29H,2-6,16H2,1H3,(H,27,30)/t22-,23+,24+/m1/s1",
      "inchiKeyParent": "UEJLJRRJJUOYFY-SGNDLWITSA-N",
      "smilesParent": "COc1ccc(cc1)c2ccc(cc2)[C@@H]3[C@H](CO)N([C@@H]3C#N)C(=O)NC4CCCCC4"
    },
    "unichem": {
      "chebi": "98041",
      "chembl": "CHEMBL3183425",
      "lincs": "LSM-9420",
      "pubchem": "54649981"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL3183425",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 419.53,
        "hba": 4,
        "hbd": 2,
        "qedWeighted": 0.77
      }
    },
    "pubchem": [
      {
        "cid": 54649981,
        "inchi": "InChI=1S/C25H29N3O3/c1-31-21-13-11-18(12-14-21)17-7-9-19(10-8-17)24-22(15-26)28(23(24)16-29)25(30)27-20-5-3-2-4-6-20/h7-14,20,22-24,29H,2-6,16H2,1H3,(H,27,30)/t22-,23+,24+/m1/s1",
        "inchikey": "UEJLJRRJJUOYFY-SGNDLWITSA-N",
        "iupac": {
          "systematic": "(2S,3S,4R)-2-cyano-N-cyclohexyl-4-(hydroxymethyl)-3-[4-(4-methoxyphenyl)phenyl]azetidine-1-carboxamide"
        },
        "smiles": {
          "canonical": "COC1=CC=C(C=C1)C2=CC=C(C=C2)C3C(N(C3C#N)C(=O)NC4CCCCC4)CO"
        },
        "molecularFormula": "C25H29N3O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:13:45Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82a5"
    },
    "name": "BRD-K51475868",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82a5.png",
    "lincs": {
      "id": "LSM-40113",
      "name": "BRD-K51475868",
      "pubchemCid": 60191125,
      "chebiId": 128559,
      "inchiParent": "InChI=1S/C24H30N2O4/c1-30-13-5-6-17-9-11-18(12-10-17)23-20-14-25(15-22(28)26(20)21(23)16-27)24(29)19-7-3-2-4-8-19/h9-12,19-21,23,27H,2-4,7-8,13-16H2,1H3/t20-,21+,23-/m0/s1",
      "inchiKeyParent": "KDYLLPKCSGYBGM-XJUOHMSHSA-N",
      "smilesParent": "COCC#Cc1ccc(cc1)[C@@H]2[C@@H](CO)N3[C@H]2CN(CC3=O)C(=O)C4CCCCC4"
    },
    "unichem": {
      "chebi": "128559",
      "lincs": "LSM-40113",
      "pubchem": "60191125"
    },
    "pubchem": [
      {
        "cid": 60191125,
        "inchi": "InChI=1S/C24H30N2O4/c1-30-13-5-6-17-9-11-18(12-10-17)23-20-14-25(15-22(28)26(20)21(23)16-27)24(29)19-7-3-2-4-8-19/h9-12,19-21,23,27H,2-4,7-8,13-16H2,1H3/t20-,21+,23-/m0/s1",
        "inchikey": "KDYLLPKCSGYBGM-XJUOHMSHSA-N",
        "iupac": {
          "systematic": "(6R,7S,8S)-4-(cyclohexanecarbonyl)-8-(hydroxymethyl)-7-[4-(3-methoxyprop-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one"
        },
        "smiles": {
          "canonical": "COCC#CC1=CC=C(C=C1)C2C3CN(CC(=O)N3C2CO)C(=O)C4CCCCC4"
        },
        "molecularFormula": "C24H30N2O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:13:47Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82d9"
    },
    "name": "BRD-K59247792",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82d9.png",
    "lincs": {
      "id": "LSM-12007",
      "name": "BRD-K59247792",
      "pubchemCid": 54638621,
      "chebiId": 100633,
      "inchiParent": "InChI=1S/C20H27FN4O4/c1-24-8-10-25(11-9-24)19(27)12-14-6-7-17(18(13-26)29-14)23-20(28)22-16-5-3-2-4-15(16)21/h2-7,14,17-18,26H,8-13H2,1H3,(H2,22,23,28)/t14-,17-,18-/m1/s1",
      "inchiKeyParent": "ZHYLMLAAZLDJNG-ZTFGCOKTSA-N",
      "smilesParent": "CN1CCN(CC1)C(=O)C[C@@H]2O[C@H](CO)[C@H](NC(=O)Nc3ccccc3F)C=C2"
    },
    "unichem": {
      "chebi": "100633",
      "lincs": "LSM-12007",
      "pubchem": "54638621"
    },
    "pubchem": [
      {
        "cid": 54638621,
        "inchi": "InChI=1S/C20H27FN4O4/c1-24-8-10-25(11-9-24)19(27)12-14-6-7-17(18(13-26)29-14)23-20(28)22-16-5-3-2-4-15(16)21/h2-7,14,17-18,26H,8-13H2,1H3,(H2,22,23,28)/t14-,17-,18-/m1/s1",
        "inchikey": "ZHYLMLAAZLDJNG-ZTFGCOKTSA-N",
        "iupac": {
          "systematic": "1-(2-fluorophenyl)-3-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-(4-methylpiperazin-1-yl)-2-oxoethyl]-3,6-dihydro-2H-pyran-3-yl]urea"
        },
        "smiles": {
          "canonical": "CN1CCN(CC1)C(=O)CC2C=CC(C(O2)CO)NC(=O)NC3=CC=CC=C3F"
        },
        "molecularFormula": "C20H27FN4O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:13:50Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c833b"
    },
    "name": "BRD-K21285939",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c833b.png",
    "lincs": {
      "id": "LSM-9722",
      "name": "BRD-K21285939",
      "pubchemCid": 54632221,
      "chebiId": 98343,
      "inchiParent": "InChI=1S/C27H35N3O5/c1-18-15-30(20(3)31)19(2)17-35-24-12-11-22(28-26(32)13-21-9-7-6-8-10-21)14-23(24)27(33)29(4)16-25(18)34-5/h6-12,14,18-19,25H,13,15-17H2,1-5H3,(H,28,32)/t18-,19+,25+/m1/s1",
      "inchiKeyParent": "BBRWISDMGXAAHU-WYEJZRMESA-N",
      "smilesParent": "CO[C@H]1CN(C)C(=O)c2cc(NC(=O)Cc3ccccc3)ccc2OC[C@H](C)N(C[C@H]1C)C(=O)C"
    },
    "unichem": {
      "chebi": "98343",
      "lincs": "LSM-9722",
      "pubchem": "54632221"
    },
    "pubchem": [
      {
        "cid": 54632221,
        "inchi": "InChI=1S/C27H35N3O5/c1-18-15-30(20(3)31)19(2)17-35-24-12-11-22(28-26(32)13-21-9-7-6-8-10-21)14-23(24)27(33)29(4)16-25(18)34-5/h6-12,14,18-19,25H,13,15-17H2,1-5H3,(H,28,32)/t18-,19+,25+/m1/s1",
        "inchikey": "BBRWISDMGXAAHU-WYEJZRMESA-N",
        "iupac": {
          "systematic": "N-[(4S,7R,8R)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-phenylacetamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(COC2=C(C=C(C=C2)NC(=O)CC3=CC=CC=C3)C(=O)N(CC1OC)C)C)C(=O)C"
        },
        "molecularFormula": "C27H35N3O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:13:52Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8273"
    },
    "name": "BRD-K31545458",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8273.png",
    "lincs": {
      "id": "LSM-10339",
      "name": "BRD-K31545458",
      "pubchemCid": 54638830,
      "chebiId": 98960,
      "inchiParent": "InChI=1S/C20H28N2O6S/c1-27-17-7-3-4-8-19(17)29(25,26)21-16-10-9-15(28-18(16)14-23)13-20(24)22-11-5-2-6-12-22/h3-4,7-10,15-16,18,21,23H,2,5-6,11-14H2,1H3/t15-,16-,18+/m0/s1",
      "inchiKeyParent": "LFPPDYCBOCBVHR-XYJFISCASA-N",
      "smilesParent": "COc1ccccc1S(=O)(=O)N[C@H]2C=C[C@@H](CC(=O)N3CCCCC3)O[C@@H]2CO"
    },
    "unichem": {
      "chebi": "98960",
      "lincs": "LSM-10339",
      "pubchem": "54638830"
    },
    "pubchem": [
      {
        "cid": 54638830,
        "inchi": "InChI=1S/C20H28N2O6S/c1-27-17-7-3-4-8-19(17)29(25,26)21-16-10-9-15(28-18(16)14-23)13-20(24)22-11-5-2-6-12-22/h3-4,7-10,15-16,18,21,23H,2,5-6,11-14H2,1H3/t15-,16-,18+/m0/s1",
        "inchikey": "LFPPDYCBOCBVHR-XYJFISCASA-N",
        "iupac": {
          "systematic": "N-[(2S,3S,6R)-2-(hydroxymethyl)-6-(2-oxo-2-piperidin-1-ylethyl)-3,6-dihydro-2H-pyran-3-yl]-2-methoxybenzenesulfonamide"
        },
        "smiles": {
          "canonical": "COC1=CC=CC=C1S(=O)(=O)NC2C=CC(OC2CO)CC(=O)N3CCCCC3"
        },
        "molecularFormula": "C20H28N2O6S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:13:54Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8286"
    },
    "name": "IWP 2",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8286.png",
    "lincs": {
      "id": "LSM-37210",
      "name": "IWP 2",
      "alternativeNames": [
        "IWP-2"
      ],
      "pubchemCid": 2155128,
      "chebiId": 125649,
      "inchiParent": "InChI=1S/C22H18N4O2S3/c1-13-7-8-15-17(11-13)31-21(23-15)25-18(27)12-30-22-24-16-9-10-29-19(16)20(28)26(22)14-5-3-2-4-6-14/h2-8,11H,9-10,12H2,1H3,(H,23,25,27)",
      "inchiKeyParent": "WRKPZSMRWPJJDH-UHFFFAOYSA-N",
      "smilesParent": "Cc1ccc2nc(NC(=O)CSC3=NC4=C(SCC4)C(=O)N3c5ccccc5)sc2c1"
    },
    "unichem": {
      "chebi": "125649",
      "chembl": "CHEMBL1257064",
      "lincs": "LSM-37210",
      "pubchem": "2155128"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL1257064",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 466.61,
        "hba": 8,
        "hbd": 1,
        "qedWeighted": 0.34
      }
    },
    "pubchem": [
      {
        "cid": 2155128,
        "inchi": "InChI=1S/C22H18N4O2S3/c1-13-7-8-15-17(11-13)31-21(23-15)25-18(27)12-30-22-24-16-9-10-29-19(16)20(28)26(22)14-5-3-2-4-6-14/h2-8,11H,9-10,12H2,1H3,(H,23,25,27)",
        "inchikey": "WRKPZSMRWPJJDH-UHFFFAOYSA-N",
        "iupac": {
          "systematic": "N-(6-methyl-1,3-benzothiazol-2-yl)-2-[(4-oxo-3-phenyl-6,7-dihydrothieno[3,2-d]pyrimidin-2-yl)sulfanyl]acetamide"
        },
        "smiles": {
          "canonical": "CC1=CC2=C(C=C1)N=C(S2)NC(=O)CSC3=NC4=C(C(=O)N3C5=CC=CC=C5)SCC4"
        },
        "molecularFormula": "C22H18N4O2S3"
      }
    ],
    "clinicaltrials": [
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01677273",
            "briefTitle": "The Effect of Hydrolyzed Casein on Energy Expenditure and Subjective Appetite",
            "officialTitle": "The Effect of Hydrolyzed Casein on Energy Expenditure and Subjective Appetite"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2012-08-29"
          },
          "conditionsModule": {
            "conditions": [
              "Increased Energy Expenditure",
              "Increased Satiety"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Diet-induced thermogenesis",
                "timeFrame": "24 hours"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Appetite assessed by visual analogue scales"
              },
              {
                "measure": "Appetite assessed by ad libitum energy intake"
              },
              {
                "measure": "Appetite regulating hormones in plasma"
              },
              {
                "measure": "Components of respiratory measures (basal metabolic rate, sleeping metabolic rate and substrate oxidations)"
              },
              {
                "measure": "Differences in insulin, glucose and atrial natriuretic peptide"
              },
              {
                "measure": "Ad libitum energy intake assessed by 24 hour dietary records"
              },
              {
                "measure": "NMR-spectroscopy based metabonomics profiling of urin"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT03926247",
            "briefTitle": "Immigrant Well-being Project: Transdisciplinary Ecological Mental Health Intervention for Mexican Immigrants",
            "officialTitle": "Addressing the Social-Structural Determinants of Mental Health Through Adaptation of a Transdisciplinary Ecological Intervention Model for Mexican Immigrants"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2019-04-12",
            "resultsFirstSubmitDate": "2024-05-10"
          },
          "conditionsModule": {
            "conditions": [
              "Mental Health"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Linear Change From Baseline to 14-month Follow-up in Depression/Anxiety Symptom Score Assessed by the Hopkins Symptom Checklist-25",
                "timeFrame": "Timepoints used in calculation: baseline, 3 months (mid), 6 months (post), 14 months (follow-up)"
              },
              {
                "measure": "Linear Change From Baseline to 14-month Follow-up in PTSD Symptom Score Assessed by the PTSD Symptom Checklist (Civilian Version)",
                "timeFrame": "Timepoints used in calculation: baseline, 3 months (mid), 6 months (post), 14 months (follow-up)"
              },
              {
                "measure": "Linear Change From Baseline to 14-month Follow-up in Stress Assessed by the Abbreviated Hispanic Stress Inventory Scale - Culturally-Specific Distress",
                "timeFrame": "Timepoints used in calculation: baseline, 3 months (mid), 6 months (post), 14 months (follow-up)"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Linear Change From Baseline to 14-month Follow-up in Social Support Assessed by the Multi-Sector Social Support Inventory"
              },
              {
                "measure": "Linear Change From Baseline to 14-month Follow-up in Access to Resources Assessed by the Satisfaction With Resources Scale"
              },
              {
                "measure": "Linear Change From Baseline to 14-month Follow-up in Access to Resources Assessed by the Difficulty Accessing Resources Scale"
              },
              {
                "measure": "Linear Change From Baseline to 14-month Follow-up in Quality of Life Assessed by the World Health Organization Quality of Life Assessment"
              }
            ]
          }
        }
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:14:05Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82e3"
    },
    "name": "CAY-10594",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82e3.png",
    "lincs": {
      "id": "LSM-6256",
      "name": "CAY-10594",
      "alternativeNames": [
        "CAY10594"
      ],
      "pubchemCid": 25105715,
      "chebiId": 95023,
      "inchiParent": "InChI=1S/C26H28N4O2/c31-24(22-11-10-20-6-4-5-7-21(20)18-22)27-14-17-29-15-12-26(13-16-29)25(32)28-19-30(26)23-8-2-1-3-9-23/h1-11,18H,12-17,19H2,(H,27,31)(H,28,32)",
      "inchiKeyParent": "FAIFAFUXFFWVNQ-UHFFFAOYSA-N",
      "smilesParent": "O=C(NCCN1CCC2(CC1)N(CNC2=O)c3ccccc3)c4ccc5ccccc5c4"
    },
    "unichem": {
      "chebi": "95023",
      "chembl": "CHEMBL511475",
      "lincs": "LSM-6256",
      "pubchem": "25105715"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL511475",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 428.54,
        "hba": 4,
        "hbd": 2,
        "qedWeighted": 0.66
      }
    },
    "pubchem": [
      {
        "cid": 25105715,
        "inchi": "InChI=1S/C26H28N4O2/c31-24(22-11-10-20-6-4-5-7-21(20)18-22)27-14-17-29-15-12-26(13-16-29)25(32)28-19-30(26)23-8-2-1-3-9-23/h1-11,18H,12-17,19H2,(H,27,31)(H,28,32)",
        "inchikey": "FAIFAFUXFFWVNQ-UHFFFAOYSA-N",
        "iupac": {
          "systematic": "N-[2-(4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)ethyl]naphthalene-2-carboxamide"
        },
        "smiles": {
          "canonical": "C1CN(CCC12C(=O)NCN2C3=CC=CC=C3)CCNC(=O)C4=CC5=CC=CC=C5C=C4"
        },
        "molecularFormula": "C26H28N4O2"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:14:16Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82ed"
    },
    "name": "BRD-K96663038",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82ed.png",
    "lincs": {
      "id": "LSM-14365",
      "name": "BRD-K96663038",
      "pubchemCid": 54654342,
      "chebiId": 103019,
      "inchiParent": "InChI=1S/C32H36N4O6/c1-36-27-13-12-25(19-30(37)33-16-15-21-7-4-3-5-8-21)42-29(27)20-41-28-14-11-23(18-26(28)31(36)38)35-32(39)34-22-9-6-10-24(17-22)40-2/h3-11,14,17-18,25,27,29H,12-13,15-16,19-20H2,1-2H3,(H,33,37)(H2,34,35,39)/t25-,27-,29+/m1/s1",
      "inchiKeyParent": "UEIQSFPBDLFQGU-NLFWHDTNSA-N",
      "smilesParent": "COc1cccc(NC(=O)Nc2ccc3OC[C@@H]4O[C@@H](CC(=O)NCCc5ccccc5)CC[C@H]4N(C)C(=O)c3c2)c1"
    },
    "unichem": {
      "chebi": "103019",
      "lincs": "LSM-14365",
      "pubchem": "54654342"
    },
    "pubchem": [
      {
        "cid": 54654342,
        "inchi": "InChI=1S/C32H36N4O6/c1-36-27-13-12-25(19-30(37)33-16-15-21-7-4-3-5-8-21)42-29(27)20-41-28-14-11-23(18-26(28)31(36)38)35-32(39)34-22-9-6-10-24(17-22)40-2/h3-11,14,17-18,25,27,29H,12-13,15-16,19-20H2,1-2H3,(H,33,37)(H2,34,35,39)/t25-,27-,29+/m1/s1",
        "inchikey": "UEIQSFPBDLFQGU-NLFWHDTNSA-N",
        "iupac": {
          "systematic": "2-[(2R,4aR,12aR)-8-[(3-methoxyphenyl)carbamoylamino]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(2-phenylethyl)acetamide"
        },
        "smiles": {
          "canonical": "CN1C2CCC(OC2COC3=C(C1=O)C=C(C=C3)NC(=O)NC4=CC(=CC=C4)OC)CC(=O)NCCC5=CC=CC=C5"
        },
        "molecularFormula": "C32H36N4O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:14:19Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8302"
    },
    "name": "BRD-K10701104",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8302.png",
    "lincs": {
      "id": "LSM-9075",
      "name": "BRD-K10701104",
      "pubchemCid": 54661303,
      "chebiId": 97696,
      "inchiParent": "InChI=1S/C26H28N4O3/c1-29-22-15-30-21(10-9-19(26(30)33)18-8-5-12-27-14-18)24(29)23(20(22)16-31)25(32)28-13-11-17-6-3-2-4-7-17/h2-10,12,14,20,22-24,31H,11,13,15-16H2,1H3,(H,28,32)/t20-,22-,23+,24+/m1/s1",
      "inchiKeyParent": "MSLHGMMBDZHUMV-AZOUXBGGSA-N",
      "smilesParent": "CN1[C@@H]2CN3C(=CC=C(C3=O)c4cccnc4)[C@H]1[C@H]([C@@H]2CO)C(=O)NCCc5ccccc5"
    },
    "unichem": {
      "chebi": "97696",
      "lincs": "LSM-9075",
      "pubchem": "54661303"
    },
    "pubchem": [
      {
        "cid": 54661303,
        "inchi": "InChI=1S/C26H28N4O3/c1-29-22-15-30-21(10-9-19(26(30)33)18-8-5-12-27-14-18)24(29)23(20(22)16-31)25(32)28-13-11-17-6-3-2-4-7-17/h2-10,12,14,20,22-24,31H,11,13,15-16H2,1H3,(H,28,32)/t20-,22-,23+,24+/m1/s1",
        "inchikey": "MSLHGMMBDZHUMV-AZOUXBGGSA-N",
        "iupac": {
          "systematic": "(1R,9S,10S,11S)-10-(hydroxymethyl)-12-methyl-6-oxo-N-(2-phenylethyl)-5-pyridin-3-yl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide"
        },
        "smiles": {
          "canonical": "CN1C2CN3C(=CC=C(C3=O)C4=CN=CC=C4)C1C(C2CO)C(=O)NCCC5=CC=CC=C5"
        },
        "molecularFormula": "C26H28N4O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:14:21Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c830c"
    },
    "name": "BRD-K91684468",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c830c.png",
    "lincs": {
      "id": "LSM-43435",
      "name": "BRD-K91684468",
      "pubchemCid": 54618781,
      "inchiParent": "InChI=1S/C24H35N3O5/c1-5-6-18-11-20-22(25-12-18)32-21(16(2)13-27(24(20)30)17(3)15-28)14-26(4)23(29)19-7-9-31-10-8-19/h5-6,11-12,16-17,19,21,28H,7-10,13-15H2,1-4H3/b6-5+/t16-,17+,21+/m1/s1",
      "inchiKeyParent": "WESXQGCLCDUYEJ-RXTVBCQOSA-N",
      "smilesParent": "C\\C=C\\c1cnc2O[C@@H](CN(C)C(=O)C3CCOCC3)[C@H](C)CN([C@@H](C)CO)C(=O)c2c1"
    },
    "unichem": {
      "lincs": "LSM-43435",
      "pubchem": "54618781"
    },
    "pubchem": [
      {
        "cid": 54618781,
        "inchi": "InChI=1S/C24H35N3O5/c1-5-6-18-11-20-22(25-12-18)32-21(16(2)13-27(24(20)30)17(3)15-28)14-26(4)23(29)19-7-9-31-10-8-19/h5-6,11-12,16-17,19,21,28H,7-10,13-15H2,1-4H3/b6-5+/t16-,17+,21+/m1/s1",
        "inchikey": "WESXQGCLCDUYEJ-RXTVBCQOSA-N",
        "iupac": {
          "systematic": "N-[[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-prop-1-enyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyloxane-4-carboxamide"
        },
        "smiles": {
          "canonical": "CC=CC1=CC2=C(N=C1)OC(C(CN(C2=O)C(C)CO)C)CN(C)C(=O)C3CCOCC3"
        },
        "molecularFormula": "C24H35N3O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:14:23Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8313"
    },
    "name": "BRD-K19487261",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8313.png",
    "lincs": {
      "id": "LSM-9603",
      "name": "BRD-K19487261",
      "pubchemCid": 54638687,
      "chebiId": 98224,
      "inchiParent": "InChI=1S/C24H27F2N3O4/c25-17-5-7-19(26)21(11-17)28-24(32)27-20-8-6-18(33-22(20)14-30)12-23(31)29-10-9-15-3-1-2-4-16(15)13-29/h1-5,7,11,18,20,22,30H,6,8-10,12-14H2,(H2,27,28,32)/t18-,20+,22+/m1/s1",
      "inchiKeyParent": "BOSRLBMZBBTOKS-CBQOVEMMSA-N",
      "smilesParent": "OC[C@@H]1O[C@@H](CC(=O)N2CCc3ccccc3C2)CC[C@@H]1NC(=O)Nc4cc(F)ccc4F"
    },
    "unichem": {
      "chebi": "98224",
      "lincs": "LSM-9603",
      "pubchem": "54638687"
    },
    "pubchem": [
      {
        "cid": 54638687,
        "inchi": "InChI=1S/C24H27F2N3O4/c25-17-5-7-19(26)21(11-17)28-24(32)27-20-8-6-18(33-22(20)14-30)12-23(31)29-10-9-15-3-1-2-4-16(15)13-29/h1-5,7,11,18,20,22,30H,6,8-10,12-14H2,(H2,27,28,32)/t18-,20+,22+/m1/s1",
        "inchikey": "BOSRLBMZBBTOKS-CBQOVEMMSA-N",
        "iupac": {
          "systematic": "1-(2,5-difluorophenyl)-3-[(2R,3S,6R)-6-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-2-(hydroxymethyl)oxan-3-yl]urea"
        },
        "smiles": {
          "canonical": "C1CC(C(OC1CC(=O)N2CCC3=CC=CC=C3C2)CO)NC(=O)NC4=C(C=CC(=C4)F)F"
        },
        "molecularFormula": "C24H27F2N3O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:14:25Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c834a"
    },
    "name": "BRD-K68552135",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c834a.png",
    "lincs": {
      "id": "LSM-12610",
      "name": "BRD-K68552135",
      "pubchemCid": 54632071,
      "chebiId": 101242,
      "inchiParent": "InChI=1S/C25H33N5O6/c1-16-12-30(23(31)15-34-4)17(2)14-36-21-10-18(28-24(32)20-11-26-8-9-27-20)6-7-19(21)25(33)29(3)13-22(16)35-5/h6-11,16-17,22H,12-15H2,1-5H3,(H,28,32)/t16-,17+,22+/m1/s1",
      "inchiKeyParent": "CTEQLXWVFDYWAW-JLHGSKIFSA-N",
      "smilesParent": "COCC(=O)N1C[C@@H](C)[C@H](CN(C)C(=O)c2ccc(NC(=O)c3cnccn3)cc2OC[C@@H]1C)OC"
    },
    "unichem": {
      "chebi": "101242",
      "lincs": "LSM-12610",
      "pubchem": "54632071"
    },
    "pubchem": [
      {
        "cid": 54632071,
        "inchi": "InChI=1S/C25H33N5O6/c1-16-12-30(23(31)15-34-4)17(2)14-36-21-10-18(28-24(32)20-11-26-8-9-27-20)6-7-19(21)25(33)29(3)13-22(16)35-5/h6-11,16-17,22H,12-15H2,1-5H3,(H,28,32)/t16-,17+,22+/m1/s1",
        "inchikey": "CTEQLXWVFDYWAW-JLHGSKIFSA-N",
        "iupac": {
          "systematic": "N-[(4S,7R,8R)-8-methoxy-5-(2-methoxyacetyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-15-yl]pyrazine-2-carboxamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(COC2=C(C=CC(=C2)NC(=O)C3=NC=CN=C3)C(=O)N(CC1OC)C)C)C(=O)COC"
        },
        "molecularFormula": "C25H33N5O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:14:28Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82da"
    },
    "name": "BRD-K70166659",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82da.png",
    "lincs": {
      "id": "LSM-12710",
      "name": "BRD-K70166659",
      "pubchemCid": 54657799,
      "chebiId": 101345,
      "inchiParent": "InChI=1S/C21H31N3O6/c1-23(2)20(26)10-17-7-8-18-19(30-17)13-29-12-15(25)11-24(18)21(27)22-14-5-4-6-16(9-14)28-3/h4-6,9,15,17-19,25H,7-8,10-13H2,1-3H3,(H,22,27)/t15-,17-,18-,19+/m0/s1",
      "inchiKeyParent": "SSPYWNJKRFMGCQ-DSLXNQLJSA-N",
      "smilesParent": "COc1cccc(NC(=O)N2C[C@H](O)COC[C@H]3O[C@H](CC(=O)N(C)C)CC[C@H]23)c1"
    },
    "unichem": {
      "chebi": "101345",
      "lincs": "LSM-12710",
      "pubchem": "54657799"
    },
    "pubchem": [
      {
        "cid": 54657799,
        "inchi": "InChI=1S/C21H31N3O6/c1-23(2)20(26)10-17-7-8-18-19(30-17)13-29-12-15(25)11-24(18)21(27)22-14-5-4-6-16(9-14)28-3/h4-6,9,15,17-19,25H,7-8,10-13H2,1-3H3,(H,22,27)/t15-,17-,18-,19+/m0/s1",
        "inchikey": "SSPYWNJKRFMGCQ-DSLXNQLJSA-N",
        "iupac": {
          "systematic": "(3S,6aS,8S,10aS)-8-[2-(dimethylamino)-2-oxoethyl]-3-hydroxy-N-(3-methoxyphenyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide"
        },
        "smiles": {
          "canonical": "CN(C)C(=O)CC1CCC2C(O1)COCC(CN2C(=O)NC3=CC(=CC=C3)OC)O"
        },
        "molecularFormula": "C21H31N3O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:14:30Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8314"
    },
    "name": "BRD-K10046096",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8314.png",
    "lincs": {
      "id": "LSM-6981",
      "name": "BRD-K10046096",
      "pubchemCid": 44505646,
      "chebiId": 95602,
      "inchiParent": "InChI=1S/C26H36N6O3/c1-19-14-31(20(2)17-33)26(34)7-5-11-32-23(13-28-29-32)18-35-25(19)16-30(3)15-21-8-9-22-6-4-10-27-24(22)12-21/h4,6,8-10,12-13,19-20,25,33H,5,7,11,14-18H2,1-3H3/t19-,20+,25-/m0/s1",
      "inchiKeyParent": "OLIWWUKSUJJEPA-DFIYOIEZSA-N",
      "smilesParent": "C[C@H](CO)N1C[C@H](C)[C@H](CN(C)Cc2ccc3cccnc3c2)OCc4cnnn4CCCC1=O"
    },
    "unichem": {
      "chebi": "95602",
      "lincs": "LSM-6981",
      "pubchem": "44505646"
    },
    "pubchem": [
      {
        "cid": 44505646,
        "inchi": "InChI=1S/C26H36N6O3/c1-19-14-31(20(2)17-33)26(34)7-5-11-32-23(13-28-29-32)18-35-25(19)16-30(3)15-21-8-9-22-6-4-10-27-24(22)12-21/h4,6,8-10,12-13,19-20,25,33H,5,7,11,14-18H2,1-3H3/t19-,20+,25-/m0/s1",
        "inchikey": "OLIWWUKSUJJEPA-DFIYOIEZSA-N",
        "iupac": {
          "systematic": "(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl(quinolin-7-ylmethyl)amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)CCCN2C(=CN=N2)COC1CN(C)CC3=CC4=C(C=CC=N4)C=C3)C(C)CO"
        },
        "molecularFormula": "C26H36N6O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:14:33Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c833c"
    },
    "name": "BRD-K86618560",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c833c.png",
    "lincs": {
      "id": "LSM-13732",
      "name": "BRD-K86618560",
      "pubchemCid": 54638374,
      "chebiId": 102381,
      "inchiParent": "InChI=1S/C20H23FN4O4/c21-14-3-1-13(2-4-14)20(28)25-17-6-5-16(29-18(17)11-26)9-19(27)23-10-15-7-8-22-12-24-15/h1-4,7-8,12,16-18,26H,5-6,9-11H2,(H,23,27)(H,25,28)/t16-,17+,18-/m0/s1",
      "inchiKeyParent": "KXCVLZMSFBFHGZ-KSZLIROESA-N",
      "smilesParent": "OC[C@@H]1O[C@H](CC(=O)NCc2ccncn2)CC[C@H]1NC(=O)c3ccc(F)cc3"
    },
    "unichem": {
      "chebi": "102381",
      "lincs": "LSM-13732",
      "pubchem": "54638374"
    },
    "pubchem": [
      {
        "cid": 54638374,
        "inchi": "InChI=1S/C20H23FN4O4/c21-14-3-1-13(2-4-14)20(28)25-17-6-5-16(29-18(17)11-26)9-19(27)23-10-15-7-8-22-12-24-15/h1-4,7-8,12,16-18,26H,5-6,9-11H2,(H,23,27)(H,25,28)/t16-,17+,18-/m0/s1",
        "inchikey": "KXCVLZMSFBFHGZ-KSZLIROESA-N",
        "iupac": {
          "systematic": "4-fluoro-N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(pyrimidin-4-ylmethylamino)ethyl]oxan-3-yl]benzamide"
        },
        "smiles": {
          "canonical": "C1CC(C(OC1CC(=O)NCC2=NC=NC=C2)CO)NC(=O)C3=CC=C(C=C3)F"
        },
        "molecularFormula": "C20H23FN4O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:14:35Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c826c"
    },
    "name": "BRD-K84568319",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c826c.png",
    "lincs": {
      "id": "LSM-44882",
      "name": "BRD-K84568319",
      "pubchemCid": 54664818,
      "inchiParent": "InChI=1S/C23H27N3O2/c1-3-5-16-7-8-20-19(12-16)23-18(21(15-27)25(20)2)9-11-26(23)22(28)13-17-6-4-10-24-14-17/h3-8,10,12,14,18,21,23,27H,9,11,13,15H2,1-2H3/b5-3+/t18-,21+,23-/m0/s1",
      "inchiKeyParent": "NAOWZUCOFVWKRA-AJPAZJGKSA-N",
      "smilesParent": "C\\C=C\\c1ccc2N(C)[C@H](CO)[C@@H]3CCN([C@@H]3c2c1)C(=O)Cc4cccnc4"
    },
    "unichem": {
      "lincs": "LSM-44882",
      "pubchem": "54664818"
    },
    "pubchem": [
      {
        "cid": 54664818,
        "inchi": "InChI=1S/C23H27N3O2/c1-3-5-16-7-8-20-19(12-16)23-18(21(15-27)25(20)2)9-11-26(23)22(28)13-17-6-4-10-24-14-17/h3-8,10,12,14,18,21,23,27H,9,11,13,15H2,1-2H3/b5-3+/t18-,21+,23-/m0/s1",
        "inchikey": "NAOWZUCOFVWKRA-AJPAZJGKSA-N",
        "iupac": {
          "systematic": "1-[(3aR,4S,9bS)-4-(hydroxymethyl)-5-methyl-8-[(E)-prop-1-enyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-1-yl]-2-pyridin-3-ylethanone"
        },
        "smiles": {
          "canonical": "CC=CC1=CC2=C(C=C1)N(C(C3C2N(CC3)C(=O)CC4=CN=CC=C4)CO)C"
        },
        "molecularFormula": "C23H27N3O2"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:14:37Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82f4"
    },
    "name": "CHEMBL2362365",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82f4.png",
    "lincs": {
      "id": "LSM-8427",
      "name": "CHEMBL2362365",
      "alternativeNames": [
        "BRD-K00043782"
      ],
      "pubchemCid": 56835356,
      "chebiId": 97048,
      "inchiParent": "InChI=1S/C35H42N4O5/c1-23-19-39(24(2)21-40)34(41)33-32(29-12-8-9-13-30(29)38(33)4)28-11-7-6-10-26(28)22-44-31(23)20-37(3)35(42)36-18-25-14-16-27(43-5)17-15-25/h6-17,23-24,31,40H,18-22H2,1-5H3,(H,36,42)/t23-,24-,31+/m0/s1",
      "inchiKeyParent": "GHOSBDATJBJZOG-ISTJGCCRSA-N",
      "smilesParent": "COc1ccc(CNC(=O)N(C)C[C@H]2OCc3ccccc3c4c(C(=O)N(C[C@@H]2C)[C@@H](C)CO)n(C)c5ccccc45)cc1"
    },
    "unichem": {
      "chebi": "97048",
      "chembl": "CHEMBL2362365",
      "lincs": "LSM-8427",
      "pubchem": "56835356"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL2362365",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 598.74,
        "hba": 6,
        "hbd": 2,
        "qedWeighted": 0.31
      }
    },
    "pubchem": [
      {
        "cid": 56835356,
        "inchi": "InChI=1S/C35H42N4O5/c1-23-19-39(24(2)21-40)34(41)33-32(29-12-8-9-13-30(29)38(33)4)28-11-7-6-10-26(28)22-44-31(23)20-37(3)35(42)36-18-25-14-16-27(43-5)17-15-25/h6-17,23-24,31,40H,18-22H2,1-5H3,(H,36,42)/t23-,24-,31+/m0/s1",
        "inchikey": "GHOSBDATJBJZOG-ISTJGCCRSA-N",
        "iupac": {
          "systematic": "1-[[(10S,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-3-[(4-methoxyphenyl)methyl]-1-methylurea"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(C3=CC=CC=C3COC1CN(C)C(=O)NCC4=CC=C(C=C4)OC)C5=CC=CC=C5N2C)C(C)CO"
        },
        "molecularFormula": "C35H42N4O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:14:48Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8342"
    },
    "name": "BRD-K67190692",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8342.png",
    "lincs": {
      "id": "LSM-12517",
      "name": "BRD-K67190692",
      "pubchemCid": 54654528,
      "chebiId": 101148,
      "inchiParent": "InChI=1S/C24H23F3N2O6/c1-29-18-7-6-16(11-21(30)31)35-20(18)12-34-19-8-5-15(10-17(19)23(29)33)28-22(32)13-3-2-4-14(9-13)24(25,26)27/h2-5,8-10,16,18,20H,6-7,11-12H2,1H3,(H,28,32)(H,30,31)/t16-,18-,20-/m0/s1",
      "inchiKeyParent": "MPULVBUDJGIXBK-QRFRQXIXSA-N",
      "smilesParent": "CN1[C@H]2CC[C@@H](CC(=O)O)O[C@H]2COc3ccc(NC(=O)c4cccc(c4)C(F)(F)F)cc3C1=O"
    },
    "unichem": {
      "chebi": "101148",
      "lincs": "LSM-12517",
      "pubchem": "54654528"
    },
    "pubchem": [
      {
        "cid": 54654528,
        "inchi": "InChI=1S/C24H23F3N2O6/c1-29-18-7-6-16(11-21(30)31)35-20(18)12-34-19-8-5-15(10-17(19)23(29)33)28-22(32)13-3-2-4-14(9-13)24(25,26)27/h2-5,8-10,16,18,20H,6-7,11-12H2,1H3,(H,28,32)(H,30,31)/t16-,18-,20-/m0/s1",
        "inchikey": "MPULVBUDJGIXBK-QRFRQXIXSA-N",
        "iupac": {
          "systematic": "2-[(2S,4aS,12aR)-5-methyl-6-oxo-8-[[3-(trifluoromethyl)benzoyl]amino]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]acetic acid"
        },
        "smiles": {
          "canonical": "CN1C2CCC(OC2COC3=C(C1=O)C=C(C=C3)NC(=O)C4=CC(=CC=C4)C(F)(F)F)CC(=O)O"
        },
        "molecularFormula": "C24H23F3N2O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:14:51Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c828c"
    },
    "name": "BRD-K28594113",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c828c.png",
    "lincs": {
      "id": "LSM-38829",
      "name": "BRD-K28594113",
      "pubchemCid": 54666637,
      "chebiId": 127269,
      "inchiParent": "InChI=1S/C26H29FN4O/c27-23-6-2-1-5-22(23)20-7-9-21(10-8-20)26-24-16-30(15-19-13-28-18-29-14-19)11-3-4-12-31(24)25(26)17-32/h1-2,5-10,13-14,18,24-26,32H,3-4,11-12,15-17H2/t24-,25-,26+/m0/s1",
      "inchiKeyParent": "XNSBVUHLLQGYEX-KKUQBAQOSA-N",
      "smilesParent": "OC[C@H]1[C@@H]([C@@H]2CN(Cc3cncnc3)CCCCN12)c4ccc(cc4)c5ccccc5F"
    },
    "unichem": {
      "chebi": "127269",
      "lincs": "LSM-38829",
      "pubchem": "54666637"
    },
    "pubchem": [
      {
        "cid": 54666637,
        "inchi": "InChI=1S/C26H29FN4O/c27-23-6-2-1-5-22(23)20-7-9-21(10-8-20)26-24-16-30(15-19-13-28-18-29-14-19)11-3-4-12-31(24)25(26)17-32/h1-2,5-10,13-14,18,24-26,32H,3-4,11-12,15-17H2/t24-,25-,26+/m0/s1",
        "inchikey": "XNSBVUHLLQGYEX-KKUQBAQOSA-N",
        "iupac": {
          "systematic": "[(8R,9R,10R)-9-[4-(2-fluorophenyl)phenyl]-6-(pyrimidin-5-ylmethyl)-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol"
        },
        "smiles": {
          "canonical": "C1CCN2C(CN(C1)CC3=CN=CN=C3)C(C2CO)C4=CC=C(C=C4)C5=CC=CC=C5F"
        },
        "molecularFormula": "C26H29FN4O"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:14:53Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82cb"
    },
    "name": "BRD-K65385622",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82cb.png",
    "lincs": {
      "id": "LSM-40842",
      "name": "BRD-K65385622",
      "pubchemCid": 54665025,
      "chebiId": 129291,
      "inchiParent": "InChI=1S/C26H22FN3O2/c27-22-7-2-1-6-19(22)26(32)30-11-10-20-24(15-31)29-23-9-8-18(13-21(23)25(20)30)17-5-3-4-16(12-17)14-28/h1-9,12-13,20,24-25,29,31H,10-11,15H2/t20-,24+,25-/m0/s1",
      "inchiKeyParent": "GUNIHDHNDNIIMI-AMDXRBSFSA-N",
      "smilesParent": "OC[C@H]1Nc2ccc(cc2[C@@H]3[C@H]1CCN3C(=O)c4ccccc4F)c5cccc(c5)C#N"
    },
    "unichem": {
      "chebi": "129291",
      "lincs": "LSM-40842",
      "pubchem": "54665025"
    },
    "pubchem": [
      {
        "cid": 54665025,
        "inchi": "InChI=1S/C26H22FN3O2/c27-22-7-2-1-6-19(22)26(32)30-11-10-20-24(15-31)29-23-9-8-18(13-21(23)25(20)30)17-5-3-4-16(12-17)14-28/h1-9,12-13,20,24-25,29,31H,10-11,15H2/t20-,24+,25-/m0/s1",
        "inchikey": "GUNIHDHNDNIIMI-AMDXRBSFSA-N",
        "iupac": {
          "systematic": "3-[(3aS,4S,9bS)-1-(2-fluorobenzoyl)-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-8-yl]benzonitrile"
        },
        "smiles": {
          "canonical": "C1CN(C2C1C(NC3=C2C=C(C=C3)C4=CC=CC(=C4)C#N)CO)C(=O)C5=CC=CC=C5F"
        },
        "molecularFormula": "C26H22FN3O2"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:14:55Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82db"
    },
    "name": "BRD-K72915790-001-01-9",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82db.png",
    "lincs": {
      "id": "LSM-12892",
      "name": "BRD-K72915790-001-01-9",
      "alternativeNames": [
        "BRD-K72915790"
      ],
      "pubchemCid": 54638443,
      "chebiId": 101529,
      "inchiParent": "InChI=1S/C15H21FN2O3/c16-12-4-2-1-3-11(12)15(20)18-13-6-5-10(7-8-17)21-14(13)9-19/h1-4,10,13-14,19H,5-9,17H2,(H,18,20)/t10-,13-,14-/m1/s1",
      "inchiKeyParent": "DUQQDWAUZUWJHX-LERXQTSPSA-N",
      "smilesParent": "NCC[C@H]1CC[C@@H](NC(=O)c2ccccc2F)[C@@H](CO)O1"
    },
    "unichem": {
      "chebi": "101529",
      "lincs": "LSM-12892",
      "pubchem": "54638443"
    },
    "pubchem": [
      {
        "cid": 54638443,
        "inchi": "InChI=1S/C15H21FN2O3/c16-12-4-2-1-3-11(12)15(20)18-13-6-5-10(7-8-17)21-14(13)9-19/h1-4,10,13-14,19H,5-9,17H2,(H,18,20)/t10-,13-,14-/m1/s1",
        "inchikey": "DUQQDWAUZUWJHX-LERXQTSPSA-N",
        "iupac": {
          "systematic": "N-[(2S,3R,6R)-6-(2-aminoethyl)-2-(hydroxymethyl)oxan-3-yl]-2-fluorobenzamide"
        },
        "smiles": {
          "canonical": "C1CC(C(OC1CCN)CO)NC(=O)C2=CC=CC=C2F"
        },
        "molecularFormula": "C15H21FN2O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:14:58Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c830a"
    },
    "name": "BRD-K42216874",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c830a.png",
    "lincs": {
      "id": "LSM-10992",
      "name": "BRD-K42216874",
      "pubchemCid": 54654037,
      "chebiId": 99613,
      "inchiParent": "InChI=1S/C31H33ClN4O5/c1-19-6-5-8-21(14-19)34-31(39)35-22-10-13-27-24(15-22)30(38)36(2)26-12-11-23(41-28(26)18-40-27)16-29(37)33-17-20-7-3-4-9-25(20)32/h3-10,13-15,23,26,28H,11-12,16-18H2,1-2H3,(H,33,37)(H2,34,35,39)/t23-,26+,28+/m0/s1",
      "inchiKeyParent": "SECMWWJMRQEFAV-DANFDKMISA-N",
      "smilesParent": "CN1[C@@H]2CC[C@@H](CC(=O)NCc3ccccc3Cl)O[C@@H]2COc4ccc(NC(=O)Nc5cccc(C)c5)cc4C1=O"
    },
    "unichem": {
      "chebi": "99613",
      "lincs": "LSM-10992",
      "pubchem": "54654037"
    },
    "pubchem": [
      {
        "cid": 54654037,
        "inchi": "InChI=1S/C31H33ClN4O5/c1-19-6-5-8-21(14-19)34-31(39)35-22-10-13-27-24(15-22)30(38)36(2)26-12-11-23(41-28(26)18-40-27)16-29(37)33-17-20-7-3-4-9-25(20)32/h3-10,13-15,23,26,28H,11-12,16-18H2,1-2H3,(H,33,37)(H2,34,35,39)/t23-,26+,28+/m0/s1",
        "inchikey": "SECMWWJMRQEFAV-DANFDKMISA-N",
        "iupac": {
          "systematic": "2-[(2S,4aR,12aS)-5-methyl-8-[(3-methylphenyl)carbamoylamino]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-[(2-chlorophenyl)methyl]acetamide"
        },
        "smiles": {
          "canonical": "CC1=CC(=CC=C1)NC(=O)NC2=CC3=C(C=C2)OCC4C(CCC(O4)CC(=O)NCC5=CC=CC=C5Cl)N(C3=O)C"
        },
        "molecularFormula": "C31H33ClN4O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:15:00Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8278"
    },
    "name": "CHEMBL3183018",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8278.png",
    "lincs": {
      "id": "LSM-37570",
      "name": "CHEMBL3183018",
      "alternativeNames": [
        "BRD-K05620072"
      ],
      "pubchemCid": 54664848,
      "chebiId": 126003,
      "inchiParent": "InChI=1S/C25H31N3O4/c1-31-19-5-2-17(3-6-19)18-4-7-22-21(14-18)25-20(23(16-29)26-22)8-9-28(25)24(30)15-27-10-12-32-13-11-27/h2-7,14,20,23,25-26,29H,8-13,15-16H2,1H3/t20-,23-,25-/m0/s1",
      "inchiKeyParent": "VBHFXKMGVUKTSE-OPHFCASCSA-N",
      "smilesParent": "COc1ccc(cc1)c2ccc3N[C@@H](CO)[C@@H]4CCN([C@@H]4c3c2)C(=O)CN5CCOCC5"
    },
    "unichem": {
      "chebi": "126003",
      "chembl": "CHEMBL3183018",
      "lincs": "LSM-37570",
      "pubchem": "54664848"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL3183018",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 437.54,
        "hba": 6,
        "hbd": 2,
        "qedWeighted": 0.75
      }
    },
    "pubchem": [
      {
        "cid": 54664848,
        "inchi": "InChI=1S/C25H31N3O4/c1-31-19-5-2-17(3-6-19)18-4-7-22-21(14-18)25-20(23(16-29)26-22)8-9-28(25)24(30)15-27-10-12-32-13-11-27/h2-7,14,20,23,25-26,29H,8-13,15-16H2,1H3/t20-,23-,25-/m0/s1",
        "inchikey": "VBHFXKMGVUKTSE-OPHFCASCSA-N",
        "iupac": {
          "systematic": "1-[(3aS,4R,9bS)-4-(hydroxymethyl)-8-(4-methoxyphenyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-2-morpholin-4-ylethanone"
        },
        "smiles": {
          "canonical": "COC1=CC=C(C=C1)C2=CC3=C(C=C2)NC(C4C3N(CC4)C(=O)CN5CCOCC5)CO"
        },
        "molecularFormula": "C25H31N3O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:15:11Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8287"
    },
    "name": "BRD-K38477985",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8287.png",
    "lincs": {
      "id": "LSM-2854",
      "name": "BRD-K38477985",
      "alternativeNames": [
        "Malonoben"
      ],
      "pubchemCid": 44483329,
      "chebiId": 92678,
      "inchiParent": "InChI=1S/C18H22N2O/c1-17(2,3)14-9-12(8-13(11-19)20-7)10-15(16(14)21)18(4,5)6/h8-10,21H,1-6H3",
      "inchiKeyParent": "MKUVGSJPVXTADZ-UHFFFAOYSA-N",
      "smilesParent": "CC(C)(C)c1cc(C=C(C#N)[N+]#[C-])cc(c1O)C(C)(C)C"
    },
    "unichem": {
      "chebi": "92678",
      "lincs": "LSM-2854",
      "pubchem": "44483329"
    },
    "pubchem": [
      {
        "cid": 44483329,
        "inchi": "InChI=1S/C18H22N2O/c1-17(2,3)14-9-12(8-13(11-19)20-7)10-15(16(14)21)18(4,5)6/h8-10,21H,1-6H3",
        "inchikey": "MKUVGSJPVXTADZ-UHFFFAOYSA-N",
        "iupac": {
          "systematic": "3-(3,5-ditert-butyl-4-hydroxyphenyl)-2-isocyanoprop-2-enenitrile"
        },
        "smiles": {
          "canonical": "CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)C=C(C#N)[N+]#[C-]"
        },
        "molecularFormula": "C18H22N2O"
      }
    ],
    "clinicaltrials": [
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT05487781",
            "briefTitle": "Phase 1 Clinical Study to Describe Biological Safety and Pharmacokinetics of Tyrphostin",
            "officialTitle": "Phase 1 Clinical Study To Describe the Biological Safety and Pharmacokinetics of Tyrphostin AG-17 Present in Oral Solid Formulations of the Fixed Dose Combination, in Three Different Concentrations of the Compound Tyrphostin AG-17 Content 10 mg, 3.3 mg and 1 mg Respectively, With 700 mg of L-Carnitine Tartrate Each Presentation, in a Single Dose in Healthy Research Subjects of Mexican Nationality"
          },
          "statusModule": {
            "overallStatus": "UNKNOWN",
            "studyFirstSubmitDate": "2022-03-01"
          },
          "conditionsModule": {
            "conditions": [
              "Healthy"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Tolerance assessment",
                "timeFrame": "30 days"
              }
            ]
          }
        }
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:15:14Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82e0"
    },
    "name": "BRD-K85114251",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82e0.png",
    "lincs": {
      "id": "LSM-41915",
      "name": "BRD-K85114251",
      "pubchemCid": 54649609,
      "chebiId": 130366,
      "inchiParent": "InChI=1S/C25H35N3O6/c1-16-21(32-5)14-28(3)25(30)19-8-6-7-17(13-26)23(19)33-12-11-18-9-10-20(31-4)22(34-18)15-27(2)24(16)29/h6-8,16,18,20-22H,9-12,14-15H2,1-5H3/t16-,18+,20+,21+,22-/m0/s1",
      "inchiKeyParent": "KKWAEGUSNQIREC-GMOZNSKDSA-N",
      "smilesParent": "CO[C@@H]1CC[C@@H]2CCOc3c(cccc3C(=O)N(C)C[C@@H](OC)[C@H](C)C(=O)N(C)C[C@@H]1O2)C#N"
    },
    "unichem": {
      "chebi": "130366",
      "lincs": "LSM-41915",
      "pubchem": "54649609"
    },
    "pubchem": [
      {
        "cid": 54649609,
        "inchi": "InChI=1S/C25H35N3O6/c1-16-21(32-5)14-28(3)25(30)19-8-6-7-17(13-26)23(19)33-12-11-18-9-10-20(31-4)22(34-18)15-27(2)24(16)29/h6-8,16,18,20-22H,9-12,14-15H2,1-5H3/t16-,18+,20+,21+,22-/m0/s1",
        "inchikey": "KKWAEGUSNQIREC-GMOZNSKDSA-N",
        "iupac": {
          "systematic": "(1R,14S,15S,19S,20R)-14,20-dimethoxy-12,15,17-trimethyl-11,16-dioxo-4,23-dioxa-12,17-diazatricyclo[17.3.1.05,10]tricosa-5,7,9-triene-6-carbonitrile"
        },
        "smiles": {
          "canonical": "CC1C(CN(C(=O)C2=CC=CC(=C2OCCC3CCC(C(O3)CN(C1=O)C)OC)C#N)C)OC"
        },
        "molecularFormula": "C25H35N3O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:15:16Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c827d"
    },
    "name": "BRD-K93112400",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c827d.png",
    "lincs": {
      "id": "LSM-14140",
      "name": "BRD-K93112400",
      "pubchemCid": 54649412,
      "chebiId": 102794,
      "inchiParent": "InChI=1S/C28H32FN3O3S/c1-5-30-27(34)23-16-21-17-32(36(35)28(2,3)4)24(12-13-33)25(21)26(31-23)20-10-6-8-18(14-20)19-9-7-11-22(29)15-19/h6-11,14-16,24,33H,5,12-13,17H2,1-4H3,(H,30,34)/t24-,36-/m0/s1",
      "inchiKeyParent": "NQAKFRRPCXCRFS-TVYQXRCNSA-N",
      "smilesParent": "CCNC(=O)c1cc2CN([C@@H](CCO)c2c(n1)c3cccc(c3)c4cccc(F)c4)[S@@](=O)C(C)(C)C"
    },
    "unichem": {
      "chebi": "102794",
      "lincs": "LSM-14140",
      "pubchem": "54649412"
    },
    "pubchem": [
      {
        "cid": 54649412,
        "inchi": "InChI=1S/C28H32FN3O3S/c1-5-30-27(34)23-16-21-17-32(36(35)28(2,3)4)24(12-13-33)25(21)26(31-23)20-10-6-8-18(14-20)19-9-7-11-22(29)15-19/h6-11,14-16,24,33H,5,12-13,17H2,1-4H3,(H,30,34)/t24-,36-/m0/s1",
        "inchikey": "NQAKFRRPCXCRFS-TVYQXRCNSA-N",
        "iupac": {
          "systematic": "(3S)-2-[(S)-tert-butylsulfinyl]-N-ethyl-4-[3-(3-fluorophenyl)phenyl]-3-(2-hydroxyethyl)-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide"
        },
        "smiles": {
          "canonical": "CCNC(=O)C1=NC(=C2C(N(CC2=C1)S(=O)C(C)(C)C)CCO)C3=CC=CC(=C3)C4=CC(=CC=C4)F"
        },
        "molecularFormula": "C28H32FN3O3S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:15:18Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8294"
    },
    "name": "BRD-K30822915",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8294.png",
    "lincs": {
      "id": "LSM-10286",
      "name": "BRD-K30822915",
      "pubchemCid": 54646061,
      "chebiId": 98907,
      "inchiParent": "InChI=1S/C25H30N2O6/c1-15(16-6-4-3-5-7-16)26-23(29)12-18-11-20-19-10-17(27-24(30)14-31-2)8-9-21(19)33-25(20)22(13-28)32-18/h3-10,15,18,20,22,25,28H,11-14H2,1-2H3,(H,26,29)(H,27,30)/t15-,18-,20+,22-,25-/m1/s1",
      "inchiKeyParent": "ALLGXHRZPBERLG-ICPKNLHRSA-N",
      "smilesParent": "COCC(=O)Nc1ccc2O[C@H]3[C@@H](CO)O[C@@H](CC(=O)N[C@H](C)c4ccccc4)C[C@H]3c2c1"
    },
    "unichem": {
      "chebi": "98907",
      "lincs": "LSM-10286",
      "pubchem": "54646061"
    },
    "pubchem": [
      {
        "cid": 54646061,
        "inchi": "InChI=1S/C25H30N2O6/c1-15(16-6-4-3-5-7-16)26-23(29)12-18-11-20-19-10-17(27-24(30)14-31-2)8-9-21(19)33-25(20)22(13-28)32-18/h3-10,15,18,20,22,25,28H,11-14H2,1-2H3,(H,26,29)(H,27,30)/t15-,18-,20+,22-,25-/m1/s1",
        "inchikey": "ALLGXHRZPBERLG-ICPKNLHRSA-N",
        "iupac": {
          "systematic": "2-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-6-[(2-methoxyacetyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-[(1R)-1-phenylethyl]acetamide"
        },
        "smiles": {
          "canonical": "CC(C1=CC=CC=C1)NC(=O)CC2CC3C(C(O2)CO)OC4=C3C=C(C=C4)NC(=O)COC"
        },
        "molecularFormula": "C25H30N2O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:15:21Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8343"
    },
    "name": "BRD-K30738885",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8343.png",
    "lincs": {
      "id": "LSM-7249",
      "name": "BRD-K30738885",
      "pubchemCid": 54618807,
      "chebiId": 95870,
      "inchiParent": "InChI=1S/C28H36N4O4/c1-20-16-32(21(2)19-33)27(34)24-14-22(9-12-28(35)10-5-6-11-28)15-30-26(24)36-25(20)18-31(3)17-23-8-4-7-13-29-23/h4,7-8,13-15,20-21,25,33,35H,5-6,10-11,16-19H2,1-3H3/t20-,21-,25-/m0/s1",
      "inchiKeyParent": "UQYDBQHFUBHFMT-WATLYSKOSA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@H](C)[C@H](CN(C)Cc2ccccn2)Oc3ncc(cc3C1=O)C#CC4(O)CCCC4"
    },
    "unichem": {
      "chebi": "95870",
      "lincs": "LSM-7249",
      "pubchem": "54618807"
    },
    "pubchem": [
      {
        "cid": 54618807,
        "inchi": "InChI=1S/C28H36N4O4/c1-20-16-32(21(2)19-33)27(34)24-14-22(9-12-28(35)10-5-6-11-28)15-30-26(24)36-25(20)18-31(3)17-23-8-4-7-13-29-23/h4,7-8,13-15,20-21,25,33,35H,5-6,10-11,16-19H2,1-3H3/t20-,21-,25-/m0/s1",
        "inchikey": "UQYDBQHFUBHFMT-WATLYSKOSA-N",
        "iupac": {
          "systematic": "(2R,3S)-8-[2-(1-hydroxycyclopentyl)ethynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-2-ylmethyl)amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(N=CC(=C2)C#CC3(CCCC3)O)OC1CN(C)CC4=CC=CC=N4)C(C)CO"
        },
        "molecularFormula": "C28H36N4O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:15:23Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82ca"
    },
    "name": "BRD-K00347265",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82ca.png",
    "lincs": {
      "id": "LSM-8447",
      "name": "BRD-K00347265",
      "pubchemCid": 54645953,
      "chebiId": 97068,
      "inchiParent": "InChI=1S/C24H32N2O5/c27-13-21-23-19(11-17(30-21)12-22(28)25-15-6-1-2-7-15)18-10-16(8-9-20(18)31-23)26-24(29)14-4-3-5-14/h8-10,14-15,17,19,21,23,27H,1-7,11-13H2,(H,25,28)(H,26,29)/t17-,19+,21-,23-/m1/s1",
      "inchiKeyParent": "MOMUNQNAFOIKEQ-GUBFDYSESA-N",
      "smilesParent": "OC[C@H]1O[C@@H](CC(=O)NC2CCCC2)C[C@@H]3[C@H]1Oc4ccc(NC(=O)C5CCC5)cc34"
    },
    "unichem": {
      "chebi": "97068",
      "lincs": "LSM-8447",
      "pubchem": "54645953"
    },
    "pubchem": [
      {
        "cid": 54645953,
        "inchi": "InChI=1S/C24H32N2O5/c27-13-21-23-19(11-17(30-21)12-22(28)25-15-6-1-2-7-15)18-10-16(8-9-20(18)31-23)26-24(29)14-4-3-5-14/h8-10,14-15,17,19,21,23,27H,1-7,11-13H2,(H,25,28)(H,26,29)/t17-,19+,21-,23-/m1/s1",
        "inchikey": "MOMUNQNAFOIKEQ-GUBFDYSESA-N",
        "iupac": {
          "systematic": "N-[(1R,3R,4aS,9aR)-3-[2-(cyclopentylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]cyclobutanecarboxamide"
        },
        "smiles": {
          "canonical": "C1CCC(C1)NC(=O)CC2CC3C(C(O2)CO)OC4=C3C=C(C=C4)NC(=O)C5CCC5"
        },
        "molecularFormula": "C24H32N2O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:15:25Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82d5"
    },
    "name": "BRD-K83577967",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82d5.png",
    "lincs": {
      "id": "LSM-41838",
      "name": "BRD-K83577967",
      "pubchemCid": 54652570,
      "chebiId": 130289,
      "inchiParent": "InChI=1S/C24H22FN3O2/c25-19-7-3-1-5-17(19)13-27-21-14-28(24(30)16-9-11-26-12-10-16)20-8-4-2-6-18(20)23(21)22(27)15-29/h1-12,21-23,29H,13-15H2/t21-,22+,23+/m0/s1",
      "inchiKeyParent": "DIEPUCPGCIJAKU-YTFSRNRJSA-N",
      "smilesParent": "OC[C@@H]1[C@H]2[C@H](CN(C(=O)c3ccncc3)c4ccccc24)N1Cc5ccccc5F"
    },
    "unichem": {
      "chebi": "130289",
      "lincs": "LSM-41838",
      "pubchem": "54652570"
    },
    "pubchem": [
      {
        "cid": 54652570,
        "inchi": "InChI=1S/C24H22FN3O2/c25-19-7-3-1-5-17(19)13-27-21-14-28(24(30)16-9-11-26-12-10-16)20-8-4-2-6-18(20)23(21)22(27)15-29/h1-12,21-23,29H,13-15H2/t21-,22+,23+/m0/s1",
        "inchikey": "DIEPUCPGCIJAKU-YTFSRNRJSA-N",
        "iupac": {
          "systematic": "[(1S,2aR,8bR)-2-[(2-fluorophenyl)methyl]-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-pyridin-4-ylmethanone"
        },
        "smiles": {
          "canonical": "C1C2C(C(N2CC3=CC=CC=C3F)CO)C4=CC=CC=C4N1C(=O)C5=CC=NC=C5"
        },
        "molecularFormula": "C24H22FN3O2"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:15:27Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8275"
    },
    "name": "BRD-K19011062",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8275.png",
    "lincs": {
      "id": "LSM-9566",
      "name": "BRD-K19011062",
      "pubchemCid": 54649548,
      "chebiId": 98187,
      "inchiParent": "InChI=1S/C29H35N3O5/c1-31-19-26-25(35-3)13-12-23(37-26)14-15-36-28-21(17-30)10-7-11-24(28)29(34)32(2)18-22(16-27(31)33)20-8-5-4-6-9-20/h4-11,22-23,25-26H,12-16,18-19H2,1-3H3/t22-,23+,25+,26-/m1/s1",
      "inchiKeyParent": "DIIJYNJFSHJSFY-MFYWSIJSSA-N",
      "smilesParent": "CO[C@H]1CC[C@H]2CCOc3c(cccc3C(=O)N(C)C[C@@H](CC(=O)N(C)C[C@H]1O2)c4ccccc4)C#N"
    },
    "unichem": {
      "chebi": "98187",
      "lincs": "LSM-9566",
      "pubchem": "54649548"
    },
    "pubchem": [
      {
        "cid": 54649548,
        "inchi": "InChI=1S/C29H35N3O5/c1-31-19-26-25(35-3)13-12-23(37-26)14-15-36-28-21(17-30)10-7-11-24(28)29(34)32(2)18-22(16-27(31)33)20-8-5-4-6-9-20/h4-11,22-23,25-26H,12-16,18-19H2,1-3H3/t22-,23+,25+,26-/m1/s1",
        "inchikey": "DIIJYNJFSHJSFY-MFYWSIJSSA-N",
        "iupac": {
          "systematic": "(1S,14S,19R,20S)-20-methoxy-12,17-dimethyl-11,16-dioxo-14-phenyl-4,23-dioxa-12,17-diazatricyclo[17.3.1.05,10]tricosa-5,7,9-triene-6-carbonitrile"
        },
        "smiles": {
          "canonical": "CN1CC2C(CCC(O2)CCOC3=C(C=CC=C3C(=O)N(CC(CC1=O)C4=CC=CC=C4)C)C#N)OC"
        },
        "molecularFormula": "C29H35N3O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:15:30Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c828b"
    },
    "name": "BRD-K40454949",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c828b.png",
    "lincs": {
      "id": "LSM-10896",
      "name": "BRD-K40454949",
      "pubchemCid": 54654474,
      "chebiId": 99517,
      "inchiParent": "InChI=1S/C34H34N4O6/c1-21-16-28(37-44-21)33(40)36-25-12-15-30-27(17-25)34(41)38(2)29-14-13-26(43-31(29)20-42-30)18-32(39)35-19-22-8-10-24(11-9-22)23-6-4-3-5-7-23/h3-12,15-17,26,29,31H,13-14,18-20H2,1-2H3,(H,35,39)(H,36,40)/t26-,29+,31+/m0/s1",
      "inchiKeyParent": "COTLGVLRTBZUTQ-QRLJAKNQSA-N",
      "smilesParent": "CN1[C@@H]2CC[C@@H](CC(=O)NCc3ccc(cc3)c4ccccc4)O[C@@H]2COc5ccc(NC(=O)c6cc(C)on6)cc5C1=O"
    },
    "unichem": {
      "chebi": "99517",
      "lincs": "LSM-10896",
      "pubchem": "54654474"
    },
    "pubchem": [
      {
        "cid": 54654474,
        "inchi": "InChI=1S/C34H34N4O6/c1-21-16-28(37-44-21)33(40)36-25-12-15-30-27(17-25)34(41)38(2)29-14-13-26(43-31(29)20-42-30)18-32(39)35-19-22-8-10-24(11-9-22)23-6-4-3-5-7-23/h3-12,15-17,26,29,31H,13-14,18-20H2,1-2H3,(H,35,39)(H,36,40)/t26-,29+,31+/m0/s1",
        "inchikey": "COTLGVLRTBZUTQ-QRLJAKNQSA-N",
        "iupac": {
          "systematic": "N-[(2S,4aR,12aS)-5-methyl-6-oxo-2-[2-oxo-2-[(4-phenylphenyl)methylamino]ethyl]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-5-methyl-1,2-oxazole-3-carboxamide"
        },
        "smiles": {
          "canonical": "CC1=CC(=NO1)C(=O)NC2=CC3=C(C=C2)OCC4C(CCC(O4)CC(=O)NCC5=CC=C(C=C5)C6=CC=CC=C6)N(C3=O)C"
        },
        "molecularFormula": "C34H34N4O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:15:32Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82a7"
    },
    "name": "BRD-K89550909",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82a7.png",
    "lincs": {
      "id": "LSM-42154",
      "name": "BRD-K89550909",
      "pubchemCid": 71759019,
      "chebiId": 130605,
      "inchiParent": "InChI=1S/C23H27N3O2/c27-14-20-22(18-6-2-1-3-7-18)23(26(20)13-19-8-4-5-11-24-19)15-25(16-23)21(28)12-17-9-10-17/h1-8,11,17,20,22,27H,9-10,12-16H2/t20-,22+/m1/s1",
      "inchiKeyParent": "WUXVANVITFJQQY-IRLDBZIGSA-N",
      "smilesParent": "OC[C@@H]1[C@H](c2ccccc2)C3(CN(C3)C(=O)CC4CC4)N1Cc5ccccn5"
    },
    "unichem": {
      "chebi": "130605",
      "lincs": "LSM-42154",
      "pubchem": "71759019"
    },
    "pubchem": [
      {
        "cid": 71759019,
        "inchi": "InChI=1S/C23H27N3O2/c27-14-20-22(18-6-2-1-3-7-18)23(26(20)13-19-8-4-5-11-24-19)15-25(16-23)21(28)12-17-9-10-17/h1-8,11,17,20,22,27H,9-10,12-16H2/t20-,22+/m1/s1",
        "inchikey": "WUXVANVITFJQQY-IRLDBZIGSA-N",
        "iupac": {
          "systematic": "2-cyclopropyl-1-[(2S,3S)-2-(hydroxymethyl)-3-phenyl-1-(pyridin-2-ylmethyl)-1,6-diazaspiro[3.3]heptan-6-yl]ethanone"
        },
        "smiles": {
          "canonical": "C1CC1CC(=O)N2CC3(C2)C(C(N3CC4=CC=CC=N4)CO)C5=CC=CC=C5"
        },
        "molecularFormula": "C23H27N3O2"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:15:34Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82cc"
    },
    "name": "BRD-K93662714",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82cc.png",
    "lincs": {
      "id": "LSM-42364",
      "name": "BRD-K93662714",
      "pubchemCid": 54666447,
      "chebiId": 130815,
      "inchiParent": "InChI=1S/C25H35N3O3/c1-31-16-6-7-19-10-12-20(13-11-19)24-22-17-27(25(30)26-21-8-2-3-9-21)14-4-5-15-28(22)23(24)18-29/h10-13,21-24,29H,2-5,8-9,14-18H2,1H3,(H,26,30)/t22-,23+,24+/m1/s1",
      "inchiKeyParent": "LNDCJTLPGUEJLJ-SGNDLWITSA-N",
      "smilesParent": "COCC#Cc1ccc(cc1)[C@@H]2[C@H](CO)N3CCCCN(C[C@H]23)C(=O)NC4CCCC4"
    },
    "unichem": {
      "chebi": "130815",
      "lincs": "LSM-42364",
      "pubchem": "54666447"
    },
    "pubchem": [
      {
        "cid": 54666447,
        "inchi": "InChI=1S/C25H35N3O3/c1-31-16-6-7-19-10-12-20(13-11-19)24-22-17-27(25(30)26-21-8-2-3-9-21)14-4-5-15-28(22)23(24)18-29/h10-13,21-24,29H,2-5,8-9,14-18H2,1H3,(H,26,30)/t22-,23+,24+/m1/s1",
        "inchikey": "LNDCJTLPGUEJLJ-SGNDLWITSA-N",
        "iupac": {
          "systematic": "(8S,9S,10R)-N-cyclopentyl-10-(hydroxymethyl)-9-[4-(3-methoxyprop-1-ynyl)phenyl]-1,6-diazabicyclo[6.2.0]decane-6-carboxamide"
        },
        "smiles": {
          "canonical": "COCC#CC1=CC=C(C=C1)C2C3CN(CCCCN3C2CO)C(=O)NC4CCCC4"
        },
        "molecularFormula": "C25H35N3O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:15:37Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82e4"
    },
    "name": "Sunitinib",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82e4.png",
    "lincs": {
      "id": "LSM-46130",
      "name": "Sunitinib",
      "pubchemCid": 3086686,
      "inchiParent": "InChI=1S/C22H27FN4O2/c1-5-27(6-2)10-9-24-22(29)20-13(3)19(25-14(20)4)12-17-16-11-15(23)7-8-18(16)26-21(17)28/h7-8,11-12,25H,5-6,9-10H2,1-4H3,(H,24,29)(H,26,28)",
      "inchiKeyParent": "WINHZLLDWRZWRT-UHFFFAOYSA-N",
      "smilesParent": "CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2C(=O)Nc3ccc(F)cc23)c1C"
    },
    "unichem": {
      "chebi": "91430",
      "chembl": "CHEMBL1990885",
      "lincs": "LSM-46130",
      "pubchem": "3086686"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL1990885",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 398.48,
        "hba": 3,
        "hbd": 3,
        "qedWeighted": 0.63
      }
    },
    "pubchem": [
      {
        "cid": 3086686,
        "inchi": "InChI=1S/C22H27FN4O2/c1-5-27(6-2)10-9-24-22(29)20-13(3)19(25-14(20)4)12-17-16-11-15(23)7-8-18(16)26-21(17)28/h7-8,11-12,25H,5-6,9-10H2,1-4H3,(H,24,29)(H,26,28)",
        "inchikey": "WINHZLLDWRZWRT-UHFFFAOYSA-N",
        "iupac": {
          "systematic": "N-[2-(diethylamino)ethyl]-5-[(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide"
        },
        "smiles": {
          "canonical": "CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C"
        },
        "molecularFormula": "C22H27FN4O2"
      }
    ],
    "clinicaltrials": [
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00474994",
            "briefTitle": "Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas",
            "officialTitle": "A Multicenter Phase II Study of Continuous Dosing of Sunitinib (Sutent\u00ae, SU11248) in Non-GIST Sarcomas"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2007-05-16",
            "resultsFirstSubmitDate": "2015-12-15"
          },
          "conditionsModule": {
            "conditions": [
              "Adult Malignant Fibrous Histiocytoma of Bone",
              "Desmoid Tumor",
              "Endometrial Cancer",
              "Ovarian Cancer",
              "Sarcoma",
              "Small Intestine Cancer"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Overall Objective Response",
                "timeFrame": "2 years"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT04033991",
            "briefTitle": "Study of Patients With Metastatic and/or Advanced Renal Cell Carcinoma, Treated With Sunitinib/Axitinib.",
            "officialTitle": "A Real World Retrospective Database Study of Patients Diagnosed With Metastatic and/or Advanced Renal Cell Carcinoma and Treated With Sunitinib and/or Axitinib in a Specialist United Kingdom Oncology Centre"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2019-07-10",
            "resultsFirstSubmitDate": "2021-12-02"
          },
          "conditionsModule": {
            "conditions": [
              "Carcinoma",
              "Renal Cell"
            ]
          },
          "designModule": {
            "studyType": "OBSERVATIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Progression Free Survival (PFS)",
                "timeFrame": "From start of treatment to PD, death or end of treatment, whichever occurred first, from inception of database (2002) until 30 June 2018, anytime in these 16 years (from the data retrieved and observed retrospectively for approximately 1.2 years)"
              },
              {
                "measure": "Progression Free Survival (PFS): Memorial Sloan-Kettering Cancer Center (MSKCC) Stratification",
                "timeFrame": "From start of treatment to PD, death or end of treatment, whichever occurred first, from inception of database (2002) until 30 June 2018, anytime in these 16 years (from the data retrieved and observed retrospectively for approximately 1.2 years)"
              },
              {
                "measure": "Progression Free Survival (PFS): International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) Stratification",
                "timeFrame": "From start of treatment to PD, death or end of treatment, whichever occurred first, from inception of database (2002) until 30 June 2018, anytime in these 16 years (from the data retrieved and observed retrospectively for approximately 1.2 years)"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Overall Survival (OS)"
              },
              {
                "measure": "Overall Survival (OS): Memorial Sloan-Kettering Cancer Center (MSKCC) Stratification"
              },
              {
                "measure": "Overall Survival (OS): International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) Stratification"
              },
              {
                "measure": "Number of Participants With Best Overall Response (BOR) for Complete Response (CR), Partial Response (PR), Stable Disease (SD), PD and Surgical CR as Per RECIST v 1.1"
              },
              {
                "measure": "Objective Response Rate (ORR)"
              },
              {
                "measure": "Duration of Response (DOR)"
              },
              {
                "measure": "Time to Treatment Discontinuation (TTD)"
              },
              {
                "measure": "Time to Treatment Discontinuation (TTD): Memorial Sloan-Kettering Cancer Center (MSKCC) Stratification"
              },
              {
                "measure": "Time to Treatment Discontinuation (TTD): International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) Stratification"
              },
              {
                "measure": "Durable Response Rate (DRR)"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00462982",
            "briefTitle": "Sunitinib in Treating Patients With Brain Metastases Caused by Kidney Cancer or Melanoma",
            "officialTitle": "A Phase II Study of SU11248 (Sunitinib) in Patients With Renal Cell Carcinoma and Melanoma Metastatic to the Brain"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2007-04-18",
            "resultsFirstSubmitDate": "2015-10-21"
          },
          "conditionsModule": {
            "conditions": [
              "Kidney Cancer",
              "Melanoma (Skin)",
              "Metastatic Cancer"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Central Nervous System (CNS) Response Rate by RECIST Criteria",
                "timeFrame": "up to a year"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00866320",
            "briefTitle": "Sorafenib in Treating Patients With Metastatic Kidney Cancer That Has Not Responded to Sunitinib or Bevacizumab",
            "officialTitle": "A Phase II Study of Sorafenib in Patients With Metastatic Renal Cell Carcinoma (RCC) Refractory to SU11248 or Bevacizumab Therapy"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2009-03-19",
            "resultsFirstSubmitDate": "2011-12-27"
          },
          "conditionsModule": {
            "conditions": [
              "Kidney Cancer"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Tumor Burden Reduction Rate (TBRR)",
                "timeFrame": "at 8 weeks (2cycles of treatment)"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Overall Survival"
              },
              {
                "measure": "Time to Progression"
              },
              {
                "measure": "Duration of Overall Response (Tumor Burden Reduction)"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02747173",
            "briefTitle": "Assessment of Bone Biomarkers for TKI Response in RCC With Bone Metastases, HRQoL and Comparison of Imaging Techniques",
            "officialTitle": "Study to Assess Bone Biomarkers for TKI Response in RCC Patients With Bone Metastasis and HRQoL in These Patients as Well as Comparing Whole Body MRI vs. Bone Scintigraphy and vs. CT in the Assessment of Metastatic Lesions"
          },
          "statusModule": {
            "overallStatus": "TERMINATED",
            "studyFirstSubmitDate": "2015-04-23"
          },
          "conditionsModule": {
            "conditions": [
              "Renal Cell Carcinoma"
            ]
          },
          "designModule": {
            "studyType": "OBSERVATIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Assess bone biomarkers in response to TKI",
                "timeFrame": "Every 3 months until an average of 12 months"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Progression free survival"
              },
              {
                "measure": "Objective response rate"
              },
              {
                "measure": "Measurements in time of bone metastases in RCC using whole body magnetic resonance and bone scintigraphy"
              },
              {
                "measure": "Change and correlation of magnetic resonance and CT results in the assessment of global disease response to TKI. Using RECIST and MASS criteria"
              },
              {
                "measure": "Quality of life of patients with RCC and bone metastases throughout the study period using the FSI-15"
              },
              {
                "measure": "Quality of life of patients with RCC and bone metastases throughout the study period using FACT-BP"
              },
              {
                "measure": "Efficacy of TKI in the improvement of pain produced by bone metastases throughout the study period"
              },
              {
                "measure": "Efficacy of TKI in the improvement of pain produced by bone metastases throughout the study period using the NPR scale"
              },
              {
                "measure": "Assessment osteonecrosis of the jaw with use of biphosphonates or denosumab throughout the study period"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT03091192",
            "briefTitle": "Savolitinib vs. Sunitinib in MET-driven PRCC.",
            "officialTitle": "A Phase III, Open Label, Randomised, Controlled, Multi-Centre Study To Assess the Efficacy and Safety of Savolitinib Versus Sunitinib in Patients With MET-Driven, Unresectable and Locally Advanced, Or Metastatic Papillary Renal Cell Carcinoma (PRCC)"
          },
          "statusModule": {
            "overallStatus": "ACTIVE_NOT_RECRUITING",
            "studyFirstSubmitDate": "2017-02-09",
            "resultsFirstSubmitDate": "2020-06-22"
          },
          "conditionsModule": {
            "conditions": [
              "Carcinoma",
              "Carcinoma, Renal Cell",
              "Kidney Neoplasms",
              "Urologic Neoplasms",
              "Kidney Diseases",
              "Neoplasms by Site",
              "Enzyme Inhibitors",
              "Protein Kinase Inhibitors"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Progression Free Survival (PFS) by Blinded Independent Central Review (BICR)",
                "timeFrame": "RECIST tumour assessments every 6 weeks from randomisation until disease progression as defined by Recist 1.1 and confirmed by BICR."
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Overall Survival (OS)"
              },
              {
                "measure": "Objective Response Rate (ORR) by BICR"
              },
              {
                "measure": "Duration of Response (DoR) by BICR"
              },
              {
                "measure": "Disease Control Rate (DCR) at 6 Months by BICR"
              },
              {
                "measure": "Disease Control Rate (DCR) at 12 Months by BICR"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00695292",
            "briefTitle": "Irinotecan, Carboplatin, and Sunitinib in First Line Extensive-Stage Small Cell Lung Cancer",
            "officialTitle": "Phase II Study of Irinotecan, Carboplatin, and Sunitinib in the First Line Treatment of Extensive-Stage Small Cell Lung Cancer"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2008-06-09",
            "resultsFirstSubmitDate": "2013-01-14"
          },
          "conditionsModule": {
            "conditions": [
              "Small Cell Lung Cancer"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "One-year Survival, The Percentage of Patients Who Are Alive One Year After Completing Protocol Treatment",
                "timeFrame": "18 months"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Overall Response Rate (ORR), the Percentage of Patients Who Experience an Objective Benefit From Treatment"
              },
              {
                "measure": "Time to Progression"
              },
              {
                "measure": "Median Overall Survival"
              },
              {
                "measure": "Number of Participants Experiencing Treatment Related Toxicity"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT03449173",
            "briefTitle": "Trial of Sunitinib in Patients With Type B3 Thymoma or Thymic Carcinoma in Second and Further Lines (Style Trial)",
            "officialTitle": "Phase II Trial of Sunitinib in Patients With Type B3 Thymoma or Thymic Carcinoma in Second and Further Lines (Style Trial)"
          },
          "statusModule": {
            "overallStatus": "UNKNOWN",
            "studyFirstSubmitDate": "2018-02-22"
          },
          "conditionsModule": {
            "conditions": [
              "Type B3 Thymoma",
              "Thymic Carcinoma"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Activity of Sunitinib",
                "timeFrame": "4 years"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Progression Free Survival (PFS)"
              },
              {
                "measure": "Overall Survival (OS)"
              },
              {
                "measure": "Duration of activity of sunitinib"
              },
              {
                "measure": "Safety and toxicity profile of sunitinib"
              },
              {
                "measure": "Incidence of adverse events (AEs)"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00499473",
            "briefTitle": "Sunitinib in Treating Patients With Recurrent Malignant Gliomas",
            "officialTitle": "A Pharmacokinetic and Phase 2 Study of Sunitinib Malate in Recurrent Malignant Gliomas"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2007-07-10",
            "resultsFirstSubmitDate": "2015-08-25"
          },
          "conditionsModule": {
            "conditions": [
              "Adult Anaplastic Astrocytoma",
              "Adult Diffuse Astrocytoma",
              "Adult Giant Cell Glioblastoma",
              "Adult Glioblastoma",
              "Adult Gliosarcoma",
              "Adult Mixed Glioma",
              "Adult Oligodendroglioma",
              "Adult Pineal Gland Astrocytoma"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Progression-free Survival at 6 Months (Stratum 1)",
                "timeFrame": "From time to registration to up to 6 months"
              },
              {
                "measure": "Maximum Tolerable Dose Based on Dose-limiting Toxicity of Sunitinib in Patients Receiving EIAC (Stratum 2)",
                "timeFrame": "From the time of first treatment with sunitinib until completion of treatment, assessed up to 30 days"
              },
              {
                "measure": "Dose Resulting in Steady-state Trough",
                "timeFrame": "At baseline (day 8) and days 15, 22, and 23"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Confirmed Objective Response (Complete Response[CR] or Partial Response [PR])"
              },
              {
                "measure": "Percentage of Patients Progression Free at 12 Months"
              },
              {
                "measure": "Overall Survival"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00906360",
            "briefTitle": "Sunitinib, Cetuximab, and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck",
            "officialTitle": "A Phase I Trial of Concurrent Chemoradiation/Chemoreirradiation With Cetuximab (ERBITUX\u00ae), Sunitinib, and Accelerated Radiation in Patients With Locally Advanced/High-risk/Recurrent Poor Prognosis Head and Neck Cancer"
          },
          "statusModule": {
            "overallStatus": "TERMINATED",
            "studyFirstSubmitDate": "2009-05-20"
          },
          "conditionsModule": {
            "conditions": [
              "Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma",
              "Recurrent Metastatic Squamous Neck Cancer With Occult Primary",
              "Recurrent Salivary Gland Cancer",
              "Recurrent Squamous Cell Carcinoma of the Hypopharynx",
              "Recurrent Squamous Cell Carcinoma of the Larynx",
              "Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity",
              "Recurrent Squamous Cell Carcinoma of the Nasopharynx",
              "Recurrent Squamous Cell Carcinoma of the Oropharynx",
              "Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity",
              "Recurrent Verrucous Carcinoma of the Larynx",
              "Recurrent Verrucous Carcinoma of the Oral Cavity",
              "Salivary Gland Squamous Cell Carcinoma",
              "Stage III Salivary Gland Cancer",
              "Stage III Squamous Cell Carcinoma of the Hypopharynx",
              "Stage III Squamous Cell Carcinoma of the Larynx",
              "Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity",
              "Stage III Squamous Cell Carcinoma of the Nasopharynx",
              "Stage III Squamous Cell Carcinoma of the Oropharynx",
              "Stage III Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity",
              "Stage III Verrucous Carcinoma of the Larynx",
              "Stage III Verrucous Carcinoma of the Oral Cavity",
              "Stage IV Salivary Gland Cancer",
              "Stage IV Squamous Cell Carcinoma of the Hypopharynx",
              "Stage IV Squamous Cell Carcinoma of the Larynx",
              "Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity",
              "Stage IV Squamous Cell Carcinoma of the Nasopharynx",
              "Stage IV Squamous Cell Carcinoma of the Oropharynx",
              "Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity",
              "Stage IV Verrucous Carcinoma of the Larynx",
              "Stage IV Verrucous Carcinoma of the Oral Cavity",
              "Tongue Cancer",
              "Untreated Metastatic Squamous Neck Cancer With Occult Primary"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Maximum-tolerated dose (MTD) of sunitinib malate",
                "timeFrame": "Up to 7-9 weeks"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Objective tumor response rates"
              },
              {
                "measure": "Locoregional control rates"
              },
              {
                "measure": "Disease control rates"
              },
              {
                "measure": "Locoregional recurrence rates"
              },
              {
                "measure": "Time to progression"
              },
              {
                "measure": "Overall survival time"
              },
              {
                "measure": "Pharmacokinetics of sunitinib malate delivered by percutaneous gastrostomy tube"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02570789",
            "briefTitle": "Evaluation of Predictive Markers for Toxicity and Efficacy in Patients With mccRCC Treated by Anti-VEGF Therapy",
            "officialTitle": "A Proof of Concept Study to Evaluate the Use of Metabonomics and Lipidomics in Predicting Toxicity and Efficacy of Anti-VEGF Therapy in Patients With Metastatic Clear Cell Renal Cell Carcinoma"
          },
          "statusModule": {
            "overallStatus": "TERMINATED",
            "whyStopped": "not enough accrual",
            "studyFirstSubmitDate": "2015-09-17"
          },
          "conditionsModule": {
            "conditions": [
              "Clear-cell Metastatic Renal Cell Carcinoma"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Treatment assessment by using RECIST 1.1 and adverse events will be documented using the NCI-CTC coding system (version 4.0)",
                "timeFrame": "up to 3 years"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Identifying the level metabolotype and/or lipidomotype of metastatic clear cell renal cell carcinoma patients before starting sunitinib or pazopanib (in comparison with healthy volunteers) on blood and urine samples by biochemistry techniques"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT03905889",
            "briefTitle": "A Study of Abemaciclib in Combination With Sunitinib in Metastatic Renal Cell Carcinoma",
            "officialTitle": "Targeting PIM1 and CDK4/6 Kinases in Renal Cell Carcinoma (PICKRCC): A Phase Ib Study of Abemaciclib (VerzenioTM) in Combination With Sunitinib in Metastatic Renal Cell Carcinoma"
          },
          "statusModule": {
            "overallStatus": "TERMINATED",
            "whyStopped": "Funding withdrawn",
            "studyFirstSubmitDate": "2019-04-03"
          },
          "conditionsModule": {
            "conditions": [
              "Renal Cell Carcinoma Metastatic"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Maximum tolerated dose (MTD)",
                "timeFrame": "At the end of Cycle 1 (each cycle is 21 days)"
              },
              {
                "measure": "Continued Toxicity assessment of the maximum tolerated dose (i.e the recommended Phase II dose) of Abemaciclib and Sunitinib as determined from the from dose escalation phase.",
                "timeFrame": "44 days after the last dose of study drug"
              },
              {
                "measure": "Pharmacokinetic Assessment of Abemaciclib and Sunitinib trough levels at steady state",
                "timeFrame": "Days 8, 15, 21, 28, 35, 42, 56, 63, 77, 84, 98 (at the beginning and weekly during cycles 1 and 2, days 1 and 15 of cycles 3-5; a cycle is 21-days)"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Disease Control Rate"
              },
              {
                "measure": "Progression Free Survival"
              },
              {
                "measure": "Overall Survival"
              },
              {
                "measure": "Median Progression Free Survival"
              },
              {
                "measure": "Median Overall Survival"
              },
              {
                "measure": "Duration of Response"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02761057",
            "briefTitle": "Testing Cabozantinib, Crizotinib, Savolitinib and Sunitinib in Kidney Cancer Which Has Progressed",
            "officialTitle": "A Randomized, Phase II Efficacy Assessment of Multiple MET Kinase Inhibitors (Cabozantinib [NSC #761968], Crizotinib [NSC #749005], Savolitinib [NSC #785348], and Sunitinib [NSC #736511]) in Metastatic Papillary Renal Carcinoma (PAPMET)"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2016-05-02",
            "resultsFirstSubmitDate": "2022-06-06"
          },
          "conditionsModule": {
            "conditions": [
              "Locally Advanced Papillary Renal Cell Carcinoma",
              "Metastatic Papillary Renal Cell Carcinoma",
              "Stage III Renal Cell Cancer AJCC v7",
              "Stage IV Renal Cell Cancer AJCC v7",
              "Type 1 Papillary Renal Cell Carcinoma",
              "Type 2 Papillary Renal Cell Carcinoma",
              "Unresectable Renal Cell Carcinoma"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Progression Free Survival (PFS)",
                "timeFrame": "From date of registration to date of first documentation of progression or symptomatic deterioration, or death due to any cause; assessed up to 3 years"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Response Rate (RR)"
              },
              {
                "measure": "Overall Survival (OS)"
              },
              {
                "measure": "Number of Participants With Gr 3 Through 5 Adverse Events That Are Related to Study Drugs"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00982657",
            "briefTitle": "A Trial Of CVX-060, An Anti-Angiogenic COVX-Body, In Combination With Sunitinib In Patients With Advanced Renal Cell Carcinoma",
            "officialTitle": "A Phase Ib/ii, Multicenter, Trial Of Cvx-060, A Selective Angiopoietin-2 (Ang-2) Binding, Anti-angiogenic Covx-body, In Combination With Sunitinib In Patients With Advanced Renal Cell Carcinoma"
          },
          "statusModule": {
            "overallStatus": "TERMINATED",
            "whyStopped": "Refer to statement in Summary Section/Detailed Description",
            "studyFirstSubmitDate": "2009-09-22",
            "resultsFirstSubmitDate": "2015-03-13"
          },
          "conditionsModule": {
            "conditions": [
              "Solid Tumor"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Maximum Tolerated Dose (MTD)",
                "timeFrame": "Baseline up to Cycle 1( Day 1 to Day 42)"
              },
              {
                "measure": "Progression-free Survival (PFS)",
                "timeFrame": "Baseline tumor progression/clinical deterioration or death (up to 28 days post last dose of study medication)"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Pharmacokinetic Parameters of CVX-060"
              },
              {
                "measure": "Number of Participants With Dose-limiting Toxicities (DLT)"
              },
              {
                "measure": "Serum Angiopoietin-2 (Ang-2) and Plasma Vascular Endothelial Growth Factor (VEGF) Levels"
              },
              {
                "measure": "Number of Participants With Treatment Emergent Serious Adverse Events (SAEs) and Non-Serious Adverse Events (Non-SAEs)"
              },
              {
                "measure": "Percentage of Participants With Objective Response"
              },
              {
                "measure": "Duration of Response"
              },
              {
                "measure": "Number of Participants With Anti- CVX-060 Antibodies"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01459757",
            "briefTitle": "Non-Interventional Retrospective Correlation Of Tumor Mutational Status To Clinical Benefit Of GIST Patients Treated With Sunitinib",
            "officialTitle": "A Non-Interventional Retrospective Correlation Of Tumor Mutation Status To Clinical Benefit From The SU011248, A6181036 Treatment Protocol Titled: A Treatment Protocol For Patients With Gastrointestinal Stromal Tumor Who Are Ineligible For Participation In Other SU011248 Protocols And Are Refractory To Or Intolerant Of Imatinib Mesylate"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2011-10-24"
          },
          "conditionsModule": {
            "conditions": [
              "GIST"
            ]
          },
          "designModule": {
            "studyType": "OBSERVATIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Mutational status data retrospectively accessed correlated with A6181036 clinical outcomes data in GIST subjects treated with sunitinib",
                "timeFrame": "9 months"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00570882",
            "briefTitle": "Study of Sunitinib Administered as 4/2 vs. 2/1 Schedule in Advanced Renal Cell Carcinoma (RCC)",
            "officialTitle": "A Randomized Phase II Trial Of Sunitinib Administered Daily For 4 Weeks, Followed By 2-Week Rest Vs. 2-Week On And 1-Week Off In Metastatic Renal Cell Carcinoma"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2007-12-10"
          },
          "conditionsModule": {
            "conditions": [
              "Metastatic Renal Cell Carcinoma"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Treatment failure rate (progressive disease, treatment withdrawal due to unacceptable toxicities, or any death)",
                "timeFrame": "12 months"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Overall response rate"
              },
              {
                "measure": "quality of life"
              },
              {
                "measure": "Progression free survival"
              },
              {
                "measure": "Overall survival"
              },
              {
                "measure": "Adverse events"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00387920",
            "briefTitle": "Sunitinib in Treating Young Patients With Refractory Solid Tumors",
            "officialTitle": "A Phase I Study of Sunitinib (SU11248), an Oral Multi-Targeted Tyrosine Kinase Inhibitor, in Children With Refractory Solid Tumors"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2006-10-12"
          },
          "conditionsModule": {
            "conditions": [
              "Central Nervous System Metastases",
              "Childhood Central Nervous System Choriocarcinoma",
              "Childhood Central Nervous System Embryonal Tumor",
              "Childhood Central Nervous System Germ Cell Tumor",
              "Childhood Central Nervous System Germinoma",
              "Childhood Central Nervous System Mixed Germ Cell Tumor",
              "Childhood Central Nervous System Teratoma",
              "Childhood Central Nervous System Yolk Sac Tumor",
              "Recurrent Childhood Central Nervous System Embryonal Tumor",
              "Unspecified Childhood Solid Tumor, Protocol Specific"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "MTD and recommended phase II dose",
                "timeFrame": "During course 1 of therapy"
              },
              {
                "measure": "Adverse events as assessed by the National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE) version 4.0",
                "timeFrame": "Weekly during course 1, assessed up to 35 days"
              },
              {
                "measure": "Pharmacokinetics of sunitinib malate using liquid spectrometry/mass spectroscopy methods",
                "timeFrame": "At baseline and days 1, 7, 14, 21, and 28 of course 1"
              },
              {
                "measure": "Tolerability and pharmacokinetic profile of capsule contents sprinkled over applesauce or yogurt",
                "timeFrame": "At baseline and days 1, 7, 14, 21, and 28 of course 1"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Correlative studies"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT04666220",
            "briefTitle": "VETC, Prognostic and Predictive Value in Renal Cell Carcinoma and Adrenal Carcinoma",
            "officialTitle": "Vessels Encapsulating Tumor Clusters (VETC), Prognostic and Predictive Value in Renal Cell Carcinoma and Adrenal Gland Carcinoma"
          },
          "statusModule": {
            "overallStatus": "UNKNOWN",
            "studyFirstSubmitDate": "2020-11-30"
          },
          "conditionsModule": {
            "conditions": [
              "Renal Cell Carcinoma",
              "Adrenal Carcinoma"
            ]
          },
          "designModule": {
            "studyType": "OBSERVATIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "VETC in RCC and AC.",
                "timeFrame": "2-3 months"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Predictive VETC (OS)"
              },
              {
                "measure": "Predictive VETC (PFS)"
              },
              {
                "measure": "Predictive VETC (control)"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00876382",
            "briefTitle": "Community Oncology Setting Disease Outcomes of Sorafenib (Nexavar) Use in Advanced Renal Cell Carcinoma",
            "officialTitle": "Community Oncology Setting Disease Outcomes of Sorafenib (Nexavar) Use in Advanced Renal Cell Carcinoma"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2009-04-03"
          },
          "conditionsModule": {
            "conditions": [
              "Renal Cell Carcinoma"
            ]
          },
          "designModule": {
            "studyType": "OBSERVATIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "To evaluate the safety and efficacy of Nexavar as second-line therapy in patients with advanced renal cell carcinoma treated with Nexavar after first-line therapy with Sutent or Avastin.",
                "timeFrame": "6 months"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "To evaluate safety and efficacy of Nexavar as first-line therapy in patients with advanced renal cell carcinoma and as first-line therapy followed by Sutent as second-line therapy in patients with advanced renal cell carcinoma."
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01216657",
            "briefTitle": "Trial of Single Agent Sunitinib for Patients With Chemo-refractory Metastatic Melanoma",
            "officialTitle": "An Open-label, Uncontrolled Phase II Trial of Single Agent Sunitinib (SU 11248) for Patients With Chemo-refractory Metastatic Melanoma"
          },
          "statusModule": {
            "overallStatus": "TERMINATED",
            "whyStopped": "slow recruitment",
            "studyFirstSubmitDate": "2010-04-12"
          },
          "conditionsModule": {
            "conditions": [
              "Chemo-refractory Melanoma"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "clinical benefit rate cycle 1-3",
                "timeFrame": "tumor assessment every 6 weeks"
              },
              {
                "measure": "clinical benefit rate cycle 4 and more",
                "timeFrame": "tumor assessment every 12 weeks"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "response rate cycle 1-3"
              },
              {
                "measure": "progression free survival"
              },
              {
                "measure": "overall survival"
              },
              {
                "measure": "response rate cycle 4 and more"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00705874",
            "briefTitle": "Study of CGC-11047 When Used in Individual Combinations With 1) Gemcitabine or 2) Docetaxel or 3) Bevacizumab or 4) Erlotinib or 5) Cisplatin or 6) 5-Flurouracil or 7) Sunitinib in Patients With Advanced Solid Tumors or Lymphoma",
            "officialTitle": "A Phase I Open Label, Multicenter, Dose-Escalation Study to Determine the Maximum Tolerated Dose, Dose Limiting Toxicity, Safety and Pharmacokinetics of CGC-11047 When Used in Individual Combinations With 1) Gemcitabine or 2) Docetaxel or 3) Bevacizumab or 4) Erlotinib or 5) Cisplatin or 6) 5-Flurouracil or 7) Sunitinib in Patients With Advanced Solid Tumors or Lymphoma"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2008-06-23",
            "resultsFirstSubmitDate": "2011-11-17"
          },
          "conditionsModule": {
            "conditions": [
              "Cancer"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Maximum Tolerated Dose (MTD)",
                "timeFrame": "End of Study"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Drug Safety"
              },
              {
                "measure": "Pharmacokinetics"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00389974",
            "briefTitle": "Sunitinib Malate in Treating Patients With Uterine Cervical Cancer That is Stage IVB, Recurrent, or Cannot Be Removed By Surgery",
            "officialTitle": "A Phase II Study of Sunitinib (SU11248; NSC 736511) an Oral Multi-Targeted Tyrosine Kinase Inhibitor, in Patients With Unresectable, Locally Advanced or Metastatic Cervical Carcinoma"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2006-10-18",
            "resultsFirstSubmitDate": "2015-02-04"
          },
          "conditionsModule": {
            "conditions": [
              "Cervical Adenocarcinoma",
              "Cervical Adenosquamous Cell Carcinoma",
              "Cervical Squamous Cell Carcinoma",
              "Recurrent Cervical Cancer",
              "Stage IVB Cervical Cancer"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Objective Response Rate (PR or CR)",
                "timeFrame": "Up to 2 years"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00077974",
            "nctIdAliases": [
              "NCT00082849"
            ],
            "briefTitle": "A Pivotal Study Of SU011248 In The Treatment Of Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma.",
            "officialTitle": "A Pivotal Study Of SU011248 In The Treatment Of Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2004-02-13",
            "resultsFirstSubmitDate": "2009-09-25"
          },
          "conditionsModule": {
            "conditions": [
              "Carcinoma, Renal Cell"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Number of Subjects With Confirmed Objective Response According to Response Evaluation Criteria in Solid Tumors(RECIST)",
                "timeFrame": "From start of study treatment until Day 28 of Cycles 1-5, Day 28 of even Cycles thereafter"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Time to Tumor Progression (TTP)"
              },
              {
                "measure": "Duration of Response (DR)"
              },
              {
                "measure": "Overall Survival (OS)"
              },
              {
                "measure": "Progression-free Survival (PFS)"
              },
              {
                "measure": "Percent Chance of Patient Survival"
              },
              {
                "measure": "Observed Plasma Trough Concentrations of Sunitinib"
              },
              {
                "measure": "Observed Plasma Trough Concentrations of Sunitinib Metabolite"
              },
              {
                "measure": "Observed Plasma Trough Concentrations of Sunitinib Plus Metabolite"
              },
              {
                "measure": "Dose Corrected Plasma Trough Concentrations of Sunitinib"
              },
              {
                "measure": "Dose Corrected Plasma Trough Concentrations of Sunitinib Metabolite"
              },
              {
                "measure": "Dose Corrected Plasma Trough Concentrations of Sunitinib Plus Metabolite"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01714765",
            "briefTitle": "Dose Escalation Study Investigating Everolimus and Dovitinib in Metastatic Clear Cell Renal Cancer",
            "officialTitle": "A Phase I Study Investigating Everolimus and Dovitinib in Metastatic Clear Cell Renal Cancer"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2012-10-17"
          },
          "conditionsModule": {
            "conditions": [
              "Metastatic Clear Cell Renal Cancer"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "To determine and establish the safety profile of everolimus and dovitinib and define the dose limiting toxicity (DLT)",
                "timeFrame": "6 Months after all patients have come off study"
              },
              {
                "measure": "To determine the maximum tolerated dose (MTD) of everolimus and dovitinib given orally in patients with VEGF resistant renal cancer",
                "timeFrame": "1 month after each cohort is closed to recruitment"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "To evaluate clinical benefit at 6 months (Stable disease, partial response and complete response ) in the 13 assessable patients who received the maximum tolerated dose (n=13)."
              },
              {
                "measure": "To evaluate tumour response in the 13 patients who received the maximum tolerated dose (n=13). This includes the 7 additional assessable patients in the expansion cohort."
              },
              {
                "measure": "To determine plasma pharmacokinetic (PK) parameters following administration of everolimus and dovitinib"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT06390826",
            "briefTitle": "Testing Sunitinib as Potentially Targeted Treatment in Cancers With cKIT Genetic Changes (MATCH - Subprotocol V)",
            "officialTitle": "MATCH Treatment Subprotocol V: Phase II Study of Sunitinib in Patients With Tumors With cKIT Mutations (Excluding GIST, Renal Cell Carcinoma or Pancreatic Neuorendocrine Tumor)"
          },
          "statusModule": {
            "overallStatus": "ACTIVE_NOT_RECRUITING",
            "studyFirstSubmitDate": "2024-04-27",
            "resultsFirstSubmitDate": "2025-02-13"
          },
          "conditionsModule": {
            "conditions": [
              "Advanced Lymphoma",
              "Advanced Malignant Solid Neoplasm",
              "Refractory Lymphoma",
              "Refractory Malignant Solid Neoplasm",
              "Refractory Multiple Myeloma"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Objective Response Rate (ORR)",
                "timeFrame": "Tumor assessments occurred at baseline, then every 3 months if patient is < 2 years from study entry, and every 6 months thereafter until disease progression, up to 3 years post registration"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "6-month Progression Free Survival (PFS)"
              },
              {
                "measure": "Progression Free Survival"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00387426",
            "briefTitle": "Sunitinib in Treating Patients With Idiopathic Myelofibrosis",
            "officialTitle": "A Phase II Study of Sunitinib Malate in Idiopathic Myelofibrosis"
          },
          "statusModule": {
            "overallStatus": "TERMINATED",
            "studyFirstSubmitDate": "2006-10-12",
            "resultsFirstSubmitDate": "2012-07-05"
          },
          "conditionsModule": {
            "conditions": [
              "Accelerated Phase Chronic Myelogenous Leukemia",
              "Acute Undifferentiated Leukemia",
              "Adult Acute Lymphoblastic Leukemia in Remission",
              "Adult Acute Myeloid Leukemia in Remission",
              "Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities",
              "Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)",
              "Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)",
              "Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)",
              "Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)",
              "Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative",
              "Blastic Phase Chronic Myelogenous Leukemia",
              "Chronic Myelomonocytic Leukemia",
              "Chronic Phase Chronic Myelogenous Leukemia",
              "Mast Cell Leukemia",
              "Meningeal Chronic Myelogenous Leukemia",
              "Primary Myelofibrosis",
              "Progressive Hairy Cell Leukemia, Initial Treatment",
              "Prolymphocytic Leukemia",
              "Recurrent Adult Acute Lymphoblastic Leukemia",
              "Recurrent Adult Acute Myeloid Leukemia",
              "Refractory Chronic Lymphocytic Leukemia",
              "Refractory Hairy Cell Leukemia",
              "Relapsing Chronic Myelogenous Leukemia",
              "Secondary Acute Myeloid Leukemia",
              "Stage I Chronic Lymphocytic Leukemia",
              "Stage II Chronic Lymphocytic Leukemia",
              "Stage III Chronic Lymphocytic Leukemia",
              "Stage IV Chronic Lymphocytic Leukemia",
              "T-cell Large Granular Lymphocyte Leukemia",
              "Untreated Adult Acute Lymphoblastic Leukemia",
              "Untreated Adult Acute Myeloid Leukemia",
              "Untreated Hairy Cell Leukemia"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Number of Participants With Objective Clinical Response to Sunitinib Therapy",
                "timeFrame": "After two 6-week treatment courses (12 weeks)"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT06427057",
            "briefTitle": "A Study of Cadonilimab\uff08AK104\uff09Combined With Standard Treatment for Function Preservation in Urinary System Tumors",
            "officialTitle": "A Prospective, Open Label, Dual Cohort Study of Cadonilimab\uff08AK104\uff09Combined With Standard Treatment for Function Preservation in Urinary System Tumors"
          },
          "statusModule": {
            "overallStatus": "NOT_YET_RECRUITING",
            "studyFirstSubmitDate": "2024-05-19"
          },
          "conditionsModule": {
            "conditions": [
              "Urinary System Tumor"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Bladder/Kidney Preservation rate",
                "timeFrame": "Up to approximately 18 Weeks (Time of surgery)"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Objective Response Rate (ORR)"
              },
              {
                "measure": "Rate of Pathologic Response"
              },
              {
                "measure": "Overall Survival (OS)"
              },
              {
                "measure": "Assess Adverse Events"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00831857",
            "briefTitle": "VEGF Imaging in Renal Cell Carcinoma",
            "officialTitle": "89Zr-bevacizumab PET Imaging in Patients With Renal Cell Carcinoma Treated With Sunitinib or Bevacizumab Plus Interferon; a Pilot Study"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2009-01-28"
          },
          "conditionsModule": {
            "conditions": [
              "Renal Cell Carcinoma"
            ]
          },
          "designModule": {
            "studyType": "OBSERVATIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "The primary endpoint is the change in SUV between baseline 89Zr-bevacizumab PET scan and the scan performed after 2 and 6 weeks of treatment with sunitinib or bevacizumab plus interferon in patients with RCC.",
                "timeFrame": "after 2 and 6 weeks"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Progressive disease according to Response Evaluation Criteria in Solid Tumors (RECIST) criteria. Progression is defined as the appearance of new disease or an increase of 20% in the sum of the longest diameters of the target lesions."
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01664182",
            "briefTitle": "Trebananib With or Without Bevacizumab, Pazopanib Hydrochloride, Sorafenib Tosylate, or Sunitinib Malate in Treating Patients With Advanced Kidney Cancer",
            "officialTitle": "A Randomized Phase 2 Study of AMG 386 With or Without Continued Anti-Vascular Endothelial Growth Factor (VEGF) Therapy in Patients With Renal Cell Carcinoma Who Have Progressed on Bevacizumab, Pazopanib, Sorafenib, or Sunitinib"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2012-08-10",
            "resultsFirstSubmitDate": "2022-01-07"
          },
          "conditionsModule": {
            "conditions": [
              "Advanced Renal Cell Carcinoma",
              "Advanced Sarcomatoid Renal Cell Carcinoma",
              "Stage III Renal Cell Cancer AJCC v7",
              "Stage IV Renal Cell Cancer AJCC v7"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Observed Response Rate",
                "timeFrame": "Up to 8 weeks"
              },
              {
                "measure": "Tumor Response",
                "timeFrame": "at 8 weeks"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Progression Free Survival (PFS)"
              },
              {
                "measure": "Number of Participants With Grade 3, 4, 5 Toxicities Related to the Treatment Drugs"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00716820",
            "briefTitle": "Special Investigation For Gist Of Sunitinib Malate (Regulatory Post Marketing Commitment Plan).",
            "officialTitle": "Outcome Survey Of Specific Use Of 12.5 Mg Sutent Capsule Against Gastrointestinal Stromal Tumor: Implementation Guidelines."
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2008-07-15",
            "resultsFirstSubmitDate": "2016-08-29"
          },
          "conditionsModule": {
            "conditions": [
              "Gastrointestinal Stromal Tumors"
            ]
          },
          "designModule": {
            "studyType": "OBSERVATIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Number of Participants With Treatment-Related Adverse Events",
                "timeFrame": "MAX 2 Years"
              },
              {
                "measure": "Objective Response Rate",
                "timeFrame": "MAX 2 Years"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Objective Response Rates by KIT Expression Status"
              },
              {
                "measure": "Objective Response Rates by c-Kit Mutation Status"
              },
              {
                "measure": "Objective Response Rates by Platelet - Derived Growth Factor Receptor Alpha (PDGFR\u03b1) Mutation Status"
              },
              {
                "measure": "Number of Participants With Treatment-Related Adverse Events in Elderly Population"
              },
              {
                "measure": "Number of Participants With Treatment-Related Adverse Events Who Had Hepatic Impairment"
              },
              {
                "measure": "Number of Participants With Treatment-Related Adverse Events Who Had Renal Impairment"
              },
              {
                "measure": "Number of Participants With Treatment-Related Adverse Events Who Used Concomitant Cytochrome P450 3A4 (CYP3A4) Inhibitors"
              },
              {
                "measure": "Number of Participants With Treatment-Related Adverse Events Who Were Under Long-Term Treatment"
              },
              {
                "measure": "Numbers of Participants With Treatment-Related Adverse Events Corresponded to Items for Priority Investigation"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00471276",
            "briefTitle": "Efficacy And Safety Of Sunitinib In Women With Advanced Breast Cancer",
            "officialTitle": "A Phase II Study Of Sunitinib Malate Single Agent For The Treatment Of Women With Advanced Breast Cancer"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2007-05-07",
            "resultsFirstSubmitDate": "2011-06-23"
          },
          "conditionsModule": {
            "conditions": [
              "Breast Neoplasms"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Number of Participants With Objective Response",
                "timeFrame": "Baseline, Week 9, and every 8 weeks up to Month 34"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Number of Participants With Clinical Benefit"
              },
              {
                "measure": "Number of Participants With Objective Response of Superficial Lesions"
              },
              {
                "measure": "Progression-Free Survival (PFS)"
              },
              {
                "measure": "Duration of Response (DR)"
              },
              {
                "measure": "Overall Survival (OS)"
              },
              {
                "measure": "Number of Participants With Objective Response for Subgroup of Participants Whom Sunitinib Was at Least a Third Line Therapy"
              },
              {
                "measure": "Change From Baseline in European Organization for Research and Treatment of Cancer Quality of Life Questionaire-C30 (EORTC- QLQ-C30) Score"
              },
              {
                "measure": "Change From Baseline in EORTC-QLQ Companion Breast Cancer Module (EORTC-QLQ-BR23) Score: Body Image"
              },
              {
                "measure": "Change From Baseline in EORTC-QLQ-BR23 Score: Future Perspective"
              },
              {
                "measure": "Change From Baseline in EORTC-QLQ-BR23 Score: Sexual Enjoyment"
              },
              {
                "measure": "Change From Baseline in EORTC-QLQ-BR23 Score: Sexual Functioning"
              },
              {
                "measure": "Change From Baseline in EORTC-QLQ-BR23 Score: Arm Symptoms"
              },
              {
                "measure": "Change From Baseline in EORTC-QLQ-BR23 Score: Breast Symptoms"
              },
              {
                "measure": "Change From Baseline in EORTC-QLQ-BR23 Score: Systemic Therapy Side Effects"
              },
              {
                "measure": "Change From Baseline in EORTC-QLQ-BR23 Score: Upset by Hair Loss"
              },
              {
                "measure": "Change From Baseline in Cancer Therapy Satisfaction Questionnaire (CTSQ) Score: Expectation of Therapy"
              },
              {
                "measure": "Change From Baseline in CTSQ Score: Feelings About Side Effects"
              },
              {
                "measure": "Change From Baseline in CTSQ Score: Satisfaction With Therapy"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00247676",
            "briefTitle": "An International Phase 2 Study Of SU011248 In Patients With Inoperable Liver Cancer",
            "officialTitle": "An Open Label International Multi-Center Phase 2 Activity And Safety Study Of SU011248 In Patients With Unresectable Hepatocellular Carcinoma"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2005-11-01",
            "resultsFirstSubmitDate": "2010-01-06"
          },
          "conditionsModule": {
            "conditions": [
              "Liver Neoplasms",
              "Unresectable Hepatocellular Carcinoma"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Best Overall Response",
                "timeFrame": "From start of treatment until Day 28 of Cycle 1, Day 28 of Cycles thereafter"
              },
              {
                "measure": "Objective Response (CR or PR)",
                "timeFrame": "From start of treatment until Day 28 of Cycle 1, Day 28 of Cycles thereafter"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Duration of Objective Response (CR or PR)"
              },
              {
                "measure": "Clinical Benefit Response (CR, PR, or SD With Duration \u226512 Weeks)"
              },
              {
                "measure": "Best Overall Response of PR or SD With Duration \u226512 Weeks"
              },
              {
                "measure": "Progression-Free Survival (Overall ITT)"
              },
              {
                "measure": "Progression-Free Survival (ITT Child Pugh Class A Subject Population)"
              },
              {
                "measure": "Time to Tumor Progression (Overall ITT)"
              },
              {
                "measure": "Time to Tumor Progression (ITT Child Pugh Class A Subject Population)"
              },
              {
                "measure": "Overall Survival (Overall ITT)"
              },
              {
                "measure": "Overall Survival (ITT Child Pugh Class A Subject Population)"
              },
              {
                "measure": "1-Year Survival Probability"
              },
              {
                "measure": "Trough Plasma Concentrations (Ctrough) of Sunitinib"
              },
              {
                "measure": "Ctrough of SU-012662 (Metabolite of Sunitinib)"
              },
              {
                "measure": "Ctrough of Total Drug (Sunitinib + SU-012662)"
              },
              {
                "measure": "Dose-Corrected Ctrough of Sunitinib"
              },
              {
                "measure": "Dose-Corrected Ctrough of SU-012662 (Metabolite of Sunitinib)"
              },
              {
                "measure": "Dose-Corrected Ctrough of Total Drug (Sunitinib + SU-012662)"
              },
              {
                "measure": "Circulating Endothelial Cells (CECs) and Circulating Endothelial Progenitor Cells (CEPs)"
              },
              {
                "measure": "Tissue Tumor Markers Assessed by Tumor Biopsy"
              },
              {
                "measure": "Plasma Concentration of Vascular Endothelial Growth Factor (VEGF)"
              },
              {
                "measure": "Plasma Concentration of VEGF-C"
              },
              {
                "measure": "Plasma Concentration of Soluble VEGF Receptor-2 (sVEGFR-2)"
              },
              {
                "measure": "Plasma Concentration of Soluble VEGF Receptor-3 (sVEGFR-3)"
              },
              {
                "measure": "Plasma Concentration of Soluble KIT (sKIT)"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01689376",
            "briefTitle": "Regorafenib in Subjects With Gastrointestinal Stromal Tumors (GIST) Who Have Progressed After Standard Therapy (Managed Access Program)",
            "officialTitle": "Guidelines for Treatment With Regorafenib in Patients With Gastrointestinal Stromal Tumors (GIST) After Disease Progression on or Intolerance to Imatinib and Sunitinib (Managed Access Program)"
          },
          "statusModule": {
            "overallStatus": "NO_LONGER_AVAILABLE",
            "studyFirstSubmitDate": "2012-07-18"
          },
          "conditionsModule": {
            "conditions": [
              "Gastrointestinal Stromal Tumors"
            ]
          },
          "designModule": {
            "studyType": "EXPANDED_ACCESS"
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00578526",
            "briefTitle": "SU011248 for Platinum-Refractory Urothelial Cancer Evaluation Trial",
            "officialTitle": "A Randomized, Placebo-controlled Phase II Study to Compare the Efficacy and Safety of SU011248 Versus Placebo in Patients With Advanced Urothelial Transitional Cell Carcinoma Who Have Failed or Are Intolerant to Cisplatin-based Chemotherapy"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2007-12-19"
          },
          "conditionsModule": {
            "conditions": [
              "Urothelial Cancer",
              "Bladder Cancer",
              "Adult"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Progression Free Survival",
                "timeFrame": "4 months"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "objective response rate"
              },
              {
                "measure": "duration of response"
              },
              {
                "measure": "Change in health-related quality of life"
              },
              {
                "measure": "Number of participants that develop an adverse event to treatment."
              },
              {
                "measure": "Overall Survival"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01185366",
            "briefTitle": "Everolimus Versus Sunitinib in Non-Clear Cell Renal Cell Carcinoma",
            "officialTitle": "Everolimus Versus Sunitinib Therapy in Patients With Advanced Non-clear Cell Renal Cell Carcinoma"
          },
          "statusModule": {
            "overallStatus": "TERMINATED",
            "studyFirstSubmitDate": "2010-08-18",
            "resultsFirstSubmitDate": "2020-09-15"
          },
          "conditionsModule": {
            "conditions": [
              "Kidney Cancer"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Progression Free Survival (PFS) for First Line Medication",
                "timeFrame": "7 months"
              },
              {
                "measure": "Progression Free Survival (PFS) for Crossover Medication",
                "timeFrame": "4 months"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Number of Participants Who Experienced Either a Grade 3 or 4 Adverse Event"
              },
              {
                "measure": "Overall Survival of the First Line Therapy"
              },
              {
                "measure": "Number of Participants With Best Overall Response for First Line Medication"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00979966",
            "briefTitle": "Study in Non-Clear Cell Renal Carcinoma (Ncc-RCC) Temsirolimus Versus Sunitinib",
            "officialTitle": "Prospective Randomized Phase-II Trial With Temsirolimus Versus Sunitinib in Previously Untreated Patients With Advanced or Metastatic Non-Clear Cell Renal Carcinoma"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2009-09-09"
          },
          "conditionsModule": {
            "conditions": [
              "Non-clear Cell Renal Cell Cancer"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Time to progression",
                "timeFrame": "7-11 months expected"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Objective response"
              },
              {
                "measure": "safety assessed using CTCAE v3.0 and safety assessed according to reported SAEs"
              },
              {
                "measure": "one year progression free survival rate (1YPFSR)"
              },
              {
                "measure": "overall survival (OS)"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00434226",
            "briefTitle": "A Study of Sunitinib in Combination With Bevacizumab, Carboplatin, and Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer (SABRE-L)",
            "officialTitle": "A Randomized, Controlled, Open-Label, Multicenter, Phase II Study of the Safety and Efficacy of Sunitinib in Combination With Bevacizumab, Carboplatin, and Paclitaxel in Previously Untreated Patients With Advanced Non-Small Cell Lung Cancer"
          },
          "statusModule": {
            "overallStatus": "TERMINATED",
            "whyStopped": "Based on data collected, the combination appeared to be poorly tolearated.",
            "studyFirstSubmitDate": "2007-02-11",
            "resultsFirstSubmitDate": "2009-07-09"
          },
          "conditionsModule": {
            "conditions": [
              "Non-Small Cell Lung Cancer"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Best Response",
                "timeFrame": "From randomization until disease progression/recurrence"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Serious Adverse Events"
              },
              {
                "measure": "Incidence of Grade \u2265 3 Adverse Events"
              },
              {
                "measure": "Incidence of Adverse Events Leading to Sunitinib Discontinuation, Dose Interruption, or Dose Reduction"
              },
              {
                "measure": "Incidence of Adverse Events Leading to Bevacizumab Discontinuation or Dose Interruption"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT03641326",
            "briefTitle": "Sunitinib in Sarcomas of the Central Nervous System",
            "officialTitle": "Phase II Clinical Trial of Sunitinib in Sarcomas of the Central Nervous System"
          },
          "statusModule": {
            "overallStatus": "TERMINATED",
            "whyStopped": "Poor accrual",
            "studyFirstSubmitDate": "2018-08-21",
            "resultsFirstSubmitDate": "2022-02-14"
          },
          "conditionsModule": {
            "conditions": [
              "Gliosarcoma",
              "Central Nervous System Sarcoma"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Number of Participants With Greater Than 50% Reduction in Objective Response",
                "timeFrame": "From enrollment to off study, approximately 3 Months, 1 Week, 4 Days"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Number of Participants With 6-month Progression Free Survival (PFS)"
              },
              {
                "measure": "Number of Participants That Have Progressive Disease After 18 Months"
              },
              {
                "measure": "Number of Adverse Events Related to Drug"
              },
              {
                "measure": "Evaluation of Tumor Tissue for Biomarkers"
              },
              {
                "measure": "Number of Responders and Non-responders With Tumor Markers of Activation"
              },
              {
                "measure": "Number of Responders and Non-responders With a Change in Perfusion Blood Volume Before and After Treatment With Sunitinib."
              },
              {
                "measure": "Number of Responders and Non-responders With Dynamic Contrast Enhanced Magnetic Resonance Imaging (MRI) Performed Before and During Treatment With Sunitinib."
              },
              {
                "measure": "Mean Symptom Severity and Interference From Baseline Using the MD Anderson Symptom Inventory-Brain Tumor Module (MDASI-BT)"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00094029",
            "briefTitle": "A Treatment Protocol for Patients With Gastrointestinal Stromal Tumor (GIST) Who May Derive Benefit From Treatment With SU011248",
            "officialTitle": "A Treatment Protocol For Patients With Gastrointestinal Stromal Tumor Who Are Ineligible For Participation In Other SU011248 Protocols And Are Refractory To Or Intolerant Of Imatinib Mesylate"
          },
          "statusModule": {
            "overallStatus": "APPROVED_FOR_MARKETING",
            "studyFirstSubmitDate": "2004-10-08"
          },
          "conditionsModule": {
            "conditions": [
              "Gastrointestinal Neoplasm"
            ]
          },
          "designModule": {
            "studyType": "EXPANDED_ACCESS"
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00672594",
            "briefTitle": "Study of Sunitinib Malate in Patients With Newly Diagnosed Prostate Cancer Prior to Prostatectomy",
            "officialTitle": "Investigator-Initiated Pilot Study of Sunitinib Malate in Patients With Newly Diagnosed Prostate Cancer Prior to Prostatectomy"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2008-05-04",
            "resultsFirstSubmitDate": "2013-10-25"
          },
          "conditionsModule": {
            "conditions": [
              "Prostate Cancer",
              "Prostatectomy"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Change in Apoptotic Indices Before and After Treatment",
                "timeFrame": "Baseline and 4 weeks"
              },
              {
                "measure": "Change in Proliferation Indices Before and After Treatment",
                "timeFrame": "Baseline and 4 weeks"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Number of Patients Experiencing Grade \u22654 Hematologic or Grade \u22653 Non-hematologic Toxicity"
              },
              {
                "measure": "Change in Pathologic (Microvessel Density)."
              },
              {
                "measure": "Change in Systemic Parameters Before and After Sunitinib Malate Treatment."
              },
              {
                "measure": "Protein Levels and Activation Status of PDGFR in Prostate Cancer Tissue."
              },
              {
                "measure": "Difference in Gene Expression Patterns Using Microarray Analysis"
              },
              {
                "measure": "Interstitial Fluid Pressure (IFP)"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01402089",
            "briefTitle": "Cytochrom p450 3A4 and 1A2 Phenotyping for the Individualization of Treatment With Sunitinib or Erlotinib in Cancer Patients",
            "officialTitle": "Cytochrom p450 3A4 and 1A2 Phenotyping for the Individualization of Treatment With Sunitinib or Erlotinib in Cancer Patients"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2011-07-20"
          },
          "conditionsModule": {
            "conditions": [
              "Non Small-cell Lung Cancer",
              "Renal-cell Cancer",
              "Gastrointestinal Stroma Tumor"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Steady-state partial area-under the plasma concentration-time curve over 24 hours (AUC24h) of sunitinib and erlotinib and CYP3A4/1A2-phenotype activity as defined in the protocol",
                "timeFrame": "2 weeks"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Sunitinib and Erlotinib-associated toxicity according to the CTC criteria (v.3.0)"
              },
              {
                "measure": "Concentrations of Sunitinib, Erlotinib and probe drugs (Midazolam, Caffeine) in whole blood, sampled from patient's dried blood spots (DBS)"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00113529",
            "briefTitle": "Study Of SU011248 Plus Gefitinib (Iressa) In Patients With Advanced Renal Cell Carcinoma",
            "officialTitle": "A Phase 1/2 Safety And Pharmacokinetic Study Of SU011248 In Combination With Gefitinib (Iressa) In Patients With Metastatic Renal Cell Carcinoma"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2005-06-08",
            "resultsFirstSubmitDate": "2010-03-01"
          },
          "conditionsModule": {
            "conditions": [
              "Carcinoma, Renal Cell"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Number of Subjects With Overall Confirmed Objective Disease Response According to the Response Evaluation Criteria in Solid Tumors (RECIST)",
                "timeFrame": "From start of treatment until Day 28 of Cycles 1 to 4, Day 28 of even cycles thereafter"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Time to Tumor Response (TTR)"
              },
              {
                "measure": "Duration of Response (DR)"
              },
              {
                "measure": "Time to Tumor Progression (TTP)"
              },
              {
                "measure": "Overall Survival (OS)"
              },
              {
                "measure": "Progression-Free Survival (PFS)"
              },
              {
                "measure": "Probability of Survival at One Year"
              },
              {
                "measure": "VEGF (Vascular Endothelial Growth Factor) Concentration at Baseline"
              },
              {
                "measure": "VEGF Ratio to Baseline at Each Time Point"
              },
              {
                "measure": "VEGF-C Concentration at Baseline"
              },
              {
                "measure": "VEGF-C Ratio to Baseline at Each Time Point"
              },
              {
                "measure": "Soluble VEGF Receptor 2 (sVEGFR2) Concentration at Baseline"
              },
              {
                "measure": "sVEGFR2 Ratio to Baseline at Each Time Point"
              },
              {
                "measure": "Soluble VEGF Receptor 3 (sVEGFR3) Concentration at Baseline"
              },
              {
                "measure": "sVEGFR3 Ratio to Baseline at Each Time Point"
              },
              {
                "measure": "Change From Baseline in VEGF by Time Point Stratified by Tumor Response (CR or PR or [SD > = 6 Weeks] Versus PD)"
              },
              {
                "measure": "Change From Baseline in VEGFC by Time Point Stratified by Tumor Response (CR or PR or [SD > = 6 Weeks] Versus PD)"
              },
              {
                "measure": "Change From Baseline in VEGFR2 by Time Point Stratified by Tumor Response (CR or PR or [SD > = 6 Weeks] Versus PD)"
              },
              {
                "measure": "Change From Baseline in VEGFR3 by Time Point Stratified by Tumor Response (CR or PR or [SD > = 6 Weeks] Versus PD)"
              },
              {
                "measure": "Change From Baseline in VEGF by Time Point Stratified by PFS >= Median and PFS < Median"
              },
              {
                "measure": "Change From Baseline in VEGFC by Time Point Stratified by PFS >= Median and PFS < Median"
              },
              {
                "measure": "Change From Baseline in VEGFR2 by Time Point Stratified by PFS >= Median and PFS < Median"
              },
              {
                "measure": "Change From Baseline in VEGFR3 by Time Point Stratified by PFS >= Median and PFS < Median"
              },
              {
                "measure": "Change From Baseline in VEGF by Time Point Stratified by TTP >= Median and TTP < Median"
              },
              {
                "measure": "Change From Baseline in VEGFC by Time Point Stratified by TTP >= Median and TTP < Median"
              },
              {
                "measure": "Change From Baseline in VEGFR2 by Time Point Stratified by TTP >= Median and TTP < Median"
              },
              {
                "measure": "Change From Baseline in VEGFR3 by Time Point Stratified by TTP >= Median and TTP < Median"
              },
              {
                "measure": "Trough Plasma Concentrations (Ctrough) of Sunitinib"
              },
              {
                "measure": "Ctrough of SU-012662 (Sunitinib's Metabolite)"
              },
              {
                "measure": "Ctrough of Gefitinib"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01121562",
            "briefTitle": "Efficacy And Safety Of Sunitinib In Patients With Advanced Well-Differentiated Pancreatic Neuroendocrine Tumors",
            "officialTitle": "A Phase II Study Of Sunitinib In Patients With Progressive Advanced/Metastatic Well-Differentiated Pancreatic Neuroendocrine Tumors"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2010-05-10",
            "resultsFirstSubmitDate": "2012-07-01"
          },
          "conditionsModule": {
            "conditions": [
              "Pancreatic Neuroendocrine Tumors"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Clinical Benefit Response Rate (CBR)",
                "timeFrame": "Up to 799 days of treatment"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Objective Response Rate (ORR)"
              },
              {
                "measure": "Tumor Shrinkage"
              },
              {
                "measure": "Progression-free Survival (PFS)"
              },
              {
                "measure": "Overall Survival (OS)"
              },
              {
                "measure": "Dose-corrected Trough Plasma Concentrations of Sunitinib, SU012662 and Total Drug (Sunitinib + SU012662)."
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02688491",
            "briefTitle": "A CpG-methylation-based Assay for Stratifying Stage III Clear Cell Renal Cell Carcinoma of Receiving Adjuvant Treatment",
            "officialTitle": "A Multi-site, Open, Perspective Study of Prognostic Value and Benefit From Adjuvant Targeted Therapy of Stage III Clear Cell Renal Cell Carcinoma Based on a CpG-methylation-based Assay"
          },
          "statusModule": {
            "overallStatus": "NOT_YET_RECRUITING",
            "studyFirstSubmitDate": "2016-02-18"
          },
          "conditionsModule": {
            "conditions": [
              "Renal Neoplasms",
              "Targeted Molecular Therapy"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Disease free survival",
                "timeFrame": "From the date of registration to up to10 years"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Overall survival"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00457691",
            "briefTitle": "Study Of FOLFIRI Chemotherapy With Or Without Sunitinib In Patients With Metastatic Colorectal Cancer",
            "officialTitle": "A Multicenter, Randomised, Double-Blind, Phase 3 Study Of Sunitinib In Metastatic Colorectal Cancer Patients Receiving Irinotecan, 5-Fluorouracil And Leucovorin (FOLFIRI) As First Line Treatment"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2007-04-04",
            "resultsFirstSubmitDate": "2011-03-09"
          },
          "conditionsModule": {
            "conditions": [
              "Metastatic Colorectal Cancer"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Progression-free Survival (PFS)",
                "timeFrame": "First dose of study treatment up to 30 months"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Overall Survival (OS)"
              },
              {
                "measure": "Number of Participants With Overall Confirmed Objective Response"
              },
              {
                "measure": "Duration of Response (DR)"
              },
              {
                "measure": "Change From Baseline in Monroe Dunaway (MD) Anderson Symptom Assessment Inventory of Gastrointestinal Symptoms (MDASI-GI) Symptom Intensity Score"
              },
              {
                "measure": "Change From Baseline in MDASI-GI Symptom Interference Score"
              },
              {
                "measure": "Change From Baseline in European Quality of Life (EuroQol) EQ-5D Self-Report Questionnaire"
              },
              {
                "measure": "Change From Baseline in EuroQol (EQ) Visual Analog Scale (VAS) (EQ-VAS)"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01391962",
            "briefTitle": "Sunitinib or Cediranib for Alveolar Soft Part Sarcoma",
            "officialTitle": "A Phase II Trial In Which Patients With Metastatic Alveolar Soft Part Sarcoma Are Randomized to Either Sunitinib or Cediranib Monotherapy, With Cross-Over at Disease Progression"
          },
          "statusModule": {
            "overallStatus": "ACTIVE_NOT_RECRUITING",
            "studyFirstSubmitDate": "2011-07-09",
            "resultsFirstSubmitDate": "2024-06-07"
          },
          "conditionsModule": {
            "conditions": [
              "Sarcoma, Alveolar Soft Part"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Part I: Objective Response Rate (ORR) of Single-agent Cediranib in Participants With Advanced Alveolar Soft Part Sarcoma (ASPS)",
                "timeFrame": "Time on treatment (an average of 497 days or 16 months)"
              },
              {
                "measure": "Part I: Objective Response Rate (ORR) of Single-agent Sunitinib in Participants With Advanced Alveolar Soft Part Sarcoma (ASPS)",
                "timeFrame": "Time on treatment (an average of 497 days or 16 months)"
              },
              {
                "measure": "Part II: Objective Response Rate (ORR) of Sunitinib in Participants Who Progress on the Cediranib Arm During Part I",
                "timeFrame": "Time on treatment (an average of 497 days or 16 months)"
              },
              {
                "measure": "Part II: Objective Response Rate (ORR) of Cediranib in Participants Who Progress on the Sunitinib Arm During Part I",
                "timeFrame": "Time on treatment (an average of 497 days or 16 months)"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Maximum Observed Plasma Concentration of Cediranib"
              },
              {
                "measure": "Percentage of Participants With Progression-free Survival (PFS) at 24 Weeks for Participants Receiving Single-agent Cediranib and Single-agent Sunitinib Malate in Participants With Advanced ASPS During Part I"
              },
              {
                "measure": "Number of Participants With Serious and/or Non-serious Adverse Events Assessed by the Common Terminology Criteria for Adverse Events (CTCAE v5.0)."
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01339962",
            "briefTitle": "Retrospective Analysis Of Progression Free Survival And Overall Survival In A National Cohort Of Patients With Metastatic Renal Cell Carcinoma Treated In Denmark From 2006-2010. DARENCA Study 2.",
            "officialTitle": "Retrospective Analysis Of Progression Free Survival And Overall Survival In A National Cohort Of Patients With Metastatic Renal Cell Carcinoma Treated In Denmark From 2006-2010. DARENCA Study 2."
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2011-04-15"
          },
          "conditionsModule": {
            "conditions": [
              "Renal Cell Carcinoma"
            ]
          },
          "designModule": {
            "studyType": "OBSERVATIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Overall survival from initiation of first systemic anticancer therapy",
                "timeFrame": "8 months"
              },
              {
                "measure": "Progression free survival from initiation of each systemic anticancer therapy separately",
                "timeFrame": "8 months"
              },
              {
                "measure": "Time to treatment failure from initiation of each systemic anticancer therapy separately",
                "timeFrame": "8 months"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Prognostic factors at baseline associated with efficacy (PFS) of each systemic anticancer therapy and overall survival"
              },
              {
                "measure": "Serious Adverse Events: Defined as AEs leading to dose adjustment, treatment interruption/ cessation or death."
              },
              {
                "measure": "Predictive factors"
              },
              {
                "measure": "Co-morbidity assessed by Charlson Comorbidity Index"
              },
              {
                "measure": "Combined PFS and OS on sequential treatment"
              },
              {
                "measure": "Assessment of first line immunotherapy\u00b4s effect on second line targeted therapy"
              },
              {
                "measure": "Assessment of prognostic factors and overall survival for patients not receiving systemic therapy"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00788060",
            "briefTitle": "A Phase Ib Study of Rad001 and Sutent to Treat Renal Cell Carcinoma",
            "officialTitle": "A Single Arm, Phase Ib Study of RAD001 and Sunitinib in Patients With Advanced Renal Cell Carcinoma"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2008-11-06"
          },
          "conditionsModule": {
            "conditions": [
              "Renal Cell Carcinoma"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "To determine the maximum tolerated dose (MTD)/recommended Phase 2 regimen of 2+1 dosing with Sunitinib and daily RAD001 in patients with advanced renal cell carcinoma.",
                "timeFrame": "1 year"
              },
              {
                "measure": "To determine the safety and tolerability of 2+1 dosing of Sunitinib and daily RAD001 in patients with advanced RCC",
                "timeFrame": "1 year"
              },
              {
                "measure": "To more fully evaluate the safety and tolerability of 2+1 dosing of Sunitinib and daily RAD001 at the MTD/recommended Phase 2 dose in patients with advanced RCC",
                "timeFrame": "1 year"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Describe the non-dose limiting toxicities associated with combination therapy using 2+1 dosing Sunitinib and daily RAD001."
              },
              {
                "measure": "Describe the pharmacokinetics of Sunitinib and RAD001 and evaluate any association with disease response"
              },
              {
                "measure": "To estimate objective response rate (partial or complete) seen in patients with advanced RCC in a dose expansion cohort treated at the MTD or recommended Phase 2 dose regimen"
              },
              {
                "measure": "To estimate the overall survival of RCC patients treated with Sunitinib and RAD001"
              },
              {
                "measure": "To estimate the time to disease progression of RCC patients treated with Sunitinib and RAD001"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT03260894",
            "briefTitle": "Pembrolizumab (MK-3475) Plus Epacadostat vs Standard of Care in mRCC (KEYNOTE-679/ECHO-302)",
            "officialTitle": "A Randomized, Open-Label, Phase 3 Study to Evaluate Efficacy and Safety of Pembrolizumab (MK-3475) Plus Epacadostat vs Standard of Care (Sunitinib or Pazopanib) as First-Line Treatment for Locally Advanced or Metastatic Renal Cell Carcinoma (mRCC) (KEYNOTE-679/ECHO-302)"
          },
          "statusModule": {
            "overallStatus": "ACTIVE_NOT_RECRUITING",
            "studyFirstSubmitDate": "2017-08-22",
            "resultsFirstSubmitDate": "2019-08-21"
          },
          "conditionsModule": {
            "conditions": [
              "Renal Cell Carcinoma (RCC)"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Objective Response Rate (ORR) of Pembrolizumab + Epacadostat Versus Standard of Care (SOC)",
                "timeFrame": "Minimum up to 6 months"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Safety and Tolerability of Pembrolizumab + Epacadostat Versus SOC as Measured by the Number of Participants Experiencing Adverse Events (AEs)"
              },
              {
                "measure": "Safety and Tolerability of Pembrolizumab + Epacadostat Versus SOC as Measured by the Number of Participants Discontinuing Study Drug Due to AEs"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT04927260",
            "briefTitle": "French Long Term Registry With Longitudinal Follow up of PDGFRA D842V-GIST Patients",
            "officialTitle": "French Long Term Registry With Longitudinal Follow up of PDGFRA D842V-GIST Patients : AVapritinib Real-life observatTORy"
          },
          "statusModule": {
            "overallStatus": "ACTIVE_NOT_RECRUITING",
            "studyFirstSubmitDate": "2021-06-02"
          },
          "conditionsModule": {
            "conditions": [
              "GIST",
              "GIST, Malignant",
              "PDGFR-Alpha D842V"
            ]
          },
          "designModule": {
            "studyType": "OBSERVATIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Survival",
                "timeFrame": "up to 48 months"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Progression Free Survival"
              },
              {
                "measure": "Incidence of long-term responders"
              },
              {
                "measure": "Duration of treatment"
              },
              {
                "measure": "Safety: Nature of AEs"
              },
              {
                "measure": "Safety : Frequency of AEs"
              },
              {
                "measure": "Safety : Severity of AEs"
              },
              {
                "measure": "Cognitive impairment in real-life according to MoCA questionnaires"
              },
              {
                "measure": "Cognitive impairment in real-life according to FACT-Cog"
              },
              {
                "measure": "Quality of life in real-life according to FACT-G questionnaire"
              }
            ]
          }
        }
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:15:48Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8323"
    },
    "name": "MLS003130329",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8323.png",
    "lincs": {
      "id": "LSM-8029",
      "name": "MLS003130329",
      "alternativeNames": [
        "BRD-K92803302"
      ],
      "pubchemCid": 44488170,
      "chebiId": 96650,
      "inchiParent": "InChI=1S/C24H37N5O4/c1-18-13-28(19(2)16-30)24(31)10-7-11-29-21(12-25-26-29)17-33-23(18)15-27(3)14-20-8-5-6-9-22(20)32-4/h5-6,8-9,12,18-19,23,30H,7,10-11,13-17H2,1-4H3/t18-,19+,23+/m1/s1",
      "inchiKeyParent": "QHTRHHVBBSPOHC-MSYCTHLASA-N",
      "smilesParent": "COc1ccccc1CN(C)C[C@@H]2OCc3cnnn3CCCC(=O)N(C[C@H]2C)[C@@H](C)CO"
    },
    "unichem": {
      "chebi": "96650",
      "chembl": "CHEMBL3559971",
      "lincs": "LSM-8029",
      "pubchem": "44488170"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL3559971",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 459.59,
        "hba": 8,
        "hbd": 1,
        "qedWeighted": 0.68
      }
    },
    "pubchem": [
      {
        "cid": 44488170,
        "inchi": "InChI=1S/C24H37N5O4/c1-18-13-28(19(2)16-30)24(31)10-7-11-29-21(12-25-26-29)17-33-23(18)15-27(3)14-20-8-5-6-9-22(20)32-4/h5-6,8-9,12,18-19,23,30H,7,10-11,13-17H2,1-4H3/t18-,19+,23+/m1/s1",
        "inchikey": "QHTRHHVBBSPOHC-MSYCTHLASA-N",
        "iupac": {
          "systematic": "(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-9-[[(2-methoxyphenyl)methyl-methylamino]methyl]-8-methyl-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)CCCN2C(=CN=N2)COC1CN(C)CC3=CC=CC=C3OC)C(C)CO"
        },
        "molecularFormula": "C24H37N5O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:16:00Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82b8"
    },
    "name": "BRD-K35861449",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82b8.png",
    "lincs": {
      "id": "LSM-39231",
      "name": "BRD-K35861449",
      "pubchemCid": 60189208,
      "chebiId": 127674,
      "inchiParent": "InChI=1S/C25H30N4O3/c30-16-22-24(19-8-6-17(7-9-19)18-10-12-26-13-11-18)21-14-28(15-23(31)29(21)22)25(32)27-20-4-2-1-3-5-20/h6-13,20-22,24,30H,1-5,14-16H2,(H,27,32)/t21-,22-,24+/m1/s1",
      "inchiKeyParent": "UNAUWIBTTZCXBK-AKFKNWHVSA-N",
      "smilesParent": "OC[C@@H]1[C@H]([C@H]2CN(CC(=O)N12)C(=O)NC3CCCCC3)c4ccc(cc4)c5ccncc5"
    },
    "unichem": {
      "chebi": "127674",
      "lincs": "LSM-39231",
      "pubchem": "60189208"
    },
    "pubchem": [
      {
        "cid": 60189208,
        "inchi": "InChI=1S/C25H30N4O3/c30-16-22-24(19-8-6-17(7-9-19)18-10-12-26-13-11-18)21-14-28(15-23(31)29(21)22)25(32)27-20-4-2-1-3-5-20/h6-13,20-22,24,30H,1-5,14-16H2,(H,27,32)/t21-,22-,24+/m1/s1",
        "inchikey": "UNAUWIBTTZCXBK-AKFKNWHVSA-N",
        "iupac": {
          "systematic": "(6S,7S,8S)-N-cyclohexyl-8-(hydroxymethyl)-2-oxo-7-(4-pyridin-4-ylphenyl)-1,4-diazabicyclo[4.2.0]octane-4-carboxamide"
        },
        "smiles": {
          "canonical": "C1CCC(CC1)NC(=O)N2CC3C(C(N3C(=O)C2)CO)C4=CC=C(C=C4)C5=CC=NC=C5"
        },
        "molecularFormula": "C25H30N4O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:16:02Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82fb"
    },
    "name": "BRD-K13207999",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82fb.png",
    "lincs": {
      "id": "LSM-7028",
      "name": "BRD-K13207999",
      "pubchemCid": 44486955,
      "chebiId": 95649,
      "inchiParent": "InChI=1S/C26H34N6O5/c1-18-13-32(19(2)16-33)25(34)10-7-11-31-14-21(27-29-31)17-36-24(18)15-30(3)26(35)22-12-23(37-28-22)20-8-5-4-6-9-20/h4-6,8-9,12,14,18-19,24,33H,7,10-11,13,15-17H2,1-3H3/t18-,19-,24-/m1/s1",
      "inchiKeyParent": "XYWPMUCHOREPKK-KHCICDEESA-N",
      "smilesParent": "C[C@H](CO)N1C[C@@H](C)[C@@H](CN(C)C(=O)c2cc(on2)c3ccccc3)OCc4cn(CCCC1=O)nn4"
    },
    "unichem": {
      "chebi": "95649",
      "lincs": "LSM-7028",
      "pubchem": "44486955"
    },
    "pubchem": [
      {
        "cid": 44486955,
        "inchi": "InChI=1S/C26H34N6O5/c1-18-13-32(19(2)16-33)25(34)10-7-11-31-14-21(27-29-31)17-36-24(18)15-30(3)26(35)22-12-23(37-28-22)20-8-5-4-6-9-20/h4-6,8-9,12,14,18-19,24,33H,7,10-11,13,15-17H2,1-3H3/t18-,19-,24-/m1/s1",
        "inchikey": "XYWPMUCHOREPKK-KHCICDEESA-N",
        "iupac": {
          "systematic": "N-[[(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methyl-5-phenyl-1,2-oxazole-3-carboxamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)CCCN2C=C(COC1CN(C)C(=O)C3=NOC(=C3)C4=CC=CC=C4)N=N2)C(C)CO"
        },
        "molecularFormula": "C26H34N6O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:16:04Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8325"
    },
    "name": "MLS003129210",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8325.png",
    "lincs": {
      "id": "LSM-7775",
      "name": "MLS003129210",
      "alternativeNames": [
        "BRD-K69431670"
      ],
      "pubchemCid": 44505762,
      "chebiId": 96396,
      "inchiParent": "InChI=1S/C21H37N5O5/c1-15(2)13-31-21(29)24(5)11-19-16(3)9-26(17(4)12-27)20(28)7-6-8-25-10-18(14-30-19)22-23-25/h10,15-17,19,27H,6-9,11-14H2,1-5H3/t16-,17-,19+/m0/s1",
      "inchiKeyParent": "UOJDQXZVAPFQKD-JENIJYKNSA-N",
      "smilesParent": "CC(C)COC(=O)N(C)C[C@H]1OCc2cn(CCCC(=O)N(C[C@@H]1C)[C@@H](C)CO)nn2"
    },
    "unichem": {
      "chebi": "96396",
      "lincs": "LSM-7775",
      "pubchem": "44505762"
    },
    "pubchem": [
      {
        "cid": 44505762,
        "inchi": "InChI=1S/C21H37N5O5/c1-15(2)13-31-21(29)24(5)11-19-16(3)9-26(17(4)12-27)20(28)7-6-8-25-10-18(14-30-19)22-23-25/h10,15-17,19,27H,6-9,11-14H2,1-5H3/t16-,17-,19+/m0/s1",
        "inchikey": "UOJDQXZVAPFQKD-JENIJYKNSA-N",
        "iupac": {
          "systematic": "2-methylpropyl N-[[(8S,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylcarbamate"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)CCCN2C=C(COC1CN(C)C(=O)OCC(C)C)N=N2)C(C)CO"
        },
        "molecularFormula": "C21H37N5O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:16:07Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c826a"
    },
    "name": "BRD-K19436903",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c826a.png",
    "lincs": {
      "id": "LSM-38320",
      "name": "BRD-K19436903",
      "pubchemCid": 60191224,
      "chebiId": 126757,
      "inchiParent": "InChI=1S/C20H19N3O2/c24-13-18-20(17-11-22-12-19(25)23(17)18)16-7-5-14(6-8-16)3-4-15-2-1-9-21-10-15/h1-2,5-10,17-18,20,22,24H,11-13H2/t17-,18-,20-/m1/s1",
      "inchiKeyParent": "RZJWPJAQJJGICA-QWFCFKBJSA-N",
      "smilesParent": "OC[C@@H]1[C@@H]([C@H]2CNCC(=O)N12)c3ccc(cc3)C#Cc4cccnc4"
    },
    "unichem": {
      "chebi": "126757",
      "lincs": "LSM-38320",
      "pubchem": "60191224"
    },
    "pubchem": [
      {
        "cid": 60191224,
        "inchi": "InChI=1S/C20H19N3O2/c24-13-18-20(17-11-22-12-19(25)23(17)18)16-7-5-14(6-8-16)3-4-15-2-1-9-21-10-15/h1-2,5-10,17-18,20,22,24H,11-13H2/t17-,18-,20-/m1/s1",
        "inchikey": "RZJWPJAQJJGICA-QWFCFKBJSA-N",
        "iupac": {
          "systematic": "(6S,7R,8S)-8-(hydroxymethyl)-7-[4-(2-pyridin-3-ylethynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one"
        },
        "smiles": {
          "canonical": "C1C2C(C(N2C(=O)CN1)CO)C3=CC=C(C=C3)C#CC4=CN=CC=C4"
        },
        "molecularFormula": "C20H19N3O2"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:16:09Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82b7"
    },
    "name": "BRD-K17139153",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82b7.png",
    "lincs": {
      "id": "LSM-9463",
      "name": "BRD-K17139153",
      "pubchemCid": 54657849,
      "chebiId": 98084,
      "inchiParent": "InChI=1S/C29H39N3O7S/c1-37-24-7-10-26(11-8-24)40(35,36)32-18-23(33)19-38-20-28-27(32)12-9-25(39-28)15-29(34)30-22-13-14-31(17-22)16-21-5-3-2-4-6-21/h2-8,10-11,22-23,25,27-28,33H,9,12-20H2,1H3,(H,30,34)/t22-,23+,25-,27+,28-/m0/s1",
      "inchiKeyParent": "IXXIZSABFJAVRH-FVWWXAAGSA-N",
      "smilesParent": "COc1ccc(cc1)S(=O)(=O)N2C[C@@H](O)COC[C@@H]3O[C@H](CC(=O)N[C@H]4CCN(Cc5ccccc5)C4)CC[C@@H]23"
    },
    "unichem": {
      "chebi": "98084",
      "lincs": "LSM-9463",
      "pubchem": "54657849"
    },
    "pubchem": [
      {
        "cid": 54657849,
        "inchi": "InChI=1S/C29H39N3O7S/c1-37-24-7-10-26(11-8-24)40(35,36)32-18-23(33)19-38-20-28-27(32)12-9-25(39-28)15-29(34)30-22-13-14-31(17-22)16-21-5-3-2-4-6-21/h2-8,10-11,22-23,25,27-28,33H,9,12-20H2,1H3,(H,30,34)/t22-,23+,25-,27+,28-/m0/s1",
        "inchikey": "IXXIZSABFJAVRH-FVWWXAAGSA-N",
        "iupac": {
          "systematic": "2-[(3R,6aR,8S,10aR)-3-hydroxy-1-(4-methoxyphenyl)sulfonyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(3S)-1-benzylpyrrolidin-3-yl]acetamide"
        },
        "smiles": {
          "canonical": "COC1=CC=C(C=C1)S(=O)(=O)N2CC(COCC3C2CCC(O3)CC(=O)NC4CCN(C4)CC5=CC=CC=C5)O"
        },
        "molecularFormula": "C29H39N3O7S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:16:12Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82ea"
    },
    "name": "BX-795",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82ea.png",
    "lincs": {
      "id": "LSM-1189",
      "name": "BX-795",
      "alternativeNames": [
        "BX795",
        "BX-795"
      ],
      "pubchemCid": 10077147,
      "chebiId": 91439,
      "inchiParent": "InChI=1S/C23H26IN7O2S/c24-18-15-27-22(30-20(18)25-9-5-10-26-21(32)19-8-4-13-34-19)28-16-6-3-7-17(14-16)29-23(33)31-11-1-2-12-31/h3-4,6-8,13-15H,1-2,5,9-12H2,(H,26,32)(H,29,33)(H2,25,27,28,30)",
      "inchiKeyParent": "VAVXGGRQQJZYBL-UHFFFAOYSA-N",
      "smilesParent": "Ic1cnc(Nc2cccc(NC(=O)N3CCCC3)c2)nc1NCCCNC(=O)c4cccs4"
    },
    "unichem": {
      "chebi": "91439",
      "chembl": "CHEMBL577784",
      "lincs": "LSM-1189",
      "pubchem": "10077147"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL577784",
      "prefName": "BX-795",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 591.48,
        "hba": 7,
        "hbd": 4,
        "qedWeighted": 0.21
      },
      "moleculeSynonyms": [
        {
          "moleculeSynonym": "BX-795",
          "synType": "RESEARCH_CODE",
          "synonyms": "BX-795"
        }
      ]
    },
    "pubchem": [
      {
        "cid": 10077147,
        "inchi": "InChI=1S/C23H26IN7O2S/c24-18-15-27-22(30-20(18)25-9-5-10-26-21(32)19-8-4-13-34-19)28-16-6-3-7-17(14-16)29-23(33)31-11-1-2-12-31/h3-4,6-8,13-15H,1-2,5,9-12H2,(H,26,32)(H,29,33)(H2,25,27,28,30)",
        "inchikey": "VAVXGGRQQJZYBL-UHFFFAOYSA-N",
        "iupac": {
          "systematic": "N-[3-[[5-iodo-4-[3-(thiophene-2-carbonylamino)propylamino]pyrimidin-2-yl]amino]phenyl]pyrrolidine-1-carboxamide"
        },
        "smiles": {
          "canonical": "C1CCN(C1)C(=O)NC2=CC=CC(=C2)NC3=NC=C(C(=N3)NCCCNC(=O)C4=CC=CS4)I"
        },
        "molecularFormula": "C23H26IN7O2S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:16:23Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82f9"
    },
    "name": "BRD-K57200229-001-01-6",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82f9.png",
    "lincs": {
      "id": "LSM-6809",
      "name": "BRD-K57200229-001-01-6",
      "alternativeNames": [
        "BRD0229",
        "SD-6-035-B3"
      ],
      "pubchemCid": 44497312,
      "chebiId": 95430,
      "inchiParent": "InChI=1S/C32H47N3O6/c1-22-17-35(23(2)20-36)32(37)27-16-26(33(4)5)11-13-28(27)41-24(3)9-7-8-14-38-31(22)19-34(6)18-25-10-12-29-30(15-25)40-21-39-29/h10-13,15-16,22-24,31,36H,7-9,14,17-21H2,1-6H3/t22-,23-,24-,31-/m1/s1",
      "inchiKeyParent": "WIYHORLWMFSPCL-FFBJJBDJSA-N",
      "smilesParent": "C[C@H](CO)N1C[C@@H](C)[C@@H](CN(C)Cc2ccc3OCOc3c2)OCCCC[C@@H](C)Oc4ccc(cc4C1=O)N(C)C"
    },
    "unichem": {
      "chebi": "95430",
      "lincs": "LSM-6809",
      "pubchem": "44497312"
    },
    "pubchem": [
      {
        "cid": 44497312,
        "inchi": "InChI=1S/C32H47N3O6/c1-22-17-35(23(2)20-36)32(37)27-16-26(33(4)5)11-13-28(27)41-24(3)9-7-8-14-38-31(22)19-34(6)18-25-10-12-29-30(15-25)40-21-39-29/h10-13,15-16,22-24,31,36H,7-9,14,17-21H2,1-6H3/t22-,23-,24-,31-/m1/s1",
        "inchikey": "WIYHORLWMFSPCL-FFBJJBDJSA-N",
        "iupac": {
          "systematic": "(3R,9S,10R)-9-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-13-one"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)N(C)C)C(C)CO)C)CN(C)CC3=CC4=C(C=C3)OCO4"
        },
        "molecularFormula": "C32H47N3O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:16:26Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8349"
    },
    "name": "MLS003129553",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8349.png",
    "lincs": {
      "id": "LSM-7686",
      "name": "MLS003129553",
      "alternativeNames": [
        "BRD-K62624932"
      ],
      "pubchemCid": 44494482,
      "chebiId": 96307,
      "inchiParent": "InChI=1S/C27H35N5O5/c1-19-15-31(20(2)17-33)26(34)9-6-12-32-23(14-28-29-32)18-36-25(19)16-30(3)27(35)37-24-11-10-21-7-4-5-8-22(21)13-24/h4-5,7-8,10-11,13-14,19-20,25,33H,6,9,12,15-18H2,1-3H3/t19-,20+,25+/m1/s1",
      "inchiKeyParent": "PZGTZQIYRXDXGV-RNHFSVANSA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@@H](C)[C@H](CN(C)C(=O)Oc2ccc3ccccc3c2)OCc4cnnn4CCCC1=O"
    },
    "unichem": {
      "chebi": "96307",
      "lincs": "LSM-7686",
      "pubchem": "44494482"
    },
    "pubchem": [
      {
        "cid": 44494482,
        "inchi": "InChI=1S/C27H35N5O5/c1-19-15-31(20(2)17-33)26(34)9-6-12-32-23(14-28-29-32)18-36-25(19)16-30(3)27(35)37-24-11-10-21-7-4-5-8-22(21)13-24/h4-5,7-8,10-11,13-14,19-20,25,33H,6,9,12,15-18H2,1-3H3/t19-,20+,25+/m1/s1",
        "inchikey": "PZGTZQIYRXDXGV-RNHFSVANSA-N",
        "iupac": {
          "systematic": "naphthalen-2-yl N-[[(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methylcarbamate"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)CCCN2C(=CN=N2)COC1CN(C)C(=O)OC3=CC4=CC=CC=C4C=C3)C(C)CO"
        },
        "molecularFormula": "C27H35N5O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:16:28Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c826b"
    },
    "name": "CHEMBL2354995",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c826b.png",
    "lincs": {
      "id": "LSM-11089",
      "name": "CHEMBL2354995",
      "alternativeNames": [
        "BRD-K43621195"
      ],
      "pubchemCid": 54649936,
      "chebiId": 99710,
      "inchiParent": "InChI=1S/C25H18FN3O2/c26-21-6-2-1-4-18(21)10-7-17-8-11-19(12-9-17)24-22(14-27)29(23(24)16-30)25(31)20-5-3-13-28-15-20/h1-6,8-9,11-13,15,22-24,30H,16H2/t22-,23-,24-/m0/s1",
      "inchiKeyParent": "NFTCJLSEEOPUCW-HJOGWXRNSA-N",
      "smilesParent": "OC[C@H]1[C@H]([C@H](C#N)N1C(=O)c2cccnc2)c3ccc(cc3)C#Cc4ccccc4F"
    },
    "unichem": {
      "chebi": "99710",
      "chembl": "CHEMBL2354995",
      "lincs": "LSM-11089",
      "pubchem": "54649936"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL2354995",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 411.44,
        "hba": 4,
        "hbd": 1,
        "qedWeighted": 0.67
      }
    },
    "pubchem": [
      {
        "cid": 54649936,
        "inchi": "InChI=1S/C25H18FN3O2/c26-21-6-2-1-4-18(21)10-7-17-8-11-19(12-9-17)24-22(14-27)29(23(24)16-30)25(31)20-5-3-13-28-15-20/h1-6,8-9,11-13,15,22-24,30H,16H2/t22-,23-,24-/m0/s1",
        "inchikey": "NFTCJLSEEOPUCW-HJOGWXRNSA-N",
        "iupac": {
          "systematic": "(2R,3S,4R)-3-[4-[2-(2-fluorophenyl)ethynyl]phenyl]-4-(hydroxymethyl)-1-(pyridine-3-carbonyl)azetidine-2-carbonitrile"
        },
        "smiles": {
          "canonical": "C1=CC=C(C(=C1)C#CC2=CC=C(C=C2)C3C(N(C3C#N)C(=O)C4=CN=CC=C4)CO)F"
        },
        "molecularFormula": "C25H18FN3O2"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:16:40Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c829e"
    },
    "name": "BRD-K49276305",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c829e.png",
    "lincs": {
      "id": "LSM-11423",
      "name": "BRD-K49276305",
      "pubchemCid": 54638782,
      "chebiId": 100044,
      "inchiParent": "InChI=1S/C21H23N3O4/c25-14-19-18(24-20(26)11-15-5-4-10-22-13-15)9-8-17(28-19)12-21(27)23-16-6-2-1-3-7-16/h1-10,13,17-19,25H,11-12,14H2,(H,23,27)(H,24,26)/t17-,18-,19+/m0/s1",
      "inchiKeyParent": "XLYDKAUYLYXOHP-GBESFXJTSA-N",
      "smilesParent": "OC[C@H]1O[C@H](CC(=O)Nc2ccccc2)C=C[C@@H]1NC(=O)Cc3cccnc3"
    },
    "unichem": {
      "chebi": "100044",
      "lincs": "LSM-11423",
      "pubchem": "54638782"
    },
    "pubchem": [
      {
        "cid": 54638782,
        "inchi": "InChI=1S/C21H23N3O4/c25-14-19-18(24-20(26)11-15-5-4-10-22-13-15)9-8-17(28-19)12-21(27)23-16-6-2-1-3-7-16/h1-10,13,17-19,25H,11-12,14H2,(H,23,27)(H,24,26)/t17-,18-,19+/m0/s1",
        "inchikey": "XLYDKAUYLYXOHP-GBESFXJTSA-N",
        "iupac": {
          "systematic": "2-[(2S,3S,6R)-2-(hydroxymethyl)-3-[(2-pyridin-3-ylacetyl)amino]-3,6-dihydro-2H-pyran-6-yl]-N-phenylacetamide"
        },
        "smiles": {
          "canonical": "C1=CC=C(C=C1)NC(=O)CC2C=CC(C(O2)CO)NC(=O)CC3=CN=CC=C3"
        },
        "molecularFormula": "C21H23N3O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:16:42Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c827a"
    },
    "name": "BRD-K23017938",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c827a.png",
    "lincs": {
      "id": "LSM-38520",
      "name": "BRD-K23017938",
      "pubchemCid": 60191018,
      "chebiId": 126957,
      "inchiParent": "InChI=1S/C23H26FN3O3/c1-2-11-25-23(30)26-12-19-22(20(14-28)27(19)21(29)13-26)17-5-3-15(4-6-17)16-7-9-18(24)10-8-16/h3-10,19-20,22,28H,2,11-14H2,1H3,(H,25,30)/t19-,20+,22-/m1/s1",
      "inchiKeyParent": "SWSDLRUKDZMMNR-RZUBCFFCSA-N",
      "smilesParent": "CCCNC(=O)N1C[C@@H]2[C@H]([C@H](CO)N2C(=O)C1)c3ccc(cc3)c4ccc(F)cc4"
    },
    "unichem": {
      "chebi": "126957",
      "lincs": "LSM-38520",
      "pubchem": "60191018"
    },
    "pubchem": [
      {
        "cid": 60191018,
        "inchi": "InChI=1S/C23H26FN3O3/c1-2-11-25-23(30)26-12-19-22(20(14-28)27(19)21(29)13-26)17-5-3-15(4-6-17)16-7-9-18(24)10-8-16/h3-10,19-20,22,28H,2,11-14H2,1H3,(H,25,30)/t19-,20+,22-/m1/s1",
        "inchikey": "SWSDLRUKDZMMNR-RZUBCFFCSA-N",
        "iupac": {
          "systematic": "(6S,7R,8R)-7-[4-(4-fluorophenyl)phenyl]-8-(hydroxymethyl)-2-oxo-N-propyl-1,4-diazabicyclo[4.2.0]octane-4-carboxamide"
        },
        "smiles": {
          "canonical": "CCCNC(=O)N1CC2C(C(N2C(=O)C1)CO)C3=CC=C(C=C3)C4=CC=C(C=C4)F"
        },
        "molecularFormula": "C23H26FN3O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:16:46Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c827e"
    },
    "name": "BRD-K27209353",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c827e.png",
    "lincs": {
      "id": "LSM-38748",
      "name": "BRD-K27209353",
      "pubchemCid": 54666388,
      "chebiId": 127188,
      "inchiParent": "InChI=1S/C27H34N4O2/c32-19-25-26(23-7-5-21(6-8-23)9-12-27(33)10-1-2-11-27)24-18-30(13-3-4-14-31(24)25)17-22-15-28-20-29-16-22/h5-8,15-16,20,24-26,32-33H,1-4,10-11,13-14,17-19H2/t24-,25+,26+/m0/s1",
      "inchiKeyParent": "XBLMBZLFERXHHT-JIMJEQGWSA-N",
      "smilesParent": "OC[C@@H]1[C@@H]([C@@H]2CN(Cc3cncnc3)CCCCN12)c4ccc(cc4)C#CC5(O)CCCC5"
    },
    "unichem": {
      "chebi": "127188",
      "lincs": "LSM-38748",
      "pubchem": "54666388"
    },
    "pubchem": [
      {
        "cid": 54666388,
        "inchi": "InChI=1S/C27H34N4O2/c32-19-25-26(23-7-5-21(6-8-23)9-12-27(33)10-1-2-11-27)24-18-30(13-3-4-14-31(24)25)17-22-15-28-20-29-16-22/h5-8,15-16,20,24-26,32-33H,1-4,10-11,13-14,17-19H2/t24-,25+,26+/m0/s1",
        "inchikey": "XBLMBZLFERXHHT-JIMJEQGWSA-N",
        "iupac": {
          "systematic": "1-[2-[4-[(8R,9R,10S)-10-(hydroxymethyl)-6-(pyrimidin-5-ylmethyl)-1,6-diazabicyclo[6.2.0]decan-9-yl]phenyl]ethynyl]cyclopentan-1-ol"
        },
        "smiles": {
          "canonical": "C1CCC(C1)(C#CC2=CC=C(C=C2)C3C4CN(CCCCN4C3CO)CC5=CN=CN=C5)O"
        },
        "molecularFormula": "C27H34N4O2"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:16:48Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8327"
    },
    "name": "BRD-K32436461",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8327.png",
    "lincs": {
      "id": "LSM-10398",
      "name": "BRD-K32436461",
      "pubchemCid": 54661016,
      "chebiId": 99019,
      "inchiParent": "InChI=1S/C28H30N4O4/c33-15-23-22-14-31-24(12-11-21(28(31)35)18-7-3-1-4-8-18)25(22)32(13-20-16-36-17-29-20)26(23)27(34)30-19-9-5-2-6-10-19/h2,5-7,9-12,16-17,22-23,25-26,33H,1,3-4,8,13-15H2,(H,30,34)/t22-,23-,25+,26-/m0/s1",
      "inchiKeyParent": "NLGBQKPPTNRTKJ-LJCOXQHRSA-N",
      "smilesParent": "OC[C@H]1[C@@H]2CN3C(=O)C(=CC=C3[C@@H]2N(Cc4cocn4)[C@@H]1C(=O)Nc5ccccc5)C6=CCCCC6"
    },
    "unichem": {
      "chebi": "99019",
      "lincs": "LSM-10398",
      "pubchem": "54661016"
    },
    "pubchem": [
      {
        "cid": 54661016,
        "inchi": "InChI=1S/C28H30N4O4/c33-15-23-22-14-31-24(12-11-21(28(31)35)18-7-3-1-4-8-18)25(22)32(13-20-16-36-17-29-20)26(23)27(34)30-19-9-5-2-6-10-19/h2,5-7,9-12,16-17,22-23,25-26,33H,1,3-4,8,13-15H2,(H,30,34)/t22-,23-,25+,26-/m0/s1",
        "inchikey": "NLGBQKPPTNRTKJ-LJCOXQHRSA-N",
        "iupac": {
          "systematic": "(2S,3S,3aR,9bR)-7-(cyclohexen-1-yl)-3-(hydroxymethyl)-1-(1,3-oxazol-4-ylmethyl)-6-oxo-N-phenyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide"
        },
        "smiles": {
          "canonical": "C1CCC(=CC1)C2=CC=C3C4C(CN3C2=O)C(C(N4CC5=COC=N5)C(=O)NC6=CC=CC=C6)CO"
        },
        "molecularFormula": "C28H30N4O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:16:50Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8269"
    },
    "name": "BRD-K46276961",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8269.png",
    "lincs": {
      "id": "LSM-11252",
      "name": "BRD-K46276961",
      "pubchemCid": 54654448,
      "chebiId": 99873,
      "inchiParent": "InChI=1S/C23H25ClN2O7S/c1-26-18-9-8-15(12-22(27)31-2)33-20(18)13-32-19-10-7-14(11-16(19)23(26)28)25-34(29,30)21-6-4-3-5-17(21)24/h3-7,10-11,15,18,20,25H,8-9,12-13H2,1-2H3/t15-,18-,20-/m0/s1",
      "inchiKeyParent": "QTFAPORQFWHYLC-QSFXBCCZSA-N",
      "smilesParent": "COC(=O)C[C@@H]1CC[C@H]2[C@H](COc3ccc(NS(=O)(=O)c4ccccc4Cl)cc3C(=O)N2C)O1"
    },
    "unichem": {
      "chebi": "99873",
      "lincs": "LSM-11252",
      "pubchem": "54654448"
    },
    "pubchem": [
      {
        "cid": 54654448,
        "inchi": "InChI=1S/C23H25ClN2O7S/c1-26-18-9-8-15(12-22(27)31-2)33-20(18)13-32-19-10-7-14(11-16(19)23(26)28)25-34(29,30)21-6-4-3-5-17(21)24/h3-7,10-11,15,18,20,25H,8-9,12-13H2,1-2H3/t15-,18-,20-/m0/s1",
        "inchikey": "QTFAPORQFWHYLC-QSFXBCCZSA-N",
        "iupac": {
          "systematic": "methyl 2-[(2S,4aS,12aR)-8-[(2-chlorophenyl)sulfonylamino]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]acetate"
        },
        "smiles": {
          "canonical": "CN1C2CCC(OC2COC3=C(C1=O)C=C(C=C3)NS(=O)(=O)C4=CC=CC=C4Cl)CC(=O)OC"
        },
        "molecularFormula": "C23H25ClN2O7S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:16:52Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c828a"
    },
    "name": "BRD-K06911479",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c828a.png",
    "lincs": {
      "id": "LSM-37644",
      "name": "BRD-K06911479",
      "pubchemCid": 60191067,
      "chebiId": 126077,
      "inchiParent": "InChI=1S/C24H31N3O4/c1-2-3-4-5-18-6-8-19(9-7-18)24-20-14-26(16-23(30)27(20)21(24)17-28)22(29)15-25-10-12-31-13-11-25/h6-9,20-21,24,28H,2-3,10-17H2,1H3/t20-,21+,24-/m0/s1",
      "inchiKeyParent": "MEZRSQVRRGLIAD-IMSXRSKXSA-N",
      "smilesParent": "CCCC#Cc1ccc(cc1)[C@@H]2[C@@H](CO)N3[C@H]2CN(CC3=O)C(=O)CN4CCOCC4"
    },
    "unichem": {
      "chebi": "126077",
      "lincs": "LSM-37644",
      "pubchem": "60191067"
    },
    "pubchem": [
      {
        "cid": 60191067,
        "inchi": "InChI=1S/C24H31N3O4/c1-2-3-4-5-18-6-8-19(9-7-18)24-20-14-26(16-23(30)27(20)21(24)17-28)22(29)15-25-10-12-31-13-11-25/h6-9,20-21,24,28H,2-3,10-17H2,1H3/t20-,21+,24-/m0/s1",
        "inchikey": "MEZRSQVRRGLIAD-IMSXRSKXSA-N",
        "iupac": {
          "systematic": "(6R,7S,8S)-8-(hydroxymethyl)-4-(2-morpholin-4-ylacetyl)-7-(4-pent-1-ynylphenyl)-1,4-diazabicyclo[4.2.0]octan-2-one"
        },
        "smiles": {
          "canonical": "CCCC#CC1=CC=C(C=C1)C2C3CN(CC(=O)N3C2CO)C(=O)CN4CCOCC4"
        },
        "molecularFormula": "C24H31N3O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:16:54Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8296"
    },
    "name": "BRD-K46664882",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8296.png",
    "lincs": {
      "id": "LSM-39862",
      "name": "BRD-K46664882",
      "pubchemCid": 60190112,
      "chebiId": 128307,
      "inchiParent": "InChI=1S/C23H28ClN3O2/c1-2-11-25-22(29)26-15-23(16-26)21(18-8-4-3-5-9-18)20(14-28)27(23)13-17-7-6-10-19(24)12-17/h3-10,12,20-21,28H,2,11,13-16H2,1H3,(H,25,29)/t20-,21+/m1/s1",
      "inchiKeyParent": "WLTMADYYAYENMT-RTWAWAEBSA-N",
      "smilesParent": "CCCNC(=O)N1CC2(C1)[C@H]([C@@H](CO)N2Cc3cccc(Cl)c3)c4ccccc4"
    },
    "unichem": {
      "chebi": "128307",
      "lincs": "LSM-39862",
      "pubchem": "60190112"
    },
    "pubchem": [
      {
        "cid": 60190112,
        "inchi": "InChI=1S/C23H28ClN3O2/c1-2-11-25-22(29)26-15-23(16-26)21(18-8-4-3-5-9-18)20(14-28)27(23)13-17-7-6-10-19(24)12-17/h3-10,12,20-21,28H,2,11,13-16H2,1H3,(H,25,29)/t20-,21+/m1/s1",
        "inchikey": "WLTMADYYAYENMT-RTWAWAEBSA-N",
        "iupac": {
          "systematic": "(2S,3S)-1-[(3-chlorophenyl)methyl]-2-(hydroxymethyl)-3-phenyl-N-propyl-1,6-diazaspiro[3.3]heptane-6-carboxamide"
        },
        "smiles": {
          "canonical": "CCCNC(=O)N1CC2(C1)C(C(N2CC3=CC(=CC=C3)Cl)CO)C4=CC=CC=C4"
        },
        "molecularFormula": "C23H28ClN3O2"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:16:57Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82c1"
    },
    "name": "BRD-K47771675",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82c1.png",
    "lincs": {
      "id": "LSM-39922",
      "name": "BRD-K47771675",
      "pubchemCid": 54652408,
      "chebiId": 128367,
      "inchiParent": "InChI=1S/C17H19N3O/c21-11-16-17-13-5-1-2-6-14(13)19-9-15(17)20(16)10-12-4-3-7-18-8-12/h1-8,15-17,19,21H,9-11H2/t15-,16+,17+/m0/s1",
      "inchiKeyParent": "YYSMFPMBCDAVOS-GVDBMIGSSA-N",
      "smilesParent": "OC[C@@H]1[C@H]2[C@H](CNc3ccccc23)N1Cc4cccnc4"
    },
    "unichem": {
      "chebi": "128367",
      "lincs": "LSM-39922",
      "pubchem": "54652408"
    },
    "pubchem": [
      {
        "cid": 54652408,
        "inchi": "InChI=1S/C17H19N3O/c21-11-16-17-13-5-1-2-6-14(13)19-9-15(17)20(16)10-12-4-3-7-18-8-12/h1-8,15-17,19,21H,9-11H2/t15-,16+,17+/m0/s1",
        "inchikey": "YYSMFPMBCDAVOS-GVDBMIGSSA-N",
        "iupac": {
          "systematic": "[(1S,2aR,8bR)-2-(pyridin-3-ylmethyl)-2a,3,4,8b-tetrahydro-1H-azeto[2,3-c]quinolin-1-yl]methanol"
        },
        "smiles": {
          "canonical": "C1C2C(C(N2CC3=CN=CC=C3)CO)C4=CC=CC=C4N1"
        },
        "molecularFormula": "C17H19N3O"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:17:01Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82cd"
    },
    "name": "BRD-K40494872",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82cd.png",
    "lincs": {
      "id": "LSM-39503",
      "name": "BRD-K40494872",
      "pubchemCid": 54652460,
      "chebiId": 127947,
      "inchiParent": "InChI=1S/C26H25N3O4/c1-33-23-11-5-3-9-19(23)26(32)28-15-21-25(18-8-2-4-10-20(18)28)22(16-30)29(21)24(31)13-17-7-6-12-27-14-17/h2-12,14,21-22,25,30H,13,15-16H2,1H3/t21-,22+,25+/m0/s1",
      "inchiKeyParent": "XLJJZSBNOHLXNG-SGIRGMQISA-N",
      "smilesParent": "COc1ccccc1C(=O)N2C[C@H]3[C@H]([C@@H](CO)N3C(=O)Cc4cccnc4)c5ccccc25"
    },
    "unichem": {
      "chebi": "127947",
      "lincs": "LSM-39503",
      "pubchem": "54652460"
    },
    "pubchem": [
      {
        "cid": 54652460,
        "inchi": "InChI=1S/C26H25N3O4/c1-33-23-11-5-3-9-19(23)26(32)28-15-21-25(18-8-2-4-10-20(18)28)22(16-30)29(21)24(31)13-17-7-6-12-27-14-17/h2-12,14,21-22,25,30H,13,15-16H2,1H3/t21-,22+,25+/m0/s1",
        "inchikey": "XLJJZSBNOHLXNG-SGIRGMQISA-N",
        "iupac": {
          "systematic": "1-[(1S,2aR,8bR)-1-(hydroxymethyl)-4-(2-methoxybenzoyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]-2-pyridin-3-ylethanone"
        },
        "smiles": {
          "canonical": "COC1=CC=CC=C1C(=O)N2CC3C(C(N3C(=O)CC4=CN=CC=C4)CO)C5=CC=CC=C52"
        },
        "molecularFormula": "C26H25N3O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:17:03Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8306"
    },
    "name": "BRD-K02544880",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8306.png",
    "lincs": {
      "id": "LSM-43444",
      "name": "BRD-K02544880",
      "pubchemCid": 54660975,
      "inchiParent": "InChI=1S/C25H24N4O4S/c1-15(31)29-21-18(19(14-30)22(29)23(32)27-25-26-11-12-34-25)13-28-20(21)10-9-17(24(28)33)8-7-16-5-3-2-4-6-16/h2-12,18-19,21-22,30H,13-14H2,1H3,(H,26,27,32)/b8-7+/t18-,19-,21+,22-/m0/s1",
      "inchiKeyParent": "JROUXBMWQRIOQN-HDTYGZQBSA-N",
      "smilesParent": "CC(=O)N1[C@@H]([C@@H](CO)[C@@H]2CN3C(=CC=C(\\C=C\\c4ccccc4)C3=O)[C@H]12)C(=O)Nc5nccs5"
    },
    "unichem": {
      "lincs": "LSM-43444",
      "pubchem": "54660975"
    },
    "pubchem": [
      {
        "cid": 54660975,
        "inchi": "InChI=1S/C25H24N4O4S/c1-15(31)29-21-18(19(14-30)22(29)23(32)27-25-26-11-12-34-25)13-28-20(21)10-9-17(24(28)33)8-7-16-5-3-2-4-6-16/h2-12,18-19,21-22,30H,13-14H2,1H3,(H,26,27,32)/b8-7+/t18-,19-,21+,22-/m0/s1",
        "inchikey": "JROUXBMWQRIOQN-HDTYGZQBSA-N",
        "iupac": {
          "systematic": "(2S,3S,3aR,9bR)-1-acetyl-3-(hydroxymethyl)-6-oxo-7-[(E)-2-phenylethenyl]-N-(1,3-thiazol-2-yl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide"
        },
        "smiles": {
          "canonical": "CC(=O)N1C2C(CN3C2=CC=C(C3=O)C=CC4=CC=CC=C4)C(C1C(=O)NC5=NC=CS5)CO"
        },
        "molecularFormula": "C25H24N4O4S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:17:05Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c832e"
    },
    "name": "BRD-K19982400",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c832e.png",
    "lincs": {
      "id": "LSM-38342",
      "name": "BRD-K19982400",
      "pubchemCid": 44488299,
      "chebiId": 126779,
      "inchiParent": "InChI=1S/C32H37N3O6/c1-21-16-35(22(2)19-36)32(38)26-15-25(33-31(37)14-23-7-5-4-6-8-23)10-12-27(26)41-30(21)18-34(3)17-24-9-11-28-29(13-24)40-20-39-28/h4-13,15,21-22,30,36H,14,16-20H2,1-3H3,(H,33,37)/t21-,22+,30+/m1/s1",
      "inchiKeyParent": "PGWILGQCTOMTBZ-DGIFUFQNSA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@@H](C)[C@H](CN(C)Cc2ccc3OCOc3c2)Oc4ccc(NC(=O)Cc5ccccc5)cc4C1=O"
    },
    "unichem": {
      "chebi": "126779",
      "lincs": "LSM-38342",
      "pubchem": "44488299"
    },
    "pubchem": [
      {
        "cid": 44488299,
        "inchi": "InChI=1S/C32H37N3O6/c1-21-16-35(22(2)19-36)32(38)26-15-25(33-31(37)14-23-7-5-4-6-8-23)10-12-27(26)41-30(21)18-34(3)17-24-9-11-28-29(13-24)40-20-39-28/h4-13,15,21-22,30,36H,14,16-20H2,1-3H3,(H,33,37)/t21-,22+,30+/m1/s1",
        "inchikey": "PGWILGQCTOMTBZ-DGIFUFQNSA-N",
        "iupac": {
          "systematic": "N-[(2R,3R)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-2-phenylacetamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(C=CC(=C2)NC(=O)CC3=CC=CC=C3)OC1CN(C)CC4=CC5=C(C=C4)OCO5)C(C)CO"
        },
        "molecularFormula": "C32H37N3O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:17:07Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c832f"
    },
    "name": "MLS003129576",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c832f.png",
    "lincs": {
      "id": "LSM-7158",
      "name": "MLS003129576",
      "alternativeNames": [
        "BRD-K23620459"
      ],
      "pubchemCid": 44495431,
      "chebiId": 95779,
      "inchiParent": "InChI=1S/C22H32ClN5O5S/c1-16-12-27(17(2)14-29)22(30)5-4-10-28-19(11-24-25-28)15-33-21(16)13-26(3)34(31,32)20-8-6-18(23)7-9-20/h6-9,11,16-17,21,29H,4-5,10,12-15H2,1-3H3/t16-,17+,21+/m0/s1",
      "inchiKeyParent": "XRXVGTRBMNTJPS-CSODHUTKSA-N",
      "smilesParent": "C[C@H](CO)N1C[C@H](C)[C@@H](CN(C)S(=O)(=O)c2ccc(Cl)cc2)OCc3cnnn3CCCC1=O"
    },
    "unichem": {
      "chebi": "95779",
      "lincs": "LSM-7158",
      "pubchem": "44495431"
    },
    "pubchem": [
      {
        "cid": 44495431,
        "inchi": "InChI=1S/C22H32ClN5O5S/c1-16-12-27(17(2)14-29)22(30)5-4-10-28-19(11-24-25-28)15-33-21(16)13-26(3)34(31,32)20-8-6-18(23)7-9-20/h6-9,11,16-17,21,29H,4-5,10,12-15H2,1-3H3/t16-,17+,21+/m0/s1",
        "inchikey": "XRXVGTRBMNTJPS-CSODHUTKSA-N",
        "iupac": {
          "systematic": "4-chloro-N-[[(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methylbenzenesulfonamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)CCCN2C(=CN=N2)COC1CN(C)S(=O)(=O)C3=CC=C(C=C3)Cl)C(C)CO"
        },
        "molecularFormula": "C22H32ClN5O5S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:17:10Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8344"
    },
    "name": "BRD-K20347745",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8344.png",
    "lincs": {
      "id": "LSM-7118",
      "name": "BRD-K20347745",
      "pubchemCid": 54618137,
      "chebiId": 95739,
      "inchiParent": "InChI=1S/C24H34N4O6S2/c1-17(2)7-8-20-9-10-23-21(11-20)34-22(18(3)12-28(19(4)15-29)35(23,30)31)13-27(6)36(32,33)24-14-26(5)16-25-24/h9-11,14,16-19,22,29H,12-13,15H2,1-6H3/t18-,19-,22+/m1/s1",
      "inchiKeyParent": "MFJAJISBYJYJML-KNKQGSTJSA-N",
      "smilesParent": "CC(C)C#Cc1ccc2c(O[C@@H](CN(C)S(=O)(=O)c3cn(C)cn3)[C@H](C)CN([C@H](C)CO)S2(=O)=O)c1"
    },
    "unichem": {
      "chebi": "95739",
      "lincs": "LSM-7118",
      "pubchem": "54618137"
    },
    "pubchem": [
      {
        "cid": 54618137,
        "inchi": "InChI=1S/C24H34N4O6S2/c1-17(2)7-8-20-9-10-23-21(11-20)34-22(18(3)12-28(19(4)15-29)35(23,30)31)13-27(6)36(32,33)24-14-26(5)16-25-24/h9-11,14,16-19,22,29H,12-13,15H2,1-6H3/t18-,19-,22+/m1/s1",
        "inchikey": "MFJAJISBYJYJML-KNKQGSTJSA-N",
        "iupac": {
          "systematic": "N-[[(4R,5R)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-8-(3-methylbut-1-ynyl)-1,1-dioxo-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-N,1-dimethylimidazole-4-sulfonamide"
        },
        "smiles": {
          "canonical": "CC1CN(S(=O)(=O)C2=C(C=C(C=C2)C#CC(C)C)OC1CN(C)S(=O)(=O)C3=CN(C=N3)C)C(C)CO"
        },
        "molecularFormula": "C24H34N4O6S2"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:17:12Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c834b"
    },
    "name": "CHEMBL2362197",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c834b.png",
    "lincs": {
      "id": "LSM-43440",
      "name": "CHEMBL2362197",
      "alternativeNames": [
        "BRD-K98216700"
      ],
      "pubchemCid": 54618289,
      "inchiParent": "InChI=1S/C30H41N3O5S/c1-22-19-33(23(2)21-34)39(36,37)29-17-16-25(15-14-24-10-6-4-7-11-24)18-27(29)38-28(22)20-32(3)30(35)31-26-12-8-5-9-13-26/h4,6-7,10-11,14-18,22-23,26,28,34H,5,8-9,12-13,19-21H2,1-3H3,(H,31,35)/b15-14+/t22-,23-,28+/m1/s1",
      "inchiKeyParent": "DIBJIDYNEHVBAV-IOIDZWFXSA-N",
      "smilesParent": "C[C@H](CO)N1C[C@@H](C)[C@H](CN(C)C(=O)NC2CCCCC2)Oc3cc(\\C=C\\c4ccccc4)ccc3S1(=O)=O"
    },
    "unichem": {
      "chembl": "CHEMBL2362197",
      "lincs": "LSM-43440",
      "pubchem": "54618289"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL2362197",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 555.74,
        "hba": 5,
        "hbd": 2,
        "qedWeighted": 0.49
      }
    },
    "pubchem": [
      {
        "cid": 54618289,
        "inchi": "InChI=1S/C30H41N3O5S/c1-22-19-33(23(2)21-34)39(36,37)29-17-16-25(15-14-24-10-6-4-7-11-24)18-27(29)38-28(22)20-32(3)30(35)31-26-12-8-5-9-13-26/h4,6-7,10-11,14-18,22-23,26,28,34H,5,8-9,12-13,19-21H2,1-3H3,(H,31,35)/b15-14+/t22-,23-,28+/m1/s1",
        "inchikey": "DIBJIDYNEHVBAV-IOIDZWFXSA-N",
        "iupac": {
          "systematic": "3-cyclohexyl-1-[[(4R,5R)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-2-phenylethenyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-1-methylurea"
        },
        "smiles": {
          "canonical": "CC1CN(S(=O)(=O)C2=C(C=C(C=C2)C=CC3=CC=CC=C3)OC1CN(C)C(=O)NC4CCCCC4)C(C)CO"
        },
        "molecularFormula": "C30H41N3O5S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:17:24Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c827c"
    },
    "name": "BRD-K74329753",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c827c.png",
    "lincs": {
      "id": "LSM-41317",
      "name": "BRD-K74329753",
      "pubchemCid": 44620812,
      "chebiId": 129766,
      "inchiParent": "InChI=1S/C35H52N4O5/c1-25-21-39(26(2)24-40)35(42)31-20-30(37-34(41)29-15-17-36-18-16-29)13-14-32(31)44-27(3)10-8-9-19-43-33(25)23-38(4)22-28-11-6-5-7-12-28/h13-18,20,25-28,33,40H,5-12,19,21-24H2,1-4H3,(H,37,41)/t25-,26-,27-,33+/m0/s1",
      "inchiKeyParent": "PRNQDRDIWPOXBY-CLFOAKAGSA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@H](C)[C@@H](CN(C)CC2CCCCC2)OCCCC[C@H](C)Oc3ccc(NC(=O)c4ccncc4)cc3C1=O"
    },
    "unichem": {
      "chebi": "129766",
      "lincs": "LSM-41317",
      "pubchem": "44620812"
    },
    "pubchem": [
      {
        "cid": 44620812,
        "inchi": "InChI=1S/C35H52N4O5/c1-25-21-39(26(2)24-40)35(42)31-20-30(37-34(41)29-15-17-36-18-16-29)13-14-32(31)44-27(3)10-8-9-19-43-33(25)23-38(4)22-28-11-6-5-7-12-28/h13-18,20,25-28,33,40H,5-12,19,21-24H2,1-4H3,(H,37,41)/t25-,26-,27-,33+/m0/s1",
        "inchikey": "PRNQDRDIWPOXBY-CLFOAKAGSA-N",
        "iupac": {
          "systematic": "N-[(3S,9S,10S)-9-[[cyclohexylmethyl(methyl)amino]methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]pyridine-4-carboxamide"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NC(=O)C3=CC=NC=C3)C(C)CO)C)CN(C)CC4CCCCC4"
        },
        "molecularFormula": "C35H52N4O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:17:26Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82a9"
    },
    "name": "BRD-K74461819",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82a9.png",
    "lincs": {
      "id": "LSM-44851",
      "name": "BRD-K74461819",
      "pubchemCid": 54666677,
      "inchiParent": "InChI=1S/C27H35N3O2/c1-28(2)19-26(32)29-16-6-7-17-30-24(18-29)27(25(30)20-31)23-14-12-22(13-15-23)11-10-21-8-4-3-5-9-21/h3-5,8-15,24-25,27,31H,6-7,16-20H2,1-2H3/b11-10+/t24-,25+,27-/m0/s1",
      "inchiKeyParent": "ZAHXKZOKOUSJMC-RLPBRSBZSA-N",
      "smilesParent": "CN(C)CC(=O)N1CCCCN2[C@H](CO)[C@H]([C@@H]2C1)c3ccc(\\C=C\\c4ccccc4)cc3"
    },
    "unichem": {
      "lincs": "LSM-44851",
      "pubchem": "54666677"
    },
    "pubchem": [
      {
        "cid": 54666677,
        "inchi": "InChI=1S/C27H35N3O2/c1-28(2)19-26(32)29-16-6-7-17-30-24(18-29)27(25(30)20-31)23-14-12-22(13-15-23)11-10-21-8-4-3-5-9-21/h3-5,8-15,24-25,27,31H,6-7,16-20H2,1-2H3/b11-10+/t24-,25+,27-/m0/s1",
        "inchikey": "ZAHXKZOKOUSJMC-RLPBRSBZSA-N",
        "iupac": {
          "systematic": "2-(dimethylamino)-1-[(8R,9S,10S)-10-(hydroxymethyl)-9-[4-[(E)-2-phenylethenyl]phenyl]-1,6-diazabicyclo[6.2.0]decan-6-yl]ethanone"
        },
        "smiles": {
          "canonical": "CN(C)CC(=O)N1CCCCN2C(C1)C(C2CO)C3=CC=C(C=C3)C=CC4=CC=CC=C4"
        },
        "molecularFormula": "C27H35N3O2"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:17:28Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82dc"
    },
    "name": "BRD-K26484692",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82dc.png",
    "lincs": {
      "id": "LSM-10032",
      "name": "BRD-K26484692",
      "pubchemCid": 54657725,
      "chebiId": 98653,
      "inchiParent": "InChI=1S/C18H33N3O4/c22-14-11-20-16-5-4-15(25-17(16)13-24-12-14)10-18(23)19-6-9-21-7-2-1-3-8-21/h14-17,20,22H,1-13H2,(H,19,23)/t14-,15+,16-,17+/m0/s1",
      "inchiKeyParent": "WSFSIZCPNKDEIH-VVLHAWIVSA-N",
      "smilesParent": "O[C@H]1CN[C@H]2CC[C@H](CC(=O)NCCN3CCCCC3)O[C@@H]2COC1"
    },
    "unichem": {
      "chebi": "98653",
      "lincs": "LSM-10032",
      "pubchem": "54657725"
    },
    "pubchem": [
      {
        "cid": 54657725,
        "inchi": "InChI=1S/C18H33N3O4/c22-14-11-20-16-5-4-15(25-17(16)13-24-12-14)10-18(23)19-6-9-21-7-2-1-3-8-21/h14-17,20,22H,1-13H2,(H,19,23)/t14-,15+,16-,17+/m0/s1",
        "inchikey": "WSFSIZCPNKDEIH-VVLHAWIVSA-N",
        "iupac": {
          "systematic": "2-[(3S,6aS,8R,10aS)-3-hydroxy-1,2,3,4,6,6a,8,9,10,10a-decahydropyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-piperidin-1-ylethyl)acetamide"
        },
        "smiles": {
          "canonical": "C1CCN(CC1)CCNC(=O)CC2CCC3C(O2)COCC(CN3)O"
        },
        "molecularFormula": "C18H33N3O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:17:30Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82f1"
    },
    "name": "BRD-K26663582",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82f1.png",
    "lincs": {
      "id": "LSM-10046",
      "name": "BRD-K26663582",
      "pubchemCid": 54632122,
      "chebiId": 98667,
      "inchiParent": "InChI=1S/C27H36N4O4/c1-18-14-31(15-20-9-11-28-12-10-20)19(2)17-35-24-13-22(29-26(32)21-5-6-21)7-8-23(24)27(33)30(3)16-25(18)34-4/h7-13,18-19,21,25H,5-6,14-17H2,1-4H3,(H,29,32)/t18-,19+,25-/m0/s1",
      "inchiKeyParent": "RHXUULWZVSTJED-CEYNDMKZSA-N",
      "smilesParent": "CO[C@H]1CN(C)C(=O)c2ccc(NC(=O)C3CC3)cc2OC[C@@H](C)N(Cc4ccncc4)C[C@@H]1C"
    },
    "unichem": {
      "chebi": "98667",
      "lincs": "LSM-10046",
      "pubchem": "54632122"
    },
    "pubchem": [
      {
        "cid": 54632122,
        "inchi": "InChI=1S/C27H36N4O4/c1-18-14-31(15-20-9-11-28-12-10-20)19(2)17-35-24-13-22(29-26(32)21-5-6-21)7-8-23(24)27(33)30(3)16-25(18)34-4/h7-13,18-19,21,25H,5-6,14-17H2,1-4H3,(H,29,32)/t18-,19+,25-/m0/s1",
        "inchikey": "RHXUULWZVSTJED-CEYNDMKZSA-N",
        "iupac": {
          "systematic": "N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(pyridin-4-ylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-15-yl]cyclopropanecarboxamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(COC2=C(C=CC(=C2)NC(=O)C3CC3)C(=O)N(CC1OC)C)C)CC4=CC=NC=C4"
        },
        "molecularFormula": "C27H36N4O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:17:33Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c831a"
    },
    "name": "BRD-K07253943",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c831a.png",
    "lincs": {
      "id": "LSM-8855",
      "name": "BRD-K07253943",
      "pubchemCid": 54637894,
      "chebiId": 97476,
      "inchiParent": "InChI=1S/C29H33FN2O5S/c1-20-16-32(21(2)18-33)29(34)25-13-7-6-12-24(25)23-11-5-4-10-22(23)19-37-27(20)17-31(3)38(35,36)28-15-9-8-14-26(28)30/h4-15,20-21,27,33H,16-19H2,1-3H3/t20-,21+,27-/m0/s1",
      "inchiKeyParent": "QWRJLEHIBFFHOL-ISCCLHIJSA-N",
      "smilesParent": "C[C@H](CO)N1C[C@H](C)[C@H](CN(C)S(=O)(=O)c2ccccc2F)OCc3ccccc3c4ccccc4C1=O"
    },
    "unichem": {
      "chebi": "97476",
      "lincs": "LSM-8855",
      "pubchem": "54637894"
    },
    "pubchem": [
      {
        "cid": 54637894,
        "inchi": "InChI=1S/C29H33FN2O5S/c1-20-16-32(21(2)18-33)29(34)25-13-7-6-12-24(25)23-11-5-4-10-22(23)19-37-27(20)17-31(3)38(35,36)28-15-9-8-14-26(28)30/h4-15,20-21,27,33H,16-19H2,1-3H3/t20-,21+,27-/m0/s1",
        "inchikey": "QWRJLEHIBFFHOL-ISCCLHIJSA-N",
        "iupac": {
          "systematic": "2-fluoro-N-[[(10R,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylbenzenesulfonamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=CC=CC=C2C3=CC=CC=C3COC1CN(C)S(=O)(=O)C4=CC=CC=C4F)C(C)CO"
        },
        "molecularFormula": "C29H33FN2O5S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:17:35Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c831f"
    },
    "name": "CHEMBL3188201",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c831f.png",
    "lincs": {
      "id": "LSM-9760",
      "name": "CHEMBL3188201",
      "alternativeNames": [
        "BRD-K22010555"
      ],
      "pubchemCid": 54649093,
      "chebiId": 98381,
      "inchiParent": "InChI=1S/C23H33ClN2O6S2/c1-17-9-11-21(12-10-17)33(28,29)25(4)15-23(32-5)18(2)14-26(19(3)16-27)34(30,31)22-8-6-7-20(24)13-22/h6-13,18-19,23,27H,14-16H2,1-5H3/t18-,19-,23+/m1/s1",
      "inchiKeyParent": "FYUSSFRUYFLLAK-PWHSHALESA-N",
      "smilesParent": "CO[C@@H](CN(C)S(=O)(=O)c1ccc(C)cc1)[C@H](C)CN([C@H](C)CO)S(=O)(=O)c2cccc(Cl)c2"
    },
    "unichem": {
      "chebi": "98381",
      "chembl": "CHEMBL3188201",
      "lincs": "LSM-9760",
      "pubchem": "54649093"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL3188201",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 533.11,
        "hba": 6,
        "hbd": 1,
        "qedWeighted": 0.45
      }
    },
    "pubchem": [
      {
        "cid": 54649093,
        "inchi": "InChI=1S/C23H33ClN2O6S2/c1-17-9-11-21(12-10-17)33(28,29)25(4)15-23(32-5)18(2)14-26(19(3)16-27)34(30,31)22-8-6-7-20(24)13-22/h6-13,18-19,23,27H,14-16H2,1-5H3/t18-,19-,23+/m1/s1",
        "inchikey": "FYUSSFRUYFLLAK-PWHSHALESA-N",
        "iupac": {
          "systematic": "3-chloro-N-[(2R)-1-hydroxypropan-2-yl]-N-[(2R,3R)-3-methoxy-2-methyl-4-[methyl-(4-methylphenyl)sulfonylamino]butyl]benzenesulfonamide"
        },
        "smiles": {
          "canonical": "CC1=CC=C(C=C1)S(=O)(=O)N(C)CC(C(C)CN(C(C)CO)S(=O)(=O)C2=CC(=CC=C2)Cl)OC"
        },
        "molecularFormula": "C23H33ClN2O6S2"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:17:46Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8320"
    },
    "name": "BRD-K40597368",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8320.png",
    "lincs": {
      "id": "LSM-10909",
      "name": "BRD-K40597368",
      "pubchemCid": 54657480,
      "chebiId": 99530,
      "inchiParent": "InChI=1S/C12H21NO5/c1-16-12(15)4-9-2-3-10-11(18-9)7-17-6-8(14)5-13-10/h8-11,13-14H,2-7H2,1H3/t8-,9+,10+,11-/m0/s1",
      "inchiKeyParent": "FKMAUGDURCCEJG-ZDCRXTMVSA-N",
      "smilesParent": "COC(=O)C[C@H]1CC[C@H]2NC[C@H](O)COC[C@@H]2O1"
    },
    "unichem": {
      "chebi": "99530",
      "lincs": "LSM-10909",
      "pubchem": "54657480"
    },
    "pubchem": [
      {
        "cid": 54657480,
        "inchi": "InChI=1S/C12H21NO5/c1-16-12(15)4-9-2-3-10-11(18-9)7-17-6-8(14)5-13-10/h8-11,13-14H,2-7H2,1H3/t8-,9+,10+,11-/m0/s1",
        "inchikey": "FKMAUGDURCCEJG-ZDCRXTMVSA-N",
        "iupac": {
          "systematic": "methyl 2-[(3S,6aR,8R,10aR)-3-hydroxy-1,2,3,4,6,6a,8,9,10,10a-decahydropyrano[2,3-c][1,5]oxazocin-8-yl]acetate"
        },
        "smiles": {
          "canonical": "COC(=O)CC1CCC2C(O1)COCC(CN2)O"
        },
        "molecularFormula": "C12H21NO5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:17:48Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8347"
    },
    "name": "BRD-K36888933",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8347.png",
    "lincs": {
      "id": "LSM-10659",
      "name": "BRD-K36888933",
      "pubchemCid": 54646458,
      "chebiId": 99280,
      "inchiParent": "InChI=1S/C26H29FN2O5/c27-17-6-1-3-15(9-17)13-28-24(31)12-19-11-21-20-10-18(29-26(32)16-4-2-5-16)7-8-22(20)34-25(21)23(14-30)33-19/h1,3,6-10,16,19,21,23,25,30H,2,4-5,11-14H2,(H,28,31)(H,29,32)/t19-,21+,23-,25-/m0/s1",
      "inchiKeyParent": "OPNBGVGHIKRRPP-PYTYSOFPSA-N",
      "smilesParent": "OC[C@@H]1O[C@H](CC(=O)NCc2cccc(F)c2)C[C@H]3[C@@H]1Oc4ccc(NC(=O)C5CCC5)cc34"
    },
    "unichem": {
      "chebi": "99280",
      "lincs": "LSM-10659",
      "pubchem": "54646458"
    },
    "pubchem": [
      {
        "cid": 54646458,
        "inchi": "InChI=1S/C26H29FN2O5/c27-17-6-1-3-15(9-17)13-28-24(31)12-19-11-21-20-10-18(29-26(32)16-4-2-5-16)7-8-22(20)34-25(21)23(14-30)33-19/h1,3,6-10,16,19,21,23,25,30H,2,4-5,11-14H2,(H,28,31)(H,29,32)/t19-,21+,23-,25-/m0/s1",
        "inchikey": "OPNBGVGHIKRRPP-PYTYSOFPSA-N",
        "iupac": {
          "systematic": "N-[(1S,3S,4aR,9aS)-3-[2-[(3-fluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]cyclobutanecarboxamide"
        },
        "smiles": {
          "canonical": "C1CC(C1)C(=O)NC2=CC3=C(C=C2)OC4C3CC(OC4CO)CC(=O)NCC5=CC(=CC=C5)F"
        },
        "molecularFormula": "C26H29FN2O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:17:51Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82ce"
    },
    "name": "BRD-K95204731",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82ce.png",
    "lincs": {
      "id": "LSM-14262",
      "name": "BRD-K95204731",
      "pubchemCid": 54657956,
      "chebiId": 102916,
      "inchiParent": "InChI=1S/C26H34N4O6/c1-34-23-5-3-2-4-21(23)29-26(33)30-15-19(31)16-35-17-24-22(30)7-6-20(36-24)14-25(32)28-13-10-18-8-11-27-12-9-18/h2-5,8-9,11-12,19-20,22,24,31H,6-7,10,13-17H2,1H3,(H,28,32)(H,29,33)/t19-,20+,22+,24-/m1/s1",
      "inchiKeyParent": "YKBSBMDVZJDWJN-CETSDDCJSA-N",
      "smilesParent": "COc1ccccc1NC(=O)N2C[C@@H](O)COC[C@H]3O[C@H](CC(=O)NCCc4ccncc4)CC[C@H]23"
    },
    "unichem": {
      "chebi": "102916",
      "lincs": "LSM-14262",
      "pubchem": "54657956"
    },
    "pubchem": [
      {
        "cid": 54657956,
        "inchi": "InChI=1S/C26H34N4O6/c1-34-23-5-3-2-4-21(23)29-26(33)30-15-19(31)16-35-17-24-22(30)7-6-20(36-24)14-25(32)28-13-10-18-8-11-27-12-9-18/h2-5,8-9,11-12,19-20,22,24,31H,6-7,10,13-17H2,1H3,(H,28,32)(H,29,33)/t19-,20+,22+,24-/m1/s1",
        "inchikey": "YKBSBMDVZJDWJN-CETSDDCJSA-N",
        "iupac": {
          "systematic": "(3R,6aS,8S,10aS)-3-hydroxy-N-(2-methoxyphenyl)-8-[2-oxo-2-(2-pyridin-4-ylethylamino)ethyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide"
        },
        "smiles": {
          "canonical": "COC1=CC=CC=C1NC(=O)N2CC(COCC3C2CCC(O3)CC(=O)NCCC4=CC=NC=C4)O"
        },
        "molecularFormula": "C26H34N4O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:17:53Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82d3"
    },
    "name": "BRD-K96834740",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82d3.png",
    "lincs": {
      "id": "LSM-42525",
      "name": "BRD-K96834740",
      "pubchemCid": 54652543,
      "chebiId": 130977,
      "inchiParent": "InChI=1S/C18H24N2O3/c1-19-10-15-17(13-4-2-3-5-14(13)19)16(11-21)20(15)18(22)12-6-8-23-9-7-12/h2-5,12,15-17,21H,6-11H2,1H3/t15-,16-,17+/m0/s1",
      "inchiKeyParent": "QKACYWAOJYTRPY-YESZJQIVSA-N",
      "smilesParent": "CN1C[C@H]2[C@H]([C@H](CO)N2C(=O)C3CCOCC3)c4ccccc14"
    },
    "unichem": {
      "chebi": "130977",
      "lincs": "LSM-42525",
      "pubchem": "54652543"
    },
    "pubchem": [
      {
        "cid": 54652543,
        "inchi": "InChI=1S/C18H24N2O3/c1-19-10-15-17(13-4-2-3-5-14(13)19)16(11-21)20(15)18(22)12-6-8-23-9-7-12/h2-5,12,15-17,21H,6-11H2,1H3/t15-,16-,17+/m0/s1",
        "inchikey": "QKACYWAOJYTRPY-YESZJQIVSA-N",
        "iupac": {
          "systematic": "[(1R,2aR,8bR)-1-(hydroxymethyl)-4-methyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]-(oxan-4-yl)methanone"
        },
        "smiles": {
          "canonical": "CN1CC2C(C(N2C(=O)C3CCOCC3)CO)C4=CC=CC=C41"
        },
        "molecularFormula": "C18H24N2O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:17:56Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8308"
    },
    "name": "BRD-K65517548",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8308.png",
    "lincs": {
      "id": "LSM-12427",
      "name": "BRD-K65517548",
      "pubchemCid": 54631955,
      "chebiId": 101054,
      "inchiParent": "InChI=1S/C25H32F2N4O4/c1-15-12-30(3)16(2)14-35-22-11-18(7-8-19(22)24(32)31(4)13-23(15)34-5)28-25(33)29-21-10-17(26)6-9-20(21)27/h6-11,15-16,23H,12-14H2,1-5H3,(H2,28,29,33)/t15-,16+,23-/m1/s1",
      "inchiKeyParent": "AKULYVRZEMKLJR-VBURHUQHSA-N",
      "smilesParent": "CO[C@@H]1CN(C)C(=O)c2ccc(NC(=O)Nc3cc(F)ccc3F)cc2OC[C@H](C)N(C)C[C@H]1C"
    },
    "unichem": {
      "chebi": "101054",
      "lincs": "LSM-12427",
      "pubchem": "54631955"
    },
    "pubchem": [
      {
        "cid": 54631955,
        "inchi": "InChI=1S/C25H32F2N4O4/c1-15-12-30(3)16(2)14-35-22-11-18(7-8-19(22)24(32)31(4)13-23(15)34-5)28-25(33)29-21-10-17(26)6-9-20(21)27/h6-11,15-16,23H,12-14H2,1-5H3,(H2,28,29,33)/t15-,16+,23-/m1/s1",
        "inchikey": "AKULYVRZEMKLJR-VBURHUQHSA-N",
        "iupac": {
          "systematic": "1-(2,5-difluorophenyl)-3-[(4S,7R,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-15-yl]urea"
        },
        "smiles": {
          "canonical": "CC1CN(C(COC2=C(C=CC(=C2)NC(=O)NC3=C(C=CC(=C3)F)F)C(=O)N(CC1OC)C)C)C"
        },
        "molecularFormula": "C25H32F2N4O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:17:58Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8340"
    },
    "name": "BRD-K43411248",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8340.png",
    "lincs": {
      "id": "LSM-11068",
      "name": "BRD-K43411248",
      "pubchemCid": 54661168,
      "chebiId": 99689,
      "inchiParent": "InChI=1S/C25H23FN2O4/c26-20-9-5-4-8-16(20)12-28-22-18(19(14-29)23(28)25(31)32)13-27-21(22)11-10-17(24(27)30)15-6-2-1-3-7-15/h1-11,18-19,22-23,29H,12-14H2,(H,31,32)/t18-,19-,22+,23-/m1/s1",
      "inchiKeyParent": "CTVHZJUSZJAUDM-PJIZGREPSA-N",
      "smilesParent": "OC[C@@H]1[C@H]2CN3C(=CC=C(C3=O)c4ccccc4)[C@H]2N(Cc5ccccc5F)[C@H]1C(=O)O"
    },
    "unichem": {
      "chebi": "99689",
      "lincs": "LSM-11068",
      "pubchem": "54661168"
    },
    "pubchem": [
      {
        "cid": 54661168,
        "inchi": "InChI=1S/C25H23FN2O4/c26-20-9-5-4-8-16(20)12-28-22-18(19(14-29)23(28)25(31)32)13-27-21(22)11-10-17(24(27)30)15-6-2-1-3-7-15/h1-11,18-19,22-23,29H,12-14H2,(H,31,32)/t18-,19-,22+,23-/m1/s1",
        "inchikey": "CTVHZJUSZJAUDM-PJIZGREPSA-N",
        "iupac": {
          "systematic": "(2R,3R,3aS,9bS)-1-[(2-fluorophenyl)methyl]-3-(hydroxymethyl)-6-oxo-7-phenyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxylic acid"
        },
        "smiles": {
          "canonical": "C1C2C(C(N(C2C3=CC=C(C(=O)N31)C4=CC=CC=C4)CC5=CC=CC=C5F)C(=O)O)CO"
        },
        "molecularFormula": "C25H23FN2O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:18:00Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c827f"
    },
    "name": "BRD-K79095355",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c827f.png",
    "lincs": {
      "id": "LSM-46074",
      "name": "BRD-K79095355",
      "inchiParent": "InChI=1S/C22H24N4O3S/c1-25-13-21(23-14-25)30(27,28)26-11-19-22(20(12-26)24-19)16-8-6-15(7-9-16)17-4-3-5-18(10-17)29-2/h3-10,13-14,19-20,22,24H,11-12H2,1-2H3/t19-,20+,22-",
      "inchiKeyParent": "YKIBEPHUZNWDRX-VTYHHJSWSA-N",
      "smilesParent": "COc1cccc(c1)c2ccc(cc2)[C@H]3[C@@H]4CN(C[C@H]3N4)S(=O)(=O)c5cn(C)cn5"
    },
    "unichem": {
      "lincs": "LSM-46074"
    },
    "createdAt": {
      "$date": "2025-05-24T08:18:02Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82ad"
    },
    "name": "BRD-K25807578",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82ad.png",
    "lincs": {
      "id": "LSM-38678",
      "name": "BRD-K25807578",
      "pubchemCid": 60191085,
      "chebiId": 127116,
      "inchiParent": "InChI=1S/C26H27FN2O3/c1-17(2)5-3-6-18-9-11-19(12-10-18)25-22-14-28(15-24(31)29(22)23(25)16-30)26(32)20-7-4-8-21(27)13-20/h4,7-13,17,22-23,25,30H,5,14-16H2,1-2H3/t22-,23-,25+/m1/s1",
      "inchiKeyParent": "VMZNVRZPRJWEKA-OYRHQHFDSA-N",
      "smilesParent": "CC(C)CC#Cc1ccc(cc1)[C@@H]2[C@@H](CO)N3[C@@H]2CN(CC3=O)C(=O)c4cccc(F)c4"
    },
    "unichem": {
      "chebi": "127116",
      "lincs": "LSM-38678",
      "pubchem": "60191085"
    },
    "pubchem": [
      {
        "cid": 60191085,
        "inchi": "InChI=1S/C26H27FN2O3/c1-17(2)5-3-6-18-9-11-19(12-10-18)25-22-14-28(15-24(31)29(22)23(25)16-30)26(32)20-7-4-8-21(27)13-20/h4,7-13,17,22-23,25,30H,5,14-16H2,1-2H3/t22-,23-,25+/m1/s1",
        "inchikey": "VMZNVRZPRJWEKA-OYRHQHFDSA-N",
        "iupac": {
          "systematic": "(6S,7S,8S)-4-(3-fluorobenzoyl)-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one"
        },
        "smiles": {
          "canonical": "CC(C)CC#CC1=CC=C(C=C1)C2C3CN(CC(=O)N3C2CO)C(=O)C4=CC(=CC=C4)F"
        },
        "molecularFormula": "C26H27FN2O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:18:04Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82b1"
    },
    "name": "BRD-K94253269",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82b1.png",
    "lincs": {
      "id": "LSM-42394",
      "name": "BRD-K94253269",
      "pubchemCid": 60191300,
      "chebiId": 130845,
      "inchiParent": "InChI=1S/C27H31N3O4/c1-28(2)27(34)21-11-7-19(8-12-21)18-5-9-20(10-6-18)26-22-14-29(24(32)13-17-3-4-17)15-25(33)30(22)23(26)16-31/h5-12,17,22-23,26,31H,3-4,13-16H2,1-2H3/t22-,23+,26+/m1/s1",
      "inchiKeyParent": "UXHPJSJBAOCQQE-UMFSSWHCSA-N",
      "smilesParent": "CN(C)C(=O)c1ccc(cc1)c2ccc(cc2)[C@@H]3[C@H](CO)N4[C@@H]3CN(CC4=O)C(=O)CC5CC5"
    },
    "unichem": {
      "chebi": "130845",
      "lincs": "LSM-42394",
      "pubchem": "60191300"
    },
    "pubchem": [
      {
        "cid": 60191300,
        "inchi": "InChI=1S/C27H31N3O4/c1-28(2)27(34)21-11-7-19(8-12-21)18-5-9-20(10-6-18)26-22-14-29(24(32)13-17-3-4-17)15-25(33)30(22)23(26)16-31/h5-12,17,22-23,26,31H,3-4,13-16H2,1-2H3/t22-,23+,26+/m1/s1",
        "inchikey": "UXHPJSJBAOCQQE-UMFSSWHCSA-N",
        "iupac": {
          "systematic": "4-[4-[(6S,7S,8R)-4-(2-cyclopropylacetyl)-8-(hydroxymethyl)-2-oxo-1,4-diazabicyclo[4.2.0]octan-7-yl]phenyl]-N,N-dimethylbenzamide"
        },
        "smiles": {
          "canonical": "CN(C)C(=O)C1=CC=C(C=C1)C2=CC=C(C=C2)C3C4CN(CC(=O)N4C3CO)C(=O)CC5CC5"
        },
        "molecularFormula": "C27H31N3O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:18:06Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82bc"
    },
    "name": "BRD-K43580610",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82bc.png",
    "lincs": {
      "id": "LSM-11085",
      "name": "BRD-K43580610",
      "pubchemCid": 54650040,
      "chebiId": 99706,
      "inchiParent": "InChI=1S/C20H21N3O2/c1-23(2)20(25)16-9-5-14(6-10-16)13-3-7-15(8-4-13)19-17(11-21)22-18(19)12-24/h3-10,17-19,22,24H,12H2,1-2H3/t17-,18-,19+/m1/s1",
      "inchiKeyParent": "BHVPTKKRAGQFTB-QRVBRYPASA-N",
      "smilesParent": "CN(C)C(=O)c1ccc(cc1)c2ccc(cc2)[C@@H]3[C@@H](CO)N[C@@H]3C#N"
    },
    "unichem": {
      "chebi": "99706",
      "lincs": "LSM-11085",
      "pubchem": "54650040"
    },
    "pubchem": [
      {
        "cid": 54650040,
        "inchi": "InChI=1S/C20H21N3O2/c1-23(2)20(25)16-9-5-14(6-10-16)13-3-7-15(8-4-13)19-17(11-21)22-18(19)12-24/h3-10,17-19,22,24H,12H2,1-2H3/t17-,18-,19+/m1/s1",
        "inchikey": "BHVPTKKRAGQFTB-QRVBRYPASA-N",
        "iupac": {
          "systematic": "4-[4-[(2S,3S,4S)-2-cyano-4-(hydroxymethyl)azetidin-3-yl]phenyl]-N,N-dimethylbenzamide"
        },
        "smiles": {
          "canonical": "CN(C)C(=O)C1=CC=C(C=C1)C2=CC=C(C=C2)C3C(NC3C#N)CO"
        },
        "molecularFormula": "C20H21N3O2"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:18:09Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82ff"
    },
    "name": "BRD-K03683936",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82ff.png",
    "lincs": {
      "id": "LSM-6909",
      "name": "BRD-K03683936",
      "pubchemCid": 54618997,
      "chebiId": 95530,
      "inchiParent": "InChI=1S/C29H35N3O5/c1-19-16-32(20(2)18-33)29(35)25-13-23(8-5-21-9-11-24(36-4)12-10-21)15-30-28(25)37-26(19)17-31(3)27(34)14-22-6-7-22/h9-13,15,19-20,22,26,33H,6-7,14,16-18H2,1-4H3/t19-,20+,26+/m0/s1",
      "inchiKeyParent": "DPWYORMJDFEMPA-OUDXUNEISA-N",
      "smilesParent": "COc1ccc(cc1)C#Cc2cnc3O[C@H](CN(C)C(=O)CC4CC4)[C@@H](C)CN([C@H](C)CO)C(=O)c3c2"
    },
    "unichem": {
      "chebi": "95530",
      "lincs": "LSM-6909",
      "pubchem": "54618997"
    },
    "pubchem": [
      {
        "cid": 54618997,
        "inchi": "InChI=1S/C29H35N3O5/c1-19-16-32(20(2)18-33)29(35)25-13-23(8-5-21-9-11-24(36-4)12-10-21)15-30-28(25)37-26(19)17-31(3)27(34)14-22-6-7-22/h9-13,15,19-20,22,26,33H,6-7,14,16-18H2,1-4H3/t19-,20+,26+/m0/s1",
        "inchikey": "DPWYORMJDFEMPA-OUDXUNEISA-N",
        "iupac": {
          "systematic": "2-cyclopropyl-N-[[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-8-[2-(4-methoxyphenyl)ethynyl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylacetamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(N=CC(=C2)C#CC3=CC=C(C=C3)OC)OC1CN(C)C(=O)CC4CC4)C(C)CO"
        },
        "molecularFormula": "C29H35N3O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:18:11Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8301"
    },
    "name": "BRD-K43605845",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8301.png",
    "lincs": {
      "id": "LSM-39669",
      "name": "BRD-K43605845",
      "pubchemCid": 54613922,
      "chebiId": 128113,
      "inchiParent": "InChI=1S/C32H46N4O5/c1-22-18-36(23(2)21-37)31(38)17-25-16-27(34-32(39)33-26-8-6-5-7-9-26)12-15-29(25)41-30(22)20-35(3)19-24-10-13-28(40-4)14-11-24/h10-16,22-23,26,30,37H,5-9,17-21H2,1-4H3,(H2,33,34,39)/t22-,23+,30+/m1/s1",
      "inchiKeyParent": "VLYSFBPSHIXFSY-HFZPWKHCSA-N",
      "smilesParent": "COc1ccc(CN(C)C[C@@H]2Oc3ccc(NC(=O)NC4CCCCC4)cc3CC(=O)N(C[C@H]2C)[C@@H](C)CO)cc1"
    },
    "unichem": {
      "chebi": "128113",
      "lincs": "LSM-39669",
      "pubchem": "54613922"
    },
    "pubchem": [
      {
        "cid": 54613922,
        "inchi": "InChI=1S/C32H46N4O5/c1-22-18-36(23(2)21-37)31(38)17-25-16-27(34-32(39)33-26-8-6-5-7-9-26)12-15-29(25)41-30(22)20-35(3)19-24-10-13-28(40-4)14-11-24/h10-16,22-23,26,30,37H,5-9,17-21H2,1-4H3,(H2,33,34,39)/t22-,23+,30+/m1/s1",
        "inchikey": "VLYSFBPSHIXFSY-HFZPWKHCSA-N",
        "iupac": {
          "systematic": "1-cyclohexyl-3-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)methyl-methylamino]methyl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]urea"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)CC2=C(C=CC(=C2)NC(=O)NC3CCCCC3)OC1CN(C)CC4=CC=C(C=C4)OC)C(C)CO"
        },
        "molecularFormula": "C32H46N4O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:18:13Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c833d"
    },
    "name": "BRD-K90061989",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c833d.png",
    "lincs": {
      "id": "LSM-13984",
      "name": "BRD-K90061989",
      "pubchemCid": 54638510,
      "chebiId": 102637,
      "inchiParent": "InChI=1S/C21H29N3O4/c1-13(2)22-21(27)24-18-8-7-17(28-19(18)12-25)11-20(26)23-16-9-14-5-3-4-6-15(14)10-16/h3-8,13,16-19,25H,9-12H2,1-2H3,(H,23,26)(H2,22,24,27)/t17-,18-,19-/m1/s1",
      "inchiKeyParent": "PBTCYEHOLZFKGG-GUDVDZBRSA-N",
      "smilesParent": "CC(C)NC(=O)N[C@@H]1C=C[C@H](CC(=O)NC2Cc3ccccc3C2)O[C@@H]1CO"
    },
    "unichem": {
      "chebi": "102637",
      "lincs": "LSM-13984",
      "pubchem": "54638510"
    },
    "pubchem": [
      {
        "cid": 54638510,
        "inchi": "InChI=1S/C21H29N3O4/c1-13(2)22-21(27)24-18-8-7-17(28-19(18)12-25)11-20(26)23-16-9-14-5-3-4-6-15(14)10-16/h3-8,13,16-19,25H,9-12H2,1-2H3,(H,23,26)(H2,22,24,27)/t17-,18-,19-/m1/s1",
        "inchikey": "PBTCYEHOLZFKGG-GUDVDZBRSA-N",
        "iupac": {
          "systematic": "N-(2,3-dihydro-1H-inden-2-yl)-2-[(2S,3R,6S)-2-(hydroxymethyl)-3-(propan-2-ylcarbamoylamino)-3,6-dihydro-2H-pyran-6-yl]acetamide"
        },
        "smiles": {
          "canonical": "CC(C)NC(=O)NC1C=CC(OC1CO)CC(=O)NC2CC3=CC=CC=C3C2"
        },
        "molecularFormula": "C21H29N3O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:18:15Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82ae"
    },
    "name": "BRD-K10211010",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82ae.png",
    "lincs": {
      "id": "LSM-9049",
      "name": "BRD-K10211010",
      "pubchemCid": 54657602,
      "chebiId": 97670,
      "inchiParent": "InChI=1S/C31H34N2O6/c34-25-17-33(16-21-6-13-28-29(14-21)38-20-37-28)27-12-11-26(39-30(27)19-36-18-25)15-31(35)32-24-9-7-23(8-10-24)22-4-2-1-3-5-22/h1-10,13-14,25-27,30,34H,11-12,15-20H2,(H,32,35)/t25-,26-,27-,30+/m0/s1",
      "inchiKeyParent": "OJBHRHOQEWVARJ-NJBJSMFESA-N",
      "smilesParent": "O[C@@H]1COC[C@H]2O[C@H](CC(=O)Nc3ccc(cc3)c4ccccc4)CC[C@@H]2N(Cc5ccc6OCOc6c5)C1"
    },
    "unichem": {
      "chebi": "97670",
      "lincs": "LSM-9049",
      "pubchem": "54657602"
    },
    "pubchem": [
      {
        "cid": 54657602,
        "inchi": "InChI=1S/C31H34N2O6/c34-25-17-33(16-21-6-13-28-29(14-21)38-20-37-28)27-12-11-26(39-30(27)19-36-18-25)15-31(35)32-24-9-7-23(8-10-24)22-4-2-1-3-5-22/h1-10,13-14,25-27,30,34H,11-12,15-20H2,(H,32,35)/t25-,26-,27-,30+/m0/s1",
        "inchikey": "OJBHRHOQEWVARJ-NJBJSMFESA-N",
        "iupac": {
          "systematic": "2-[(3S,6aS,8S,10aS)-1-(1,3-benzodioxol-5-ylmethyl)-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(4-phenylphenyl)acetamide"
        },
        "smiles": {
          "canonical": "C1CC2C(COCC(CN2CC3=CC4=C(C=C3)OCO4)O)OC1CC(=O)NC5=CC=C(C=C5)C6=CC=CC=C6"
        },
        "molecularFormula": "C31H34N2O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:18:18Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8297"
    },
    "name": "CHEMBL2357838",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8297.png",
    "lincs": {
      "id": "LSM-11974",
      "name": "CHEMBL2357838",
      "alternativeNames": [
        "BRD-K58703114"
      ],
      "pubchemCid": 54645833,
      "chebiId": 100600,
      "inchiParent": "InChI=1S/C31H30F3N3O5/c32-31(33,34)20-5-7-21(8-6-20)35-30(40)36-22-9-10-26-24(13-22)25-14-23(41-27(17-38)29(25)42-26)15-28(39)37-12-11-18-3-1-2-4-19(18)16-37/h1-10,13,23,25,27,29,38H,11-12,14-17H2,(H2,35,36,40)/t23-,25+,27-,29-/m0/s1",
      "inchiKeyParent": "HHNPVBFCYHNCMG-KLPDMWAPSA-N",
      "smilesParent": "OC[C@@H]1O[C@H](CC(=O)N2CCc3ccccc3C2)C[C@H]4[C@@H]1Oc5ccc(NC(=O)Nc6ccc(cc6)C(F)(F)F)cc45"
    },
    "unichem": {
      "chebi": "100600",
      "chembl": "CHEMBL2357838",
      "lincs": "LSM-11974",
      "pubchem": "54645833"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL2357838",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 581.59,
        "hba": 5,
        "hbd": 3,
        "qedWeighted": 0.38
      }
    },
    "pubchem": [
      {
        "cid": 54645833,
        "inchi": "InChI=1S/C31H30F3N3O5/c32-31(33,34)20-5-7-21(8-6-20)35-30(40)36-22-9-10-26-24(13-22)25-14-23(41-27(17-38)29(25)42-26)15-28(39)37-12-11-18-3-1-2-4-19(18)16-37/h1-10,13,23,25,27,29,38H,11-12,14-17H2,(H2,35,36,40)/t23-,25+,27-,29-/m0/s1",
        "inchikey": "HHNPVBFCYHNCMG-KLPDMWAPSA-N",
        "iupac": {
          "systematic": "1-[(1S,3S,4aR,9aS)-3-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]-3-[4-(trifluoromethyl)phenyl]urea"
        },
        "smiles": {
          "canonical": "C1CN(CC2=CC=CC=C21)C(=O)CC3CC4C(C(O3)CO)OC5=C4C=C(C=C5)NC(=O)NC6=CC=C(C=C6)C(F)(F)F"
        },
        "molecularFormula": "C31H30F3N3O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:18:29Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82c4"
    },
    "name": "BRD-K35868313",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82c4.png",
    "lincs": {
      "id": "LSM-10582",
      "name": "BRD-K35868313",
      "pubchemCid": 54645956,
      "chebiId": 99203,
      "inchiParent": "InChI=1S/C24H32N2O5/c27-13-21-23-19(11-17(30-21)12-22(28)25-15-6-1-2-7-15)18-10-16(8-9-20(18)31-23)26-24(29)14-4-3-5-14/h8-10,14-15,17,19,21,23,27H,1-7,11-13H2,(H,25,28)(H,26,29)/t17-,19-,21+,23+/m1/s1",
      "inchiKeyParent": "MOMUNQNAFOIKEQ-YZBYQZESSA-N",
      "smilesParent": "OC[C@@H]1O[C@@H](CC(=O)NC2CCCC2)C[C@H]3[C@@H]1Oc4ccc(NC(=O)C5CCC5)cc34"
    },
    "unichem": {
      "chebi": "99203",
      "lincs": "LSM-10582",
      "pubchem": "54645956"
    },
    "pubchem": [
      {
        "cid": 54645956,
        "inchi": "InChI=1S/C24H32N2O5/c27-13-21-23-19(11-17(30-21)12-22(28)25-15-6-1-2-7-15)18-10-16(8-9-20(18)31-23)26-24(29)14-4-3-5-14/h8-10,14-15,17,19,21,23,27H,1-7,11-13H2,(H,25,28)(H,26,29)/t17-,19-,21+,23+/m1/s1",
        "inchikey": "MOMUNQNAFOIKEQ-YZBYQZESSA-N",
        "iupac": {
          "systematic": "N-[(1S,3R,4aR,9aS)-3-[2-(cyclopentylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]cyclobutanecarboxamide"
        },
        "smiles": {
          "canonical": "C1CCC(C1)NC(=O)CC2CC3C(C(O2)CO)OC4=C3C=C(C=C4)NC(=O)C5CCC5"
        },
        "molecularFormula": "C24H32N2O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:18:31Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8300"
    },
    "name": "BRD-K30803694",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8300.png",
    "lincs": {
      "id": "LSM-10285",
      "name": "BRD-K30803694",
      "pubchemCid": 54631920,
      "chebiId": 98906,
      "inchiParent": "InChI=1S/C29H37N3O6/c1-18-13-32(14-20-5-6-20)19(2)16-36-24-10-8-22(12-23(24)29(34)31(3)15-27(18)35-4)30-28(33)21-7-9-25-26(11-21)38-17-37-25/h7-12,18-20,27H,5-6,13-17H2,1-4H3,(H,30,33)/t18-,19+,27-/m1/s1",
      "inchiKeyParent": "KBKSWHGSXCIXAL-VXLXPWSCSA-N",
      "smilesParent": "CO[C@@H]1CN(C)C(=O)c2cc(NC(=O)c3ccc4OCOc4c3)ccc2OC[C@H](C)N(CC5CC5)C[C@H]1C"
    },
    "unichem": {
      "chebi": "98906",
      "lincs": "LSM-10285",
      "pubchem": "54631920"
    },
    "pubchem": [
      {
        "cid": 54631920,
        "inchi": "InChI=1S/C29H37N3O6/c1-18-13-32(14-20-5-6-20)19(2)16-36-24-10-8-22(12-23(24)29(34)31(3)15-27(18)35-4)30-28(33)21-7-9-25-26(11-21)38-17-37-25/h7-12,18-20,27H,5-6,13-17H2,1-4H3,(H,30,33)/t18-,19+,27-/m1/s1",
        "inchikey": "KBKSWHGSXCIXAL-VXLXPWSCSA-N",
        "iupac": {
          "systematic": "N-[(4S,7R,8S)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1,3-benzodioxole-5-carboxamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(COC2=C(C=C(C=C2)NC(=O)C3=CC4=C(C=C3)OCO4)C(=O)N(CC1OC)C)C)CC5CC5"
        },
        "molecularFormula": "C29H37N3O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:18:33Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c830b"
    },
    "name": "BRD-K97981711",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c830b.png",
    "lincs": {
      "id": "LSM-14450",
      "name": "BRD-K97981711",
      "pubchemCid": 54657583,
      "chebiId": 103105,
      "inchiParent": "InChI=1S/C27H35N3O5/c31-23-17-30(16-20-2-1-3-22(14-20)21-6-8-28-9-7-21)25-5-4-24(35-26(25)19-34-18-23)15-27(32)29-10-12-33-13-11-29/h1-3,6-9,14,23-26,31H,4-5,10-13,15-19H2/t23-,24-,25-,26+/m1/s1",
      "inchiKeyParent": "VMOCTUISBGPURH-POTDNYQPSA-N",
      "smilesParent": "O[C@H]1COC[C@@H]2O[C@@H](CC(=O)N3CCOCC3)CC[C@H]2N(Cc4cccc(c4)c5ccncc5)C1"
    },
    "unichem": {
      "chebi": "103105",
      "lincs": "LSM-14450",
      "pubchem": "54657583"
    },
    "pubchem": [
      {
        "cid": 54657583,
        "inchi": "InChI=1S/C27H35N3O5/c31-23-17-30(16-20-2-1-3-22(14-20)21-6-8-28-9-7-21)25-5-4-24(35-26(25)19-34-18-23)15-27(32)29-10-12-33-13-11-29/h1-3,6-9,14,23-26,31H,4-5,10-13,15-19H2/t23-,24-,25-,26+/m1/s1",
        "inchikey": "VMOCTUISBGPURH-POTDNYQPSA-N",
        "iupac": {
          "systematic": "2-[(3R,6aR,8R,10aR)-3-hydroxy-1-[(3-pyridin-4-ylphenyl)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-morpholin-4-ylethanone"
        },
        "smiles": {
          "canonical": "C1CC2C(COCC(CN2CC3=CC(=CC=C3)C4=CC=NC=C4)O)OC1CC(=O)N5CCOCC5"
        },
        "molecularFormula": "C27H35N3O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:18:37Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8315"
    },
    "name": "BRD-K79118917",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8315.png",
    "lincs": {
      "id": "LSM-13263",
      "name": "BRD-K79118917",
      "pubchemCid": 54631896,
      "chebiId": 101902,
      "inchiParent": "InChI=1S/C25H33N3O4/c1-17-14-26-18(2)16-32-22-11-10-20(27-24(29)12-19-8-6-5-7-9-19)13-21(22)25(30)28(3)15-23(17)31-4/h5-11,13,17-18,23,26H,12,14-16H2,1-4H3,(H,27,29)/t17-,18+,23+/m0/s1",
      "inchiKeyParent": "RIFMDYVXBSMSIP-YZZKKUAISA-N",
      "smilesParent": "CO[C@@H]1CN(C)C(=O)c2cc(NC(=O)Cc3ccccc3)ccc2OC[C@@H](C)NC[C@@H]1C"
    },
    "unichem": {
      "chebi": "101902",
      "lincs": "LSM-13263",
      "pubchem": "54631896"
    },
    "pubchem": [
      {
        "cid": 54631896,
        "inchi": "InChI=1S/C25H33N3O4/c1-17-14-26-18(2)16-32-22-11-10-20(27-24(29)12-19-8-6-5-7-9-19)13-21(22)25(30)28(3)15-23(17)31-4/h5-11,13,17-18,23,26H,12,14-16H2,1-4H3,(H,27,29)/t17-,18+,23+/m0/s1",
        "inchikey": "RIFMDYVXBSMSIP-YZZKKUAISA-N",
        "iupac": {
          "systematic": "N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-phenylacetamide"
        },
        "smiles": {
          "canonical": "CC1CNC(COC2=C(C=C(C=C2)NC(=O)CC3=CC=CC=C3)C(=O)N(CC1OC)C)C"
        },
        "molecularFormula": "C25H33N3O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:18:39Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8316"
    },
    "name": "BRD-K11518623",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8316.png",
    "lincs": {
      "id": "LSM-6995",
      "name": "BRD-K11518623",
      "pubchemCid": 49835851,
      "chebiId": 95616,
      "inchiParent": "InChI=1S/C29H37N3O7S/c1-20-17-32(21(2)19-33)28(34)25-15-22(11-14-29(35)12-5-6-13-29)16-30-27(25)39-26(20)18-31(3)40(36,37)24-9-7-23(38-4)8-10-24/h7-10,15-16,20-21,26,33,35H,5-6,12-13,17-19H2,1-4H3/t20-,21+,26+/m1/s1",
      "inchiKeyParent": "BLVPPUGYXWKWFY-SWYRRKHMSA-N",
      "smilesParent": "COc1ccc(cc1)S(=O)(=O)N(C)C[C@@H]2Oc3ncc(cc3C(=O)N(C[C@H]2C)[C@@H](C)CO)C#CC4(O)CCCC4"
    },
    "unichem": {
      "chebi": "95616",
      "lincs": "LSM-6995",
      "pubchem": "49835851"
    },
    "pubchem": [
      {
        "cid": 49835851,
        "inchi": "InChI=1S/C29H37N3O7S/c1-20-17-32(21(2)19-33)28(34)25-15-22(11-14-29(35)12-5-6-13-29)16-30-27(25)39-26(20)18-31(3)40(36,37)24-9-7-23(38-4)8-10-24/h7-10,15-16,20-21,26,33,35H,5-6,12-13,17-19H2,1-4H3/t20-,21+,26+/m1/s1",
        "inchikey": "BLVPPUGYXWKWFY-SWYRRKHMSA-N",
        "iupac": {
          "systematic": "N-[[(2R,3R)-8-[2-(1-hydroxycyclopentyl)ethynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-4-methoxy-N-methylbenzenesulfonamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(N=CC(=C2)C#CC3(CCCC3)O)OC1CN(C)S(=O)(=O)C4=CC=C(C=C4)OC)C(C)CO"
        },
        "molecularFormula": "C29H37N3O7S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:18:42Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8330"
    },
    "name": "BRD-K07678162",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8330.png",
    "lincs": {
      "id": "LSM-8891",
      "name": "BRD-K07678162",
      "pubchemCid": 54638963,
      "chebiId": 97512,
      "inchiParent": "InChI=1S/C24H27N3O6/c1-15(16-5-3-2-4-6-16)25-23(29)12-18-8-9-19(22(13-28)33-18)27-24(30)26-17-7-10-20-21(11-17)32-14-31-20/h2-11,15,18-19,22,28H,12-14H2,1H3,(H,25,29)(H2,26,27,30)/t15-,18-,19+,22-/m0/s1",
      "inchiKeyParent": "UDMIDSQAUXVXMN-XCRNZQRYSA-N",
      "smilesParent": "C[C@H](NC(=O)C[C@H]1O[C@@H](CO)[C@H](NC(=O)Nc2ccc3OCOc3c2)C=C1)c4ccccc4"
    },
    "unichem": {
      "chebi": "97512",
      "lincs": "LSM-8891",
      "pubchem": "54638963"
    },
    "pubchem": [
      {
        "cid": 54638963,
        "inchi": "InChI=1S/C24H27N3O6/c1-15(16-5-3-2-4-6-16)25-23(29)12-18-8-9-19(22(13-28)33-18)27-24(30)26-17-7-10-20-21(11-17)32-14-31-20/h2-11,15,18-19,22,28H,12-14H2,1H3,(H,25,29)(H2,26,27,30)/t15-,18-,19+,22-/m0/s1",
        "inchikey": "UDMIDSQAUXVXMN-XCRNZQRYSA-N",
        "iupac": {
          "systematic": "2-[(2R,3R,6R)-3-(1,3-benzodioxol-5-ylcarbamoylamino)-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[(1S)-1-phenylethyl]acetamide"
        },
        "smiles": {
          "canonical": "CC(C1=CC=CC=C1)NC(=O)CC2C=CC(C(O2)CO)NC(=O)NC3=CC4=C(C=C3)OCO4"
        },
        "molecularFormula": "C24H27N3O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:18:45Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8270"
    },
    "name": "BRD-K45151011",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8270.png",
    "lincs": {
      "id": "LSM-11177",
      "name": "BRD-K45151011",
      "pubchemCid": 54650049,
      "chebiId": 99798,
      "inchiParent": "InChI=1S/C22H26N2O3/c23-13-19-21(17-7-5-16(6-8-17)15-3-1-2-4-15)20(14-25)24(19)22(26)18-9-11-27-12-10-18/h3,5-8,18-21,25H,1-2,4,9-12,14H2/t19-,20+,21+/m0/s1",
      "inchiKeyParent": "RYSHWXRXFKBMCF-PWRODBHTSA-N",
      "smilesParent": "OC[C@@H]1[C@@H]([C@H](C#N)N1C(=O)C2CCOCC2)c3ccc(cc3)C4=CCCC4"
    },
    "unichem": {
      "chebi": "99798",
      "lincs": "LSM-11177",
      "pubchem": "54650049"
    },
    "pubchem": [
      {
        "cid": 54650049,
        "inchi": "InChI=1S/C22H26N2O3/c23-13-19-21(17-7-5-16(6-8-17)15-3-1-2-4-15)20(14-25)24(19)22(26)18-9-11-27-12-10-18/h3,5-8,18-21,25H,1-2,4,9-12,14H2/t19-,20+,21+/m0/s1",
        "inchikey": "RYSHWXRXFKBMCF-PWRODBHTSA-N",
        "iupac": {
          "systematic": "(2R,3R,4S)-3-[4-(cyclopenten-1-yl)phenyl]-4-(hydroxymethyl)-1-(oxane-4-carbonyl)azetidine-2-carbonitrile"
        },
        "smiles": {
          "canonical": "C1CC=C(C1)C2=CC=C(C=C2)C3C(N(C3C#N)C(=O)C4CCOCC4)CO"
        },
        "molecularFormula": "C22H26N2O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:18:47Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8285"
    },
    "name": "BRD-K14483137",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8285.png",
    "lincs": {
      "id": "LSM-38020",
      "name": "BRD-K14483137",
      "pubchemCid": 60192113,
      "chebiId": 126456,
      "inchiParent": "InChI=1S/C19H26F3N3O2/c1-23(2)10-16(27)25-15(11-26)17(14-6-4-3-5-7-14)18(25)12-24(13-18)9-8-19(20,21)22/h3-7,15,17,26H,8-13H2,1-2H3/t15-,17+/m1/s1",
      "inchiKeyParent": "UKUPLVQGLJTKLT-WBVHZDCISA-N",
      "smilesParent": "CN(C)CC(=O)N1[C@H](CO)[C@H](c2ccccc2)C13CN(CCC(F)(F)F)C3"
    },
    "unichem": {
      "chebi": "126456",
      "lincs": "LSM-38020",
      "pubchem": "60192113"
    },
    "pubchem": [
      {
        "cid": 60192113,
        "inchi": "InChI=1S/C19H26F3N3O2/c1-23(2)10-16(27)25-15(11-26)17(14-6-4-3-5-7-14)18(25)12-24(13-18)9-8-19(20,21)22/h3-7,15,17,26H,8-13H2,1-2H3/t15-,17+/m1/s1",
        "inchikey": "UKUPLVQGLJTKLT-WBVHZDCISA-N",
        "iupac": {
          "systematic": "2-(dimethylamino)-1-[(2S,3S)-2-(hydroxymethyl)-3-phenyl-6-(3,3,3-trifluoropropyl)-1,6-diazaspiro[3.3]heptan-1-yl]ethanone"
        },
        "smiles": {
          "canonical": "CN(C)CC(=O)N1C(C(C12CN(C2)CCC(F)(F)F)C3=CC=CC=C3)CO"
        },
        "molecularFormula": "C19H26F3N3O2"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:18:49Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8289"
    },
    "name": "BRD-K37405154",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8289.png",
    "lincs": {
      "id": "LSM-10688",
      "name": "BRD-K37405154",
      "pubchemCid": 54649410,
      "chebiId": 99309,
      "inchiParent": "InChI=1S/C31H34N4O4S/c1-31(2,3)40(38)35-20-25-18-26(30(37)34-12-15-39-16-13-34)33-29(28(25)27(35)11-14-36)24-6-4-5-23(17-24)22-9-7-21(19-32)8-10-22/h4-10,17-18,27,36H,11-16,20H2,1-3H3/t27-,40-/m1/s1",
      "inchiKeyParent": "IMNSYTYGXZBRLR-KSTXALNGSA-N",
      "smilesParent": "CC(C)(C)[S@@](=O)N1Cc2cc(nc(c3cccc(c3)c4ccc(cc4)C#N)c2[C@H]1CCO)C(=O)N5CCOCC5"
    },
    "unichem": {
      "chebi": "99309",
      "lincs": "LSM-10688",
      "pubchem": "54649410"
    },
    "pubchem": [
      {
        "cid": 54649410,
        "inchi": "InChI=1S/C31H34N4O4S/c1-31(2,3)40(38)35-20-25-18-26(30(37)34-12-15-39-16-13-34)33-29(28(25)27(35)11-14-36)24-6-4-5-23(17-24)22-9-7-21(19-32)8-10-22/h4-10,17-18,27,36H,11-16,20H2,1-3H3/t27-,40-/m1/s1",
        "inchikey": "IMNSYTYGXZBRLR-KSTXALNGSA-N",
        "iupac": {
          "systematic": "4-[3-[(3R)-2-[(R)-tert-butylsulfinyl]-3-(2-hydroxyethyl)-6-(morpholine-4-carbonyl)-1,3-dihydropyrrolo[3,4-c]pyridin-4-yl]phenyl]benzonitrile"
        },
        "smiles": {
          "canonical": "CC(C)(C)S(=O)N1CC2=CC(=NC(=C2C1CCO)C3=CC=CC(=C3)C4=CC=C(C=C4)C#N)C(=O)N5CCOCC5"
        },
        "molecularFormula": "C31H34N4O4S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:18:52Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82b6"
    },
    "name": "BRD-K90526552",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82b6.png",
    "lincs": {
      "id": "LSM-42210",
      "name": "BRD-K90526552",
      "pubchemCid": 60189990,
      "chebiId": 130661,
      "inchiParent": "InChI=1S/C25H24FN3O2/c26-20-10-6-9-19(13-20)24(31)28-16-25(17-28)23(18-7-2-1-3-8-18)22(15-30)29(25)14-21-11-4-5-12-27-21/h1-13,22-23,30H,14-17H2/t22-,23+/m0/s1",
      "inchiKeyParent": "XGAGPUGBXVVIKK-XZOQPEGZSA-N",
      "smilesParent": "OC[C@H]1[C@@H](c2ccccc2)C3(CN(C3)C(=O)c4cccc(F)c4)N1Cc5ccccn5"
    },
    "unichem": {
      "chebi": "130661",
      "lincs": "LSM-42210",
      "pubchem": "60189990"
    },
    "pubchem": [
      {
        "cid": 60189990,
        "inchi": "InChI=1S/C25H24FN3O2/c26-20-10-6-9-19(13-20)24(31)28-16-25(17-28)23(18-7-2-1-3-8-18)22(15-30)29(25)14-21-11-4-5-12-27-21/h1-13,22-23,30H,14-17H2/t22-,23+/m0/s1",
        "inchikey": "XGAGPUGBXVVIKK-XZOQPEGZSA-N",
        "iupac": {
          "systematic": "(3-fluorophenyl)-[(2R,3R)-2-(hydroxymethyl)-3-phenyl-1-(pyridin-2-ylmethyl)-1,6-diazaspiro[3.3]heptan-6-yl]methanone"
        },
        "smiles": {
          "canonical": "C1C2(CN1C(=O)C3=CC(=CC=C3)F)C(C(N2CC4=CC=CC=N4)CO)C5=CC=CC=C5"
        },
        "molecularFormula": "C25H24FN3O2"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:18:54Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82c3"
    },
    "name": "BRD-K00918977",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82c3.png",
    "lincs": {
      "id": "LSM-8489",
      "name": "BRD-K00918977",
      "pubchemCid": 54658079,
      "chebiId": 97110,
      "inchiParent": "InChI=1S/C26H40N4O5/c1-2-11-27-26(33)30-16-21(31)17-34-18-24-23(30)9-8-22(35-24)13-25(32)28-20-10-12-29(15-20)14-19-6-4-3-5-7-19/h3-7,20-24,31H,2,8-18H2,1H3,(H,27,33)(H,28,32)/t20-,21-,22+,23+,24-/m1/s1",
      "inchiKeyParent": "WWAGOAOIMIOBRQ-URYYLNOGSA-N",
      "smilesParent": "CCCNC(=O)N1C[C@@H](O)COC[C@H]2O[C@H](CC(=O)N[C@@H]3CCN(Cc4ccccc4)C3)CC[C@H]12"
    },
    "unichem": {
      "chebi": "97110",
      "lincs": "LSM-8489",
      "pubchem": "54658079"
    },
    "pubchem": [
      {
        "cid": 54658079,
        "inchi": "InChI=1S/C26H40N4O5/c1-2-11-27-26(33)30-16-21(31)17-34-18-24-23(30)9-8-22(35-24)13-25(32)28-20-10-12-29(15-20)14-19-6-4-3-5-7-19/h3-7,20-24,31H,2,8-18H2,1H3,(H,27,33)(H,28,32)/t20-,21-,22+,23+,24-/m1/s1",
        "inchikey": "WWAGOAOIMIOBRQ-URYYLNOGSA-N",
        "iupac": {
          "systematic": "(3R,6aS,8S,10aS)-8-[2-[[(3R)-1-benzylpyrrolidin-3-yl]amino]-2-oxoethyl]-3-hydroxy-N-propyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide"
        },
        "smiles": {
          "canonical": "CCCNC(=O)N1CC(COCC2C1CCC(O2)CC(=O)NC3CCN(C3)CC4=CC=CC=C4)O"
        },
        "molecularFormula": "C26H40N4O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:18:56Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c830d"
    },
    "name": "BRD-M78319284",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c830d.png",
    "lincs": {
      "id": "LSM-45068",
      "name": "BRD-M78319284",
      "pubchemCid": 54661335,
      "chebiId": 103305,
      "inchiParent": "InChI=1S/C27H33FN4O4/c1-4-8-17-11-12-21-24-23(25(34)29-13-7-14-30(2)3)19(16-33)22(15-31(21)26(17)35)32(24)27(36)18-9-5-6-10-20(18)28/h4-6,8-12,19,22-24,33H,7,13-16H2,1-3H3,(H,29,34)/t19-,22-,23+,24+/m0/s1",
      "inchiKeyParent": "ZXRDMZYXGOPOHF-ZMUKGBGYSA-N",
      "smilesParent": "CC=CC1=CC=C2[C@@H]3[C@@H]([C@@H](CO)[C@H](CN2C1=O)N3C(=O)c4ccccc4F)C(=O)NCCCN(C)C"
    },
    "unichem": {
      "chebi": "103305",
      "lincs": "LSM-45068",
      "pubchem": "139032152"
    },
    "pubchem": [
      {
        "cid": 139032152,
        "inchi": "InChI=1S/C27H33FN4O4/c1-4-8-17-11-12-21-24-23(25(34)29-13-7-14-30(2)3)19(16-33)22(15-31(21)26(17)35)32(24)27(36)18-9-5-6-10-20(18)28/h4-6,8-12,19,22-24,33H,7,13-16H2,1-3H3,(H,29,34)/t19-,22-,23+,24+/m0/s1",
        "inchikey": "ZXRDMZYXGOPOHF-ZMUKGBGYSA-N",
        "iupac": {
          "systematic": "(1S,9R,10R,11R)-N-[3-(dimethylamino)propyl]-12-(2-fluorobenzoyl)-10-(hydroxymethyl)-6-oxo-5-prop-1-enyl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide"
        },
        "smiles": {
          "canonical": "CC=CC1=CC=C2C3C(C(C(N3C(=O)C4=CC=CC=C4F)CN2C1=O)CO)C(=O)NCCCN(C)C"
        },
        "molecularFormula": "C27H33FN4O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:18:59Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8338"
    },
    "name": "BRD-K01556781",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8338.png",
    "lincs": {
      "id": "LSM-6879",
      "name": "BRD-K01556781",
      "pubchemCid": 54618272,
      "chebiId": 95500,
      "inchiParent": "InChI=1S/C27H31FN2O5S/c1-18-15-30(19(2)17-31)36(33,34)26-12-11-21(10-9-20-7-8-20)13-24(26)35-25(18)16-29(3)27(32)22-5-4-6-23(28)14-22/h4-6,11-14,18-20,25,31H,7-8,15-17H2,1-3H3/t18-,19+,25-/m0/s1",
      "inchiKeyParent": "VIOYSSVCFLGZJY-CEYNDMKZSA-N",
      "smilesParent": "C[C@H](CO)N1C[C@H](C)[C@H](CN(C)C(=O)c2cccc(F)c2)Oc3cc(ccc3S1(=O)=O)C#CC4CC4"
    },
    "unichem": {
      "chebi": "95500",
      "lincs": "LSM-6879",
      "pubchem": "54618272"
    },
    "pubchem": [
      {
        "cid": 54618272,
        "inchi": "InChI=1S/C27H31FN2O5S/c1-18-15-30(19(2)17-31)36(33,34)26-12-11-21(10-9-20-7-8-20)13-24(26)35-25(18)16-29(3)27(32)22-5-4-6-23(28)14-22/h4-6,11-14,18-20,25,31H,7-8,15-17H2,1-3H3/t18-,19+,25-/m0/s1",
        "inchikey": "VIOYSSVCFLGZJY-CEYNDMKZSA-N",
        "iupac": {
          "systematic": "N-[[(4S,5R)-8-(2-cyclopropylethynyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-3-fluoro-N-methylbenzamide"
        },
        "smiles": {
          "canonical": "CC1CN(S(=O)(=O)C2=C(C=C(C=C2)C#CC3CC3)OC1CN(C)C(=O)C4=CC(=CC=C4)F)C(C)CO"
        },
        "molecularFormula": "C27H31FN2O5S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:19:01Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8293"
    },
    "name": "BRD-K52564648",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8293.png",
    "lincs": {
      "id": "LSM-11639",
      "name": "BRD-K52564648",
      "pubchemCid": 54631470,
      "chebiId": 100264,
      "inchiParent": "InChI=1S/C29H36FN3O5/c1-18-15-33(27(34)13-20-5-6-20)19(2)17-38-25-14-23(31-28(35)21-7-9-22(30)10-8-21)11-12-24(25)29(36)32(3)16-26(18)37-4/h7-12,14,18-20,26H,5-6,13,15-17H2,1-4H3,(H,31,35)/t18-,19-,26+/m0/s1",
      "inchiKeyParent": "QTFKJTMJQVNOKY-LZJCXSABSA-N",
      "smilesParent": "CO[C@@H]1CN(C)C(=O)c2ccc(NC(=O)c3ccc(F)cc3)cc2OC[C@H](C)N(C[C@@H]1C)C(=O)CC4CC4"
    },
    "unichem": {
      "chebi": "100264",
      "lincs": "LSM-11639",
      "pubchem": "54631470"
    },
    "pubchem": [
      {
        "cid": 54631470,
        "inchi": "InChI=1S/C29H36FN3O5/c1-18-15-33(27(34)13-20-5-6-20)19(2)17-38-25-14-23(31-28(35)21-7-9-22(30)10-8-21)11-12-24(25)29(36)32(3)16-26(18)37-4/h7-12,14,18-20,26H,5-6,13,15-17H2,1-4H3,(H,31,35)/t18-,19-,26+/m0/s1",
        "inchikey": "QTFKJTMJQVNOKY-LZJCXSABSA-N",
        "iupac": {
          "systematic": "N-[(4S,7S,8S)-5-(2-cyclopropylacetyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-15-yl]-4-fluorobenzamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(COC2=C(C=CC(=C2)NC(=O)C3=CC=C(C=C3)F)C(=O)N(CC1OC)C)C)C(=O)CC4CC4"
        },
        "molecularFormula": "C29H36FN3O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:19:03Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82cf"
    },
    "name": "BRD-K58791909",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82cf.png",
    "lincs": {
      "id": "LSM-40482",
      "name": "BRD-K58791909",
      "pubchemCid": 54666414,
      "chebiId": 128930,
      "inchiParent": "InChI=1S/C29H35FN2O2/c30-26-6-2-1-5-24(26)10-7-22-8-11-25(12-9-22)29-27-20-31(19-23-13-17-34-18-14-23)15-3-4-16-32(27)28(29)21-33/h1-2,5-6,8-9,11-12,23,27-29,33H,3-4,13-21H2/t27-,28-,29+/m0/s1",
      "inchiKeyParent": "CUZIWLSYIOFIPC-YTCPBCGMSA-N",
      "smilesParent": "OC[C@H]1[C@@H]([C@@H]2CN(CC3CCOCC3)CCCCN12)c4ccc(cc4)C#Cc5ccccc5F"
    },
    "unichem": {
      "chebi": "128930",
      "lincs": "LSM-40482",
      "pubchem": "54666414"
    },
    "pubchem": [
      {
        "cid": 54666414,
        "inchi": "InChI=1S/C29H35FN2O2/c30-26-6-2-1-5-24(26)10-7-22-8-11-25(12-9-22)29-27-20-31(19-23-13-17-34-18-14-23)15-3-4-16-32(27)28(29)21-33/h1-2,5-6,8-9,11-12,23,27-29,33H,3-4,13-21H2/t27-,28-,29+/m0/s1",
        "inchikey": "CUZIWLSYIOFIPC-YTCPBCGMSA-N",
        "iupac": {
          "systematic": "[(8R,9R,10R)-9-[4-[2-(2-fluorophenyl)ethynyl]phenyl]-6-(oxan-4-ylmethyl)-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol"
        },
        "smiles": {
          "canonical": "C1CCN2C(CN(C1)CC3CCOCC3)C(C2CO)C4=CC=C(C=C4)C#CC5=CC=CC=C5F"
        },
        "molecularFormula": "C29H35FN2O2"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:19:05Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82ec"
    },
    "name": "BRD-K13185593",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82ec.png",
    "lincs": {
      "id": "LSM-9220",
      "name": "BRD-K13185593",
      "pubchemCid": 54646240,
      "chebiId": 97841,
      "inchiParent": "InChI=1S/C28H30N4O6/c1-36-20-8-5-17(6-9-20)31-28(35)32-18-7-10-24-22(12-18)23-13-21(37-25(16-33)27(23)38-24)14-26(34)30-15-19-4-2-3-11-29-19/h2-12,21,23,25,27,33H,13-16H2,1H3,(H,30,34)(H2,31,32,35)/t21-,23-,25-,27+/m0/s1",
      "inchiKeyParent": "FWDZHOQSJMEDFJ-NTYBTQPHSA-N",
      "smilesParent": "COc1ccc(NC(=O)Nc2ccc3O[C@H]4[C@H](CO)O[C@H](CC(=O)NCc5ccccn5)C[C@H]4c3c2)cc1"
    },
    "unichem": {
      "chebi": "97841",
      "lincs": "LSM-9220",
      "pubchem": "54646240"
    },
    "pubchem": [
      {
        "cid": 54646240,
        "inchi": "InChI=1S/C28H30N4O6/c1-36-20-8-5-17(6-9-20)31-28(35)32-18-7-10-24-22(12-18)23-13-21(37-25(16-33)27(23)38-24)14-26(34)30-15-19-4-2-3-11-29-19/h2-12,21,23,25,27,33H,13-16H2,1H3,(H,30,34)(H2,31,32,35)/t21-,23-,25-,27+/m0/s1",
        "inchikey": "FWDZHOQSJMEDFJ-NTYBTQPHSA-N",
        "iupac": {
          "systematic": "2-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-6-[(4-methoxyphenyl)carbamoylamino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-(pyridin-2-ylmethyl)acetamide"
        },
        "smiles": {
          "canonical": "COC1=CC=C(C=C1)NC(=O)NC2=CC3=C(C=C2)OC4C3CC(OC4CO)CC(=O)NCC5=CC=CC=N5"
        },
        "molecularFormula": "C28H30N4O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:19:08Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8288"
    },
    "name": "BRD-K49093373",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8288.png",
    "lincs": {
      "id": "LSM-11413",
      "name": "BRD-K49093373",
      "pubchemCid": 54638761,
      "chebiId": 100034,
      "inchiParent": "InChI=1S/C15H20FNO6S/c1-22-15(19)8-10-6-7-12(13(9-18)23-10)17-24(20,21)14-5-3-2-4-11(14)16/h2-5,10,12-13,17-18H,6-9H2,1H3/t10-,12+,13-/m0/s1",
      "inchiKeyParent": "OBZPPVVKYJWSJI-UHTWSYAYSA-N",
      "smilesParent": "COC(=O)C[C@@H]1CC[C@@H](NS(=O)(=O)c2ccccc2F)[C@H](CO)O1"
    },
    "unichem": {
      "chebi": "100034",
      "lincs": "LSM-11413",
      "pubchem": "54638761"
    },
    "pubchem": [
      {
        "cid": 54638761,
        "inchi": "InChI=1S/C15H20FNO6S/c1-22-15(19)8-10-6-7-12(13(9-18)23-10)17-24(20,21)14-5-3-2-4-11(14)16/h2-5,10,12-13,17-18H,6-9H2,1H3/t10-,12+,13-/m0/s1",
        "inchikey": "OBZPPVVKYJWSJI-UHTWSYAYSA-N",
        "iupac": {
          "systematic": "methyl 2-[(2S,5R,6R)-5-[(2-fluorophenyl)sulfonylamino]-6-(hydroxymethyl)oxan-2-yl]acetate"
        },
        "smiles": {
          "canonical": "COC(=O)CC1CCC(C(O1)CO)NS(=O)(=O)C2=CC=CC=C2F"
        },
        "molecularFormula": "C15H20FNO6S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:19:10Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82c9"
    },
    "name": "BRD-K66857089",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82c9.png",
    "lincs": {
      "id": "LSM-44830",
      "name": "BRD-K66857089",
      "pubchemCid": 60190191,
      "inchiParent": "InChI=1S/C24H28N2O4S/c1-3-22(28)26-21(15-27)23(24(26)16-25(17-24)31(2,29)30)20-13-11-19(12-14-20)10-9-18-7-5-4-6-8-18/h4-14,21,23,27H,3,15-17H2,1-2H3/b10-9+/t21-,23-/m1/s1",
      "inchiKeyParent": "YDJCYRFUPYUWQG-KJWVINOWSA-N",
      "smilesParent": "CCC(=O)N1[C@H](CO)[C@@H](c2ccc(\\C=C\\c3ccccc3)cc2)C14CN(C4)S(=O)(=O)C"
    },
    "unichem": {
      "lincs": "LSM-44830",
      "pubchem": "60190191"
    },
    "pubchem": [
      {
        "cid": 60190191,
        "inchi": "InChI=1S/C24H28N2O4S/c1-3-22(28)26-21(15-27)23(24(26)16-25(17-24)31(2,29)30)20-13-11-19(12-14-20)10-9-18-7-5-4-6-8-18/h4-14,21,23,27H,3,15-17H2,1-2H3/b10-9+/t21-,23-/m1/s1",
        "inchikey": "YDJCYRFUPYUWQG-KJWVINOWSA-N",
        "iupac": {
          "systematic": "1-[(2S,3R)-2-(hydroxymethyl)-6-methylsulfonyl-3-[4-[(E)-2-phenylethenyl]phenyl]-1,6-diazaspiro[3.3]heptan-1-yl]propan-1-one"
        },
        "smiles": {
          "canonical": "CCC(=O)N1C(C(C12CN(C2)S(=O)(=O)C)C3=CC=C(C=C3)C=CC4=CC=CC=C4)CO"
        },
        "molecularFormula": "C24H28N2O4S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:19:12Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82d1"
    },
    "name": "BRD-K47033137",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82d1.png",
    "lincs": {
      "id": "LSM-44777",
      "name": "BRD-K47033137",
      "pubchemCid": 54666620,
      "inchiParent": "InChI=1S/C25H32N2O4S/c1-3-6-19-7-9-20(10-8-19)25-23-17-26(15-4-5-16-27(23)24(25)18-28)32(29,30)22-13-11-21(31-2)12-14-22/h3,6-14,23-25,28H,4-5,15-18H2,1-2H3/b6-3+/t23-,24+,25+/m1/s1",
      "inchiKeyParent": "YCMWBXHYJYTYML-QTGVXFKFSA-N",
      "smilesParent": "COc1ccc(cc1)S(=O)(=O)N2CCCCN3[C@@H](CO)[C@H]([C@H]3C2)c4ccc(\\C=C\\C)cc4"
    },
    "unichem": {
      "lincs": "LSM-44777",
      "pubchem": "54666620"
    },
    "pubchem": [
      {
        "cid": 54666620,
        "inchi": "InChI=1S/C25H32N2O4S/c1-3-6-19-7-9-20(10-8-19)25-23-17-26(15-4-5-16-27(23)24(25)18-28)32(29,30)22-13-11-21(31-2)12-14-22/h3,6-14,23-25,28H,4-5,15-18H2,1-2H3/b6-3+/t23-,24+,25+/m1/s1",
        "inchikey": "YCMWBXHYJYTYML-QTGVXFKFSA-N",
        "iupac": {
          "systematic": "[(8S,9S,10R)-6-(4-methoxyphenyl)sulfonyl-9-[4-[(E)-prop-1-enyl]phenyl]-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol"
        },
        "smiles": {
          "canonical": "CC=CC1=CC=C(C=C1)C2C3CN(CCCCN3C2CO)S(=O)(=O)C4=CC=C(C=C4)OC"
        },
        "molecularFormula": "C25H32N2O4S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:19:15Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8336"
    },
    "name": "BRD-K66757832",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8336.png",
    "lincs": {
      "id": "LSM-12496",
      "name": "BRD-K66757832",
      "pubchemCid": 54646647,
      "chebiId": 101127,
      "inchiParent": "InChI=1S/C29H31N3O5/c1-18(20-5-3-2-4-6-20)31-28(35)16-22-15-24-23-14-21(32-27(34)13-19-9-11-30-12-10-19)7-8-25(23)37-29(24)26(17-33)36-22/h2-12,14,18,22,24,26,29,33H,13,15-17H2,1H3,(H,31,35)(H,32,34)/t18-,22+,24+,26+,29-/m0/s1",
      "inchiKeyParent": "XWECZACFMCVSEP-VFSPHUKHSA-N",
      "smilesParent": "C[C@H](NC(=O)C[C@H]1C[C@H]2[C@H](Oc3ccc(NC(=O)Cc4ccncc4)cc23)[C@@H](CO)O1)c5ccccc5"
    },
    "unichem": {
      "chebi": "101127",
      "lincs": "LSM-12496",
      "pubchem": "54646647"
    },
    "pubchem": [
      {
        "cid": 54646647,
        "inchi": "InChI=1S/C29H31N3O5/c1-18(20-5-3-2-4-6-20)31-28(35)16-22-15-24-23-14-21(32-27(34)13-19-9-11-30-12-10-19)7-8-25(23)37-29(24)26(17-33)36-22/h2-12,14,18,22,24,26,29,33H,13,15-17H2,1H3,(H,31,35)(H,32,34)/t18-,22+,24+,26+,29-/m0/s1",
        "inchikey": "XWECZACFMCVSEP-VFSPHUKHSA-N",
        "iupac": {
          "systematic": "2-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-6-[(2-pyridin-4-ylacetyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-[(1S)-1-phenylethyl]acetamide"
        },
        "smiles": {
          "canonical": "CC(C1=CC=CC=C1)NC(=O)CC2CC3C(C(O2)CO)OC4=C3C=C(C=C4)NC(=O)CC5=CC=NC=C5"
        },
        "molecularFormula": "C29H31N3O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:19:17Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8299"
    },
    "name": "BRD-K08446420",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8299.png",
    "lincs": {
      "id": "LSM-37732",
      "name": "BRD-K08446420",
      "pubchemCid": 60192110,
      "chebiId": 126165,
      "inchiParent": "InChI=1S/C26H24F2N2O2/c27-21-11-12-22(28)20(13-21)14-30-23(15-31)24(18-7-3-1-4-8-18)26(30)16-29(17-26)25(32)19-9-5-2-6-10-19/h1-13,23-24,31H,14-17H2/t23-,24+/m0/s1",
      "inchiKeyParent": "MSBHWXQEIAZCAP-BJKOFHAPSA-N",
      "smilesParent": "OC[C@H]1[C@@H](c2ccccc2)C3(CN(C3)C(=O)c4ccccc4)N1Cc5cc(F)ccc5F"
    },
    "unichem": {
      "chebi": "126165",
      "lincs": "LSM-37732",
      "pubchem": "60192110"
    },
    "pubchem": [
      {
        "cid": 60192110,
        "inchi": "InChI=1S/C26H24F2N2O2/c27-21-11-12-22(28)20(13-21)14-30-23(15-31)24(18-7-3-1-4-8-18)26(30)16-29(17-26)25(32)19-9-5-2-6-10-19/h1-13,23-24,31H,14-17H2/t23-,24+/m0/s1",
        "inchikey": "MSBHWXQEIAZCAP-BJKOFHAPSA-N",
        "iupac": {
          "systematic": "[(2R,3R)-1-[(2,5-difluorophenyl)methyl]-2-(hydroxymethyl)-3-phenyl-1,6-diazaspiro[3.3]heptan-6-yl]-phenylmethanone"
        },
        "smiles": {
          "canonical": "C1C2(CN1C(=O)C3=CC=CC=C3)C(C(N2CC4=C(C=CC(=C4)F)F)CO)C5=CC=CC=C5"
        },
        "molecularFormula": "C26H24F2N2O2"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:19:19Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82f3"
    },
    "name": "BRD-K48479537",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82f3.png",
    "lincs": {
      "id": "LSM-11378",
      "name": "BRD-K48479537",
      "pubchemCid": 54631367,
      "chebiId": 99999,
      "inchiParent": "InChI=1S/C25H30N4O4S/c1-15-12-26-16(2)14-33-20-11-17(9-10-18(20)25(31)29(3)13-21(15)32-4)27-23(30)24-28-19-7-5-6-8-22(19)34-24/h5-11,15-16,21,26H,12-14H2,1-4H3,(H,27,30)/t15-,16-,21+/m0/s1",
      "inchiKeyParent": "HNVRJEXAKGMODG-CKJXQJPGSA-N",
      "smilesParent": "CO[C@@H]1CN(C)C(=O)c2ccc(NC(=O)c3nc4ccccc4s3)cc2OC[C@H](C)NC[C@@H]1C"
    },
    "unichem": {
      "chebi": "99999",
      "lincs": "LSM-11378",
      "pubchem": "54631367"
    },
    "pubchem": [
      {
        "cid": 54631367,
        "inchi": "InChI=1S/C25H30N4O4S/c1-15-12-26-16(2)14-33-20-11-17(9-10-18(20)25(31)29(3)13-21(15)32-4)27-23(30)24-28-19-7-5-6-8-22(19)34-24/h5-11,15-16,21,26H,12-14H2,1-4H3,(H,27,30)/t15-,16-,21+/m0/s1",
        "inchikey": "HNVRJEXAKGMODG-CKJXQJPGSA-N",
        "iupac": {
          "systematic": "N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-15-yl]-1,3-benzothiazole-2-carboxamide"
        },
        "smiles": {
          "canonical": "CC1CNC(COC2=C(C=CC(=C2)NC(=O)C3=NC4=CC=CC=C4S3)C(=O)N(CC1OC)C)C"
        },
        "molecularFormula": "C25H30N4O4S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:19:22Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8274"
    },
    "name": "BRD-K45043387",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8274.png",
    "lincs": {
      "id": "LSM-39764",
      "name": "BRD-K45043387",
      "pubchemCid": 60191416,
      "chebiId": 128209,
      "inchiParent": "InChI=1S/C23H23N3O3/c1-2-21(28)25-12-19-23(20(14-27)26(19)22(29)13-25)18-9-7-17(8-10-18)16-5-3-15(11-24)4-6-16/h3-10,19-20,23,27H,2,12-14H2,1H3/t19-,20-,23-/m1/s1",
      "inchiKeyParent": "DEKGAOOYVBFWKT-TXTKFYIRSA-N",
      "smilesParent": "CCC(=O)N1C[C@@H]2[C@H]([C@@H](CO)N2C(=O)C1)c3ccc(cc3)c4ccc(cc4)C#N"
    },
    "unichem": {
      "chebi": "128209",
      "lincs": "LSM-39764",
      "pubchem": "60191416"
    },
    "pubchem": [
      {
        "cid": 60191416,
        "inchi": "InChI=1S/C23H23N3O3/c1-2-21(28)25-12-19-23(20(14-27)26(19)22(29)13-25)18-9-7-17(8-10-18)16-5-3-15(11-24)4-6-16/h3-10,19-20,23,27H,2,12-14H2,1H3/t19-,20-,23-/m1/s1",
        "inchikey": "DEKGAOOYVBFWKT-TXTKFYIRSA-N",
        "iupac": {
          "systematic": "4-[4-[(6S,7R,8S)-8-(hydroxymethyl)-2-oxo-4-propanoyl-1,4-diazabicyclo[4.2.0]octan-7-yl]phenyl]benzonitrile"
        },
        "smiles": {
          "canonical": "CCC(=O)N1CC2C(C(N2C(=O)C1)CO)C3=CC=C(C=C3)C4=CC=C(C=C4)C#N"
        },
        "molecularFormula": "C23H23N3O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:19:24Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82c2"
    },
    "name": "BRD-K59308946",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82c2.png",
    "lincs": {
      "id": "LSM-40515",
      "name": "BRD-K59308946",
      "pubchemCid": 60191099,
      "chebiId": 128963,
      "inchiParent": "InChI=1S/C28H23FN2O3/c29-23-9-5-4-8-22(23)28(34)30-16-24-27(25(18-32)31(24)26(33)17-30)21-14-12-20(13-15-21)11-10-19-6-2-1-3-7-19/h1-9,12-15,24-25,27,32H,16-18H2/t24-,25-,27+/m1/s1",
      "inchiKeyParent": "JVSILEAOSOYGNI-SLQPCKNISA-N",
      "smilesParent": "OC[C@@H]1[C@H]([C@H]2CN(CC(=O)N12)C(=O)c3ccccc3F)c4ccc(cc4)C#Cc5ccccc5"
    },
    "unichem": {
      "chebi": "128963",
      "lincs": "LSM-40515",
      "pubchem": "60191099"
    },
    "pubchem": [
      {
        "cid": 60191099,
        "inchi": "InChI=1S/C28H23FN2O3/c29-23-9-5-4-8-22(23)28(34)30-16-24-27(25(18-32)31(24)26(33)17-30)21-14-12-20(13-15-21)11-10-19-6-2-1-3-7-19/h1-9,12-15,24-25,27,32H,16-18H2/t24-,25-,27+/m1/s1",
        "inchikey": "JVSILEAOSOYGNI-SLQPCKNISA-N",
        "iupac": {
          "systematic": "(6S,7S,8S)-4-(2-fluorobenzoyl)-8-(hydroxymethyl)-7-[4-(2-phenylethynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one"
        },
        "smiles": {
          "canonical": "C1C2C(C(N2C(=O)CN1C(=O)C3=CC=CC=C3F)CO)C4=CC=C(C=C4)C#CC5=CC=CC=C5"
        },
        "molecularFormula": "C28H23FN2O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:19:26Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82d4"
    },
    "name": "BRD-K26484639",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82d4.png",
    "lincs": {
      "id": "LSM-10031",
      "name": "BRD-K26484639",
      "pubchemCid": 54645891,
      "chebiId": 98652,
      "inchiParent": "InChI=1S/C23H26FN3O5/c1-27(2)21(29)11-16-10-18-17-9-15(7-8-19(17)32-22(18)20(12-28)31-16)26-23(30)25-14-5-3-13(24)4-6-14/h3-9,16,18,20,22,28H,10-12H2,1-2H3,(H2,25,26,30)/t16-,18+,20+,22-/m0/s1",
      "inchiKeyParent": "HTNOASUNFPMBNX-ZMUPPCTCSA-N",
      "smilesParent": "CN(C)C(=O)C[C@@H]1C[C@H]2[C@H](Oc3ccc(NC(=O)Nc4ccc(F)cc4)cc23)[C@@H](CO)O1"
    },
    "unichem": {
      "chebi": "98652",
      "lincs": "LSM-10031",
      "pubchem": "54645891"
    },
    "pubchem": [
      {
        "cid": 54645891,
        "inchi": "InChI=1S/C23H26FN3O5/c1-27(2)21(29)11-16-10-18-17-9-15(7-8-19(17)32-22(18)20(12-28)31-16)26-23(30)25-14-5-3-13(24)4-6-14/h3-9,16,18,20,22,28H,10-12H2,1-2H3,(H2,25,26,30)/t16-,18+,20+,22-/m0/s1",
        "inchikey": "HTNOASUNFPMBNX-ZMUPPCTCSA-N",
        "iupac": {
          "systematic": "2-[(1R,3S,4aR,9aS)-6-[(4-fluorophenyl)carbamoylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N,N-dimethylacetamide"
        },
        "smiles": {
          "canonical": "CN(C)C(=O)CC1CC2C(C(O1)CO)OC3=C2C=C(C=C3)NC(=O)NC4=CC=C(C=C4)F"
        },
        "molecularFormula": "C23H26FN3O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:19:28Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82e9"
    },
    "name": "QS-11",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82e9.png",
    "lincs": {
      "id": "LSM-5212",
      "name": "QS-11",
      "alternativeNames": [
        "QS 11"
      ],
      "pubchemCid": 42623900,
      "chebiId": 94469,
      "inchiParent": "InChI=1S/C36H33N5O2/c42-23-31(20-25-8-3-1-4-9-25)38-34-33-35(40-36(39-34)43-32-19-18-28-12-7-13-30(28)21-32)41(24-37-33)22-26-14-16-29(17-15-26)27-10-5-2-6-11-27/h1-6,8-11,14-19,21,24,31,42H,7,12-13,20,22-23H2,(H,38,39,40)/t31-/m0/s1",
      "inchiKeyParent": "DOKZLKDGUQWMSX-HKBQPEDESA-N",
      "smilesParent": "OC[C@H](Cc1ccccc1)Nc2nc(Oc3ccc4CCCc4c3)nc5c2ncn5Cc6ccc(cc6)c7ccccc7"
    },
    "unichem": {
      "chebi": "94469",
      "chembl": "CHEMBL259181",
      "lincs": "LSM-5212",
      "pubchem": "42623900"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL259181",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 567.69,
        "hba": 7,
        "hbd": 2,
        "qedWeighted": 0.19
      }
    },
    "pubchem": [
      {
        "cid": 42623900,
        "inchi": "InChI=1S/C36H33N5O2/c42-23-31(20-25-8-3-1-4-9-25)38-34-33-35(40-36(39-34)43-32-19-18-28-12-7-13-30(28)21-32)41(24-37-33)22-26-14-16-29(17-15-26)27-10-5-2-6-11-27/h1-6,8-11,14-19,21,24,31,42H,7,12-13,20,22-23H2,(H,38,39,40)/t31-/m0/s1",
        "inchikey": "DOKZLKDGUQWMSX-HKBQPEDESA-N",
        "iupac": {
          "systematic": "(2S)-2-[[2-(2,3-dihydro-1H-inden-5-yloxy)-9-[(4-phenylphenyl)methyl]purin-6-yl]amino]-3-phenylpropan-1-ol"
        },
        "smiles": {
          "canonical": "C1CC2=C(C1)C=C(C=C2)OC3=NC(=C4C(=N3)N(C=N4)CC5=CC=C(C=C5)C6=CC=CC=C6)NC(CC7=CC=CC=C7)CO"
        },
        "molecularFormula": "C36H33N5O2"
      }
    ],
    "clinicaltrials": [
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT03972592",
            "briefTitle": "Topical Sirolimus in Cutaneous Lymphatic Malformations",
            "officialTitle": "0.1% Topical Sirolimus in the Treatment of Cutaneous Microcystic Lymphatic Malformations in Children and Adults: Phase II, Split-body Randomized, Double-blind, Vehicle-controlled Clinical Trial"
          },
          "statusModule": {
            "overallStatus": "UNKNOWN",
            "studyFirstSubmitDate": "2019-05-24"
          },
          "conditionsModule": {
            "conditions": [
              "Vascular Malformations",
              "Lymphatic Malformation"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Efficacy of a 12-week application period of 0.1% topical sirolimus in cutaneous microcystic lymphatic malformation versus topical vehicle",
                "timeFrame": "Week 12"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Efficacy of 0.1% topical sirolimus in cutaneous microcystic lymphatic malformation versus topical vehicle"
              },
              {
                "measure": "Efficacy of 0.1% topical sirolimus vs vehicle regarding each of the following complications of the CMLM: oozing, bleeding, erythema, and thickness"
              },
              {
                "measure": "Number of independent experts who correctly identify which area among both received the active treatment for each patient on the basis of standardised photographs"
              },
              {
                "measure": "Global self-reported efficacy of topical sirolimus vs vehicle (with help of parents in case of children under 16 years)"
              },
              {
                "measure": "Functional and esthetic impairments (self-reported with help of parents in case of children under 16 years)"
              },
              {
                "measure": "Pain linked to the CMLM (with help of parents in case of children under 16 years)"
              },
              {
                "measure": "Effect on quality of life"
              },
              {
                "measure": "Evaluation of systemic passage of sirolimus by dosage of serum level of sirolimus"
              },
              {
                "measure": "Number of patients with biological adverse events and total number of biological adverse events (to assess the biological tolerance of topical sirolimus)"
              },
              {
                "measure": "Number of patients with clinical adverse events and total number of clinical adverse events (to assess the clinical tolerance of topical sirolimus)"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT06103929",
            "briefTitle": "Adult Eating Disorder Assessment Study",
            "officialTitle": "Evaluation of Eating Difficulties Assessment Measures in Clinical Practice and in Epidemiological Surveys"
          },
          "statusModule": {
            "overallStatus": "RECRUITING",
            "studyFirstSubmitDate": "2023-07-25"
          },
          "conditionsModule": {
            "conditions": [
              "Eating Disorders"
            ]
          },
          "designModule": {
            "studyType": "OBSERVATIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "The threshold on the questionnaires and SCAN examination output algorithm scores calibrated against the clinician diagnostic thresholds for eating disorder, taking account of the level of agreement between the questionnaires and SCAN",
                "timeFrame": "The WP1 SCAN interview battery (60-84 minutes)"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "The threshold on the EDE-QS examination output algorithm scores calibrated against the clinician diagnostic thresholds for eating disorder, taking account of the level of agreement between the EDE-QS and SCAN"
              },
              {
                "measure": "The threshold on the SCOFF examination output algorithm scores calibrated against the clinician diagnostic thresholds for eating disorder, taking account of the level of agreement between the SCOFF and SCAN"
              },
              {
                "measure": "A retest comparison of findings from the SCAN among a subgroup of participants subject to repeated assessment"
              },
              {
                "measure": "A retest comparison of findings from the EDE-QS among a subgroup of participants subject to repeated assessment"
              },
              {
                "measure": "A retest comparison of findings from the SCOFF among a subgroup of participants subject to repeated assessment"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT04705792",
            "briefTitle": "Physical Rehabilitation in Sickle Cell Anemia",
            "officialTitle": "Physical Rehabilitation in Adults With Sickle Cell Anemia: Effects on Muscle Function, Functional Capacity and Quality of Life"
          },
          "statusModule": {
            "overallStatus": "UNKNOWN",
            "studyFirstSubmitDate": "2021-01-08"
          },
          "conditionsModule": {
            "conditions": [
              "Sickle Cell Anemia",
              "Muscle Dysfunction",
              "Quality of Life",
              "Physical Activity",
              "Exercise"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Quality of life related to activities of daily living through the Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36) before and after the execution of the treatment plan.",
                "timeFrame": "12 weeks"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Peripheral muscle function before and after the execution of the treatment plan."
              },
              {
                "measure": "Functional capacity through the 6-minute walk test (6MWT) before and after the execution of the treatment plan."
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT04373343",
            "briefTitle": "Food Addiction Clinical Treatment Program",
            "officialTitle": "Pilot Investigation of a Novel Therapeutic Intervention for Food Addiction: Food Addiction Clinical Treatment (FACT) Program"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2020-04-21"
          },
          "conditionsModule": {
            "conditions": [
              "Food Addiction"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Yale Food Addiction Scale 2.0 (YFAS)",
                "timeFrame": "pre 16-week intervention"
              },
              {
                "measure": "Yale Food Addiction Scale 2.0 (YFAS)",
                "timeFrame": "post 16-week intervention"
              },
              {
                "measure": "Weight Self-Stigma Questionnaire (WSSQ)",
                "timeFrame": "pre 16-week intervention"
              },
              {
                "measure": "Weight Self-Stigma Questionnaire (WSSQ)",
                "timeFrame": "post 16-week intervention"
              },
              {
                "measure": "Patient Health Questionnaire (PHQ-9) with suicide question removed",
                "timeFrame": "pre 16-week intervention"
              },
              {
                "measure": "Patient Health Questionnaire (PHQ-9) with suicide question removed",
                "timeFrame": "post 16-week intervention"
              },
              {
                "measure": "Generalized Anxiety Disorder (GAD-7)",
                "timeFrame": "pre 16-week intervention"
              },
              {
                "measure": "Generalized Anxiety Disorder (GAD-7)",
                "timeFrame": "post16-week intervention"
              },
              {
                "measure": "Alcohol Use Disorder Identification Test (AUDIT)",
                "timeFrame": "pre 16-week intervention"
              },
              {
                "measure": "Alcohol Use Disorder Identification Test (AUDIT)",
                "timeFrame": "post 16-week intervention"
              },
              {
                "measure": "Cannabis Use Disorder Identification Test (CUDIT)",
                "timeFrame": "pre 16-week intervention"
              },
              {
                "measure": "Cannabis Use Disorder Identification Test (CUDIT)",
                "timeFrame": "post 16-week intervention"
              },
              {
                "measure": "Sense of Self-Efficacy Scale",
                "timeFrame": "pre 16-week intervention"
              },
              {
                "measure": "Sense of Self-Efficacy Scale",
                "timeFrame": "post 16-week intervention"
              },
              {
                "measure": "World Health Organization Quality of Life - BREF (WHOQOL-BREF)",
                "timeFrame": "pre 16-week intervention"
              },
              {
                "measure": "World Health Organization Quality of Life - BREF (WHOQOL-BREF)",
                "timeFrame": "post 16-week intervention"
              },
              {
                "measure": "Physical Fitness Assessment (height)",
                "timeFrame": "pre 16-week intervention"
              },
              {
                "measure": "Physical Fitness Assessment (weight)",
                "timeFrame": "pre 16-week intervention"
              },
              {
                "measure": "Physical Fitness Assessment (weight)",
                "timeFrame": "post 16-week intervention"
              },
              {
                "measure": "Physical Fitness Assessment (body composition)",
                "timeFrame": "pre 16-week intervention"
              },
              {
                "measure": "Physical Fitness Assessment (body composition)",
                "timeFrame": "post 16-week intervention"
              },
              {
                "measure": "Resting Metabolic Rate",
                "timeFrame": "post 16-week intervention"
              },
              {
                "measure": "4-meter timed walk test",
                "timeFrame": "pre 16-week intervention"
              },
              {
                "measure": "chair rise test",
                "timeFrame": "pre 16-week intervention"
              },
              {
                "measure": "chair rise test",
                "timeFrame": "post 16-week intervention"
              },
              {
                "measure": "Hand use",
                "timeFrame": "pre 16-week intervention"
              },
              {
                "measure": "Physical Fitness Assessment (height)",
                "timeFrame": "post 16-week intervention"
              },
              {
                "measure": "Resting Metabolic Rate",
                "timeFrame": "pre 16-week intervention"
              },
              {
                "measure": "4-meter timed walk test",
                "timeFrame": "post 16-week intervention"
              },
              {
                "measure": "Hand use",
                "timeFrame": "post 16-week intervention"
              },
              {
                "measure": "Hand Dynamometer assessment",
                "timeFrame": "pre 16-week intervention"
              },
              {
                "measure": "Hand Dynamometer assessment",
                "timeFrame": "post 16-week intervention"
              },
              {
                "measure": "level of physical activity over the past 7 days",
                "timeFrame": "pre 16-week intervention"
              },
              {
                "measure": "level of physical activity over the past 7 days",
                "timeFrame": "post 16-week intervention"
              },
              {
                "measure": "Barratt's Impulsivity Scale (BIS-11), Inhibitory Control subscale",
                "timeFrame": "pre 16-week intervention"
              },
              {
                "measure": "Urgency, Premeditation, Perseverance, and Sensation Seeking (UPPS) Impulsive Behavior Scale",
                "timeFrame": "pre 16-week intervention"
              },
              {
                "measure": "Posttraumatic Stress Disorder Checklist (PCL-5)",
                "timeFrame": "pre 16-week intervention"
              },
              {
                "measure": "Weight Control History",
                "timeFrame": "pre 16-week intervention"
              },
              {
                "measure": "Modified Yale Food Addiction Scale 2.0 (mYFAS 2.0)",
                "timeFrame": "week 1 post start of study"
              },
              {
                "measure": "Modified Yale Food Addiction Scale 2.0 (mYFAS 2.0)",
                "timeFrame": "week 5 post start of study"
              },
              {
                "measure": "Modified Yale Food Addiction Scale 2.0 (mYFAS 2.0)",
                "timeFrame": "week 9 post start of study"
              },
              {
                "measure": "Modified Yale Food Addiction Scale 2.0 (mYFAS 2.0)",
                "timeFrame": "week 15 post start of study"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Dutch Eating Behavior Questionnaire (DEBQ) Excluding the restraint subscale"
              },
              {
                "measure": "Dutch Eating Behavior Questionnaire (DEBQ) Excluding the restraint subscale"
              },
              {
                "measure": "Eating Disorder Examination - Questionnaire Short (EDE-QS)"
              },
              {
                "measure": "Eating Disorder Examination - Questionnaire Short (EDE-QS)"
              },
              {
                "measure": "Eating Disorder Diagnostic Scale (EDDS) Restraint Subscale"
              },
              {
                "measure": "Eating Disorder Diagnostic Scale (EDDS) Restraint Subscale"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00471146",
            "briefTitle": "Study Of Gemcitabine Plus AG-013736 Versus Gemcitabine For Advanced Pancreatic Cancer.",
            "officialTitle": "A Randomized, Double-Blind Phase 3 Study Of Gemcitabine Plus AG-013736 Versus Gemcitabine Plus Placebo For The First-Line Treatment Of Patients With Locally Advanced, Unresectable Or Metastatic Pancreatic Cancer."
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2007-05-07",
            "resultsFirstSubmitDate": "2012-02-25"
          },
          "conditionsModule": {
            "conditions": [
              "Carcinoma, Pancreatic Ductal"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Overall Survival (OS)",
                "timeFrame": "Baseline until death or at least 1 year after the randomization of last participant"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Progression Free Survival (PFS)"
              },
              {
                "measure": "Percentage of Participants With Objective Response (OR)"
              },
              {
                "measure": "Duration of Response (DR)"
              },
              {
                "measure": "Change From Baseline in European Organization for Research and Treatment of Cancer, Quality of Life Questionnaire Core-30 (EORTC QLQ- C30) Score"
              },
              {
                "measure": "Change From Baseline in European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Pancreatic 26 (EORTC QLQ- PAN26) Score"
              },
              {
                "measure": "Change From Baseline Brief Pain Inventory-short Form (BPI-sf) Score"
              },
              {
                "measure": "Change From Baseline in Euro QoL Questionnaire- 5 Dimension (EQ-5D) Health State Profile"
              },
              {
                "measure": "Change From Baseline in Euro QoL Questionnaire- 5 Dimension (EQ-5D) VAS Score"
              },
              {
                "measure": "Population Pharmacokinetic (PK) Analysis for Axitinib (AG-013736)"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01538069",
            "briefTitle": "Heart Failure and Sleep Apnea: Exercise Training and Continuous Positive Airway Pressure",
            "officialTitle": "Comparison Between Exercise Training and CPAP Treatment for Patients With Heart Failure and Sleep Apnea."
          },
          "statusModule": {
            "overallStatus": "UNKNOWN",
            "studyFirstSubmitDate": "2012-02-15"
          },
          "conditionsModule": {
            "conditions": [
              "Heart Failure",
              "Sleep Apnea Syndromes"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Polysomnography",
                "timeFrame": "Two evaluations (baseline and 3 month)"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Cardiopulmonary exercise testing"
              },
              {
                "measure": "Isokinetic strength and endurance"
              },
              {
                "measure": "Quality of Life"
              },
              {
                "measure": "Sexual Function"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT03226769",
            "briefTitle": "Safety and Efficacy of TrueTear\u2122 for the Treatment of Meibomian Gland Disease",
            "officialTitle": "Prospective, Open-Label, Randomized, Proof of Concept Study Exploring Application of TrueTear\u2122 for the Treatment of Meibomian Gland Disease"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2017-07-20",
            "resultsFirstSubmitDate": "2020-10-08"
          },
          "conditionsModule": {
            "conditions": [
              "Meibomian Glands",
              "Dry Eye Syndromes"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Change From Baseline in Meibomian Gland Dysfunction (MGD) Impact Questionnaire Score",
                "timeFrame": "Baseline (Day 0) to Day 30"
              },
              {
                "measure": "Change From Baseline in MGD Symptoms Questionnaire Score",
                "timeFrame": "Baseline (Day 0) to Day 30"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT06349096",
            "briefTitle": "Safety And Efficacy Investigation Of The Effects Of ClearLift Q-Switched Nd:Yag 1064nm Laser Module In The Treatment Of Facial Skin Wrinkles",
            "officialTitle": "Open-Label, Safety And Efficacy Investigation Of The Effects Of ClearLift Q-Switched Nd:Yag 1064nm Laser Module In The Treatment Of Facial Skin Wrinkles"
          },
          "statusModule": {
            "overallStatus": "NOT_YET_RECRUITING",
            "studyFirstSubmitDate": "2024-03-21"
          },
          "conditionsModule": {
            "conditions": [
              "Facial Skin Wrinkles"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Primary endpoint",
                "timeFrame": "at the 3-month follow-up"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Secondary endpoint"
              },
              {
                "measure": "Secondary endpoint"
              },
              {
                "measure": "Secondary endpoint"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT03390049",
            "briefTitle": "Randomized CO2 vs Sham Laser Treatment of Provoked Vestibulodynia",
            "officialTitle": "Randomized Controlled Trial of Fractional CO2 Laser vs Sham Laser for Women With Provoked Vestibulodynia Who Have Failed Conservative Management"
          },
          "statusModule": {
            "overallStatus": "WITHDRAWN",
            "whyStopped": "No funding",
            "studyFirstSubmitDate": "2017-12-26"
          },
          "conditionsModule": {
            "conditions": [
              "Vestibulodynia"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Mean change from baseline in subjects' vulvar pain NRS scores",
                "timeFrame": "24 weeks"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Mean change from baseline in subjects' scores on pain severity subscale VPAQ"
              },
              {
                "measure": "Mean change from baseline in subjects' scores on pain severity subscale SF-MPQ"
              },
              {
                "measure": "Mean change from baseline in subjects' scores on pain descriptors subscale VPAQ"
              },
              {
                "measure": "Mean change from baseline in subjects' scores on the SF-36"
              },
              {
                "measure": "Mean change from baseline in subjects' scores on the pain interference subscale of the BPI"
              },
              {
                "measure": "Mean change from baseline in subjects' scores on the life interference subscale of the VPAQ"
              },
              {
                "measure": "Mean change from baseline in subjects' scores on the life interference subscale of the FSFI"
              },
              {
                "measure": "Mean change from baseline in subjects' scores on the sexual function interference subscale of the VPAQ"
              },
              {
                "measure": "Mean change from baseline in subjects' scores on the sexual function interference subscale of the PHQ-9"
              },
              {
                "measure": "Comparison of percentages of subjects in each treatment arm endorsing improvement in symptoms on the PGIC scale"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT04661514",
            "briefTitle": "Evaluation of Psilocybin in Anorexia Nervosa: Safety and Efficacy",
            "officialTitle": "Evaluation of Psilocybin in Anorexia Nervosa: Safety and Efficacy"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2020-11-19"
          },
          "conditionsModule": {
            "conditions": [
              "Anorexia Nervosa"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Incidence and occurrence of changes in AEs",
                "timeFrame": "Baseline to Day 28"
              },
              {
                "measure": "Incidence and occurrence of changes in AEs",
                "timeFrame": "Day 1 to Day 28"
              },
              {
                "measure": "Incidence of clinically important changes in ECG parameters",
                "timeFrame": "Baseline to Day 1"
              },
              {
                "measure": "Incidence of clinically important changes in ECG parameters",
                "timeFrame": "Baseline to Day 7"
              },
              {
                "measure": "Incidence of clinically important changes in ECG parameters",
                "timeFrame": "Baseline to Day 28"
              },
              {
                "measure": "Incidence of clinically important changes in laboratory tests",
                "timeFrame": "Baseline to Day 1"
              },
              {
                "measure": "Incidence of clinically important changes in laboratory tests",
                "timeFrame": "Baseline to Day 7"
              },
              {
                "measure": "Incidence of clinically important changes in laboratory tests",
                "timeFrame": "Baseline to Day 28"
              },
              {
                "measure": "Incidence of clinically significant changes in vital signs",
                "timeFrame": "Baseline to Day 1"
              },
              {
                "measure": "Incidence of clinically significant changes in vital signs",
                "timeFrame": "Baseline to Day 7"
              },
              {
                "measure": "Incidence of clinically significant changes in vital signs",
                "timeFrame": "Baseline to Day 28"
              },
              {
                "measure": "Incidence of changes in the Columbia-Suicide Severity Rating Scale (C-SSRS) at each post-Baseline visit",
                "timeFrame": "Baseline to Day 28"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Change in Eating Disorder Examination (EDE) scores for Dietary Restraint, Eating Concern, and Shape Concern"
              },
              {
                "measure": "Change in weight (kg)"
              },
              {
                "measure": "Change in trait anxiety and state anxiety total scores on the Spielberger State-Trait Anxiety Inventory (STAI)"
              },
              {
                "measure": "Change in Physical Appearance State and Trait Anxiety Scale (PASTAS) trait total score and state score"
              },
              {
                "measure": "Change in Body Image State Scale (BISS) total score"
              },
              {
                "measure": "Change in Yale Brown Cornell Eating Disorder Scale (YBC-EDS-SRQ)"
              },
              {
                "measure": "Change in Eating Disorder Inventory (EDI) total score"
              },
              {
                "measure": "Change in Eating Disorder Examination Questionnaire Short Form (EDE-QS) total scores"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01306279",
            "briefTitle": "The Infective Pulmonary Exacerbations in Cystic Fibrosis - an Ecological Perspective",
            "officialTitle": "The Infective Pulmonary Exacerbations in Cystic Fibrosis - an Ecological Perspective"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2011-02-28"
          },
          "conditionsModule": {
            "conditions": [
              "Cystic Fibrosis"
            ]
          },
          "designModule": {
            "studyType": "OBSERVATIONAL"
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT03409107",
            "briefTitle": "Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat in Non-Dialysis Subjects Evaluating Hemoglobin (Hgb) and Quality of Life (ASCEND-NHQ)",
            "officialTitle": "A 28-week, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-center, Study in Recombinant Human Erythropoietin (rhEPO) na\u00efve Non-dialysis Participants With Anemia Associated With Chronic Kidney Disease to Evaluate the Efficacy, Safety and Effects on Quality of Life of Daprodustat Compared to Placebo"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2018-01-08",
            "resultsFirstSubmitDate": "2021-10-05"
          },
          "conditionsModule": {
            "conditions": [
              "Anaemia"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Mean Change in Hemoglobin From Baseline and Over the Evaluation Period (Mean Over Week 24 and 28)",
                "timeFrame": "Baseline (Day 1) and Week 24 to Week 28"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Percentage of Participants With Hemoglobin Increase of >=1.0 Grams Per Deciliter From Baseline to Evaluation Period"
              },
              {
                "measure": "Change From Baseline in Short Form-36 (SF-36) Questionnaire Vitality Domain Score by Traditional Scoring at Week 28"
              },
              {
                "measure": "Percentage of Participants With Hgb Response (Hgb in the 11-12 Grams/Deciliter Range) During Evaluation Period (Week 24 to Week 28 Inclusive)"
              },
              {
                "measure": "Percentage of Time With Hgb Within the Target Range (11-12 Grams Per Deciliter) During Evaluation Period (Week 24 to Week 28 Inclusive) (Hodges-Lehmann Estimate)"
              },
              {
                "measure": "Percentage of Time With Hgb Within the Target Range (11-12 Grams Per Deciliter) During Evaluation Period (Week 24 to Week 28 Inclusive) (Mann-Whitney Estimate)"
              },
              {
                "measure": "Change From Baseline in Post-randomization Hgb at Week 28"
              },
              {
                "measure": "Rate of Participants Permanently Stopping Randomized Treatment Due to Meeting Rescue Criteria"
              },
              {
                "measure": "Change From Baseline by Domain and Single Item Scores on the Chronic Kidney Disease -Anemia Questionnaire (CKD-AQ) Symptom Questionnaire"
              },
              {
                "measure": "Change From Baseline in Patient Global Impression of Severity (PGI-S)"
              },
              {
                "measure": "Change From Baseline in the SF-36 Physical Functioning Domain"
              },
              {
                "measure": "Change From Baseline of the SF-36 Individual Items in the Vitality Domain"
              },
              {
                "measure": "Number of Participants Currently Employed as Per Work Productivity and Activity Impairment Questionnaire: Anemic Symptoms Clinical Practice Version (WPAI-ANS-CPV)"
              },
              {
                "measure": "Change From Baseline in WPAI-ANS-CPV: Percent Time Missed From Work"
              },
              {
                "measure": "Change From Baseline in WPAI-ANS-CPV: Mean Hours Missed From Work in the Past 7 Days"
              },
              {
                "measure": "Change From Baseline in WPAI: Percent Impairment at Work"
              },
              {
                "measure": "Change From Baseline in WPAI: Percent Overall Work Impairment"
              },
              {
                "measure": "Change From Baseline in WPAI: Percent Regular Daily Activity Impairment"
              },
              {
                "measure": "Change From Baseline in EuroQol 5 Dimension 5 Level Health Utility Index (EQ-5D-5L) Utility Score"
              },
              {
                "measure": "Change From Baseline in EuroQol Visual Analogue Scale (EQ-VAS) Score"
              },
              {
                "measure": "Change From Baseline in Systolic Blood Pressure (SBP), Diastolic Blood Pressure (DBP), Mean Arterial Pressure (MAP) at Week 28"
              },
              {
                "measure": "Percentage of Participants With at Least One Blood Pressure (BP) Exacerbation Event"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT06205056",
            "briefTitle": "Evaluation of Safety and Immunogenicity of Ad26.Mos4.HIV and CH505 TF chTrimer Combination in Healthy Adults",
            "officialTitle": "Phase I, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of an Ad26.Mos4.HIV and CH505 TF chTrimer (Env) Combination to Mimic Acute HIV Viral Replication Kinetics in Healthy Adults"
          },
          "statusModule": {
            "overallStatus": "RECRUITING",
            "studyFirstSubmitDate": "2023-10-10"
          },
          "conditionsModule": {
            "conditions": [
              "Human Immunodeficiency Virus"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Occurrence and severity of solicited local and systemic adverse events (AEs) following candidate vaccine administration",
                "timeFrame": "Day 0 - Day 505"
              },
              {
                "measure": "Occurrence, severity, and relationship to vaccination of unsolicited adverse events after candidate vaccine administration",
                "timeFrame": "Day 0 - Day 505"
              },
              {
                "measure": "Occurrence of serious adverse events (SAEs) following candidate vaccine administration",
                "timeFrame": "Day 0 - Day 505"
              },
              {
                "measure": "Occurrence of adverse events of special interest (AESIs) following candidate vaccine administration",
                "timeFrame": "Day 0 - Day 505"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Quantify IgG binding antibodies to HIV Env in terms of magnitude, breadth, and durability between Arms"
              },
              {
                "measure": "Quantify neutralizing antibodies to HIV Env in terms of magnitude, breadth, and durability between Arms"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT03593356",
            "briefTitle": "Baby's First Years",
            "officialTitle": "Household Income and Child Development in the First Three Years of Life (Phase 1) Household Income and Child Development in the First Years of Life (Phase 2)"
          },
          "statusModule": {
            "overallStatus": "ACTIVE_NOT_RECRUITING",
            "studyFirstSubmitDate": "2018-05-29",
            "resultsFirstSubmitDate": "2023-06-30"
          },
          "conditionsModule": {
            "conditions": [
              "Child Development",
              "Brain Development",
              "Household and Family Processes"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Child Language Development: Vocabulary",
                "timeFrame": "Age 48 months"
              },
              {
                "measure": "Child Language Development: Vocabulary",
                "timeFrame": "Age 6"
              },
              {
                "measure": "Child Language Development: Vocabulary",
                "timeFrame": "Age 8"
              },
              {
                "measure": "Child Language Development: Maternal Concern for Language Delay",
                "timeFrame": "Age 36 months"
              },
              {
                "measure": "Child Executive Function & Behavioral Regulation: Executive Function",
                "timeFrame": "Age 48 months"
              },
              {
                "measure": "Child Executive Function & Behavioral Regulation: Executive Function",
                "timeFrame": "Age 6"
              },
              {
                "measure": "Child Executive Function & Behavioral Regulation: Executive Function",
                "timeFrame": "Age 8"
              },
              {
                "measure": "Child Executive Function & Behavioral Regulation: Inhibitory Control and Attention",
                "timeFrame": "Age 6"
              },
              {
                "measure": "Child Executive Function & Behavioral Regulation: Inhibitory Control and Attention",
                "timeFrame": "Age 8"
              },
              {
                "measure": "Child Executive Function & Behavioral Regulation: Working Memory",
                "timeFrame": "Age 6"
              },
              {
                "measure": "Child Executive Function & Behavioral Regulation: Working Memory",
                "timeFrame": "Age 8"
              },
              {
                "measure": "Child Socio-Emotional Processing: Behavior/Problems",
                "timeFrame": "Age 36 months"
              },
              {
                "measure": "Child Socio-Emotional Processing: Maternal Concern for Behavioral and Social-Emotional Problems",
                "timeFrame": "Age 36 months"
              },
              {
                "measure": "Child Socio-Emotional Processing: Behavior/Problems",
                "timeFrame": "Age 48 months"
              },
              {
                "measure": "Child Socio-Emotional Processing: Behavior/Problems",
                "timeFrame": "Age 6"
              },
              {
                "measure": "Child Socio-Emotional Processing: Behavior/Problems",
                "timeFrame": "Age 8"
              },
              {
                "measure": "Child Brain Function: Resting Brain Function",
                "timeFrame": "Age 48 months"
              },
              {
                "measure": "Child Brain Function: Resting Brain Function",
                "timeFrame": "Age 6"
              },
              {
                "measure": "Child Brain Function: Resting Brain Function",
                "timeFrame": "Age 8"
              },
              {
                "measure": "Child Health, Sleep",
                "timeFrame": "Age 36 months"
              },
              {
                "measure": "Child Health, Overall Health, Medical Care, Diagnosis of Condition or Disability",
                "timeFrame": "Age 36 months"
              },
              {
                "measure": "Child Academic Achievement: Reading",
                "timeFrame": "Age 6"
              },
              {
                "measure": "Child Academic Achievement: Reading",
                "timeFrame": "Age 8"
              },
              {
                "measure": "Child Academic Achievement: Reading Comprehension",
                "timeFrame": "Age 8"
              },
              {
                "measure": "Child Academic Achievement: Math",
                "timeFrame": "Age 6"
              },
              {
                "measure": "Child Academic Achievement: Math",
                "timeFrame": "Age 8"
              },
              {
                "measure": "Child Fluid Reasoning",
                "timeFrame": "Age 6"
              },
              {
                "measure": "Child Perceptual Reasoning",
                "timeFrame": "Age 8"
              },
              {
                "measure": "Child Physiological Stress: Nail Cortisol",
                "timeFrame": "Age 6"
              },
              {
                "measure": "Child Physiological Stress: Nail Cortisol",
                "timeFrame": "Age 8"
              },
              {
                "measure": "Maternal Attentional Resources",
                "timeFrame": "Age 6"
              },
              {
                "measure": "Maternal Attentional Resources",
                "timeFrame": "Age 8"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Child Language Development: Language Milestones"
              },
              {
                "measure": "Child Language Development: Vocabulary"
              },
              {
                "measure": "Child Executive Function: Executive Function"
              },
              {
                "measure": "Child Socio-Emotional Processing: Behavior"
              },
              {
                "measure": "Child Socio-Emotional Processing: Problems"
              },
              {
                "measure": "Child Socio-Emotional Processing: Problems"
              },
              {
                "measure": "Child Pre-Literacy"
              },
              {
                "measure": "Child Intelligence Quotient"
              },
              {
                "measure": "Child Resting Brain Function"
              },
              {
                "measure": "Child Resting Brain Function"
              },
              {
                "measure": "Child Resting Brain Function"
              },
              {
                "measure": "Child Resting Brain Function"
              },
              {
                "measure": "Child Task-Related Brain Function"
              },
              {
                "measure": "Child Health: Body Mass Index (BMI)"
              },
              {
                "measure": "Child Health: Body Mass Index (BMI)"
              },
              {
                "measure": "Child Health: Body Mass Index (BMI)"
              },
              {
                "measure": "Child Health, Physiological Stress"
              },
              {
                "measure": "Child Health, Sleep"
              },
              {
                "measure": "Child Health, Sleep"
              },
              {
                "measure": "Child Health, Overall Health, Medical Care, Diagnosis of Condition or Disability"
              },
              {
                "measure": "Child Health, Overall Health, Medical Care, Diagnosis of Condition or Disability"
              },
              {
                "measure": "Child Health, Overall Health, Diagnosis of Condition or Disability"
              },
              {
                "measure": "Child Health, Overall Health"
              },
              {
                "measure": "Child Health, Overall Health"
              },
              {
                "measure": "Child Health: Chronic Health Condition"
              },
              {
                "measure": "Child Health: Chronic Health Condition"
              },
              {
                "measure": "Child Epigenetic Pace of Aging"
              },
              {
                "measure": "Child Epigenetic Pace of Aging"
              },
              {
                "measure": "Child Epigenetic Pace of Aging"
              },
              {
                "measure": "Child DNA Methylation"
              },
              {
                "measure": "Child DNA Methylation"
              },
              {
                "measure": "Child DNA Methylation"
              },
              {
                "measure": "Child Nutrition: Consumption of Healthy Foods"
              },
              {
                "measure": "Child Nutrition: Consumption of Healthy Food"
              },
              {
                "measure": "Child Nutrition: Consumption of Healthy Foods"
              },
              {
                "measure": "Child Nutrition: Consumption of Unhealthy Foods"
              },
              {
                "measure": "Child Nutrition: Consumption of Unhealthy Foods"
              },
              {
                "measure": "Child Nutrition: Consumption of Unhealthy Foods"
              },
              {
                "measure": "Any Maternal Concern for Developmental Delay: Total \"Predictive Concerns\" in the Parents' Evaluation of Developmental Status (PEDS)"
              },
              {
                "measure": "Any Maternal Concern for Developmental Delay: Parents' Evaluation of Developmental Status (PEDS)"
              },
              {
                "measure": "Diagnosis of Developmental Condition"
              },
              {
                "measure": "Diagnosis of Developmental Condition"
              },
              {
                "measure": "Diagnosis of Developmental Condition"
              },
              {
                "measure": "Child Special Services (IEP)"
              },
              {
                "measure": "Child Special Services (IEP)"
              },
              {
                "measure": "Household Economic Hardship: Household Poverty Rate"
              },
              {
                "measure": "Household Economic Hardship: Household Poverty Rate"
              },
              {
                "measure": "Household Economic Hardship: Household Poverty Rate"
              },
              {
                "measure": "Household Economic Hardship: Household Poverty Rate"
              },
              {
                "measure": "Household Economic Hardship: Household Poverty Rate"
              },
              {
                "measure": "Household Economic Hardship: Household Poverty Rate"
              },
              {
                "measure": "Household Economic Hardship: Index of Economic Stress"
              },
              {
                "measure": "Household Economic Hardship: Index of Economic Stress"
              },
              {
                "measure": "Household Economic Hardship: Index of Economic Stress"
              },
              {
                "measure": "Household Economic Hardship: Index of Economic Stress"
              },
              {
                "measure": "Household Economic Hardship: Index of Ecomomic Stress"
              },
              {
                "measure": "Household Economic Hardship: Index of Economic Stress"
              },
              {
                "measure": "Household Economic Hardship: Maternal Hardship"
              },
              {
                "measure": "Household Economic Hardship: Maternal Hardship"
              },
              {
                "measure": "Household Economic Hardship: Index of Food Insecurity"
              },
              {
                "measure": "Household Economic Hardship: Index of Food Insecurity"
              },
              {
                "measure": "Household Economic Hardship: Index of Food Insecurity"
              },
              {
                "measure": "Household Economic Hardship: Index of Food Insecurity"
              },
              {
                "measure": "Social Services Receipt; Number of Benefits Received by Mother"
              },
              {
                "measure": "Social Services Receipt; Number of Benefits Received by Mother"
              },
              {
                "measure": "Social Services Receipt; Number of Benefits Received by Mother"
              },
              {
                "measure": "Mother's Labor Market and Education Participation: Time to Labor Market Re-entry From Birth"
              },
              {
                "measure": "Mother's Labor Market and Education Participation: Time to Full-Time Labor Market Reentry From Birth"
              },
              {
                "measure": "Mother's Labor Market and Education Participation: Mother's Labor Market Participation"
              },
              {
                "measure": "Mother's Labor Market and Education Participation: Mother's Labor Market Participation"
              },
              {
                "measure": "Mother's Labor Market and Education Participation: Mother's Labor Market Participation"
              },
              {
                "measure": "Mother's Labor Market and Education Participation: Mother's Education and Training Attainment"
              },
              {
                "measure": "Mother's Labor Market and Education Participation: Mother's Education and Training Attainment"
              },
              {
                "measure": "Mother's Labor Market and Education Participation: Mother's Education and Training Attainment"
              },
              {
                "measure": "Mother's Labor Market and Education Participation: Mother's Education Attainment"
              },
              {
                "measure": "Mother's Labor Market and Education Participation: Mother's Education Attainment"
              },
              {
                "measure": "Mother's Labor Market and Education Participation: Mother's Training Attainment"
              },
              {
                "measure": "Mother's Labor Market and Education Participation: Mother's Training Attainment"
              },
              {
                "measure": "Mother's Labor Market and Education Participation: Maternal Earnings"
              },
              {
                "measure": "Mother's Labor Market and Education Participation: Maternal Earnings"
              },
              {
                "measure": "Mother's Labor Market and Education Participation: Maternal Earnings"
              },
              {
                "measure": "Child-Focused Expenditures: Index of Expenditures Since Birth"
              },
              {
                "measure": "Child-Focused Expenditures: Index of Expenditures in Past 30 Days"
              },
              {
                "measure": "Child-Focused Expenditures: Index of Expenditures in Past 30 Days"
              },
              {
                "measure": "Child-Focused Expenditures: Index of Expenditures in Past 30 Days"
              },
              {
                "measure": "Child-Focused Expenditures: Index of Expenditures in Past 30 Days"
              },
              {
                "measure": "Child-focused Expenditures: Index of Child-Focused Expenditures in Past 30 Days"
              },
              {
                "measure": "Child-focused Expenditures: Index of Child-focused Expenditures in Past 30 Days"
              },
              {
                "measure": "Child-focused Expenditures: Index of Expenditures on All Children in the Household, Including Target Child"
              },
              {
                "measure": "Child-focused Expenditures: Index of Expenditures on All Children in the Household, Including Target Child"
              },
              {
                "measure": "Child-Focused Expenditures: Cost of Paid Child Care"
              },
              {
                "measure": "Child-Focused Expenditures: Cost of Paid Child Care"
              },
              {
                "measure": "Child-Focused Expenditures: Cost of Paid Child Care"
              },
              {
                "measure": "Child-Focused Expenditures: Cost of Paid Child Care"
              },
              {
                "measure": "Child-Focused Expenditures: Use of Center-Based Care"
              },
              {
                "measure": "Child-Focused Expenditures: Use of Center-Based Care"
              },
              {
                "measure": "Child-Focused Expenditures: Use of Center-Based Care"
              },
              {
                "measure": "Child-Focused Expenditures: Use of Center-Based Care"
              },
              {
                "measure": "Housing and Neighborhoods: Index of Perceptions of Neighborhood Safety"
              },
              {
                "measure": "Housing and Neighborhoods: Index of Perceptions of Neighborhood Safety"
              },
              {
                "measure": "Housing and Neighborhoods: Index of Perceptions of Neighborhood Safety"
              },
              {
                "measure": "Housing and Neighborhoods: Index of Housing Quality"
              },
              {
                "measure": "Housing and Neighborhoods: Index of Housing Quality"
              },
              {
                "measure": "Housing and Neighborhoods: Excessive Residential Mobility"
              },
              {
                "measure": "Housing and Neighborhoods: Excessive Residential Mobility"
              },
              {
                "measure": "Housing and Neighborhoods: Excessive Residential Mobility"
              },
              {
                "measure": "Housing and Neighborhoods: Homelessness"
              },
              {
                "measure": "Housing and Neighborhoods: Homelessness"
              },
              {
                "measure": "Housing and Neighborhoods: Homelessness"
              },
              {
                "measure": "Housing and Neighborhoods: Neighborhood Poverty"
              },
              {
                "measure": "Housing and Neighborhoods: Neighborhood Poverty"
              },
              {
                "measure": "Housing and Neighborhoods: Neighborhood Poverty"
              },
              {
                "measure": "Housing and Neighborhoods: Neighborhood Poverty"
              },
              {
                "measure": "Housing and Neighborhoods: Neighborhood Poverty"
              },
              {
                "measure": "Housing and Neighborhoods: Neighborhood Poverty"
              },
              {
                "measure": "Family and Maternal Perceived Stress: Perceived Stress"
              },
              {
                "measure": "Family and Maternal Perceived Stress: Parenting Stress"
              },
              {
                "measure": "Family and Maternal Perceived Stress: Perceived Stress"
              },
              {
                "measure": "Family and Maternal Perceived Stress: Parenting Stress"
              },
              {
                "measure": "Family and Maternal Perceived Stress: Perceived Stress"
              },
              {
                "measure": "Family and Maternal Perceived Stress: Parenting Stress"
              },
              {
                "measure": "Maternal Happiness and Optimism: Global Happiness"
              },
              {
                "measure": "Maternal Happiness and Optimism: Global Happiness"
              },
              {
                "measure": "Maternal Happiness and Optimism: Global Happiness"
              },
              {
                "measure": "Maternal Happiness"
              },
              {
                "measure": "Maternal Happiness"
              },
              {
                "measure": "Maternal Happiness and Optimism: Optimism"
              },
              {
                "measure": "Maternal Happiness and Optimism: Optimism"
              },
              {
                "measure": "Maternal Happiness and Optimism: Optimism"
              },
              {
                "measure": "Maternal Physiological Stress: Maternal Hair Cortisol"
              },
              {
                "measure": "Maternal Physiological Stress: Maternal Hair Cortisol"
              },
              {
                "measure": "Maternal Executive Function"
              },
              {
                "measure": "Maternal Executive Function"
              },
              {
                "measure": "Maternal Executive Function"
              },
              {
                "measure": "Maternal Mental Health: Index of Maternal Depression"
              },
              {
                "measure": "Maternal Mental Health: Index of Maternal Depression"
              },
              {
                "measure": "Maternal Mental Health: Index of Maternal Depression"
              },
              {
                "measure": "Maternal Mental Health: Index of Maternal Depression"
              },
              {
                "measure": "Maternal Mental Health: Index of Maternal Depression"
              },
              {
                "measure": "Maternal Mental Health: Index of Maternal Depression"
              },
              {
                "measure": "Maternal Mental Health: Index of Maternal Anxiety"
              },
              {
                "measure": "Maternal Mental Health: Index of Maternal Anxiety"
              },
              {
                "measure": "Maternal Mental Health: Index 1 of Maternal Anxiety"
              },
              {
                "measure": "Maternal Mental Health: Index 2 of Maternal Anxiety"
              },
              {
                "measure": "Maternal Mental Health: Index of Maternal Anxiety"
              },
              {
                "measure": "Maternal Mental Health: Index of Maternal Anxiety"
              },
              {
                "measure": "Maternal Mental Health: Index of Maternal Anxiety"
              },
              {
                "measure": "Maternal Substance Abuse: Alcohol and Cigarette Use"
              },
              {
                "measure": "Maternal Substance Abuse: Alcohol and Cigarette Use"
              },
              {
                "measure": "Maternal Substance Abuse: Opioid Use"
              },
              {
                "measure": "Maternal Substance Abuse: Opioid Use"
              },
              {
                "measure": "Chaos in the Home: Index of Chaos in the Home"
              },
              {
                "measure": "Chaos in the Home: Index of Chaos in the Home"
              },
              {
                "measure": "Maternal Relationships: Physical Abuse"
              },
              {
                "measure": "Maternal Relationships: Physical Abuse"
              },
              {
                "measure": "Maternal Relationships: Frequency of Arguing"
              },
              {
                "measure": "Maternal Relationships: Frequency of Arguing"
              },
              {
                "measure": "Maternal Relationships: Relationship Quality"
              },
              {
                "measure": "Maternal Relationships: Relationship Quality"
              },
              {
                "measure": "Maternal Relationships: Relationship Quality"
              },
              {
                "measure": "Maternal Physical Health: Global Health"
              },
              {
                "measure": "Maternal Physical Health: Global Health"
              },
              {
                "measure": "Maternal Physical Health: Global Health"
              },
              {
                "measure": "Maternal Physical Health: Global Health"
              },
              {
                "measure": "Maternal Physical Health: Sleep"
              },
              {
                "measure": "Maternal Physical Health: Sleep"
              },
              {
                "measure": "Maternal Physical Health: Body Mass Index"
              },
              {
                "measure": "Maternal Physical Health: Body Mass Index"
              },
              {
                "measure": "Maternal Physical Health: Body Mass Index"
              },
              {
                "measure": "Parent-Child Interaction Quality: Adult Word Count"
              },
              {
                "measure": "Parent-Child Interaction Quality: Conversational Turns"
              },
              {
                "measure": "Parent-Child Interaction Quality: Index of Mother's Positive Parenting Behaviors"
              },
              {
                "measure": "Parent-Child Interaction Quality: Index of Mother's Positive Parenting Behaviors"
              },
              {
                "measure": "Parent-Child Interaction Quality: Index of Mother's Positive Parenting Behaviors"
              },
              {
                "measure": "Parent-Child Interaction Quality: Index of Mother's Positive Parenting Behaviors"
              },
              {
                "measure": "Parent-Child Interaction Quality: Maternal Language Quantity"
              },
              {
                "measure": "Parent-Child Interaction Quality: Maternal Language Quantity"
              },
              {
                "measure": "Parent-Child Interaction Quality: Maternal Language Quality"
              },
              {
                "measure": "Parent-Child Interaction Quality: Maternal Language Quality"
              },
              {
                "measure": "Maternal Epigenetic Pace of Aging"
              },
              {
                "measure": "Maternal Epigenetic Pace of Aging"
              },
              {
                "measure": "Maternal Epigenetic Pace of Aging"
              },
              {
                "measure": "Maternal DNA Methylation"
              },
              {
                "measure": "Frequency of Parent-Child Activity: Self-Report of Parent-Child Activities"
              },
              {
                "measure": "Frequency of Parent-Child Activity: Self-Report of Parent-Child Activities"
              },
              {
                "measure": "Frequency of Parent-Child Activity: Self-Report of Parent-Child Activities"
              },
              {
                "measure": "Frequency of Parent-Child Activity: Self-Report of Parent-Child Activities"
              },
              {
                "measure": "Frequency of Parent-Child Activity: Self-Report of Parent-Child Activities"
              },
              {
                "measure": "Frequency of Parent-Child Activity: Self-Report of Parent-Child Activities"
              },
              {
                "measure": "Frequency of Parent-Child Activity: Child Meal and Sleep Routine Index"
              },
              {
                "measure": "Frequency of Parent-Child Activity: Child Meal and Sleep Routine Index"
              },
              {
                "measure": "Frequency of Parent-Child Activity: Child Meal and Sleep Routine Index"
              },
              {
                "measure": "Maternal Discipline: Spanking Discipline Strategy"
              },
              {
                "measure": "Maternal Discipline; Spanking Discipline Strategy"
              },
              {
                "measure": "Maternal Discipline; Spanking Discipline Strategy"
              },
              {
                "measure": "Maternal Discipline: Parent-Child Conflict Tactics Scale (CTSPC)"
              },
              {
                "measure": "Maternal Discipline: Parent-Child Conflict Tactics Scale (CTSPC)"
              },
              {
                "measure": "Child School Retention"
              },
              {
                "measure": "Child School Retention"
              },
              {
                "measure": "Child Engagement in School"
              },
              {
                "measure": "Child Engagement in School"
              },
              {
                "measure": "Child School Suspensions"
              },
              {
                "measure": "Child School Suspensions"
              },
              {
                "measure": "Child School Attendance"
              },
              {
                "measure": "School Quality"
              },
              {
                "measure": "Parent School Involvement"
              },
              {
                "measure": "Enrichment Activities: Child Enrichment"
              },
              {
                "measure": "Enrichment Activities: Child Enrichment"
              },
              {
                "measure": "Enrichment Activities: Child Lessons, Sports, Etc. Activity Participation"
              },
              {
                "measure": "Enrichment Activities: Child Lessons, Sports, Etc. Activity Participation"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT04000607",
            "briefTitle": "Exploratory Study of the Edwards APTURE Transcatheter Shunt System (ALT-FLOW Canada)",
            "officialTitle": "Exploratory Study of the Edwards APTURE Transcatheter Shunt System (ALT-FLOW Canada)"
          },
          "statusModule": {
            "overallStatus": "ACTIVE_NOT_RECRUITING",
            "studyFirstSubmitDate": "2019-06-24"
          },
          "conditionsModule": {
            "conditions": [
              "Heart Failure"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Rate of major cardiac/cerebrovascular/renal events and re-intervention (Safety Endpoint)",
                "timeFrame": "30 Days"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Rate at which device is successfully implanted (Device Success)"
              },
              {
                "measure": "Rate at which device is patent and subject is discharged from hospital without the need for additional intervention for the device (Procedural Success)"
              },
              {
                "measure": "Rate at which the procedure is successful without major cardiac/cerebrovascular/renal events and re-intervention (Clinical Success)"
              },
              {
                "measure": "Change in the ratio of systemic blood flow (Qs) to the pulmonary blood flow (Qp), called \"Qp/Qs\", from Baseline to Follow Up"
              },
              {
                "measure": "Change in pulmonary capillary wedge pressure (PCWP) from Baseline to Follow Up"
              },
              {
                "measure": "Change in mean systolic & diastolic pulmonary artery pressure (PAP) and change in mean right atrial pressure (RAP) from Baseline to Follow Up"
              },
              {
                "measure": "Change in Pulmonary Vascular Resistance (PVR) from Baseline to Follow Up"
              },
              {
                "measure": "Change in two parameters related to Tricuspid Annular Plane Excursion (TAPSE) from Baseline to Follow Up"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT06101485",
            "briefTitle": "Future Patient - Telerehabilitation of Patients With Atrial Fibrillation",
            "officialTitle": "Future Patient - Telerehabilitering af Patienter Med Atrieflimren (FP-AF)"
          },
          "statusModule": {
            "overallStatus": "RECRUITING",
            "studyFirstSubmitDate": "2023-06-26"
          },
          "conditionsModule": {
            "conditions": [
              "Atrial Fibrillation"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Changes in AF specific health-related quality of life",
                "timeFrame": "For both intervention and control group: QoL will be measured at baseline, end of telerehabilitation (16 weeks) and after 28 weeks"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Changes in AF knowledge"
              },
              {
                "measure": "Measurement of weight"
              },
              {
                "measure": "Measurement of bloodpressure"
              },
              {
                "measure": "Measurement of pulse"
              },
              {
                "measure": "Measurement of steps"
              },
              {
                "measure": "Measurement of sleep"
              },
              {
                "measure": "Measurement of heart rhythm"
              },
              {
                "measure": "Changes in anxiety and depression"
              },
              {
                "measure": "Changes in motivation"
              },
              {
                "measure": "Changes in motivation"
              },
              {
                "measure": "Changes in motivation"
              },
              {
                "measure": "Burden of AF"
              },
              {
                "measure": "Patients' and relatives' expectations for and experiences with participation in the tele-rehabilitation program (including the Heartportal)"
              },
              {
                "measure": "Patients' and relatives' expectations for and experiences with participation in the tele-rehabilitation program (including the Heartportal)"
              },
              {
                "measure": "Healthcare professionals' experiences with workflows and collaboration with each other in the telerehabilitation program."
              },
              {
                "measure": "Healthcare professionals' experiences with workflows and collaboration with each other in the telerehabilitation program."
              },
              {
                "measure": "Cost-effectiveness analysis of the FP-AF telerehabilitation program compared to conventional care"
              },
              {
                "measure": "Cost-effectiveness analysis of the FP-AF telerehabilitation program compared to conventional care"
              },
              {
                "measure": "Patterns in multiparametric clinical monitoring"
              },
              {
                "measure": "Patterns in multiparametric clinical monitoring"
              },
              {
                "measure": "Patterns in multiparametric clinical monitoring"
              },
              {
                "measure": "Patterns in multiparametric clinical monitoring"
              },
              {
                "measure": "Patterns in multiparametric clinical monitoring"
              },
              {
                "measure": "Patterns in multiparametric clinical monitoring"
              },
              {
                "measure": "Future governance and infrastructure for telerehabilitation of AF patients"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01332747",
            "briefTitle": "Clinical Study to Evaluate Antihyperlipidemic Effect of a Classical Unani Antiobesity Formulation",
            "officialTitle": "Clinical Study on Hyperlipidemia and Comparative Evaluation of Efficacy of a Compound Unani Formulation (Safoof e Muhazzil) and Compressed Tablet of Safoof e Muhazzil in Its Management"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2011-04-05"
          },
          "conditionsModule": {
            "conditions": [
              "Hyperlipidemia"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Total Cholesterol (TC)",
                "timeFrame": "six weeks"
              },
              {
                "measure": "Low density Lipoprotein (LDL)",
                "timeFrame": "six weeks"
              },
              {
                "measure": "Triglycerides (TG)",
                "timeFrame": "six weeks"
              },
              {
                "measure": "High Density Lipoprotein (HDL)",
                "timeFrame": "six weeks"
              },
              {
                "measure": "Very Low Density Lipoprotein (VLDL)",
                "timeFrame": "six weeks"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Waist to Hip ratio"
              },
              {
                "measure": "Body Mass Index"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT06129253",
            "briefTitle": "Global Burden Estimation of Human Papillomavirus (GLOBE-HPV)",
            "officialTitle": "Global Burden Estimation of Human Papillomavirus (GLOBE-HPV)"
          },
          "statusModule": {
            "overallStatus": "RECRUITING",
            "studyFirstSubmitDate": "2023-10-17"
          },
          "conditionsModule": {
            "conditions": [
              "HPV Infection"
            ]
          },
          "designModule": {
            "studyType": "OBSERVATIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "To estimate the prevalence (single time point detection) of HPV 16 and/or 18 infection among a representative sample of girls and women aged 9-50y in a range of settings.",
                "timeFrame": "Q4 2023 to Q4 2024"
              },
              {
                "measure": "To estimate the incidence of \u22656-month persistent HPV 16 and/or 18 infection (defined as two sequential type-specific positives with an interval of 6 months) in selected populations over 2 years.",
                "timeFrame": "Q4 2023 to Q4 2026"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "To estimate the prevalence of high risk (HR) HPV infection among a representative sample of girls and women aged 9-50 years in a range of settings, and to evaluate potential risk factors for HPV infection."
              },
              {
                "measure": "To estimate the incidence of \u22656-month persistent HR HPV infection in selected populations over 2 years."
              },
              {
                "measure": "Descriptive statistics of the knowledge, attitudes, and beliefs regarding HPV vaccination, cervical cancer screening and treatment."
              },
              {
                "measure": "Descriptive statistics of the perceptions of gender norms and stigma, and gender-related dynamics that may influence HPV burden and/or create barriers that influence girls/women's access to and uptake of HPV prevention, screening, and treatment services"
              },
              {
                "measure": "Sensitivity, specificity, Accuracy, ROC, Cohen's kappa coefficient of HPV genotyping results obtained from urine and self-collected vaginal swabs (SCVS)."
              }
            ]
          }
        }
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:19:39Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8282"
    },
    "name": "BRD-K39799535",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8282.png",
    "lincs": {
      "id": "LSM-10851",
      "name": "BRD-K39799535",
      "pubchemCid": 54638476,
      "chebiId": 99472,
      "inchiParent": "InChI=1S/C20H26F3N5O4/c1-31-12-15-10-28(27-26-15)9-8-16-6-7-17(18(11-29)32-16)25-19(30)24-14-4-2-13(3-5-14)20(21,22)23/h2-5,10,16-18,29H,6-9,11-12H2,1H3,(H2,24,25,30)/t16-,17+,18-/m0/s1",
      "inchiKeyParent": "ZOURSNKVQGBTHH-KSZLIROESA-N",
      "smilesParent": "COCc1cn(CC[C@@H]2CC[C@@H](NC(=O)Nc3ccc(cc3)C(F)(F)F)[C@H](CO)O2)nn1"
    },
    "unichem": {
      "chebi": "99472",
      "lincs": "LSM-10851",
      "pubchem": "54638476"
    },
    "pubchem": [
      {
        "cid": 54638476,
        "inchi": "InChI=1S/C20H26F3N5O4/c1-31-12-15-10-28(27-26-15)9-8-16-6-7-17(18(11-29)32-16)25-19(30)24-14-4-2-13(3-5-14)20(21,22)23/h2-5,10,16-18,29H,6-9,11-12H2,1H3,(H2,24,25,30)/t16-,17+,18-/m0/s1",
        "inchikey": "ZOURSNKVQGBTHH-KSZLIROESA-N",
        "iupac": {
          "systematic": "1-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-[4-(methoxymethyl)triazol-1-yl]ethyl]oxan-3-yl]-3-[4-(trifluoromethyl)phenyl]urea"
        },
        "smiles": {
          "canonical": "COCC1=CN(N=N1)CCC2CCC(C(O2)CO)NC(=O)NC3=CC=C(C=C3)C(F)(F)F"
        },
        "molecularFormula": "C20H26F3N5O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:19:41Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82a4"
    },
    "name": "BRD-K06851272",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82a4.png",
    "lincs": {
      "id": "LSM-37637",
      "name": "BRD-K06851272",
      "pubchemCid": 60190176,
      "chebiId": 126070,
      "inchiParent": "InChI=1S/C25H25N3O2/c29-16-22-23(20-11-5-2-6-12-20)25(28(22)15-19-9-3-1-4-10-19)17-27(18-25)24(30)21-13-7-8-14-26-21/h1-14,22-23,29H,15-18H2/t22-,23-/m1/s1",
      "inchiKeyParent": "AMLRGBIIZRJNRU-DHIUTWEWSA-N",
      "smilesParent": "OC[C@@H]1[C@@H](c2ccccc2)C3(CN(C3)C(=O)c4ccccn4)N1Cc5ccccc5"
    },
    "unichem": {
      "chebi": "126070",
      "lincs": "LSM-37637",
      "pubchem": "60190176"
    },
    "pubchem": [
      {
        "cid": 60190176,
        "inchi": "InChI=1S/C25H25N3O2/c29-16-22-23(20-11-5-2-6-12-20)25(28(22)15-19-9-3-1-4-10-19)17-27(18-25)24(30)21-13-7-8-14-26-21/h1-14,22-23,29H,15-18H2/t22-,23-/m1/s1",
        "inchikey": "AMLRGBIIZRJNRU-DHIUTWEWSA-N",
        "iupac": {
          "systematic": "[(2S,3R)-1-benzyl-2-(hydroxymethyl)-3-phenyl-1,6-diazaspiro[3.3]heptan-6-yl]-pyridin-2-ylmethanone"
        },
        "smiles": {
          "canonical": "C1C2(CN1C(=O)C3=CC=CC=N3)C(C(N2CC4=CC=CC=C4)CO)C5=CC=CC=C5"
        },
        "molecularFormula": "C25H25N3O2"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:19:44Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82d6"
    },
    "name": "BRD-K57512343",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82d6.png",
    "lincs": {
      "id": "LSM-40425",
      "name": "BRD-K57512343",
      "pubchemCid": 60184906,
      "chebiId": 128873,
      "inchiParent": "InChI=1S/C27H29N3O6/c1-16(32)30-14-27(24-19-5-4-18(34-2)12-20(19)28-25(24)21(30)13-31)7-9-29(10-8-27)26(33)17-3-6-22-23(11-17)36-15-35-22/h3-6,11-12,21,28,31H,7-10,13-15H2,1-2H3/t21-/m0/s1",
      "inchiKeyParent": "CNXBXNFKSPAOAI-NRFANRHFSA-N",
      "smilesParent": "COc1ccc2c3c([nH]c2c1)[C@H](CO)N(CC34CCN(CC4)C(=O)c5ccc6OCOc6c5)C(=O)C"
    },
    "unichem": {
      "chebi": "128873",
      "chembl": "CHEMBL3561019",
      "lincs": "LSM-40425",
      "pubchem": "60184906"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL3561019",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 491.54,
        "hba": 6,
        "hbd": 2,
        "qedWeighted": 0.58
      }
    },
    "pubchem": [
      {
        "cid": 60184906,
        "inchi": "InChI=1S/C27H29N3O6/c1-16(32)30-14-27(24-19-5-4-18(34-2)12-20(19)28-25(24)21(30)13-31)7-9-29(10-8-27)26(33)17-3-6-22-23(11-17)36-15-35-22/h3-6,11-12,21,28,31H,7-10,13-15H2,1-2H3/t21-/m0/s1",
        "inchikey": "CNXBXNFKSPAOAI-NRFANRHFSA-N",
        "iupac": {
          "systematic": "1-[(1R)-1'-(1,3-benzodioxole-5-carbonyl)-1-(hydroxymethyl)-7-methoxyspiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4'-piperidine]-2-yl]ethanone"
        },
        "smiles": {
          "canonical": "CC(=O)N1CC2(CCN(CC2)C(=O)C3=CC4=C(C=C3)OCO4)C5=C(C1CO)NC6=C5C=CC(=C6)OC"
        },
        "molecularFormula": "C27H29N3O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:19:54Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8305"
    },
    "name": "BRD-K11749439",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8305.png",
    "lincs": {
      "id": "LSM-9141",
      "name": "BRD-K11749439",
      "pubchemCid": 54654509,
      "chebiId": 97762,
      "inchiParent": "InChI=1S/C23H33N3O6S/c1-26-19-10-9-17(13-22(27)24-15-6-4-3-5-7-15)32-21(19)14-31-20-11-8-16(25-33(2,29)30)12-18(20)23(26)28/h8,11-12,15,17,19,21,25H,3-7,9-10,13-14H2,1-2H3,(H,24,27)/t17-,19-,21-/m1/s1",
      "inchiKeyParent": "VOOHCFNIWPJMMM-YFVAEKQCSA-N",
      "smilesParent": "CN1[C@@H]2CC[C@H](CC(=O)NC3CCCCC3)O[C@@H]2COc4ccc(NS(=O)(=O)C)cc4C1=O"
    },
    "unichem": {
      "chebi": "97762",
      "lincs": "LSM-9141",
      "pubchem": "54654509"
    },
    "pubchem": [
      {
        "cid": 54654509,
        "inchi": "InChI=1S/C23H33N3O6S/c1-26-19-10-9-17(13-22(27)24-15-6-4-3-5-7-15)32-21(19)14-31-20-11-8-16(25-33(2,29)30)12-18(20)23(26)28/h8,11-12,15,17,19,21,25H,3-7,9-10,13-14H2,1-2H3,(H,24,27)/t17-,19-,21-/m1/s1",
        "inchikey": "VOOHCFNIWPJMMM-YFVAEKQCSA-N",
        "iupac": {
          "systematic": "2-[(2R,4aR,12aS)-8-(methanesulfonamido)-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-cyclohexylacetamide"
        },
        "smiles": {
          "canonical": "CN1C2CCC(OC2COC3=C(C1=O)C=C(C=C3)NS(=O)(=O)C)CC(=O)NC4CCCCC4"
        },
        "molecularFormula": "C23H33N3O6S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:19:57Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c832c"
    },
    "name": "BRD-K51740186",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c832c.png",
    "lincs": {
      "id": "LSM-7513",
      "name": "BRD-K51740186",
      "pubchemCid": 44484523,
      "chebiId": 96134,
      "inchiParent": "InChI=1S/C24H35N5O5/c1-17-7-9-21(10-8-17)34-24(32)27(4)14-22-18(2)12-29(19(3)15-30)23(31)6-5-11-28-13-20(16-33-22)25-26-28/h7-10,13,18-19,22,30H,5-6,11-12,14-16H2,1-4H3/t18-,19+,22-/m1/s1",
      "inchiKeyParent": "VOGIWUFDXLFNKS-XQBPLPMBSA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@@H](C)[C@@H](CN(C)C(=O)Oc2ccc(C)cc2)OCc3cn(CCCC1=O)nn3"
    },
    "unichem": {
      "chebi": "96134",
      "lincs": "LSM-7513",
      "pubchem": "44484523"
    },
    "pubchem": [
      {
        "cid": 44484523,
        "inchi": "InChI=1S/C24H35N5O5/c1-17-7-9-21(10-8-17)34-24(32)27(4)14-22-18(2)12-29(19(3)15-30)23(31)6-5-11-28-13-20(16-33-22)25-26-28/h7-10,13,18-19,22,30H,5-6,11-12,14-16H2,1-4H3/t18-,19+,22-/m1/s1",
        "inchikey": "VOGIWUFDXLFNKS-XQBPLPMBSA-N",
        "iupac": {
          "systematic": "(4-methylphenyl) N-[[(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylcarbamate"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)CCCN2C=C(COC1CN(C)C(=O)OC3=CC=C(C=C3)C)N=N2)C(C)CO"
        },
        "molecularFormula": "C24H35N5O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:19:59Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82fe"
    },
    "name": "BRD-K14270906",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82fe.png",
    "lincs": {
      "id": "LSM-38006",
      "name": "BRD-K14270906",
      "pubchemCid": 44494645,
      "chebiId": 126442,
      "inchiParent": "InChI=1S/C31H43N5O6/c1-20-17-36(21(2)19-37)29(38)25-11-8-12-26(34-30(39)32-22-9-6-5-7-10-22)28(25)42-27(20)18-35(3)31(40)33-23-13-15-24(41-4)16-14-23/h8,11-16,20-22,27,37H,5-7,9-10,17-19H2,1-4H3,(H,33,40)(H2,32,34,39)/t20-,21+,27+/m1/s1",
      "inchiKeyParent": "SWAMQWMVKYBBNH-BUEREQSYSA-N",
      "smilesParent": "COc1ccc(NC(=O)N(C)C[C@@H]2Oc3c(NC(=O)NC4CCCCC4)cccc3C(=O)N(C[C@H]2C)[C@@H](C)CO)cc1"
    },
    "unichem": {
      "chebi": "126442",
      "lincs": "LSM-38006",
      "pubchem": "44494645"
    },
    "pubchem": [
      {
        "cid": 44494645,
        "inchi": "InChI=1S/C31H43N5O6/c1-20-17-36(21(2)19-37)29(38)25-11-8-12-26(34-30(39)32-22-9-6-5-7-10-22)28(25)42-27(20)18-35(3)31(40)33-23-13-15-24(41-4)16-14-23/h8,11-16,20-22,27,37H,5-7,9-10,17-19H2,1-4H3,(H,33,40)(H2,32,34,39)/t20-,21+,27+/m1/s1",
        "inchikey": "SWAMQWMVKYBBNH-BUEREQSYSA-N",
        "iupac": {
          "systematic": "1-[[(2R,3R)-10-(cyclohexylcarbamoylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-3-(4-methoxyphenyl)-1-methylurea"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(C(=CC=C2)NC(=O)NC3CCCCC3)OC1CN(C)C(=O)NC4=CC=C(C=C4)OC)C(C)CO"
        },
        "molecularFormula": "C31H43N5O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:20:02Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8310"
    },
    "name": "BRD-K90601358",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8310.png",
    "lincs": {
      "id": "LSM-14008",
      "name": "BRD-K90601358",
      "pubchemCid": 54631891,
      "chebiId": 102661,
      "inchiParent": "InChI=1S/C27H38N4O5/c1-18-12-31(13-22-16-35-17-28-22)19(2)15-36-24-11-21(29-26(32)20-7-5-6-8-20)9-10-23(24)27(33)30(3)14-25(18)34-4/h9-11,16-20,25H,5-8,12-15H2,1-4H3,(H,29,32)/t18-,19-,25+/m1/s1",
      "inchiKeyParent": "MYQCBFUDPAPJCT-RRQZXNHTSA-N",
      "smilesParent": "CO[C@H]1CN(C)C(=O)c2ccc(NC(=O)C3CCCC3)cc2OC[C@@H](C)N(Cc4cocn4)C[C@H]1C"
    },
    "unichem": {
      "chebi": "102661",
      "lincs": "LSM-14008",
      "pubchem": "54631891"
    },
    "pubchem": [
      {
        "cid": 54631891,
        "inchi": "InChI=1S/C27H38N4O5/c1-18-12-31(13-22-16-35-17-28-22)19(2)15-36-24-11-21(29-26(32)20-7-5-6-8-20)9-10-23(24)27(33)30(3)14-25(18)34-4/h9-11,16-20,25H,5-8,12-15H2,1-4H3,(H,29,32)/t18-,19-,25+/m1/s1",
        "inchikey": "MYQCBFUDPAPJCT-RRQZXNHTSA-N",
        "iupac": {
          "systematic": "N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-5-(1,3-oxazol-4-ylmethyl)-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-15-yl]cyclopentanecarboxamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(COC2=C(C=CC(=C2)NC(=O)C3CCCC3)C(=O)N(CC1OC)C)C)CC4=COC=N4"
        },
        "molecularFormula": "C27H38N4O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:20:04Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c829a"
    },
    "name": "BRD-K79652816",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c829a.png",
    "lincs": {
      "id": "LSM-13291",
      "name": "BRD-K79652816",
      "pubchemCid": 54637749,
      "chebiId": 101930,
      "inchiParent": "InChI=1S/C30H33N3O5S/c1-21-17-33(22(2)19-34)30(35)28-14-7-6-13-27(28)26-12-5-4-10-24(26)20-38-29(21)18-32(3)39(36,37)25-11-8-9-23(15-25)16-31/h4-15,21-22,29,34H,17-20H2,1-3H3/t21-,22-,29-/m1/s1",
      "inchiKeyParent": "RWOMJVAVZPFCIF-IEOSBIPESA-N",
      "smilesParent": "C[C@H](CO)N1C[C@@H](C)[C@@H](CN(C)S(=O)(=O)c2cccc(c2)C#N)OCc3ccccc3c4ccccc4C1=O"
    },
    "unichem": {
      "chebi": "101930",
      "lincs": "LSM-13291",
      "pubchem": "54637749"
    },
    "pubchem": [
      {
        "cid": 54637749,
        "inchi": "InChI=1S/C30H33N3O5S/c1-21-17-33(22(2)19-34)30(35)28-14-7-6-13-27(28)26-12-5-4-10-24(26)20-38-29(21)18-32(3)39(36,37)25-11-8-9-23(15-25)16-31/h4-15,21-22,29,34H,17-20H2,1-3H3/t21-,22-,29-/m1/s1",
        "inchikey": "RWOMJVAVZPFCIF-IEOSBIPESA-N",
        "iupac": {
          "systematic": "3-cyano-N-[[(10S,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylbenzenesulfonamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=CC=CC=C2C3=CC=CC=C3COC1CN(C)S(=O)(=O)C4=CC=CC(=C4)C#N)C(C)CO"
        },
        "molecularFormula": "C30H33N3O5S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:20:06Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8307"
    },
    "name": "BRD-K87010407",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8307.png",
    "lincs": {
      "id": "LSM-8394",
      "name": "BRD-K87010407",
      "pubchemCid": 44486348,
      "chebiId": 97015,
      "inchiParent": "InChI=1S/C28H43N7O4/c1-21-16-35(22(2)19-36)27(37)6-5-11-34-17-24(29-30-34)20-39-26(21)18-32(4)28(38)23-7-9-25(10-8-23)33-14-12-31(3)13-15-33/h7-10,17,21-22,26,36H,5-6,11-16,18-20H2,1-4H3/t21-,22+,26-/m1/s1",
      "inchiKeyParent": "OIASBGFOQSUHIL-TVZXLZGTSA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@@H](C)[C@@H](CN(C)C(=O)c2ccc(cc2)N3CCN(C)CC3)OCc4cn(CCCC1=O)nn4"
    },
    "unichem": {
      "chebi": "97015",
      "lincs": "LSM-8394",
      "pubchem": "44486348"
    },
    "pubchem": [
      {
        "cid": 44486348,
        "inchi": "InChI=1S/C28H43N7O4/c1-21-16-35(22(2)19-36)27(37)6-5-11-34-17-24(29-30-34)20-39-26(21)18-32(4)28(38)23-7-9-25(10-8-23)33-14-12-31(3)13-15-33/h7-10,17,21-22,26,36H,5-6,11-16,18-20H2,1-4H3/t21-,22+,26-/m1/s1",
        "inchikey": "OIASBGFOQSUHIL-TVZXLZGTSA-N",
        "iupac": {
          "systematic": "N-[[(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methyl-4-(4-methylpiperazin-1-yl)benzamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)CCCN2C=C(COC1CN(C)C(=O)C3=CC=C(C=C3)N4CCN(CC4)C)N=N2)C(C)CO"
        },
        "molecularFormula": "C28H43N7O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:20:08Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c830e"
    },
    "name": "BRD-K07609594",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c830e.png",
    "lincs": {
      "id": "LSM-43447",
      "name": "BRD-K07609594",
      "pubchemCid": 54660798,
      "inchiParent": "InChI=1S/C28H36N4O4/c1-30-25-22(23(19-33)26(30)27(34)29-12-5-13-31-14-16-36-17-15-31)18-32-24(25)11-10-21(28(32)35)9-8-20-6-3-2-4-7-20/h2-4,6-11,22-23,25-26,33H,5,12-19H2,1H3,(H,29,34)/b9-8+/t22-,23-,25+,26-/m1/s1",
      "inchiKeyParent": "LTCABXOBQOXXRS-MDDGOGIGSA-N",
      "smilesParent": "CN1[C@H]([C@H](CO)[C@H]2CN3C(=O)C(=CC=C3[C@@H]12)\\C=C\\c4ccccc4)C(=O)NCCCN5CCOCC5"
    },
    "unichem": {
      "lincs": "LSM-43447",
      "pubchem": "54660798"
    },
    "pubchem": [
      {
        "cid": 54660798,
        "inchi": "InChI=1S/C28H36N4O4/c1-30-25-22(23(19-33)26(30)27(34)29-12-5-13-31-14-16-36-17-15-31)18-32-24(25)11-10-21(28(32)35)9-8-20-6-3-2-4-7-20/h2-4,6-11,22-23,25-26,33H,5,12-19H2,1H3,(H,29,34)/b9-8+/t22-,23-,25+,26-/m1/s1",
        "inchikey": "LTCABXOBQOXXRS-MDDGOGIGSA-N",
        "iupac": {
          "systematic": "(2R,3R,3aS,9bS)-3-(hydroxymethyl)-1-methyl-N-(3-morpholin-4-ylpropyl)-6-oxo-7-[(E)-2-phenylethenyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide"
        },
        "smiles": {
          "canonical": "CN1C2C(CN3C2=CC=C(C3=O)C=CC4=CC=CC=C4)C(C1C(=O)NCCCN5CCOCC5)CO"
        },
        "molecularFormula": "C28H36N4O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:20:10Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8317"
    },
    "name": "BRD-K10323659",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8317.png",
    "lincs": {
      "id": "LSM-14718",
      "name": "BRD-K10323659",
      "pubchemCid": 44494915,
      "chebiId": 103374,
      "inchiParent": "InChI=1S/C33H49N5O6/c1-22(2)34-33(42)37(6)20-30-23(3)19-38(24(4)21-39)31(40)28-18-27(36-32(41)35-26-13-8-7-9-14-26)15-16-29(28)44-25(5)12-10-11-17-43-30/h7-9,13-16,18,22-25,30,39H,10-12,17,19-21H2,1-6H3,(H,34,42)(H2,35,36,41)/t23-,24+,25+,30-/m0/s1",
      "inchiKeyParent": "YYAGCQUXHYGTOT-RPQPUBLWSA-N",
      "smilesParent": "CC(C)NC(=O)N(C)C[C@@H]1OCCCC[C@@H](C)Oc2ccc(NC(=O)Nc3ccccc3)cc2C(=O)N(C[C@@H]1C)[C@H](C)CO"
    },
    "unichem": {
      "chebi": "103374",
      "lincs": "LSM-14718",
      "pubchem": "44494915"
    },
    "pubchem": [
      {
        "cid": 44494915,
        "inchi": "InChI=1S/C33H49N5O6/c1-22(2)34-33(42)37(6)20-30-23(3)19-38(24(4)21-39)31(40)28-18-27(36-32(41)35-26-13-8-7-9-14-26)15-16-29(28)44-25(5)12-10-11-17-43-30/h7-9,13-16,18,22-25,30,39H,10-12,17,19-21H2,1-6H3,(H,34,42)(H2,35,36,41)/t23-,24+,25+,30-/m0/s1",
        "inchikey": "YYAGCQUXHYGTOT-RPQPUBLWSA-N",
        "iupac": {
          "systematic": "1-[[(3R,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-(phenylcarbamoylamino)-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-propan-2-ylurea"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NC(=O)NC3=CC=CC=C3)C(C)CO)C)CN(C)C(=O)NC(C)C"
        },
        "molecularFormula": "C33H49N5O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:20:12Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8318"
    },
    "name": "BRD-K49956785",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8318.png",
    "lincs": {
      "id": "LSM-11467",
      "name": "BRD-K49956785",
      "pubchemCid": 54631745,
      "chebiId": 100088,
      "inchiParent": "InChI=1S/C25H36N4O4S/c1-6-7-23(30)27-19-8-9-21-20(12-19)25(31)28(4)14-22(32-5)17(2)13-29(18(3)16-33-21)15-24-26-10-11-34-24/h8-12,17-18,22H,6-7,13-16H2,1-5H3,(H,27,30)/t17-,18+,22+/m0/s1",
      "inchiKeyParent": "LLNFNSHBDLACGS-NJNPRVFISA-N",
      "smilesParent": "CCCC(=O)Nc1ccc2OC[C@@H](C)N(Cc3nccs3)C[C@H](C)[C@@H](CN(C)C(=O)c2c1)OC"
    },
    "unichem": {
      "chebi": "100088",
      "lincs": "LSM-11467",
      "pubchem": "54631745"
    },
    "pubchem": [
      {
        "cid": 54631745,
        "inchi": "InChI=1S/C25H36N4O4S/c1-6-7-23(30)27-19-8-9-21-20(12-19)25(31)28(4)14-22(32-5)17(2)13-29(18(3)16-33-21)15-24-26-10-11-34-24/h8-12,17-18,22H,6-7,13-16H2,1-5H3,(H,27,30)/t17-,18+,22+/m0/s1",
        "inchikey": "LLNFNSHBDLACGS-NJNPRVFISA-N",
        "iupac": {
          "systematic": "N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(1,3-thiazol-2-ylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide"
        },
        "smiles": {
          "canonical": "CCCC(=O)NC1=CC2=C(C=C1)OCC(N(CC(C(CN(C2=O)C)OC)C)CC3=NC=CS3)C"
        },
        "molecularFormula": "C25H36N4O4S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:20:15Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c831c"
    },
    "name": "BRD-K20978396",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c831c.png",
    "lincs": {
      "id": "LSM-9707",
      "name": "BRD-K20978396",
      "pubchemCid": 54657870,
      "chebiId": 98328,
      "inchiParent": "InChI=1S/C22H29Cl2N3O6/c23-14-7-15(24)9-16(8-14)25-22(30)27-11-17(28)12-32-13-20-19(27)2-1-18(33-20)10-21(29)26-3-5-31-6-4-26/h7-9,17-20,28H,1-6,10-13H2,(H,25,30)/t17-,18+,19-,20+/m1/s1",
      "inchiKeyParent": "IDLNHXHJUITYBI-WCIQWLHISA-N",
      "smilesParent": "O[C@H]1COC[C@@H]2O[C@H](CC(=O)N3CCOCC3)CC[C@H]2N(C1)C(=O)Nc4cc(Cl)cc(Cl)c4"
    },
    "unichem": {
      "chebi": "98328",
      "lincs": "LSM-9707",
      "pubchem": "54657870"
    },
    "pubchem": [
      {
        "cid": 54657870,
        "inchi": "InChI=1S/C22H29Cl2N3O6/c23-14-7-15(24)9-16(8-14)25-22(30)27-11-17(28)12-32-13-20-19(27)2-1-18(33-20)10-21(29)26-3-5-31-6-4-26/h7-9,17-20,28H,1-6,10-13H2,(H,25,30)/t17-,18+,19-,20+/m1/s1",
        "inchikey": "IDLNHXHJUITYBI-WCIQWLHISA-N",
        "iupac": {
          "systematic": "(3R,6aR,8S,10aR)-N-(3,5-dichlorophenyl)-3-hydroxy-8-(2-morpholin-4-yl-2-oxoethyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide"
        },
        "smiles": {
          "canonical": "C1CC2C(COCC(CN2C(=O)NC3=CC(=CC(=C3)Cl)Cl)O)OC1CC(=O)N4CCOCC4"
        },
        "molecularFormula": "C22H29Cl2N3O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:20:17Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c831d"
    },
    "name": "BRD-K13835847",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c831d.png",
    "lincs": {
      "id": "LSM-9265",
      "name": "BRD-K13835847",
      "pubchemCid": 54632085,
      "chebiId": 97886,
      "inchiParent": "InChI=1S/C25H38N4O5/c1-15(2)26-25(32)29-12-16(3)22(33-6)13-28(5)24(31)20-11-19(27-23(30)18-7-8-18)9-10-21(20)34-14-17(29)4/h9-11,15-18,22H,7-8,12-14H2,1-6H3,(H,26,32)(H,27,30)/t16-,17+,22-/m0/s1",
      "inchiKeyParent": "CYXOTKWKLUXHGN-JKSBSHDWSA-N",
      "smilesParent": "CO[C@H]1CN(C)C(=O)c2cc(NC(=O)C3CC3)ccc2OC[C@@H](C)N(C[C@@H]1C)C(=O)NC(C)C"
    },
    "unichem": {
      "chebi": "97886",
      "lincs": "LSM-9265",
      "pubchem": "54632085"
    },
    "pubchem": [
      {
        "cid": 54632085,
        "inchi": "InChI=1S/C25H38N4O5/c1-15(2)26-25(32)29-12-16(3)22(33-6)13-28(5)24(31)20-11-19(27-23(30)18-7-8-18)9-10-21(20)34-14-17(29)4/h9-11,15-18,22H,7-8,12-14H2,1-6H3,(H,26,32)(H,27,30)/t16-,17+,22-/m0/s1",
        "inchikey": "CYXOTKWKLUXHGN-JKSBSHDWSA-N",
        "iupac": {
          "systematic": "(4R,7S,8R)-14-(cyclopropanecarbonylamino)-8-methoxy-4,7,10-trimethyl-11-oxo-N-propan-2-yl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-5-carboxamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(COC2=C(C=C(C=C2)NC(=O)C3CC3)C(=O)N(CC1OC)C)C)C(=O)NC(C)C"
        },
        "molecularFormula": "C25H38N4O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:20:19Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c833a"
    },
    "name": "CHEMBL2135140",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c833a.png",
    "lincs": {
      "id": "LSM-7402",
      "name": "CHEMBL2135140",
      "alternativeNames": [
        "BRD-K43714340"
      ],
      "pubchemCid": 54618460,
      "chebiId": 96023,
      "inchiParent": "InChI=1S/C27H36N2O5S/c1-18-5-9-22(10-6-18)23-11-12-26-24(14-23)34-25(16-28(4)27(31)13-21-7-8-21)19(2)15-29(20(3)17-30)35(26,32)33/h5-6,9-12,14,19-21,25,30H,7-8,13,15-17H2,1-4H3/t19-,20-,25-/m1/s1",
      "inchiKeyParent": "GCPZFZZKEDFKSA-UMEGOILYSA-N",
      "smilesParent": "C[C@H](CO)N1C[C@@H](C)[C@@H](CN(C)C(=O)CC2CC2)Oc3cc(ccc3S1(=O)=O)c4ccc(C)cc4"
    },
    "unichem": {
      "chebi": "96023",
      "chembl": "CHEMBL2135140",
      "lincs": "LSM-7402",
      "pubchem": "54618460"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL2135140",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 500.66,
        "hba": 5,
        "hbd": 1,
        "qedWeighted": 0.63
      }
    },
    "pubchem": [
      {
        "cid": 54618460,
        "inchi": "InChI=1S/C27H36N2O5S/c1-18-5-9-22(10-6-18)23-11-12-26-24(14-23)34-25(16-28(4)27(31)13-21-7-8-21)19(2)15-29(20(3)17-30)35(26,32)33/h5-6,9-12,14,19-21,25,30H,7-8,13,15-17H2,1-4H3/t19-,20-,25-/m1/s1",
        "inchikey": "GCPZFZZKEDFKSA-UMEGOILYSA-N",
        "iupac": {
          "systematic": "2-cyclopropyl-N-[[(4R,5S)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-8-(4-methylphenyl)-1,1-dioxo-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-N-methylacetamide"
        },
        "smiles": {
          "canonical": "CC1CN(S(=O)(=O)C2=C(C=C(C=C2)C3=CC=C(C=C3)C)OC1CN(C)C(=O)CC4CC4)C(C)CO"
        },
        "molecularFormula": "C27H36N2O5S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:20:30Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c826f"
    },
    "name": "BRD-K05356589",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c826f.png",
    "lincs": {
      "id": "LSM-8745",
      "name": "BRD-K05356589",
      "pubchemCid": 54649417,
      "chebiId": 97366,
      "inchiParent": "InChI=1S/C34H36N4O3S/c1-34(2,3)42(41)38-22-28-20-29(33(40)37-17-13-23-7-4-5-8-27(23)21-37)36-32(31(28)30(38)14-18-39)26-10-6-9-25(19-26)24-11-15-35-16-12-24/h4-12,15-16,19-20,30,39H,13-14,17-18,21-22H2,1-3H3/t30-,42-/m0/s1",
      "inchiKeyParent": "HAAGBLBLWADVDZ-MIKJVJEASA-N",
      "smilesParent": "CC(C)(C)[S@](=O)N1Cc2cc(nc(c3cccc(c3)c4ccncc4)c2[C@@H]1CCO)C(=O)N5CCc6ccccc6C5"
    },
    "unichem": {
      "chebi": "97366",
      "lincs": "LSM-8745",
      "pubchem": "54649417"
    },
    "pubchem": [
      {
        "cid": 54649417,
        "inchi": "InChI=1S/C34H36N4O3S/c1-34(2,3)42(41)38-22-28-20-29(33(40)37-17-13-23-7-4-5-8-27(23)21-37)36-32(31(28)30(38)14-18-39)26-10-6-9-25(19-26)24-11-15-35-16-12-24/h4-12,15-16,19-20,30,39H,13-14,17-18,21-22H2,1-3H3/t30-,42-/m0/s1",
        "inchikey": "HAAGBLBLWADVDZ-MIKJVJEASA-N",
        "iupac": {
          "systematic": "[(3S)-2-[(S)-tert-butylsulfinyl]-3-(2-hydroxyethyl)-4-(3-pyridin-4-ylphenyl)-1,3-dihydropyrrolo[3,4-c]pyridin-6-yl]-(3,4-dihydro-1H-isoquinolin-2-yl)methanone"
        },
        "smiles": {
          "canonical": "CC(C)(C)S(=O)N1CC2=CC(=NC(=C2C1CCO)C3=CC=CC(=C3)C4=CC=NC=C4)C(=O)N5CCC6=CC=CC=C6C5"
        },
        "molecularFormula": "C34H36N4O3S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:20:32Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8280"
    },
    "name": "BRD-K37477851",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8280.png",
    "lincs": {
      "id": "LSM-36536",
      "name": "BRD-K37477851",
      "pubchemCid": 60184949,
      "chebiId": 125074,
      "inchiParent": "InChI=1S/C24H23FN2O3S/c1-30-19-6-4-5-18(13-19)16-9-11-17(12-10-16)24-21-14-27(15-22(24)26-21)31(28,29)23-8-3-2-7-20(23)25/h2-13,21-22,24,26H,14-15H2,1H3/t21-,22+,24?",
      "inchiKeyParent": "HJLMFKKZRBIGPI-RIKCKFAHSA-N",
      "smilesParent": "COc1cccc(c1)c2ccc(cc2)[C@@H]3[C@@H]4CN(C[C@H]3N4)S(=O)(=O)c5ccccc5F"
    },
    "unichem": {
      "chebi": "125074",
      "lincs": "LSM-36536",
      "pubchem": "60184949"
    },
    "pubchem": [
      {
        "cid": 60184949,
        "inchi": "InChI=1S/C24H23FN2O3S/c1-30-19-6-4-5-18(13-19)16-9-11-17(12-10-16)24-21-14-27(15-22(24)26-21)31(28,29)23-8-3-2-7-20(23)25/h2-13,21-22,24,26H,14-15H2,1H3/t21-,22+,24?",
        "inchikey": "HJLMFKKZRBIGPI-RIKCKFAHSA-N",
        "iupac": {
          "systematic": "(1R,5S)-3-(2-fluorophenyl)sulfonyl-7-[4-(3-methoxyphenyl)phenyl]-3,6-diazabicyclo[3.1.1]heptane"
        },
        "smiles": {
          "canonical": "COC1=CC=CC(=C1)C2=CC=C(C=C2)C3C4CN(CC3N4)S(=O)(=O)C5=CC=CC=C5F"
        },
        "molecularFormula": "C24H23FN2O3S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:20:35Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82b2"
    },
    "name": "BRD-K90136643",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82b2.png",
    "lincs": {
      "id": "LSM-42185",
      "name": "BRD-K90136643",
      "pubchemCid": 54649873,
      "chebiId": 130636,
      "inchiParent": "InChI=1S/C23H26N4O3/c1-29-21-9-7-17(8-10-21)13-19-11-12-27-14-20(25-26-27)15-30-16-22(24-23(19)28)18-5-3-2-4-6-18/h2-10,14,19,22H,11-13,15-16H2,1H3,(H,24,28)/t19-,22-/m0/s1",
      "inchiKeyParent": "ULAPSIWOROLXDY-UGKGYDQZSA-N",
      "smilesParent": "COc1ccc(C[C@@H]2CCn3cc(COC[C@H](NC2=O)c4ccccc4)nn3)cc1"
    },
    "unichem": {
      "chebi": "130636",
      "lincs": "LSM-42185",
      "pubchem": "54649873"
    },
    "pubchem": [
      {
        "cid": 54649873,
        "inchi": "InChI=1S/C23H26N4O3/c1-29-21-9-7-17(8-10-21)13-19-11-12-27-14-20(25-26-27)15-30-16-22(24-23(19)28)18-5-3-2-4-6-18/h2-10,14,19,22H,11-13,15-16H2,1H3,(H,24,28)/t19-,22-/m0/s1",
        "inchikey": "ULAPSIWOROLXDY-UGKGYDQZSA-N",
        "iupac": {
          "systematic": "(4R,7R)-4-[(4-methoxyphenyl)methyl]-7-phenyl-9-oxa-1,6,12,13-tetrazabicyclo[9.2.1]tetradeca-11(14),12-dien-5-one"
        },
        "smiles": {
          "canonical": "COC1=CC=C(C=C1)CC2CCN3C=C(COCC(NC2=O)C4=CC=CC=C4)N=N3"
        },
        "molecularFormula": "C23H26N4O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:20:37Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82d8"
    },
    "name": "BRD-K85979978",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82d8.png",
    "lincs": {
      "id": "LSM-7947",
      "name": "BRD-K85979978",
      "pubchemCid": 44485075,
      "chebiId": 96568,
      "inchiParent": "InChI=1S/C22H35N7O5/c1-14-9-29(15(2)12-30)20(31)7-6-8-28-10-18(24-26-28)13-33-19(14)11-27(5)22(32)23-21-16(3)25-34-17(21)4/h10,14-15,19,30H,6-9,11-13H2,1-5H3,(H,23,32)/t14-,15+,19-/m1/s1",
      "inchiKeyParent": "ZMFVFBQYBHAIKE-ZRGWGRIASA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@@H](C)[C@@H](CN(C)C(=O)Nc2c(C)onc2C)OCc3cn(CCCC1=O)nn3"
    },
    "unichem": {
      "chebi": "96568",
      "lincs": "LSM-7947",
      "pubchem": "44485075"
    },
    "pubchem": [
      {
        "cid": 44485075,
        "inchi": "InChI=1S/C22H35N7O5/c1-14-9-29(15(2)12-30)20(31)7-6-8-28-10-18(24-26-28)13-33-19(14)11-27(5)22(32)23-21-16(3)25-34-17(21)4/h10,14-15,19,30H,6-9,11-13H2,1-5H3,(H,23,32)/t14-,15+,19-/m1/s1",
        "inchikey": "ZMFVFBQYBHAIKE-ZRGWGRIASA-N",
        "iupac": {
          "systematic": "3-(3,5-dimethyl-1,2-oxazol-4-yl)-1-[[(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methylurea"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)CCCN2C=C(COC1CN(C)C(=O)NC3=C(ON=C3C)C)N=N2)C(C)CO"
        },
        "molecularFormula": "C22H35N7O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:20:39Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8329"
    },
    "name": "BRD-K74390607",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8329.png",
    "lincs": {
      "id": "LSM-12984",
      "name": "BRD-K74390607",
      "pubchemCid": 54638817,
      "chebiId": 101621,
      "inchiParent": "InChI=1S/C18H23ClN2O5/c1-25-11-18(24)21-15-7-6-14(26-16(15)10-22)8-17(23)20-9-12-2-4-13(19)5-3-12/h2-7,14-16,22H,8-11H2,1H3,(H,20,23)(H,21,24)/t14-,15+,16-/m0/s1",
      "inchiKeyParent": "XHJSWNOOJCOHJI-XHSDSOJGSA-N",
      "smilesParent": "COCC(=O)N[C@@H]1C=C[C@@H](CC(=O)NCc2ccc(Cl)cc2)O[C@H]1CO"
    },
    "unichem": {
      "chebi": "101621",
      "lincs": "LSM-12984",
      "pubchem": "54638817"
    },
    "pubchem": [
      {
        "cid": 54638817,
        "inchi": "InChI=1S/C18H23ClN2O5/c1-25-11-18(24)21-15-7-6-14(26-16(15)10-22)8-17(23)20-9-12-2-4-13(19)5-3-12/h2-7,14-16,22H,8-11H2,1H3,(H,20,23)(H,21,24)/t14-,15+,16-/m0/s1",
        "inchikey": "XHJSWNOOJCOHJI-XHSDSOJGSA-N",
        "iupac": {
          "systematic": "N-[(4-chlorophenyl)methyl]-2-[(2R,3R,6R)-2-(hydroxymethyl)-3-[(2-methoxyacetyl)amino]-3,6-dihydro-2H-pyran-6-yl]acetamide"
        },
        "smiles": {
          "canonical": "COCC(=O)NC1C=CC(OC1CO)CC(=O)NCC2=CC=C(C=C2)Cl"
        },
        "molecularFormula": "C18H23ClN2O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:20:41Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82ee"
    },
    "name": "BRD-K82504171",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82ee.png",
    "lincs": {
      "id": "LSM-41781",
      "name": "BRD-K82504171",
      "pubchemCid": 44484438,
      "chebiId": 130232,
      "inchiParent": "InChI=1S/C31H39N3O5S/c1-22-18-34(23(2)21-35)31(36)17-27-16-28(32-40(4,37)38)14-15-29(27)39-30(22)20-33(3)19-24-10-12-26(13-11-24)25-8-6-5-7-9-25/h5-16,22-23,30,32,35H,17-21H2,1-4H3/t22-,23+,30-/m0/s1",
      "inchiKeyParent": "XYJNBNRQTGEDGH-BURCIIJTSA-N",
      "smilesParent": "C[C@H](CO)N1C[C@H](C)[C@H](CN(C)Cc2ccc(cc2)c3ccccc3)Oc4ccc(NS(=O)(=O)C)cc4CC1=O"
    },
    "unichem": {
      "chebi": "130232",
      "lincs": "LSM-41781",
      "pubchem": "44484438"
    },
    "pubchem": [
      {
        "cid": 44484438,
        "inchi": "InChI=1S/C31H39N3O5S/c1-22-18-34(23(2)21-35)31(36)17-27-16-28(32-40(4,37)38)14-15-29(27)39-30(22)20-33(3)19-24-10-12-26(13-11-24)25-8-6-5-7-9-25/h5-16,22-23,30,32,35H,17-21H2,1-4H3/t22-,23+,30-/m0/s1",
        "inchikey": "XYJNBNRQTGEDGH-BURCIIJTSA-N",
        "iupac": {
          "systematic": "N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]methanesulfonamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)CC2=C(C=CC(=C2)NS(=O)(=O)C)OC1CN(C)CC3=CC=C(C=C3)C4=CC=CC=C4)C(C)CO"
        },
        "molecularFormula": "C31H39N3O5S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:20:44Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8272"
    },
    "name": "BRD-K16339566",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8272.png",
    "lincs": {
      "id": "LSM-9413",
      "name": "BRD-K16339566",
      "pubchemCid": 54631308,
      "chebiId": 98034,
      "inchiParent": "InChI=1S/C23H35N3O5/c1-15-12-24-16(2)14-31-20-11-18(25-22(27)17-7-9-30-10-8-17)5-6-19(20)23(28)26(3)13-21(15)29-4/h5-6,11,15-17,21,24H,7-10,12-14H2,1-4H3,(H,25,27)/t15-,16-,21+/m1/s1",
      "inchiKeyParent": "BIFUFKYMXIZDEA-ZOCZFRKYSA-N",
      "smilesParent": "CO[C@H]1CN(C)C(=O)c2ccc(NC(=O)C3CCOCC3)cc2OC[C@@H](C)NC[C@H]1C"
    },
    "unichem": {
      "chebi": "98034",
      "lincs": "LSM-9413",
      "pubchem": "54631308"
    },
    "pubchem": [
      {
        "cid": 54631308,
        "inchi": "InChI=1S/C23H35N3O5/c1-15-12-24-16(2)14-31-20-11-18(25-22(27)17-7-9-30-10-8-17)5-6-19(20)23(28)26(3)13-21(15)29-4/h5-6,11,15-17,21,24H,7-10,12-14H2,1-4H3,(H,25,27)/t15-,16-,21+/m1/s1",
        "inchikey": "BIFUFKYMXIZDEA-ZOCZFRKYSA-N",
        "iupac": {
          "systematic": "N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-15-yl]oxane-4-carboxamide"
        },
        "smiles": {
          "canonical": "CC1CNC(COC2=C(C=CC(=C2)NC(=O)C3CCOCC3)C(=O)N(CC1OC)C)C"
        },
        "molecularFormula": "C23H35N3O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:20:46Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8290"
    },
    "name": "BRD-K97633445",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8290.png",
    "lincs": {
      "id": "LSM-14427",
      "name": "BRD-K97633445",
      "pubchemCid": 54654320,
      "chebiId": 103082,
      "inchiParent": "InChI=1S/C26H31N3O6/c1-15-9-16(2)11-18(10-15)28-26(32)27-17-5-8-22-20(12-17)25(31)29(3)21-7-6-19(13-24(30)33-4)35-23(21)14-34-22/h5,8-12,19,21,23H,6-7,13-14H2,1-4H3,(H2,27,28,32)/t19-,21-,23+/m1/s1",
      "inchiKeyParent": "ANPNCKARMDTJMY-LSWJPFSZSA-N",
      "smilesParent": "COC(=O)C[C@H]1CC[C@@H]2[C@H](COc3ccc(NC(=O)Nc4cc(C)cc(C)c4)cc3C(=O)N2C)O1"
    },
    "unichem": {
      "chebi": "103082",
      "lincs": "LSM-14427",
      "pubchem": "54654320"
    },
    "pubchem": [
      {
        "cid": 54654320,
        "inchi": "InChI=1S/C26H31N3O6/c1-15-9-16(2)11-18(10-15)28-26(32)27-17-5-8-22-20(12-17)25(31)29(3)21-7-6-19(13-24(30)33-4)35-23(21)14-34-22/h5,8-12,19,21,23H,6-7,13-14H2,1-4H3,(H2,27,28,32)/t19-,21-,23+/m1/s1",
        "inchikey": "ANPNCKARMDTJMY-LSWJPFSZSA-N",
        "iupac": {
          "systematic": "methyl 2-[(2R,4aR,12aR)-8-[(3,5-dimethylphenyl)carbamoylamino]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]acetate"
        },
        "smiles": {
          "canonical": "CC1=CC(=CC(=C1)NC(=O)NC2=CC3=C(C=C2)OCC4C(CCC(O4)CC(=O)OC)N(C3=O)C)C"
        },
        "molecularFormula": "C26H31N3O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:20:48Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82b3"
    },
    "name": "BRD-K23688566",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82b3.png",
    "lincs": {
      "id": "LSM-9854",
      "name": "BRD-K23688566",
      "pubchemCid": 54638433,
      "chebiId": 98475,
      "inchiParent": "InChI=1S/C20H29N3O5/c1-23(2)12-20(26)22-16-9-8-15(28-18(16)13-24)10-19(25)21-11-14-6-4-5-7-17(14)27-3/h4-9,15-16,18,24H,10-13H2,1-3H3,(H,21,25)(H,22,26)/t15-,16-,18-/m1/s1",
      "inchiKeyParent": "YJKUDHPPBXQQCK-JFIYKMOQSA-N",
      "smilesParent": "COc1ccccc1CNC(=O)C[C@@H]2O[C@H](CO)[C@H](NC(=O)CN(C)C)C=C2"
    },
    "unichem": {
      "chebi": "98475",
      "lincs": "LSM-9854",
      "pubchem": "54638433"
    },
    "pubchem": [
      {
        "cid": 54638433,
        "inchi": "InChI=1S/C20H29N3O5/c1-23(2)12-20(26)22-16-9-8-15(28-18(16)13-24)10-19(25)21-11-14-6-4-5-7-17(14)27-3/h4-9,15-16,18,24H,10-13H2,1-3H3,(H,21,25)(H,22,26)/t15-,16-,18-/m1/s1",
        "inchikey": "YJKUDHPPBXQQCK-JFIYKMOQSA-N",
        "iupac": {
          "systematic": "2-[(2S,3R,6S)-3-[[2-(dimethylamino)acetyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[(2-methoxyphenyl)methyl]acetamide"
        },
        "smiles": {
          "canonical": "CN(C)CC(=O)NC1C=CC(OC1CO)CC(=O)NCC2=CC=CC=C2OC"
        },
        "molecularFormula": "C20H29N3O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:20:50Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82f2"
    },
    "name": "CHEMBL2132048",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82f2.png",
    "lincs": {
      "id": "LSM-7630",
      "name": "CHEMBL2132048",
      "alternativeNames": [
        "BRD-K59155687"
      ],
      "pubchemCid": 54618353,
      "chebiId": 96251,
      "inchiParent": "InChI=1S/C27H31FN2O5S/c1-18-15-30(19(2)17-31)36(33,34)26-12-11-21(10-9-20-7-8-20)13-24(26)35-25(18)16-29(3)27(32)22-5-4-6-23(28)14-22/h4-6,11-14,18-20,25,31H,7-8,15-17H2,1-3H3/t18-,19-,25-/m1/s1",
      "inchiKeyParent": "VIOYSSVCFLGZJY-MPCDZSKCSA-N",
      "smilesParent": "C[C@H](CO)N1C[C@@H](C)[C@@H](CN(C)C(=O)c2cccc(F)c2)Oc3cc(ccc3S1(=O)=O)C#CC4CC4"
    },
    "unichem": {
      "chebi": "96251",
      "chembl": "CHEMBL2132048",
      "lincs": "LSM-7630",
      "pubchem": "54618353"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL2132048",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 514.62,
        "hba": 5,
        "hbd": 1,
        "qedWeighted": 0.62
      }
    },
    "pubchem": [
      {
        "cid": 54618353,
        "inchi": "InChI=1S/C27H31FN2O5S/c1-18-15-30(19(2)17-31)36(33,34)26-12-11-21(10-9-20-7-8-20)13-24(26)35-25(18)16-29(3)27(32)22-5-4-6-23(28)14-22/h4-6,11-14,18-20,25,31H,7-8,15-17H2,1-3H3/t18-,19-,25-/m1/s1",
        "inchikey": "VIOYSSVCFLGZJY-MPCDZSKCSA-N",
        "iupac": {
          "systematic": "N-[[(4R,5S)-8-(2-cyclopropylethynyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-3-fluoro-N-methylbenzamide"
        },
        "smiles": {
          "canonical": "CC1CN(S(=O)(=O)C2=C(C=C(C=C2)C#CC3CC3)OC1CN(C)C(=O)C4=CC(=CC=C4)F)C(C)CO"
        },
        "molecularFormula": "C27H31FN2O5S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:21:01Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c830f"
    },
    "name": "Vemurafenib",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c830f.png",
    "lincs": {
      "id": "LSM-1068",
      "name": "Vemurafenib",
      "alternativeNames": [
        "PLX4032",
        "PLX-4032",
        "RG-7204",
        "RO-5185426",
        "RO-51-85426",
        "Vemurafenib",
        "Vemurafenib (plx4032, rg7204)",
        "Zelboraf"
      ],
      "pubchemCid": 42611257,
      "chebiId": 63637,
      "inchiParent": "InChI=1S/C23H18ClF2N3O3S/c1-2-9-33(31,32)29-19-8-7-18(25)20(21(19)26)22(30)17-12-28-23-16(17)10-14(11-27-23)13-3-5-15(24)6-4-13/h3-8,10-12,29H,2,9H2,1H3,(H,27,28)",
      "inchiKeyParent": "GPXBXXGIAQBQNI-UHFFFAOYSA-N",
      "smilesParent": "CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(cc23)c4ccc(Cl)cc4)c1F"
    },
    "unichem": {
      "chebi": "63637",
      "chembl": "CHEMBL1229517",
      "lincs": "LSM-1068",
      "pubchem": "42611257",
      "drugbank": "DB08881"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL1229517",
      "prefName": "VEMURAFENIB",
      "maxPhase": 4.0,
      "maxPhaseCurated": "Approved",
      "firstApproval": 2011,
      "chebiParId": "63637",
      "oral": true,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 489.93,
        "hba": 4,
        "hbd": 2,
        "qedWeighted": 0.33
      },
      "moleculeSynonyms": [
        {
          "moleculeSynonym": "PLX-4032",
          "synType": "RESEARCH_CODE",
          "synonyms": "PLX-4032"
        },
        {
          "moleculeSynonym": "PLX4032",
          "synType": "RESEARCH_CODE",
          "synonyms": "PLX4032"
        },
        {
          "moleculeSynonym": "RG 7204",
          "synType": "RESEARCH_CODE",
          "synonyms": "RG 7204"
        },
        {
          "moleculeSynonym": "RG-7204",
          "synType": "RESEARCH_CODE",
          "synonyms": "RG-7204"
        },
        {
          "moleculeSynonym": "RO 5185426",
          "synType": "RESEARCH_CODE",
          "synonyms": "RO 5185426"
        },
        {
          "moleculeSynonym": "RO-51-85426",
          "synType": "RESEARCH_CODE",
          "synonyms": "RO-51-85426"
        },
        {
          "moleculeSynonym": "RO-5185426",
          "synType": "RESEARCH_CODE",
          "synonyms": "RO-5185426"
        },
        {
          "moleculeSynonym": "Vemurafenib",
          "synType": "ATC",
          "synonyms": "VEMURAFENIB"
        },
        {
          "moleculeSynonym": "Vemurafenib",
          "synType": "BNF",
          "synonyms": "VEMURAFENIB"
        },
        {
          "moleculeSynonym": "Vemurafenib",
          "synType": "EMA",
          "synonyms": "VEMURAFENIB"
        },
        {
          "moleculeSynonym": "Vemurafenib",
          "synType": "FDA",
          "synonyms": "VEMURAFENIB"
        },
        {
          "moleculeSynonym": "Vemurafenib",
          "synType": "INN",
          "synonyms": "VEMURAFENIB"
        },
        {
          "moleculeSynonym": "Vemurafenib",
          "synType": "MERCK_INDEX",
          "synonyms": "VEMURAFENIB"
        },
        {
          "moleculeSynonym": "Vemurafenib",
          "synType": "OTHER",
          "synonyms": "VEMURAFENIB"
        },
        {
          "moleculeSynonym": "Vemurafenib",
          "synType": "USAN",
          "synonyms": "VEMURAFENIB"
        },
        {
          "moleculeSynonym": "Zelboraf",
          "synType": "TRADE_NAME",
          "synonyms": "Zelboraf"
        }
      ],
      "drugIndications": [
        {
          "efoId": "EFO:0000756",
          "efoTerm": "melanoma",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT00949702,NCT01006980,NCT01271803,NCT01307397,NCT01378975,NCT01400451,NCT01474551,NCT01519323,NCT01585415,NCT01586195,NCT01597908,NCT01603212,NCT01611675,NCT01638676,NCT01656642,NCT01657591,NCT01667419,NCT01673854,NCT01689519,NCT01754376,NCT01765543,NCT01765556,NCT01765569,NCT01781026,NCT01813214,NCT01835184,NCT01843738,NCT01844674,NCT01849666,NCT01851824,NCT01897116,NCT01898585,NCT01909453,NCT01910181,NCT01942993,NCT01943422,NCT01959633,NCT01983124,NCT02036086,NCT02042040,NCT02050321,NCT02068079,NCT02145910,NCT02230306,NCT02303951,NCT02427893,NCT02441465,NCT02537600,NCT02583516,NCT02721459,NCT02818023,NCT02902029,NCT02908672,NCT02968303,NCT03005639,NCT03101254,NCT04722575,NCT05263453"
            ]
          },
          "maxPhaseForInd": 4.0,
          "meshHeading": "Melanoma"
        },
        {
          "efoId": "EFO:0002617",
          "efoTerm": "metastatic melanoma",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT01495988,NCT01512251,NCT01659151,NCT01683188,NCT01826448,NCT01876641,NCT02052193,NCT02095652,NCT02354690,NCT02414750,NCT02608034,NCT02768207,NCT03625141"
            ]
          },
          "maxPhaseForInd": 4.0,
          "meshHeading": "Melanoma"
        },
        {
          "efoId": "EFO:0001378",
          "efoTerm": "multiple myeloma",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT01524978,NCT02115035"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Multiple Myeloma"
        },
        {
          "efoId": "EFO:0000616",
          "efoTerm": "neoplasm",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT01286753,NCT01673737,NCT01739764,NCT01767623,NCT01771458,NCT01974258,NCT03239015,NCT03781219,NCT04423185"
            ]
          },
          "maxPhaseForInd": 4.0,
          "meshHeading": "Neoplasms"
        },
        {
          "efoId": "EFO:0000326",
          "efoTerm": "central nervous system cancer",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT01748149"
            ]
          },
          "maxPhaseForInd": 0.5,
          "meshHeading": "Glioma"
        },
        {
          "efoId": "EFO:0003060",
          "efoTerm": "non-small cell lung carcinoma",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT02314481,NCT03178552,NCT04302025,NCT05900219"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Carcinoma, Non-Small-Cell Lung"
        },
        {
          "efoId": "EFO:0000222",
          "efoTerm": "acute myeloid leukemia",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT02638428"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Leukemia, Myeloid, Acute"
        },
        {
          "efoId": "EFO:0000389",
          "efoTerm": "cutaneous melanoma",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT03224208,NCT03554083"
            ]
          },
          "maxPhaseForInd": 4.0,
          "meshHeading": "Melanoma"
        },
        {
          "efoId": "EFO:0000574",
          "efoTerm": "lymphoma",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT03013491"
            ]
          },
          "maxPhaseForInd": 1.0,
          "meshHeading": "Lymphoma"
        },
        {
          "efoId": "EFO:1000209",
          "efoTerm": "Craniopharyngioma",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT03224767"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Craniopharyngioma"
        },
        {
          "efoId": "EFO:1000956",
          "efoTerm": "hairy cell leukemia",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT01711632,NCT03410875,NCT05388123"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Leukemia, Hairy Cell"
        },
        {
          "efoId": "EFO:1001951",
          "efoTerm": "colorectal carcinoma",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT02164916,NCT02291289,NCT03727763,NCT05233332"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Colorectal Neoplasms"
        },
        {
          "efoId": "EFO:0000365",
          "efoTerm": "colorectal adenocarcinoma",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT01787500"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Colorectal Neoplasms"
        },
        {
          "efoId": "EFO:1000318",
          "efoTerm": "Langerhans Cell Histiocytosis",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT03585686"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Histiocytosis, Langerhans-Cell"
        },
        {
          "efoId": "MONDO:0002108",
          "efoTerm": "thyroid cancer",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT01709292,NCT02456701"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Thyroid Neoplasms"
        },
        {
          "efoId": "EFO:0002892",
          "efoTerm": "thyroid carcinoma",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT03181100"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Thyroid Neoplasms"
        },
        {
          "efoId": "HP:0100727",
          "efoTerm": "Histiocytosis",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT04943198"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Histiocytosis"
        },
        {
          "efoId": "MONDO:0002898",
          "efoTerm": "skin cancer",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT02721459"
            ]
          },
          "maxPhaseForInd": 1.0,
          "meshHeading": "Skin Neoplasms"
        },
        {
          "efoId": "EFO:0002618",
          "efoTerm": "pancreatic carcinoma",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT05068752"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Pancreatic Neoplasms"
        },
        {
          "efoId": "EFO:0001642",
          "efoTerm": "lymphoid neoplasm",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT05722886"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Hematologic Neoplasms"
        },
        {
          "efoId": "MONDO:0004992",
          "efoTerm": "cancer",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT01596140,NCT01616199,NCT01636622,NCT02925234,NCT03498521,NCT04341181,NCT04551521,NCT05159245"
            ]
          },
          "maxPhaseForInd": 4.0,
          "meshHeading": "Neoplasms"
        }
      ],
      "drugMechanisms": [
        {
          "mechanismOfAction": "Serine/threonine-protein kinase B-raf inhibitor",
          "actionType": "INHIBITOR",
          "targetName": "Serine/threonine-protein kinase B-raf",
          "targetOrganism": "Homo sapiens",
          "targetType": "SINGLE PROTEIN",
          "targetComponents": [
            {
              "uniprot": [
                "P15056"
              ]
            }
          ]
        }
      ]
    },
    "pubchem": [
      {
        "cid": 42611257,
        "inchi": "InChI=1S/C23H18ClF2N3O3S/c1-2-9-33(31,32)29-19-8-7-18(25)20(21(19)26)22(30)17-12-28-23-16(17)10-14(11-27-23)13-3-5-15(24)6-4-13/h3-8,10-12,29H,2,9H2,1H3,(H,27,28)",
        "inchikey": "GPXBXXGIAQBQNI-UHFFFAOYSA-N",
        "iupac": {
          "systematic": "N-[3-[5-(4-chlorophenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluorophenyl]propane-1-sulfonamide"
        },
        "smiles": {
          "canonical": "CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=C2C=C(C=N3)C4=CC=C(C=C4)Cl)F"
        },
        "molecularFormula": "C23H18ClF2N3O3S"
      }
    ],
    "clinicaltrials": [
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT03013491",
            "briefTitle": "PROCLAIM-CX-072: A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas",
            "officialTitle": "An Open-Label, Dose-Finding and Proof of Concept Study of the PD-L1 Probody\u2122 Therapeutic , CX-072, as Monotherapy and in Combination With Yervoy (Ipilimumab) or With Zelboraf (Vemurafenib) in Subjects With Advanced or Recurrent Solid Tumors or Lymphomas"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2016-12-26"
          },
          "conditionsModule": {
            "conditions": [
              "Solid Tumor",
              "Lymphoma"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "The number of subjects experiencing a dose limiting toxicity at various dose levels when given multiple doses of CX-072 as a monotherapy or in combination with ipilimumab or vemurafenib",
                "timeFrame": "28 days (dose limiting toxicity period)"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "The percentage of subjects experiencing anti-cancer activity (ORR) at various dose levels when given multiple doses of CX-072 as a monotherapy or in combination with ipilimumab or vemurafenib"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT06692491",
            "briefTitle": "Study of Precision Treatment for Rare Tumours in China Guided by PDO and NGS",
            "officialTitle": "A Phase II Clinical Study on Precision Treatment of Rare Tumours in China Guided by Patient-Derived Tumor Organoids (PDO) and Next-Generation Sequencing (NGS)"
          },
          "statusModule": {
            "overallStatus": "NOT_YET_RECRUITING",
            "studyFirstSubmitDate": "2024-09-16"
          },
          "conditionsModule": {
            "conditions": [
              "Rare Tumour"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Objective Response Rate (ORR)",
                "timeFrame": "From enrollment to the end of treatment at 8 weeks"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Disease Control Rate (DCR)"
              },
              {
                "measure": "Progression free survival (PFS)"
              },
              {
                "measure": "Overall survival (OS)"
              },
              {
                "measure": "Duration of response (DOR)"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01638676",
            "briefTitle": "A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients",
            "officialTitle": "A Phase I/II Trial of Vemurafenib and Metformin to Unresectable Stage IIIC and Stage IV BRAF.V600E+ Melanoma Patients"
          },
          "statusModule": {
            "overallStatus": "RECRUITING",
            "studyFirstSubmitDate": "2012-06-01"
          },
          "conditionsModule": {
            "conditions": [
              "Melanoma"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Observation of CTCAE grade 4 or higher adverse events in six patients",
                "timeFrame": "Duration of phase I portion, approximately six months"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Overall Survival Follow up"
              },
              {
                "measure": "Number of adverse events"
              },
              {
                "measure": "type of adverse events"
              },
              {
                "measure": "Objective response rate (ORR)as measure of efficacy"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01657591",
            "briefTitle": "Study of XL888 With Vemurafenib for Patients With Unresectable BRAF Mutated Stage III/IV Melanoma",
            "officialTitle": "Phase I Study of Escalating Doses of XL888 With Vemurafenib for Patients With Unresectable BRAF Mutated Stage III/IV Melanoma"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2012-08-02"
          },
          "conditionsModule": {
            "conditions": [
              "Melanoma"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Maximum Tolerated Dose (MTD) and Recommended Phase II Dose (RP2D)",
                "timeFrame": "Average of 36 weeks"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Progression Free Survival (PFS) Rate"
              },
              {
                "measure": "Overall Survival (OS) Rate"
              },
              {
                "measure": "Best Overall Response Rate (ORR)"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01754376",
            "briefTitle": "Combined BRAF-Targeted Therapy & Immunotherapy for Melanoma",
            "officialTitle": "COMBAT 1: A Phase II Trial of Combined BRAF-Targeted Therapy and Immunotherapy for Melanoma"
          },
          "statusModule": {
            "overallStatus": "TERMINATED",
            "whyStopped": "changes in available treatments for melanoma",
            "studyFirstSubmitDate": "2012-12-16",
            "resultsFirstSubmitDate": "2017-01-18"
          },
          "conditionsModule": {
            "conditions": [
              "Melanoma"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Progression Free Survival",
                "timeFrame": "3 years"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Overall Response Rate"
              },
              {
                "measure": "Overall Survival"
              },
              {
                "measure": "Number of Participants Experiencing Grade 3 (Severe) Adverse Events"
              },
              {
                "measure": "Mean Percentage of Aldesleukin Doses Received Per Participant"
              },
              {
                "measure": "Ratio of CD8+ T Cells to Regulatory T Cells"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01006980",
            "briefTitle": "A Study of Vemurafenib (RO5185426) in Comparison With Dacarbazine in Previously Untreated Patients With Metastatic Melanoma (BRIM 3)",
            "officialTitle": "BRIM 3: A Randomized, Open-Label, Controlled, Multicenter, Phase III Study in Previously Untreated Patients With Unresectable Stage IIIC or Stage IV Melanoma With V600E BRAF Mutation Receiving Vemurafenib (RO5185426) or Dacarbazine"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2009-10-30",
            "resultsFirstSubmitDate": "2011-07-29"
          },
          "conditionsModule": {
            "conditions": [
              "Malignant Melanoma"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Overall Survival",
                "timeFrame": "From randomization (initiated January 2010) to December 30 2010. Median follow-up time in the vemurafenib group was 3.75 months (range 0.3 to 10.8) and in the dacarbazine group was 2.33 months (range <0.1 to 10.3)."
              },
              {
                "measure": "Progression-free Survival",
                "timeFrame": "From randomization (initiated January 2010) to December 30 2010."
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Participants With a Best Overall Response (BOR) of Complete Response or Partial Response"
              },
              {
                "measure": "Duration of Response"
              },
              {
                "measure": "Time to Confirmed Response"
              },
              {
                "measure": "Time to Treatment Failure"
              },
              {
                "measure": "Number of Participants With Adverse Events (AEs)"
              },
              {
                "measure": "Pre and Post-dose Plasma Vemurafenib Concentration by Study Day"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT04790448",
            "briefTitle": "Efficacy of VIC Regimen in BRAF Mutant Metastatic Colorectal Cancer",
            "officialTitle": "A Phase Ia/II, Single Arm Trial on the Efficacy of Vemurafenib in Combination With Irinotecan and Cetuximab in BRAF V600E-Mutant Metastatic Colorectal Cancer"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2021-03-07"
          },
          "conditionsModule": {
            "conditions": [
              "Colorectal Cancer Metastatic"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Overall response rate from the date of first drug administration until the date of first documented progression or date of death, whichever came first.",
                "timeFrame": "up to 17 months"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Progression free survival from the date of first drug administration until the date of first documented progression or date of death, whichever came first."
              },
              {
                "measure": "Overall Survival from the date of first drug administration until the date of death from any cause."
              },
              {
                "measure": "Number of patients with adverse events and severity according to NCI CTCAE v5.0"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT03155620",
            "briefTitle": "Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)",
            "officialTitle": "NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) Screening Protocol"
          },
          "statusModule": {
            "overallStatus": "ACTIVE_NOT_RECRUITING",
            "studyFirstSubmitDate": "2017-05-15"
          },
          "conditionsModule": {
            "conditions": [
              "Advanced Malignant Solid Neoplasm",
              "Ann Arbor Stage III Non-Hodgkin Lymphoma",
              "Ann Arbor Stage IV Non-Hodgkin Lymphoma",
              "Histiocytic Sarcoma",
              "Juvenile Xanthogranuloma",
              "Langerhans Cell Histiocytosis",
              "Malignant Glioma",
              "Recurrent Childhood Rhabdomyosarcoma",
              "Recurrent Ependymoma",
              "Recurrent Ewing Sarcoma",
              "Recurrent Glioma",
              "Recurrent Hepatoblastoma",
              "Recurrent Langerhans Cell Histiocytosis",
              "Recurrent Malignant Germ Cell Tumor",
              "Recurrent Malignant Solid Neoplasm",
              "Recurrent Medulloblastoma",
              "Recurrent Neuroblastoma",
              "Recurrent Non-Hodgkin Lymphoma",
              "Recurrent Osteosarcoma",
              "Recurrent Peripheral Primitive Neuroectodermal Tumor",
              "Recurrent Primary Central Nervous System Neoplasm",
              "Recurrent Rhabdoid Tumor",
              "Recurrent Soft Tissue Sarcoma",
              "Refractory Ewing Sarcoma",
              "Refractory Glioma",
              "Refractory Hepatoblastoma",
              "Refractory Langerhans Cell Histiocytosis",
              "Refractory Malignant Germ Cell Tumor",
              "Refractory Malignant Solid Neoplasm",
              "Refractory Medulloblastoma",
              "Refractory Neuroblastoma",
              "Refractory Non-Hodgkin Lymphoma",
              "Refractory Osteosarcoma",
              "Refractory Peripheral Primitive Neuroectodermal Tumor",
              "Refractory Primary Central Nervous System Neoplasm",
              "Refractory Rhabdoid Tumor",
              "Refractory Rhabdomyosarcoma",
              "Rhabdoid Tumor",
              "Stage III Osteosarcoma AJCC v7",
              "Stage III Soft Tissue Sarcoma AJCC v7",
              "Stage IV Osteosarcoma AJCC v7",
              "Stage IV Soft Tissue Sarcoma AJCC v7",
              "Stage IVA Osteosarcoma AJCC v7",
              "Stage IVB Osteosarcoma AJCC v7",
              "Wilms Tumor"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Objective response rate (complete response/partial response)",
                "timeFrame": "From enrollment to the end of treatment, up to 2 years on subprotocol"
              },
              {
                "measure": "Proportion of pediatric patients whose advanced tumors have pathway alterations that can be targeted by select anti-cancer drugs",
                "timeFrame": "Up to 4 years"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Percentage of patients with grade 3 or 4 adverse events"
              },
              {
                "measure": "Incidence of research biopsy related target toxicity"
              },
              {
                "measure": "Progression free survival (PFS)"
              },
              {
                "measure": "Pharmacokinetic (PK) parameters"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01826448",
            "briefTitle": "A Phase 1b Open Label, Dose Escalation Study of PLX3397 in Combination With Vemurafenib in V600-mutated BRAF Melanoma",
            "officialTitle": "A Phase 1b Open Label, Dose Escalation Study to Assess Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of PLX3397 in Combination With Vemurafenib in V600-mutated BRAF Unresectable or Metastatic Melanoma"
          },
          "statusModule": {
            "overallStatus": "TERMINATED",
            "whyStopped": "No activity was observed. BRAFi-na\u00efve participants should have received triple combination treatment (including MEK inhibitor). Continuation was not justified.",
            "studyFirstSubmitDate": "2013-04-01",
            "resultsFirstSubmitDate": "2020-05-12"
          },
          "conditionsModule": {
            "conditions": [
              "V600-mutated BRAF Unresectable Melanoma",
              "V600-mutated BRAF Metastatic Melanoma",
              "Stage III or Stage IV Metastatic Melanoma That Has Not Been Previously Treated With a Selective BRAF Inhibitor"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Percentage of Participants With Adverse Events Who Received PLX3397 in Combination With Vemurafenib in V600-mutated BRAF Melanoma",
                "timeFrame": "1 year"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01990248",
            "briefTitle": "An Observational Safety Study in Zelboraf (Vemurafenib)-Treated Patients With BRAF-V600 Mutation-Positive Unresectable or Metastatic Melanoma (ZeSS)",
            "officialTitle": "ZeSS: A Prospective Observational Safety Study of Patients With BRAF-V600 Mutation-positive Unresectable or Metastatic Melanoma Treated With Vemurafenib (Zelboraf\u00ae)"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2013-11-15"
          },
          "conditionsModule": {
            "conditions": [
              "Malignant Melanoma"
            ]
          },
          "designModule": {
            "studyType": "OBSERVATIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Incidence of non-cutaneous squamous cell carcinoma",
                "timeFrame": "2 years"
              },
              {
                "measure": "Incidence of cutaneous squamous cell carcinoma",
                "timeFrame": "2 years"
              },
              {
                "measure": "Incidence of QT prolongation (defined as QTc >500 ms or an increase in QTc >60 ms)",
                "timeFrame": "2 years"
              },
              {
                "measure": "Incidence of abnormal liver function",
                "timeFrame": "2 years"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Incidence of a second (or subsequent) primary melanoma"
              },
              {
                "measure": "Incidence of gastrointestinal polyps"
              },
              {
                "measure": "Incidence of adverse events"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02441465",
            "briefTitle": "Bioavailability Study of Vemurafenib in Participants With BRAF^V600 Mutation-Positive Malignancies",
            "officialTitle": "A Phase 1, Open-Label, Absolute Bioavailability Study of Vemurafenib in Patients With BRAF^V600 Mutation-Positive Malignancies"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2015-04-30"
          },
          "conditionsModule": {
            "conditions": [
              "Malignant Melanoma, Cancer"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Area Under the Concentration-Time Curve (AUC) of 14C-Labeled Vemurafenib From Time 0 to Last Measurable Concentration Timepoint (AUC0-last)",
                "timeFrame": "Day 21: Predose (Hour 0); end of infusion (infusion duration: 15 minutes); 5, 15 and 30 minutes post-infusion; 1, 2, 3, 4, 6, 8, 12, 24, 48, 72, 96, 120, 168 hours post-infusion of 14C-labeled vemurafenib"
              },
              {
                "measure": "AUC of 14C-Labeled Vemurafenib From Time 0 to Infinity (AUC0-inf)",
                "timeFrame": "Day 21: Predose (Hour 0); end of infusion (infusion duration: 15 minutes); 5, 15 and 30 minutes post-infusion; 1, 2, 3, 4, 6, 8, 12, 24, 48, 72, 96, 120, 168 hours post-infusion of 14C-labeled vemurafenib"
              },
              {
                "measure": "AUC of Unlabeled Vemurafenib During the Dosing Interval (AUCtau)",
                "timeFrame": "Predose (0 hour) on Days 18, 19, 20; Day 21: pre-dose (0 hour), 15 minutes after oral dose (at the end of IV infusion), at 30 and 45 minutes, and 1.15, 2.25, 3.25, 4.25, 6.25, 8.25, and 12 hours following oral administration of unlabeled vemurafenib"
              },
              {
                "measure": "Maximum Observed Plasma Concentration (Cmax) of 14C-Labeled Vemurafenib",
                "timeFrame": "Day 21: Predose (Hour 0); end of infusion (infusion duration: 15 minutes); 5, 15 and 30 minutes post-infusion; 1, 2, 3, 4, 6, 8, 12, 24, 48, 72, 96, 120, 168 hours post-infusion of 14C-labeled vemurafenib"
              },
              {
                "measure": "Terminal Half-Life (t1/2) of 14C-Labeled Vemurafenib",
                "timeFrame": "Day 21: Predose (Hour 0); end of infusion (infusion duration: 15 minutes); 5, 15 and 30 minutes post-infusion; 1, 2, 3, 4, 6, 8, 12, 24, 48, 72, 96, 120, 168 hours post-infusion of 14C-labeled vemurafenib"
              },
              {
                "measure": "Clearance (CL) of 14C-Labeled Vemurafenib",
                "timeFrame": "Day 21: Predose (Hour 0); end of infusion (infusion duration: 15 minutes); 5, 15 and 30 minutes post-infusion; 1, 2, 3, 4, 6, 8, 12, 24, 48, 72, 96, 120, 168 hours post-infusion of 14C-labeled vemurafenib"
              },
              {
                "measure": "Volume of Distribution (V) of 14C-Labeled Vemurafenib",
                "timeFrame": "Day 21: Predose (Hour 0); end of infusion (infusion duration: 15 minutes); 5, 15 and 30 minutes post-infusion; 1, 2, 3, 4, 6, 8, 12 hours post-infusion of 14C-labeled vemurafenib"
              },
              {
                "measure": "Absolute Bioavailability (%F) of Vemurafenib",
                "timeFrame": "Day 21 (detailed timeframe is provided in description field)"
              },
              {
                "measure": "Renal Clearance (CLr) of 14C-Labeled Vemurafenib",
                "timeFrame": "Day 21 (urine samples): Predose (-8 to 0 hour), 0-4, 4-12, 12-24, 24-48, 48-72, 72-96 hours post-infusion (infusion duration: 15 minutes) of 14C-labeled vemurafenib"
              },
              {
                "measure": "Total Amount of 14C-Labeled Vemurafenib (Parent Drug) Excreted Into Urine",
                "timeFrame": "Day 21 (urine samples): Predose (-8 to 0 hour), 0-4, 4-12, 12-24, 24-48, 48-72, 72-96 hours post-infusion (infusion duration: 15 minutes) of 14C-labeled vemurafenib"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Percentage of Participants With Adverse Events (AEs) and Serious Adverse Events (SAEs)"
              },
              {
                "measure": "Cmax of Unlabeled Vemurafenib"
              },
              {
                "measure": "Time to Maximum Concentration (Tmax) of Unlabeled Vemurafenib"
              },
              {
                "measure": "Percentage of 14C-Labeled Vemurafenib Dose Recovered as Total Radioactivity in Urine"
              },
              {
                "measure": "Percentage of 14C-Labeled Vemurafenib Dose Recovered as Total Radioactivity in Feces"
              },
              {
                "measure": "14C-Labeled Vemurafenib Concentration Over Time Intervals in Urine"
              },
              {
                "measure": "14C-Labeled Vemurafenib Concentration Over Time Intervals in Feces"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01781026",
            "briefTitle": "Phase 2 Study of Neoadjuvant Vemurafenib in Melanoma Patients With Untreated Brain Metastases",
            "officialTitle": "A Phase 2 Study of Neoadjuvant Vemurafenib in Melanoma Patients With Untreated Brain Metastases, Whose Tumors Harbor B-raf Mutations"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2013-01-29",
            "resultsFirstSubmitDate": "2015-03-10"
          },
          "conditionsModule": {
            "conditions": [
              "Melanoma"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Activity of Vemurafenib in Untreated Brain Metastases",
                "timeFrame": "1 year"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT03005639",
            "briefTitle": "ML29255 Neoadjuvant Vemurafenib and Cobimetinib Melanoma",
            "officialTitle": "Neoadjuvant Vemurafenib and Cobimetinib in BRAF V600 Mutant Stage IIIB-C Melanoma"
          },
          "statusModule": {
            "overallStatus": "WITHDRAWN",
            "whyStopped": "Sponsor has decided to close study.",
            "studyFirstSubmitDate": "2016-05-02"
          },
          "conditionsModule": {
            "conditions": [
              "Stage IIIB-C Melanoma"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Radiologic Complete Response Rate",
                "timeFrame": "Day 56 (+/- 3 days)"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Overall response rate, pathologic complete response rate"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02038348",
            "briefTitle": "Interest of the 18F-DOPA-PET Imaging in Metastatic Melanoma Treated With B-RAF Inhibitors: a Pilot Study",
            "officialTitle": "Interest of the 18F-DOPA-PET Imaging in Metastatic Melanoma Treated With B-RAF Inhibitors: a Pilot Study"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2013-12-03"
          },
          "conditionsModule": {
            "conditions": [
              "Metastatic Melanoma"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "brain metastases metabolic profile obtained with PET 18F-FDOPA",
                "timeFrame": "24 MONTHS"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01164891",
            "briefTitle": "A Pharmacokinetic and Metabolism Study of 14C-labeled RO5185426 on Patients With Metastatic Melanoma",
            "officialTitle": "A Phase I, Open-label, Excretion Balance, Pharmacokinetic and Metabolism Study After Single Oral Dose of 14C-labeled RO5185426 in Previously Treated and Untreated Patients With Metastatic Melanoma"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2010-07-16",
            "resultsFirstSubmitDate": "2015-07-29"
          },
          "conditionsModule": {
            "conditions": [
              "Malignant Melanoma"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Plasma RO5185426 Trough Concentrations on Days 15,16, and 17",
                "timeFrame": "Pre-dose on Days 15, 16 and 17"
              },
              {
                "measure": "Maximum Plasma Concentration of 14C-labeled RO5185426 (Cmax) in Both Blood and Plasma",
                "timeFrame": "0 hour (prior to evening dose) on Day 14; 0 hour (pre dose), 1, 2, 4, 6, 12, 24, 36, 48, 72, 96, 168, 216, 312 hours post dose on Day 15, and then every 96 hour until recovery criteria met (maximum: 432 hours)"
              },
              {
                "measure": "Time to Reach Cmax in Both Blood and Plasma",
                "timeFrame": "0 hour (prior to evening dose) on Day 14; 0 hour (pre dose), 1, 2, 4, 6, 12, 24, 36, 48, 72, 96, 168, 216, 312 hours post dose on Day 15, and then every 96 hour until recovery criteria met (maximum: 432 hours)"
              },
              {
                "measure": "Area Under the Plasma Concentration Time Curve From Time Zero to the Last Quantifiable Sample (AUClast) of 14C-RO5185426 in Both Blood and Plasma",
                "timeFrame": "0 hour (prior to evening dose) on Day 14; 0 hour (pre dose), 1, 2, 4, 6, 12, 24, 36, 48, 72, 96, 168, 216, 312 hours post dose on Day 15, and then every 96 hour until recovery criteria met (maximum: 432 hours)"
              },
              {
                "measure": "Half-life of 14C-labeled RO5185426 in Both Blood and Plasma",
                "timeFrame": "0 hour (prior to evening dose) on Day 14; 0 hour (pre dose), 1, 2, 4, 6, 12, 24, 36, 48, 72, 96, 168, 216, 312 hours post dose on Day 15, and then every 96 hour until recovery criteria met (maximum: 432 hours)"
              },
              {
                "measure": "AUC Ratio of Blood:Plasma 14C-labeled RO5185426",
                "timeFrame": "0 hour (prior to evening dose) on Day 14; 0 hour (pre dose), 1, 2, 4, 6, 12, 24, 36, 48, 72, 96, 168, 216, 312 hours post dose on Day 15, and then every 96 hour until recovery criteria met (maximum: 432 hours)"
              },
              {
                "measure": "14C-labeled RO5185426 Recovery: Percentage of Dose Excreted in Feces and Urine",
                "timeFrame": "Urine:0 hour (pre dose),in quantitative fraction(0-6,6-12,12-24 hours) post dose on Day 15,during 24 hour interval thereafter;Feces:From Day 14 upto pre dose on Day 15,during 24 hour interval post dose until recovery criterion;(maximum:432 hours for both)"
              },
              {
                "measure": "Percentage of Total Integrated Radioactivity in Plasma of 14C-labeled RO5185426 and 14C-labeled Metabolite",
                "timeFrame": "4+6 hours, 12 +24 hours, 36+48 hours post dose on Day 15"
              },
              {
                "measure": "Plasma 14C-labeled RO5185426 and 14C-labeled Metabolite Levels",
                "timeFrame": "4+6 hours, 12 +24 hours, 36+48 hours post dose on Day 15"
              },
              {
                "measure": "Percentage of Total Integrated Radioactivity in Feces of 14C-labeled RO5185426 and 14C-labeled Metabolite",
                "timeFrame": "0-24 + 24-48 hours, 48-72 + 72-96 hours post dose on Day 15"
              },
              {
                "measure": "Percentage of Total Dose in 14C-labeled RO5185426 and 14C-labeled Metabolite in Pooled Fecal Samples",
                "timeFrame": "0-24 + 24-48 hours, 48-72 + 72-96 hours post dose on Day 15"
              },
              {
                "measure": "Percentage of Total Integrated Radioactivity in Urine of 14C-labeled RO5185426 and 14C-labeled Metabolite",
                "timeFrame": "0 up to 96 hours post dose on Day 15"
              },
              {
                "measure": "Percentage of Total Dose in 14C-labeled RO5185426 and 14C-labeled Metabolite in Pooled Urine Samples",
                "timeFrame": "0 up to 96 hours post dose on Day 15"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Number of Participants With a Response by Confirmed Best Overall Response"
              },
              {
                "measure": "Overall Survival"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01596140",
            "briefTitle": "Vemurafenib in Combination With Everolimus or Temsirolimus With Advanced Cancer",
            "officialTitle": "A Phase I Dose-Escalation Study of the BRAF Inhibitor Vemurafenib (Zelboraf\u00ae) in Combination With an mTOR Inhibitor, Everolimus (Afinitor\u00ae) or Temsirolimus (Torisel\u00ae), in Subjects With Advanced Cancer"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2012-05-08"
          },
          "conditionsModule": {
            "conditions": [
              "Advanced Cancer",
              "Solid Tumor"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Maximum Tolerated Dose (MTD) of Combination Vemurafenib",
                "timeFrame": "First cycle of 28 day cycle"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Tumor Response"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02456701",
            "briefTitle": "Enhancing Radioiodine Incorporation Into BRAF Mutant Thyroid Cancers With the Combination of Vemurafenib and KTN3379",
            "officialTitle": "Enhancing Radioiodine (RAI) Incorporation Into BRAF Mutant, RAI Refractory Thyroid Cancers With the Combination of BRAF Inhibitor Vemurafenib and Anti-ErbB3 Antibody KTN3379: A Pilot Study With a Phase 1 Run-in"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2015-05-20"
          },
          "conditionsModule": {
            "conditions": [
              "Thyroid Cancer"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "The number of patients with BRAF MUT, radioiodine-refractory thyroid cancer in which the combination of vemurafenib and KTN3379 can increase tumoral iodine incorporation to warrant 131I treatment",
                "timeFrame": "4 to 6 weeks"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Safety and tolerability of the combination of vemurafenib and KTN3379 by assessing adverse events"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01841463",
            "briefTitle": "Study of an Oral Cdk Inhibitor Administered With an Oral BRAF Inhibitor in Patients With Advanced or Inoperable Malignant Melanoma With BRAF Mutation",
            "officialTitle": "An Open Label, Multicenter, Phase I Extension Study of an Oral Cdk Inhibitor P1446A-05 Administered With an Oral BRAF Inhibitor Vemurafenib (Zelboraf\u00ae) in Patients With Advanced or Inoperable Malignant Melanoma With BRAF Mutation"
          },
          "statusModule": {
            "overallStatus": "SUSPENDED",
            "whyStopped": "Sponsor decision not related to patient safety",
            "studyFirstSubmitDate": "2013-04-17"
          },
          "conditionsModule": {
            "conditions": [
              "Advanced or Inoperable Malignant Melanoma With BRAF Mutation"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Maximum Tolerated Dose and Dose Limiting Toxicity",
                "timeFrame": "Until disease progression or unacceptable toxicity (expected to be 6-8 months)"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Tumor Response"
              },
              {
                "measure": "Pharmacokinetic (PK)"
              },
              {
                "measure": "Biomarker Analysis"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT03727763",
            "briefTitle": "Cetuximab and Vemurafenib Plus FOLFIRI for BRAF V600E Mutated Advanced Colorectal Cancer (IMPROVEMENT)",
            "officialTitle": "Cetuximab and Vemurafenib Plus FOLFIRI for BRAF V600E Mutated Advanced Colorectal Cancer (IMPROVEMENT): A Single-arm Study"
          },
          "statusModule": {
            "overallStatus": "UNKNOWN",
            "studyFirstSubmitDate": "2018-10-31"
          },
          "conditionsModule": {
            "conditions": [
              "Colorectal Cancer"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Objective Response Rate(ORR)",
                "timeFrame": "up to 55 months"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Disease Control Rate (DCR)"
              },
              {
                "measure": "Progression-free survival"
              },
              {
                "measure": "Overall survival"
              },
              {
                "measure": "adverse events"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02115035",
            "briefTitle": "A Single Agent Study to Evaluate the Overall Response Rate, Safety and Tolerability of Orally Administered Vemurafenib",
            "officialTitle": "A Phase II Single Agent Study to Evaluate the Overall Response Rate, Safety and Tolerability of Orally Administered Vemurafenib (VMRB) in Patients With Relapsed or Refractory Multiple Myeloma Who Have Activated BRAF Mutation"
          },
          "statusModule": {
            "overallStatus": "WITHDRAWN",
            "whyStopped": "Funding issues",
            "studyFirstSubmitDate": "2014-04-09"
          },
          "conditionsModule": {
            "conditions": [
              "Multiple Myeloma"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Changes in serum values",
                "timeFrame": "3 year"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT05525858",
            "briefTitle": "KPMNG Study of MOlecular Profiling Guided Therapy Based on Genomic Alterations in Advanced Solid Tumors II",
            "officialTitle": "KOrean Precision Medicine Networking Group Study of MOlecular Profiling Guided Therapy Based on Genomic Alterations in Advanced Solid Tumors II"
          },
          "statusModule": {
            "overallStatus": "RECRUITING",
            "studyFirstSubmitDate": "2022-08-29"
          },
          "conditionsModule": {
            "conditions": [
              "Solid Tumor",
              "Advanced Solid Tumor",
              "Metastatic Cancer"
            ]
          },
          "designModule": {
            "studyType": "OBSERVATIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "To evaluate the feasibility of molecular profiling guided therapies (MGT) based on genomic alterations in patients with advanced solid tumors in terms of the proportion of receipt of the treatment",
                "timeFrame": "12 months after treatment initiation (estimated average)"
              },
              {
                "measure": "To evaluate the effectiveness of molecular profiling guided therapies in terms of clinical benefit rate (CR/PR/SD beyond 16 +/- 2 weeks) in Tier 1* population",
                "timeFrame": "Assessed at 16 weeks of treatment"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Objective response rate"
              },
              {
                "measure": "Progression-free survival"
              },
              {
                "measure": "Treatment duration"
              },
              {
                "measure": "1-year overall survival rate"
              },
              {
                "measure": "To evaluate safety of molecular profiling guided therapies"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT05238831",
            "briefTitle": "SMMART Adaptive Clinical Treatment (ACT) Trial",
            "officialTitle": "Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) Trial: Adaptive Clinical Treatment (ACT)"
          },
          "statusModule": {
            "overallStatus": "WITHDRAWN",
            "whyStopped": "Withdrawn due to a change in therapeutic interventions.",
            "studyFirstSubmitDate": "2022-02-09"
          },
          "conditionsModule": {
            "conditions": [
              "Advanced Breast Carcinoma",
              "Advanced Malignant Solid Neoplasm",
              "Advanced Ovarian Carcinoma",
              "Advanced Pancreatic Carcinoma",
              "Advanced Prostate Carcinoma",
              "Advanced Sarcoma",
              "Anatomic Stage III Breast Cancer AJCC v8",
              "Anatomic Stage IV Breast Cancer AJCC v8",
              "Recurrent Adult Soft Tissue Sarcoma",
              "Recurrent Breast Carcinoma",
              "Recurrent Ovarian Carcinoma",
              "Recurrent Prostate Carcinoma",
              "Stage II Pancreatic Cancer AJCC v8",
              "Stage III Ovarian Cancer AJCC v8",
              "Stage III Pancreatic Cancer AJCC v8",
              "Stage IV Ovarian Cancer AJCC v8",
              "Stage IV Pancreatic Cancer AJCC v8"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Proportion of participants who receive an ACT therapy based an ACT Tumor Board recommendation.",
                "timeFrame": "From time of SMMART-ACT Tumor Board review to first dose of SMMART-ACT study drug regime as evaluated at interim analysis (approximately 2 years)"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Incidence of treatment-emergent adverse events"
              },
              {
                "measure": "Rate of treatment discontinuation due to toxicities and/or intolerability."
              },
              {
                "measure": "Overall response rate (ORR)"
              },
              {
                "measure": "Progression free survival"
              },
              {
                "measure": "Disease-specific survival"
              },
              {
                "measure": "Overall survival"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01943422",
            "briefTitle": "Safety and Efficacy Study of Vemurafenib and High-dose Interferon Alfa-2b in Melanoma",
            "officialTitle": "Dose-seeking and Efficacy Study of the Combination of the BRAF Inhibitor Vemurafenib and High-dose Interferon Alfa-2b for Therapy of Advanced Melanoma"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2013-08-27"
          },
          "conditionsModule": {
            "conditions": [
              "Melanoma"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Number of Participants with Adverse Events to determine Ph II dose",
                "timeFrame": "12-24 months from study start"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Progression Free and overall survival (Efficacy)"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01636622",
            "briefTitle": "Study of Vemurafenib, Carboplatin, and Paclitaxel",
            "officialTitle": "Phase I Study of the Combination of Vemurafenib With Carboplatin and Paclitaxel in Patients With Advanced Malignancy"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2012-07-06"
          },
          "conditionsModule": {
            "conditions": [
              "Advanced Cancers"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Maximum Tolerated Dose (MTD) of Vemurafenib with Carboplatin and Paclitaxel",
                "timeFrame": "6 weeks"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Overall Response Rate"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01804140",
            "briefTitle": "A Screening Study to Detect BRAF V600 Mutation-Positive Patients For Enrollment Into Clinical Research Studies of Zelboraf (Vemurafenib)",
            "officialTitle": "Screening Protocol to Detect BRAF V600 Mutation-Positive Patients for Enrollment Into Clinical Research Studies of Vemurafenib"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2013-02-26",
            "resultsFirstSubmitDate": "2015-06-16"
          },
          "conditionsModule": {
            "conditions": [
              "Multiple Myeloma, Neoplasms"
            ]
          },
          "designModule": {
            "studyType": "OBSERVATIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Percentage of Participants With BRAF V600 Mutation Positivity in Tumor Samples by Cancer Type",
                "timeFrame": "Up to 1 year"
              },
              {
                "measure": "Number of Participants Classified Based on Different Types of BRAF V600 Mutation Patterns in Tumor Samples",
                "timeFrame": "Up to 1 year"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT04341181",
            "briefTitle": "ProTarget - A Danish Nationwide Clinical Trial on Targeted Cancer Treatment Based on Genomic Profiling",
            "officialTitle": "ProTarget - A Danish Nationwide Clinical Trial on Targeted Cancer Treatment Based on Genomic Profiling"
          },
          "statusModule": {
            "overallStatus": "UNKNOWN",
            "studyFirstSubmitDate": "2020-04-08"
          },
          "conditionsModule": {
            "conditions": [
              "Cancer",
              "Tumors",
              "Neoplasms",
              "Neoplasia"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Response rate",
                "timeFrame": "16 weeks"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01910181",
            "briefTitle": "A Study of Vemurafenib (Zelboraf) in Chinese Participants With BRAF V600 Mutation-Positive Unresectable or Metastatic Melanoma",
            "officialTitle": "A Phase I Open-Label, Multicenter, Multiple-Dose Study to Investigate the Pharmacokinetics, Safety, and Efficacy of Vemurafenib in Chinese Patients With BRAF V600 Mutation-Positive Unresectable or Metastatic Melanoma"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2013-07-25",
            "resultsFirstSubmitDate": "2016-04-15"
          },
          "conditionsModule": {
            "conditions": [
              "Malignant Melanoma"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Area Under the Plasma Concentration-Time Curve (AUC) of RO5185426 From 0 to 8 Hours on Day 1",
                "timeFrame": "Pre-dose (0 hours) and post-dose (1, 2, 4, 5, 8 hours) on Day 1"
              },
              {
                "measure": "AUC of RO5185426 From 0 to 8 Hours on Day 21",
                "timeFrame": "Pre-dose (0 hours) and post-dose (1, 2, 4, 5, 8 hours) on Day 21"
              },
              {
                "measure": "AUC of RO5185426 From 0 to 12 Hours on Day 1",
                "timeFrame": "Pre-dose (0 hours) and post-dose (1, 2, 4, 5, 8, 12 hours) on Day 1"
              },
              {
                "measure": "AUC of RO5185426 From 0 to 12 Hours on Day 21",
                "timeFrame": "Pre-dose (0 hours) and post-dose (1, 2, 4, 5, 8, 12 hours) on Day 21"
              },
              {
                "measure": "Maximum Plasma Concentration (Cmax) of RO5185426 on Day 1",
                "timeFrame": "Pre-dose (0 hours) and post-dose (1, 2, 4, 5, 8, 12 hours) on Day 1"
              },
              {
                "measure": "Cmax of RO5185426 Following Day 21 Dose",
                "timeFrame": "Pre-dose (0 hours) and post-dose (1, 2, 4, 5, 8, 12, 24, 28, 72, 76, 168 hours) from Day 21"
              },
              {
                "measure": "Time of Maximum Plasma Concentration (Tmax) of RO5185426 on Day 1",
                "timeFrame": "Pre-dose (0 hours) and post-dose (1, 2, 4, 5, 8, 12 hours) on Day 1"
              },
              {
                "measure": "Tmax of RO5185426 Following Day 21 Dose",
                "timeFrame": "Pre-dose (0 hours) and post-dose (1, 2, 4, 5, 8, 12, 24, 28, 72, 76, 168 hours) from Day 21"
              },
              {
                "measure": "AUC From 0 to 168 Hours of RO5185426 Following Day 21 Dose",
                "timeFrame": "Pre-dose (0 hours) and post-dose (1, 2, 4, 5, 8, 12, 24, 28, 72, 76, 168 hours) from Day 21"
              },
              {
                "measure": "Elimination Half-Life (t1/2) of RO5185426 Following Day 21 Dose",
                "timeFrame": "Pre-dose (0 hours) and post-dose (1, 2, 4, 5, 8, 12, 24, 28, 72, 76, 168 hours) from Day 21"
              },
              {
                "measure": "Trough Plasma Concentration (Ctrough) of RO5185426 on Day 15",
                "timeFrame": "Pre-dose (0 hours) on Day 15"
              },
              {
                "measure": "Ctrough of RO5185426 on Day 19",
                "timeFrame": "Pre-dose (0 hours) on Day 19"
              },
              {
                "measure": "Ctrough of RO5185426 on Day 21",
                "timeFrame": "Pre-dose (0 hours) on Day 21"
              },
              {
                "measure": "Accumulation Ratio of RO5185426 AUC From 0 to 8 Hours Between Day 21 and Day 1",
                "timeFrame": "Pre-dose (0 hours) and post-dose (1, 2, 4, 5, 8 hours) on Days 1 and 21"
              },
              {
                "measure": "Terminal Elimination Rate Constant (Kel) of RO5185426 on Day 21",
                "timeFrame": "Pre-dose (0 hours) and post-dose (1, 2, 4, 5, 8, 12, 24, 28, 72, 76, 168 hours) from Day 21"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Percentage of Participants With a Best Overall Response of Complete Response (CR) or Partial Response (PR) According to Response Evaluation Criteria in Solid Tumors (RECIST) Version 1.1"
              },
              {
                "measure": "Percentage of Participants With Disease Progression or Death Among Participants With a Previous Assessment of CR or PR According to RECIST Version 1.1"
              },
              {
                "measure": "Duration of Response According to RECIST Version 1.1"
              },
              {
                "measure": "Percentage of Participants With Death or Disease Progression According to RECIST Version 1.1"
              },
              {
                "measure": "Progression-Free Survival (PFS)"
              },
              {
                "measure": "Percentage of Participants Who Died"
              },
              {
                "measure": "Overall Survival (OS)"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01709292",
            "briefTitle": "Vemurafenib Neoadjuvant Trial in Locally Advanced Thyroid Cancer",
            "officialTitle": "Pharmacodynamic Study of Vemurafenib in the Neoadjuvant Setting in Patients With Locally Advanced Thyroid Cancer"
          },
          "statusModule": {
            "overallStatus": "ACTIVE_NOT_RECRUITING",
            "studyFirstSubmitDate": "2012-07-25"
          },
          "conditionsModule": {
            "conditions": [
              "Thyroid Cancer"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Percent Change in ERK (Extracellular-Signal-Regulated Kinase) Phosphorylation and Tumor Size",
                "timeFrame": "56 days"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Objective Response Rate"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01765543",
            "briefTitle": "A Pharmacokinetics (PK) Study to Investigate the Effect of Rifampin on PK of Vemurafenib (Zelboraf)",
            "officialTitle": "A Phase I, Open-Label, Multicenter, Three-Period, One-Sequence Study to Investigate the Effect of Rifampin on the Pharmacokinetics of a Single Oral Dose of 960 mg of Vemurafenib"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2013-01-09",
            "resultsFirstSubmitDate": "2016-10-21"
          },
          "conditionsModule": {
            "conditions": [
              "Malignant Melanoma, Neoplasms"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Area Under the Plasma Concentration Time-curve From Zero to the Last Measurable Concentration Time Point (AUClast) of Vemurafenib",
                "timeFrame": "Predose (0 hour), 1, 2, 4, 6, 8, 12, 24, 30-32, 48, 72, 96, 120, 168 hours post vemurafenib-dose on Day 1 (Period A) and Day 17 (Period C)"
              },
              {
                "measure": "Area Under the Plasma Concentration Time-curve From Zero to Extrapolated Infinite Time (AUC[0-inf]) of Vemurafenib",
                "timeFrame": "Predose (0 hour), 1, 2, 4, 6, 8, 12, 24, 30-32, 48, 72, 96, 120, 168 hours post vemurafenib-dose on Day 1 (Period A) and Day 17 (Period C)"
              },
              {
                "measure": "Maximum Observed Plasma Concentration (Cmax) of Vemurafenib",
                "timeFrame": "Predose (0 hour), 1, 2, 4, 6, 8, 12, 24, 30-32, 48, 72, 96, 120, 168 hours post vemurafenib-dose on Day 1 (Period A) and Day 17 (Period C)"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01603212",
            "briefTitle": "Systemic Therapy With Interferon, Interleukin-2 and BRAF Inhibitor",
            "officialTitle": "Systemic Therapy of Metastatic Melanoma With Multidrug Regimen Including Interferon, Interleukin-2 and BRAF Inhibitor"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2012-05-18"
          },
          "conditionsModule": {
            "conditions": [
              "Melanoma"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Maximum Tolerated Dose (MTD) of Vemurafenib in Combination With Interferon Alpha 2b and IL-2",
                "timeFrame": "21 days"
              },
              {
                "measure": "Progression-Free Survival (PFS)",
                "timeFrame": "6 months"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT05722886",
            "briefTitle": "DETERMINE (Determining Extended Therapeutic Indications for Existing Drugs in Rare Molecularly Defined Indications Using a National Evaluation Platform Trial) - Master Screening Protocol",
            "officialTitle": "DETERMINE (Determining Extended Therapeutic Indications for Existing Drugs in Rare Molecularly Defined Indications Using a National Evaluation Platform Trial): An Umbrella-Basket Platform Trial to Evaluate the Efficacy of Targeted Therapies in Rare Adult, Paediatric and Teenage/Young Adult (TYA) Cancers With Actionable Genomic Alterations, Including Common Cancers With Rare Actionable Alterations"
          },
          "statusModule": {
            "overallStatus": "RECRUITING",
            "studyFirstSubmitDate": "2022-11-24"
          },
          "conditionsModule": {
            "conditions": [
              "Solid Tumor",
              "Haematological Malignancy"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Number of patients who consent to each arm.",
                "timeFrame": "Up to 5 years."
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT03878524",
            "briefTitle": "Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial",
            "officialTitle": "Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) Trial: PRIME"
          },
          "statusModule": {
            "overallStatus": "TERMINATED",
            "whyStopped": "Low accrual",
            "studyFirstSubmitDate": "2019-03-14"
          },
          "conditionsModule": {
            "conditions": [
              "Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive",
              "Anatomic Stage IV Breast Cancer AJCC v8",
              "Anemia",
              "Ann Arbor Stage III Hodgkin Lymphoma",
              "Ann Arbor Stage III Non-Hodgkin Lymphoma",
              "Ann Arbor Stage IV Hodgkin Lymphoma",
              "Ann Arbor Stage IV Non-Hodgkin Lymphoma",
              "Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative",
              "Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive",
              "Castration-Resistant Prostate Carcinoma",
              "Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive",
              "Hematopoietic and Lymphoid System Neoplasm",
              "Locally Advanced Pancreatic Adenocarcinoma",
              "Metastatic Breast Carcinoma",
              "Metastatic Malignant Solid Neoplasm",
              "Metastatic Pancreatic Adenocarcinoma",
              "Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis",
              "Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable",
              "Primary Myelofibrosis",
              "Recurrent Acute Lymphoblastic Leukemia",
              "Recurrent Acute Myeloid Leukemia",
              "Recurrent Chronic Lymphocytic Leukemia",
              "Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive",
              "Recurrent Hematologic Malignancy",
              "Recurrent Hodgkin Lymphoma",
              "Recurrent Myelodysplastic Syndrome",
              "Recurrent Myelodysplastic/Myeloproliferative Neoplasm",
              "Recurrent Myeloproliferative Neoplasm",
              "Recurrent Non-Hodgkin Lymphoma",
              "Recurrent Plasma Cell Myeloma",
              "Recurrent Small Lymphocytic Lymphoma",
              "Refractory Acute Lymphoblastic Leukemia",
              "Refractory Acute Myeloid Leukemia",
              "Refractory Chronic Lymphocytic Leukemia",
              "Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive",
              "Refractory Chronic Myelomonocytic Leukemia",
              "Refractory Hematologic Malignancy",
              "Refractory Hodgkin Lymphoma",
              "Refractory Malignant Solid Neoplasm",
              "Refractory Myelodysplastic Syndrome",
              "Refractory Myelodysplastic/Myeloproliferative Neoplasm",
              "Refractory Non-Hodgkin Lymphoma",
              "Refractory Plasma Cell Myeloma",
              "Refractory Primary Myelofibrosis",
              "Refractory Small Lymphocytic Lymphoma",
              "Stage II Pancreatic Cancer AJCC v8",
              "Stage III Pancreatic Cancer AJCC v8",
              "Stage IV Pancreatic Cancer AJCC v8",
              "Stage IV Prostate Cancer AJCC v8",
              "Unresectable Pancreatic Adenocarcinoma"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Feasibility of implementing an individualized treatment strategy (number of participants to receive first dose)",
                "timeFrame": "From date of tumor board recommendation to first dose of SMMART-PRIME Therapy #1 (up to 3 months)"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Incidence of grade 3+ toxicities attributable to assigned study drug(s)"
              },
              {
                "measure": "Time to treatment discontinuation"
              },
              {
                "measure": "Overall survival (OS)"
              },
              {
                "measure": "Time to decline (TTD)"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT03220035",
            "briefTitle": "Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial)",
            "officialTitle": "NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice)- Phase 2 Subprotocol of Vemurafenib in Patients With Tumors Harboring BRAF V600 Mutations"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2017-07-17",
            "resultsFirstSubmitDate": "2023-05-10"
          },
          "conditionsModule": {
            "conditions": [
              "Advanced Malignant Solid Neoplasm",
              "Ann Arbor Stage III Childhood Non-Hodgkin Lymphoma",
              "Ann Arbor Stage IV Childhood Non-Hodgkin Lymphoma",
              "Ependymoma",
              "Ewing Sarcoma",
              "Hepatoblastoma",
              "Langerhans Cell Histiocytosis",
              "Malignant Germ Cell Tumor",
              "Malignant Glioma",
              "Osteosarcoma",
              "Peripheral Primitive Neuroectodermal Tumor",
              "Recurrent Childhood Central Nervous System Neoplasm",
              "Recurrent Childhood Non-Hodgkin Lymphoma",
              "Recurrent Malignant Solid Neoplasm",
              "Recurrent Neuroblastoma",
              "Refractory Malignant Solid Neoplasm",
              "Refractory Neuroblastoma",
              "Refractory Non-Hodgkin Lymphoma",
              "Refractory Primary Central Nervous System Neoplasm",
              "Rhabdoid Tumor",
              "Rhabdomyosarcoma",
              "Soft Tissue Sarcoma",
              "Wilms Tumor"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Objective Response Rate (ORR)",
                "timeFrame": "From enrollment to the end of treatment, up to 2 years"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Progress Free Survival (PFS)"
              },
              {
                "measure": "Percentage of Patients Experiencing Grade 3 or Higher Adverse Events"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02693535",
            "briefTitle": "TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer",
            "officialTitle": "Targeted Agent and Profiling Utilization Registry (TAPUR) Study"
          },
          "statusModule": {
            "overallStatus": "RECRUITING",
            "studyFirstSubmitDate": "2016-02-11"
          },
          "conditionsModule": {
            "conditions": [
              "Lymphoma, Non-Hodgkin",
              "Multiple Myeloma",
              "Advanced Solid Tumors"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Objective Response Rate defined as % of participants in a cohort with complete or partial response or with stable disease according to standard response criteria",
                "timeFrame": "Assessed at 16 weeks of treatment"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Overall survival (OS)"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02091141",
            "briefTitle": "My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors",
            "officialTitle": "My Pathway: An Open-Label Phase IIa Study Evaluating Trastuzumab/Pertuzumab, Erlotinib, Vemurafenib/Cobimetinib, Vismodegib, Alectinib, and Atezolizumab in Patients Who Have Advanced Solid Tumors With Mutations or Gene Expression Abnormalities Predictive of Response to One of These Agents"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2014-03-17",
            "resultsFirstSubmitDate": "2024-05-23"
          },
          "conditionsModule": {
            "conditions": [
              "Neoplasms",
              "Solid Tumors",
              "Biliary Cancer",
              "Salivary Cancer",
              "Bladder Cancer"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Percentage of Participants in All Tumor-Pathway Cohorts With Overall Response, as Assessed by the Investigator",
                "timeFrame": "From the date of first study treatment until disease progression or death from any cause, whichever occurs first (72.1 months)"
              },
              {
                "measure": "Percentage of Atezolizumab-Treated Participants With Tissue Tumor Mutational Burden (tTMB) \u226516 Mutations/Mb With Overall Response, as Assessed by the Independent Review Committee (IRC)",
                "timeFrame": "From the date of first study treatment until disease progression or death from any cause, whichever occurs first (68.9 months)"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Percentage of Participants With Disease Control"
              },
              {
                "measure": "Progression-Free Survival (PFS)"
              },
              {
                "measure": "Overall Survival (OS)"
              },
              {
                "measure": "Duration of Response (DoR)"
              },
              {
                "measure": "Number of Participants With Adverse Events"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02145910",
            "briefTitle": "Vemurafenib Combined With Whole Brain Radiation Therapy or Radiosurgery in Patients With BRAF Mutation-Positive Melanoma and Brain Metastases",
            "officialTitle": "Phase I Study of Vemurafenib Combined With Whole Brain Radiation Therapy (WBRT) or Radiosurgery (SRS) for Melanoma Patients With BRAF Mutation Presented With Brain Metastases"
          },
          "statusModule": {
            "overallStatus": "WITHDRAWN",
            "whyStopped": "Study was never opened to accrual. There is no clinical benefit to patients.",
            "studyFirstSubmitDate": "2014-05-13"
          },
          "conditionsModule": {
            "conditions": [
              "Recurrent Melanoma",
              "Stage IV Melanoma",
              "Tumors Metastatic to Brain"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Maximum tolerated dose (MTD) of vemurafenib",
                "timeFrame": "Up to 1 year"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Proportion with complete response"
              },
              {
                "measure": "Proportion with partial response"
              },
              {
                "measure": "Median survival"
              },
              {
                "measure": "Progression free survival based on Response Evaluation Criteria In Solid Tumors (RECIST) criteria based on the brain MRI and systematic assessment by the treating physician"
              },
              {
                "measure": "Overall survival"
              },
              {
                "measure": "Local control rates of brain metastases"
              },
              {
                "measure": "Rate of developing new brain metastasis"
              },
              {
                "measure": "Response of extracranial disease"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02314481",
            "briefTitle": "Deciphering Antitumour Response and Resistance With INtratumour Heterogeneity",
            "officialTitle": "Deciphering Antitumour Response and Resistance With INtratumour Heterogeneity - DARWINII"
          },
          "statusModule": {
            "overallStatus": "ACTIVE_NOT_RECRUITING",
            "studyFirstSubmitDate": "2014-12-05"
          },
          "conditionsModule": {
            "conditions": [
              "Non-small Cell Lung Cancer"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Progression free survival (PFS)",
                "timeFrame": "From date of registration until the date of first documented progression or death (whichever occurs first), assessed up to 84 months"
              },
              {
                "measure": "Overall survival",
                "timeFrame": "From date of registration until death date, assessed up to 84 months"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Objective response rate"
              },
              {
                "measure": "Progression"
              },
              {
                "measure": "Duration of response"
              },
              {
                "measure": "Toxicity - Dose reductions, interruptions, modifications and exposure"
              },
              {
                "measure": "Exploratory assessments"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01767623",
            "briefTitle": "A Study of The Impact of Severe Hepatic Impairment on the Pharmacokinetics and Safety of Vemurafenib in BRAF V600 Mutation-Positive Cancer Participants",
            "officialTitle": "An Open Label, Phase I Study to Evaluate the Impact of Severe Hepatic Impairment on the Pharmacokinetics and Safety of Vemurafenib in BRAF V600 Mutation Positive Cancer Patients"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2013-01-11"
          },
          "conditionsModule": {
            "conditions": [
              "Neoplasms"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Dose-Normalized Area Under the Concentration-Time Curve (AUC) of Vemurafenib During the Dose Interval (12 hours) (AUCtau) on Day 20",
                "timeFrame": "Pre-dose (0 hour); 1, 2, 3, 4, 6, 8, 12, 24, 48, 72, 96, 120, and 168 hours after the morning dose on Day 20"
              },
              {
                "measure": "Dose-Normalized Maximum Observed Concentration (Cmax) of Vemurafenib on Day 20",
                "timeFrame": "Pre-dose (0 hour); 1, 2, 3, 4, 6, 8, 12, 24, 48, 72, 96, 120, and 168 hours after the morning dose on Day 20"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Percentage of Participants with Adverse Events (AEs)"
              },
              {
                "measure": "Dose-Normalized AUCtau of of Vemurafenib on Day 1"
              },
              {
                "measure": "Dose-Normalized AUC from Time 0 to Last Measurable Concentration Time Point (AUC0-last) of Vemurafenib on Day 20"
              },
              {
                "measure": "Dose-Normalized AUC from Time 0 to Infinity (AUC0-\u221e) of Vemurafenib on Day 20"
              },
              {
                "measure": "Dose-Normalized Cmax of Vemurafenib on Day 1"
              },
              {
                "measure": "Time to Maximum Concentration (tmax) of Vemurafenib on Day 1 and Day 20"
              },
              {
                "measure": "Half-life (t1/2) of Vemurafenib in Plasma on Day 20"
              },
              {
                "measure": "Dose Normalized Apparent Clearance (CL/F) of Vemurafenib on Day 20"
              },
              {
                "measure": "Trough Plasma Concentration (Cmin or Ctrough) of Vemurafenib"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01586195",
            "briefTitle": "Study Of Zelboraf (Vemurafenib) in Patients With Locally-Advanced, Unresectable, Stage IIIc Or Metastatic Melanoma and Activating Exon 15 BRAF Mutations Other Than V600E",
            "officialTitle": "An Open-Label, Multicenter, Phase II Study Of Continuous Oral Zelboraf (Vemurafenib) in Patients With Locally-Advanced, Unresectable, Stage IIIc Or Metastatic Melanoma and Activating Exon 15 BRAF Mutations Other Than V600E"
          },
          "statusModule": {
            "overallStatus": "TERMINATED",
            "whyStopped": "Recruitment challenges",
            "studyFirstSubmitDate": "2012-04-24",
            "resultsFirstSubmitDate": "2016-07-07"
          },
          "conditionsModule": {
            "conditions": [
              "Malignant Melanoma"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Best Objective Response Rate (BORR)",
                "timeFrame": "Up to 42 months"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Time to BORR"
              },
              {
                "measure": "Duration of Response"
              },
              {
                "measure": "Progression-free Survival (PFS)"
              },
              {
                "measure": "Overall Survival (OS)"
              },
              {
                "measure": "Percentage of Participants With 6-Month Survival"
              },
              {
                "measure": "Percentage of Participants With 12-Month Survival"
              },
              {
                "measure": "Number of Participants With an Adverse Event (AE)"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02925234",
            "briefTitle": "The Drug Rediscovery Protocol (DRUP Trial)",
            "officialTitle": "A Dutch National Study on Behalf of the CPCT to Facilitate Patient Access to Commercially Available, Targeted Anti-cancer Drugs to Determine the Potential Efficacy in Treatment of Advanced Cancers With a Known Molecular Profile"
          },
          "statusModule": {
            "overallStatus": "RECRUITING",
            "studyFirstSubmitDate": "2016-08-26"
          },
          "conditionsModule": {
            "conditions": [
              "Cancer",
              "Tumors",
              "Neoplasm",
              "Neoplasia"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Percentage of patients that are treated based on their molecular tumor profile",
                "timeFrame": "6 months after treatment initiation (estimated average)"
              },
              {
                "measure": "Objective tumor response",
                "timeFrame": "6 months after treatment initiation (estimated average)"
              },
              {
                "measure": "Stable disease",
                "timeFrame": "6 months after treatment initiation (estimated average)"
              },
              {
                "measure": "Treatment-related grade\u22653 and serious adverse events",
                "timeFrame": "6 months after treatment initiation (estimated average)"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Progression-free survival"
              },
              {
                "measure": "Overall survival"
              },
              {
                "measure": "Duration of treatment on study (time on drug)"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT05019534",
            "briefTitle": "Tolerability and Safety of Vemurafenib, Cetuximab Combined With Camrelizumab for BRAF V600E-mutated /MSS Metastatic Colorectal Cancer",
            "officialTitle": "A Phase I Study on Tolerance and Safety of Vemurafenib Film-coated Tablets, Cetuximab Solution for Infusion and Camrelizumab Protocol(VCC) in the After Line Therapy of BRAF V600E Mutation/MSS Metastatic Colorectal Cancer"
          },
          "statusModule": {
            "overallStatus": "UNKNOWN",
            "studyFirstSubmitDate": "2021-08-05"
          },
          "conditionsModule": {
            "conditions": [
              "BRAF V600E-mutated /MSS Metastatic Colorectal Cancer",
              "Vemurafenib (BRAFi) Plus Cetuximab (EGFRi) Combined With PD-1 Monoclonal Antibody"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Evaluate tolerability and safety and identify the recommended Phase 2 dose(RP2D)",
                "timeFrame": "Subjects will be treated and observed for dose-limiting toxicity(DLT) through the end of the first cycle (Days 1-28)"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Object Response Rate (ORR)"
              },
              {
                "measure": "Disease Control Rate (DCR)"
              },
              {
                "measure": "Progression Free Survival (PFS)"
              },
              {
                "measure": "Overall Survival (OS)"
              },
              {
                "measure": "Preliminary efficacy"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01983124",
            "briefTitle": "Vemurafenib + Fotemustine to Treat Advanced Melanoma Patients With V600BRAF Mutation Recurred While on Vemurafenib",
            "officialTitle": "A Phase II Single-arm Study for the Treatment After Recurrence of Advanced Melanoma Patients Harboring the V600BRAF Mutation and Pretreated With Vemurafenib, With the Association of Vemurafenib Plus Fotemustine."
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2013-11-06"
          },
          "conditionsModule": {
            "conditions": [
              "Malignant Melanoma Stage IV"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Progression-free survival",
                "timeFrame": "6 months"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Incidence of Grade 3-4 toxicities (any type)"
              },
              {
                "measure": "Rate, duration of response and proportion of patients with duration of response lasting > 24 weeks"
              },
              {
                "measure": "Disease control rate;"
              },
              {
                "measure": "Time to progression of brain metastases (BM), Including incidence of BM in pts free from BM at the time of enrolment"
              },
              {
                "measure": "Overall survival (OS)."
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02164916",
            "briefTitle": "S1406 Phase II Study of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF Mutant Metastatic Colorectal Cancer",
            "officialTitle": "Randomized Phase II Study of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF Mutant Metastatic Colorectal Cancer"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2014-06-13",
            "resultsFirstSubmitDate": "2017-07-13"
          },
          "conditionsModule": {
            "conditions": [
              "Colorectal Cancer"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Progression-free Survival",
                "timeFrame": "Up to 3 years from randomization"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Number of Patients With Grade 3 Through 5 Adverse Events That Are Related to Study Drug"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01107418",
            "briefTitle": "A Pharmacokinetic/Pharmacodynamic Study of RO5185426 in Previously Treated Patients With Metastatic Melanoma",
            "officialTitle": "A Phase I, Randomized, Open-label, Multi-center, Multiple Dose Study to Investigate the Pharmacokinetics and Pharmacodynamics of RO5185426 Administered as 240 mg Tablets to Previously Treated BRAF V600E Positive Metastatic Melanoma Patients"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2010-04-12",
            "resultsFirstSubmitDate": "2015-07-29"
          },
          "conditionsModule": {
            "conditions": [
              "Malignant Melanoma"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Area Under the Plasma Concentration-Time Curve From Time Zero to 8 Hours (AUC[0-8h]) of Vemurafenib on Day 1",
                "timeFrame": "Pre-dose, 1, 2, 4, 5, 8 hours post-dose on Day 1"
              },
              {
                "measure": "Area Under the Plasma Concentration-Time Curve From Time Zero to 24 Hours (AUC[0-24h]) of Vemurafenib on Day 1",
                "timeFrame": "Pre-dose, 1, 2, 4, 5, 8, 24 hours post-dose on Day 1"
              },
              {
                "measure": "Maximum Plasma Concentration (Cmax) of Vemurafenib on Day 1",
                "timeFrame": "Pre-dose, 1, 2, 4, 5, 8 hours post-dose on Day 1"
              },
              {
                "measure": "Time to Reach Maximum Plasma Concentration (Tmax) of Vemurafenib on Day 1",
                "timeFrame": "Pre-dose, 1, 2, 4, 5, 8 hours post-dose on Day 1"
              },
              {
                "measure": "Area Under the Plasma Concentration-Time Curve From Time Zero to 8 Hours (AUC[0-8h]) of Vemurafenib on Day 9",
                "timeFrame": "Pre-dose, 1, 2, 4, 5, 8 hours post-dose on Day 9"
              },
              {
                "measure": "Maximum Plasma Concentration (Cmax) of Vemurafenib on Day 9",
                "timeFrame": "Pre-dose, 1, 2, 4, 5, 8 hours post-dose on Day 9"
              },
              {
                "measure": "Time to Reach Maximum Plasma Concentration (Tmax) of Vemurafenib on Day 9",
                "timeFrame": "Pre-dose, 1, 2, 4, 5, 8 hours post-dose on Day 9"
              },
              {
                "measure": "Area Under the Plasma Concentration-Time Curve From Time Zero to 8 Hours (AUC[0-8h]) of Vemurafenib on Day 15",
                "timeFrame": "Pre-dose, 1, 2, 4, 5, 8 hours post-dose on Day 15"
              },
              {
                "measure": "Area Under the Plasma Concentration-Time Curve From Time Zero to 24 Hours (AUC[0-24h]) of Vemurafenib on Day 15",
                "timeFrame": "Pre-dose, 1, 2, 4, 5, 8, 24 hours post-dose on Day 15"
              },
              {
                "measure": "Area Under the Plasma Concentration-Time Curve From Time Zero to 168 Hours (AUC[0-168h]) of Vemurafenib on Day 15",
                "timeFrame": "Pre-dose, 1, 2, 4, 5, 8, 24, 28, 72, 76, 168 hours post-dose on Day 15"
              },
              {
                "measure": "Maximum Plasma Concentration (Cmax) of Vemurafenib on Day 15",
                "timeFrame": "Pre-dose, 1, 2, 4, 5, 8, 24, 28, 72, 76, 168 hours post-dose on Day 15"
              },
              {
                "measure": "Time to Reach Maximum Plasma Concentration (Tmax) of Vemurafenib on Day 15",
                "timeFrame": "Pre-dose, 1, 2, 4, 5, 8, 24, 28, 72, 76, 168 hours post-dose on Day 15"
              },
              {
                "measure": "Apparent Clearance (CL/F) of Vemurafenib on Day 15",
                "timeFrame": "Pre-dose, 1, 2, 4, 5, 8, 24, 28, 72, 76, 168 hours post-dose on Day 15"
              },
              {
                "measure": "Terminal Elimination Half-Life (t1/2) of Vemurafenib on Day 15",
                "timeFrame": "Pre-dose, 1, 2, 4, 5, 8, 24, 28, 72, 76, 168 hours post-dose on Day 15"
              },
              {
                "measure": "Accumulation Ratio of Vemurafenib on Day 15",
                "timeFrame": "Pre-dose, 1, 2, 4, 5, 8 hours post-dose on Day 1 and 15"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Percentage of Participants With a Confirmed Best Overall Response of Complete Response (CR) or Partial Response (PR)"
              },
              {
                "measure": "Overall Survival (OS)"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01689519",
            "briefTitle": "A Study Comparing Vemurafenib Versus Vemurafenib Plus Cobimetinib in Participants With Metastatic Melanoma",
            "officialTitle": "A Phase III, Double-Blind, Placebo-Controlled Study of Vemurafenib Versus Vemurafenib Plus GDC-0973 in Previously Untreated BRAF^600-Mutation Positive Patients With Unresectable Locally Advanced or Metastatic Melanoma"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2012-09-18",
            "resultsFirstSubmitDate": "2015-07-01"
          },
          "conditionsModule": {
            "conditions": [
              "Malignant Melanoma"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Progression-free Survival",
                "timeFrame": "Baseline to the 21 July 2019 data cut-off (up to 7 years, 6 months)"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Overall Survival"
              },
              {
                "measure": "Percentage of Participants With an Objective Response"
              },
              {
                "measure": "Duration of Response"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01851824",
            "briefTitle": "A Study of the Effect of Vemurafenib on the Pharmacokinetics of Acenocoumarol in Patients With BRAFV600 Mutation-Positive Metastatic Malignancy",
            "officialTitle": "A PHASE I, OPEN-LABEL, MULTICENTER, 3-PERIOD, FIXED-SEQUENCE STUDY TO INVESTIGATE THE EFFECT OF VEMURAFENIB ON THE PHARMACOKINETICS OF A SINGLE ORAL DOSE OF ACENOCOUMAROL IN PATIENTS WITH BRAFV600 MUTATION-POSITIVE METASTATIC MALIGNANCY"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2013-05-03"
          },
          "conditionsModule": {
            "conditions": [
              "Malignant Melanoma, Neoplasms"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Pharmacokinetics of single-dose acenocoumarol under conditions of vemurafenib steady-state exposure: Area under the concentration-time curve (AUC)",
                "timeFrame": "Pre-dose and up to 72 hours post-dose"
              },
              {
                "measure": "Pharmacokinetics of single-dose acenocoumarol under conditions of vemurafenib steady-state exposure: Maximum plasma concentration (Cmax)",
                "timeFrame": "Pre-dose and up to 72 hours post-dose"
              },
              {
                "measure": "Pharmacokinetics of single-dose acenocoumarol under conditions of vemurafenib steady-state exposure: Time to maximum plasma concentration (Tmax)",
                "timeFrame": "Pre-dose and up to 72 hours post-dose"
              },
              {
                "measure": "Pharmacokinetics of single-dose acenocoumarol under conditions of vemurafenib steady-state exposure: Terminal half-life (t1/2)",
                "timeFrame": "Pre-dose and up to 72 hours post-dose"
              },
              {
                "measure": "Pharmacokinetics of single-dose acenocoumarol under conditions of vemurafenib steady-state exposure: Apparent clearance (CL/F)",
                "timeFrame": "Pre-dose and up to 72 hours post-dose"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Safety: Incidence of Adverse Events and Serious Adverse Events"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01519323",
            "briefTitle": "BRIM-P: A Study of Vemurafenib in Pediatric Patients With Stage IIIC or Stage IV Melanoma Harboring BRAFV600 Mutations",
            "officialTitle": "An Open-label, Multicenter, Single-arm, Phase I Dose-escalation With Efficacy Tail Extension Study of Vemurafenib (RO5185426) in Pediatric Patients With Surgically Incurable and Unresectable Stage IIIC or Stage IV Melanoma Harboring BRAFV600 Mutations"
          },
          "statusModule": {
            "overallStatus": "TERMINATED",
            "whyStopped": "Study was terminated due to low enrollment.",
            "studyFirstSubmitDate": "2012-01-16",
            "resultsFirstSubmitDate": "2016-06-17"
          },
          "conditionsModule": {
            "conditions": [
              "Malignant Melanoma"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Maximum Tolerated Dose (MTD)/Recommended Dose",
                "timeFrame": "Up to 28 days of treatment"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Area Under the Concentration-Time Curve for Vemurafenib"
              },
              {
                "measure": "Number of Participants With an Adverse Event (AE)"
              },
              {
                "measure": "Best Overall Response Rate (BORR)"
              },
              {
                "measure": "Clinical Benefit Rate (CBR)"
              },
              {
                "measure": "Progression-free Survival (PFS)"
              },
              {
                "measure": "Overall Survival (OS)"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02414750",
            "briefTitle": "Vemurafenib Plus Cobimetinib in Metastatic Melanoma",
            "officialTitle": "A Phase II, Open-Label, Multicenter Study of Vemurafenib Plus Cobimetinib (GDC-0973) in Unresectable Stage IIIc or Stage IV Melanoma; Response Monitoring and Resistance Prediction With Positron Emission Tomography and Tumor Characteristics"
          },
          "statusModule": {
            "overallStatus": "TERMINATED",
            "whyStopped": "Slow accrual and changing treatment landscape",
            "studyFirstSubmitDate": "2015-02-11"
          },
          "conditionsModule": {
            "conditions": [
              "Metastatic Melanoma"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Progression Free survival (PFS)",
                "timeFrame": "Participants will be followed until they have progressive disease based on RECIST1.1, an expected median of 10 months."
              },
              {
                "measure": "Standardized Uptake Value (SUV) of 18F-FDG and 18F-FLT as measured by PET.",
                "timeFrame": "Participants will be followed until they have progressive disease based on RECIST1.1, an expected median of 10 months."
              },
              {
                "measure": "RECIST 1.1 tumor size measurement on diagnostic CT.",
                "timeFrame": "Participants will be followed until they have progressive disease based on RECIST1.1, an expected median of 10 months."
              },
              {
                "measure": "Cut-off values of metabolic tracer uptake of 18F-FDG/FLT on PET as a measure of response.",
                "timeFrame": "Participants will be followed until they have progressive disease based on RECIST1.1, an expected median of 10 months."
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Diagnostic accuracy of metabolic tracer uptake on PET in responders and non-responders."
              },
              {
                "measure": "Glycolytic Index, Metabolic Tumor Volume and % Injected Dose of 18F-FDG/FLT on PET."
              },
              {
                "measure": "Immunohistochemical analysis of tumor tissue in responders and non-responders."
              },
              {
                "measure": "Changes of DNA in tumor tissue as measured by DNA deep sequencing analysis."
              },
              {
                "measure": "Changes of RNA in tumor tissue as measured by RNA expression analysis."
              },
              {
                "measure": "Changes of phosphoproteomic profiles in tumor tissue measured by nano-liquid chromatography coupled to tandem mass spectrometry (nanoLC-MS/MS)."
              },
              {
                "measure": "Changes in vemurafenib and cobimetinib drug concentrations in plasma as measured by a validated Liquid Chromotography tandem Mass Spectrometry assay"
              },
              {
                "measure": "Overall Survival (OS)"
              },
              {
                "measure": "ECOG Performance status"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT06440850",
            "briefTitle": "Vemurafenib and Cobimetinib for the Treatment of Patients With High Risk Differentiated Thyroid Carcinoma With BRAFV600E Mutation",
            "officialTitle": "A Pilot Clinical Trial of Vemurafenib and Cobimetinib as a Redifferentiation Strategy in High-Risk, Radioactive Iodine (RAI) Na\u00efve, BRAFV600E Mutated Differentiated Thyroid Carcinoma Patients Undergoing Initial RAI Therapy"
          },
          "statusModule": {
            "overallStatus": "RECRUITING",
            "studyFirstSubmitDate": "2024-04-19"
          },
          "conditionsModule": {
            "conditions": [
              "Thyroid Gland Follicular Carcinoma",
              "Thyroid Gland Oncocytic Carcinoma",
              "Thyroid Gland Papillary Carcinoma"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Patients who achieve excellent or indeterminate response with vemurafenib and cobimetinib treatment prior to radioactive iodine therapy",
                "timeFrame": "Up to completion of 6 week vemurafenib and cobimetinib therapy"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Proportion of patients who achieve increased iodine incorporation to a predicted lesion absorbed dose of 2000 cGy with I-131 dose of \u2264 300 mCi"
              },
              {
                "measure": "Incidence of treatment related adverse events"
              },
              {
                "measure": "Progression free survival"
              },
              {
                "measure": "Changes in thyroglobulin levels"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01656642",
            "briefTitle": "A Phase 1b Study of Atezolizumab in Combination With Vemurafenib or Vemurafenib Plus Cobimetinib in Participants With BRAFV600-Mutation Positive Metastatic Melanoma",
            "officialTitle": "A Phase Ib, Open-Label Study of The Safety and Pharmacology of Atezolizumab (Anti PD-L1 Antibody) Administered in Combination With Vemurafenib or Vemurafenib Plus Cobimetinib in Patients With BRAFV600-Mutation Positive Metastatic Melanoma"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2012-08-01"
          },
          "conditionsModule": {
            "conditions": [
              "Malignant Melanoma"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Percentage of Participants With Dose Limiting Toxicities",
                "timeFrame": "21 days (or 28 days for Cohort 4) following the first administration of atezolizumab"
              },
              {
                "measure": "Percentage of Participants With Adverse Events",
                "timeFrame": "Baseline up to approximately 6 years"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Area Under the Concentration-Time Curve (AUC) of Atezolizumab"
              },
              {
                "measure": "Maximum Serum Concentration of Atezolizumab"
              },
              {
                "measure": "Maximum Plasma Concentration of Vemurafenib"
              },
              {
                "measure": "Minimum Observed Plasma Trough Concentration (Cmin) of Vemurafenib"
              },
              {
                "measure": "Maximum Plasma Concentration of Cobimetinib"
              },
              {
                "measure": "Cmin of Cobimetinib"
              },
              {
                "measure": "Percentage of Participants With Best Overall Response According to Response Evaluation Criteria in Solid Tumors (RECIST) Version 1.1 (v1.1)"
              },
              {
                "measure": "Percentage of Participants with Objective Response According to RECIST v1.1"
              },
              {
                "measure": "Percentage of Participants with Objective Response According to Immune-Related Response Criteria (irRC)"
              },
              {
                "measure": "Duration of Objective Response According to RECIST v1.1"
              },
              {
                "measure": "Duration of Objective Response According to irRC"
              },
              {
                "measure": "Progression Free Survival According to RECIST v1.1"
              },
              {
                "measure": "Progression Free Survival According to irRC"
              },
              {
                "measure": "Overall Survival Duration"
              },
              {
                "measure": "Mean Atezolizumab Dose"
              },
              {
                "measure": "Total Number of Atezolizumab Cycles"
              },
              {
                "measure": "Percentage of Participants With Anti-Atezolizumab Antibodies"
              }
            ]
          }
        }
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:21:14Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8295"
    },
    "name": "BRD-K84521734",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8295.png",
    "lincs": {
      "id": "LSM-44881",
      "name": "BRD-K84521734",
      "pubchemCid": 60191277,
      "inchiParent": "InChI=1S/C23H24FN3O3/c1-2-3-15-4-6-16(7-5-15)22-19-12-26(13-21(29)27(19)20(22)14-28)23(30)25-18-10-8-17(24)9-11-18/h2-11,19-20,22,28H,12-14H2,1H3,(H,25,30)/b3-2+/t19-,20-,22+/m1/s1",
      "inchiKeyParent": "PXSSOCWCVDYTEO-MZWZRJJPSA-N",
      "smilesParent": "C\\C=C\\c1ccc(cc1)[C@@H]2[C@@H](CO)N3[C@@H]2CN(CC3=O)C(=O)Nc4ccc(F)cc4"
    },
    "unichem": {
      "lincs": "LSM-44881",
      "pubchem": "60191277"
    },
    "pubchem": [
      {
        "cid": 60191277,
        "inchi": "InChI=1S/C23H24FN3O3/c1-2-3-15-4-6-16(7-5-15)22-19-12-26(13-21(29)27(19)20(22)14-28)23(30)25-18-10-8-17(24)9-11-18/h2-11,19-20,22,28H,12-14H2,1H3,(H,25,30)/b3-2+/t19-,20-,22+/m1/s1",
        "inchikey": "PXSSOCWCVDYTEO-MZWZRJJPSA-N",
        "iupac": {
          "systematic": "(6S,7S,8S)-N-(4-fluorophenyl)-8-(hydroxymethyl)-2-oxo-7-[4-[(E)-prop-1-enyl]phenyl]-1,4-diazabicyclo[4.2.0]octane-4-carboxamide"
        },
        "smiles": {
          "canonical": "CC=CC1=CC=C(C=C1)C2C3CN(CC(=O)N3C2CO)C(=O)NC4=CC=C(C=C4)F"
        },
        "molecularFormula": "C23H24FN3O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:21:17Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c829f"
    },
    "name": "BRD-K60056473",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c829f.png",
    "lincs": {
      "id": "LSM-44808",
      "name": "BRD-K60056473",
      "pubchemCid": 54664819,
      "inchiParent": "InChI=1S/C23H27N3O2/c1-3-5-16-7-8-20-19(12-16)23-18(21(15-27)25(20)2)9-11-26(23)22(28)13-17-6-4-10-24-14-17/h3-8,10,12,14,18,21,23,27H,9,11,13,15H2,1-2H3/b5-3+/t18-,21+,23-/m1/s1",
      "inchiKeyParent": "NAOWZUCOFVWKRA-AWHYRPJTSA-N",
      "smilesParent": "C\\C=C\\c1ccc2N(C)[C@@H](CO)[C@H]3CCN([C@H]3c2c1)C(=O)Cc4cccnc4"
    },
    "unichem": {
      "lincs": "LSM-44808",
      "pubchem": "54664819"
    },
    "pubchem": [
      {
        "cid": 54664819,
        "inchi": "InChI=1S/C23H27N3O2/c1-3-5-16-7-8-20-19(12-16)23-18(21(15-27)25(20)2)9-11-26(23)22(28)13-17-6-4-10-24-14-17/h3-8,10,12,14,18,21,23,27H,9,11,13,15H2,1-2H3/b5-3+/t18-,21+,23-/m1/s1",
        "inchikey": "NAOWZUCOFVWKRA-AWHYRPJTSA-N",
        "iupac": {
          "systematic": "1-[(3aS,4R,9bR)-4-(hydroxymethyl)-5-methyl-8-[(E)-prop-1-enyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-1-yl]-2-pyridin-3-ylethanone"
        },
        "smiles": {
          "canonical": "CC=CC1=CC2=C(C=C1)N(C(C3C2N(CC3)C(=O)CC4=CN=CC=C4)CO)C"
        },
        "molecularFormula": "C23H27N3O2"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:21:19Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8281"
    },
    "name": "BRD-K45440108",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8281.png",
    "lincs": {
      "id": "LSM-11197",
      "name": "BRD-K45440108",
      "pubchemCid": 54646043,
      "chebiId": 99818,
      "inchiParent": "InChI=1S/C21H31N3O6/c1-24(2)11-20(27)23-13-4-5-17-15(8-13)16-9-14(10-19(26)22-6-7-28-3)29-18(12-25)21(16)30-17/h4-5,8,14,16,18,21,25H,6-7,9-12H2,1-3H3,(H,22,26)(H,23,27)/t14-,16+,18+,21-/m1/s1",
      "inchiKeyParent": "ZSBYESKXZOGBOW-NHAHXKBOSA-N",
      "smilesParent": "COCCNC(=O)C[C@H]1C[C@@H]2[C@@H](Oc3ccc(NC(=O)CN(C)C)cc23)[C@H](CO)O1"
    },
    "unichem": {
      "chebi": "99818",
      "lincs": "LSM-11197",
      "pubchem": "54646043"
    },
    "pubchem": [
      {
        "cid": 54646043,
        "inchi": "InChI=1S/C21H31N3O6/c1-24(2)11-20(27)23-13-4-5-17-15(8-13)16-9-14(10-19(26)22-6-7-28-3)29-18(12-25)21(16)30-17/h4-5,8,14,16,18,21,25H,6-7,9-12H2,1-3H3,(H,22,26)(H,23,27)/t14-,16+,18+,21-/m1/s1",
        "inchikey": "ZSBYESKXZOGBOW-NHAHXKBOSA-N",
        "iupac": {
          "systematic": "2-[(1S,3R,4aS,9aR)-6-[[2-(dimethylamino)acetyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-(2-methoxyethyl)acetamide"
        },
        "smiles": {
          "canonical": "CN(C)CC(=O)NC1=CC2=C(C=C1)OC3C2CC(OC3CO)CC(=O)NCCOC"
        },
        "molecularFormula": "C21H31N3O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:21:21Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82a3"
    },
    "name": "BRD-K01383339",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82a3.png",
    "lincs": {
      "id": "LSM-8522",
      "name": "BRD-K01383339",
      "pubchemCid": 54658051,
      "chebiId": 97143,
      "inchiParent": "InChI=1S/C15H24F3NO5/c1-22-14(21)6-11-2-3-12-13(24-11)9-23-8-10(20)7-19(12)5-4-15(16,17)18/h10-13,20H,2-9H2,1H3/t10-,11-,12+,13-/m1/s1",
      "inchiKeyParent": "NGKDTDLAKVOKMV-FVCCEPFGSA-N",
      "smilesParent": "COC(=O)C[C@H]1CC[C@H]2[C@@H](COC[C@H](O)CN2CCC(F)(F)F)O1"
    },
    "unichem": {
      "chebi": "97143",
      "lincs": "LSM-8522",
      "pubchem": "54658051"
    },
    "pubchem": [
      {
        "cid": 54658051,
        "inchi": "InChI=1S/C15H24F3NO5/c1-22-14(21)6-11-2-3-12-13(24-11)9-23-8-10(20)7-19(12)5-4-15(16,17)18/h10-13,20H,2-9H2,1H3/t10-,11-,12+,13-/m1/s1",
        "inchikey": "NGKDTDLAKVOKMV-FVCCEPFGSA-N",
        "iupac": {
          "systematic": "methyl 2-[(3R,6aS,8R,10aS)-3-hydroxy-1-(3,3,3-trifluoropropyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]acetate"
        },
        "smiles": {
          "canonical": "COC(=O)CC1CCC2C(O1)COCC(CN2CCC(F)(F)F)O"
        },
        "molecularFormula": "C15H24F3NO5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:21:23Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82b4"
    },
    "name": "BRD-K36618611",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82b4.png",
    "lincs": {
      "id": "LSM-10641",
      "name": "BRD-K36618611",
      "pubchemCid": 54638362,
      "chebiId": 99262,
      "inchiParent": "InChI=1S/C21H30N4O4/c26-15-19-18(24-21(28)16-5-4-8-22-14-16)7-6-17(29-19)13-20(27)23-9-12-25-10-2-1-3-11-25/h4-8,14,17-19,26H,1-3,9-13,15H2,(H,23,27)(H,24,28)/t17-,18-,19-/m0/s1",
      "inchiKeyParent": "VGDFEWNPUKUXSQ-FHWLQOOXSA-N",
      "smilesParent": "OC[C@@H]1O[C@H](CC(=O)NCCN2CCCCC2)C=C[C@@H]1NC(=O)c3cccnc3"
    },
    "unichem": {
      "chebi": "99262",
      "lincs": "LSM-10641",
      "pubchem": "54638362"
    },
    "pubchem": [
      {
        "cid": 54638362,
        "inchi": "InChI=1S/C21H30N4O4/c26-15-19-18(24-21(28)16-5-4-8-22-14-16)7-6-17(29-19)13-20(27)23-9-12-25-10-2-1-3-11-25/h4-8,14,17-19,26H,1-3,9-13,15H2,(H,23,27)(H,24,28)/t17-,18-,19-/m0/s1",
        "inchikey": "VGDFEWNPUKUXSQ-FHWLQOOXSA-N",
        "iupac": {
          "systematic": "N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(2-piperidin-1-ylethylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]pyridine-3-carboxamide"
        },
        "smiles": {
          "canonical": "C1CCN(CC1)CCNC(=O)CC2C=CC(C(O2)CO)NC(=O)C3=CN=CC=C3"
        },
        "molecularFormula": "C21H30N4O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:21:25Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82d0"
    },
    "name": "BRD-K49525275",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82d0.png",
    "lincs": {
      "id": "LSM-40020",
      "name": "BRD-K49525275",
      "pubchemCid": 54649841,
      "chebiId": 128466,
      "inchiParent": "InChI=1S/C19H26N4O2/c1-14(2)18-13-25-12-17-11-23(22-21-17)9-8-16(19(24)20-18)10-15-6-4-3-5-7-15/h3-7,11,14,16,18H,8-10,12-13H2,1-2H3,(H,20,24)/t16-,18-/m1/s1",
      "inchiKeyParent": "QOGRSGMMWNTNNL-SJLPKXTDSA-N",
      "smilesParent": "CC(C)[C@H]1COCc2cn(CC[C@H](Cc3ccccc3)C(=O)N1)nn2"
    },
    "unichem": {
      "chebi": "128466",
      "lincs": "LSM-40020",
      "pubchem": "54649841"
    },
    "pubchem": [
      {
        "cid": 54649841,
        "inchi": "InChI=1S/C19H26N4O2/c1-14(2)18-13-25-12-17-11-23(22-21-17)9-8-16(19(24)20-18)10-15-6-4-3-5-7-15/h3-7,11,14,16,18H,8-10,12-13H2,1-2H3,(H,20,24)/t16-,18-/m1/s1",
        "inchikey": "QOGRSGMMWNTNNL-SJLPKXTDSA-N",
        "iupac": {
          "systematic": "(4S,7S)-4-benzyl-7-propan-2-yl-9-oxa-1,6,12,13-tetrazabicyclo[9.2.1]tetradeca-11(14),12-dien-5-one"
        },
        "smiles": {
          "canonical": "CC(C)C1COCC2=CN(CCC(C(=O)N1)CC3=CC=CC=C3)N=N2"
        },
        "molecularFormula": "C19H26N4O2"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:21:28Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82f7"
    },
    "name": "MLS003487538",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82f7.png",
    "lincs": {
      "id": "LSM-42506",
      "name": "MLS003487538",
      "alternativeNames": [
        "BRD-K96411295"
      ],
      "pubchemCid": 53299821,
      "chebiId": 130958,
      "inchiParent": "InChI=1S/C26H30N4O5S/c1-3-36(33,34)30-17-21-16-22(26(32)28-12-14-35-2)29-25(24(21)23(30)9-13-31)20-6-4-5-19(15-20)18-7-10-27-11-8-18/h4-8,10-11,15-16,23,31H,3,9,12-14,17H2,1-2H3,(H,28,32)/t23-/m1/s1",
      "inchiKeyParent": "HISLUEZGKSFRIL-HSZRJFAPSA-N",
      "smilesParent": "CCS(=O)(=O)N1Cc2cc(nc(c3cccc(c3)c4ccncc4)c2[C@H]1CCO)C(=O)NCCOC"
    },
    "unichem": {
      "chebi": "130958",
      "lincs": "LSM-42506",
      "pubchem": "53299821"
    },
    "pubchem": [
      {
        "cid": 53299821,
        "inchi": "InChI=1S/C26H30N4O5S/c1-3-36(33,34)30-17-21-16-22(26(32)28-12-14-35-2)29-25(24(21)23(30)9-13-31)20-6-4-5-19(15-20)18-7-10-27-11-8-18/h4-8,10-11,15-16,23,31H,3,9,12-14,17H2,1-2H3,(H,28,32)/t23-/m1/s1",
        "inchikey": "HISLUEZGKSFRIL-HSZRJFAPSA-N",
        "iupac": {
          "systematic": "(3R)-2-ethylsulfonyl-3-(2-hydroxyethyl)-N-(2-methoxyethyl)-4-(3-pyridin-4-ylphenyl)-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide"
        },
        "smiles": {
          "canonical": "CCS(=O)(=O)N1CC2=CC(=NC(=C2C1CCO)C3=CC=CC(=C3)C4=CC=NC=C4)C(=O)NCCOC"
        },
        "molecularFormula": "C26H30N4O5S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:21:30Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82f8"
    },
    "name": "BRD-K12511144",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82f8.png",
    "lincs": {
      "id": "LSM-9175",
      "name": "BRD-K12511144",
      "pubchemCid": 54654100,
      "chebiId": 97796,
      "inchiParent": "InChI=1S/C28H35N3O6/c1-17(2)27(33)30-19-7-12-24-22(13-19)28(34)31(3)23-11-10-21(37-25(23)16-36-24)14-26(32)29-15-18-5-8-20(35-4)9-6-18/h5-9,12-13,17,21,23,25H,10-11,14-16H2,1-4H3,(H,29,32)(H,30,33)/t21-,23+,25+/m0/s1",
      "inchiKeyParent": "WOMWNJCZYVCUPK-QQKQFIJSSA-N",
      "smilesParent": "COc1ccc(CNC(=O)C[C@@H]2CC[C@@H]3[C@@H](COc4ccc(NC(=O)C(C)C)cc4C(=O)N3C)O2)cc1"
    },
    "unichem": {
      "chebi": "97796",
      "lincs": "LSM-9175",
      "pubchem": "54654100"
    },
    "pubchem": [
      {
        "cid": 54654100,
        "inchi": "InChI=1S/C28H35N3O6/c1-17(2)27(33)30-19-7-12-24-22(13-19)28(34)31(3)23-11-10-21(37-25(23)16-36-24)14-26(32)29-15-18-5-8-20(35-4)9-6-18/h5-9,12-13,17,21,23,25H,10-11,14-16H2,1-4H3,(H,29,32)(H,30,33)/t21-,23+,25+/m0/s1",
        "inchikey": "WOMWNJCZYVCUPK-QQKQFIJSSA-N",
        "iupac": {
          "systematic": "N-[(2S,4aR,12aS)-2-[2-[(4-methoxyphenyl)methylamino]-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-2-methylpropanamide"
        },
        "smiles": {
          "canonical": "CC(C)C(=O)NC1=CC2=C(C=C1)OCC3C(CCC(O3)CC(=O)NCC4=CC=C(C=C4)OC)N(C2=O)C"
        },
        "molecularFormula": "C28H35N3O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:21:32Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c831b"
    },
    "name": "BRD-K80831196",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c831b.png",
    "lincs": {
      "id": "LSM-13373",
      "name": "BRD-K80831196",
      "pubchemCid": 54646730,
      "chebiId": 102012,
      "inchiParent": "InChI=1S/C25H34N2O6/c28-15-22-24-20(13-18(32-22)14-23(29)27-8-2-1-3-9-27)19-12-17(4-5-21(19)33-24)26-25(30)16-6-10-31-11-7-16/h4-5,12,16,18,20,22,24,28H,1-3,6-11,13-15H2,(H,26,30)/t18-,20+,22+,24-/m1/s1",
      "inchiKeyParent": "SADUCKDCBXEUGG-HJBWUJCXSA-N",
      "smilesParent": "OC[C@@H]1O[C@@H](CC(=O)N2CCCCC2)C[C@@H]3[C@H]1Oc4ccc(NC(=O)C5CCOCC5)cc34"
    },
    "unichem": {
      "chebi": "102012",
      "lincs": "LSM-13373",
      "pubchem": "54646730"
    },
    "pubchem": [
      {
        "cid": 54646730,
        "inchi": "InChI=1S/C25H34N2O6/c28-15-22-24-20(13-18(32-22)14-23(29)27-8-2-1-3-9-27)19-12-17(4-5-21(19)33-24)26-25(30)16-6-10-31-11-7-16/h4-5,12,16,18,20,22,24,28H,1-3,6-11,13-15H2,(H,26,30)/t18-,20+,22+,24-/m1/s1",
        "inchikey": "SADUCKDCBXEUGG-HJBWUJCXSA-N",
        "iupac": {
          "systematic": "N-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-3-(2-oxo-2-piperidin-1-ylethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]oxane-4-carboxamide"
        },
        "smiles": {
          "canonical": "C1CCN(CC1)C(=O)CC2CC3C(C(O2)CO)OC4=C3C=C(C=C4)NC(=O)C5CCOCC5"
        },
        "molecularFormula": "C25H34N2O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:21:35Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8291"
    },
    "name": "BRD-K65402741-019-01-9",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8291.png",
    "lincs": {
      "id": "LSM-36576",
      "name": "BRD-K65402741-019-01-9",
      "alternativeNames": [
        "BRD-K65402741",
        "BRD-K93685980"
      ],
      "pubchemCid": 60185172,
      "chebiId": 125114,
      "inchiParent": "InChI=1S/C25H29N3O2/c1-27(2)24(29)20-12-8-17(9-13-20)16-6-10-18(11-7-16)23-21-14-28(15-22(23)26-21)25(30)19-4-3-5-19/h6-13,19,21-23,26H,3-5,14-15H2,1-2H3/t21-,22+,23?",
      "inchiKeyParent": "CAIRMNGGSRXYSX-AIZNXBIQSA-N",
      "smilesParent": "CN(C)C(=O)c1ccc(cc1)c2ccc(cc2)[C@@H]3[C@@H]4CN(C[C@H]3N4)C(=O)C5CCC5"
    },
    "unichem": {
      "chebi": "125114",
      "lincs": "LSM-36576",
      "pubchem": "60185172"
    },
    "pubchem": [
      {
        "cid": 60185172,
        "inchi": "InChI=1S/C25H29N3O2/c1-27(2)24(29)20-12-8-17(9-13-20)16-6-10-18(11-7-16)23-21-14-28(15-22(23)26-21)25(30)19-4-3-5-19/h6-13,19,21-23,26H,3-5,14-15H2,1-2H3/t21-,22+,23?",
        "inchikey": "CAIRMNGGSRXYSX-AIZNXBIQSA-N",
        "iupac": {
          "systematic": "4-[4-[(1R,5S)-3-(cyclobutanecarbonyl)-3,6-diazabicyclo[3.1.1]heptan-7-yl]phenyl]-N,N-dimethylbenzamide"
        },
        "smiles": {
          "canonical": "CN(C)C(=O)C1=CC=C(C=C1)C2=CC=C(C=C2)C3C4CN(CC3N4)C(=O)C5CCC5"
        },
        "molecularFormula": "C25H29N3O2"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:21:38Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82e2"
    },
    "name": "CHEMBL3188670",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82e2.png",
    "lincs": {
      "id": "LSM-36489",
      "name": "CHEMBL3188670",
      "alternativeNames": [
        "BRD-K14031425"
      ],
      "pubchemCid": 60185127,
      "chebiId": 125027,
      "inchiParent": "InChI=1S/C25H26N2O2S/c1-17-6-12-22(13-7-17)30(28,29)27-15-23-25(24(16-27)26-23)20-10-8-19(9-11-20)21-5-3-4-18(2)14-21/h3-14,23-26H,15-16H2,1-2H3/t23-,24+,25?",
      "inchiKeyParent": "CXXKKGQDDQXONQ-XMGLRAKGSA-N",
      "smilesParent": "Cc1ccc(cc1)S(=O)(=O)N2C[C@@H]3N[C@H](C2)[C@@H]3c4ccc(cc4)c5cccc(C)c5"
    },
    "unichem": {
      "chebi": "125027",
      "lincs": "LSM-36489",
      "pubchem": "60185127"
    },
    "pubchem": [
      {
        "cid": 60185127,
        "inchi": "InChI=1S/C25H26N2O2S/c1-17-6-12-22(13-7-17)30(28,29)27-15-23-25(24(16-27)26-23)20-10-8-19(9-11-20)21-5-3-4-18(2)14-21/h3-14,23-26H,15-16H2,1-2H3/t23-,24+,25?",
        "inchikey": "CXXKKGQDDQXONQ-XMGLRAKGSA-N",
        "iupac": {
          "systematic": "(1R,5S)-7-[4-(3-methylphenyl)phenyl]-3-(4-methylphenyl)sulfonyl-3,6-diazabicyclo[3.1.1]heptane"
        },
        "smiles": {
          "canonical": "CC1=CC=C(C=C1)S(=O)(=O)N2CC3C(C(C2)N3)C4=CC=C(C=C4)C5=CC=CC(=C5)C"
        },
        "molecularFormula": "C25H26N2O2S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:21:40Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8312"
    },
    "name": "BRD-K00224166",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8312.png",
    "lincs": {
      "id": "LSM-8438",
      "name": "BRD-K00224166",
      "pubchemCid": 54657932,
      "chebiId": 97059,
      "inchiParent": "InChI=1S/C23H32FN3O5/c1-25-8-10-26(11-9-25)22(29)12-17-6-7-20-21(32-17)15-31-14-16(28)13-27(20)23(30)18-4-2-3-5-19(18)24/h2-5,16-17,20-21,28H,6-15H2,1H3/t16-,17-,20+,21-/m1/s1",
      "inchiKeyParent": "JLPSQBARJGYMKN-SGLNWRHMSA-N",
      "smilesParent": "CN1CCN(CC1)C(=O)C[C@H]2CC[C@H]3[C@@H](COC[C@H](O)CN3C(=O)c4ccccc4F)O2"
    },
    "unichem": {
      "chebi": "97059",
      "lincs": "LSM-8438",
      "pubchem": "54657932"
    },
    "pubchem": [
      {
        "cid": 54657932,
        "inchi": "InChI=1S/C23H32FN3O5/c1-25-8-10-26(11-9-25)22(29)12-17-6-7-20-21(32-17)15-31-14-16(28)13-27(20)23(30)18-4-2-3-5-19(18)24/h2-5,16-17,20-21,28H,6-15H2,1H3/t16-,17-,20+,21-/m1/s1",
        "inchikey": "JLPSQBARJGYMKN-SGLNWRHMSA-N",
        "iupac": {
          "systematic": "2-[(3R,6aS,8R,10aS)-1-(2-fluorobenzoyl)-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(4-methylpiperazin-1-yl)ethanone"
        },
        "smiles": {
          "canonical": "CN1CCN(CC1)C(=O)CC2CCC3C(O2)COCC(CN3C(=O)C4=CC=CC=C4F)O"
        },
        "molecularFormula": "C23H32FN3O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:21:42Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8322"
    },
    "name": "BRD-K79664955",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8322.png",
    "lincs": {
      "id": "LSM-13293",
      "name": "BRD-K79664955",
      "pubchemCid": 54646048,
      "chebiId": 101932,
      "inchiParent": "InChI=1S/C24H30N2O5/c1-26(2)16-8-9-21-18(10-16)19-11-17(30-22(14-27)24(19)31-21)12-23(28)25-13-15-6-4-5-7-20(15)29-3/h4-10,17,19,22,24,27H,11-14H2,1-3H3,(H,25,28)/t17-,19-,22-,24+/m1/s1",
      "inchiKeyParent": "YXRWVZTUBKEEPU-NAOSLSSXSA-N",
      "smilesParent": "COc1ccccc1CNC(=O)C[C@H]2C[C@H]3[C@H](Oc4ccc(cc34)N(C)C)[C@@H](CO)O2"
    },
    "unichem": {
      "chebi": "101932",
      "lincs": "LSM-13293",
      "pubchem": "54646048"
    },
    "pubchem": [
      {
        "cid": 54646048,
        "inchi": "InChI=1S/C24H30N2O5/c1-26(2)16-8-9-21-18(10-16)19-11-17(30-22(14-27)24(19)31-21)12-23(28)25-13-15-6-4-5-7-20(15)29-3/h4-10,17,19,22,24,27H,11-14H2,1-3H3,(H,25,28)/t17-,19-,22-,24+/m1/s1",
        "inchikey": "YXRWVZTUBKEEPU-NAOSLSSXSA-N",
        "iupac": {
          "systematic": "2-[(1R,3R,4aR,9aS)-6-(dimethylamino)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-[(2-methoxyphenyl)methyl]acetamide"
        },
        "smiles": {
          "canonical": "CN(C)C1=CC2=C(C=C1)OC3C2CC(OC3CO)CC(=O)NCC4=CC=CC=C4OC"
        },
        "molecularFormula": "C24H30N2O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:21:44Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c832d"
    },
    "name": "BRD-K68178066",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c832d.png",
    "lincs": {
      "id": "LSM-12584",
      "name": "BRD-K68178066",
      "pubchemCid": 54646135,
      "chebiId": 101215,
      "inchiParent": "InChI=1S/C26H31N3O5/c30-15-23-25-21(12-19(33-23)13-24(31)28-17-6-2-1-3-7-17)20-11-18(8-9-22(20)34-25)29-26(32)16-5-4-10-27-14-16/h4-5,8-11,14,17,19,21,23,25,30H,1-3,6-7,12-13,15H2,(H,28,31)(H,29,32)/t19-,21-,23+,25+/m1/s1",
      "inchiKeyParent": "CCIDSNZUNACLPU-ASASOQJESA-N",
      "smilesParent": "OC[C@@H]1O[C@@H](CC(=O)NC2CCCCC2)C[C@H]3[C@@H]1Oc4ccc(NC(=O)c5cccnc5)cc34"
    },
    "unichem": {
      "chebi": "101215",
      "lincs": "LSM-12584",
      "pubchem": "54646135"
    },
    "pubchem": [
      {
        "cid": 54646135,
        "inchi": "InChI=1S/C26H31N3O5/c30-15-23-25-21(12-19(33-23)13-24(31)28-17-6-2-1-3-7-17)20-11-18(8-9-22(20)34-25)29-26(32)16-5-4-10-27-14-16/h4-5,8-11,14,17,19,21,23,25,30H,1-3,6-7,12-13,15H2,(H,28,31)(H,29,32)/t19-,21-,23+,25+/m1/s1",
        "inchikey": "CCIDSNZUNACLPU-ASASOQJESA-N",
        "iupac": {
          "systematic": "N-[(1S,3R,4aR,9aS)-3-[2-(cyclohexylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]pyridine-3-carboxamide"
        },
        "smiles": {
          "canonical": "C1CCC(CC1)NC(=O)CC2CC3C(C(O2)CO)OC4=C3C=C(C=C4)NC(=O)C5=CN=CC=C5"
        },
        "molecularFormula": "C26H31N3O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:21:47Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8284"
    },
    "name": "BRD-K87445406",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8284.png",
    "lincs": {
      "id": "LSM-13793",
      "name": "BRD-K87445406",
      "pubchemCid": 54654366,
      "chebiId": 102442,
      "inchiParent": "InChI=1S/C27H38N4O6/c1-29-9-11-31(12-10-29)25(32)16-20-4-5-22-24(37-20)17-36-23-6-3-19(15-21(23)27(34)30(22)2)28-26(33)18-7-13-35-14-8-18/h3,6,15,18,20,22,24H,4-5,7-14,16-17H2,1-2H3,(H,28,33)/t20-,22-,24+/m0/s1",
      "inchiKeyParent": "HKYXYLDUIXPRSO-ODGPQVTHSA-N",
      "smilesParent": "CN1CCN(CC1)C(=O)C[C@@H]2CC[C@H]3[C@@H](COc4ccc(NC(=O)C5CCOCC5)cc4C(=O)N3C)O2"
    },
    "unichem": {
      "chebi": "102442",
      "lincs": "LSM-13793",
      "pubchem": "54654366"
    },
    "pubchem": [
      {
        "cid": 54654366,
        "inchi": "InChI=1S/C27H38N4O6/c1-29-9-11-31(12-10-29)25(32)16-20-4-5-22-24(37-20)17-36-23-6-3-19(15-21(23)27(34)30(22)2)28-26(33)18-7-13-35-14-8-18/h3,6,15,18,20,22,24H,4-5,7-14,16-17H2,1-2H3,(H,28,33)/t20-,22-,24+/m0/s1",
        "inchikey": "HKYXYLDUIXPRSO-ODGPQVTHSA-N",
        "iupac": {
          "systematic": "N-[(2S,4aS,12aS)-5-methyl-2-[2-(4-methylpiperazin-1-yl)-2-oxoethyl]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]oxane-4-carboxamide"
        },
        "smiles": {
          "canonical": "CN1CCN(CC1)C(=O)CC2CCC3C(O2)COC4=C(C=C(C=C4)NC(=O)C5CCOCC5)C(=O)N3C"
        },
        "molecularFormula": "C27H38N4O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:21:49Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82a8"
    },
    "name": "BRD-K51725102",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82a8.png",
    "lincs": {
      "id": "LSM-11592",
      "name": "BRD-K51725102",
      "pubchemCid": 54631404,
      "chebiId": 100215,
      "inchiParent": "InChI=1S/C25H35N5O4/c1-6-11-30-14-17(2)23(33-5)15-29(4)25(32)20-12-19(7-8-22(20)34-16-18(30)3)28-24(31)21-13-26-9-10-27-21/h7-10,12-13,17-18,23H,6,11,14-16H2,1-5H3,(H,28,31)/t17-,18-,23-/m1/s1",
      "inchiKeyParent": "ZGJMWZDWXNCIBA-PMAPCBKXSA-N",
      "smilesParent": "CCCN1C[C@@H](C)[C@@H](CN(C)C(=O)c2cc(NC(=O)c3cnccn3)ccc2OC[C@H]1C)OC"
    },
    "unichem": {
      "chebi": "100215",
      "lincs": "LSM-11592",
      "pubchem": "54631404"
    },
    "pubchem": [
      {
        "cid": 54631404,
        "inchi": "InChI=1S/C25H35N5O4/c1-6-11-30-14-17(2)23(33-5)15-29(4)25(32)20-12-19(7-8-22(20)34-16-18(30)3)28-24(31)21-13-26-9-10-27-21/h7-10,12-13,17-18,23H,6,11,14-16H2,1-5H3,(H,28,31)/t17-,18-,23-/m1/s1",
        "inchikey": "ZGJMWZDWXNCIBA-PMAPCBKXSA-N",
        "iupac": {
          "systematic": "N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]pyrazine-2-carboxamide"
        },
        "smiles": {
          "canonical": "CCCN1CC(C(CN(C(=O)C2=C(C=CC(=C2)NC(=O)C3=NC=CN=C3)OCC1C)C)OC)C"
        },
        "molecularFormula": "C25H35N5O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:21:51Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82be"
    },
    "name": "BRD-K14538540",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82be.png",
    "lincs": {
      "id": "LSM-46141",
      "name": "BRD-K14538540",
      "inchiParent": "InChI=1S/C26H25N3O/c30-25(16-21-12-14-27-15-13-21)29-17-23-26(24(18-29)28-23)22-10-8-20(9-11-22)7-6-19-4-2-1-3-5-19/h1-15,23-24,26,28H,16-18H2/b7-6+/t23-,24+,26-",
      "inchiKeyParent": "WOCRQZHTIDNKHB-SYOAQCMCSA-N",
      "smilesParent": "O=C(Cc1ccncc1)N2C[C@@H]3N[C@H](C2)[C@H]3c4ccc(\\C=C\\c5ccccc5)cc4"
    },
    "unichem": {
      "lincs": "LSM-46141"
    },
    "createdAt": {
      "$date": "2025-05-24T08:21:53Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82f6"
    },
    "name": "BRD-K00463020",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82f6.png",
    "lincs": {
      "id": "LSM-6865",
      "name": "BRD-K00463020",
      "pubchemCid": 54618377,
      "chebiId": 95486,
      "inchiParent": "InChI=1S/C28H39N3O6/c1-19-16-31(20(2)18-32)27(34)23-14-21(6-11-28(35)9-4-5-10-28)15-29-25(23)37-24(19)17-30(3)26(33)22-7-12-36-13-8-22/h14-15,19-20,22,24,32,35H,4-5,7-10,12-13,16-18H2,1-3H3/t19-,20+,24+/m0/s1",
      "inchiKeyParent": "FLFHXFOLABGIIH-DCLXLUIPSA-N",
      "smilesParent": "C[C@H](CO)N1C[C@H](C)[C@@H](CN(C)C(=O)C2CCOCC2)Oc3ncc(cc3C1=O)C#CC4(O)CCCC4"
    },
    "unichem": {
      "chebi": "95486",
      "lincs": "LSM-6865",
      "pubchem": "54618377"
    },
    "pubchem": [
      {
        "cid": 54618377,
        "inchi": "InChI=1S/C28H39N3O6/c1-19-16-31(20(2)18-32)27(34)23-14-21(6-11-28(35)9-4-5-10-28)15-29-25(23)37-24(19)17-30(3)26(33)22-7-12-36-13-8-22/h14-15,19-20,22,24,32,35H,4-5,7-10,12-13,16-18H2,1-3H3/t19-,20+,24+/m0/s1",
        "inchikey": "FLFHXFOLABGIIH-DCLXLUIPSA-N",
        "iupac": {
          "systematic": "N-[[(2S,3S)-8-[2-(1-hydroxycyclopentyl)ethynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyloxane-4-carboxamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(N=CC(=C2)C#CC3(CCCC3)O)OC1CN(C)C(=O)C4CCOCC4)C(C)CO"
        },
        "molecularFormula": "C28H39N3O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:21:55Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8303"
    },
    "name": "BRD-K33994902",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8303.png",
    "lincs": {
      "id": "LSM-10485",
      "name": "BRD-K33994902",
      "pubchemCid": 54654591,
      "chebiId": 99106,
      "inchiParent": "InChI=1S/C30H35N3O8/c1-33-23-5-4-21(14-28(34)31-15-18-2-6-25-26(12-18)40-17-39-25)41-27(23)16-38-24-7-3-20(13-22(24)30(33)36)32-29(35)19-8-10-37-11-9-19/h2-3,6-7,12-13,19,21,23,27H,4-5,8-11,14-17H2,1H3,(H,31,34)(H,32,35)/t21-,23-,27+/m0/s1",
      "inchiKeyParent": "JZWHDUCFLDKMHA-JEYPMZLKSA-N",
      "smilesParent": "CN1[C@H]2CC[C@@H](CC(=O)NCc3ccc4OCOc4c3)O[C@@H]2COc5ccc(NC(=O)C6CCOCC6)cc5C1=O"
    },
    "unichem": {
      "chebi": "99106",
      "lincs": "LSM-10485",
      "pubchem": "54654591"
    },
    "pubchem": [
      {
        "cid": 54654591,
        "inchi": "InChI=1S/C30H35N3O8/c1-33-23-5-4-21(14-28(34)31-15-18-2-6-25-26(12-18)40-17-39-25)41-27(23)16-38-24-7-3-20(13-22(24)30(33)36)32-29(35)19-8-10-37-11-9-19/h2-3,6-7,12-13,19,21,23,27H,4-5,8-11,14-17H2,1H3,(H,31,34)(H,32,35)/t21-,23-,27+/m0/s1",
        "inchikey": "JZWHDUCFLDKMHA-JEYPMZLKSA-N",
        "iupac": {
          "systematic": "N-[(2S,4aS,12aS)-2-[2-(1,3-benzodioxol-5-ylmethylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]oxane-4-carboxamide"
        },
        "smiles": {
          "canonical": "CN1C2CCC(OC2COC3=C(C1=O)C=C(C=C3)NC(=O)C4CCOCC4)CC(=O)NCC5=CC6=C(C=C5)OCO6"
        },
        "molecularFormula": "C30H35N3O8"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:21:57Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82c7"
    },
    "name": "BRD-K92947165",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82c7.png",
    "lincs": {
      "id": "LSM-14127",
      "name": "BRD-K92947165",
      "pubchemCid": 54654334,
      "chebiId": 102781,
      "inchiParent": "InChI=1S/C34H36F2N4O5/c1-39-29-11-9-25(17-32(41)37-24-13-14-40(19-24)18-21-5-3-2-4-6-21)45-31(29)20-44-30-12-8-23(16-26(30)34(39)43)38-33(42)22-7-10-27(35)28(36)15-22/h2-8,10,12,15-16,24-25,29,31H,9,11,13-14,17-20H2,1H3,(H,37,41)(H,38,42)/t24-,25-,29+,31+/m1/s1",
      "inchiKeyParent": "UWMJOJNRDSZDAZ-JUTMGGSISA-N",
      "smilesParent": "CN1[C@H]2CC[C@H](CC(=O)N[C@@H]3CCN(Cc4ccccc4)C3)O[C@H]2COc5ccc(NC(=O)c6ccc(F)c(F)c6)cc5C1=O"
    },
    "unichem": {
      "chebi": "102781",
      "lincs": "LSM-14127",
      "pubchem": "54654334"
    },
    "pubchem": [
      {
        "cid": 54654334,
        "inchi": "InChI=1S/C34H36F2N4O5/c1-39-29-11-9-25(17-32(41)37-24-13-14-40(19-24)18-21-5-3-2-4-6-21)45-31(29)20-44-30-12-8-23(16-26(30)34(39)43)38-33(42)22-7-10-27(35)28(36)15-22/h2-8,10,12,15-16,24-25,29,31H,9,11,13-14,17-20H2,1H3,(H,37,41)(H,38,42)/t24-,25-,29+,31+/m1/s1",
        "inchikey": "UWMJOJNRDSZDAZ-JUTMGGSISA-N",
        "iupac": {
          "systematic": "N-[(2R,4aS,12aR)-2-[2-[[(3R)-1-benzylpyrrolidin-3-yl]amino]-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-3,4-difluorobenzamide"
        },
        "smiles": {
          "canonical": "CN1C2CCC(OC2COC3=C(C1=O)C=C(C=C3)NC(=O)C4=CC(=C(C=C4)F)F)CC(=O)NC5CCN(C5)CC6=CC=CC=C6"
        },
        "molecularFormula": "C34H36F2N4O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:21:59Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8334"
    },
    "name": "BRD-K68441823",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8334.png",
    "lincs": {
      "id": "LSM-12604",
      "name": "BRD-K68441823",
      "pubchemCid": 54632109,
      "chebiId": 101236,
      "inchiParent": "InChI=1S/C24H38N4O6/c1-15(2)25-24(31)28-11-16(3)21(33-7)12-27(5)23(30)19-9-8-18(26-22(29)14-32-6)10-20(19)34-13-17(28)4/h8-10,15-17,21H,11-14H2,1-7H3,(H,25,31)(H,26,29)/t16-,17-,21+/m0/s1",
      "inchiKeyParent": "AOOMHDUDPOWWMY-XGHQBKJUSA-N",
      "smilesParent": "COCC(=O)Nc1ccc2C(=O)N(C)C[C@@H](OC)[C@@H](C)CN([C@@H](C)COc2c1)C(=O)NC(C)C"
    },
    "unichem": {
      "chebi": "101236",
      "lincs": "LSM-12604",
      "pubchem": "54632109"
    },
    "pubchem": [
      {
        "cid": 54632109,
        "inchi": "InChI=1S/C24H38N4O6/c1-15(2)25-24(31)28-11-16(3)21(33-7)12-27(5)23(30)19-9-8-18(26-22(29)14-32-6)10-20(19)34-13-17(28)4/h8-10,15-17,21H,11-14H2,1-7H3,(H,25,31)(H,26,29)/t16-,17-,21+/m0/s1",
        "inchikey": "AOOMHDUDPOWWMY-XGHQBKJUSA-N",
        "iupac": {
          "systematic": "(4S,7S,8S)-8-methoxy-15-[(2-methoxyacetyl)amino]-4,7,10-trimethyl-11-oxo-N-propan-2-yl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-5-carboxamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(COC2=C(C=CC(=C2)NC(=O)COC)C(=O)N(CC1OC)C)C)C(=O)NC(C)C"
        },
        "molecularFormula": "C24H38N4O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:22:01Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82b0"
    },
    "name": "BRD-K95328825",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82b0.png",
    "lincs": {
      "id": "LSM-14271",
      "name": "BRD-K95328825",
      "pubchemCid": 54657992,
      "chebiId": 102925,
      "inchiParent": "InChI=1S/C23H34FN3O4/c1-25-7-9-26(10-8-25)23(29)12-20-5-6-21-22(31-20)16-30-15-19(28)14-27(21)13-17-3-2-4-18(24)11-17/h2-4,11,19-22,28H,5-10,12-16H2,1H3/t19-,20+,21+,22-/m0/s1",
      "inchiKeyParent": "UZQWVSGPDQQYNK-CBPXPLCBSA-N",
      "smilesParent": "CN1CCN(CC1)C(=O)C[C@H]2CC[C@@H]3[C@H](COC[C@@H](O)CN3Cc4cccc(F)c4)O2"
    },
    "unichem": {
      "chebi": "102925",
      "lincs": "LSM-14271",
      "pubchem": "54657992"
    },
    "pubchem": [
      {
        "cid": 54657992,
        "inchi": "InChI=1S/C23H34FN3O4/c1-25-7-9-26(10-8-25)23(29)12-20-5-6-21-22(31-20)16-30-15-19(28)14-27(21)13-17-3-2-4-18(24)11-17/h2-4,11,19-22,28H,5-10,12-16H2,1H3/t19-,20+,21+,22-/m0/s1",
        "inchikey": "UZQWVSGPDQQYNK-CBPXPLCBSA-N",
        "iupac": {
          "systematic": "2-[(3S,6aR,8R,10aR)-1-[(3-fluorophenyl)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(4-methylpiperazin-1-yl)ethanone"
        },
        "smiles": {
          "canonical": "CN1CCN(CC1)C(=O)CC2CCC3C(O2)COCC(CN3CC4=CC(=CC=C4)F)O"
        },
        "molecularFormula": "C23H34FN3O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:22:04Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82bf"
    },
    "name": "BRD-K36115238",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82bf.png",
    "lincs": {
      "id": "LSM-39247",
      "name": "BRD-K36115238",
      "pubchemCid": 54664929,
      "chebiId": 127690,
      "inchiParent": "InChI=1S/C19H20BrN3O2/c20-13-1-2-16-15(10-13)19-14(17(11-24)22-16)5-8-23(19)18(25)9-12-3-6-21-7-4-12/h1-4,6-7,10,14,17,19,22,24H,5,8-9,11H2/t14-,17+,19-/m1/s1",
      "inchiKeyParent": "SMISTCVGXCUIKS-DKSSEZFCSA-N",
      "smilesParent": "OC[C@@H]1Nc2ccc(Br)cc2[C@H]3[C@@H]1CCN3C(=O)Cc4ccncc4"
    },
    "unichem": {
      "chebi": "127690",
      "lincs": "LSM-39247",
      "pubchem": "54664929"
    },
    "pubchem": [
      {
        "cid": 54664929,
        "inchi": "InChI=1S/C19H20BrN3O2/c20-13-1-2-16-15(10-13)19-14(17(11-24)22-16)5-8-23(19)18(25)9-12-3-6-21-7-4-12/h1-4,6-7,10,14,17,19,22,24H,5,8-9,11H2/t14-,17+,19-/m1/s1",
        "inchikey": "SMISTCVGXCUIKS-DKSSEZFCSA-N",
        "iupac": {
          "systematic": "1-[(3aR,4R,9bR)-8-bromo-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-2-pyridin-4-ylethanone"
        },
        "smiles": {
          "canonical": "C1CN(C2C1C(NC3=C2C=C(C=C3)Br)CO)C(=O)CC4=CC=NC=C4"
        },
        "molecularFormula": "C19H20BrN3O2"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:22:06Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8339"
    },
    "name": "BRD-K01619611",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8339.png",
    "lincs": {
      "id": "LSM-6882",
      "name": "BRD-K01619611",
      "pubchemCid": 54618604,
      "chebiId": 95503,
      "inchiParent": "InChI=1S/C27H34FN3O5S/c1-5-6-7-10-21-13-14-26-24(15-21)36-25(19(2)16-31(20(3)18-32)37(26,34)35)17-30(4)27(33)29-23-12-9-8-11-22(23)28/h8-9,11-15,19-20,25,32H,5-6,16-18H2,1-4H3,(H,29,33)/t19-,20-,25+/m0/s1",
      "inchiKeyParent": "ZRJLNIRQYSTGIF-ZYLNGJIFSA-N",
      "smilesParent": "CCCC#Cc1ccc2c(O[C@H](CN(C)C(=O)Nc3ccccc3F)[C@@H](C)CN([C@@H](C)CO)S2(=O)=O)c1"
    },
    "unichem": {
      "chebi": "95503",
      "lincs": "LSM-6882",
      "pubchem": "54618604"
    },
    "pubchem": [
      {
        "cid": 54618604,
        "inchi": "InChI=1S/C27H34FN3O5S/c1-5-6-7-10-21-13-14-26-24(15-21)36-25(19(2)16-31(20(3)18-32)37(26,34)35)17-30(4)27(33)29-23-12-9-8-11-22(23)28/h8-9,11-15,19-20,25,32H,5-6,16-18H2,1-4H3,(H,29,33)/t19-,20-,25+/m0/s1",
        "inchikey": "ZRJLNIRQYSTGIF-ZYLNGJIFSA-N",
        "iupac": {
          "systematic": "3-(2-fluorophenyl)-1-[[(4S,5S)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-pent-1-ynyl-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-1-methylurea"
        },
        "smiles": {
          "canonical": "CCCC#CC1=CC2=C(C=C1)S(=O)(=O)N(CC(C(O2)CN(C)C(=O)NC3=CC=CC=C3F)C)C(C)CO"
        },
        "molecularFormula": "C27H34FN3O5S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:22:08Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82ba"
    },
    "name": "BRD-K85672685",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82ba.png",
    "lincs": {
      "id": "LSM-13671",
      "name": "BRD-K85672685",
      "pubchemCid": 54631577,
      "chebiId": 102318,
      "inchiParent": "InChI=1S/C27H43N3O4/c1-6-9-26(31)28-22-12-13-24-23(14-22)27(32)29(4)17-25(33-5)19(2)15-30(20(3)18-34-24)16-21-10-7-8-11-21/h12-14,19-21,25H,6-11,15-18H2,1-5H3,(H,28,31)/t19-,20+,25+/m1/s1",
      "inchiKeyParent": "VSOIFNIWZGPCNV-RNHFSVANSA-N",
      "smilesParent": "CCCC(=O)Nc1ccc2OC[C@H](C)N(CC3CCCC3)C[C@@H](C)[C@H](CN(C)C(=O)c2c1)OC"
    },
    "unichem": {
      "chebi": "102318",
      "lincs": "LSM-13671",
      "pubchem": "54631577"
    },
    "pubchem": [
      {
        "cid": 54631577,
        "inchi": "InChI=1S/C27H43N3O4/c1-6-9-26(31)28-22-12-13-24-23(14-22)27(32)29(4)17-25(33-5)19(2)15-30(20(3)18-34-24)16-21-10-7-8-11-21/h12-14,19-21,25H,6-11,15-18H2,1-5H3,(H,28,31)/t19-,20+,25+/m1/s1",
        "inchikey": "VSOIFNIWZGPCNV-RNHFSVANSA-N",
        "iupac": {
          "systematic": "N-[(4S,7R,8R)-5-(cyclopentylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide"
        },
        "smiles": {
          "canonical": "CCCC(=O)NC1=CC2=C(C=C1)OCC(N(CC(C(CN(C2=O)C)OC)C)CC3CCCC3)C"
        },
        "molecularFormula": "C27H43N3O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:22:10Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82fd"
    },
    "name": "BRD-K00124439",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82fd.png",
    "lincs": {
      "id": "LSM-8431",
      "name": "BRD-K00124439",
      "pubchemCid": 54649967,
      "chebiId": 97052,
      "inchiParent": "InChI=1S/C23H21N3O2/c24-14-20-23(18-10-8-17(9-11-18)7-6-16-4-5-16)21(15-27)26(20)22(28)13-19-3-1-2-12-25-19/h1-3,8-12,16,20-21,23,27H,4-5,13,15H2/t20-,21-,23-/m0/s1",
      "inchiKeyParent": "FLQYRXYGAVUNDA-FUDKSRODSA-N",
      "smilesParent": "OC[C@H]1[C@H]([C@H](C#N)N1C(=O)Cc2ccccn2)c3ccc(cc3)C#CC4CC4"
    },
    "unichem": {
      "chebi": "97052",
      "lincs": "LSM-8431",
      "pubchem": "54649967"
    },
    "pubchem": [
      {
        "cid": 54649967,
        "inchi": "InChI=1S/C23H21N3O2/c24-14-20-23(18-10-8-17(9-11-18)7-6-16-4-5-16)21(15-27)26(20)22(28)13-19-3-1-2-12-25-19/h1-3,8-12,16,20-21,23,27H,4-5,13,15H2/t20-,21-,23-/m0/s1",
        "inchikey": "FLQYRXYGAVUNDA-FUDKSRODSA-N",
        "iupac": {
          "systematic": "(2R,3S,4R)-3-[4-(2-cyclopropylethynyl)phenyl]-4-(hydroxymethyl)-1-(2-pyridin-2-ylacetyl)azetidine-2-carbonitrile"
        },
        "smiles": {
          "canonical": "C1CC1C#CC2=CC=C(C=C2)C3C(N(C3C#N)C(=O)CC4=CC=CC=N4)CO"
        },
        "molecularFormula": "C23H21N3O2"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:22:12Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c832b"
    },
    "name": "MLS003650139",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c832b.png",
    "lincs": {
      "id": "LSM-9842",
      "name": "MLS003650139",
      "alternativeNames": [
        "BRD-K23557133"
      ],
      "pubchemCid": 53382788,
      "chebiId": 98463,
      "inchiParent": "InChI=1S/C26H40N4O5/c1-2-11-27-26(33)30-16-21(31)17-34-18-24-23(30)9-8-22(35-24)13-25(32)28-20-10-12-29(15-20)14-19-6-4-3-5-7-19/h3-7,20-24,31H,2,8-18H2,1H3,(H,27,33)(H,28,32)/t20-,21+,22-,23+,24-/m1/s1",
      "inchiKeyParent": "WWAGOAOIMIOBRQ-QWQGWLCTSA-N",
      "smilesParent": "CCCNC(=O)N1C[C@H](O)COC[C@H]2O[C@@H](CC(=O)N[C@@H]3CCN(Cc4ccccc4)C3)CC[C@H]12"
    },
    "unichem": {
      "chebi": "98463",
      "chembl": "CHEMBL3185151",
      "lincs": "LSM-9842",
      "pubchem": "53382788"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL3185151",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 488.63,
        "hba": 6,
        "hbd": 3,
        "qedWeighted": 0.54
      }
    },
    "pubchem": [
      {
        "cid": 53382788,
        "inchi": "InChI=1S/C26H40N4O5/c1-2-11-27-26(33)30-16-21(31)17-34-18-24-23(30)9-8-22(35-24)13-25(32)28-20-10-12-29(15-20)14-19-6-4-3-5-7-19/h3-7,20-24,31H,2,8-18H2,1H3,(H,27,33)(H,28,32)/t20-,21+,22-,23+,24-/m1/s1",
        "inchikey": "WWAGOAOIMIOBRQ-QWQGWLCTSA-N",
        "iupac": {
          "systematic": "(3S,6aS,8R,10aS)-8-[2-[[(3R)-1-benzylpyrrolidin-3-yl]amino]-2-oxoethyl]-3-hydroxy-N-propyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide"
        },
        "smiles": {
          "canonical": "CCCNC(=O)N1CC(COCC2C1CCC(O2)CC(=O)NC3CCN(C3)CC4=CC=CC=C4)O"
        },
        "molecularFormula": "C26H40N4O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:22:23Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8346"
    },
    "name": "BRD-K24750847",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8346.png",
    "lincs": {
      "id": "LSM-7165",
      "name": "BRD-K24750847",
      "pubchemCid": 54618983,
      "chebiId": 95786,
      "inchiParent": "InChI=1S/C20H29N3O6S/c1-14-11-23(15(2)13-24)20(25)17-9-16(7-6-8-28-4)10-21-19(17)29-18(14)12-22(3)30(5,26)27/h9-10,14-15,18,24H,8,11-13H2,1-5H3/t14-,15+,18+/m1/s1",
      "inchiKeyParent": "ZLBUSWVWPMDVDO-VKJFTORMSA-N",
      "smilesParent": "COCC#Cc1cnc2O[C@@H](CN(C)S(=O)(=O)C)[C@H](C)CN([C@@H](C)CO)C(=O)c2c1"
    },
    "unichem": {
      "chebi": "95786",
      "lincs": "LSM-7165",
      "pubchem": "54618983"
    },
    "pubchem": [
      {
        "cid": 54618983,
        "inchi": "InChI=1S/C20H29N3O6S/c1-14-11-23(15(2)13-24)20(25)17-9-16(7-6-8-28-4)10-21-19(17)29-18(14)12-22(3)30(5,26)27/h9-10,14-15,18,24H,8,11-13H2,1-5H3/t14-,15+,18+/m1/s1",
        "inchikey": "ZLBUSWVWPMDVDO-VKJFTORMSA-N",
        "iupac": {
          "systematic": "N-[[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-8-(3-methoxyprop-1-ynyl)-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylmethanesulfonamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(N=CC(=C2)C#CCOC)OC1CN(C)S(=O)(=O)C)C(C)CO"
        },
        "molecularFormula": "C20H29N3O6S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:22:26Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82c5"
    },
    "name": "BRD-K96534186",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82c5.png",
    "lincs": {
      "id": "LSM-14348",
      "name": "BRD-K96534186",
      "pubchemCid": 54649509,
      "chebiId": 103002,
      "inchiParent": "InChI=1S/C25H35N3O6/c1-16-22(32-5)14-28(3)25(30)19-12-17(13-26)6-8-20(19)33-15-23-21(31-4)9-7-18(34-23)10-11-27(2)24(16)29/h6,8,12,16,18,21-23H,7,9-11,14-15H2,1-5H3/t16-,18+,21+,22+,23+/m1/s1",
      "inchiKeyParent": "YDHXSWOLXDIZHC-UNVSHWJJSA-N",
      "smilesParent": "CO[C@H]1CC[C@H]2CCN(C)C(=O)[C@H](C)[C@H](CN(C)C(=O)c3cc(ccc3OC[C@@H]1O2)C#N)OC"
    },
    "unichem": {
      "chebi": "103002",
      "lincs": "LSM-14348",
      "pubchem": "54649509"
    },
    "pubchem": [
      {
        "cid": 54649509,
        "inchi": "InChI=1S/C25H35N3O6/c1-16-22(32-5)14-28(3)25(30)19-12-17(13-26)6-8-20(19)33-15-23-21(31-4)9-7-18(34-23)10-11-27(2)24(16)29/h6,8,12,16,18,21-23H,7,9-11,14-15H2,1-5H3/t16-,18+,21+,22+,23+/m1/s1",
        "inchikey": "YDHXSWOLXDIZHC-UNVSHWJJSA-N",
        "iupac": {
          "systematic": "(1S,13R,14R,19S,22S)-13,22-dimethoxy-11,14,16-trimethyl-10,15-dioxo-3,23-dioxa-11,16-diazatricyclo[17.3.1.04,9]tricosa-4(9),5,7-triene-7-carbonitrile"
        },
        "smiles": {
          "canonical": "CC1C(CN(C(=O)C2=C(C=CC(=C2)C#N)OCC3C(CCC(O3)CCN(C1=O)C)OC)C)OC"
        },
        "molecularFormula": "C25H35N3O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:22:28Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8331"
    },
    "name": "BRD-K05214965",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8331.png",
    "lincs": {
      "id": "LSM-8739",
      "name": "BRD-K05214965",
      "pubchemCid": 54631792,
      "chebiId": 97360,
      "inchiParent": "InChI=1S/C22H30N4O5/c1-13-10-23-14(2)12-30-19-7-6-16(24-21(27)18-8-15(3)31-25-18)9-17(19)22(28)26(4)11-20(13)29-5/h6-9,13-14,20,23H,10-12H2,1-5H3,(H,24,27)/t13-,14+,20+/m0/s1",
      "inchiKeyParent": "JSRBXIHVEPNVJQ-LRDNONRASA-N",
      "smilesParent": "CO[C@@H]1CN(C)C(=O)c2cc(NC(=O)c3cc(C)on3)ccc2OC[C@@H](C)NC[C@@H]1C"
    },
    "unichem": {
      "chebi": "97360",
      "lincs": "LSM-8739",
      "pubchem": "54631792"
    },
    "pubchem": [
      {
        "cid": 54631792,
        "inchi": "InChI=1S/C22H30N4O5/c1-13-10-23-14(2)12-30-19-7-6-16(24-21(27)18-8-15(3)31-25-18)9-17(19)22(28)26(4)11-20(13)29-5/h6-9,13-14,20,23H,10-12H2,1-5H3,(H,24,27)/t13-,14+,20+/m0/s1",
        "inchikey": "JSRBXIHVEPNVJQ-LRDNONRASA-N",
        "iupac": {
          "systematic": "N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-5-methyl-1,2-oxazole-3-carboxamide"
        },
        "smiles": {
          "canonical": "CC1CNC(COC2=C(C=C(C=C2)NC(=O)C3=NOC(=C3)C)C(=O)N(CC1OC)C)C"
        },
        "molecularFormula": "C22H30N4O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:22:30Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c829d"
    },
    "name": "BRD-K86089324",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c829d.png",
    "lincs": {
      "id": "LSM-41970",
      "name": "BRD-K86089324",
      "pubchemCid": 60191855,
      "chebiId": 130421,
      "inchiParent": "InChI=1S/C26H33N3O4S/c30-16-23-24(21-12-6-2-7-13-21)26(29(23)34(32,33)17-20-10-4-1-5-11-20)18-28(19-26)25(31)27-22-14-8-3-9-15-22/h1-2,4-7,10-13,22-24,30H,3,8-9,14-19H2,(H,27,31)/t23-,24+/m1/s1",
      "inchiKeyParent": "YZYJXWPDYMJSBS-RPWUZVMVSA-N",
      "smilesParent": "OC[C@@H]1[C@H](c2ccccc2)C3(CN(C3)C(=O)NC4CCCCC4)N1S(=O)(=O)Cc5ccccc5"
    },
    "unichem": {
      "chebi": "130421",
      "lincs": "LSM-41970",
      "pubchem": "60191855"
    },
    "pubchem": [
      {
        "cid": 60191855,
        "inchi": "InChI=1S/C26H33N3O4S/c30-16-23-24(21-12-6-2-7-13-21)26(29(23)34(32,33)17-20-10-4-1-5-11-20)18-28(19-26)25(31)27-22-14-8-3-9-15-22/h1-2,4-7,10-13,22-24,30H,3,8-9,14-19H2,(H,27,31)/t23-,24+/m1/s1",
        "inchikey": "YZYJXWPDYMJSBS-RPWUZVMVSA-N",
        "iupac": {
          "systematic": "(2S,3S)-1-benzylsulfonyl-N-cyclohexyl-2-(hydroxymethyl)-3-phenyl-1,6-diazaspiro[3.3]heptane-6-carboxamide"
        },
        "smiles": {
          "canonical": "C1CCC(CC1)NC(=O)N2CC3(C2)C(C(N3S(=O)(=O)CC4=CC=CC=C4)CO)C5=CC=CC=C5"
        },
        "molecularFormula": "C26H33N3O4S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:22:32Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82a1"
    },
    "name": "BRD-K29227213",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82a1.png",
    "lincs": {
      "id": "LSM-38856",
      "name": "BRD-K29227213",
      "pubchemCid": 60191376,
      "chebiId": 127296,
      "inchiParent": "InChI=1S/C25H27N3O3/c1-17(2)6-5-7-18-9-11-19(12-10-18)24-21-14-27(15-23(30)28(21)22(24)16-29)25(31)20-8-3-4-13-26-20/h3-4,8-13,17,21-22,24,29H,6,14-16H2,1-2H3/t21-,22-,24+/m0/s1",
      "inchiKeyParent": "PXGCQOQEEDCUOW-WPFOTENUSA-N",
      "smilesParent": "CC(C)CC#Cc1ccc(cc1)[C@H]2[C@H](CO)N3[C@H]2CN(CC3=O)C(=O)c4ccccn4"
    },
    "unichem": {
      "chebi": "127296",
      "lincs": "LSM-38856",
      "pubchem": "60191376"
    },
    "pubchem": [
      {
        "cid": 60191376,
        "inchi": "InChI=1S/C25H27N3O3/c1-17(2)6-5-7-18-9-11-19(12-10-18)24-21-14-27(15-23(30)28(21)22(24)16-29)25(31)20-8-3-4-13-26-20/h3-4,8-13,17,21-22,24,29H,6,14-16H2,1-2H3/t21-,22-,24+/m0/s1",
        "inchikey": "PXGCQOQEEDCUOW-WPFOTENUSA-N",
        "iupac": {
          "systematic": "(6R,7R,8R)-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-4-(pyridine-2-carbonyl)-1,4-diazabicyclo[4.2.0]octan-2-one"
        },
        "smiles": {
          "canonical": "CC(C)CC#CC1=CC=C(C=C1)C2C3CN(CC(=O)N3C2CO)C(=O)C4=CC=CC=N4"
        },
        "molecularFormula": "C25H27N3O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:22:35Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82eb"
    },
    "name": "GSK-3 Inhibitor IX",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82eb.png",
    "lincs": {
      "id": "LSM-42780",
      "name": "GSK-3 Inhibitor IX",
      "alternativeNames": [
        "Bio",
        "KIN001-043"
      ],
      "pubchemCid": 5287844,
      "inchiParent": "InChI=1S/C16H10BrN3O2/c17-8-5-6-9-12(7-8)19-16(21)13(9)15-14(20-22)10-3-1-2-4-11(10)18-15/h1-7,18,22H,(H,19,21)/b15-13-,20-14?",
      "inchiKeyParent": "DDLZLOKCJHBUHD-PHQNPPNDSA-N",
      "smilesParent": "Oc1[nH]c2cc(Br)ccc2c1c3[nH]c4ccccc4c3N=O"
    },
    "unichem": {
      "lincs": "LSM-42780"
    },
    "pubchem": [
      {
        "cid": 5287844,
        "inchi": "InChI=1S/C16H10BrN3O2/c17-8-5-6-9-12(7-8)19-16(21)13(9)15-14(20-22)10-3-1-2-4-11(10)18-15/h1-7,20,22H,(H,19,21)/b15-13-",
        "inchikey": "WNWSUJQVZJJGLF-SQFISAMPSA-N",
        "iupac": {
          "systematic": "(3Z)-6-bromo-3-[3-(hydroxyamino)indol-2-ylidene]-1H-indol-2-one"
        },
        "smiles": {
          "canonical": "C1=CC2=C(C(=C3C4=C(C=C(C=C4)Br)NC3=O)N=C2C=C1)NO"
        },
        "molecularFormula": "C16H10BrN3O2"
      }
    ],
    "clinicaltrials": [
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT04065594",
            "briefTitle": "Platelet Rich Plasma (PRP) Bio Stimulant Gel Dressing in Treating Chronic Non Healing Leg and Foot Ulcers: Cost and Effectiveness",
            "officialTitle": "Platelet Rich Plasma (PRP) Bio Stimulant Gel Dressing in Treating Chronic Non Healing Leg and Foot Ulcers: Cost and Effectiveness"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2019-08-12"
          },
          "conditionsModule": {
            "conditions": [
              "Ulcer Foot",
              "Chronic Skin Ulcer",
              "Non-Healing Ulcer of Skin"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "change the ulcer size",
                "timeFrame": "1.8 years"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02229994",
            "briefTitle": "Development of a New Tool for Dyspnea Measurement in Chronic Respiratory Diseases",
            "officialTitle": "Development of a New Tool for Dyspnea Measurement (DYSLIM for Dyspnea Limitation) in Chronic Respiratory Diseases"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2014-08-29"
          },
          "conditionsModule": {
            "conditions": [
              "COPD (With - Without Rehabilitation)",
              "Diffuse Interstitial Lung Diseases",
              "Pulmonary Arterial Hypertension Primary or Secondary (Post Embolic .....)",
              "Cystic Fibrosis of the Adult"
            ]
          },
          "designModule": {
            "studyType": "OBSERVATIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Psychometric validity of the questionnaire",
                "timeFrame": "Until end of treatment (making a total of 6 months)"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Analysis of responses distribution"
              },
              {
                "measure": "Structural analysis (in principal components)"
              },
              {
                "measure": "External and convergent validity"
              },
              {
                "measure": "Internal coherence"
              },
              {
                "measure": "Reproducibility"
              },
              {
                "measure": "Reproducibility"
              },
              {
                "measure": "Discriminating properties"
              },
              {
                "measure": "Derivation of a scoring algorithm"
              },
              {
                "measure": "Sensitivity to change"
              },
              {
                "measure": "Minimal difference clinically relevant"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT06878794",
            "briefTitle": "IIT Study on the Use of Medical Bio Glue for Repairing Meniscus Tears",
            "officialTitle": "IIT Study on the Use of Medical Bio Glue for Repairing Meniscus Tears"
          },
          "statusModule": {
            "overallStatus": "ENROLLING_BY_INVITATION",
            "studyFirstSubmitDate": "2024-11-28"
          },
          "conditionsModule": {
            "conditions": [
              "Unilateral Meniscus Tear of the Knee Joint"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "MOCART score",
                "timeFrame": "Baseline (Before treatment), 6 and 12 months after treatment"
              },
              {
                "measure": "Lysholm score",
                "timeFrame": "Baseline (Before treatment), 3\u3001 6 and 12 months after treatment"
              },
              {
                "measure": "IKDC score",
                "timeFrame": "Baseline (Before treatment), 3\u3001 6 and 12 months after treatment"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "T2 mapping"
              },
              {
                "measure": "Equipment use and evaluation"
              },
              {
                "measure": "The occurrence of adverse events related to the test device"
              },
              {
                "measure": "The incidence of device related SAE requiring further surgical intervention within 12 months after surgical"
              },
              {
                "measure": "Equipment defect incidence rate"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT04818294",
            "briefTitle": "Clinical Trial to Monitor the Efficacy of the Elosan Treatment by Applying Electrostatic",
            "officialTitle": "Prospective, Multi-center, Clinical Trial (Phase IV Study) to Monitor the Efficacy of Treatment by Applying a High Electrostatic Charge to Patients With Chronic Pain, in the Practice of Clinical or Out-patient Pain Treatment Facilities."
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2021-03-19"
          },
          "conditionsModule": {
            "conditions": [
              "Chronic Pain"
            ]
          },
          "designModule": {
            "studyType": "OBSERVATIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Change of Pain Intensity is being assessed by Visual Analogue Scale (VAS)",
                "timeFrame": "8-9 weeks"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Composite outcome physical health (PCS) and mental health (MCS) to determine the quality of life assessed by the SF-12 Questionnaire"
              },
              {
                "measure": "Pain medication / therapy and any changes thereof shall be recorded during the study."
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT06730594",
            "briefTitle": "A Study to Assess the Effect of the Bio-K+ Probiotic Capsules (VL-BK-02) in Adults With Functional Constipation",
            "officialTitle": "A Randomized, Double-Blind, Placebo-Controlled, Parallel Design Clinical Study to Assess the Effect of the Bio-K+ Probiotic Capsules (VL-BK-02) in Adults With Functional Constipation"
          },
          "statusModule": {
            "overallStatus": "RECRUITING",
            "studyFirstSubmitDate": "2024-11-13"
          },
          "conditionsModule": {
            "conditions": [
              "Functional Constipation"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "To assess the effect of VL-BK-02 on changes in the frequency of Complete Spontaneous Bowel Movements (CSBMs)",
                "timeFrame": "per week from baseline to the end of study visit."
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "To assess the effect of Investigational product (IP) in comparison to baseline and placebo on Stool consistency as assessed by Bristol Stool Form Scale (BSFS)"
              },
              {
                "measure": "To assess the effect of Investigational product (IP) in comparison to baseline and placebo on Constipation symptoms by using Participant Assessment of Constipation Symptoms (PAC-SYM)"
              },
              {
                "measure": "To assess the effect of Investigational product (IP) in comparison to baseline and placebo on Quality of life by using Participant Assessment of Constipation QoL (PAC-QoL)"
              },
              {
                "measure": "To assess the effect of Investigational product (IP) in comparison to baseline and placebo Percentage responders are defined as the number of participants with an increase by 1 or more frequencies of SBM with no sensation of incomplete evacuation"
              },
              {
                "measure": "To assess the effect of Investigational product (IP) in comparison to baseline and placebo Gut microbiome (alpha and beta diversity)"
              },
              {
                "measure": "To assess the effect of Investigational product (IP) in comparison to baseline and placebo Difference in the usage of rescue medication throughout the study duration as compared to placebo."
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT03292094",
            "briefTitle": "The African-PREDICT Study",
            "officialTitle": "African Prospective Study for the Early Detection and Identification of Cardiovascular Disease and Hypertension (African-PREDICT Study)"
          },
          "statusModule": {
            "overallStatus": "ACTIVE_NOT_RECRUITING",
            "studyFirstSubmitDate": "2017-09-12"
          },
          "conditionsModule": {
            "conditions": [
              "Cardiovascular Diseases",
              "Hypertension",
              "Health Risk Behaviors",
              "Arterial Stiffness",
              "Young",
              "Renin Hypertension"
            ]
          },
          "designModule": {
            "studyType": "OBSERVATIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Incident Hypertension",
                "timeFrame": "5 years"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT06163794",
            "briefTitle": "Multidimensional Phenotyping Towards Personalized Preventive Nutritional Support for Elderly People",
            "officialTitle": "New Participatory Research Strategy and Multidimensional Phenotyping Towards Personalized Preventive Nutritional Support for Elderly People"
          },
          "statusModule": {
            "overallStatus": "RECRUITING",
            "studyFirstSubmitDate": "2023-11-10"
          },
          "conditionsModule": {
            "conditions": [
              "Non Dependant 60 to 75 Year-old Men and Women"
            ]
          },
          "designModule": {
            "studyType": "OBSERVATIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Characterize the inter-individual variability of the blood glucose postprandial response",
                "timeFrame": "Within the first month of study realization"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Questionnaires about food habits and preferences (with a special focus on polyphenols)"
              },
              {
                "measure": "Test to assess taste abilities"
              },
              {
                "measure": "Test to assess olfactory abilities"
              },
              {
                "measure": "Time to walk 4 meters"
              },
              {
                "measure": "Time to stand up 5 times from a chair"
              },
              {
                "measure": "Maximum tolerated muscle power"
              },
              {
                "measure": "Maximal isometric strength"
              },
              {
                "measure": "Questionnaires about usual physical activity"
              },
              {
                "measure": "Measurement of total body lean mass (kg)"
              },
              {
                "measure": "Measurement of total body fat mass (kg)"
              },
              {
                "measure": "Measurement of peripheral endothelial function (RHI, %)"
              },
              {
                "measure": "Measurement of microvascular stiffness (Augmentation Index)"
              },
              {
                "measure": "Assessment of oral status"
              },
              {
                "measure": "Assessment of cognitive function"
              },
              {
                "measure": "Assessment of depression status"
              },
              {
                "measure": "Assessment of socio-economic status"
              },
              {
                "measure": "Assessment of self-esteem"
              },
              {
                "measure": "Assessment of intestinal function"
              },
              {
                "measure": "Stool collection"
              },
              {
                "measure": "Measurement of plasma insulin levels (micro U / mL)"
              },
              {
                "measure": "Measurement of plasma triglycerides levels (mg / dL)"
              },
              {
                "measure": "Measurement of plasma C Reactive Protein (mg / L)"
              },
              {
                "measure": "Measurement of plasma amino acid levels (\u00b5Mol)"
              },
              {
                "measure": "Measurement of plasma metabolite through open metabolomics"
              },
              {
                "measure": "Measurement of plasma free fatty acids (mg / L)"
              },
              {
                "measure": "Measurement of plasma cytokines (U / L)"
              },
              {
                "measure": "Measurement of plasma albumin (g / L)"
              },
              {
                "measure": "Measurement of various gene expression in peripheral blood mononuclear cells isolated from blood samples."
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT05635591",
            "briefTitle": "KSD-101 Therapy for EBV-associated Haematologic Neoplasms: an Exploratory Clinical Trial",
            "officialTitle": "KSD-101 Therapy for EBV-associated Haematologic Neoplasms: an Exploratory Clinical Trial"
          },
          "statusModule": {
            "overallStatus": "ENROLLING_BY_INVITATION",
            "studyFirstSubmitDate": "2022-11-14"
          },
          "conditionsModule": {
            "conditions": [
              "EBV-associated Haematologic Neoplasms"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Incidence of dose-limiting toxicity (DLT) by dose group",
                "timeFrame": "1 years after DC Vaccines injection"
              },
              {
                "measure": "Incidence of maximally tolerated dose (MTD) by dose grouphaematologic neoplasms",
                "timeFrame": "1 years after DC Vaccines injection"
              },
              {
                "measure": "Type and incidence of adverse events (AEs) and serious adverse events (SAEs) by dose group",
                "timeFrame": "1 years after DC Vaccines injection"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "EBV-DNA load"
              },
              {
                "measure": "Objective response rate (ORR)"
              },
              {
                "measure": "Disease control rate (DCR)"
              },
              {
                "measure": "Duration of response (DOR)"
              },
              {
                "measure": "Progression-free survival (PFS)"
              },
              {
                "measure": "Overall survival (OS)"
              },
              {
                "measure": "Levels of EBV-specific CD8+ T cells"
              },
              {
                "measure": "Levels of B cells"
              },
              {
                "measure": "Levels of NK cells"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT03523494",
            "briefTitle": "Feasibility of Lymph Edema-induced Reticulation Subtraction Based on Computerized Tomography",
            "officialTitle": "Feasibility of Lymph Edema-induced Reticulation Subtraction Based on Computerized Tomography."
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2018-04-17"
          },
          "conditionsModule": {
            "conditions": [
              "Lymphedema",
              "Secondary Lymphedema",
              "CT"
            ]
          },
          "designModule": {
            "studyType": "OBSERVATIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Reticulation Ratio from Computerized Tomography",
                "timeFrame": "1 week"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Multi-frequency bio-electric impedance analysis"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT05154591",
            "briefTitle": "CKDu Treated With Intra-arterial Infusion of Autologous SVF Cells",
            "officialTitle": "Chronic Kidney Disease of Unknown Cause (CKDu) Treated With Directed Local Intra-arterial Infusion of Autologous Stromal Vascular Fraction (SVF) Cells."
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2021-11-06"
          },
          "conditionsModule": {
            "conditions": [
              "Chronic Renal Failure of Unknown Cause"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Incidence of treatment related adverse events",
                "timeFrame": "36-months follow-up post intervention."
              },
              {
                "measure": "Preliminary evidence of efficacy",
                "timeFrame": "Assessment of changes between day 7 and month 36 post intervention."
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Renal blood flow."
              },
              {
                "measure": "Kidney volume."
              },
              {
                "measure": "Renal arterial resistive index."
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT04494191",
            "briefTitle": "Bioequivalence Study of Flibanserin From AphroFemine 100 mg F.C.T (Bio Med for Pharmaceuticals Industries (BIOMED), Egypt) Versus Addyi 100 mg Tablets (Sprout Pharmaceuticals, Inc., USA)",
            "officialTitle": "Comparative Randomized, Single Dose, Two-way Crossover Open-label Study to Determine the Bioequivalence of Flibanserin From AphroFemine 100 mg F.C.T (Bio Med for Pharmaceuticals Industries (BIOMED), Egypt) Versus Addyi 100 mg Tablets (Sprout Pharmaceuticals, Inc., USA)"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2020-07-28"
          },
          "conditionsModule": {
            "conditions": [
              "Healthy"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Cmax",
                "timeFrame": "Up to 48 hours post dose in each treatment period"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Time of the maximum plasma concentration (Tmax)"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT04008394",
            "briefTitle": "Anti-CD30 CAR-T Therapy in Patients With Refractory/Relapsed Lymphocyte Malignancies",
            "officialTitle": "Efficacy and Safety of Anti-CD30 CAR-T Therapy in Patients With Refractory/Relapsed Lymphocyte Malignancies\uff1aa Single-center, Open, Single-arm Clinical Study."
          },
          "statusModule": {
            "overallStatus": "UNKNOWN",
            "studyFirstSubmitDate": "2019-07-02"
          },
          "conditionsModule": {
            "conditions": [
              "Adult T-Cell Lymphoma/Leukaemia",
              "Anaplastic Large Cell Lymphoma",
              "Angioimmunoblastic T-cell Lymphoma",
              "NK/T-cell Lymphoma",
              "Peripheral T Cell Lymphoma",
              "Hodgkin Lymphoma"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Number of participants with adverse events",
                "timeFrame": "3 years"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "One-month remission rate"
              },
              {
                "measure": "Overall survival"
              },
              {
                "measure": "Event-free survival"
              },
              {
                "measure": "Relapse-free survival"
              },
              {
                "measure": "Quantity of anti-CD30 CAR-T cells in bone marrow cells and peripheral blood cells"
              },
              {
                "measure": "Quantity of anti-CD30 CAR copies in bone marrow cells and peripheral blood cells"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02878720",
            "briefTitle": "Combining Non-Invasive Vagus Nerve Stimulation and Robotic Training in Upper Limb-Impaired Chronic Stroke Patients",
            "officialTitle": "Combining Non-Invasive Vagus Nerve Stimulation and Robotic Training in Upper Limb-Impaired Chronic Stroke Patients"
          },
          "statusModule": {
            "overallStatus": "UNKNOWN",
            "studyFirstSubmitDate": "2016-08-16"
          },
          "conditionsModule": {
            "conditions": [
              "Stroke"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Change in Fugl-Meyer Score",
                "timeFrame": "immediately, one months and three months after the intervention"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Change in kinematic data (Motion Accuracy) measured by the robot"
              },
              {
                "measure": "Change in kinematic data (Motion Direction) measured by the robot"
              },
              {
                "measure": "Change in kinematic data (Smoothness) measured by the robot"
              },
              {
                "measure": "Change in kinematic data (Speed) measured by the robot"
              },
              {
                "measure": "Change in kinematic data (Movement Duration) measured by the robot"
              },
              {
                "measure": "Change in kinematic data (Efficiency) measured by the robot"
              },
              {
                "measure": "Incidence of adverse events that are related to treatment"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT03294720",
            "briefTitle": "BioACL Reconstruction With Amnion Collagen Matrix Wrap and Stem Cells Case Series",
            "officialTitle": "Augmentation of ACL Reconstruction With Bone Marrow Stem Cells and Amnion Collagen Matrix Wrap: a Case Series"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2017-09-20"
          },
          "conditionsModule": {
            "conditions": [
              "ACL - Anterior Cruciate Ligament Rupture"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "MRI graft maturation and integration",
                "timeFrame": "3 months, 6 months, 9 months, and 12 months post-op"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Changes in patient-reported pain rating"
              },
              {
                "measure": "Changes in Knee injury and Osteoarthritis Outcome Score (KOOS)"
              },
              {
                "measure": "Changes in Short Form 12 (SF-12) patient ratings"
              },
              {
                "measure": "Changes in Single Assessment Numerical Evaluation (SANE) patient ratings for function"
              },
              {
                "measure": "Marx Activity Scale Rating"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT04456920",
            "briefTitle": "Pain Monitoring After Breast Biopsy: Benefit of E-health",
            "officialTitle": "Pain Monitoring After Breast Biopsy: Benefit of E-health"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2020-06-23",
            "resultsFirstSubmitDate": "2024-06-07"
          },
          "conditionsModule": {
            "conditions": [
              "Breast Cancer",
              "Biopsy Wound"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Number of Participants by Pain Intensity at Day 4 Post Breast Biopsy With a Benefit of Intervention by E-health (Phone Consultation With a Professional or Connected Objects (Smartphone or Tablet)) Compared of the Standard Follow up",
                "timeFrame": "From date of randomization until the Day 4 post biopsy"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Pain Intensity During the Consultation of Results Announcement After a Breast Biopsy Between the Benefit of Intervention by E-health (Phone Consultation With a Professional or Connected Objects) Compared to the Standard Follow up"
              },
              {
                "measure": "the Benefit According to the Type of Intervention by E-health (Phone Consultation With a Professional or Connected Objects) on the Pain Intensity of Patients at 4 Days (D4) and During the Consultation of Results Announcement After a Breast Biopsy."
              },
              {
                "measure": "the Benefit of Intervention by E-health (Phone Consultation With a Professional or Connected Objects) With the Standard Follow up of the Anxiety Intensity of Patients at 4 Days and During the Consultation of Results Announcement, After a Breast Biopsy."
              },
              {
                "measure": "the Benefit of Intervention by E-health (Phone Consultation With a Professional or Connected Objects) With the Standard Follow up of the Esthetic Impact of Patients at 4 and 10 Days (D4, D10) After a Breast Biopsy."
              },
              {
                "measure": "the Benefit According to the Type of Intervention by E-health (Phone Consultation With a Professional or Connected Objects) on the Insomnia of Patients at 10 Days (About Day 10), After a Breast Biopsy."
              },
              {
                "measure": "the Benefit of Intervention by E-health (Phone Consultation With a Professional or Connected Objects) With the Standard Follow up of Patient's Management"
              },
              {
                "measure": "the Use of a Biopsy-related Drug Intervention in Patients With E-health Interventions (Phone Consultation or Smartphone), With the Standard Follow-up, at 10 Days After a Breast Biopsy."
              },
              {
                "measure": "Adverse Events in Patients With E-health Interventions (Phone Consultation With a Professional or Connected Objects), With the Standard Follow-up, During the Consultation of Results Announcement (About D10) After a Breast Biopsy."
              },
              {
                "measure": "Assess Satisfaction With Specific Study Management."
              },
              {
                "measure": "Assess Compliance."
              },
              {
                "measure": "Assess Compliance."
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT05357820",
            "briefTitle": "A Study of AB-106 in Chinese Healthy Adult Men Evaluated the Effects of Itraconazole and Rifampicin on AB-106 PK",
            "officialTitle": "A Phase I, Single-center, Open-label, Fixed-sequence Study of AB-106 in Chinese Healthy Adult Men Evaluated the Effects of Itraconazole and Rifampicin on AB-106 Pharmacokinetics"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2021-07-09"
          },
          "conditionsModule": {
            "conditions": [
              "Solid Tumor"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "AB-106 PK Exposure Parameters",
                "timeFrame": "29 days"
              },
              {
                "measure": "AB-106 PK Exposure Parameters",
                "timeFrame": "29 days"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "AB-106 PK Parameters"
              },
              {
                "measure": "AB-106 PK Parameters"
              },
              {
                "measure": "AB-106 PK Parameters"
              },
              {
                "measure": "AB-106 PK Parameters"
              },
              {
                "measure": "AB-106 PK Parameters"
              },
              {
                "measure": "AB-106 PK Parameters"
              },
              {
                "measure": "Safety Assessment"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00082420",
            "nctIdAliases": [
              "NCT00072696"
            ],
            "briefTitle": "Retinol Equivalence of Plant Carotenoids in Children"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2004-05-06"
          },
          "conditionsModule": {
            "conditions": [
              "Vitamin A Deficiency"
            ]
          },
          "designModule": {
            "studyType": "OBSERVATIONAL"
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01061320",
            "briefTitle": "Efficacy of Alpha Tocopherol for Prevention of Contrast-induced Nephropathy in Chronic Kidney Disease (CKD) Patients",
            "officialTitle": "Efficacy of Alpha Tocopherol and New Biomarker (Urine NGAL) for Prevention and Early Diagnosis of Contrast-induced Nephropathy in CKD Patients Undergoing Elective Coronary Procedures"
          },
          "statusModule": {
            "overallStatus": "UNKNOWN",
            "studyFirstSubmitDate": "2010-02-02"
          },
          "conditionsModule": {
            "conditions": [
              "Contrast Induced Nephropathy"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "The primary end-point of this study is the development of CIN in placebo group compared with alpha tocopherol group.",
                "timeFrame": "1 year"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "The secondary end-point of this study is compare urine NGAL level in CIN patients between both groups."
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT06236620",
            "briefTitle": "Zinc Absorption in Flakes Derived from Sprouted or Hydrothermally Processed Wheat",
            "officialTitle": "Zinc Absorption in Flakes Derived from Sprouted or Hydrothermally Processed Wheat"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2024-01-24"
          },
          "conditionsModule": {
            "conditions": [
              "Zinc Absorption"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Zinc absorption",
                "timeFrame": "day 1 (before test meal) and day 5,6,7 and 8"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT03641482",
            "briefTitle": "NBF Gingival Gel Application After Impacted Lower Third Molar Surgery",
            "officialTitle": "Effect of NBF Gingival Gel Application in Controlling Post-surgical Complications After Impacted Lower Third Molar Surgery"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2018-08-01"
          },
          "conditionsModule": {
            "conditions": [
              "Alveolar Osteitis"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Alveolar Osteitis: intense neuralgic pain in the post-extraction socket in the second or third postoperative day that do not disappear with analgesics beside a partially or totally disintegrated clot",
                "timeFrame": "from baseline to 24, 48, 72 hours post intervention"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Swelling: it was evaluated with a flexible metric tape measuring the facial perimeter from trago to pogonion. A first measurement was made before surgery, which was compared with the measurements taken at 24, 48 and 72 hours of the extraction."
              },
              {
                "measure": "Trismus: it was assessed measuring the maximum opening from the inter incisive points."
              },
              {
                "measure": "Wound healing: it was assessed with a semi-quantitative scale (good, satisfactory or insufficient)."
              },
              {
                "measure": "Post extraction pain: it was recorded using a visual analog scale, ranging from 0 (no pain) to 10 (the worst pain imaginable) at 9 pm of 7 consecutive days."
              },
              {
                "measure": "Number of rescue analgesic pills consumption: recorded for the first 3 days by the patients."
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT03393520",
            "briefTitle": "Assessment of the Efficacy, Safety, and Tolerability of AVP-786 (Deudextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type",
            "officialTitle": "A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-design Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 (Deudextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2018-01-03"
          },
          "conditionsModule": {
            "conditions": [
              "Agitation in Patients With Dementia of the Alzheimer's Type"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Change from Baseline to Week 12 in the Cohen-Mansfield Agitation Inventory (CMAI) Composite Score",
                "timeFrame": "Baseline; Week 12"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Change from Baseline to Week 12 in the Clinical Global Impression of Severity (CGIS)-Agitation Domain Score"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT04857320",
            "briefTitle": "Transdermal Insulin Response In Healthy Volunteers",
            "officialTitle": "A Physician-Initiated Randomised, Multiple-Dose, Single Period, Phase II Dose Ranging Study to Examine Transdermal Human Insulin In Adult Healthy Volunteer Patients"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2021-04-21",
            "resultsFirstSubmitDate": "2021-11-23"
          },
          "conditionsModule": {
            "conditions": [
              "Pharmacodynamic Response to Small Doses of Insulin"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Postprandial Serum Glucose in mg/dL as a Response to Small Doses (0.075 to 0.15 IUs/Kg) Human Insulin Averaged Per Subject",
                "timeFrame": "Pre-dose Baseline & a Mean of readings over 3.5 hours"
              },
              {
                "measure": "Daily Average Serum Glucose Measured in mg/dL as a Response to Small Doses (0.075 to 0.15 IUs/Kg) Human Insulin",
                "timeFrame": "72 hours"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "OECD Acute Dermal Irritation/Corrosion Score According to to the Organisation for Economic Co-operation and Development (OECD) Guideline for Testing of Chemicals No. 404"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT03993782",
            "briefTitle": "CSD190102: A Study to Assess Nicotine Pharmacokinetic Parameters After Use of Two Smokeless Tobacco Products",
            "officialTitle": "CSD190102: An Unblinded, Randomized, Multi-site, Two-way Crossover Study to Assess Nicotine Pharmacokinetic Parameters After Use of Two Smokeless Tobacco Products A19010-R and B19010-O in Healthy Adult Snus Consumers."
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2019-06-19"
          },
          "conditionsModule": {
            "conditions": [
              "Tobacco Use"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "AUCnic 0-240",
                "timeFrame": "240 minutes"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT06559982",
            "briefTitle": "Effects of a Brown Seaweed Tart Cherry Blend in Mild-moderate Hypertension",
            "officialTitle": "Effects of a Brown Seaweed Extract and Tart Cherry Blend Cardiometabolic Outcomes in Participants With Mild-moderate Hypertension an Ex-vivo Optimized Pilot Feasibility Trial"
          },
          "statusModule": {
            "overallStatus": "NOT_YET_RECRUITING",
            "studyFirstSubmitDate": "2024-08-15"
          },
          "conditionsModule": {
            "conditions": [
              "Hypertension"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Systolic blood pressure",
                "timeFrame": "Baseline"
              },
              {
                "measure": "Systolic blood pressure",
                "timeFrame": "20 days"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Diastolic blood pressure"
              },
              {
                "measure": "Diastolic blood pressure"
              },
              {
                "measure": "Percent bodyfat and fat mass"
              },
              {
                "measure": "Percent bodyfat and fat mass"
              },
              {
                "measure": "Waist circumference"
              },
              {
                "measure": "Waist circumference"
              },
              {
                "measure": "Waist to hip ratio"
              },
              {
                "measure": "Waist to hip ratio"
              },
              {
                "measure": "Blood glucose"
              },
              {
                "measure": "Blood glucose"
              },
              {
                "measure": "Blood triglycerides"
              },
              {
                "measure": "Blood triglycerides"
              },
              {
                "measure": "Blood cholesterol (Total, HDL & LDL)"
              },
              {
                "measure": "Blood cholesterol (Total, HDL & LDL)"
              },
              {
                "measure": "Total and HDL cholesterol ratio"
              },
              {
                "measure": "Total and HDL cholesterol ratio"
              },
              {
                "measure": "LDL and HDL cholesterol ratio"
              },
              {
                "measure": "LDL and HDL cholesterol ratio"
              },
              {
                "measure": "Triglyceride glucose index"
              },
              {
                "measure": "Triglyceride glucose index"
              },
              {
                "measure": "Coop-Wonka chart"
              },
              {
                "measure": "Coop-Wonka chart"
              },
              {
                "measure": "Beck Depression Inventory"
              },
              {
                "measure": "Beck Depression Inventory"
              },
              {
                "measure": "State Trait Anxiety Inventory"
              },
              {
                "measure": "State Trait Anxiety Inventory"
              },
              {
                "measure": "Insomnia Severity Index"
              },
              {
                "measure": "Insomnia Severity Index"
              },
              {
                "measure": "Pittsburgh Sleep Quality Index"
              },
              {
                "measure": "Pittsburgh Sleep Quality Index"
              },
              {
                "measure": "Epworth Sleepiness Scale"
              },
              {
                "measure": "Epworth Sleepiness Scale"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02250573",
            "briefTitle": "An Open-study to Investigate the Safety and Efficacy of Replenine\u00ae-VF in Haemophilia B Subjects Undergoing Surgery",
            "officialTitle": "An Open-study to Investigate the Safety and Efficacy of Replenine\u00ae-VF in Haemophilia B Subjects Undergoing Surgery."
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2014-09-02"
          },
          "conditionsModule": {
            "conditions": [
              "Haemophilia B"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Incremental recovery for Factor IX",
                "timeFrame": "90 min post-dose"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01226173",
            "briefTitle": "Dengue Virus NS1 Antigen (Bio-Rad) Clinical Protocol",
            "officialTitle": "Study of Bio-Rad Laboratories Platelia Dengue NS1 Ag Assay in Blood Donors."
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2010-10-19"
          },
          "conditionsModule": {
            "conditions": [
              "Mass Screening"
            ]
          },
          "designModule": {
            "studyType": "OBSERVATIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Number of blood donors with repeatedly reactive Platelia Dengue NS1 Ag test results.",
                "timeFrame": "Two and a half years"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Number of blood donors with PCR and/or TMA confirmed positive dengue test results."
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT05848973",
            "briefTitle": "NutriMind: A Combination of Healthy Diet and Psychotherapy to Treat Depression",
            "officialTitle": "The NutriMind Trial: A Low-cost Randomized Trial Combining a Healthy Diet and Psychotherapy to Treat Depressive Symptoms Among University Students - The Case of Uganda"
          },
          "statusModule": {
            "overallStatus": "RECRUITING",
            "studyFirstSubmitDate": "2023-03-27"
          },
          "conditionsModule": {
            "conditions": [
              "Depression"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Change from baseline to 24 months in depressive symptoms using the Center for Epidemiological Studies - Depression (CES-D) score among the study participants randomized to each of the three intervention arms compared with the controls.",
                "timeFrame": "24 months"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Change from baseline to 24 months in depressive symptoms using the Beck Depression Inventory-II (BDI-II) score among the study participants randomized to each of the three intervention arms compared with the controls."
              },
              {
                "measure": "The health economic costs of each of the three intervention arms compared with the control group."
              },
              {
                "measure": "Change from baseline to 24 months in body weight among the study participants randomized to each of the three intervention arms compared with the controls."
              },
              {
                "measure": "Change from baseline to 24 months in body height among the study participants randomized to each of the three intervention arms compared with the controls."
              },
              {
                "measure": "Change from baseline to 24 months in body composition among the study participants randomized to each of the three intervention arms compared with the controls."
              },
              {
                "measure": "Change from baseline to 24 months in blood cholesterol levels among the study participants randomized to each of the three intervention arms compared with the controls."
              },
              {
                "measure": "Change from baseline to 24 months in blood CRP levels among the study participants randomized to each of the three intervention arms compared with the controls."
              },
              {
                "measure": "Change from baseline to 24 months in fecal microbiota composition levels among the study participants randomized to each of the three intervention arms compared with the controls."
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00209573",
            "briefTitle": "A Study of AQUAVAN\u00ae Injection Versus Midazolam HCl for Sedation in Patients Undergoing Elective Colonoscopy",
            "officialTitle": "A Phase III, Randomized, Open-Label Study to Assess the Safety and Efficacy of AQUAVAN Injection Versus Midazolam HCl for Sedation in Patients Undergoing Colonoscopy Procedures"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2005-09-13"
          },
          "conditionsModule": {
            "conditions": [
              "Colonoscopy",
              "Colon Polyps"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "The primary efficacy hypothesis was that AQUAVAN could sedate (\u22653 consecutive Modified OAA/S scores \u22644) patients AND that they could complete the procedure successfully without requiring alternative sedative medication AND without requiring manual or"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Secondary Efficacy Endpoints"
              },
              {
                "measure": "Time to Fully Recovered from end of procedure"
              },
              {
                "measure": "Time to Fully Alert from end of procedure"
              },
              {
                "measure": "Change from baseline DSST score over time during recovery period"
              },
              {
                "measure": "Duration and percent of time when a patient's Modified OAA/S score is at each level between the first dose of study medications and Fully Alert, inclusive"
              },
              {
                "measure": "Duration of sedation"
              },
              {
                "measure": "Number of doses of study medication administered for the procedure"
              },
              {
                "measure": "Time to sedation"
              },
              {
                "measure": "Time to reach splenic flexure, hepatic flexure, cecum, and end of procedure"
              },
              {
                "measure": "Number of repositionings"
              },
              {
                "measure": "Number of procedure interruptions due to inadequate sedation"
              },
              {
                "measure": "Patient's rating of experience after Fully Recovered"
              },
              {
                "measure": "Patient's rating at 24 hour post discharge telephone survey"
              },
              {
                "measure": "Investigator's rating at end of procedure"
              },
              {
                "measure": "Blinded evaluator's rating after patient is Fully Recovered"
              },
              {
                "measure": "Safety Endpoints"
              },
              {
                "measure": "Nature, frequency, severity, relationship to treatment, and outcome of all adverse events"
              },
              {
                "measure": "Airway assistance"
              },
              {
                "measure": "Sedation-related adverse events"
              },
              {
                "measure": "Laboratory parameters and vital signs"
              },
              {
                "measure": "Concomitant medications"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02064673",
            "briefTitle": "Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical Prostatectomy",
            "officialTitle": "Randomized Trial of Adjuvant Curcumin After Prostatectomy"
          },
          "statusModule": {
            "overallStatus": "RECRUITING",
            "studyFirstSubmitDate": "2014-02-10"
          },
          "conditionsModule": {
            "conditions": [
              "Prostate Cancer"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Serum prostate specific antigen",
                "timeFrame": "3 years"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT06159673",
            "briefTitle": "ACP-204 in Adults With Alzheimer's Disease Psychosis",
            "officialTitle": "A Master Protocol for Three Independent, Seamlessly Enrolling, Double-blind, Placebo-controlled Efficacy and Safety Studies of ACP-204 in Adults With Alzheimer's Disease Psychosis"
          },
          "statusModule": {
            "overallStatus": "RECRUITING",
            "studyFirstSubmitDate": "2023-11-27"
          },
          "conditionsModule": {
            "conditions": [
              "Alzheimer's Disease Psychosis"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Scale for the Assessment of Positive Symptoms-Hallucinations and Delusions subscales (SAPS-H+D) total score change from baseline (Substudies 1, 2A, 2B)",
                "timeFrame": "From baseline to Week 6"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Clinical Global Impression-Improvement in the ADP context (CGI-I-ADP) score"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02597673",
            "briefTitle": "Trial of Self-managed Approaches for Patellofemoral Pain Syndrome in Active Duty",
            "officialTitle": "Trial of Self-managed Approaches for Patellofemoral Pain Syndrome in Active Duty"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2015-10-05",
            "resultsFirstSubmitDate": "2020-06-01"
          },
          "conditionsModule": {
            "conditions": [
              "Patellofemoral Pain Syndrome"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Lower Extremity Muscle Strength- Extension",
                "timeFrame": "0, 3, 6, and 9 weeks"
              },
              {
                "measure": "Lower Extremity Muscle Strength- Flexion",
                "timeFrame": "0, 3, 6, and 9 weeks"
              },
              {
                "measure": "Lower Extremity Strength- 30-Second Chair Stand Test",
                "timeFrame": "0, 3, 6, and 9 weeks"
              },
              {
                "measure": "Lower Extremity Strength- Timed Stair Climb Test",
                "timeFrame": "0, 3, 6, and 9 weeks"
              },
              {
                "measure": "Lower Extremity Mobility- Forward Step-down Test",
                "timeFrame": "0, 3, 6, and 9 weeks"
              },
              {
                "measure": "Lower Extremity Mobility- 6-Minute Walk Test",
                "timeFrame": "0, 3, 6, and 9 weeks"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Current Knee Pain"
              },
              {
                "measure": "Knee Pain Following Performance Testing- 30-Second Chair Stand Test"
              },
              {
                "measure": "Knee Pain Following Performance Testing- Stair Climb Test"
              },
              {
                "measure": "Knee Pain Following Performance Testing- Forward Step Down Test"
              },
              {
                "measure": "Knee Pain Following Performance Testing- 6-Minute Walk Test"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT06752473",
            "briefTitle": "KSD-101 Therapy for Standard Treatment Failed EBV-associated Nasopharyngeal Carcinoma: an Exploratory Clinical Trial",
            "officialTitle": "KSD-101 Therapy for Standard Treatment Failed EBV-associated Nasopharyngeal Carcinoma: an Exploratory Clinical Trial"
          },
          "statusModule": {
            "overallStatus": "NOT_YET_RECRUITING",
            "studyFirstSubmitDate": "2024-12-27"
          },
          "conditionsModule": {
            "conditions": [
              "Nasopharyngeal Carcinoma (NPC)",
              "EBV"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "The incidence Adverse events (Safety endpoint)",
                "timeFrame": "1 year after DC Vaccines injection"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "EBV-DNA load"
              },
              {
                "measure": "Objective response rate (ORR)"
              },
              {
                "measure": "Disease control rate (DCR)"
              },
              {
                "measure": "Duration of response (DOR)"
              },
              {
                "measure": "Progression-free survival (PFS)"
              },
              {
                "measure": "Overall survival (OS)"
              },
              {
                "measure": "Levels of EBV-specific CD8+ T cells"
              },
              {
                "measure": "Levels of B cells"
              },
              {
                "measure": "Levels of NK cells"
              },
              {
                "measure": "According to EORTC QLQ-C30"
              },
              {
                "measure": "According to EQ-5D-5L"
              },
              {
                "measure": "According to EORTC QLQ-H&N35"
              },
              {
                "measure": "According to ECOG fitness status"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT04842773",
            "briefTitle": "Ultrasound (US) Measurement of Sarcopenia in the Elder Subject",
            "officialTitle": "MESSAge Study : Ultrasound Measurement of Sarcopenia in the Elder Subject"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2021-04-07"
          },
          "conditionsModule": {
            "conditions": [
              "Sarcopenia"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Combinaison of US measurements",
                "timeFrame": "1 day"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Inter-operator reproductibility"
              },
              {
                "measure": "Muscle elasticity"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT04004273",
            "briefTitle": "Diabetes, Exercise and Liver Fat (DELIVER)",
            "officialTitle": "The Impact of Type 2 Diabetes and Exercise on Liver Fat Quality"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2018-08-07"
          },
          "conditionsModule": {
            "conditions": [
              "Type 2 Diabetes Mellitus",
              "Non-Alcoholic Fatty Liver Disease",
              "Obesity",
              "Insulin Resistance",
              "Liver Diseases",
              "Fatty Liver",
              "Diabetes Mellitus",
              "Glucose Metabolism Disorders",
              "Glucose Intolerance",
              "Metabolic Disease"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Change in liver saturated lipid index (%) determined by proton magnetic resonance spectroscopy (1H-MRS) using a 3T MRI scanner",
                "timeFrame": "2 measurements: Baseline, week 6"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Change in Liver unsaturated lipid index (%) - measured using 1H-MRS"
              },
              {
                "measure": "Change in Liver polyunsaturated lipid index (%) - measured using 1H-MRS"
              },
              {
                "measure": "Change in total hepatic lipid composition (%) - measured using 1H-MRS"
              },
              {
                "measure": "Change in visceral adipose tissue - measured using magnetic resonance imaging (MRI) with a 3T Philips Ingenia MRI scanner"
              },
              {
                "measure": "Change in subcutaneous abdominal adipose tissue - measured using magnetic resonance imaging (MRI) with a 3T Philips Ingenia MRI scanner"
              },
              {
                "measure": "Change in body mass"
              },
              {
                "measure": "Change in body fat percentage"
              },
              {
                "measure": "Change in aerobic fitness (peak oxygen uptake)"
              },
              {
                "measure": "Change in liver enzymes"
              },
              {
                "measure": "Change in glucose"
              },
              {
                "measure": "Change in insulin"
              },
              {
                "measure": "Change in lipids"
              },
              {
                "measure": "Change in HbA1c"
              },
              {
                "measure": "Change in homeostasis model assessment of insulin resistance (HOMA-IR; surrogate marker of hepatic insulin resistance)"
              },
              {
                "measure": "Change in adipose tissue insulin resistance (ADIPO-IR; surrogate marker of adipose tissue insulin resistance)"
              },
              {
                "measure": "Change in circulating Inflammatory proteins"
              },
              {
                "measure": "Change in Hepatokines"
              },
              {
                "measure": "Change in objectively measured sedentary time - GENEactiv physical activity monitor"
              },
              {
                "measure": "Change in objectively measured physical activity - GENEactiv physical activity monitor"
              },
              {
                "measure": "Change in energy intake"
              },
              {
                "measure": "Change in macronutrient intake"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT06985173",
            "briefTitle": "Patient Satisfaction in Occlusal Splints Fabricated Using Fully Digital Versus Conventional Workflow",
            "officialTitle": "Patient Satisfaction and Occlusal Adjustments in Occlusal Splints Fabricated Using Fully Digital Versus Conventional Workflow in TMD Patients. (Randomized Controlled Clinical Trial)"
          },
          "statusModule": {
            "overallStatus": "NOT_YET_RECRUITING",
            "studyFirstSubmitDate": "2025-05-06"
          },
          "conditionsModule": {
            "conditions": [
              "Temporomandibular Joint Disorders"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Patient satisfaction",
                "timeFrame": "'' Up to 12 weeks''"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Amount of occlusal adjustments"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT06838273",
            "briefTitle": "A Study of BL-B01D1 in Combination With Osimertinib Versus Osimertinib as First-Line Treatment in Patients With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer",
            "officialTitle": "A Phase III Randomized Study of BL-B01D1 in Combination With Osimertinib Versus Osimertinib as First-Line Treatment in Patients With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer"
          },
          "statusModule": {
            "overallStatus": "RECRUITING",
            "studyFirstSubmitDate": "2025-02-16"
          },
          "conditionsModule": {
            "conditions": [
              "Non-small Cell Lung Cancer"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Progression-free survival (PFS)",
                "timeFrame": "Up to approximately 36 months"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Overall survival (OS)"
              },
              {
                "measure": "Objective Response Rate (ORR)"
              },
              {
                "measure": "Disease Control Rate (DCR)"
              },
              {
                "measure": "Duration of Response (DOR)"
              },
              {
                "measure": "Treatment Emergent Adverse Event (TEAE)"
              },
              {
                "measure": "Anti-drug antibody (ADA)"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01057173",
            "briefTitle": "The Nordic Aortic Valve Intervention Trial",
            "officialTitle": "Transcatheter Versus Surgical Aortic Valve Implantation in Patients With Severe Aortic Valve Stenosis"
          },
          "statusModule": {
            "overallStatus": "ACTIVE_NOT_RECRUITING",
            "studyFirstSubmitDate": "2010-01-26"
          },
          "conditionsModule": {
            "conditions": [
              "Critical Aortic Stenosis"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Combined rate of death from any cause, myocardial infarction, and stroke",
                "timeFrame": "1 year"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Procedural complications"
              },
              {
                "measure": "Admission lengths (ICU and interventional center)"
              },
              {
                "measure": "Combined rate of noncardiac and cardiac death, prosthesis reintervention, cardiac-, cerebral-, renal-, and pulmonary complications"
              },
              {
                "measure": "Functional status (NYHA-classification) and Quality of Life (SF-36)"
              },
              {
                "measure": "Echocardiographic prosthesis and ventricular structural and functional status"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02227992",
            "briefTitle": "The EVARREST\u00ae Paediatric Mild/Moderate Liver and Soft Tissue Bleeding Study",
            "officialTitle": "A Prospective, Randomized, Controlled, Study Evaluating the Safety and Effectiveness of EVARREST\u00ae Sealant Matrix in Controlling Mild or Moderate Hepatic Parenchyma or Soft Tissue Bleeding During Open Abdominal, Retroperitoneal, Pelvic and Thoracic (Non-cardiac) Surgery in Paediatric Patients"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2014-07-28",
            "resultsFirstSubmitDate": "2022-10-27"
          },
          "conditionsModule": {
            "conditions": [
              "Hemorrhage",
              "Soft Tissue Bleeding",
              "Hepatic Parenchyma Bleeding"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Absolute Time to Haemostasis (TTH)",
                "timeFrame": "Up to 1 day (Intraoperative)"
              },
              {
                "measure": "Absolute Time to Haemostasis (TTH) by Age Group",
                "timeFrame": "Up to 1 day (Intraoperative)"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Percentage of Participants Achieving Haemostatic Success at 4 Minutes Following Randomization With No Bleeding Requiring Treatment at the Target Bleeding Site Occurring Any Time Prior to Final Fascial Closure"
              },
              {
                "measure": "Percentage of Participants Achieving Haemostatic Success at 10 Minutes Following Randomization With No Bleeding Requiring Treatment at the Target Bleeding Site Occurring Any Time Prior to Final Fascial Closure"
              },
              {
                "measure": "Percentage of Participants With No Re-bleeding at the Target Bleeding Site"
              },
              {
                "measure": "Number of Participants With Adverse Events (AEs) That Were Potentially Related To Bleeding at the TBS"
              },
              {
                "measure": "Number of Participants With AEs That Were Potentially Related To Thrombotic Events"
              },
              {
                "measure": "Number of Participants Who Required Re-treatment At The Target Bleeding Site"
              },
              {
                "measure": "Number of Participants With Adverse Events"
              },
              {
                "measure": "Change From Baseline to Post-surgery in Haemoglobin"
              },
              {
                "measure": "Change From Baseline to Post-surgery in Haematocrit"
              },
              {
                "measure": "Change From Baseline to Post-surgery in Platelet Count"
              },
              {
                "measure": "Estimated Volume of Blood Loss"
              },
              {
                "measure": "Number of Participants Who Received Blood Transfusions"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02055092",
            "briefTitle": "Young Onset Dementia - the Difficult Diagnosis and the Stressful Life for the Whole Family",
            "officialTitle": "A Nordic Multicentre Observational Study of Persons With Young Onset Dementia and Their Families - Factors Influencing Quality of Life, Theirs Specific Needs and the Use of Healthcare Resources"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2014-01-31"
          },
          "conditionsModule": {
            "conditions": [
              "Frontotemporal Dementia",
              "Alzheimer Disease"
            ]
          },
          "designModule": {
            "studyType": "OBSERVATIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Quality of life",
                "timeFrame": "Baseline"
              },
              {
                "measure": "Change from baseline in quality of life at 12 months",
                "timeFrame": "Baseline, 12 months"
              },
              {
                "measure": "Change from baseline in quality of life at 24 months",
                "timeFrame": "Baseline, 24 months"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Specific needs"
              },
              {
                "measure": "Use of healthcare resources"
              },
              {
                "measure": "Cognition"
              },
              {
                "measure": "Neuropsychiatric symptoms"
              },
              {
                "measure": "Activities of Daily Living (ADL)"
              },
              {
                "measure": "Relative's stress"
              },
              {
                "measure": "Specific needs"
              },
              {
                "measure": "Specific needs"
              },
              {
                "measure": "Use of healthcare resources"
              },
              {
                "measure": "Use of healthcare resources"
              },
              {
                "measure": "Cognition"
              },
              {
                "measure": "Cognition"
              },
              {
                "measure": "Neuropsychiatric symptoms"
              },
              {
                "measure": "Neuropsychiatric symptoms"
              },
              {
                "measure": "Activities of Daily Living (ADL)"
              },
              {
                "measure": "Relative's stress"
              },
              {
                "measure": "Activities of Daily Living (ADL)"
              },
              {
                "measure": "Relative's stress"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01830192",
            "nctIdAliases": [
              "NCT01830179"
            ],
            "briefTitle": "REM (Risk Of Endometrial Malignancy)",
            "officialTitle": "REM (Risk Of Endometrial Malignancy): A Proposal for a New Scoring System to Evaluate Risk of Endometrial Malignancy"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2013-04-05"
          },
          "conditionsModule": {
            "conditions": [
              "Endometrial Disease"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "REM (RISK OF ENDOMETRIAL MALIGNANCY): a proposal for a new scoring system to evaluate risk of endometrial malignancy.",
                "timeFrame": "2 year"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "REM"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01915992",
            "briefTitle": "Natural Killer Cells Functions, Tumoral Escape to Immune System and Regulation of Natural Cytotoxixity Receptors in Haematological Malignancies",
            "officialTitle": "Natural Killer Cells Functions, Tumoral Escape to Immune System and Regulation of Natural Cytotoxixity Receptors in Haematological Malignancies"
          },
          "statusModule": {
            "overallStatus": "UNKNOWN",
            "studyFirstSubmitDate": "2013-02-20"
          },
          "conditionsModule": {
            "conditions": [
              "Leukemia"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "blood sample",
                "timeFrame": "18 months"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT05679492",
            "briefTitle": "Study on the Safety and Efficacy of Meplazumab for Injection Patients COVID-19",
            "officialTitle": "A Multicenter, Randomized, Double-blind, Placebo-controlled, add-on Phase III Clinical Study on the Efficacy and Safety of Meplazumab for Injection in Adults With Mild and Moderate COVID-19 Infections"
          },
          "statusModule": {
            "overallStatus": "WITHDRAWN",
            "whyStopped": "Based on current epidemic situation in China, there is few Mild and Moderate COVID-19 patients.",
            "studyFirstSubmitDate": "2023-01-10"
          },
          "conditionsModule": {
            "conditions": [
              "COVID-19"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "12 cases of SARS-CoV-2 infection reached the duration of clinical recovery",
                "timeFrame": "Day 28"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "The time and proportion of SARS-CoV-2 nucleic acid to turn negative"
              },
              {
                "measure": "12clinical symptoms of SARS-CoV-2 infection reached the proportion of clinical sustained recovery"
              },
              {
                "measure": "The proportion of light/medium to heavy/critical types"
              },
              {
                "measure": "Change from baseline in each of the 12 clinical symptom assessments of SARS-Cov-2 infection"
              },
              {
                "measure": "The time and rate of improvement from baseline in lung imaging during the 28-day tria"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT04293692",
            "briefTitle": "Therapy for Pneumonia Patients iInfected by 2019 Novel Coronavirus",
            "officialTitle": "Human Umbilical Cord Mesenchymal Stem Cells Treatment for Pneumonia Patients Infected by 2019 Novel Coronavirus"
          },
          "statusModule": {
            "overallStatus": "WITHDRAWN",
            "whyStopped": "Patients were transferred to designated hospitals for treatment as needed, the clinical trials cannot be conducted.",
            "studyFirstSubmitDate": "2020-02-24"
          },
          "conditionsModule": {
            "conditions": [
              "COVID-19"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Size of lesion area by chest imaging",
                "timeFrame": "At baseline, Day 1, Week 1, Week 2, Week 4, Week 8"
              },
              {
                "measure": "Blood oxygen saturation",
                "timeFrame": "At baseline, Day 1, Week 1, Week 2, Week 4, Week 8"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Rate of mortality within 28-days"
              },
              {
                "measure": "Sequential organ failure assessment"
              },
              {
                "measure": "Side effects in the UC-MSCs treatment group"
              },
              {
                "measure": "Electrocardiogram, the changes of ST-T interval mostly"
              },
              {
                "measure": "Concentration of C-reactive protein C-reactive protein, immunoglobulin"
              },
              {
                "measure": "CD4+ and CD8+ T cells count"
              },
              {
                "measure": "Concentration of the blood cytokine (IL-1\u03b2, IL-6, IL-8,IL-10,TNF-\u03b1)"
              },
              {
                "measure": "Concentration of the myocardial enzymes"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT04860492",
            "briefTitle": "The Impact of Renalof\u00ae Dietary Supplement on Upper Urinary Tract Stone Volume",
            "officialTitle": "A Randomized, Double-blind, Placebo-controlled Study of Agropyron Repens, Mannitol and Magnesium Supplement for the Treatment of Calcium Oxalate Upper Urinary Tract Stones: The AMMOS Study"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2021-04-13"
          },
          "conditionsModule": {
            "conditions": [
              "Calculus of Upper Urinary Tract (Disorder)"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Stone volume",
                "timeFrame": "90 days"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Stent-related symptoms score in the cohort of patients with DJ stents."
              },
              {
                "measure": "Overactive Bladder (OAB) Symptoms score"
              },
              {
                "measure": "Pain level"
              },
              {
                "measure": "Microbial growth of double J stents in the cohort of patients with DJ stents."
              },
              {
                "measure": "Incidence of documented urinary tract infections"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT04955873",
            "briefTitle": "Ridge Preservation Using Xenogenic Bone Graft and Pre-hydrated Collagen Membrane",
            "officialTitle": "Ridge Preservation With the Use of a Xenogenic Bone Graft Material (Symbios Xenograft Granules) and a Pre-hydrated Collagen Membrane Symbios Pre-hydrated Collagen Resorbable Membrane): A Pilot Multicenter Randomized Controlled Study"
          },
          "statusModule": {
            "overallStatus": "UNKNOWN",
            "studyFirstSubmitDate": "2021-07-05"
          },
          "conditionsModule": {
            "conditions": [
              "Alveolar Bone Resorption",
              "Edentulous Alveolar Ridge"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Composition of new-formed hard tissue into the post-extractive socket",
                "timeFrame": "Six months after surgery"
              },
              {
                "measure": "Composition of new-formed soft tissue over the post-extractive socket",
                "timeFrame": "Six months after surgery"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Implant torque at insertion"
              },
              {
                "measure": "Width of keratinized mucosa"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT03293173",
            "briefTitle": "Biomarker Driven Intensified ChemoImmunotherapy With Early CNS Prophylaxis",
            "officialTitle": "Biomarker Driven and Dose Intensified Chemoimmunotherapy With Early CNS Prophylaxis in Patients Less Than 65 Years With High Risk Diffuse Large B-Cell Lymphoma"
          },
          "statusModule": {
            "overallStatus": "ACTIVE_NOT_RECRUITING",
            "studyFirstSubmitDate": "2017-09-05"
          },
          "conditionsModule": {
            "conditions": [
              "Lymphoma, Large B-Cell, Diffuse"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Time to treatment failure (TTF) of the patients with biological risk factors",
                "timeFrame": "At 3 years"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Time to treatment failure (TTF) at 3 years from date of registration of all patients and the patients in the low risk group"
              },
              {
                "measure": "Incidence of treatment-emergent adverse events (Safety and tolerability)"
              },
              {
                "measure": "Clinical response rate of all patients and the patients with biological risk factors"
              },
              {
                "measure": "CNS relapse rate"
              },
              {
                "measure": "Progression free survival rate (PFS) of all patients and the patients with biological risk factors"
              },
              {
                "measure": "Overall survival rate (OS) of all patients and the patients with biological risk factors"
              },
              {
                "measure": "Molecular correlates for survival"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT05243173",
            "briefTitle": "Biomarkers of Response to Systemic Treatments in FH-deficient RCC",
            "officialTitle": "Renji Hospital, School of Medicine, Shanghai Jiao Tong University"
          },
          "statusModule": {
            "overallStatus": "UNKNOWN",
            "studyFirstSubmitDate": "2021-12-20"
          },
          "conditionsModule": {
            "conditions": [
              "Metabolomics",
              "Renal Cell Carcinoma",
              "FH-Deficient RCC",
              "Systemic Treatments"
            ]
          },
          "designModule": {
            "studyType": "OBSERVATIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Metabolomics",
                "timeFrame": "2 years"
              },
              {
                "measure": "Determine genotype/phenotype correlations",
                "timeFrame": "3 years"
              },
              {
                "measure": "Discovery of predicting bio-markers for FH-deficient RCC systemic treatments response",
                "timeFrame": "3 years"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT06860373",
            "briefTitle": "LIFE-DSR-Biomarker Sub-study of Biomarkers in Down Syndrome Related Alzheimer's Disease (DS-AD)",
            "officialTitle": "LIFE-DSR-Biomarker Sub-study of Biomarkers in Down Syndrome Related Alzheimer's Disease (DS-AD)"
          },
          "statusModule": {
            "overallStatus": "TERMINATED",
            "whyStopped": "Unable to recruit",
            "studyFirstSubmitDate": "2024-03-22"
          },
          "conditionsModule": {
            "conditions": [
              "Down Syndrome"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Primary Outcome Measure to establish a biobank specifically for DS participants",
                "timeFrame": "Month 0 and Month 16 or Month 16 and Month 32"
              },
              {
                "measure": "Primary Outcome to ascertain the degree and distribution of tau pathology in DS as a function of age using tau PET",
                "timeFrame": "Month 0 and Month 16 or Month 16 and Month 32"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Secondary Outcome is to increase knowledge of biomarkers of interest in DS-AD clinical progression and perform deep immunophenotyping of PBMC and plasma samples."
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02377973",
            "briefTitle": "Diet and Well-being of Young Danish Children Born by Obese Mothers",
            "officialTitle": "The SKOT II Cohort - a Prospective Cohort Study of Diet and Well-being in Young Danish Children Born by Obese Mothers"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2015-02-27"
          },
          "conditionsModule": {
            "conditions": [
              "Growth",
              "Overweight",
              "Metabolic Syndrome",
              "Obesity"
            ]
          },
          "designModule": {
            "studyType": "OBSERVATIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Change in anthropometric measurements in periods of early childhood",
                "timeFrame": "9, 18 and 36 months of age"
              },
              {
                "measure": "Body composition in early childhood",
                "timeFrame": "36 months of age"
              },
              {
                "measure": "Markers of Metabolic syndrome in early life",
                "timeFrame": "9 and 36 months of age"
              },
              {
                "measure": "Diet in periods of early life",
                "timeFrame": "9, 18 and 36 months of age"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Breastfeeding duration in infancy and early childhood"
              },
              {
                "measure": "Insulin like growth factor at 9 and 36 months of age"
              },
              {
                "measure": "Physical activity, sedentary behavior and sleep in early childhood"
              },
              {
                "measure": "Vitamin D status in infancy"
              },
              {
                "measure": "Allergy and chronic diseases"
              },
              {
                "measure": "Appetite hormones in infancy"
              },
              {
                "measure": "Change in gut microbiota"
              },
              {
                "measure": "Achievement of milestones"
              },
              {
                "measure": "Metabolomics in the urine"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT04524273",
            "briefTitle": "Myasthenia Gravis Inebilizumab Trial",
            "officialTitle": "A Randomized, Double-blind, Multicenter, Placebo-controlled Phase 3 Study With Open-label Period to Evaluate the Efficacy and Safety of Inebilizumab in Adults With Myasthenia Gravis"
          },
          "statusModule": {
            "overallStatus": "ACTIVE_NOT_RECRUITING",
            "studyFirstSubmitDate": "2020-08-10"
          },
          "conditionsModule": {
            "conditions": [
              "Myasthenia Gravis"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Change from baseline in Myasthenia Gravis Activities of Daily Living (MG-ADL) Profile score.",
                "timeFrame": "Baseline to Week 26"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Change from baseline in Quantitative Myasthenia Gravis (QMG) scores."
              },
              {
                "measure": "Proportion of participants with both \u2265 3-point improvement from baseline in MG-ADL and did not initiate rescue therapy."
              },
              {
                "measure": "Change from baseline in MG-ADL"
              },
              {
                "measure": "Time to first gMG exacerbation."
              },
              {
                "measure": "Change from baseline in Myasthenia Gravis Composite (MGC) score."
              },
              {
                "measure": "Change from baseline in Myasthenia Gravis Quality of Life-15, revised (MGQOL-15r) score."
              },
              {
                "measure": "Patient Global Impression of Change (PGIC) score."
              },
              {
                "measure": "Number of participants with treatment-emergent adverse events (TEAEs), adverse events of special interest (AESIs), and treatment-emergent serious adverse events (TESAEs) during the RCP and OLP."
              },
              {
                "measure": "Proportion of participants with steroid tapered to \u2264 5 mg/day."
              },
              {
                "measure": "Proportion of participants with a steroid dose reduction from baseline of \u2265 50%."
              },
              {
                "measure": "Proportion of participants achieving minimal symptom expression."
              },
              {
                "measure": "Proportion of participants with anti-drug antibodies (ADAs) to inebilizumab"
              },
              {
                "measure": "Titers of ADAs"
              }
            ]
          }
        }
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:22:37Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c833f"
    },
    "name": "BRD-K27772696",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c833f.png",
    "lincs": {
      "id": "LSM-8184",
      "name": "BRD-K27772696",
      "pubchemCid": 44505661,
      "chebiId": 96805,
      "inchiParent": "InChI=1S/C24H34F3N5O3/c1-17-11-32(18(2)15-33)23(34)9-6-10-31-13-20(28-29-31)16-35-22(17)14-30(3)12-19-7-4-5-8-21(19)24(25,26)27/h4-5,7-8,13,17-18,22,33H,6,9-12,14-16H2,1-3H3/t17-,18+,22+/m0/s1",
      "inchiKeyParent": "ZTOSEQHRKGCZOZ-NJNPRVFISA-N",
      "smilesParent": "C[C@H](CO)N1C[C@H](C)[C@@H](CN(C)Cc2ccccc2C(F)(F)F)OCc3cn(CCCC1=O)nn3"
    },
    "unichem": {
      "chebi": "96805",
      "lincs": "LSM-8184",
      "pubchem": "44505661"
    },
    "pubchem": [
      {
        "cid": 44505661,
        "inchi": "InChI=1S/C24H34F3N5O3/c1-17-11-32(18(2)15-33)23(34)9-6-10-31-13-20(28-29-31)16-35-22(17)14-30(3)12-19-7-4-5-8-21(19)24(25,26)27/h4-5,7-8,13,17-18,22,33H,6,9-12,14-16H2,1-3H3/t17-,18+,22+/m0/s1",
        "inchikey": "ZTOSEQHRKGCZOZ-NJNPRVFISA-N",
        "iupac": {
          "systematic": "(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[[2-(trifluoromethyl)phenyl]methyl]amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)CCCN2C=C(COC1CN(C)CC3=CC=CC=C3C(F)(F)F)N=N2)C(C)CO"
        },
        "molecularFormula": "C24H34F3N5O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:22:39Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c828f"
    },
    "name": "BRD-K23149749",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c828f.png",
    "lincs": {
      "id": "LSM-9830",
      "name": "BRD-K23149749",
      "pubchemCid": 54654484,
      "chebiId": 98451,
      "inchiParent": "InChI=1S/C23H25N3O6/c1-26-18-9-8-16(12-21(27)28)32-20(18)13-31-19-10-7-15(11-17(19)22(26)29)25-23(30)24-14-5-3-2-4-6-14/h2-7,10-11,16,18,20H,8-9,12-13H2,1H3,(H,27,28)(H2,24,25,30)/t16-,18+,20-/m0/s1",
      "inchiKeyParent": "HJRBVKTVNLVVPO-HQRMLTQVSA-N",
      "smilesParent": "CN1[C@@H]2CC[C@@H](CC(=O)O)O[C@H]2COc3ccc(NC(=O)Nc4ccccc4)cc3C1=O"
    },
    "unichem": {
      "chebi": "98451",
      "lincs": "LSM-9830",
      "pubchem": "54654484"
    },
    "pubchem": [
      {
        "cid": 54654484,
        "inchi": "InChI=1S/C23H25N3O6/c1-26-18-9-8-16(12-21(27)28)32-20(18)13-31-19-10-7-15(11-17(19)22(26)29)25-23(30)24-14-5-3-2-4-6-14/h2-7,10-11,16,18,20H,8-9,12-13H2,1H3,(H,27,28)(H2,24,25,30)/t16-,18+,20-/m0/s1",
        "inchikey": "HJRBVKTVNLVVPO-HQRMLTQVSA-N",
        "iupac": {
          "systematic": "2-[(2S,4aR,12aR)-5-methyl-6-oxo-8-(phenylcarbamoylamino)-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]acetic acid"
        },
        "smiles": {
          "canonical": "CN1C2CCC(OC2COC3=C(C1=O)C=C(C=C3)NC(=O)NC4=CC=CC=C4)CC(=O)O"
        },
        "molecularFormula": "C23H25N3O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:22:41Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82f0"
    },
    "name": "BRD-K61823824",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82f0.png",
    "lincs": {
      "id": "LSM-8298",
      "name": "BRD-K61823824",
      "pubchemCid": 44504998,
      "chebiId": 96919,
      "inchiParent": "InChI=1S/C20H35N5O5/c1-14(2)30-20(28)23(5)11-18-15(3)9-25(16(4)12-26)19(27)7-6-8-24-10-17(13-29-18)21-22-24/h10,14-16,18,26H,6-9,11-13H2,1-5H3/t15-,16+,18-/m1/s1",
      "inchiKeyParent": "FYUBIBUWDYYNKH-SOLBZPMBSA-N",
      "smilesParent": "CC(C)OC(=O)N(C)C[C@H]1OCc2cn(CCCC(=O)N(C[C@H]1C)[C@@H](C)CO)nn2"
    },
    "unichem": {
      "chebi": "96919",
      "lincs": "LSM-8298",
      "pubchem": "44504998"
    },
    "pubchem": [
      {
        "cid": 44504998,
        "inchi": "InChI=1S/C20H35N5O5/c1-14(2)30-20(28)23(5)11-18-15(3)9-25(16(4)12-26)19(27)7-6-8-24-10-17(13-29-18)21-22-24/h10,14-16,18,26H,6-9,11-13H2,1-5H3/t15-,16+,18-/m1/s1",
        "inchikey": "FYUBIBUWDYYNKH-SOLBZPMBSA-N",
        "iupac": {
          "systematic": "propan-2-yl N-[[(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylcarbamate"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)CCCN2C=C(COC1CN(C)C(=O)OC(C)C)N=N2)C(C)CO"
        },
        "molecularFormula": "C20H35N5O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:22:44Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c829b"
    },
    "name": "BRD-K43540029",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c829b.png",
    "lincs": {
      "id": "LSM-39664",
      "name": "BRD-K43540029",
      "pubchemCid": 54666627,
      "chebiId": 128108,
      "inchiParent": "InChI=1S/C28H34N2O3S/c31-21-27-28(24-16-14-23(15-17-24)13-12-22-8-4-5-9-22)26-20-29(18-6-7-19-30(26)27)34(32,33)25-10-2-1-3-11-25/h1-3,10-11,14-17,22,26-28,31H,4-9,18-21H2/t26-,27+,28-/m1/s1",
      "inchiKeyParent": "OYGJGQMEHJXORO-OZNIXHKMSA-N",
      "smilesParent": "OC[C@H]1[C@@H]([C@H]2CN(CCCCN12)S(=O)(=O)c3ccccc3)c4ccc(cc4)C#CC5CCCC5"
    },
    "unichem": {
      "chebi": "128108",
      "lincs": "LSM-39664",
      "pubchem": "54666627"
    },
    "pubchem": [
      {
        "cid": 54666627,
        "inchi": "InChI=1S/C28H34N2O3S/c31-21-27-28(24-16-14-23(15-17-24)13-12-22-8-4-5-9-22)26-20-29(18-6-7-19-30(26)27)34(32,33)25-10-2-1-3-11-25/h1-3,10-11,14-17,22,26-28,31H,4-9,18-21H2/t26-,27+,28-/m1/s1",
        "inchikey": "OYGJGQMEHJXORO-OZNIXHKMSA-N",
        "iupac": {
          "systematic": "[(8S,9R,10R)-6-(benzenesulfonyl)-9-[4-(2-cyclopentylethynyl)phenyl]-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol"
        },
        "smiles": {
          "canonical": "C1CCC(C1)C#CC2=CC=C(C=C2)C3C4CN(CCCCN4C3CO)S(=O)(=O)C5=CC=CC=C5"
        },
        "molecularFormula": "C28H34N2O3S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:22:46Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82bd"
    },
    "name": "BRD-K88327759",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82bd.png",
    "lincs": {
      "id": "LSM-13856",
      "name": "BRD-K88327759",
      "pubchemCid": 54654303,
      "chebiId": 102507,
      "inchiParent": "InChI=1S/C27H34N4O5/c1-4-28-27(34)30-19-10-13-23-21(14-19)26(33)31(3)22-12-11-20(36-24(22)16-35-23)15-25(32)29-17(2)18-8-6-5-7-9-18/h5-10,13-14,17,20,22,24H,4,11-12,15-16H2,1-3H3,(H,29,32)(H2,28,30,34)/t17-,20-,22-,24+/m1/s1",
      "inchiKeyParent": "YBRLGVDHYMUGPQ-QSOCRCLWSA-N",
      "smilesParent": "CCNC(=O)Nc1ccc2OC[C@@H]3O[C@@H](CC(=O)N[C@H](C)c4ccccc4)CC[C@H]3N(C)C(=O)c2c1"
    },
    "unichem": {
      "chebi": "102507",
      "lincs": "LSM-13856",
      "pubchem": "54654303"
    },
    "pubchem": [
      {
        "cid": 54654303,
        "inchi": "InChI=1S/C27H34N4O5/c1-4-28-27(34)30-19-10-13-23-21(14-19)26(33)31(3)22-12-11-20(36-24(22)16-35-23)15-25(32)29-17(2)18-8-6-5-7-9-18/h5-10,13-14,17,20,22,24H,4,11-12,15-16H2,1-3H3,(H,29,32)(H2,28,30,34)/t17-,20-,22-,24+/m1/s1",
        "inchikey": "YBRLGVDHYMUGPQ-QSOCRCLWSA-N",
        "iupac": {
          "systematic": "2-[(2R,4aR,12aR)-8-(ethylcarbamoylamino)-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-[(1R)-1-phenylethyl]acetamide"
        },
        "smiles": {
          "canonical": "CCNC(=O)NC1=CC2=C(C=C1)OCC3C(CCC(O3)CC(=O)NC(C)C4=CC=CC=C4)N(C2=O)C"
        },
        "molecularFormula": "C27H34N4O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:22:48Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82d2"
    },
    "name": "BRD-K26715911",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82d2.png",
    "lincs": {
      "id": "LSM-10049",
      "name": "BRD-K26715911",
      "pubchemCid": 54660785,
      "chebiId": 98670,
      "inchiParent": "InChI=1S/C27H35N3O4/c1-28(2)27(33)25-22(16-31)21-15-29-23(24(21)30(25)14-17-6-4-5-7-17)13-12-20(26(29)32)18-8-10-19(34-3)11-9-18/h8-13,17,21-22,24-25,31H,4-7,14-16H2,1-3H3/t21-,22-,24+,25-/m0/s1",
      "inchiKeyParent": "BQGNOLIJCHASHD-HFOXQMJASA-N",
      "smilesParent": "COc1ccc(cc1)C2=CC=C3[C@H]4[C@@H](CN3C2=O)[C@H](CO)[C@H](N4CC5CCCC5)C(=O)N(C)C"
    },
    "unichem": {
      "chebi": "98670",
      "lincs": "LSM-10049",
      "pubchem": "54660785"
    },
    "pubchem": [
      {
        "cid": 54660785,
        "inchi": "InChI=1S/C27H35N3O4/c1-28(2)27(33)25-22(16-31)21-15-29-23(24(21)30(25)14-17-6-4-5-7-17)13-12-20(26(29)32)18-8-10-19(34-3)11-9-18/h8-13,17,21-22,24-25,31H,4-7,14-16H2,1-3H3/t21-,22-,24+,25-/m0/s1",
        "inchikey": "BQGNOLIJCHASHD-HFOXQMJASA-N",
        "iupac": {
          "systematic": "(2S,3S,3aR,9bR)-1-(cyclopentylmethyl)-3-(hydroxymethyl)-7-(4-methoxyphenyl)-N,N-dimethyl-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide"
        },
        "smiles": {
          "canonical": "CN(C)C(=O)C1C(C2CN3C(=CC=C(C3=O)C4=CC=C(C=C4)OC)C2N1CC5CCCC5)CO"
        },
        "molecularFormula": "C27H35N3O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:22:50Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82df"
    },
    "name": "BRD-K47443018",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82df.png",
    "lincs": {
      "id": "LSM-39897",
      "name": "BRD-K47443018",
      "pubchemCid": 54666669,
      "chebiId": 128342,
      "inchiParent": "InChI=1S/C22H27FN2O/c1-24-12-2-3-13-25-20(14-24)22(21(25)15-26)18-6-4-16(5-7-18)17-8-10-19(23)11-9-17/h4-11,20-22,26H,2-3,12-15H2,1H3/t20-,21-,22-/m0/s1",
      "inchiKeyParent": "DFXXWLCMZUFDSQ-FKBYEOEOSA-N",
      "smilesParent": "CN1CCCCN2[C@@H](CO)[C@H]([C@@H]2C1)c3ccc(cc3)c4ccc(F)cc4"
    },
    "unichem": {
      "chebi": "128342",
      "lincs": "LSM-39897",
      "pubchem": "54666669"
    },
    "pubchem": [
      {
        "cid": 54666669,
        "inchi": "InChI=1S/C22H27FN2O/c1-24-12-2-3-13-25-20(14-24)22(21(25)15-26)18-6-4-16(5-7-18)17-8-10-19(23)11-9-17/h4-11,20-22,26H,2-3,12-15H2,1H3/t20-,21-,22-/m0/s1",
        "inchikey": "DFXXWLCMZUFDSQ-FKBYEOEOSA-N",
        "iupac": {
          "systematic": "[(8R,9S,10R)-9-[4-(4-fluorophenyl)phenyl]-6-methyl-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol"
        },
        "smiles": {
          "canonical": "CN1CCCCN2C(C1)C(C2CO)C3=CC=C(C=C3)C4=CC=C(C=C4)F"
        },
        "molecularFormula": "C22H27FN2O"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:22:52Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82e8"
    },
    "name": "Purpurogallin",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82e8.png",
    "lincs": {
      "id": "LSM-37040",
      "name": "Purpurogallin",
      "pubchemCid": 5281571,
      "chebiId": 8647,
      "inchiParent": "InChI=1S/C11H8O5/c12-6-3-1-2-5-4-7(13)10(15)11(16)8(5)9(6)14/h1-4,13,15-16H,(H,12,14)",
      "inchiKeyParent": "WDGFFVCWBZVLCE-UHFFFAOYSA-N",
      "smilesParent": "OC1=CC=Cc2cc(O)c(O)c(O)c2C1=O"
    },
    "unichem": {
      "chebi": "8647",
      "chembl": "CHEMBL66953",
      "lincs": "LSM-37040",
      "pubchem": [
        "135403797",
        "5281571"
      ]
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL66953",
      "prefName": "PURPUROGALLIN",
      "chebiParId": "8647",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 220.18,
        "hba": 5,
        "hbd": 4,
        "qedWeighted": 0.5
      }
    },
    "pubchem": [
      {
        "cid": 5281571,
        "inchi": "InChI=1S/C11H8O5/c12-6-3-1-2-5-4-7(13)10(15)11(16)8(5)9(6)14/h1-4,13,15-16H,(H,12,14)",
        "inchikey": "WDGFFVCWBZVLCE-UHFFFAOYSA-N",
        "iupac": {
          "systematic": "2,3,4,5-tetrahydroxybenzo[7]annulen-6-one"
        },
        "smiles": {
          "canonical": "C1=CC(=O)C(=C2C(=C1)C=C(C(=C2O)O)O)O"
        },
        "molecularFormula": "C11H8O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:23:04Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c831e"
    },
    "name": "BRD-K85158753",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c831e.png",
    "lincs": {
      "id": "LSM-7942",
      "name": "BRD-K85158753",
      "pubchemCid": 54618277,
      "chebiId": 96563,
      "inchiParent": "InChI=1S/C23H35N3O6S/c1-15(2)24-23(29)25(6)13-21-16(3)12-26(17(4)14-27)33(30,31)22-10-9-19(8-7-18(5)28)11-20(22)32-21/h9-11,15-18,21,27-28H,12-14H2,1-6H3,(H,24,29)/t16-,17+,18+,21-/m0/s1",
      "inchiKeyParent": "VEFOSOMUCSIFLK-OOSNJVJTSA-N",
      "smilesParent": "CC(C)NC(=O)N(C)C[C@@H]1Oc2cc(ccc2S(=O)(=O)N(C[C@@H]1C)[C@H](C)CO)C#C[C@@H](C)O"
    },
    "unichem": {
      "chebi": "96563",
      "lincs": "LSM-7942",
      "pubchem": "54618277"
    },
    "pubchem": [
      {
        "cid": 54618277,
        "inchi": "InChI=1S/C23H35N3O6S/c1-15(2)24-23(29)25(6)13-21-16(3)12-26(17(4)14-27)33(30,31)22-10-9-19(8-7-18(5)28)11-20(22)32-21/h9-11,15-18,21,27-28H,12-14H2,1-6H3,(H,24,29)/t16-,17+,18+,21-/m0/s1",
        "inchikey": "VEFOSOMUCSIFLK-OOSNJVJTSA-N",
        "iupac": {
          "systematic": "1-[[(4S,5R)-8-[(3R)-3-hydroxybut-1-ynyl]-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-1-methyl-3-propan-2-ylurea"
        },
        "smiles": {
          "canonical": "CC1CN(S(=O)(=O)C2=C(C=C(C=C2)C#CC(C)O)OC1CN(C)C(=O)NC(C)C)C(C)CO"
        },
        "molecularFormula": "C23H35N3O6S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:23:06Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8345"
    },
    "name": "BRD-K34320757",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8345.png",
    "lincs": {
      "id": "LSM-10494",
      "name": "BRD-K34320757",
      "pubchemCid": 54637923,
      "chebiId": 99115,
      "inchiParent": "InChI=1S/C30H35FN2O3/c1-21-16-33(22(2)19-34)30(35)28-11-7-6-10-27(28)26-9-5-4-8-24(26)20-36-29(21)18-32(3)17-23-12-14-25(31)15-13-23/h4-15,21-22,29,34H,16-20H2,1-3H3/t21-,22-,29+/m0/s1",
      "inchiKeyParent": "KXTDYBDROYGOSG-IHMCZWCLSA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@H](C)[C@@H](CN(C)Cc2ccc(F)cc2)OCc3ccccc3c4ccccc4C1=O"
    },
    "unichem": {
      "chebi": "99115",
      "lincs": "LSM-10494",
      "pubchem": "54637923"
    },
    "pubchem": [
      {
        "cid": 54637923,
        "inchi": "InChI=1S/C30H35FN2O3/c1-21-16-33(22(2)19-34)30(35)28-11-7-6-10-27(28)26-9-5-4-8-24(26)20-36-29(21)18-32(3)17-23-12-14-25(31)15-13-23/h4-15,21-22,29,34H,16-20H2,1-3H3/t21-,22-,29+/m0/s1",
        "inchikey": "KXTDYBDROYGOSG-IHMCZWCLSA-N",
        "iupac": {
          "systematic": "(10S,11S)-10-[[(4-fluorophenyl)methyl-methylamino]methyl]-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-14-one"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=CC=CC=C2C3=CC=CC=C3COC1CN(C)CC4=CC=C(C=C4)F)C(C)CO"
        },
        "molecularFormula": "C30H35FN2O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:23:08Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8277"
    },
    "name": "MLS003129699",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8277.png",
    "lincs": {
      "id": "LSM-6866",
      "name": "MLS003129699",
      "alternativeNames": [
        "BRD-K00468432"
      ],
      "pubchemCid": 44504957,
      "chebiId": 95487,
      "inchiParent": "InChI=1S/C23H35N5O6S/c1-17-12-28(18(2)15-29)23(30)9-6-10-27-13-19(24-25-27)16-34-22(17)14-26(3)35(31,32)21-8-5-7-20(11-21)33-4/h5,7-8,11,13,17-18,22,29H,6,9-10,12,14-16H2,1-4H3/t17-,18+,22+/m1/s1",
      "inchiKeyParent": "RLIRIECCVMDDQV-FGSXEWAUSA-N",
      "smilesParent": "COc1cccc(c1)S(=O)(=O)N(C)C[C@@H]2OCc3cn(CCCC(=O)N(C[C@H]2C)[C@@H](C)CO)nn3"
    },
    "unichem": {
      "chebi": "95487",
      "chembl": "CHEMBL1892904",
      "lincs": "LSM-6866",
      "pubchem": "44504957"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL1892904",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 509.63,
        "hba": 9,
        "hbd": 1,
        "qedWeighted": 0.59
      }
    },
    "pubchem": [
      {
        "cid": 44504957,
        "inchi": "InChI=1S/C23H35N5O6S/c1-17-12-28(18(2)15-29)23(30)9-6-10-27-13-19(24-25-27)16-34-22(17)14-26(3)35(31,32)21-8-5-7-20(11-21)33-4/h5,7-8,11,13,17-18,22,29H,6,9-10,12,14-16H2,1-4H3/t17-,18+,22+/m1/s1",
        "inchikey": "RLIRIECCVMDDQV-FGSXEWAUSA-N",
        "iupac": {
          "systematic": "N-[[(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-3-methoxy-N-methylbenzenesulfonamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)CCCN2C=C(COC1CN(C)S(=O)(=O)C3=CC=CC(=C3)OC)N=N2)C(C)CO"
        },
        "molecularFormula": "C23H35N5O6S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:23:19Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82e7"
    },
    "name": "GW-9662",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82e7.png",
    "lincs": {
      "id": "LSM-4097",
      "name": "GW-9662",
      "alternativeNames": [
        "GW9662",
        "GW 9662"
      ],
      "pubchemCid": 644213,
      "chebiId": 79993,
      "inchiParent": "InChI=1S/C13H9ClN2O3/c14-12-7-6-10(16(18)19)8-11(12)13(17)15-9-4-2-1-3-5-9/h1-8H,(H,15,17)",
      "inchiKeyParent": "DNTSIBUQMRRYIU-UHFFFAOYSA-N",
      "smilesParent": "[O-][N+](=O)c1ccc(Cl)c(c1)C(=O)Nc2ccccc2"
    },
    "unichem": {
      "chebi": "79993",
      "chembl": "CHEMBL375270",
      "lincs": "LSM-4097",
      "pubchem": "644213",
      "drugbank": "DB07863"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL375270",
      "chebiParId": "79993",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 276.68,
        "hba": 3,
        "hbd": 1,
        "qedWeighted": 0.69
      },
      "moleculeSynonyms": [
        {
          "moleculeSynonym": "GW9662",
          "synType": "RESEARCH_CODE",
          "synonyms": "GW-9662"
        }
      ]
    },
    "pubchem": [
      {
        "cid": 644213,
        "inchi": "InChI=1S/C13H9ClN2O3/c14-12-7-6-10(16(18)19)8-11(12)13(17)15-9-4-2-1-3-5-9/h1-8H,(H,15,17)",
        "inchikey": "DNTSIBUQMRRYIU-UHFFFAOYSA-N",
        "iupac": {
          "systematic": "2-chloro-5-nitro-N-phenylbenzamide"
        },
        "smiles": {
          "canonical": "C1=CC=C(C=C1)NC(=O)C2=C(C=CC(=C2)[N+](=O)[O-])Cl"
        },
        "molecularFormula": "C13H9ClN2O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:23:31Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8304"
    },
    "name": "BRD-K77422873",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8304.png",
    "lincs": {
      "id": "LSM-7855",
      "name": "BRD-K77422873",
      "pubchemCid": 54618591,
      "chebiId": 96476,
      "inchiParent": "InChI=1S/C26H32N4O5/c1-17-14-30(18(2)16-31)26(34)22-11-21(6-5-19(3)32)13-28-25(22)35-23(17)15-29(4)24(33)12-20-7-9-27-10-8-20/h7-11,13,17-19,23,31-32H,12,14-16H2,1-4H3/t17-,18-,19-,23-/m0/s1",
      "inchiKeyParent": "XXZIILLLBOPLBY-KGYLXKDPSA-N",
      "smilesParent": "C[C@H](O)C#Cc1cnc2O[C@@H](CN(C)C(=O)Cc3ccncc3)[C@@H](C)CN([C@@H](C)CO)C(=O)c2c1"
    },
    "unichem": {
      "chebi": "96476",
      "lincs": "LSM-7855",
      "pubchem": "54618591"
    },
    "pubchem": [
      {
        "cid": 54618591,
        "inchi": "InChI=1S/C26H32N4O5/c1-17-14-30(18(2)16-31)26(34)22-11-21(6-5-19(3)32)13-28-25(22)35-23(17)15-29(4)24(33)12-20-7-9-27-10-8-20/h7-11,13,17-19,23,31-32H,12,14-16H2,1-4H3/t17-,18-,19-,23-/m0/s1",
        "inchikey": "XXZIILLLBOPLBY-KGYLXKDPSA-N",
        "iupac": {
          "systematic": "N-[[(2R,3S)-8-[(3S)-3-hydroxybut-1-ynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-pyridin-4-ylacetamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(N=CC(=C2)C#CC(C)O)OC1CN(C)C(=O)CC3=CC=NC=C3)C(C)CO"
        },
        "molecularFormula": "C26H32N4O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:23:33Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8321"
    },
    "name": "BRD-K01604266",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8321.png",
    "lincs": {
      "id": "LSM-6881",
      "name": "BRD-K01604266",
      "pubchemCid": 54618659,
      "chebiId": 95502,
      "inchiParent": "InChI=1S/C24H33FN2O4S/c1-5-11-26(4)15-23-17(2)14-27(18(3)16-28)32(29,30)24-10-9-20(13-22(24)31-23)19-7-6-8-21(25)12-19/h6-10,12-13,17-18,23,28H,5,11,14-16H2,1-4H3/t17-,18+,23-/m1/s1",
      "inchiKeyParent": "BJNIKYIOOVPCTN-IEGUWTFLSA-N",
      "smilesParent": "CCCN(C)C[C@H]1Oc2cc(ccc2S(=O)(=O)N(C[C@H]1C)[C@@H](C)CO)c3cccc(F)c3"
    },
    "unichem": {
      "chebi": "95502",
      "lincs": "LSM-6881",
      "pubchem": "54618659"
    },
    "pubchem": [
      {
        "cid": 54618659,
        "inchi": "InChI=1S/C24H33FN2O4S/c1-5-11-26(4)15-23-17(2)14-27(18(3)16-28)32(29,30)24-10-9-20(13-22(24)31-23)19-7-6-8-21(25)12-19/h6-10,12-13,17-18,23,28H,5,11,14-16H2,1-4H3/t17-,18+,23-/m1/s1",
        "inchikey": "BJNIKYIOOVPCTN-IEGUWTFLSA-N",
        "iupac": {
          "systematic": "(2S)-2-[(4R,5S)-8-(3-fluorophenyl)-4-methyl-5-[[methyl(propyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-2-yl]propan-1-ol"
        },
        "smiles": {
          "canonical": "CCCN(C)CC1C(CN(S(=O)(=O)C2=C(O1)C=C(C=C2)C3=CC(=CC=C3)F)C(C)CO)C"
        },
        "molecularFormula": "C24H33FN2O4S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:23:35Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c832a"
    },
    "name": "BRD-K89885223",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c832a.png",
    "lincs": {
      "id": "LSM-13970",
      "name": "BRD-K89885223",
      "pubchemCid": 54657618,
      "chebiId": 102623,
      "inchiParent": "InChI=1S/C19H32N2O5/c1-20(2)18(23)9-15-7-8-16-17(26-15)12-25-11-14(22)10-21(16)19(24)13-5-3-4-6-13/h13-17,22H,3-12H2,1-2H3/t14-,15+,16+,17-/m1/s1",
      "inchiKeyParent": "XUIBJKJBLJUMMA-LTIDMASMSA-N",
      "smilesParent": "CN(C)C(=O)C[C@@H]1CC[C@H]2[C@@H](COC[C@H](O)CN2C(=O)C3CCCC3)O1"
    },
    "unichem": {
      "chebi": "102623",
      "lincs": "LSM-13970",
      "pubchem": "54657618"
    },
    "pubchem": [
      {
        "cid": 54657618,
        "inchi": "InChI=1S/C19H32N2O5/c1-20(2)18(23)9-15-7-8-16-17(26-15)12-25-11-14(22)10-21(16)19(24)13-5-3-4-6-13/h13-17,22H,3-12H2,1-2H3/t14-,15+,16+,17-/m1/s1",
        "inchikey": "XUIBJKJBLJUMMA-LTIDMASMSA-N",
        "iupac": {
          "systematic": "2-[(3R,6aS,8S,10aS)-1-(cyclopentanecarbonyl)-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N,N-dimethylacetamide"
        },
        "smiles": {
          "canonical": "CN(C)C(=O)CC1CCC2C(O1)COCC(CN2C(=O)C3CCCC3)O"
        },
        "molecularFormula": "C19H32N2O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:23:37Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8332"
    },
    "name": "BRD-K61535492",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8332.png",
    "lincs": {
      "id": "LSM-7667",
      "name": "BRD-K61535492",
      "pubchemCid": 54618809,
      "chebiId": 96288,
      "inchiParent": "InChI=1S/C25H33N5O3/c1-17(2)6-7-20-8-22-24(28-11-20)33-23(14-29(5)13-21-9-26-16-27-10-21)18(3)12-30(25(22)32)19(4)15-31/h8-11,16-19,23,31H,12-15H2,1-5H3/t18-,19-,23-/m1/s1",
      "inchiKeyParent": "KVTAKNNJYPDOHV-DNVFCKCGSA-N",
      "smilesParent": "CC(C)C#Cc1cnc2O[C@H](CN(C)Cc3cncnc3)[C@H](C)CN([C@H](C)CO)C(=O)c2c1"
    },
    "unichem": {
      "chebi": "96288",
      "lincs": "LSM-7667",
      "pubchem": "54618809"
    },
    "pubchem": [
      {
        "cid": 54618809,
        "inchi": "InChI=1S/C25H33N5O3/c1-17(2)6-7-20-8-22-24(28-11-20)33-23(14-29(5)13-21-9-26-16-27-10-21)18(3)12-30(25(22)32)19(4)15-31/h8-11,16-19,23,31H,12-15H2,1-5H3/t18-,19-,23-/m1/s1",
        "inchikey": "KVTAKNNJYPDOHV-DNVFCKCGSA-N",
        "iupac": {
          "systematic": "(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-8-(3-methylbut-1-ynyl)-2-[[methyl(pyrimidin-5-ylmethyl)amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(N=CC(=C2)C#CC(C)C)OC1CN(C)CC3=CN=CN=C3)C(C)CO"
        },
        "molecularFormula": "C25H33N5O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:23:39Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82dd"
    },
    "name": "MLS004342420",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82dd.png",
    "lincs": {
      "id": "LSM-42532",
      "name": "MLS004342420",
      "alternativeNames": [
        "BRD-K97114030"
      ],
      "pubchemCid": 54664795,
      "chebiId": 130984,
      "inchiParent": "InChI=1S/C13H17BrN2O/c1-16-11-3-2-8(14)6-10(11)13-9(4-5-15-13)12(16)7-17/h2-3,6,9,12-13,15,17H,4-5,7H2,1H3/t9-,12+,13-/m1/s1",
      "inchiKeyParent": "WZXLZJWWSUUIOX-JIMOISOXSA-N",
      "smilesParent": "CN1[C@@H](CO)[C@H]2CCN[C@H]2c3cc(Br)ccc13"
    },
    "unichem": {
      "chebi": "130984",
      "lincs": "LSM-42532",
      "pubchem": "54664795"
    },
    "pubchem": [
      {
        "cid": 54664795,
        "inchi": "InChI=1S/C13H17BrN2O/c1-16-11-3-2-8(14)6-10(11)13-9(4-5-15-13)12(16)7-17/h2-3,6,9,12-13,15,17H,4-5,7H2,1H3/t9-,12+,13-/m1/s1",
        "inchikey": "WZXLZJWWSUUIOX-JIMOISOXSA-N",
        "iupac": {
          "systematic": "[(3aS,4R,9bR)-8-bromo-5-methyl-1,2,3,3a,4,9b-hexahydropyrrolo[3,2-c]quinolin-4-yl]methanol"
        },
        "smiles": {
          "canonical": "CN1C(C2CCNC2C3=C1C=CC(=C3)Br)CO"
        },
        "molecularFormula": "C13H17BrN2O"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:23:42Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c826e"
    },
    "name": "BRD-K35199432",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c826e.png",
    "lincs": {
      "id": "LSM-10547",
      "name": "BRD-K35199432",
      "pubchemCid": 54638631,
      "chebiId": 99168,
      "inchiParent": "InChI=1S/C17H28N4O3/c1-11(2)15-9-21(20-19-15)8-7-13-5-6-14(16(10-22)24-13)18-17(23)12-3-4-12/h9,11-14,16,22H,3-8,10H2,1-2H3,(H,18,23)/t13-,14+,16+/m1/s1",
      "inchiKeyParent": "TWVDNKQJDYICCW-YCPHGPKFSA-N",
      "smilesParent": "CC(C)c1cn(CC[C@H]2CC[C@H](NC(=O)C3CC3)[C@H](CO)O2)nn1"
    },
    "unichem": {
      "chebi": "99168",
      "lincs": "LSM-10547",
      "pubchem": "54638631"
    },
    "pubchem": [
      {
        "cid": 54638631,
        "inchi": "InChI=1S/C17H28N4O3/c1-11(2)15-9-21(20-19-15)8-7-13-5-6-14(16(10-22)24-13)18-17(23)12-3-4-12/h9,11-14,16,22H,3-8,10H2,1-2H3,(H,18,23)/t13-,14+,16+/m1/s1",
        "inchikey": "TWVDNKQJDYICCW-YCPHGPKFSA-N",
        "iupac": {
          "systematic": "N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-(4-propan-2-yltriazol-1-yl)ethyl]oxan-3-yl]cyclopropanecarboxamide"
        },
        "smiles": {
          "canonical": "CC(C)C1=CN(N=N1)CCC2CCC(C(O2)CO)NC(=O)C3CC3"
        },
        "molecularFormula": "C17H28N4O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:23:44Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82d7"
    },
    "name": "BRD-K38908436",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82d7.png",
    "lincs": {
      "id": "LSM-39414",
      "name": "BRD-K38908436",
      "pubchemCid": 60189838,
      "chebiId": 127858,
      "inchiParent": "InChI=1S/C25H25N3O3/c1-16(30)28-22(13-29)23(25(28)14-27(15-25)24(31)21-10-11-21)20-8-6-19(7-9-20)18-4-2-17(12-26)3-5-18/h2-9,21-23,29H,10-11,13-15H2,1H3/t22-,23+/m1/s1",
      "inchiKeyParent": "QRUIMFSAEGDYOH-PKTZIBPZSA-N",
      "smilesParent": "CC(=O)N1[C@H](CO)[C@H](c2ccc(cc2)c3ccc(cc3)C#N)C14CN(C4)C(=O)C5CC5"
    },
    "unichem": {
      "chebi": "127858",
      "lincs": "LSM-39414",
      "pubchem": "60189838"
    },
    "pubchem": [
      {
        "cid": 60189838,
        "inchi": "InChI=1S/C25H25N3O3/c1-16(30)28-22(13-29)23(25(28)14-27(15-25)24(31)21-10-11-21)20-8-6-19(7-9-20)18-4-2-17(12-26)3-5-18/h2-9,21-23,29H,10-11,13-15H2,1H3/t22-,23+/m1/s1",
        "inchikey": "QRUIMFSAEGDYOH-PKTZIBPZSA-N",
        "iupac": {
          "systematic": "4-[4-[(2S,3S)-1-acetyl-6-(cyclopropanecarbonyl)-2-(hydroxymethyl)-1,6-diazaspiro[3.3]heptan-3-yl]phenyl]benzonitrile"
        },
        "smiles": {
          "canonical": "CC(=O)N1C(C(C12CN(C2)C(=O)C3CC3)C4=CC=C(C=C4)C5=CC=C(C=C5)C#N)CO"
        },
        "molecularFormula": "C25H25N3O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:23:46Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8319"
    },
    "name": "BRD-K97727250",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8319.png",
    "lincs": {
      "id": "LSM-42562",
      "name": "BRD-K97727250",
      "pubchemCid": 44490160,
      "chebiId": 131014,
      "inchiParent": "InChI=1S/C29H47N5O5/c1-20-17-34(21(2)19-35)28(37)24-16-23(30-27(36)12-9-15-32(3)4)13-14-25(24)39-26(20)18-33(5)29(38)31-22-10-7-6-8-11-22/h13-14,16,20-22,26,35H,6-12,15,17-19H2,1-5H3,(H,30,36)(H,31,38)/t20-,21-,26-/m0/s1",
      "inchiKeyParent": "HVZAAXCGJPPTNA-WOVHNISZSA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@H](C)[C@H](CN(C)C(=O)NC2CCCCC2)Oc3ccc(NC(=O)CCCN(C)C)cc3C1=O"
    },
    "unichem": {
      "chebi": "131014",
      "lincs": "LSM-42562",
      "pubchem": "44490160"
    },
    "pubchem": [
      {
        "cid": 44490160,
        "inchi": "InChI=1S/C29H47N5O5/c1-20-17-34(21(2)19-35)28(37)24-16-23(30-27(36)12-9-15-32(3)4)13-14-25(24)39-26(20)18-33(5)29(38)31-22-10-7-6-8-11-22/h13-14,16,20-22,26,35H,6-12,15,17-19H2,1-5H3,(H,30,36)(H,31,38)/t20-,21-,26-/m0/s1",
        "inchikey": "HVZAAXCGJPPTNA-WOVHNISZSA-N",
        "iupac": {
          "systematic": "N-[(2R,3S)-2-[[cyclohexylcarbamoyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4-(dimethylamino)butanamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(C=CC(=C2)NC(=O)CCCN(C)C)OC1CN(C)C(=O)NC3CCCCC3)C(C)CO"
        },
        "molecularFormula": "C29H47N5O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:23:49Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82ab"
    },
    "name": "BRD-K65109005",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82ab.png",
    "lincs": {
      "id": "LSM-40823",
      "name": "BRD-K65109005",
      "pubchemCid": 60189535,
      "chebiId": 129272,
      "inchiParent": "InChI=1S/C21H24N2O4S/c1-14-5-3-4-6-17(14)15-7-9-16(10-8-15)21-18-11-22(28(2,26)27)12-20(25)23(18)19(21)13-24/h3-10,18-19,21,24H,11-13H2,1-2H3/t18-,19+,21-/m1/s1",
      "inchiKeyParent": "IMRBVWRRZLZKRA-SVFBPWRDSA-N",
      "smilesParent": "Cc1ccccc1c2ccc(cc2)[C@H]3[C@H](CO)N4[C@@H]3CN(CC4=O)S(=O)(=O)C"
    },
    "unichem": {
      "chebi": "129272",
      "lincs": "LSM-40823",
      "pubchem": "60189535"
    },
    "pubchem": [
      {
        "cid": 60189535,
        "inchi": "InChI=1S/C21H24N2O4S/c1-14-5-3-4-6-17(14)15-7-9-16(10-8-15)21-18-11-22(28(2,26)27)12-20(25)23(18)19(21)13-24/h3-10,18-19,21,24H,11-13H2,1-2H3/t18-,19+,21-/m1/s1",
        "inchikey": "IMRBVWRRZLZKRA-SVFBPWRDSA-N",
        "iupac": {
          "systematic": "(6S,7R,8R)-8-(hydroxymethyl)-7-[4-(2-methylphenyl)phenyl]-4-methylsulfonyl-1,4-diazabicyclo[4.2.0]octan-2-one"
        },
        "smiles": {
          "canonical": "CC1=CC=CC=C1C2=CC=C(C=C2)C3C4CN(CC(=O)N4C3CO)S(=O)(=O)C"
        },
        "molecularFormula": "C21H24N2O4S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:23:51Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82b5"
    },
    "name": "BRD-K06163572",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82b5.png",
    "lincs": {
      "id": "LSM-44680",
      "name": "BRD-K06163572",
      "pubchemCid": 60191197,
      "inchiParent": "InChI=1S/C26H24N4O3/c31-17-23-25(20-10-8-19(9-11-20)7-6-18-4-2-1-3-5-18)22-15-29(16-24(32)30(22)23)26(33)21-14-27-12-13-28-21/h1-14,22-23,25,31H,15-17H2/b7-6+/t22-,23+,25-/m0/s1",
      "inchiKeyParent": "GBNDAOCBOQNOMP-LMLBSLPGSA-N",
      "smilesParent": "OC[C@@H]1[C@H]([C@@H]2CN(CC(=O)N12)C(=O)c3cnccn3)c4ccc(\\C=C\\c5ccccc5)cc4"
    },
    "unichem": {
      "lincs": "LSM-44680",
      "pubchem": "60191197"
    },
    "pubchem": [
      {
        "cid": 60191197,
        "inchi": "InChI=1S/C26H24N4O3/c31-17-23-25(20-10-8-19(9-11-20)7-6-18-4-2-1-3-5-18)22-15-29(16-24(32)30(22)23)26(33)21-14-27-12-13-28-21/h1-14,22-23,25,31H,15-17H2/b7-6+/t22-,23+,25-/m0/s1",
        "inchikey": "GBNDAOCBOQNOMP-LMLBSLPGSA-N",
        "iupac": {
          "systematic": "(6R,7S,8S)-8-(hydroxymethyl)-7-[4-[(E)-2-phenylethenyl]phenyl]-4-(pyrazine-2-carbonyl)-1,4-diazabicyclo[4.2.0]octan-2-one"
        },
        "smiles": {
          "canonical": "C1C2C(C(N2C(=O)CN1C(=O)C3=NC=CN=C3)CO)C4=CC=C(C=C4)C=CC5=CC=CC=C5"
        },
        "molecularFormula": "C26H24N4O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:23:53Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82bb"
    },
    "name": "BRD-K31028119",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82bb.png",
    "lincs": {
      "id": "LSM-10300",
      "name": "BRD-K31028119",
      "pubchemCid": 54638834,
      "chebiId": 98921,
      "inchiParent": "InChI=1S/C19H30N4O4S/c24-13-16-15(21-17(25)6-10-23-8-2-1-3-9-23)5-4-14(27-16)12-18(26)22-19-20-7-11-28-19/h7,11,14-16,24H,1-6,8-10,12-13H2,(H,21,25)(H,20,22,26)/t14-,15+,16+/m0/s1",
      "inchiKeyParent": "IZCYNDJXNVTGPG-ARFHVFGLSA-N",
      "smilesParent": "OC[C@H]1O[C@H](CC(=O)Nc2nccs2)CC[C@H]1NC(=O)CCN3CCCCC3"
    },
    "unichem": {
      "chebi": "98921",
      "lincs": "LSM-10300",
      "pubchem": "54638834"
    },
    "pubchem": [
      {
        "cid": 54638834,
        "inchi": "InChI=1S/C19H30N4O4S/c24-13-16-15(21-17(25)6-10-23-8-2-1-3-9-23)5-4-14(27-16)12-18(26)22-19-20-7-11-28-19/h7,11,14-16,24H,1-6,8-10,12-13H2,(H,21,25)(H,20,22,26)/t14-,15+,16+/m0/s1",
        "inchikey": "IZCYNDJXNVTGPG-ARFHVFGLSA-N",
        "iupac": {
          "systematic": "N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(1,3-thiazol-2-ylamino)ethyl]oxan-3-yl]-3-piperidin-1-ylpropanamide"
        },
        "smiles": {
          "canonical": "C1CCN(CC1)CCC(=O)NC2CCC(OC2CO)CC(=O)NC3=NC=CS3"
        },
        "molecularFormula": "C19H30N4O4S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:23:55Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82c8"
    },
    "name": "BRD-K51166678",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82c8.png",
    "lincs": {
      "id": "LSM-46094",
      "name": "BRD-K51166678",
      "inchiParent": "InChI=1S/C24H23N3O2/c1-2-19(11-25-9-1)17-4-6-18(7-5-17)24-20-13-27(14-21(24)26-20)12-16-3-8-22-23(10-16)29-15-28-22/h1-11,20-21,24,26H,12-15H2/t20-,21+,24-",
      "inchiKeyParent": "WBGXRZPLVSELSO-RUMRUAAYSA-N",
      "smilesParent": "C(N1C[C@@H]2N[C@H](C1)[C@H]2c3ccc(cc3)c4cccnc4)c5ccc6OCOc6c5"
    },
    "unichem": {
      "lincs": "LSM-46094"
    },
    "createdAt": {
      "$date": "2025-05-24T08:23:57Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82de"
    },
    "name": "BRD-K87730884",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82de.png",
    "lincs": {
      "id": "LSM-13808",
      "name": "BRD-K87730884",
      "pubchemCid": 54654600,
      "chebiId": 102457,
      "inchiParent": "InChI=1S/C29H32N4O5S/c1-33-24-6-5-21(16-27(34)31-13-10-19-8-11-30-12-9-19)38-26(24)18-37-25-7-4-20(15-23(25)29(33)36)32-28(35)17-22-3-2-14-39-22/h2-4,7-9,11-12,14-15,21,24,26H,5-6,10,13,16-18H2,1H3,(H,31,34)(H,32,35)/t21-,24-,26-/m0/s1",
      "inchiKeyParent": "OJLJDVMGKDSXAU-CVJWPJSTSA-N",
      "smilesParent": "CN1[C@H]2CC[C@@H](CC(=O)NCCc3ccncc3)O[C@H]2COc4ccc(NC(=O)Cc5cccs5)cc4C1=O"
    },
    "unichem": {
      "chebi": "102457",
      "lincs": "LSM-13808",
      "pubchem": "54654600"
    },
    "pubchem": [
      {
        "cid": 54654600,
        "inchi": "InChI=1S/C29H32N4O5S/c1-33-24-6-5-21(16-27(34)31-13-10-19-8-11-30-12-9-19)38-26(24)18-37-25-7-4-20(15-23(25)29(33)36)32-28(35)17-22-3-2-14-39-22/h2-4,7-9,11-12,14-15,21,24,26H,5-6,10,13,16-18H2,1H3,(H,31,34)(H,32,35)/t21-,24-,26-/m0/s1",
        "inchikey": "OJLJDVMGKDSXAU-CVJWPJSTSA-N",
        "iupac": {
          "systematic": "2-[(2S,4aS,12aR)-5-methyl-6-oxo-8-[(2-thiophen-2-ylacetyl)amino]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(2-pyridin-4-ylethyl)acetamide"
        },
        "smiles": {
          "canonical": "CN1C2CCC(OC2COC3=C(C1=O)C=C(C=C3)NC(=O)CC4=CC=CS4)CC(=O)NCCC5=CC=NC=C5"
        },
        "molecularFormula": "C29H32N4O5S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:23:59Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8328"
    },
    "name": "BRD-K37631226",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8328.png",
    "lincs": {
      "id": "LSM-39344",
      "name": "BRD-K37631226",
      "pubchemCid": 54615034,
      "chebiId": 127788,
      "inchiParent": "InChI=1S/C34H43N5O6/c1-23-20-39(24(2)22-40)34(43)29-19-28(37-32(41)26-10-14-35-15-11-26)8-9-30(29)45-25(3)7-5-6-18-44-31(23)21-38(4)33(42)27-12-16-36-17-13-27/h8-17,19,23-25,31,40H,5-7,18,20-22H2,1-4H3,(H,37,41)/t23-,24-,25-,31-/m0/s1",
      "inchiKeyParent": "INBITKGVNBCCNN-OSYMNAPVSA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@H](C)[C@H](CN(C)C(=O)c2ccncc2)OCCCC[C@H](C)Oc3ccc(NC(=O)c4ccncc4)cc3C1=O"
    },
    "unichem": {
      "chebi": "127788",
      "lincs": "LSM-39344",
      "pubchem": "54615034"
    },
    "pubchem": [
      {
        "cid": 54615034,
        "inchi": "InChI=1S/C34H43N5O6/c1-23-20-39(24(2)22-40)34(43)29-19-28(37-32(41)26-10-14-35-15-11-26)8-9-30(29)45-25(3)7-5-6-18-44-31(23)21-38(4)33(42)27-12-16-36-17-13-27/h8-17,19,23-25,31,40H,5-7,18,20-22H2,1-4H3,(H,37,41)/t23-,24-,25-,31-/m0/s1",
        "inchikey": "INBITKGVNBCCNN-OSYMNAPVSA-N",
        "iupac": {
          "systematic": "N-[(3S,9R,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(pyridine-4-carbonyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]pyridine-4-carboxamide"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NC(=O)C3=CC=NC=C3)C(C)CO)C)CN(C)C(=O)C4=CC=NC=C4"
        },
        "molecularFormula": "C34H43N5O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:24:02Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c826d"
    },
    "name": "BRD-K61076106",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c826d.png",
    "lincs": {
      "id": "LSM-12124",
      "name": "BRD-K61076106",
      "pubchemCid": 56835215,
      "chebiId": 100750,
      "inchiParent": "InChI=1S/C31H37N3O5/c1-21-17-34(22(2)19-35)30(36)28-15-8-7-14-27(28)26-13-6-5-10-23(26)20-39-29(21)18-33(3)31(37)32-24-11-9-12-25(16-24)38-4/h5-16,21-22,29,35H,17-20H2,1-4H3,(H,32,37)/t21-,22-,29-/m0/s1",
      "inchiKeyParent": "WYYHNXRAZIWUBG-SYZUXVNWSA-N",
      "smilesParent": "COc1cccc(NC(=O)N(C)C[C@@H]2OCc3ccccc3c4ccccc4C(=O)N(C[C@@H]2C)[C@@H](C)CO)c1"
    },
    "unichem": {
      "chebi": "100750",
      "lincs": "LSM-12124",
      "pubchem": "56835215"
    },
    "pubchem": [
      {
        "cid": 56835215,
        "inchi": "InChI=1S/C31H37N3O5/c1-21-17-34(22(2)19-35)30(36)28-15-8-7-14-27(28)26-13-6-5-10-23(26)20-39-29(21)18-33(3)31(37)32-24-11-9-12-25(16-24)38-4/h5-16,21-22,29,35H,17-20H2,1-4H3,(H,32,37)/t21-,22-,29-/m0/s1",
        "inchikey": "WYYHNXRAZIWUBG-SYZUXVNWSA-N",
        "iupac": {
          "systematic": "1-[[(10R,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-3-(3-methoxyphenyl)-1-methylurea"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=CC=CC=C2C3=CC=CC=C3COC1CN(C)C(=O)NC4=CC(=CC=C4)OC)C(C)CO"
        },
        "molecularFormula": "C31H37N3O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:24:04Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8279"
    },
    "name": "BRD-K58893765",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8279.png",
    "lincs": {
      "id": "LSM-40490",
      "name": "BRD-K58893765",
      "pubchemCid": 54665080,
      "chebiId": 128938,
      "inchiParent": "InChI=1S/C26H24FN3O3S/c1-29-23-11-10-18(8-9-19-5-4-13-28-16-19)15-21(23)26-20(24(29)17-31)12-14-30(26)34(32,33)25-7-3-2-6-22(25)27/h2-7,10-11,13,15-16,20,24,26,31H,12,14,17H2,1H3/t20-,24+,26-/m1/s1",
      "inchiKeyParent": "MGGTXCHPOZATJI-UGIARPQZSA-N",
      "smilesParent": "CN1[C@@H](CO)[C@H]2CCN([C@H]2c3cc(ccc13)C#Cc4cccnc4)S(=O)(=O)c5ccccc5F"
    },
    "unichem": {
      "chebi": "128938",
      "lincs": "LSM-40490",
      "pubchem": "54665080"
    },
    "pubchem": [
      {
        "cid": 54665080,
        "inchi": "InChI=1S/C26H24FN3O3S/c1-29-23-11-10-18(8-9-19-5-4-13-28-16-19)15-21(23)26-20(24(29)17-31)12-14-30(26)34(32,33)25-7-3-2-6-22(25)27/h2-7,10-11,13,15-16,20,24,26,31H,12,14,17H2,1H3/t20-,24+,26-/m1/s1",
        "inchikey": "MGGTXCHPOZATJI-UGIARPQZSA-N",
        "iupac": {
          "systematic": "[(3aR,4R,9bR)-1-(2-fluorophenyl)sulfonyl-5-methyl-8-(2-pyridin-3-ylethynyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-4-yl]methanol"
        },
        "smiles": {
          "canonical": "CN1C(C2CCN(C2C3=C1C=CC(=C3)C#CC4=CN=CC=C4)S(=O)(=O)C5=CC=CC=C5F)CO"
        },
        "molecularFormula": "C26H24FN3O3S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:24:06Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c827b"
    },
    "name": "BRD-K61565464",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c827b.png",
    "lincs": {
      "id": "LSM-40639",
      "name": "BRD-K61565464",
      "pubchemCid": 60189306,
      "chebiId": 129087,
      "inchiParent": "InChI=1S/C27H23FN4O3/c28-21-9-11-22(12-10-21)30-27(35)31-15-23-26(24(17-33)32(23)25(34)16-31)20-7-5-18(6-8-20)3-4-19-2-1-13-29-14-19/h1-2,5-14,23-24,26,33H,15-17H2,(H,30,35)/t23-,24+,26-/m0/s1",
      "inchiKeyParent": "RFRREKCMRAAOSC-GSLIJJQTSA-N",
      "smilesParent": "OC[C@@H]1[C@H]([C@@H]2CN(CC(=O)N12)C(=O)Nc3ccc(F)cc3)c4ccc(cc4)C#Cc5cccnc5"
    },
    "unichem": {
      "chebi": "129087",
      "lincs": "LSM-40639",
      "pubchem": "60189306"
    },
    "pubchem": [
      {
        "cid": 60189306,
        "inchi": "InChI=1S/C27H23FN4O3/c28-21-9-11-22(12-10-21)30-27(35)31-15-23-26(24(17-33)32(23)25(34)16-31)20-7-5-18(6-8-20)3-4-19-2-1-13-29-14-19/h1-2,5-14,23-24,26,33H,15-17H2,(H,30,35)/t23-,24+,26-/m0/s1",
        "inchikey": "RFRREKCMRAAOSC-GSLIJJQTSA-N",
        "iupac": {
          "systematic": "(6R,7S,8S)-N-(4-fluorophenyl)-8-(hydroxymethyl)-2-oxo-7-[4-(2-pyridin-3-ylethynyl)phenyl]-1,4-diazabicyclo[4.2.0]octane-4-carboxamide"
        },
        "smiles": {
          "canonical": "C1C2C(C(N2C(=O)CN1C(=O)NC3=CC=C(C=C3)F)CO)C4=CC=C(C=C4)C#CC5=CN=CC=C5"
        },
        "molecularFormula": "C27H23FN4O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:24:08Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82aa"
    },
    "name": "BRD-K95642310",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82aa.png",
    "lincs": {
      "id": "LSM-44915",
      "name": "BRD-K95642310",
      "pubchemCid": 60191976,
      "inchiParent": "InChI=1S/C24H34N2O2/c1-3-7-18-10-12-20(13-11-18)23-21(15-27)26(14-19-8-5-6-9-19)24(23)16-25(17-24)22(28)4-2/h3,7,10-13,19,21,23,27H,4-6,8-9,14-17H2,1-2H3/b7-3+/t21-,23+/m0/s1",
      "inchiKeyParent": "ZAVIOMULRGKDPY-PPJOZSLSSA-N",
      "smilesParent": "CCC(=O)N1CC2(C1)[C@@H]([C@H](CO)N2CC3CCCC3)c4ccc(\\C=C\\C)cc4"
    },
    "unichem": {
      "lincs": "LSM-44915",
      "pubchem": "60191976"
    },
    "pubchem": [
      {
        "cid": 60191976,
        "inchi": "InChI=1S/C24H34N2O2/c1-3-7-18-10-12-20(13-11-18)23-21(15-27)26(14-19-8-5-6-9-19)24(23)16-25(17-24)22(28)4-2/h3,7,10-13,19,21,23,27H,4-6,8-9,14-17H2,1-2H3/b7-3+/t21-,23+/m0/s1",
        "inchikey": "ZAVIOMULRGKDPY-PPJOZSLSSA-N",
        "iupac": {
          "systematic": "1-[(2R,3R)-1-(cyclopentylmethyl)-2-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]-1,6-diazaspiro[3.3]heptan-6-yl]propan-1-one"
        },
        "smiles": {
          "canonical": "CCC(=O)N1CC2(C1)C(C(N2CC3CCCC3)CO)C4=CC=C(C=C4)C=CC"
        },
        "molecularFormula": "C24H34N2O2"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:24:10Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82c6"
    },
    "name": "BRD-K89489862",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82c6.png",
    "lincs": {
      "id": "LSM-13942",
      "name": "BRD-K89489862",
      "pubchemCid": 54654408,
      "chebiId": 102595,
      "inchiParent": "InChI=1S/C29H36N4O6/c1-33-24-4-3-22(17-27(34)31-13-8-19-6-11-30-12-7-19)39-26(24)18-38-25-5-2-21(16-23(25)29(33)36)32-28(35)20-9-14-37-15-10-20/h2,5-7,11-12,16,20,22,24,26H,3-4,8-10,13-15,17-18H2,1H3,(H,31,34)(H,32,35)/t22-,24+,26+/m1/s1",
      "inchiKeyParent": "XUZKWORPTAYLRR-CWDLOFLHSA-N",
      "smilesParent": "CN1[C@H]2CC[C@H](CC(=O)NCCc3ccncc3)O[C@H]2COc4ccc(NC(=O)C5CCOCC5)cc4C1=O"
    },
    "unichem": {
      "chebi": "102595",
      "lincs": "LSM-13942",
      "pubchem": "54654408"
    },
    "pubchem": [
      {
        "cid": 54654408,
        "inchi": "InChI=1S/C29H36N4O6/c1-33-24-4-3-22(17-27(34)31-13-8-19-6-11-30-12-7-19)39-26(24)18-38-25-5-2-21(16-23(25)29(33)36)32-28(35)20-9-14-37-15-10-20/h2,5-7,11-12,16,20,22,24,26H,3-4,8-10,13-15,17-18H2,1H3,(H,31,34)(H,32,35)/t22-,24+,26+/m1/s1",
        "inchikey": "XUZKWORPTAYLRR-CWDLOFLHSA-N",
        "iupac": {
          "systematic": "N-[(2R,4aS,12aR)-5-methyl-6-oxo-2-[2-oxo-2-(2-pyridin-4-ylethylamino)ethyl]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]oxane-4-carboxamide"
        },
        "smiles": {
          "canonical": "CN1C2CCC(OC2COC3=C(C1=O)C=C(C=C3)NC(=O)C4CCOCC4)CC(=O)NCCC5=CC=NC=C5"
        },
        "molecularFormula": "C29H36N4O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:24:13Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8333"
    },
    "name": "BRD-K10008415",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8333.png",
    "lincs": {
      "id": "LSM-14716",
      "name": "BRD-K10008415",
      "pubchemCid": 54614983,
      "chebiId": 103372,
      "inchiParent": "InChI=1S/C32H49N3O6S/c1-7-17-34(6)21-31-24(3)20-35(25(4)22-36)32(37)29-19-27(33-42(38,39)28-14-11-23(2)12-15-28)13-16-30(29)41-26(5)10-8-9-18-40-31/h11-16,19,24-26,31,33,36H,7-10,17-18,20-22H2,1-6H3/t24-,25-,26-,31-/m1/s1",
      "inchiKeyParent": "YZTWEKNKNNRJIX-YSRRZRNESA-N",
      "smilesParent": "CCCN(C)C[C@H]1OCCCC[C@@H](C)Oc2ccc(NS(=O)(=O)c3ccc(C)cc3)cc2C(=O)N(C[C@H]1C)[C@H](C)CO"
    },
    "unichem": {
      "chebi": "103372",
      "lincs": "LSM-14716",
      "pubchem": "54614983"
    },
    "pubchem": [
      {
        "cid": 54614983,
        "inchi": "InChI=1S/C32H49N3O6S/c1-7-17-34(6)21-31-24(3)20-35(25(4)22-36)32(37)29-19-27(33-42(38,39)28-14-11-23(2)12-15-28)13-16-30(29)41-26(5)10-8-9-18-40-31/h11-16,19,24-26,31,33,36H,7-10,17-18,20-22H2,1-6H3/t24-,25-,26-,31-/m1/s1",
        "inchikey": "YZTWEKNKNNRJIX-YSRRZRNESA-N",
        "iupac": {
          "systematic": "N-[(3R,9S,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(propyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-methylbenzenesulfonamide"
        },
        "smiles": {
          "canonical": "CCCN(C)CC1C(CN(C(=O)C2=C(C=CC(=C2)NS(=O)(=O)C3=CC=C(C=C3)C)OC(CCCCO1)C)C(C)CO)C"
        },
        "molecularFormula": "C32H49N3O6S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:24:15Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c828e"
    },
    "name": "BRD-K39548949",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c828e.png",
    "lincs": {
      "id": "LSM-39450",
      "name": "BRD-K39548949",
      "pubchemCid": 60189394,
      "chebiId": 127894,
      "inchiParent": "InChI=1S/C21H26N2O2/c24-14-19-21(18-12-22-13-20(25)23(18)19)17-10-8-16(9-11-17)7-6-15-4-2-1-3-5-15/h8-11,15,18-19,21-22,24H,1-5,12-14H2/t18-,19+,21+/m0/s1",
      "inchiKeyParent": "XPSHGEXNPFHUTP-QKNQBKEWSA-N",
      "smilesParent": "OC[C@@H]1[C@@H]([C@@H]2CNCC(=O)N12)c3ccc(cc3)C#CC4CCCCC4"
    },
    "unichem": {
      "chebi": "127894",
      "lincs": "LSM-39450",
      "pubchem": "60189394"
    },
    "pubchem": [
      {
        "cid": 60189394,
        "inchi": "InChI=1S/C21H26N2O2/c24-14-19-21(18-12-22-13-20(25)23(18)19)17-10-8-16(9-11-17)7-6-15-4-2-1-3-5-15/h8-11,15,18-19,21-22,24H,1-5,12-14H2/t18-,19+,21+/m0/s1",
        "inchikey": "XPSHGEXNPFHUTP-QKNQBKEWSA-N",
        "iupac": {
          "systematic": "(6R,7R,8S)-7-[4-(2-cyclohexylethynyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one"
        },
        "smiles": {
          "canonical": "C1CCC(CC1)C#CC2=CC=C(C=C2)C3C4CNCC(=O)N4C3CO"
        },
        "molecularFormula": "C21H26N2O2"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:24:17Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82a0"
    },
    "name": "CHEMBL3187627",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82a0.png",
    "lincs": {
      "id": "LSM-38755",
      "name": "CHEMBL3187627",
      "alternativeNames": [
        "BRD-K27304876"
      ],
      "pubchemCid": 60185175,
      "chebiId": 127195,
      "inchiParent": "InChI=1S/C23H20ClFN2O2S/c24-18-8-10-20(11-9-18)30(28,29)27-21-13-26-14-22(27)23(21)16-6-4-15(5-7-16)17-2-1-3-19(25)12-17/h1-12,21-23,26H,13-14H2/t21-,22+,23?",
      "inchiKeyParent": "JJYSTWNHAMIOJE-AIZNXBIQSA-N",
      "smilesParent": "Fc1cccc(c1)c2ccc(cc2)[C@H]3[C@H]4CNC[C@@H]3N4S(=O)(=O)c5ccc(Cl)cc5"
    },
    "unichem": {
      "chebi": "127195",
      "lincs": "LSM-38755",
      "pubchem": "60185175"
    },
    "pubchem": [
      {
        "cid": 60185175,
        "inchi": "InChI=1S/C23H20ClFN2O2S/c24-18-8-10-20(11-9-18)30(28,29)27-21-13-26-14-22(27)23(21)16-6-4-15(5-7-16)17-2-1-3-19(25)12-17/h1-12,21-23,26H,13-14H2/t21-,22+,23?",
        "inchikey": "JJYSTWNHAMIOJE-AIZNXBIQSA-N",
        "iupac": {
          "systematic": "(1R,5S)-6-(4-chlorophenyl)sulfonyl-7-[4-(3-fluorophenyl)phenyl]-3,6-diazabicyclo[3.1.1]heptane"
        },
        "smiles": {
          "canonical": "C1C2C(C(N2S(=O)(=O)C3=CC=C(C=C3)Cl)CN1)C4=CC=C(C=C4)C5=CC(=CC=C5)F"
        },
        "molecularFormula": "C23H20ClFN2O2S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:24:20Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8326"
    },
    "name": "BRD-K00472408",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8326.png",
    "lincs": {
      "id": "LSM-8458",
      "name": "BRD-K00472408",
      "pubchemCid": 56835589,
      "chebiId": 97079,
      "inchiParent": "InChI=1S/C32H44N4O5S/c1-31(2,3)42(40)36-22-25-21-26(30(38)33-13-7-14-35-15-18-41-19-16-35)34-29(28(25)27(36)11-17-37)24-9-6-8-23(20-24)10-12-32(4,5)39/h6,8-9,20-21,27,37,39H,7,11,13-19,22H2,1-5H3,(H,33,38)/t27-,42?/m1/s1",
      "inchiKeyParent": "UFLNOMSZNUMDSV-IJEDNORESA-N",
      "smilesParent": "CC(C)(O)C#Cc1cccc(c1)c2nc(cc3CN([C@H](CCO)c23)S(=O)C(C)(C)C)C(=O)NCCCN4CCOCC4"
    },
    "unichem": {
      "chebi": "97079",
      "lincs": "LSM-8458",
      "pubchem": "56835589"
    },
    "pubchem": [
      {
        "cid": 56835589,
        "inchi": "InChI=1S/C32H44N4O5S/c1-31(2,3)42(40)36-22-25-21-26(30(38)33-13-7-14-35-15-18-41-19-16-35)34-29(28(25)27(36)11-17-37)24-9-6-8-23(20-24)10-12-32(4,5)39/h6,8-9,20-21,27,37,39H,7,11,13-19,22H2,1-5H3,(H,33,38)/t27-,42?/m1/s1",
        "inchikey": "UFLNOMSZNUMDSV-IJEDNORESA-N",
        "iupac": {
          "systematic": "(3R)-2-tert-butylsulfinyl-3-(2-hydroxyethyl)-4-[3-(3-hydroxy-3-methylbut-1-ynyl)phenyl]-N-(3-morpholin-4-ylpropyl)-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide"
        },
        "smiles": {
          "canonical": "CC(C)(C)S(=O)N1CC2=CC(=NC(=C2C1CCO)C3=CC=CC(=C3)C#CC(C)(C)O)C(=O)NCCCN4CCOCC4"
        },
        "molecularFormula": "C32H44N4O5S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:24:22Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c835c"
    },
    "name": "CX-4945 (Silmitasertib)",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c835c.png",
    "lincs": {
      "id": "LSM-45467",
      "name": "CX-4945 (Silmitasertib)",
      "alternativeNames": [
        "CX4945",
        "CX 4945",
        "CX-4945",
        "Silmitasertib"
      ],
      "pubchemCid": 24748573,
      "inchiParent": "InChI=1S/C19H12ClN3O2/c20-12-2-1-3-13(9-12)22-18-15-6-7-21-10-16(15)14-5-4-11(19(24)25)8-17(14)23-18/h1-10H,(H,22,23)(H,24,25)",
      "inchiKeyParent": "MUOKSQABCJCOPU-UHFFFAOYSA-N",
      "smilesParent": "OC(=O)c1ccc2c(c1)nc(Nc3cccc(Cl)c3)c4ccncc24"
    },
    "unichem": {
      "chembl": "CHEMBL1230165",
      "lincs": "LSM-45467",
      "pubchem": "24748573",
      "drugbank": "DB15408"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL1230165",
      "prefName": "SILMITASERTIB",
      "maxPhase": 2.0,
      "maxPhaseCurated": "Phase 2 Clinical Trials",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 349.78,
        "hba": 4,
        "hbd": 2,
        "qedWeighted": 0.52
      },
      "moleculeSynonyms": [
        {
          "moleculeSynonym": "CX 4945",
          "synType": "RESEARCH_CODE",
          "synonyms": "CX 4945"
        },
        {
          "moleculeSynonym": "Cx-4945",
          "synType": "OTHER",
          "synonyms": "CX-4945"
        },
        {
          "moleculeSynonym": "CX-4945",
          "synType": "RESEARCH_CODE",
          "synonyms": "CX-4945"
        },
        {
          "moleculeSynonym": "CX4945",
          "synType": "RESEARCH_CODE",
          "synonyms": "CX4945"
        },
        {
          "moleculeSynonym": "Cx-4945 free acid",
          "synType": "OTHER",
          "synonyms": "CX-4945 FREE ACID"
        },
        {
          "moleculeSynonym": "Silmitasertib",
          "synType": "INN",
          "synonyms": "Silmitasertib"
        },
        {
          "moleculeSynonym": "Silmitasertib",
          "synType": "OTHER",
          "synonyms": "SILMITASERTIB"
        }
      ],
      "drugIndications": [
        {
          "efoId": "EFO:0001378",
          "efoTerm": "multiple myeloma",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT01199718"
            ]
          },
          "maxPhaseForInd": 1.0,
          "meshHeading": "Multiple Myeloma"
        },
        {
          "efoId": "EFO:0005221",
          "efoTerm": "cholangiocarcinoma",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT02128282"
            ]
          },
          "maxPhaseForInd": 1.0,
          "meshHeading": "Cholangiocarcinoma"
        },
        {
          "efoId": "EFO:0004193",
          "efoTerm": "basal cell carcinoma",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT03897036"
            ]
          },
          "maxPhaseForInd": 1.0,
          "meshHeading": "Carcinoma, Basal Cell"
        },
        {
          "efoId": "EFO:0002939",
          "efoTerm": "medulloblastoma",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT03904862"
            ]
          },
          "maxPhaseForInd": 1.0,
          "meshHeading": "Medulloblastoma"
        },
        {
          "efoId": "MONDO:0100096",
          "efoTerm": "COVID-19",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT04663737,NCT04668209,NCT05817708"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Severe Acute Respiratory Syndrome"
        }
      ],
      "drugMechanisms": [
        {
          "mechanismOfAction": "Casein kinase II alpha inhibitor",
          "actionType": "INHIBITOR",
          "targetName": "Casein kinase II alpha",
          "targetOrganism": "Homo sapiens",
          "targetType": "SINGLE PROTEIN",
          "targetComponents": [
            {
              "uniprot": [
                "P68400"
              ]
            }
          ]
        }
      ]
    },
    "pubchem": [
      {
        "cid": 24748573,
        "inchi": "InChI=1S/C19H12ClN3O2/c20-12-2-1-3-13(9-12)22-18-15-6-7-21-10-16(15)14-5-4-11(19(24)25)8-17(14)23-18/h1-10H,(H,22,23)(H,24,25)",
        "inchikey": "MUOKSQABCJCOPU-UHFFFAOYSA-N",
        "iupac": {
          "systematic": "5-(3-chloroanilino)benzo[c][2,6]naphthyridine-8-carboxylic acid"
        },
        "smiles": {
          "canonical": "C1=CC(=CC(=C1)Cl)NC2=NC3=C(C=CC(=C3)C(=O)O)C4=C2C=CN=C4"
        },
        "molecularFormula": "C19H12ClN3O2"
      }
    ],
    "clinicaltrials": [
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02128282",
            "briefTitle": "Study of CX-4945 in Combination With Gemcitabine and Cisplatin for Frontline Treatment of Cholangiocarcinoma",
            "officialTitle": "A Phase I/II Study of CX-4945 in Combination With Gemcitabine and Cisplatin in the Frontline Treatment of Patients With Cholangiocarcinoma"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2014-04-28"
          },
          "conditionsModule": {
            "conditions": [
              "Cholangiocarcinoma"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Maximum Tolerated Dose (MTD) of CX-4945 when used in combination with gemcitabine plus cisplatin. (Phase 1)",
                "timeFrame": "Cycle 1, 1 Full cycle up to twenty-one (21) days"
              },
              {
                "measure": "Comparison of the Progression-free survival (PFS) between the test and the control arms using Response Evaluation Criteria in Solid Tumors (RECIST) v.1.1 (Phase 2)",
                "timeFrame": "From date of randomization to date of progression or death from any cause up to 52 weeks."
              },
              {
                "measure": "Recommended Phase II dose (RP2D) and schedule of CX-4945 in combination with gemcitabine plus cisplatin (Phase I)",
                "timeFrame": "Cycle 1, 1 Full cycle up to twenty-one (21) days"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Comparison of the Overall Response Rate (ORR) between the test and the control arms using Response Evaluation Criteria in Solid Tumors (RECIST) v.1.1"
              },
              {
                "measure": "Comparison of the number of patient who transition to surgical resection"
              },
              {
                "measure": "Comparison of the Overall Survival (OS) between the test and the control arms"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT06541262",
            "briefTitle": "Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors",
            "officialTitle": "Phase I/II Study of Silmitasertib (CX-4945) in Combination With Chemotherapy in Children and Young Adults With Relapsed Refractory Solid Tumors"
          },
          "statusModule": {
            "overallStatus": "RECRUITING",
            "studyFirstSubmitDate": "2024-08-02"
          },
          "conditionsModule": {
            "conditions": [
              "Neuroblastoma Recurrent",
              "Ewing's Sarcoma Recurrent",
              "Osteosarcoma Recurrent",
              "Rhabdomyosarcoma Recurrent",
              "Liposarcoma Recurrent"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Phase I- Number of Participants with Adverse Events as a Measure of Safety and Tolerability",
                "timeFrame": "2 years plus 30 days"
              },
              {
                "measure": "Phase I- Number of Participants with Dose Limiting Toxicities to determine RP2D",
                "timeFrame": "21 days"
              },
              {
                "measure": "Phase II- Determine the Overall Response Rate (ORR) of Participants using INRC",
                "timeFrame": "2 years"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Phase I- Determine the Overall Response Rate (ORR) of Participants using INRC"
              },
              {
                "measure": "Number of participants with progression free survival (PFS) during study"
              },
              {
                "measure": "Phase II- Length of time that participants experience Overall Survival (OS)"
              },
              {
                "measure": "Phase II- Number of Participants with Adverse Events as a Measure of Safety and Tolerability"
              },
              {
                "measure": "Phase II - Determine the Disease Control Rate (DCR) of participants based on response"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT03904862",
            "briefTitle": "Testing the Safety and Tolerability of CX-4945 in Patients With Recurrent Medulloblastoma Who May or May Not Have Surgery",
            "officialTitle": "PBTC-053: A Pediatric Brain Tumor Consortium Phase I/ II and Surgical Study of CX-4945 in Patients With Recurrent SHH Medulloblastoma"
          },
          "statusModule": {
            "overallStatus": "RECRUITING",
            "studyFirstSubmitDate": "2019-04-01"
          },
          "conditionsModule": {
            "conditions": [
              "Medulloblastoma, Childhood",
              "Medulloblastoma Recurrent",
              "Medulloblastoma"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Phase I: Maximum tolerated dose of CX-4945",
                "timeFrame": "4 weeks"
              },
              {
                "measure": "Phase I: Plasma pharmacokinetics of CX-4945 in skeletally-immature children",
                "timeFrame": "4 weeks"
              },
              {
                "measure": "Surgical Study: Intratumoral PK concentrations",
                "timeFrame": "Prior to starting CX-4945 (Day -5 or -7), prior to dose on Day -3, prior to dose on Day -1, day of surgery and during surgery at the time of tissue collection"
              },
              {
                "measure": "Phase II: Sustained objective response rate (PR-CR) rate in the skeletally mature cohort",
                "timeFrame": "Up to 2 years from enrollment"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Progression free survival"
              },
              {
                "measure": "Objective response rate in the skeletally-immature cohort"
              },
              {
                "measure": "Plasma pharmacokinetics of CX-4945 in skeletally-mature subjects"
              },
              {
                "measure": "Relative frequency of genomic alterations in archival tissue"
              },
              {
                "measure": "Surgical study: Reduction in CK2-mediated signaling in tumor."
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00891280",
            "briefTitle": "Dose-escalation Study of Oral CX-4945",
            "officialTitle": "A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of CX-4945 Administered Orally to Patients With Advanced Solid Tumors, Castleman's Disease or Multiple Myeloma"
          },
          "statusModule": {
            "overallStatus": "UNKNOWN",
            "studyFirstSubmitDate": "2009-04-29"
          },
          "conditionsModule": {
            "conditions": [
              "Advanced Solid Tumors",
              "Breast Cancer",
              "Inflammatory Breast Cancer",
              "Castleman's Disease",
              "Multiple Myeloma"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Safety (Dose limiting toxicities, maximum tolerated dose)",
                "timeFrame": "One year (Assessed at Cycle 1)"
              },
              {
                "measure": "Drug-related adverse events",
                "timeFrame": "One Year (Asessed from first administration of study drug through 30 days after the last dose)"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Pharmacokinetic and pharmacodynamic assessments"
              },
              {
                "measure": "Observe evidence of antitumor activity"
              },
              {
                "measure": "Establish the recommended Phase 2 dose"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT03571438",
            "briefTitle": "Evaluation of a Promising New Combination of Protein Kinase Inhibitors on Organotypic Cultures of Human Renal Tumors",
            "officialTitle": "Evaluation of a Promising New Combination of Protein Kinase Inhibitors on Organotypic Cultures of Human Renal Tumors"
          },
          "statusModule": {
            "overallStatus": "UNKNOWN",
            "studyFirstSubmitDate": "2018-06-15"
          },
          "conditionsModule": {
            "conditions": [
              "Kidney Cancer"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Incidence of cell death on organotypic cultures of human renal tumors (Efficacy)",
                "timeFrame": "after the treatment period (between 48 and 96 hours)"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT03897036",
            "briefTitle": "Treatment Duration Increment and Pharmacodynamic Study of CX-4945 in Patients With Basal Cell Carcinoma (BCC)",
            "officialTitle": "A Phase I, Multi-Center, Open-Label, Treatment Duration Increment, Expansion, Safety, and Pharmacodynamic Study of CX-4945 Administered Orally Twice Daily to Patients With Advanced Basal Cell Carcinoma"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2019-03-28",
            "resultsFirstSubmitDate": "2025-01-26"
          },
          "conditionsModule": {
            "conditions": [
              "Carcinoma, Basal Cell"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Determination of RP2D",
                "timeFrame": "Cycle 1, twenty-eight (28) day continuous dosing schedule"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT06202521",
            "briefTitle": "CX-4945 in Viral Community Acquired Pneumonia",
            "officialTitle": "Evaluation of the Safety and Efficacy of Silmitasertib (CX-4945) in Combination With Standard of Care (SOC) for Treating Patients With Community-Acquired Pneumonia (CAP) Associated With SARS-CoV-2 and Influenza Viral Infections"
          },
          "statusModule": {
            "overallStatus": "TERMINATED",
            "whyStopped": "The trial ended early in March 2025 due to changes in disease epidemiology, affecting patient availability and recruitment feasibility.",
            "studyFirstSubmitDate": "2024-01-01"
          },
          "conditionsModule": {
            "conditions": [
              "Community-acquired Pneumonia",
              "SARS-CoV-2 -Associated Pneumonia",
              "Influenza With Pneumonia"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "The percentage of subjects requiring hospitalization, including emergency room visits, or resulting in death due to progression of CAP related to SARS-CoV-2 or influenza.",
                "timeFrame": "Day 1 to Day 29"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "The percentage of subjects with all cause hospitalization, emergency room visits, or death during study period."
              },
              {
                "measure": "The percentage of subjects with improved pulmonary X-ray findings for pneumonia, relative to baseline or showing a return to normalcy"
              },
              {
                "measure": "The symptom resolution for fever is defined as body temperature lower than the following definition for 24 hours (ear temperature < 38 \u00b0C, base of the tongue temperature < 37.5 \u00b0C, or axillary temperature < 37 \u00b0C)"
              },
              {
                "measure": "Change from baseline in SpO2/FiO2 ratio"
              },
              {
                "measure": "The percentage of subjects exhibiting disease progression in health status Disease progression is defined as an increase of score on the National Institute of Allergy and Infectious Diseases (NIAID) 8-point ordinal scale"
              },
              {
                "measure": "The percentage of subjects exhibiting health improvement in health status Health improvement is defined as a reduction of score on the National Institute of Allergy and Infectious Diseases (NIAID) 8-point ordinal scale"
              },
              {
                "measure": "The percentage of subjects with a negative RT-PCR result for the SARS-CoV-2 (only for SARS-CoV-2 domain) or the influenza virus (only for influenza virus domain) on Day 7."
              },
              {
                "measure": "Change from baseline in viral load in nasal secretions by RT-PCR (only for SARS-CoV-2 domain)"
              },
              {
                "measure": "Change from baseline in Ct values (only for SARS-CoV-2 domain)"
              },
              {
                "measure": "TEAEs and SAEs"
              },
              {
                "measure": "Laboratory test"
              },
              {
                "measure": "Vital signs"
              },
              {
                "measure": "Electrocardiogram (ECG) results"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT05817708",
            "briefTitle": "A Study of Silmitasertib (CX-4945) in Healthy Subject",
            "officialTitle": "A Dose Selection Phase 1 Study Evaluating the Safety and Tolerability of Silmitasertib"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2023-01-30",
            "resultsFirstSubmitDate": "2024-09-20"
          },
          "conditionsModule": {
            "conditions": [
              "COVID-19"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Number of Participants With Treatment-emergent Adverse Events (TEAT)",
                "timeFrame": "Day 1 to Day 5"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Evaluate Changes in Blood Chemistry."
              },
              {
                "measure": "Evaluate Changes in Blood Chemistry."
              },
              {
                "measure": "To Evaluate Changes in Blood Chemistry."
              },
              {
                "measure": "To Evaluate Changes in Blood Chemistry."
              },
              {
                "measure": "To Evaluate Changes in Blood Chemistry."
              },
              {
                "measure": "To Evaluate Changes in Blood Chemistry."
              },
              {
                "measure": "Number of Participants Evaluated as Having Abnormalities (CS or NCS) in Their ECG"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01199718",
            "briefTitle": "Study of CX-4945 in Patients With Relapsed or Refractory Multiple Myeloma",
            "officialTitle": "A Phase 1, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of CX-4945 Administered Orally to Patients With Relapsed or Refractory Multiple Myeloma"
          },
          "statusModule": {
            "overallStatus": "UNKNOWN",
            "studyFirstSubmitDate": "2010-09-09"
          },
          "conditionsModule": {
            "conditions": [
              "Multiple Myeloma"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Safety",
                "timeFrame": "One year (assessed at Cycle 1)."
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Pharmacokinetic and pharmacodynamic assessments."
              },
              {
                "measure": "Assess for efficacy response"
              },
              {
                "measure": "Establish the recommended Phase 2 dose"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT04663737",
            "briefTitle": "Evaluating Safety, Pharmacokinetics and Clinical Benefit of Silmitasertib (CX-4945) in Subjects With Moderate COVID-19",
            "officialTitle": "A Phase II, Randomized and Controlled Investigator Initiated Trial Evaluating Safety, Pharmacokinetics and Clinical Benefit of Silmitasertib (CX-4945) in Outpatient Adult Subjects With Moderate Coronavirus Disease 2019 (COVID-19)"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2020-12-01",
            "resultsFirstSubmitDate": "2024-09-19"
          },
          "conditionsModule": {
            "conditions": [
              "Covid19"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Incidence of Treatment-Emergent Adverse Events [Safety and Tolerability]) Within the CX-4945 Treatment Group",
                "timeFrame": "From randomization (Day 1) to Day 60"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Clinical Recovery Associated With COVID-19 Within the CX-4945 Treatment Group"
              },
              {
                "measure": "Anti-Viral Activity of CX-4945"
              },
              {
                "measure": "Maximum Plasma Concentration [Cmax] of CX-4945"
              },
              {
                "measure": "Time to Maximum Observed Plasma Concentration [Tmax] of CX-4945"
              },
              {
                "measure": "Area Under the Concentration-Time Curve [AUC0-6] of CX-4945"
              },
              {
                "measure": "Clinical Benefit of CX-4945 i.e. All-cause Mortality Status - the Number of Deaths Occurred in Each Treatment Group From Randomization (Day 1) Through Day 60"
              },
              {
                "measure": "Clinical Benefit of CX-4945 i.e. Number of Respiratory Failures Occurred in Each Treatment Group From Randomization (Day 1) Through Day 45"
              },
              {
                "measure": "Clinical Benefit of CX-4945 i.e. Number of Subjects Hospitalized in Each Treatment Group From Randomization (Day 1) to Day 45"
              },
              {
                "measure": "Clinical Benefit of CX-4945 i.e. Number of Days to Normalization of Oxygen Saturation Level Measured by Pulse Oximeter at Randomization (Day 1), Day 4, Day 8, Day 11, Day 14, Day 28 and Day 45 and Categorized as <96% Versus \u226596%."
              },
              {
                "measure": "Clinical Benefit of CX-4945 i.e. Proportion of Subjects With Disease Progression or Improvement in Health Status Occurring From Randomization (Day 1) to Day 28."
              },
              {
                "measure": "Clinical Benefit of CX-4945 i.e. Changes in the Total Score for Q1~Q5 of the EQ-D5-5L From Randomization (Day 1) to Day 8, Day 14 and Day 28."
              },
              {
                "measure": "Clinical Benefit of CX-4945 i.e. Changes in the Imaginable Health Status of the EQ-D5-5L From Randomization (Day 1) to Day 8, Day 14 and Day 28."
              },
              {
                "measure": "CX-4945 Inflammatory Marker Outcomes i.e. Plasma IL-6"
              },
              {
                "measure": "CX-4945 Inflammatory Marker Outcomes i.e. Plasma CRP"
              },
              {
                "measure": "CX-4945 Inflammatory Marker Outcomes i.e. Plasma LDH"
              },
              {
                "measure": "CX-4945 Inflammatory Marker Outcomes i.e. Plasma CPK"
              },
              {
                "measure": "CX-4945 Inflammatory Marker Outcomes i.e. Plasma Ferritin"
              },
              {
                "measure": "CX-4945 Inflammatory Marker Outcomes i.e. Plasma D-Dimer"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT04668209",
            "briefTitle": "Silmitasertib (CX-4945) in Patients With Severe Coronavirus Disease 2019 (COVID-19)",
            "officialTitle": "Phase II, Randomized, Investigator Initiated Trial to Evaluate Safety and to Explore Clinical Benefit of Silmitasertib (CX-4945) in Patients With Severe Coronavirus Disease 2019 (COVID-19)"
          },
          "statusModule": {
            "overallStatus": "TERMINATED",
            "whyStopped": "After 15 months of active enrollment and a lack of qualifying hospitalized COVID-19 patients, the Sponsor-Investigator, Marilyn Csete Glassberg, MD, decided to terminate recruitment before meeting the stated enrollment objectives.",
            "studyFirstSubmitDate": "2020-12-02",
            "resultsFirstSubmitDate": "2023-06-09"
          },
          "conditionsModule": {
            "conditions": [
              "Coronavirus"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Incidence of Treatment Emergent Adverse Events [Safety and Tolerability]",
                "timeFrame": "Through Day 60"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "To Compare Time to Clinical Recovery in CX-4945 Treatment Group Evaluated From Randomization Through Day 28 as Compared to the Control Arm."
              },
              {
                "measure": "To Compare Time to Clinical Recovery in CX-4945 Treatment Group Evaluated From Randomization Through Day 28 as Compared to the Control Arm."
              },
              {
                "measure": "To Compare Time to Clinical Recovery in CX-4945 Treatment Group Evaluated From Randomization Through Day 28 as Compared to the Control Arm."
              },
              {
                "measure": "To Compare Changes in Clinical Status of Patients Enrolled to CX-4945 Treatment Arm as Compared to the Control Arm at Day 14 and Day 28."
              },
              {
                "measure": "To Compare Changes in Clinical Status of Patients Enrolled to CX-4945 Treatment Arm as Compared to the Control Arm at Day 14 and Day 28."
              },
              {
                "measure": "To Evaluate Preliminary Evidence of Anti-viral Activity of CX-4945 as Compared to the Control Arm."
              },
              {
                "measure": "To Evaluate Preliminary Evidence of Anti-viral Activity of CX-4945 as Compared to the Control Arm."
              },
              {
                "measure": "Number of Days Hospitalized"
              },
              {
                "measure": "To Evaluate Changes in IL-6 Level"
              },
              {
                "measure": "To Evaluate Changes in CRP"
              },
              {
                "measure": "To Evaluate Changes in LDH"
              },
              {
                "measure": "To Evaluate Changes in CPK"
              },
              {
                "measure": "To Evaluate Changes in Ferritin"
              },
              {
                "measure": "To Evaluate Changes in D-dimer"
              },
              {
                "measure": "Number of Days of Supplemental Oxygen Use"
              },
              {
                "measure": "All-cause Mortality Status"
              },
              {
                "measure": "Number of Days of On-invasive Ventilation/High Flow Oxygen"
              },
              {
                "measure": "Number of Days of Invasive Mechanical Ventilation/ECMO"
              },
              {
                "measure": "Number of Patients Returned to Room Air"
              },
              {
                "measure": "Change in Pulse Oxygen Saturation"
              },
              {
                "measure": "Number of Thrombosis Events"
              },
              {
                "measure": "Changes in EQ-D5-5L"
              }
            ]
          }
        }
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:24:34Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c837a"
    },
    "name": "BRD-K07594626",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c837a.png",
    "lincs": {
      "id": "LSM-8883",
      "name": "BRD-K07594626",
      "pubchemCid": 54654005,
      "chebiId": 97504,
      "inchiParent": "InChI=1S/C29H35N3O7/c1-32-24-8-7-22(16-27(33)30-19-4-3-5-21(14-19)36-2)39-26(24)17-38-25-9-6-20(15-23(25)29(32)35)31-28(34)18-10-12-37-13-11-18/h3-6,9,14-15,18,22,24,26H,7-8,10-13,16-17H2,1-2H3,(H,30,33)(H,31,34)/t22-,24-,26-/m0/s1",
      "inchiKeyParent": "VRPVHEJOGHTQDQ-GVUKDKGQSA-N",
      "smilesParent": "COc1cccc(NC(=O)C[C@@H]2CC[C@H]3[C@H](COc4ccc(NC(=O)C5CCOCC5)cc4C(=O)N3C)O2)c1"
    },
    "unichem": {
      "chebi": "97504",
      "lincs": "LSM-8883",
      "pubchem": "54654005"
    },
    "pubchem": [
      {
        "cid": 54654005,
        "inchi": "InChI=1S/C29H35N3O7/c1-32-24-8-7-22(16-27(33)30-19-4-3-5-21(14-19)36-2)39-26(24)17-38-25-9-6-20(15-23(25)29(32)35)31-28(34)18-10-12-37-13-11-18/h3-6,9,14-15,18,22,24,26H,7-8,10-13,16-17H2,1-2H3,(H,30,33)(H,31,34)/t22-,24-,26-/m0/s1",
        "inchikey": "VRPVHEJOGHTQDQ-GVUKDKGQSA-N",
        "iupac": {
          "systematic": "N-[(2S,4aS,12aR)-2-[2-(3-methoxyanilino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]oxane-4-carboxamide"
        },
        "smiles": {
          "canonical": "CN1C2CCC(OC2COC3=C(C1=O)C=C(C=C3)NC(=O)C4CCOCC4)CC(=O)NC5=CC(=CC=C5)OC"
        },
        "molecularFormula": "C29H35N3O7"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:24:36Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83a1"
    },
    "name": "BRD-K31284555",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83a1.png",
    "lincs": {
      "id": "LSM-10320",
      "name": "BRD-K31284555",
      "pubchemCid": 54637892,
      "chebiId": 98941,
      "inchiParent": "InChI=1S/C24H32N2O5S/c1-17-13-26(18(2)15-27)24(28)22-12-8-7-11-21(22)20-10-6-5-9-19(20)16-31-23(17)14-25(3)32(4,29)30/h5-12,17-18,23,27H,13-16H2,1-4H3/t17-,18-,23-/m1/s1",
      "inchiKeyParent": "UZINPKAPIFGTKL-PMAPCBKXSA-N",
      "smilesParent": "C[C@H](CO)N1C[C@@H](C)[C@@H](CN(C)S(=O)(=O)C)OCc2ccccc2c3ccccc3C1=O"
    },
    "unichem": {
      "chebi": "98941",
      "lincs": "LSM-10320",
      "pubchem": "54637892"
    },
    "pubchem": [
      {
        "cid": 54637892,
        "inchi": "InChI=1S/C24H32N2O5S/c1-17-13-26(18(2)15-27)24(28)22-12-8-7-11-21(22)20-10-6-5-9-19(20)16-31-23(17)14-25(3)32(4,29)30/h5-12,17-18,23,27H,13-16H2,1-4H3/t17-,18-,23-/m1/s1",
        "inchikey": "UZINPKAPIFGTKL-PMAPCBKXSA-N",
        "iupac": {
          "systematic": "N-[[(10S,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylmethanesulfonamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=CC=CC=C2C3=CC=CC=C3COC1CN(C)S(=O)(=O)C)C(C)CO"
        },
        "molecularFormula": "C24H32N2O5S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:24:38Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83f2"
    },
    "name": "BRD-K40034561",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83f2.png",
    "lincs": {
      "id": "LSM-10868",
      "name": "BRD-K40034561",
      "pubchemCid": 54654467,
      "chebiId": 99489,
      "inchiParent": "InChI=1S/C25H30FN3O6S/c1-3-36(32,33)28-17-8-11-22-19(12-17)25(31)29(2)21-10-9-18(35-23(21)15-34-22)13-24(30)27-14-16-6-4-5-7-20(16)26/h4-8,11-12,18,21,23,28H,3,9-10,13-15H2,1-2H3,(H,27,30)/t18-,21-,23-/m1/s1",
      "inchiKeyParent": "MAZJZTZSELFTOO-JMUQELJHSA-N",
      "smilesParent": "CCS(=O)(=O)Nc1ccc2OC[C@H]3O[C@@H](CC(=O)NCc4ccccc4F)CC[C@H]3N(C)C(=O)c2c1"
    },
    "unichem": {
      "chebi": "99489",
      "lincs": "LSM-10868",
      "pubchem": "54654467"
    },
    "pubchem": [
      {
        "cid": 54654467,
        "inchi": "InChI=1S/C25H30FN3O6S/c1-3-36(32,33)28-17-8-11-22-19(12-17)25(31)29(2)21-10-9-18(35-23(21)15-34-22)13-24(30)27-14-16-6-4-5-7-20(16)26/h4-8,11-12,18,21,23,28H,3,9-10,13-15H2,1-2H3,(H,27,30)/t18-,21-,23-/m1/s1",
        "inchikey": "MAZJZTZSELFTOO-JMUQELJHSA-N",
        "iupac": {
          "systematic": "2-[(2R,4aR,12aS)-8-(ethylsulfonylamino)-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-[(2-fluorophenyl)methyl]acetamide"
        },
        "smiles": {
          "canonical": "CCS(=O)(=O)NC1=CC2=C(C=C1)OCC3C(CCC(O3)CC(=O)NCC4=CC=CC=C4F)N(C2=O)C"
        },
        "molecularFormula": "C25H30FN3O6S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:24:40Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8400"
    },
    "name": "BRD-K35039537",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8400.png",
    "lincs": {
      "id": "LSM-10535",
      "name": "BRD-K35039537",
      "pubchemCid": 54631830,
      "chebiId": 99156,
      "inchiParent": "InChI=1S/C22H30N4O7S/c1-14-11-26(34(5,29)30)15(2)13-32-18-7-6-16(24-21(27)19-8-9-23-33-19)10-17(18)22(28)25(3)12-20(14)31-4/h6-10,14-15,20H,11-13H2,1-5H3,(H,24,27)/t14-,15-,20-/m0/s1",
      "inchiKeyParent": "CRZDWKBDRGRNEI-AVYPCKFXSA-N",
      "smilesParent": "CO[C@H]1CN(C)C(=O)c2cc(NC(=O)c3oncc3)ccc2OC[C@H](C)N(C[C@@H]1C)S(=O)(=O)C"
    },
    "unichem": {
      "chebi": "99156",
      "lincs": "LSM-10535",
      "pubchem": "54631830"
    },
    "pubchem": [
      {
        "cid": 54631830,
        "inchi": "InChI=1S/C22H30N4O7S/c1-14-11-26(34(5,29)30)15(2)13-32-18-7-6-16(24-21(27)19-8-9-23-33-19)10-17(18)22(28)25(3)12-20(14)31-4/h6-10,14-15,20H,11-13H2,1-5H3,(H,24,27)/t14-,15-,20-/m0/s1",
        "inchikey": "CRZDWKBDRGRNEI-AVYPCKFXSA-N",
        "iupac": {
          "systematic": "N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-5-methylsulfonyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1,2-oxazole-5-carboxamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(COC2=C(C=C(C=C2)NC(=O)C3=CC=NO3)C(=O)N(CC1OC)C)C)S(=O)(=O)C"
        },
        "molecularFormula": "C22H30N4O7S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:24:43Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8376"
    },
    "name": "BRD-K88628885",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8376.png",
    "lincs": {
      "id": "LSM-8398",
      "name": "BRD-K88628885",
      "pubchemCid": 44506055,
      "chebiId": 97019,
      "inchiParent": "InChI=1S/C24H37N5O3/c1-18-7-5-8-21(11-18)13-27(4)15-23-19(2)12-29(20(3)16-30)24(31)9-6-10-28-14-22(17-32-23)25-26-28/h5,7-8,11,14,19-20,23,30H,6,9-10,12-13,15-17H2,1-4H3/t19-,20+,23-/m1/s1",
      "inchiKeyParent": "MEJUTVOAQGGYHA-ZRCGQRJVSA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@@H](C)[C@@H](CN(C)Cc2cccc(C)c2)OCc3cn(CCCC1=O)nn3"
    },
    "unichem": {
      "chebi": "97019",
      "lincs": "LSM-8398",
      "pubchem": "44506055"
    },
    "pubchem": [
      {
        "cid": 44506055,
        "inchi": "InChI=1S/C24H37N5O3/c1-18-7-5-8-21(11-18)13-27(4)15-23-19(2)12-29(20(3)16-30)24(31)9-6-10-28-14-22(17-32-23)25-26-28/h5,7-8,11,14,19-20,23,30H,6,9-10,12-13,15-17H2,1-4H3/t19-,20+,23-/m1/s1",
        "inchikey": "MEJUTVOAQGGYHA-ZRCGQRJVSA-N",
        "iupac": {
          "systematic": "(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(3-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)CCCN2C=C(COC1CN(C)CC3=CC=CC(=C3)C)N=N2)C(C)CO"
        },
        "molecularFormula": "C24H37N5O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:24:45Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c839f"
    },
    "name": "BRD-K81060234",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c839f.png",
    "lincs": {
      "id": "LSM-41695",
      "name": "BRD-K81060234",
      "pubchemCid": 44484464,
      "chebiId": 130145,
      "inchiParent": "InChI=1S/C30H43N5O5/c1-22-18-35(23(2)21-36)30(38)17-25-16-26(32-29(37)8-11-34-12-14-39-15-13-34)4-5-27(25)40-28(22)20-33(3)19-24-6-9-31-10-7-24/h4-7,9-10,16,22-23,28,36H,8,11-15,17-21H2,1-3H3,(H,32,37)/t22-,23+,28-/m1/s1",
      "inchiKeyParent": "ZUUUVKJMPUIRPC-AWVRMFGXSA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@@H](C)[C@@H](CN(C)Cc2ccncc2)Oc3ccc(NC(=O)CCN4CCOCC4)cc3CC1=O"
    },
    "unichem": {
      "chebi": "130145",
      "lincs": "LSM-41695",
      "pubchem": "44484464"
    },
    "pubchem": [
      {
        "cid": 44484464,
        "inchi": "InChI=1S/C30H43N5O5/c1-22-18-35(23(2)21-36)30(38)17-25-16-26(32-29(37)8-11-34-12-14-39-15-13-34)4-5-27(25)40-28(22)20-33(3)19-24-6-9-31-10-7-24/h4-7,9-10,16,22-23,28,36H,8,11-15,17-21H2,1-3H3,(H,32,37)/t22-,23+,28-/m1/s1",
        "inchikey": "ZUUUVKJMPUIRPC-AWVRMFGXSA-N",
        "iupac": {
          "systematic": "N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-morpholin-4-ylpropanamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)CC2=C(C=CC(=C2)NC(=O)CCN3CCOCC3)OC1CN(C)CC4=CC=NC=C4)C(C)CO"
        },
        "molecularFormula": "C30H43N5O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:24:47Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83dd"
    },
    "name": "BRD-K68233995",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83dd.png",
    "lincs": {
      "id": "LSM-7758",
      "name": "BRD-K68233995",
      "pubchemCid": 54618618,
      "chebiId": 96379,
      "inchiParent": "InChI=1S/C28H33N3O6/c1-17-13-31(18(2)15-32)28(34)22-10-21(19-6-4-5-7-19)12-29-26(22)37-25(17)14-30(3)27(33)20-8-9-23-24(11-20)36-16-35-23/h6,8-12,17-18,25,32H,4-5,7,13-16H2,1-3H3/t17-,18-,25-/m1/s1",
      "inchiKeyParent": "PGLSEMLPCXRKER-QJMRKGMQSA-N",
      "smilesParent": "C[C@H](CO)N1C[C@@H](C)[C@@H](CN(C)C(=O)c2ccc3OCOc3c2)Oc4ncc(cc4C1=O)C5=CCCC5"
    },
    "unichem": {
      "chebi": "96379",
      "lincs": "LSM-7758",
      "pubchem": "54618618"
    },
    "pubchem": [
      {
        "cid": 54618618,
        "inchi": "InChI=1S/C28H33N3O6/c1-17-13-31(18(2)15-32)28(34)22-10-21(19-6-4-5-7-19)12-29-26(22)37-25(17)14-30(3)27(33)20-8-9-23-24(11-20)36-16-35-23/h6,8-12,17-18,25,32H,4-5,7,13-16H2,1-3H3/t17-,18-,25-/m1/s1",
        "inchikey": "PGLSEMLPCXRKER-QJMRKGMQSA-N",
        "iupac": {
          "systematic": "N-[[(2S,3R)-8-(cyclopenten-1-yl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-1,3-benzodioxole-5-carboxamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(N=CC(=C2)C3=CCCC3)OC1CN(C)C(=O)C4=CC5=C(C=C4)OCO5)C(C)CO"
        },
        "molecularFormula": "C28H33N3O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:24:49Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c834d"
    },
    "name": "BRD-K85616320",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c834d.png",
    "lincs": {
      "id": "LSM-13663",
      "name": "BRD-K85616320",
      "pubchemCid": 54657962,
      "chebiId": 102310,
      "inchiParent": "InChI=1S/C21H32N4O6/c1-12-20(13(2)31-24-12)23-21(28)25-9-15(26)10-29-11-18-17(25)6-5-16(30-18)7-19(27)22-8-14-3-4-14/h14-18,26H,3-11H2,1-2H3,(H,22,27)(H,23,28)/t15-,16-,17-,18+/m1/s1",
      "inchiKeyParent": "XOXZVIQHUYDNGA-TVFCKZIOSA-N",
      "smilesParent": "Cc1onc(C)c1NC(=O)N2C[C@@H](O)COC[C@@H]3O[C@@H](CC(=O)NCC4CC4)CC[C@@H]23"
    },
    "unichem": {
      "chebi": "102310",
      "lincs": "LSM-13663",
      "pubchem": "54657962"
    },
    "pubchem": [
      {
        "cid": 54657962,
        "inchi": "InChI=1S/C21H32N4O6/c1-12-20(13(2)31-24-12)23-21(28)25-9-15(26)10-29-11-18-17(25)6-5-16(30-18)7-19(27)22-8-14-3-4-14/h14-18,26H,3-11H2,1-2H3,(H,22,27)(H,23,28)/t15-,16-,17-,18+/m1/s1",
        "inchikey": "XOXZVIQHUYDNGA-TVFCKZIOSA-N",
        "iupac": {
          "systematic": "(3R,6aR,8R,10aR)-8-[2-(cyclopropylmethylamino)-2-oxoethyl]-N-(3,5-dimethyl-1,2-oxazol-4-yl)-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide"
        },
        "smiles": {
          "canonical": "CC1=C(C(=NO1)C)NC(=O)N2CC(COCC3C2CCC(O3)CC(=O)NCC4CC4)O"
        },
        "molecularFormula": "C21H32N4O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:24:52Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8390"
    },
    "name": "BRD-K47078472",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8390.png",
    "lincs": {
      "id": "LSM-11303",
      "name": "BRD-K47078472",
      "pubchemCid": 54632127,
      "chebiId": 99924,
      "inchiParent": "InChI=1S/C24H33N3O5S/c1-17-13-25-18(2)15-32-22-11-10-20(12-21(22)24(28)27(3)14-23(17)31-4)26-33(29,30)16-19-8-6-5-7-9-19/h5-12,17-18,23,25-26H,13-16H2,1-4H3/t17-,18-,23+/m1/s1",
      "inchiKeyParent": "ITUDOLAPOXZKHG-PNCHPQGNSA-N",
      "smilesParent": "CO[C@H]1CN(C)C(=O)c2cc(NS(=O)(=O)Cc3ccccc3)ccc2OC[C@@H](C)NC[C@H]1C"
    },
    "unichem": {
      "chebi": "99924",
      "lincs": "LSM-11303",
      "pubchem": "54632127"
    },
    "pubchem": [
      {
        "cid": 54632127,
        "inchi": "InChI=1S/C24H33N3O5S/c1-17-13-25-18(2)15-32-22-11-10-20(12-21(22)24(28)27(3)14-23(17)31-4)26-33(29,30)16-19-8-6-5-7-9-19/h5-12,17-18,23,25-26H,13-16H2,1-4H3/t17-,18-,23+/m1/s1",
        "inchikey": "ITUDOLAPOXZKHG-PNCHPQGNSA-N",
        "iupac": {
          "systematic": "N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1-phenylmethanesulfonamide"
        },
        "smiles": {
          "canonical": "CC1CNC(COC2=C(C=C(C=C2)NS(=O)(=O)CC3=CC=CC=C3)C(=O)N(CC1OC)C)C"
        },
        "molecularFormula": "C24H33N3O5S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:24:54Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83c6"
    },
    "name": "MLS003129244",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83c6.png",
    "lincs": {
      "id": "LSM-7100",
      "name": "MLS003129244",
      "alternativeNames": [
        "BRD-K19471718"
      ],
      "pubchemCid": 44488699,
      "chebiId": 95721,
      "inchiParent": "InChI=1S/C24H34N6O6/c1-16-10-30(17(2)13-31)23(32)5-4-8-29-11-19(26-27-29)14-34-22(16)12-28(3)24(33)25-18-6-7-20-21(9-18)36-15-35-20/h6-7,9,11,16-17,22,31H,4-5,8,10,12-15H2,1-3H3,(H,25,33)/t16-,17+,22+/m0/s1",
      "inchiKeyParent": "DEGZSTUNWMGQCY-GSHUGGBRSA-N",
      "smilesParent": "C[C@H](CO)N1C[C@H](C)[C@@H](CN(C)C(=O)Nc2ccc3OCOc3c2)OCc4cn(CCCC1=O)nn4"
    },
    "unichem": {
      "chebi": "95721",
      "lincs": "LSM-7100",
      "pubchem": "44488699"
    },
    "pubchem": [
      {
        "cid": 44488699,
        "inchi": "InChI=1S/C24H34N6O6/c1-16-10-30(17(2)13-31)23(32)5-4-8-29-11-19(26-27-29)14-34-22(16)12-28(3)24(33)25-18-6-7-20-21(9-18)36-15-35-20/h6-7,9,11,16-17,22,31H,4-5,8,10,12-15H2,1-3H3,(H,25,33)/t16-,17+,22+/m0/s1",
        "inchikey": "DEGZSTUNWMGQCY-GSHUGGBRSA-N",
        "iupac": {
          "systematic": "3-(1,3-benzodioxol-5-yl)-1-[[(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methylurea"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)CCCN2C=C(COC1CN(C)C(=O)NC3=CC4=C(C=C3)OCO4)N=N2)C(C)CO"
        },
        "molecularFormula": "C24H34N6O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:24:56Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83d2"
    },
    "name": "BRD-K54737430",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83d2.png",
    "lincs": {
      "id": "LSM-11750",
      "name": "BRD-K54737430",
      "pubchemCid": 54646715,
      "chebiId": 100375,
      "inchiParent": "InChI=1S/C26H29ClN2O5/c27-17-5-3-16(4-6-17)13-28-24(31)12-19-11-21-20-10-18(29-25(32)9-15-1-2-15)7-8-22(20)34-26(21)23(14-30)33-19/h3-8,10,15,19,21,23,26,30H,1-2,9,11-14H2,(H,28,31)(H,29,32)/t19-,21+,23+,26-/m1/s1",
      "inchiKeyParent": "LDGCPXKMKGRZSF-HMMJVGNDSA-N",
      "smilesParent": "OC[C@@H]1O[C@@H](CC(=O)NCc2ccc(Cl)cc2)C[C@@H]3[C@H]1Oc4ccc(NC(=O)CC5CC5)cc34"
    },
    "unichem": {
      "chebi": "100375",
      "lincs": "LSM-11750",
      "pubchem": "54646715"
    },
    "pubchem": [
      {
        "cid": 54646715,
        "inchi": "InChI=1S/C26H29ClN2O5/c27-17-5-3-16(4-6-17)13-28-24(31)12-19-11-21-20-10-18(29-25(32)9-15-1-2-15)7-8-22(20)34-26(21)23(14-30)33-19/h3-8,10,15,19,21,23,26,30H,1-2,9,11-14H2,(H,28,31)(H,29,32)/t19-,21+,23+,26-/m1/s1",
        "inchikey": "LDGCPXKMKGRZSF-HMMJVGNDSA-N",
        "iupac": {
          "systematic": "N-[(1S,3R,4aS,9aR)-3-[2-[(4-chlorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]-2-cyclopropylacetamide"
        },
        "smiles": {
          "canonical": "C1CC1CC(=O)NC2=CC3=C(C=C2)OC4C3CC(OC4CO)CC(=O)NCC5=CC=C(C=C5)Cl"
        },
        "molecularFormula": "C26H29ClN2O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:24:59Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83dc"
    },
    "name": "BRD-K44261129",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83dc.png",
    "lincs": {
      "id": "LSM-39710",
      "name": "BRD-K44261129",
      "pubchemCid": 44484675,
      "chebiId": 128155,
      "inchiParent": "InChI=1S/C33H42N4O4/c1-22(2)34-33(40)35-28-15-16-30-29(17-28)32(39)37(24(4)21-38)18-23(3)31(41-30)20-36(5)19-25-11-13-27(14-12-25)26-9-7-6-8-10-26/h6-17,22-24,31,38H,18-21H2,1-5H3,(H2,34,35,40)/t23-,24-,31+/m0/s1",
      "inchiKeyParent": "KRCYYDXJFSFYMC-ISTJGCCRSA-N",
      "smilesParent": "CC(C)NC(=O)Nc1ccc2O[C@H](CN(C)Cc3ccc(cc3)c4ccccc4)[C@@H](C)CN([C@@H](C)CO)C(=O)c2c1"
    },
    "unichem": {
      "chebi": "128155",
      "lincs": "LSM-39710",
      "pubchem": "44484675"
    },
    "pubchem": [
      {
        "cid": 44484675,
        "inchi": "InChI=1S/C33H42N4O4/c1-22(2)34-33(40)35-28-15-16-30-29(17-28)32(39)37(24(4)21-38)18-23(3)31(41-30)20-36(5)19-25-11-13-27(14-12-25)26-9-7-6-8-10-26/h6-17,22-24,31,38H,18-21H2,1-5H3,(H2,34,35,40)/t23-,24-,31+/m0/s1",
        "inchikey": "KRCYYDXJFSFYMC-ISTJGCCRSA-N",
        "iupac": {
          "systematic": "1-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-propan-2-ylurea"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(C=CC(=C2)NC(=O)NC(C)C)OC1CN(C)CC3=CC=C(C=C3)C4=CC=CC=C4)C(C)CO"
        },
        "molecularFormula": "C33H42N4O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:25:01Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8410"
    },
    "name": "BRD-K08911251",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8410.png",
    "lincs": {
      "id": "LSM-8963",
      "name": "BRD-K08911251",
      "pubchemCid": 54646676,
      "chebiId": 97584,
      "inchiParent": "InChI=1S/C26H33N3O6/c1-29(2)14-25(32)28-17-8-9-22-19(10-17)20-11-18(34-23(15-30)26(20)35-22)12-24(31)27-13-16-6-4-5-7-21(16)33-3/h4-10,18,20,23,26,30H,11-15H2,1-3H3,(H,27,31)(H,28,32)/t18-,20+,23-,26-/m1/s1",
      "inchiKeyParent": "YCZDHCVCWSKGTE-ZBYDKNLWSA-N",
      "smilesParent": "COc1ccccc1CNC(=O)C[C@H]2C[C@@H]3[C@@H](Oc4ccc(NC(=O)CN(C)C)cc34)[C@@H](CO)O2"
    },
    "unichem": {
      "chebi": "97584",
      "lincs": "LSM-8963",
      "pubchem": "54646676"
    },
    "pubchem": [
      {
        "cid": 54646676,
        "inchi": "InChI=1S/C26H33N3O6/c1-29(2)14-25(32)28-17-8-9-22-19(10-17)20-11-18(34-23(15-30)26(20)35-22)12-24(31)27-13-16-6-4-5-7-21(16)33-3/h4-10,18,20,23,26,30H,11-15H2,1-3H3,(H,27,31)(H,28,32)/t18-,20+,23-,26-/m1/s1",
        "inchikey": "YCZDHCVCWSKGTE-ZBYDKNLWSA-N",
        "iupac": {
          "systematic": "2-[(1R,3R,4aS,9aR)-6-[[2-(dimethylamino)acetyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-[(2-methoxyphenyl)methyl]acetamide"
        },
        "smiles": {
          "canonical": "CN(C)CC(=O)NC1=CC2=C(C=C1)OC3C2CC(OC3CO)CC(=O)NCC4=CC=CC=C4OC"
        },
        "molecularFormula": "C26H33N3O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:25:03Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8392"
    },
    "name": "BRD-K03430401",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8392.png",
    "lincs": {
      "id": "LSM-8646",
      "name": "BRD-K03430401",
      "pubchemCid": 54654420,
      "chebiId": 97267,
      "inchiParent": "InChI=1S/C29H38N4O6S/c1-3-40(36,37)31-21-9-12-26-24(15-21)29(35)32(2)25-11-10-23(39-27(25)19-38-26)16-28(34)30-22-13-14-33(18-22)17-20-7-5-4-6-8-20/h4-9,12,15,22-23,25,27,31H,3,10-11,13-14,16-19H2,1-2H3,(H,30,34)/t22-,23-,25+,27+/m0/s1",
      "inchiKeyParent": "IJWLFSVDDGQQHF-CFFRGQMRSA-N",
      "smilesParent": "CCS(=O)(=O)Nc1ccc2OC[C@H]3O[C@H](CC(=O)N[C@H]4CCN(Cc5ccccc5)C4)CC[C@H]3N(C)C(=O)c2c1"
    },
    "unichem": {
      "chebi": "97267",
      "lincs": "LSM-8646",
      "pubchem": "54654420"
    },
    "pubchem": [
      {
        "cid": 54654420,
        "inchi": "InChI=1S/C29H38N4O6S/c1-3-40(36,37)31-21-9-12-26-24(15-21)29(35)32(2)25-11-10-23(39-27(25)19-38-26)16-28(34)30-22-13-14-33(18-22)17-20-7-5-4-6-8-20/h4-9,12,15,22-23,25,27,31H,3,10-11,13-14,16-19H2,1-2H3,(H,30,34)/t22-,23-,25+,27+/m0/s1",
        "inchikey": "IJWLFSVDDGQQHF-CFFRGQMRSA-N",
        "iupac": {
          "systematic": "2-[(2S,4aR,12aS)-8-(ethylsulfonylamino)-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-[(3S)-1-benzylpyrrolidin-3-yl]acetamide"
        },
        "smiles": {
          "canonical": "CCS(=O)(=O)NC1=CC2=C(C=C1)OCC3C(CCC(O3)CC(=O)NC4CCN(C4)CC5=CC=CC=C5)N(C2=O)C"
        },
        "molecularFormula": "C29H38N4O6S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:25:06Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83ce"
    },
    "name": "BMS-299897",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83ce.png",
    "lincs": {
      "id": "LSM-6207",
      "name": "BMS-299897",
      "alternativeNames": [
        "BMS 299897",
        "BMS-299897",
        "Gamma-secretase inhibitor xxiv, bms299897"
      ],
      "pubchemCid": 11249248,
      "chebiId": 94983,
      "inchiParent": "InChI=1S/C24H21ClF3NO4S/c1-15(21-11-7-18(26)13-16(21)3-2-4-24(30)31)29(23-14-19(27)8-12-22(23)28)34(32,33)20-9-5-17(25)6-10-20/h5-15H,2-4H2,1H3,(H,30,31)/t15-/m1/s1",
      "inchiKeyParent": "IZAOBRWCUGOKNH-OAHLLOKOSA-N",
      "smilesParent": "C[C@@H](N(c1cc(F)ccc1F)S(=O)(=O)c2ccc(Cl)cc2)c3ccc(F)cc3CCCC(=O)O"
    },
    "unichem": {
      "chebi": "94983",
      "chembl": "CHEMBL247471",
      "lincs": "LSM-6207",
      "pubchem": "11249248"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL247471",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 511.95,
        "hba": 3,
        "hbd": 1,
        "qedWeighted": 0.38
      },
      "moleculeSynonyms": [
        {
          "moleculeSynonym": "BMS-299897",
          "synType": "RESEARCH_CODE",
          "synonyms": "BMS-299897"
        }
      ]
    },
    "pubchem": [
      {
        "cid": 11249248,
        "inchi": "InChI=1S/C24H21ClF3NO4S/c1-15(21-11-7-18(26)13-16(21)3-2-4-24(30)31)29(23-14-19(27)8-12-22(23)28)34(32,33)20-9-5-17(25)6-10-20/h5-15H,2-4H2,1H3,(H,30,31)/t15-/m1/s1",
        "inchikey": "IZAOBRWCUGOKNH-OAHLLOKOSA-N",
        "iupac": {
          "systematic": "4-[2-[(1R)-1-(N-(4-chlorophenyl)sulfonyl-2,5-difluoroanilino)ethyl]-5-fluorophenyl]butanoic acid"
        },
        "smiles": {
          "canonical": "CC(C1=C(C=C(C=C1)F)CCCC(=O)O)N(C2=C(C=CC(=C2)F)F)S(=O)(=O)C3=CC=C(C=C3)Cl"
        },
        "molecularFormula": "C24H21ClF3NO4S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:25:17Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83e5"
    },
    "name": "BRD-K79235289",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83e5.png",
    "lincs": {
      "id": "LSM-13270",
      "name": "BRD-K79235289",
      "pubchemCid": 56835228,
      "chebiId": 101909,
      "inchiParent": "InChI=1S/C30H33F3N2O5S/c1-20-16-35(21(2)18-36)29(37)27-11-7-6-10-26(27)25-9-5-4-8-22(25)19-40-28(20)17-34(3)41(38,39)24-14-12-23(13-15-24)30(31,32)33/h4-15,20-21,28,36H,16-19H2,1-3H3/t20-,21+,28+/m1/s1",
      "inchiKeyParent": "VUGFGKFGZUURHO-GGJMMHKRSA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@@H](C)[C@H](CN(C)S(=O)(=O)c2ccc(cc2)C(F)(F)F)OCc3ccccc3c4ccccc4C1=O"
    },
    "unichem": {
      "chebi": "101909",
      "lincs": "LSM-13270",
      "pubchem": "56835228"
    },
    "pubchem": [
      {
        "cid": 56835228,
        "inchi": "InChI=1S/C30H33F3N2O5S/c1-20-16-35(21(2)18-36)29(37)27-11-7-6-10-26(27)25-9-5-4-8-22(25)19-40-28(20)17-34(3)41(38,39)24-14-12-23(13-15-24)30(31,32)33/h4-15,20-21,28,36H,16-19H2,1-3H3/t20-,21+,28+/m1/s1",
        "inchikey": "VUGFGKFGZUURHO-GGJMMHKRSA-N",
        "iupac": {
          "systematic": "N-[[(10R,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methyl-4-(trifluoromethyl)benzenesulfonamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=CC=CC=C2C3=CC=CC=C3COC1CN(C)S(=O)(=O)C4=CC=C(C=C4)C(F)(F)F)C(C)CO"
        },
        "molecularFormula": "C30H33F3N2O5S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:25:19Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8415"
    },
    "name": "BRD-K57179401",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8415.png",
    "lincs": {
      "id": "LSM-7604",
      "name": "BRD-K57179401",
      "pubchemCid": 54618959,
      "chebiId": 96225,
      "inchiParent": "InChI=1S/C29H38N2O6S/c1-20-16-31(21(2)19-32)38(35,36)28-13-12-24(23-9-5-4-6-10-23)15-26(28)37-27(20)18-30(3)17-22-8-7-11-25(14-22)29(33)34/h7-9,11-15,20-21,27,32H,4-6,10,16-19H2,1-3H3,(H,33,34)/t20-,21-,27-/m1/s1",
      "inchiKeyParent": "FZGPYLHWXNIREJ-LGVUCKNBSA-N",
      "smilesParent": "C[C@H](CO)N1C[C@@H](C)[C@@H](CN(C)Cc2cccc(c2)C(=O)O)Oc3cc(ccc3S1(=O)=O)C4=CCCCC4"
    },
    "unichem": {
      "chebi": "96225",
      "lincs": "LSM-7604",
      "pubchem": "54618959"
    },
    "pubchem": [
      {
        "cid": 54618959,
        "inchi": "InChI=1S/C29H38N2O6S/c1-20-16-31(21(2)19-32)38(35,36)28-13-12-24(23-9-5-4-6-10-23)15-26(28)37-27(20)18-30(3)17-22-8-7-11-25(14-22)29(33)34/h7-9,11-15,20-21,27,32H,4-6,10,16-19H2,1-3H3,(H,33,34)/t20-,21-,27-/m1/s1",
        "inchikey": "FZGPYLHWXNIREJ-LGVUCKNBSA-N",
        "iupac": {
          "systematic": "3-[[[(4R,5S)-8-(cyclohexen-1-yl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl-methylamino]methyl]benzoic acid"
        },
        "smiles": {
          "canonical": "CC1CN(S(=O)(=O)C2=C(C=C(C=C2)C3=CCCCC3)OC1CN(C)CC4=CC(=CC=C4)C(=O)O)C(C)CO"
        },
        "molecularFormula": "C29H38N2O6S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:25:22Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c836e"
    },
    "name": "BRD-K60644933",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c836e.png",
    "lincs": {
      "id": "LSM-8291",
      "name": "BRD-K60644933",
      "pubchemCid": 44488162,
      "chebiId": 96912,
      "inchiParent": "InChI=1S/C23H35N5O3/c1-18-12-28(19(2)16-29)23(30)10-7-11-27-14-21(24-25-27)17-31-22(18)15-26(3)13-20-8-5-4-6-9-20/h4-6,8-9,14,18-19,22,29H,7,10-13,15-17H2,1-3H3/t18-,19-,22-/m0/s1",
      "inchiKeyParent": "AIVZVDBTBOXKNA-IPJJNNNSSA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@H](C)[C@H](CN(C)Cc2ccccc2)OCc3cn(CCCC1=O)nn3"
    },
    "unichem": {
      "chebi": "96912",
      "lincs": "LSM-8291",
      "pubchem": "44488162"
    },
    "pubchem": [
      {
        "cid": 44488162,
        "inchi": "InChI=1S/C23H35N5O3/c1-18-12-28(19(2)16-29)23(30)10-7-11-27-14-21(24-25-27)17-31-22(18)15-26(3)13-20-8-5-4-6-9-20/h4-6,8-9,14,18-19,22,29H,7,10-13,15-17H2,1-3H3/t18-,19-,22-/m0/s1",
        "inchikey": "AIVZVDBTBOXKNA-IPJJNNNSSA-N",
        "iupac": {
          "systematic": "(8S,9R)-9-[[benzyl(methyl)amino]methyl]-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)CCCN2C=C(COC1CN(C)CC3=CC=CC=C3)N=N2)C(C)CO"
        },
        "molecularFormula": "C23H35N5O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:25:24Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8389"
    },
    "name": "BRD-K98970645",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8389.png",
    "lincs": {
      "id": "LSM-8094",
      "name": "BRD-K98970645",
      "pubchemCid": 54618817,
      "chebiId": 96715,
      "inchiParent": "InChI=1S/C32H38N2O5S/c1-23-19-34(24(2)22-35)40(37,38)32-17-14-26(11-10-25(3)36)18-30(32)39-31(23)21-33(4)20-27-12-15-29(16-13-27)28-8-6-5-7-9-28/h5-9,12-18,23-25,31,35-36H,19-22H2,1-4H3/t23-,24-,25+,31-/m1/s1",
      "inchiKeyParent": "AXBJPSYRCLUHNL-RXDUGQIKSA-N",
      "smilesParent": "C[C@H](O)C#Cc1ccc2c(O[C@H](CN(C)Cc3ccc(cc3)c4ccccc4)[C@H](C)CN([C@H](C)CO)S2(=O)=O)c1"
    },
    "unichem": {
      "chebi": "96715",
      "lincs": "LSM-8094",
      "pubchem": "54618817"
    },
    "pubchem": [
      {
        "cid": 54618817,
        "inchi": "InChI=1S/C32H38N2O5S/c1-23-19-34(24(2)22-35)40(37,38)32-17-14-26(11-10-25(3)36)18-30(32)39-31(23)21-33(4)20-27-12-15-29(16-13-27)28-8-6-5-7-9-28/h5-9,12-18,23-25,31,35-36H,19-22H2,1-4H3/t23-,24-,25+,31-/m1/s1",
        "inchikey": "AXBJPSYRCLUHNL-RXDUGQIKSA-N",
        "iupac": {
          "systematic": "(2S)-4-[(4R,5S)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-5-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-8-yl]but-3-yn-2-ol"
        },
        "smiles": {
          "canonical": "CC1CN(S(=O)(=O)C2=C(C=C(C=C2)C#CC(C)O)OC1CN(C)CC3=CC=C(C=C3)C4=CC=CC=C4)C(C)CO"
        },
        "molecularFormula": "C32H38N2O5S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:25:26Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8395"
    },
    "name": "BRD-K08520424",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8395.png",
    "lincs": {
      "id": "LSM-8943",
      "name": "BRD-K08520424",
      "pubchemCid": 54660765,
      "chebiId": 97564,
      "inchiParent": "InChI=1S/C27H33FN4O4/c1-2-12-29-27(36)32-23-20(21(16-33)24(32)26(35)30-13-4-3-5-14-30)15-31-22(23)11-10-19(25(31)34)17-6-8-18(28)9-7-17/h6-11,20-21,23-24,33H,2-5,12-16H2,1H3,(H,29,36)/t20-,21-,23+,24-/m0/s1",
      "inchiKeyParent": "VKYOLVDQZLNZRC-ZQRMPTRQSA-N",
      "smilesParent": "CCCNC(=O)N1[C@@H]([C@@H](CO)[C@@H]2CN3C(=O)C(=CC=C3[C@H]12)c4ccc(F)cc4)C(=O)N5CCCCC5"
    },
    "unichem": {
      "chebi": "97564",
      "lincs": "LSM-8943",
      "pubchem": "54660765"
    },
    "pubchem": [
      {
        "cid": 54660765,
        "inchi": "InChI=1S/C27H33FN4O4/c1-2-12-29-27(36)32-23-20(21(16-33)24(32)26(35)30-13-4-3-5-14-30)15-31-22(23)11-10-19(25(31)34)17-6-8-18(28)9-7-17/h6-11,20-21,23-24,33H,2-5,12-16H2,1H3,(H,29,36)/t20-,21-,23+,24-/m0/s1",
        "inchikey": "VKYOLVDQZLNZRC-ZQRMPTRQSA-N",
        "iupac": {
          "systematic": "(2S,3S,3aR,9bR)-7-(4-fluorophenyl)-3-(hydroxymethyl)-6-oxo-2-(piperidine-1-carbonyl)-N-propyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-1-carboxamide"
        },
        "smiles": {
          "canonical": "CCCNC(=O)N1C2C(CN3C2=CC=C(C3=O)C4=CC=C(C=C4)F)C(C1C(=O)N5CCCCC5)CO"
        },
        "molecularFormula": "C27H33FN4O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:25:28Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83d7"
    },
    "name": "BRD-K41182633",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83d7.png",
    "lincs": {
      "id": "LSM-10934",
      "name": "BRD-K41182633",
      "pubchemCid": 54646616,
      "chebiId": 99555,
      "inchiParent": "InChI=1S/C28H27N3O7/c32-14-25-27-21(10-19(37-25)11-26(33)30-13-16-2-1-7-29-12-16)20-9-18(4-6-22(20)38-27)31-28(34)17-3-5-23-24(8-17)36-15-35-23/h1-9,12,19,21,25,27,32H,10-11,13-15H2,(H,30,33)(H,31,34)/t19-,21-,25-,27+/m1/s1",
      "inchiKeyParent": "PHEIPYKARIAFSI-HXMVMFLPSA-N",
      "smilesParent": "OC[C@H]1O[C@@H](CC(=O)NCc2cccnc2)C[C@H]3[C@@H]1Oc4ccc(NC(=O)c5ccc6OCOc6c5)cc34"
    },
    "unichem": {
      "chebi": "99555",
      "lincs": "LSM-10934",
      "pubchem": "54646616"
    },
    "pubchem": [
      {
        "cid": 54646616,
        "inchi": "InChI=1S/C28H27N3O7/c32-14-25-27-21(10-19(37-25)11-26(33)30-13-16-2-1-7-29-12-16)20-9-18(4-6-22(20)38-27)31-28(34)17-3-5-23-24(8-17)36-15-35-23/h1-9,12,19,21,25,27,32H,10-11,13-15H2,(H,30,33)(H,31,34)/t19-,21-,25-,27+/m1/s1",
        "inchikey": "PHEIPYKARIAFSI-HXMVMFLPSA-N",
        "iupac": {
          "systematic": "N-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(pyridin-3-ylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide"
        },
        "smiles": {
          "canonical": "C1C(OC(C2C1C3=C(O2)C=CC(=C3)NC(=O)C4=CC5=C(C=C4)OCO5)CO)CC(=O)NCC6=CN=CC=C6"
        },
        "molecularFormula": "C28H27N3O7"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:25:30Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83f3"
    },
    "name": "MLS003129717",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83f3.png",
    "lincs": {
      "id": "LSM-8414",
      "name": "MLS003129717",
      "alternativeNames": [
        "BRD-K95323755"
      ],
      "pubchemCid": 44485753,
      "chebiId": 97035,
      "inchiParent": "InChI=1S/C24H35N5O5/c1-17-7-9-21(10-8-17)34-24(32)27(4)14-22-18(2)12-29(19(3)15-30)23(31)6-5-11-28-13-20(16-33-22)25-26-28/h7-10,13,18-19,22,30H,5-6,11-12,14-16H2,1-4H3/t18-,19-,22+/m0/s1",
      "inchiKeyParent": "VOGIWUFDXLFNKS-CNNODRBYSA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@H](C)[C@@H](CN(C)C(=O)Oc2ccc(C)cc2)OCc3cn(CCCC1=O)nn3"
    },
    "unichem": {
      "chebi": "97035",
      "lincs": "LSM-8414",
      "pubchem": "44485753"
    },
    "pubchem": [
      {
        "cid": 44485753,
        "inchi": "InChI=1S/C24H35N5O5/c1-17-7-9-21(10-8-17)34-24(32)27(4)14-22-18(2)12-29(19(3)15-30)23(31)6-5-11-28-13-20(16-33-22)25-26-28/h7-10,13,18-19,22,30H,5-6,11-12,14-16H2,1-4H3/t18-,19-,22+/m0/s1",
        "inchikey": "VOGIWUFDXLFNKS-CNNODRBYSA-N",
        "iupac": {
          "systematic": "(4-methylphenyl) N-[[(8S,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylcarbamate"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)CCCN2C=C(COC1CN(C)C(=O)OC3=CC=C(C=C3)C)N=N2)C(C)CO"
        },
        "molecularFormula": "C24H35N5O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:25:33Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c840b"
    },
    "name": "BRD-K68455755",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c840b.png",
    "lincs": {
      "id": "LSM-40992",
      "name": "BRD-K68455755",
      "pubchemCid": 44486391,
      "chebiId": 129441,
      "inchiParent": "InChI=1S/C26H39N3O6S2/c1-18-16-29(19(2)17-30)26(31)22-14-21(28-37(32,33)25-9-7-13-36-25)10-11-23(22)35-20(3)8-5-6-12-34-24(18)15-27-4/h7,9-11,13-14,18-20,24,27-28,30H,5-6,8,12,15-17H2,1-4H3/t18-,19+,20-,24-/m1/s1",
      "inchiKeyParent": "HTMJKWITGYZJOG-ZBNTXBBCSA-N",
      "smilesParent": "CNC[C@H]1OCCCC[C@@H](C)Oc2ccc(NS(=O)(=O)c3cccs3)cc2C(=O)N(C[C@H]1C)[C@@H](C)CO"
    },
    "unichem": {
      "chebi": "129441",
      "lincs": "LSM-40992",
      "pubchem": "44486391"
    },
    "pubchem": [
      {
        "cid": 44486391,
        "inchi": "InChI=1S/C26H39N3O6S2/c1-18-16-29(19(2)17-30)26(31)22-14-21(28-37(32,33)25-9-7-13-36-25)10-11-23(22)35-20(3)8-5-6-12-34-24(18)15-27-4/h7,9-11,13-14,18-20,24,27-28,30H,5-6,8,12,15-17H2,1-4H3/t18-,19+,20-,24-/m1/s1",
        "inchikey": "HTMJKWITGYZJOG-ZBNTXBBCSA-N",
        "iupac": {
          "systematic": "N-[(3R,9S,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]thiophene-2-sulfonamide"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NS(=O)(=O)C3=CC=CS3)C(C)CO)C)CNC"
        },
        "molecularFormula": "C26H39N3O6S2"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:25:35Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8379"
    },
    "name": "Valinomycin",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8379.png",
    "lincs": {
      "id": "LSM-6389",
      "name": "Valinomycin",
      "alternativeNames": [
        "GNF-PF-5297"
      ],
      "pubchemCid": 5649,
      "chebiId": 95123,
      "inchiParent": "InChI=1S/C54H90N6O18/c1-22(2)34-49(67)73-31(19)43(61)55-38(26(9)10)53(71)77-41(29(15)16)47(65)59-36(24(5)6)51(69)75-33(21)45(63)57-39(27(11)12)54(72)78-42(30(17)18)48(66)60-35(23(3)4)50(68)74-32(20)44(62)56-37(25(7)8)52(70)76-40(28(13)14)46(64)58-34/h22-42H,1-21H3,(H,55,61)(H,56,62)(H,57,63)(H,58,64)(H,59,65)(H,60,66)",
      "inchiKeyParent": "FCFNRCROJUBPLU-UHFFFAOYSA-N",
      "smilesParent": "CC(C)C1NC(=O)C(C)OC(=O)C(NC(=O)C(OC(=O)C(NC(=O)C(C)OC(=O)C(NC(=O)C(OC(=O)C(NC(=O)C(C)OC(=O)C(NC(=O)C(OC1=O)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C"
    },
    "unichem": {
      "chebi": "95123",
      "chembl": "CHEMBL602575",
      "lincs": "LSM-6389",
      "pubchem": "5649"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL602575",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 1111.34
      },
      "moleculeSynonyms": [
        {
          "moleculeSynonym": "GNF-Pf-5297",
          "synType": "RESEARCH_CODE",
          "synonyms": "GNF-Pf-5297"
        }
      ]
    },
    "pubchem": [
      {
        "cid": 5649,
        "inchi": "InChI=1S/C54H90N6O18/c1-22(2)34-49(67)73-31(19)43(61)55-38(26(9)10)53(71)77-41(29(15)16)47(65)59-36(24(5)6)51(69)75-33(21)45(63)57-39(27(11)12)54(72)78-42(30(17)18)48(66)60-35(23(3)4)50(68)74-32(20)44(62)56-37(25(7)8)52(70)76-40(28(13)14)46(64)58-34/h22-42H,1-21H3,(H,55,61)(H,56,62)(H,57,63)(H,58,64)(H,59,65)(H,60,66)",
        "inchikey": "FCFNRCROJUBPLU-UHFFFAOYSA-N",
        "iupac": {
          "systematic": "6,18,30-trimethyl-3,9,12,15,21,24,27,33,36-nona(propan-2-yl)-1,7,13,19,25,31-hexaoxa-4,10,16,22,28,34-hexazacyclohexatriacontane-2,5,8,11,14,17,20,23,26,29,32,35-dodecone"
        },
        "smiles": {
          "canonical": "CC1C(=O)NC(C(=O)OC(C(=O)NC(C(=O)OC(C(=O)NC(C(=O)OC(C(=O)NC(C(=O)OC(C(=O)NC(C(=O)OC(C(=O)NC(C(=O)O1)C(C)C)C(C)C)C(C)C)C)C(C)C)C(C)C)C(C)C)C)C(C)C)C(C)C)C(C)C"
        },
        "molecularFormula": "C54H90N6O18"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:25:46Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8394"
    },
    "name": "BRD-K92748025",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8394.png",
    "lincs": {
      "id": "LSM-8028",
      "name": "BRD-K92748025",
      "pubchemCid": 54618640,
      "chebiId": 96649,
      "inchiParent": "InChI=1S/C23H29N3O4S/c1-17-14-26(18(2)16-27)31(28,29)23-11-9-19(8-10-20-7-5-6-12-24-20)13-21(23)30-22(17)15-25(3)4/h5-7,9,11-13,17-18,22,27H,14-16H2,1-4H3/t17-,18+,22-/m1/s1",
      "inchiKeyParent": "OBRGIGMGBKKHMR-KGVIQGDOSA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@@H](C)[C@@H](CN(C)C)Oc2cc(ccc2S1(=O)=O)C#Cc3ccccn3"
    },
    "unichem": {
      "chebi": "96649",
      "lincs": "LSM-8028",
      "pubchem": "54618640"
    },
    "pubchem": [
      {
        "cid": 54618640,
        "inchi": "InChI=1S/C23H29N3O4S/c1-17-14-26(18(2)16-27)31(28,29)23-11-9-19(8-10-20-7-5-6-12-24-20)13-21(23)30-22(17)15-25(3)4/h5-7,9,11-13,17-18,22,27H,14-16H2,1-4H3/t17-,18+,22-/m1/s1",
        "inchikey": "OBRGIGMGBKKHMR-KGVIQGDOSA-N",
        "iupac": {
          "systematic": "(2S)-2-[(4R,5S)-5-[(dimethylamino)methyl]-4-methyl-1,1-dioxo-8-(2-pyridin-2-ylethynyl)-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-2-yl]propan-1-ol"
        },
        "smiles": {
          "canonical": "CC1CN(S(=O)(=O)C2=C(C=C(C=C2)C#CC3=CC=CC=N3)OC1CN(C)C)C(C)CO"
        },
        "molecularFormula": "C23H29N3O4S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:25:49Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83a6"
    },
    "name": "BRD-K28589277",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83a6.png",
    "lincs": {
      "id": "LSM-10161",
      "name": "BRD-K28589277",
      "pubchemCid": 54661404,
      "chebiId": 98782,
      "inchiParent": "InChI=1S/C21H22FN3O4/c1-23(2)21(29)18-14(11-26)16-10-24-15(4-3-5-17(24)27)19(18)25(16)20(28)12-6-8-13(22)9-7-12/h3-9,14,16,18-19,26H,10-11H2,1-2H3/t14-,16-,18+,19+/m0/s1",
      "inchiKeyParent": "BBMUHFCQMOUBDR-IAAVTCLWSA-N",
      "smilesParent": "CN(C)C(=O)[C@@H]1[C@@H](CO)[C@@H]2CN3C(=O)C=CC=C3[C@H]1N2C(=O)c4ccc(F)cc4"
    },
    "unichem": {
      "chebi": "98782",
      "lincs": "LSM-10161",
      "pubchem": "54661404"
    },
    "pubchem": [
      {
        "cid": 54661404,
        "inchi": "InChI=1S/C21H22FN3O4/c1-23(2)21(29)18-14(11-26)16-10-24-15(4-3-5-17(24)27)19(18)25(16)20(28)12-6-8-13(22)9-7-12/h3-9,14,16,18-19,26H,10-11H2,1-2H3/t14-,16-,18+,19+/m0/s1",
        "inchikey": "BBMUHFCQMOUBDR-IAAVTCLWSA-N",
        "iupac": {
          "systematic": "(1S,9R,10R,11R)-12-(4-fluorobenzoyl)-10-(hydroxymethyl)-N,N-dimethyl-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide"
        },
        "smiles": {
          "canonical": "CN(C)C(=O)C1C(C2CN3C(=O)C=CC=C3C1N2C(=O)C4=CC=C(C=C4)F)CO"
        },
        "molecularFormula": "C21H22FN3O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:25:51Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83ee"
    },
    "name": "BRD-K65766198",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83ee.png",
    "lincs": {
      "id": "LSM-12439",
      "name": "BRD-K65766198",
      "pubchemCid": 54646143,
      "chebiId": 101067,
      "inchiParent": "InChI=1S/C20H28N2O6S/c1-29(25,26)22-13-6-7-17-15(8-13)16-9-14(27-18(11-23)20(16)28-17)10-19(24)21-12-4-2-3-5-12/h6-8,12,14,16,18,20,22-23H,2-5,9-11H2,1H3,(H,21,24)/t14-,16-,18-,20+/m0/s1",
      "inchiKeyParent": "BEWGTMHICYCEOA-PFSLXQJOSA-N",
      "smilesParent": "CS(=O)(=O)Nc1ccc2O[C@H]3[C@H](CO)O[C@H](CC(=O)NC4CCCC4)C[C@H]3c2c1"
    },
    "unichem": {
      "chebi": "101067",
      "lincs": "LSM-12439",
      "pubchem": "54646143"
    },
    "pubchem": [
      {
        "cid": 54646143,
        "inchi": "InChI=1S/C20H28N2O6S/c1-29(25,26)22-13-6-7-17-15(8-13)16-9-14(27-18(11-23)20(16)28-17)10-19(24)21-12-4-2-3-5-12/h6-8,12,14,16,18,20,22-23H,2-5,9-11H2,1H3,(H,21,24)/t14-,16-,18-,20+/m0/s1",
        "inchikey": "BEWGTMHICYCEOA-PFSLXQJOSA-N",
        "iupac": {
          "systematic": "2-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-cyclopentylacetamide"
        },
        "smiles": {
          "canonical": "CS(=O)(=O)NC1=CC2=C(C=C1)OC3C2CC(OC3CO)CC(=O)NC4CCCC4"
        },
        "molecularFormula": "C20H28N2O6S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:25:53Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8374"
    },
    "name": "BRD-K12913157",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8374.png",
    "lincs": {
      "id": "LSM-43367",
      "name": "BRD-K12913157",
      "pubchemCid": 54618099,
      "inchiParent": "InChI=1S/C22H31N5O5S/c1-6-7-17-8-18-21(23-9-17)32-19(15(2)10-27(22(18)29)16(3)13-28)11-26(5)33(30,31)20-12-25(4)14-24-20/h6-9,12,14-16,19,28H,10-11,13H2,1-5H3/b7-6+/t15-,16-,19+/m0/s1",
      "inchiKeyParent": "KGPKEHLIXQTDQP-LAJBOSMKSA-N",
      "smilesParent": "C\\C=C\\c1cnc2O[C@H](CN(C)S(=O)(=O)c3cn(C)cn3)[C@@H](C)CN([C@@H](C)CO)C(=O)c2c1"
    },
    "unichem": {
      "lincs": "LSM-43367",
      "pubchem": "54618099"
    },
    "pubchem": [
      {
        "cid": 54618099,
        "inchi": "InChI=1S/C22H31N5O5S/c1-6-7-17-8-18-21(23-9-17)32-19(15(2)10-27(22(18)29)16(3)13-28)11-26(5)33(30,31)20-12-25(4)14-24-20/h6-9,12,14-16,19,28H,10-11,13H2,1-5H3/b7-6+/t15-,16-,19+/m0/s1",
        "inchikey": "KGPKEHLIXQTDQP-LAJBOSMKSA-N",
        "iupac": {
          "systematic": "N-[[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-prop-1-enyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N,1-dimethylimidazole-4-sulfonamide"
        },
        "smiles": {
          "canonical": "CC=CC1=CC2=C(N=C1)OC(C(CN(C2=O)C(C)CO)C)CN(C)S(=O)(=O)C3=CN(C=N3)C"
        },
        "molecularFormula": "C22H31N5O5S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:25:55Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83a2"
    },
    "name": "BRD-K45265806",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83a2.png",
    "lincs": {
      "id": "LSM-11183",
      "name": "BRD-K45265806",
      "pubchemCid": 56835348,
      "chebiId": 99804,
      "inchiParent": "InChI=1S/C32H36FN3O5S/c1-21-17-36(22(2)19-37)32(38)31-30(25-13-7-9-15-27(25)35(31)4)24-12-6-5-11-23(24)20-41-28(21)18-34(3)42(39,40)29-16-10-8-14-26(29)33/h5-16,21-22,28,37H,17-20H2,1-4H3/t21-,22-,28+/m0/s1",
      "inchiKeyParent": "PCQGWFREXHAZIT-RXYILKCJSA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@H](C)[C@@H](CN(C)S(=O)(=O)c2ccccc2F)OCc3ccccc3c4c(C1=O)n(C)c5ccccc45"
    },
    "unichem": {
      "chebi": "99804",
      "chembl": "CHEMBL3561843",
      "lincs": "LSM-11183",
      "pubchem": "56835348"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL3561843",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 593.72,
        "hba": 6,
        "hbd": 1,
        "qedWeighted": 0.35
      }
    },
    "pubchem": [
      {
        "cid": 56835348,
        "inchi": "InChI=1S/C32H36FN3O5S/c1-21-17-36(22(2)19-37)32(38)31-30(25-13-7-9-15-27(25)35(31)4)24-12-6-5-11-23(24)20-41-28(21)18-34(3)42(39,40)29-16-10-8-14-26(29)33/h5-16,21-22,28,37H,17-20H2,1-4H3/t21-,22-,28+/m0/s1",
        "inchikey": "PCQGWFREXHAZIT-RXYILKCJSA-N",
        "iupac": {
          "systematic": "2-fluoro-N-[[(10S,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylbenzenesulfonamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(C3=CC=CC=C3COC1CN(C)S(=O)(=O)C4=CC=CC=C4F)C5=CC=CC=C5N2C)C(C)CO"
        },
        "molecularFormula": "C32H36FN3O5S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:26:06Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8398"
    },
    "name": "BRD-K42740486",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8398.png",
    "lincs": {
      "id": "LSM-14828",
      "name": "BRD-K42740486",
      "pubchemCid": 44493615,
      "chebiId": 103484,
      "inchiParent": "InChI=1S/C26H44N4O5/c1-17(2)28-26(33)29-21-10-11-23-22(13-21)25(32)30(19(4)16-31)15-18(3)24(14-27-6)34-12-8-7-9-20(5)35-23/h10-11,13,17-20,24,27,31H,7-9,12,14-16H2,1-6H3,(H2,28,29,33)/t18-,19+,20-,24-/m1/s1",
      "inchiKeyParent": "DGSOXKKLHVIDDH-ZBNTXBBCSA-N",
      "smilesParent": "CNC[C@H]1OCCCC[C@@H](C)Oc2ccc(NC(=O)NC(C)C)cc2C(=O)N(C[C@H]1C)[C@@H](C)CO"
    },
    "unichem": {
      "chebi": "103484",
      "lincs": "LSM-14828",
      "pubchem": "44493615"
    },
    "pubchem": [
      {
        "cid": 44493615,
        "inchi": "InChI=1S/C26H44N4O5/c1-17(2)28-26(33)29-21-10-11-23-22(13-21)25(32)30(19(4)16-31)15-18(3)24(14-27-6)34-12-8-7-9-20(5)35-23/h10-11,13,17-20,24,27,31H,7-9,12,14-16H2,1-6H3,(H2,28,29,33)/t18-,19+,20-,24-/m1/s1",
        "inchikey": "DGSOXKKLHVIDDH-ZBNTXBBCSA-N",
        "iupac": {
          "systematic": "1-[(3R,9S,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-propan-2-ylurea"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NC(=O)NC(C)C)C(C)CO)C)CNC"
        },
        "molecularFormula": "C26H44N4O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:26:08Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83bd"
    },
    "name": "BRD-K26857129",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83bd.png",
    "lincs": {
      "id": "LSM-10056",
      "name": "BRD-K26857129",
      "pubchemCid": 54631784,
      "chebiId": 98677,
      "inchiParent": "InChI=1S/C29H38N4O5/c1-19-16-33(27(34)14-21-10-11-21)20(2)18-38-25-13-12-23(31-29(36)30-22-8-6-5-7-9-22)15-24(25)28(35)32(3)17-26(19)37-4/h5-9,12-13,15,19-21,26H,10-11,14,16-18H2,1-4H3,(H2,30,31,36)/t19-,20+,26-/m0/s1",
      "inchiKeyParent": "ZWMNFEZEGHFZOH-UNVFRBQDSA-N",
      "smilesParent": "CO[C@H]1CN(C)C(=O)c2cc(NC(=O)Nc3ccccc3)ccc2OC[C@@H](C)N(C[C@@H]1C)C(=O)CC4CC4"
    },
    "unichem": {
      "chebi": "98677",
      "lincs": "LSM-10056",
      "pubchem": "54631784"
    },
    "pubchem": [
      {
        "cid": 54631784,
        "inchi": "InChI=1S/C29H38N4O5/c1-19-16-33(27(34)14-21-10-11-21)20(2)18-38-25-13-12-23(31-29(36)30-22-8-6-5-7-9-22)15-24(25)28(35)32(3)17-26(19)37-4/h5-9,12-13,15,19-21,26H,10-11,14,16-18H2,1-4H3,(H2,30,31,36)/t19-,20+,26-/m0/s1",
        "inchikey": "ZWMNFEZEGHFZOH-UNVFRBQDSA-N",
        "iupac": {
          "systematic": "1-[(4R,7S,8R)-5-(2-cyclopropylacetyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-phenylurea"
        },
        "smiles": {
          "canonical": "CC1CN(C(COC2=C(C=C(C=C2)NC(=O)NC3=CC=CC=C3)C(=O)N(CC1OC)C)C)C(=O)CC4CC4"
        },
        "molecularFormula": "C29H38N4O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:26:10Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83c5"
    },
    "name": "Epigalocatechin Gallate",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83c5.png",
    "lincs": {
      "id": "LSM-5661",
      "name": "Epigalocatechin Gallate",
      "alternativeNames": [
        "Egcg",
        "(-)-Epigallocatechin gallate",
        "(?)-Epigallocatechin gallate",
        "Epigallocatechin Gallate",
        "Epigalocatechin Gallate"
      ],
      "pubchemCid": 65064,
      "chebiId": 4806,
      "inchiParent": "InChI=1S/C22H18O11/c23-10-5-12(24)11-7-18(33-22(31)9-3-15(27)20(30)16(28)4-9)21(32-17(11)6-10)8-1-13(25)19(29)14(26)2-8/h1-6,18,21,23-30H,7H2/t18-,21-/m1/s1",
      "inchiKeyParent": "WMBWREPUVVBILR-WIYYLYMNSA-N",
      "smilesParent": "Oc1cc(O)c2C[C@@H](OC(=O)c3cc(O)c(O)c(O)c3)[C@H](Oc2c1)c4cc(O)c(O)c(O)c4"
    },
    "unichem": {
      "chebi": "4806",
      "chembl": "CHEMBL297453",
      "lincs": "LSM-5661",
      "pubchem": "65064",
      "drugbank": "DB12116"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL297453",
      "prefName": "EPIGALOCATECHIN GALLATE",
      "maxPhase": 3.0,
      "maxPhaseCurated": "Phase 3 Clinical Trials",
      "chebiParId": "4806",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 458.38,
        "hba": 11,
        "hbd": 8,
        "qedWeighted": 0.21
      },
      "moleculeSynonyms": [
        {
          "moleculeSynonym": "(-)-Epigallocatechin Gallate",
          "synType": "OTHER",
          "synonyms": "(-)-Epigallocatechin Gallate"
        },
        {
          "moleculeSynonym": "Epigalocatechin gallate",
          "synType": "OTHER",
          "synonyms": "EPIGALOCATECHIN GALLATE"
        }
      ],
      "drugIndications": [
        {
          "efoId": "EFO:0000280",
          "efoTerm": "Barrett's esophagus",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT00233935"
            ]
          },
          "maxPhaseForInd": 1.0,
          "meshHeading": "Barrett Esophagus"
        },
        {
          "efoId": "EFO:0000284",
          "efoTerm": "benign prostatic hyperplasia",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT00596011"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Prostatic Hyperplasia"
        },
        {
          "efoId": "EFO:0000565",
          "efoTerm": "leukemia",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT00262743"
            ]
          },
          "maxPhaseForInd": 1.0,
          "meshHeading": "Leukemia"
        },
        {
          "efoId": "EFO:0000616",
          "efoTerm": "neoplasm",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT00003197,NCT00091325"
            ]
          },
          "maxPhaseForInd": 1.0,
          "meshHeading": "Neoplasms"
        },
        {
          "efoId": "EFO:0000673",
          "efoTerm": "prostate adenocarcinoma",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT00459407,NCT01912820"
            ]
          },
          "maxPhaseForInd": 1.0,
          "meshHeading": "Prostatic Neoplasms"
        },
        {
          "efoId": "EFO:0000764",
          "efoTerm": "HIV infection",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT01433289"
            ]
          },
          "maxPhaseForInd": 1.0,
          "meshHeading": "HIV Infections"
        },
        {
          "efoId": "EFO:0000768",
          "efoTerm": "idiopathic pulmonary fibrosis",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT03928847"
            ]
          },
          "maxPhaseForInd": 0.5,
          "meshHeading": "Idiopathic Pulmonary Fibrosis"
        },
        {
          "efoId": "EFO:0001064",
          "efoTerm": "Down syndrome",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT01394796,NCT01699711"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Down Syndrome"
        },
        {
          "efoId": "EFO:0001065",
          "efoTerm": "endometriosis",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT02832271"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Endometriosis"
        },
        {
          "efoId": "EFO:0001378",
          "efoTerm": "multiple myeloma",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT00942422"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Multiple Myeloma"
        },
        {
          "efoId": "EFO:0001422",
          "efoTerm": "cirrhosis of liver",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT03278925"
            ]
          },
          "maxPhaseForInd": 1.0,
          "meshHeading": "Liver Cirrhosis"
        },
        {
          "efoId": "EFO:0003060",
          "efoTerm": "non-small cell lung carcinoma",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT00707252"
            ]
          },
          "maxPhaseForInd": 1.0,
          "meshHeading": "Carcinoma, Non-Small-Cell Lung"
        },
        {
          "efoId": "EFO:0003882",
          "efoTerm": "osteoporosis",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT00625391"
            ]
          },
          "maxPhaseForInd": 1.0,
          "meshHeading": "Osteoporosis"
        },
        {
          "efoId": "EFO:0003929",
          "efoTerm": "relapsing-remitting multiple sclerosis",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT00525668"
            ]
          },
          "maxPhaseForInd": 1.0,
          "meshHeading": "Multiple Sclerosis, Relapsing-Remitting"
        },
        {
          "efoId": "EFO:0004252",
          "efoTerm": "nasopharyngeal neoplasm",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT01744587"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Nasopharyngeal Neoplasms"
        },
        {
          "efoId": "EFO:0007147",
          "efoTerm": "anogenital venereal wart",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT00449982"
            ]
          },
          "maxPhaseForInd": 3.0,
          "meshHeading": "Condylomata Acuminata"
        },
        {
          "efoId": "EFO:0008517",
          "efoTerm": "oral lichen planus",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT02329600"
            ]
          },
          "maxPhaseForInd": 3.0,
          "meshHeading": "Lichen Planus, Oral"
        },
        {
          "efoId": "EFO:1001050",
          "efoTerm": "multiple system atrophy",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT02008721"
            ]
          },
          "maxPhaseForInd": 3.0,
          "meshHeading": "Multiple System Atrophy"
        },
        {
          "efoId": "Orphanet:303",
          "efoTerm": "Dystrophic epidermolysis bullosa",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT00951964"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Epidermolysis Bullosa Dystrophica"
        },
        {
          "efoId": "EFO:0000432",
          "efoTerm": "breast ductal carcinoma in situ",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT01060345"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Carcinoma, Intraductal, Noninfiltrating"
        },
        {
          "efoId": "EFO:0000731",
          "efoTerm": "uterine fibroid",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT04177693,NCT05364008"
            ]
          },
          "maxPhaseForInd": 3.0,
          "meshHeading": "Leiomyoma"
        },
        {
          "efoId": "MONDO:0001187",
          "efoTerm": "urinary bladder cancer",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT00088946,NCT00666562"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Urinary Bladder Neoplasms"
        },
        {
          "efoId": "MONDO:0007254",
          "efoTerm": "breast cancer",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT00516243,NCT00676793,NCT00917735"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Breast Neoplasms"
        },
        {
          "efoId": "MONDO:0008315",
          "efoTerm": "prostate cancer",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT00005828,NCT00676780,NCT01340599"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Prostatic Neoplasms, Castration-Resistant"
        },
        {
          "efoId": "MONDO:0008903",
          "efoTerm": "lung cancer",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT00363805"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Lung Neoplasms"
        },
        {
          "efoId": "MONDO:0018906",
          "efoTerm": "follicular lymphoma",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT00455416"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Lymphoma, Follicular"
        },
        {
          "efoId": "MONDO:0021063",
          "efoTerm": "malignant colon neoplasm",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT02891538"
            ]
          },
          "maxPhaseForInd": 0.5,
          "meshHeading": "Colonic Neoplasms"
        },
        {
          "efoId": "MONDO:0043510",
          "efoTerm": "brain injury",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT02731495"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Brain Injuries"
        },
        {
          "efoId": "MP:0001845",
          "efoTerm": "inflammation",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT04553666"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Inflammation"
        },
        {
          "efoId": "EFO:0000763",
          "efoTerm": "viral disease",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT04898023"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Virus Diseases"
        },
        {
          "efoId": "MONDO:0004975",
          "efoTerm": "Alzheimer disease",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT00951834"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Alzheimer Disease"
        },
        {
          "efoId": "MONDO:0005148",
          "efoTerm": "type 2 diabetes mellitus",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT00567905,NCT02627898"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Diabetes Mellitus, Type 2"
        },
        {
          "efoId": "MONDO:0005180",
          "efoTerm": "Parkinson disease",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT00461942"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Parkinson Disease"
        },
        {
          "efoId": "MONDO:0005301",
          "efoTerm": "multiple sclerosis",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT00799890,NCT00836719,NCT01451723"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Multiple Sclerosis"
        },
        {
          "efoId": "MONDO:0007739",
          "efoTerm": "Huntington disease",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT01357681"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Huntington Disease"
        },
        {
          "efoId": "MONDO:0010383",
          "efoTerm": "fragile X syndrome",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT01855971"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Fragile X Syndrome"
        },
        {
          "efoId": "MONDO:0010679",
          "efoTerm": "Duchenne muscular dystrophy",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT01183767"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Muscular Dystrophy, Duchenne"
        },
        {
          "efoId": "MONDO:0019438",
          "efoTerm": "AL amyloidosis",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT02015312"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Amyloidosis, Familial"
        },
        {
          "efoId": "MONDO:0007915",
          "efoTerm": "systemic lupus erythematosus",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT02875691"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Lupus Erythematosus, Systemic"
        }
      ]
    },
    "pubchem": [
      {
        "cid": 65064,
        "inchi": "InChI=1S/C22H18O11/c23-10-5-12(24)11-7-18(33-22(31)9-3-15(27)20(30)16(28)4-9)21(32-17(11)6-10)8-1-13(25)19(29)14(26)2-8/h1-6,18,21,23-30H,7H2/t18-,21-/m1/s1",
        "inchikey": "WMBWREPUVVBILR-WIYYLYMNSA-N",
        "iupac": {
          "systematic": "[(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl] 3,4,5-trihydroxybenzoate"
        },
        "smiles": {
          "canonical": "C1C(C(OC2=CC(=CC(=C21)O)O)C3=CC(=C(C(=C3)O)O)O)OC(=O)C4=CC(=C(C(=C4)O)O)O"
        },
        "molecularFormula": "C22H18O11"
      }
    ],
    "clinicaltrials": [
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00718094",
            "briefTitle": "Pilot Study of Green Tea Extract (Polyphenon E\u00ae)in Ulcerative Colitis",
            "officialTitle": "A Phase IIa Pilot Study to Determine the Safety of an Oral Dose of Green Tea Extract (Polyphenon E\u00ae) and Provide Preliminary Evidence to Support Its Efficacy in Ulcerative Colitis"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2008-07-16",
            "resultsFirstSubmitDate": "2017-04-12"
          },
          "conditionsModule": {
            "conditions": [
              "Mild to Moderately Active Ulcerative Colitis"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Number of Subjects With a Reduction in the Disease Activity Index of >3, or Clinical Remission.",
                "timeFrame": "day 56"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01008020",
            "briefTitle": "Effects of Tea Catechin Consumption on the Prophylaxis of Influenza Infection",
            "officialTitle": "A Randomized Controlled Study on the Effects of Tea Catechin Consumption on the Prevention of Influenza Infection in Healthy Adults"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2009-10-29"
          },
          "conditionsModule": {
            "conditions": [
              "Influenza Infection"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "the incidence rates of influenza infection",
                "timeFrame": "Until 5 months consumption of the study capsules"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "the incidence rates of upper respiratory tract infections"
              },
              {
                "measure": "the severity of the symptoms and the duration of the cold among incident cases"
              },
              {
                "measure": "occurrence of the adverse events"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00981292",
            "briefTitle": "Effects of Epigallocatechin Gallate (EGCG) in Healthy, Young Adults",
            "officialTitle": "Cerebral Blood Flow, Cerebro-electrical Activity and Behavioural Effects of Epigallocatechin Gallate (EGCG) Administration in Healthy, Young Adults"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2009-09-21",
            "resultsFirstSubmitDate": "2010-06-25"
          },
          "conditionsModule": {
            "conditions": [
              "Cognitive Function",
              "Mood"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Modulation of Levels of Total Haemoglobin",
                "timeFrame": "42 minutes"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Number of Participants With Significant Modulation of Cognitive Performance"
              },
              {
                "measure": "Number of Participants With Significant Modulation of Mood."
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT06285357",
            "briefTitle": "The Effect of the Association EGCG, Folic Acid and Vitamin B12 in Preventing the Persistence of HPV Infection.",
            "officialTitle": "A Pilot Study to Test the Effect of the Association of Epigallocatechin Gallate (EGCG), Folic Acid and Vitamin B12 in Preventing the Persistence of Human Papilloma Virus (HPV) Infection."
          },
          "statusModule": {
            "overallStatus": "RECRUITING",
            "studyFirstSubmitDate": "2024-02-22"
          },
          "conditionsModule": {
            "conditions": [
              "HPV Infection"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "HPV DNA test negativity",
                "timeFrame": "8 months of treatment"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT03194620",
            "briefTitle": "Absorption, Metabolism and Excretion of Dietary Polyphenolic Bioactives in Humans",
            "officialTitle": "Absorption, Metabolism and Excretion of Dietary Polyphenolic Bioactives in Humans"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2017-06-19"
          },
          "conditionsModule": {
            "conditions": [
              "Healthy"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Changes in the concentration of flavanol metabolites in urine.",
                "timeFrame": "Urine collected 12h previous to intervention and up to 24 h after intervention"
              },
              {
                "measure": "Changes in the concentration of flavanol metabolites in plasma",
                "timeFrame": "Plasma collected before (0h) and up to 6h post intervention"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00666562",
            "briefTitle": "Green Tea Extract in Treating Patients With Nonmetastatic Bladder Cancer",
            "officialTitle": "A Phase II Randomized, Placebo-Controlled Trial of Polyphenon E to Evaluate Bladder Tissue Levels of EGCG"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2008-04-24",
            "resultsFirstSubmitDate": "2016-01-20"
          },
          "conditionsModule": {
            "conditions": [
              "Stage I Bladder Cancer",
              "Stage II Bladder Cancer",
              "Stage III Bladder Cancer"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Epigallocatechin Gallate (EGCG) Levels in Nonmalignant Bladder Tissue (e.g., Normal-appearing Urothelium, Inflammatory Lesions in the Bladder, Sessile Noninvasive Bladder Tumors, and Papillary Noninvasive Bladder Tumors)",
                "timeFrame": "up to 28 days"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Levels of EGCG in Malignant Bladder Tissue"
              },
              {
                "measure": "Levels of Surrogate Intermediate Endpoint Biomarkers in Malignant and Nonmalignant Bladder Tissue Assessed by Immunohistochemistry"
              },
              {
                "measure": "Serum Insulin Growth Factor-1 (IGF-1) Levels Assessed by ELISA"
              },
              {
                "measure": "Levels of Other Catechins (Epicatechin Gallate, Epicatechin, and Epigallocatechin) Found in Polyphenon E Tumor Tissue Samples"
              },
              {
                "measure": "Absolute Change for Baseline From EGCG in Serum Samples"
              },
              {
                "measure": "Metabolism of EGCG in Serum and Urine in Relation to Pharmacogenetic Polymorphisms in Catechol-O-Methyltransferase (COMT)"
              },
              {
                "measure": "Serum IGFBP-3 Levels Assessed by ELISA"
              },
              {
                "measure": "Levels of Other Catechins (Epicatechin Gallate, Epicatechin, and Epigallocatechin) Found in Polyphenon E Normal Tissue Samples"
              },
              {
                "measure": "Absolute Change From Baseline of Other Catechins (Epicatechin Gallate, Epicatechin, and Epigallocatechin) Found in Polyphenon E in Urine Samples"
              },
              {
                "measure": "Absolute Change From Baseline of Other Catechins (Epicatechin Gallate, Epicatechin, and Epigallocatechin) Found in Polyphenon E Plasma Samples"
              },
              {
                "measure": "Absolute Change for Baseline of EGCG in Urine Samples"
              },
              {
                "measure": "Metabolism of EGCG in Serum and Urine in Relation to Pharmacogenetic Polymorphisms in Uridinediphosphate- Glucuronosyltransferase (UGT)"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT03608176",
            "briefTitle": "Evaluation of the Plant-based Approaches to Stop Obesity Diet for the Treatment of Overweight and Obesity",
            "officialTitle": "Evaluation of the Efficacy of Plant-based Approaches to Stop Obesity Diet in Comparison With a Control Group on Body Weight in Mexican Adults With Overweight and Obesity: Randomized Controlled Trial"
          },
          "statusModule": {
            "overallStatus": "UNKNOWN",
            "studyFirstSubmitDate": "2018-07-23"
          },
          "conditionsModule": {
            "conditions": [
              "Overweight and Obesity"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Change in body weight",
                "timeFrame": "baseline to 3 months"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Change in waist circumference"
              },
              {
                "measure": "Change in body fat percentage"
              },
              {
                "measure": "Change in the Beck Depression Inventory score"
              },
              {
                "measure": "Change in the Short Form-36 Health Survey score"
              },
              {
                "measure": "Change in systolic and diastolic blood pressure"
              },
              {
                "measure": "Change in fasting glucose"
              },
              {
                "measure": "Change in total cholesterol"
              },
              {
                "measure": "Change in LDL-cholesterol"
              },
              {
                "measure": "Change in HDL-cholesterol"
              },
              {
                "measure": "Change in triglycerides"
              },
              {
                "measure": "Change in gamma glutamyl transferase"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT03883880",
            "briefTitle": "Salivary Interactions With Chemosensations",
            "officialTitle": "Salivary Interactions With Chemosensations"
          },
          "statusModule": {
            "overallStatus": "TERMINATED",
            "whyStopped": "COVID (completed first intervention type only)",
            "studyFirstSubmitDate": "2019-03-18"
          },
          "conditionsModule": {
            "conditions": [
              "Diet, Food Choice, Taste"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Salivary proteins",
                "timeFrame": "9 months per sub-study (intervention type)"
              },
              {
                "measure": "Flavor intensity ratings",
                "timeFrame": "9 months per sub-study (intervention type)"
              },
              {
                "measure": "Flavor rankings",
                "timeFrame": "9 months per sub-study (intervention type)"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT04553666",
            "briefTitle": "Reducing Frailty for Older Cancer Survivors Using Supplements",
            "officialTitle": "Reducing Frailty for Older Cancer Survivors Using Supplements (ReFOCUS): A Phase 2 Randomized Controlled Trial of Epigallocatechin-3-Gallate (EGCG) on Frailty and Inflammation in Older Survivors of Cancer"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2020-09-04",
            "resultsFirstSubmitDate": "2024-08-07"
          },
          "conditionsModule": {
            "conditions": [
              "Frailty",
              "Inflammation"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Recruitment Feasibility: Rates of Consent",
                "timeFrame": "Baseline"
              },
              {
                "measure": "Recruitment Feasibility: Rates of Randomization",
                "timeFrame": "Baseline"
              },
              {
                "measure": "The Proportion of Participants That Completed the Study",
                "timeFrame": "12 week"
              },
              {
                "measure": "The Proportion of Participants That Were Adherent to the Intervention",
                "timeFrame": "12 week"
              },
              {
                "measure": "Safety of the EGCG Intervention",
                "timeFrame": "12 weeks"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT04446065",
            "briefTitle": "Previfenon\u00ae as Chemoprophylaxis of COVID-19 in Health Workers",
            "officialTitle": "A Multicenter, Double-blind, Randomized, Placebo-controlled Clinical Trial to Protect Health Workers Against COVID-19 by Using Previfenon\u00ae as Chemoprophylaxis During a SARS-CoV-2 Outbreak. The HERD Study"
          },
          "statusModule": {
            "overallStatus": "UNKNOWN",
            "studyFirstSubmitDate": "2020-06-23"
          },
          "conditionsModule": {
            "conditions": [
              "COVID-19",
              "SARS-CoV2"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Event of clinical acute respiratory disease with a diagnosis of COVID-19 confirmed with rtPCR",
                "timeFrame": "The date for censoring a case will be defined as that date when the rtPCR test results positive minus 4 days, with the aim to calculate the time free of clinically defined COVID-19 infection over 40 to 70 days of intervention"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Rate of positive cases for IgM and IgG anti-SARS-CoV-2"
              },
              {
                "measure": "Composite outcome considering symptomatic and asymptomatic cases with positive rtPCR test"
              },
              {
                "measure": "Hospitalization due to any acute respiratory infection"
              },
              {
                "measure": "Event of upper and lower airway respiratory infection"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01993966",
            "briefTitle": "EGCG Modulate the Cytotoxic Effects of Chemotherapeutic Agents in Human Urothelial Carcinoma Cells",
            "officialTitle": "Mechanism of (-)-Epigallocatechin -3-gallate (EGCG) to Modulate the Cytotoxic Effects of Chemotherapeutic Agents in Human Urothelial Carcinoma Cells"
          },
          "statusModule": {
            "overallStatus": "UNKNOWN",
            "studyFirstSubmitDate": "2013-10-24"
          },
          "conditionsModule": {
            "conditions": [
              "Urothelial Carcinoma"
            ]
          },
          "designModule": {
            "studyType": "OBSERVATIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "The IHC staining score",
                "timeFrame": "at the time of surgery"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01360320",
            "briefTitle": "Minimizing the Risk of Metachronous Adenomas of the Colorectum With Green Tea Extract -MIRACLE-",
            "officialTitle": "Minimizing the Risk of Metachronous Adenomas of the Colorectum With Green Tea Extract -MIRACLE-"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2011-05-23"
          },
          "conditionsModule": {
            "conditions": [
              "Colorectal Serrated Adenomas",
              "Colorectal Tubular Adenomas",
              "Colorectal Villous Adenomas",
              "Colorectal Tubulovillous Adenomas"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Incidence of metachronous colorectal adenomas (tubulovillous, tubular, villous and serrated lesions) at the 3 year follow-up colonoscopy",
                "timeFrame": "3 years"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Occurrences of colorectal adenomas or mucosal lesions"
              },
              {
                "measure": "Number of colorectal adenomas or mucosal lesions"
              },
              {
                "measure": "Size of colorectal adenomas or mucosal lesions"
              },
              {
                "measure": "Localization of colorectal adenomas or mucosal lesions"
              },
              {
                "measure": "Histological subtypes of colorectal adenomas or mucosal lesions"
              },
              {
                "measure": "Invasive growth of colorectal adenomas or mucosal lesions"
              },
              {
                "measure": "Incidence of colorectal carcinoma"
              },
              {
                "measure": "Translational research"
              },
              {
                "measure": "Toxicity and feasibility"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT03199430",
            "briefTitle": "Epigallocatechin Gallate Lowers Circulating Catecholamine Concentrations and Alters Lipid Metabolism.",
            "officialTitle": "The Polyphenol Epigallocatechin Gallate Lowers Circulating Catecholamine Concentrations and Alters Lipid Metabolism During Graded Exercise in Man."
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2016-08-03"
          },
          "conditionsModule": {
            "conditions": [
              "EGCG Influence on Catecholamine Metabolism"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "change in Adrenaline & Noradrenaline concentrations (nmol.l-1)",
                "timeFrame": "Relativised to each metabolic domain; rest, 2 hours post ingestion, highest lipid oxidation rate during exercise, lactate threshold and VO2peak (participant dependant)"
              },
              {
                "measure": "Changes in Metanephrine and Normetanephrine (pmol.l-1)",
                "timeFrame": "Relativised to each metabolic domain; rest, 2 hours post ingestion, highest lipid oxidation rate during exercise, lactate threshold and VO2peak (participant dependant)"
              },
              {
                "measure": "Changes in lipid and carbohydrate oxidation (g.min-1)",
                "timeFrame": "Over a period of approximately 2 and a half hours with the data collected relativised to each metabolic domain; rest, highest lipid oxidation rate during exercise, lactate threshold and VO2peak (participant dependant)"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Changes in blood glucose concentrations (mmol.l-1)"
              },
              {
                "measure": "Changes in exercise performance (S) under EGCG and placebo conditions."
              },
              {
                "measure": "Changes in blood lactate concentrations (mmol.l-1)"
              },
              {
                "measure": "Changes in exercise performance (W) under EGCG and placebo conditions."
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00812448",
            "briefTitle": "Catechin Containing Mask for the Prevention of Influenza Infection",
            "officialTitle": "The Effects of Tea Catechin Extracts Containing Mask on the Prevention of Influenza Infection"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2008-12-18"
          },
          "conditionsModule": {
            "conditions": [
              "Influenza Infection"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "the incidence rate of influenza infection during the study",
                "timeFrame": "assessed at each month"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "the incidence rates of upper respiratory tract infections"
              },
              {
                "measure": "the severity of the symptoms and the duration of the cold among incident cases"
              },
              {
                "measure": "he incidence-free time for influenza or upper respiratory tract infections after the intervention"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT05448365",
            "briefTitle": "Vitamin D, Epigallocatechin Gallate, D-chiro-inositol and Vitamin B6 in Uterine Fibroid",
            "officialTitle": "The Use of Vitamin D in Combination with Epigallocatechin Gallate, D-chiro-inositol and Vitamin B6 in the Treatment of Women with Uterine Fibroid"
          },
          "statusModule": {
            "overallStatus": "RECRUITING",
            "studyFirstSubmitDate": "2022-07-04"
          },
          "conditionsModule": {
            "conditions": [
              "Uterine Fibroids",
              "D-chiro-inositol",
              "Inositol",
              "Epigallocatechin Gallate",
              "Vitamin D",
              "Vitamin B6"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Diameter",
                "timeFrame": "3 months"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Volume"
              },
              {
                "measure": "Need for surgery"
              },
              {
                "measure": "pVEGF-R"
              },
              {
                "measure": "Marker of cellular proliferation"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00692731",
            "briefTitle": "Efficacy of a Tea Catechin Sports Drink for Enhancing Exercise-Induced Fat Loss",
            "officialTitle": "A Randomized, Double-Blind, Controlled Study to Assess the Efficacy of a Tea Catechin Sports Drink for Enhancing Exercise-Induced Fat Loss"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2008-06-04"
          },
          "conditionsModule": {
            "conditions": [
              "Overweight",
              "Obesity"
            ]
          },
          "designModule": {
            "studyType": "OBSERVATIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Changes in body fat mass.",
                "timeFrame": "Baseline to end-of-treatment"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Changes in body weight"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT03278925",
            "briefTitle": "Defined Green Tea Catechin Extract in Preventing Liver Cancer in Participants With Cirrhosis",
            "officialTitle": "A Phase I Single-arm, Multicenter Pilot Study Aimed at Validating \u03b3-OHPdG as a Biomarker and Testing the Effects of Polyphenon E on Its Levels in Patients With Cirrhosis"
          },
          "statusModule": {
            "overallStatus": "ACTIVE_NOT_RECRUITING",
            "studyFirstSubmitDate": "2017-09-11"
          },
          "conditionsModule": {
            "conditions": [
              "Cirrhosis"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Maximum tolerated dose of Polyphenon E",
                "timeFrame": "Up to 4 weeks"
              },
              {
                "measure": "Change in gamma-hydroxy-1,N(2)-propanodeoxyguanosine (gamma-OHPdG) expression in cirrhotic liver",
                "timeFrame": "Baseline up to 24 weeks"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Fraction of patients with liver cirrhosis that have high levels of gamma-OHPdG"
              },
              {
                "measure": "Change in gamma-OHPdG"
              },
              {
                "measure": "Polyphenon E pharmacokinetic data in blood and urine in patients with cirrhosis"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00091325",
            "briefTitle": "Green Tea Extract (Polyphenon E) in Preventing Cancer in Healthy Participants",
            "officialTitle": "Phase I Drug Interaction Clinical Study of Polyphenon E"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2004-09-07"
          },
          "conditionsModule": {
            "conditions": [
              "Unspecified Adult Solid Tumor, Protocol Specific"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01433289",
            "briefTitle": "Study to Evaluate Safety and Toxicity of Polyphenon E (EGCG) in HIV-1-Infected Individuals",
            "officialTitle": "Placebo-Controlled, Dose-Blinded, Dose Escalation Study to Evaluate Safety, Tolerability, Pharmacokinetics and Antiviral Activity of Polyphenon E (EGCG) 14 Day Monotherapy in Antiretroviral Na\u00efve and Experienced, HIV-1-Infected Subjects"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2011-09-09",
            "resultsFirstSubmitDate": "2022-01-20"
          },
          "conditionsModule": {
            "conditions": [
              "HIV Infection"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Number of Participants With Adverse Events",
                "timeFrame": "14 days"
              },
              {
                "measure": "Median Change of log10 HIV-1 RNA Copies/ml",
                "timeFrame": "Baseline and 14 days"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Number of Participants Achieving > 0.75 or 1.0 log10 Reduction in HIV-1 RNA or <400 Copies/ml"
              },
              {
                "measure": "The Mean Change in CD4+ T Lymphocyte Counts"
              },
              {
                "measure": "Composite of Pharmacokinetics Time Frame: Predose, 0,0.5,1,1.5,2,3,4,6,8,12 Hours Post-dose"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT05409872",
            "briefTitle": "Effects of Vitamin D, Epigallocatechin Gallate, Vitamin B6, and D-Chiro-inositol Combination on Uterine Fibroids",
            "officialTitle": "Effects of Vitamin D, Epigallocatechin Gallate, Vitamin B6, and D-Chiro-inositol Combination on Uterine Fibroids: a Randomized Controlled Trial"
          },
          "statusModule": {
            "overallStatus": "RECRUITING",
            "studyFirstSubmitDate": "2022-06-03"
          },
          "conditionsModule": {
            "conditions": [
              "Leiomyoma, Uterine"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Symptoms related to uterine fibromatosis (UFS-QoL questionnaire)",
                "timeFrame": "After 3 months of treatment"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "The proportion of patients who refuse surgery due to regression of symptoms."
              },
              {
                "measure": "Volume of the larger fibroid"
              },
              {
                "measure": "Quality of life (UFS-QoL questionnaire)"
              },
              {
                "measure": "The total score obtained in the Menstrual assessment chart"
              },
              {
                "measure": "The total score obtained in the Pad test"
              },
              {
                "measure": "Proportion of patients who reported side effects or who stopped taking the treatment"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00525668",
            "briefTitle": "Sunphenon Epigallocatechin-gallate (EGCg) in Relapsing-remitting Multiple Sclerosis (SuniMS Study)",
            "officialTitle": "Sunphenon EGCg (Epigallocatechin-gallate) in Relapsing-remitting Multiple Sclerosis (SuniMS Study)"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2007-09-04"
          },
          "conditionsModule": {
            "conditions": [
              "Relapsing-remitting Multiple Sclerosis"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "number of new T2 lesions on brain MRI performed after 18 months of Sunphenon treatment compared to baseline MRI in the verum arm versus placebo",
                "timeFrame": "18 months"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "development of brain atrophy under treatment with EGCG vs. placebo"
              },
              {
                "measure": "Safety and tolerability"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT06768086",
            "briefTitle": "Preoperative Administration of EGCG, Vitamin D and DCI Prior Hysteroscopic Myomectomy",
            "officialTitle": "3 Months Preoperative Administration of Eutris Plus Prior Hysteroscopic Myomectomy: a Pilot Study"
          },
          "statusModule": {
            "overallStatus": "NOT_YET_RECRUITING",
            "studyFirstSubmitDate": "2024-12-31"
          },
          "conditionsModule": {
            "conditions": [
              "Uterine Fibroids",
              "Hysteroscopic Myomectomy",
              "Treatment Compliance",
              "Patient Compliance",
              "Treatment Complication"
            ]
          },
          "designModule": {
            "studyType": "OBSERVATIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Operative results",
                "timeFrame": "8 months"
              },
              {
                "measure": "Surgical results",
                "timeFrame": "8 months"
              },
              {
                "measure": "Hysteroscopic results",
                "timeFrame": "8 months"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Complete resection of fibroids"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00942422",
            "nctIdAliases": [
              "NCT01589887"
            ],
            "briefTitle": "Green Tea Extract in Treating Patients With Monoclonal Gammopathy of Undetermined Significance and/or Smoldering Multiple Myeloma",
            "officialTitle": "The Clinical and Biologic Evaluation of Polyphenon E, an Extract of Green Tea Containing EGCG, in Plasma Cell Dyscrasias - Pilot Study"
          },
          "statusModule": {
            "overallStatus": "TERMINATED",
            "whyStopped": "Low accrual and early termination",
            "studyFirstSubmitDate": "2009-07-17",
            "resultsFirstSubmitDate": "2015-02-03"
          },
          "conditionsModule": {
            "conditions": [
              "Multiple Myeloma and Plasma Cell Neoplasm",
              "Precancerous Condition"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Sustained M-protein Reduction of \u2265 25% From Baseline",
                "timeFrame": "Day one of each 28-day cycle for a total of up to 6 cycles"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT03413735",
            "briefTitle": "Dietary Green Tea Confection For Resolving Gut Permeability-Induced Metabolic Endotoxemia In Obese Adults",
            "officialTitle": "Dietary Green Tea Confection For Resolving Gut Permeability-Induced Metabolic Endotoxemia In Obese Adults"
          },
          "statusModule": {
            "overallStatus": "UNKNOWN",
            "studyFirstSubmitDate": "2018-01-22"
          },
          "conditionsModule": {
            "conditions": [
              "Obesity",
              "Endotoxemia",
              "Inflammation"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Endotoxin",
                "timeFrame": "Week 0 - Fasting"
              },
              {
                "measure": "Endotoxin",
                "timeFrame": "Week 2 - Fasting"
              },
              {
                "measure": "Endotoxin",
                "timeFrame": "Week 4 - Fasting"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Gut Permeability - Lactulose to Mannitol Ratio"
              },
              {
                "measure": "Gut Permeability - Lactulose to Mannitol Ratio"
              },
              {
                "measure": "Gut Permeability - Lactulose to Mannitol Ratio"
              },
              {
                "measure": "Gut Permeability - Lactulose to Mannitol Ratio"
              },
              {
                "measure": "Gut Permeability - Sucralose to Erythritol Ratio"
              },
              {
                "measure": "Gut Permeability - Sucralose to Erythritol Ratio"
              },
              {
                "measure": "Gut Permeability - Sucralose to Erythritol Ratio"
              },
              {
                "measure": "Gut Permeability - Sucralose to Erythritol Ratio"
              },
              {
                "measure": "Firmicutes to Bacteroidetes Ratio - Microbiota"
              },
              {
                "measure": "Firmicutes to Bacteroidetes Ratio - Microbiota"
              },
              {
                "measure": "Bioavailability - Epigallocatechin gallate"
              },
              {
                "measure": "Bioavailability - Epigallocatechin"
              },
              {
                "measure": "Bioavailability - Epicatechin gallate"
              },
              {
                "measure": "Bioavailability - Epicatechin"
              },
              {
                "measure": "Cmax of Epigallocatechin gallate"
              },
              {
                "measure": "Cmax of Epigallocatechin"
              },
              {
                "measure": "Cmax of Epicatechin gallate"
              },
              {
                "measure": "Cmax of Epicatechin"
              },
              {
                "measure": "Tmax of Epigallocatechin gallate"
              },
              {
                "measure": "Tmax of Epigallocatechin"
              },
              {
                "measure": "Tmax of Epicatechin gallate"
              },
              {
                "measure": "Tmax of Epicatechin"
              },
              {
                "measure": "Calprotectin"
              },
              {
                "measure": "Calprotectin"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01511263",
            "briefTitle": "Epigallocatechingallate (EGCG) in Cardiac AL Amyloidosis",
            "officialTitle": "A Phase II Open-label Randomized Study of Dietary Supplement With Epigallocatechin Gallate (EGCG) to Improve Cardiac Dysfunction in Patients With AL Amyloidosis Who do Not Require Chemotherapy (EpiCardiAL)"
          },
          "statusModule": {
            "overallStatus": "TERMINATED",
            "studyFirstSubmitDate": "2012-01-10"
          },
          "conditionsModule": {
            "conditions": [
              "Primary Amyloidosis of Light Chain Type"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Cardiac response",
                "timeFrame": "6 months"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Rate of adverse events"
              },
              {
                "measure": "Rate of cardiac progression"
              },
              {
                "measure": "Time to cardiac progression"
              },
              {
                "measure": "Rate of cardiac events"
              },
              {
                "measure": "Time to cardiac events"
              },
              {
                "measure": "Survival"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT06531863",
            "briefTitle": "Curcumin and EGCG Supplementation to Improve Serum BDNF and Mood Disturbance",
            "officialTitle": "A Randomized Controlled Trial to Determine the Effects of Curcumin and Epigallocatechin Gallate Supplementation on Serum Brain Derived Neurotrophic Factor and Mood Disturbance in Adults"
          },
          "statusModule": {
            "overallStatus": "RECRUITING",
            "studyFirstSubmitDate": "2024-07-16"
          },
          "conditionsModule": {
            "conditions": [
              "Mood Disturbance"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Changes in total distress as measured via DASS-21 total score.",
                "timeFrame": "8-weeks"
              },
              {
                "measure": "Changes in serum brain derived neurotrophic factor (BDNF).",
                "timeFrame": "8-weeks"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Changes in DASS-21 subscales (depression, anxiety, stress)."
              },
              {
                "measure": "Changes in subjective sleep quality."
              },
              {
                "measure": "Changes in subjective physical activity."
              },
              {
                "measure": "Changes in diet quality."
              },
              {
                "measure": "Number of Participants who report daily adherence to supplementation intake"
              },
              {
                "measure": "Changes in fasting alanine aminotransferase (ALT)"
              },
              {
                "measure": "Changes in fasting aspartate aminotransferase (AST)"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01451723",
            "briefTitle": "Safety and Neuroprotective Effects of Polyphenon E in MS; Phase II",
            "officialTitle": "Phase 2 Randomized Placebo Controlled Trial of Polyphenon E in MS"
          },
          "statusModule": {
            "overallStatus": "TERMINATED",
            "whyStopped": "Unusual high frequency of elevated liver function tests.",
            "studyFirstSubmitDate": "2011-10-11",
            "resultsFirstSubmitDate": "2013-12-10"
          },
          "conditionsModule": {
            "conditions": [
              "Multiple Sclerosis"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Rate of Change in NAA Levels Adjusted for Water Content.",
                "timeFrame": "1 year"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Brain Atrophy"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01105338",
            "briefTitle": "Lycopene or Green Tea for Men at Risk of Prostate Cancer",
            "officialTitle": "Lycopene or Green Tea a Feasibility Study in Men at Risk of Prostate Cancer"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2010-04-15"
          },
          "conditionsModule": {
            "conditions": [
              "Prostate Cancer"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Serum lycopene and epigallocatechin-3-gallate (green tea) levels at 6 months following randomization",
                "timeFrame": "6 months"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Trial recruitment and randomization rates at each stage of the study"
              },
              {
                "measure": "Intervention tolerability (adverse event reporting during the six months of follow-up)"
              },
              {
                "measure": "Compliance (returned tablet counts and self-reported counts at 6 months)"
              },
              {
                "measure": "Trial retention (participants completing 6-month follow-up and questionnaires)"
              },
              {
                "measure": "PSA values at baseline and at 6 months"
              },
              {
                "measure": "Dietary compliance with recommendations (dietary questionnaire completed at 6 months and participant data reporting dietary change)"
              },
              {
                "measure": "Weight and body mass index at 1 and 6 months"
              },
              {
                "measure": "Blood pressure at 1 and 6 months"
              },
              {
                "measure": "Attitudes and views of men and their spouses about dietary modification and participation in long-term study (qualitative interviews conducted throughout the study)"
              },
              {
                "measure": "Anxiety, depression, and psychological state as measured by the Hospital Anxiety and Depression Scale and the Profile of Moods States"
              },
              {
                "measure": "Urinary symptoms as measured by the ICSmaleSF questionnaire (including voiding and incontinence scores, nocturia, frequency, and urinary-specific quality-of-life care data sources)"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00476138",
            "briefTitle": "Effect of Epigallocatechin-Gallate on Inner Retinal Function in Ocular Hypertension and Early Glaucoma",
            "officialTitle": "Functional Effects of Epigallocatechingallate on Retinal Function in Glaucoma"
          },
          "statusModule": {
            "overallStatus": "UNKNOWN",
            "studyFirstSubmitDate": "2007-05-18"
          },
          "conditionsModule": {
            "conditions": [
              "Primary Open Angle Glaucoma",
              "Ocular Hypertension"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "PERG",
                "timeFrame": "six months"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "IOP"
              },
              {
                "measure": "Optical Coherence Tomography measurements of retinal nerve fiber layer thickness"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01490008",
            "briefTitle": "Systemic Exposure of Catechins From Veregen 15% Ointment in Patients With External Anogenital Warts and From Oral Intake of Green Tea Beverage in Healthy Volunteers",
            "officialTitle": "An Open-label, Single-center Triqal to Evaluate Systemic Exposure of Catechins From Commercially Available, Topically Applied Veregen 15% Ointment in Patients With External Anogenital Warts and From Oral Intake of Green Tea Beverage in Healthy Volunteers"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2011-12-02"
          },
          "conditionsModule": {
            "conditions": [
              "Anogenital Warts"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Systemic exposure of green tea catechin EGC",
                "timeFrame": "At time points 0, i.e. prior to the morning ingestion of 500 mL of commercial green tea beverage or the morning application of 250 mg Veregen\u00ae 15%, and 0.5, 1, 2, 4, 6, 8, 10, 12, 14, and 24 hours afterwards."
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01357681",
            "briefTitle": "Effects of EGCG (Epigallocatechin Gallate) in Huntington's Disease (ETON-Study)",
            "officialTitle": "Effects of EGCG (Epigallocatechin Gallate) in Huntington's Disease The ETON-Study - A Randomized, Double-blind, Stratified, Placebo-controlled Prospective Investigator Initiated Multicenter Trial -"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2011-05-19"
          },
          "conditionsModule": {
            "conditions": [
              "Huntington Disease"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Change of cognitive functions (UHDRS-Cognition: composite score of Stroop test, Verbal fluency & Symbol Digit Modalities Test) after 12 months in comparison to baseline",
                "timeFrame": "Month 0, Month 12"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "UHDRS Motor Score"
              },
              {
                "measure": "UHDRS Behavioural Score"
              },
              {
                "measure": "UHDRS Functional Assessment"
              },
              {
                "measure": "UHDRS Total Functional Capacity (TFC)"
              },
              {
                "measure": "Clinical Global Impression (CGI)"
              },
              {
                "measure": "Depression: Beck Depression Inventory (BDI)"
              },
              {
                "measure": "Health-related Quality of Life: Short Form (36) Health Survey (SF-36)"
              },
              {
                "measure": "Subjective Well-Being: Satisfaction With Life Scale (SWLS)"
              },
              {
                "measure": "Affective Processing: Positive and Negative Affect Schedule (PANAS)"
              },
              {
                "measure": "Tonic and phasic Alertness"
              },
              {
                "measure": "Global Cognition: Mini Mental State Examination"
              },
              {
                "measure": "Quantitative evaluation of motor functions: Qmotor"
              },
              {
                "measure": "Brain atrophy: assessed by magnetic resonance imaging (MRI)-voxel-based morphometry (VBM)"
              },
              {
                "measure": "Pharmacokinetics and tolerability of EGCG"
              },
              {
                "measure": "Determination of huntingtin expression levels"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01183767",
            "briefTitle": "Sunphenon Epigallocatechin-Gallate (EGCg) in Duchenne Muscular Dystrophy",
            "officialTitle": "Sunphenon Epigallocatechin-Gallate (EGCg) in Duchenne Muscular Dystrophy"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2010-08-17"
          },
          "conditionsModule": {
            "conditions": [
              "Duchenne Muscular Dystrophy"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "safety and tolerability",
                "timeFrame": "12 months"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "efficacy"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00253643",
            "briefTitle": "Fish Oil and Green Tea Extract in Preventing Prostate Cancer in Patients Who Are at Risk for Developing Prostate Cancer",
            "officialTitle": "Catechins and Omega-3 Fatty Acids Impact on Fatty Acid Synthase Activity in the Prostate: A Randomized Controlled Trial"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2005-11-11",
            "resultsFirstSubmitDate": "2014-12-19"
          },
          "conditionsModule": {
            "conditions": [
              "Precancerous Condition",
              "Prostate Cancer"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Fatty Acid Synthase Expression by Immunohistochemistry at Pre- and Post-intervention (FAS Summary Score)",
                "timeFrame": "Baseline (pre-intervention) and end of study (time to surgery for those with malignant findings or up to 8 weeks for those with benign biopsies, post-intervention)"
              },
              {
                "measure": "Cell Proliferation by Ki67-immunohistochemistry at Pre- and Post-intervention",
                "timeFrame": "End of study"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT06363201",
            "briefTitle": "Effect and Safety of Ocoxin Oral Solution on the Quality of Life of Paediatric Patients With Advanced Stage Solid Tumours",
            "officialTitle": "Exploratory Study to Evaluate the Effect and Safety of the Use of Ocoxin Oral Solution on the Quality of Life of Paediatric Patients With Advanced Stage Solid Tumours"
          },
          "statusModule": {
            "overallStatus": "NOT_YET_RECRUITING",
            "studyFirstSubmitDate": "2024-04-09"
          },
          "conditionsModule": {
            "conditions": [
              "Advanced Cancer",
              "Advanced Solid Tumor",
              "Lymphoma, Hodgkin",
              "Central Nervous System Tumor",
              "Sarcoma",
              "Germ Cell Tumor",
              "Pediatric Cancer"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Quality of Life",
                "timeFrame": "7 months"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Degree of toxicity related to oncospecific treatment"
              },
              {
                "measure": "Nutritional Status"
              },
              {
                "measure": "Presence of Adverse Events (AE)"
              },
              {
                "measure": "Metabolic Status"
              },
              {
                "measure": "Physical Status"
              },
              {
                "measure": "Response to oncospecific treatment"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00611650",
            "briefTitle": "Green Tea Extract in Treating Current or Former Smokers With Bronchial Dysplasia",
            "officialTitle": "Phase II Trial of Polyphenon E in Current and Former Smokers With Bronchial Dysplasia"
          },
          "statusModule": {
            "overallStatus": "TERMINATED",
            "whyStopped": "Slow recruitment",
            "studyFirstSubmitDate": "2008-02-08"
          },
          "conditionsModule": {
            "conditions": [
              "Lung Cancer",
              "Precancerous Condition",
              "Tobacco Use Disorder"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Change in the severity of dysplasia (as defined by WHO criteria) in bronchial biopsy specimens as assessed at baseline and at 3 months",
                "timeFrame": "3 months"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Change in the morphometric index in bronchial biopsy specimens as assessed at baseline and at 3 months"
              },
              {
                "measure": "Change in the concentrations (or grades) of Ki-67, p53, cleaved caspase-3, and VEGF in bronchial biopsy specimens as assessed by immunostaining at baseline and at 3 months"
              },
              {
                "measure": "Methylation biomarkers in bronchoalveolar lavage (BAL) cells as assessed at baseline and at 3 months"
              },
              {
                "measure": "Oncogene/ tumor suppressor gene expression in bronchial brush cells as assessed by cDNA microarray analysis at baseline and at 3 months"
              },
              {
                "measure": "Phase I and II enzyme regulation in bronchial brush cells as assessed by Affymetrix microarray analysis at baseline and at 3 months"
              },
              {
                "measure": "Change in C-reactive protein levels in plasma as assessed by enzyme-linked immunoassay (ELISA) at baseline and then monthly for 3 months"
              },
              {
                "measure": "Volumetric measurement of CT-detected lung nodules at baseline and then every 3-12 months for up to 24 months, depending on the size of the nodule"
              },
              {
                "measure": "Change in the concentrations (or grades) of surfactant protein D, oxidized glutathione, interleukin (IL)-6, IL-13, and MPIF-1 in plasma and BAL cells as assessed by ELISA at baseline and at 3 months"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT05520424",
            "briefTitle": "An Exploratory Investigation of a Supplement to Promote Brain Health",
            "officialTitle": "An Exploratory Investigation of a Supplement to Promote Brain Health"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2022-08-26"
          },
          "conditionsModule": {
            "conditions": [
              "Memory Deficits",
              "Cognitive Change",
              "Stress"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Perceived changes in mental health symptoms as measured by Questionnaires",
                "timeFrame": "31 days"
              },
              {
                "measure": "Perceived changes in stress management as measured by Questionnaires",
                "timeFrame": "31 days"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Changes in Cognitive Functioning"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00233935",
            "briefTitle": "Defined Green Tea Catechin Extract in Preventing Esophageal Cancer in Patients With Barrett's Esophagus",
            "officialTitle": "Phase Ib Randomized, Double-Blinded, Placebo-Controlled, Dose Escalation Study of Polyphenon E in Patients With Barrett's Esophagus"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2005-10-05"
          },
          "conditionsModule": {
            "conditions": [
              "Barrett Esophagus"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Toxicity defined according to the National Cancer Institute Common Toxicity Criteria for Adverse Events (Version 3.0)",
                "timeFrame": "Up to 6 months"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Dose-related biologic effects and pharmacodynamic properties of Poly E"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02147041",
            "briefTitle": "The Effect of Extract of Green Tea on Obese Women and Obese Related Hormone Peptides",
            "officialTitle": "The Effect of Extract of Green Tea on Obese Women Obese Related Hormone Peptides"
          },
          "statusModule": {
            "overallStatus": "UNKNOWN",
            "studyFirstSubmitDate": "2014-01-20"
          },
          "conditionsModule": {
            "conditions": [
              "Diabetes Mellitus",
              "Hyperlipidemia"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "composite of anthropometric measures",
                "timeFrame": "compare between the beginning of the study and after 12 weeks of treatment."
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Hormone peptide change"
              },
              {
                "measure": "biochemical characteristic change"
              },
              {
                "measure": "traditional chinese medicine syndrome classification"
              },
              {
                "measure": "Quality of life evaluation"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01417312",
            "briefTitle": "Metabolic Effects of a Green Tea Extract in Multiple Sclerosis Patients"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2011-08-15"
          },
          "conditionsModule": {
            "conditions": [
              "Multiple Sclerosis, Relapsing-Remitting"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Fasting and postprandial lipid oxidation in grams per hour, assessed by indirect calorimetry, after 3 months intake of green tea extract versus placebo",
                "timeFrame": "Three months"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01363869",
            "briefTitle": "Effects of Green Tea on Level of Serum Uric Acid in Healthy Individuals",
            "officialTitle": "Effects of Green Tea on Level of Serum Uric Acid in Healthy Individuals"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2011-05-31"
          },
          "conditionsModule": {
            "conditions": [
              "Hyperuricemia",
              "Gout"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "serum uric acid",
                "timeFrame": "4 weeks (prior to, immediately after and 7 days after intervention)"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "urinary uric acid excretion"
              },
              {
                "measure": "serum antioxidant activity"
              },
              {
                "measure": "serum EGCG level"
              },
              {
                "measure": "Adverse events"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01902069",
            "briefTitle": "The Gut-brain Axis in Food Reward and Alcohol Consumption",
            "officialTitle": "The Gut-brain Axis in Food Reward and Alcohol Consumption"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2013-07-15"
          },
          "conditionsModule": {
            "conditions": [
              "Impulsivity",
              "Alcohol Consumption"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Fat and sweet preference",
                "timeFrame": "21 days"
              },
              {
                "measure": "Impulsivity",
                "timeFrame": "21 days"
              },
              {
                "measure": "Alcohol consumption",
                "timeFrame": "21 days"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02321969",
            "briefTitle": "Green Tea Extracts for the Prevention of Colorectal Adenomas and Colorectal Cancer",
            "officialTitle": "Green Tea Extracts for the Prevention of Colorectal Adenomas and Colorectal Cancer"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2014-12-17"
          },
          "conditionsModule": {
            "conditions": [
              "Neoplasms, Colorectal"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Recurrence/Number/Size of metachronous colorectal adenoma(s)",
                "timeFrame": "1 year"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Recurrence/Number/Size of metachronous colorectal polyp(s) including hyperplastic polyp(s)"
              },
              {
                "measure": "Change of lipid profiles after green tea extract (GTE) supplementation"
              },
              {
                "measure": "Change of body weight, BMI and waist circumference"
              },
              {
                "measure": "Adverse effect(s) of GTE supplementation"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01311869",
            "briefTitle": "Green Tea Extract: a Non-Surgical Alternative for Treatment of Uterine Fibroids",
            "officialTitle": "Green Tea Extract: a Non-Surgical Alternative for Treatment of Uterine Fibroids"
          },
          "statusModule": {
            "overallStatus": "TERMINATED",
            "whyStopped": "IRB Decision",
            "studyFirstSubmitDate": "2011-03-07"
          },
          "conditionsModule": {
            "conditions": [
              "Leiomyoma"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "fibroid size",
                "timeFrame": "6 months"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Quality of life"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00134381",
            "briefTitle": "Green Tea and Ultraviolet Light-induced Skin Damage",
            "officialTitle": "The Effects of Topically Applied Constituents of Green Tea on UV Induced Increase in p53 and Apoptotic Markers in the Skin of Human Volunteers"
          },
          "statusModule": {
            "overallStatus": "TERMINATED",
            "whyStopped": "Principal Investigator left institution before study could complete.",
            "studyFirstSubmitDate": "2005-08-22",
            "resultsFirstSubmitDate": "2017-04-11"
          },
          "conditionsModule": {
            "conditions": [
              "Healthy"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Change in UVB-Induced Active Caspase-3-Positive Keratinocytes by Green Tea Compounds",
                "timeFrame": "48 hrs"
              },
              {
                "measure": "Change in UVB-Induced Apoptotic \"Sunburn\" Cells by Green Tea Compounds",
                "timeFrame": "48 hr"
              },
              {
                "measure": "Effect of Topical Applications of 4-6% Caffeine on UVB-Induced Increases in Apoptotic \"Sunburn\" Cells",
                "timeFrame": "48 hr"
              },
              {
                "measure": "Effect of Topical Applications of 4-6% Caffeine on UVB-Induced Increases in Caspase-3-Positive Cells",
                "timeFrame": "48 hr"
              },
              {
                "measure": "Effect of Topical Applications of 4-6% Caffeine on UVB-Induced Increases in Phospho-p53 (Ser15) Positive Cells",
                "timeFrame": "48 hr"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Effect of Green Tea Compounds on UVB-Induced Erythema"
              },
              {
                "measure": "Effect of 4-6% Caffeine on UVB-Induced Erythema"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT03740295",
            "briefTitle": "Impact of Ketone Bodies and Epigallocatechin Gallate in Multiple Sclerosis",
            "officialTitle": "Impact of Ketone Bodies and Epigallocatechin Gallate in Multiple Sclerosis"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2018-10-05"
          },
          "conditionsModule": {
            "conditions": [
              "Multiple Sclerosis"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Lipid peroxidation Malondialdehyde (MDA)",
                "timeFrame": "0-4 months"
              },
              {
                "measure": "Tumor necrosis factor alfa (TNF-alpha)",
                "timeFrame": "0-4 months"
              },
              {
                "measure": "Interleukin 6 (IL-6)",
                "timeFrame": "0-4 months"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Quantitative electroencephalogram (QEEG)"
              },
              {
                "measure": "Betahydroxybutyrate"
              },
              {
                "measure": "C-reactive protein"
              },
              {
                "measure": "Haptoglobin"
              },
              {
                "measure": "Field oxide (FOX)"
              },
              {
                "measure": "Total antioxidants (TEAC)"
              },
              {
                "measure": "Copper reduction capacity (CUPRAC)"
              },
              {
                "measure": "Iron reduction capacity (FRAP)"
              },
              {
                "measure": "Paraoxonase 1 (PON1)"
              },
              {
                "measure": "Anxiety"
              },
              {
                "measure": "Depression"
              },
              {
                "measure": "Satiety"
              },
              {
                "measure": "Sociodemographic"
              },
              {
                "measure": "Berg"
              },
              {
                "measure": "Exercise tolerance"
              },
              {
                "measure": "Gait speed"
              },
              {
                "measure": "Physical function and symptoms"
              },
              {
                "measure": "Neurological impairment"
              },
              {
                "measure": "Manual dexterity"
              },
              {
                "measure": "Hand Grip Strength"
              },
              {
                "measure": "Muscle power"
              },
              {
                "measure": "Muscle Strength Assessment Dynamometer (NEDDFM/IBV )"
              },
              {
                "measure": "Body diameters"
              },
              {
                "measure": "Body perimeters"
              },
              {
                "measure": "Skinfold calipe"
              },
              {
                "measure": "Height"
              },
              {
                "measure": "Weight"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00867555",
            "briefTitle": "Green Tea, High in Epigallocatechin Gallate (EGCG) and Postprandial Fat Oxidation",
            "officialTitle": "Effects of the Green Tea Extract TEAVIGO High in EGCG, on Postprandial Fat Oxidation in Overweight Volunteers"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2009-03-23"
          },
          "conditionsModule": {
            "conditions": [
              "Obesity",
              "Type 2 Diabetes Mellitus"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "postprandial fat oxidation",
                "timeFrame": "8 months"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT04300855",
            "briefTitle": "Clinical Trial of Green Tea Catechins in Men on Active Surveillance",
            "officialTitle": "Phase II Clinical Trial of Green Tea Catechins in Men on Active Surveillance (AS)"
          },
          "statusModule": {
            "overallStatus": "ACTIVE_NOT_RECRUITING",
            "studyFirstSubmitDate": "2020-03-05"
          },
          "conditionsModule": {
            "conditions": [
              "Prostate Cancer",
              "Prostate Adenocarcinoma"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Rate of Progression to Prostate Cancer (PCa)",
                "timeFrame": "24 months"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Occurrence of Adverse Events per Study Arm"
              },
              {
                "measure": "Adherence of Green Tea Catechins vs.Placebo"
              },
              {
                "measure": "Acceptability of Green Tea Catechins vs.Placebo"
              },
              {
                "measure": "Change in (prostate-specific antigen) PSA and PSA kinetics"
              },
              {
                "measure": "Change in gene expression panel"
              },
              {
                "measure": "Proportion of men with no cancer"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00516243",
            "briefTitle": "Defined Green Tea Catechin Extract in Treating Women With Hormone Receptor Negative Stage I-III Breast Cancer",
            "officialTitle": "Phase IB Randomized, Double-Blinded, Placebo-Controlled, Dose Escalation Study of Polyphenon E in Women With a History of Hormone Receptor-Negative Breast Cancer"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2007-08-14"
          },
          "conditionsModule": {
            "conditions": [
              "Estrogen Receptor-negative Breast Cancer",
              "Progesterone Receptor-negative Breast Cancer",
              "Stage I Breast Cancer",
              "Stage II Breast Cancer",
              "Stage IIIA Breast Cancer",
              "Stage IIIB Breast Cancer"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "MTD defined as the dose that causes 25% DLT assessed using NCI CTCAE version 3.0",
                "timeFrame": "6 months"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Breast tissue histology (nonproliferative, proliferative without atypia, atypical hyperplasia)"
              },
              {
                "measure": "COMT genotype"
              },
              {
                "measure": "Quality-of-life measures assessed using SF-36"
              },
              {
                "measure": "Protein expression levels in benign breast tissue (Ki-67, p53, EGFR, HER2/neu, cleaved caspase-3, and ER)"
              },
              {
                "measure": "Quantitative mammographic breast density"
              },
              {
                "measure": "Hormone metabolite levels (estradiol, testosterone, IGF-1, IGFBP-3, SHBG)"
              },
              {
                "measure": "Eicosanoid levels (urine PGE-M)"
              },
              {
                "measure": "Levels of oxidative damage biomarkers (urine 8-OHdG, isoprostane)"
              },
              {
                "measure": "Serum CRP levels"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00949923",
            "briefTitle": "Green Tea in Breast Cancer Patients",
            "officialTitle": "Green Tea Supplement in Women With Incident Breast Cancer"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2009-07-29"
          },
          "conditionsModule": {
            "conditions": [
              "Incident Breast Cancer"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "level of reduction in proliferation or increase in apoptosis in association with short-term EGCG",
                "timeFrame": "At surgery"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00917735",
            "briefTitle": "Green Tea and Reduction of Breast Cancer Risk",
            "officialTitle": "Phase II, Randomized,Double-blind, Placebo-controlled, Study of the Efficacy of Green Tea Extract on Biomarkers of Breast Cancer Risk in High Risk Women With Differing Catechol-O-methyl Transferase (COMT) Genotypes"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2009-06-08",
            "resultsFirstSubmitDate": "2015-07-29"
          },
          "conditionsModule": {
            "conditions": [
              "Breast Cancer"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Mammographic Density",
                "timeFrame": "Baseline and month 12"
              },
              {
                "measure": "Circulating Concentrations of Reproductive Hormones Including Estrone, Estradiol, Androstenedione, Testosterone, and Sex Hormone Binding Globulin (SHBG)",
                "timeFrame": "Baseline and month 12"
              },
              {
                "measure": "Circulating Concentrations of IGF Axis Proteins Including IGF-1 and IGFBP-3",
                "timeFrame": "Baseline and month 12"
              }
            ]
          }
        }
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:26:22Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83ef"
    },
    "name": "BRD-K70117295",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83ef.png",
    "lincs": {
      "id": "LSM-12709",
      "name": "BRD-K70117295",
      "pubchemCid": 54654108,
      "chebiId": 101344,
      "inchiParent": "InChI=1S/C30H36FN3O5/c1-34-25-13-12-22(16-28(35)32-17-20-9-5-6-10-24(20)31)39-27(25)18-38-26-14-11-21(15-23(26)30(34)37)33-29(36)19-7-3-2-4-8-19/h5-6,9-11,14-15,19,22,25,27H,2-4,7-8,12-13,16-18H2,1H3,(H,32,35)(H,33,36)/t22-,25-,27-/m1/s1",
      "inchiKeyParent": "CEZHWMAQWNYMAY-AVPJRLCVSA-N",
      "smilesParent": "CN1[C@@H]2CC[C@H](CC(=O)NCc3ccccc3F)O[C@@H]2COc4ccc(NC(=O)C5CCCCC5)cc4C1=O"
    },
    "unichem": {
      "chebi": "101344",
      "lincs": "LSM-12709",
      "pubchem": "54654108"
    },
    "pubchem": [
      {
        "cid": 54654108,
        "inchi": "InChI=1S/C30H36FN3O5/c1-34-25-13-12-22(16-28(35)32-17-20-9-5-6-10-24(20)31)39-27(25)18-38-26-14-11-21(15-23(26)30(34)37)33-29(36)19-7-3-2-4-8-19/h5-6,9-11,14-15,19,22,25,27H,2-4,7-8,12-13,16-18H2,1H3,(H,32,35)(H,33,36)/t22-,25-,27-/m1/s1",
        "inchikey": "CEZHWMAQWNYMAY-AVPJRLCVSA-N",
        "iupac": {
          "systematic": "N-[(2R,4aR,12aS)-2-[2-[(2-fluorophenyl)methylamino]-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]cyclohexanecarboxamide"
        },
        "smiles": {
          "canonical": "CN1C2CCC(OC2COC3=C(C1=O)C=C(C=C3)NC(=O)C4CCCCC4)CC(=O)NCC5=CC=CC=C5F"
        },
        "molecularFormula": "C30H36FN3O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:26:24Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8359"
    },
    "name": "UK 356618",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8359.png",
    "lincs": {
      "id": "LSM-4940",
      "name": "UK 356618",
      "alternativeNames": [
        "UK-356618"
      ],
      "pubchemCid": 10370504,
      "chebiId": 94305,
      "inchiParent": "InChI=1S/C34H43N3O4/c1-23-21-25(19-20-29(23)27-16-10-7-11-17-27)13-12-18-28(22-30(38)37-41)32(39)36-31(34(3,4)5)33(40)35-24(2)26-14-8-6-9-15-26/h6-11,14-17,19-21,24,28,31,41H,12-13,18,22H2,1-5H3,(H,35,40)(H,36,39)(H,37,38)/t24-,28-,31-/m1/s1",
      "inchiKeyParent": "JJHRUUKMPWUYIB-HVOSOHGQSA-N",
      "smilesParent": "C[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCc1ccc(c(C)c1)c2ccccc2)CC(=O)NO)C(C)(C)C)c3ccccc3"
    },
    "unichem": {
      "chebi": "94305",
      "chembl": "CHEMBL117225",
      "lincs": "LSM-4940",
      "pubchem": "10370504"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL117225",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 557.74,
        "hba": 4,
        "hbd": 4,
        "qedWeighted": 0.16
      },
      "moleculeSynonyms": [
        {
          "moleculeSynonym": "UK-356618",
          "synType": "RESEARCH_CODE",
          "synonyms": "UK-356618"
        }
      ]
    },
    "pubchem": [
      {
        "cid": 10370504,
        "inchi": "InChI=1S/C34H43N3O4/c1-23-21-25(19-20-29(23)27-16-10-7-11-17-27)13-12-18-28(22-30(38)37-41)32(39)36-31(34(3,4)5)33(40)35-24(2)26-14-8-6-9-15-26/h6-11,14-17,19-21,24,28,31,41H,12-13,18,22H2,1-5H3,(H,35,40)(H,36,39)(H,37,38)/t24-,28-,31-/m1/s1",
        "inchikey": "JJHRUUKMPWUYIB-HVOSOHGQSA-N",
        "iupac": {
          "systematic": "(2R)-N-[(2S)-3,3-dimethyl-1-oxo-1-[[(1R)-1-phenylethyl]amino]butan-2-yl]-N'-hydroxy-2-[3-(3-methyl-4-phenylphenyl)propyl]butanediamide"
        },
        "smiles": {
          "canonical": "CC1=C(C=CC(=C1)CCCC(CC(=O)NO)C(=O)NC(C(=O)NC(C)C2=CC=CC=C2)C(C)(C)C)C3=CC=CC=C3"
        },
        "molecularFormula": "C34H43N3O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:26:36Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8361"
    },
    "name": "BRD-K88597074",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8361.png",
    "lincs": {
      "id": "LSM-7983",
      "name": "BRD-K88597074",
      "pubchemCid": 54618422,
      "chebiId": 96604,
      "inchiParent": "InChI=1S/C32H35N5O4/c1-22-17-37(23(2)20-38)32(39)29-13-25(26-14-33-21-34-15-26)16-35-31(29)41-30(22)19-36(3)18-24-9-11-28(12-10-24)40-27-7-5-4-6-8-27/h4-16,21-23,30,38H,17-20H2,1-3H3/t22-,23-,30-/m0/s1",
      "inchiKeyParent": "ANXFQERLRQGOSV-ZRLASMASSA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@H](C)[C@H](CN(C)Cc2ccc(Oc3ccccc3)cc2)Oc4ncc(cc4C1=O)c5cncnc5"
    },
    "unichem": {
      "chebi": "96604",
      "lincs": "LSM-7983",
      "pubchem": "54618422"
    },
    "pubchem": [
      {
        "cid": 54618422,
        "inchi": "InChI=1S/C32H35N5O4/c1-22-17-37(23(2)20-38)32(39)29-13-25(26-14-33-21-34-15-26)16-35-31(29)41-30(22)19-36(3)18-24-9-11-28(12-10-24)40-27-7-5-4-6-8-27/h4-16,21-23,30,38H,17-20H2,1-3H3/t22-,23-,30-/m0/s1",
        "inchikey": "ANXFQERLRQGOSV-ZRLASMASSA-N",
        "iupac": {
          "systematic": "(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-8-pyrimidin-5-yl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(N=CC(=C2)C3=CN=CN=C3)OC1CN(C)CC4=CC=C(C=C4)OC5=CC=CC=C5)C(C)CO"
        },
        "molecularFormula": "C32H35N5O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:26:38Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c841a"
    },
    "name": "BRD-K73141149",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c841a.png",
    "lincs": {
      "id": "LSM-12908",
      "name": "BRD-K73141149",
      "pubchemCid": 54631696,
      "chebiId": 101545,
      "inchiParent": "InChI=1S/C26H37N3O5S/c1-6-14-29-16-19(2)25(33-5)17-28(4)26(30)23-15-21(12-13-24(23)34-18-20(29)3)27-35(31,32)22-10-8-7-9-11-22/h7-13,15,19-20,25,27H,6,14,16-18H2,1-5H3/t19-,20+,25-/m0/s1",
      "inchiKeyParent": "HWYKCLATECFWDF-DFIYOIEZSA-N",
      "smilesParent": "CCCN1C[C@H](C)[C@H](CN(C)C(=O)c2cc(NS(=O)(=O)c3ccccc3)ccc2OC[C@H]1C)OC"
    },
    "unichem": {
      "chebi": "101545",
      "lincs": "LSM-12908",
      "pubchem": "54631696"
    },
    "pubchem": [
      {
        "cid": 54631696,
        "inchi": "InChI=1S/C26H37N3O5S/c1-6-14-29-16-19(2)25(33-5)17-28(4)26(30)23-15-21(12-13-24(23)34-18-20(29)3)27-35(31,32)22-10-8-7-9-11-22/h7-13,15,19-20,25,27H,6,14,16-18H2,1-5H3/t19-,20+,25-/m0/s1",
        "inchikey": "HWYKCLATECFWDF-DFIYOIEZSA-N",
        "iupac": {
          "systematic": "N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide"
        },
        "smiles": {
          "canonical": "CCCN1CC(C(CN(C(=O)C2=C(C=CC(=C2)NS(=O)(=O)C3=CC=CC=C3)OCC1C)C)OC)C"
        },
        "molecularFormula": "C26H37N3O5S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:26:40Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c834f"
    },
    "name": "BRD-K03276924",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c834f.png",
    "lincs": {
      "id": "LSM-8639",
      "name": "BRD-K03276924",
      "pubchemCid": 54631490,
      "chebiId": 97260,
      "inchiParent": "InChI=1S/C29H39N3O5/c1-19-15-32(16-21-6-11-24(35-4)12-7-21)20(2)18-37-26-13-10-23(30-28(33)22-8-9-22)14-25(26)29(34)31(3)17-27(19)36-5/h6-7,10-14,19-20,22,27H,8-9,15-18H2,1-5H3,(H,30,33)/t19-,20-,27-/m0/s1",
      "inchiKeyParent": "SOKZPMDKQQIJSP-OSOCVKALSA-N",
      "smilesParent": "CO[C@H]1CN(C)C(=O)c2cc(NC(=O)C3CC3)ccc2OC[C@H](C)N(Cc4ccc(OC)cc4)C[C@@H]1C"
    },
    "unichem": {
      "chebi": "97260",
      "lincs": "LSM-8639",
      "pubchem": "54631490"
    },
    "pubchem": [
      {
        "cid": 54631490,
        "inchi": "InChI=1S/C29H39N3O5/c1-19-15-32(16-21-6-11-24(35-4)12-7-21)20(2)18-37-26-13-10-23(30-28(33)22-8-9-22)14-25(26)29(34)31(3)17-27(19)36-5/h6-7,10-14,19-20,22,27H,8-9,15-18H2,1-5H3,(H,30,33)/t19-,20-,27-/m0/s1",
        "inchikey": "SOKZPMDKQQIJSP-OSOCVKALSA-N",
        "iupac": {
          "systematic": "N-[(4S,7S,8R)-8-methoxy-5-[(4-methoxyphenyl)methyl]-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(COC2=C(C=C(C=C2)NC(=O)C3CC3)C(=O)N(CC1OC)C)C)CC4=CC=C(C=C4)OC"
        },
        "molecularFormula": "C29H39N3O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:26:42Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8382"
    },
    "name": "BRD-K81646882",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8382.png",
    "lincs": {
      "id": "LSM-41730",
      "name": "BRD-K81646882",
      "pubchemCid": 44618802,
      "chebiId": 131324,
      "inchiParent": "InChI=1S/C31H45Cl2N3O4/c1-21-17-36(22(2)20-37)31(38)26-16-25(34(4)5)11-13-29(26)40-23(3)9-7-8-14-39-30(21)19-35(6)18-24-10-12-27(32)28(33)15-24/h10-13,15-16,21-23,30,37H,7-9,14,17-20H2,1-6H3/t21-,22-,23+,30+/m0/s1",
      "inchiKeyParent": "HDXBPNDJZFTSGZ-CXDLDTBJSA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@H](C)[C@@H](CN(C)Cc2ccc(Cl)c(Cl)c2)OCCCC[C@@H](C)Oc3ccc(cc3C1=O)N(C)C"
    },
    "unichem": {
      "chebi": "131324",
      "lincs": "LSM-41730",
      "pubchem": "44618802"
    },
    "pubchem": [
      {
        "cid": 44618802,
        "inchi": "InChI=1S/C31H45Cl2N3O4/c1-21-17-36(22(2)20-37)31(38)26-16-25(34(4)5)11-13-29(26)40-23(3)9-7-8-14-39-30(21)19-35(6)18-24-10-12-27(32)28(33)15-24/h10-13,15-16,21-23,30,37H,7-9,14,17-20H2,1-6H3/t21-,22-,23+,30+/m0/s1",
        "inchikey": "HDXBPNDJZFTSGZ-CXDLDTBJSA-N",
        "iupac": {
          "systematic": "(3R,9S,10S)-9-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-13-one"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)N(C)C)C(C)CO)C)CN(C)CC3=CC(=C(C=C3)Cl)Cl"
        },
        "molecularFormula": "C31H45Cl2N3O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:26:45Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c839d"
    },
    "name": "BRD-K36701739",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c839d.png",
    "lincs": {
      "id": "LSM-10648",
      "name": "BRD-K36701739",
      "pubchemCid": 54661401,
      "chebiId": 99269,
      "inchiParent": "InChI=1S/C28H29N3O4/c1-35-20-8-4-7-18(13-20)21-9-10-24-25-22(14-31(24)28(21)34)23(15-32)26(30-25)27(33)29-19-11-16-5-2-3-6-17(16)12-19/h2-10,13,19,22-23,25-26,30,32H,11-12,14-15H2,1H3,(H,29,33)/t22-,23-,25+,26-/m1/s1",
      "inchiKeyParent": "CTULAYPPZYFJRD-VHCQPULKSA-N",
      "smilesParent": "COc1cccc(c1)C2=CC=C3[C@H]4N[C@H]([C@H](CO)[C@H]4CN3C2=O)C(=O)NC5Cc6ccccc6C5"
    },
    "unichem": {
      "chebi": "99269",
      "lincs": "LSM-10648",
      "pubchem": "54661401"
    },
    "pubchem": [
      {
        "cid": 54661401,
        "inchi": "InChI=1S/C28H29N3O4/c1-35-20-8-4-7-18(13-20)21-9-10-24-25-22(14-31(24)28(21)34)23(15-32)26(30-25)27(33)29-19-11-16-5-2-3-6-17(16)12-19/h2-10,13,19,22-23,25-26,30,32H,11-12,14-15H2,1H3,(H,29,33)/t22-,23-,25+,26-/m1/s1",
        "inchikey": "CTULAYPPZYFJRD-VHCQPULKSA-N",
        "iupac": {
          "systematic": "(2R,3R,3aS,9bS)-N-(2,3-dihydro-1H-inden-2-yl)-3-(hydroxymethyl)-7-(3-methoxyphenyl)-6-oxo-1,2,3,3a,4,9b-hexahydropyrrolo[2,3-a]indolizine-2-carboxamide"
        },
        "smiles": {
          "canonical": "COC1=CC=CC(=C1)C2=CC=C3C4C(CN3C2=O)C(C(N4)C(=O)NC5CC6=CC=CC=C6C5)CO"
        },
        "molecularFormula": "C28H29N3O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:26:47Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83a7"
    },
    "name": "BRD-K47647527",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83a7.png",
    "lincs": {
      "id": "LSM-7459",
      "name": "BRD-K47647527",
      "pubchemCid": 54618834,
      "chebiId": 96080,
      "inchiParent": "InChI=1S/C25H32N6O4/c1-17-14-31(18(2)16-32)24(33)20-11-19(7-6-10-29(3)4)12-28-23(20)35-22(17)15-30(5)25(34)21-13-26-8-9-27-21/h8-9,11-13,17-18,22,32H,10,14-16H2,1-5H3/t17-,18+,22-/m1/s1",
      "inchiKeyParent": "GDMNEEJFLGDCSP-KGVIQGDOSA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@@H](C)[C@@H](CN(C)C(=O)c2cnccn2)Oc3ncc(cc3C1=O)C#CCN(C)C"
    },
    "unichem": {
      "chebi": "96080",
      "lincs": "LSM-7459",
      "pubchem": "54618834"
    },
    "pubchem": [
      {
        "cid": 54618834,
        "inchi": "InChI=1S/C25H32N6O4/c1-17-14-31(18(2)16-32)24(33)20-11-19(7-6-10-29(3)4)12-28-23(20)35-22(17)15-30(5)25(34)21-13-26-8-9-27-21/h8-9,11-13,17-18,22,32H,10,14-16H2,1-5H3/t17-,18+,22-/m1/s1",
        "inchikey": "GDMNEEJFLGDCSP-KGVIQGDOSA-N",
        "iupac": {
          "systematic": "N-[[(2S,3R)-8-[3-(dimethylamino)prop-1-ynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylpyrazine-2-carboxamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(N=CC(=C2)C#CCN(C)C)OC1CN(C)C(=O)C3=NC=CN=C3)C(C)CO"
        },
        "molecularFormula": "C25H32N6O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:26:50Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83b3"
    },
    "name": "BRD-K27014041",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83b3.png",
    "lincs": {
      "id": "LSM-38739",
      "name": "BRD-K27014041",
      "pubchemCid": 44488065,
      "chebiId": 127179,
      "inchiParent": "InChI=1S/C35H38N4O6/c1-22-18-39(23(2)21-40)33(41)28-11-7-13-30(37-35(44)36-29-12-6-9-25-8-4-5-10-27(25)29)32(28)45-31(22)20-38(3)19-24-14-16-26(17-15-24)34(42)43/h4-17,22-23,31,40H,18-21H2,1-3H3,(H,42,43)(H2,36,37,44)/t22-,23-,31-/m1/s1",
      "inchiKeyParent": "PVYYJUYRHZFQFU-CEFNRUSXSA-N",
      "smilesParent": "C[C@H](CO)N1C[C@@H](C)[C@@H](CN(C)Cc2ccc(cc2)C(=O)O)Oc3c(NC(=O)Nc4cccc5ccccc45)cccc3C1=O"
    },
    "unichem": {
      "chebi": "127179",
      "lincs": "LSM-38739",
      "pubchem": "44488065"
    },
    "pubchem": [
      {
        "cid": 44488065,
        "inchi": "InChI=1S/C35H38N4O6/c1-22-18-39(23(2)21-40)33(41)28-11-7-13-30(37-35(44)36-29-12-6-9-25-8-4-5-10-27(25)29)32(28)45-31(22)20-38(3)19-24-14-16-26(17-15-24)34(42)43/h4-17,22-23,31,40H,18-21H2,1-3H3,(H,42,43)(H2,36,37,44)/t22-,23-,31-/m1/s1",
        "inchikey": "PVYYJUYRHZFQFU-CEFNRUSXSA-N",
        "iupac": {
          "systematic": "4-[[[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-10-(naphthalen-1-ylcarbamoylamino)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl-methylamino]methyl]benzoic acid"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(C(=CC=C2)NC(=O)NC3=CC=CC4=CC=CC=C43)OC1CN(C)CC5=CC=C(C=C5)C(=O)O)C(C)CO"
        },
        "molecularFormula": "C35H38N4O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:26:52Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c834c"
    },
    "name": "BRD-K36741877",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c834c.png",
    "lincs": {
      "id": "LSM-10652",
      "name": "BRD-K36741877",
      "pubchemCid": 54649462,
      "chebiId": 99273,
      "inchiParent": "InChI=1S/C35H36N4O4S/c1-35(2,3)44(42)39-22-28-19-30(34(41)37-21-24-10-14-29(43-4)15-11-24)38-33(32(28)31(39)16-17-40)27-7-5-6-26(18-27)25-12-8-23(20-36)9-13-25/h5-15,18-19,31,40H,16-17,21-22H2,1-4H3,(H,37,41)/t31-,44-/m0/s1",
      "inchiKeyParent": "JYXARMWTMOZTGK-JCFUSDQVSA-N",
      "smilesParent": "COc1ccc(CNC(=O)c2cc3CN([C@@H](CCO)c3c(n2)c4cccc(c4)c5ccc(cc5)C#N)[S@@](=O)C(C)(C)C)cc1"
    },
    "unichem": {
      "chebi": "99273",
      "lincs": "LSM-10652",
      "pubchem": "54649462"
    },
    "pubchem": [
      {
        "cid": 54649462,
        "inchi": "InChI=1S/C35H36N4O4S/c1-35(2,3)44(42)39-22-28-19-30(34(41)37-21-24-10-14-29(43-4)15-11-24)38-33(32(28)31(39)16-17-40)27-7-5-6-26(18-27)25-12-8-23(20-36)9-13-25/h5-15,18-19,31,40H,16-17,21-22H2,1-4H3,(H,37,41)/t31-,44-/m0/s1",
        "inchikey": "JYXARMWTMOZTGK-JCFUSDQVSA-N",
        "iupac": {
          "systematic": "(3S)-2-[(S)-tert-butylsulfinyl]-4-[3-(4-cyanophenyl)phenyl]-3-(2-hydroxyethyl)-N-[(4-methoxyphenyl)methyl]-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide"
        },
        "smiles": {
          "canonical": "CC(C)(C)S(=O)N1CC2=CC(=NC(=C2C1CCO)C3=CC=CC(=C3)C4=CC=C(C=C4)C#N)C(=O)NCC5=CC=C(C=C5)OC"
        },
        "molecularFormula": "C35H36N4O4S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:26:54Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c836d"
    },
    "name": "BRD-K28154645",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c836d.png",
    "lincs": {
      "id": "LSM-38806",
      "name": "BRD-K28154645",
      "pubchemCid": 44491957,
      "chebiId": 127246,
      "inchiParent": "InChI=1S/C31H42N4O6/c1-20-16-35(21(2)19-36)29(37)25-10-7-11-26(33-31(40)32-24-8-5-4-6-9-24)28(25)41-27(20)18-34(3)17-22-12-14-23(15-13-22)30(38)39/h7,10-15,20-21,24,27,36H,4-6,8-9,16-19H2,1-3H3,(H,38,39)(H2,32,33,40)/t20-,21-,27-/m1/s1",
      "inchiKeyParent": "DHFYMYKOVLGPGL-LGVUCKNBSA-N",
      "smilesParent": "C[C@H](CO)N1C[C@@H](C)[C@@H](CN(C)Cc2ccc(cc2)C(=O)O)Oc3c(NC(=O)NC4CCCCC4)cccc3C1=O"
    },
    "unichem": {
      "chebi": "127246",
      "lincs": "LSM-38806",
      "pubchem": "44491957"
    },
    "pubchem": [
      {
        "cid": 44491957,
        "inchi": "InChI=1S/C31H42N4O6/c1-20-16-35(21(2)19-36)29(37)25-10-7-11-26(33-31(40)32-24-8-5-4-6-9-24)28(25)41-27(20)18-34(3)17-22-12-14-23(15-13-22)30(38)39/h7,10-15,20-21,24,27,36H,4-6,8-9,16-19H2,1-3H3,(H,38,39)(H2,32,33,40)/t20-,21-,27-/m1/s1",
        "inchikey": "DHFYMYKOVLGPGL-LGVUCKNBSA-N",
        "iupac": {
          "systematic": "4-[[[(2S,3R)-10-(cyclohexylcarbamoylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl-methylamino]methyl]benzoic acid"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(C(=CC=C2)NC(=O)NC3CCCCC3)OC1CN(C)CC4=CC=C(C=C4)C(=O)O)C(C)CO"
        },
        "molecularFormula": "C31H42N4O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:26:56Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c837f"
    },
    "name": "BRD-K68166950",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c837f.png",
    "lincs": {
      "id": "LSM-12582",
      "name": "BRD-K68166950",
      "pubchemCid": 54654436,
      "chebiId": 101213,
      "inchiParent": "InChI=1S/C33H38N4O5S/c1-36-28-11-10-25(17-31(38)35-24-13-14-37(20-24)19-22-6-3-2-4-7-22)42-30(28)21-41-29-12-9-23(16-27(29)33(36)40)34-32(39)18-26-8-5-15-43-26/h2-9,12,15-16,24-25,28,30H,10-11,13-14,17-21H2,1H3,(H,34,39)(H,35,38)/t24-,25+,28-,30+/m1/s1",
      "inchiKeyParent": "YIAMBQQGWRAZTQ-ZQTJCAEQSA-N",
      "smilesParent": "CN1[C@@H]2CC[C@@H](CC(=O)N[C@@H]3CCN(Cc4ccccc4)C3)O[C@H]2COc5ccc(NC(=O)Cc6cccs6)cc5C1=O"
    },
    "unichem": {
      "chebi": "101213",
      "lincs": "LSM-12582",
      "pubchem": "54654436"
    },
    "pubchem": [
      {
        "cid": 54654436,
        "inchi": "InChI=1S/C33H38N4O5S/c1-36-28-11-10-25(17-31(38)35-24-13-14-37(20-24)19-22-6-3-2-4-7-22)42-30(28)21-41-29-12-9-23(16-27(29)33(36)40)34-32(39)18-26-8-5-15-43-26/h2-9,12,15-16,24-25,28,30H,10-11,13-14,17-21H2,1H3,(H,34,39)(H,35,38)/t24-,25+,28-,30+/m1/s1",
        "inchikey": "YIAMBQQGWRAZTQ-ZQTJCAEQSA-N",
        "iupac": {
          "systematic": "2-[(2S,4aR,12aR)-5-methyl-6-oxo-8-[(2-thiophen-2-ylacetyl)amino]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-[(3R)-1-benzylpyrrolidin-3-yl]acetamide"
        },
        "smiles": {
          "canonical": "CN1C2CCC(OC2COC3=C(C1=O)C=C(C=C3)NC(=O)CC4=CC=CS4)CC(=O)NC5CCN(C5)CC6=CC=CC=C6"
        },
        "molecularFormula": "C33H38N4O5S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:26:58Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83eb"
    },
    "name": "BRD-K35400569-001-01-7",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83eb.png",
    "lincs": {
      "id": "LSM-10551",
      "name": "BRD-K35400569-001-01-7",
      "alternativeNames": [
        "BRD-K35400569"
      ],
      "pubchemCid": 54657906,
      "chebiId": 99172,
      "inchiParent": "InChI=1S/C14H21N3O4S/c18-9-6-16-11-2-1-10(21-12(11)8-20-7-9)5-13(19)17-14-15-3-4-22-14/h3-4,9-12,16,18H,1-2,5-8H2,(H,15,17,19)/t9-,10+,11-,12+/m0/s1",
      "inchiKeyParent": "LPUMVFGYOYFXDR-WHOHXGKFSA-N",
      "smilesParent": "O[C@H]1CN[C@H]2CC[C@H](CC(=O)Nc3nccs3)O[C@@H]2COC1"
    },
    "unichem": {
      "chebi": "99172",
      "lincs": "LSM-10551",
      "pubchem": "54657906"
    },
    "pubchem": [
      {
        "cid": 54657906,
        "inchi": "InChI=1S/C14H21N3O4S/c18-9-6-16-11-2-1-10(21-12(11)8-20-7-9)5-13(19)17-14-15-3-4-22-14/h3-4,9-12,16,18H,1-2,5-8H2,(H,15,17,19)/t9-,10+,11-,12+/m0/s1",
        "inchikey": "LPUMVFGYOYFXDR-WHOHXGKFSA-N",
        "iupac": {
          "systematic": "2-[(3S,6aS,8R,10aS)-3-hydroxy-1,2,3,4,6,6a,8,9,10,10a-decahydropyrano[2,3-c][1,5]oxazocin-8-yl]-N-(1,3-thiazol-2-yl)acetamide"
        },
        "smiles": {
          "canonical": "C1CC2C(COCC(CN2)O)OC1CC(=O)NC3=NC=CS3"
        },
        "molecularFormula": "C14H21N3O4S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:27:01Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8403"
    },
    "name": "BRD-K89020690",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8403.png",
    "lincs": {
      "id": "LSM-42122",
      "name": "BRD-K89020690",
      "pubchemCid": 44487083,
      "chebiId": 130573,
      "inchiParent": "InChI=1S/C30H36F3N5O5/c1-17-13-38(18(2)16-39)28(40)24-12-23(34-29(41)35-27-19(3)36-43-20(27)4)10-11-25(24)42-26(17)15-37(5)14-21-6-8-22(9-7-21)30(31,32)33/h6-12,17-18,26,39H,13-16H2,1-5H3,(H2,34,35,41)/t17-,18-,26+/m1/s1",
      "inchiKeyParent": "SUHQAMSFJCSMJM-KABRZNFWSA-N",
      "smilesParent": "C[C@H](CO)N1C[C@@H](C)[C@H](CN(C)Cc2ccc(cc2)C(F)(F)F)Oc3ccc(NC(=O)Nc4c(C)onc4C)cc3C1=O"
    },
    "unichem": {
      "chebi": "130573",
      "lincs": "LSM-42122",
      "pubchem": "44487083"
    },
    "pubchem": [
      {
        "cid": 44487083,
        "inchi": "InChI=1S/C30H36F3N5O5/c1-17-13-38(18(2)16-39)28(40)24-12-23(34-29(41)35-27-19(3)36-43-20(27)4)10-11-25(24)42-26(17)15-37(5)14-21-6-8-22(9-7-21)30(31,32)33/h6-12,17-18,26,39H,13-16H2,1-5H3,(H2,34,35,41)/t17-,18-,26+/m1/s1",
        "inchikey": "SUHQAMSFJCSMJM-KABRZNFWSA-N",
        "iupac": {
          "systematic": "1-(3,5-dimethyl-1,2-oxazol-4-yl)-3-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]urea"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(C=CC(=C2)NC(=O)NC3=C(ON=C3C)C)OC1CN(C)CC4=CC=C(C=C4)C(F)(F)F)C(C)CO"
        },
        "molecularFormula": "C30H36F3N5O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:27:03Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c840f"
    },
    "name": "BRD-K78226445",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c840f.png",
    "lincs": {
      "id": "LSM-13211",
      "name": "BRD-K78226445",
      "pubchemCid": 54631884,
      "chebiId": 101849,
      "inchiParent": "InChI=1S/C23H30FN3O5S/c1-15-12-25-16(2)14-32-21-9-8-18(11-20(21)23(28)27(3)13-22(15)31-4)26-33(29,30)19-7-5-6-17(24)10-19/h5-11,15-16,22,25-26H,12-14H2,1-4H3/t15-,16-,22-/m0/s1",
      "inchiKeyParent": "FAXXRWNSKSYYIM-WCJKSRRJSA-N",
      "smilesParent": "CO[C@H]1CN(C)C(=O)c2cc(NS(=O)(=O)c3cccc(F)c3)ccc2OC[C@H](C)NC[C@@H]1C"
    },
    "unichem": {
      "chebi": "101849",
      "lincs": "LSM-13211",
      "pubchem": "54631884"
    },
    "pubchem": [
      {
        "cid": 54631884,
        "inchi": "InChI=1S/C23H30FN3O5S/c1-15-12-25-16(2)14-32-21-9-8-18(11-20(21)23(28)27(3)13-22(15)31-4)26-33(29,30)19-7-5-6-17(24)10-19/h5-11,15-16,22,25-26H,12-14H2,1-4H3/t15-,16-,22-/m0/s1",
        "inchikey": "FAXXRWNSKSYYIM-WCJKSRRJSA-N",
        "iupac": {
          "systematic": "3-fluoro-N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide"
        },
        "smiles": {
          "canonical": "CC1CNC(COC2=C(C=C(C=C2)NS(=O)(=O)C3=CC=CC(=C3)F)C(=O)N(CC1OC)C)C"
        },
        "molecularFormula": "C23H30FN3O5S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:27:06Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8309"
    },
    "name": "BRD-K34922409",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8309.png",
    "lincs": {
      "id": "LSM-10529",
      "name": "BRD-K34922409",
      "pubchemCid": 54637649,
      "chebiId": 99150,
      "inchiParent": "InChI=1S/C33H36N4O5S/c1-22-18-37(23(2)20-38)33(39)32-31(27-14-8-9-15-28(27)36(32)4)26-13-7-5-12-25(26)21-42-29(22)19-35(3)43(40,41)30-16-10-6-11-24(30)17-34/h5-16,22-23,29,38H,18-21H2,1-4H3/t22-,23+,29-/m1/s1",
      "inchiKeyParent": "VOTKEIORIBNPMA-RLPNJSHFSA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@@H](C)[C@@H](CN(C)S(=O)(=O)c2ccccc2C#N)OCc3ccccc3c4c(C1=O)n(C)c5ccccc45"
    },
    "unichem": {
      "chebi": "99150",
      "lincs": "LSM-10529",
      "pubchem": "54637649"
    },
    "pubchem": [
      {
        "cid": 54637649,
        "inchi": "InChI=1S/C33H36N4O5S/c1-22-18-37(23(2)20-38)33(39)32-31(27-14-8-9-15-28(27)36(32)4)26-13-7-5-12-25(26)21-42-29(22)19-35(3)43(40,41)30-16-10-6-11-24(30)17-34/h5-16,22-23,29,38H,18-21H2,1-4H3/t22-,23+,29-/m1/s1",
        "inchikey": "VOTKEIORIBNPMA-RLPNJSHFSA-N",
        "iupac": {
          "systematic": "2-cyano-N-[[(10S,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylbenzenesulfonamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(C3=CC=CC=C3COC1CN(C)S(=O)(=O)C4=CC=CC=C4C#N)C5=CC=CC=C5N2C)C(C)CO"
        },
        "molecularFormula": "C33H36N4O5S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:27:08Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8341"
    },
    "name": "BRD-K26362026",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8341.png",
    "lincs": {
      "id": "LSM-38706",
      "name": "BRD-K26362026",
      "pubchemCid": 44487676,
      "chebiId": 127144,
      "inchiParent": "InChI=1S/C27H32Cl2F3N3O4/c1-16-12-35(17(2)15-36)26(38)20-11-19(33-25(37)8-9-27(30,31)32)5-7-23(20)39-24(16)14-34(3)13-18-4-6-21(28)22(29)10-18/h4-7,10-11,16-17,24,36H,8-9,12-15H2,1-3H3,(H,33,37)/t16-,17-,24+/m1/s1",
      "inchiKeyParent": "WYNCONGFJQZCFS-OJLQRUNKSA-N",
      "smilesParent": "C[C@H](CO)N1C[C@@H](C)[C@H](CN(C)Cc2ccc(Cl)c(Cl)c2)Oc3ccc(NC(=O)CCC(F)(F)F)cc3C1=O"
    },
    "unichem": {
      "chebi": "127144",
      "lincs": "LSM-38706",
      "pubchem": "44487676"
    },
    "pubchem": [
      {
        "cid": 44487676,
        "inchi": "InChI=1S/C27H32Cl2F3N3O4/c1-16-12-35(17(2)15-36)26(38)20-11-19(33-25(37)8-9-27(30,31)32)5-7-23(20)39-24(16)14-34(3)13-18-4-6-21(28)22(29)10-18/h4-7,10-11,16-17,24,36H,8-9,12-15H2,1-3H3,(H,33,37)/t16-,17-,24+/m1/s1",
        "inchikey": "WYNCONGFJQZCFS-OJLQRUNKSA-N",
        "iupac": {
          "systematic": "N-[(2R,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4,4,4-trifluorobutanamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(C=CC(=C2)NC(=O)CCC(F)(F)F)OC1CN(C)CC3=CC(=C(C=C3)Cl)Cl)C(C)CO"
        },
        "molecularFormula": "C27H32Cl2F3N3O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:27:10Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82f5"
    },
    "name": "BRD-K62430643",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82f5.png",
    "lincs": {
      "id": "LSM-43486",
      "name": "BRD-K62430643",
      "pubchemCid": 54660763,
      "inchiParent": "InChI=1S/C28H28N4O4/c1-30(2)28(36)25-22(17-33)21-16-31-23(24(21)32(25)27(35)20-9-6-14-29-15-20)13-12-19(26(31)34)11-10-18-7-4-3-5-8-18/h3-15,21-22,24-25,33H,16-17H2,1-2H3/b11-10+/t21-,22-,24+,25-/m1/s1",
      "inchiKeyParent": "JLXJOKBWOBKOCH-BTOBFZAUSA-N",
      "smilesParent": "CN(C)C(=O)[C@H]1[C@H](CO)[C@H]2CN3C(=CC=C(\\C=C\\c4ccccc4)C3=O)[C@H]2N1C(=O)c5cccnc5"
    },
    "unichem": {
      "lincs": "LSM-43486",
      "pubchem": "54660763"
    },
    "pubchem": [
      {
        "cid": 54660763,
        "inchi": "InChI=1S/C28H28N4O4/c1-30(2)28(36)25-22(17-33)21-16-31-23(24(21)32(25)27(35)20-9-6-14-29-15-20)13-12-19(26(31)34)11-10-18-7-4-3-5-8-18/h3-15,21-22,24-25,33H,16-17H2,1-2H3/b11-10+/t21-,22-,24+,25-/m1/s1",
        "inchikey": "JLXJOKBWOBKOCH-BTOBFZAUSA-N",
        "iupac": {
          "systematic": "(2R,3R,3aS,9bS)-3-(hydroxymethyl)-N,N-dimethyl-6-oxo-7-[(E)-2-phenylethenyl]-1-(pyridine-3-carbonyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide"
        },
        "smiles": {
          "canonical": "CN(C)C(=O)C1C(C2CN3C(=CC=C(C3=O)C=CC4=CC=CC=C4)C2N1C(=O)C5=CN=CC=C5)CO"
        },
        "molecularFormula": "C28H28N4O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:27:12Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82fa"
    },
    "name": "BRD-K17193648",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82fa.png",
    "lincs": {
      "id": "LSM-7073",
      "name": "BRD-K17193648",
      "pubchemCid": 54618736,
      "chebiId": 95694,
      "inchiParent": "InChI=1S/C28H36N4O4/c1-20-16-32(21(2)19-33)27(34)24-14-22(9-12-28(35)10-5-6-11-28)15-30-26(24)36-25(20)18-31(3)17-23-8-4-7-13-29-23/h4,7-8,13-15,20-21,25,33,35H,5-6,10-11,16-19H2,1-3H3/t20-,21-,25+/m0/s1",
      "inchiKeyParent": "UQYDBQHFUBHFMT-STWLZBDKSA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@H](C)[C@@H](CN(C)Cc2ccccn2)Oc3ncc(cc3C1=O)C#CC4(O)CCCC4"
    },
    "unichem": {
      "chebi": "95694",
      "lincs": "LSM-7073",
      "pubchem": "54618736"
    },
    "pubchem": [
      {
        "cid": 54618736,
        "inchi": "InChI=1S/C28H36N4O4/c1-20-16-32(21(2)19-33)27(34)24-14-22(9-12-28(35)10-5-6-11-28)15-30-26(24)36-25(20)18-31(3)17-23-8-4-7-13-29-23/h4,7-8,13-15,20-21,25,33,35H,5-6,10-11,16-19H2,1-3H3/t20-,21-,25+/m0/s1",
        "inchikey": "UQYDBQHFUBHFMT-STWLZBDKSA-N",
        "iupac": {
          "systematic": "(2S,3S)-8-[2-(1-hydroxycyclopentyl)ethynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-2-ylmethyl)amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(N=CC(=C2)C#CC3(CCCC3)O)OC1CN(C)CC4=CC=CC=N4)C(C)CO"
        },
        "molecularFormula": "C28H36N4O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:27:14Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8384"
    },
    "name": "BRD-K65354878",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8384.png",
    "lincs": {
      "id": "LSM-12412",
      "name": "BRD-K65354878",
      "pubchemCid": 54649072,
      "chebiId": 101039,
      "inchiParent": "InChI=1S/C23H32ClFN2O4S/c1-17(13-27(18(2)16-28)14-19-7-5-6-8-22(19)24)23(31-4)15-26(3)32(29,30)21-11-9-20(25)10-12-21/h5-12,17-18,23,28H,13-16H2,1-4H3/t17-,18+,23+/m0/s1",
      "inchiKeyParent": "IVUAVXPBXQRVFC-YZZKKUAISA-N",
      "smilesParent": "CO[C@H](CN(C)S(=O)(=O)c1ccc(F)cc1)[C@@H](C)CN(Cc2ccccc2Cl)[C@H](C)CO"
    },
    "unichem": {
      "chebi": "101039",
      "lincs": "LSM-12412",
      "pubchem": "54649072"
    },
    "pubchem": [
      {
        "cid": 54649072,
        "inchi": "InChI=1S/C23H32ClFN2O4S/c1-17(13-27(18(2)16-28)14-19-7-5-6-8-22(19)24)23(31-4)15-26(3)32(29,30)21-11-9-20(25)10-12-21/h5-12,17-18,23,28H,13-16H2,1-4H3/t17-,18+,23+/m0/s1",
        "inchikey": "IVUAVXPBXQRVFC-YZZKKUAISA-N",
        "iupac": {
          "systematic": "N-[(2S,3S)-4-[(2-chlorophenyl)methyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-4-fluoro-N-methylbenzenesulfonamide"
        },
        "smiles": {
          "canonical": "CC(CN(CC1=CC=CC=C1Cl)C(C)CO)C(CN(C)S(=O)(=O)C2=CC=C(C=C2)F)OC"
        },
        "molecularFormula": "C23H32ClFN2O4S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:27:17Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8358"
    },
    "name": "CHEMBL520231",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8358.png",
    "lincs": {
      "id": "LSM-43280",
      "name": "CHEMBL520231",
      "alternativeNames": [
        "7B-CIS"
      ],
      "pubchemCid": 44589607,
      "inchiParent": "InChI=1S/C12H11ClN4O2/c1-2-19-11(18)6-7-17-15-12(14-16-17)9-4-3-5-10(13)8-9/h3-8H,2H2,1H3/b7-6-",
      "inchiKeyParent": "AICKZRPQDLFSPA-SREVYHEPSA-N",
      "smilesParent": "CCOC(=O)\\C=C/n1nnc(n1)c2cccc(Cl)c2"
    },
    "unichem": {
      "chembl": "CHEMBL520231",
      "lincs": "LSM-43280",
      "pubchem": "44589607"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL520231",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 278.7,
        "hba": 6,
        "hbd": 0,
        "qedWeighted": 0.63
      }
    },
    "pubchem": [
      {
        "cid": 44589607,
        "inchi": "InChI=1S/C12H11ClN4O2/c1-2-19-11(18)6-7-17-15-12(14-16-17)9-4-3-5-10(13)8-9/h3-8H,2H2,1H3/b7-6-",
        "inchikey": "AICKZRPQDLFSPA-SREVYHEPSA-N",
        "iupac": {
          "systematic": "ethyl (Z)-3-[5-(3-chlorophenyl)tetrazol-2-yl]prop-2-enoate"
        },
        "smiles": {
          "canonical": "CCOC(=O)C=CN1N=C(N=N1)C2=CC(=CC=C2)Cl"
        },
        "molecularFormula": "C12H11ClN4O2"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:27:28Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8364"
    },
    "name": "BRD-K79793338",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8364.png",
    "lincs": {
      "id": "LSM-13299",
      "name": "BRD-K79793338",
      "pubchemCid": 54631502,
      "chebiId": 101938,
      "inchiParent": "InChI=1S/C23H35N3O5/c1-7-21(27)24-17-9-10-19-18(11-17)23(29)25(5)13-20(30-6)15(3)12-26(22(28)8-2)16(4)14-31-19/h9-11,15-16,20H,7-8,12-14H2,1-6H3,(H,24,27)/t15-,16+,20+/m0/s1",
      "inchiKeyParent": "ILJGMXMVVDGLNM-RZQQEMMASA-N",
      "smilesParent": "CCC(=O)Nc1ccc2OC[C@@H](C)N(C[C@H](C)[C@@H](CN(C)C(=O)c2c1)OC)C(=O)CC"
    },
    "unichem": {
      "chebi": "101938",
      "lincs": "LSM-13299",
      "pubchem": "54631502"
    },
    "pubchem": [
      {
        "cid": 54631502,
        "inchi": "InChI=1S/C23H35N3O5/c1-7-21(27)24-17-9-10-19-18(11-17)23(29)25(5)13-20(30-6)15(3)12-26(22(28)8-2)16(4)14-31-19/h9-11,15-16,20H,7-8,12-14H2,1-6H3,(H,24,27)/t15-,16+,20+/m0/s1",
        "inchikey": "ILJGMXMVVDGLNM-RZQQEMMASA-N",
        "iupac": {
          "systematic": "N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propanoyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide"
        },
        "smiles": {
          "canonical": "CCC(=O)NC1=CC2=C(C=C1)OCC(N(CC(C(CN(C2=O)C)OC)C)C(=O)CC)C"
        },
        "molecularFormula": "C23H35N3O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:27:31Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83b8"
    },
    "name": "BRD-K18456137",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83b8.png",
    "lincs": {
      "id": "LSM-9541",
      "name": "BRD-K18456137",
      "pubchemCid": 54658053,
      "chebiId": 98162,
      "inchiParent": "InChI=1S/C15H24F3NO5/c1-22-14(21)6-11-2-3-12-13(24-11)9-23-8-10(20)7-19(12)5-4-15(16,17)18/h10-13,20H,2-9H2,1H3/t10-,11+,12-,13+/m1/s1",
      "inchiKeyParent": "NGKDTDLAKVOKMV-XQHKEYJVSA-N",
      "smilesParent": "COC(=O)C[C@@H]1CC[C@@H]2[C@H](COC[C@H](O)CN2CCC(F)(F)F)O1"
    },
    "unichem": {
      "chebi": "98162",
      "lincs": "LSM-9541",
      "pubchem": "54658053"
    },
    "pubchem": [
      {
        "cid": 54658053,
        "inchi": "InChI=1S/C15H24F3NO5/c1-22-14(21)6-11-2-3-12-13(24-11)9-23-8-10(20)7-19(12)5-4-15(16,17)18/h10-13,20H,2-9H2,1H3/t10-,11+,12-,13+/m1/s1",
        "inchikey": "NGKDTDLAKVOKMV-XQHKEYJVSA-N",
        "iupac": {
          "systematic": "methyl 2-[(3R,6aR,8S,10aR)-3-hydroxy-1-(3,3,3-trifluoropropyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]acetate"
        },
        "smiles": {
          "canonical": "COC(=O)CC1CCC2C(O1)COCC(CN2CCC(F)(F)F)O"
        },
        "molecularFormula": "C15H24F3NO5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:27:33Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83db"
    },
    "name": "BRD-K99055802",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83db.png",
    "lincs": {
      "id": "LSM-14511",
      "name": "BRD-K99055802",
      "pubchemCid": 54638223,
      "chebiId": 103166,
      "inchiParent": "InChI=1S/C22H27N3O6S/c1-30-17-2-5-19(6-3-17)32(28,29)25-20-7-4-18(31-21(20)15-26)14-22(27)24-13-10-16-8-11-23-12-9-16/h2-9,11-12,18,20-21,25-26H,10,13-15H2,1H3,(H,24,27)/t18-,20+,21+/m1/s1",
      "inchiKeyParent": "SKMIIEGWSYGYOW-GIVPXCGWSA-N",
      "smilesParent": "COc1ccc(cc1)S(=O)(=O)N[C@H]2C=C[C@H](CC(=O)NCCc3ccncc3)O[C@H]2CO"
    },
    "unichem": {
      "chebi": "103166",
      "lincs": "LSM-14511",
      "pubchem": "54638223"
    },
    "pubchem": [
      {
        "cid": 54638223,
        "inchi": "InChI=1S/C22H27N3O6S/c1-30-17-2-5-19(6-3-17)32(28,29)25-20-7-4-18(31-21(20)15-26)14-22(27)24-13-10-16-8-11-23-12-9-16/h2-9,11-12,18,20-21,25-26H,10,13-15H2,1H3,(H,24,27)/t18-,20+,21+/m1/s1",
        "inchikey": "SKMIIEGWSYGYOW-GIVPXCGWSA-N",
        "iupac": {
          "systematic": "2-[(2R,3S,6S)-2-(hydroxymethyl)-3-[(4-methoxyphenyl)sulfonylamino]-3,6-dihydro-2H-pyran-6-yl]-N-(2-pyridin-4-ylethyl)acetamide"
        },
        "smiles": {
          "canonical": "COC1=CC=C(C=C1)S(=O)(=O)NC2C=CC(OC2CO)CC(=O)NCCC3=CC=NC=C3"
        },
        "molecularFormula": "C22H27N3O6S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:27:35Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83e4"
    },
    "name": "MLS003129122",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83e4.png",
    "lincs": {
      "id": "LSM-8206",
      "name": "MLS003129122",
      "alternativeNames": [
        "BRD-K34556006"
      ],
      "pubchemCid": 44497710,
      "chebiId": 96827,
      "inchiParent": "InChI=1S/C23H35N5O6S/c1-17-13-27(18(2)15-29)23(30)6-5-11-28-19(12-24-25-28)16-34-22(17)14-26(3)35(31,32)21-9-7-20(33-4)8-10-21/h7-10,12,17-18,22,29H,5-6,11,13-16H2,1-4H3/t17-,18+,22+/m0/s1",
      "inchiKeyParent": "QVFRXOMYJDWMPT-NJNPRVFISA-N",
      "smilesParent": "COc1ccc(cc1)S(=O)(=O)N(C)C[C@H]2OCc3cnnn3CCCC(=O)N(C[C@@H]2C)[C@H](C)CO"
    },
    "unichem": {
      "chebi": "96827",
      "lincs": "LSM-8206",
      "pubchem": "44497710"
    },
    "pubchem": [
      {
        "cid": 44497710,
        "inchi": "InChI=1S/C23H35N5O6S/c1-17-13-27(18(2)15-29)23(30)6-5-11-28-19(12-24-25-28)16-34-22(17)14-26(3)35(31,32)21-9-7-20(33-4)8-10-21/h7-10,12,17-18,22,29H,5-6,11,13-16H2,1-4H3/t17-,18+,22+/m0/s1",
        "inchikey": "QVFRXOMYJDWMPT-NJNPRVFISA-N",
        "iupac": {
          "systematic": "N-[[(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-4-methoxy-N-methylbenzenesulfonamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)CCCN2C(=CN=N2)COC1CN(C)S(=O)(=O)C3=CC=C(C=C3)OC)C(C)CO"
        },
        "molecularFormula": "C23H35N5O6S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:27:38Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8381"
    },
    "name": "BRD-K42156657",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8381.png",
    "lincs": {
      "id": "LSM-10987",
      "name": "BRD-K42156657",
      "pubchemCid": 54650169,
      "chebiId": 99608,
      "inchiParent": "InChI=1S/C22H21N3O2/c23-13-19-21(17-10-8-16(9-11-17)15-5-1-2-6-15)20(14-26)25(19)22(27)18-7-3-4-12-24-18/h3-5,7-12,19-21,26H,1-2,6,14H2/t19-,20-,21+/m1/s1",
      "inchiKeyParent": "MYJKJHLNWUIKMG-NJYVYQBISA-N",
      "smilesParent": "OC[C@@H]1[C@H]([C@@H](C#N)N1C(=O)c2ccccn2)c3ccc(cc3)C4=CCCC4"
    },
    "unichem": {
      "chebi": "99608",
      "lincs": "LSM-10987",
      "pubchem": "54650169"
    },
    "pubchem": [
      {
        "cid": 54650169,
        "inchi": "InChI=1S/C22H21N3O2/c23-13-19-21(17-10-8-16(9-11-17)15-5-1-2-6-15)20(14-26)25(19)22(27)18-7-3-4-12-24-18/h3-5,7-12,19-21,26H,1-2,6,14H2/t19-,20-,21+/m1/s1",
        "inchikey": "MYJKJHLNWUIKMG-NJYVYQBISA-N",
        "iupac": {
          "systematic": "(2S,3S,4S)-3-[4-(cyclopenten-1-yl)phenyl]-4-(hydroxymethyl)-1-(pyridine-2-carbonyl)azetidine-2-carbonitrile"
        },
        "smiles": {
          "canonical": "C1CC=C(C1)C2=CC=C(C=C2)C3C(N(C3C#N)C(=O)C4=CC=CC=N4)CO"
        },
        "molecularFormula": "C22H21N3O2"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:27:40Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83c0"
    },
    "name": "BRD-K93061078",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83c0.png",
    "lincs": {
      "id": "LSM-8036",
      "name": "BRD-K93061078",
      "pubchemCid": 44485768,
      "chebiId": 96657,
      "inchiParent": "InChI=1S/C16H29N5O3/c1-12-8-21(13(2)10-22)16(23)5-4-6-20-9-14(18-19-20)11-24-15(12)7-17-3/h9,12-13,15,17,22H,4-8,10-11H2,1-3H3/t12-,13+,15-/m1/s1",
      "inchiKeyParent": "DOGJCEWMCMFHOH-VNHYZAJKSA-N",
      "smilesParent": "CNC[C@H]1OCc2cn(CCCC(=O)N(C[C@H]1C)[C@@H](C)CO)nn2"
    },
    "unichem": {
      "chebi": "96657",
      "lincs": "LSM-8036",
      "pubchem": "44485768"
    },
    "pubchem": [
      {
        "cid": 44485768,
        "inchi": "InChI=1S/C16H29N5O3/c1-12-8-21(13(2)10-22)16(23)5-4-6-20-9-14(18-19-20)11-24-15(12)7-17-3/h9,12-13,15,17,22H,4-8,10-11H2,1-3H3/t12-,13+,15-/m1/s1",
        "inchikey": "DOGJCEWMCMFHOH-VNHYZAJKSA-N",
        "iupac": {
          "systematic": "(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-(methylaminomethyl)-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)CCCN2C=C(COC1CNC)N=N2)C(C)CO"
        },
        "molecularFormula": "C16H29N5O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:27:42Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83f0"
    },
    "name": "BRD-K77933659",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83f0.png",
    "lincs": {
      "id": "LSM-13197",
      "name": "BRD-K77933659",
      "pubchemCid": 54646494,
      "chebiId": 101835,
      "inchiParent": "InChI=1S/C24H35N3O5/c1-27(2)13-23(30)26-16-8-9-20-18(10-16)19-11-17(31-21(14-28)24(19)32-20)12-22(29)25-15-6-4-3-5-7-15/h8-10,15,17,19,21,24,28H,3-7,11-14H2,1-2H3,(H,25,29)(H,26,30)/t17-,19+,21+,24-/m0/s1",
      "inchiKeyParent": "KRQAAGOFZVBHDO-FCMRVMJTSA-N",
      "smilesParent": "CN(C)CC(=O)Nc1ccc2O[C@@H]3[C@@H](CO)O[C@H](CC(=O)NC4CCCCC4)C[C@@H]3c2c1"
    },
    "unichem": {
      "chebi": "101835",
      "lincs": "LSM-13197",
      "pubchem": "54646494"
    },
    "pubchem": [
      {
        "cid": 54646494,
        "inchi": "InChI=1S/C24H35N3O5/c1-27(2)13-23(30)26-16-8-9-20-18(10-16)19-11-17(31-21(14-28)24(19)32-20)12-22(29)25-15-6-4-3-5-7-15/h8-10,15,17,19,21,24,28H,3-7,11-14H2,1-2H3,(H,25,29)(H,26,30)/t17-,19+,21+,24-/m0/s1",
        "inchikey": "KRQAAGOFZVBHDO-FCMRVMJTSA-N",
        "iupac": {
          "systematic": "2-[(1R,3S,4aR,9aS)-6-[[2-(dimethylamino)acetyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-cyclohexylacetamide"
        },
        "smiles": {
          "canonical": "CN(C)CC(=O)NC1=CC2=C(C=C1)OC3C2CC(OC3CO)CC(=O)NC4CCCCC4"
        },
        "molecularFormula": "C24H35N3O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:27:45Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8411"
    },
    "name": "MLS003130062",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8411.png",
    "lincs": {
      "id": "LSM-7536",
      "name": "MLS003130062",
      "alternativeNames": [
        "BRD-K53185063"
      ],
      "pubchemCid": 46903425,
      "chebiId": 96157,
      "inchiParent": "InChI=1S/C32H38N2O5S/c1-23-19-34(24(2)22-35)40(37,38)32-17-14-26(11-10-25(3)36)18-30(32)39-31(23)21-33(4)20-27-12-15-29(16-13-27)28-8-6-5-7-9-28/h5-9,12-18,23-25,31,35-36H,19-22H2,1-4H3/t23-,24-,25-,31-/m1/s1",
      "inchiKeyParent": "AXBJPSYRCLUHNL-GTEDWBNGSA-N",
      "smilesParent": "C[C@@H](O)C#Cc1ccc2c(O[C@H](CN(C)Cc3ccc(cc3)c4ccccc4)[C@H](C)CN([C@H](C)CO)S2(=O)=O)c1"
    },
    "unichem": {
      "chebi": "96157",
      "chembl": "CHEMBL1890857",
      "lincs": "LSM-7536",
      "pubchem": "46903425"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL1890857",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 562.73,
        "hba": 6,
        "hbd": 2,
        "qedWeighted": 0.42
      }
    },
    "pubchem": [
      {
        "cid": 46903425,
        "inchi": "InChI=1S/C32H38N2O5S/c1-23-19-34(24(2)22-35)40(37,38)32-17-14-26(11-10-25(3)36)18-30(32)39-31(23)21-33(4)20-27-12-15-29(16-13-27)28-8-6-5-7-9-28/h5-9,12-18,23-25,31,35-36H,19-22H2,1-4H3/t23-,24-,25-,31-/m1/s1",
        "inchikey": "AXBJPSYRCLUHNL-GTEDWBNGSA-N",
        "iupac": {
          "systematic": "(2R)-4-[(4R,5S)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-5-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-8-yl]but-3-yn-2-ol"
        },
        "smiles": {
          "canonical": "CC1CN(S(=O)(=O)C2=C(C=C(C=C2)C#CC(C)O)OC1CN(C)CC3=CC=C(C=C3)C4=CC=CC=C4)C(C)CO"
        },
        "molecularFormula": "C32H38N2O5S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:27:56Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c837e"
    },
    "name": "BRD-K36853464",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c837e.png",
    "lincs": {
      "id": "LSM-10657",
      "name": "BRD-K36853464",
      "pubchemCid": 54654172,
      "chebiId": 99278,
      "inchiParent": "InChI=1S/C29H31N3O6S/c1-32-23-10-9-21(15-27(33)30-16-18-5-3-6-20(13-18)36-2)38-25(23)17-37-24-11-8-19(14-22(24)29(32)35)31-28(34)26-7-4-12-39-26/h3-8,11-14,21,23,25H,9-10,15-17H2,1-2H3,(H,30,33)(H,31,34)/t21-,23-,25+/m1/s1",
      "inchiKeyParent": "DZYZVJKKUJSUJU-PFATUAPWSA-N",
      "smilesParent": "COc1cccc(CNC(=O)C[C@H]2CC[C@@H]3[C@H](COc4ccc(NC(=O)c5cccs5)cc4C(=O)N3C)O2)c1"
    },
    "unichem": {
      "chebi": "99278",
      "lincs": "LSM-10657",
      "pubchem": "54654172"
    },
    "pubchem": [
      {
        "cid": 54654172,
        "inchi": "InChI=1S/C29H31N3O6S/c1-32-23-10-9-21(15-27(33)30-16-18-5-3-6-20(13-18)36-2)38-25(23)17-37-24-11-8-19(14-22(24)29(32)35)31-28(34)26-7-4-12-39-26/h3-8,11-14,21,23,25H,9-10,15-17H2,1-2H3,(H,30,33)(H,31,34)/t21-,23-,25+/m1/s1",
        "inchikey": "DZYZVJKKUJSUJU-PFATUAPWSA-N",
        "iupac": {
          "systematic": "N-[(2R,4aR,12aR)-2-[2-[(3-methoxyphenyl)methylamino]-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]thiophene-2-carboxamide"
        },
        "smiles": {
          "canonical": "CN1C2CCC(OC2COC3=C(C1=O)C=C(C=C3)NC(=O)C4=CC=CS4)CC(=O)NCC5=CC(=CC=C5)OC"
        },
        "molecularFormula": "C29H31N3O6S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:27:58Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83b0"
    },
    "name": "BRD-K29324759",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83b0.png",
    "lincs": {
      "id": "LSM-10205",
      "name": "BRD-K29324759",
      "pubchemCid": 54631753,
      "chebiId": 98826,
      "inchiParent": "InChI=1S/C27H37FN4O4/c1-6-13-32-15-18(2)25(35-5)16-31(4)26(33)21-14-20(11-12-24(21)36-17-19(32)3)29-27(34)30-23-10-8-7-9-22(23)28/h7-12,14,18-19,25H,6,13,15-17H2,1-5H3,(H2,29,30,34)/t18-,19+,25-/m0/s1",
      "inchiKeyParent": "HTKHLCDDEOIAQO-CEYNDMKZSA-N",
      "smilesParent": "CCCN1C[C@H](C)[C@H](CN(C)C(=O)c2cc(NC(=O)Nc3ccccc3F)ccc2OC[C@H]1C)OC"
    },
    "unichem": {
      "chebi": "98826",
      "lincs": "LSM-10205",
      "pubchem": "54631753"
    },
    "pubchem": [
      {
        "cid": 54631753,
        "inchi": "InChI=1S/C27H37FN4O4/c1-6-13-32-15-18(2)25(35-5)16-31(4)26(33)21-14-20(11-12-24(21)36-17-19(32)3)29-27(34)30-23-10-8-7-9-22(23)28/h7-12,14,18-19,25H,6,13,15-17H2,1-5H3,(H2,29,30,34)/t18-,19+,25-/m0/s1",
        "inchikey": "HTKHLCDDEOIAQO-CEYNDMKZSA-N",
        "iupac": {
          "systematic": "1-(2-fluorophenyl)-3-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea"
        },
        "smiles": {
          "canonical": "CCCN1CC(C(CN(C(=O)C2=C(C=CC(=C2)NC(=O)NC3=CC=CC=C3F)OCC1C)C)OC)C"
        },
        "molecularFormula": "C27H37FN4O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:28:01Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83b1"
    },
    "name": "CHEMBL2139042",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83b1.png",
    "lincs": {
      "id": "LSM-7955",
      "name": "CHEMBL2139042",
      "alternativeNames": [
        "BRD-K86524553"
      ],
      "pubchemCid": 54618475,
      "chebiId": 96576,
      "inchiParent": "InChI=1S/C32H35N5O4/c1-22-17-37(23(2)20-38)32(39)29-13-25(26-14-33-21-34-15-26)16-35-31(29)41-30(22)19-36(3)18-24-9-11-28(12-10-24)40-27-7-5-4-6-8-27/h4-16,21-23,30,38H,17-20H2,1-3H3/t22-,23+,30+/m0/s1",
      "inchiKeyParent": "ANXFQERLRQGOSV-DDFCPOBKSA-N",
      "smilesParent": "C[C@H](CO)N1C[C@H](C)[C@@H](CN(C)Cc2ccc(Oc3ccccc3)cc2)Oc4ncc(cc4C1=O)c5cncnc5"
    },
    "unichem": {
      "chebi": "96576",
      "chembl": "CHEMBL2139042",
      "lincs": "LSM-7955",
      "pubchem": "54618475"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL2139042",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 553.66,
        "hba": 8,
        "hbd": 1,
        "qedWeighted": 0.32
      }
    },
    "pubchem": [
      {
        "cid": 54618475,
        "inchi": "InChI=1S/C32H35N5O4/c1-22-17-37(23(2)20-38)32(39)29-13-25(26-14-33-21-34-15-26)16-35-31(29)41-30(22)19-36(3)18-24-9-11-28(12-10-24)40-27-7-5-4-6-8-27/h4-16,21-23,30,38H,17-20H2,1-3H3/t22-,23+,30+/m0/s1",
        "inchikey": "ANXFQERLRQGOSV-DDFCPOBKSA-N",
        "iupac": {
          "systematic": "(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-8-pyrimidin-5-yl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(N=CC(=C2)C3=CN=CN=C3)OC1CN(C)CC4=CC=C(C=C4)OC5=CC=CC=C5)C(C)CO"
        },
        "molecularFormula": "C32H35N5O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:28:12Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83ed"
    },
    "name": "BRD-K62601469",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83ed.png",
    "lincs": {
      "id": "LSM-12229",
      "name": "BRD-K62601469",
      "pubchemCid": 54632126,
      "chebiId": 100855,
      "inchiParent": "InChI=1S/C28H40N4O4/c1-19(2)29-28(34)30-23-12-13-25-24(14-23)27(33)31(5)17-26(35-6)20(3)15-32(21(4)18-36-25)16-22-10-8-7-9-11-22/h7-14,19-21,26H,15-18H2,1-6H3,(H2,29,30,34)/t20-,21+,26-/m0/s1",
      "inchiKeyParent": "XLOJZIOISXYGBL-UZINWLIJSA-N",
      "smilesParent": "CO[C@H]1CN(C)C(=O)c2cc(NC(=O)NC(C)C)ccc2OC[C@@H](C)N(Cc3ccccc3)C[C@@H]1C"
    },
    "unichem": {
      "chebi": "100855",
      "lincs": "LSM-12229",
      "pubchem": "54632126"
    },
    "pubchem": [
      {
        "cid": 54632126,
        "inchi": "InChI=1S/C28H40N4O4/c1-19(2)29-28(34)30-23-12-13-25-24(14-23)27(33)31(5)17-26(35-6)20(3)15-32(21(4)18-36-25)16-22-10-8-7-9-11-22/h7-14,19-21,26H,15-18H2,1-6H3,(H2,29,30,34)/t20-,21+,26-/m0/s1",
        "inchikey": "XLOJZIOISXYGBL-UZINWLIJSA-N",
        "iupac": {
          "systematic": "1-[(4R,7S,8R)-5-benzyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propan-2-ylurea"
        },
        "smiles": {
          "canonical": "CC1CN(C(COC2=C(C=C(C=C2)NC(=O)NC(C)C)C(=O)N(CC1OC)C)C)CC3=CC=CC=C3"
        },
        "molecularFormula": "C28H40N4O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:28:14Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8406"
    },
    "name": "BRD-K50639228",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8406.png",
    "lincs": {
      "id": "LSM-7497",
      "name": "BRD-K50639228",
      "pubchemCid": 54618585,
      "chebiId": 96118,
      "inchiParent": "InChI=1S/C25H37N3O5/c1-17-13-28(18(2)16-29)25(31)22-11-21(6-5-19(3)30)12-26-24(22)33-23(17)15-27(4)14-20-7-9-32-10-8-20/h11-12,17-20,23,29-30H,7-10,13-16H2,1-4H3/t17-,18+,19-,23+/m1/s1",
      "inchiKeyParent": "AEYCXANGZGGWKX-KCESLBEFSA-N",
      "smilesParent": "C[C@@H](O)C#Cc1cnc2O[C@@H](CN(C)CC3CCOCC3)[C@H](C)CN([C@@H](C)CO)C(=O)c2c1"
    },
    "unichem": {
      "chebi": "96118",
      "lincs": "LSM-7497",
      "pubchem": "54618585"
    },
    "pubchem": [
      {
        "cid": 54618585,
        "inchi": "InChI=1S/C25H37N3O5/c1-17-13-28(18(2)16-29)25(31)22-11-21(6-5-19(3)30)12-26-24(22)33-23(17)15-27(4)14-20-7-9-32-10-8-20/h11-12,17-20,23,29-30H,7-10,13-16H2,1-4H3/t17-,18+,19-,23+/m1/s1",
        "inchikey": "AEYCXANGZGGWKX-KCESLBEFSA-N",
        "iupac": {
          "systematic": "(2R,3R)-8-[(3R)-3-hydroxybut-1-ynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(oxan-4-ylmethyl)amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(N=CC(=C2)C#CC(C)O)OC1CN(C)CC3CCOCC3)C(C)CO"
        },
        "molecularFormula": "C25H37N3O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:28:16Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8408"
    },
    "name": "BRD-K58096890",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8408.png",
    "lincs": {
      "id": "LSM-40449",
      "name": "BRD-K58096890",
      "pubchemCid": 44501313,
      "chebiId": 128897,
      "inchiParent": "InChI=1S/C28H45N5O5/c1-18(2)29-27(36)30-23-11-12-24-21(13-23)14-26(35)33(20(4)17-34)15-19(3)25(38-24)16-32(5)28(37)31-22-9-7-6-8-10-22/h11-13,18-20,22,25,34H,6-10,14-17H2,1-5H3,(H,31,37)(H2,29,30,36)/t19-,20+,25-/m0/s1",
      "inchiKeyParent": "RCXZWUYRMIXVKB-DFIYOIEZSA-N",
      "smilesParent": "CC(C)NC(=O)Nc1ccc2O[C@@H](CN(C)C(=O)NC3CCCCC3)[C@@H](C)CN([C@H](C)CO)C(=O)Cc2c1"
    },
    "unichem": {
      "chebi": "128897",
      "lincs": "LSM-40449",
      "pubchem": "44501313"
    },
    "pubchem": [
      {
        "cid": 44501313,
        "inchi": "InChI=1S/C28H45N5O5/c1-18(2)29-27(36)30-23-11-12-24-21(13-23)14-26(35)33(20(4)17-34)15-19(3)25(38-24)16-32(5)28(37)31-22-9-7-6-8-10-22/h11-13,18-20,22,25,34H,6-10,14-17H2,1-5H3,(H,31,37)(H2,29,30,36)/t19-,20+,25-/m0/s1",
        "inchikey": "RCXZWUYRMIXVKB-DFIYOIEZSA-N",
        "iupac": {
          "systematic": "3-cyclohexyl-1-[[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-9-(propan-2-ylcarbamoylamino)-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methylurea"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)CC2=C(C=CC(=C2)NC(=O)NC(C)C)OC1CN(C)C(=O)NC3CCCCC3)C(C)CO"
        },
        "molecularFormula": "C28H45N5O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:28:19Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c839e"
    },
    "name": "BRD-K37545156",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c839e.png",
    "lincs": {
      "id": "LSM-7332",
      "name": "BRD-K37545156",
      "pubchemCid": 44485078,
      "chebiId": 95953,
      "inchiParent": "InChI=1S/C17H31N5O3/c1-13-8-22(14(2)11-23)17(24)6-5-7-21-9-15(18-19-21)12-25-16(13)10-20(3)4/h9,13-14,16,23H,5-8,10-12H2,1-4H3/t13-,14+,16-/m1/s1",
      "inchiKeyParent": "WAHUPRWPWKVPJH-IJEWVQPXSA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@@H](C)[C@@H](CN(C)C)OCc2cn(CCCC1=O)nn2"
    },
    "unichem": {
      "chebi": "95953",
      "lincs": "LSM-7332",
      "pubchem": "44485078"
    },
    "pubchem": [
      {
        "cid": 44485078,
        "inchi": "InChI=1S/C17H31N5O3/c1-13-8-22(14(2)11-23)17(24)6-5-7-21-9-15(18-19-21)12-25-16(13)10-20(3)4/h9,13-14,16,23H,5-8,10-12H2,1-4H3/t13-,14+,16-/m1/s1",
        "inchikey": "WAHUPRWPWKVPJH-IJEWVQPXSA-N",
        "iupac": {
          "systematic": "(8R,9S)-9-[(dimethylamino)methyl]-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)CCCN2C=C(COC1CN(C)C)N=N2)C(C)CO"
        },
        "molecularFormula": "C17H31N5O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:28:21Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8404"
    },
    "name": "BRD-K88306467",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8404.png",
    "lincs": {
      "id": "LSM-13854",
      "name": "BRD-K88306467",
      "pubchemCid": 54649390,
      "chebiId": 102505,
      "inchiParent": "InChI=1S/C29H35N3O4S/c1-29(2,3)37(35)32-18-22-17-24(28(34)31(4)5)30-27(26(22)25(32)14-15-33)21-9-7-8-20(16-21)19-10-12-23(36-6)13-11-19/h7-13,16-17,25,33H,14-15,18H2,1-6H3/t25-,37-/m0/s1",
      "inchiKeyParent": "QYSQYMZBXYWZNF-RSUXDYMJSA-N",
      "smilesParent": "COc1ccc(cc1)c2cccc(c2)c3nc(cc4CN([C@@H](CCO)c34)[S@@](=O)C(C)(C)C)C(=O)N(C)C"
    },
    "unichem": {
      "chebi": "102505",
      "lincs": "LSM-13854",
      "pubchem": "54649390"
    },
    "pubchem": [
      {
        "cid": 54649390,
        "inchi": "InChI=1S/C29H35N3O4S/c1-29(2,3)37(35)32-18-22-17-24(28(34)31(4)5)30-27(26(22)25(32)14-15-33)21-9-7-8-20(16-21)19-10-12-23(36-6)13-11-19/h7-13,16-17,25,33H,14-15,18H2,1-6H3/t25-,37-/m0/s1",
        "inchikey": "QYSQYMZBXYWZNF-RSUXDYMJSA-N",
        "iupac": {
          "systematic": "(3S)-2-[(S)-tert-butylsulfinyl]-3-(2-hydroxyethyl)-4-[3-(4-methoxyphenyl)phenyl]-N,N-dimethyl-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide"
        },
        "smiles": {
          "canonical": "CC(C)(C)S(=O)N1CC2=CC(=NC(=C2C1CCO)C3=CC=CC(=C3)C4=CC=C(C=C4)OC)C(=O)N(C)C"
        },
        "molecularFormula": "C29H35N3O4S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:28:23Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8354"
    },
    "name": "BRD-K61001510",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8354.png",
    "lincs": {
      "id": "LSM-40608",
      "name": "BRD-K61001510",
      "pubchemCid": 44498600,
      "chebiId": 129056,
      "inchiParent": "InChI=1S/C29H42N4O7S/c1-20-17-33(21(2)19-34)29(36)25-16-24(31-28(35)23-11-13-30-14-12-23)9-10-26(25)40-22(3)8-6-7-15-39-27(20)18-32(4)41(5,37)38/h9-14,16,20-22,27,34H,6-8,15,17-19H2,1-5H3,(H,31,35)/t20-,21+,22-,27-/m1/s1",
      "inchiKeyParent": "RGRLROMATPOZOC-RSOWOKRSSA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@@H](C)[C@@H](CN(C)S(=O)(=O)C)OCCCC[C@@H](C)Oc2ccc(NC(=O)c3ccncc3)cc2C1=O"
    },
    "unichem": {
      "chebi": "129056",
      "lincs": "LSM-40608",
      "pubchem": "44498600"
    },
    "pubchem": [
      {
        "cid": 44498600,
        "inchi": "InChI=1S/C29H42N4O7S/c1-20-17-33(21(2)19-34)29(36)25-16-24(31-28(35)23-11-13-30-14-12-23)9-10-26(25)40-22(3)8-6-7-15-39-27(20)18-32(4)41(5,37)38/h9-14,16,20-22,27,34H,6-8,15,17-19H2,1-5H3,(H,31,35)/t20-,21+,22-,27-/m1/s1",
        "inchikey": "RGRLROMATPOZOC-RSOWOKRSSA-N",
        "iupac": {
          "systematic": "N-[(3R,9S,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(methylsulfonyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]pyridine-4-carboxamide"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NC(=O)C3=CC=NC=C3)C(C)CO)C)CN(C)S(=O)(=O)C"
        },
        "molecularFormula": "C29H42N4O7S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:28:26Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c836c"
    },
    "name": "BRD-K89226093",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c836c.png",
    "lincs": {
      "id": "LSM-13921",
      "name": "BRD-K89226093",
      "pubchemCid": 54660697,
      "chebiId": 102574,
      "inchiParent": "InChI=1S/C23H26F3N3O3/c1-14(15-6-3-2-4-7-15)27-22(32)20-16(13-30)18-12-29-17(8-5-9-19(29)31)21(20)28(18)11-10-23(24,25)26/h2-9,14,16,18,20-21,30H,10-13H2,1H3,(H,27,32)/t14-,16+,18+,20-,21-/m0/s1",
      "inchiKeyParent": "LOVSINJIWNBKBE-SJRSHZEHSA-N",
      "smilesParent": "C[C@H](NC(=O)[C@H]1[C@H](CO)[C@H]2CN3C(=O)C=CC=C3[C@@H]1N2CCC(F)(F)F)c4ccccc4"
    },
    "unichem": {
      "chebi": "102574",
      "lincs": "LSM-13921",
      "pubchem": "54660697"
    },
    "pubchem": [
      {
        "cid": 54660697,
        "inchi": "InChI=1S/C23H26F3N3O3/c1-14(15-6-3-2-4-7-15)27-22(32)20-16(13-30)18-12-29-17(8-5-9-19(29)31)21(20)28(18)11-10-23(24,25)26/h2-9,14,16,18,20-21,30H,10-13H2,1H3,(H,27,32)/t14-,16+,18+,20-,21-/m0/s1",
        "inchikey": "LOVSINJIWNBKBE-SJRSHZEHSA-N",
        "iupac": {
          "systematic": "(1R,9S,10S,11S)-10-(hydroxymethyl)-6-oxo-N-[(1S)-1-phenylethyl]-12-(3,3,3-trifluoropropyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide"
        },
        "smiles": {
          "canonical": "CC(C1=CC=CC=C1)NC(=O)C2C(C3CN4C(=O)C=CC=C4C2N3CCC(F)(F)F)CO"
        },
        "molecularFormula": "C23H26F3N3O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:28:28Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8387"
    },
    "name": "BRD-K05653239",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8387.png",
    "lincs": {
      "id": "LSM-6934",
      "name": "BRD-K05653239",
      "pubchemCid": 54618254,
      "chebiId": 95555,
      "inchiParent": "InChI=1S/C30H32FN3O5S/c1-21-18-34(22(2)20-35)40(37,38)29-11-9-23(8-10-25-6-4-5-7-26(25)31)16-27(29)39-28(21)19-33(3)30(36)17-24-12-14-32-15-13-24/h4-7,9,11-16,21-22,28,35H,17-20H2,1-3H3/t21-,22+,28+/m1/s1",
      "inchiKeyParent": "FRFGYBSWUNYCIP-WENCSYSZSA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@@H](C)[C@H](CN(C)C(=O)Cc2ccncc2)Oc3cc(ccc3S1(=O)=O)C#Cc4ccccc4F"
    },
    "unichem": {
      "chebi": "95555",
      "lincs": "LSM-6934",
      "pubchem": "54618254"
    },
    "pubchem": [
      {
        "cid": 54618254,
        "inchi": "InChI=1S/C30H32FN3O5S/c1-21-18-34(22(2)20-35)40(37,38)29-11-9-23(8-10-25-6-4-5-7-26(25)31)16-27(29)39-28(21)19-33(3)30(36)17-24-12-14-32-15-13-24/h4-7,9,11-16,21-22,28,35H,17-20H2,1-3H3/t21-,22+,28+/m1/s1",
        "inchikey": "FRFGYBSWUNYCIP-WENCSYSZSA-N",
        "iupac": {
          "systematic": "N-[[(4R,5R)-8-[2-(2-fluorophenyl)ethynyl]-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyridin-4-ylacetamide"
        },
        "smiles": {
          "canonical": "CC1CN(S(=O)(=O)C2=C(C=C(C=C2)C#CC3=CC=CC=C3F)OC1CN(C)C(=O)CC4=CC=NC=C4)C(C)CO"
        },
        "molecularFormula": "C30H32FN3O5S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:28:30Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8391"
    },
    "name": "BRD-K68687385",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8391.png",
    "lincs": {
      "id": "LSM-12618",
      "name": "BRD-K68687385",
      "pubchemCid": 54632174,
      "chebiId": 101250,
      "inchiParent": "InChI=1S/C24H37N5O5S/c1-7-10-29-12-17(2)22(33-6)13-28(5)24(30)20-9-8-19(11-21(20)34-15-18(29)3)26-35(31,32)23-14-27(4)16-25-23/h8-9,11,14,16-18,22,26H,7,10,12-13,15H2,1-6H3/t17-,18+,22-/m0/s1",
      "inchiKeyParent": "LWIIWTGMFNHRDM-SVMVAKDDSA-N",
      "smilesParent": "CCCN1C[C@H](C)[C@H](CN(C)C(=O)c2ccc(NS(=O)(=O)c3cn(C)cn3)cc2OC[C@H]1C)OC"
    },
    "unichem": {
      "chebi": "101250",
      "lincs": "LSM-12618",
      "pubchem": "54632174"
    },
    "pubchem": [
      {
        "cid": 54632174,
        "inchi": "InChI=1S/C24H37N5O5S/c1-7-10-29-12-17(2)22(33-6)13-28(5)24(30)20-9-8-19(11-21(20)34-15-18(29)3)26-35(31,32)23-14-27(4)16-25-23/h8-9,11,14,16-18,22,26H,7,10,12-13,15H2,1-6H3/t17-,18+,22-/m0/s1",
        "inchikey": "LWIIWTGMFNHRDM-SVMVAKDDSA-N",
        "iupac": {
          "systematic": "N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-15-yl]-1-methylimidazole-4-sulfonamide"
        },
        "smiles": {
          "canonical": "CCCN1CC(C(CN(C(=O)C2=C(C=C(C=C2)NS(=O)(=O)C3=CN(C=N3)C)OCC1C)C)OC)C"
        },
        "molecularFormula": "C24H37N5O5S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:28:32Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83ae"
    },
    "name": "BRD-K29452018",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83ae.png",
    "lincs": {
      "id": "LSM-10214",
      "name": "BRD-K29452018",
      "pubchemCid": 54639068,
      "chebiId": 98835,
      "inchiParent": "InChI=1S/C16H26N2O5/c1-22-11-15(20)17-13-6-5-12(23-14(13)10-19)9-16(21)18-7-3-2-4-8-18/h5-6,12-14,19H,2-4,7-11H2,1H3,(H,17,20)/t12-,13+,14+/m0/s1",
      "inchiKeyParent": "BHRCWANBCSKYFS-BFHYXJOUSA-N",
      "smilesParent": "COCC(=O)N[C@@H]1C=C[C@@H](CC(=O)N2CCCCC2)O[C@@H]1CO"
    },
    "unichem": {
      "chebi": "98835",
      "lincs": "LSM-10214",
      "pubchem": "54639068"
    },
    "pubchem": [
      {
        "cid": 54639068,
        "inchi": "InChI=1S/C16H26N2O5/c1-22-11-15(20)17-13-6-5-12(23-14(13)10-19)9-16(21)18-7-3-2-4-8-18/h5-6,12-14,19H,2-4,7-11H2,1H3,(H,17,20)/t12-,13+,14+/m0/s1",
        "inchikey": "BHRCWANBCSKYFS-BFHYXJOUSA-N",
        "iupac": {
          "systematic": "N-[(2S,3R,6R)-2-(hydroxymethyl)-6-(2-oxo-2-piperidin-1-ylethyl)-3,6-dihydro-2H-pyran-3-yl]-2-methoxyacetamide"
        },
        "smiles": {
          "canonical": "COCC(=O)NC1C=CC(OC1CO)CC(=O)N2CCCCC2"
        },
        "molecularFormula": "C16H26N2O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:28:35Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83ca"
    },
    "name": "BRD-K19405573",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83ca.png",
    "lincs": {
      "id": "LSM-9598",
      "name": "BRD-K19405573",
      "pubchemCid": 54657823,
      "chebiId": 98219,
      "inchiParent": "InChI=1S/C27H37N3O4S/c31-22-16-30(17-26-28-10-13-35-26)24-7-6-23(34-25(24)19-33-18-22)15-27(32)29-11-8-21(9-12-29)14-20-4-2-1-3-5-20/h1-5,10,13,21-25,31H,6-9,11-12,14-19H2/t22-,23+,24+,25-/m1/s1",
      "inchiKeyParent": "XKLJDQDBSRSGED-WSOYEBOPSA-N",
      "smilesParent": "O[C@H]1COC[C@H]2O[C@H](CC(=O)N3CCC(Cc4ccccc4)CC3)CC[C@@H]2N(Cc5nccs5)C1"
    },
    "unichem": {
      "chebi": "98219",
      "lincs": "LSM-9598",
      "pubchem": "54657823"
    },
    "pubchem": [
      {
        "cid": 54657823,
        "inchi": "InChI=1S/C27H37N3O4S/c31-22-16-30(17-26-28-10-13-35-26)24-7-6-23(34-25(24)19-33-18-22)15-27(32)29-11-8-21(9-12-29)14-20-4-2-1-3-5-20/h1-5,10,13,21-25,31H,6-9,11-12,14-19H2/t22-,23+,24+,25-/m1/s1",
        "inchikey": "XKLJDQDBSRSGED-WSOYEBOPSA-N",
        "iupac": {
          "systematic": "2-[(3R,6aS,8S,10aS)-3-hydroxy-1-(1,3-thiazol-2-ylmethyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(4-benzylpiperidin-1-yl)ethanone"
        },
        "smiles": {
          "canonical": "C1CC2C(COCC(CN2CC3=NC=CS3)O)OC1CC(=O)N4CCC(CC4)CC5=CC=CC=C5"
        },
        "molecularFormula": "C27H37N3O4S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:28:37Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83d9"
    },
    "name": "BRD-K02311587",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83d9.png",
    "lincs": {
      "id": "LSM-8576",
      "name": "BRD-K02311587",
      "pubchemCid": 54645885,
      "chebiId": 97197,
      "inchiParent": "InChI=1S/C27H32FN3O5/c28-22-8-4-1-5-16(22)14-29-25(33)13-19-12-21-20-11-18(31-27(34)30-17-6-2-3-7-17)9-10-23(20)36-26(21)24(15-32)35-19/h1,4-5,8-11,17,19,21,24,26,32H,2-3,6-7,12-15H2,(H,29,33)(H2,30,31,34)/t19-,21+,24+,26-/m1/s1",
      "inchiKeyParent": "MSBIHNOYSLVJHR-ZHRNDHIYSA-N",
      "smilesParent": "OC[C@@H]1O[C@@H](CC(=O)NCc2ccccc2F)C[C@@H]3[C@H]1Oc4ccc(NC(=O)NC5CCCC5)cc34"
    },
    "unichem": {
      "chebi": "97197",
      "lincs": "LSM-8576",
      "pubchem": "54645885"
    },
    "pubchem": [
      {
        "cid": 54645885,
        "inchi": "InChI=1S/C27H32FN3O5/c28-22-8-4-1-5-16(22)14-29-25(33)13-19-12-21-20-11-18(31-27(34)30-17-6-2-3-7-17)9-10-23(20)36-26(21)24(15-32)35-19/h1,4-5,8-11,17,19,21,24,26,32H,2-3,6-7,12-15H2,(H,29,33)(H2,30,31,34)/t19-,21+,24+,26-/m1/s1",
        "inchikey": "MSBIHNOYSLVJHR-ZHRNDHIYSA-N",
        "iupac": {
          "systematic": "2-[(1S,3R,4aS,9aR)-6-(cyclopentylcarbamoylamino)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-[(2-fluorophenyl)methyl]acetamide"
        },
        "smiles": {
          "canonical": "C1CCC(C1)NC(=O)NC2=CC3=C(C=C2)OC4C3CC(OC4CO)CC(=O)NCC5=CC=CC=C5F"
        },
        "molecularFormula": "C27H32FN3O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:28:39Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83df"
    },
    "name": "Oligomycin-A",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83df.png",
    "lincs": {
      "id": "LSM-43347",
      "name": "Oligomycin-A",
      "inchiParent": "InChI=1S/C45H74O11/c1-12-34-17-15-13-14-16-27(4)42(51)44(11,53)43(52)32(9)40(50)31(8)39(49)30(7)38(48)26(3)18-21-37(47)54-41-29(6)35(20-19-34)55-45(33(41)10)23-22-25(2)36(56-45)24-28(5)46/h13-15,17-18,21,25-36,38,40-42,46,48,50-51,53H,12,16,19-20,22-24H2,1-11H3/b14-13+,17-15+,21-18+/t25-,26-,27+,28+,29+,30-,31-,32-,33-,34-,35-,36-,38+,40+,41+,42-,44+,45-/m1/s1",
      "inchiKeyParent": "MNULEGDCPYONBU-WMBHJXFZSA-N",
      "smilesParent": "CC[C@H]1CC[C@H]2O[C@@]3(CC[C@@H](C)[C@@H](C[C@H](C)O)O3)[C@H](C)[C@@H](OC(=O)\\C=C\\[C@@H](C)[C@H](O)[C@@H](C)C(=O)[C@@H](C)[C@H](O)[C@@H](C)C(=O)[C@@](C)(O)[C@H](O)[C@@H](C)C\\C=C\\C=C\\1)[C@H]2C"
    },
    "unichem": {
      "chembl": "CHEMBL3039432",
      "lincs": "LSM-43347",
      "pubchem": "5281899"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL3039432",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 791.08,
        "hba": 11,
        "hbd": 5,
        "qedWeighted": 0.22
      }
    },
    "pubchem": [
      {
        "cid": 5281899,
        "inchi": "InChI=1S/C45H74O11/c1-12-34-17-15-13-14-16-27(4)42(51)44(11,53)43(52)32(9)40(50)31(8)39(49)30(7)38(48)26(3)18-21-37(47)54-41-29(6)35(20-19-34)55-45(33(41)10)23-22-25(2)36(56-45)24-28(5)46/h13-15,17-18,21,25-36,38,40-42,46,48,50-51,53H,12,16,19-20,22-24H2,1-11H3/b14-13+,17-15+,21-18+/t25-,26-,27+,28+,29+,30-,31-,32-,33-,34-,35-,36-,38+,40+,41+,42-,44+,45-/m1/s1",
        "inchikey": "MNULEGDCPYONBU-WMBHJXFZSA-N",
        "iupac": {
          "systematic": "(1S,4E,5'R,6R,6'R,7S,8R,10S,11S,12R,14S,15R,16S,18E,20E,22S,25R,27S,28R,29S)-22-ethyl-7,11,14,15-tetrahydroxy-6'-[(2S)-2-hydroxypropyl]-5',6,8,10,12,14,16,28,29-nonamethylspiro[2,26-dioxabicyclo[23.3.1]nonacosa-4,18,20-triene-27,2'-oxane]-3,9,13-trione"
        },
        "smiles": {
          "canonical": "CCC1CCC2C(C(C(C3(O2)CCC(C(O3)CC(C)O)C)C)OC(=O)C=CC(C(C(C(=O)C(C(C(C(=O)C(C(C(CC=CC=C1)C)O)(C)O)C)O)C)C)O)C)C"
        },
        "molecularFormula": "C45H74O11"
      }
    ],
    "clinicaltrials": [
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT05798260",
            "briefTitle": "T-Cell Mitochondrial Respiration Response to Ketone Monoester Supplement in Healthy Volunteers and COVID-19",
            "officialTitle": "Intensive Care Unit (ICU) Biospecimen and Data Repository"
          },
          "statusModule": {
            "overallStatus": "WITHDRAWN",
            "whyStopped": "Study Never Started",
            "studyFirstSubmitDate": "2023-03-28"
          },
          "conditionsModule": {
            "conditions": [
              "COVID-19 Acute Respiratory Distress Syndrome"
            ]
          },
          "designModule": {
            "studyType": "OBSERVATIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Spare Respiratory Capacity (SRC)",
                "timeFrame": "through study completion, an average of 2 months"
              },
              {
                "measure": "Basal Respiration",
                "timeFrame": "through study completion, an average of 2 months"
              },
              {
                "measure": "ATP production-coupled Respiration",
                "timeFrame": "upon admission"
              },
              {
                "measure": "Maximal Respiration",
                "timeFrame": "upon admission"
              },
              {
                "measure": "Non-Mitochondrial Respiration",
                "timeFrame": "through study completion, an average of 2 months"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Oxygen Consumption Rate (OCR)"
              },
              {
                "measure": "extracellular acidification rate (ECAR)"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01813929",
            "briefTitle": "Effect of Metformin on Vascular and Mitochondrial Function in Type 1 Diabetes",
            "officialTitle": "Effect of Metformin on Vascular and Mitochondrial Function in Type 1 Diabetes"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2012-09-28",
            "resultsFirstSubmitDate": "2021-10-07"
          },
          "conditionsModule": {
            "conditions": [
              "Type 1 Diabetes"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Insulin Sensitivity by Hyperinsulinemic Euglycemic Clamp",
                "timeFrame": "End of each 6 week intervention period"
              },
              {
                "measure": "Flow-mediated Brachial Artery Dilation",
                "timeFrame": "End of each 6 week intervention period"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Arterial Stiffness by PWV"
              },
              {
                "measure": "Arterial Stiffness by AI@75"
              },
              {
                "measure": "Mitochondrial Measures: Oxygen Consumption"
              },
              {
                "measure": "Mitochondrial Measures: Protein Expression Levels of Electron Transport Chain Complexes"
              },
              {
                "measure": "Inflammatory Marker: hsCRP"
              },
              {
                "measure": "Heart Rate Variability"
              },
              {
                "measure": "Continuous Glucose Monitor Measures of Mean Glucose"
              },
              {
                "measure": "Continuous Glucose Monitor Measures of Hypoglycemia"
              },
              {
                "measure": "Metabolic Markers: Glucagon"
              },
              {
                "measure": "Metabolic Markers: Glucose, Triglycerides, Cholesterol"
              },
              {
                "measure": "Metabolic Markers: Fatty Acids"
              },
              {
                "measure": "Metabolic Markers: Glycerol"
              },
              {
                "measure": "Metabolic Markers: Insulin"
              },
              {
                "measure": "Metabolic Markers: Lactate"
              },
              {
                "measure": "Metabolic Markers: Adiponection"
              },
              {
                "measure": "Vascular Markers: Endothelin-1 (pg/ml)"
              },
              {
                "measure": "In Vivo Mitochondrial Function: Ratio of the Amount of ATP Generated Per Unit of Oxygen Consumed"
              },
              {
                "measure": "In Vivo Mitochondrial Function: Time Constants"
              },
              {
                "measure": "In Vivo Mitochondrial Function: QMax, VPCr"
              },
              {
                "measure": "In Vivo Mitochondrial Function: Oxidative Phosphorylation"
              },
              {
                "measure": "In Vivo Mitochondrial Function:AnGly"
              },
              {
                "measure": "Cardiac Function"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT04984226",
            "briefTitle": "Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD",
            "officialTitle": "Randomized Cross-over Trial of Sodium Bicarbonate on Muscle Mitochondrial Energetics and Physical Endurance in Chronic Kidney Disease and Metabolic Acidosis"
          },
          "statusModule": {
            "overallStatus": "RECRUITING",
            "studyFirstSubmitDate": "2021-07-08"
          },
          "conditionsModule": {
            "conditions": [
              "Chronic Kidney Diseases",
              "Metabolic Acidosis",
              "Fatigue",
              "Physical Endurance",
              "Insulin Resistance",
              "Mitochondrial Energetics",
              "Diabetes"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "muscle mitochondrial oxidative capacity by 31P MRS",
                "timeFrame": "16 weeks"
              },
              {
                "measure": "Insulin sensitivity (SI) by insulin clamp",
                "timeFrame": "16 weeks"
              },
              {
                "measure": "total work performed on cycle ergometry VO2",
                "timeFrame": "16 weeks"
              },
              {
                "measure": "muscle work efficiency cycle ergometry",
                "timeFrame": "16 weeks"
              },
              {
                "measure": "Walking endurance by 6-minute walk",
                "timeFrame": "16 weeks"
              },
              {
                "measure": "FACIT-F Fatigue (PRO)",
                "timeFrame": "16 weeks"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Intermuscular fat by MRI"
              },
              {
                "measure": "30 second sit to stand test"
              },
              {
                "measure": "PROMIS Fatigue (PRO)"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT03328338",
            "briefTitle": "Mitochondrial Function in Transthyretin Amyloidosis",
            "officialTitle": "Mitochondrial Function in Transthyretin Amyloidosis : the MIT-AMYLOSE Study."
          },
          "statusModule": {
            "overallStatus": "TERMINATED",
            "whyStopped": "Mitochondrial respiration measurement technique faulty",
            "studyFirstSubmitDate": "2017-10-28"
          },
          "conditionsModule": {
            "conditions": [
              "Cardiac Amyloidosis"
            ]
          },
          "designModule": {
            "studyType": "OBSERVATIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Oxygen consumption measure in subcutaneous abdominal fat biopsies",
                "timeFrame": "Three months"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Rates of oxygen consumption"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT04500938",
            "briefTitle": "Cardiac Mitochondrial Function in Explanted Human Hearts",
            "officialTitle": "Cardiac Mitochondrial Function in Explanted Human Hearts"
          },
          "statusModule": {
            "overallStatus": "UNKNOWN",
            "studyFirstSubmitDate": "2020-07-22"
          },
          "conditionsModule": {
            "conditions": [
              "End-stage Heart Failure"
            ]
          },
          "designModule": {
            "studyType": "OBSERVATIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "State 2 respiration (GM)",
                "timeFrame": "Within 5 minutes."
              },
              {
                "measure": "State 3 respiration (GM3)",
                "timeFrame": "Within 10 minutes."
              },
              {
                "measure": "State 3 respiration (GMS3)",
                "timeFrame": "Within 15 minutes."
              },
              {
                "measure": "State 4 respiration (4o)",
                "timeFrame": "Within 30 minutes."
              },
              {
                "measure": "Residual Oxygen Consumption (ROX)",
                "timeFrame": "Within 45 minutes."
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT06003855",
            "briefTitle": "Oxygen-guided Supervised Exercise Therapy",
            "officialTitle": "Oxygen-guided Supervised Exercise Therapy in Peripheral Artery Disease"
          },
          "statusModule": {
            "overallStatus": "RECRUITING",
            "studyFirstSubmitDate": "2023-07-25"
          },
          "conditionsModule": {
            "conditions": [
              "Peripheral Artery Disease"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Distance walked",
                "timeFrame": "Before and after 12 week exercise program"
              },
              {
                "measure": "Energy expenditure",
                "timeFrame": "Before and after 12 weeks after the exercise program"
              },
              {
                "measure": "Reactive oxygen species",
                "timeFrame": "Before exercise, immediately after exercise, 30 minutes after exercise, and 1 hour after exercise"
              },
              {
                "measure": "Protein expression of ROS-related enzymes",
                "timeFrame": "Before exercise, immediately after exercise, 30 minutes after exercise, and 1 hour after exercise"
              },
              {
                "measure": "Markers of systemic inflammation",
                "timeFrame": "Before exercise, immediately after exercise, 30 minutes after exercise, and 1 hour after exercise"
              },
              {
                "measure": "Initial and absolute walking distances",
                "timeFrame": "Before and after 12 week supervised exercise program"
              },
              {
                "measure": "Comprehensive mitochondrial respiratory complex function",
                "timeFrame": "Before and after 12 week supervised exercise program"
              },
              {
                "measure": "Mitochondrial dynamics",
                "timeFrame": "Before and after 12 week supervised exercise program"
              },
              {
                "measure": "Mitochondrial reactive oxygen species production",
                "timeFrame": "Before and after 12 week supervised exercise program"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Metabolic equivalents of task"
              },
              {
                "measure": "Physical activity enjoyment scale"
              },
              {
                "measure": "Rating of perceived exertion"
              },
              {
                "measure": "Physical activity average steps/day"
              },
              {
                "measure": "Muscle strength"
              },
              {
                "measure": "Acceptability"
              },
              {
                "measure": "Maximum cadence/day"
              },
              {
                "measure": "Muscle endurance"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT03144128",
            "briefTitle": "Vitamin D for Muscle Metabolic Function in Cancer Cachexia",
            "officialTitle": "The Contribution of Vitamin D to Muscle Metabolic Function in Cancer Cachexia"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2017-03-20"
          },
          "conditionsModule": {
            "conditions": [
              "Cancer Cachexia",
              "Vitamin D Deficiency"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Non-invasive quantification of muscle lipid distribution",
                "timeFrame": "Change between Week 0 and Week 12"
              },
              {
                "measure": "Local muscle oxygen consumption",
                "timeFrame": "Change between Week 0 and Week 12"
              },
              {
                "measure": "Muscle Mass",
                "timeFrame": "Change between Week 0 and Week 12"
              },
              {
                "measure": "Muscle Strength",
                "timeFrame": "Change between Week 0, Week 6, Week 12"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Mitochondrial Function in Muscle Fibers in Fresh Muscle Fibers ex vivo"
              },
              {
                "measure": "Mitochondrial Function in Muscle Fibers in Fresh Muscle Fibers ex vivo"
              },
              {
                "measure": "Stable Isotope-Resolved Metabolomics to describe Fatty Acid Metabolism in relationship to other fuel substrates in Fresh Muscle Fibers ex vivo"
              },
              {
                "measure": "Utilize cell culture experimentation to understand anabolic signaling in response to vitamin D with or without fiber stretch."
              },
              {
                "measure": "Utilize cell culture experimentation to measure mitochondrial activity in response to vitamin D with or without fiber stretch."
              },
              {
                "measure": "Utilize cell culture experimentation to measure mitochondrial activity in response to vitamin D with or without fiber stretch."
              }
            ]
          }
        }
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:29:00Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c838d"
    },
    "name": "BRD-K51388814",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c838d.png",
    "lincs": {
      "id": "LSM-14850",
      "name": "BRD-K51388814",
      "pubchemCid": 54615005,
      "chebiId": 103506,
      "inchiParent": "InChI=1S/C32H49N3O6S/c1-7-17-34(6)21-31-24(3)20-35(25(4)22-36)32(37)29-19-27(33-42(38,39)28-14-11-23(2)12-15-28)13-16-30(29)41-26(5)10-8-9-18-40-31/h11-16,19,24-26,31,33,36H,7-10,17-18,20-22H2,1-6H3/t24-,25+,26-,31-/m1/s1",
      "inchiKeyParent": "YZTWEKNKNNRJIX-FVCFNFBRSA-N",
      "smilesParent": "CCCN(C)C[C@H]1OCCCC[C@@H](C)Oc2ccc(NS(=O)(=O)c3ccc(C)cc3)cc2C(=O)N(C[C@H]1C)[C@@H](C)CO"
    },
    "unichem": {
      "chebi": "103506",
      "lincs": "LSM-14850",
      "pubchem": "54615005"
    },
    "pubchem": [
      {
        "cid": 54615005,
        "inchi": "InChI=1S/C32H49N3O6S/c1-7-17-34(6)21-31-24(3)20-35(25(4)22-36)32(37)29-19-27(33-42(38,39)28-14-11-23(2)12-15-28)13-16-30(29)41-26(5)10-8-9-18-40-31/h11-16,19,24-26,31,33,36H,7-10,17-18,20-22H2,1-6H3/t24-,25+,26-,31-/m1/s1",
        "inchikey": "YZTWEKNKNNRJIX-FVCFNFBRSA-N",
        "iupac": {
          "systematic": "N-[(3R,9S,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(propyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-methylbenzenesulfonamide"
        },
        "smiles": {
          "canonical": "CCCN(C)CC1C(CN(C(=O)C2=C(C=CC(=C2)NS(=O)(=O)C3=CC=C(C=C3)C)OC(CCCCO1)C)C(C)CO)C"
        },
        "molecularFormula": "C32H49N3O6S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:29:02Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83ff"
    },
    "name": "BRD-K62143565",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83ff.png",
    "lincs": {
      "id": "LSM-12201",
      "name": "BRD-K62143565",
      "pubchemCid": 54638990,
      "chebiId": 100827,
      "inchiParent": "InChI=1S/C22H28N4O4/c27-15-20-19(26-22(29)13-17-3-1-2-9-24-17)5-4-18(30-20)14-21(28)25-12-8-16-6-10-23-11-7-16/h1-3,6-7,9-11,18-20,27H,4-5,8,12-15H2,(H,25,28)(H,26,29)/t18-,19+,20+/m0/s1",
      "inchiKeyParent": "GUCCOCGWZUYAMY-XUVXKRRUSA-N",
      "smilesParent": "OC[C@H]1O[C@H](CC(=O)NCCc2ccncc2)CC[C@H]1NC(=O)Cc3ccccn3"
    },
    "unichem": {
      "chebi": "100827",
      "lincs": "LSM-12201",
      "pubchem": "54638990"
    },
    "pubchem": [
      {
        "cid": 54638990,
        "inchi": "InChI=1S/C22H28N4O4/c27-15-20-19(26-22(29)13-17-3-1-2-9-24-17)5-4-18(30-20)14-21(28)25-12-8-16-6-10-23-11-7-16/h1-3,6-7,9-11,18-20,27H,4-5,8,12-15H2,(H,25,28)(H,26,29)/t18-,19+,20+/m0/s1",
        "inchikey": "GUCCOCGWZUYAMY-XUVXKRRUSA-N",
        "iupac": {
          "systematic": "2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[(2-pyridin-2-ylacetyl)amino]oxan-2-yl]-N-(2-pyridin-4-ylethyl)acetamide"
        },
        "smiles": {
          "canonical": "C1CC(C(OC1CC(=O)NCCC2=CC=NC=C2)CO)NC(=O)CC3=CC=CC=N3"
        },
        "molecularFormula": "C22H28N4O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:29:05Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8351"
    },
    "name": "BRD-K57900436",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8351.png",
    "lincs": {
      "id": "LSM-40441",
      "name": "BRD-K57900436",
      "pubchemCid": 44618986,
      "chebiId": 128889,
      "inchiParent": "InChI=1S/C27H38N4O5/c1-18-15-31(19(2)17-32)26(33)14-20-13-22(29(3)4)9-12-24(20)36-25(18)16-30(5)27(34)28-21-7-10-23(35-6)11-8-21/h7-13,18-19,25,32H,14-17H2,1-6H3,(H,28,34)/t18-,19+,25+/m1/s1",
      "inchiKeyParent": "ATOUFFMQMQIITO-WYEJZRMESA-N",
      "smilesParent": "COc1ccc(NC(=O)N(C)C[C@@H]2Oc3ccc(cc3CC(=O)N(C[C@H]2C)[C@@H](C)CO)N(C)C)cc1"
    },
    "unichem": {
      "chebi": "128889",
      "lincs": "LSM-40441",
      "pubchem": "44618986"
    },
    "pubchem": [
      {
        "cid": 44618986,
        "inchi": "InChI=1S/C27H38N4O5/c1-18-15-31(19(2)17-32)26(33)14-20-13-22(29(3)4)9-12-24(20)36-25(18)16-30(5)27(34)28-21-7-10-23(35-6)11-8-21/h7-13,18-19,25,32H,14-17H2,1-6H3,(H,28,34)/t18-,19+,25+/m1/s1",
        "inchikey": "ATOUFFMQMQIITO-WYEJZRMESA-N",
        "iupac": {
          "systematic": "1-[[(2R,3R)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-3-(4-methoxyphenyl)-1-methylurea"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)CC2=C(C=CC(=C2)N(C)C)OC1CN(C)C(=O)NC3=CC=C(C=C3)OC)C(C)CO"
        },
        "molecularFormula": "C27H38N4O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:29:07Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8373"
    },
    "name": "BRD-K77264557",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8373.png",
    "lincs": {
      "id": "LSM-41488",
      "name": "BRD-K77264557",
      "pubchemCid": 44487168,
      "chebiId": 129937,
      "inchiParent": "InChI=1S/C33H37N5O4/c1-22-18-38(23(2)21-39)32(40)28-17-26(35-33(41)36-29-10-6-8-25-7-4-5-9-27(25)29)11-12-30(28)42-31(22)20-37(3)19-24-13-15-34-16-14-24/h4-17,22-23,31,39H,18-21H2,1-3H3,(H2,35,36,41)/t22-,23-,31+/m0/s1",
      "inchiKeyParent": "VJMXJNGUWGEFKS-WDCWYOMISA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@H](C)[C@@H](CN(C)Cc2ccncc2)Oc3ccc(NC(=O)Nc4cccc5ccccc45)cc3C1=O"
    },
    "unichem": {
      "chebi": "129937",
      "lincs": "LSM-41488",
      "pubchem": "44487168"
    },
    "pubchem": [
      {
        "cid": 44487168,
        "inchi": "InChI=1S/C33H37N5O4/c1-22-18-38(23(2)21-39)32(40)28-17-26(35-33(41)36-29-10-6-8-25-7-4-5-9-27(25)29)11-12-30(28)42-31(22)20-37(3)19-24-13-15-34-16-14-24/h4-17,22-23,31,39H,18-21H2,1-3H3,(H2,35,36,41)/t22-,23-,31+/m0/s1",
        "inchikey": "VJMXJNGUWGEFKS-WDCWYOMISA-N",
        "iupac": {
          "systematic": "1-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-naphthalen-1-ylurea"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(C=CC(=C2)NC(=O)NC3=CC=CC4=CC=CC=C43)OC1CN(C)CC5=CC=NC=C5)C(C)CO"
        },
        "molecularFormula": "C33H37N5O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:29:09Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c838a"
    },
    "name": "BRD-K46450665",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c838a.png",
    "lincs": {
      "id": "LSM-43399",
      "name": "BRD-K46450665",
      "pubchemCid": 54618648,
      "inchiParent": "InChI=1S/C25H33N3O5S/c1-5-7-20-9-10-24-22(12-20)33-23(18(2)15-28(19(3)17-29)34(24,31)32)16-27(4)25(30)13-21-8-6-11-26-14-21/h5-12,14,18-19,23,29H,13,15-17H2,1-4H3/b7-5+/t18-,19-,23+/m0/s1",
      "inchiKeyParent": "JSQMQZOUAVKGAV-VRWPWIMQSA-N",
      "smilesParent": "C\\C=C\\c1ccc2c(O[C@H](CN(C)C(=O)Cc3cccnc3)[C@@H](C)CN([C@@H](C)CO)S2(=O)=O)c1"
    },
    "unichem": {
      "lincs": "LSM-43399",
      "pubchem": "54618648"
    },
    "pubchem": [
      {
        "cid": 54618648,
        "inchi": "InChI=1S/C25H33N3O5S/c1-5-7-20-9-10-24-22(12-20)33-23(18(2)15-28(19(3)17-29)34(24,31)32)16-27(4)25(30)13-21-8-6-11-26-14-21/h5-12,14,18-19,23,29H,13,15-17H2,1-4H3/b7-5+/t18-,19-,23+/m0/s1",
        "inchikey": "JSQMQZOUAVKGAV-VRWPWIMQSA-N",
        "iupac": {
          "systematic": "N-[[(4S,5S)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyridin-3-ylacetamide"
        },
        "smiles": {
          "canonical": "CC=CC1=CC2=C(C=C1)S(=O)(=O)N(CC(C(O2)CN(C)C(=O)CC3=CN=CC=C3)C)C(C)CO"
        },
        "molecularFormula": "C25H33N3O5S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:29:11Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83ac"
    },
    "name": "CHEMBL3182510",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83ac.png",
    "lincs": {
      "id": "LSM-12629",
      "name": "CHEMBL3182510",
      "alternativeNames": [
        "BRD-K68836298"
      ],
      "pubchemCid": 54631434,
      "chebiId": 101262,
      "inchiParent": "InChI=1S/C25H31F3N4O4/c1-15-12-29-16(2)14-36-21-10-9-19(11-20(21)23(33)32(3)13-22(15)35-4)31-24(34)30-18-7-5-17(6-8-18)25(26,27)28/h5-11,15-16,22,29H,12-14H2,1-4H3,(H2,30,31,34)/t15-,16+,22+/m1/s1",
      "inchiKeyParent": "GXRZKRPKTHFHBM-VVBPWWLESA-N",
      "smilesParent": "CO[C@H]1CN(C)C(=O)c2cc(NC(=O)Nc3ccc(cc3)C(F)(F)F)ccc2OC[C@H](C)NC[C@H]1C"
    },
    "unichem": {
      "chebi": "101262",
      "chembl": "CHEMBL3182510",
      "lincs": "LSM-12629",
      "pubchem": "54631434"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL3182510",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 508.54,
        "hba": 5,
        "hbd": 3,
        "qedWeighted": 0.57
      }
    },
    "pubchem": [
      {
        "cid": 54631434,
        "inchi": "InChI=1S/C25H31F3N4O4/c1-15-12-29-16(2)14-36-21-10-9-19(11-20(21)23(33)32(3)13-22(15)35-4)31-24(34)30-18-7-5-17(6-8-18)25(26,27)28/h5-11,15-16,22,29H,12-14H2,1-4H3,(H2,30,31,34)/t15-,16+,22+/m1/s1",
        "inchikey": "GXRZKRPKTHFHBM-VVBPWWLESA-N",
        "iupac": {
          "systematic": "1-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-[4-(trifluoromethyl)phenyl]urea"
        },
        "smiles": {
          "canonical": "CC1CNC(COC2=C(C=C(C=C2)NC(=O)NC3=CC=C(C=C3)C(F)(F)F)C(=O)N(CC1OC)C)C"
        },
        "molecularFormula": "C25H31F3N4O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:29:22Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8401"
    },
    "name": "BRD-K90830329",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8401.png",
    "lincs": {
      "id": "LSM-14018",
      "name": "BRD-K90830329",
      "pubchemCid": 54646024,
      "chebiId": 102671,
      "inchiParent": "InChI=1S/C25H35N3O5/c29-15-22-24-20(13-18(32-22)14-23(30)28-10-4-1-5-11-28)19-12-17(8-9-21(19)33-24)27-25(31)26-16-6-2-3-7-16/h8-9,12,16,18,20,22,24,29H,1-7,10-11,13-15H2,(H2,26,27,31)/t18-,20+,22+,24-/m0/s1",
      "inchiKeyParent": "GFIPGJIGSRXJBU-AYEZKCMBSA-N",
      "smilesParent": "OC[C@H]1O[C@H](CC(=O)N2CCCCC2)C[C@H]3[C@@H]1Oc4ccc(NC(=O)NC5CCCC5)cc34"
    },
    "unichem": {
      "chebi": "102671",
      "lincs": "LSM-14018",
      "pubchem": "54646024"
    },
    "pubchem": [
      {
        "cid": 54646024,
        "inchi": "InChI=1S/C25H35N3O5/c29-15-22-24-20(13-18(32-22)14-23(30)28-10-4-1-5-11-28)19-12-17(8-9-21(19)33-24)27-25(31)26-16-6-2-3-7-16/h8-9,12,16,18,20,22,24,29H,1-7,10-11,13-15H2,(H2,26,27,31)/t18-,20+,22+,24-/m0/s1",
        "inchikey": "GFIPGJIGSRXJBU-AYEZKCMBSA-N",
        "iupac": {
          "systematic": "1-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-3-(2-oxo-2-piperidin-1-ylethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]-3-cyclopentylurea"
        },
        "smiles": {
          "canonical": "C1CCN(CC1)C(=O)CC2CC3C(C(O2)CO)OC4=C3C=C(C=C4)NC(=O)NC5CCCC5"
        },
        "molecularFormula": "C25H35N3O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:29:25Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c835e"
    },
    "name": "BRD-K91729331",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c835e.png",
    "lincs": {
      "id": "LSM-14063",
      "name": "BRD-K91729331",
      "pubchemCid": 54657633,
      "chebiId": 102716,
      "inchiParent": "InChI=1S/C21H29F3N2O4/c1-25(2)20(28)9-17-7-8-18-19(30-17)13-29-12-16(27)11-26(18)10-14-3-5-15(6-4-14)21(22,23)24/h3-6,16-19,27H,7-13H2,1-2H3/t16-,17+,18-,19+/m0/s1",
      "inchiKeyParent": "OUTWOBHUWTVFCP-ZSYWTGECSA-N",
      "smilesParent": "CN(C)C(=O)C[C@H]1CC[C@H]2[C@@H](COC[C@@H](O)CN2Cc3ccc(cc3)C(F)(F)F)O1"
    },
    "unichem": {
      "chebi": "102716",
      "lincs": "LSM-14063",
      "pubchem": "54657633"
    },
    "pubchem": [
      {
        "cid": 54657633,
        "inchi": "InChI=1S/C21H29F3N2O4/c1-25(2)20(28)9-17-7-8-18-19(30-17)13-29-12-16(27)11-26(18)10-14-3-5-15(6-4-14)21(22,23)24/h3-6,16-19,27H,7-13H2,1-2H3/t16-,17+,18-,19+/m0/s1",
        "inchikey": "OUTWOBHUWTVFCP-ZSYWTGECSA-N",
        "iupac": {
          "systematic": "2-[(3S,6aS,8R,10aS)-3-hydroxy-1-[[4-(trifluoromethyl)phenyl]methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N,N-dimethylacetamide"
        },
        "smiles": {
          "canonical": "CN(C)C(=O)CC1CCC2C(O1)COCC(CN2CC3=CC=C(C=C3)C(F)(F)F)O"
        },
        "molecularFormula": "C21H29F3N2O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:29:27Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c839c"
    },
    "name": "BRD-K27817736",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c839c.png",
    "lincs": {
      "id": "LSM-10107",
      "name": "BRD-K27817736",
      "pubchemCid": 54646045,
      "chebiId": 98728,
      "inchiParent": "InChI=1S/C21H31N3O6/c1-24(2)11-20(27)23-13-4-5-17-15(8-13)16-9-14(10-19(26)22-6-7-28-3)29-18(12-25)21(16)30-17/h4-5,8,14,16,18,21,25H,6-7,9-12H2,1-3H3,(H,22,26)(H,23,27)/t14-,16+,18-,21-/m0/s1",
      "inchiKeyParent": "ZSBYESKXZOGBOW-WTFQOOOSSA-N",
      "smilesParent": "COCCNC(=O)C[C@@H]1C[C@H]2[C@H](Oc3ccc(NC(=O)CN(C)C)cc23)[C@H](CO)O1"
    },
    "unichem": {
      "chebi": "98728",
      "lincs": "LSM-10107",
      "pubchem": "54646045"
    },
    "pubchem": [
      {
        "cid": 54646045,
        "inchi": "InChI=1S/C21H31N3O6/c1-24(2)11-20(27)23-13-4-5-17-15(8-13)16-9-14(10-19(26)22-6-7-28-3)29-18(12-25)21(16)30-17/h4-5,8,14,16,18,21,25H,6-7,9-12H2,1-3H3,(H,22,26)(H,23,27)/t14-,16+,18-,21-/m0/s1",
        "inchikey": "ZSBYESKXZOGBOW-WTFQOOOSSA-N",
        "iupac": {
          "systematic": "2-[(1S,3S,4aR,9aS)-6-[[2-(dimethylamino)acetyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-(2-methoxyethyl)acetamide"
        },
        "smiles": {
          "canonical": "CN(C)CC(=O)NC1=CC2=C(C=C1)OC3C2CC(OC3CO)CC(=O)NCCOC"
        },
        "molecularFormula": "C21H31N3O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:29:29Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8350"
    },
    "name": "BRD-K48296029",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8350.png",
    "lincs": {
      "id": "LSM-11366",
      "name": "BRD-K48296029",
      "pubchemCid": 54650186,
      "chebiId": 99987,
      "inchiParent": "InChI=1S/C21H27N3O2/c1-2-12-23-21(26)24-18(13-22)20(19(24)14-25)17-10-8-16(9-11-17)15-6-4-3-5-7-15/h6,8-11,18-20,25H,2-5,7,12,14H2,1H3,(H,23,26)/t18-,19-,20+/m1/s1",
      "inchiKeyParent": "BSUDBHASFVKNIG-AQNXPRMDSA-N",
      "smilesParent": "CCCNC(=O)N1[C@H](CO)[C@H]([C@H]1C#N)c2ccc(cc2)C3=CCCCC3"
    },
    "unichem": {
      "chebi": "99987",
      "chembl": "CHEMBL3559878",
      "lincs": "LSM-11366",
      "pubchem": "54650186"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL3559878",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 353.47,
        "hba": 3,
        "hbd": 2,
        "qedWeighted": 0.85
      }
    },
    "pubchem": [
      {
        "cid": 54650186,
        "inchi": "InChI=1S/C21H27N3O2/c1-2-12-23-21(26)24-18(13-22)20(19(24)14-25)17-10-8-16(9-11-17)15-6-4-3-5-7-15/h6,8-11,18-20,25H,2-5,7,12,14H2,1H3,(H,23,26)/t18-,19-,20+/m1/s1",
        "inchikey": "BSUDBHASFVKNIG-AQNXPRMDSA-N",
        "iupac": {
          "systematic": "(2S,3S,4S)-2-cyano-3-[4-(cyclohexen-1-yl)phenyl]-4-(hydroxymethyl)-N-propylazetidine-1-carboxamide"
        },
        "smiles": {
          "canonical": "CCCNC(=O)N1C(C(C1C#N)C2=CC=C(C=C2)C3=CCCCC3)CO"
        },
        "molecularFormula": "C21H27N3O2"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:29:40Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c835f"
    },
    "name": "BRD-K70836798",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c835f.png",
    "lincs": {
      "id": "LSM-41128",
      "name": "BRD-K70836798",
      "pubchemCid": 44618191,
      "chebiId": 129577,
      "inchiParent": "InChI=1S/C37H55N3O6/c1-26-22-40(27(2)25-41)37(43)33-21-31(38-36(42)30-12-7-6-8-13-30)16-19-34(33)46-28(3)11-9-10-20-45-35(26)24-39(4)23-29-14-17-32(44-5)18-15-29/h14-19,21,26-28,30,35,41H,6-13,20,22-25H2,1-5H3,(H,38,42)/t26-,27+,28+,35+/m1/s1",
      "inchiKeyParent": "UVSCGJDGVAXROK-PNCWTNKOSA-N",
      "smilesParent": "COc1ccc(CN(C)C[C@@H]2OCCCC[C@H](C)Oc3ccc(NC(=O)C4CCCCC4)cc3C(=O)N(C[C@H]2C)[C@@H](C)CO)cc1"
    },
    "unichem": {
      "chebi": "129577",
      "lincs": "LSM-41128",
      "pubchem": "44618191"
    },
    "pubchem": [
      {
        "cid": 44618191,
        "inchi": "InChI=1S/C37H55N3O6/c1-26-22-40(27(2)25-41)37(43)33-21-31(38-36(42)30-12-7-6-8-13-30)16-19-34(33)46-28(3)11-9-10-20-45-35(26)24-39(4)23-29-14-17-32(44-5)18-15-29/h14-19,21,26-28,30,35,41H,6-13,20,22-25H2,1-5H3,(H,38,42)/t26-,27+,28+,35+/m1/s1",
        "inchikey": "UVSCGJDGVAXROK-PNCWTNKOSA-N",
        "iupac": {
          "systematic": "N-[(3S,9R,10R)-12-[(2S)-1-hydroxypropan-2-yl]-9-[[(4-methoxyphenyl)methyl-methylamino]methyl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]cyclohexanecarboxamide"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NC(=O)C3CCCCC3)C(C)CO)C)CN(C)CC4=CC=C(C=C4)OC"
        },
        "molecularFormula": "C37H55N3O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:29:42Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8360"
    },
    "name": "BRD-K64380185",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8360.png",
    "lincs": {
      "id": "LSM-12356",
      "name": "BRD-K64380185",
      "pubchemCid": 54645912,
      "chebiId": 100983,
      "inchiParent": "InChI=1S/C23H28N2O6S/c1-32(28,29)25-16-7-8-20-18(11-16)19-12-17(30-21(14-26)23(19)31-20)13-22(27)24-10-9-15-5-3-2-4-6-15/h2-8,11,17,19,21,23,25-26H,9-10,12-14H2,1H3,(H,24,27)/t17-,19-,21+,23+/m1/s1",
      "inchiKeyParent": "TVZJESBMTOHXDE-YZBYQZESSA-N",
      "smilesParent": "CS(=O)(=O)Nc1ccc2O[C@@H]3[C@H](CO)O[C@@H](CC(=O)NCCc4ccccc4)C[C@@H]3c2c1"
    },
    "unichem": {
      "chebi": "100983",
      "lincs": "LSM-12356",
      "pubchem": "54645912"
    },
    "pubchem": [
      {
        "cid": 54645912,
        "inchi": "InChI=1S/C23H28N2O6S/c1-32(28,29)25-16-7-8-20-18(11-16)19-12-17(30-21(14-26)23(19)31-20)13-22(27)24-10-9-15-5-3-2-4-6-15/h2-8,11,17,19,21,23,25-26H,9-10,12-14H2,1H3,(H,24,27)/t17-,19-,21+,23+/m1/s1",
        "inchikey": "TVZJESBMTOHXDE-YZBYQZESSA-N",
        "iupac": {
          "systematic": "2-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-(2-phenylethyl)acetamide"
        },
        "smiles": {
          "canonical": "CS(=O)(=O)NC1=CC2=C(C=C1)OC3C2CC(OC3CO)CC(=O)NCCC4=CC=CC=C4"
        },
        "molecularFormula": "C23H28N2O6S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:29:44Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8388"
    },
    "name": "BRD-K68120955",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8388.png",
    "lincs": {
      "id": "LSM-12580",
      "name": "BRD-K68120955",
      "pubchemCid": 54646640,
      "chebiId": 101211,
      "inchiParent": "InChI=1S/C28H29N3O5/c1-17(18-6-3-2-4-7-18)30-26(33)14-21-13-23-22-12-20(31-28(34)19-8-5-11-29-15-19)9-10-24(22)36-27(23)25(16-32)35-21/h2-12,15,17,21,23,25,27,32H,13-14,16H2,1H3,(H,30,33)(H,31,34)/t17-,21-,23+,25-,27-/m1/s1",
      "inchiKeyParent": "SNGIXDWGPLKZOT-NZAHZBTPSA-N",
      "smilesParent": "C[C@@H](NC(=O)C[C@H]1C[C@@H]2[C@@H](Oc3ccc(NC(=O)c4cccnc4)cc23)[C@@H](CO)O1)c5ccccc5"
    },
    "unichem": {
      "chebi": "101211",
      "lincs": "LSM-12580",
      "pubchem": "54646640"
    },
    "pubchem": [
      {
        "cid": 54646640,
        "inchi": "InChI=1S/C28H29N3O5/c1-17(18-6-3-2-4-7-18)30-26(33)14-21-13-23-22-12-20(31-28(34)19-8-5-11-29-15-19)9-10-24(22)36-27(23)25(16-32)35-21/h2-12,15,17,21,23,25,27,32H,13-14,16H2,1H3,(H,30,33)(H,31,34)/t17-,21-,23+,25-,27-/m1/s1",
        "inchikey": "SNGIXDWGPLKZOT-NZAHZBTPSA-N",
        "iupac": {
          "systematic": "N-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-[[(1R)-1-phenylethyl]amino]ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]pyridine-3-carboxamide"
        },
        "smiles": {
          "canonical": "CC(C1=CC=CC=C1)NC(=O)CC2CC3C(C(O2)CO)OC4=C3C=C(C=C4)NC(=O)C5=CN=CC=C5"
        },
        "molecularFormula": "C28H29N3O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:29:46Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83af"
    },
    "name": "BRD-K50314382",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83af.png",
    "lincs": {
      "id": "LSM-11491",
      "name": "BRD-K50314382",
      "pubchemCid": 54650200,
      "chebiId": 100112,
      "inchiParent": "InChI=1S/C23H29N3O2/c1-16(2)25-23(28)26-20(14-24)22(21(26)15-27)19-12-10-18(11-13-19)9-8-17-6-4-3-5-7-17/h10-13,16-17,20-22,27H,3-7,15H2,1-2H3,(H,25,28)/t20-,21-,22+/m1/s1",
      "inchiKeyParent": "FHQNTJUBGIRGFL-VSKRKVRLSA-N",
      "smilesParent": "CC(C)NC(=O)N1[C@H](CO)[C@H]([C@H]1C#N)c2ccc(cc2)C#CC3CCCCC3"
    },
    "unichem": {
      "chebi": "100112",
      "lincs": "LSM-11491",
      "pubchem": "54650200"
    },
    "pubchem": [
      {
        "cid": 54650200,
        "inchi": "InChI=1S/C23H29N3O2/c1-16(2)25-23(28)26-20(14-24)22(21(26)15-27)19-12-10-18(11-13-19)9-8-17-6-4-3-5-7-17/h10-13,16-17,20-22,27H,3-7,15H2,1-2H3,(H,25,28)/t20-,21-,22+/m1/s1",
        "inchikey": "FHQNTJUBGIRGFL-VSKRKVRLSA-N",
        "iupac": {
          "systematic": "(2S,3S,4S)-2-cyano-3-[4-(2-cyclohexylethynyl)phenyl]-4-(hydroxymethyl)-N-propan-2-ylazetidine-1-carboxamide"
        },
        "smiles": {
          "canonical": "CC(C)NC(=O)N1C(C(C1C#N)C2=CC=C(C=C2)C#CC3CCCCC3)CO"
        },
        "molecularFormula": "C23H29N3O2"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:29:49Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83d4"
    },
    "name": "BRD-K81826010",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83d4.png",
    "lincs": {
      "id": "LSM-6854",
      "name": "BRD-K81826010",
      "pubchemCid": 54654538,
      "chebiId": 95475,
      "inchiParent": "InChI=1S/C28H35N5O5/c1-33-23-9-8-20(14-26(34)31-15-18-5-3-2-4-6-18)38-25(23)17-37-24-10-7-19(13-21(24)28(33)36)32-27(35)22-16-29-11-12-30-22/h7,10-13,16,18,20,23,25H,2-6,8-9,14-15,17H2,1H3,(H,31,34)(H,32,35)/t20-,23-,25-/m0/s1",
      "inchiKeyParent": "KUAQBUHJEIVZQC-OPHFCASCSA-N",
      "smilesParent": "CN1[C@H]2CC[C@@H](CC(=O)NCC3CCCCC3)O[C@H]2COc4ccc(NC(=O)c5cnccn5)cc4C1=O"
    },
    "unichem": {
      "chebi": "95475",
      "lincs": "LSM-6854",
      "pubchem": "54654538"
    },
    "pubchem": [
      {
        "cid": 54654538,
        "inchi": "InChI=1S/C28H35N5O5/c1-33-23-9-8-20(14-26(34)31-15-18-5-3-2-4-6-18)38-25(23)17-37-24-10-7-19(13-21(24)28(33)36)32-27(35)22-16-29-11-12-30-22/h7,10-13,16,18,20,23,25H,2-6,8-9,14-15,17H2,1H3,(H,31,34)(H,32,35)/t20-,23-,25-/m0/s1",
        "inchikey": "KUAQBUHJEIVZQC-OPHFCASCSA-N",
        "iupac": {
          "systematic": "N-[(2S,4aS,12aR)-2-[2-(cyclohexylmethylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]pyrazine-2-carboxamide"
        },
        "smiles": {
          "canonical": "CN1C2CCC(OC2COC3=C(C1=O)C=C(C=C3)NC(=O)C4=NC=CN=C4)CC(=O)NCC5CCCCC5"
        },
        "molecularFormula": "C28H35N5O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:29:51Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83ea"
    },
    "name": "BRD-K21473123",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83ea.png",
    "lincs": {
      "id": "LSM-9731",
      "name": "BRD-K21473123",
      "pubchemCid": 54660946,
      "chebiId": 98352,
      "inchiParent": "InChI=1S/C26H28N4O3/c1-16(17-6-4-3-5-7-17)28-25(32)24-21(15-31)20-14-30-22(23(20)29(24)2)9-8-19(26(30)33)18-10-12-27-13-11-18/h3-13,16,20-21,23-24,31H,14-15H2,1-2H3,(H,28,32)/t16-,20+,21+,23-,24+/m1/s1",
      "inchiKeyParent": "XRCXBUPUCMDVHO-PJVFYWIPSA-N",
      "smilesParent": "C[C@@H](NC(=O)[C@@H]1[C@@H](CO)[C@@H]2CN3C(=CC=C(C3=O)c4ccncc4)[C@@H]2N1C)c5ccccc5"
    },
    "unichem": {
      "chebi": "98352",
      "lincs": "LSM-9731",
      "pubchem": "54660946"
    },
    "pubchem": [
      {
        "cid": 54660946,
        "inchi": "InChI=1S/C26H28N4O3/c1-16(17-6-4-3-5-7-17)28-25(32)24-21(15-31)20-14-30-22(23(20)29(24)2)9-8-19(26(30)33)18-10-12-27-13-11-18/h3-13,16,20-21,23-24,31H,14-15H2,1-2H3,(H,28,32)/t16-,20+,21+,23-,24+/m1/s1",
        "inchikey": "XRCXBUPUCMDVHO-PJVFYWIPSA-N",
        "iupac": {
          "systematic": "(2S,3S,3aR,9bR)-3-(hydroxymethyl)-1-methyl-6-oxo-N-[(1R)-1-phenylethyl]-7-pyridin-4-yl-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide"
        },
        "smiles": {
          "canonical": "CC(C1=CC=CC=C1)NC(=O)C2C(C3CN4C(=CC=C(C4=O)C5=CC=NC=C5)C3N2C)CO"
        },
        "molecularFormula": "C26H28N4O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:29:53Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c840e"
    },
    "name": "BRD-K07426711",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c840e.png",
    "lincs": {
      "id": "LSM-6952",
      "name": "BRD-K07426711",
      "pubchemCid": 54618843,
      "chebiId": 95573,
      "inchiParent": "InChI=1S/C26H31FN2O6S/c1-18-15-29(19(2)17-30)36(32,33)25-12-11-20(8-7-13-34-4)14-23(25)35-24(18)16-28(3)26(31)21-9-5-6-10-22(21)27/h5-6,9-12,14,18-19,24,30H,13,15-17H2,1-4H3/t18-,19-,24+/m0/s1",
      "inchiKeyParent": "KBQBGAWQEUXRRY-AXHZCLLHSA-N",
      "smilesParent": "COCC#Cc1ccc2c(O[C@H](CN(C)C(=O)c3ccccc3F)[C@@H](C)CN([C@@H](C)CO)S2(=O)=O)c1"
    },
    "unichem": {
      "chebi": "95573",
      "lincs": "LSM-6952",
      "pubchem": "54618843"
    },
    "pubchem": [
      {
        "cid": 54618843,
        "inchi": "InChI=1S/C26H31FN2O6S/c1-18-15-29(19(2)17-30)36(32,33)25-12-11-20(8-7-13-34-4)14-23(25)35-24(18)16-28(3)26(31)21-9-5-6-10-22(21)27/h5-6,9-12,14,18-19,24,30H,13,15-17H2,1-4H3/t18-,19-,24+/m0/s1",
        "inchikey": "KBQBGAWQEUXRRY-AXHZCLLHSA-N",
        "iupac": {
          "systematic": "2-fluoro-N-[[(4S,5S)-2-[(2S)-1-hydroxypropan-2-yl]-8-(3-methoxyprop-1-ynyl)-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-N-methylbenzamide"
        },
        "smiles": {
          "canonical": "CC1CN(S(=O)(=O)C2=C(C=C(C=C2)C#CCOC)OC1CN(C)C(=O)C3=CC=CC=C3F)C(C)CO"
        },
        "molecularFormula": "C26H31FN2O6S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:29:55Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8357"
    },
    "name": "BMS 191011",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8357.png",
    "lincs": {
      "id": "LSM-4148",
      "name": "BMS 191011",
      "alternativeNames": [
        "BMS-191011"
      ],
      "pubchemCid": 10474339,
      "chebiId": 93672,
      "inchiParent": "InChI=1S/C16H10ClF3N2O3/c17-12-5-6-13(23)10(7-12)8-22-15(24)25-14(21-22)9-1-3-11(4-2-9)16(18,19)20/h1-7,23H,8H2",
      "inchiKeyParent": "QKOWACXSXTXRKA-UHFFFAOYSA-N",
      "smilesParent": "Oc1ccc(Cl)cc1CN2N=C(OC2=O)c3ccc(cc3)C(F)(F)F"
    },
    "unichem": {
      "chebi": "93672",
      "chembl": "CHEMBL45349",
      "lincs": "LSM-4148",
      "pubchem": "10474339"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL45349",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 370.71,
        "hba": 5,
        "hbd": 1,
        "qedWeighted": 0.76
      },
      "moleculeSynonyms": [
        {
          "moleculeSynonym": "BMS-191011",
          "synType": "RESEARCH_CODE",
          "synonyms": "BMS-191011"
        }
      ]
    },
    "pubchem": [
      {
        "cid": 10474339,
        "inchi": "InChI=1S/C16H10ClF3N2O3/c17-12-5-6-13(23)10(7-12)8-22-15(24)25-14(21-22)9-1-3-11(4-2-9)16(18,19)20/h1-7,23H,8H2",
        "inchikey": "QKOWACXSXTXRKA-UHFFFAOYSA-N",
        "iupac": {
          "systematic": "3-[(5-chloro-2-hydroxyphenyl)methyl]-5-[4-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-one"
        },
        "smiles": {
          "canonical": "C1=CC(=CC=C1C2=NN(C(=O)O2)CC3=C(C=CC(=C3)Cl)O)C(F)(F)F"
        },
        "molecularFormula": "C16H10ClF3N2O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:30:07Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c836f"
    },
    "name": "BRD-K62314156",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c836f.png",
    "lincs": {
      "id": "LSM-12213",
      "name": "BRD-K62314156",
      "pubchemCid": 54632050,
      "chebiId": 100839,
      "inchiParent": "InChI=1S/C29H40N4O5/c1-19-15-33(16-21-9-10-21)20(2)18-38-26-12-11-23(14-25(26)28(34)32(3)17-27(19)37-5)31-29(35)30-22-7-6-8-24(13-22)36-4/h6-8,11-14,19-21,27H,9-10,15-18H2,1-5H3,(H2,30,31,35)/t19-,20-,27+/m0/s1",
      "inchiKeyParent": "NFEVTECKVPPYCJ-OWOAZTCBSA-N",
      "smilesParent": "CO[C@@H]1CN(C)C(=O)c2cc(NC(=O)Nc3cccc(OC)c3)ccc2OC[C@H](C)N(CC4CC4)C[C@@H]1C"
    },
    "unichem": {
      "chebi": "100839",
      "lincs": "LSM-12213",
      "pubchem": "54632050"
    },
    "pubchem": [
      {
        "cid": 54632050,
        "inchi": "InChI=1S/C29H40N4O5/c1-19-15-33(16-21-9-10-21)20(2)18-38-26-12-11-23(14-25(26)28(34)32(3)17-27(19)37-5)31-29(35)30-22-7-6-8-24(13-22)36-4/h6-8,11-14,19-21,27H,9-10,15-18H2,1-5H3,(H2,30,31,35)/t19-,20-,27+/m0/s1",
        "inchikey": "NFEVTECKVPPYCJ-OWOAZTCBSA-N",
        "iupac": {
          "systematic": "1-[(4S,7S,8S)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-(3-methoxyphenyl)urea"
        },
        "smiles": {
          "canonical": "CC1CN(C(COC2=C(C=C(C=C2)NC(=O)NC3=CC(=CC=C3)OC)C(=O)N(CC1OC)C)C)CC4CC4"
        },
        "molecularFormula": "C29H40N4O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:30:09Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8399"
    },
    "name": "BRD-K04117492",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8399.png",
    "lincs": {
      "id": "LSM-37496",
      "name": "BRD-K04117492",
      "pubchemCid": 44486138,
      "chebiId": 125929,
      "inchiParent": "InChI=1S/C28H35N3O6/c1-17-13-31(18(2)16-32)27(34)23-12-22(29-26(33)20-8-9-20)10-11-24(23)37-25(17)15-30(3)14-19-4-6-21(7-5-19)28(35)36/h4-7,10-12,17-18,20,25,32H,8-9,13-16H2,1-3H3,(H,29,33)(H,35,36)/t17-,18-,25+/m1/s1",
      "inchiKeyParent": "KUULAZFVSMPUFO-GAKIBJFNSA-N",
      "smilesParent": "C[C@H](CO)N1C[C@@H](C)[C@H](CN(C)Cc2ccc(cc2)C(=O)O)Oc3ccc(NC(=O)C4CC4)cc3C1=O"
    },
    "unichem": {
      "chebi": "125929",
      "lincs": "LSM-37496",
      "pubchem": "44486138"
    },
    "pubchem": [
      {
        "cid": 44486138,
        "inchi": "InChI=1S/C28H35N3O6/c1-17-13-31(18(2)16-32)27(34)23-12-22(29-26(33)20-8-9-20)10-11-24(23)37-25(17)15-30(3)14-19-4-6-21(7-5-19)28(35)36/h4-7,10-12,17-18,20,25,32H,8-9,13-16H2,1-3H3,(H,29,33)(H,35,36)/t17-,18-,25+/m1/s1",
        "inchikey": "KUULAZFVSMPUFO-GAKIBJFNSA-N",
        "iupac": {
          "systematic": "4-[[[(2R,3R)-8-(cyclopropanecarbonylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl-methylamino]methyl]benzoic acid"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(C=CC(=C2)NC(=O)C3CC3)OC1CN(C)CC4=CC=C(C=C4)C(=O)O)C(C)CO"
        },
        "molecularFormula": "C28H35N3O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:30:11Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c839b"
    },
    "name": "BRD-K57552506",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c839b.png",
    "lincs": {
      "id": "LSM-11912",
      "name": "BRD-K57552506",
      "pubchemCid": 54637707,
      "chebiId": 100538,
      "inchiParent": "InChI=1S/C30H36F3N3O4/c1-19-15-36(20(2)17-37)29(39)28-27(23-11-7-8-12-24(23)35(28)4)22-10-6-5-9-21(22)18-40-25(19)16-34(3)26(38)13-14-30(31,32)33/h5-12,19-20,25,37H,13-18H2,1-4H3/t19-,20+,25-/m1/s1",
      "inchiKeyParent": "RDYUFLZMPZQAJV-OHUGHZGNSA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@@H](C)[C@@H](CN(C)C(=O)CCC(F)(F)F)OCc2ccccc2c3c(C1=O)n(C)c4ccccc34"
    },
    "unichem": {
      "chebi": "100538",
      "lincs": "LSM-11912",
      "pubchem": "54637707"
    },
    "pubchem": [
      {
        "cid": 54637707,
        "inchi": "InChI=1S/C30H36F3N3O4/c1-19-15-36(20(2)17-37)29(39)28-27(23-11-7-8-12-24(23)35(28)4)22-10-6-5-9-21(22)18-40-25(19)16-34(3)26(38)13-14-30(31,32)33/h5-12,19-20,25,37H,13-18H2,1-4H3/t19-,20+,25-/m1/s1",
        "inchikey": "RDYUFLZMPZQAJV-OHUGHZGNSA-N",
        "iupac": {
          "systematic": "4,4,4-trifluoro-N-[[(10S,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylbutanamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(C3=CC=CC=C3COC1CN(C)C(=O)CCC(F)(F)F)C4=CC=CC=C4N2C)C(C)CO"
        },
        "molecularFormula": "C30H36F3N3O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:30:13Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83a5"
    },
    "name": "BRD-K46734661",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83a5.png",
    "lincs": {
      "id": "LSM-11282",
      "name": "BRD-K46734661",
      "pubchemCid": 54654526,
      "chebiId": 99903,
      "inchiParent": "InChI=1S/C24H25FN2O6/c1-27-19-9-8-15(12-22(28)31-2)33-21(19)13-32-20-10-7-14(11-17(20)24(27)30)26-23(29)16-5-3-4-6-18(16)25/h3-7,10-11,15,19,21H,8-9,12-13H2,1-2H3,(H,26,29)/t15-,19-,21-/m0/s1",
      "inchiKeyParent": "QVBIDJFZXMTPPC-ZRCAFCQKSA-N",
      "smilesParent": "COC(=O)C[C@@H]1CC[C@H]2[C@H](COc3ccc(NC(=O)c4ccccc4F)cc3C(=O)N2C)O1"
    },
    "unichem": {
      "chebi": "99903",
      "lincs": "LSM-11282",
      "pubchem": "54654526"
    },
    "pubchem": [
      {
        "cid": 54654526,
        "inchi": "InChI=1S/C24H25FN2O6/c1-27-19-9-8-15(12-22(28)31-2)33-21(19)13-32-20-10-7-14(11-17(20)24(27)30)26-23(29)16-5-3-4-6-18(16)25/h3-7,10-11,15,19,21H,8-9,12-13H2,1-2H3,(H,26,29)/t15-,19-,21-/m0/s1",
        "inchikey": "QVBIDJFZXMTPPC-ZRCAFCQKSA-N",
        "iupac": {
          "systematic": "methyl 2-[(2S,4aS,12aR)-8-[(2-fluorobenzoyl)amino]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]acetate"
        },
        "smiles": {
          "canonical": "CN1C2CCC(OC2COC3=C(C1=O)C=C(C=C3)NC(=O)C4=CC=CC=C4F)CC(=O)OC"
        },
        "molecularFormula": "C24H25FN2O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:30:16Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82b9"
    },
    "name": "BRD-K30797133",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82b9.png",
    "lincs": {
      "id": "LSM-38955",
      "name": "BRD-K30797133",
      "pubchemCid": 54649704,
      "chebiId": 127397,
      "inchiParent": "InChI=1S/C22H29N3O5/c1-14-21(26)24(2)11-10-16-8-9-18(28-4)19(30-16)13-29-20-15(12-23)6-5-7-17(20)22(27)25(14)3/h5-7,14,16,18-19H,8-11,13H2,1-4H3/t14-,16-,18+,19-/m1/s1",
      "inchiKeyParent": "HLSMAPUQSFTYPM-SKWUIDRYSA-N",
      "smilesParent": "CO[C@H]1CC[C@@H]2CCN(C)C(=O)[C@@H](C)N(C)C(=O)c3cccc(C#N)c3OC[C@H]1O2"
    },
    "unichem": {
      "chebi": "127397",
      "lincs": "LSM-38955",
      "pubchem": "54649704"
    },
    "pubchem": [
      {
        "cid": 54649704,
        "inchi": "InChI=1S/C22H29N3O5/c1-14-21(26)24(2)11-10-16-8-9-18(28-4)19(30-16)13-29-20-15(12-23)6-5-7-17(20)22(27)25(14)3/h5-7,14,16,18-19H,8-11,13H2,1-4H3/t14-,16-,18+,19-/m1/s1",
        "inchikey": "HLSMAPUQSFTYPM-SKWUIDRYSA-N",
        "iupac": {
          "systematic": "(1R,12R,17R,20S)-20-methoxy-11,12,14-trimethyl-10,13-dioxo-3,21-dioxa-11,14-diazatricyclo[15.3.1.04,9]henicosa-4,6,8-triene-5-carbonitrile"
        },
        "smiles": {
          "canonical": "CC1C(=O)N(CCC2CCC(C(O2)COC3=C(C=CC=C3C(=O)N1C)C#N)OC)C"
        },
        "molecularFormula": "C22H29N3O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:30:18Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82e6"
    },
    "name": "Loxapine",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82e6.png",
    "lincs": {
      "id": "LSM-2881",
      "name": "Loxapine",
      "alternativeNames": [
        "Adasuve",
        "CL-62362",
        "CL-71563",
        "Loxapac",
        "Loxapine",
        "Loxapine HCl",
        "Loxapine Succinate",
        "Loxitane",
        "Loxitane C",
        "Loxitane-C Oral Suspension [As Hydrochloride]",
        "Loxitane IM",
        "Loxitane Intramuscular [As Hydrochloride]",
        "SUM 3170",
        "SUM-3170"
      ],
      "pubchemCid": 3964,
      "chebiId": [
        50841,
        6549
      ],
      "inchiParent": "InChI=1S/C18H18ClN3O/c1-21-8-10-22(11-9-21)18-14-12-13(19)6-7-16(14)23-17-5-3-2-4-15(17)20-18/h2-7,12H,8-11H2,1H3",
      "inchiKeyParent": "XJGVXQDUIWGIRW-UHFFFAOYSA-N",
      "smilesParent": "CN1CCN(CC1)C2=Nc3ccccc3Oc4ccc(Cl)cc24"
    },
    "unichem": {
      "chebi": "50841",
      "chembl": "CHEMBL831",
      "lincs": "LSM-2881",
      "pubchem": "3964",
      "drugbank": "DB00408"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL831",
      "prefName": "LOXAPINE",
      "maxPhase": 4.0,
      "maxPhaseCurated": "Approved",
      "firstApproval": 1975,
      "chebiParId": "50841",
      "oral": true,
      "parenteral": true,
      "withdrawnFlag": false,
      "blackBoxWarning": true,
      "moleculeProperties": {
        "fullMwt": 327.81,
        "hba": 4,
        "hbd": 0,
        "qedWeighted": 0.74
      },
      "moleculeSynonyms": [
        {
          "moleculeSynonym": "Adasuve",
          "synType": "TRADE_NAME",
          "synonyms": "Adasuve"
        },
        {
          "moleculeSynonym": "CL 62,362",
          "synType": "RESEARCH_CODE",
          "synonyms": "CL 62,362"
        },
        {
          "moleculeSynonym": "CL-62362",
          "synType": "RESEARCH_CODE",
          "synonyms": "CL-62362"
        },
        {
          "moleculeSynonym": "Loxapac",
          "synType": "OTHER",
          "synonyms": "Loxapac"
        },
        {
          "moleculeSynonym": "Loxapina",
          "synType": "INN_SPANISH",
          "synonyms": "LOXAPINA"
        },
        {
          "moleculeSynonym": "Loxapine",
          "synType": "ATC",
          "synonyms": "LOXAPINE"
        },
        {
          "moleculeSynonym": "Loxapine",
          "synType": "BAN",
          "synonyms": "LOXAPINE"
        },
        {
          "moleculeSynonym": "Loxapine",
          "synType": "EMA",
          "synonyms": "LOXAPINE"
        },
        {
          "moleculeSynonym": "Loxapine",
          "synType": "FDA",
          "synonyms": "LOXAPINE"
        },
        {
          "moleculeSynonym": "Loxapine",
          "synType": "INN",
          "synonyms": "LOXAPINE"
        },
        {
          "moleculeSynonym": "Loxapine",
          "synType": "OTHER",
          "synonyms": "LOXAPINE"
        },
        {
          "moleculeSynonym": "Loxapine",
          "synType": "USAN",
          "synonyms": "LOXAPINE"
        },
        {
          "moleculeSynonym": "Loxitane",
          "synType": "OTHER",
          "synonyms": "Loxitane"
        },
        {
          "moleculeSynonym": "SUM 3170",
          "synType": "RESEARCH_CODE",
          "synonyms": "SUM 3170"
        },
        {
          "moleculeSynonym": "SUM-3170",
          "synType": "RESEARCH_CODE",
          "synonyms": "SUM-3170"
        }
      ],
      "drugIndications": [
        {
          "efoId": "EFO:0003768",
          "efoTerm": "nicotine dependence",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT00873769"
            ]
          },
          "maxPhaseForInd": 1.0,
          "meshHeading": "Tobacco Use Disorder"
        },
        {
          "efoId": "EFO:0005407",
          "efoTerm": "psychosis",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT00555412"
            ]
          },
          "maxPhaseForInd": 4.0,
          "meshHeading": "Psychotic Disorders"
        },
        {
          "efoId": "EFO:0000341",
          "efoTerm": "chronic obstructive pulmonary disease",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT00889837"
            ]
          },
          "maxPhaseForInd": 1.0,
          "meshHeading": "Pulmonary Disease, Chronic Obstructive"
        },
        {
          "efoId": "EFO:0005762",
          "efoTerm": "neuropathic pain",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT02820519"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Neuralgia"
        },
        {
          "efoId": "EFO:0005230",
          "efoTerm": "anxiety",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT00290082"
            ]
          },
          "maxPhaseForInd": 3.0,
          "meshHeading": "Anxiety"
        },
        {
          "efoId": "HP:0000713",
          "efoTerm": "Agitation",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT03110900"
            ]
          },
          "maxPhaseForInd": 4.0,
          "meshHeading": "Psychomotor Agitation"
        },
        {
          "efoId": "EFO:0009963",
          "efoTerm": "bipolar I disorder",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT00721955"
            ]
          },
          "maxPhaseForInd": 4.0,
          "meshHeading": "Bipolar Disorder"
        },
        {
          "efoId": "HP:0000713",
          "efoTerm": "Agitation",
          "maxPhaseForInd": 4.0,
          "meshHeading": "Mental Disorders"
        },
        {
          "efoId": "EFO:0009267",
          "efoTerm": "delirium",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT05324852"
            ]
          },
          "maxPhaseForInd": 3.0,
          "meshHeading": "Delirium"
        },
        {
          "efoId": "MONDO:0004979",
          "efoTerm": "asthma",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT00890175"
            ]
          },
          "maxPhaseForInd": 1.0,
          "meshHeading": "Asthma"
        },
        {
          "efoId": "MONDO:0005090",
          "efoTerm": "schizophrenia",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT00369577,NCT00444028"
            ]
          },
          "maxPhaseForInd": 4.0,
          "meshHeading": "Schizophrenia"
        },
        {
          "efoId": "MONDO:0005277",
          "efoTerm": "migraine disorder",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT00489476,NCT00825500"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Migraine Disorders"
        },
        {
          "efoId": "MONDO:0004985",
          "efoTerm": "bipolar disorder",
          "maxPhaseForInd": 4.0,
          "meshHeading": "Bipolar Disorder"
        }
      ],
      "drugMechanisms": [
        {
          "mechanismOfAction": "Serotonin 2a (5-HT2a) receptor antagonist",
          "actionType": "ANTAGONIST",
          "targetName": "Serotonin 2a (5-HT2a) receptor",
          "targetOrganism": "Homo sapiens",
          "targetType": "SINGLE PROTEIN",
          "targetComponents": [
            {
              "uniprot": [
                "P28223"
              ]
            }
          ]
        },
        {
          "mechanismOfAction": "Serotonin 2c (5-HT2c) receptor antagonist",
          "actionType": "ANTAGONIST",
          "targetName": "Serotonin 2c (5-HT2c) receptor",
          "targetOrganism": "Homo sapiens",
          "targetType": "SINGLE PROTEIN",
          "targetComponents": [
            {
              "uniprot": [
                "P28335"
              ]
            }
          ]
        },
        {
          "mechanismOfAction": "D2-like dopamine receptor antagonist",
          "actionType": "ANTAGONIST",
          "targetName": "D2-like dopamine receptor",
          "targetOrganism": "Homo sapiens",
          "targetType": "PROTEIN FAMILY",
          "targetComponents": [
            {
              "uniprot": [
                "P14416",
                "P35462",
                "P21917"
              ]
            }
          ]
        }
      ]
    },
    "pubchem": [
      {
        "cid": 3964,
        "inchi": "InChI=1S/C18H18ClN3O/c1-21-8-10-22(11-9-21)18-14-12-13(19)6-7-16(14)23-17-5-3-2-4-15(17)20-18/h2-7,12H,8-11H2,1H3",
        "inchikey": "XJGVXQDUIWGIRW-UHFFFAOYSA-N",
        "iupac": {
          "systematic": "8-chloro-6-(4-methylpiperazin-1-yl)benzo[b][1,4]benzoxazepine"
        },
        "smiles": {
          "canonical": "CN1CCN(CC1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl"
        },
        "molecularFormula": "C18H18ClN3O"
      }
    ],
    "clinicaltrials": [
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01877642",
            "briefTitle": "ADASUVE-Lorazepam Drug-Drug Interaction",
            "officialTitle": "ADASUVE\u00ae-Lorazepam Drug-Drug Interaction Study"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2013-06-12",
            "resultsFirstSubmitDate": "2017-03-13"
          },
          "conditionsModule": {
            "conditions": [
              "Healthy Volunteers"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Maximum Level of Sedation for Lorazepam 1 mg IM + ADASUVE 10 mg",
                "timeFrame": "24 hours"
              },
              {
                "measure": "Relative Pharmacodynamic Effect on Respiration Rate for Combined vs Individual (Lorazepam, Loxapine)",
                "timeFrame": "24 hours"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Relative Pharmacodynamic Effect on Systolic Blood Pressure for Combined vs Individual (Lorazepam, Loxapine)"
              },
              {
                "measure": "Relative Pharmacodynamic Effect on Sedation for Combined vs Individual (Lorazepam, Loxapine)"
              },
              {
                "measure": "Relative Pharmacodynamic Effect on Pulse Oximetry for Combined vs Individual (Lorazepam, Loxapine)"
              },
              {
                "measure": "Relative Pharmacodynamic Effect on Heart Rate for Combined vs Individual (Lorazepam, Loxapine)"
              },
              {
                "measure": "Relative Pharmacodynamic Effect on Diastolic Blood Pressure for Combined vs Individual (Lorazepam, Loxapine)"
              },
              {
                "measure": "Relative Pharmacodynamic Effect on Cogscreen Pathfinder Response for Combined vs Individual (Lorazepam, Loxapine)"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02435095",
            "briefTitle": "Antipsychotic Induced Structural and Functional Brain Changes",
            "officialTitle": "Are Antipsychotics Neurotoxic or Neuroprotective? A Long-term Comparison of Two Treatment Strategies"
          },
          "statusModule": {
            "overallStatus": "TERMINATED",
            "whyStopped": "slow patient recruitment, low patient-commpliance, high dropout rates,",
            "studyFirstSubmitDate": "2015-04-14"
          },
          "conditionsModule": {
            "conditions": [
              "Schizophrenia"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Total grey matter volume",
                "timeFrame": "over 12 months"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Grey matter volume (hippocampus, prefrontal cortex)"
              },
              {
                "measure": "Assessment of safety as assessed with the following instrument: EPS"
              },
              {
                "measure": "Assessment of safety as assessed with the following instrument: BARS"
              },
              {
                "measure": "Assessment of safety as assessed with the following instrument: Arizona Scale"
              },
              {
                "measure": "Global assessment of safety as assessed with laboratory values"
              },
              {
                "measure": "Cognition"
              },
              {
                "measure": "Quality of life"
              },
              {
                "measure": "Psychopathology as assessed with the PANSS"
              },
              {
                "measure": "Psychopathology as assessed with the CGI"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT03110900",
            "briefTitle": "Inhaled Loxapine vs Intramuscular (IM) Haloperidol + Lorazepam for Agitation",
            "officialTitle": "A Randomized Double-blind Multicenter Double-dummy Non-inferiority Trial of Inhaled Loxapine and Intramuscular Haloperidol + Lorazepam for the Reduction of Agitation"
          },
          "statusModule": {
            "overallStatus": "TERMINATED",
            "whyStopped": "Sponsor Withdrawal",
            "studyFirstSubmitDate": "2017-03-16",
            "resultsFirstSubmitDate": "2018-04-09"
          },
          "conditionsModule": {
            "conditions": [
              "Agitation,Psychomotor",
              "Haloperidol Causing Adverse Effects in Therapeutic Use",
              "Lorazepam Causing Adverse Effects in Therapeutic Use",
              "Loxapine Causing Adverse Effects in Therapeutic Use"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Number of Subjects Reporting Reduction of Agitation on Positive and Negative Syndrome Scale (PANSS)",
                "timeFrame": "120 minutes"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00648778",
            "briefTitle": "Fasting Study of Loxapine Succinate Capsules 25 mg and Loxitane\u00ae Capsules 25 mg",
            "officialTitle": "Single-Dose Fasting In Vivo Bioequivalence Study of Loxapine Succinate Capsules (25 mg; Mylan) and Loxitane\u00ae Capsules (25 mg; Watson) in Healthy Volunteers"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2008-03-30"
          },
          "conditionsModule": {
            "conditions": [
              "Healthy"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Bioequivalence",
                "timeFrame": "within 30 days"
              }
            ]
          }
        }
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:30:31Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8311"
    },
    "name": "BRD-K92754298",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8311.png",
    "lincs": {
      "id": "LSM-14112",
      "name": "BRD-K92754298",
      "pubchemCid": 54657903,
      "chebiId": 102766,
      "inchiParent": "InChI=1S/C27H30Cl2N2O5/c28-20-9-19(10-21(29)11-20)27(34)31-14-22(32)15-35-16-25-24(31)6-5-23(36-25)12-26(33)30-8-7-17-3-1-2-4-18(17)13-30/h1-4,9-11,22-25,32H,5-8,12-16H2/t22-,23-,24-,25+/m0/s1",
      "inchiKeyParent": "RFSVTUPSJXWLCE-OJJQZRKESA-N",
      "smilesParent": "O[C@@H]1COC[C@H]2O[C@H](CC(=O)N3CCc4ccccc4C3)CC[C@@H]2N(C1)C(=O)c5cc(Cl)cc(Cl)c5"
    },
    "unichem": {
      "chebi": "102766",
      "lincs": "LSM-14112",
      "pubchem": "54657903"
    },
    "pubchem": [
      {
        "cid": 54657903,
        "inchi": "InChI=1S/C27H30Cl2N2O5/c28-20-9-19(10-21(29)11-20)27(34)31-14-22(32)15-35-16-25-24(31)6-5-23(36-25)12-26(33)30-8-7-17-3-1-2-4-18(17)13-30/h1-4,9-11,22-25,32H,5-8,12-16H2/t22-,23-,24-,25+/m0/s1",
        "inchikey": "RFSVTUPSJXWLCE-OJJQZRKESA-N",
        "iupac": {
          "systematic": "2-[(3S,6aS,8S,10aS)-1-(3,5-dichlorobenzoyl)-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(3,4-dihydro-1H-isoquinolin-2-yl)ethanone"
        },
        "smiles": {
          "canonical": "C1CC2C(COCC(CN2C(=O)C3=CC(=CC(=C3)Cl)Cl)O)OC1CC(=O)N4CCC5=CC=CC=C5C4"
        },
        "molecularFormula": "C27H30Cl2N2O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:30:33Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c833e"
    },
    "name": "BRD-K89298751",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c833e.png",
    "lincs": {
      "id": "LSM-42139",
      "name": "BRD-K89298751",
      "pubchemCid": 54613930,
      "chebiId": 130590,
      "inchiParent": "InChI=1S/C25H40N4O4/c1-16(2)26-25(32)27-21-8-9-22-20(10-21)11-24(31)29(18(4)15-30)12-17(3)23(33-22)14-28(5)13-19-6-7-19/h8-10,16-19,23,30H,6-7,11-15H2,1-5H3,(H2,26,27,32)/t17-,18+,23+/m0/s1",
      "inchiKeyParent": "UCKREMIJSDYNRS-YZZKKUAISA-N",
      "smilesParent": "CC(C)NC(=O)Nc1ccc2O[C@H](CN(C)CC3CC3)[C@@H](C)CN([C@H](C)CO)C(=O)Cc2c1"
    },
    "unichem": {
      "chebi": "130590",
      "lincs": "LSM-42139",
      "pubchem": "54613930"
    },
    "pubchem": [
      {
        "cid": 54613930,
        "inchi": "InChI=1S/C25H40N4O4/c1-16(2)26-25(32)27-21-8-9-22-20(10-21)11-24(31)29(18(4)15-30)12-17(3)23(33-22)14-28(5)13-19-6-7-19/h8-10,16-19,23,30H,6-7,11-15H2,1-5H3,(H2,26,27,32)/t17-,18+,23+/m0/s1",
        "inchikey": "UCKREMIJSDYNRS-YZZKKUAISA-N",
        "iupac": {
          "systematic": "1-[(2S,3S)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-propan-2-ylurea"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)CC2=C(C=CC(=C2)NC(=O)NC(C)C)OC1CN(C)CC3CC3)C(C)CO"
        },
        "molecularFormula": "C25H40N4O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:30:35Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8348"
    },
    "name": "BRD-K18309912",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8348.png",
    "lincs": {
      "id": "LSM-9526",
      "name": "BRD-K18309912",
      "pubchemCid": 54654573,
      "chebiId": 98147,
      "inchiParent": "InChI=1S/C21H29N3O7S/c1-23-17-5-4-15(12-20(25)24-7-9-29-10-8-24)31-19(17)13-30-18-6-3-14(22-32(2,27)28)11-16(18)21(23)26/h3,6,11,15,17,19,22H,4-5,7-10,12-13H2,1-2H3/t15-,17-,19+/m0/s1",
      "inchiKeyParent": "VPEDYPFQYJVQKE-VDZJLULYSA-N",
      "smilesParent": "CN1[C@H]2CC[C@@H](CC(=O)N3CCOCC3)O[C@@H]2COc4ccc(NS(=O)(=O)C)cc4C1=O"
    },
    "unichem": {
      "chebi": "98147",
      "lincs": "LSM-9526",
      "pubchem": "54654573"
    },
    "pubchem": [
      {
        "cid": 54654573,
        "inchi": "InChI=1S/C21H29N3O7S/c1-23-17-5-4-15(12-20(25)24-7-9-29-10-8-24)31-19(17)13-30-18-6-3-14(22-32(2,27)28)11-16(18)21(23)26/h3,6,11,15,17,19,22H,4-5,7-10,12-13H2,1-2H3/t15-,17-,19+/m0/s1",
        "inchikey": "VPEDYPFQYJVQKE-VDZJLULYSA-N",
        "iupac": {
          "systematic": "N-[(2S,4aS,12aS)-5-methyl-2-(2-morpholin-4-yl-2-oxoethyl)-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]methanesulfonamide"
        },
        "smiles": {
          "canonical": "CN1C2CCC(OC2COC3=C(C1=O)C=C(C=C3)NS(=O)(=O)C)CC(=O)N4CCOCC4"
        },
        "molecularFormula": "C21H29N3O7S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:30:37Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c828d"
    },
    "name": "BRD-K75880427",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c828d.png",
    "lincs": {
      "id": "LSM-41403",
      "name": "BRD-K75880427",
      "pubchemCid": 60189712,
      "chebiId": 129852,
      "inchiParent": "InChI=1S/C21H29N3O4/c1-28-12-18(26)23-13-21(14-23)19(15-7-3-2-4-8-15)17(11-25)24(21)20(27)22-16-9-5-6-10-16/h2-4,7-8,16-17,19,25H,5-6,9-14H2,1H3,(H,22,27)/t17-,19-/m1/s1",
      "inchiKeyParent": "UVTCAZPAFBBAKN-IEBWSBKVSA-N",
      "smilesParent": "COCC(=O)N1CC2(C1)[C@@H]([C@@H](CO)N2C(=O)NC3CCCC3)c4ccccc4"
    },
    "unichem": {
      "chebi": "129852",
      "lincs": "LSM-41403",
      "pubchem": "60189712"
    },
    "pubchem": [
      {
        "cid": 60189712,
        "inchi": "InChI=1S/C21H29N3O4/c1-28-12-18(26)23-13-21(14-23)19(15-7-3-2-4-8-15)17(11-25)24(21)20(27)22-16-9-5-6-10-16/h2-4,7-8,16-17,19,25H,5-6,9-14H2,1H3,(H,22,27)/t17-,19-/m1/s1",
        "inchikey": "UVTCAZPAFBBAKN-IEBWSBKVSA-N",
        "iupac": {
          "systematic": "(2S,3R)-N-cyclopentyl-2-(hydroxymethyl)-6-(2-methoxyacetyl)-3-phenyl-1,6-diazaspiro[3.3]heptane-1-carboxamide"
        },
        "smiles": {
          "canonical": "COCC(=O)N1CC2(C1)C(C(N2C(=O)NC3CCCC3)CO)C4=CC=CC=C4"
        },
        "molecularFormula": "C21H29N3O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:30:40Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8292"
    },
    "name": "BRD-K18246949",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8292.png",
    "lincs": {
      "id": "LSM-9522",
      "name": "BRD-K18246949",
      "pubchemCid": 54649300,
      "chebiId": 98143,
      "inchiParent": "InChI=1S/C22H32F3N3O4/c1-14(19(32-4)12-27(3)20(30)16-5-6-16)11-28(15(2)13-29)21(31)26-18-9-7-17(8-10-18)22(23,24)25/h7-10,14-16,19,29H,5-6,11-13H2,1-4H3,(H,26,31)/t14-,15-,19-/m0/s1",
      "inchiKeyParent": "GUZASBNVYSIPQO-DOXZYTNZSA-N",
      "smilesParent": "CO[C@@H](CN(C)C(=O)C1CC1)[C@@H](C)CN([C@@H](C)CO)C(=O)Nc2ccc(cc2)C(F)(F)F"
    },
    "unichem": {
      "chebi": "98143",
      "lincs": "LSM-9522",
      "pubchem": "54649300"
    },
    "pubchem": [
      {
        "cid": 54649300,
        "inchi": "InChI=1S/C22H32F3N3O4/c1-14(19(32-4)12-27(3)20(30)16-5-6-16)11-28(15(2)13-29)21(31)26-18-9-7-17(8-10-18)22(23,24)25/h7-10,14-16,19,29H,5-6,11-13H2,1-4H3,(H,26,31)/t14-,15-,19-/m0/s1",
        "inchikey": "GUZASBNVYSIPQO-DOXZYTNZSA-N",
        "iupac": {
          "systematic": "N-[(2R,3S)-4-[[(2S)-1-hydroxypropan-2-yl]-[[4-(trifluoromethyl)phenyl]carbamoyl]amino]-2-methoxy-3-methylbutyl]-N-methylcyclopropanecarboxamide"
        },
        "smiles": {
          "canonical": "CC(CN(C(C)CO)C(=O)NC1=CC=C(C=C1)C(F)(F)F)C(CN(C)C(=O)C2CC2)OC"
        },
        "molecularFormula": "C22H32F3N3O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:30:42Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8386"
    },
    "name": "BRD-K20500634",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8386.png",
    "lincs": {
      "id": "LSM-9678",
      "name": "BRD-K20500634",
      "pubchemCid": 56835355,
      "chebiId": 98299,
      "inchiParent": "InChI=1S/C31H38N4O6S/c1-19-15-35(20(2)17-36)31(37)29-28(25-13-9-10-14-26(25)34(29)6)24-12-8-7-11-23(24)18-40-27(19)16-33(5)42(38,39)30-21(3)32-41-22(30)4/h7-14,19-20,27,36H,15-18H2,1-6H3/t19-,20-,27+/m0/s1",
      "inchiKeyParent": "HAVPCKYPPPKWEI-OWOAZTCBSA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@H](C)[C@@H](CN(C)S(=O)(=O)c2c(C)onc2C)OCc3ccccc3c4c(C1=O)n(C)c5ccccc45"
    },
    "unichem": {
      "chebi": "98299",
      "lincs": "LSM-9678",
      "pubchem": "56835355"
    },
    "pubchem": [
      {
        "cid": 56835355,
        "inchi": "InChI=1S/C31H38N4O6S/c1-19-15-35(20(2)17-36)31(37)29-28(25-13-9-10-14-26(25)34(29)6)24-12-8-7-11-23(24)18-40-27(19)16-33(5)42(38,39)30-21(3)32-41-22(30)4/h7-14,19-20,27,36H,15-18H2,1-6H3/t19-,20-,27+/m0/s1",
        "inchikey": "HAVPCKYPPPKWEI-OWOAZTCBSA-N",
        "iupac": {
          "systematic": "N-[[(10S,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N,3,5-trimethyl-1,2-oxazole-4-sulfonamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(C3=CC=CC=C3COC1CN(C)S(=O)(=O)C4=C(ON=C4C)C)C5=CC=CC=C5N2C)C(C)CO"
        },
        "molecularFormula": "C31H38N4O6S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:30:44Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c839a"
    },
    "name": "BRD-K78232231",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c839a.png",
    "lincs": {
      "id": "LSM-7870",
      "name": "BRD-K78232231",
      "pubchemCid": 54618386,
      "chebiId": 96491,
      "inchiParent": "InChI=1S/C28H38N2O7S/c1-19-16-30(20(2)18-31)38(33,34)27-9-8-23(22-6-5-7-24(14-22)35-4)15-25(27)37-26(19)17-29(3)28(32)21-10-12-36-13-11-21/h5-9,14-15,19-21,26,31H,10-13,16-18H2,1-4H3/t19-,20+,26+/m0/s1",
      "inchiKeyParent": "HDWGWTYDTDHGLT-OUDXUNEISA-N",
      "smilesParent": "COc1cccc(c1)c2ccc3c(O[C@H](CN(C)C(=O)C4CCOCC4)[C@@H](C)CN([C@H](C)CO)S3(=O)=O)c2"
    },
    "unichem": {
      "chebi": "96491",
      "lincs": "LSM-7870",
      "pubchem": "54618386"
    },
    "pubchem": [
      {
        "cid": 54618386,
        "inchi": "InChI=1S/C28H38N2O7S/c1-19-16-30(20(2)18-31)38(33,34)27-9-8-23(22-6-5-7-24(14-22)35-4)15-25(27)37-26(19)17-29(3)28(32)21-10-12-36-13-11-21/h5-9,14-15,19-21,26,31H,10-13,16-18H2,1-4H3/t19-,20+,26+/m0/s1",
        "inchikey": "HDWGWTYDTDHGLT-OUDXUNEISA-N",
        "iupac": {
          "systematic": "N-[[(4S,5S)-2-[(2R)-1-hydroxypropan-2-yl]-8-(3-methoxyphenyl)-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-N-methyloxane-4-carboxamide"
        },
        "smiles": {
          "canonical": "CC1CN(S(=O)(=O)C2=C(C=C(C=C2)C3=CC(=CC=C3)OC)OC1CN(C)C(=O)C4CCOCC4)C(C)CO"
        },
        "molecularFormula": "C28H38N2O7S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:30:47Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8409"
    },
    "name": "BRD-K55504273",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8409.png",
    "lincs": {
      "id": "LSM-7582",
      "name": "BRD-K55504273",
      "pubchemCid": 54618909,
      "chebiId": 96203,
      "inchiParent": "InChI=1S/C28H37N3O5S/c1-20-17-31(21(2)19-32)37(34,35)27-10-9-24(23-7-5-4-6-8-23)16-25(27)36-26(20)18-30(3)28(33)15-22-11-13-29-14-12-22/h7,9-14,16,20-21,26,32H,4-6,8,15,17-19H2,1-3H3/t20-,21+,26-/m0/s1",
      "inchiKeyParent": "DSAVDXHQQHIKAO-UZINWLIJSA-N",
      "smilesParent": "C[C@H](CO)N1C[C@H](C)[C@H](CN(C)C(=O)Cc2ccncc2)Oc3cc(ccc3S1(=O)=O)C4=CCCCC4"
    },
    "unichem": {
      "chebi": "96203",
      "lincs": "LSM-7582",
      "pubchem": "54618909"
    },
    "pubchem": [
      {
        "cid": 54618909,
        "inchi": "InChI=1S/C28H37N3O5S/c1-20-17-31(21(2)19-32)37(34,35)27-10-9-24(23-7-5-4-6-8-23)16-25(27)36-26(20)18-30(3)28(33)15-22-11-13-29-14-12-22/h7,9-14,16,20-21,26,32H,4-6,8,15,17-19H2,1-3H3/t20-,21+,26-/m0/s1",
        "inchikey": "DSAVDXHQQHIKAO-UZINWLIJSA-N",
        "iupac": {
          "systematic": "N-[[(4S,5R)-8-(cyclohexen-1-yl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyridin-4-ylacetamide"
        },
        "smiles": {
          "canonical": "CC1CN(S(=O)(=O)C2=C(C=C(C=C2)C3=CCCCC3)OC1CN(C)C(=O)CC4=CC=NC=C4)C(C)CO"
        },
        "molecularFormula": "C28H37N3O5S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:30:49Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c840d"
    },
    "name": "BRD-K41885374",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c840d.png",
    "lincs": {
      "id": "LSM-10972",
      "name": "BRD-K41885374",
      "pubchemCid": 54646256,
      "chebiId": 99593,
      "inchiParent": "InChI=1S/C28H27N3O7/c32-14-25-27-21(11-19(37-25)12-26(33)30-13-18-3-1-2-8-29-18)20-10-17(5-7-22(20)38-27)31-28(34)16-4-6-23-24(9-16)36-15-35-23/h1-10,19,21,25,27,32H,11-15H2,(H,30,33)(H,31,34)/t19-,21+,25+,27-/m1/s1",
      "inchiKeyParent": "FEEKZGTVSGSFLP-ZPNKKQCCSA-N",
      "smilesParent": "OC[C@@H]1O[C@@H](CC(=O)NCc2ccccn2)C[C@@H]3[C@H]1Oc4ccc(NC(=O)c5ccc6OCOc6c5)cc34"
    },
    "unichem": {
      "chebi": "99593",
      "lincs": "LSM-10972",
      "pubchem": "54646256"
    },
    "pubchem": [
      {
        "cid": 54646256,
        "inchi": "InChI=1S/C28H27N3O7/c32-14-25-27-21(11-19(37-25)12-26(33)30-13-18-3-1-2-8-29-18)20-10-17(5-7-22(20)38-27)31-28(34)16-4-6-23-24(9-16)36-15-35-23/h1-10,19,21,25,27,32H,11-15H2,(H,30,33)(H,31,34)/t19-,21+,25+,27-/m1/s1",
        "inchikey": "FEEKZGTVSGSFLP-ZPNKKQCCSA-N",
        "iupac": {
          "systematic": "N-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(pyridin-2-ylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide"
        },
        "smiles": {
          "canonical": "C1C(OC(C2C1C3=C(O2)C=CC(=C3)NC(=O)C4=CC5=C(C=C4)OCO5)CO)CC(=O)NCC6=CC=CC=N6"
        },
        "molecularFormula": "C28H27N3O7"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:30:51Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83c7"
    },
    "name": "BRD-K22177698",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83c7.png",
    "lincs": {
      "id": "LSM-9771",
      "name": "BRD-K22177698",
      "pubchemCid": 54660693,
      "chebiId": 98392,
      "inchiParent": "InChI=1S/C21H24N4O4S/c26-11-13-15-10-24-14(6-3-7-16(24)27)18(25(15)20(29)12-4-1-2-5-12)17(13)19(28)23-21-22-8-9-30-21/h3,6-9,12-13,15,17-18,26H,1-2,4-5,10-11H2,(H,22,23,28)/t13-,15-,17+,18+/m1/s1",
      "inchiKeyParent": "WZQJIBXYFKEECF-WCZJQEMASA-N",
      "smilesParent": "OC[C@@H]1[C@H]2CN3C(=O)C=CC=C3[C@@H]([C@H]1C(=O)Nc4nccs4)N2C(=O)C5CCCC5"
    },
    "unichem": {
      "chebi": "98392",
      "lincs": "LSM-9771",
      "pubchem": "54660693"
    },
    "pubchem": [
      {
        "cid": 54660693,
        "inchi": "InChI=1S/C21H24N4O4S/c26-11-13-15-10-24-14(6-3-7-16(24)27)18(25(15)20(29)12-4-1-2-5-12)17(13)19(28)23-21-22-8-9-30-21/h3,6-9,12-13,15,17-18,26H,1-2,4-5,10-11H2,(H,22,23,28)/t13-,15-,17+,18+/m1/s1",
        "inchikey": "WZQJIBXYFKEECF-WCZJQEMASA-N",
        "iupac": {
          "systematic": "(1R,9S,10S,11S)-12-(cyclopentanecarbonyl)-10-(hydroxymethyl)-6-oxo-N-(1,3-thiazol-2-yl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide"
        },
        "smiles": {
          "canonical": "C1CCC(C1)C(=O)N2C3CN4C(=O)C=CC=C4C2C(C3CO)C(=O)NC5=NC=CS5"
        },
        "molecularFormula": "C21H24N4O4S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:30:53Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8355"
    },
    "name": "MLS003129789",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8355.png",
    "lincs": {
      "id": "LSM-8385",
      "name": "MLS003129789",
      "alternativeNames": [
        "BRD-K84992272"
      ],
      "pubchemCid": 44505949,
      "chebiId": 97006,
      "inchiParent": "InChI=1S/C28H37N5O5S/c1-21-17-32(22(2)19-34)28(35)10-7-15-33-25(16-29-30-33)20-38-27(21)18-31(3)39(36,37)26-13-11-24(12-14-26)23-8-5-4-6-9-23/h4-6,8-9,11-14,16,21-22,27,34H,7,10,15,17-20H2,1-3H3/t21-,22+,27+/m1/s1",
      "inchiKeyParent": "BKQPNZMATHQHFX-VHSZZVNMSA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@@H](C)[C@H](CN(C)S(=O)(=O)c2ccc(cc2)c3ccccc3)OCc4cnnn4CCCC1=O"
    },
    "unichem": {
      "chebi": "97006",
      "chembl": "CHEMBL2142891",
      "lincs": "LSM-8385",
      "pubchem": "44505949"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL2142891",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 555.7,
        "hba": 8,
        "hbd": 1,
        "qedWeighted": 0.48
      }
    },
    "pubchem": [
      {
        "cid": 44505949,
        "inchi": "InChI=1S/C28H37N5O5S/c1-21-17-32(22(2)19-34)28(35)10-7-15-33-25(16-29-30-33)20-38-27(21)18-31(3)39(36,37)26-13-11-24(12-14-26)23-8-5-4-6-9-23/h4-6,8-9,11-14,16,21-22,27,34H,7,10,15,17-20H2,1-3H3/t21-,22+,27+/m1/s1",
        "inchikey": "BKQPNZMATHQHFX-VHSZZVNMSA-N",
        "iupac": {
          "systematic": "N-[[(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methyl-4-phenylbenzenesulfonamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)CCCN2C(=CN=N2)COC1CN(C)S(=O)(=O)C3=CC=C(C=C3)C4=CC=CC=C4)C(C)CO"
        },
        "molecularFormula": "C28H37N5O5S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:31:04Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c836a"
    },
    "name": "BRD-K58918780",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c836a.png",
    "lincs": {
      "id": "LSM-40493",
      "name": "BRD-K58918780",
      "pubchemCid": 44490089,
      "chebiId": 128941,
      "inchiParent": "InChI=1S/C30H42N4O6/c1-20-16-34(21(2)19-35)29(37)25-15-24(31-28(36)7-6-14-32(3)4)12-13-26(25)40-27(20)18-33(5)17-22-8-10-23(11-9-22)30(38)39/h8-13,15,20-21,27,35H,6-7,14,16-19H2,1-5H3,(H,31,36)(H,38,39)/t20-,21+,27-/m1/s1",
      "inchiKeyParent": "NGHZCWRCBPRMGW-PBDKAQRYSA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@@H](C)[C@@H](CN(C)Cc2ccc(cc2)C(=O)O)Oc3ccc(NC(=O)CCCN(C)C)cc3C1=O"
    },
    "unichem": {
      "chebi": "128941",
      "lincs": "LSM-40493",
      "pubchem": "44490089"
    },
    "pubchem": [
      {
        "cid": 44490089,
        "inchi": "InChI=1S/C30H42N4O6/c1-20-16-34(21(2)19-35)29(37)25-15-24(31-28(36)7-6-14-32(3)4)12-13-26(25)40-27(20)18-33(5)17-22-8-10-23(11-9-22)30(38)39/h8-13,15,20-21,27,35H,6-7,14,16-19H2,1-5H3,(H,31,36)(H,38,39)/t20-,21+,27-/m1/s1",
        "inchikey": "NGHZCWRCBPRMGW-PBDKAQRYSA-N",
        "iupac": {
          "systematic": "4-[[[(2S,3R)-8-[4-(dimethylamino)butanoylamino]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl-methylamino]methyl]benzoic acid"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(C=CC(=C2)NC(=O)CCCN(C)C)OC1CN(C)CC3=CC=C(C=C3)C(=O)O)C(C)CO"
        },
        "molecularFormula": "C30H42N4O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:31:07Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c837c"
    },
    "name": "BRD-K80058142",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c837c.png",
    "lincs": {
      "id": "LSM-41638",
      "name": "BRD-K80058142",
      "pubchemCid": 44483487,
      "chebiId": 130088,
      "inchiParent": "InChI=1S/C31H39N5O5/c1-19(2)32-30(39)33-23-13-14-27-25(15-23)29(38)36(21(4)18-37)16-20(3)28(41-27)17-35(5)31(40)34-26-12-8-10-22-9-6-7-11-24(22)26/h6-15,19-21,28,37H,16-18H2,1-5H3,(H,34,40)(H2,32,33,39)/t20-,21-,28+/m0/s1",
      "inchiKeyParent": "KYHZFTDIMWCHFE-YHGPEZAFSA-N",
      "smilesParent": "CC(C)NC(=O)Nc1ccc2O[C@H](CN(C)C(=O)Nc3cccc4ccccc34)[C@@H](C)CN([C@@H](C)CO)C(=O)c2c1"
    },
    "unichem": {
      "chebi": "130088",
      "lincs": "LSM-41638",
      "pubchem": "44483487"
    },
    "pubchem": [
      {
        "cid": 44483487,
        "inchi": "InChI=1S/C31H39N5O5/c1-19(2)32-30(39)33-23-13-14-27-25(15-23)29(38)36(21(4)18-37)16-20(3)28(41-27)17-35(5)31(40)34-26-12-8-10-22-9-6-7-11-24(22)26/h6-15,19-21,28,37H,16-18H2,1-5H3,(H,34,40)(H2,32,33,39)/t20-,21-,28+/m0/s1",
        "inchikey": "KYHZFTDIMWCHFE-YHGPEZAFSA-N",
        "iupac": {
          "systematic": "1-[[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-(propan-2-ylcarbamoylamino)-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-naphthalen-1-ylurea"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(C=CC(=C2)NC(=O)NC(C)C)OC1CN(C)C(=O)NC3=CC=CC4=CC=CC=C43)C(C)CO"
        },
        "molecularFormula": "C31H39N5O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:31:09Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83a9"
    },
    "name": "BRD-K09936924",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83a9.png",
    "lincs": {
      "id": "LSM-9041",
      "name": "BRD-K09936924",
      "pubchemCid": 54657877,
      "chebiId": 97662,
      "inchiParent": "InChI=1S/C23H27FN4O5/c24-16-3-1-15(2-4-16)10-27-22(30)9-18-5-6-20-21(33-18)14-32-13-17(29)12-28(20)23(31)19-11-25-7-8-26-19/h1-4,7-8,11,17-18,20-21,29H,5-6,9-10,12-14H2,(H,27,30)/t17-,18-,20-,21+/m1/s1",
      "inchiKeyParent": "AVCDQRNGDYLZTC-UKAVVXHISA-N",
      "smilesParent": "O[C@H]1COC[C@@H]2O[C@@H](CC(=O)NCc3ccc(F)cc3)CC[C@H]2N(C1)C(=O)c4cnccn4"
    },
    "unichem": {
      "chebi": "97662",
      "lincs": "LSM-9041",
      "pubchem": "54657877"
    },
    "pubchem": [
      {
        "cid": 54657877,
        "inchi": "InChI=1S/C23H27FN4O5/c24-16-3-1-15(2-4-16)10-27-22(30)9-18-5-6-20-21(33-18)14-32-13-17(29)12-28(20)23(31)19-11-25-7-8-26-19/h1-4,7-8,11,17-18,20-21,29H,5-6,9-10,12-14H2,(H,27,30)/t17-,18-,20-,21+/m1/s1",
        "inchikey": "AVCDQRNGDYLZTC-UKAVVXHISA-N",
        "iupac": {
          "systematic": "2-[(3R,6aR,8R,10aR)-3-hydroxy-1-(pyrazine-2-carbonyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(4-fluorophenyl)methyl]acetamide"
        },
        "smiles": {
          "canonical": "C1CC2C(COCC(CN2C(=O)C3=NC=CN=C3)O)OC1CC(=O)NCC4=CC=C(C=C4)F"
        },
        "molecularFormula": "C23H27FN4O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:31:11Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83ba"
    },
    "name": "BRD-K92573321",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83ba.png",
    "lincs": {
      "id": "LSM-14103",
      "name": "BRD-K92573321",
      "pubchemCid": 54631673,
      "chebiId": 102757,
      "inchiParent": "InChI=1S/C26H40N4O5/c1-16(2)27-26(33)28-20-10-11-22-21(12-20)25(32)29(5)14-23(34-6)17(3)13-30(18(4)15-35-22)24(31)19-8-7-9-19/h10-12,16-19,23H,7-9,13-15H2,1-6H3,(H2,27,28,33)/t17-,18+,23+/m0/s1",
      "inchiKeyParent": "FNBLPFIHIJQMKK-YZZKKUAISA-N",
      "smilesParent": "CO[C@@H]1CN(C)C(=O)c2cc(NC(=O)NC(C)C)ccc2OC[C@@H](C)N(C[C@@H]1C)C(=O)C3CCC3"
    },
    "unichem": {
      "chebi": "102757",
      "lincs": "LSM-14103",
      "pubchem": "54631673"
    },
    "pubchem": [
      {
        "cid": 54631673,
        "inchi": "InChI=1S/C26H40N4O5/c1-16(2)27-26(33)28-20-10-11-22-21(12-20)25(32)29(5)14-23(34-6)17(3)13-30(18(4)15-35-22)24(31)19-8-7-9-19/h10-12,16-19,23H,7-9,13-15H2,1-6H3,(H2,27,28,33)/t17-,18+,23+/m0/s1",
        "inchikey": "FNBLPFIHIJQMKK-YZZKKUAISA-N",
        "iupac": {
          "systematic": "1-[(4R,7S,8S)-5-(cyclobutanecarbonyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propan-2-ylurea"
        },
        "smiles": {
          "canonical": "CC1CN(C(COC2=C(C=C(C=C2)NC(=O)NC(C)C)C(=O)N(CC1OC)C)C)C(=O)C3CCC3"
        },
        "molecularFormula": "C26H40N4O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:31:14Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83d0"
    },
    "name": "Clomipramine",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83d0.png",
    "lincs": {
      "id": "LSM-3171",
      "name": "Clomipramine",
      "alternativeNames": [
        "Anafranil",
        "Anafranil SR",
        "Chlorimipramine",
        "Clomipramine",
        "Clomipramine HCl",
        "Clomipramine Hydrochloride",
        "G-34586",
        "NSC-169865",
        "Tranquax"
      ],
      "pubchemCid": 2801,
      "chebiId": [
        3755,
        47780
      ],
      "inchiParent": "InChI=1S/C19H23ClN2/c1-21(2)12-5-13-22-18-7-4-3-6-15(18)8-9-16-10-11-17(20)14-19(16)22/h3-4,6-7,10-11,14H,5,8-9,12-13H2,1-2H3",
      "inchiKeyParent": "GDLIGKIOYRNHDA-UHFFFAOYSA-N",
      "smilesParent": "CN(C)CCCN1c2ccccc2CCc3ccc(Cl)cc13"
    },
    "unichem": {
      "chebi": "47780",
      "chembl": "CHEMBL415",
      "lincs": "LSM-3171",
      "pubchem": "2801",
      "drugbank": "DB01242"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL415",
      "prefName": "CLOMIPRAMINE",
      "maxPhase": 4.0,
      "maxPhaseCurated": "Approved",
      "firstApproval": 1989,
      "chebiParId": "47780",
      "oral": true,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": true,
      "moleculeProperties": {
        "fullMwt": 314.86,
        "hba": 2,
        "hbd": 0,
        "qedWeighted": 0.82
      },
      "moleculeSynonyms": [
        {
          "moleculeSynonym": "3-chloro-iminodibenzyl",
          "synType": "OTHER",
          "synonyms": "3-CHLORO-IMINODIBENZYL"
        },
        {
          "moleculeSynonym": "Anafranil",
          "synType": "OTHER",
          "synonyms": "Anafranil"
        },
        {
          "moleculeSynonym": "Anapramine",
          "synType": "OTHER",
          "synonyms": "ANAPRAMINE"
        },
        {
          "moleculeSynonym": "Chlorimipramine",
          "synType": "OTHER",
          "synonyms": "CHLORIMIPRAMINE"
        },
        {
          "moleculeSynonym": "Clomicalm",
          "synType": "OTHER",
          "synonyms": "CLOMICALM"
        },
        {
          "moleculeSynonym": "Clomipramina",
          "synType": "INN_SPANISH",
          "synonyms": "CLOMIPRAMINA"
        },
        {
          "moleculeSynonym": "Clomipramine",
          "synType": "FDA",
          "synonyms": "Clomipramine"
        },
        {
          "moleculeSynonym": "Clomipramine",
          "synType": "ATC",
          "synonyms": "CLOMIPRAMINE"
        },
        {
          "moleculeSynonym": "Clomipramine",
          "synType": "BAN",
          "synonyms": "CLOMIPRAMINE"
        },
        {
          "moleculeSynonym": "Clomipramine",
          "synType": "INN",
          "synonyms": "CLOMIPRAMINE"
        },
        {
          "moleculeSynonym": "Clomipramine",
          "synType": "MERCK_INDEX",
          "synonyms": "CLOMIPRAMINE"
        },
        {
          "moleculeSynonym": "Clomipramine",
          "synType": "OTHER",
          "synonyms": "CLOMIPRAMINE"
        },
        {
          "moleculeSynonym": "NSC-169865",
          "synType": "RESEARCH_CODE",
          "synonyms": "NSC-169865"
        }
      ],
      "drugIndications": [
        {
          "efoId": "EFO:0003761",
          "efoTerm": "unipolar depression",
          "maxPhaseForInd": 4.0,
          "meshHeading": "Depressive Disorder"
        },
        {
          "efoId": "EFO:0004242",
          "efoTerm": "obsessive-compulsive disorder",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT00004310,NCT00074815,NCT00254735"
            ]
          },
          "maxPhaseForInd": 3.0,
          "meshHeading": "Obsessive-Compulsive Disorder"
        },
        {
          "efoId": "EFO:0005230",
          "efoTerm": "anxiety",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT02374567"
            ]
          },
          "maxPhaseForInd": 3.0,
          "meshHeading": "Anxiety"
        },
        {
          "efoId": "HP:0000726",
          "efoTerm": "Dementia",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT02374567"
            ]
          },
          "maxPhaseForInd": 3.0,
          "meshHeading": "Dementia"
        },
        {
          "efoId": "MONDO:0002050",
          "efoTerm": "depressive disorder",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT02374567"
            ]
          },
          "maxPhaseForInd": 4.0,
          "meshHeading": "Depressive Disorder"
        },
        {
          "efoId": "MONDO:0005090",
          "efoTerm": "schizophrenia",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT02374567"
            ]
          },
          "maxPhaseForInd": 3.0,
          "meshHeading": "Schizophrenia"
        },
        {
          "efoId": "EFO:0803321",
          "efoTerm": "premature ejaculation",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT01203202,NCT01439984"
            ]
          },
          "maxPhaseForInd": 3.0,
          "meshHeading": "Premature Ejaculation"
        }
      ]
    },
    "pubchem": [
      {
        "cid": 2801,
        "inchi": "InChI=1S/C19H23ClN2/c1-21(2)12-5-13-22-18-7-4-3-6-15(18)8-9-16-10-11-17(20)14-19(16)22/h3-4,6-7,10-11,14H,5,8-9,12-13H2,1-2H3",
        "inchikey": "GDLIGKIOYRNHDA-UHFFFAOYSA-N",
        "iupac": {
          "systematic": "3-(2-chloro-5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethylpropan-1-amine"
        },
        "smiles": {
          "canonical": "CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl"
        },
        "molecularFormula": "C19H23ClN2"
      }
    ],
    "clinicaltrials": [
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT06942494",
            "briefTitle": "Effect of a Family-Based CBT Self-Help Intervention for Adolescents With OCD",
            "officialTitle": "Effect of a Family-Based Cognitive Behavioral Therapy Self-Help Intervention for Adolescents With Obsessive-Compulsive Disorder\uff1aA Randomized Controlled Trial"
          },
          "statusModule": {
            "overallStatus": "NOT_YET_RECRUITING",
            "studyFirstSubmitDate": "2025-04-07"
          },
          "conditionsModule": {
            "conditions": [
              "Obsessive - Compulsive Disorder"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Change in Children's Yale-Brown Obsessive-Compulsive Scale (CY-BOCS) Total Score",
                "timeFrame": "Baseline, Week 12 (post-intervention), Week 16 (1-month follow-up), Week 24 (3-month follow-up)"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Change in Children's Depression Inventory (CDI) Total Score"
              },
              {
                "measure": "Change in Obsessive-Compulsive Inventory - Child Version (OCI-CV) Total Score"
              },
              {
                "measure": "Change in Screen for Child Anxiety Related Emotional Disorders (SCARED) Total Score"
              },
              {
                "measure": "Clinical Global Impression - Improvement (CGI-I)"
              },
              {
                "measure": "Clinical Global Impression - Severity (CGI-S)"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT06659094",
            "briefTitle": "Reducing Maximal Support in OCD: Efficacy of Stepped-Care Online CBT",
            "officialTitle": "Step Down from Maximal Support: Efficacy of Stepped-care Internet-based Cognitive Behavior Therapy for Obsessive-compulsive Disorder"
          },
          "statusModule": {
            "overallStatus": "RECRUITING",
            "studyFirstSubmitDate": "2024-10-23"
          },
          "conditionsModule": {
            "conditions": [
              "Obsessive Compulsive Disorder (OCD)"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Change of Yale-Brown Obsessive-Compulsive Scale (YBOCS)",
                "timeFrame": "Change from Baseline at 6 weeks"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Change of Florida Obsessive-Compulsive Inventory (FOCI)"
              },
              {
                "measure": "Change of Self-rating Depression Scale (SDS)"
              },
              {
                "measure": "Change of Self-rating Anxiety Scale (SAS)"
              },
              {
                "measure": "The University of Rhode Island Change Assessment"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01944657",
            "briefTitle": "Supplemental Transcranial Magnetic Stimulation (TMS) vs. Standard Medication Monotherapy for Treating Major Depression: An Exploratory Field Study",
            "officialTitle": "Supplemental TMS vs. Standard Medication Monotherapy for Treating Major Depression: An Exploratory Field Study"
          },
          "statusModule": {
            "overallStatus": "WITHDRAWN",
            "whyStopped": "unable to enroll subjects",
            "studyFirstSubmitDate": "2013-09-06"
          },
          "conditionsModule": {
            "conditions": [
              "1. Major Depressive Disorder"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Montgomery-\u00c5sberg Depression Rating Scale (MADRS)",
                "timeFrame": "Baseline / Four Weeks / Six Weeks / Eight Weeks"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Hamilton Rating Scale for Depression (HRSD)"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT05931965",
            "briefTitle": "Combination Therapy of Different Antidepressants With Dietary Supplements",
            "officialTitle": "Comparative Efficacy of Antidepressants With L-methylfolate, B12, and Magnesium in Depressive Disorders"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2023-06-14"
          },
          "conditionsModule": {
            "conditions": [
              "Depression"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Patient Health Questionnaire (PHQ-9)",
                "timeFrame": "Baseline and 4 weeks"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Patient Health Questionnaire (PHQ-9)"
              },
              {
                "measure": "Side-effects"
              },
              {
                "measure": "Depressive symptoms remission"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT03299166",
            "briefTitle": "Troriluzole (BHV-4157) in Adult Participants With Obsessive Compulsive Disorder",
            "officialTitle": "A Randomized, Double-blind, Placebo-controlled Trial of Adjunctive Troriluzole in Obsessive Compulsive Disorder"
          },
          "statusModule": {
            "overallStatus": "ACTIVE_NOT_RECRUITING",
            "studyFirstSubmitDate": "2017-09-28",
            "resultsFirstSubmitDate": "2023-05-04"
          },
          "conditionsModule": {
            "conditions": [
              "Obsessive-Compulsive Disorder"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Change From Baseline in the Yale-Brown Obsessive Compulsive Scale (Y-BOCS) Total Score",
                "timeFrame": "Baseline, Week 12"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Number of Participants With Adverse Events (AEs), Serious AEs (SAEs) and AEs Leading to Study Drug Discontinuation in the DB Randomization Phase"
              },
              {
                "measure": "Number of Participants With Adverse Events (AEs), Serious AEs (SAEs) and AEs Leading to Study Drug Discontinuation in the Open-Label Extension Phase"
              },
              {
                "measure": "Number of Participants With Clinically Significant Laboratory Abnormalities During the DB Randomization Phase"
              },
              {
                "measure": "Change From Baseline in Functional Disability Assessed Using the Sheehan Disability Scale (SDS) Total Score"
              },
              {
                "measure": "Change From Baseline in Clinical Global Impression of Severity Scale (CGI-S) Score"
              },
              {
                "measure": "Change From Baseline in the Y-BOCS Obsessions Sub-Scale Score"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT04923425",
            "briefTitle": "Gustatory Modulators Among a Sample of Depressed Egyptian Adults Under Anti-depressants Therapy",
            "officialTitle": "Gustatory Modulators Among a Sample of Depressed Egyptian Adults Under Anti-depressants Therapy. A Retrospective Cohort Study"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2021-06-06"
          },
          "conditionsModule": {
            "conditions": [
              "Taste Disorders"
            ]
          },
          "designModule": {
            "studyType": "OBSERVATIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Gustatory dysfunction modulators",
                "timeFrame": "during a period of 7months from February 2020 till August 2020"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00704860",
            "briefTitle": "Treatment-Resistant Depression, Hippocampus Atrophy and Serotonin Genetic Polymorphism",
            "officialTitle": "Treatment-Resistant Depression, Hippocampus Atrophy and Serotonin Genetic Polymorphism"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2008-06-18"
          },
          "conditionsModule": {
            "conditions": [
              "Major Depression"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Sustained Remission from Depression and Hippocampal Atrophy",
                "timeFrame": "6 months"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "5-HT1a Genetic Markers"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00944996",
            "briefTitle": "Assessment of Pituitary Adenylate Cyclase Activating Polypeptide-Brain Derived Neurotrophic Factor (PACAP-BDNF) Signaling System Involvement in Etiology and Treatment of Major Depression",
            "officialTitle": "Assessment of PACAP-BDNF Signaling System Involvement in Etiology and Treatment of Major Depression"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2009-07-19"
          },
          "conditionsModule": {
            "conditions": [
              "Major Depression"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Measurements of PACAP and BDNF serum levels",
                "timeFrame": "Blood samples will be collected at the study base line, two and three weeks after that and at the study end point (8 weeks after study initiation)"
              },
              {
                "measure": "Analysis of genetic variants of PACAP and PAC1 coding and regulatory regions",
                "timeFrame": "Blood samples will be collected at the study base line, two and three weeks after that and at the study end point (8 weeks after study initiation)"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01575158",
            "briefTitle": "Citalopram vs Clomipramine vs Placebo in Recurrent Depression"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2012-04-10"
          },
          "conditionsModule": {
            "conditions": [
              "Depression"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "2 Hamilton Depression Rating Scale scores of at least 16 with one weeks interval or initiation of another antidepressant treatment",
                "timeFrame": "2 years of follow-up"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Study termination due to adverse event or non-compliance"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02191358",
            "briefTitle": "YouScript IMPACT Registry",
            "officialTitle": "YouScript IMPACT (Improving Medication Protocols and Abating Cost of Treatment) Registry"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2014-07-14"
          },
          "conditionsModule": {
            "conditions": [
              "Adverse Drug Events",
              "Adverse Drug Reactions",
              "Drug Interaction Potentiation",
              "Drug Metabolism, Poor, CYP2D6-RELATED",
              "Drug Metabolism, Poor, CYP2C19-RELATED",
              "Cytochrome P450 Enzyme Deficiency",
              "Cytochrome P450 CYP2D6 Enzyme Deficiency",
              "Cytochrome P450 CYP2C9 Enzyme Deficiency",
              "Cytochrome P450 CYP2C19 Enzyme Deficiency",
              "Cytochrome P450 CYP3A Enzyme Deficiency",
              "Poor Metabolizer Due to Cytochrome P450 CYP2C9 Variant",
              "Poor Metabolizer Due to Cytochrome P450 CYP2C19 Variant",
              "Poor Metabolizer Due to Cytochrome P450 CYP2D6 Variant"
            ]
          },
          "designModule": {
            "studyType": "OBSERVATIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Healthcare Resource Utilization",
                "timeFrame": "120 days"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Clinical decision-making"
              },
              {
                "measure": "Adverse Drug Events"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02571101",
            "briefTitle": "A Phase 2 Study of On-demand Therapy With Clomipramine and Sildenafil Combination in Premature Ejaculation",
            "officialTitle": "A Prospective, Randomized, Double-blinded, Active-control, 3-Treatment Arm, Parallel, Multi-center, Phase 2 Trial to Evaluate Safety and Efficacy With CDFR0812-15/25mg and CDFR0812-15/50mg Compared to Clomipramine HCl 15mg in Male Patients Diagnosed With Premature Ejaculation"
          },
          "statusModule": {
            "overallStatus": "UNKNOWN",
            "studyFirstSubmitDate": "2015-10-06"
          },
          "conditionsModule": {
            "conditions": [
              "Premature Ejaculation"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "The fold change of IELT",
                "timeFrame": "From 4 weeks to 8 weeks after dosing"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "The % change of IELT"
              },
              {
                "measure": "The mean change of IELT"
              },
              {
                "measure": "The response rate"
              },
              {
                "measure": "Global impression reported by patient"
              },
              {
                "measure": "Administration time of study drug"
              },
              {
                "measure": "Number of patients with adverse events"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02374567",
            "briefTitle": "Pharmacovigilance in Gerontopsychiatric Patients",
            "officialTitle": "Pharmacovigilance in Gerontopsychiatric Patients"
          },
          "statusModule": {
            "overallStatus": "TERMINATED",
            "studyFirstSubmitDate": "2015-01-05"
          },
          "conditionsModule": {
            "conditions": [
              "Dementia",
              "Depression",
              "Schizophrenia",
              "Psychosomatic Disorders",
              "Anxiety Disorders"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Assessment of frequency and severity of adverse events",
                "timeFrame": "Participants will be followed for the duration of hospital stay and the follow-up-visit, an expected average of 6 weeks"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Assessment of cognitive functioning"
              },
              {
                "measure": "Quality of life"
              },
              {
                "measure": "Adverse drug reactions"
              },
              {
                "measure": "Serum level of substances"
              },
              {
                "measure": "Electrocardiogram"
              },
              {
                "measure": "Medication intake"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00964886",
            "briefTitle": "Efficacy of Antidepressants in Chronic Back Pain",
            "officialTitle": "Efficacy of Antidepressants in Chronic Back Pain"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2009-08-24",
            "resultsFirstSubmitDate": "2016-11-23"
          },
          "conditionsModule": {
            "conditions": [
              "Back Pain"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Intent-toTreat Analysis of Descriptor Differential Scale (DDS) of Pain Intensity",
                "timeFrame": "12 weeks after baseline (or last observation carried forward)"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Roland and Morris Disability Questionnaire"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00004310",
            "briefTitle": "Phase II Randomized Study of Intravenous Versus Oral Clomipramine in Patients With Obsessive Compulsive Disorder"
          },
          "statusModule": {
            "overallStatus": "UNKNOWN",
            "studyFirstSubmitDate": "1999-10-18"
          },
          "conditionsModule": {
            "conditions": [
              "Obsessive-Compulsive Disorder"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02450695",
            "briefTitle": "rTMS in Treatment Refractory Obsessive-Compulsive Disorder",
            "officialTitle": "A Randomized Crossed-over Trial Examining Efficacy of Repetitive Transcranial Magnetic Stimulation (rTMS) in Treatment Refractory Obsessive-Compulsive Disorder."
          },
          "statusModule": {
            "overallStatus": "WITHDRAWN",
            "whyStopped": "No participants were recruited.",
            "studyFirstSubmitDate": "2015-05-19"
          },
          "conditionsModule": {
            "conditions": [
              "Obsessive-Compulsive Disorder"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Yale Brown Obsessive Compulsive Scale",
                "timeFrame": "7 Weeks"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Barratt Impulsiveness Scale"
              },
              {
                "measure": "Hamilton Anxiety rating Scale"
              },
              {
                "measure": "Hamilton Depression Rating Scale"
              },
              {
                "measure": "Clinical Global Impression Scale"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00254735",
            "briefTitle": "Quetiapine Augmentation in Severe Obsessive Compulsive Disorder",
            "officialTitle": "Quetiapine Augmentation in Severe Obsessive Compulsive Disorder (OCD) - Pilot Study"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2005-11-15"
          },
          "conditionsModule": {
            "conditions": [
              "Obsessive Compulsive Disorder"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Absolute change of OCD symptoms from baseline to endpoint on the total Y-BOCS score."
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Change of comorbid psychiatric symptoms and measures of quality of life from baseline to endpoint documented by different scales."
              },
              {
                "measure": "Evaluation of the safety and tolerability profile of quetiapine compared to placebo added to a baseline medication of SSRI/clomipramine."
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01148316",
            "briefTitle": "Developing Adaptive Treatment Strategies for Children and Adolescents With Obsessive-compulsive Disorder.",
            "officialTitle": "Adaptive Treatment Strategies for Children and Adolescents With Psychiatric Disorders in the Context of Public Health: \"Medicine in Practice\""
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2010-06-02"
          },
          "conditionsModule": {
            "conditions": [
              "Obsessive-Compulsive Disorder"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Treatment response status at week 28",
                "timeFrame": "Yale-Brown Obsessive-Compulsive Scale scores at week 28"
              },
              {
                "measure": "Treatment response status at week 14",
                "timeFrame": "Yale-Brown Obsessive Compulsive Scale Score at week 14"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Predictors of treatment response at week 28"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT04708834",
            "briefTitle": "Long-term Safety Study of Adjunctive Troriluzole in Subjects With Obsessive Compulsive Disorder",
            "officialTitle": "A Multicenter, Long-Term Open-Label Safety Study of Adjunctive Troriluzole in Subjects With Obsessive Compulsive Disorder"
          },
          "statusModule": {
            "overallStatus": "ENROLLING_BY_INVITATION",
            "studyFirstSubmitDate": "2021-01-11"
          },
          "conditionsModule": {
            "conditions": [
              "Obsessive Compulsive Disorder"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "To evaluate the long term safety and tolerability of troriluzole as adjunctive therapy in subjects with OCD who have had an inadequate response to SSRI, clomipramine, venlafaxine or desvenfaxine treatment",
                "timeFrame": "Change from Baseline to week 240"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01896349",
            "briefTitle": "Interpersonal Psychotherapy for Treatment Resistant Depression",
            "officialTitle": "Efficacy of Interpersonal Psychotherapy in Treatment Resistant Depression"
          },
          "statusModule": {
            "overallStatus": "UNKNOWN",
            "studyFirstSubmitDate": "2013-07-01"
          },
          "conditionsModule": {
            "conditions": [
              "Treatment Resistant Depression"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Hamilton Depression Scale (HAM-D) - continuous",
                "timeFrame": "End point week 19 and Week 24"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Beck depression Inventory (BDI)"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT04989413",
            "briefTitle": "Cannabidiol 133mg + Cannabigerol 66mg + Tetrahydrocannabinol 4mg Vs Placebo As Adjuvant Treatment in Chronic Migraine -",
            "officialTitle": "Randomized, Double Blind Clinical Trial to Study the Effect of Cannabidiol (CBD) 133mg + Cannabigerol (CBG) 66mg + Tetrahydrocannabinol (THC) 4mg a Day As Adjunctive Therapy in the Treatment of Chronic Migraine - CAMTREA TRIAL"
          },
          "statusModule": {
            "overallStatus": "TERMINATED",
            "whyStopped": "an interim analysis to rule out futility was positive, we completed active patients and stopped recruitment with 75 patients enrolled",
            "studyFirstSubmitDate": "2021-05-24"
          },
          "conditionsModule": {
            "conditions": [
              "Chronic Migraine, Headache",
              "Overuse Headache Medication"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Migraine days",
                "timeFrame": "16 weeks"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Headache days"
              },
              {
                "measure": "migraine duration"
              },
              {
                "measure": "migraine intensity"
              },
              {
                "measure": "pain medicine intake"
              },
              {
                "measure": "number of patients with migraine reduction greater than 50%"
              },
              {
                "measure": "number of patients with headache reduction greater than 50%"
              },
              {
                "measure": "Change in MIDAS score"
              },
              {
                "measure": "Change in HIT-6 score"
              },
              {
                "measure": "Change in Beck's Anxiety Inventory scores"
              },
              {
                "measure": "Change in Beck's Depression Inventory scores"
              },
              {
                "measure": "Change in Severity of Dependence Scale scores"
              },
              {
                "measure": "Change in Epworth Sleepiness Scale scores"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT05952713",
            "briefTitle": "Comparative Responses to 15 Different Antidepressants in Major Depressive Disorder",
            "officialTitle": "Comparative Responses to 15 Different Antidepressants in Major Depressive Disorder - Results From a Long-term Nation-wide Population-based Study Emulating a Randomized Trial"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2023-07-11"
          },
          "conditionsModule": {
            "conditions": [
              "Major Depressive Disorder"
            ]
          },
          "designModule": {
            "studyType": "OBSERVATIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Response",
                "timeFrame": "2 years"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01439984",
            "briefTitle": "Trial of PED-1 in Male Patients With Premature Ejaculation",
            "officialTitle": "A Randomized, Double-blind, Placebo-controlled, Fixed Dose, Parallel Grouped, Multi-center Clinical Study to Evaluate the Safety and Efficacy of PED-1 in Male Patients With Premature Ejaculation"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2011-09-18"
          },
          "conditionsModule": {
            "conditions": [
              "Premature Ejaculation"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Intravaginal ejaculation latency time (IELT)(seconds)",
                "timeFrame": "12 weeks"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Drug coitus interval time (hours)"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT04923321",
            "briefTitle": "Taste Supra-thresholds Among a Sample of Depressed Egyptian Adult Under Anti-depressants Therapy",
            "officialTitle": "Taste Supra-thresholds Among a Sample of Depressed Egyptian Adults Under Anti-depressants Therapy A Retrospective Cohort Study"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2021-06-06"
          },
          "conditionsModule": {
            "conditions": [
              "Taste Disorders"
            ]
          },
          "designModule": {
            "studyType": "OBSERVATIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Taste intensity at supra-threshold",
                "timeFrame": "during a period of 3 months from February 2021 till April 2021]"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00564564",
            "briefTitle": "Quetiapine Augmentation Versus Clomipramine Augmentation of SSRI for Obsessive-compulsive Disorder Patients",
            "officialTitle": "Quetiapine Augmentation Versus Clomipramine Augmentation of Selective Serotonin Reuptake Inhibitors for Obsessive-compulsive Disorder Patients That do Not Respond to a SSRI Trial: a Randomized Open-trial."
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2007-11-26"
          },
          "conditionsModule": {
            "conditions": [
              "Obsessive Compulsive Disorder"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "YBOCS",
                "timeFrame": "12 weeks"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "CGI"
              },
              {
                "measure": "Tolerability"
              },
              {
                "measure": "Cardiotoxicity"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01203202",
            "briefTitle": "Phase 2 Trial of PED-1 and PED-2 in Male Patients With Premature Ejaculation",
            "officialTitle": "A Randomized, Double-blind, Placebo-controlled, Fixed Dose, Parallel Grouped Clinical Study to Evaluate the Tolerability and to Determine the Adequate Dosage of PED-1 and PED-2 in Male Patients With Premature Ejaculation"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2010-09-14"
          },
          "conditionsModule": {
            "conditions": [
              "Premature Ejaculation"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Fold cahnges of Intraviginal ejaculation latency time (IELT)",
                "timeFrame": "4 weeks"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Drug coitus interval time"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT04436952",
            "briefTitle": "Is There a New Gold Standard for the Treatment of Obsessive-Compulsive Disorder?",
            "officialTitle": "An Open Label Study to Compare and Evaluate the Efficacy of the Deep Transcranial Magnetic Stimulation With and Without Exposure and Response Prevention (ERP) to Repetitive Transcranial Magnetic Stimulation With and Without ERP to ERP."
          },
          "statusModule": {
            "overallStatus": "WITHDRAWN",
            "whyStopped": "Change in Protocol",
            "studyFirstSubmitDate": "2020-05-23"
          },
          "conditionsModule": {
            "conditions": [
              "Obsessive-Compulsive Disorder"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Reduction in the severity of OCD symptoms",
                "timeFrame": "8 weeks"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Clinical Global Impression - Severity (CGI-S) and Improvement (CGI-I) scores."
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00913952",
            "briefTitle": "To Demonstrate the Relative Bioavailability of Geneva and Basel (Anafranil) 25 mg Clomipramine Hydrochloride Capsules Under Fed and Fasted Conditions",
            "officialTitle": "Comparative, Randomized, 3-way Crossover Bioavailability Study of Geneva and Basel (Anafranil) 25 mg Clomipramine Hydrochloride Capsules In Health Adult Males Under Fed and Fasted Conditions"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2009-06-02"
          },
          "conditionsModule": {
            "conditions": [
              "Depression"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Bioequivalence based on AUC and Cmax",
                "timeFrame": "53 days"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT03548675",
            "briefTitle": "Pharmacogenetics Informed Tricyclic Antidepressant Dosing (PITA)",
            "officialTitle": "Pharmacogenetics to Improve Personalized Antidepressant Dosing in Patients With Severe Depression;a Randomized Controlled Trial Using Tricyclic Antidepressants"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2018-05-23"
          },
          "conditionsModule": {
            "conditions": [
              "Depressive Disorder, Major"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Time to TCA plasma concentration in the therapeutic range",
                "timeFrame": "During the 7 weeks treatment phase"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Reduction of depressive symptoms"
              },
              {
                "measure": "Highest level of side effects"
              },
              {
                "measure": "Economic Evaluation (Cost Effectiveness)"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00018200",
            "briefTitle": "Effect of Antidepressants on Back Pain",
            "officialTitle": "Efficacy of Antidepressants in Chronic Back Pain"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2001-07-03"
          },
          "conditionsModule": {
            "conditions": [
              "Back Pain",
              "Sciatica"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Descriptor Differential Scale Pain Intensity",
                "timeFrame": "12 weeks post baseline"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01305707",
            "briefTitle": "Continuation Electroconvulsive Therapy (C-ECT) for Relapse Prevention in Major Depression",
            "officialTitle": "Continuation Electroconvulsive Therapy Associated With Pharmacotherapy Versus Pharmacotherapy Alone for Relapse Prevention in Major Depression. A Clinical, Controlled, Prospective and Randomized Trial"
          },
          "statusModule": {
            "overallStatus": "TERMINATED",
            "whyStopped": "Difficulties in recruiting",
            "studyFirstSubmitDate": "2011-02-28"
          },
          "conditionsModule": {
            "conditions": [
              "Depression"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Hamilton Depression Rating Scale 21 items (HDRS-21)",
                "timeFrame": "One year. HDRS will be assessed in each follow-up visit (weekly the first month, fortnightly the second and third month, monthly the following 6 months and quarterly at 12 and 15 months)."
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Mini-Mental State Examination (MMSE 35)"
              },
              {
                "measure": "UKU - Adverse effects rating scales"
              },
              {
                "measure": "Demographical Data Memory (MEDABI-20)"
              },
              {
                "measure": "Rey Figure"
              },
              {
                "measure": "Trail Making Test A"
              },
              {
                "measure": "Trail Making Test B"
              },
              {
                "measure": "Stroop Test"
              },
              {
                "measure": "Direct and inverse digits (WAIS, Weschler Adults Intelligence Sacle)."
              },
              {
                "measure": "Vocabulary WAIS (Weschler Adults Intelligence Scale)"
              },
              {
                "measure": "Frequency Hospitalization Quotient"
              },
              {
                "measure": "Hospital Day Quotient (HDQ)"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00466609",
            "briefTitle": "Using Drug Augmentation to Treat Obsessive Compulsive Disorder Patients Who Did Not Respond to Previous Treatment",
            "officialTitle": "Pharmacological Augmentation Strategies for Obsessive Compulsive Disorder Patients Non-respondent to First Line Medication Treatment: a Double Blind Placebo Controlled Study"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2007-04-26"
          },
          "conditionsModule": {
            "conditions": [
              "Obsessive Compulsive Disorder"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "YBOCS",
                "timeFrame": "12 weeks"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "QoL"
              },
              {
                "measure": "Social Adaptation"
              },
              {
                "measure": "Tolerability"
              },
              {
                "measure": "BDI"
              },
              {
                "measure": "BAI"
              },
              {
                "measure": "CGI"
              },
              {
                "measure": "Cardiotoxicity"
              },
              {
                "measure": "Plasma levels"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00074815",
            "briefTitle": "Treatment of Obsessive Compulsive Disorder in Children",
            "officialTitle": "Treatment of Pediatric OCD for SRI Partial Responders"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2003-12-19",
            "resultsFirstSubmitDate": "2012-11-15"
          },
          "conditionsModule": {
            "conditions": [
              "Obsessive-Compulsive Disorder"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Children's Yale-Brown Obsessive Compulsive Scale (CY-BOCS)",
                "timeFrame": "Measured at baseline and Week 12."
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Child Obsessive -Compulsive Impact Scale (COIS)"
              },
              {
                "measure": "Child Depression Inventory"
              },
              {
                "measure": "Pediatric Adverse Event Rating Scale (PAERS)"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT05737511",
            "briefTitle": "Efficacy of Hydroxyzine for Patients With Panic Disorder",
            "officialTitle": "Efficacy of Hydroxyzine Versus Treatment as Usual for Panic Disorder: An Eight-Week, Open Label, Pilot, Randomized Controlled Trial."
          },
          "statusModule": {
            "overallStatus": "NOT_YET_RECRUITING",
            "studyFirstSubmitDate": "2023-02-10"
          },
          "conditionsModule": {
            "conditions": [
              "Panic Disorder"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Change in Panic Disorder Severity Scale (PDSS) Mean Score",
                "timeFrame": "8 weeks"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Change in Clinical Global Impression Scale (CGI) Mean Score"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT03599011",
            "briefTitle": "Gustatory Dysfunction Among a Sample of Depressed Egyptian Adults Under Anti-depressants Therapy",
            "officialTitle": "Gustatory Dysfunction Among a Sample of Depressed Egyptian Adults Under Anti-depressants Therapy A Retrospective Cohort Study"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2018-07-16"
          },
          "conditionsModule": {
            "conditions": [
              "Taste Disorders"
            ]
          },
          "designModule": {
            "studyType": "OBSERVATIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Gustatory thresholds",
                "timeFrame": "during anticipated period of 7 months from February 2020 till August 2020"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Taste intensity at supra-threshold"
              },
              {
                "measure": "Gustatory dysfunction modulators"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01404871",
            "briefTitle": "Predicting Medication Response in Obsessive Compulsive Disorder",
            "officialTitle": "Predicting Medication Response in Obsessive Compulsive Disorder"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2009-02-06"
          },
          "conditionsModule": {
            "conditions": [
              "Obsessive Compulsive Disorder"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "YBOCS Obsessive-Compulsive Severity Score",
                "timeFrame": "Bi-monthly (every 2 weeks for duration of trial. Approx. 12 weeks)"
              },
              {
                "measure": "Clinical Global Improvement - Improvement Scale",
                "timeFrame": "Bi-monthly (every 2 weeks for duration of trial. Approx. 12 weeks)"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Change in cortical Inhibition (CI) as measured with Transcranial Magnetic Stimulation."
              },
              {
                "measure": "Genotype marker data for SLC1A1, GRIN2B, 5HT1B, 5HT2A and P450 enzymes CYP2D6 and CYP2C19."
              },
              {
                "measure": "Tolerability/side effects measure with Udvalg for Liniske Undersogelser Side Effect Rating Scale (UKU)."
              },
              {
                "measure": "Clinical Global Impression - Severity Scale."
              },
              {
                "measure": "Depression symptoms will be rated with the Beck Depression Inventory (BDI)."
              },
              {
                "measure": "DYBOCS (Dimensional Yale-Brown Obsessive-Compulsive Scale)"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00913783",
            "briefTitle": "To Demonstrate the Relative Bioavailability of Geneva and Basel (Anafranil) 25 mg Clomipramine Hydrochloride Capsules Under Fasted Conditions",
            "officialTitle": "Comparative, Randomized, 2-way Crossover Bioavailability Study of Geneva and Basel (Anafranil) 25 mg Clomipramine Hydrochloride Capsules In Health Adult Males Under Fasted Conditions"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2009-06-02"
          },
          "conditionsModule": {
            "conditions": [
              "Depression"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Bioequivalence based on AUC and Cmax",
                "timeFrame": "34 days"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02431845",
            "briefTitle": "Pharmaco(Epi)Genetic, Proteomic, and Microbiomic Study of Obsessive-Compulsive Disorder",
            "officialTitle": "Pharmaco(Epi)Genetic, Proteomic, and Microbiomic Study of Obsessive-Compulsive"
          },
          "statusModule": {
            "overallStatus": "RECRUITING",
            "studyFirstSubmitDate": "2015-04-23"
          },
          "conditionsModule": {
            "conditions": [
              "Obsessive-Compulsive Disorder"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Change from baseline in the Yale-Brown Obsessive-Compulsive Scale",
                "timeFrame": "baseline, 3 or 4 months, 6 months, 1 year"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Change from the baseline Montgomery-Asberg Depression Rating Scale"
              },
              {
                "measure": "Occurrence of any side effects during the SSRIs treatment"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02028598",
            "briefTitle": "Drug-Drug Interaction of Clomipramine HCl and Sildenafil Citrate in Healthy Males",
            "officialTitle": "A Randomized, Open-labeled, 6-sequence, 3-period, 3-treatment Crossover Study to Evaluate the Effect of Co-administration of Clomipramine HCl (Condencia Tab.) 15mg and Sildenafil Citrate (Viagra Tab.) 100mg on the Safety and Pharmacokinetic/Pharmacodynamic Properties of Clomipramine and Sildenafil Compared to the Effects After Single Oral Administration in Healthy Male Volunteers"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2014-01-03"
          },
          "conditionsModule": {
            "conditions": [
              "Healthy"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "The systemic exposure measured as area under the curve (AUC)",
                "timeFrame": "From Day 1(dosing) to Day 4(72hrs)"
              },
              {
                "measure": "The maximum concentration (Cmax)",
                "timeFrame": "From Day 1(dosing) to Day 4(72hrs)"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Pharmacokinetic parameters except the primary endpoints"
              },
              {
                "measure": "The maximum change of systolic blood pressures within 12hrs after dosing"
              },
              {
                "measure": "Adverse events"
              },
              {
                "measure": "The maximum change of dystolic blood pressure within 12hrs after dosing"
              },
              {
                "measure": "The maximum change of heart rates within 12 hours after dosing"
              },
              {
                "measure": "The rate of the subjects who experienced the clinically significant change of blood pressures"
              }
            ]
          }
        }
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:31:25Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83d5"
    },
    "name": "BRD-K57119046",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83d5.png",
    "lincs": {
      "id": "LSM-40400",
      "name": "BRD-K57119046",
      "pubchemCid": 44484034,
      "chebiId": 128848,
      "inchiParent": "InChI=1S/C35H46N4O5/c1-25-21-39(26(2)24-40)35(42)31-20-28(36-34(41)12-9-19-37(3)4)15-18-32(31)44-33(25)23-38(5)22-27-13-16-30(17-14-27)43-29-10-7-6-8-11-29/h6-8,10-11,13-18,20,25-26,33,40H,9,12,19,21-24H2,1-5H3,(H,36,41)/t25-,26-,33+/m1/s1",
      "inchiKeyParent": "JBTWBXKZNZMQHX-ZJDJHBDQSA-N",
      "smilesParent": "C[C@H](CO)N1C[C@@H](C)[C@H](CN(C)Cc2ccc(Oc3ccccc3)cc2)Oc4ccc(NC(=O)CCCN(C)C)cc4C1=O"
    },
    "unichem": {
      "chebi": "128848",
      "lincs": "LSM-40400",
      "pubchem": "44484034"
    },
    "pubchem": [
      {
        "cid": 44484034,
        "inchi": "InChI=1S/C35H46N4O5/c1-25-21-39(26(2)24-40)35(42)31-20-28(36-34(41)12-9-19-37(3)4)15-18-32(31)44-33(25)23-38(5)22-27-13-16-30(17-14-27)43-29-10-7-6-8-11-29/h6-8,10-11,13-18,20,25-26,33,40H,9,12,19,21-24H2,1-5H3,(H,36,41)/t25-,26-,33+/m1/s1",
        "inchikey": "JBTWBXKZNZMQHX-ZJDJHBDQSA-N",
        "iupac": {
          "systematic": "4-(dimethylamino)-N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]butanamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(C=CC(=C2)NC(=O)CCCN(C)C)OC1CN(C)CC3=CC=C(C=C3)OC4=CC=CC=C4)C(C)CO"
        },
        "molecularFormula": "C35H46N4O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:31:27Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8419"
    },
    "name": "BRD-K64930062",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8419.png",
    "lincs": {
      "id": "LSM-12394",
      "name": "BRD-K64930062",
      "pubchemCid": 54657733,
      "chebiId": 101021,
      "inchiParent": "InChI=1S/C26H32F3N3O4/c27-26(28,29)20-3-1-2-19(12-20)14-32-15-21(33)16-35-17-24-23(32)5-4-22(36-24)13-25(34)31-11-8-18-6-9-30-10-7-18/h1-3,6-7,9-10,12,21-24,33H,4-5,8,11,13-17H2,(H,31,34)/t21-,22-,23+,24-/m0/s1",
      "inchiKeyParent": "QCHQNBIYSRQADD-XQUALCHDSA-N",
      "smilesParent": "O[C@@H]1COC[C@@H]2O[C@H](CC(=O)NCCc3ccncc3)CC[C@H]2N(Cc4cccc(c4)C(F)(F)F)C1"
    },
    "unichem": {
      "chebi": "101021",
      "lincs": "LSM-12394",
      "pubchem": "54657733"
    },
    "pubchem": [
      {
        "cid": 54657733,
        "inchi": "InChI=1S/C26H32F3N3O4/c27-26(28,29)20-3-1-2-19(12-20)14-32-15-21(33)16-35-17-24-23(32)5-4-22(36-24)13-25(34)31-11-8-18-6-9-30-10-7-18/h1-3,6-7,9-10,12,21-24,33H,4-5,8,11,13-17H2,(H,31,34)/t21-,22-,23+,24-/m0/s1",
        "inchikey": "QCHQNBIYSRQADD-XQUALCHDSA-N",
        "iupac": {
          "systematic": "2-[(3S,6aR,8S,10aR)-3-hydroxy-1-[[3-(trifluoromethyl)phenyl]methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-pyridin-4-ylethyl)acetamide"
        },
        "smiles": {
          "canonical": "C1CC2C(COCC(CN2CC3=CC(=CC=C3)C(F)(F)F)O)OC1CC(=O)NCCC4=CC=NC=C4"
        },
        "molecularFormula": "C26H32F3N3O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:31:29Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83b4"
    },
    "name": "BRD-K86857638",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83b4.png",
    "lincs": {
      "id": "LSM-13756",
      "name": "BRD-K86857638",
      "pubchemCid": 54638829,
      "chebiId": 102405,
      "inchiParent": "InChI=1S/C20H28N2O6S/c1-27-17-7-3-4-8-19(17)29(25,26)21-16-10-9-15(28-18(16)14-23)13-20(24)22-11-5-2-6-12-22/h3-4,7-10,15-16,18,21,23H,2,5-6,11-14H2,1H3/t15-,16-,18-/m0/s1",
      "inchiKeyParent": "LFPPDYCBOCBVHR-BQFCYCMXSA-N",
      "smilesParent": "COc1ccccc1S(=O)(=O)N[C@H]2C=C[C@@H](CC(=O)N3CCCCC3)O[C@H]2CO"
    },
    "unichem": {
      "chebi": "102405",
      "lincs": "LSM-13756",
      "pubchem": "54638829"
    },
    "pubchem": [
      {
        "cid": 54638829,
        "inchi": "InChI=1S/C20H28N2O6S/c1-27-17-7-3-4-8-19(17)29(25,26)21-16-10-9-15(28-18(16)14-23)13-20(24)22-11-5-2-6-12-22/h3-4,7-10,15-16,18,21,23H,2,5-6,11-14H2,1H3/t15-,16-,18-/m0/s1",
        "inchikey": "LFPPDYCBOCBVHR-BQFCYCMXSA-N",
        "iupac": {
          "systematic": "N-[(2R,3S,6R)-2-(hydroxymethyl)-6-(2-oxo-2-piperidin-1-ylethyl)-3,6-dihydro-2H-pyran-3-yl]-2-methoxybenzenesulfonamide"
        },
        "smiles": {
          "canonical": "COC1=CC=CC=C1S(=O)(=O)NC2C=CC(OC2CO)CC(=O)N3CCCCC3"
        },
        "molecularFormula": "C20H28N2O6S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:31:31Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83ec"
    },
    "name": "BRD-K97748079",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83ec.png",
    "lincs": {
      "id": "LSM-14436",
      "name": "BRD-K97748079",
      "pubchemCid": 54638314,
      "chebiId": 103091,
      "inchiParent": "InChI=1S/C27H36N2O6S/c1-34-22-7-10-24(11-8-22)36(32,33)28-25-12-9-23(35-26(25)19-30)18-27(31)29-15-13-21(14-16-29)17-20-5-3-2-4-6-20/h2-8,10-11,21,23,25-26,28,30H,9,12-19H2,1H3/t23-,25+,26+/m1/s1",
      "inchiKeyParent": "JXWMWOXWMMUZLT-AFESJLNVSA-N",
      "smilesParent": "COc1ccc(cc1)S(=O)(=O)N[C@H]2CC[C@H](CC(=O)N3CCC(Cc4ccccc4)CC3)O[C@H]2CO"
    },
    "unichem": {
      "chebi": "103091",
      "lincs": "LSM-14436",
      "pubchem": "54638314"
    },
    "pubchem": [
      {
        "cid": 54638314,
        "inchi": "InChI=1S/C27H36N2O6S/c1-34-22-7-10-24(11-8-22)36(32,33)28-25-12-9-23(35-26(25)19-30)18-27(31)29-15-13-21(14-16-29)17-20-5-3-2-4-6-20/h2-8,10-11,21,23,25-26,28,30H,9,12-19H2,1H3/t23-,25+,26+/m1/s1",
        "inchikey": "JXWMWOXWMMUZLT-AFESJLNVSA-N",
        "iupac": {
          "systematic": "N-[(2R,3S,6R)-6-[2-(4-benzylpiperidin-1-yl)-2-oxoethyl]-2-(hydroxymethyl)oxan-3-yl]-4-methoxybenzenesulfonamide"
        },
        "smiles": {
          "canonical": "COC1=CC=C(C=C1)S(=O)(=O)NC2CCC(OC2CO)CC(=O)N3CCC(CC3)CC4=CC=CC=C4"
        },
        "molecularFormula": "C27H36N2O6S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:31:33Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8370"
    },
    "name": "BRD-K22428007",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8370.png",
    "lincs": {
      "id": "LSM-9786",
      "name": "BRD-K22428007",
      "pubchemCid": 54638379,
      "chebiId": 98407,
      "inchiParent": "InChI=1S/C28H29N3O5/c1-35-23-9-5-8-22(16-23)30-28(34)31-25-15-14-24(36-26(25)18-32)17-27(33)29-21-12-10-20(11-13-21)19-6-3-2-4-7-19/h2-16,24-26,32H,17-18H2,1H3,(H,29,33)(H2,30,31,34)/t24-,25-,26+/m1/s1",
      "inchiKeyParent": "HIZAXMBYTZOIAT-CYXNTTPDSA-N",
      "smilesParent": "COc1cccc(NC(=O)N[C@@H]2C=C[C@H](CC(=O)Nc3ccc(cc3)c4ccccc4)O[C@H]2CO)c1"
    },
    "unichem": {
      "chebi": "98407",
      "lincs": "LSM-9786",
      "pubchem": "54638379"
    },
    "pubchem": [
      {
        "cid": 54638379,
        "inchi": "InChI=1S/C28H29N3O5/c1-35-23-9-5-8-22(16-23)30-28(34)31-25-15-14-24(36-26(25)18-32)17-27(33)29-21-12-10-20(11-13-21)19-6-3-2-4-7-19/h2-16,24-26,32H,17-18H2,1H3,(H,29,33)(H2,30,31,34)/t24-,25-,26+/m1/s1",
        "inchikey": "HIZAXMBYTZOIAT-CYXNTTPDSA-N",
        "iupac": {
          "systematic": "2-[(2R,3R,6S)-2-(hydroxymethyl)-3-[(3-methoxyphenyl)carbamoylamino]-3,6-dihydro-2H-pyran-6-yl]-N-(4-phenylphenyl)acetamide"
        },
        "smiles": {
          "canonical": "COC1=CC=CC(=C1)NC(=O)NC2C=CC(OC2CO)CC(=O)NC3=CC=C(C=C3)C4=CC=CC=C4"
        },
        "molecularFormula": "C28H29N3O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:31:36Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c837b"
    },
    "name": "BRD-K23349860",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c837b.png",
    "lincs": {
      "id": "LSM-7154",
      "name": "BRD-K23349860",
      "pubchemCid": 44487412,
      "chebiId": 95775,
      "inchiParent": "InChI=1S/C24H35N5O4/c1-18-13-29(19(2)16-30)23(31)10-7-11-28-14-21(25-26-28)17-33-22(18)15-27(3)24(32)12-20-8-5-4-6-9-20/h4-6,8-9,14,18-19,22,30H,7,10-13,15-17H2,1-3H3/t18-,19+,22-/m1/s1",
      "inchiKeyParent": "GMDADKPJAYHJFG-XQBPLPMBSA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@@H](C)[C@@H](CN(C)C(=O)Cc2ccccc2)OCc3cn(CCCC1=O)nn3"
    },
    "unichem": {
      "chebi": "95775",
      "lincs": "LSM-7154",
      "pubchem": "44487412"
    },
    "pubchem": [
      {
        "cid": 44487412,
        "inchi": "InChI=1S/C24H35N5O4/c1-18-13-29(19(2)16-30)23(31)10-7-11-28-14-21(25-26-28)17-33-22(18)15-27(3)24(32)12-20-8-5-4-6-9-20/h4-6,8-9,14,18-19,22,30H,7,10-13,15-17H2,1-3H3/t18-,19+,22-/m1/s1",
        "inchikey": "GMDADKPJAYHJFG-XQBPLPMBSA-N",
        "iupac": {
          "systematic": "N-[[(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methyl-2-phenylacetamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)CCCN2C=C(COC1CN(C)C(=O)CC3=CC=CC=C3)N=N2)C(C)CO"
        },
        "molecularFormula": "C24H35N5O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:31:38Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8393"
    },
    "name": "BRD-K01222176",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8393.png",
    "lincs": {
      "id": "LSM-8507",
      "name": "BRD-K01222176",
      "pubchemCid": 56835276,
      "chebiId": 97128,
      "inchiParent": "InChI=1S/C29H33FN2O5S/c1-20-16-32(21(2)18-33)29(34)27-14-7-6-13-26(27)25-12-5-4-9-22(25)19-37-28(20)17-31(3)38(35,36)24-11-8-10-23(30)15-24/h4-15,20-21,28,33H,16-19H2,1-3H3/t20-,21-,28-/m0/s1",
      "inchiKeyParent": "APRVPIVHITUHLQ-CZBREUMFSA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@H](C)[C@H](CN(C)S(=O)(=O)c2cccc(F)c2)OCc3ccccc3c4ccccc4C1=O"
    },
    "unichem": {
      "chebi": "97128",
      "lincs": "LSM-8507",
      "pubchem": "56835276"
    },
    "pubchem": [
      {
        "cid": 56835276,
        "inchi": "InChI=1S/C29H33FN2O5S/c1-20-16-32(21(2)18-33)29(34)27-14-7-6-13-26(27)25-12-5-4-9-22(25)19-37-28(20)17-31(3)38(35,36)24-11-8-10-23(30)15-24/h4-15,20-21,28,33H,16-19H2,1-3H3/t20-,21-,28-/m0/s1",
        "inchikey": "APRVPIVHITUHLQ-CZBREUMFSA-N",
        "iupac": {
          "systematic": "3-fluoro-N-[[(10R,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylbenzenesulfonamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=CC=CC=C2C3=CC=CC=C3COC1CN(C)S(=O)(=O)C4=CC=CC(=C4)F)C(C)CO"
        },
        "molecularFormula": "C29H33FN2O5S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:31:40Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83d6"
    },
    "name": "BRD-K60050469",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83d6.png",
    "lincs": {
      "id": "LSM-12059",
      "name": "BRD-K60050469",
      "pubchemCid": 54631865,
      "chebiId": 100685,
      "inchiParent": "InChI=1S/C26H36N4O5/c1-17-14-29(3)18(2)16-35-22-12-11-19(13-20(22)25(31)30(4)15-24(17)34-6)27-26(32)28-21-9-7-8-10-23(21)33-5/h7-13,17-18,24H,14-16H2,1-6H3,(H2,27,28,32)/t17-,18+,24+/m1/s1",
      "inchiKeyParent": "MQWQDAVBIBJDRV-YTZAWJCFSA-N",
      "smilesParent": "CO[C@H]1CN(C)C(=O)c2cc(NC(=O)Nc3ccccc3OC)ccc2OC[C@H](C)N(C)C[C@H]1C"
    },
    "unichem": {
      "chebi": "100685",
      "lincs": "LSM-12059",
      "pubchem": "54631865"
    },
    "pubchem": [
      {
        "cid": 54631865,
        "inchi": "InChI=1S/C26H36N4O5/c1-17-14-29(3)18(2)16-35-22-12-11-19(13-20(22)25(31)30(4)15-24(17)34-6)27-26(32)28-21-9-7-8-10-23(21)33-5/h7-13,17-18,24H,14-16H2,1-6H3,(H2,27,28,32)/t17-,18+,24+/m1/s1",
        "inchikey": "MQWQDAVBIBJDRV-YTZAWJCFSA-N",
        "iupac": {
          "systematic": "1-(2-methoxyphenyl)-3-[(4S,7R,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea"
        },
        "smiles": {
          "canonical": "CC1CN(C(COC2=C(C=C(C=C2)NC(=O)NC3=CC=CC=C3OC)C(=O)N(CC1OC)C)C)C"
        },
        "molecularFormula": "C26H36N4O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:31:42Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8385"
    },
    "name": "CHEMBL2142658",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8385.png",
    "lincs": {
      "id": "LSM-7797",
      "name": "CHEMBL2142658",
      "alternativeNames": [
        "BRD-K71819159"
      ],
      "pubchemCid": 54618658,
      "chebiId": 96418,
      "inchiParent": "InChI=1S/C24H31FN2O6S/c1-16-12-27(17(2)14-28)34(30,31)23-10-9-18(19-7-5-6-8-20(19)25)11-21(23)33-22(16)13-26(3)24(29)15-32-4/h5-11,16-17,22,28H,12-15H2,1-4H3/t16-,17-,22-/m1/s1",
      "inchiKeyParent": "YKCDBQLHOOFCLT-DRSNIGMVSA-N",
      "smilesParent": "COCC(=O)N(C)C[C@H]1Oc2cc(ccc2S(=O)(=O)N(C[C@H]1C)[C@H](C)CO)c3ccccc3F"
    },
    "unichem": {
      "chebi": "96418",
      "chembl": "CHEMBL2142658",
      "lincs": "LSM-7797",
      "pubchem": "54618658"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL2142658",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 494.59,
        "hba": 6,
        "hbd": 1,
        "qedWeighted": 0.64
      }
    },
    "pubchem": [
      {
        "cid": 54618658,
        "inchi": "InChI=1S/C24H31FN2O6S/c1-16-12-27(17(2)14-28)34(30,31)23-10-9-18(19-7-5-6-8-20(19)25)11-21(23)33-22(16)13-26(3)24(29)15-32-4/h5-11,16-17,22,28H,12-15H2,1-4H3/t16-,17-,22-/m1/s1",
        "inchikey": "YKCDBQLHOOFCLT-DRSNIGMVSA-N",
        "iupac": {
          "systematic": "N-[[(4R,5S)-8-(2-fluorophenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-2-methoxy-N-methylacetamide"
        },
        "smiles": {
          "canonical": "CC1CN(S(=O)(=O)C2=C(C=C(C=C2)C3=CC=CC=C3F)OC1CN(C)C(=O)COC)C(C)CO"
        },
        "molecularFormula": "C24H31FN2O6S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:31:54Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8396"
    },
    "name": "MLS003129246",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8396.png",
    "lincs": {
      "id": "LSM-7128",
      "name": "MLS003129246",
      "alternativeNames": [
        "BRD-K21153751"
      ],
      "pubchemCid": 44505142,
      "chebiId": 95749,
      "inchiParent": "InChI=1S/C23H35N5O6S/c1-17-13-27(18(2)15-29)23(30)10-7-11-28-19(12-24-25-28)16-34-21(17)14-26(3)35(31,32)22-9-6-5-8-20(22)33-4/h5-6,8-9,12,17-18,21,29H,7,10-11,13-16H2,1-4H3/t17-,18-,21-/m1/s1",
      "inchiKeyParent": "QLGFDRXFQQZFKX-DBXWQHBBSA-N",
      "smilesParent": "COc1ccccc1S(=O)(=O)N(C)C[C@H]2OCc3cnnn3CCCC(=O)N(C[C@H]2C)[C@H](C)CO"
    },
    "unichem": {
      "chebi": "95749",
      "lincs": "LSM-7128",
      "pubchem": "44505142"
    },
    "pubchem": [
      {
        "cid": 44505142,
        "inchi": "InChI=1S/C23H35N5O6S/c1-17-13-27(18(2)15-29)23(30)10-7-11-28-19(12-24-25-28)16-34-21(17)14-26(3)35(31,32)22-9-6-5-8-20(22)33-4/h5-6,8-9,12,17-18,21,29H,7,10-11,13-16H2,1-4H3/t17-,18-,21-/m1/s1",
        "inchikey": "QLGFDRXFQQZFKX-DBXWQHBBSA-N",
        "iupac": {
          "systematic": "N-[[(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-2-methoxy-N-methylbenzenesulfonamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)CCCN2C(=CN=N2)COC1CN(C)S(=O)(=O)C3=CC=CC=C3OC)C(C)CO"
        },
        "molecularFormula": "C23H35N5O6S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:31:56Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83b7"
    },
    "name": "BRD-K31427141",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83b7.png",
    "lincs": {
      "id": "LSM-10333",
      "name": "BRD-K31427141",
      "pubchemCid": 54650152,
      "chebiId": 98954,
      "inchiParent": "InChI=1S/C22H25N3OS/c1-2-18-13-24-22(27-18)25-19(12-23)21(20(25)14-26)17-10-8-16(9-11-17)15-6-4-3-5-7-15/h6,8-11,13,19-21,26H,2-5,7,14H2,1H3/t19-,20-,21-/m1/s1",
      "inchiKeyParent": "DBVJKEGLTFFIFT-NJDAHSKKSA-N",
      "smilesParent": "CCc1cnc(s1)N2[C@H](CO)[C@@H]([C@H]2C#N)c3ccc(cc3)C4=CCCCC4"
    },
    "unichem": {
      "chebi": "98954",
      "lincs": "LSM-10333",
      "pubchem": "54650152"
    },
    "pubchem": [
      {
        "cid": 54650152,
        "inchi": "InChI=1S/C22H25N3OS/c1-2-18-13-24-22(27-18)25-19(12-23)21(20(25)14-26)17-10-8-16(9-11-17)15-6-4-3-5-7-15/h6,8-11,13,19-21,26H,2-5,7,14H2,1H3/t19-,20-,21-/m1/s1",
        "inchikey": "DBVJKEGLTFFIFT-NJDAHSKKSA-N",
        "iupac": {
          "systematic": "(2S,3R,4S)-3-[4-(cyclohexen-1-yl)phenyl]-1-(5-ethyl-1,3-thiazol-2-yl)-4-(hydroxymethyl)azetidine-2-carbonitrile"
        },
        "smiles": {
          "canonical": "CCC1=CN=C(S1)N2C(C(C2C#N)C3=CC=C(C=C3)C4=CCCCC4)CO"
        },
        "molecularFormula": "C22H25N3OS"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:31:58Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83e9"
    },
    "name": "MLS003129104",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83e9.png",
    "lincs": {
      "id": "LSM-6922",
      "name": "MLS003129104",
      "alternativeNames": [
        "BRD-K04749191"
      ],
      "pubchemCid": 44486960,
      "chebiId": 95543,
      "inchiParent": "InChI=1S/C28H37N7O5/c1-20-15-35(21(2)18-36)27(37)11-7-13-34-16-23(31-32-34)19-39-25(20)17-33(3)28(38)30-22-8-6-9-24(14-22)40-26-10-4-5-12-29-26/h4-6,8-10,12,14,16,20-21,25,36H,7,11,13,15,17-19H2,1-3H3,(H,30,38)/t20-,21+,25+/m1/s1",
      "inchiKeyParent": "WYPGSQIBOYUSAK-CZSZKKDXSA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@@H](C)[C@H](CN(C)C(=O)Nc2cccc(Oc3ccccn3)c2)OCc4cn(CCCC1=O)nn4"
    },
    "unichem": {
      "chebi": "95543",
      "lincs": "LSM-6922",
      "pubchem": "44486960"
    },
    "pubchem": [
      {
        "cid": 44486960,
        "inchi": "InChI=1S/C28H37N7O5/c1-20-15-35(21(2)18-36)27(37)11-7-13-34-16-23(31-32-34)19-39-25(20)17-33(3)28(38)30-22-8-6-9-24(14-22)40-26-10-4-5-12-29-26/h4-6,8-10,12,14,16,20-21,25,36H,7,11,13,15,17-19H2,1-3H3,(H,30,38)/t20-,21+,25+/m1/s1",
        "inchikey": "WYPGSQIBOYUSAK-CZSZKKDXSA-N",
        "iupac": {
          "systematic": "1-[[(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methyl-3-(3-pyridin-2-yloxyphenyl)urea"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)CCCN2C=C(COC1CN(C)C(=O)NC3=CC(=CC=C3)OC4=CC=CC=N4)N=N2)C(C)CO"
        },
        "molecularFormula": "C28H37N7O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:32:01Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83fe"
    },
    "name": "BRD-K11112971",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83fe.png",
    "lincs": {
      "id": "LSM-9107",
      "name": "BRD-K11112971",
      "pubchemCid": 54637956,
      "chebiId": 97728,
      "inchiParent": "InChI=1S/C32H38N4O5/c1-19-15-36(20(2)17-37)32(39)30-29(25-13-9-10-14-26(25)35(30)6)24-12-8-7-11-23(24)18-40-27(19)16-34(5)31(38)28-21(3)33-41-22(28)4/h7-14,19-20,27,37H,15-18H2,1-6H3/t19-,20+,27-/m1/s1",
      "inchiKeyParent": "LBGXIXNVJUEMSO-IOKPGSKQSA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@@H](C)[C@@H](CN(C)C(=O)c2c(C)onc2C)OCc3ccccc3c4c(C1=O)n(C)c5ccccc45"
    },
    "unichem": {
      "chebi": "97728",
      "lincs": "LSM-9107",
      "pubchem": "54637956"
    },
    "pubchem": [
      {
        "cid": 54637956,
        "inchi": "InChI=1S/C32H38N4O5/c1-19-15-36(20(2)17-37)32(39)30-29(25-13-9-10-14-26(25)35(30)6)24-12-8-7-11-23(24)18-40-27(19)16-34(5)31(38)28-21(3)33-41-22(28)4/h7-14,19-20,27,37H,15-18H2,1-6H3/t19-,20+,27-/m1/s1",
        "inchikey": "LBGXIXNVJUEMSO-IOKPGSKQSA-N",
        "iupac": {
          "systematic": "N-[[(10S,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N,3,5-trimethyl-1,2-oxazole-4-carboxamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(C3=CC=CC=C3COC1CN(C)C(=O)C4=C(ON=C4C)C)C5=CC=CC=C5N2C)C(C)CO"
        },
        "molecularFormula": "C32H38N4O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:32:04Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c838e"
    },
    "name": "BRD-K06486491",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c838e.png",
    "lincs": {
      "id": "LSM-6942",
      "name": "BRD-K06486491",
      "pubchemCid": 54618175,
      "chebiId": 95563,
      "inchiParent": "InChI=1S/C24H32N4O4/c1-15-13-28(16(2)14-29)24(31)20-10-19(11-26-22(20)32-21(15)12-25-3)17-7-6-8-18(9-17)23(30)27(4)5/h6-11,15-16,21,25,29H,12-14H2,1-5H3/t15-,16+,21-/m1/s1",
      "inchiKeyParent": "JOFZJSROTWODFL-VWKPWSFCSA-N",
      "smilesParent": "CNC[C@H]1Oc2ncc(cc2C(=O)N(C[C@H]1C)[C@@H](C)CO)c3cccc(c3)C(=O)N(C)C"
    },
    "unichem": {
      "chebi": "95563",
      "lincs": "LSM-6942",
      "pubchem": "54618175"
    },
    "pubchem": [
      {
        "cid": 54618175,
        "inchi": "InChI=1S/C24H32N4O4/c1-15-13-28(16(2)14-29)24(31)20-10-19(11-26-22(20)32-21(15)12-25-3)17-7-6-8-18(9-17)23(30)27(4)5/h6-11,15-16,21,25,29H,12-14H2,1-5H3/t15-,16+,21-/m1/s1",
        "inchikey": "JOFZJSROTWODFL-VWKPWSFCSA-N",
        "iupac": {
          "systematic": "3-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-8-yl]-N,N-dimethylbenzamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(N=CC(=C2)C3=CC(=CC=C3)C(=O)N(C)C)OC1CNC)C(C)CO"
        },
        "molecularFormula": "C24H32N4O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:32:06Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83f4"
    },
    "name": "MLS002474002",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83f4.png",
    "lincs": {
      "id": "LSM-41070",
      "name": "MLS002474002",
      "alternativeNames": [
        "BRD-K69791739",
        "BRD-K69791739-001"
      ],
      "pubchemCid": 44202600,
      "chebiId": 129519,
      "inchiParent": "InChI=1S/C25H40N4O4/c1-17-14-29(18(2)16-30)24(31)20-12-9-13-21(27(3)4)23(20)33-22(17)15-28(5)25(32)26-19-10-7-6-8-11-19/h9,12-13,17-19,22,30H,6-8,10-11,14-16H2,1-5H3,(H,26,32)/t17-,18+,22+/m0/s1",
      "inchiKeyParent": "LUEDFXFVYWVEMN-NJNPRVFISA-N",
      "smilesParent": "C[C@H](CO)N1C[C@H](C)[C@@H](CN(C)C(=O)NC2CCCCC2)Oc3c(cccc3C1=O)N(C)C"
    },
    "unichem": {
      "chebi": "129519",
      "chembl": "CHEMBL2131434",
      "lincs": "LSM-41070",
      "pubchem": "44202600"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL2131434",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 460.62,
        "hba": 5,
        "hbd": 2,
        "qedWeighted": 0.68
      }
    },
    "pubchem": [
      {
        "cid": 44202600,
        "inchi": "InChI=1S/C25H40N4O4/c1-17-14-29(18(2)16-30)24(31)20-12-9-13-21(27(3)4)23(20)33-22(17)15-28(5)25(32)26-19-10-7-6-8-11-19/h9,12-13,17-19,22,30H,6-8,10-11,14-16H2,1-5H3,(H,26,32)/t17-,18+,22+/m0/s1",
        "inchikey": "LUEDFXFVYWVEMN-NJNPRVFISA-N",
        "iupac": {
          "systematic": "3-cyclohexyl-1-[[(2S,3S)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(C(=CC=C2)N(C)C)OC1CN(C)C(=O)NC3CCCCC3)C(C)CO"
        },
        "molecularFormula": "C25H40N4O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:32:17Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83f8"
    },
    "name": "BRD-K87300242",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83f8.png",
    "lincs": {
      "id": "LSM-13780",
      "name": "BRD-K87300242",
      "pubchemCid": 54631846,
      "chebiId": 102429,
      "inchiParent": "InChI=1S/C25H33N3O4/c1-17-14-26-18(2)16-32-22-11-10-20(27-24(29)12-19-8-6-5-7-9-19)13-21(22)25(30)28(3)15-23(17)31-4/h5-11,13,17-18,23,26H,12,14-16H2,1-4H3,(H,27,29)/t17-,18+,23+/m1/s1",
      "inchiKeyParent": "RIFMDYVXBSMSIP-STSQHVNTSA-N",
      "smilesParent": "CO[C@H]1CN(C)C(=O)c2cc(NC(=O)Cc3ccccc3)ccc2OC[C@H](C)NC[C@H]1C"
    },
    "unichem": {
      "chebi": "102429",
      "lincs": "LSM-13780",
      "pubchem": "54631846"
    },
    "pubchem": [
      {
        "cid": 54631846,
        "inchi": "InChI=1S/C25H33N3O4/c1-17-14-26-18(2)16-32-22-11-10-20(27-24(29)12-19-8-6-5-7-9-19)13-21(22)25(30)28(3)15-23(17)31-4/h5-11,13,17-18,23,26H,12,14-16H2,1-4H3,(H,27,29)/t17-,18+,23+/m1/s1",
        "inchikey": "RIFMDYVXBSMSIP-STSQHVNTSA-N",
        "iupac": {
          "systematic": "N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-phenylacetamide"
        },
        "smiles": {
          "canonical": "CC1CNC(COC2=C(C=C(C=C2)NC(=O)CC3=CC=CC=C3)C(=O)N(CC1OC)C)C"
        },
        "molecularFormula": "C25H33N3O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:32:19Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83fa"
    },
    "name": "BRD-K35152204",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83fa.png",
    "lincs": {
      "id": "LSM-7298",
      "name": "BRD-K35152204",
      "pubchemCid": 54618424,
      "chebiId": 95919,
      "inchiParent": "InChI=1S/C27H35N3O4/c1-17-7-5-6-8-22(17)21-12-23-26(28-13-21)34-24(15-29(4)25(32)11-20-9-10-20)18(2)14-30(27(23)33)19(3)16-31/h5-8,12-13,18-20,24,31H,9-11,14-16H2,1-4H3/t18-,19-,24-/m0/s1",
      "inchiKeyParent": "DUJQZBWFZFXOJW-JXQFQVJHSA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@H](C)[C@H](CN(C)C(=O)CC2CC2)Oc3ncc(cc3C1=O)c4ccccc4C"
    },
    "unichem": {
      "chebi": "95919",
      "lincs": "LSM-7298",
      "pubchem": "54618424"
    },
    "pubchem": [
      {
        "cid": 54618424,
        "inchi": "InChI=1S/C27H35N3O4/c1-17-7-5-6-8-22(17)21-12-23-26(28-13-21)34-24(15-29(4)25(32)11-20-9-10-20)18(2)14-30(27(23)33)19(3)16-31/h5-8,12-13,18-20,24,31H,9-11,14-16H2,1-4H3/t18-,19-,24-/m0/s1",
        "inchikey": "DUJQZBWFZFXOJW-JXQFQVJHSA-N",
        "iupac": {
          "systematic": "2-cyclopropyl-N-[[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-8-(2-methylphenyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylacetamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(N=CC(=C2)C3=CC=CC=C3C)OC1CN(C)C(=O)CC4CC4)C(C)CO"
        },
        "molecularFormula": "C27H35N3O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:32:21Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83bb"
    },
    "name": "BRD-K39367499",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83bb.png",
    "lincs": {
      "id": "LSM-10816",
      "name": "BRD-K39367499",
      "pubchemCid": 54653985,
      "chebiId": 99437,
      "inchiParent": "InChI=1S/C30H32FN5O5/c1-36-25-8-7-21(17-28(37)33-15-12-19-10-13-32-14-11-19)41-27(25)18-40-26-9-6-20(16-22(26)29(36)38)34-30(39)35-24-5-3-2-4-23(24)31/h2-6,9-11,13-14,16,21,25,27H,7-8,12,15,17-18H2,1H3,(H,33,37)(H2,34,35,39)/t21-,25-,27+/m0/s1",
      "inchiKeyParent": "KLEFMXRWIUTPPC-IDNYDCHQSA-N",
      "smilesParent": "CN1[C@H]2CC[C@@H](CC(=O)NCCc3ccncc3)O[C@@H]2COc4ccc(NC(=O)Nc5ccccc5F)cc4C1=O"
    },
    "unichem": {
      "chebi": "99437",
      "lincs": "LSM-10816",
      "pubchem": "54653985"
    },
    "pubchem": [
      {
        "cid": 54653985,
        "inchi": "InChI=1S/C30H32FN5O5/c1-36-25-8-7-21(17-28(37)33-15-12-19-10-13-32-14-11-19)41-27(25)18-40-26-9-6-20(16-22(26)29(36)38)34-30(39)35-24-5-3-2-4-23(24)31/h2-6,9-11,13-14,16,21,25,27H,7-8,12,15,17-18H2,1H3,(H,33,37)(H2,34,35,39)/t21-,25-,27+/m0/s1",
        "inchikey": "KLEFMXRWIUTPPC-IDNYDCHQSA-N",
        "iupac": {
          "systematic": "2-[(2S,4aS,12aS)-8-[(2-fluorophenyl)carbamoylamino]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(2-pyridin-4-ylethyl)acetamide"
        },
        "smiles": {
          "canonical": "CN1C2CCC(OC2COC3=C(C1=O)C=C(C=C3)NC(=O)NC4=CC=CC=C4F)CC(=O)NCCC5=CC=NC=C5"
        },
        "molecularFormula": "C30H32FN5O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:32:24Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8380"
    },
    "name": "BRD-K48553449",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8380.png",
    "lincs": {
      "id": "LSM-11383",
      "name": "BRD-K48553449",
      "pubchemCid": 54631371,
      "chebiId": 100004,
      "inchiParent": "InChI=1S/C29H32F2N6O5/c1-17-14-37(28(39)24-13-32-9-10-33-24)18(2)16-42-25-12-20(6-7-21(25)27(38)36(3)15-26(17)41-4)34-29(40)35-23-11-19(30)5-8-22(23)31/h5-13,17-18,26H,14-16H2,1-4H3,(H2,34,35,40)/t17-,18-,26+/m0/s1",
      "inchiKeyParent": "ZXQGUZCJBQNBQR-QSAFDGGLSA-N",
      "smilesParent": "CO[C@@H]1CN(C)C(=O)c2ccc(NC(=O)Nc3cc(F)ccc3F)cc2OC[C@H](C)N(C[C@@H]1C)C(=O)c4cnccn4"
    },
    "unichem": {
      "chebi": "100004",
      "lincs": "LSM-11383",
      "pubchem": "54631371"
    },
    "pubchem": [
      {
        "cid": 54631371,
        "inchi": "InChI=1S/C29H32F2N6O5/c1-17-14-37(28(39)24-13-32-9-10-33-24)18(2)16-42-25-12-20(6-7-21(25)27(38)36(3)15-26(17)41-4)34-29(40)35-23-11-19(30)5-8-22(23)31/h5-13,17-18,26H,14-16H2,1-4H3,(H2,34,35,40)/t17-,18-,26+/m0/s1",
        "inchikey": "ZXQGUZCJBQNBQR-QSAFDGGLSA-N",
        "iupac": {
          "systematic": "1-(2,5-difluorophenyl)-3-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(pyrazine-2-carbonyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-15-yl]urea"
        },
        "smiles": {
          "canonical": "CC1CN(C(COC2=C(C=CC(=C2)NC(=O)NC3=C(C=CC(=C3)F)F)C(=O)N(CC1OC)C)C)C(=O)C4=NC=CN=C4"
        },
        "molecularFormula": "C29H32F2N6O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:32:26Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c838b"
    },
    "name": "BRD-K87791256",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c838b.png",
    "lincs": {
      "id": "LSM-7975",
      "name": "BRD-K87791256",
      "pubchemCid": 54618671,
      "chebiId": 96596,
      "inchiParent": "InChI=1S/C23H29N3O4S/c1-17-14-26(18(2)16-27)31(28,29)23-11-9-19(8-10-20-7-5-6-12-24-20)13-21(23)30-22(17)15-25(3)4/h5-7,9,11-13,17-18,22,27H,14-16H2,1-4H3/t17-,18-,22+/m1/s1",
      "inchiKeyParent": "OBRGIGMGBKKHMR-HMFYCAOWSA-N",
      "smilesParent": "C[C@H](CO)N1C[C@@H](C)[C@H](CN(C)C)Oc2cc(ccc2S1(=O)=O)C#Cc3ccccn3"
    },
    "unichem": {
      "chebi": "96596",
      "lincs": "LSM-7975",
      "pubchem": "54618671"
    },
    "pubchem": [
      {
        "cid": 54618671,
        "inchi": "InChI=1S/C23H29N3O4S/c1-17-14-26(18(2)16-27)31(28,29)23-11-9-19(8-10-20-7-5-6-12-24-20)13-21(23)30-22(17)15-25(3)4/h5-7,9,11-13,17-18,22,27H,14-16H2,1-4H3/t17-,18-,22+/m1/s1",
        "inchikey": "OBRGIGMGBKKHMR-HMFYCAOWSA-N",
        "iupac": {
          "systematic": "(2R)-2-[(4R,5R)-5-[(dimethylamino)methyl]-4-methyl-1,1-dioxo-8-(2-pyridin-2-ylethynyl)-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-2-yl]propan-1-ol"
        },
        "smiles": {
          "canonical": "CC1CN(S(=O)(=O)C2=C(C=C(C=C2)C#CC3=CC=CC=N3)OC1CN(C)C)C(C)CO"
        },
        "molecularFormula": "C23H29N3O4S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:32:28Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82a6"
    },
    "name": "BRD-K72980353",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82a6.png",
    "lincs": {
      "id": "LSM-12896",
      "name": "BRD-K72980353",
      "pubchemCid": 54658031,
      "chebiId": 101533,
      "inchiParent": "InChI=1S/C20H28N2O4/c23-16-10-21-18-6-5-17(26-19(18)12-25-11-16)9-20(24)22-15-7-13-3-1-2-4-14(13)8-15/h1-4,15-19,21,23H,5-12H2,(H,22,24)/t16-,17+,18+,19-/m0/s1",
      "inchiKeyParent": "VINMFOKKSKWMTO-MANSERQUSA-N",
      "smilesParent": "O[C@H]1CN[C@@H]2CC[C@H](CC(=O)NC3Cc4ccccc4C3)O[C@H]2COC1"
    },
    "unichem": {
      "chebi": "101533",
      "lincs": "LSM-12896",
      "pubchem": "54658031"
    },
    "pubchem": [
      {
        "cid": 54658031,
        "inchi": "InChI=1S/C20H28N2O4/c23-16-10-21-18-6-5-17(26-19(18)12-25-11-16)9-20(24)22-15-7-13-3-1-2-4-14(13)8-15/h1-4,15-19,21,23H,5-12H2,(H,22,24)/t16-,17+,18+,19-/m0/s1",
        "inchikey": "VINMFOKKSKWMTO-MANSERQUSA-N",
        "iupac": {
          "systematic": "2-[(3S,6aR,8R,10aR)-3-hydroxy-1,2,3,4,6,6a,8,9,10,10a-decahydropyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2,3-dihydro-1H-inden-2-yl)acetamide"
        },
        "smiles": {
          "canonical": "C1CC2C(COCC(CN2)O)OC1CC(=O)NC3CC4=CC=CC=C4C3"
        },
        "molecularFormula": "C20H28N2O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:32:30Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82ac"
    },
    "name": "BRD-K35842817",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82ac.png",
    "lincs": {
      "id": "LSM-39230",
      "name": "BRD-K35842817",
      "pubchemCid": 54666558,
      "chebiId": 127673,
      "inchiParent": "InChI=1S/C30H41N3O3/c1-31(2)30(35)26-7-5-6-25(18-26)23-8-10-24(11-9-23)29-27-20-32(19-22-12-16-36-17-13-22)14-3-4-15-33(27)28(29)21-34/h5-11,18,22,27-29,34H,3-4,12-17,19-21H2,1-2H3/t27-,28+,29+/m1/s1",
      "inchiKeyParent": "HTOXPRASVGCNJV-ULNSLHSMSA-N",
      "smilesParent": "CN(C)C(=O)c1cccc(c1)c2ccc(cc2)[C@@H]3[C@H](CO)N4CCCCN(CC5CCOCC5)C[C@H]34"
    },
    "unichem": {
      "chebi": "127673",
      "lincs": "LSM-39230",
      "pubchem": "54666558"
    },
    "pubchem": [
      {
        "cid": 54666558,
        "inchi": "InChI=1S/C30H41N3O3/c1-31(2)30(35)26-7-5-6-25(18-26)23-8-10-24(11-9-23)29-27-20-32(19-22-12-16-36-17-13-22)14-3-4-15-33(27)28(29)21-34/h5-11,18,22,27-29,34H,3-4,12-17,19-21H2,1-2H3/t27-,28+,29+/m1/s1",
        "inchikey": "HTOXPRASVGCNJV-ULNSLHSMSA-N",
        "iupac": {
          "systematic": "3-[4-[(8S,9S,10R)-10-(hydroxymethyl)-6-(oxan-4-ylmethyl)-1,6-diazabicyclo[6.2.0]decan-9-yl]phenyl]-N,N-dimethylbenzamide"
        },
        "smiles": {
          "canonical": "CN(C)C(=O)C1=CC=CC(=C1)C2=CC=C(C=C2)C3C4CN(CCCCN4C3CO)CC5CCOCC5"
        },
        "molecularFormula": "C30H41N3O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:32:32Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8324"
    },
    "name": "BRD-K75291656",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8324.png",
    "lincs": {
      "id": "LSM-7824",
      "name": "BRD-K75291656",
      "pubchemCid": 44485745,
      "chebiId": 96445,
      "inchiParent": "InChI=1S/C26H34N6O5/c1-18-13-32(19(2)16-33)25(34)10-7-11-31-14-21(27-29-31)17-36-24(18)15-30(3)26(35)22-12-23(37-28-22)20-8-5-4-6-9-20/h4-6,8-9,12,14,18-19,24,33H,7,10-11,13,15-17H2,1-3H3/t18-,19+,24-/m1/s1",
      "inchiKeyParent": "XYWPMUCHOREPKK-YDIMBITNSA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@@H](C)[C@@H](CN(C)C(=O)c2cc(on2)c3ccccc3)OCc4cn(CCCC1=O)nn4"
    },
    "unichem": {
      "chebi": "96445",
      "lincs": "LSM-7824",
      "pubchem": "44485745"
    },
    "pubchem": [
      {
        "cid": 44485745,
        "inchi": "InChI=1S/C26H34N6O5/c1-18-13-32(19(2)16-33)25(34)10-7-11-31-14-21(27-29-31)17-36-24(18)15-30(3)26(35)22-12-23(37-28-22)20-8-5-4-6-9-20/h4-6,8-9,12,14,18-19,24,33H,7,10-11,13,15-17H2,1-3H3/t18-,19+,24-/m1/s1",
        "inchikey": "XYWPMUCHOREPKK-YDIMBITNSA-N",
        "iupac": {
          "systematic": "N-[[(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methyl-5-phenyl-1,2-oxazole-3-carboxamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)CCCN2C=C(COC1CN(C)C(=O)C3=NOC(=C3)C4=CC=CC=C4)N=N2)C(C)CO"
        },
        "molecularFormula": "C26H34N6O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:32:34Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8283"
    },
    "name": "MLS003130344",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8283.png",
    "lincs": {
      "id": "LSM-7879",
      "name": "MLS003130344",
      "alternativeNames": [
        "BRD-K78824440"
      ],
      "pubchemCid": 44505071,
      "chebiId": 96500,
      "inchiParent": "InChI=1S/C16H29N5O3/c1-12-9-20(13(2)10-22)16(23)5-4-6-21-14(7-18-19-21)11-24-15(12)8-17-3/h7,12-13,15,17,22H,4-6,8-11H2,1-3H3/t12-,13+,15+/m0/s1",
      "inchiKeyParent": "FOLOUAULJSJVDY-GZBFAFLISA-N",
      "smilesParent": "CNC[C@H]1OCc2cnnn2CCCC(=O)N(C[C@@H]1C)[C@H](C)CO"
    },
    "unichem": {
      "chebi": "96500",
      "lincs": "LSM-7879",
      "pubchem": "44505071"
    },
    "pubchem": [
      {
        "cid": 44505071,
        "inchi": "InChI=1S/C16H29N5O3/c1-12-9-20(13(2)10-22)16(23)5-4-6-21-14(7-18-19-21)11-24-15(12)8-17-3/h7,12-13,15,17,22H,4-6,8-11H2,1-3H3/t12-,13+,15+/m0/s1",
        "inchikey": "FOLOUAULJSJVDY-GZBFAFLISA-N",
        "iupac": {
          "systematic": "(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-(methylaminomethyl)-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)CCCN2C(=CN=N2)COC1CNC)C(C)CO"
        },
        "molecularFormula": "C16H29N5O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:32:37Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c82c0"
    },
    "name": "BRD-K66253082",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c82c0.png",
    "lincs": {
      "id": "LSM-40886",
      "name": "BRD-K66253082",
      "pubchemCid": 54664933,
      "chebiId": 129335,
      "inchiParent": "InChI=1S/C24H28N2O3S/c1-3-4-6-9-18-12-13-22-21(16-18)24-20(23(17-27)25(22)2)14-15-26(24)30(28,29)19-10-7-5-8-11-19/h5,7-8,10-13,16,20,23-24,27H,3-4,14-15,17H2,1-2H3/t20-,23+,24-/m0/s1",
      "inchiKeyParent": "WMKATUJMKCUOLP-ZTCOLXNVSA-N",
      "smilesParent": "CCCC#Cc1ccc2N(C)[C@H](CO)[C@@H]3CCN([C@@H]3c2c1)S(=O)(=O)c4ccccc4"
    },
    "unichem": {
      "chebi": "129335",
      "lincs": "LSM-40886",
      "pubchem": "54664933"
    },
    "pubchem": [
      {
        "cid": 54664933,
        "inchi": "InChI=1S/C24H28N2O3S/c1-3-4-6-9-18-12-13-22-21(16-18)24-20(23(17-27)25(22)2)14-15-26(24)30(28,29)19-10-7-5-8-11-19/h5,7-8,10-13,16,20,23-24,27H,3-4,14-15,17H2,1-2H3/t20-,23+,24-/m0/s1",
        "inchikey": "WMKATUJMKCUOLP-ZTCOLXNVSA-N",
        "iupac": {
          "systematic": "[(3aS,4S,9bS)-1-(benzenesulfonyl)-5-methyl-8-pent-1-ynyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-4-yl]methanol"
        },
        "smiles": {
          "canonical": "CCCC#CC1=CC2=C(C=C1)N(C(C3C2N(CC3)S(=O)(=O)C4=CC=CC=C4)CO)C"
        },
        "molecularFormula": "C24H28N2O3S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:32:39Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8362"
    },
    "name": "BRD-K89920769",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8362.png",
    "lincs": {
      "id": "LSM-13973",
      "name": "BRD-K89920769",
      "pubchemCid": 54632142,
      "chebiId": 102626,
      "inchiParent": "InChI=1S/C30H37FN6O6/c1-17-14-37(30(40)34-27-19(3)35-43-20(27)4)18(2)16-42-25-11-10-23(13-24(25)28(38)36(5)15-26(17)41-6)33-29(39)32-22-9-7-8-21(31)12-22/h7-13,17-18,26H,14-16H2,1-6H3,(H,34,40)(H2,32,33,39)/t17-,18-,26+/m1/s1",
      "inchiKeyParent": "DJGRJRLVSKCCNZ-KABRZNFWSA-N",
      "smilesParent": "CO[C@H]1CN(C)C(=O)c2cc(NC(=O)Nc3cccc(F)c3)ccc2OC[C@@H](C)N(C[C@H]1C)C(=O)Nc4c(C)onc4C"
    },
    "unichem": {
      "chebi": "102626",
      "lincs": "LSM-13973",
      "pubchem": "54632142"
    },
    "pubchem": [
      {
        "cid": 54632142,
        "inchi": "InChI=1S/C30H37FN6O6/c1-17-14-37(30(40)34-27-19(3)35-43-20(27)4)18(2)16-42-25-11-10-23(13-24(25)28(38)36(5)15-26(17)41-6)33-29(39)32-22-9-7-8-21(31)12-22/h7-13,17-18,26H,14-16H2,1-6H3,(H,34,40)(H2,32,33,39)/t17-,18-,26+/m1/s1",
        "inchikey": "DJGRJRLVSKCCNZ-KABRZNFWSA-N",
        "iupac": {
          "systematic": "(4R,7R,8R)-N-(3,5-dimethyl-1,2-oxazol-4-yl)-14-[(3-fluorophenyl)carbamoylamino]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-5-carboxamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(COC2=C(C=C(C=C2)NC(=O)NC3=CC(=CC=C3)F)C(=O)N(CC1OC)C)C)C(=O)NC4=C(ON=C4C)C"
        },
        "molecularFormula": "C30H37FN6O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:32:41Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83fb"
    },
    "name": "BRD-K83486374",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83fb.png",
    "lincs": {
      "id": "LSM-13534",
      "name": "BRD-K83486374",
      "pubchemCid": 54645932,
      "chebiId": 102176,
      "inchiParent": "InChI=1S/C27H25F2N3O5/c28-17-3-5-22(29)16(8-17)13-31-25(34)11-19-10-21-20-9-18(32-27(35)15-2-1-7-30-12-15)4-6-23(20)37-26(21)24(14-33)36-19/h1-9,12,19,21,24,26,33H,10-11,13-14H2,(H,31,34)(H,32,35)/t19-,21+,24+,26-/m1/s1",
      "inchiKeyParent": "MRHMXTIRULDPKA-ZHRNDHIYSA-N",
      "smilesParent": "OC[C@@H]1O[C@@H](CC(=O)NCc2cc(F)ccc2F)C[C@@H]3[C@H]1Oc4ccc(NC(=O)c5cccnc5)cc34"
    },
    "unichem": {
      "chebi": "102176",
      "lincs": "LSM-13534",
      "pubchem": "54645932"
    },
    "pubchem": [
      {
        "cid": 54645932,
        "inchi": "InChI=1S/C27H25F2N3O5/c28-17-3-5-22(29)16(8-17)13-31-25(34)11-19-10-21-20-9-18(32-27(35)15-2-1-7-30-12-15)4-6-23(20)37-26(21)24(14-33)36-19/h1-9,12,19,21,24,26,33H,10-11,13-14H2,(H,31,34)(H,32,35)/t19-,21+,24+,26-/m1/s1",
        "inchikey": "MRHMXTIRULDPKA-ZHRNDHIYSA-N",
        "iupac": {
          "systematic": "N-[(1S,3R,4aS,9aR)-3-[2-[(2,5-difluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]pyridine-3-carboxamide"
        },
        "smiles": {
          "canonical": "C1C(OC(C2C1C3=C(O2)C=CC(=C3)NC(=O)C4=CN=CC=C4)CO)CC(=O)NCC5=C(C=CC(=C5)F)F"
        },
        "molecularFormula": "C27H25F2N3O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:32:44Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c834e"
    },
    "name": "BRD-K78657294",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c834e.png",
    "lincs": {
      "id": "LSM-7876",
      "name": "BRD-K78657294",
      "pubchemCid": 54618676,
      "chebiId": 96497,
      "inchiParent": "InChI=1S/C24H33N3O3/c1-5-11-26(4)15-22-17(2)14-27(18(3)16-28)24(29)21-12-20(13-25-23(21)30-22)19-9-7-6-8-10-19/h6-10,12-13,17-18,22,28H,5,11,14-16H2,1-4H3/t17-,18-,22+/m0/s1",
      "inchiKeyParent": "SVKJOHOIDWZOJW-NPPFBWRTSA-N",
      "smilesParent": "CCCN(C)C[C@H]1Oc2ncc(cc2C(=O)N(C[C@@H]1C)[C@@H](C)CO)c3ccccc3"
    },
    "unichem": {
      "chebi": "96497",
      "lincs": "LSM-7876",
      "pubchem": "54618676"
    },
    "pubchem": [
      {
        "cid": 54618676,
        "inchi": "InChI=1S/C24H33N3O3/c1-5-11-26(4)15-22-17(2)14-27(18(3)16-28)24(29)21-12-20(13-25-23(21)30-22)19-9-7-6-8-10-19/h6-10,12-13,17-18,22,28H,5,11,14-16H2,1-4H3/t17-,18-,22+/m0/s1",
        "inchikey": "SVKJOHOIDWZOJW-NPPFBWRTSA-N",
        "iupac": {
          "systematic": "(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(propyl)amino]methyl]-8-phenyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one"
        },
        "smiles": {
          "canonical": "CCCN(C)CC1C(CN(C(=O)C2=C(O1)N=CC(=C2)C3=CC=CC=C3)C(C)CO)C"
        },
        "molecularFormula": "C24H33N3O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:32:46Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c836b"
    },
    "name": "BRD-K93666423",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c836b.png",
    "lincs": {
      "id": "LSM-14170",
      "name": "BRD-K93666423",
      "pubchemCid": 54661350,
      "chebiId": 102824,
      "inchiParent": "InChI=1S/C25H28N4O4/c30-13-18-20-12-28-19(8-7-17(25(28)33)16-2-1-9-26-11-16)22(29(20)24(32)15-5-6-15)21(18)23(31)27-10-14-3-4-14/h1-2,7-9,11,14-15,18,20-22,30H,3-6,10,12-13H2,(H,27,31)/t18-,20-,21+,22+/m0/s1",
      "inchiKeyParent": "YVZLAXVGGRSZTP-VXSCBNMQSA-N",
      "smilesParent": "OC[C@H]1[C@@H]2CN3C(=CC=C(C3=O)c4cccnc4)[C@H]([C@@H]1C(=O)NCC5CC5)N2C(=O)C6CC6"
    },
    "unichem": {
      "chebi": "102824",
      "lincs": "LSM-14170",
      "pubchem": "54661350"
    },
    "pubchem": [
      {
        "cid": 54661350,
        "inchi": "InChI=1S/C25H28N4O4/c30-13-18-20-12-28-19(8-7-17(25(28)33)16-2-1-9-26-11-16)22(29(20)24(32)15-5-6-15)21(18)23(31)27-10-14-3-4-14/h1-2,7-9,11,14-15,18,20-22,30H,3-6,10,12-13H2,(H,27,31)/t18-,20-,21+,22+/m0/s1",
        "inchikey": "YVZLAXVGGRSZTP-VXSCBNMQSA-N",
        "iupac": {
          "systematic": "(1S,9R,10R,11R)-12-(cyclopropanecarbonyl)-N-(cyclopropylmethyl)-10-(hydroxymethyl)-6-oxo-5-pyridin-3-yl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide"
        },
        "smiles": {
          "canonical": "C1CC1CNC(=O)C2C(C3CN4C(=CC=C(C4=O)C5=CN=CC=C5)C2N3C(=O)C6CC6)CO"
        },
        "molecularFormula": "C25H28N4O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:32:48Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83b9"
    },
    "name": "SCHEMBL17487092",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83b9.png",
    "lincs": {
      "id": "LSM-6884",
      "name": "SCHEMBL17487092",
      "alternativeNames": [
        "BRD-K01676918"
      ],
      "pubchemCid": 44487406,
      "chebiId": 95505,
      "inchiParent": "InChI=1S/C20H33N5O4/c1-14-9-25(15(2)12-26)19(27)5-4-8-24-10-17(21-22-24)13-29-18(14)11-23(3)20(28)16-6-7-16/h10,14-16,18,26H,4-9,11-13H2,1-3H3/t14-,15+,18-/m1/s1",
      "inchiKeyParent": "HEIBNMHSSNMFIU-RVKKMQEKSA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@@H](C)[C@@H](CN(C)C(=O)C2CC2)OCc3cn(CCCC1=O)nn3"
    },
    "unichem": {
      "chebi": "95505",
      "lincs": "LSM-6884",
      "pubchem": "44487406"
    },
    "pubchem": [
      {
        "cid": 44487406,
        "inchi": "InChI=1S/C20H33N5O4/c1-14-9-25(15(2)12-26)19(27)5-4-8-24-10-17(21-22-24)13-29-18(14)11-23(3)20(28)16-6-7-16/h10,14-16,18,26H,4-9,11-13H2,1-3H3/t14-,15+,18-/m1/s1",
        "inchikey": "HEIBNMHSSNMFIU-RVKKMQEKSA-N",
        "iupac": {
          "systematic": "N-[[(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylcyclopropanecarboxamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)CCCN2C=C(COC1CN(C)C(=O)C3CC3)N=N2)C(C)CO"
        },
        "molecularFormula": "C20H33N5O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:32:51Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83fc"
    },
    "name": "BRD-K11156132",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83fc.png",
    "lincs": {
      "id": "LSM-9110",
      "name": "BRD-K11156132",
      "pubchemCid": 54631686,
      "chebiId": 97731,
      "inchiParent": "InChI=1S/C23H33N5O5/c1-13-10-24-14(2)12-32-19-9-17(25-23(30)26-21-15(3)27-33-16(21)4)7-8-18(19)22(29)28(5)11-20(13)31-6/h7-9,13-14,20,24H,10-12H2,1-6H3,(H2,25,26,30)/t13-,14+,20+/m0/s1",
      "inchiKeyParent": "RYHWAKGNXXOPFN-LRDNONRASA-N",
      "smilesParent": "CO[C@@H]1CN(C)C(=O)c2ccc(NC(=O)Nc3c(C)onc3C)cc2OC[C@@H](C)NC[C@@H]1C"
    },
    "unichem": {
      "chebi": "97731",
      "lincs": "LSM-9110",
      "pubchem": "54631686"
    },
    "pubchem": [
      {
        "cid": 54631686,
        "inchi": "InChI=1S/C23H33N5O5/c1-13-10-24-14(2)12-32-19-9-17(25-23(30)26-21-15(3)27-33-16(21)4)7-8-18(19)22(29)28(5)11-20(13)31-6/h7-9,13-14,20,24H,10-12H2,1-6H3,(H2,25,26,30)/t13-,14+,20+/m0/s1",
        "inchikey": "RYHWAKGNXXOPFN-LRDNONRASA-N",
        "iupac": {
          "systematic": "1-(3,5-dimethyl-1,2-oxazol-4-yl)-3-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-15-yl]urea"
        },
        "smiles": {
          "canonical": "CC1CNC(COC2=C(C=CC(=C2)NC(=O)NC3=C(ON=C3C)C)C(=O)N(CC1OC)C)C"
        },
        "molecularFormula": "C23H33N5O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:32:53Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8352"
    },
    "name": "BRD-K54278059",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8352.png",
    "lincs": {
      "id": "LSM-7555",
      "name": "BRD-K54278059",
      "pubchemCid": 54618269,
      "chebiId": 96176,
      "inchiParent": "InChI=1S/C29H36FN3O5S/c1-20-17-33(21(2)19-34)29(35)26-14-23(13-12-22-8-5-4-6-9-22)16-31-28(26)38-27(20)18-32(3)39(36,37)25-11-7-10-24(30)15-25/h7,10-11,14-16,20-22,27,34H,4-6,8-9,17-19H2,1-3H3/t20-,21+,27-/m1/s1",
      "inchiKeyParent": "FWJMPRMSYCMNDB-PBDKAQRYSA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@@H](C)[C@@H](CN(C)S(=O)(=O)c2cccc(F)c2)Oc3ncc(cc3C1=O)C#CC4CCCCC4"
    },
    "unichem": {
      "chebi": "96176",
      "lincs": "LSM-7555",
      "pubchem": "54618269"
    },
    "pubchem": [
      {
        "cid": 54618269,
        "inchi": "InChI=1S/C29H36FN3O5S/c1-20-17-33(21(2)19-34)29(35)26-14-23(13-12-22-8-5-4-6-9-22)16-31-28(26)38-27(20)18-32(3)39(36,37)25-11-7-10-24(30)15-25/h7,10-11,14-16,20-22,27,34H,4-6,8-9,17-19H2,1-3H3/t20-,21+,27-/m1/s1",
        "inchikey": "FWJMPRMSYCMNDB-PBDKAQRYSA-N",
        "iupac": {
          "systematic": "N-[[(2S,3R)-8-(2-cyclohexylethynyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-3-fluoro-N-methylbenzenesulfonamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(N=CC(=C2)C#CC3CCCCC3)OC1CN(C)S(=O)(=O)C4=CC=CC(=C4)F)C(C)CO"
        },
        "molecularFormula": "C29H36FN3O5S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:32:55Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c835d"
    },
    "name": "Cytosporone B",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c835d.png",
    "lincs": {
      "id": "LSM-6280",
      "name": "Cytosporone B",
      "pubchemCid": 10687292,
      "chebiId": 95039,
      "inchiParent": "InChI=1S/C18H26O5/c1-3-5-6-7-8-9-15(20)18-13(11-17(22)23-4-2)10-14(19)12-16(18)21/h10,12,19,21H,3-9,11H2,1-2H3",
      "inchiKeyParent": "UVVWQQKSNZLUQA-UHFFFAOYSA-N",
      "smilesParent": "CCCCCCCC(=O)c1c(O)cc(O)cc1CC(=O)OCC"
    },
    "unichem": {
      "chebi": "95039",
      "chembl": "CHEMBL1221517",
      "lincs": "LSM-6280",
      "pubchem": "10687292"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL1221517",
      "prefName": "CYTOSPORONE B",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 322.4,
        "hba": 5,
        "hbd": 2,
        "qedWeighted": 0.39
      }
    },
    "pubchem": [
      {
        "cid": 10687292,
        "inchi": "InChI=1S/C18H26O5/c1-3-5-6-7-8-9-15(20)18-13(11-17(22)23-4-2)10-14(19)12-16(18)21/h10,12,19,21H,3-9,11H2,1-2H3",
        "inchikey": "UVVWQQKSNZLUQA-UHFFFAOYSA-N",
        "iupac": {
          "systematic": "ethyl 2-(3,5-dihydroxy-2-octanoylphenyl)acetate"
        },
        "smiles": {
          "canonical": "CCCCCCCC(=O)C1=C(C=C(C=C1O)O)CC(=O)OCC"
        },
        "molecularFormula": "C18H26O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:33:06Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8363"
    },
    "name": "MLS003129733",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8363.png",
    "lincs": {
      "id": "LSM-7789",
      "name": "MLS003129733",
      "alternativeNames": [
        "BRD-K70102743"
      ],
      "pubchemCid": 44505755,
      "chebiId": 96410,
      "inchiParent": "InChI=1S/C21H37N5O5/c1-15(2)13-31-21(29)24(5)11-19-16(3)10-25(17(4)12-27)20(28)7-6-8-26-18(14-30-19)9-22-23-26/h9,15-17,19,27H,6-8,10-14H2,1-5H3/t16-,17-,19+/m1/s1",
      "inchiKeyParent": "MNAJUJYQFCFYAB-LMMKCTJWSA-N",
      "smilesParent": "CC(C)COC(=O)N(C)C[C@@H]1OCc2cnnn2CCCC(=O)N(C[C@H]1C)[C@H](C)CO"
    },
    "unichem": {
      "chebi": "96410",
      "chembl": "CHEMBL1873530",
      "lincs": "LSM-7789",
      "pubchem": "44505755"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL1873530",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 439.56,
        "hba": 8,
        "hbd": 1,
        "qedWeighted": 0.72
      }
    },
    "pubchem": [
      {
        "cid": 44505755,
        "inchi": "InChI=1S/C21H37N5O5/c1-15(2)13-31-21(29)24(5)11-19-16(3)10-25(17(4)12-27)20(28)7-6-8-26-18(14-30-19)9-22-23-26/h9,15-17,19,27H,6-8,10-14H2,1-5H3/t16-,17-,19+/m1/s1",
        "inchikey": "MNAJUJYQFCFYAB-LMMKCTJWSA-N",
        "iupac": {
          "systematic": "2-methylpropyl N-[[(8R,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methylcarbamate"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)CCCN2C(=CN=N2)COC1CN(C)C(=O)OCC(C)C)C(C)CO"
        },
        "molecularFormula": "C21H37N5O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:33:17Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83c8"
    },
    "name": "BRD-K20191348",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83c8.png",
    "lincs": {
      "id": "LSM-43454",
      "name": "BRD-K20191348",
      "pubchemCid": 54661199,
      "inchiParent": "InChI=1S/C29H33N3O4/c33-17-22-24-16-31-23(14-13-21(28(31)35)12-11-18-5-2-1-3-6-18)26(32(24)29(36)20-7-4-8-20)25(22)27(34)30-15-19-9-10-19/h1-3,5-6,11-14,19-20,22,24-26,33H,4,7-10,15-17H2,(H,30,34)/b12-11+/t22-,24-,25+,26+/m1/s1",
      "inchiKeyParent": "IAXCLMCZIRASFG-RONVXQAYSA-N",
      "smilesParent": "OC[C@@H]1[C@H]2CN3C(=O)C(=CC=C3[C@@H]([C@H]1C(=O)NCC4CC4)N2C(=O)C5CCC5)\\C=C\\c6ccccc6"
    },
    "unichem": {
      "lincs": "LSM-43454",
      "pubchem": "54661199"
    },
    "pubchem": [
      {
        "cid": 54661199,
        "inchi": "InChI=1S/C29H33N3O4/c33-17-22-24-16-31-23(14-13-21(28(31)35)12-11-18-5-2-1-3-6-18)26(32(24)29(36)20-7-4-8-20)25(22)27(34)30-15-19-9-10-19/h1-3,5-6,11-14,19-20,22,24-26,33H,4,7-10,15-17H2,(H,30,34)/b12-11+/t22-,24-,25+,26+/m1/s1",
        "inchikey": "IAXCLMCZIRASFG-RONVXQAYSA-N",
        "iupac": {
          "systematic": "(1R,9S,10S,11S)-12-(cyclobutanecarbonyl)-N-(cyclopropylmethyl)-10-(hydroxymethyl)-6-oxo-5-[(E)-2-phenylethenyl]-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide"
        },
        "smiles": {
          "canonical": "C1CC(C1)C(=O)N2C3CN4C(=CC=C(C4=O)C=CC5=CC=CC=C5)C2C(C3CO)C(=O)NCC6CC6"
        },
        "molecularFormula": "C29H33N3O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:33:20Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83d8"
    },
    "name": "BRD-K43225681",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83d8.png",
    "lincs": {
      "id": "LSM-11057",
      "name": "BRD-K43225681",
      "pubchemCid": 54654593,
      "chebiId": 99678,
      "inchiParent": "InChI=1S/C30H35N3O8/c1-33-23-5-4-21(14-28(34)31-15-18-2-6-25-26(12-18)40-17-39-25)41-27(23)16-38-24-7-3-20(13-22(24)30(33)36)32-29(35)19-8-10-37-11-9-19/h2-3,6-7,12-13,19,21,23,27H,4-5,8-11,14-17H2,1H3,(H,31,34)(H,32,35)/t21-,23-,27+/m1/s1",
      "inchiKeyParent": "JZWHDUCFLDKMHA-CIXCFARBSA-N",
      "smilesParent": "CN1[C@@H]2CC[C@H](CC(=O)NCc3ccc4OCOc4c3)O[C@H]2COc5ccc(NC(=O)C6CCOCC6)cc5C1=O"
    },
    "unichem": {
      "chebi": "99678",
      "lincs": "LSM-11057",
      "pubchem": "54654593"
    },
    "pubchem": [
      {
        "cid": 54654593,
        "inchi": "InChI=1S/C30H35N3O8/c1-33-23-5-4-21(14-28(34)31-15-18-2-6-25-26(12-18)40-17-39-25)41-27(23)16-38-24-7-3-20(13-22(24)30(33)36)32-29(35)19-8-10-37-11-9-19/h2-3,6-7,12-13,19,21,23,27H,4-5,8-11,14-17H2,1H3,(H,31,34)(H,32,35)/t21-,23-,27+/m1/s1",
        "inchikey": "JZWHDUCFLDKMHA-CIXCFARBSA-N",
        "iupac": {
          "systematic": "N-[(2R,4aR,12aR)-2-[2-(1,3-benzodioxol-5-ylmethylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]oxane-4-carboxamide"
        },
        "smiles": {
          "canonical": "CN1C2CCC(OC2COC3=C(C1=O)C=C(C=C3)NC(=O)C4CCOCC4)CC(=O)NCC5=CC6=C(C=C5)OCO6"
        },
        "molecularFormula": "C30H35N3O8"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:33:22Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83e2"
    },
    "name": "BRD-K64133040",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83e2.png",
    "lincs": {
      "id": "LSM-12344",
      "name": "BRD-K64133040",
      "pubchemCid": 54661235,
      "chebiId": 100971,
      "inchiParent": "InChI=1S/C27H28N2O5/c1-33-23-11-7-6-10-18(23)19-12-13-21-25-24(27(32)34-2)20(16-30)22(15-29(21)26(19)31)28(25)14-17-8-4-3-5-9-17/h3-13,20,22,24-25,30H,14-16H2,1-2H3/t20-,22-,24+,25+/m1/s1",
      "inchiKeyParent": "VLQJEDUGSYPRCL-KAKDDGLXSA-N",
      "smilesParent": "COC(=O)[C@H]1[C@H](CO)[C@H]2CN3C(=CC=C(C3=O)c4ccccc4OC)[C@@H]1N2Cc5ccccc5"
    },
    "unichem": {
      "chebi": "100971",
      "lincs": "LSM-12344",
      "pubchem": "54661235"
    },
    "pubchem": [
      {
        "cid": 54661235,
        "inchi": "InChI=1S/C27H28N2O5/c1-33-23-11-7-6-10-18(23)19-12-13-21-25-24(27(32)34-2)20(16-30)22(15-29(21)26(19)31)28(25)14-17-8-4-3-5-9-17/h3-13,20,22,24-25,30H,14-16H2,1-2H3/t20-,22-,24+,25+/m1/s1",
        "inchikey": "VLQJEDUGSYPRCL-KAKDDGLXSA-N",
        "iupac": {
          "systematic": "methyl (1R,9S,10S,11S)-12-benzyl-10-(hydroxymethyl)-5-(2-methoxyphenyl)-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxylate"
        },
        "smiles": {
          "canonical": "COC1=CC=CC=C1C2=CC=C3C4C(C(C(N4CC5=CC=CC=C5)CN3C2=O)CO)C(=O)OC"
        },
        "molecularFormula": "C27H28N2O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:33:24Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8413"
    },
    "name": "MLS003129325",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8413.png",
    "lincs": {
      "id": "LSM-7978",
      "name": "MLS003129325",
      "alternativeNames": [
        "BRD-K87904079"
      ],
      "pubchemCid": 44496392,
      "chebiId": 96599,
      "inchiParent": "InChI=1S/C23H35N5O6S/c1-17-13-27(18(2)15-29)23(30)10-7-11-28-19(12-24-25-28)16-34-21(17)14-26(3)35(31,32)22-9-6-5-8-20(22)33-4/h5-6,8-9,12,17-18,21,29H,7,10-11,13-16H2,1-4H3/t17-,18+,21+/m0/s1",
      "inchiKeyParent": "QLGFDRXFQQZFKX-WAOWUJCRSA-N",
      "smilesParent": "COc1ccccc1S(=O)(=O)N(C)C[C@H]2OCc3cnnn3CCCC(=O)N(C[C@@H]2C)[C@H](C)CO"
    },
    "unichem": {
      "chebi": "96599",
      "chembl": "CHEMBL2136422",
      "lincs": "LSM-7978",
      "pubchem": "44496392"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL2136422",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 509.63,
        "hba": 9,
        "hbd": 1,
        "qedWeighted": 0.59
      }
    },
    "pubchem": [
      {
        "cid": 44496392,
        "inchi": "InChI=1S/C23H35N5O6S/c1-17-13-27(18(2)15-29)23(30)10-7-11-28-19(12-24-25-28)16-34-21(17)14-26(3)35(31,32)22-9-6-5-8-20(22)33-4/h5-6,8-9,12,17-18,21,29H,7,10-11,13-16H2,1-4H3/t17-,18+,21+/m0/s1",
        "inchikey": "QLGFDRXFQQZFKX-WAOWUJCRSA-N",
        "iupac": {
          "systematic": "N-[[(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-2-methoxy-N-methylbenzenesulfonamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)CCCN2C(=CN=N2)COC1CN(C)S(=O)(=O)C3=CC=CC=C3OC)C(C)CO"
        },
        "molecularFormula": "C23H35N5O6S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:33:35Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c835b"
    },
    "name": "Clarithromycin",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c835b.png",
    "lincs": {
      "id": "LSM-5606",
      "name": "Clarithromycin",
      "alternativeNames": [
        "ABBOTT-56268",
        "TE-031",
        "Zeclar",
        "Clarithromycin Extended Release",
        "Clarithromycin",
        "Biaxin",
        "Febzin XL",
        "Clarithromycin Identity",
        "Clarosip",
        "Klaricid I.V.",
        "A-56268",
        "Biaxin XL",
        "Klaricid Adult",
        "Klaricid XL",
        "KLARICID 500",
        "Biaxin Xl PAC",
        "Klaricid",
        "Klaricid PAED",
        "Clarie XL",
        "Xetinin XL",
        "Prevpac",
        "Mycifor XL"
      ],
      "pubchemCid": 84029,
      "chebiId": 3732,
      "inchiParent": "InChI=1S/C38H69NO13/c1-15-26-38(10,45)31(42)21(4)28(40)19(2)17-37(9,47-14)33(52-35-29(41)25(39(11)12)16-20(3)48-35)22(5)30(23(6)34(44)50-26)51-27-18-36(8,46-13)32(43)24(7)49-27/h19-27,29-33,35,41-43,45H,15-18H2,1-14H3/t19-,20-,21+,22+,23-,24+,25+,26-,27+,29-,30+,31-,32+,33-,35+,36-,37-,38-/m1/s1",
      "inchiKeyParent": "AGOYDEPGAOXOCK-KCBOHYOISA-N",
      "smilesParent": "CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O)OC"
    },
    "unichem": {
      "chebi": "3732",
      "chembl": "CHEMBL1741",
      "lincs": "LSM-5606",
      "pubchem": "84029",
      "drugbank": "DB01211"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL1741",
      "prefName": "CLARITHROMYCIN",
      "maxPhase": 4.0,
      "maxPhaseCurated": "Approved",
      "firstApproval": 1991,
      "chebiParId": "3732",
      "oral": true,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 747.96,
        "hba": 14,
        "hbd": 4,
        "qedWeighted": 0.27
      },
      "moleculeSynonyms": [
        {
          "moleculeSynonym": "6-o-methylerythromycin",
          "synType": "OTHER",
          "synonyms": "6-O-METHYLERYTHROMYCIN"
        },
        {
          "moleculeSynonym": "A-56268",
          "synType": "RESEARCH_CODE",
          "synonyms": "A-56268"
        },
        {
          "moleculeSynonym": "ABBOTT-56268",
          "synType": "OTHER",
          "synonyms": "ABBOTT-56268"
        },
        {
          "moleculeSynonym": "ABBOTT-56268",
          "synType": "RESEARCH_CODE",
          "synonyms": "ABBOTT-56268"
        },
        {
          "moleculeSynonym": "Biaxin",
          "synType": "OTHER",
          "synonyms": "Biaxin"
        },
        {
          "moleculeSynonym": "Biaxin",
          "synType": "TRADE_NAME",
          "synonyms": "BIAXIN"
        },
        {
          "moleculeSynonym": "Biaxin xl",
          "synType": "TRADE_NAME",
          "synonyms": "BIAXIN XL"
        },
        {
          "moleculeSynonym": "Biaxin Xl Pac",
          "synType": "TRADE_NAME",
          "synonyms": "Biaxin XL Pac"
        },
        {
          "moleculeSynonym": "Clarie xl",
          "synType": "TRADE_NAME",
          "synonyms": "CLARIE XL"
        },
        {
          "moleculeSynonym": "Clarithromycin",
          "synType": "ATC",
          "synonyms": "CLARITHROMYCIN"
        },
        {
          "moleculeSynonym": "Clarithromycin",
          "synType": "BAN",
          "synonyms": "CLARITHROMYCIN"
        },
        {
          "moleculeSynonym": "Clarithromycin",
          "synType": "BNF",
          "synonyms": "CLARITHROMYCIN"
        },
        {
          "moleculeSynonym": "Clarithromycin",
          "synType": "FDA",
          "synonyms": "CLARITHROMYCIN"
        },
        {
          "moleculeSynonym": "Clarithromycin",
          "synType": "INN",
          "synonyms": "CLARITHROMYCIN"
        },
        {
          "moleculeSynonym": "Clarithromycin",
          "synType": "JAN",
          "synonyms": "CLARITHROMYCIN"
        },
        {
          "moleculeSynonym": "Clarithromycin",
          "synType": "MERCK_INDEX",
          "synonyms": "CLARITHROMYCIN"
        },
        {
          "moleculeSynonym": "Clarithromycin",
          "synType": "OTHER",
          "synonyms": "CLARITHROMYCIN"
        },
        {
          "moleculeSynonym": "Clarithromycin",
          "synType": "TRADE_NAME",
          "synonyms": "CLARITHROMYCIN"
        },
        {
          "moleculeSynonym": "Clarithromycin",
          "synType": "USAN",
          "synonyms": "CLARITHROMYCIN"
        },
        {
          "moleculeSynonym": "Clarithromycin",
          "synType": "USP",
          "synonyms": "CLARITHROMYCIN"
        },
        {
          "moleculeSynonym": "Clarithromycine",
          "synType": "INN_FRENCH",
          "synonyms": "CLARITHROMYCINE"
        },
        {
          "moleculeSynonym": "Clarithromycin Extended Release",
          "synType": "TRADE_NAME",
          "synonyms": "Clarithromycin extended release"
        },
        {
          "moleculeSynonym": "Clarithromycin identity",
          "synType": "USP",
          "synonyms": "CLARITHROMYCIN IDENTITY"
        },
        {
          "moleculeSynonym": "Claritromicina",
          "synType": "INN_SPANISH",
          "synonyms": "CLARITROMICINA"
        },
        {
          "moleculeSynonym": "Clarosip",
          "synType": "TRADE_NAME",
          "synonyms": "CLAROSIP"
        },
        {
          "moleculeSynonym": "Cyllind",
          "synType": "OTHER",
          "synonyms": "CYLLIND"
        },
        {
          "moleculeSynonym": "Erythromycin, 6-o-methyl-",
          "synType": "OTHER",
          "synonyms": "ERYTHROMYCIN, 6-O-METHYL-"
        },
        {
          "moleculeSynonym": "Febzin xl",
          "synType": "TRADE_NAME",
          "synonyms": "FEBZIN XL"
        },
        {
          "moleculeSynonym": "Klacid",
          "synType": "OTHER",
          "synonyms": "KLACID"
        },
        {
          "moleculeSynonym": "Klaricid",
          "synType": "TRADE_NAME",
          "synonyms": "KLARICID"
        },
        {
          "moleculeSynonym": "Klaricid 500",
          "synType": "TRADE_NAME",
          "synonyms": "KLARICID 500"
        },
        {
          "moleculeSynonym": "Klaricid adult",
          "synType": "TRADE_NAME",
          "synonyms": "KLARICID ADULT"
        },
        {
          "moleculeSynonym": "Klaricid i.v.",
          "synType": "TRADE_NAME",
          "synonyms": "KLARICID I.V."
        },
        {
          "moleculeSynonym": "Klaricid paed",
          "synType": "TRADE_NAME",
          "synonyms": "KLARICID PAED"
        },
        {
          "moleculeSynonym": "Klaricid xl",
          "synType": "TRADE_NAME",
          "synonyms": "KLARICID XL"
        },
        {
          "moleculeSynonym": "Macladin",
          "synType": "OTHER",
          "synonyms": "MACLADIN"
        },
        {
          "moleculeSynonym": "Mavid",
          "synType": "OTHER",
          "synonyms": "MAVID"
        },
        {
          "moleculeSynonym": "Mycifor xl",
          "synType": "TRADE_NAME",
          "synonyms": "MYCIFOR XL"
        },
        {
          "moleculeSynonym": "NSC-758704",
          "synType": "RESEARCH_CODE",
          "synonyms": "NSC-758704"
        },
        {
          "moleculeSynonym": "Prevpac",
          "synType": "OTHER",
          "synonyms": "Prevpac"
        },
        {
          "moleculeSynonym": "TE-031",
          "synType": "RESEARCH_CODE",
          "synonyms": "TE-031"
        },
        {
          "moleculeSynonym": "Veclam",
          "synType": "OTHER",
          "synonyms": "VECLAM"
        },
        {
          "moleculeSynonym": "Xetinin xl",
          "synType": "TRADE_NAME",
          "synonyms": "XETININ XL"
        },
        {
          "moleculeSynonym": "Zeclar",
          "synType": "TRADE_NAME",
          "synonyms": "ZECLAR"
        }
      ],
      "drugIndications": [
        {
          "efoId": "EFO:0006505",
          "efoTerm": "chronic bronchitis",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT00645086"
            ]
          },
          "maxPhaseForInd": 4.0,
          "meshHeading": "Bronchitis, Chronic"
        },
        {
          "efoId": "EFO:0007486",
          "efoTerm": "sinusitis",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT00644553"
            ]
          },
          "maxPhaseForInd": 4.0,
          "meshHeading": "Sinusitis"
        },
        {
          "efoId": "EFO:0000544",
          "efoTerm": "infection",
          "indicationRefs": {
            "fda": [
              "label/2000/50662S29lbl.pdf"
            ]
          },
          "maxPhaseForInd": 4.0,
          "meshHeading": "Infections"
        },
        {
          "efoId": "EFO:0000384",
          "efoTerm": "Crohn's disease",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT00269386,NCT03009396"
            ]
          },
          "maxPhaseForInd": 3.0,
          "meshHeading": "Crohn Disease"
        },
        {
          "efoId": "EFO:0001378",
          "efoTerm": "multiple myeloma",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT00006219,NCT00151203,NCT00182663,NCT00445692,NCT00538733,NCT01159574,NCT01374217,NCT01559935,NCT01745588,NCT02248428,NCT02343042,NCT02516696,NCT02542657,NCT02573935,NCT02575144,NCT02986451,NCT04063189,NCT04287660,NCT04302324,NCT04843579"
            ]
          },
          "maxPhaseForInd": 3.0,
          "meshHeading": "Multiple Myeloma"
        },
        {
          "efoId": "EFO:0000574",
          "efoTerm": "lymphoma",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT00002682,NCT00003151,NCT01454076,NCT01516606,NCT03031483"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Lymphoma"
        },
        {
          "efoId": "EFO:0003106",
          "efoTerm": "pneumonia",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT00336505,NCT00336544,NCT00643227,NCT00717561,NCT00818610"
            ]
          },
          "maxPhaseForInd": 4.0,
          "meshHeading": "Pneumonia"
        },
        {
          "efoId": "EFO:0003777",
          "efoTerm": "heart disease",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT00121550"
            ]
          },
          "maxPhaseForInd": 3.0,
          "meshHeading": "Heart Diseases"
        },
        {
          "efoId": "EFO:0000649",
          "efoTerm": "periodontitis",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT02969928,NCT03132714"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Periodontitis"
        },
        {
          "efoId": "EFO:0000095",
          "efoTerm": "chronic lymphocytic leukemia",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT01279252"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Leukemia, Lymphocytic, Chronic, B-Cell"
        },
        {
          "efoId": "EFO:0000191",
          "efoTerm": "MALT lymphoma",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT00201422"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Lymphoma, B-Cell, Marginal Zone"
        },
        {
          "efoId": "EFO:0000616",
          "efoTerm": "neoplasm",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT02117648"
            ]
          },
          "maxPhaseForInd": 1.0,
          "meshHeading": "Neoplasms"
        },
        {
          "efoId": "EFO:0000708",
          "efoTerm": "squamous cell lung carcinoma",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT02852083"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Carcinoma, Squamous Cell"
        },
        {
          "efoId": "EFO:0000764",
          "efoTerm": "HIV infection",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT00002194"
            ]
          },
          "maxPhaseForInd": 1.0,
          "meshHeading": "HIV Infections"
        },
        {
          "efoId": "EFO:0003060",
          "efoTerm": "non-small cell lung carcinoma",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT02852083"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Carcinoma, Non-Small-Cell Lung"
        },
        {
          "efoId": "EFO:0003102",
          "efoTerm": "osteomyelitis",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT02099240"
            ]
          },
          "maxPhaseForInd": 0.5,
          "meshHeading": "Osteomyelitis"
        },
        {
          "efoId": "EFO:0004286",
          "efoTerm": "venous thromboembolism",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT02912234"
            ]
          },
          "maxPhaseForInd": 1.0,
          "meshHeading": "Venous Thromboembolism"
        },
        {
          "efoId": "EFO:0005952",
          "efoTerm": "non-Hodgkins lymphoma",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT00154440"
            ]
          },
          "maxPhaseForInd": 3.0,
          "meshHeading": "Lymphoma, Non-Hodgkin"
        },
        {
          "efoId": "EFO:0006834",
          "efoTerm": "septic shock",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT01223690"
            ]
          },
          "maxPhaseForInd": 3.0,
          "meshHeading": "Shock, Septic"
        },
        {
          "efoId": "EFO:0007183",
          "efoTerm": "bronchiolitis obliterans",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT00381147"
            ]
          },
          "maxPhaseForInd": 3.0,
          "meshHeading": "Bronchiolitis Obliterans"
        },
        {
          "efoId": "EFO:0007200",
          "efoTerm": "cerebral toxoplasmosis",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT00000794"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Toxoplasmosis, Cerebral"
        },
        {
          "efoId": "EFO:0007386",
          "efoTerm": "Mycobacterium avium complex disease",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT00000644,NCT00001030,NCT00001047,NCT00001058,NCT00002101,NCT00002140,NCT00004689,NCT04630145"
            ]
          },
          "maxPhaseForInd": 3.0,
          "meshHeading": "Mycobacterium avium-intracellulare Infection"
        },
        {
          "efoId": "EFO:0007456",
          "efoTerm": "pseudomyxoma peritonei",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT02387203"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Pseudomyxoma Peritonei"
        },
        {
          "efoId": "EFO:1000961",
          "efoTerm": "Helicobacter pylori infectious disease",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT00149084,NCT00403364,NCT00669955,NCT00719420,NCT01481844,NCT01505127,NCT02090738,NCT02422706,NCT02892409,NCT03142620,NCT03317223,NCT03498456,NCT04167670,NCT04198363,NCT04753437,NCT05857163,NCT05861687"
            ]
          },
          "maxPhaseForInd": 3.0,
          "meshHeading": "Helicobacter Infections"
        },
        {
          "efoId": "EFO:1001272",
          "efoTerm": "bacterial pneumonia",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT00621504"
            ]
          },
          "maxPhaseForInd": 3.0,
          "meshHeading": "Pneumonia, Bacterial"
        },
        {
          "efoId": "HP:0100806",
          "efoTerm": "Sepsis",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT01223690"
            ]
          },
          "maxPhaseForInd": 3.0,
          "meshHeading": "Sepsis"
        },
        {
          "efoId": "MP:0001914",
          "efoTerm": "hemorrhage",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT03362281"
            ]
          },
          "maxPhaseForInd": 3.0,
          "meshHeading": "Hemorrhage"
        },
        {
          "efoId": "EFO:0004607",
          "efoTerm": "duodenal ulcer",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT00149084,NCT01922765"
            ]
          },
          "maxPhaseForInd": 4.0,
          "meshHeading": "Duodenal Ulcer"
        },
        {
          "efoId": "EFO:0000180",
          "efoTerm": "HIV-1 infection",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT03709355"
            ]
          },
          "maxPhaseForInd": 1.0,
          "meshHeading": "HIV Infections"
        },
        {
          "efoId": "EFO:0009708",
          "efoTerm": "metastasis",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT02117648"
            ]
          },
          "maxPhaseForInd": 1.0,
          "meshHeading": "Neoplasm Metastasis"
        },
        {
          "efoId": "EFO:0000771",
          "efoTerm": "bacterial disease",
          "maxPhaseForInd": 4.0,
          "meshHeading": "Bacterial Infections"
        },
        {
          "efoId": "MONDO:0001056",
          "efoTerm": "gastric cancer",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT00003617"
            ]
          },
          "maxPhaseForInd": 3.0,
          "meshHeading": "Stomach Neoplasms"
        },
        {
          "efoId": "MONDO:0002009",
          "efoTerm": "major depressive disorder",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT01460407"
            ]
          },
          "maxPhaseForInd": 1.0,
          "meshHeading": "Depressive Disorder, Major"
        },
        {
          "efoId": "MONDO:0002775",
          "efoTerm": "anovulation",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT01289756"
            ]
          },
          "maxPhaseForInd": 1.0,
          "meshHeading": "Anovulation"
        },
        {
          "efoId": "MONDO:0008315",
          "efoTerm": "prostate cancer",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT03043989"
            ]
          },
          "maxPhaseForInd": 1.0,
          "meshHeading": "Prostatic Neoplasms, Castration-Resistant"
        },
        {
          "efoId": "MONDO:0021107",
          "efoTerm": "narcolepsy",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT01146600"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Narcolepsy"
        },
        {
          "efoId": "EFO:0000217",
          "efoTerm": "gastritis",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT00149084"
            ]
          },
          "maxPhaseForInd": 3.0,
          "meshHeading": "Gastritis"
        },
        {
          "efoId": "EFO:0009454",
          "efoTerm": "gastric ulcer",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT00149084"
            ]
          },
          "maxPhaseForInd": 3.0,
          "meshHeading": "Stomach Ulcer"
        },
        {
          "efoId": "MONDO:0100096",
          "efoTerm": "COVID-19",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT04398004"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Severe Acute Respiratory Syndrome"
        },
        {
          "efoId": "EFO:0004992",
          "efoTerm": "Otitis media",
          "maxPhaseForInd": 4.0,
          "meshHeading": "Otitis Media"
        },
        {
          "efoId": "EFO:0007361",
          "efoTerm": "maxillary sinusitis",
          "maxPhaseForInd": 4.0,
          "meshHeading": "Maxillary Sinusitis"
        },
        {
          "efoId": "HP:0011110",
          "efoTerm": "Recurrent tonsillitis",
          "maxPhaseForInd": 4.0,
          "meshHeading": "Tonsillitis"
        },
        {
          "efoId": "MONDO:0002258",
          "efoTerm": "pharyngitis",
          "maxPhaseForInd": 4.0,
          "meshHeading": "Pharyngitis"
        },
        {
          "efoId": "MONDO:0018044",
          "efoTerm": "idiopathic hypersomnia",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT01146600"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Idiopathic Hypersomnia"
        },
        {
          "efoId": "MONDO:0000327",
          "efoTerm": "Buruli ulcer disease",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT00321178,NCT01659437,NCT05169554"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Buruli Ulcer"
        },
        {
          "efoId": "MONDO:0004979",
          "efoTerm": "asthma",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT00318708"
            ]
          },
          "maxPhaseForInd": 3.0,
          "meshHeading": "Asthma"
        },
        {
          "efoId": "MONDO:0005180",
          "efoTerm": "Parkinson disease",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT03440112,NCT04070495"
            ]
          },
          "maxPhaseForInd": 1.0,
          "meshHeading": "Parkinson Disease"
        },
        {
          "efoId": "MONDO:0009061",
          "efoTerm": "cystic fibrosis",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT00205634"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Cystic Fibrosis"
        },
        {
          "efoId": "MONDO:0018076",
          "efoTerm": "tuberculosis",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT01298336"
            ]
          },
          "maxPhaseForInd": 3.0,
          "meshHeading": "Tuberculosis"
        },
        {
          "efoId": "MONDO:0019091",
          "efoTerm": "bronchopulmonary dysplasia",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT01652118"
            ]
          },
          "maxPhaseForInd": 3.0,
          "meshHeading": "Bronchopulmonary Dysplasia"
        },
        {
          "efoId": "MONDO:0004992",
          "efoTerm": "cancer",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT01454076,NCT04551963"
            ]
          },
          "maxPhaseForInd": 1.0,
          "meshHeading": "Neoplasms"
        }
      ],
      "drugMechanisms": [
        {
          "mechanismOfAction": "Bacterial 70S ribosome inhibitor",
          "actionType": "INHIBITOR",
          "targetName": "Bacterial 70S ribosome",
          "targetOrganism": "Bacteria",
          "targetType": "PROTEIN NUCLEIC-ACID COMPLEX",
          "targetComponents": [
            {
              "uniprot": [
                "P0A7V0",
                "P60723",
                "P0AG67",
                "P0A7R5",
                "P0A7R9",
                "P0A7S3",
                "P0A7S9",
                "P0AG59",
                "P0ADZ4",
                "P0A7T3",
                "P0AG63",
                "P0A7T7",
                "P0A7U3",
                "P0A7U7",
                "P68679",
                "P0A7V3",
                "P0A7V8",
                "P0A7W1",
                "P02358",
                "P02359",
                "P0A7W7",
                "P0A7X3",
                "P0A7J3",
                "P0A7J7",
                "P0AA10",
                "P0ADY3",
                "P02413",
                "P0ADY7",
                "P0AG44",
                "P0C018",
                "P0A7K6",
                "P0A7L0",
                "P0A7L3",
                "P0AG48",
                "P61175",
                "P0ADZ0",
                "P60624",
                "P68919",
                "P0A7L8",
                "P0A7M2",
                "P0A7M6",
                "P60422",
                "P0AG51",
                "P0A7N1",
                "P0A7M9",
                "P0A7N4",
                "P0A7N9",
                "P0A7P5",
                "P0A7Q1",
                "Q2EEQ2",
                "P0A7Q6",
                "P60438",
                "P62399",
                "P0AG55",
                "P0A7K2"
              ]
            }
          ]
        }
      ]
    },
    "pubchem": [
      {
        "cid": 84029,
        "inchi": "InChI=1S/C38H69NO13/c1-15-26-38(10,45)31(42)21(4)28(40)19(2)17-37(9,47-14)33(52-35-29(41)25(39(11)12)16-20(3)48-35)22(5)30(23(6)34(44)50-26)51-27-18-36(8,46-13)32(43)24(7)49-27/h19-27,29-33,35,41-43,45H,15-18H2,1-14H3/t19-,20-,21+,22+,23-,24+,25+,26-,27+,29-,30+,31-,32+,33-,35+,36-,37-,38-/m1/s1",
        "inchikey": "AGOYDEPGAOXOCK-KCBOHYOISA-N",
        "iupac": {
          "systematic": "(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-12,13-dihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-7-methoxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione"
        },
        "smiles": {
          "canonical": "CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O"
        },
        "molecularFormula": "C38H69NO13"
      }
    ],
    "clinicaltrials": [
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT04107194",
            "briefTitle": "Non-invasive Test-guided Tailored Therapy Versus Empiric Treatment for Helicobacter Pylori Infection.",
            "officialTitle": "Comparison Between Tailored Therapy Guided by a Non-invasive Antibiotic Susceptibility Test and Empiric Treatment for First-line Helicobacter Pylori Eradication in Patients With Dyspepsia: a Randomized Controlled Trial."
          },
          "statusModule": {
            "overallStatus": "UNKNOWN",
            "studyFirstSubmitDate": "2019-09-25"
          },
          "conditionsModule": {
            "conditions": [
              "Helicobacter Pylori Infection",
              "Antibiotic Resistant Infection",
              "Antibiotic Resistant Strain"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Eradication rate",
                "timeFrame": "30 days"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Adverse events"
              },
              {
                "measure": "Participants' compliance"
              },
              {
                "measure": "Treatment withdrawal"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00000794",
            "briefTitle": "Phase II Randomized Open-Label Trial of Atovaquone Plus Pyrimethamine and Atovaquone Plus Sulfadiazine for the Treatment of Acute Toxoplasmic Encephalitis",
            "officialTitle": "Phase II Randomized Open-Label Trial of Atovaquone Plus Pyrimethamine and Atovaquone Plus Sulfadiazine for the Treatment of Acute Toxoplasmic Encephalitis"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "1999-11-02"
          },
          "conditionsModule": {
            "conditions": [
              "Toxoplasmosis, Cerebral",
              "HIV Infections"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01593592",
            "briefTitle": "Lactobacillus Reuteri in Management of Helicobacter Pylori Infection in Dyspeptic Patients",
            "officialTitle": "Lactobacillus Reuteri in Management of Helicobacter Pylori Infection in Dyspeptic Patients: a Double Blind Placebo Controlled Randomized Clinical Trial"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2012-05-05",
            "resultsFirstSubmitDate": "2015-03-07"
          },
          "conditionsModule": {
            "conditions": [
              "Helicobacter Pylori Infection"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Eradication of H Pylori Infection 4 Weeks After Completion of Therapy",
                "timeFrame": "4 weeks therapy"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Severe Adverse Effects to the Used Medications and Dietary Supplements."
              },
              {
                "measure": "The Secondary End Point Was the Development of Severe Adverse Effects to the Used Medications and Dietary Supplements."
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02182492",
            "briefTitle": "Efficacy of Macrolide and Glucocorticoid in the Treatment of Chronic Rhinosinusitis After Endoscopic Sinus Surgery",
            "officialTitle": "Comparison of Different Efficacy of Macrolide and Glucocorticoid in the Treatment of Chronic Rhinosinusitis Patients After Endoscopic Sinus Surgery"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2014-06-30",
            "resultsFirstSubmitDate": "2017-06-30"
          },
          "conditionsModule": {
            "conditions": [
              "Chronic Rhinosinusitis",
              "Endoscopic Sinus Surgery"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Total Subjective Symptoms Visual Analog Scores (VAS)",
                "timeFrame": "Scores will be recorded just before ESS and at 1-, 3-, 6- and 12-month follow-up visit."
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Total Nasal Endoscopic Scores"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01667692",
            "briefTitle": "Aizthromycin or Clarithromycin in H-pylori Eradication Regimen",
            "officialTitle": "Comparison of Azithromycin or Clarithromycin in 3drugs Protocol of H-pylori Eradication Regimen"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2012-08-12"
          },
          "conditionsModule": {
            "conditions": [
              "Peptic Ulcer",
              "Dyspepsia",
              "H-pylori"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "H-pylori cinfirmation",
                "timeFrame": "1-3 months before study"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "h-pylori eradication confirmation"
              },
              {
                "measure": "side effect of study srugs"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT03142776",
            "briefTitle": "Nonsurgical Periodontal Treatment Associated or Not With Systemic Antibiotics and Photodynamic Therapy",
            "officialTitle": "Evaluation of the Local Effect of Nonsurgical Periodontal Treatment of Generalized Aggressive Periodontitis Associated or Not With Systemic Antibiotics and Photodynamic Therapy.: a Randomized Clinical Trial"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2017-05-02"
          },
          "conditionsModule": {
            "conditions": [
              "Aggressive Periodontitis, Generalized"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Clinical attachment level",
                "timeFrame": "6 months"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Probing depth"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT03583476",
            "briefTitle": "The Impact of Antibiotics MIC Value on the Efficacy of Treatment Regimens for Helicobacter Pylori Infection.",
            "officialTitle": "The Impact of Antibiotics MIC Value on the Efficacy of Treatment Regimens for Helicobacter Pylori Infection."
          },
          "statusModule": {
            "overallStatus": "UNKNOWN",
            "studyFirstSubmitDate": "2018-06-22"
          },
          "conditionsModule": {
            "conditions": [
              "Helicobacter Pylori Infection"
            ]
          },
          "designModule": {
            "studyType": "OBSERVATIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Relationship between eradication rate (%) of therapy regimen and influencing factors (eg. sex, age, diagnosis, MIC).",
                "timeFrame": "4 weeks after treatment finished."
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT05453994",
            "briefTitle": "Bismuth for PCAB-based H. Pylori Eradication",
            "officialTitle": "Efficacy of Bismuth Added to Potassium-competitive Acid Blocker-based Triple Regimen for First-line Helicobacter Pylori Eradication"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2022-07-06"
          },
          "conditionsModule": {
            "conditions": [
              "H. Pylori Infection"
            ]
          },
          "designModule": {
            "studyType": "OBSERVATIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "H. pylori infection status",
                "timeFrame": "6 weeks"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00445692",
            "briefTitle": "Lenalidomide, Dexamethasone, and Clarithromycin in Treating Patients Who Have Undergone Stem Cell Transplant for Multiple Myeloma",
            "officialTitle": "Maintenance Therapy With Lenalidomide, Dexamethasone and Clarithromycin (Biaxin) Following Autologous/Syngeneic Transplant for Multiple Myeloma"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2007-03-07",
            "resultsFirstSubmitDate": "2018-02-22"
          },
          "conditionsModule": {
            "conditions": [
              "DS Stage I Plasma Cell Myeloma",
              "DS Stage II Plasma Cell Myeloma",
              "DS Stage III Plasma Cell Myeloma",
              "Refractory Plasma Cell Myeloma"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Episodes of Grade 3-4 Non Infectious, Non-dermatological or Non-neurological Toxicities, Episodes of Any Infections, Grade 3-4 Dermatological or Episodes of Grade 2-3 Peripheral Neuropathy Common Terminology Criteria for Adverse Events Version 3",
                "timeFrame": "First year of therapy"
              },
              {
                "measure": "Time to Disease Progression",
                "timeFrame": "Up to 10.25 years"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Survival"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00002192",
            "briefTitle": "Tolerance, Safety, and Activity of Rifapentine Alone and in Combination Therapy in AIDS Patients With Mycobacterium Avium Complex Bacteremia.",
            "officialTitle": "Tolerance, Safety, and Activity of Rifapentine Alone and in Combination Therapy in AIDS Patients With Mycobacterium Avium Complex Bacteremia."
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "1999-11-02"
          },
          "conditionsModule": {
            "conditions": [
              "Mycobacterium Avium-Intracellulare Infection",
              "HIV Infections"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT04353180",
            "briefTitle": "Assessment the Activity Value of Isotretinoin (13- Cis-Retinoic Acid ) in the Treatment of COVID-19 ( Isotretinoin in Treatment of COVID-19) (Randomized)",
            "officialTitle": "Isotretinoin in Treatment of COVID-19 (Randomized)"
          },
          "statusModule": {
            "overallStatus": "UNKNOWN",
            "studyFirstSubmitDate": "2020-04-10"
          },
          "conditionsModule": {
            "conditions": [
              "COVID19"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "lung injury score",
                "timeFrame": "at 7and 14 days"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Absolute lymphocyte counts (CD4,CD8 and CD25+FOXP3+ Regulatory T)"
              },
              {
                "measure": "Serum levels of IL-6,TNF,TLR3,CRP, ESR and Type I interferon"
              },
              {
                "measure": "Serum level of COVID19 RNA"
              },
              {
                "measure": "All cause mortality rate"
              },
              {
                "measure": "Ventilation free days"
              },
              {
                "measure": "ICU free days"
              },
              {
                "measure": "d-dimers"
              },
              {
                "measure": "Time to first negative SARS-CoV-2 PCR in NP swap"
              },
              {
                "measure": "Angiotensin 1-7 (Ang 1-7) changes over time"
              },
              {
                "measure": "Angiotensin 1-5 (Ang 1-5) changes over time"
              },
              {
                "measure": "Renin changes over time"
              },
              {
                "measure": "Aldosterone changes over time"
              },
              {
                "measure": "Angiotensin-converting enzyme II (ACE2) changes over time"
              },
              {
                "measure": "Frequency of adverse events and severe adverse events"
              },
              {
                "measure": "Angiotensin II (Ang II) changes over time"
              },
              {
                "measure": "Sequential organ failure assessment score(SOFA score) over time"
              },
              {
                "measure": "Transe membrane protease ,serine II (TMPRSS2) changes over time"
              },
              {
                "measure": "Testosterone levels changes over time"
              },
              {
                "measure": "Dihydrotestosterone(DHT) levels changes over time"
              },
              {
                "measure": "Cholesterol levels changes over time"
              },
              {
                "measure": "Thrombin time (TT)"
              },
              {
                "measure": "IgA antibodies"
              },
              {
                "measure": "Melanoma differentiation-associated protein-5, retinoic acid inducible gene-1 (RIG-1)"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT06576882",
            "briefTitle": "7 Days vs. 14 Days of Vonoprazan-based Triple Therapy for H. Pylori Eradication",
            "officialTitle": "7-day Versus 14-day Vonoprazan-based Triple Therapy for Eradication of H. Pylori in Adolescents: A Randomized Controlled Trial"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2024-08-26"
          },
          "conditionsModule": {
            "conditions": [
              "Helicobacter Pylori Infection",
              "Gastritis",
              "Vonoprazan",
              "Adolescents"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "H. Pylori eradication rate",
                "timeFrame": "4 weeks after completion of treatment"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Adverse events during treatment."
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT03142620",
            "briefTitle": "Effect of Vitamin D on Drug Resistant Helicobacter Pylori (HP) Eradication Study",
            "officialTitle": "Delineation of Therapeutic Potential and the Causal Relationship Between Vitamin D and Helicobacter Pylori (HP) Infection and Gastritis"
          },
          "statusModule": {
            "overallStatus": "UNKNOWN",
            "studyFirstSubmitDate": "2015-02-09"
          },
          "conditionsModule": {
            "conditions": [
              "H. Pylori Infection"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "The eradication status of H. pylori infection",
                "timeFrame": "Week 4"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Comparisons of the levels of 25-hydroxylvitamin D3 and 1,25-hydroxylvitamin D3, mRNA and protein expression of vitamin D receptors, CYP24A1, CYP27B1, vitamin-D binding protein and Cathelicidin before (Week 0) and after (Week 4) treatment"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT03237182",
            "briefTitle": "The Individualized M(X) Drug-resistant TB Treatment Strategy Study",
            "officialTitle": "The Individualized M(X) Drug-resistant TB Treatment Strategy Study A Strategy to Improve Treatment Outcomes in Patients With Drug-resistant TB"
          },
          "statusModule": {
            "overallStatus": "TERMINATED",
            "whyStopped": "WHO 2022 guidelines for DR-TB treatment are set to change. These guidelines recommend the use of an all-oral short course BPAL regimen.Therefore ongoing implementation of the study is considered futile.",
            "studyFirstSubmitDate": "2017-07-27"
          },
          "conditionsModule": {
            "conditions": [
              "Tuberculosis, Multidrug-Resistant"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Culture negative survival rate",
                "timeFrame": "24 months"
              },
              {
                "measure": "Culture negative survival rate",
                "timeFrame": "30 months"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Tuberculosis treatment outcomes"
              },
              {
                "measure": "Rates of adverse events"
              },
              {
                "measure": "Characterization of multi drug-resistant tuberculosis strains"
              },
              {
                "measure": "Drug Concentration"
              },
              {
                "measure": "Measure of adherence"
              },
              {
                "measure": "Evolution of HIV drug resistance"
              },
              {
                "measure": "Improved assessment and management of DR-TB"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT06585020",
            "briefTitle": "Amikacin Liposome Inhalation Suspension for Treatment of Mycobacterium Xenopi Pulmonary Infection",
            "officialTitle": "Amikacin Liposome Inhalation Suspension for Treatment of Mycobacterium Xenopi Pulmonary Infection"
          },
          "statusModule": {
            "overallStatus": "NOT_YET_RECRUITING",
            "studyFirstSubmitDate": "2024-08-13"
          },
          "conditionsModule": {
            "conditions": [
              "Mycobacterium; Xenopi",
              "Lung Diseases"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "variation of sputum conversion rate in ARIKAYCE\u00ae addition group compared to standard treatment",
                "timeFrame": "3 months"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "variation of time to culture conversion between both groups"
              },
              {
                "measure": "variation of mortality between both groups"
              },
              {
                "measure": "variation of mortality between both groups"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT06060782",
            "briefTitle": "Thiotepa, Cyclophosphamide, Clarithromycin and Cytarabine",
            "officialTitle": "Clinical Study on the Efficacy and Safety of Auto-HSCT in Adult Patients with Burkitt Lymphoma, Lymphoblastic Lymphoma, and Acute Lymphoblastic Leukemia Who Received TCCA Conditioning Regimen"
          },
          "statusModule": {
            "overallStatus": "RECRUITING",
            "studyFirstSubmitDate": "2023-09-25"
          },
          "conditionsModule": {
            "conditions": [
              "Burkitt Lymphoma",
              "Lymphoblastic Lymphoma, Adult",
              "Acute Lymphoblastic Leukemia, Adult"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "3-year recurrence-free survival rate",
                "timeFrame": "3 years after transplantation"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "3-year overall survival rate"
              },
              {
                "measure": "3-year recurrence rate"
              },
              {
                "measure": "Transplant-related mortality"
              },
              {
                "measure": "The patient's tolerance and mucositis grade"
              },
              {
                "measure": "The incidence of cataracts and second tumors"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02542657",
            "briefTitle": "Ixazomib with Pomalidomide, Clarithromycin and Dexamethasone in Treating Patients with Multiple Myeloma",
            "officialTitle": "Phase I/II Study of Ixazomib in Combination with Pomalidomide, Clarithromycin and Dexamethasone (PiC-D) in Patients with Double Refractory Multiple Myeloma"
          },
          "statusModule": {
            "overallStatus": "ACTIVE_NOT_RECRUITING",
            "studyFirstSubmitDate": "2015-05-08"
          },
          "conditionsModule": {
            "conditions": [
              "Myeloma"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "MTD of clarithromycin when given in combination with ixazomib citrate, pomalidomide, and dexamethasone assessed by the National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE) version 4.0 (Phase I)",
                "timeFrame": "28 days"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Clinical best response"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT03555526",
            "briefTitle": "Genotypic Resistance Guided Therapy for Refractory H. Pylori Infection",
            "officialTitle": "Comparison of Genotypic Resistance Guided Versus Susceptibility Testing Guided Therapy for the Third-line Eradication of H. Pylori- a Multicenter Randomized Trial"
          },
          "statusModule": {
            "overallStatus": "UNKNOWN",
            "studyFirstSubmitDate": "2017-12-14"
          },
          "conditionsModule": {
            "conditions": [
              "H Pylori Infection"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Eradication rate by intention to treat analysis",
                "timeFrame": "8 weeks"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Eradication rate by per protocol analysis"
              },
              {
                "measure": "frequency of adverse effects during eradication therapy"
              },
              {
                "measure": "changes of fecal microbiota"
              },
              {
                "measure": "reinfection rate"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT03413020",
            "briefTitle": "Tailored Therapy for Helicobacter Pylori Rescue Treatment",
            "officialTitle": "Efficacy of Tailored for Helicobacter Pylori Rescue Treatment Based on Antimicrobial-susceptibility Testing"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2018-01-22"
          },
          "conditionsModule": {
            "conditions": [
              "Helicobacter Pylori Infection"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Helicobacter pylori eradication rate",
                "timeFrame": "Six weeks after completion of therapy"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Rate of adverse effects"
              },
              {
                "measure": "Compliance rate"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT03948620",
            "briefTitle": "Macrolide in Pregnancy and Adverse Child Outcomes",
            "officialTitle": "Associations Between Macrolide Antibiotics Prescribed During Pregnancy and Adverse Child Outcomes"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2019-05-10"
          },
          "conditionsModule": {
            "conditions": [
              "Infection"
            ]
          },
          "designModule": {
            "studyType": "OBSERVATIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Number of major malformation overall",
                "timeFrame": "From birth up to 4 years after birth."
              },
              {
                "measure": "Number of cardiovascular malformation",
                "timeFrame": "From birth up to 4 years after birth."
              },
              {
                "measure": "Number of nervous system malformation",
                "timeFrame": "From birth up to 4 years after birth."
              },
              {
                "measure": "Number of gastrointestinal system malformation",
                "timeFrame": "From birth up to 4 years after birth."
              },
              {
                "measure": "Number of genital malformation",
                "timeFrame": "From birth up to 4 years after birth."
              },
              {
                "measure": "Number of urinary malformation",
                "timeFrame": "From birth up to 4 years after birth."
              },
              {
                "measure": "Rate of cerebral palsy",
                "timeFrame": "From birth up to 15 years after birth."
              },
              {
                "measure": "Rate of epilepsy",
                "timeFrame": "From birth up to 15 years after birth."
              },
              {
                "measure": "Rate of attention-deficit/hyperactivity disorder (ADHD)",
                "timeFrame": "From birth up to 15 years after birth."
              },
              {
                "measure": "Rate of autism spectrum disorder (ASD)",
                "timeFrame": "From birth up to 15 years after birth."
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT03779074",
            "briefTitle": "Comparing the Efficacy of Hybrid, High-dose Dual and Bismuth Quadruple Therapies",
            "officialTitle": "Efficacies of Hybrid, High-dose Dual and Bismuth Quadruple Therapies for the First-line Anti-H Pylori Treatment and Tetracycline-levofloxacin Quadruple Therapy for the Second-line Anti-H Pylori Treatment - a Multicentre Randomized Trial"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2018-12-16"
          },
          "conditionsModule": {
            "conditions": [
              "Helicobacter Pylori Infection"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Number of Participants in Which H. Pylori Was Eradicated",
                "timeFrame": "sixth week after the end of anti- H. pylori therapy"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00002682",
            "briefTitle": "Antibiotic Therapy and Antacids in Patients With Malt Lymphoma of the Stomach",
            "officialTitle": "CURRENT PRACTICE STUDY OF ANTIBIOTIC TREATMENT OF GASTRIC MALT LYMPHOMA"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "1999-11-01"
          },
          "conditionsModule": {
            "conditions": [
              "Lymphoma"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Number of Patients with Response to Antibiotic Treatment of Gastric Malt Lymphoma",
                "timeFrame": "3 Years"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT06101420",
            "briefTitle": "Potassium Copetitive Acid Blockers Efficacy in H.Pylori Eradication",
            "officialTitle": "Efficacy of Potassium Competitive Acid Blockers (P-CABs) Versus Proton Pump Inhibitors (PPIs) in the First and the Second Lines Eradication Regimens for H. Pylori in Egyptian Patients"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2023-10-06"
          },
          "conditionsModule": {
            "conditions": [
              "Helicobacter Pylori Eradication"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "H.pylori eradication",
                "timeFrame": "six weeks"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Safety of Vonoprazan use"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT03366974",
            "briefTitle": "Assessment of Change in CYP3A Activity by Route of Administration Using Metabolic Markers in Healthy Male Volunteers",
            "officialTitle": "Assessment of Change in CYP3A Activity by Route of Administration Using Metabolic Markers in Healthy Male Volunteers"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2017-12-04"
          },
          "conditionsModule": {
            "conditions": [
              "Healthy Volunteers"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Area under the curve of midazolam (AUClast)",
                "timeFrame": "Up to 12 hours after midazolam administration"
              },
              {
                "measure": "Metabolic ratio of steroids",
                "timeFrame": "Up to 12 hours before/after midazolam administration"
              },
              {
                "measure": "Clearance (CL) of midazolam",
                "timeFrame": "Up to 12 hours after midazolam administration"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT05419674",
            "briefTitle": "Efficacy and Safety of Dual Therapy as First-line Treatment for Hp Infection",
            "officialTitle": "Ten-day Amoxicillin-containing Dual Therapy as First-line Helicobacter Pylori Treatment in Elderly Patients: a Randomized Trial"
          },
          "statusModule": {
            "overallStatus": "UNKNOWN",
            "studyFirstSubmitDate": "2022-06-10"
          },
          "conditionsModule": {
            "conditions": [
              "Helicobacter Pylori Infection"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Helicobacter pylori Eradication Rate",
                "timeFrame": "Six to eight weeks after completion of the medication"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Rate of Adverse Drug Reaction(ADR)"
              },
              {
                "measure": "Compliance Rate"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT03220074",
            "briefTitle": "Linezolid for Treatment of Nontuberculous Mycobacterial Diseases",
            "officialTitle": "Efficacy and Tolerability of Linezolid for Treatment of Nontuberculous Mycobacterial Diseases"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2017-07-12"
          },
          "conditionsModule": {
            "conditions": [
              "Non-tuberculous Mycobacterial Infections"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "cure rate",
                "timeFrame": "6 months"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "rate of common adverse event (AE)"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01602874",
            "briefTitle": "Study Evaluating Tigecycline Versus Ceftriaxone In Complicated Intra-Abdominal Infections & Community Acquired Pneumonia",
            "officialTitle": "Multicenter, Randomized, And Double-Blind Study To Evaluate The Safety Of Tigecycline Versus A Ceftriaxone Regimen In The Treatment Of Complicated Intra-Abdominal Infections And Community-Acquired Pneumonia In Subjects Of 8-17 Years"
          },
          "statusModule": {
            "overallStatus": "WITHDRAWN",
            "studyFirstSubmitDate": "2012-05-17"
          },
          "conditionsModule": {
            "conditions": [
              "Community Acquired Bacterial Pneumonia",
              "Complicated Intra-Abdominal Infection"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Clinical efficacy response (cure, failure, or indeterminate) at the test of cure (TOC) visit for 2 co-primary populations: the clinically evaluable (CE) and clinical modified Intent-to-Treat (c-mITT) populations",
                "timeFrame": "2 to 7 weeks for cIAI and 2 to 5 weeks for CAP"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Clinical response at the IV last day of therapy (LDOT) for co-primary populations: the CE and c-mITT populations"
              },
              {
                "measure": "Clinical response at follow up (FUP) visits for co-primary populations: the CE and c-mITT populations"
              },
              {
                "measure": "Microbiological response at the subject and the pathogen level"
              },
              {
                "measure": "Response rate by pathogen and minimum inhibitory concentration (MIC) value"
              },
              {
                "measure": "Response rates for polymicrobial/monomicrobial infections, and susceptibility evaluations"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01951326",
            "briefTitle": "Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease",
            "officialTitle": "A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2013-09-19",
            "resultsFirstSubmitDate": "2020-03-29"
          },
          "conditionsModule": {
            "conditions": [
              "Crohn's Disease"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Remission at Week 26",
                "timeFrame": "Week 26"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Response at Week 26"
              },
              {
                "measure": "Remission at Week 52"
              },
              {
                "measure": "Durable Remission Week 26 Through Week 52"
              },
              {
                "measure": "Remission at Week 16"
              },
              {
                "measure": "Steroid Free Remission at Week 52"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00000826",
            "briefTitle": "Effect of Fluconazole, Clarithromycin, and Rifabutin on the Pharmacokinetics of Sulfamethoxazole-Trimethoprim and Dapsone and Their Hydroxylamine Metabolites",
            "officialTitle": "Effect of Fluconazole, Clarithromycin, and Rifabutin on the Pharmacokinetics of Sulfamethoxazole and Dapsone and Their Hydroxylamine Metabolites"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "1999-11-02"
          },
          "conditionsModule": {
            "conditions": [
              "Bacterial Infections",
              "Mycoses",
              "HIV Infections"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02343289",
            "briefTitle": "A Study to Evaluate the Absolute Bioavailability of Intranasal and Oral Esketamine and the Effects of Clarithromycin on the Pharmacokinetics of Intranasal Esketamine in Healthy Participants",
            "officialTitle": "An Open-Label Study to Evaluate the Absolute Bioavailability of Intranasal and Oral Esketamine and the Effects of Clarithromycin on the Pharmacokinetics of Intranasal Esketamine in Healthy Subjects"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2015-01-15"
          },
          "conditionsModule": {
            "conditions": [
              "Healthy"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Maximum Plasma Concentration (Cmax) of Esketamine",
                "timeFrame": "Pre-dose, 0.25, 0.33, 0.5, 0.66, 1, 1.5, 2, 3, 4, 5, 6, 8, 10, 12, 18 hour (hr) post-dose on Day 1; 24, 36 hr post-dose on Day 2; 48 hr post-dose on Day 3 in all periods"
              },
              {
                "measure": "Time to Reach Maximum Plasma Concentration (Tmax) of Esketamine",
                "timeFrame": "Pre-dose, 0.25, 0.33, 0.5, 0.66, 1, 1.5, 2, 3, 4, 5, 6, 8, 10, 12, 18 hour (hr) post-dose on Day 1; 24, 36 hr post-dose on Day 2; 48 hr post-dose on Day 3 in all periods"
              },
              {
                "measure": "Area Under the Plasma Concentration-time Curve From Time 0 to 12 Hours (AUC12h) of Esketamine",
                "timeFrame": "Pre-dose, 0.25, 0.33, 0.5, 0.66, 1, 1.5, 2, 3, 4, 5, 6, 8, 10, 12 hour (hr) post-dose on Day 1 in all periods"
              },
              {
                "measure": "Area Under the Plasma Concentration-Time Curve From Time Zero to Time of the Last Quantifiable Concentration AUC(0-last) of Esketamine",
                "timeFrame": "Pre-dose, 0.25, 0.33, 0.5, 0.66, 1, 1.5, 2, 3, 4, 5, 6, 8, 10, 12, 18 hour (hr) post-dose on Day 1; 24, 36 hr post-dose on Day 2; 48 hr post-dose on Day 3 in all periods"
              },
              {
                "measure": "Area Under the Plasma Concentration-Time Curve From Time Zero to Infinite Time (AUC [0-infinity]) of Esketamine",
                "timeFrame": "Pre-dose, 0.25, 0.33, 0.5, 0.66, 1, 1.5, 2, 3, 4, 5, 6, 8, 10, 12, 18 hour (hr) post-dose on Day 1; 24, 36 hr post-dose on Day 2; 48 hr post-dose on Day 3 in all periods"
              },
              {
                "measure": "Percentage of Area Under the Plasma Concentration-time Curve Obtained by Extrapolation (%AUC [infinity,ex]) of Esketamine",
                "timeFrame": "Pre-dose, 0.25, 0.33, 0.5, 0.66, 1, 1.5, 2, 3, 4, 5, 6, 8, 10, 12, 18 hour (hr) post-dose on Day 1; 24, 36 hr post-dose on Day 2; 48 hr post-dose on Day 3 in all periods"
              },
              {
                "measure": "Elimination Half-life (t1/2) of Esketamine",
                "timeFrame": "Pre-dose, 0.25, 0.33, 0.5, 0.66, 1, 1.5, 2, 3, 4, 5, 6, 8, 10, 12, 18 hour (hr) post-dose on Day 1; 24, 36 hr post-dose on Day 2; 48 hr post-dose on Day 3 in all periods"
              },
              {
                "measure": "Rate Constant (Lambda[z]) of Esketamine",
                "timeFrame": "Pre-dose, 0.25, 0.33, 0.5, 0.66, 1, 1.5, 2, 3, 4, 5, 6, 8, 10, 12, 18 hour (hr) post-dose on Day 1; 24, 36 hr post-dose on Day 2; 48 hr post-dose on Day 3 in all periods"
              },
              {
                "measure": "Absolute Bioavailability (Fabs) of Esketamine",
                "timeFrame": "Pre-dose, 0.25, 0.33, 0.5, 0.66, 1, 1.5, 2, 3, 4, 5, 6, 8, 10, 12, 18 hour (hr) post-dose on Day 1; 24, 36 hr post-dose on Day 2; 48 hr post-dose on Day 3 in all periods"
              },
              {
                "measure": "Relative Bioavailability of Esketamine (Frel)",
                "timeFrame": "Pre-dose, 0.25, 0.33, 0.5, 0.66, 1, 1.5, 2, 3, 4, 5, 6, 8, 10, 12, 18 hour (hr) post-dose on Day 1; 24, 36 hr post-dose on Day 2; 48 hr post-dose on Day 3 in all periods"
              },
              {
                "measure": "Number of Participants With Adverse Events (AEs) or Serious Adverse Events (SAEs)",
                "timeFrame": "Throughout the duration of study (approximately up to 98 days)"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT06823791",
            "briefTitle": "Furazolidone Quadruple Regimen Eradicate H. Pylori Infection",
            "officialTitle": "Efficacy and Safety of Furazolidone Containing Quadruple Therapy for First-line Helicobacter Pylori Eradication"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2023-09-04"
          },
          "conditionsModule": {
            "conditions": [
              "Helicobacter Pylori Infection",
              "Eradication"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Hp eradication rate",
                "timeFrame": "6 months"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "adverse reactions"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02835560",
            "briefTitle": "Efficacy and Safety of Ilaprazole Based Bismuth-containing Quadruple Regimen for the First-line Treatment of Helicobacter Pylori Infection",
            "officialTitle": "Efficacy and Safety of Ilaprazole Based Bismuth-containing Quadruple Regimen for the First-line Treatment of Helicobacter Pylori Infection"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2016-07-09"
          },
          "conditionsModule": {
            "conditions": [
              "Helicobacter Pylori Eradication Antibiotic"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Eradication rate of Helicobacter pylori as assessed by UBT test",
                "timeFrame": "up to 2 months"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00002194",
            "briefTitle": "An Open-Label Study in HIV+ Patients to Determine the Effects of Nevirapine (Viramune) on the Pharmacokinetics of Clarithromycin and Activity of Cytochrome 3A4.",
            "officialTitle": "An Open-Label Study in HIV+ Patients to Determine the Effects of Nevirapine (Viramune) on the Pharmacokinetics of Clarithromycin and Activity of Cytochrome 3A4."
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "1999-11-02"
          },
          "conditionsModule": {
            "conditions": [
              "HIV Infections"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT03397680",
            "briefTitle": "Effectiveness of Once-daily Dose Regimen of 7-day and 14-day High Dose Rabeprazole-levofloxacin Based Quadruple Therapy for H. Pylori Eradication in Thai Patients With Non-ulcer Dyspepsia",
            "officialTitle": "Effectiveness of Once-daily Dose Regimen of 7-day and 14-day High Dose Rabeprazole-levofloxacin Based Quadruple Therapy for H. Pylori Eradication in Thai Patients With Non-ulcer Dyspepsia"
          },
          "statusModule": {
            "overallStatus": "UNKNOWN",
            "studyFirstSubmitDate": "2017-09-09"
          },
          "conditionsModule": {
            "conditions": [
              "Helicobacter Pylori Infection"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "To measure eradication rate of participants with once-daily dose regimen of 14-day rabeprazole-levofloxacin based quadruple therapy for H. pylori eradication by Urea Breath Test in Thai patients with non-ulcer dyspepsia",
                "timeFrame": "6 weeks"
              },
              {
                "measure": "To measure eradication rate of participants with once-daily dose regimen of 7-day rabeprazole-levofloxacin based quadruple therapy for H. pylori eradication by Urea Breath Test in Thai patients with non-ulcer dyspepsia",
                "timeFrame": "5 weeks"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "To measure the adverse effect reaction of once-daily regimen of high dose rabeprazole-levofloxacin based quadruple therapy"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT05184491",
            "briefTitle": "Nitazoxanide and Lansoprazole Based Regimens for H. Pylori Management",
            "officialTitle": "Nitazoxanide and Lansoprazole Based Regimens for Managing Helicobacter Pylori in Egyptian Patients (NILE Study)"
          },
          "statusModule": {
            "overallStatus": "UNKNOWN",
            "studyFirstSubmitDate": "2021-11-13"
          },
          "conditionsModule": {
            "conditions": [
              "Helicobacter Pylori"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Number of participants with negative results of enzyme immunoassay H. pylori antigen test in stool (Monocent, Inc., CA, USA).",
                "timeFrame": "4 weeks after completion of treatment"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Number of participants with treatment-related adverse events as assessed by Egyptian pharmacovigilance Center (EPVC) criteria"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02635191",
            "briefTitle": "Tailored Therapy for Helicobacter Pylori in Children",
            "officialTitle": "Tailored Therapy Versus Standard Triple Therapy for Helicobacter Pylori Eradication in Children: A Randomized Trial"
          },
          "statusModule": {
            "overallStatus": "UNKNOWN",
            "studyFirstSubmitDate": "2015-11-25"
          },
          "conditionsModule": {
            "conditions": [
              "Helicobacter Pylori Infection"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Compare the eradication rates in each group",
                "timeFrame": "One month after treatment"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT04622891",
            "briefTitle": "Clarithromycin Versus Azithromycin in Treatment of Mild COVID-19 Infection",
            "officialTitle": "Efficacy of Clarithromycin in Comparison to Azithromycin in Treatment of Mild COVID-19 Infection, Randomized Controlled Trial"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2020-11-06"
          },
          "conditionsModule": {
            "conditions": [
              "Covid19"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "time to fever control",
                "timeFrame": "15 days"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "PCR conversion"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02047994",
            "briefTitle": "Multicentric Randomized Study of H. Pylori Eradication and Pepsinogen Testing for Prevention of Gastric Cancer Mortality",
            "officialTitle": "Multicentric Randomized Study of H. Pylori Eradication and Pepsinogen Testing for Prevention of Gastric Cancer Mortality"
          },
          "statusModule": {
            "overallStatus": "RECRUITING",
            "studyFirstSubmitDate": "2014-01-27"
          },
          "conditionsModule": {
            "conditions": [
              "Helicobacter Pylori Infections",
              "Atrophic Gastritis",
              "Gastric Cancer"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Gastric cancer mortality",
                "timeFrame": "15 years"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Gastric cancer incidence"
              },
              {
                "measure": "All-cause mortality"
              },
              {
                "measure": "Incidence of- and mortality from other medical conditions"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT04287660",
            "briefTitle": "Study of BiRd Regimen Combined With BCMA CAR T-cell Therapy in Newly Diagnosed Multiple Myeloma (MM) Patients",
            "officialTitle": "A Phase 3, Single Arm, Multi-Center Study to Assess the Efficacy and Safety of Clarithromycin(Biaxin)-Lenalidomide-Low-Dose-Dexamethasone (BiRd) Combined With B-cell Maturation Antigen (BCMA)-Directed Chimeric Antigen Receptor (CAR) T-cell Therapy in Patients With Newly Diagnosed Multiple Myeloma"
          },
          "statusModule": {
            "overallStatus": "UNKNOWN",
            "studyFirstSubmitDate": "2020-02-19"
          },
          "conditionsModule": {
            "conditions": [
              "Multiple Myeloma"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Overall response rate (ORR)",
                "timeFrame": "4 weeks after CAR T-cells infusion (up to 14 weeks)"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Overall survival (OS)"
              },
              {
                "measure": "Event-free survival (EFS)"
              },
              {
                "measure": "Cumulative incidence of relapse(CIR)"
              },
              {
                "measure": "Number of adverse events"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT06684860",
            "briefTitle": "RUT vs. Molecular Testing for H. Pylori",
            "officialTitle": "Comparative Diagnostic Performance of Rapid Urease Test Versus Molecular Testing for Diagnosis of Helicobacter Pylori"
          },
          "statusModule": {
            "overallStatus": "RECRUITING",
            "studyFirstSubmitDate": "2024-11-10"
          },
          "conditionsModule": {
            "conditions": [
              "H.Pylori Infection"
            ]
          },
          "designModule": {
            "studyType": "OBSERVATIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Current H. pylori infection status",
                "timeFrame": "1 day"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02711176",
            "briefTitle": "Comparison of Daily Single Dose Triple and Conventional Triple Therapies for Helicobacter Pylori Infection",
            "officialTitle": "Comparison of Daily Single Dose Triple and Conventional Triple Therapies for Helicobacter Pylori Infection"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2016-02-09"
          },
          "conditionsModule": {
            "conditions": [
              "Helicobacter Infection"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "The rate of H.pylori eradication",
                "timeFrame": "42 days after study completion"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Drug Compliance"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT03099876",
            "briefTitle": "A Study on Eradication Rate of Triple Therapy According to Treatment Period and CYP2C19 Polymorphisms in H.Pylori Patients",
            "officialTitle": "A Study on Eradication Rate of Triple Therapy Including Low Dose-PPI, Clarithromycin, Amoxicillin According to Treatment Period and CYP2C19 Polymorphisms in H.Pylori Patients"
          },
          "statusModule": {
            "overallStatus": "UNKNOWN",
            "studyFirstSubmitDate": "2017-03-28"
          },
          "conditionsModule": {
            "conditions": [
              "Helicobacter Pylori Infection"
            ]
          },
          "designModule": {
            "studyType": "OBSERVATIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "The eradication rate of H.pylori at Day 49\u00b15(or Day 52\u00b15) as assessed by UBT test or Biopsy",
                "timeFrame": "Day 49\u00b15(or Day 52\u00b15)"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "The safety of Noltec(Ilaprazole) 10mg BID treatment at Day 49\u00b15(or Day 52\u00b15). Record the number of patients with adverse Events."
              },
              {
                "measure": "The eradication rate of H.pylori according to CYP polymorphism of patients."
              },
              {
                "measure": "The eradication rate of H.pylori according to stage of disease of patients."
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT03172676",
            "briefTitle": "Effects of Helicobacter Pylori Eradication in Children With Chronic Immune Thrombocytopenic Purpura",
            "officialTitle": "Effects of Helicobacter Pylori Eradication Therapy in Children With Chronic Immune Thrombocytopenic Purpura"
          },
          "statusModule": {
            "overallStatus": "UNKNOWN",
            "studyFirstSubmitDate": "2017-05-26"
          },
          "conditionsModule": {
            "conditions": [
              "Immune Thrombocytopenia"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "effects of Helicobacter pylori infection eradication on platelet counts of chronic immune thrombocytopenic patients",
                "timeFrame": "6 months"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT04315194",
            "briefTitle": "Efficacy of Clarithromycin-Naproxen-Oseltamivir Combination Therapy vs. Oseltamivir Alone for Hospitalised Paediatric Influenza Patients",
            "officialTitle": "Efficacy of Clarithromycin-Naproxen-Oseltamivir Combination Therapy vs. Oseltamivir Alone for Hospitalised Paediatric Influenza Patients"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2020-03-17"
          },
          "conditionsModule": {
            "conditions": [
              "Efficacy of Clarithromycin-Naproxen-Oseltamivir Combination Therapy vs. Oseltamivir Alone for Hospitalised Paediatric Influenza Patients"
            ]
          },
          "designModule": {
            "studyType": "OBSERVATIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "severity of symptoms and signs",
                "timeFrame": "1 month"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01454076",
            "briefTitle": "Pharmacokinetics Study of Oral IXAZOMIB in Participants With Advanced Nonhematologic Malignancies or Lymphoma",
            "officialTitle": "A Phase 1 Study of Oral IXAZOMIB (MLN9708) to Assess Relative Bioavailability, Food Effect, Drug-Drug Interaction With Ketoconazole, Clarithromycin or Rifampin; and Safety and Tolerability in Patients With Advanced Nonhematologic Malignancies or Lymphoma"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2011-10-13",
            "resultsFirstSubmitDate": "2017-06-16"
          },
          "conditionsModule": {
            "conditions": [
              "Nonhematologic Malignancies",
              "Lymphoma"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Cmax: Maximum Observed Plasma Concentration for Ixazomib",
                "timeFrame": "Arm 1:Days 1, 15 and Arm 5:Day 6 pre-dose and at multiple time points(up to 264 hours[hrs])post-dose;Arm 2, 3:Days 1,15 pre-dose and at multiple time points(up to 216 hrs)post-dose;Arm 4:Day 8 pre-dose and at multiple time points(up to 168 hrs)post-dose"
              },
              {
                "measure": "AUClast: Area Under the Plasma Concentration-time Curve From Time 0 to the Time of the Last Quantifiable Concentration for Ixazomib",
                "timeFrame": "Arm 1:Days 1, 15 and Arm 5:Day 6 pre-dose and at multiple time points(up to 264 hrs)post-dose;Arm 2, 3:Days 1,15 pre-dose and at multiple time points(up to 216 hrs)post-dose;Arm 4:Day 8 pre-dose and at multiple time points(up to 168 hrs)post-dose"
              },
              {
                "measure": "Tmax: Time to Reach the Maximum Plasma Concentration (Cmax) for Ixazomib",
                "timeFrame": "Arm 1:Days 1, 15 and Arm 5:Day 6 pre-dose and at multiple time points(up to 264 hrs)post-dose;Arm 2, 3:Days 1,15 pre-dose and at multiple time points(up to 216 hrs)post-dose;Arm 4:Day 8 pre-dose and at multiple time points(up to 168 hrs)post-dose"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Number of Participants Reporting One or More Treatment-emergent Adverse Events (TEAEs) and Serious Adverse Events (SAEs)"
              },
              {
                "measure": "Number of Participants With Clinically Significant TEAEs Related to Laboratory Abnormalities"
              },
              {
                "measure": "Number of Participants With Clinically Significant Vital Sign Abnormalities"
              },
              {
                "measure": "Percentage of Participants With Best Overall Response"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01464060",
            "briefTitle": "14-day Quadruple Hybrid vs. Concomitant Therapies for Helicobacter Pylori Eradication",
            "officialTitle": "Phase 4, Prospective, Randomized Study Comparing 14-day Non-bismuth Quadruple \"Hybrid\" and \"Concomitant\" Therapies for Helicobacter Pylori Eradication in Settings With High Clarithromycin Resistance"
          },
          "statusModule": {
            "overallStatus": "UNKNOWN",
            "studyFirstSubmitDate": "2011-10-25"
          },
          "conditionsModule": {
            "conditions": [
              "Helicobacter Pylori Infection"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "\"Intention to treat\" eradication rates",
                "timeFrame": "1 year"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "\" Per protocol\" eradication rate"
              },
              {
                "measure": "Treatment compliance"
              },
              {
                "measure": "Number of participants with adverse events"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT05731427",
            "briefTitle": "Research on the Mechanism Affecting Progression of Bronchiectasis",
            "officialTitle": "Research on the Mechanism Affecting Progression of Bronchiectasis Based on Omics Method"
          },
          "statusModule": {
            "overallStatus": "RECRUITING",
            "studyFirstSubmitDate": "2021-09-15"
          },
          "conditionsModule": {
            "conditions": [
              "Bronchiectasis"
            ]
          },
          "designModule": {
            "studyType": "OBSERVATIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Acute exacerbations and mortality",
                "timeFrame": "February 10, 2026"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Lung function"
              },
              {
                "measure": "Symptoms assessment"
              },
              {
                "measure": "Stool and sputum microtioba"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00643227",
            "briefTitle": "A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Clarithromycin Extended Release for the Treatment of Pneumonia in Adult Patients",
            "officialTitle": "A Multicenter, Randomized, Double-Blind, Double-Dummy Comparative Trial of Azithromycin SR Versus Clarithromycin Extended Release for the Treatment of Mild to Moderate Community-Acquired Pneumonia in Adults"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2008-03-19"
          },
          "conditionsModule": {
            "conditions": [
              "Pneumonia"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "sponsor assessment of clinical response (clinical cure rate) in the Clinical Per Protocol population",
                "timeFrame": "Test of Cure (TOC) visit (Day 14-21)"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "bacteriologic response (eradication rate) in the Bacteriological Per Protocol population"
              },
              {
                "measure": "investigator assessment of clinical response in the Clinical Per Protocol population"
              },
              {
                "measure": "sponsor assessment of clinical response by baseline pathogen"
              },
              {
                "measure": "sponsor assessment of clinical response in the non-primary population"
              },
              {
                "measure": "sponsor assessment of clinical responses in the Clinical Per Protocol population"
              },
              {
                "measure": "susceptibilities of baseline pathogens"
              },
              {
                "measure": "adverse events"
              },
              {
                "measure": "vital signs"
              },
              {
                "measure": "physical examination"
              },
              {
                "measure": "clinical laboratory assessments (blood chemistry and hematology)"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02159976",
            "briefTitle": "Compare Sequential and Quadruple Therapy for the Eradication of Helicobacter Pylori in Korea",
            "officialTitle": "A Prospective, Multi-center, Randomized, Open-label, Parallel Design Clinical Trial to Compare 10-day Sequential Therapy and 14-day Modified Bismuth Quadruple Therapy for the Eradication of Helicobacter Pylori in Korea"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2014-06-03",
            "resultsFirstSubmitDate": "2016-05-05"
          },
          "conditionsModule": {
            "conditions": [
              "Helicobacter Pylori Infection"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Counts of Participants With Successful H. Pylori Eradication",
                "timeFrame": "4 weeks after termination of eradication therapy, up to 6 weeks"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Counts of Participants Whose Drug Compliance is More Than 85%"
              },
              {
                "measure": "Counts of Participants With Adverse Event"
              },
              {
                "measure": "Functional Dyspepsia Symptom Responses Rate"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01678027",
            "briefTitle": "Gastric Cancer Prevention in the Family Members by Helicobacter Pylori Eradication",
            "officialTitle": "Helicobacter Pylori Eradication to Prevent Gastric Cancer in Subjects With Family History of Gastric Cancer: A Randomized Controlled Study"
          },
          "statusModule": {
            "overallStatus": "ACTIVE_NOT_RECRUITING",
            "studyFirstSubmitDate": "2012-08-17"
          },
          "conditionsModule": {
            "conditions": [
              "Gastric Cancer",
              "Helicobacter Pylori Infection",
              "Family Members"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Gastric cancer incidence",
                "timeFrame": "6 years after last participant enrollment"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Gastric dysplasia incidence"
              },
              {
                "measure": "Gastric cancer incidence between H. pylori treatment and H. pylori uninfected groups"
              },
              {
                "measure": "Gastric cancer incidence according to H. pylori status"
              },
              {
                "measure": "All-cause mortality"
              }
            ]
          }
        }
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:33:49Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83b2"
    },
    "name": "BRD-K00598313",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83b2.png",
    "lincs": {
      "id": "LSM-8473",
      "name": "BRD-K00598313",
      "pubchemCid": 54646609,
      "chebiId": 97094,
      "inchiParent": "InChI=1S/C23H28N2O7S/c1-30-10-9-24-22(27)13-16-12-19-18-11-15(25-33(28,29)17-5-3-2-4-6-17)7-8-20(18)32-23(19)21(14-26)31-16/h2-8,11,16,19,21,23,25-26H,9-10,12-14H2,1H3,(H,24,27)/t16-,19-,21+,23+/m1/s1",
      "inchiKeyParent": "GQLDDSCVBIFPRR-ZLTNCQPASA-N",
      "smilesParent": "COCCNC(=O)C[C@H]1C[C@H]2[C@H](Oc3ccc(NS(=O)(=O)c4ccccc4)cc23)[C@H](CO)O1"
    },
    "unichem": {
      "chebi": "97094",
      "lincs": "LSM-8473",
      "pubchem": "54646609"
    },
    "pubchem": [
      {
        "cid": 54646609,
        "inchi": "InChI=1S/C23H28N2O7S/c1-30-10-9-24-22(27)13-16-12-19-18-11-15(25-33(28,29)17-5-3-2-4-6-17)7-8-20(18)32-23(19)21(14-26)31-16/h2-8,11,16,19,21,23,25-26H,9-10,12-14H2,1H3,(H,24,27)/t16-,19-,21+,23+/m1/s1",
        "inchikey": "GQLDDSCVBIFPRR-ZLTNCQPASA-N",
        "iupac": {
          "systematic": "2-[(1S,3R,4aR,9aS)-6-(benzenesulfonamido)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-(2-methoxyethyl)acetamide"
        },
        "smiles": {
          "canonical": "COCCNC(=O)CC1CC2C(C(O1)CO)OC3=C2C=C(C=C3)NS(=O)(=O)C4=CC=CC=C4"
        },
        "molecularFormula": "C23H28N2O7S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:33:51Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83f1"
    },
    "name": "BRD-K24734706",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83f1.png",
    "lincs": {
      "id": "LSM-38620",
      "name": "BRD-K24734706",
      "pubchemCid": 54649596,
      "chebiId": 127057,
      "inchiParent": "InChI=1S/C22H29N3O5/c1-14-21(26)24(2)13-19-18(28-4)9-8-16(30-19)10-11-29-20-15(12-23)6-5-7-17(20)22(27)25(14)3/h5-7,14,16,18-19H,8-11,13H2,1-4H3/t14-,16+,18-,19+/m1/s1",
      "inchiKeyParent": "LYYREMJMDQKNES-HYEGPXJVSA-N",
      "smilesParent": "CO[C@@H]1CC[C@H]2CCOc3c(cccc3C(=O)N(C)[C@H](C)C(=O)N(C)C[C@@H]1O2)C#N"
    },
    "unichem": {
      "chebi": "127057",
      "lincs": "LSM-38620",
      "pubchem": "54649596"
    },
    "pubchem": [
      {
        "cid": 54649596,
        "inchi": "InChI=1S/C22H29N3O5/c1-14-21(26)24(2)13-19-18(28-4)9-8-16(30-19)10-11-29-20-15(12-23)6-5-7-17(20)22(27)25(14)3/h5-7,14,16,18-19H,8-11,13H2,1-4H3/t14-,16+,18-,19+/m1/s1",
        "inchikey": "LYYREMJMDQKNES-HYEGPXJVSA-N",
        "iupac": {
          "systematic": "(1S,13R,17S,18R)-18-methoxy-12,13,15-trimethyl-11,14-dioxo-4,21-dioxa-12,15-diazatricyclo[15.3.1.05,10]henicosa-5,7,9-triene-6-carbonitrile"
        },
        "smiles": {
          "canonical": "CC1C(=O)N(CC2C(CCC(O2)CCOC3=C(C=CC=C3C(=O)N1C)C#N)OC)C"
        },
        "molecularFormula": "C22H29N3O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:33:54Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8353"
    },
    "name": "BRD-K04718515",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8353.png",
    "lincs": {
      "id": "LSM-8721",
      "name": "BRD-K04718515",
      "pubchemCid": 54649067,
      "chebiId": 97342,
      "inchiParent": "InChI=1S/C24H32N2O7S/c1-17(13-26(18(2)15-27)34(29,30)20-8-6-5-7-9-20)23(31-4)14-25(3)24(28)19-10-11-21-22(12-19)33-16-32-21/h5-12,17-18,23,27H,13-16H2,1-4H3/t17-,18-,23+/m0/s1",
      "inchiKeyParent": "ADONDIFMYIEKMI-IUKKYPGJSA-N",
      "smilesParent": "CO[C@H](CN(C)C(=O)c1ccc2OCOc2c1)[C@@H](C)CN([C@@H](C)CO)S(=O)(=O)c3ccccc3"
    },
    "unichem": {
      "chebi": "97342",
      "lincs": "LSM-8721",
      "pubchem": "54649067"
    },
    "pubchem": [
      {
        "cid": 54649067,
        "inchi": "InChI=1S/C24H32N2O7S/c1-17(13-26(18(2)15-27)34(29,30)20-8-6-5-7-9-20)23(31-4)14-25(3)24(28)19-10-11-21-22(12-19)33-16-32-21/h5-12,17-18,23,27H,13-16H2,1-4H3/t17-,18-,23+/m0/s1",
        "inchikey": "ADONDIFMYIEKMI-IUKKYPGJSA-N",
        "iupac": {
          "systematic": "N-[(2S,3S)-4-[benzenesulfonyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methyl-1,3-benzodioxole-5-carboxamide"
        },
        "smiles": {
          "canonical": "CC(CN(C(C)CO)S(=O)(=O)C1=CC=CC=C1)C(CN(C)C(=O)C2=CC3=C(C=C2)OCO3)OC"
        },
        "molecularFormula": "C24H32N2O7S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:33:56Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8378"
    },
    "name": "BRD-K91063002",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8378.png",
    "lincs": {
      "id": "LSM-42236",
      "name": "BRD-K91063002",
      "pubchemCid": 44501482,
      "chebiId": 130687,
      "inchiParent": "InChI=1S/C29H36N4O6S/c1-19-16-33(20(2)18-34)28(35)15-22-14-23(31-40(4,37)38)12-13-26(22)39-27(19)17-32(3)29(36)30-25-11-7-9-21-8-5-6-10-24(21)25/h5-14,19-20,27,31,34H,15-18H2,1-4H3,(H,30,36)/t19-,20-,27-/m0/s1",
      "inchiKeyParent": "PFQWGWQENUDDJX-OSOCVKALSA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@H](C)[C@H](CN(C)C(=O)Nc2cccc3ccccc23)Oc4ccc(NS(=O)(=O)C)cc4CC1=O"
    },
    "unichem": {
      "chebi": "130687",
      "lincs": "LSM-42236",
      "pubchem": "44501482"
    },
    "pubchem": [
      {
        "cid": 44501482,
        "inchi": "InChI=1S/C29H36N4O6S/c1-19-16-33(20(2)18-34)28(35)15-22-14-23(31-40(4,37)38)12-13-26(22)39-27(19)17-32(3)29(36)30-25-11-7-9-21-8-5-6-10-24(21)25/h5-14,19-20,27,31,34H,15-18H2,1-4H3,(H,30,36)/t19-,20-,27-/m0/s1",
        "inchikey": "PFQWGWQENUDDJX-OSOCVKALSA-N",
        "iupac": {
          "systematic": "1-[[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-9-(methanesulfonamido)-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methyl-3-naphthalen-1-ylurea"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)CC2=C(C=CC(=C2)NS(=O)(=O)C)OC1CN(C)C(=O)NC3=CC=CC4=CC=CC=C43)C(C)CO"
        },
        "molecularFormula": "C29H36N4O6S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:33:58Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8383"
    },
    "name": "BRD-K99514625",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8383.png",
    "lincs": {
      "id": "LSM-8098",
      "name": "BRD-K99514625",
      "pubchemCid": 54618278,
      "chebiId": 96719,
      "inchiParent": "InChI=1S/C26H34N4O5S/c1-18(2)7-6-8-21-9-10-25-23(13-21)35-24(16-29(5)26(32)22-14-27-11-12-28-22)19(3)15-30(20(4)17-31)36(25,33)34/h9-14,18-20,24,31H,7,15-17H2,1-5H3/t19-,20-,24-/m1/s1",
      "inchiKeyParent": "ALBVOUUIQWHTKA-YOSAUDMPSA-N",
      "smilesParent": "CC(C)CC#Cc1ccc2c(O[C@H](CN(C)C(=O)c3cnccn3)[C@H](C)CN([C@H](C)CO)S2(=O)=O)c1"
    },
    "unichem": {
      "chebi": "96719",
      "lincs": "LSM-8098",
      "pubchem": "54618278"
    },
    "pubchem": [
      {
        "cid": 54618278,
        "inchi": "InChI=1S/C26H34N4O5S/c1-18(2)7-6-8-21-9-10-25-23(13-21)35-24(16-29(5)26(32)22-14-27-11-12-28-22)19(3)15-30(20(4)17-31)36(25,33)34/h9-14,18-20,24,31H,7,15-17H2,1-5H3/t19-,20-,24-/m1/s1",
        "inchikey": "ALBVOUUIQWHTKA-YOSAUDMPSA-N",
        "iupac": {
          "systematic": "N-[[(4R,5S)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-8-(4-methylpent-1-ynyl)-1,1-dioxo-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-N-methylpyrazine-2-carboxamide"
        },
        "smiles": {
          "canonical": "CC1CN(S(=O)(=O)C2=C(C=C(C=C2)C#CCC(C)C)OC1CN(C)C(=O)C3=NC=CN=C3)C(C)CO"
        },
        "molecularFormula": "C26H34N4O5S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:34:00Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83a4"
    },
    "name": "CHEMBL2134019",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83a4.png",
    "lincs": {
      "id": "LSM-13877",
      "name": "CHEMBL2134019",
      "alternativeNames": [
        "BRD-K88641895"
      ],
      "pubchemCid": 54646629,
      "chebiId": 102530,
      "inchiParent": "InChI=1S/C22H22F3N3O5/c23-22(24,25)11-27-19(30)8-14-7-16-15-6-13(28-21(31)12-2-1-5-26-9-12)3-4-17(15)33-20(16)18(10-29)32-14/h1-6,9,14,16,18,20,29H,7-8,10-11H2,(H,27,30)(H,28,31)/t14-,16-,18-,20+/m1/s1",
      "inchiKeyParent": "ILIPRRONQGJVHL-ODZKNYGOSA-N",
      "smilesParent": "OC[C@H]1O[C@@H](CC(=O)NCC(F)(F)F)C[C@H]2[C@@H]1Oc3ccc(NC(=O)c4cccnc4)cc23"
    },
    "unichem": {
      "chebi": "102530",
      "chembl": "CHEMBL2134019",
      "lincs": "LSM-13877",
      "pubchem": "54646629"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL2134019",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 465.43,
        "hba": 6,
        "hbd": 3,
        "qedWeighted": 0.6
      }
    },
    "pubchem": [
      {
        "cid": 54646629,
        "inchi": "InChI=1S/C22H22F3N3O5/c23-22(24,25)11-27-19(30)8-14-7-16-15-6-13(28-21(31)12-2-1-5-26-9-12)3-4-17(15)33-20(16)18(10-29)32-14/h1-6,9,14,16,18,20,29H,7-8,10-11H2,(H,27,30)(H,28,31)/t14-,16-,18-,20+/m1/s1",
        "inchikey": "ILIPRRONQGJVHL-ODZKNYGOSA-N",
        "iupac": {
          "systematic": "N-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]pyridine-3-carboxamide"
        },
        "smiles": {
          "canonical": "C1C(OC(C2C1C3=C(O2)C=CC(=C3)NC(=O)C4=CN=CC=C4)CO)CC(=O)NCC(F)(F)F"
        },
        "molecularFormula": "C22H22F3N3O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:34:11Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c835a"
    },
    "name": "SB-216763",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c835a.png",
    "lincs": {
      "id": "LSM-1161",
      "name": "SB-216763",
      "alternativeNames": [
        "SB 216763",
        "SB-216763"
      ],
      "pubchemCid": 176158,
      "chebiId": 91421,
      "inchiParent": "InChI=1S/C19H12Cl2N2O2/c1-23-9-13(11-4-2-3-5-15(11)23)17-16(18(24)22-19(17)25)12-7-6-10(20)8-14(12)21/h2-9H,1H3,(H,22,24,25)",
      "inchiKeyParent": "JCSGFHVFHSKIJH-UHFFFAOYSA-N",
      "smilesParent": "Cn1cc(C2=C(C(=O)NC2=O)c3ccc(Cl)cc3Cl)c4ccccc14"
    },
    "unichem": {
      "chebi": "91421",
      "chembl": "CHEMBL102714",
      "lincs": "LSM-1161",
      "pubchem": "176158"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL102714",
      "prefName": "SB-216763",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 371.22,
        "hba": 3,
        "hbd": 1,
        "qedWeighted": 0.69
      },
      "moleculeSynonyms": [
        {
          "moleculeSynonym": "SB-216763",
          "synType": "RESEARCH_CODE",
          "synonyms": "SB-216763"
        }
      ]
    },
    "pubchem": [
      {
        "cid": 176158,
        "inchi": "InChI=1S/C19H12Cl2N2O2/c1-23-9-13(11-4-2-3-5-15(11)23)17-16(18(24)22-19(17)25)12-7-6-10(20)8-14(12)21/h2-9H,1H3,(H,22,24,25)",
        "inchikey": "JCSGFHVFHSKIJH-UHFFFAOYSA-N",
        "iupac": {
          "systematic": "3-(2,4-dichlorophenyl)-4-(1-methylindol-3-yl)pyrrole-2,5-dione"
        },
        "smiles": {
          "canonical": "CN1C=C(C2=CC=CC=C21)C3=C(C(=O)NC3=O)C4=C(C=C(C=C4)Cl)Cl"
        },
        "molecularFormula": "C19H12Cl2N2O2"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:34:22Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8375"
    },
    "name": "BRD-K58879212",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8375.png",
    "lincs": {
      "id": "LSM-11986",
      "name": "BRD-K58879212",
      "pubchemCid": 54632113,
      "chebiId": 100612,
      "inchiParent": "InChI=1S/C27H35F2N3O5/c1-17-12-32(13-19-10-20(28)6-8-23(19)29)18(2)15-37-24-9-7-21(30-26(33)16-35-4)11-22(24)27(34)31(3)14-25(17)36-5/h6-11,17-18,25H,12-16H2,1-5H3,(H,30,33)/t17-,18-,25-/m1/s1",
      "inchiKeyParent": "ZVOSTPFCAQQCID-QJMRKGMQSA-N",
      "smilesParent": "COCC(=O)Nc1ccc2OC[C@@H](C)N(Cc3cc(F)ccc3F)C[C@@H](C)[C@@H](CN(C)C(=O)c2c1)OC"
    },
    "unichem": {
      "chebi": "100612",
      "lincs": "LSM-11986",
      "pubchem": "54632113"
    },
    "pubchem": [
      {
        "cid": 54632113,
        "inchi": "InChI=1S/C27H35F2N3O5/c1-17-12-32(13-19-10-20(28)6-8-23(19)29)18(2)15-37-24-9-7-21(30-26(33)16-35-4)11-22(24)27(34)31(3)14-25(17)36-5/h6-11,17-18,25H,12-16H2,1-5H3,(H,30,33)/t17-,18-,25-/m1/s1",
        "inchikey": "ZVOSTPFCAQQCID-QJMRKGMQSA-N",
        "iupac": {
          "systematic": "N-[(4R,7R,8S)-5-[(2,5-difluorophenyl)methyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(COC2=C(C=C(C=C2)NC(=O)COC)C(=O)N(CC1OC)C)C)CC3=C(C=CC(=C3)F)F"
        },
        "molecularFormula": "C27H35F2N3O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:34:25Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8356"
    },
    "name": "Colforsin",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8356.png",
    "lincs": {
      "id": "LSM-2193",
      "name": "Colforsin",
      "alternativeNames": [
        "Boforsin",
        "Colforsin",
        "Forskolin",
        "HL-362",
        "L-751362B"
      ],
      "pubchemCid": 47936,
      "chebiId": 42471,
      "inchiParent": "InChI=1S/C22H34O7/c1-8-19(5)11-14(25)22(27)20(6)13(24)9-10-18(3,4)16(20)15(26)17(28-12(2)23)21(22,7)29-19/h8,13,15-17,24,26-27H,1,9-11H2,2-7H3/t13-,15-,16-,17-,19-,20-,21+,22-/m0/s1",
      "inchiKeyParent": "OHCQJHSOBUTRHG-KGGHGJDLSA-N",
      "smilesParent": "CC(=O)O[C@H]1[C@@H](O)[C@H]2C(C)(C)CC[C@H](O)[C@]2(C)[C@@]3(O)C(=O)C[C@@](C)(O[C@]13C)C=C"
    },
    "unichem": {
      "chebi": "42471",
      "chembl": "CHEMBL52606",
      "lincs": "LSM-2193",
      "pubchem": "47936",
      "drugbank": "DB02587"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL52606",
      "prefName": "COLFORSIN",
      "maxPhase": 2.0,
      "maxPhaseCurated": "Phase 2 Clinical Trials",
      "chebiParId": "42471",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 410.51,
        "hba": 7,
        "hbd": 3,
        "qedWeighted": 0.47
      },
      "moleculeSynonyms": [
        {
          "moleculeSynonym": "Boforsin",
          "synType": "OTHER",
          "synonyms": "BOFORSIN"
        },
        {
          "moleculeSynonym": "Colforsin",
          "synType": "OTHER",
          "synonyms": "Colforsin"
        },
        {
          "moleculeSynonym": "Colforsin",
          "synType": "INN",
          "synonyms": "COLFORSIN"
        },
        {
          "moleculeSynonym": "Colforsin",
          "synType": "USAN",
          "synonyms": "COLFORSIN"
        },
        {
          "moleculeSynonym": "Colforsina",
          "synType": "INN_SPANISH",
          "synonyms": "COLFORSINA"
        },
        {
          "moleculeSynonym": "Colforsine",
          "synType": "INN_FRENCH",
          "synonyms": "COLFORSINE"
        },
        {
          "moleculeSynonym": "Forskolin",
          "synType": "OTHER",
          "synonyms": "FORSKOLIN"
        },
        {
          "moleculeSynonym": "HL 362",
          "synType": "RESEARCH_CODE",
          "synonyms": "HL 362"
        },
        {
          "moleculeSynonym": "HL-362",
          "synType": "RESEARCH_CODE",
          "synonyms": "HL-362"
        },
        {
          "moleculeSynonym": "L 75 1362B",
          "synType": "RESEARCH_CODE",
          "synonyms": "L 75 1362B"
        },
        {
          "moleculeSynonym": "L-75-1362B",
          "synType": "RESEARCH_CODE",
          "synonyms": "L-75-1362B"
        },
        {
          "moleculeSynonym": "L-751362B",
          "synType": "RESEARCH_CODE",
          "synonyms": "L-751362B"
        },
        {
          "moleculeSynonym": "NSC-357088",
          "synType": "RESEARCH_CODE",
          "synonyms": "NSC-357088"
        },
        {
          "moleculeSynonym": "NSC-375489",
          "synType": "RESEARCH_CODE",
          "synonyms": "NSC-375489"
        }
      ]
    },
    "pubchem": [
      {
        "cid": 47936,
        "inchi": "InChI=1S/C22H34O7/c1-8-19(5)11-14(25)22(27)20(6)13(24)9-10-18(3,4)16(20)15(26)17(28-12(2)23)21(22,7)29-19/h8,13,15-17,24,26-27H,1,9-11H2,2-7H3/t13-,15-,16-,17-,19-,20-,21+,22-/m0/s1",
        "inchikey": "OHCQJHSOBUTRHG-KGGHGJDLSA-N",
        "iupac": {
          "systematic": "[(3R,4aR,5S,6S,6aS,10S,10aR,10bS)-3-ethenyl-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-5,6,6a,8,9,10-hexahydro-2H-benzo[f]chromen-5-yl] acetate"
        },
        "smiles": {
          "canonical": "CC(=O)OC1C(C2C(CCC(C2(C3(C1(OC(CC3=O)(C)C=C)C)O)C)O)(C)C)O"
        },
        "molecularFormula": "C22H34O7"
      }
    ],
    "clinicaltrials": [
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT03894657",
            "briefTitle": "Validation of Respiratory Epithelial Functional Assessment to Predict Clinical Efficacy of Orkambi\u00ae.",
            "officialTitle": "Validation of Respiratory Epithelial Functional Assessment to Predict Clinical Efficacy of Orkambi\u00ae. Pathway to Personalized Therapy in Cystic Fibrosis"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2019-02-12"
          },
          "conditionsModule": {
            "conditions": [
              "Cystic Fibrosis",
              "Homozygous F508del Mutation"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Percentage of FEV1",
                "timeFrame": "Baseline, Week 24"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Z-score of FEV1"
              },
              {
                "measure": "Percentage of FEV1"
              },
              {
                "measure": "% of FVC"
              },
              {
                "measure": "% of RFC"
              },
              {
                "measure": "Lung clearance index"
              },
              {
                "measure": "Height"
              },
              {
                "measure": "Weight"
              },
              {
                "measure": "colony forming unit (CFU)"
              },
              {
                "measure": "Number of exacerbations"
              },
              {
                "measure": "Sweat Cl-"
              },
              {
                "measure": "Level in Forskolin/IBMXdependant Short Circuit Current"
              },
              {
                "measure": "percentage of cells displaying apical staining"
              },
              {
                "measure": "Area under the curve (AUC) of Lumacaftor/Ivacaftor"
              },
              {
                "measure": "Drug concentrations of Lumacaftor/Ivacaftor"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT05848830",
            "briefTitle": "Home-based Training and Supplementation in DM1 Patients",
            "officialTitle": "The Effects of Home-based Exercise Training and Multi-ingredient Supplementation on Functional Outcomes and Skeletal Muscle Adaptations in Patients With Myotonic Dystrophy Type 1"
          },
          "statusModule": {
            "overallStatus": "NOT_YET_RECRUITING",
            "studyFirstSubmitDate": "2023-04-28"
          },
          "conditionsModule": {
            "conditions": [
              "Myotonic Dystrophy 1"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Body Composition Index",
                "timeFrame": "4 months from enrolment"
              },
              {
                "measure": "VO2 Max",
                "timeFrame": "4 months from enrolment"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "6-minute walk test"
              },
              {
                "measure": "5x sit to stand"
              },
              {
                "measure": "Timed up and go"
              },
              {
                "measure": "Leg muscle strength"
              },
              {
                "measure": "Grip strength"
              },
              {
                "measure": "Single leg stance test"
              },
              {
                "measure": "Muscle fibre cross sectional area"
              },
              {
                "measure": "Muscle stem cell mitochondrial function"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT05384431",
            "briefTitle": "Can We Achieve 'high-quality' Weight Loss Through Supplementation and Exercise? the TRIM MUSCLE Study",
            "officialTitle": "Can We Achieve 'high-quality' Weight Loss Through Supplementation and Exercise? the TRIM MUSCLE Study"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2022-05-10"
          },
          "conditionsModule": {
            "conditions": [
              "Overweight",
              "Obesity"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Bodyweight change",
                "timeFrame": "baseline 0 weeks (\"pre study\") to 12 weeks (\"post study\")"
              },
              {
                "measure": "BMI change",
                "timeFrame": "baseline 0 weeks (\"pre study\") to 12 weeks (\"post study\")"
              },
              {
                "measure": "Fat mass change",
                "timeFrame": "baseline 0 weeks (\"pre study\") to 12 weeks (\"post study\")"
              },
              {
                "measure": "Lean mass change",
                "timeFrame": "baseline 0 weeks (\"pre study\") to 12 weeks (\"post study\")"
              },
              {
                "measure": "Lean mass/fat mass (body composition index) change",
                "timeFrame": "baseline 0 weeks (\"pre study\") to 12 weeks (\"post study\")"
              },
              {
                "measure": "Percent body fat change",
                "timeFrame": "baseline 0 weeks (\"pre study\") to 12 weeks (\"post study\")"
              },
              {
                "measure": "Waist-to-hip ratio change",
                "timeFrame": "baseline 0 weeks (\"pre study\") to 12 weeks (\"post study\")"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "VO2max change"
              },
              {
                "measure": "Lower body strength change"
              },
              {
                "measure": "Upper body strength change"
              },
              {
                "measure": "Appendicular lean mass change"
              },
              {
                "measure": "Insulin sensitivity change"
              },
              {
                "measure": "Blood lipids change"
              },
              {
                "measure": "Inflammation CRP change"
              },
              {
                "measure": "Inflammation TNF-alpha change"
              },
              {
                "measure": "Inflammation IL-1 change"
              },
              {
                "measure": "Inflammation IL-10 change"
              },
              {
                "measure": "Inflammation IL-6 change"
              },
              {
                "measure": "Antioxidant capacity change"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT04732910",
            "briefTitle": "Cystic Fibrosis Transmembrane Regulator (CFTR) Biomarker Study to Evaluate the Rescue of Mutant CFTR in Patients With Cystic Fibrosis Treated With CFTR-modulators",
            "officialTitle": "CFTR Biomarker Studie Bei Patient*Innen Mit Mukoviszidose Und CFTR-Modulatortherapie"
          },
          "statusModule": {
            "overallStatus": "RECRUITING",
            "studyFirstSubmitDate": "2021-01-25"
          },
          "conditionsModule": {
            "conditions": [
              "Cystic Fibrosis"
            ]
          },
          "designModule": {
            "studyType": "OBSERVATIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Intestinal current measurement (ICM)",
                "timeFrame": "12 weeks"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Forced expiratory volume in 1 second (FEV1)"
              },
              {
                "measure": "Nasal potential Difference (NPD)"
              },
              {
                "measure": "Sweat chloride"
              },
              {
                "measure": "Lung clearance index (LCI)"
              },
              {
                "measure": "Lung magnetic resonance imaging (MRI)"
              },
              {
                "measure": "Lung computer tomography"
              },
              {
                "measure": "Paranasal sinus magnetic resonance imaging (MRI)"
              },
              {
                "measure": "Fecal elastase"
              },
              {
                "measure": "Weight"
              },
              {
                "measure": "Airway Microbiome"
              },
              {
                "measure": "Sputum Elasticity"
              },
              {
                "measure": "Sputum Viscocity"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01920841",
            "briefTitle": "A Blinded Comparison Trial of Two Topical Creams to Reduce Thigh Girth and to Smooth Thigh Skin in Women",
            "officialTitle": "A Blinded Comparison Trial of Two Topical Creams to Reduce Thigh Girth and to Smooth Thigh Skin in Women."
          },
          "statusModule": {
            "overallStatus": "WITHDRAWN",
            "whyStopped": "Study Design changed and will be resubmitted as a new study",
            "studyFirstSubmitDate": "2013-08-08"
          },
          "conditionsModule": {
            "conditions": [
              "Weight Loss"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Difference in girth of the two thighs from baseline over the course of the treatment period",
                "timeFrame": "Four weeks"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Smoothness of the skin on the thighs treated with the two lipolytic creams differing in their bases compared to baseline using standardized photographs at baseline and at the end of the treatment."
              },
              {
                "measure": "Adverse events"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01254006",
            "briefTitle": "Retinal Nerve Fibres Layers Thickness Study in Glaucomatous Patients"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2010-11-29"
          },
          "conditionsModule": {
            "conditions": [
              "Glaucoma"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "retinal nerve fibres layer thickness"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "global risk threshold for glaucoma progression"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02143349",
            "briefTitle": "The Effect of Coleus Forskohlii Extract on the Risk Factors of Metabolic Syndrome",
            "officialTitle": "Investigation of Appetite Suppressant Properties Associated With Coleus Forskohlii in Overweight and Obese Individuals"
          },
          "statusModule": {
            "overallStatus": "UNKNOWN",
            "studyFirstSubmitDate": "2014-05-17"
          },
          "conditionsModule": {
            "conditions": [
              "Metabolic Syndrome",
              "Obesity"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "changes in appetite will be assessed using visual analogue scale; blood hormone levels will also be measured using commercial kits.",
                "timeFrame": "Baseline and 12 weeks"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "reduction in central obesity - waist circumference will be measured on fortnight basis"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT03652090",
            "briefTitle": "Primary Nasal Cell Culture as a Tool for Personalized Therapy in Cystic Fibrosis",
            "officialTitle": "Evaluation of the Primary Human Nasal Epithelial Cell Culture Model in the Context of Personalized Therapy in Cystic Fibrosis"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2018-08-28"
          },
          "conditionsModule": {
            "conditions": [
              "Cystic Fibrosis"
            ]
          },
          "designModule": {
            "studyType": "OBSERVATIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "variation in the short-circuit-current (Isc) after Forskolin (Forskolin)/IBMx and VX-770 (\u2206IscFsk/IBMx+VX-770)",
                "timeFrame": "1 day"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "percentage of cells displaying apical staining"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT03390985",
            "briefTitle": "Canadian Observation Trial in CF Patients Undergoing Treatment With Ivacaftor",
            "officialTitle": "Canadian Observation Trial in CF Patients Undergoing Treatment With Ivacaftor"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2017-12-18"
          },
          "conditionsModule": {
            "conditions": [
              "Cystic Fibrosis"
            ]
          },
          "designModule": {
            "studyType": "OBSERVATIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Functional in vivo Cystic fibrosis transmembrane conductor regulator (CFTR) tests: Nasal Potential difference (NPD) measurements",
                "timeFrame": "7 study visits over a 2 year period"
              },
              {
                "measure": "Functional in vivo test: Beta-adrenergic sweat secretion test",
                "timeFrame": "7 study visits over a 2 year period"
              },
              {
                "measure": "Functional in vitro test: Rectal tissue biopsies to measure CFTR function in vitro using Ussing chamber studies and organoids",
                "timeFrame": "one study visit"
              },
              {
                "measure": "Functional in vitro test: Collect nasal brushes for CFTR to generate nasal cell cultures for the assessment of ivacaftor response and CFTR function",
                "timeFrame": "2 study visits in 6 months"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Measurement of aqua wrinkling"
              },
              {
                "measure": "Measurement of exhaled fractionated nitrogen oxide (FeNo)"
              },
              {
                "measure": "Measurements of the lung clearance index"
              },
              {
                "measure": "Measurements of the pancreas function using fecal elastase test"
              },
              {
                "measure": "Measurements of the pancreas function using serum trypsinogen"
              },
              {
                "measure": "Assessment of the nutritional status"
              },
              {
                "measure": "Measurements of the resting energy expenditure"
              },
              {
                "measure": "Assessment of pulmonary radiological changes using high resolution CT"
              },
              {
                "measure": "Assessment of glucose tolerance"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02807415",
            "briefTitle": "ICM to Evaluate the Activation of p.Phe508del-CFTR by Lumacaftor in Combination With Ivacaftor",
            "officialTitle": "Intestinal Current Measurements (ICM) to Evaluate the Activation of Mutant CFTR in Subjects With Cystic Fibrosis Aged 12 Years and Older, Homozygous for the p.Phe508del-CFTR Mutation, Treated With Lumacaftor in Combination With Ivacaftor"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2016-06-16"
          },
          "conditionsModule": {
            "conditions": [
              "Cystic Fibrosis"
            ]
          },
          "designModule": {
            "studyType": "OBSERVATIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "ICM Absolute change from baseline of the cumulative chloride secretory ion current response to forskolin/IBMX and carbachol in rectal tissue as a CFTR biomarker",
                "timeFrame": "Measurement at the baseline visit within a 4-week interval prior to the start of oral treatment with lumacaftor and ivacaftor; second measurement at a day 10 - 14 weeks after the initiation of oral treatment with lumacaftor and ivacaftor"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Spirometry Absolute change from baseline in percent predicted forced expiratory volume in 1 second (FEV1)"
              },
              {
                "measure": "NPD Absolute change from baseline of the Sermet score of nasal transepithelial potential difference measurements (NPD) as a CFTR biomarker"
              },
              {
                "measure": "Sweat chloride testing Absolute change from baseline of the chloride concentration in Gibson-Cooke pilocarpine iontophoresis sweat test as a CFTR biomarker"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01439009",
            "briefTitle": "Effect of Tolvaptan on Mid- to Long-term Prognosis of Heart Failure Patients",
            "officialTitle": "A Multi-center,_double-blind,_pararel-group Comparison Trial to Investigate the Effect of Short-term Administration of Tolvaptan on Mid- to Long-term Prognosis of Heart Failure Patients (Phase_4 Study)"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2011-09-15",
            "resultsFirstSubmitDate": "2015-02-23"
          },
          "conditionsModule": {
            "conditions": [
              "Heart Failure"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Cummulative Incidence of Events at Week 26",
                "timeFrame": "Week 26"
              },
              {
                "measure": "Mortality \uff08Number of Death\uff09",
                "timeFrame": "Week26"
              },
              {
                "measure": "Body Weight",
                "timeFrame": "Day15"
              },
              {
                "measure": "Number of Subjects Whose Lower Limb Edema Severity Grading Improved by One or More Grade",
                "timeFrame": "Day15"
              },
              {
                "measure": "Jugular Venous Distension",
                "timeFrame": "Day15"
              },
              {
                "measure": "Change in Liver Size From Baseline",
                "timeFrame": "Day15"
              },
              {
                "measure": "Pulmonary Rales",
                "timeFrame": "Day15"
              },
              {
                "measure": "Third Heart Sound",
                "timeFrame": "Day15"
              },
              {
                "measure": "Cardiothoracic Ratio",
                "timeFrame": "Day15"
              },
              {
                "measure": "Pulmonary Congestion",
                "timeFrame": "Day15"
              },
              {
                "measure": "Plasma Brain Natriuretic Peptide (BNP) Concentration",
                "timeFrame": "Day15"
              },
              {
                "measure": "Dypnea",
                "timeFrame": "Day15"
              },
              {
                "measure": "Number of Subjects Whose New York Heart Association (NYHA) Classification Improved by One More Grade From Baseline",
                "timeFrame": "The day after last IMP administration and Baseline"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT03894137",
            "briefTitle": "The Acute Effect of Grains of Paradise (Aframomum Melegueta) on REE",
            "officialTitle": "The Acute Effect of Grains of Paradise (Aframomum Melegueta) on Resting Energy Expenditure in Lean, Healthy, Adults"
          },
          "statusModule": {
            "overallStatus": "UNKNOWN",
            "studyFirstSubmitDate": "2019-03-25"
          },
          "conditionsModule": {
            "conditions": [
              "Obesity"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Resting metabolic Rate (Liters of oxygen consumed per minute)",
                "timeFrame": "3 weeks"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Resting substrate oxidation"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00864578",
            "briefTitle": "Effects of Forskolin on Intraocular Pressure in Glaucomatous Patients Under Maximum Tolerated Medical Therapy",
            "officialTitle": "Effects of the Oral Administration of an Association of Forskolin With Rutin and Vitamins B on Intraocular Pressure (IOP) in Patients Affected by Primary Open Angle Glaucoma (POAG) Under Maximun Tolerated Medical Therapy (MTMT)"
          },
          "statusModule": {
            "overallStatus": "WITHDRAWN",
            "whyStopped": "loss of interest before enrolment started",
            "studyFirstSubmitDate": "2009-03-17"
          },
          "conditionsModule": {
            "conditions": [
              "Primary Open Angle Glaucoma",
              "Intraocular Pressure"
            ]
          },
          "designModule": {
            "studyType": "OBSERVATIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Intraocular pressure",
                "timeFrame": "Enrollment, 1, 2, 3, 4 weeks after initiation of treatment"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Intraocular pressure fluctuations during the day"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00863811",
            "briefTitle": "Effects of Forskolin on Intraocular Pressure in Glaucomatous Patients Under Treatment With Either Beta-blockers or Prostaglandins Eye Drops",
            "officialTitle": "Effects of the Oral Administration of an Association of Forskolin With Rutin and Vitamins B on Intraocular Pressure in Patients Affected by Primary Open Angle Glaucoma and Treated With Either Beta-blockers or Prostaglandin Eye Drops"
          },
          "statusModule": {
            "overallStatus": "WITHDRAWN",
            "whyStopped": "loss of interest before enrolment started",
            "studyFirstSubmitDate": "2009-03-17"
          },
          "conditionsModule": {
            "conditions": [
              "Primary Open Angle Glaucoma",
              "Intraocular Pressure"
            ]
          },
          "designModule": {
            "studyType": "OBSERVATIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Intraocular pressure",
                "timeFrame": "Enrollment, 1, 2, 3 months"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Intraocular pressure fluctuations during the day"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT06130228",
            "briefTitle": "Nutritional Therapy in Late-onset Pompe Disease",
            "officialTitle": "Multi-ingredient Supplementation as an Adjunctive Therapy in Late-onset Pompe Disease"
          },
          "statusModule": {
            "overallStatus": "NOT_YET_RECRUITING",
            "studyFirstSubmitDate": "2023-11-08"
          },
          "conditionsModule": {
            "conditions": [
              "Pompe Disease",
              "Muscle Loss",
              "Obesity",
              "Nutrition Poor",
              "Lysosomal Storage Diseases",
              "Glycogen Storage Disease Type II",
              "Glycogen Storage Disease Type II Late Onset",
              "Glycogen Storage Disease Type II, Adult"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Percent change in the body composition index by DEXA analyses",
                "timeFrame": "Baseline to 4 months"
              },
              {
                "measure": "Percent change in seated pulmonary function by spirometry",
                "timeFrame": "Baseline to 4 months"
              },
              {
                "measure": "Percent change in supine pulmonary function by spirometry",
                "timeFrame": "Baseline to 4 months"
              },
              {
                "measure": "Percent change in 6-minute walking test distance",
                "timeFrame": "Baseline to 4 months"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Percent change in health-related quality of life by SF-36 Survey"
              },
              {
                "measure": "Percent change in health-related quality of life by Rotterdam Handicap Score"
              },
              {
                "measure": "Percent change in health-related quality of life by the R-Pact Questionnaire"
              },
              {
                "measure": "Percent change in maximal grip strength by dynamometry"
              },
              {
                "measure": "Percent change in isometric leg strength by Biodex"
              },
              {
                "measure": "Percent change in leg strength by 4-step stair climb test"
              },
              {
                "measure": "Percent change in lower extremity functioning by short physical performance battery (SPPB)"
              },
              {
                "measure": "Percent change in lower extremity functioning by timed get up and go test (TUG)"
              },
              {
                "measure": "Percent change in total muscle glycogen by ELISA"
              },
              {
                "measure": "Percent change in lysosomal glycogen in muscle by high-resolution light microscopy"
              },
              {
                "measure": "Percent change in autophagic area in muscle by electron microscopy"
              },
              {
                "measure": "Percent change in p62 expression in muscle by Western blotting"
              },
              {
                "measure": "Percent change in complex I-V expression in muscle by Western blotting"
              },
              {
                "measure": "Percent change in 4-hydroxynonenal levels in muscle by Western blotting"
              },
              {
                "measure": "Percent change in galactin-3 expression in muscle by Western blotting"
              },
              {
                "measure": "Percent change in superoxide dismutase 1 expression in muscle by Western blotting"
              },
              {
                "measure": "Percent change in superoxide dismutase 2 expression in muscle by Western blotting"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02586883",
            "briefTitle": "Bronchial Trans-epithelial Transport in Patients With Idiopathic Multiple Dilations of the Bronchi",
            "officialTitle": "Study of the Bronchial Trans-epithelial Transport in Patients With Idiopathic Multiple Dilations of the Bronchi"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2015-07-13"
          },
          "conditionsModule": {
            "conditions": [
              "Idiopathic Dilation of the Bronchi"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Response to isoproterenol in solution without chloride ions during bronchial potential difference test (\u0394Isoprot\u00e9r\u00e9nol / bronchial).",
                "timeFrame": "up to 5 days"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Response to amiloride during bronchial potential difference test"
              },
              {
                "measure": "trans-epithelial ionic transport in the nasal epithelium (nasal DDP)"
              },
              {
                "measure": "trans-epithelial ionic transport of sweat epithelium (sweat test)"
              },
              {
                "measure": "Basal current short circuit"
              },
              {
                "measure": "Response to Epithelial Sodium Channel (ENaC) inhibitors"
              },
              {
                "measure": "Activation of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)"
              },
              {
                "measure": "Inhibition of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) (inh-172)"
              },
              {
                "measure": "Activation of Calcium (Ca)-dependent Chloride (Cl-) ion channels"
              },
              {
                "measure": "Inhibition of Solute Carrier family 26, member 9 (SLC26A9)"
              },
              {
                "measure": "Response to inhibitors of potassium (K+ ) secretion basolateral"
              },
              {
                "measure": "Bicarbonate (HCO3- ) secretion in response to forskolin"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT04254705",
            "briefTitle": "Organoid Study R334W",
            "officialTitle": "Response to CFTR-modulators in Intestinal Organoids of Patients With CF Having at Least One R334W Mutation"
          },
          "statusModule": {
            "overallStatus": "WITHDRAWN",
            "whyStopped": "Changes in modulator landscape",
            "studyFirstSubmitDate": "2020-01-27"
          },
          "conditionsModule": {
            "conditions": [
              "Cystic Fibrosis"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Response to CFTR-modulator in Intestinal Organoids: Increase in Forskolin induced swelling by addition of tezacaftor+ivacaftor after stimulation with Forskolin (0.8 \u00b5mol/L)",
                "timeFrame": "At study completion (when rectal biopsy is performed or when organoids are retrieved from the biobank and FIS has been performed), an average of 2 months"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT03455153",
            "briefTitle": "Association of Physical Activity Levels and Inflammatory Markers Following Pulmonary Rehabilitation",
            "officialTitle": "The Association of Physical Activity Levels and Inflammatory Markers in COPD Patients Following Pulmonary Rehabilitation"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2018-02-07"
          },
          "conditionsModule": {
            "conditions": [
              "COPD"
            ]
          },
          "designModule": {
            "studyType": "OBSERVATIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Cytokines",
                "timeFrame": "May 2018 - August 2018"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Leukocyte count"
              },
              {
                "measure": "Cell function"
              },
              {
                "measure": "Cell sensitivity to corticosteroids"
              }
            ]
          }
        }
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:34:37Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c838c"
    },
    "name": "BRD-K76138094",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c838c.png",
    "lincs": {
      "id": "LSM-41425",
      "name": "BRD-K76138094",
      "pubchemCid": 44487519,
      "chebiId": 129874,
      "inchiParent": "InChI=1S/C26H39N3O6S2/c1-18-16-29(19(2)17-30)26(31)22-14-21(28-37(32,33)25-9-7-13-36-25)10-11-23(22)35-20(3)8-5-6-12-34-24(18)15-27-4/h7,9-11,13-14,18-20,24,27-28,30H,5-6,8,12,15-17H2,1-4H3/t18-,19+,20+,24+/m1/s1",
      "inchiKeyParent": "HTMJKWITGYZJOG-XUJKJYMVSA-N",
      "smilesParent": "CNC[C@@H]1OCCCC[C@H](C)Oc2ccc(NS(=O)(=O)c3cccs3)cc2C(=O)N(C[C@H]1C)[C@@H](C)CO"
    },
    "unichem": {
      "chebi": "129874",
      "lincs": "LSM-41425",
      "pubchem": "44487519"
    },
    "pubchem": [
      {
        "cid": 44487519,
        "inchi": "InChI=1S/C26H39N3O6S2/c1-18-16-29(19(2)17-30)26(31)22-14-21(28-37(32,33)25-9-7-13-36-25)10-11-23(22)35-20(3)8-5-6-12-34-24(18)15-27-4/h7,9-11,13-14,18-20,24,27-28,30H,5-6,8,12,15-17H2,1-4H3/t18-,19+,20+,24+/m1/s1",
        "inchikey": "HTMJKWITGYZJOG-XUJKJYMVSA-N",
        "iupac": {
          "systematic": "N-[(3S,9R,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]thiophene-2-sulfonamide"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NS(=O)(=O)C3=CC=CS3)C(C)CO)C)CNC"
        },
        "molecularFormula": "C26H39N3O6S2"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:34:39Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8414"
    },
    "name": "CHEMBL2138717",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8414.png",
    "lincs": {
      "id": "LSM-9488",
      "name": "CHEMBL2138717",
      "alternativeNames": [
        "BRD-K17654006"
      ],
      "pubchemCid": 54654039,
      "chebiId": 98109,
      "inchiParent": "InChI=1S/C31H33ClN4O5/c1-19-6-5-8-21(14-19)34-31(39)35-22-10-13-27-24(15-22)30(38)36(2)26-12-11-23(41-28(26)18-40-27)16-29(37)33-17-20-7-3-4-9-25(20)32/h3-10,13-15,23,26,28H,11-12,16-18H2,1-2H3,(H,33,37)(H2,34,35,39)/t23-,26+,28-/m0/s1",
      "inchiKeyParent": "SECMWWJMRQEFAV-AQHOXQCLSA-N",
      "smilesParent": "CN1[C@@H]2CC[C@@H](CC(=O)NCc3ccccc3Cl)O[C@H]2COc4ccc(NC(=O)Nc5cccc(C)c5)cc4C1=O"
    },
    "unichem": {
      "chebi": "98109",
      "chembl": "CHEMBL2138717",
      "lincs": "LSM-9488",
      "pubchem": "54654039"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL2138717",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 577.08,
        "hba": 5,
        "hbd": 3,
        "qedWeighted": 0.37
      }
    },
    "pubchem": [
      {
        "cid": 54654039,
        "inchi": "InChI=1S/C31H33ClN4O5/c1-19-6-5-8-21(14-19)34-31(39)35-22-10-13-27-24(15-22)30(38)36(2)26-12-11-23(41-28(26)18-40-27)16-29(37)33-17-20-7-3-4-9-25(20)32/h3-10,13-15,23,26,28H,11-12,16-18H2,1-2H3,(H,33,37)(H2,34,35,39)/t23-,26+,28-/m0/s1",
        "inchikey": "SECMWWJMRQEFAV-AQHOXQCLSA-N",
        "iupac": {
          "systematic": "2-[(2S,4aR,12aR)-5-methyl-8-[(3-methylphenyl)carbamoylamino]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-[(2-chlorophenyl)methyl]acetamide"
        },
        "smiles": {
          "canonical": "CC1=CC(=CC=C1)NC(=O)NC2=CC3=C(C=C2)OCC4C(CCC(O4)CC(=O)NCC5=CC=CC=C5Cl)N(C3=O)C"
        },
        "molecularFormula": "C31H33ClN4O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:34:50Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8367"
    },
    "name": "BRD-K72783054",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8367.png",
    "lincs": {
      "id": "LSM-7805",
      "name": "BRD-K72783054",
      "pubchemCid": 44505438,
      "chebiId": 96426,
      "inchiParent": "InChI=1S/C25H38N6O6/c1-17-12-31(18(2)15-32)24(33)7-6-10-30-13-19(27-28-30)16-37-23(17)14-29(3)25(34)26-21-9-8-20(35-4)11-22(21)36-5/h8-9,11,13,17-18,23,32H,6-7,10,12,14-16H2,1-5H3,(H,26,34)/t17-,18-,23-/m1/s1",
      "inchiKeyParent": "DZDKJIRUSJXCKT-PMAPCBKXSA-N",
      "smilesParent": "COc1ccc(NC(=O)N(C)C[C@H]2OCc3cn(CCCC(=O)N(C[C@H]2C)[C@H](C)CO)nn3)c(OC)c1"
    },
    "unichem": {
      "chebi": "96426",
      "lincs": "LSM-7805",
      "pubchem": "44505438"
    },
    "pubchem": [
      {
        "cid": 44505438,
        "inchi": "InChI=1S/C25H38N6O6/c1-17-12-31(18(2)15-32)24(33)7-6-10-30-13-19(27-28-30)16-37-23(17)14-29(3)25(34)26-21-9-8-20(35-4)11-22(21)36-5/h8-9,11,13,17-18,23,32H,6-7,10,12,14-16H2,1-5H3,(H,26,34)/t17-,18-,23-/m1/s1",
        "inchikey": "DZDKJIRUSJXCKT-PMAPCBKXSA-N",
        "iupac": {
          "systematic": "3-(2,4-dimethoxyphenyl)-1-[[(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methylurea"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)CCCN2C=C(COC1CN(C)C(=O)NC3=C(C=C(C=C3)OC)OC)N=N2)C(C)CO"
        },
        "molecularFormula": "C25H38N6O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:34:52Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8368"
    },
    "name": "BRD-K06723172",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8368.png",
    "lincs": {
      "id": "LSM-8824",
      "name": "BRD-K06723172",
      "pubchemCid": 54631838,
      "chebiId": 97445,
      "inchiParent": "InChI=1S/C26H36N4O5/c1-17-14-29(3)18(2)16-35-22-12-11-19(13-20(22)25(31)30(4)15-24(17)34-6)27-26(32)28-21-9-7-8-10-23(21)33-5/h7-13,17-18,24H,14-16H2,1-6H3,(H2,27,28,32)/t17-,18-,24-/m0/s1",
      "inchiKeyParent": "MQWQDAVBIBJDRV-XFAGBWLFSA-N",
      "smilesParent": "CO[C@H]1CN(C)C(=O)c2cc(NC(=O)Nc3ccccc3OC)ccc2OC[C@H](C)N(C)C[C@@H]1C"
    },
    "unichem": {
      "chebi": "97445",
      "lincs": "LSM-8824",
      "pubchem": "54631838"
    },
    "pubchem": [
      {
        "cid": 54631838,
        "inchi": "InChI=1S/C26H36N4O5/c1-17-14-29(3)18(2)16-35-22-12-11-19(13-20(22)25(31)30(4)15-24(17)34-6)27-26(32)28-21-9-7-8-10-23(21)33-5/h7-13,17-18,24H,14-16H2,1-6H3,(H2,27,28,32)/t17-,18-,24-/m0/s1",
        "inchikey": "MQWQDAVBIBJDRV-XFAGBWLFSA-N",
        "iupac": {
          "systematic": "1-(2-methoxyphenyl)-3-[(4S,7S,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea"
        },
        "smiles": {
          "canonical": "CC1CN(C(COC2=C(C=C(C=C2)NC(=O)NC3=CC=CC=C3OC)C(=O)N(CC1OC)C)C)C"
        },
        "molecularFormula": "C26H36N4O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:34:55Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83bf"
    },
    "name": "BRD-K98956791",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83bf.png",
    "lincs": {
      "id": "LSM-14503",
      "name": "BRD-K98956791",
      "pubchemCid": 54657969,
      "chebiId": 103158,
      "inchiParent": "InChI=1S/C21H32N4O6/c1-12-20(13(2)31-24-12)23-21(28)25-9-15(26)10-29-11-18-17(25)6-5-16(30-18)7-19(27)22-8-14-3-4-14/h14-18,26H,3-11H2,1-2H3,(H,22,27)(H,23,28)/t15-,16+,17+,18-/m0/s1",
      "inchiKeyParent": "XOXZVIQHUYDNGA-MLHJIOFPSA-N",
      "smilesParent": "Cc1onc(C)c1NC(=O)N2C[C@H](O)COC[C@@H]3O[C@@H](CC(=O)NCC4CC4)CC[C@@H]23"
    },
    "unichem": {
      "chebi": "103158",
      "lincs": "LSM-14503",
      "pubchem": "54657969"
    },
    "pubchem": [
      {
        "cid": 54657969,
        "inchi": "InChI=1S/C21H32N4O6/c1-12-20(13(2)31-24-12)23-21(28)25-9-15(26)10-29-11-18-17(25)6-5-16(30-18)7-19(27)22-8-14-3-4-14/h14-18,26H,3-11H2,1-2H3,(H,22,27)(H,23,28)/t15-,16+,17+,18-/m0/s1",
        "inchikey": "XOXZVIQHUYDNGA-MLHJIOFPSA-N",
        "iupac": {
          "systematic": "(3S,6aR,8R,10aR)-8-[2-(cyclopropylmethylamino)-2-oxoethyl]-N-(3,5-dimethyl-1,2-oxazol-4-yl)-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide"
        },
        "smiles": {
          "canonical": "CC1=C(C(=NO1)C)NC(=O)N2CC(COCC3C2CCC(O3)CC(=O)NCC4CC4)O"
        },
        "molecularFormula": "C21H32N4O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:34:57Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83c3"
    },
    "name": "CID-2858522",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83c3.png",
    "lincs": {
      "id": "LSM-3337",
      "name": "CID-2858522",
      "alternativeNames": [
        "1-(3, 5-Di-tert-butyl-4-hydroxyphenyl)-2-(2-(3-hydroxypropylamino)-5,6-dimethyl-1H-benzo[d]imidazol-1-yl)ethanone sp-5-111",
        "2858522",
        "CID 2858522"
      ],
      "pubchemCid": 2858523,
      "chebiId": 93053,
      "inchiParent": "InChI=1S/C28H39N3O3/c1-17-12-22-23(13-18(17)2)31(26(30-22)29-10-9-11-32)16-24(33)19-14-20(27(3,4)5)25(34)21(15-19)28(6,7)8/h12-15,32,34H,9-11,16H2,1-8H3,(H,29,30)",
      "inchiKeyParent": "CYCGGKILBWERDJ-UHFFFAOYSA-N",
      "smilesParent": "Cc1cc2nc(NCCCO)n(CC(=O)c3cc(c(O)c(c3)C(C)(C)C)C(C)(C)C)c2cc1C"
    },
    "unichem": {
      "chebi": "93053",
      "chembl": "CHEMBL374350",
      "lincs": "LSM-3337",
      "pubchem": "2858523"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL374350",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 465.64,
        "hba": 6,
        "hbd": 3,
        "qedWeighted": 0.31
      },
      "moleculeSynonyms": [
        {
          "moleculeSynonym": "CID 2858522",
          "synType": "OTHER",
          "synonyms": "CID 2858522"
        }
      ]
    },
    "pubchem": [
      {
        "cid": 2858523,
        "inchi": "InChI=1S/C28H39N3O3/c1-17-12-22-23(13-18(17)2)31(26(30-22)29-10-9-11-32)16-24(33)19-14-20(27(3,4)5)25(34)21(15-19)28(6,7)8/h12-15,32,34H,9-11,16H2,1-8H3,(H,29,30)",
        "inchikey": "CYCGGKILBWERDJ-UHFFFAOYSA-N",
        "iupac": {
          "systematic": "1-(3,5-ditert-butyl-4-hydroxyphenyl)-2-[2-(3-hydroxypropylamino)-5,6-dimethylbenzimidazol-1-yl]ethanone"
        },
        "smiles": {
          "canonical": "CC1=CC2=C(C=C1C)N(C(=N2)NCCCO)CC(=O)C3=CC(=C(C(=C3)C(C)(C)C)O)C(C)(C)C"
        },
        "molecularFormula": "C28H39N3O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:35:11Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83cd"
    },
    "name": "BRD-K22211348",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83cd.png",
    "lincs": {
      "id": "LSM-14757",
      "name": "BRD-K22211348",
      "pubchemCid": 44494556,
      "chebiId": 103413,
      "inchiParent": "InChI=1S/C34H50N4O6/c1-23(2)35-34(42)37(6)21-31-24(3)20-38(25(4)22-39)33(41)29-19-28(36-32(40)18-27-13-8-7-9-14-27)15-16-30(29)44-26(5)12-10-11-17-43-31/h7-9,13-16,19,23-26,31,39H,10-12,17-18,20-22H2,1-6H3,(H,35,42)(H,36,40)/t24-,25+,26-,31+/m1/s1",
      "inchiKeyParent": "JEEWDARUSPNTGW-ANKKVJNISA-N",
      "smilesParent": "CC(C)NC(=O)N(C)C[C@@H]1OCCCC[C@@H](C)Oc2ccc(NC(=O)Cc3ccccc3)cc2C(=O)N(C[C@H]1C)[C@@H](C)CO"
    },
    "unichem": {
      "chebi": "103413",
      "lincs": "LSM-14757",
      "pubchem": "44494556"
    },
    "pubchem": [
      {
        "cid": 44494556,
        "inchi": "InChI=1S/C34H50N4O6/c1-23(2)35-34(42)37(6)21-31-24(3)20-38(25(4)22-39)33(41)29-19-28(36-32(40)18-27-13-8-7-9-14-27)15-16-30(29)44-26(5)12-10-11-17-43-31/h7-9,13-16,19,23-26,31,39H,10-12,17-18,20-22H2,1-6H3,(H,35,42)(H,36,40)/t24-,25+,26-,31+/m1/s1",
        "inchikey": "JEEWDARUSPNTGW-ANKKVJNISA-N",
        "iupac": {
          "systematic": "N-[(3R,9R,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(propan-2-ylcarbamoyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-2-phenylacetamide"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NC(=O)CC3=CC=CC=C3)C(C)CO)C)CN(C)C(=O)NC(C)C"
        },
        "molecularFormula": "C34H50N4O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:35:13Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8402"
    },
    "name": "BRD-K81080300",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8402.png",
    "lincs": {
      "id": "LSM-7905",
      "name": "BRD-K81080300",
      "pubchemCid": 54618531,
      "chebiId": 96526,
      "inchiParent": "InChI=1S/C30H36FN3O4/c1-20-17-34(21(2)19-35)30(37)25-15-22(13-14-23-9-7-8-12-26(23)31)16-32-28(25)38-27(20)18-33(3)29(36)24-10-5-4-6-11-24/h7-9,12,15-16,20-21,24,27,35H,4-6,10-11,17-19H2,1-3H3/t20-,21-,27-/m1/s1",
      "inchiKeyParent": "SOBUUYUTYHYENZ-LGVUCKNBSA-N",
      "smilesParent": "C[C@H](CO)N1C[C@@H](C)[C@@H](CN(C)C(=O)C2CCCCC2)Oc3ncc(cc3C1=O)C#Cc4ccccc4F"
    },
    "unichem": {
      "chebi": "96526",
      "lincs": "LSM-7905",
      "pubchem": "54618531"
    },
    "pubchem": [
      {
        "cid": 54618531,
        "inchi": "InChI=1S/C30H36FN3O4/c1-20-17-34(21(2)19-35)30(37)25-15-22(13-14-23-9-7-8-12-26(23)31)16-32-28(25)38-27(20)18-33(3)29(36)24-10-5-4-6-11-24/h7-9,12,15-16,20-21,24,27,35H,4-6,10-11,17-19H2,1-3H3/t20-,21-,27-/m1/s1",
        "inchikey": "SOBUUYUTYHYENZ-LGVUCKNBSA-N",
        "iupac": {
          "systematic": "N-[[(2S,3R)-8-[2-(2-fluorophenyl)ethynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylcyclohexanecarboxamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(N=CC(=C2)C#CC3=CC=CC=C3F)OC1CN(C)C(=O)C4CCCCC4)C(C)CO"
        },
        "molecularFormula": "C30H36FN3O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:35:16Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c838f"
    },
    "name": "BRD-K91857575",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c838f.png",
    "lincs": {
      "id": "LSM-14075",
      "name": "BRD-K91857575",
      "pubchemCid": 54632002,
      "chebiId": 102729,
      "inchiParent": "InChI=1S/C27H35N3O5/c1-6-25(31)30-15-18(2)24(34-5)16-29(4)27(33)22-13-12-21(14-23(22)35-17-19(30)3)28-26(32)20-10-8-7-9-11-20/h7-14,18-19,24H,6,15-17H2,1-5H3,(H,28,32)/t18-,19+,24-/m1/s1",
      "inchiKeyParent": "OTFQVXLKCTXKNS-YDIMBITNSA-N",
      "smilesParent": "CCC(=O)N1C[C@@H](C)[C@@H](CN(C)C(=O)c2ccc(NC(=O)c3ccccc3)cc2OC[C@@H]1C)OC"
    },
    "unichem": {
      "chebi": "102729",
      "lincs": "LSM-14075",
      "pubchem": "54632002"
    },
    "pubchem": [
      {
        "cid": 54632002,
        "inchi": "InChI=1S/C27H35N3O5/c1-6-25(31)30-15-18(2)24(34-5)16-29(4)27(33)22-13-12-21(14-23(22)35-17-19(30)3)28-26(32)20-10-8-7-9-11-20/h7-14,18-19,24H,6,15-17H2,1-5H3,(H,28,32)/t18-,19+,24-/m1/s1",
        "inchikey": "OTFQVXLKCTXKNS-YDIMBITNSA-N",
        "iupac": {
          "systematic": "N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propanoyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-15-yl]benzamide"
        },
        "smiles": {
          "canonical": "CCC(=O)N1CC(C(CN(C(=O)C2=C(C=C(C=C2)NC(=O)C3=CC=CC=C3)OCC1C)C)OC)C"
        },
        "molecularFormula": "C27H35N3O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:35:18Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83cb"
    },
    "name": "BRD-K18641148",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83cb.png",
    "lincs": {
      "id": "LSM-38266",
      "name": "BRD-K18641148",
      "pubchemCid": 44489766,
      "chebiId": 126703,
      "inchiParent": "InChI=1S/C31H38N4O5/c1-21-17-35(22(2)20-36)30(37)16-25-15-26(33-31(38)24-11-13-32-14-12-24)7-10-28(25)40-29(21)19-34(3)18-23-5-8-27(39-4)9-6-23/h5-15,21-22,29,36H,16-20H2,1-4H3,(H,33,38)/t21-,22+,29-/m0/s1",
      "inchiKeyParent": "AGTOXIQHWXFKCO-KERYWQKISA-N",
      "smilesParent": "COc1ccc(CN(C)C[C@@H]2Oc3ccc(NC(=O)c4ccncc4)cc3CC(=O)N(C[C@@H]2C)[C@H](C)CO)cc1"
    },
    "unichem": {
      "chebi": "126703",
      "lincs": "LSM-38266",
      "pubchem": "44489766"
    },
    "pubchem": [
      {
        "cid": 44489766,
        "inchi": "InChI=1S/C31H38N4O5/c1-21-17-35(22(2)20-36)30(37)16-25-15-26(33-31(38)24-11-13-32-14-12-24)7-10-28(25)40-29(21)19-34(3)18-23-5-8-27(39-4)9-6-23/h5-15,21-22,29,36H,16-20H2,1-4H3,(H,33,38)/t21-,22+,29-/m0/s1",
        "inchikey": "AGTOXIQHWXFKCO-KERYWQKISA-N",
        "iupac": {
          "systematic": "N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)methyl-methylamino]methyl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]pyridine-4-carboxamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)CC2=C(C=CC(=C2)NC(=O)C3=CC=NC=C3)OC1CN(C)CC4=CC=C(C=C4)OC)C(C)CO"
        },
        "molecularFormula": "C31H38N4O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:35:20Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83e3"
    },
    "name": "BRD-K22789789",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83e3.png",
    "lincs": {
      "id": "LSM-38504",
      "name": "BRD-K22789789",
      "pubchemCid": 44489490,
      "chebiId": 126941,
      "inchiParent": "InChI=1S/C31H39N5O5/c1-19(2)32-30(39)33-23-13-14-27-25(15-23)29(38)36(21(4)18-37)16-20(3)28(41-27)17-35(5)31(40)34-26-12-8-10-22-9-6-7-11-24(22)26/h6-15,19-21,28,37H,16-18H2,1-5H3,(H,34,40)(H2,32,33,39)/t20-,21+,28+/m1/s1",
      "inchiKeyParent": "KYHZFTDIMWCHFE-GGJMMHKRSA-N",
      "smilesParent": "CC(C)NC(=O)Nc1ccc2O[C@@H](CN(C)C(=O)Nc3cccc4ccccc34)[C@H](C)CN([C@@H](C)CO)C(=O)c2c1"
    },
    "unichem": {
      "chebi": "126941",
      "lincs": "LSM-38504",
      "pubchem": "44489490"
    },
    "pubchem": [
      {
        "cid": 44489490,
        "inchi": "InChI=1S/C31H39N5O5/c1-19(2)32-30(39)33-23-13-14-27-25(15-23)29(38)36(21(4)18-37)16-20(3)28(41-27)17-35(5)31(40)34-26-12-8-10-22-9-6-7-11-24(22)26/h6-15,19-21,28,37H,16-18H2,1-5H3,(H,34,40)(H2,32,33,39)/t20-,21+,28+/m1/s1",
        "inchikey": "KYHZFTDIMWCHFE-GGJMMHKRSA-N",
        "iupac": {
          "systematic": "1-[[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-(propan-2-ylcarbamoylamino)-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-naphthalen-1-ylurea"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(C=CC(=C2)NC(=O)NC(C)C)OC1CN(C)C(=O)NC3=CC=CC4=CC=CC=C43)C(C)CO"
        },
        "molecularFormula": "C31H39N5O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:35:23Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8365"
    },
    "name": "BRD-K27935463",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8365.png",
    "lincs": {
      "id": "LSM-10118",
      "name": "BRD-K27935463",
      "pubchemCid": 54646374,
      "chebiId": 98739,
      "inchiParent": "InChI=1S/C31H35N3O5/c1-34(2)18-30(37)33-23-12-13-27-25(14-23)26-15-24(38-28(19-35)31(26)39-27)16-29(36)32-17-20-8-10-22(11-9-20)21-6-4-3-5-7-21/h3-14,24,26,28,31,35H,15-19H2,1-2H3,(H,32,36)(H,33,37)/t24-,26+,28-,31-/m1/s1",
      "inchiKeyParent": "BRDKARYWUSDFKE-FZYTTXFFSA-N",
      "smilesParent": "CN(C)CC(=O)Nc1ccc2O[C@H]3[C@@H](CO)O[C@@H](CC(=O)NCc4ccc(cc4)c5ccccc5)C[C@H]3c2c1"
    },
    "unichem": {
      "chebi": "98739",
      "lincs": "LSM-10118",
      "pubchem": "54646374"
    },
    "pubchem": [
      {
        "cid": 54646374,
        "inchi": "InChI=1S/C31H35N3O5/c1-34(2)18-30(37)33-23-12-13-27-25(14-23)26-15-24(38-28(19-35)31(26)39-27)16-29(36)32-17-20-8-10-22(11-9-20)21-6-4-3-5-7-21/h3-14,24,26,28,31,35H,15-19H2,1-2H3,(H,32,36)(H,33,37)/t24-,26+,28-,31-/m1/s1",
        "inchikey": "BRDKARYWUSDFKE-FZYTTXFFSA-N",
        "iupac": {
          "systematic": "2-[(1R,3R,4aS,9aR)-6-[[2-(dimethylamino)acetyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-[(4-phenylphenyl)methyl]acetamide"
        },
        "smiles": {
          "canonical": "CN(C)CC(=O)NC1=CC2=C(C=C1)OC3C2CC(OC3CO)CC(=O)NCC4=CC=C(C=C4)C5=CC=CC=C5"
        },
        "molecularFormula": "C31H35N3O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:35:25Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c837d"
    },
    "name": "BRD-K71533707",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c837d.png",
    "lincs": {
      "id": "LSM-26287",
      "name": "BRD-K71533707",
      "pubchemCid": 54650834,
      "chebiId": 114825,
      "inchiParent": "InChI=1S/C24H25N3O3/c1-26(2)23(29)18-9-5-16(6-10-18)15-3-7-17(8-4-15)22-20(13-25)27(21(22)14-28)24(30)19-11-12-19/h3-10,19-22,28H,11-12,14H2,1-2H3/t20-,21+,22-/m1/s1",
      "inchiKeyParent": "BYRAUYRNNUGPGD-BHIFYINESA-N",
      "smilesParent": "CN(C)C(=O)c1ccc(cc1)c2ccc(cc2)[C@H]3[C@H](CO)N([C@@H]3C#N)C(=O)C4CC4"
    },
    "unichem": {
      "chebi": "114825",
      "lincs": "LSM-26287",
      "pubchem": "54650834"
    },
    "pubchem": [
      {
        "cid": 54650834,
        "inchi": "InChI=1S/C24H25N3O3/c1-26(2)23(29)18-9-5-16(6-10-18)15-3-7-17(8-4-15)22-20(13-25)27(21(22)14-28)24(30)19-11-12-19/h3-10,19-22,28H,11-12,14H2,1-2H3/t20-,21+,22-/m1/s1",
        "inchikey": "BYRAUYRNNUGPGD-BHIFYINESA-N",
        "iupac": {
          "systematic": "4-[4-[(2S,3R,4R)-2-cyano-1-(cyclopropanecarbonyl)-4-(hydroxymethyl)azetidin-3-yl]phenyl]-N,N-dimethylbenzamide"
        },
        "smiles": {
          "canonical": "CN(C)C(=O)C1=CC=C(C=C1)C2=CC=C(C=C2)C3C(N(C3C#N)C(=O)C4CC4)CO"
        },
        "molecularFormula": "C24H25N3O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:35:27Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83a8"
    },
    "name": "BRD-K75381775",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83a8.png",
    "lincs": {
      "id": "LSM-13038",
      "name": "BRD-K75381775",
      "pubchemCid": 54631742,
      "chebiId": 101675,
      "inchiParent": "InChI=1S/C23H35N3O4/c1-15-12-25(3)16(2)14-30-20-10-9-18(24-22(27)17-7-6-8-17)11-19(20)23(28)26(4)13-21(15)29-5/h9-11,15-17,21H,6-8,12-14H2,1-5H3,(H,24,27)/t15-,16-,21-/m0/s1",
      "inchiKeyParent": "IMTXHMNNEPVREU-QYWGDWMGSA-N",
      "smilesParent": "CO[C@H]1CN(C)C(=O)c2cc(NC(=O)C3CCC3)ccc2OC[C@H](C)N(C)C[C@@H]1C"
    },
    "unichem": {
      "chebi": "101675",
      "lincs": "LSM-13038",
      "pubchem": "54631742"
    },
    "pubchem": [
      {
        "cid": 54631742,
        "inchi": "InChI=1S/C23H35N3O4/c1-15-12-25(3)16(2)14-30-20-10-9-18(24-22(27)17-7-6-8-17)11-19(20)23(28)26(4)13-21(15)29-5/h9-11,15-17,21H,6-8,12-14H2,1-5H3,(H,24,27)/t15-,16-,21-/m0/s1",
        "inchikey": "IMTXHMNNEPVREU-QYWGDWMGSA-N",
        "iupac": {
          "systematic": "N-[(4S,7S,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclobutanecarboxamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(COC2=C(C=C(C=C2)NC(=O)C3CCC3)C(=O)N(CC1OC)C)C)C"
        },
        "molecularFormula": "C23H35N3O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:35:29Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83aa"
    },
    "name": "BRD-K71498541",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83aa.png",
    "lincs": {
      "id": "LSM-41160",
      "name": "BRD-K71498541",
      "pubchemCid": 44491776,
      "chebiId": 129609,
      "inchiParent": "InChI=1S/C30H46N4O5/c1-20-17-34(21(2)19-35)29(37)25-16-24(31-28(36)22-10-6-4-7-11-22)14-15-26(25)39-27(20)18-33(3)30(38)32-23-12-8-5-9-13-23/h14-16,20-23,27,35H,4-13,17-19H2,1-3H3,(H,31,36)(H,32,38)/t20-,21+,27-/m1/s1",
      "inchiKeyParent": "BPHDJJLUUFUQJF-PBDKAQRYSA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@@H](C)[C@@H](CN(C)C(=O)NC2CCCCC2)Oc3ccc(NC(=O)C4CCCCC4)cc3C1=O"
    },
    "unichem": {
      "chebi": "129609",
      "lincs": "LSM-41160",
      "pubchem": "44491776"
    },
    "pubchem": [
      {
        "cid": 44491776,
        "inchi": "InChI=1S/C30H46N4O5/c1-20-17-34(21(2)19-35)29(37)25-16-24(31-28(36)22-10-6-4-7-11-22)14-15-26(25)39-27(20)18-33(3)30(38)32-23-12-8-5-9-13-23/h14-16,20-23,27,35H,4-13,17-19H2,1-3H3,(H,31,36)(H,32,38)/t20-,21+,27-/m1/s1",
        "inchikey": "BPHDJJLUUFUQJF-PBDKAQRYSA-N",
        "iupac": {
          "systematic": "N-[(2S,3R)-2-[[cyclohexylcarbamoyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclohexanecarboxamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(C=CC(=C2)NC(=O)C3CCCCC3)OC1CN(C)C(=O)NC4CCCCC4)C(C)CO"
        },
        "molecularFormula": "C30H46N4O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:35:31Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83b6"
    },
    "name": "BRD-K02492147",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83b6.png",
    "lincs": {
      "id": "LSM-8589",
      "name": "BRD-K02492147",
      "pubchemCid": 54639126,
      "chebiId": 97210,
      "inchiParent": "InChI=1S/C19H26FN3O5S/c1-22-7-9-23(10-8-22)19(25)12-15-5-6-17(18(13-24)28-15)21-29(26,27)16-4-2-3-14(20)11-16/h2-6,11,15,17-18,21,24H,7-10,12-13H2,1H3/t15-,17+,18-/m1/s1",
      "inchiKeyParent": "BAJOMULNWMTCGT-BPQIPLTHSA-N",
      "smilesParent": "CN1CCN(CC1)C(=O)C[C@@H]2O[C@H](CO)[C@@H](NS(=O)(=O)c3cccc(F)c3)C=C2"
    },
    "unichem": {
      "chebi": "97210",
      "lincs": "LSM-8589",
      "pubchem": "54639126"
    },
    "pubchem": [
      {
        "cid": 54639126,
        "inchi": "InChI=1S/C19H26FN3O5S/c1-22-7-9-23(10-8-22)19(25)12-15-5-6-17(18(13-24)28-15)21-29(26,27)16-4-2-3-14(20)11-16/h2-6,11,15,17-18,21,24H,7-10,12-13H2,1H3/t15-,17+,18-/m1/s1",
        "inchikey": "BAJOMULNWMTCGT-BPQIPLTHSA-N",
        "iupac": {
          "systematic": "3-fluoro-N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-(4-methylpiperazin-1-yl)-2-oxoethyl]-3,6-dihydro-2H-pyran-3-yl]benzenesulfonamide"
        },
        "smiles": {
          "canonical": "CN1CCN(CC1)C(=O)CC2C=CC(C(O2)CO)NS(=O)(=O)C3=CC=CC(=C3)F"
        },
        "molecularFormula": "C19H26FN3O5S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:35:34Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c840c"
    },
    "name": "BRD-K44480417",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c840c.png",
    "lincs": {
      "id": "LSM-11135",
      "name": "BRD-K44480417",
      "pubchemCid": 56835500,
      "chebiId": 99756,
      "inchiParent": "InChI=1S/C30H36N2O6S/c1-21-17-32(22(2)19-33)30(34)26-14-8-7-13-25(26)24-12-6-5-11-23(24)20-38-28(21)18-31(3)39(35,36)29-16-10-9-15-27(29)37-4/h5-16,21-22,28,33H,17-20H2,1-4H3/t21-,22+,28+/m1/s1",
      "inchiKeyParent": "IDILRECQKBLRIF-WENCSYSZSA-N",
      "smilesParent": "COc1ccccc1S(=O)(=O)N(C)C[C@@H]2OCc3ccccc3c4ccccc4C(=O)N(C[C@H]2C)[C@@H](C)CO"
    },
    "unichem": {
      "chebi": "99756",
      "lincs": "LSM-11135",
      "pubchem": "56835500"
    },
    "pubchem": [
      {
        "cid": 56835500,
        "inchi": "InChI=1S/C30H36N2O6S/c1-21-17-32(22(2)19-33)30(34)26-14-8-7-13-25(26)24-12-6-5-11-23(24)20-38-28(21)18-31(3)39(35,36)29-16-10-9-15-27(29)37-4/h5-16,21-22,28,33H,17-20H2,1-4H3/t21-,22+,28+/m1/s1",
        "inchikey": "IDILRECQKBLRIF-WENCSYSZSA-N",
        "iupac": {
          "systematic": "N-[[(10R,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-2-methoxy-N-methylbenzenesulfonamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=CC=CC=C2C3=CC=CC=C3COC1CN(C)S(=O)(=O)C4=CC=CC=C4OC)C(C)CO"
        },
        "molecularFormula": "C30H36N2O6S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:35:36Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83be"
    },
    "name": "BRD-K15418616",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83be.png",
    "lincs": {
      "id": "LSM-9351",
      "name": "BRD-K15418616",
      "pubchemCid": 54649185,
      "chebiId": 97972,
      "inchiParent": "InChI=1S/C23H32FN3O5S/c1-17(22(32-4)15-26(3)33(30,31)19-10-6-5-7-11-19)14-27(18(2)16-28)23(29)25-21-13-9-8-12-20(21)24/h5-13,17-18,22,28H,14-16H2,1-4H3,(H,25,29)/t17-,18+,22+/m1/s1",
      "inchiKeyParent": "PETXHQBGDUFNPW-FGSXEWAUSA-N",
      "smilesParent": "CO[C@@H](CN(C)S(=O)(=O)c1ccccc1)[C@H](C)CN([C@@H](C)CO)C(=O)Nc2ccccc2F"
    },
    "unichem": {
      "chebi": "97972",
      "lincs": "LSM-9351",
      "pubchem": "54649185"
    },
    "pubchem": [
      {
        "cid": 54649185,
        "inchi": "InChI=1S/C23H32FN3O5S/c1-17(22(32-4)15-26(3)33(30,31)19-10-6-5-7-11-19)14-27(18(2)16-28)23(29)25-21-13-9-8-12-20(21)24/h5-13,17-18,22,28H,14-16H2,1-4H3,(H,25,29)/t17-,18+,22+/m1/s1",
        "inchikey": "PETXHQBGDUFNPW-FGSXEWAUSA-N",
        "iupac": {
          "systematic": "1-[(2R,3R)-4-[benzenesulfonyl(methyl)amino]-3-methoxy-2-methylbutyl]-3-(2-fluorophenyl)-1-[(2S)-1-hydroxypropan-2-yl]urea"
        },
        "smiles": {
          "canonical": "CC(CN(C(C)CO)C(=O)NC1=CC=CC=C1F)C(CN(C)S(=O)(=O)C2=CC=CC=C2)OC"
        },
        "molecularFormula": "C23H32FN3O5S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:35:38Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83c9"
    },
    "name": "BRD-K25249292",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83c9.png",
    "lincs": {
      "id": "LSM-9964",
      "name": "BRD-K25249292",
      "pubchemCid": 54631720,
      "chebiId": 98585,
      "inchiParent": "InChI=1S/C32H36FN3O5/c1-21-18-36(32(39)25-12-8-9-13-27(25)33)22(2)20-41-28-17-24(34-30(37)16-23-10-6-5-7-11-23)14-15-26(28)31(38)35(3)19-29(21)40-4/h5-15,17,21-22,29H,16,18-20H2,1-4H3,(H,34,37)/t21-,22-,29-/m1/s1",
      "inchiKeyParent": "QUELGMPZNWRZSJ-IEOSBIPESA-N",
      "smilesParent": "CO[C@@H]1CN(C)C(=O)c2ccc(NC(=O)Cc3ccccc3)cc2OC[C@@H](C)N(C[C@H]1C)C(=O)c4ccccc4F"
    },
    "unichem": {
      "chebi": "98585",
      "lincs": "LSM-9964",
      "pubchem": "54631720"
    },
    "pubchem": [
      {
        "cid": 54631720,
        "inchi": "InChI=1S/C32H36FN3O5/c1-21-18-36(32(39)25-12-8-9-13-27(25)33)22(2)20-41-28-17-24(34-30(37)16-23-10-6-5-7-11-23)14-15-26(28)31(38)35(3)19-29(21)40-4/h5-15,17,21-22,29H,16,18-20H2,1-4H3,(H,34,37)/t21-,22-,29-/m1/s1",
        "inchikey": "QUELGMPZNWRZSJ-IEOSBIPESA-N",
        "iupac": {
          "systematic": "N-[(4R,7R,8S)-5-(2-fluorobenzoyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-15-yl]-2-phenylacetamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(COC2=C(C=CC(=C2)NC(=O)CC3=CC=CC=C3)C(=O)N(CC1OC)C)C)C(=O)C4=CC=CC=C4F"
        },
        "molecularFormula": "C32H36FN3O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:35:40Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83e1"
    },
    "name": "BRD-K23491633",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83e1.png",
    "lincs": {
      "id": "LSM-7156",
      "name": "BRD-K23491633",
      "pubchemCid": 54618932,
      "chebiId": 95777,
      "inchiParent": "InChI=1S/C26H32N4O4/c1-17(2)8-9-20-11-22-24(28-12-20)34-23(18(3)14-30(26(22)33)19(4)16-31)15-29(5)25(32)21-7-6-10-27-13-21/h6-7,10-13,17-19,23,31H,14-16H2,1-5H3/t18-,19+,23-/m0/s1",
      "inchiKeyParent": "YBQMRNJYNXSOKR-YYDVJCTNSA-N",
      "smilesParent": "CC(C)C#Cc1cnc2O[C@@H](CN(C)C(=O)c3cccnc3)[C@@H](C)CN([C@H](C)CO)C(=O)c2c1"
    },
    "unichem": {
      "chebi": "95777",
      "lincs": "LSM-7156",
      "pubchem": "54618932"
    },
    "pubchem": [
      {
        "cid": 54618932,
        "inchi": "InChI=1S/C26H32N4O4/c1-17(2)8-9-20-11-22-24(28-12-20)34-23(18(3)14-30(26(22)33)19(4)16-31)15-29(5)25(32)21-7-6-10-27-13-21/h6-7,10-13,17-19,23,31H,14-16H2,1-5H3/t18-,19+,23-/m0/s1",
        "inchikey": "YBQMRNJYNXSOKR-YYDVJCTNSA-N",
        "iupac": {
          "systematic": "N-[[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-8-(3-methylbut-1-ynyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylpyridine-3-carboxamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(N=CC(=C2)C#CC(C)C)OC1CN(C)C(=O)C3=CN=CC=C3)C(C)CO"
        },
        "molecularFormula": "C26H32N4O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:35:43Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8371"
    },
    "name": "BRD-K91849632",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8371.png",
    "lincs": {
      "id": "LSM-14074",
      "name": "BRD-K91849632",
      "pubchemCid": 54637845,
      "chebiId": 102728,
      "inchiParent": "InChI=1S/C30H37N5O5S/c1-20-14-35(21(2)17-36)30(37)29-28(24-12-8-9-13-25(24)34(29)5)23-11-7-6-10-22(23)18-40-26(20)15-33(4)41(38,39)27-16-32(3)19-31-27/h6-13,16,19-21,26,36H,14-15,17-18H2,1-5H3/t20-,21-,26-/m1/s1",
      "inchiKeyParent": "NRKUZRFIJSCRHL-IPVFLDMMSA-N",
      "smilesParent": "C[C@H](CO)N1C[C@@H](C)[C@@H](CN(C)S(=O)(=O)c2cn(C)cn2)OCc3ccccc3c4c(C1=O)n(C)c5ccccc45"
    },
    "unichem": {
      "chebi": "102728",
      "lincs": "LSM-14074",
      "pubchem": "54637845"
    },
    "pubchem": [
      {
        "cid": 54637845,
        "inchi": "InChI=1S/C30H37N5O5S/c1-20-14-35(21(2)17-36)30(37)29-28(24-12-8-9-13-25(24)34(29)5)23-11-7-6-10-22(23)18-40-26(20)15-33(4)41(38,39)27-16-32(3)19-31-27/h6-13,16,19-21,26,36H,14-15,17-18H2,1-5H3/t20-,21-,26-/m1/s1",
        "inchikey": "NRKUZRFIJSCRHL-IPVFLDMMSA-N",
        "iupac": {
          "systematic": "N-[[(10S,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N,1-dimethylimidazole-4-sulfonamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(C3=CC=CC=C3COC1CN(C)S(=O)(=O)C4=CN(C=N4)C)C5=CC=CC=C5N2C)C(C)CO"
        },
        "molecularFormula": "C30H37N5O5S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:35:45Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83ab"
    },
    "name": "BRD-K05211263",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83ab.png",
    "lincs": {
      "id": "LSM-37547",
      "name": "BRD-K05211263",
      "pubchemCid": 54615093,
      "chebiId": 125980,
      "inchiParent": "InChI=1S/C32H49N5O6/c1-20-16-37(21(2)19-38)31(39)27-15-26(33-32(40)34-30-23(4)35-43-24(30)5)12-13-28(27)42-22(3)9-7-8-14-41-29(20)18-36(6)17-25-10-11-25/h12-13,15,20-22,25,29,38H,7-11,14,16-19H2,1-6H3,(H2,33,34,40)/t20-,21-,22-,29+/m1/s1",
      "inchiKeyParent": "JVILTGOVTWEXFK-GFGAIRHFSA-N",
      "smilesParent": "C[C@H](CO)N1C[C@@H](C)[C@H](CN(C)CC2CC2)OCCCC[C@@H](C)Oc3ccc(NC(=O)Nc4c(C)onc4C)cc3C1=O"
    },
    "unichem": {
      "chebi": "125980",
      "lincs": "LSM-37547",
      "pubchem": "54615093"
    },
    "pubchem": [
      {
        "cid": 54615093,
        "inchi": "InChI=1S/C32H49N5O6/c1-20-16-37(21(2)19-38)31(39)27-15-26(33-32(40)34-30-23(4)35-43-24(30)5)12-13-28(27)42-22(3)9-7-8-14-41-29(20)18-36(6)17-25-10-11-25/h12-13,15,20-22,25,29,38H,7-11,14,16-19H2,1-6H3,(H2,33,34,40)/t20-,21-,22-,29+/m1/s1",
        "inchikey": "JVILTGOVTWEXFK-GFGAIRHFSA-N",
        "iupac": {
          "systematic": "1-[(3R,9R,10R)-9-[[cyclopropylmethyl(methyl)amino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-(3,5-dimethyl-1,2-oxazol-4-yl)urea"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NC(=O)NC3=C(ON=C3C)C)C(C)CO)C)CN(C)CC4CC4"
        },
        "molecularFormula": "C32H49N5O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:35:47Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83cf"
    },
    "name": "MLS003129493",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83cf.png",
    "lincs": {
      "id": "LSM-8117",
      "name": "MLS003129493",
      "alternativeNames": [
        "BRD-K03155021"
      ],
      "pubchemCid": 44505339,
      "chebiId": 96738,
      "inchiParent": "InChI=1S/C23H35N5O6S/c1-17-12-28(18(2)15-29)23(30)6-5-11-27-13-19(24-25-27)16-34-22(17)14-26(3)35(31,32)21-9-7-20(33-4)8-10-21/h7-10,13,17-18,22,29H,5-6,11-12,14-16H2,1-4H3/t17-,18+,22+/m0/s1",
      "inchiKeyParent": "AWVASGRLDZTAAI-NJNPRVFISA-N",
      "smilesParent": "COc1ccc(cc1)S(=O)(=O)N(C)C[C@H]2OCc3cn(CCCC(=O)N(C[C@@H]2C)[C@H](C)CO)nn3"
    },
    "unichem": {
      "chebi": "96738",
      "chembl": "CHEMBL2140841",
      "lincs": "LSM-8117",
      "pubchem": "44505339"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL2140841",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 509.63,
        "hba": 9,
        "hbd": 1,
        "qedWeighted": 0.59
      }
    },
    "pubchem": [
      {
        "cid": 44505339,
        "inchi": "InChI=1S/C23H35N5O6S/c1-17-12-28(18(2)15-29)23(30)6-5-11-27-13-19(24-25-27)16-34-22(17)14-26(3)35(31,32)21-9-7-20(33-4)8-10-21/h7-10,13,17-18,22,29H,5-6,11-12,14-16H2,1-4H3/t17-,18+,22+/m0/s1",
        "inchikey": "AWVASGRLDZTAAI-NJNPRVFISA-N",
        "iupac": {
          "systematic": "N-[[(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-4-methoxy-N-methylbenzenesulfonamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)CCCN2C=C(COC1CN(C)S(=O)(=O)C3=CC=C(C=C3)OC)N=N2)C(C)CO"
        },
        "molecularFormula": "C23H35N5O6S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:35:59Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c842d"
    },
    "name": "BRD-K69589246",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c842d.png",
    "lincs": {
      "id": "LSM-12675",
      "name": "BRD-K69589246",
      "pubchemCid": 54631566,
      "chebiId": 101309,
      "inchiParent": "InChI=1S/C29H35N3O6S/c1-20-17-30-21(2)19-37-27-16-22(10-15-26(27)29(33)32(3)18-28(20)36-4)31-39(34,35)25-13-11-24(12-14-25)38-23-8-6-5-7-9-23/h5-16,20-21,28,30-31H,17-19H2,1-4H3/t20-,21+,28+/m0/s1",
      "inchiKeyParent": "NZYQBFQVYSNMPI-BALWLHIASA-N",
      "smilesParent": "CO[C@@H]1CN(C)C(=O)c2ccc(NS(=O)(=O)c3ccc(Oc4ccccc4)cc3)cc2OC[C@@H](C)NC[C@@H]1C"
    },
    "unichem": {
      "chebi": "101309",
      "lincs": "LSM-12675",
      "pubchem": "54631566"
    },
    "pubchem": [
      {
        "cid": 54631566,
        "inchi": "InChI=1S/C29H35N3O6S/c1-20-17-30-21(2)19-37-27-16-22(10-15-26(27)29(33)32(3)18-28(20)36-4)31-39(34,35)25-13-11-24(12-14-25)38-23-8-6-5-7-9-23/h5-16,20-21,28,30-31H,17-19H2,1-4H3/t20-,21+,28+/m0/s1",
        "inchikey": "NZYQBFQVYSNMPI-BALWLHIASA-N",
        "iupac": {
          "systematic": "N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-15-yl]-4-phenoxybenzenesulfonamide"
        },
        "smiles": {
          "canonical": "CC1CNC(COC2=C(C=CC(=C2)NS(=O)(=O)C3=CC=C(C=C3)OC4=CC=CC=C4)C(=O)N(CC1OC)C)C"
        },
        "molecularFormula": "C29H35N3O6S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:36:01Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c841d"
    },
    "name": "BRD-K40056507",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c841d.png",
    "lincs": {
      "id": "LSM-39477",
      "name": "BRD-K40056507",
      "pubchemCid": 44495340,
      "chebiId": 127921,
      "inchiParent": "InChI=1S/C30H42N4O6/c1-20-16-34(21(2)19-35)29(37)25-15-24(31-28(36)7-6-14-32(3)4)12-13-26(25)40-27(20)18-33(5)17-22-8-10-23(11-9-22)30(38)39/h8-13,15,20-21,27,35H,6-7,14,16-19H2,1-5H3,(H,31,36)(H,38,39)/t20-,21-,27-/m1/s1",
      "inchiKeyParent": "NGHZCWRCBPRMGW-LGVUCKNBSA-N",
      "smilesParent": "C[C@H](CO)N1C[C@@H](C)[C@@H](CN(C)Cc2ccc(cc2)C(=O)O)Oc3ccc(NC(=O)CCCN(C)C)cc3C1=O"
    },
    "unichem": {
      "chebi": "127921",
      "lincs": "LSM-39477",
      "pubchem": "44495340"
    },
    "pubchem": [
      {
        "cid": 44495340,
        "inchi": "InChI=1S/C30H42N4O6/c1-20-16-34(21(2)19-35)29(37)25-15-24(31-28(36)7-6-14-32(3)4)12-13-26(25)40-27(20)18-33(5)17-22-8-10-23(11-9-22)30(38)39/h8-13,15,20-21,27,35H,6-7,14,16-19H2,1-5H3,(H,31,36)(H,38,39)/t20-,21-,27-/m1/s1",
        "inchikey": "NGHZCWRCBPRMGW-LGVUCKNBSA-N",
        "iupac": {
          "systematic": "4-[[[(2S,3R)-8-[4-(dimethylamino)butanoylamino]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl-methylamino]methyl]benzoic acid"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(C=CC(=C2)NC(=O)CCCN(C)C)OC1CN(C)CC3=CC=C(C=C3)C(=O)O)C(C)CO"
        },
        "molecularFormula": "C30H42N4O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:36:04Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8436"
    },
    "name": "BRD-K44266302",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8436.png",
    "lincs": {
      "id": "LSM-39711",
      "name": "BRD-K44266302",
      "pubchemCid": 71760516,
      "chebiId": 128156,
      "inchiParent": "InChI=1S/C26H35N5O3S/c1-17(2)28-25(33)31-16-26(7-10-30(11-8-26)14-22-27-9-12-35-22)23-19-6-5-18(34-4)13-20(19)29(3)24(23)21(31)15-32/h5-6,9,12-13,17,21,32H,7-8,10-11,14-16H2,1-4H3,(H,28,33)/t21-/m1/s1",
      "inchiKeyParent": "PPRTXVLQEFGUPH-OAQYLSRUSA-N",
      "smilesParent": "COc1ccc2c3c([C@@H](CO)N(CC34CCN(Cc5nccs5)CC4)C(=O)NC(C)C)n(C)c2c1"
    },
    "unichem": {
      "chebi": "128156",
      "lincs": "LSM-39711",
      "pubchem": "71760516"
    },
    "pubchem": [
      {
        "cid": 71760516,
        "inchi": "InChI=1S/C26H35N5O3S/c1-17(2)28-25(33)31-16-26(7-10-30(11-8-26)14-22-27-9-12-35-22)23-19-6-5-18(34-4)13-20(19)29(3)24(23)21(31)15-32/h5-6,9,12-13,17,21,32H,7-8,10-11,14-16H2,1-4H3,(H,28,33)/t21-/m1/s1",
        "inchikey": "PPRTXVLQEFGUPH-OAQYLSRUSA-N",
        "iupac": {
          "systematic": "(1S)-1-(hydroxymethyl)-7-methoxy-9-methyl-N-propan-2-yl-1'-(1,3-thiazol-2-ylmethyl)spiro[1,3-dihydropyrido[3,4-b]indole-4,4'-piperidine]-2-carboxamide"
        },
        "smiles": {
          "canonical": "CC(C)NC(=O)N1CC2(CCN(CC2)CC3=NC=CS3)C4=C(C1CO)N(C5=C4C=CC(=C5)OC)C"
        },
        "molecularFormula": "C26H35N5O3S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:36:06Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8441"
    },
    "name": "Saracatinib",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8441.png",
    "lincs": {
      "id": "LSM-1032",
      "name": "Saracatinib",
      "alternativeNames": [
        "AZ-10353926",
        "AZD0530",
        "AZD-0530",
        "AZD-0530 DIFUMARATE",
        "Saracatinib",
        "SARACATINIB (AZD0530)",
        "Saracatinib Difumarate"
      ],
      "pubchemCid": 10302451,
      "inchiParent": "InChI=1S/C27H32ClN5O5/c1-32-6-8-33(9-7-32)10-13-35-19-14-21-24(23(15-19)38-18-4-11-34-12-5-18)27(30-16-29-21)31-25-20(28)2-3-22-26(25)37-17-36-22/h2-3,14-16,18H,4-13,17H2,1H3,(H,29,30,31)",
      "inchiKeyParent": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
      "smilesParent": "CN1CCN(CCOc2cc(OC3CCOCC3)c4c(Nc5c(Cl)ccc6OCOc56)ncnc4c2)CC1"
    },
    "unichem": {
      "chebi": "47458",
      "chembl": "CHEMBL217092",
      "lincs": "LSM-1032",
      "pubchem": "10302451",
      "drugbank": "DB11805"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL217092",
      "prefName": "SARACATINIB",
      "maxPhase": 3.0,
      "maxPhaseCurated": "Phase 3 Clinical Trials",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 542.04,
        "hba": 10,
        "hbd": 1,
        "qedWeighted": 0.45
      },
      "moleculeSynonyms": [
        {
          "moleculeSynonym": "AZ-10353926",
          "synType": "RESEARCH_CODE",
          "synonyms": "AZ-10353926"
        },
        {
          "moleculeSynonym": "Azd-0530",
          "synType": "OTHER",
          "synonyms": "AZD-0530"
        },
        {
          "moleculeSynonym": "AZD-0530",
          "synType": "RESEARCH_CODE",
          "synonyms": "AZD-0530"
        },
        {
          "moleculeSynonym": "AZD0530",
          "synType": "RESEARCH_CODE",
          "synonyms": "AZD0530"
        },
        {
          "moleculeSynonym": "Saracatinib",
          "synType": "USAN",
          "synonyms": "Saracatinib"
        },
        {
          "moleculeSynonym": "Saracatinib",
          "synType": "INN",
          "synonyms": "SARACATINIB"
        },
        {
          "moleculeSynonym": "Saracatinib",
          "synType": "OTHER",
          "synonyms": "SARACATINIB"
        }
      ],
      "drugIndications": [
        {
          "efoId": "EFO:0000637",
          "efoTerm": "osteosarcoma",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT00752206"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Osteosarcoma"
        },
        {
          "efoId": "EFO:0003060",
          "efoTerm": "non-small cell lung carcinoma",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT00638937"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Carcinoma, Non-Small-Cell Lung"
        },
        {
          "efoId": "EFO:0006861",
          "efoTerm": "male breast carcinoma",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT00559507"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Breast Neoplasms, Male"
        },
        {
          "efoId": "EFO:0000616",
          "efoTerm": "neoplasm",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT00475956,NCT00496028,NCT00704366"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Neoplasms"
        },
        {
          "efoId": "EFO:0000756",
          "efoTerm": "melanoma",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT00669019"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Melanoma"
        },
        {
          "efoId": "EFO:0004329",
          "efoTerm": "alcohol drinking",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT02732587,NCT02955186"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Alcohol Drinking"
        },
        {
          "efoId": "EFO:0002618",
          "efoTerm": "pancreatic carcinoma",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT00265876"
            ]
          },
          "maxPhaseForInd": 1.0,
          "meshHeading": "Pancreatic Neoplasms"
        },
        {
          "efoId": "EFO:1000581",
          "efoTerm": "Thymoma",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT00718809"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Thymoma"
        },
        {
          "efoId": "EFO:0000365",
          "efoTerm": "colorectal adenocarcinoma",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT00397878"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Colorectal Neoplasms"
        },
        {
          "efoId": "EFO:1000657",
          "efoTerm": "rectum cancer",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT00397878"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Rectal Neoplasms"
        },
        {
          "efoId": "MONDO:0002158",
          "efoTerm": "fallopian tube cancer",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT01196741"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Fallopian Tube Neoplasms"
        },
        {
          "efoId": "MONDO:0008170",
          "efoTerm": "ovarian cancer",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT00610714,NCT01196741"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Ovarian Neoplasms"
        },
        {
          "efoId": "MONDO:0008315",
          "efoTerm": "prostate cancer",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT00513071,NCT01267266"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Prostatic Neoplasms, Castration-Resistant"
        },
        {
          "efoId": "MONDO:0021063",
          "efoTerm": "malignant colon neoplasm",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT00397878"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Colonic Neoplasms"
        },
        {
          "efoId": "MONDO:0007254",
          "efoTerm": "breast cancer",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT01216176"
            ]
          },
          "maxPhaseForInd": 1.0,
          "meshHeading": "Breast Neoplasms"
        },
        {
          "efoId": "MONDO:0004975",
          "efoTerm": "Alzheimer disease",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT01864655,NCT02167256"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Alzheimer Disease"
        },
        {
          "efoId": "MONDO:0007079",
          "efoTerm": "alcohol dependence",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT02262026"
            ]
          },
          "maxPhaseForInd": 1.0,
          "meshHeading": "Alcoholism"
        },
        {
          "efoId": "MONDO:0007606",
          "efoTerm": "fibrodysplasia ossificans progressiva",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT04307953"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Myositis Ossificans"
        },
        {
          "efoId": "MONDO:0011705",
          "efoTerm": "lymphangioleiomyomatosis",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT02116712,NCT02737202"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Lymphangioleiomyomatosis"
        },
        {
          "efoId": "MONDO:0004992",
          "efoTerm": "cancer",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT02085603"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Neoplasms"
        }
      ],
      "drugMechanisms": [
        {
          "mechanismOfAction": "Tyrosine-protein kinase ABL inhibitor",
          "actionType": "INHIBITOR",
          "targetName": "Tyrosine-protein kinase ABL",
          "targetOrganism": "Homo sapiens",
          "targetType": "SINGLE PROTEIN",
          "targetComponents": [
            {
              "uniprot": [
                "P00519"
              ]
            }
          ]
        },
        {
          "mechanismOfAction": "Tyrosine-protein kinase SRC inhibitor",
          "actionType": "INHIBITOR",
          "targetName": "Tyrosine-protein kinase SRC",
          "targetOrganism": "Homo sapiens",
          "targetType": "SINGLE PROTEIN",
          "targetComponents": [
            {
              "uniprot": [
                "P12931"
              ]
            }
          ]
        }
      ]
    },
    "pubchem": [
      {
        "cid": 10302451,
        "inchi": "InChI=1S/C27H32ClN5O5/c1-32-6-8-33(9-7-32)10-13-35-19-14-21-24(23(15-19)38-18-4-11-34-12-5-18)27(30-16-29-21)31-25-20(28)2-3-22-26(25)37-17-36-22/h2-3,14-16,18H,4-13,17H2,1H3,(H,29,30,31)",
        "inchikey": "OUKYUETWWIPKQR-UHFFFAOYSA-N",
        "iupac": {
          "systematic": "N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-(oxan-4-yloxy)quinazolin-4-amine"
        },
        "smiles": {
          "canonical": "CN1CCN(CC1)CCOC2=CC3=C(C(=C2)OC4CCOCC4)C(=NC=N3)NC5=C(C=CC6=C5OCO6)Cl"
        },
        "molecularFormula": "C27H32ClN5O5"
      }
    ],
    "clinicaltrials": [
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00659360",
            "briefTitle": "AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma",
            "officialTitle": "A Phase 2 Study of AZD0530 in Recurrent or Metastatic Soft Tissue Sarcoma"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2008-04-15",
            "resultsFirstSubmitDate": "2014-06-19"
          },
          "conditionsModule": {
            "conditions": [
              "Adult Fibrosarcoma",
              "Adult Leiomyosarcoma",
              "Adult Liposarcoma",
              "Adult Malignant Fibrous Histiocytoma",
              "Adult Rhabdomyosarcoma",
              "Dermatofibrosarcoma Protuberans",
              "Endometrial Stromal Sarcoma",
              "Recurrent Adult Soft Tissue Sarcoma",
              "Recurrent Uterine Sarcoma",
              "Stage III Adult Soft Tissue Sarcoma",
              "Stage III Uterine Sarcoma",
              "Stage IV Adult Soft Tissue Sarcoma",
              "Stage IV Uterine Sarcoma",
              "Uterine Carcinosarcoma",
              "Uterine Leiomyosarcoma"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Disease Control Rate, Defined as the Number of Patients Who Achieved Complete Response, Partial Response or Stable Disease For a Period of More Than 4 Months.",
                "timeFrame": "Up to 5 years"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Objective Response Rate"
              },
              {
                "measure": "Overall Survival"
              },
              {
                "measure": "Stable Disease Rate"
              },
              {
                "measure": "Duration of Response"
              },
              {
                "measure": "Time to Disease Progression"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01216176",
            "briefTitle": "A Pharmacokinetic and Randomized Trial of Neoadjuvant Treatment With Anastrozole Plus AZD0530 in Postmenopausal Patients With Hormone Receptor Positive Breast Cancer",
            "officialTitle": "A Phase I Pharmacokinetic and Randomized Phase II Trial of Neoadjuvant Treatment With Anastrozole Plus AZD0530 in Postmenopausal Patients With Hormone Receptor Positive Breast Cancer"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2010-10-05",
            "resultsFirstSubmitDate": "2019-05-02"
          },
          "conditionsModule": {
            "conditions": [
              "Breast Cancer"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Phase I Cohort A: Maximum Tolerated AZD0530 Daily Dose Used in Combination With Daily Oral Anastrozole",
                "timeFrame": "Cycle 1: Days 1 - 28"
              },
              {
                "measure": "Phase II - Cohort B: Compare Treatment Groups (AZD0530 + Anastrozole Versus Anastrozole With Placebo) With Respect to Clinical Response",
                "timeFrame": "Baseline, cycle 6"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Phase I - Cohort A: Plasma Concentrations of AZD0530 (Saracatinib) and Anastrozole"
              },
              {
                "measure": "Phase 1-Cohort A: Peak Concentration of Each Study Drug ( AZD0530 (Saracatinib) and Anastrozole)"
              },
              {
                "measure": "Phase II Cohort B: Change in Tumor Size by Comparison of Serial MRI"
              },
              {
                "measure": "Phase II - Cohort B: Number of Participants With Pathologic Complete Response (pCR)"
              },
              {
                "measure": "Phase II - Cohort B: The Number of Participants Achieving Clinical Benefit Defined as Complete Response (CR), or Partial Response (PR) or Stable Disease (SD)"
              },
              {
                "measure": "Phase II - Cohort B: To Report the Pharmacokinetics (Mean Blood Levels of Drug) of AZD0530 (Saracatinib) and Anastrozole"
              },
              {
                "measure": "Phase II - Cohort B: Treatment Emergent Adverse Events Associated With AZD0530 (Saracatinib) Given With Anastrozole and of Anastrozole Given With Placebo"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00704366",
            "briefTitle": "AZD0530 Study 21 - Phase I Study in Patients With Solid Tumours",
            "officialTitle": "A Phase I, Open-label, Dose-escalation Study to Assess the Safety and Tolerability of AZD0530 in Patients With Advanced Solid Malignancies"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2008-06-23"
          },
          "conditionsModule": {
            "conditions": [
              "Solid Tumor"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "The primary objective of this study is to evaluate the safety and tolerability of AZD0530 in Japanese patients with advanced solid malignancies by assessment of AEs, vital signs, ECG, laboratory findings, thoracic imaging and pulmonary function test.",
                "timeFrame": "Assessed on an ongoing basis after starting daily dosing with AZD0530"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "To determine the single and multiple dose PK of AZD0530 when administered orally to patients with advanced solid malignancies by assessment of Cmin, Cmax, tmax, Cssmax, Cssmin, AUC0-t, AUC0-24, AUC, AUCss0-24, CL/F, t1/2 and R"
              },
              {
                "measure": "Tumor response"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00607594",
            "briefTitle": "Saracatinib in Treating Patients With Locally Advanced or Metastatic Stomach or Gastroesophageal Junction Cancer",
            "officialTitle": "A Phase 2 Study of AZD0530 in Patients With Metastatic or Locally Advanced Gastric Carcinoma"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2008-02-01",
            "resultsFirstSubmitDate": "2014-06-19"
          },
          "conditionsModule": {
            "conditions": [
              "Adenocarcinoma of the Gastroesophageal Junction",
              "Adenocarcinoma of the Stomach",
              "Recurrent Gastric Cancer",
              "Stage III Gastric Cancer",
              "Stage III Esophageal Cancer",
              "Stage IV Esophageal Cancer",
              "Stage IV Gastric Cancer"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Objective Tumor Response (Defined as Partial [PR] or Complete Response [CR] by RECIST Criteria)",
                "timeFrame": "Every 2 weeks for the first 4 weeks, and then every 4-8 weeks thereafter, for at least 16 weeks up to 37 weeks"
              },
              {
                "measure": "Prolonged Stable Disease Rate (Defined as Stable Disease for \u2265 16 Weeks)",
                "timeFrame": "Every 2 weeks for the first 4 weeks, and then every 4-8 weeks thereafter, for at least 16 weeks up to 37 weeks"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Time to Progression"
              },
              {
                "measure": "Progression-free Survival"
              },
              {
                "measure": "Median Survival"
              },
              {
                "measure": "Overall Survival"
              },
              {
                "measure": "Highest Grade Toxicity as Assessed by the National Cancer Institute (NCI) Common Toxicity Criteria Version 3.0."
              },
              {
                "measure": "Patient Tolerability"
              },
              {
                "measure": "Association Between Correlative Markers and Clinical Outcomes"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00265876",
            "briefTitle": "AZD0530 and Gemcitabine in Locally Advanced/Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery",
            "officialTitle": "A Phase I/II Study of AZD0530 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2005-12-14"
          },
          "conditionsModule": {
            "conditions": [
              "Pancreatic Cancer"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Response (complete [CR] and partial response [PR] or stable disease [SD]) at 8 weeks",
                "timeFrame": "4 years"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Toxicity"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01267266",
            "briefTitle": "Saracatinib in Treating Patients With Prostate Cancer",
            "officialTitle": "A Randomized Discontinuation Phase 2 Study of AZD0530 as a Metastasis Inhibitor in Castrate Resistant Prostate Cancer"
          },
          "statusModule": {
            "overallStatus": "TERMINATED",
            "whyStopped": "Per protocol, study was terminated due to low rate of randomized patients.",
            "studyFirstSubmitDate": "2010-12-24",
            "resultsFirstSubmitDate": "2015-01-30"
          },
          "conditionsModule": {
            "conditions": [
              "Hormone-resistant Prostate Cancer",
              "Recurrent Prostate Cancer",
              "Stage IV Prostate Cancer"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Duration of Stable Disease. (Time to Disease Progression by CT and/or Bone Scan or Clinical Progression.)",
                "timeFrame": "Up to 6 months."
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Toxicity and Incidence of Adverse Events"
              },
              {
                "measure": "Toxicity and Incidence of Adverse Events."
              },
              {
                "measure": "Correlation of Molecular Profile With Clinical Outcomes"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT03661125",
            "briefTitle": "SRC Inhibition as a Potential Target for Parkinson's Disease Psychosis",
            "officialTitle": "A Randomised, Balanced, Double-blind Two-way Crossover Design Study to Evaluate the Effects of SRC Kinase Inhibitor, Saracatinib, on Brain Activity Associated With Visual Processing in Patients With Parkinson's Disease Psychosis."
          },
          "statusModule": {
            "overallStatus": "UNKNOWN",
            "studyFirstSubmitDate": "2018-09-04"
          },
          "conditionsModule": {
            "conditions": [
              "Parkinson Disease Psychosis"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Difference between study drug and placebo in BOLD activity in the ventral visual stream during visual recognition vs. the control task measure using fMRI",
                "timeFrame": "2 months (two treatment arms)"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Difference between study drug and placebo in BOLD activity in the occipito-temporal region during the visual processing task (Kanisza illusion)"
              },
              {
                "measure": "Change in Mismatch negativity (MMN) in microvolts (mV) and connectivity with the posterior cingulate hub of the default mode network"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02262026",
            "briefTitle": "The Tolerability and Effects of AZD0530 in Individuals With or Without a Family History of Alcoholism",
            "officialTitle": "A Phase One Study Investigating the Tolerability and Effects of AZD0530 on Functional Neuroimaging Responses in Individuals With or Without a Family History of Alcoholism"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2014-10-01"
          },
          "conditionsModule": {
            "conditions": [
              "Alcoholism"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "BOLD activation during A1 phase",
                "timeFrame": "4 Hours post medication administration"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "BOLD signal activation in the anterior cingulate cortex(ACC)"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00558272",
            "briefTitle": "Study to Evaluate the Safety and Effects AZD0530 on Prostate and Breast Cancer Subjects With Metastatic Bone Disease",
            "officialTitle": "A Phase II, Randomised, Open-Label, Pilot Study to Evaluate the Safety and Effects on Bone Resorption of AZD0530 in Patients With Prostate Cancer or Breast Cancer With Metastatic Bone Disease."
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2007-11-13",
            "resultsFirstSubmitDate": "2011-05-27"
          },
          "conditionsModule": {
            "conditions": [
              "Breast Cancer",
              "Prostate Cancer",
              "Bone Neoplasms"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Percentage Change From Baseline in Serum Beta C-terminal Cross-linking Telopeptide of Type I Collagen (betaCTX) at Week 4",
                "timeFrame": "Baseline to Week 4"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Percentage Change From Baseline in Serum Bone-specific Alkaline Phosphatase (bALP) at Week 4"
              },
              {
                "measure": "Percentage Change From Baseline in Serum Cross-linked C-terminal Telopeptide of Type I Collagen (ICTP) at Week 4"
              },
              {
                "measure": "Percentage Change From Baseline in Serum N-terminal Propeptide of Type I Procollagen (PINP) at Week 4"
              },
              {
                "measure": "Percentage Change From Baseline in Serum Tartrate-resistant Acid Phosphatase 5b (TRAP5b) at Week 4"
              },
              {
                "measure": "Percentage Change From Baseline in Urine N-terminal Cross-linking Telopeptide of Type I Collagen Normalised to Creatinine (NTx/Cr) at Week 4"
              },
              {
                "measure": "Percentage Change From Baseline in Urine Alpha-alpha C-terminal Cross-linking Telopeptide of Type I Collagen Normalised to Creatinine (aaCTx/Cr) at Week 4"
              },
              {
                "measure": "Saracatinib: Area Under the Curve at Steady State (AUCss)"
              },
              {
                "measure": "Saracatinib: Plasma Clearance at Steady State (CLss/F)"
              },
              {
                "measure": "Saracatinib: Maximum Plasma Concentration at Steady State (Css,Max)"
              },
              {
                "measure": "Saracatinib: Minimum Plasma Concentration at Steady State (Css,Min)"
              },
              {
                "measure": "Saracatinib: Time to Cssmax (Tmax)"
              },
              {
                "measure": "N-desmethyl Metabolite of Saracatinib: Area Under the Curve at Steady State (AUCss)"
              },
              {
                "measure": "N-desmethyl Metabolite of Saracatinib: Maximum Plasma Concentration at Steady State (Css,Max)"
              },
              {
                "measure": "N-desmethyl Metabolite of Saracatinib: Minimum Plasma Concentration at Steady State (Css,Min)"
              },
              {
                "measure": "N-desmethyl Metabolite of Saracatinib: AUCss Metabolite to Parent Ratio"
              },
              {
                "measure": "N-desmethyl Metabolite of Saracatinib: Time to Cssmax (Tmax)"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01000896",
            "briefTitle": "Study to Assess Safety and Tolerability of AZD0530 in Combination With Carboplatin and Paclitaxel",
            "officialTitle": "A Phase I, Open-Label, Study to Assess the Safety, Tolerability, and Pharmacokinetics of Ascending Doses of AZD0530 in Combination With Carboplatin and Paclitaxel Chemotherapy in Japanese Patients With Advanced Solid Malignancies"
          },
          "statusModule": {
            "overallStatus": "WITHDRAWN",
            "whyStopped": "AstraZeneca has discontinued the development of AZD0530. No new AstraZeneca-sponsored clinical studies will be initiated..",
            "studyFirstSubmitDate": "2009-10-14"
          },
          "conditionsModule": {
            "conditions": [
              "Cancer",
              "Non Small Cell Lung Cancer",
              "Epithelial Ovarian Cancer"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Assessment of adverse events (based on CTCAE version 3.0), laboratory values, vital sign measurements, general examination, HRCT, SpO2, ECG",
                "timeFrame": "Laboratory assessment prior to chemotherapy administration in all treatment cycles and on days 2, 8 and 15 in cycle 1. General exam, SpO2 and ECG prior to chemotherapy administration in all treatment cycles. HRCT scans performed days 21, 42, 70-98."
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Assessment of the pharmacokinetics of AZD0530 (Cssmax, Cssmin, tmax, AUCss0-24, CL/F), its N-desmethyl metabolite M594347 (Cssmax, Cssmin, tmax, AUCss0-24), and carboplatin / paclitaxel (Cmax, AUC, AUC0-t, t1/2, CL and Vss)"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01144481",
            "briefTitle": "Risk Factors for Skeletal Related Events in Breast Cancer Patients Receiving Bisphosphonates for Bone Metastases",
            "officialTitle": "Prospective Identification of Risk Factors for Skeletal Related Events in Breast Cancer Patients Receiving Bisphosphonates for Bone Metastases"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2010-06-11"
          },
          "conditionsModule": {
            "conditions": [
              "Bone Metastases",
              "Breast Cancer"
            ]
          },
          "designModule": {
            "studyType": "OBSERVATIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Skeletal related event",
                "timeFrame": "0 to 24 months"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00513435",
            "nctIdAliases": [
              "NCT01645618",
              "NCT01664468"
            ],
            "briefTitle": "Saracatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer",
            "officialTitle": "A Phase II Study of AZD0530 for Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2007-08-06",
            "resultsFirstSubmitDate": "2013-08-13"
          },
          "conditionsModule": {
            "conditions": [
              "Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma",
              "Recurrent Metastatic Squamous Neck Cancer With Occult Primary",
              "Recurrent Squamous Cell Carcinoma of the Hypopharynx",
              "Recurrent Squamous Cell Carcinoma of the Larynx",
              "Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity",
              "Recurrent Squamous Cell Carcinoma of the Nasopharynx",
              "Recurrent Squamous Cell Carcinoma of the Oropharynx",
              "Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity",
              "Recurrent Verrucous Carcinoma of the Larynx",
              "Recurrent Verrucous Carcinoma of the Oral Cavity",
              "Stage III Squamous Cell Carcinoma of the Hypopharynx",
              "Stage III Squamous Cell Carcinoma of the Larynx",
              "Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity",
              "Stage III Squamous Cell Carcinoma of the Nasopharynx",
              "Stage III Squamous Cell Carcinoma of the Oropharynx",
              "Stage III Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity",
              "Stage III Verrucous Carcinoma of the Larynx",
              "Stage III Verrucous Carcinoma of the Oral Cavity",
              "Stage IV Squamous Cell Carcinoma of the Hypopharynx",
              "Stage IV Squamous Cell Carcinoma of the Nasopharynx",
              "Stage IVA Squamous Cell Carcinoma of the Larynx",
              "Stage IVA Squamous Cell Carcinoma of the Lip and Oral Cavity",
              "Stage IVA Squamous Cell Carcinoma of the Oropharynx",
              "Stage IVA Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity",
              "Stage IVA Verrucous Carcinoma of the Larynx",
              "Stage IVA Verrucous Carcinoma of the Oral Cavity",
              "Stage IVB Squamous Cell Carcinoma of the Larynx",
              "Stage IVB Squamous Cell Carcinoma of the Lip and Oral Cavity",
              "Stage IVB Squamous Cell Carcinoma of the Oropharynx",
              "Stage IVB Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity",
              "Stage IVB Verrucous Carcinoma of the Larynx",
              "Stage IVB Verrucous Carcinoma of the Oral Cavity",
              "Stage IVC Squamous Cell Carcinoma of the Larynx",
              "Stage IVC Squamous Cell Carcinoma of the Lip and Oral Cavity",
              "Stage IVC Squamous Cell Carcinoma of the Oropharynx",
              "Stage IVC Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity",
              "Stage IVC Verrucous Carcinoma of the Larynx",
              "Stage IVC Verrucous Carcinoma of the Oral Cavity",
              "Tongue Cancer"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Overall Response Rate",
                "timeFrame": "From the start of treatment for up to 12 weeks"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Overall Survival"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00735917",
            "nctIdAliases": [
              "NCT01647035"
            ],
            "briefTitle": "Saracatinib in Treating Patients With Previously Treated Metastatic Pancreatic Cancer",
            "officialTitle": "A Phase II Trial of AZD0530 in Previously Treated Metastatic Pancreas Cancer"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2008-08-14",
            "resultsFirstSubmitDate": "2013-10-07"
          },
          "conditionsModule": {
            "conditions": [
              "Adenocarcinoma of the Pancreas",
              "Recurrent Pancreatic Cancer",
              "Stage IV Pancreatic Cancer"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Six Month Survival",
                "timeFrame": "Up to 6 months"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Overall Survival"
              },
              {
                "measure": "Confirmed Tumor Responses (Complete Response [CR] or Partial Response [PR])"
              },
              {
                "measure": "Duration of Response"
              },
              {
                "measure": "Progression-Free Survival"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01196741",
            "briefTitle": "Saracatinib and Paclitaxel in Platinum-resistant Ovarian Cancer",
            "officialTitle": "A Randomised Placebo-controlled Trial of Saracatinib (AZD0530) Plus Weekly Paclitaxel in Platinum Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2010-09-01",
            "resultsFirstSubmitDate": "2014-09-18"
          },
          "conditionsModule": {
            "conditions": [
              "Ovarian Cancer",
              "Fallopian Tube Cancer",
              "Primary Peritoneal Cancer"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "6 Month Progression-free Survival Rate (PFS) (Based on Combined Response Evaluation Criteria In Solid Tumours (RECIST) v1.1 +/- Gynecologic Cancer Intergroup (GCIG) CA125 Criteria)",
                "timeFrame": "Using RECIST v1.1 at baseline; at Week 7 or 8 of each chemotherapy cycle; and 3 monthly during follow up. CA125 response will be assessed at baseline, weeks 1, 3 and 6 of each chemotherapy cycle, and at every follow up visit."
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Overall Survival"
              },
              {
                "measure": "Objective Response Rate Based on Investigator Assessment Based on RECIST v1.1 +/- GCIG CA125 Criteria"
              },
              {
                "measure": "Median Duration of Response"
              },
              {
                "measure": "Quality of Life: Trial Outcome Index (TOI) Based on FACT-O"
              },
              {
                "measure": "Median Time To Progression Based on RECIST v1.1 and GCIG CA125 Criteria"
              },
              {
                "measure": "Median PFS"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00610714",
            "briefTitle": "AZD0530 Phase II Study in Patients With Advanced Ovarian Cancer",
            "officialTitle": "A Phase II, Double-blind, Placebo-controlled, Multi-centre, Randomised Study of AZD0530 in Patients With Advanced Ovarian Cancer Sensitive to Platinum-based Chemotherapy"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2008-01-23",
            "resultsFirstSubmitDate": "2011-05-03"
          },
          "conditionsModule": {
            "conditions": [
              "Ovarian Neoplasms",
              "Ovarian Cancer"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Objective Response Rate as Evaluated by Response Evaluation Criteria In Solid Tumors ( RECIST)",
                "timeFrame": "Response is evaluated from randomization to objective disease progression per RECIST criteria or death due to any cause in the absence of progression (conducted when a minimum of 78 progression free survival events had occurred)"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Progression-free Survival (PFS) as Evaluated by RECIST"
              },
              {
                "measure": "Overall Survival (Number of Deaths)"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02955186",
            "briefTitle": "Saracatinib and Alcohol Drinking",
            "officialTitle": "Fyn Kinase Inhibitors and Alcohol Drinking"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2016-11-01",
            "resultsFirstSubmitDate": "2020-04-23"
          },
          "conditionsModule": {
            "conditions": [
              "Alcohol Drinking"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Change in the Number of Drinks Consumed From Baseline to Day 8 (Minus Baseline)",
                "timeFrame": "Baseline and Day 8"
              },
              {
                "measure": "Craving-Baseline Adjusted Total Area Under the Curve (AUC) During the Drinking Session Using the YCS",
                "timeFrame": "Baseline and Day 7"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Area Under the Curve (AUC) During the Drinking Session Using the Stimulation Responses to Alcohol (BAES)"
              },
              {
                "measure": "Area Under the Curve (AUC) During the Drinking Session Using the Sedation Responses to Alcohol (BAES)"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00669019",
            "briefTitle": "Saracatinib in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery",
            "officialTitle": "A Phase 2 Study of AZD0530 in Metastatic Melanoma"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2008-04-26",
            "resultsFirstSubmitDate": "2013-12-10"
          },
          "conditionsModule": {
            "conditions": [
              "Recurrent Melanoma",
              "Stage IIA Melanoma",
              "Stage IIB Melanoma",
              "Stage IIC Melanoma",
              "Stage IV Melanoma"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Objective Response Rate",
                "timeFrame": "Up to 25 weeks"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Progression-free Survival"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT04598919",
            "briefTitle": "Saracatinib in the Treatment of Idiopathic Pulmonary Fibrosis",
            "officialTitle": "Use of the Src Family Kinase Inhibitor Saracatinib in the Treatment of Idiopathic Pulmonary Fibrosis"
          },
          "statusModule": {
            "overallStatus": "ACTIVE_NOT_RECRUITING",
            "studyFirstSubmitDate": "2020-09-15"
          },
          "conditionsModule": {
            "conditions": [
              "Idiopathic Pulmonary Fibrosis (IPF)"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Safety of saracatinib in IPF as measured by frequency of adverse events",
                "timeFrame": "24 weeks"
              },
              {
                "measure": "Tolerability of saracatinib in IPF as measured by Severity of adverse events",
                "timeFrame": "24 weeks"
              },
              {
                "measure": "Pharmacokinetics of saracatinib in IPF as measured by serum levels",
                "timeFrame": "24 weeks"
              },
              {
                "measure": "Pharmacodynamics of saracatinib in IPF as measured by change in serum \u03b2-CTX",
                "timeFrame": "24 weeks"
              },
              {
                "measure": "Efficacy of saracatinib in IPF as measured by change in FVC",
                "timeFrame": "24 weeks"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Efficacy of saracatinib in IPF (HRCT)"
              },
              {
                "measure": "Efficacy of saracatinib in IPF (DLCO) as measured by change in DLCO"
              },
              {
                "measure": "Efficacy of saracatinib in IPF (exacerbations) as measured in time to first acute exacerbation"
              },
              {
                "measure": "Efficacy of saracatinib in quality of life in IPF (SGRQ) as measured by total score on SGRQ questionnaire"
              },
              {
                "measure": "Efficacy of saracatinib in quality of life in IPF (L-IPF) as measured by total score on L-IPF questionnaire"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02116712",
            "briefTitle": "The Tolerability of Saracatinib in Subjects With Lymphangioleiomyomatosis (LAM) (SLAM-1)",
            "officialTitle": "The Tolerability of Saracatinib in Subjects With Lymphangioleiomyomatosis (LAM) (SLAM-1)"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2014-04-15"
          },
          "conditionsModule": {
            "conditions": [
              "Pulmonary Lymphangioleiomyomatosis"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Dose Determination",
                "timeFrame": "Saracatinib will be given for 4 weeks, the subject will be followed for a total of 8 weeks."
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Safety Profile"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00771979",
            "briefTitle": "Relative Bioavailability of Phase II and Phase III Formulations of AZD0530",
            "officialTitle": "A Phase I, Randomised, Open-Label, Cross-Over, Single Centre Study in Healthy Volunteers to Determine the Relative Bioavailability of the Phase III Tablet Formulation to the Phase II Tablet Formulation of AZD0530"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2008-10-14"
          },
          "conditionsModule": {
            "conditions": [
              "Healthy"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "To compare the pharmacokinetic parameters for AZD0530 when administered as Phase III formulation in relation to Phase II formulation.",
                "timeFrame": "Pre-dose sample, 0.5, 1, 2, 3, 4, 5, 6, 7, 8, 10, 12, 24, 48, 72, 120, 168 hours post dose samples."
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "To monitor the safety of all subjects by assessment of vital signs, ECG, clinical chemistry, haematology, urinalysis and adverse events."
              },
              {
                "measure": "An exploratory objective is to characterise the Pharmacokinetic profile of an oral solution of AZD0530 and 4 additional tablet variants of the Phase III formulation of AZD0530"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02085603",
            "briefTitle": "SarCaBon: A Randomised Phase II Trial of Saracatinib Versus Placebo for Cancer-induced Bone Pain",
            "officialTitle": "SarCaBon: A Randomised Phase II Trial of Saracatinib Versus Placebo for Cancer-induced Bone Pain"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2014-03-11"
          },
          "conditionsModule": {
            "conditions": [
              "Cancer"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Is pain score lower after 4 weeks on treatment?",
                "timeFrame": "4 weeks"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Does analgesic drug usage decreases when patients take saracatinib?"
              },
              {
                "measure": "Does pain increase after treatment"
              },
              {
                "measure": "Does symptoms and quality of life improve after treatment?"
              },
              {
                "measure": "Is bone turnover further reduced by saracatinib?"
              },
              {
                "measure": "Safety of treatment"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01864655",
            "briefTitle": "Safety and Tolerability of AZD0530 (Saracatinib) in Alzheimer's Disease",
            "officialTitle": "A Phase Ib Multiple Ascending Dose Study of the Safety, Tolerability, and CNS Availability of AZD0530 in Alzheimer's Disease"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2013-05-08"
          },
          "conditionsModule": {
            "conditions": [
              "Alzheimer's Disease"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Number of Participants with Adverse Events on AZD0530",
                "timeFrame": "up to 4 weeks"
              },
              {
                "measure": "CNS availability of AZD0530 after oral dosing",
                "timeFrame": "4 weeks"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Effects of AZD0530 on cognitive function in patients with Alzheimer's disease"
              },
              {
                "measure": "Effect of AZD0530 on brain glucose metabolism in patients with Alzheimer's disease"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02737202",
            "briefTitle": "Safety and Efficacy of Saracatinib In Subjects With Lymphangioleiomyomatosis",
            "officialTitle": "Safety and Efficacy of Saracatinib In Subjects With Lymphangioleiomyomatosis"
          },
          "statusModule": {
            "overallStatus": "TERMINATED",
            "studyFirstSubmitDate": "2016-03-31"
          },
          "conditionsModule": {
            "conditions": [
              "Pulmonary Lymphangioleiomyomatosis"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "FEV1",
                "timeFrame": "9 months"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Angiomyolipoma measured volumetrically on MRI"
              },
              {
                "measure": "Lung Cyst size measured on chest CT"
              },
              {
                "measure": "VEGF-D serum levels"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02732587",
            "briefTitle": "Investigating the Interactions of AZD0530 With Alcohol in Social Drinkers",
            "officialTitle": "A Phase 1 Study Investigating the Interactions of AZD0530 With Alcohol in Social Drinkers"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2015-11-09",
            "resultsFirstSubmitDate": "2019-07-08"
          },
          "conditionsModule": {
            "conditions": [
              "Alcohol Drinking"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Safety/Tolerability of Study Medication.",
                "timeFrame": "8 days"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00752206",
            "nctIdAliases": [
              "NCT00923286"
            ],
            "briefTitle": "A Placebo-Controlled Study of Saracatinib (AZD0530) in Patients With Recurrent Osteosarcoma Localized to the Lung",
            "officialTitle": "A Randomized, Double-Blinded, Placebo-Controlled, Multi-Institutional, Cross-over, Phase II.5 Study of Saracatinib (AZD0530), a Selective Src Kinase Inhibitor, In Patients With Recurrent Osteosarcoma Localized to the Lung"
          },
          "statusModule": {
            "overallStatus": "TERMINATED",
            "whyStopped": "The Data Safety Monitoring Board (DSMB) recommended study termination for slow accrual and futility.",
            "studyFirstSubmitDate": "2008-09-11",
            "resultsFirstSubmitDate": "2019-04-12"
          },
          "conditionsModule": {
            "conditions": [
              "Osteosarcoma"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Progression Free Survival Rate Among Patients Treated With Saracatinib and Placebo.",
                "timeFrame": "Evaluation for recurrence/progression will be made every 3 months for the 1st year, then every 6 months up to 2 years, then every year up to 5 years after starting treatment."
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Change in Overall Survival With the Addition of Saracatinib to Pulmonary Metastasectomy, Versus Placebo and Pulmonary Metastasectomy"
              },
              {
                "measure": "Change in Time to Treatment Failure With the Addition of Saracatinib to Pulmonary Metastasectomy, Versus Placebo and Pulmonary Metastasectomy"
              },
              {
                "measure": "Number of Genes Identified for Prediction of Recurrence of Osteosarcoma"
              },
              {
                "measure": "Biomarkers Related to Activation of Src and Src Substrates"
              },
              {
                "measure": "Cell Lines and Murine Xenografts From Recurrent Tumor Samples"
              },
              {
                "measure": "Number of Mutations Identified That May be Causative For Recurrent Osteosarcoma"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00638937",
            "briefTitle": "AZD0530 to Treat Recurrent Stage IIIB/IV NSCLC Previously Treated With Combination Chemotherapy",
            "officialTitle": "A Phase 2 Study of AZD0530 in Patients With Advanced, Recurrent Non-Small Cell Lung Cancer Who Have Previously Received Platinum-Based Combination Chemotherapy"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2008-03-18",
            "resultsFirstSubmitDate": "2014-08-28"
          },
          "conditionsModule": {
            "conditions": [
              "Recurrent Non-small Cell Lung Cancer",
              "Stage IIIB Non-small Cell Lung Cancer",
              "Stage IV Non-small Cell Lung Cancer"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Rate of Disease Control (Freedom From Disease Progression)",
                "timeFrame": "112 days"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Objective Response Rate (Complete and Partial Response)"
              },
              {
                "measure": "Stable Disease Rate"
              },
              {
                "measure": "Duration of Response or Stable Disease"
              },
              {
                "measure": "Median Progression-free Survival"
              },
              {
                "measure": "Progression-free Survival"
              },
              {
                "measure": "Median Overall Survival"
              },
              {
                "measure": "Overall Survival"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02167256",
            "briefTitle": "A Phase IIa Multi-Center Study of 18F-FDG PET, Safety, and Tolerability of AZD0530 in Mild Alzheimer's Disease",
            "officialTitle": "A Phase IIa Multi-Center Study of 18F-FDG PET, Safety, and Tolerability of AZD0530 in Mild Alzheimer's Disease"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2014-06-12",
            "resultsFirstSubmitDate": "2019-06-19"
          },
          "conditionsModule": {
            "conditions": [
              "Alzheimer's Disease"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Change in Brain Glucose Uptake Measured Using 18F-FDG PET Imaging",
                "timeFrame": "12 months"
              },
              {
                "measure": "Number of Participants With One or More Serious/Other Adverse Events Subjects With Mild AD as Assessed by Analysis of Adverse Events, Including Symptoms, and Abnormal Findings on Physical and Neurological Examinations, and Standard Labs.",
                "timeFrame": "12 months"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "The Effect of Treatment With AZD0530 on Cognitive and Behavioral Function"
              },
              {
                "measure": "Percent Change in Brain Volume Before and After Treatment"
              },
              {
                "measure": "Cerebrospinal Fluid Levels of Total Tau, Phospho-tau (p-Tau), and Amyloid-beta 1-42 (Abeta 1-42)"
              },
              {
                "measure": "Change in Brain Glucose Uptake Measured Using 18F-FDG PET Imaging"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00475956",
            "briefTitle": "Safety and Tolerability Study of AZD2171 in Combination With AZD0530 in Patients With Advanced Solid Tumours",
            "officialTitle": "Phase I, Open-Label Study To Assess the Safety, Tolerability and Pharmacokinetics of Daily Oral Doses of Cediranib (RECENTIN\u2122;AZD2171) (20, 30 or 45mg) When Co-Administered With Daily Oral Doses of AZD0530 (125mg or 175mg) in Patients With Advanced Solid Tumours"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2007-05-18"
          },
          "conditionsModule": {
            "conditions": [
              "Neoplasms"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Determine the safety and tolerability of ascending daily oral doses of AZD2171 when co-administered with AZD0530 to patients with advanced solid tumours by assessment of AEs, vital signs, HRCT Scans, clin chem, haematology, urinalysis, ECG and phys exam",
                "timeFrame": "assessed at each visit"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Pharmacokinetics (PK) of AZD2171 alone and in combination with AZD0530"
              },
              {
                "measure": "Safety and efficacy"
              },
              {
                "measure": "Genetic variation of pathways targeted by AZD2171 and AZD0530"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00559507",
            "nctIdAliases": [
              "NCT01645605",
              "NCT01664481"
            ],
            "briefTitle": "Saracatinib in Treating Patients With Metastatic or Locally Advanced Breast Cancer That Cannot Be Removed By Surgery",
            "officialTitle": "A Phase II Study of AZD0530 in Hormone Receptor-Negative, Metastatic or Unresectable, Locally Advanced Breast Cancer"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2007-11-15",
            "resultsFirstSubmitDate": "2013-08-14"
          },
          "conditionsModule": {
            "conditions": [
              "Estrogen Receptor-negative Breast Cancer",
              "Male Breast Cancer",
              "Progesterone Receptor-negative Breast Cancer",
              "Recurrent Breast Cancer",
              "Stage IIIB Breast Cancer",
              "Stage IIIC Breast Cancer",
              "Stage IV Breast Cancer"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Disease Control Rate (DCR)",
                "timeFrame": "After 24 weeks of study therapy"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Overall Response Rate (CR and PR)"
              },
              {
                "measure": "Median Time to Treatment Failure"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00718809",
            "briefTitle": "Saracatinib in Treating Patients With Relapsed or Refractory Thymoma or Thymic Cancer",
            "officialTitle": "Phase II Trial of AZD0530 for Patients With Relapsed/Refractory Thymic Malignancies (Thymoma and Thymic Carcinoma)"
          },
          "statusModule": {
            "overallStatus": "TERMINATED",
            "studyFirstSubmitDate": "2008-07-18",
            "resultsFirstSubmitDate": "2015-05-15"
          },
          "conditionsModule": {
            "conditions": [
              "Invasive Thymoma and Thymic Carcinoma",
              "Recurrent Thymoma and Thymic Carcinoma",
              "Stage III Thymoma",
              "Stage IVA Thymoma",
              "Stage IVB Thymoma"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Objective Response Rate (Complete and Partial Response)",
                "timeFrame": "Up to 5 years"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Progression-free Survival"
              },
              {
                "measure": "Overall Survival"
              },
              {
                "measure": "Disease Control Rate"
              },
              {
                "measure": "Expected Toxicities Including Skin Rashes and Diarrhea"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00513071",
            "briefTitle": "AZD0530 in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy",
            "officialTitle": "A Phase II Trial of AZD0530 in Hormone Refractory Prostate Cancer (HRPC)"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2007-08-06",
            "resultsFirstSubmitDate": "2014-07-30"
          },
          "conditionsModule": {
            "conditions": [
              "Hormone-resistant Prostate Cancer",
              "Recurrent Prostate Cancer"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "PSA Response Rate",
                "timeFrame": "PSA measured every 4 weeks"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Progression-free Survival (PFS)"
              },
              {
                "measure": "Time to Treatment Failure"
              },
              {
                "measure": "Overall Survival"
              },
              {
                "measure": "Toxicity Data"
              },
              {
                "measure": "Relationship Between Changes in Laboratory Correlates and Response and Survival"
              },
              {
                "measure": "N-telopeptide and Deoxypyridinoline as Prognostic Bone Markers"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00397878",
            "briefTitle": "AZD0530 (NSC 735464) in Treating Patients With Previously Treated Metastatic Colon Cancer or Rectal Cancer",
            "officialTitle": "Phase II Study of AZD0530 (NSC 735464) in Patients With Previously Treated Metastatic Colorectal Cancer"
          },
          "statusModule": {
            "overallStatus": "TERMINATED",
            "whyStopped": "The study was terminated after all enrolled participants progressed.",
            "studyFirstSubmitDate": "2006-11-09",
            "resultsFirstSubmitDate": "2013-12-17"
          },
          "conditionsModule": {
            "conditions": [
              "Adenocarcinoma of the Colon",
              "Adenocarcinoma of the Rectum",
              "Recurrent Colon Cancer",
              "Recurrent Rectal Cancer",
              "Stage IV Colon Cancer",
              "Stage IV Rectal Cancer"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Median Progression Free Survival (PFS)",
                "timeFrame": "Time from start of treatment to time of progression, up to 4 months"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Overall Survival"
              },
              {
                "measure": "Time to Progression"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00496028",
            "briefTitle": "Phase I Study in Patients With Solid Tumours",
            "officialTitle": "A Phase I, Open-label Study to Assess the Safety and Tolerability of AZD0530 in Combination With Carboplatin and/or Paclitaxel Chemotherapy in Patients With Solid Tumours"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2007-07-03"
          },
          "conditionsModule": {
            "conditions": [
              "Neoplasms"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "To evaluate the safety and tolerability of AZD0530 in combination with carboplatin and/or paclitaxel regimens with solid tumours by assessment of AEs, physical examination, BP, pulse, ECG, laboratory findings, PFTs and thoracic CT scans.",
                "timeFrame": "Assessed at each visit"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "To determine the Maximum Tolerated Dose of AZD0530 when administered in combination with carboplatin and/or paclitaxel by assessment of safety and tolerability data generated for each treatment arm."
              },
              {
                "measure": "To make a preliminary evaluation of clinical response by assessment of RECIST evaluation, time to progression and serum tumour markers."
              },
              {
                "measure": "To investigate the PK of AZD0530. paclitaxel and carboplatin when co-administered to patients with solid tumours, by assessment of appropriate PK parameters."
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00853983",
            "briefTitle": "Phase I Study to Assess Absorption, Metabolism & Excretion of a Single Oral Dose [14C]AZD0530 in Healthy Male Volunteers",
            "officialTitle": "An Open-Label, Phase I Study to Assess Absorption, Metabolism and Excretion of a Single Oral Dose of [14C]AZD0530 in Healthy Male Volunteers"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2009-02-27"
          },
          "conditionsModule": {
            "conditions": [
              "Healthy"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "To characterise the absorption, metabolism and excretion of a single oral dose of 400mg [14C]AZD0530",
                "timeFrame": "Multiple PK, Urine and faeces samples taken between predose to 240 hours post dose"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "To evaluate the safety profile by assessment of adverse events, physical examination, pulse, blood pressure, clinical chemistry, haematology, urinalysis & ECG"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT04307953",
            "briefTitle": "Saracatinib Trial TO Prevent FOP",
            "officialTitle": "Saracatinib Trial TO Prevent FOP"
          },
          "statusModule": {
            "overallStatus": "RECRUITING",
            "studyFirstSubmitDate": "2020-03-11"
          },
          "conditionsModule": {
            "conditions": [
              "Fibrodysplasia Ossificans Progressiva"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "The objective change between the two arms measured in heterotopic bone volume measured by low-dose whole body CT over the initial 6 month RCT",
                "timeFrame": "Baseline, month 6"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Safety and tolerability assessments are the incidence and severity of adverse events (AE) during the RCT at the end of week 28."
              },
              {
                "measure": "The change in heterotopic bone volume measured by low-dose whole body CT over six-months treatment during open-label extension of AZD0530 compared to the previous placebo arm of the RCT"
              },
              {
                "measure": "The change in heterotopic bone volume measured by low-dose whole body CT over twelve-months treatment during open-label extension of AZD0530 compared to the historical data of Clementia (NCT02322255)"
              },
              {
                "measure": "Change in the volume of individual HO lesions"
              },
              {
                "measure": "Change in number of HO lesions measured by CT over the initial 6 month RCT and in addition the change over twelve-months during open-label extension of AZD0530 compared to the historical data of Clementia and compared to the 6 months placebo-arm."
              },
              {
                "measure": "In patients with at least 1 active lesion at baseline: Change (and Area Under the Curve (AUC) analysis) of lesion activity"
              },
              {
                "measure": "In patients with at least 1 active lesion at baseline: Change in number of active lesion on 18F-NaF PET from baseline to 6 and 12months"
              },
              {
                "measure": "Change and percent change from baseline in biomarkers of bone formation levels in serum over time."
              },
              {
                "measure": "Joint function assessment by physician at baseline and week 3, month 3,6,9,12,and18 by the cumulative analog joint involvement scale (CAJIS) and the quantitative detailed multi-joint assessment at baseline and month 6, 12 and 18"
              },
              {
                "measure": "Patient-reported global health status the 36-item Short Form Health Survey (SF-36) at baseline and week 3, month 3,6,9,12,and 18"
              },
              {
                "measure": "FOP disease activity assessed by movement disabilities and quality of life using FOP Independent Activity of Daily Living (FOP I-ADL)"
              },
              {
                "measure": "Number of reported flare-ups by the patient"
              },
              {
                "measure": "Pharmacokinetic measurements: blood for determination of plasma concentrations of AZD0530 (pre-dose)on the day of the study visits at 6, 12 and 18months"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00528645",
            "briefTitle": "AZD0530 in Treating Patients With Extensive Stage Small Cell Lung Cancer",
            "officialTitle": "Phase II Study of the c-SRC Inhibitor AZD0530 After Four Cycles of Cytoreductive Chemotherapy for Patients With Extensive Stage Small Cell Lung Carcinoma"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2007-09-10",
            "resultsFirstSubmitDate": "2013-12-05"
          },
          "conditionsModule": {
            "conditions": [
              "Extensive Stage Small Cell Lung Cancer",
              "Lung Metastases",
              "Malignant Pleural Effusion",
              "Recurrent Small Cell Lung Cancer"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Progression-free Survival Rate at 12 Weeks",
                "timeFrame": "12 weeks"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Overall Survival"
              },
              {
                "measure": "Confirmed Tumor Response (Defined as Complete or Partial Response on 2 Consecutive Evaluations at Least 4 Weeks Apart)"
              },
              {
                "measure": "Progression Free Survival"
              }
            ]
          }
        }
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:36:19Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8446"
    },
    "name": "BRD-K23664396",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8446.png",
    "lincs": {
      "id": "LSM-9851",
      "name": "BRD-K23664396",
      "pubchemCid": 54654259,
      "chebiId": 98472,
      "inchiParent": "InChI=1S/C28H30FN5O5/c1-16-22(14-33(2)32-16)31-26(35)13-20-8-9-23-25(39-20)15-38-24-10-7-19(12-21(24)28(37)34(23)3)30-27(36)17-5-4-6-18(29)11-17/h4-7,10-12,14,20,23,25H,8-9,13,15H2,1-3H3,(H,30,36)(H,31,35)/t20-,23+,25+/m0/s1",
      "inchiKeyParent": "LLFGMIFPADLUOD-QUURXOELSA-N",
      "smilesParent": "CN1[C@@H]2CC[C@@H](CC(=O)Nc3cn(C)nc3C)O[C@@H]2COc4ccc(NC(=O)c5cccc(F)c5)cc4C1=O"
    },
    "unichem": {
      "chebi": "98472",
      "lincs": "LSM-9851",
      "pubchem": "54654259"
    },
    "pubchem": [
      {
        "cid": 54654259,
        "inchi": "InChI=1S/C28H30FN5O5/c1-16-22(14-33(2)32-16)31-26(35)13-20-8-9-23-25(39-20)15-38-24-10-7-19(12-21(24)28(37)34(23)3)30-27(36)17-5-4-6-18(29)11-17/h4-7,10-12,14,20,23,25H,8-9,13,15H2,1-3H3,(H,30,36)(H,31,35)/t20-,23+,25+/m0/s1",
        "inchikey": "LLFGMIFPADLUOD-QUURXOELSA-N",
        "iupac": {
          "systematic": "N-[(2S,4aR,12aS)-2-[2-[(1,3-dimethylpyrazol-4-yl)amino]-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-3-fluorobenzamide"
        },
        "smiles": {
          "canonical": "CC1=NN(C=C1NC(=O)CC2CCC3C(O2)COC4=C(C=C(C=C4)NC(=O)C5=CC(=CC=C5)F)C(=O)N3C)C"
        },
        "molecularFormula": "C28H30FN5O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:36:21Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84e7"
    },
    "name": "BRD-K97095445",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84e7.png",
    "lincs": {
      "id": "LSM-42531",
      "name": "BRD-K97095445",
      "pubchemCid": 60185065,
      "chebiId": 130983,
      "inchiParent": "InChI=1S/C25H29N3O4/c1-16(30)28-14-25(15-28)13-27(11-17-6-4-5-7-22(17)32-3)21(12-29)24-23(25)19-9-8-18(31-2)10-20(19)26-24/h4-10,21,26,29H,11-15H2,1-3H3/t21-/m1/s1",
      "inchiKeyParent": "GORXVTYAZVGSBL-OAQYLSRUSA-N",
      "smilesParent": "COc1ccc2c3c([nH]c2c1)[C@@H](CO)N(Cc4ccccc4OC)CC35CN(C5)C(=O)C"
    },
    "unichem": {
      "chebi": "130983",
      "lincs": "LSM-42531",
      "pubchem": "60185065"
    },
    "pubchem": [
      {
        "cid": 60185065,
        "inchi": "InChI=1S/C25H29N3O4/c1-16(30)28-14-25(15-28)13-27(11-17-6-4-5-7-22(17)32-3)21(12-29)24-23(25)19-9-8-18(31-2)10-20(19)26-24/h4-10,21,26,29H,11-15H2,1-3H3/t21-/m1/s1",
        "inchikey": "GORXVTYAZVGSBL-OAQYLSRUSA-N",
        "iupac": {
          "systematic": "1-[(1S)-1-(hydroxymethyl)-7-methoxy-2-[(2-methoxyphenyl)methyl]spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3'-azetidine]-1'-yl]ethanone"
        },
        "smiles": {
          "canonical": "CC(=O)N1CC2(C1)CN(C(C3=C2C4=C(N3)C=C(C=C4)OC)CO)CC5=CC=CC=C5OC"
        },
        "molecularFormula": "C25H29N3O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:36:23Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8453"
    },
    "name": "BRD-K50791850",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8453.png",
    "lincs": {
      "id": "LSM-11524",
      "name": "BRD-K50791850",
      "pubchemCid": 54654105,
      "chebiId": 100145,
      "inchiParent": "InChI=1S/C28H35N3O6/c1-17(2)27(33)30-19-7-12-24-22(13-19)28(34)31(3)23-11-10-21(37-25(23)16-36-24)14-26(32)29-15-18-5-8-20(35-4)9-6-18/h5-9,12-13,17,21,23,25H,10-11,14-16H2,1-4H3,(H,29,32)(H,30,33)/t21-,23-,25+/m0/s1",
      "inchiKeyParent": "WOMWNJCZYVCUPK-UMXIMWEHSA-N",
      "smilesParent": "COc1ccc(CNC(=O)C[C@@H]2CC[C@H]3[C@@H](COc4ccc(NC(=O)C(C)C)cc4C(=O)N3C)O2)cc1"
    },
    "unichem": {
      "chebi": "100145",
      "lincs": "LSM-11524",
      "pubchem": "54654105"
    },
    "pubchem": [
      {
        "cid": 54654105,
        "inchi": "InChI=1S/C28H35N3O6/c1-17(2)27(33)30-19-7-12-24-22(13-19)28(34)31(3)23-11-10-21(37-25(23)16-36-24)14-26(32)29-15-18-5-8-20(35-4)9-6-18/h5-9,12-13,17,21,23,25H,10-11,14-16H2,1-4H3,(H,29,32)(H,30,33)/t21-,23-,25+/m0/s1",
        "inchikey": "WOMWNJCZYVCUPK-UMXIMWEHSA-N",
        "iupac": {
          "systematic": "N-[(2S,4aS,12aS)-2-[2-[(4-methoxyphenyl)methylamino]-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-2-methylpropanamide"
        },
        "smiles": {
          "canonical": "CC(C)C(=O)NC1=CC2=C(C=C1)OCC3C(CCC(O3)CC(=O)NCC4=CC=C(C=C4)OC)N(C2=O)C"
        },
        "molecularFormula": "C28H35N3O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:36:25Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8455"
    },
    "name": "BRD-K29776425",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8455.png",
    "lincs": {
      "id": "LSM-10234",
      "name": "BRD-K29776425",
      "pubchemCid": 54638378,
      "chebiId": 98855,
      "inchiParent": "InChI=1S/C28H29N3O5/c1-35-23-9-5-8-22(16-23)30-28(34)31-25-15-14-24(36-26(25)18-32)17-27(33)29-21-12-10-20(11-13-21)19-6-3-2-4-7-19/h2-16,24-26,32H,17-18H2,1H3,(H,29,33)(H2,30,31,34)/t24-,25-,26+/m0/s1",
      "inchiKeyParent": "HIZAXMBYTZOIAT-KKUQBAQOSA-N",
      "smilesParent": "COc1cccc(NC(=O)N[C@H]2C=C[C@@H](CC(=O)Nc3ccc(cc3)c4ccccc4)O[C@@H]2CO)c1"
    },
    "unichem": {
      "chebi": "98855",
      "lincs": "LSM-10234",
      "pubchem": "54638378"
    },
    "pubchem": [
      {
        "cid": 54638378,
        "inchi": "InChI=1S/C28H29N3O5/c1-35-23-9-5-8-22(16-23)30-28(34)31-25-15-14-24(36-26(25)18-32)17-27(33)29-21-12-10-20(11-13-21)19-6-3-2-4-7-19/h2-16,24-26,32H,17-18H2,1H3,(H,29,33)(H2,30,31,34)/t24-,25-,26+/m0/s1",
        "inchikey": "HIZAXMBYTZOIAT-KKUQBAQOSA-N",
        "iupac": {
          "systematic": "2-[(2S,3S,6R)-2-(hydroxymethyl)-3-[(3-methoxyphenyl)carbamoylamino]-3,6-dihydro-2H-pyran-6-yl]-N-(4-phenylphenyl)acetamide"
        },
        "smiles": {
          "canonical": "COC1=CC=CC(=C1)NC(=O)NC2C=CC(OC2CO)CC(=O)NC3=CC=C(C=C3)C4=CC=CC=C4"
        },
        "molecularFormula": "C28H29N3O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:36:27Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8475"
    },
    "name": "BRD-K63423329",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8475.png",
    "lincs": {
      "id": "LSM-44816",
      "name": "BRD-K63423329",
      "pubchemCid": 54666687,
      "inchiParent": "InChI=1S/C29H33N3O/c33-22-28-29(26-14-12-24(13-15-26)11-10-23-7-2-1-3-8-23)27-21-31(17-4-5-18-32(27)28)20-25-9-6-16-30-19-25/h1-3,6-16,19,27-29,33H,4-5,17-18,20-22H2/b11-10+/t27-,28+,29+/m1/s1",
      "inchiKeyParent": "ORVIWTYNJHNTDZ-CIQFPYSWSA-N",
      "smilesParent": "OC[C@H]1[C@H]([C@H]2CN(Cc3cccnc3)CCCCN12)c4ccc(\\C=C\\c5ccccc5)cc4"
    },
    "unichem": {
      "lincs": "LSM-44816",
      "pubchem": "54666687"
    },
    "pubchem": [
      {
        "cid": 54666687,
        "inchi": "InChI=1S/C29H33N3O/c33-22-28-29(26-14-12-24(13-15-26)11-10-23-7-2-1-3-8-23)27-21-31(17-4-5-18-32(27)28)20-25-9-6-16-30-19-25/h1-3,6-16,19,27-29,33H,4-5,17-18,20-22H2/b11-10+/t27-,28+,29+/m1/s1",
        "inchikey": "ORVIWTYNJHNTDZ-CIQFPYSWSA-N",
        "iupac": {
          "systematic": "[(8S,9S,10R)-9-[4-[(E)-2-phenylethenyl]phenyl]-6-(pyridin-3-ylmethyl)-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol"
        },
        "smiles": {
          "canonical": "C1CCN2C(CN(C1)CC3=CN=CC=C3)C(C2CO)C4=CC=C(C=C4)C=CC5=CC=CC=C5"
        },
        "molecularFormula": "C29H33N3O"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:36:30Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c848b"
    },
    "name": "SA-1919875",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c848b.png",
    "lincs": {
      "id": "LSM-37856",
      "name": "SA-1919875",
      "pubchemCid": 54666573,
      "chebiId": 126290,
      "inchiParent": "InChI=1S/C30H32N4O3/c1-37-28-10-3-2-9-25(28)32-30(36)33-15-4-5-16-34-26(19-33)29(27(34)20-35)23-13-11-22(12-14-23)24-8-6-7-21(17-24)18-31/h2-3,6-14,17,26-27,29,35H,4-5,15-16,19-20H2,1H3,(H,32,36)/t26-,27+,29-/m0/s1",
      "inchiKeyParent": "WYTFSBUXHVGTCT-GKRYNVPLSA-N",
      "smilesParent": "COc1ccccc1NC(=O)N2CCCCN3[C@H](CO)[C@H]([C@@H]3C2)c4ccc(cc4)c5cccc(c5)C#N"
    },
    "unichem": {
      "chebi": "126290",
      "lincs": "LSM-37856",
      "pubchem": "54666573"
    },
    "pubchem": [
      {
        "cid": 54666573,
        "inchi": "InChI=1S/C30H32N4O3/c1-37-28-10-3-2-9-25(28)32-30(36)33-15-4-5-16-34-26(19-33)29(27(34)20-35)23-13-11-22(12-14-23)24-8-6-7-21(17-24)18-31/h2-3,6-14,17,26-27,29,35H,4-5,15-16,19-20H2,1H3,(H,32,36)/t26-,27+,29-/m0/s1",
        "inchikey": "WYTFSBUXHVGTCT-GKRYNVPLSA-N",
        "iupac": {
          "systematic": "(8R,9S,10S)-9-[4-(3-cyanophenyl)phenyl]-10-(hydroxymethyl)-N-(2-methoxyphenyl)-1,6-diazabicyclo[6.2.0]decane-6-carboxamide"
        },
        "smiles": {
          "canonical": "COC1=CC=CC=C1NC(=O)N2CCCCN3C(C2)C(C3CO)C4=CC=C(C=C4)C5=CC=CC(=C5)C#N"
        },
        "molecularFormula": "C30H32N4O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:36:32Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c848c"
    },
    "name": "BRD-K41520144",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c848c.png",
    "lincs": {
      "id": "LSM-46993",
      "name": "BRD-K41520144",
      "pubchemCid": 44487608,
      "inchiParent": "InChI=1S/C32H40N4O4/c1-21-17-36(22(2)20-37)31(38)16-25-15-26(13-14-29(25)40-30(21)19-35(3)18-23-11-12-23)33-32(39)34-28-10-6-8-24-7-4-5-9-27(24)28/h4-10,13-15,21-23,30,37H,11-12,16-20H2,1-3H3,(H2,33,34,39)/t21-,22+,30+/m1/s1",
      "inchiKeyParent": "XMNRWSIHUYWWSG-DGIFUFQNSA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@@H](C)[C@H](CN(C)CC2CC2)Oc3ccc(NC(=O)Nc4cccc5ccccc45)cc3CC1=O"
    },
    "unichem": {
      "pubchem": "44487608"
    },
    "pubchem": [
      {
        "cid": 44487608,
        "inchi": "InChI=1S/C32H40N4O4/c1-21-17-36(22(2)20-37)31(38)16-25-15-26(13-14-29(25)40-30(21)19-35(3)18-23-11-12-23)33-32(39)34-28-10-6-8-24-7-4-5-9-27(24)28/h4-10,13-15,21-23,30,37H,11-12,16-20H2,1-3H3,(H2,33,34,39)/t21-,22+,30+/m1/s1",
        "inchikey": "XMNRWSIHUYWWSG-DGIFUFQNSA-N",
        "iupac": {
          "systematic": "1-[(2R,3R)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-naphthalen-1-ylurea"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)CC2=C(C=CC(=C2)NC(=O)NC3=CC=CC4=CC=CC=C43)OC1CN(C)CC5CC5)C(C)CO"
        },
        "molecularFormula": "C32H40N4O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:36:34Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8437"
    },
    "name": "BRD-K62932832",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8437.png",
    "lincs": {
      "id": "LSM-40715",
      "name": "BRD-K62932832",
      "pubchemCid": 60185059,
      "chebiId": 129164,
      "inchiParent": "InChI=1S/C25H31N5O3/c1-28(2)12-22(32)30-15-25(16-30)14-29(11-17-6-8-26-9-7-17)21(13-31)24-23(25)19-5-4-18(33-3)10-20(19)27-24/h4-10,21,27,31H,11-16H2,1-3H3/t21-/m1/s1",
      "inchiKeyParent": "OCJWVYYATIBFAT-OAQYLSRUSA-N",
      "smilesParent": "COc1ccc2c3c([nH]c2c1)[C@@H](CO)N(Cc4ccncc4)CC35CN(C5)C(=O)CN(C)C"
    },
    "unichem": {
      "chebi": "129164",
      "lincs": "LSM-40715",
      "pubchem": "60185059"
    },
    "pubchem": [
      {
        "cid": 60185059,
        "inchi": "InChI=1S/C25H31N5O3/c1-28(2)12-22(32)30-15-25(16-30)14-29(11-17-6-8-26-9-7-17)21(13-31)24-23(25)19-5-4-18(33-3)10-20(19)27-24/h4-10,21,27,31H,11-16H2,1-3H3/t21-/m1/s1",
        "inchikey": "OCJWVYYATIBFAT-OAQYLSRUSA-N",
        "iupac": {
          "systematic": "2-(dimethylamino)-1-[(1S)-1-(hydroxymethyl)-7-methoxy-2-(pyridin-4-ylmethyl)spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3'-azetidine]-1'-yl]ethanone"
        },
        "smiles": {
          "canonical": "CN(C)CC(=O)N1CC2(C1)CN(C(C3=C2C4=C(N3)C=C(C=C4)OC)CO)CC5=CC=NC=C5"
        },
        "molecularFormula": "C25H31N5O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:36:36Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84af"
    },
    "name": "BRD-K90805324",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84af.png",
    "lincs": {
      "id": "LSM-14017",
      "name": "BRD-K90805324",
      "pubchemCid": 54650202,
      "chebiId": 102670,
      "inchiParent": "InChI=1S/C22H20FN3OS/c1-2-18-12-25-22(28-18)26-19(11-24)21(20(26)13-27)15-8-6-14(7-9-15)16-4-3-5-17(23)10-16/h3-10,12,19-21,27H,2,13H2,1H3/t19-,20-,21+/m0/s1",
      "inchiKeyParent": "IQRVCTXELZIWDH-PCCBWWKXSA-N",
      "smilesParent": "CCc1cnc(s1)N2[C@@H](CO)[C@@H]([C@@H]2C#N)c3ccc(cc3)c4cccc(F)c4"
    },
    "unichem": {
      "chebi": "102670",
      "lincs": "LSM-14017",
      "pubchem": "54650202"
    },
    "pubchem": [
      {
        "cid": 54650202,
        "inchi": "InChI=1S/C22H20FN3OS/c1-2-18-12-25-22(28-18)26-19(11-24)21(20(26)13-27)15-8-6-14(7-9-15)16-4-3-5-17(23)10-16/h3-10,12,19-21,27H,2,13H2,1H3/t19-,20-,21+/m0/s1",
        "inchikey": "IQRVCTXELZIWDH-PCCBWWKXSA-N",
        "iupac": {
          "systematic": "(2R,3R,4R)-1-(5-ethyl-1,3-thiazol-2-yl)-3-[4-(3-fluorophenyl)phenyl]-4-(hydroxymethyl)azetidine-2-carbonitrile"
        },
        "smiles": {
          "canonical": "CCC1=CN=C(S1)N2C(C(C2C#N)C3=CC=C(C=C3)C4=CC(=CC=C4)F)CO"
        },
        "molecularFormula": "C22H20FN3OS"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:36:38Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8451"
    },
    "name": "BRD-K49111930",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8451.png",
    "lincs": {
      "id": "LSM-11414",
      "name": "BRD-K49111930",
      "pubchemCid": 54637855,
      "chebiId": 100035,
      "inchiParent": "InChI=1S/C31H36N2O5/c1-21-15-33(22(2)18-34)31(35)27-11-7-6-10-26(27)25-9-5-4-8-24(25)19-36-30(21)17-32(3)16-23-12-13-28-29(14-23)38-20-37-28/h4-14,21-22,30,34H,15-20H2,1-3H3/t21-,22+,30+/m0/s1",
      "inchiKeyParent": "VTMUWCMJICVSQX-IABYTQIASA-N",
      "smilesParent": "C[C@H](CO)N1C[C@H](C)[C@@H](CN(C)Cc2ccc3OCOc3c2)OCc4ccccc4c5ccccc5C1=O"
    },
    "unichem": {
      "chebi": "100035",
      "lincs": "LSM-11414",
      "pubchem": "54637855"
    },
    "pubchem": [
      {
        "cid": 54637855,
        "inchi": "InChI=1S/C31H36N2O5/c1-21-15-33(22(2)18-34)31(35)27-11-7-6-10-26(27)25-9-5-4-8-24(25)19-36-30(21)17-32(3)16-23-12-13-28-29(14-23)38-20-37-28/h4-14,21-22,30,34H,15-20H2,1-3H3/t21-,22+,30+/m0/s1",
        "inchikey": "VTMUWCMJICVSQX-IABYTQIASA-N",
        "iupac": {
          "systematic": "(10S,11S)-10-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-14-one"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=CC=CC=C2C3=CC=CC=C3COC1CN(C)CC4=CC5=C(C=C4)OCO5)C(C)CO"
        },
        "molecularFormula": "C31H36N2O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:36:41Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c848d"
    },
    "name": "CHEMBL3188928",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c848d.png",
    "lincs": {
      "id": "LSM-39286",
      "name": "CHEMBL3188928",
      "alternativeNames": [
        "SA-1922257"
      ],
      "pubchemCid": 54666566,
      "chebiId": 127729,
      "inchiParent": "InChI=1S/C30H32N4O3/c1-37-28-10-3-2-9-25(28)32-30(36)33-15-4-5-16-34-26(19-33)29(27(34)20-35)23-13-11-22(12-14-23)24-8-6-7-21(17-24)18-31/h2-3,6-14,17,26-27,29,35H,4-5,15-16,19-20H2,1H3,(H,32,36)/t26-,27+,29+/m0/s1",
      "inchiKeyParent": "WYTFSBUXHVGTCT-YIKNKFAXSA-N",
      "smilesParent": "COc1ccccc1NC(=O)N2CCCCN3[C@H](CO)[C@@H]([C@@H]3C2)c4ccc(cc4)c5cccc(c5)C#N"
    },
    "unichem": {
      "chebi": "127729",
      "chembl": "CHEMBL3188928",
      "lincs": "LSM-39286",
      "pubchem": "54666566"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL3188928",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 496.61,
        "hba": 5,
        "hbd": 2,
        "qedWeighted": 0.54
      }
    },
    "pubchem": [
      {
        "cid": 54666566,
        "inchi": "InChI=1S/C30H32N4O3/c1-37-28-10-3-2-9-25(28)32-30(36)33-15-4-5-16-34-26(19-33)29(27(34)20-35)23-13-11-22(12-14-23)24-8-6-7-21(17-24)18-31/h2-3,6-14,17,26-27,29,35H,4-5,15-16,19-20H2,1H3,(H,32,36)/t26-,27+,29+/m0/s1",
        "inchikey": "WYTFSBUXHVGTCT-YIKNKFAXSA-N",
        "iupac": {
          "systematic": "(8R,9R,10S)-9-[4-(3-cyanophenyl)phenyl]-10-(hydroxymethyl)-N-(2-methoxyphenyl)-1,6-diazabicyclo[6.2.0]decane-6-carboxamide"
        },
        "smiles": {
          "canonical": "COC1=CC=CC=C1NC(=O)N2CCCCN3C(C2)C(C3CO)C4=CC=C(C=C4)C5=CC=CC(=C5)C#N"
        },
        "molecularFormula": "C30H32N4O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:36:52Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84b1"
    },
    "name": "Roxithromycin",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84b1.png",
    "lincs": {
      "id": "LSM-45095",
      "name": "Roxithromycin",
      "alternativeNames": [
        "Roxithromycin",
        "RU-28965",
        "RU-965",
        "Rulid",
        "Rulide"
      ],
      "pubchemCid": 5480431,
      "chebiId": 48935,
      "inchiParent": "InChI=1S/C41H76N2O15/c1-15-29-41(10,49)34(45)24(4)31(42-53-21-52-17-16-50-13)22(2)19-39(8,48)36(58-38-32(44)28(43(11)12)18-23(3)54-38)25(5)33(26(6)37(47)56-29)57-30-20-40(9,51-14)35(46)27(7)55-30/h22-30,32-36,38,44-46,48-49H,15-21H2,1-14H3/b42-31+/t22-,23-,24+,25+,26-,27+,28+,29-,30+,32-,33+,34-,35+,36-,38+,39-,40-,41-/m1/s1",
      "inchiKeyParent": "RXZBMPWDPOLZGW-XMRMVWPWSA-N",
      "smilesParent": "CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)\\C(=N/OCOCCOC)\\[C@H](C)[C@@H](O)[C@]1(C)O"
    },
    "unichem": {
      "chebi": "48935",
      "chembl": "CHEMBL1214185",
      "lincs": "LSM-45095",
      "pubchem": "6915744"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL1214185",
      "prefName": "ROXITHROMYCIN",
      "maxPhase": 4.0,
      "maxPhaseCurated": "Approved",
      "chebiParId": "48935",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 837.06,
        "hba": 17,
        "hbd": 5,
        "qedWeighted": 0.08
      },
      "moleculeSynonyms": [
        {
          "moleculeSynonym": "NSC-758443",
          "synType": "RESEARCH_CODE",
          "synonyms": "NSC-758443"
        },
        {
          "moleculeSynonym": "Roxithromycin",
          "synType": "ATC",
          "synonyms": "ROXITHROMYCIN"
        },
        {
          "moleculeSynonym": "Roxithromycin",
          "synType": "BNF",
          "synonyms": "ROXITHROMYCIN"
        },
        {
          "moleculeSynonym": "Roxithromycin",
          "synType": "INN",
          "synonyms": "ROXITHROMYCIN"
        },
        {
          "moleculeSynonym": "Roxithromycin",
          "synType": "JAN",
          "synonyms": "ROXITHROMYCIN"
        },
        {
          "moleculeSynonym": "Roxithromycin",
          "synType": "MERCK_INDEX",
          "synonyms": "ROXITHROMYCIN"
        },
        {
          "moleculeSynonym": "Roxithromycin",
          "synType": "OTHER",
          "synonyms": "ROXITHROMYCIN"
        },
        {
          "moleculeSynonym": "Roxithromycin",
          "synType": "USAN",
          "synonyms": "ROXITHROMYCIN"
        },
        {
          "moleculeSynonym": "Roxithromycine",
          "synType": "INN_FRENCH",
          "synonyms": "ROXITHROMYCINE"
        },
        {
          "moleculeSynonym": "Roxitromicina",
          "synType": "INN_SPANISH",
          "synonyms": "ROXITROMICINA"
        },
        {
          "moleculeSynonym": "RU 28965",
          "synType": "RESEARCH_CODE",
          "synonyms": "RU 28965"
        },
        {
          "moleculeSynonym": "RU-28965",
          "synType": "RESEARCH_CODE",
          "synonyms": "RU-28965"
        },
        {
          "moleculeSynonym": "RU 965",
          "synType": "RESEARCH_CODE",
          "synonyms": "RU 965"
        },
        {
          "moleculeSynonym": "RU-965",
          "synType": "RESEARCH_CODE",
          "synonyms": "RU-965"
        },
        {
          "moleculeSynonym": "Rulid",
          "synType": "TRADE_NAME",
          "synonyms": "RULID"
        }
      ],
      "drugIndications": [
        {
          "efoId": "EFO:0000771",
          "efoTerm": "bacterial disease",
          "maxPhaseForInd": 4.0,
          "meshHeading": "Bacterial Infections"
        }
      ]
    },
    "pubchem": [
      {
        "cid": 6915744,
        "inchi": "InChI=1S/C41H76N2O15/c1-15-29-41(10,49)34(45)24(4)31(42-53-21-52-17-16-50-13)22(2)19-39(8,48)36(58-38-32(44)28(43(11)12)18-23(3)54-38)25(5)33(26(6)37(47)56-29)57-30-20-40(9,51-14)35(46)27(7)55-30/h22-30,32-36,38,44-46,48-49H,15-21H2,1-14H3/b42-31+/t22-,23-,24+,25+,26-,27+,28+,29-,30+,32-,33+,34-,35+,36-,38+,39-,40-,41-/m1/s1",
        "inchikey": "RXZBMPWDPOLZGW-XMRMVWPWSA-N",
        "iupac": {
          "systematic": "(3R,4S,5S,6R,7R,9R,10E,11S,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-10-(2-methoxyethoxymethoxyimino)-3,5,7,9,11,13-hexamethyl-oxacyclotetradecan-2-one"
        },
        "smiles": {
          "canonical": "CCC1C(C(C(C(=NOCOCCOC)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O"
        },
        "molecularFormula": "C41H76N2O15"
      }
    ],
    "clinicaltrials": [
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00439062",
            "briefTitle": "Treatment of Rheumatoid Arthritis With Roxithromycin",
            "officialTitle": "Treatment of Rheumatoid Arthritis With Roxithromycin"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2007-02-20"
          },
          "conditionsModule": {
            "conditions": [
              "Rheumatoid Arthritis"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "The primary efficacy variable was the percentage of patients who had a 20 percent improvement according to American College of Rheumatology (ACR) criteria (an ACR 20 response) at six months."
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Secondary outcome measures were 50 percent improvement and 70 percent improvement according to ACR criteria (an ACR 50 response and an ACR 70 response, respectively)."
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT03571230",
            "briefTitle": "Antimicrobial Susceptibility Testing Guided Therapy Versus Empirical Therapy for the First-line Helicobacter Pylori Eradication.",
            "officialTitle": "10-Day Antimicrobial Susceptibility Testing Guided Triple Therapy Versus 14-Day Empirical Tailored Therapy for the First-line Treatment of Helicobacter Pylori Infection-A Randomized Controlled Trail"
          },
          "statusModule": {
            "overallStatus": "UNKNOWN",
            "studyFirstSubmitDate": "2018-06-18"
          },
          "conditionsModule": {
            "conditions": [
              "Helicobacter Pylori Infection",
              "Antimicrobial Susceptibility Testing"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Eradication rates in 2 groups",
                "timeFrame": "6 months"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "The rate of improving dyspepsia symptoms after Helicobacter pylori eradication."
              },
              {
                "measure": "The rate of adverse events happening"
              },
              {
                "measure": "The rate of good compliance"
              },
              {
                "measure": "Difference of cost per patient for each eradication achieved in two groups"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT03148444",
            "briefTitle": "Impact of Antibiotic Treatment Following Implantation of Cardiac Electronic Device on Patient's Outcome",
            "officialTitle": "Impact of Antibiotic Treatment Following Implantation of Cardiac Electronic Device on Patient's Outcome"
          },
          "statusModule": {
            "overallStatus": "UNKNOWN",
            "studyFirstSubmitDate": "2017-05-09"
          },
          "conditionsModule": {
            "conditions": [
              "Infection, Bacterial",
              "Pacemaker Complication"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "wound infection",
                "timeFrame": "1 year"
              },
              {
                "measure": "bacteremia and vegetations",
                "timeFrame": "1 year"
              },
              {
                "measure": "re-operation",
                "timeFrame": "1 year"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "infection unrelated to implantation"
              },
              {
                "measure": "hospitalization"
              },
              {
                "measure": "adverse event of antibiotics"
              },
              {
                "measure": "death from any cause"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT04122040",
            "briefTitle": "Effects of Roxithromycin on Quality of Life and Physiological Outcomes in Bronchiectasis",
            "officialTitle": "Effects of Roxithromycin on Quality of Life and Physiologic Outcomes in Bronchiectasis Patients During Treatment and Posttreatment Period"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2019-10-08"
          },
          "conditionsModule": {
            "conditions": [
              "Quality of Life",
              "Respiratory Function Tests"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "SGRQ scores",
                "timeFrame": "for 12 weeks"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "pulmonary function tests"
              },
              {
                "measure": "sputum volumes"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01843946",
            "briefTitle": "Clinical Efficacy of Roxithromycin in Men With Chronic Prostatitis/Chronic Pelvic Pain Syndrome"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2013-04-27"
          },
          "conditionsModule": {
            "conditions": [
              "Chronic Prostatitis",
              "Chronic Pelvic Pain Syndrome"
            ]
          },
          "designModule": {
            "studyType": "OBSERVATIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "NIH-CPSI score",
                "timeFrame": "12 weeks"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00197379",
            "briefTitle": "The Effect of 0.5% Roxithromycin Lotion for Androgenetic Alopecia",
            "officialTitle": "The Study for New Effect of Roxithromycin on Androgenetic Alopecia."
          },
          "statusModule": {
            "overallStatus": "UNKNOWN",
            "studyFirstSubmitDate": "2005-09-12"
          },
          "conditionsModule": {
            "conditions": [
              "Alopecia"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "secondaryOutcomes": [
              {
                "measure": "Pathological study taken from lesional scalp skin."
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT03414918",
            "briefTitle": "Macrolides for KCNJ5 - Mutated Aldosterone-Producing Adenoma (MAPA)",
            "officialTitle": "Macrolides for KCNJ5 - Mutated Aldosterone-Producing Adenoma (MAPA): A Study Of Personalized Diagnosis of Primary Aldosteronism With Implications For Treatment"
          },
          "statusModule": {
            "overallStatus": "UNKNOWN",
            "studyFirstSubmitDate": "2017-12-27"
          },
          "conditionsModule": {
            "conditions": [
              "Hyperaldosteronism"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Study 1: Change in Relative Aldosterone Secretion Index (RASI).",
                "timeFrame": "Baseline and after 45min clarithromycin infusion."
              },
              {
                "measure": "Study 2: Change in plasma aldosterone concentration (PAC).",
                "timeFrame": "Baseline and after 60 and 120 minutes roxitromycin administration"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02819570",
            "briefTitle": "Comparison of Two Antibiotic Prophylactic Protocols in Preterm Premature Rupture of the Membranes",
            "officialTitle": "Comparison of Two Antibiotic Prophylactic Protocols in Preterm Premature Rupture of the Membranes. A Randomized Prospective, Open Trial"
          },
          "statusModule": {
            "overallStatus": "UNKNOWN",
            "studyFirstSubmitDate": "2016-06-02"
          },
          "conditionsModule": {
            "conditions": [
              "Premature Rupture of Membrane"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "EARLY NEONATAL SEPSIS - positive blood culture",
                "timeFrame": "within 3 days of delivery"
              },
              {
                "measure": "latency period",
                "timeFrame": "from date of randomization until the date of delivery assessed up to 10 weeks"
              },
              {
                "measure": "Chorioamnionitis rate",
                "timeFrame": "from day of randomization until date of clinical/laboratory chorioamnionitis diagnosis assessed up to 10 weeks"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Neonatal weight"
              },
              {
                "measure": "Apgar score"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT06433700",
            "briefTitle": "Risk of Revision Following Knee Arthroplasty in Bariatric Surgery Patients",
            "officialTitle": "Risk of Revision and Other Complications Following Knee Arthroplasty in Patients Previously Exposed to Bariatric Surgeries: A Nationwide, Register-based Study"
          },
          "statusModule": {
            "overallStatus": "ACTIVE_NOT_RECRUITING",
            "studyFirstSubmitDate": "2023-09-07"
          },
          "conditionsModule": {
            "conditions": [
              "Arthritis Knee",
              "Bariatric Surgery Candidate",
              "Prosthesis Failure",
              "Prosthesis Survival",
              "Prosthesis-Related Infections"
            ]
          },
          "designModule": {
            "studyType": "OBSERVATIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Hazard rate of Revision due to any cause",
                "timeFrame": "within 90 days and within 2 years"
              },
              {
                "measure": "Hazard rate of Revision due to infection",
                "timeFrame": "within 90 days and within 2 years"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Hazard rate of Knee related antibiotic use within 30- and 90-days following KA"
              },
              {
                "measure": "Hazard rate of Antibiotic use due to other causes"
              },
              {
                "measure": "Mortality"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02735707",
            "briefTitle": "Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia",
            "officialTitle": "Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia"
          },
          "statusModule": {
            "overallStatus": "RECRUITING",
            "studyFirstSubmitDate": "2015-12-11"
          },
          "conditionsModule": {
            "conditions": [
              "Community-acquired Pneumonia, Influenza, COVID-19"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "All-cause mortality",
                "timeFrame": "Day 90"
              },
              {
                "measure": "Days alive and not receiving organ support in ICU",
                "timeFrame": "Day 21"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "ICU Mortality"
              },
              {
                "measure": "ICU length of stay"
              },
              {
                "measure": "Hospital length of stay"
              },
              {
                "measure": "Ventilator free days"
              },
              {
                "measure": "Organ failure free days"
              },
              {
                "measure": "All-cause mortality"
              },
              {
                "measure": "Health-related Quality of life assessment"
              },
              {
                "measure": "Proportion of intubated patients who receive a tracheostomy"
              },
              {
                "measure": "Destination at time of hospital discharge"
              },
              {
                "measure": "Readmission to the index ICU during the index hospitalization"
              },
              {
                "measure": "World Health Organisation 8-point ordinal scale outcome"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00621387",
            "briefTitle": "Study of Long-Term Antibiotic Treatment in Reactive Arthritis",
            "officialTitle": "Double-Blind, Placebo-Controlled Study of Three-Month Treatment With the Combination of Ofloxacin and Roxithromycin in Recent-Onset Reactive Arthritis"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2008-02-11"
          },
          "conditionsModule": {
            "conditions": [
              "Reactive Arthritis"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Proportion of patients recovered from arthritis",
                "timeFrame": "6 months"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Swollen joint count"
              },
              {
                "measure": "Tender joint count"
              },
              {
                "measure": "Ritchie index"
              },
              {
                "measure": "Joint pain (visual analogue scale)"
              },
              {
                "measure": "Serum C-reactive protein level"
              },
              {
                "measure": "Blood erythrocyte sedimentation rate"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00285493",
            "briefTitle": "Low Back Pain and Antibiotic Treatment",
            "officialTitle": "Phase 1 Study of Antibiotic Treatment for Low Back Pain"
          },
          "statusModule": {
            "overallStatus": "WITHDRAWN",
            "whyStopped": "Withdrawn: study halted prematurely, prior to enrollment of first participant",
            "studyFirstSubmitDate": "2006-02-01"
          },
          "conditionsModule": {
            "conditions": [
              "Low Back Pain"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "protocol designed to assess or examine persons or groups in a systematic way to identify specific markers for eligibility for further evaluation"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02469298",
            "briefTitle": "Safety, Tolerability and Clinical Effect of Danirixin in Adults With Influenza",
            "officialTitle": "A Randomized, Double-blind, Placebo Controlled Study to Evaluate the Safety, Tolerability and Clinical Effect of Oral Danirixin (GSK1325756) in the Treatment of Healthy Adults With Acute, Uncomplicated Influenza (201682)"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2015-04-23",
            "resultsFirstSubmitDate": "2017-07-23"
          },
          "conditionsModule": {
            "conditions": [
              "Virus Diseases"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Number of Participants With Adverse Events (AE) and Serious Adverse Events (SAE)",
                "timeFrame": "Up to Day 28/withdrawal"
              },
              {
                "measure": "Change From Baseline in Hematology Parameters-Basophils, Eosinophils, Lymphocytes, Monocytes, Total Neutrophils (Total Absolute Neutrophil Count [Total ANC]), Platelet Count and White Blood Cell (WBC) Count",
                "timeFrame": "Baseline (Day 1) and up to Day 28/withdrawal"
              },
              {
                "measure": "Change From Baseline in Hematology Parameters- Hemoglobin",
                "timeFrame": "Baseline (Day 1) and up to Day 28/withdrawal"
              },
              {
                "measure": "Change From Baseline in Hematology Parameters- Hematocrit",
                "timeFrame": "Baseline (Day 1) and up to Day 28/withdrawal"
              },
              {
                "measure": "Change From Baseline in Hematology Parameters- Mean Corpuscle Hemoglobin (MCH)",
                "timeFrame": "Baseline (Day 1) and up to Day 28/withdrawal"
              },
              {
                "measure": "Change From Baseline in Hematology Parameters- Mean Corpuscle Volume (MCV)",
                "timeFrame": "Baseline (Day 1) and up to Day 28/withdrawal"
              },
              {
                "measure": "Change From Baseline in Hematology Parameters- Red Blood Cell (RBC) Count and Reticulocytes Count",
                "timeFrame": "Baseline (Day 1) and up to Day 28/withdrawal"
              },
              {
                "measure": "Change From Baseline in Clinical Chemistry Parameters- Albumin and Total Protein",
                "timeFrame": "Baseline (Day 1) and up to Day 28/withdrawal"
              },
              {
                "measure": "Change From Baseline in Clinical Chemistry- Alkaline Phosphatase (ALP), Alanine Amino Transferase (ALT), Aspartate Amino Transferase (AST) and Gamma Glutamyl Transferase (GGT)",
                "timeFrame": "Baseline (Day 1) and up to Day 28/withdrawal"
              },
              {
                "measure": "Change From Baseline in Clinical Chemistry Parameters- Direct Bilirubin, Total Bilirubin, Creatinine and Uric Acid",
                "timeFrame": "Baseline (Day 1) and up to Day 28/withdrawal"
              },
              {
                "measure": "Change From Baseline in Clinical Chemistry Parameters- Calcium, Carbon Dioxide (CO2) Content/ Bicarbonate, Glucose, Potassium, Sodium and Urea/Blood Urea Nitrogen (BUN)",
                "timeFrame": "Baseline (Day 1) and up to Day 28/withdrawal"
              },
              {
                "measure": "Change From Baseline in Urinalysis Parameters- Urine pH",
                "timeFrame": "Baseline (Day 1), Day 5 and Day 28/withdrawal"
              },
              {
                "measure": "Change From Baseline in Urinalysis Parameters- Urine Specific Gravity",
                "timeFrame": "Baseline (Day 1), Day 5 and Day 28/withdrawal"
              },
              {
                "measure": "Number of Participants With Maximum Post-baseline Urine Dipstick Abnormalities- Urine Occult Blood (Dipstick)",
                "timeFrame": "Up to Day 28/withdrawal"
              },
              {
                "measure": "Number of Participants With Maximum Post-baseline Urine Dipstick Abnormalities- Urine Glucose (Dipstick)",
                "timeFrame": "Up to Day 28/withdrawal"
              },
              {
                "measure": "Number of Participants With Maximum Post-baseline Urine Dipstick Abnormalities- Urine Protein (Dipstick)",
                "timeFrame": "Up to Day 28/withdrawal"
              },
              {
                "measure": "Change From Baseline in Vital Signs- Diastolic Blood Pressure (DBP) and Systolic Blood Pressure (SBP)",
                "timeFrame": "Baseline (Day 1) and up to Day 28/withdrawal"
              },
              {
                "measure": "Change From Baseline in Vital Signs- Heart Rate (HR)",
                "timeFrame": "Baseline (Day 1) and up to Day 28/withdrawal"
              },
              {
                "measure": "Change From Baseline in Vital Signs- Respiration Rate (RR)",
                "timeFrame": "Baseline (Day 1) and up to Day 28/withdrawal"
              },
              {
                "measure": "Change From Baseline in Vital Signs- Temperature",
                "timeFrame": "Baseline (Day 1) and up to Day 28/withdrawal"
              },
              {
                "measure": "Change From Baseline in Vital Signs- Percent Oxygen in Blood (POB)",
                "timeFrame": "Baseline (Day 1) and up to Day 28/withdrawal"
              },
              {
                "measure": "Change From Baseline in Electrocardiogram (ECG) Parameters",
                "timeFrame": "Baseline (Day 1) and up to Day 28/withdrawal"
              },
              {
                "measure": "Number of Participants With Disease Related Events (DREs) of Interest",
                "timeFrame": "Up to Day 28/withdrawal"
              },
              {
                "measure": "Number of Participants With DRE of Interest-associated Antibiotic Use",
                "timeFrame": "Up to Day 28/withdrawal"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Time to Resolution of Fever Over Time Post Initiation of Treatment"
              },
              {
                "measure": "Number of Afebrile Participants Over Time Post Initiation of Treatment"
              },
              {
                "measure": "Number of Participants Who Used Relief Medication"
              },
              {
                "measure": "Number of Hospital Admissions Due to Influenza Infection"
              },
              {
                "measure": "Change From Baseline in Influenza Viral Load as Measured by Quantitative Reverse Transcription-polymerase Chain Reaction (qRT-PCR) From Nasopharyngeal Swabs on Day 3, Day 5, Day 8 and Day 14"
              },
              {
                "measure": "Number of Participants With no Detectable Influenza Viral RNA by qRT-PCR From Nasopharyngeal Swabs on Baseline (Day 1), Day 3, Day 5, Day 8 and Day 14"
              },
              {
                "measure": "Total Dose of Relief Medication"
              },
              {
                "measure": "Change From Baseline in Influenza Viral Load as Measured by Quantitative Virus Culture From Nasopharyngeal Swabs on Day 3, Day 5, Day 8 and Day 14"
              },
              {
                "measure": "Number of Participants With no Detectable Influenza Viral RNA by Quantitative Virus Culture From Nasopharyngeal Swabs on Baseline (Day 1), Day 3, Day 5, Day 8 and Day 14"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT06798051",
            "briefTitle": "Bioequivalence Study of Two Roxithromycin Tablets in Healthy Subjects",
            "officialTitle": "A Single-dose, Fasting, Randomized, Open-label, Two-treatment, Three-period, Partially-replicated, Reference-corrected Crossover Bioequivalence Study of Roxithromycin Tablets in Healthy Subjects"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2025-01-14"
          },
          "conditionsModule": {
            "conditions": [
              "Bioequivalence of Roxithromycin Tablets From Two Different Manufacturers"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "maximum observed serum or plasma concentration",
                "timeFrame": "3 day"
              },
              {
                "measure": "area under the serum or plasma concentration-time curve from 0 to t",
                "timeFrame": "3 day"
              },
              {
                "measure": "area under the serum or plasma concentration-time curve from 0 to infinity",
                "timeFrame": "3 day"
              }
            ]
          }
        }
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:37:03Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84bc"
    },
    "name": "BRD-K54456094",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84bc.png",
    "lincs": {
      "id": "LSM-11735",
      "name": "BRD-K54456094",
      "pubchemCid": 54631431,
      "chebiId": 100360,
      "inchiParent": "InChI=1S/C28H37FN4O5/c1-6-13-30-28(36)31-20-11-12-24-22(14-20)26(34)32(4)16-25(37-5)18(2)15-33(19(3)17-38-24)27(35)21-9-7-8-10-23(21)29/h7-12,14,18-19,25H,6,13,15-17H2,1-5H3,(H2,30,31,36)/t18-,19-,25-/m1/s1",
      "inchiKeyParent": "IESMZGXEKVWDTA-MPCDZSKCSA-N",
      "smilesParent": "CCCNC(=O)Nc1ccc2OC[C@@H](C)N(C[C@@H](C)[C@@H](CN(C)C(=O)c2c1)OC)C(=O)c3ccccc3F"
    },
    "unichem": {
      "chebi": "100360",
      "lincs": "LSM-11735",
      "pubchem": "54631431"
    },
    "pubchem": [
      {
        "cid": 54631431,
        "inchi": "InChI=1S/C28H37FN4O5/c1-6-13-30-28(36)31-20-11-12-24-22(14-20)26(34)32(4)16-25(37-5)18(2)15-33(19(3)17-38-24)27(35)21-9-7-8-10-23(21)29/h7-12,14,18-19,25H,6,13,15-17H2,1-5H3,(H2,30,31,36)/t18-,19-,25-/m1/s1",
        "inchikey": "IESMZGXEKVWDTA-MPCDZSKCSA-N",
        "iupac": {
          "systematic": "1-[(4R,7R,8S)-5-(2-fluorobenzoyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propylurea"
        },
        "smiles": {
          "canonical": "CCCNC(=O)NC1=CC2=C(C=C1)OCC(N(CC(C(CN(C2=O)C)OC)C)C(=O)C3=CC=CC=C3F)C"
        },
        "molecularFormula": "C28H37FN4O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:37:05Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c841e"
    },
    "name": "BRD-K36726271",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c841e.png",
    "lincs": {
      "id": "LSM-8214",
      "name": "BRD-K36726271",
      "pubchemCid": 44505846,
      "chebiId": 96835,
      "inchiParent": "InChI=1S/C23H33FN6O4/c1-16-11-30(17(2)14-31)22(32)8-5-9-29-12-20(26-27-29)15-34-21(16)13-28(3)23(33)25-19-7-4-6-18(24)10-19/h4,6-7,10,12,16-17,21,31H,5,8-9,11,13-15H2,1-3H3,(H,25,33)/t16-,17-,21-/m1/s1",
      "inchiKeyParent": "VTXUSJLMEZRIOV-CBGDNZLLSA-N",
      "smilesParent": "C[C@H](CO)N1C[C@@H](C)[C@@H](CN(C)C(=O)Nc2cccc(F)c2)OCc3cn(CCCC1=O)nn3"
    },
    "unichem": {
      "chebi": "96835",
      "lincs": "LSM-8214",
      "pubchem": "44505846"
    },
    "pubchem": [
      {
        "cid": 44505846,
        "inchi": "InChI=1S/C23H33FN6O4/c1-16-11-30(17(2)14-31)22(32)8-5-9-29-12-20(26-27-29)15-34-21(16)13-28(3)23(33)25-19-7-4-6-18(24)10-19/h4,6-7,10,12,16-17,21,31H,5,8-9,11,13-15H2,1-3H3,(H,25,33)/t16-,17-,21-/m1/s1",
        "inchikey": "VTXUSJLMEZRIOV-CBGDNZLLSA-N",
        "iupac": {
          "systematic": "3-(3-fluorophenyl)-1-[[(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methylurea"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)CCCN2C=C(COC1CN(C)C(=O)NC3=CC(=CC=C3)F)N=N2)C(C)CO"
        },
        "molecularFormula": "C23H33FN6O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:37:07Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8420"
    },
    "name": "BRD-K60820896",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8420.png",
    "lincs": {
      "id": "LSM-7658",
      "name": "BRD-K60820896",
      "pubchemCid": 54618203,
      "chebiId": 96279,
      "inchiParent": "InChI=1S/C30H36N2O6S/c1-20-7-5-6-8-26(20)25-13-14-29-27(15-25)38-28(21(2)16-32(22(3)19-33)39(29,36)37)18-31(4)17-23-9-11-24(12-10-23)30(34)35/h5-15,21-22,28,33H,16-19H2,1-4H3,(H,34,35)/t21-,22-,28+/m0/s1",
      "inchiKeyParent": "VHCZRFPKNWPULV-RXYILKCJSA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@H](C)[C@@H](CN(C)Cc2ccc(cc2)C(=O)O)Oc3cc(ccc3S1(=O)=O)c4ccccc4C"
    },
    "unichem": {
      "chebi": "96279",
      "lincs": "LSM-7658",
      "pubchem": "54618203"
    },
    "pubchem": [
      {
        "cid": 54618203,
        "inchi": "InChI=1S/C30H36N2O6S/c1-20-7-5-6-8-26(20)25-13-14-29-27(15-25)38-28(21(2)16-32(22(3)19-33)39(29,36)37)18-31(4)17-23-9-11-24(12-10-23)30(34)35/h5-15,21-22,28,33H,16-19H2,1-4H3,(H,34,35)/t21-,22-,28+/m0/s1",
        "inchikey": "VHCZRFPKNWPULV-RXYILKCJSA-N",
        "iupac": {
          "systematic": "4-[[[(4S,5S)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-8-(2-methylphenyl)-1,1-dioxo-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl-methylamino]methyl]benzoic acid"
        },
        "smiles": {
          "canonical": "CC1CN(S(=O)(=O)C2=C(C=C(C=C2)C3=CC=CC=C3C)OC1CN(C)CC4=CC=C(C=C4)C(=O)O)C(C)CO"
        },
        "molecularFormula": "C30H36N2O6S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:37:09Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8440"
    },
    "name": "BRD-K80786583-001-01-5",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8440.png",
    "lincs": {
      "id": "LSM-41674",
      "name": "BRD-K80786583-001-01-5",
      "alternativeNames": [
        "BRD-K80786583"
      ],
      "pubchemCid": 44616501,
      "chebiId": 130124,
      "inchiParent": "InChI=1S/C38H49F3N4O6/c1-25-21-45(26(2)24-46)36(47)33-20-31(43-37(48)42-30-13-11-29(12-14-30)38(39,40)41)15-18-34(33)51-27(3)8-6-7-19-50-35(25)23-44(4)22-28-9-16-32(49-5)17-10-28/h9-18,20,25-27,35,46H,6-8,19,21-24H2,1-5H3,(H2,42,43,48)/t25-,26-,27+,35+/m0/s1",
      "inchiKeyParent": "XGMQKVJTWVADHD-JALBGMRZSA-N",
      "smilesParent": "COc1ccc(CN(C)C[C@H]2OCCCC[C@@H](C)Oc3ccc(NC(=O)Nc4ccc(cc4)C(F)(F)F)cc3C(=O)N(C[C@@H]2C)[C@@H](C)CO)cc1"
    },
    "unichem": {
      "chebi": "130124",
      "lincs": "LSM-41674",
      "pubchem": "44616501"
    },
    "pubchem": [
      {
        "cid": 44616501,
        "inchi": "InChI=1S/C38H49F3N4O6/c1-25-21-45(26(2)24-46)36(47)33-20-31(43-37(48)42-30-13-11-29(12-14-30)38(39,40)41)15-18-34(33)51-27(3)8-6-7-19-50-35(25)23-44(4)22-28-9-16-32(49-5)17-10-28/h9-18,20,25-27,35,46H,6-8,19,21-24H2,1-5H3,(H2,42,43,48)/t25-,26-,27+,35+/m0/s1",
        "inchikey": "XGMQKVJTWVADHD-JALBGMRZSA-N",
        "iupac": {
          "systematic": "1-[(3R,9S,10S)-12-[(2S)-1-hydroxypropan-2-yl]-9-[[(4-methoxyphenyl)methyl-methylamino]methyl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-[4-(trifluoromethyl)phenyl]urea"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NC(=O)NC3=CC=C(C=C3)C(F)(F)F)C(C)CO)C)CN(C)CC4=CC=C(C=C4)OC"
        },
        "molecularFormula": "C38H49F3N4O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:37:12Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8461"
    },
    "name": "BRD-K35060817",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8461.png",
    "lincs": {
      "id": "LSM-10537",
      "name": "BRD-K35060817",
      "pubchemCid": 54638413,
      "chebiId": 99158,
      "inchiParent": "InChI=1S/C23H27Cl2N3O5/c1-32-20-5-3-2-4-18(20)27-23(31)28-19-9-7-15(33-21(19)13-29)11-22(30)26-12-14-6-8-16(24)17(25)10-14/h2-6,8,10,15,19,21,29H,7,9,11-13H2,1H3,(H,26,30)(H2,27,28,31)/t15-,19+,21-/m0/s1",
      "inchiKeyParent": "XCDRDXJNPKYISK-DLVCFXQMSA-N",
      "smilesParent": "COc1ccccc1NC(=O)N[C@@H]2CC[C@@H](CC(=O)NCc3ccc(Cl)c(Cl)c3)O[C@H]2CO"
    },
    "unichem": {
      "chebi": "99158",
      "lincs": "LSM-10537",
      "pubchem": "54638413"
    },
    "pubchem": [
      {
        "cid": 54638413,
        "inchi": "InChI=1S/C23H27Cl2N3O5/c1-32-20-5-3-2-4-18(20)27-23(31)28-19-9-7-15(33-21(19)13-29)11-22(30)26-12-14-6-8-16(24)17(25)10-14/h2-6,8,10,15,19,21,29H,7,9,11-13H2,1H3,(H,26,30)(H2,27,28,31)/t15-,19+,21-/m0/s1",
        "inchikey": "XCDRDXJNPKYISK-DLVCFXQMSA-N",
        "iupac": {
          "systematic": "N-[(3,4-dichlorophenyl)methyl]-2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[(2-methoxyphenyl)carbamoylamino]oxan-2-yl]acetamide"
        },
        "smiles": {
          "canonical": "COC1=CC=CC=C1NC(=O)NC2CCC(OC2CO)CC(=O)NCC3=CC(=C(C=C3)Cl)Cl"
        },
        "molecularFormula": "C23H27Cl2N3O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:37:14Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c848a"
    },
    "name": "CHEMBL2354474",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c848a.png",
    "lincs": {
      "id": "LSM-37873",
      "name": "CHEMBL2354474",
      "alternativeNames": [
        "BRD-K11795542"
      ],
      "pubchemCid": 44498604,
      "chebiId": 126307,
      "inchiParent": "InChI=1S/C36H58N4O6/c1-25-22-40(26(2)24-41)35(43)31-21-30(37-34(42)28-14-7-5-8-15-28)18-19-32(31)46-27(3)13-11-12-20-45-33(25)23-39(4)36(44)38-29-16-9-6-10-17-29/h18-19,21,25-29,33,41H,5-17,20,22-24H2,1-4H3,(H,37,42)(H,38,44)/t25-,26+,27-,33-/m1/s1",
      "inchiKeyParent": "PJJFGNJDCNNRAD-GLPSKGHJSA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@@H](C)[C@@H](CN(C)C(=O)NC2CCCCC2)OCCCC[C@@H](C)Oc3ccc(NC(=O)C4CCCCC4)cc3C1=O"
    },
    "unichem": {
      "chebi": "126307",
      "chembl": "CHEMBL2354474",
      "lincs": "LSM-37873",
      "pubchem": "44498604"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL2354474",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 642.88,
        "hba": 6,
        "hbd": 3,
        "qedWeighted": 0.34
      }
    },
    "pubchem": [
      {
        "cid": 44498604,
        "inchi": "InChI=1S/C36H58N4O6/c1-25-22-40(26(2)24-41)35(43)31-21-30(37-34(42)28-14-7-5-8-15-28)18-19-32(31)46-27(3)13-11-12-20-45-33(25)23-39(4)36(44)38-29-16-9-6-10-17-29/h18-19,21,25-29,33,41H,5-17,20,22-24H2,1-4H3,(H,37,42)(H,38,44)/t25-,26+,27-,33-/m1/s1",
        "inchikey": "PJJFGNJDCNNRAD-GLPSKGHJSA-N",
        "iupac": {
          "systematic": "N-[(3R,9S,10R)-9-[[cyclohexylcarbamoyl(methyl)amino]methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]cyclohexanecarboxamide"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NC(=O)C3CCCCC3)C(C)CO)C)CN(C)C(=O)NC4CCCCC4"
        },
        "molecularFormula": "C36H58N4O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:37:25Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84a0"
    },
    "name": "BRD-K43556160",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84a0.png",
    "lincs": {
      "id": "LSM-11081",
      "name": "BRD-K43556160",
      "pubchemCid": 54637728,
      "chebiId": 99702,
      "inchiParent": "InChI=1S/C31H37N3O5/c1-21-17-34(22(2)19-35)30(36)26-14-8-7-13-25(26)24-12-6-5-11-23(24)20-39-29(21)18-33(3)31(37)32-27-15-9-10-16-28(27)38-4/h5-16,21-22,29,35H,17-20H2,1-4H3,(H,32,37)/t21-,22+,29-/m0/s1",
      "inchiKeyParent": "ONXKQUJAHGZTDG-KERYWQKISA-N",
      "smilesParent": "COc1ccccc1NC(=O)N(C)C[C@@H]2OCc3ccccc3c4ccccc4C(=O)N(C[C@@H]2C)[C@H](C)CO"
    },
    "unichem": {
      "chebi": "99702",
      "lincs": "LSM-11081",
      "pubchem": "54637728"
    },
    "pubchem": [
      {
        "cid": 54637728,
        "inchi": "InChI=1S/C31H37N3O5/c1-21-17-34(22(2)19-35)30(36)26-14-8-7-13-25(26)24-12-6-5-11-23(24)20-39-29(21)18-33(3)31(37)32-27-15-9-10-16-28(27)38-4/h5-16,21-22,29,35H,17-20H2,1-4H3,(H,32,37)/t21-,22+,29-/m0/s1",
        "inchikey": "ONXKQUJAHGZTDG-KERYWQKISA-N",
        "iupac": {
          "systematic": "1-[[(10R,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-3-(2-methoxyphenyl)-1-methylurea"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=CC=CC=C2C3=CC=CC=C3COC1CN(C)C(=O)NC4=CC=CC=C4OC)C(C)CO"
        },
        "molecularFormula": "C31H37N3O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:37:27Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c843f"
    },
    "name": "BRD-K68906258",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c843f.png",
    "lincs": {
      "id": "LSM-44835",
      "name": "BRD-K68906258",
      "pubchemCid": 54666691,
      "inchiParent": "InChI=1S/C29H33N3O/c33-22-28-29(26-14-12-24(13-15-26)11-10-23-7-2-1-3-8-23)27-21-31(17-4-5-18-32(27)28)20-25-9-6-16-30-19-25/h1-3,6-16,19,27-29,33H,4-5,17-18,20-22H2/b11-10+/t27-,28+,29-/m0/s1",
      "inchiKeyParent": "ORVIWTYNJHNTDZ-AKJFFMAQSA-N",
      "smilesParent": "OC[C@@H]1[C@H]([C@@H]2CN(Cc3cccnc3)CCCCN12)c4ccc(\\C=C\\c5ccccc5)cc4"
    },
    "unichem": {
      "lincs": "LSM-44835",
      "pubchem": "54666691"
    },
    "pubchem": [
      {
        "cid": 54666691,
        "inchi": "InChI=1S/C29H33N3O/c33-22-28-29(26-14-12-24(13-15-26)11-10-23-7-2-1-3-8-23)27-21-31(17-4-5-18-32(27)28)20-25-9-6-16-30-19-25/h1-3,6-16,19,27-29,33H,4-5,17-18,20-22H2/b11-10+/t27-,28+,29-/m0/s1",
        "inchikey": "ORVIWTYNJHNTDZ-AKJFFMAQSA-N",
        "iupac": {
          "systematic": "[(8R,9S,10S)-9-[4-[(E)-2-phenylethenyl]phenyl]-6-(pyridin-3-ylmethyl)-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol"
        },
        "smiles": {
          "canonical": "C1CCN2C(CN(C1)CC3=CN=CC=C3)C(C2CO)C4=CC=C(C=C4)C=CC5=CC=CC=C5"
        },
        "molecularFormula": "C29H33N3O"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:37:30Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8478"
    },
    "name": "CHEMBL2355935",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8478.png",
    "lincs": {
      "id": "LSM-38052",
      "name": "CHEMBL2355935",
      "alternativeNames": [
        "BRD-K15050703"
      ],
      "pubchemCid": 54615109,
      "chebiId": 126488,
      "inchiParent": "InChI=1S/C35H47F3N4O7S/c1-22-18-42(23(2)21-43)34(44)30-17-29(40-50(45,46)33-25(4)39-49-26(33)5)14-15-31(30)48-24(3)9-7-8-16-47-32(22)20-41(6)19-27-10-12-28(13-11-27)35(36,37)38/h10-15,17,22-24,32,40,43H,7-9,16,18-21H2,1-6H3/t22-,23+,24-,32-/m0/s1",
      "inchiKeyParent": "CBAAPWVHONFTKW-DWLUSBQNSA-N",
      "smilesParent": "C[C@H](CO)N1C[C@H](C)[C@H](CN(C)Cc2ccc(cc2)C(F)(F)F)OCCCC[C@H](C)Oc3ccc(NS(=O)(=O)c4c(C)onc4C)cc3C1=O"
    },
    "unichem": {
      "chebi": "126488",
      "chembl": "CHEMBL2355935",
      "lincs": "LSM-38052",
      "pubchem": "54615109"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL2355935",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 724.84,
        "hba": 9,
        "hbd": 2,
        "qedWeighted": 0.27
      }
    },
    "pubchem": [
      {
        "cid": 54615109,
        "inchi": "InChI=1S/C35H47F3N4O7S/c1-22-18-42(23(2)21-43)34(44)30-17-29(40-50(45,46)33-25(4)39-49-26(33)5)14-15-31(30)48-24(3)9-7-8-16-47-32(22)20-41(6)19-27-10-12-28(13-11-27)35(36,37)38/h10-15,17,22-24,32,40,43H,7-9,16,18-21H2,1-6H3/t22-,23+,24-,32-/m0/s1",
        "inchikey": "CBAAPWVHONFTKW-DWLUSBQNSA-N",
        "iupac": {
          "systematic": "N-[(3S,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3,5-dimethyl-1,2-oxazole-4-sulfonamide"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NS(=O)(=O)C3=C(ON=C3C)C)C(C)CO)C)CN(C)CC4=CC=C(C=C4)C(F)(F)F"
        },
        "molecularFormula": "C35H47F3N4O7S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:37:41Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84a3"
    },
    "name": "BRD-K01146969",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84a3.png",
    "lincs": {
      "id": "LSM-8503",
      "name": "BRD-K01146969",
      "pubchemCid": 56835440,
      "chebiId": 97124,
      "inchiParent": "InChI=1S/C31H36N2O4/c1-22-18-33(23(2)20-34)31(36)28-16-10-9-15-27(28)26-14-8-7-13-25(26)21-37-29(22)19-32(3)30(35)17-24-11-5-4-6-12-24/h4-16,22-23,29,34H,17-21H2,1-3H3/t22-,23-,29-/m0/s1",
      "inchiKeyParent": "VEXUQYCDGUTBQK-BOSRLCDASA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@H](C)[C@H](CN(C)C(=O)Cc2ccccc2)OCc3ccccc3c4ccccc4C1=O"
    },
    "unichem": {
      "chebi": "97124",
      "lincs": "LSM-8503",
      "pubchem": "56835440"
    },
    "pubchem": [
      {
        "cid": 56835440,
        "inchi": "InChI=1S/C31H36N2O4/c1-22-18-33(23(2)20-34)31(36)28-16-10-9-15-27(28)26-14-8-7-13-25(26)21-37-29(22)19-32(3)30(35)17-24-11-5-4-6-12-24/h4-16,22-23,29,34H,17-21H2,1-3H3/t22-,23-,29-/m0/s1",
        "inchikey": "VEXUQYCDGUTBQK-BOSRLCDASA-N",
        "iupac": {
          "systematic": "N-[[(10R,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methyl-2-phenylacetamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=CC=CC=C2C3=CC=CC=C3COC1CN(C)C(=O)CC4=CC=CC=C4)C(C)CO"
        },
        "molecularFormula": "C31H36N2O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:37:43Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84b8"
    },
    "name": "BRD-K38933129",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84b8.png",
    "lincs": {
      "id": "LSM-10785",
      "name": "BRD-K38933129",
      "pubchemCid": 54638298,
      "chebiId": 99406,
      "inchiParent": "InChI=1S/C19H31N5O5/c1-12-18(13(2)29-22-12)21-19(27)20-15-5-4-14(28-16(15)11-25)10-17(26)24-8-6-23(3)7-9-24/h14-16,25H,4-11H2,1-3H3,(H2,20,21,27)/t14-,15+,16+/m1/s1",
      "inchiKeyParent": "ZKSUBHWMVQQNNI-PMPSAXMXSA-N",
      "smilesParent": "CN1CCN(CC1)C(=O)C[C@H]2CC[C@H](NC(=O)Nc3c(C)onc3C)[C@H](CO)O2"
    },
    "unichem": {
      "chebi": "99406",
      "lincs": "LSM-10785",
      "pubchem": "54638298"
    },
    "pubchem": [
      {
        "cid": 54638298,
        "inchi": "InChI=1S/C19H31N5O5/c1-12-18(13(2)29-22-12)21-19(27)20-15-5-4-14(28-16(15)11-25)10-17(26)24-8-6-23(3)7-9-24/h14-16,25H,4-11H2,1-3H3,(H2,20,21,27)/t14-,15+,16+/m1/s1",
        "inchikey": "ZKSUBHWMVQQNNI-PMPSAXMXSA-N",
        "iupac": {
          "systematic": "1-(3,5-dimethyl-1,2-oxazol-4-yl)-3-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-(4-methylpiperazin-1-yl)-2-oxoethyl]oxan-3-yl]urea"
        },
        "smiles": {
          "canonical": "CC1=C(C(=NO1)C)NC(=O)NC2CCC(OC2CO)CC(=O)N3CCN(CC3)C"
        },
        "molecularFormula": "C19H31N5O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:37:45Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84c3"
    },
    "name": "BRD-K70237789",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84c3.png",
    "lincs": {
      "id": "LSM-12716",
      "name": "BRD-K70237789",
      "pubchemCid": 54638966,
      "chebiId": 101351,
      "inchiParent": "InChI=1S/C22H24Cl2FN3O4/c23-17-7-5-15(11-18(17)24)27-22(31)28-19-8-6-16(32-20(19)12-29)9-10-26-21(30)13-1-3-14(25)4-2-13/h1-5,7,11,16,19-20,29H,6,8-10,12H2,(H,26,30)(H2,27,28,31)/t16-,19+,20+/m1/s1",
      "inchiKeyParent": "ONEMPWMAPHHZJV-UXPWSPDFSA-N",
      "smilesParent": "OC[C@@H]1O[C@@H](CCNC(=O)c2ccc(F)cc2)CC[C@@H]1NC(=O)Nc3ccc(Cl)c(Cl)c3"
    },
    "unichem": {
      "chebi": "101351",
      "lincs": "LSM-12716",
      "pubchem": "54638966"
    },
    "pubchem": [
      {
        "cid": 54638966,
        "inchi": "InChI=1S/C22H24Cl2FN3O4/c23-17-7-5-15(11-18(17)24)27-22(31)28-19-8-6-16(32-20(19)12-29)9-10-26-21(30)13-1-3-14(25)4-2-13/h1-5,7,11,16,19-20,29H,6,8-10,12H2,(H,26,30)(H2,27,28,31)/t16-,19+,20+/m1/s1",
        "inchikey": "ONEMPWMAPHHZJV-UXPWSPDFSA-N",
        "iupac": {
          "systematic": "N-[2-[(2R,5S,6R)-5-[(3,4-dichlorophenyl)carbamoylamino]-6-(hydroxymethyl)oxan-2-yl]ethyl]-4-fluorobenzamide"
        },
        "smiles": {
          "canonical": "C1CC(C(OC1CCNC(=O)C2=CC=C(C=C2)F)CO)NC(=O)NC3=CC(=C(C=C3)Cl)Cl"
        },
        "molecularFormula": "C22H24Cl2FN3O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:37:47Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84a4"
    },
    "name": "BRD-K89386994",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84a4.png",
    "lincs": {
      "id": "LSM-13933",
      "name": "BRD-K89386994",
      "pubchemCid": 54638509,
      "chebiId": 102586,
      "inchiParent": "InChI=1S/C21H29N3O4/c1-13(2)22-21(27)24-18-8-7-17(28-19(18)12-25)11-20(26)23-16-9-14-5-3-4-6-15(14)10-16/h3-8,13,16-19,25H,9-12H2,1-2H3,(H,23,26)(H2,22,24,27)/t17-,18+,19+/m1/s1",
      "inchiKeyParent": "PBTCYEHOLZFKGG-QYZOEREBSA-N",
      "smilesParent": "CC(C)NC(=O)N[C@H]1C=C[C@H](CC(=O)NC2Cc3ccccc3C2)O[C@H]1CO"
    },
    "unichem": {
      "chebi": "102586",
      "lincs": "LSM-13933",
      "pubchem": "54638509"
    },
    "pubchem": [
      {
        "cid": 54638509,
        "inchi": "InChI=1S/C21H29N3O4/c1-13(2)22-21(27)24-18-8-7-17(28-19(18)12-25)11-20(26)23-16-9-14-5-3-4-6-15(14)10-16/h3-8,13,16-19,25H,9-12H2,1-2H3,(H,23,26)(H2,22,24,27)/t17-,18+,19+/m1/s1",
        "inchikey": "PBTCYEHOLZFKGG-QYZOEREBSA-N",
        "iupac": {
          "systematic": "N-(2,3-dihydro-1H-inden-2-yl)-2-[(2R,3S,6S)-2-(hydroxymethyl)-3-(propan-2-ylcarbamoylamino)-3,6-dihydro-2H-pyran-6-yl]acetamide"
        },
        "smiles": {
          "canonical": "CC(C)NC(=O)NC1C=CC(OC1CO)CC(=O)NC2CC3=CC=CC=C3C2"
        },
        "molecularFormula": "C21H29N3O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:37:50Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84f5"
    },
    "name": "SCHEMBL17783870",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84f5.png",
    "lincs": {
      "id": "LSM-37667",
      "name": "SCHEMBL17783870",
      "alternativeNames": [
        "BRD-K07378992"
      ],
      "pubchemCid": 60184995,
      "chebiId": 126100,
      "inchiParent": "InChI=1S/C26H28F2N4O4/c1-15(34)32-14-26(23-18-5-4-17(36-2)12-21(18)29-24(23)22(32)13-33)7-9-31(10-8-26)25(35)30-20-6-3-16(27)11-19(20)28/h3-6,11-12,22,29,33H,7-10,13-14H2,1-2H3,(H,30,35)/t22-/m0/s1",
      "inchiKeyParent": "GCLZSVQZAJNLBF-QFIPXVFZSA-N",
      "smilesParent": "COc1ccc2c3c([nH]c2c1)[C@H](CO)N(CC34CCN(CC4)C(=O)Nc5ccc(F)cc5F)C(=O)C"
    },
    "unichem": {
      "chebi": "126100",
      "chembl": "CHEMBL3560151",
      "lincs": "LSM-37667",
      "pubchem": "60184995"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL3560151",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 498.53,
        "hba": 4,
        "hbd": 3,
        "qedWeighted": 0.51
      }
    },
    "pubchem": [
      {
        "cid": 60184995,
        "inchi": "InChI=1S/C26H28F2N4O4/c1-15(34)32-14-26(23-18-5-4-17(36-2)12-21(18)29-24(23)22(32)13-33)7-9-31(10-8-26)25(35)30-20-6-3-16(27)11-19(20)28/h3-6,11-12,22,29,33H,7-10,13-14H2,1-2H3,(H,30,35)/t22-/m0/s1",
        "inchikey": "GCLZSVQZAJNLBF-QFIPXVFZSA-N",
        "iupac": {
          "systematic": "(1R)-2-acetyl-N-(2,4-difluorophenyl)-1-(hydroxymethyl)-7-methoxyspiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4'-piperidine]-1'-carboxamide"
        },
        "smiles": {
          "canonical": "CC(=O)N1CC2(CCN(CC2)C(=O)NC3=C(C=C(C=C3)F)F)C4=C(C1CO)NC5=C4C=CC(=C5)OC"
        },
        "molecularFormula": "C26H28F2N4O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:38:01Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8434"
    },
    "name": "Cyclohexanecarboxamide, 4-(1-aminoethyl)-n-4-pyridinyl-, trans-",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8434.png",
    "lincs": {
      "id": "LSM-1177",
      "name": "Cyclohexanecarboxamide, 4-(1-aminoethyl)-n-4-pyridinyl-, trans-",
      "alternativeNames": [
        "Y27632",
        "Y-27632"
      ],
      "pubchemCid": 5711,
      "chebiId": 91431,
      "inchiParent": "InChI=1S/C14H21N3O/c1-10(15)11-2-4-12(5-3-11)14(18)17-13-6-8-16-9-7-13/h6-12H,2-5,15H2,1H3,(H,16,17,18)",
      "inchiKeyParent": "IYOZTVGMEWJPKR-UHFFFAOYSA-N",
      "smilesParent": "CC(N)C1CCC(CC1)C(=O)Nc2ccncc2"
    },
    "unichem": {
      "chebi": "91431",
      "chembl": "CHEMBL1994526",
      "lincs": "LSM-1177",
      "pubchem": "5711"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL1994526",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 247.34,
        "hba": 3,
        "hbd": 2,
        "qedWeighted": 0.86
      }
    },
    "pubchem": [
      {
        "cid": 5711,
        "inchi": "InChI=1S/C14H21N3O/c1-10(15)11-2-4-12(5-3-11)14(18)17-13-6-8-16-9-7-13/h6-12H,2-5,15H2,1H3,(H,16,17,18)",
        "inchikey": "IYOZTVGMEWJPKR-UHFFFAOYSA-N",
        "iupac": {
          "systematic": "4-(1-aminoethyl)-N-pyridin-4-ylcyclohexane-1-carboxamide"
        },
        "smiles": {
          "canonical": "CC(C1CCC(CC1)C(=O)NC2=CC=NC=C2)N"
        },
        "molecularFormula": "C14H21N3O"
      }
    ],
    "clinicaltrials": [
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT06630169",
            "briefTitle": "Study of Cryopreserved AURN001 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction",
            "officialTitle": "APANECA: A Prospective, Parallel-arm, Multi-Surgeon Study of Cryopreserved AURN001 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction (2024-E002-C)"
          },
          "statusModule": {
            "overallStatus": "ACTIVE_NOT_RECRUITING",
            "studyFirstSubmitDate": "2024-10-04"
          },
          "conditionsModule": {
            "conditions": [
              "Corneal Edema"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "BCVA - 15-letter improvement (3-line gain)",
                "timeFrame": "Month 6"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT05309135",
            "briefTitle": "A Safety and Efficacy Study of Corneal Injection for Endothelial Dysfunction Using Human Corneal Endothelial Cell Therapy in Subjects With Corneal Edema Secondary to Endothelial Dysfunction",
            "officialTitle": "A Phase 1, Double-Masked, Randomized, Safety and Efficacy, Single Center Clinical Evaluation of Corneal Injection for Endothelial Dysfunction Using Human Corneal Endothelial Cell Therapy (HCEC-1) in Adult Subjects With Corneal Edema Secondary to Endothelial Dysfunction"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2022-03-16"
          },
          "conditionsModule": {
            "conditions": [
              "Corneal Edema"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Incidence and severity of Treatment Emergent Ocular Adverse Events (TEAEs)",
                "timeFrame": "12 months"
              },
              {
                "measure": "Incidence and severity of non-ocular TEAEs",
                "timeFrame": "12 months"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Change from baseline in Central Corneal Thickness (CCT) as measured by pachymetry"
              },
              {
                "measure": "Change from baseline in Best-Corrected Visual Acuity (BCVA) as measured by LogMAR score"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT06041256",
            "briefTitle": "A Phase 1/2 Study of AURN001 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction (ABA-1)",
            "officialTitle": "CLARA: A Phase 1/2 Multi-center, Randomized, Double-Masked, Prospective, Parallel-Arm Study of AURN001 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction (ABA-1)"
          },
          "statusModule": {
            "overallStatus": "ACTIVE_NOT_RECRUITING",
            "studyFirstSubmitDate": "2023-09-11"
          },
          "conditionsModule": {
            "conditions": [
              "Corneal Edema",
              "Corneal Endothelial Dysfunction"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "BCVA - 15-letter improvement (3-line gain)",
                "timeFrame": "Month 6"
              }
            ]
          }
        }
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:38:12Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8465"
    },
    "name": "BRD-K49480198",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8465.png",
    "lincs": {
      "id": "LSM-11437",
      "name": "BRD-K49480198",
      "pubchemCid": 54649301,
      "chebiId": 100058,
      "inchiParent": "InChI=1S/C22H32F3N3O4/c1-14(19(32-4)12-27(3)20(30)16-5-6-16)11-28(15(2)13-29)21(31)26-18-9-7-17(8-10-18)22(23,24)25/h7-10,14-16,19,29H,5-6,11-13H2,1-4H3,(H,26,31)/t14-,15-,19-/m1/s1",
      "inchiKeyParent": "GUZASBNVYSIPQO-SPYBWZPUSA-N",
      "smilesParent": "CO[C@H](CN(C)C(=O)C1CC1)[C@H](C)CN([C@H](C)CO)C(=O)Nc2ccc(cc2)C(F)(F)F"
    },
    "unichem": {
      "chebi": "100058",
      "lincs": "LSM-11437",
      "pubchem": "54649301"
    },
    "pubchem": [
      {
        "cid": 54649301,
        "inchi": "InChI=1S/C22H32F3N3O4/c1-14(19(32-4)12-27(3)20(30)16-5-6-16)11-28(15(2)13-29)21(31)26-18-9-7-17(8-10-18)22(23,24)25/h7-10,14-16,19,29H,5-6,11-13H2,1-4H3,(H,26,31)/t14-,15-,19-/m1/s1",
        "inchikey": "GUZASBNVYSIPQO-SPYBWZPUSA-N",
        "iupac": {
          "systematic": "N-[(2S,3R)-4-[[(2R)-1-hydroxypropan-2-yl]-[[4-(trifluoromethyl)phenyl]carbamoyl]amino]-2-methoxy-3-methylbutyl]-N-methylcyclopropanecarboxamide"
        },
        "smiles": {
          "canonical": "CC(CN(C(C)CO)C(=O)NC1=CC=C(C=C1)C(F)(F)F)C(CN(C)C(=O)C2CC2)OC"
        },
        "molecularFormula": "C22H32F3N3O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:38:14Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c849c"
    },
    "name": "BRD-K98168679",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c849c.png",
    "lincs": {
      "id": "LSM-14463",
      "name": "BRD-K98168679",
      "pubchemCid": 56835414,
      "chebiId": 103118,
      "inchiParent": "InChI=1S/C32H42N4O4/c1-21-17-36(22(2)19-37)32(39)30-29(25-13-8-9-14-26(25)35(30)5)24-12-7-6-11-23(24)20-40-28(21)18-34(4)31(38)27-15-10-16-33(27)3/h6-9,11-14,21-22,27-28,37H,10,15-20H2,1-5H3/t21-,22+,27-,28+/m0/s1",
      "inchiKeyParent": "QNPXTRYBNJAKIP-ICLSSZMYSA-N",
      "smilesParent": "C[C@H](CO)N1C[C@H](C)[C@@H](CN(C)C(=O)[C@@H]2CCCN2C)OCc3ccccc3c4c(C1=O)n(C)c5ccccc45"
    },
    "unichem": {
      "chebi": "103118",
      "lincs": "LSM-14463",
      "pubchem": "56835414"
    },
    "pubchem": [
      {
        "cid": 56835414,
        "inchi": "InChI=1S/C32H42N4O4/c1-21-17-36(22(2)19-37)32(39)30-29(25-13-8-9-14-26(25)35(30)5)24-12-7-6-11-23(24)20-40-28(21)18-34(4)31(38)27-15-10-16-33(27)3/h6-9,11-14,21-22,27-28,37H,10,15-20H2,1-5H3/t21-,22+,27-,28+/m0/s1",
        "inchikey": "QNPXTRYBNJAKIP-ICLSSZMYSA-N",
        "iupac": {
          "systematic": "(2S)-N-[[(10S,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N,1-dimethylpyrrolidine-2-carboxamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(C3=CC=CC=C3COC1CN(C)C(=O)C4CCCN4C)C5=CC=CC=C5N2C)C(C)CO"
        },
        "molecularFormula": "C32H42N4O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:38:16Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c845c"
    },
    "name": "BRD-K18480277",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c845c.png",
    "lincs": {
      "id": "LSM-9542",
      "name": "BRD-K18480277",
      "pubchemCid": 54638849,
      "chebiId": 98163,
      "inchiParent": "InChI=1S/C22H32FN3O4/c23-17-8-4-5-9-18(17)25-22(29)26-19-11-10-16(30-20(19)14-27)12-13-24-21(28)15-6-2-1-3-7-15/h4-5,8-9,15-16,19-20,27H,1-3,6-7,10-14H2,(H,24,28)(H2,25,26,29)/t16-,19-,20-/m1/s1",
      "inchiKeyParent": "ABKGFAHRWOKBSI-NSISKUIASA-N",
      "smilesParent": "OC[C@H]1O[C@@H](CCNC(=O)C2CCCCC2)CC[C@H]1NC(=O)Nc3ccccc3F"
    },
    "unichem": {
      "chebi": "98163",
      "lincs": "LSM-9542",
      "pubchem": "54638849"
    },
    "pubchem": [
      {
        "cid": 54638849,
        "inchi": "InChI=1S/C22H32FN3O4/c23-17-8-4-5-9-18(17)25-22(29)26-19-11-10-16(30-20(19)14-27)12-13-24-21(28)15-6-2-1-3-7-15/h4-5,8-9,15-16,19-20,27H,1-3,6-7,10-14H2,(H,24,28)(H2,25,26,29)/t16-,19-,20-/m1/s1",
        "inchikey": "ABKGFAHRWOKBSI-NSISKUIASA-N",
        "iupac": {
          "systematic": "N-[2-[(2R,5R,6S)-5-[(2-fluorophenyl)carbamoylamino]-6-(hydroxymethyl)oxan-2-yl]ethyl]cyclohexanecarboxamide"
        },
        "smiles": {
          "canonical": "C1CCC(CC1)C(=O)NCCC2CCC(C(O2)CO)NC(=O)NC3=CC=CC=C3F"
        },
        "molecularFormula": "C22H32FN3O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:38:18Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c846c"
    },
    "name": "BRD-K75633187",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c846c.png",
    "lincs": {
      "id": "LSM-13054",
      "name": "BRD-K75633187",
      "pubchemCid": 54657723,
      "chebiId": 101691,
      "inchiParent": "InChI=1S/C18H33N3O4/c22-14-11-20-16-5-4-15(25-17(16)13-24-12-14)10-18(23)19-6-9-21-7-2-1-3-8-21/h14-17,20,22H,1-13H2,(H,19,23)/t14-,15+,16-,17+/m1/s1",
      "inchiKeyParent": "WSFSIZCPNKDEIH-TWMKSMIVSA-N",
      "smilesParent": "O[C@@H]1CN[C@@H]2CC[C@@H](CC(=O)NCCN3CCCCC3)O[C@H]2COC1"
    },
    "unichem": {
      "chebi": "101691",
      "lincs": "LSM-13054",
      "pubchem": "54657723"
    },
    "pubchem": [
      {
        "cid": 54657723,
        "inchi": "InChI=1S/C18H33N3O4/c22-14-11-20-16-5-4-15(25-17(16)13-24-12-14)10-18(23)19-6-9-21-7-2-1-3-8-21/h14-17,20,22H,1-13H2,(H,19,23)/t14-,15+,16-,17+/m1/s1",
        "inchikey": "WSFSIZCPNKDEIH-TWMKSMIVSA-N",
        "iupac": {
          "systematic": "2-[(3R,6aR,8S,10aR)-3-hydroxy-1,2,3,4,6,6a,8,9,10,10a-decahydropyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-piperidin-1-ylethyl)acetamide"
        },
        "smiles": {
          "canonical": "C1CCN(CC1)CCNC(=O)CC2CCC3C(O2)COCC(CN3)O"
        },
        "molecularFormula": "C18H33N3O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:38:21Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8471"
    },
    "name": "BRD-K84447616",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8471.png",
    "lincs": {
      "id": "LSM-44880",
      "name": "BRD-K84447616",
      "pubchemCid": 54666676,
      "inchiParent": "InChI=1S/C27H35N3O2/c1-28(2)19-26(32)29-16-6-7-17-30-24(18-29)27(25(30)20-31)23-14-12-22(13-15-23)11-10-21-8-4-3-5-9-21/h3-5,8-15,24-25,27,31H,6-7,16-20H2,1-2H3/b11-10+/t24-,25+,27-/m1/s1",
      "inchiKeyParent": "ZAHXKZOKOUSJMC-IYQUBAFESA-N",
      "smilesParent": "CN(C)CC(=O)N1CCCCN2[C@@H](CO)[C@@H]([C@H]2C1)c3ccc(\\C=C\\c4ccccc4)cc3"
    },
    "unichem": {
      "lincs": "LSM-44880",
      "pubchem": "54666676"
    },
    "pubchem": [
      {
        "cid": 54666676,
        "inchi": "InChI=1S/C27H35N3O2/c1-28(2)19-26(32)29-16-6-7-17-30-24(18-29)27(25(30)20-31)23-14-12-22(13-15-23)11-10-21-8-4-3-5-9-21/h3-5,8-15,24-25,27,31H,6-7,16-20H2,1-2H3/b11-10+/t24-,25+,27-/m1/s1",
        "inchikey": "ZAHXKZOKOUSJMC-IYQUBAFESA-N",
        "iupac": {
          "systematic": "2-(dimethylamino)-1-[(8S,9R,10R)-10-(hydroxymethyl)-9-[4-[(E)-2-phenylethenyl]phenyl]-1,6-diazabicyclo[6.2.0]decan-6-yl]ethanone"
        },
        "smiles": {
          "canonical": "CN(C)CC(=O)N1CCCCN2C(C1)C(C2CO)C3=CC=C(C=C3)C=CC4=CC=CC=C4"
        },
        "molecularFormula": "C27H35N3O2"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:38:23Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c847b"
    },
    "name": "BRD-K22801678",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c847b.png",
    "lincs": {
      "id": "LSM-43378",
      "name": "BRD-K22801678",
      "pubchemCid": 54618548,
      "inchiParent": "InChI=1S/C30H35N3O6S/c1-21-18-33(22(2)20-34)30(35)27-16-24(11-10-23-8-6-5-7-9-23)17-31-29(27)39-28(21)19-32(3)40(36,37)26-14-12-25(38-4)13-15-26/h5-17,21-22,28,34H,18-20H2,1-4H3/b11-10+/t21-,22-,28-/m1/s1",
      "inchiKeyParent": "RWAKEFQIDXFPPV-FJJQBDJBSA-N",
      "smilesParent": "COc1ccc(cc1)S(=O)(=O)N(C)C[C@H]2Oc3ncc(\\C=C\\c4ccccc4)cc3C(=O)N(C[C@H]2C)[C@H](C)CO"
    },
    "unichem": {
      "lincs": "LSM-43378",
      "pubchem": "54618548"
    },
    "pubchem": [
      {
        "cid": 54618548,
        "inchi": "InChI=1S/C30H35N3O6S/c1-21-18-33(22(2)20-34)30(35)27-16-24(11-10-23-8-6-5-7-9-23)17-31-29(27)39-28(21)19-32(3)40(36,37)26-14-12-25(38-4)13-15-26/h5-17,21-22,28,34H,18-20H2,1-4H3/b11-10+/t21-,22-,28-/m1/s1",
        "inchikey": "RWAKEFQIDXFPPV-FJJQBDJBSA-N",
        "iupac": {
          "systematic": "N-[[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-2-phenylethenyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-4-methoxy-N-methylbenzenesulfonamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(N=CC(=C2)C=CC3=CC=CC=C3)OC1CN(C)S(=O)(=O)C4=CC=C(C=C4)OC)C(C)CO"
        },
        "molecularFormula": "C30H35N3O6S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:38:25Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84c2"
    },
    "name": "BRD-K84022666",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84c2.png",
    "lincs": {
      "id": "LSM-13562",
      "name": "BRD-K84022666",
      "pubchemCid": 54654430,
      "chebiId": 102204,
      "inchiParent": "InChI=1S/C33H38N4O5S/c1-36-28-11-10-25(17-31(38)35-24-13-14-37(20-24)19-22-6-3-2-4-7-22)42-30(28)21-41-29-12-9-23(16-27(29)33(36)40)34-32(39)18-26-8-5-15-43-26/h2-9,12,15-16,24-25,28,30H,10-11,13-14,17-21H2,1H3,(H,34,39)(H,35,38)/t24-,25-,28-,30+/m0/s1",
      "inchiKeyParent": "YIAMBQQGWRAZTQ-FCJWUBJXSA-N",
      "smilesParent": "CN1[C@H]2CC[C@@H](CC(=O)N[C@H]3CCN(Cc4ccccc4)C3)O[C@@H]2COc5ccc(NC(=O)Cc6cccs6)cc5C1=O"
    },
    "unichem": {
      "chebi": "102204",
      "lincs": "LSM-13562",
      "pubchem": "54654430"
    },
    "pubchem": [
      {
        "cid": 54654430,
        "inchi": "InChI=1S/C33H38N4O5S/c1-36-28-11-10-25(17-31(38)35-24-13-14-37(20-24)19-22-6-3-2-4-7-22)42-30(28)21-41-29-12-9-23(16-27(29)33(36)40)34-32(39)18-26-8-5-15-43-26/h2-9,12,15-16,24-25,28,30H,10-11,13-14,17-21H2,1H3,(H,34,39)(H,35,38)/t24-,25-,28-,30+/m0/s1",
        "inchikey": "YIAMBQQGWRAZTQ-FCJWUBJXSA-N",
        "iupac": {
          "systematic": "2-[(2S,4aS,12aS)-5-methyl-6-oxo-8-[(2-thiophen-2-ylacetyl)amino]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-[(3S)-1-benzylpyrrolidin-3-yl]acetamide"
        },
        "smiles": {
          "canonical": "CN1C2CCC(OC2COC3=C(C1=O)C=C(C=C3)NC(=O)CC4=CC=CS4)CC(=O)NC5CCN(C5)CC6=CC=CC=C6"
        },
        "molecularFormula": "C33H38N4O5S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:38:27Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8485"
    },
    "name": "CHEMBL3188581",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8485.png",
    "lincs": {
      "id": "LSM-38540",
      "name": "CHEMBL3188581",
      "alternativeNames": [
        "BRD-K23319301"
      ],
      "pubchemCid": 71758969,
      "chebiId": 126977,
      "inchiParent": "InChI=1S/C30H36FN3O4/c1-37-23-5-6-24-25(16-23)32-28-26(18-35)34(29(36)21-7-13-38-14-8-21)19-30(27(24)28)9-11-33(12-10-30)17-20-3-2-4-22(31)15-20/h2-6,15-16,21,26,32,35H,7-14,17-19H2,1H3/t26-/m0/s1",
      "inchiKeyParent": "IWQQPQHTVOLVIH-SANMLTNESA-N",
      "smilesParent": "COc1ccc2c3c([nH]c2c1)[C@H](CO)N(CC34CCN(Cc5cccc(F)c5)CC4)C(=O)C6CCOCC6"
    },
    "unichem": {
      "chebi": "126977",
      "chembl": "CHEMBL3188581",
      "lincs": "LSM-38540",
      "pubchem": "71758969"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL3188581",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 521.63,
        "hba": 5,
        "hbd": 2,
        "qedWeighted": 0.53
      }
    },
    "pubchem": [
      {
        "cid": 71758969,
        "inchi": "InChI=1S/C30H36FN3O4/c1-37-23-5-6-24-25(16-23)32-28-26(18-35)34(29(36)21-7-13-38-14-8-21)19-30(27(24)28)9-11-33(12-10-30)17-20-3-2-4-22(31)15-20/h2-6,15-16,21,26,32,35H,7-14,17-19H2,1H3/t26-/m0/s1",
        "inchikey": "IWQQPQHTVOLVIH-SANMLTNESA-N",
        "iupac": {
          "systematic": "[(1R)-1'-[(3-fluorophenyl)methyl]-1-(hydroxymethyl)-7-methoxyspiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4'-piperidine]-2-yl]-(oxan-4-yl)methanone"
        },
        "smiles": {
          "canonical": "COC1=CC2=C(C=C1)C3=C(N2)C(N(CC34CCN(CC4)CC5=CC(=CC=C5)F)C(=O)C6CCOCC6)CO"
        },
        "molecularFormula": "C30H36FN3O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:38:38Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84b6"
    },
    "name": "BRD-K82071478",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84b6.png",
    "lincs": {
      "id": "LSM-13442",
      "name": "BRD-K82071478",
      "pubchemCid": 54638468,
      "chebiId": 102082,
      "inchiParent": "InChI=1S/C18H25N3O5/c22-12-16-14(20-18(24)15-3-1-2-6-19-15)5-4-13(26-16)11-17(23)21-7-9-25-10-8-21/h1-3,6,13-14,16,22H,4-5,7-12H2,(H,20,24)/t13-,14+,16-/m0/s1",
      "inchiKeyParent": "QWCXAENNPFGWBU-LZWOXQAQSA-N",
      "smilesParent": "OC[C@@H]1O[C@H](CC(=O)N2CCOCC2)CC[C@H]1NC(=O)c3ccccn3"
    },
    "unichem": {
      "chebi": "102082",
      "lincs": "LSM-13442",
      "pubchem": "54638468"
    },
    "pubchem": [
      {
        "cid": 54638468,
        "inchi": "InChI=1S/C18H25N3O5/c22-12-16-14(20-18(24)15-3-1-2-6-19-15)5-4-13(26-16)11-17(23)21-7-9-25-10-8-21/h1-3,6,13-14,16,22H,4-5,7-12H2,(H,20,24)/t13-,14+,16-/m0/s1",
        "inchikey": "QWCXAENNPFGWBU-LZWOXQAQSA-N",
        "iupac": {
          "systematic": "N-[(2R,3R,6S)-2-(hydroxymethyl)-6-(2-morpholin-4-yl-2-oxoethyl)oxan-3-yl]pyridine-2-carboxamide"
        },
        "smiles": {
          "canonical": "C1CC(C(OC1CC(=O)N2CCOCC2)CO)NC(=O)C3=CC=CC=N3"
        },
        "molecularFormula": "C18H25N3O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:38:40Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84d0"
    },
    "name": "CHEMBL2361021",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84d0.png",
    "lincs": {
      "id": "LSM-38978",
      "name": "CHEMBL2361021",
      "alternativeNames": [
        "BRD-K31380618"
      ],
      "pubchemCid": 54615108,
      "chebiId": 127420,
      "inchiParent": "InChI=1S/C35H47F3N4O7S/c1-22-18-42(23(2)21-43)34(44)30-17-29(40-50(45,46)33-25(4)39-49-26(33)5)14-15-31(30)48-24(3)9-7-8-16-47-32(22)20-41(6)19-27-10-12-28(13-11-27)35(36,37)38/h10-15,17,22-24,32,40,43H,7-9,16,18-21H2,1-6H3/t22-,23-,24-,32-/m0/s1",
      "inchiKeyParent": "CBAAPWVHONFTKW-TWQFHJJKSA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@H](C)[C@H](CN(C)Cc2ccc(cc2)C(F)(F)F)OCCCC[C@H](C)Oc3ccc(NS(=O)(=O)c4c(C)onc4C)cc3C1=O"
    },
    "unichem": {
      "chebi": "127420",
      "chembl": "CHEMBL2361021",
      "lincs": "LSM-38978",
      "pubchem": "54615108"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL2361021",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 724.84,
        "hba": 9,
        "hbd": 2,
        "qedWeighted": 0.27
      }
    },
    "pubchem": [
      {
        "cid": 54615108,
        "inchi": "InChI=1S/C35H47F3N4O7S/c1-22-18-42(23(2)21-43)34(44)30-17-29(40-50(45,46)33-25(4)39-49-26(33)5)14-15-31(30)48-24(3)9-7-8-16-47-32(22)20-41(6)19-27-10-12-28(13-11-27)35(36,37)38/h10-15,17,22-24,32,40,43H,7-9,16,18-21H2,1-6H3/t22-,23-,24-,32-/m0/s1",
        "inchikey": "CBAAPWVHONFTKW-TWQFHJJKSA-N",
        "iupac": {
          "systematic": "N-[(3S,9R,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3,5-dimethyl-1,2-oxazole-4-sulfonamide"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NS(=O)(=O)C3=C(ON=C3C)C)C(C)CO)C)CN(C)CC4=CC=C(C=C4)C(F)(F)F"
        },
        "molecularFormula": "C35H47F3N4O7S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:38:52Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8422"
    },
    "name": "BRD-K34347561",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8422.png",
    "lincs": {
      "id": "LSM-10499",
      "name": "BRD-K34347561",
      "pubchemCid": 54637822,
      "chebiId": 99120,
      "inchiParent": "InChI=1S/C32H39N5O5/c1-19-15-37(20(2)17-38)31(39)30-28(25-13-9-10-14-26(25)36(30)6)24-12-8-7-11-23(24)18-41-27(19)16-35(5)32(40)33-29-21(3)34-42-22(29)4/h7-14,19-20,27,38H,15-18H2,1-6H3,(H,33,40)/t19-,20-,27-/m1/s1",
      "inchiKeyParent": "WBCPGODJHKXDGU-SEXOINJZSA-N",
      "smilesParent": "C[C@H](CO)N1C[C@@H](C)[C@@H](CN(C)C(=O)Nc2c(C)onc2C)OCc3ccccc3c4c(C1=O)n(C)c5ccccc45"
    },
    "unichem": {
      "chebi": "99120",
      "lincs": "LSM-10499",
      "pubchem": "54637822"
    },
    "pubchem": [
      {
        "cid": 54637822,
        "inchi": "InChI=1S/C32H39N5O5/c1-19-15-37(20(2)17-38)31(39)30-28(25-13-9-10-14-26(25)36(30)6)24-12-8-7-11-23(24)18-41-27(19)16-35(5)32(40)33-29-21(3)34-42-22(29)4/h7-14,19-20,27,38H,15-18H2,1-6H3,(H,33,40)/t19-,20-,27-/m1/s1",
        "inchikey": "WBCPGODJHKXDGU-SEXOINJZSA-N",
        "iupac": {
          "systematic": "3-(3,5-dimethyl-1,2-oxazol-4-yl)-1-[[(10S,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-1-methylurea"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(C3=CC=CC=C3COC1CN(C)C(=O)NC4=C(ON=C4C)C)C5=CC=CC=C5N2C)C(C)CO"
        },
        "molecularFormula": "C32H39N5O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:38:54Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8433"
    },
    "name": "Erastin",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8433.png",
    "lincs": {
      "id": "LSM-4914",
      "name": "Erastin",
      "alternativeNames": [
        "Erastin"
      ],
      "pubchemCid": 11214940,
      "chebiId": 94287,
      "inchiParent": "InChI=1S/C30H31ClN4O4/c1-3-38-27-11-7-6-10-26(27)35-29(32-25-9-5-4-8-24(25)30(35)37)21(2)33-16-18-34(19-17-33)28(36)20-39-23-14-12-22(31)13-15-23/h4-15,21H,3,16-20H2,1-2H3",
      "inchiKeyParent": "BKQFRNYHFIQEKN-UHFFFAOYSA-N",
      "smilesParent": "CCOc1ccccc1N2C(=O)c3ccccc3N=C2C(C)N4CCN(CC4)C(=O)COc5ccc(Cl)cc5"
    },
    "unichem": {
      "chebi": "94287",
      "chembl": "CHEMBL401989",
      "lincs": "LSM-4914",
      "pubchem": "11214940"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL401989",
      "prefName": "ERASTIN",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 547.06,
        "hba": 7,
        "hbd": 0,
        "qedWeighted": 0.32
      },
      "moleculeSynonyms": [
        {
          "moleculeSynonym": "Erastin",
          "synType": "OTHER",
          "synonyms": "Erastin"
        }
      ]
    },
    "pubchem": [
      {
        "cid": 11214940,
        "inchi": "InChI=1S/C30H31ClN4O4/c1-3-38-27-11-7-6-10-26(27)35-29(32-25-9-5-4-8-24(25)30(35)37)21(2)33-16-18-34(19-17-33)28(36)20-39-23-14-12-22(31)13-15-23/h4-15,21H,3,16-20H2,1-2H3",
        "inchikey": "BKQFRNYHFIQEKN-UHFFFAOYSA-N",
        "iupac": {
          "systematic": "2-[1-[4-[2-(4-chlorophenoxy)acetyl]piperazin-1-yl]ethyl]-3-(2-ethoxyphenyl)quinazolin-4-one"
        },
        "smiles": {
          "canonical": "CCOC1=CC=CC=C1N2C(=O)C3=CC=CC=C3N=C2C(C)N4CCN(CC4)C(=O)COC5=CC=C(C=C5)Cl"
        },
        "molecularFormula": "C30H31ClN4O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:39:05Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c845a"
    },
    "name": "BRD-K84468307",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c845a.png",
    "lincs": {
      "id": "LSM-13592",
      "name": "BRD-K84468307",
      "pubchemCid": 54638506,
      "chebiId": 102236,
      "inchiParent": "InChI=1S/C29H30N2O7/c32-17-27-24(31-29(34)20-8-13-25-26(14-20)36-18-35-25)12-11-23(38-27)15-28(33)30-16-19-6-9-22(10-7-19)37-21-4-2-1-3-5-21/h1-10,13-14,23-24,27,32H,11-12,15-18H2,(H,30,33)(H,31,34)/t23-,24+,27-/m1/s1",
      "inchiKeyParent": "IKYPBPDRSBKALY-ONBPZOJHSA-N",
      "smilesParent": "OC[C@H]1O[C@@H](CC(=O)NCc2ccc(Oc3ccccc3)cc2)CC[C@@H]1NC(=O)c4ccc5OCOc5c4"
    },
    "unichem": {
      "chebi": "102236",
      "lincs": "LSM-13592",
      "pubchem": "54638506"
    },
    "pubchem": [
      {
        "cid": 54638506,
        "inchi": "InChI=1S/C29H30N2O7/c32-17-27-24(31-29(34)20-8-13-25-26(14-20)36-18-35-25)12-11-23(38-27)15-28(33)30-16-19-6-9-22(10-7-19)37-21-4-2-1-3-5-21/h1-10,13-14,23-24,27,32H,11-12,15-18H2,(H,30,33)(H,31,34)/t23-,24+,27-/m1/s1",
        "inchikey": "IKYPBPDRSBKALY-ONBPZOJHSA-N",
        "iupac": {
          "systematic": "N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-[(4-phenoxyphenyl)methylamino]ethyl]oxan-3-yl]-1,3-benzodioxole-5-carboxamide"
        },
        "smiles": {
          "canonical": "C1CC(C(OC1CC(=O)NCC2=CC=C(C=C2)OC3=CC=CC=C3)CO)NC(=O)C4=CC5=C(C=C4)OCO5"
        },
        "molecularFormula": "C29H30N2O7"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:39:07Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8486"
    },
    "name": "BRD-K74260000",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8486.png",
    "lincs": {
      "id": "LSM-12974",
      "name": "BRD-K74260000",
      "pubchemCid": 54650163,
      "chebiId": 101611,
      "inchiParent": "InChI=1S/C19H22N2O/c20-12-17-19(18(13-22)21-17)16-10-8-15(9-11-16)7-6-14-4-2-1-3-5-14/h8-11,14,17-19,21-22H,1-5,13H2/t17-,18+,19-/m0/s1",
      "inchiKeyParent": "ANDSQWRABKLSGR-OTWHNJEPSA-N",
      "smilesParent": "OC[C@H]1N[C@@H](C#N)[C@@H]1c2ccc(cc2)C#CC3CCCCC3"
    },
    "unichem": {
      "chebi": "101611",
      "lincs": "LSM-12974",
      "pubchem": "54650163"
    },
    "pubchem": [
      {
        "cid": 54650163,
        "inchi": "InChI=1S/C19H22N2O/c20-12-17-19(18(13-22)21-17)16-10-8-15(9-11-16)7-6-14-4-2-1-3-5-14/h8-11,14,17-19,21-22H,1-5,13H2/t17-,18+,19-/m0/s1",
        "inchikey": "ANDSQWRABKLSGR-OTWHNJEPSA-N",
        "iupac": {
          "systematic": "(2R,3S,4S)-3-[4-(2-cyclohexylethynyl)phenyl]-4-(hydroxymethyl)azetidine-2-carbonitrile"
        },
        "smiles": {
          "canonical": "C1CCC(CC1)C#CC2=CC=C(C=C2)C3C(NC3C#N)CO"
        },
        "molecularFormula": "C19H22N2O"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:39:09Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8491"
    },
    "name": "BRD-K06188599",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8491.png",
    "lincs": {
      "id": "LSM-47131",
      "name": "BRD-K06188599",
      "pubchemCid": 46903887,
      "inchiParent": "InChI=1S/C37H49FN4O6/c1-25-21-42(26(2)24-43)36(44)33-20-31(40-37(45)39-30-13-11-29(38)12-14-30)15-18-34(33)48-27(3)8-6-7-19-47-35(25)23-41(4)22-28-9-16-32(46-5)17-10-28/h9-18,20,25-27,35,43H,6-8,19,21-24H2,1-5H3,(H2,39,40,45)/t25-,26-,27+,35+/m1/s1",
      "inchiKeyParent": "DICSNASCOVLQDJ-NUNJUMJCSA-N",
      "smilesParent": "COc1ccc(CN(C)C[C@@H]2OCCCC[C@H](C)Oc3ccc(NC(=O)Nc4ccc(F)cc4)cc3C(=O)N(C[C@H]2C)[C@H](C)CO)cc1"
    },
    "unichem": {
      "chembl": "CHEMBL1882717",
      "pubchem": "46903887"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL1882717",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 664.82,
        "hba": 7,
        "hbd": 3,
        "qedWeighted": 0.24
      }
    },
    "pubchem": [
      {
        "cid": 46903887,
        "inchi": "InChI=1S/C37H49FN4O6/c1-25-21-42(26(2)24-43)36(44)33-20-31(40-37(45)39-30-13-11-29(38)12-14-30)15-18-34(33)48-27(3)8-6-7-19-47-35(25)23-41(4)22-28-9-16-32(46-5)17-10-28/h9-18,20,25-27,35,43H,6-8,19,21-24H2,1-5H3,(H2,39,40,45)/t25-,26-,27+,35+/m1/s1",
        "inchikey": "DICSNASCOVLQDJ-NUNJUMJCSA-N",
        "iupac": {
          "systematic": "1-(4-fluorophenyl)-3-[(3S,9R,10R)-12-[(2R)-1-hydroxypropan-2-yl]-9-[[(4-methoxyphenyl)methyl-methylamino]methyl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]urea"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NC(=O)NC3=CC=C(C=C3)F)C(C)CO)C)CN(C)CC4=CC=C(C=C4)OC"
        },
        "molecularFormula": "C37H49FN4O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:39:21Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8498"
    },
    "name": "BRD-K99702099",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8498.png",
    "lincs": {
      "id": "LSM-20087",
      "name": "BRD-K99702099",
      "pubchemCid": 44489657,
      "chebiId": 108688,
      "inchiParent": "InChI=1S/C22H31N5O5/c1-12-10-27(13(2)11-28)21(29)16-7-6-8-17(20(16)31-18(12)9-23-5)24-22(30)25-19-14(3)26-32-15(19)4/h6-8,12-13,18,23,28H,9-11H2,1-5H3,(H2,24,25,30)/t12-,13+,18+/m0/s1",
      "inchiKeyParent": "MPDMLCBONFVZSW-VEVIJQCQSA-N",
      "smilesParent": "CNC[C@H]1Oc2c(NC(=O)Nc3c(C)onc3C)cccc2C(=O)N(C[C@@H]1C)[C@H](C)CO"
    },
    "unichem": {
      "chebi": "108688",
      "lincs": "LSM-20087",
      "pubchem": "44489657"
    },
    "pubchem": [
      {
        "cid": 44489657,
        "inchi": "InChI=1S/C22H31N5O5/c1-12-10-27(13(2)11-28)21(29)16-7-6-8-17(20(16)31-18(12)9-23-5)24-22(30)25-19-14(3)26-32-15(19)4/h6-8,12-13,18,23,28H,9-11H2,1-5H3,(H2,24,25,30)/t12-,13+,18+/m0/s1",
        "inchikey": "MPDMLCBONFVZSW-VEVIJQCQSA-N",
        "iupac": {
          "systematic": "1-(3,5-dimethyl-1,2-oxazol-4-yl)-3-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]urea"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(C(=CC=C2)NC(=O)NC3=C(ON=C3C)C)OC1CNC)C(C)CO"
        },
        "molecularFormula": "C22H31N5O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:39:23Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84a6"
    },
    "name": "BRD-K01055635",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84a6.png",
    "lincs": {
      "id": "LSM-8501",
      "name": "BRD-K01055635",
      "pubchemCid": 54657536,
      "chebiId": 97122,
      "inchiParent": "InChI=1S/C26H32ClN3O5/c1-17(18-6-3-2-4-7-18)28-25(32)13-22-10-11-23-24(35-22)16-34-15-21(31)14-30(23)26(33)29-20-9-5-8-19(27)12-20/h2-9,12,17,21-24,31H,10-11,13-16H2,1H3,(H,28,32)(H,29,33)/t17-,21+,22+,23-,24+/m0/s1",
      "inchiKeyParent": "QYSMODXJNCJWNA-JYZZCPHSSA-N",
      "smilesParent": "C[C@H](NC(=O)C[C@H]1CC[C@H]2[C@@H](COC[C@H](O)CN2C(=O)Nc3cccc(Cl)c3)O1)c4ccccc4"
    },
    "unichem": {
      "chebi": "97122",
      "lincs": "LSM-8501",
      "pubchem": "54657536"
    },
    "pubchem": [
      {
        "cid": 54657536,
        "inchi": "InChI=1S/C26H32ClN3O5/c1-17(18-6-3-2-4-7-18)28-25(32)13-22-10-11-23-24(35-22)16-34-15-21(31)14-30(23)26(33)29-20-9-5-8-19(27)12-20/h2-9,12,17,21-24,31H,10-11,13-16H2,1H3,(H,28,32)(H,29,33)/t17-,21+,22+,23-,24+/m0/s1",
        "inchikey": "QYSMODXJNCJWNA-JYZZCPHSSA-N",
        "iupac": {
          "systematic": "(3R,6aS,8R,10aS)-N-(3-chlorophenyl)-3-hydroxy-8-[2-oxo-2-[[(1S)-1-phenylethyl]amino]ethyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide"
        },
        "smiles": {
          "canonical": "CC(C1=CC=CC=C1)NC(=O)CC2CCC3C(O2)COCC(CN3C(=O)NC4=CC(=CC=C4)Cl)O"
        },
        "molecularFormula": "C26H32ClN3O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:39:25Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84cf"
    },
    "name": "BRD-K96688934",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84cf.png",
    "lincs": {
      "id": "LSM-14366",
      "name": "BRD-K96688934",
      "pubchemCid": 54637904,
      "chebiId": 103020,
      "inchiParent": "InChI=1S/C33H39N3O6S/c1-22-18-36(23(2)20-37)33(38)32-31(26-14-8-9-15-27(26)35(32)4)25-13-7-6-12-24(25)21-42-29(22)19-34(3)43(39,40)30-17-11-10-16-28(30)41-5/h6-17,22-23,29,37H,18-21H2,1-5H3/t22-,23-,29-/m0/s1",
      "inchiKeyParent": "VHDWJFVGOVHSLC-BOSRLCDASA-N",
      "smilesParent": "COc1ccccc1S(=O)(=O)N(C)C[C@@H]2OCc3ccccc3c4c(C(=O)N(C[C@@H]2C)[C@@H](C)CO)n(C)c5ccccc45"
    },
    "unichem": {
      "chebi": "103020",
      "chembl": "CHEMBL3559951",
      "lincs": "LSM-14366",
      "pubchem": "54637904"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL3559951",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 605.76,
        "hba": 7,
        "hbd": 1,
        "qedWeighted": 0.33
      }
    },
    "pubchem": [
      {
        "cid": 54637904,
        "inchi": "InChI=1S/C33H39N3O6S/c1-22-18-36(23(2)20-37)33(38)32-31(26-14-8-9-15-27(26)35(32)4)25-13-7-6-12-24(25)21-42-29(22)19-34(3)43(39,40)30-17-11-10-16-28(30)41-5/h6-17,22-23,29,37H,18-21H2,1-5H3/t22-,23-,29-/m0/s1",
        "inchikey": "VHDWJFVGOVHSLC-BOSRLCDASA-N",
        "iupac": {
          "systematic": "N-[[(10R,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-2-methoxy-N-methylbenzenesulfonamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(C3=CC=CC=C3COC1CN(C)S(=O)(=O)C4=CC=CC=C4OC)C5=CC=CC=C5N2C)C(C)CO"
        },
        "molecularFormula": "C33H39N3O6S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:39:36Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c841b"
    },
    "name": "BRD-K29322455",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c841b.png",
    "lincs": {
      "id": "LSM-10204",
      "name": "BRD-K29322455",
      "pubchemCid": 54649914,
      "chebiId": 98825,
      "inchiParent": "InChI=1S/C25H23N3OS/c26-14-22-24(20-12-10-18(11-13-20)17-6-4-5-7-17)23(15-29)28(22)25-27-21(16-30-25)19-8-2-1-3-9-19/h1-3,6,8-13,16,22-24,29H,4-5,7,15H2/t22-,23+,24-/m0/s1",
      "inchiKeyParent": "YWUOOJZCEOJKLU-VXNXHJTFSA-N",
      "smilesParent": "OC[C@@H]1[C@H]([C@H](C#N)N1c2nc(cs2)c3ccccc3)c4ccc(cc4)C5=CCCC5"
    },
    "unichem": {
      "chebi": "98825",
      "lincs": "LSM-10204",
      "pubchem": "54649914"
    },
    "pubchem": [
      {
        "cid": 54649914,
        "inchi": "InChI=1S/C25H23N3OS/c26-14-22-24(20-12-10-18(11-13-20)17-6-4-5-7-17)23(15-29)28(22)25-27-21(16-30-25)19-8-2-1-3-9-19/h1-3,6,8-13,16,22-24,29H,4-5,7,15H2/t22-,23+,24-/m0/s1",
        "inchikey": "YWUOOJZCEOJKLU-VXNXHJTFSA-N",
        "iupac": {
          "systematic": "(2R,3S,4S)-3-[4-(cyclopenten-1-yl)phenyl]-4-(hydroxymethyl)-1-(4-phenyl-1,3-thiazol-2-yl)azetidine-2-carbonitrile"
        },
        "smiles": {
          "canonical": "C1CC=C(C1)C2=CC=C(C=C2)C3C(N(C3C#N)C4=NC(=CS4)C5=CC=CC=C5)CO"
        },
        "molecularFormula": "C25H23N3OS"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:39:38Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8425"
    },
    "name": "CHEMBL2145122",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8425.png",
    "lincs": {
      "id": "LSM-14536",
      "name": "CHEMBL2145122",
      "alternativeNames": [
        "BRD-K99469929"
      ],
      "pubchemCid": 54631408,
      "chebiId": 103191,
      "inchiParent": "InChI=1S/C33H43N5O4/c1-6-16-35-33(40)36-27-14-15-30-28(18-27)32(39)37(4)21-31(41-5)23(2)19-38(24(3)22-42-30)20-25-10-12-26(13-11-25)29-9-7-8-17-34-29/h7-15,17-18,23-24,31H,6,16,19-22H2,1-5H3,(H2,35,36,40)/t23-,24+,31-/m0/s1",
      "inchiKeyParent": "DHPIXDXHWYRYQT-JLELKNTQSA-N",
      "smilesParent": "CCCNC(=O)Nc1ccc2OC[C@@H](C)N(Cc3ccc(cc3)c4ccccn4)C[C@H](C)[C@H](CN(C)C(=O)c2c1)OC"
    },
    "unichem": {
      "chebi": "103191",
      "chembl": "CHEMBL2145122",
      "lincs": "LSM-14536",
      "pubchem": "54631408"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL2145122",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 573.74,
        "hba": 6,
        "hbd": 2,
        "qedWeighted": 0.4
      }
    },
    "pubchem": [
      {
        "cid": 54631408,
        "inchi": "InChI=1S/C33H43N5O4/c1-6-16-35-33(40)36-27-14-15-30-28(18-27)32(39)37(4)21-31(41-5)23(2)19-38(24(3)22-42-30)20-25-10-12-26(13-11-25)29-9-7-8-17-34-29/h7-15,17-18,23-24,31H,6,16,19-22H2,1-5H3,(H2,35,36,40)/t23-,24+,31-/m0/s1",
        "inchikey": "DHPIXDXHWYRYQT-JLELKNTQSA-N",
        "iupac": {
          "systematic": "1-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[(4-pyridin-2-ylphenyl)methyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propylurea"
        },
        "smiles": {
          "canonical": "CCCNC(=O)NC1=CC2=C(C=C1)OCC(N(CC(C(CN(C2=O)C)OC)C)CC3=CC=C(C=C3)C4=CC=CC=N4)C"
        },
        "molecularFormula": "C33H43N5O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:39:50Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8426"
    },
    "name": "BRD-K54419202",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8426.png",
    "lincs": {
      "id": "LSM-7559",
      "name": "BRD-K54419202",
      "pubchemCid": 54618507,
      "chebiId": 96180,
      "inchiParent": "InChI=1S/C32H40N4O7S/c1-21-18-36(22(2)20-37)44(40,41)30-15-10-24(23-8-7-9-25(16-23)31(38)34(3)4)17-28(30)43-29(21)19-35(5)32(39)33-26-11-13-27(42-6)14-12-26/h7-17,21-22,29,37H,18-20H2,1-6H3,(H,33,39)/t21-,22+,29-/m1/s1",
      "inchiKeyParent": "CBOPBGRHGQIOTR-UETOGOEVSA-N",
      "smilesParent": "COc1ccc(NC(=O)N(C)C[C@H]2Oc3cc(ccc3S(=O)(=O)N(C[C@H]2C)[C@@H](C)CO)c4cccc(c4)C(=O)N(C)C)cc1"
    },
    "unichem": {
      "chebi": "96180",
      "lincs": "LSM-7559",
      "pubchem": "54618507"
    },
    "pubchem": [
      {
        "cid": 54618507,
        "inchi": "InChI=1S/C32H40N4O7S/c1-21-18-36(22(2)20-37)44(40,41)30-15-10-24(23-8-7-9-25(16-23)31(38)34(3)4)17-28(30)43-29(21)19-35(5)32(39)33-26-11-13-27(42-6)14-12-26/h7-17,21-22,29,37H,18-20H2,1-6H3,(H,33,39)/t21-,22+,29-/m1/s1",
        "inchikey": "CBOPBGRHGQIOTR-UETOGOEVSA-N",
        "iupac": {
          "systematic": "3-[(4R,5S)-2-[(2S)-1-hydroxypropan-2-yl]-5-[[(4-methoxyphenyl)carbamoyl-methylamino]methyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-8-yl]-N,N-dimethylbenzamide"
        },
        "smiles": {
          "canonical": "CC1CN(S(=O)(=O)C2=C(C=C(C=C2)C3=CC(=CC=C3)C(=O)N(C)C)OC1CN(C)C(=O)NC4=CC=C(C=C4)OC)C(C)CO"
        },
        "molecularFormula": "C32H40N4O7S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:39:52Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c852e"
    },
    "name": "BRD-K58808184",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c852e.png",
    "lincs": {
      "id": "LSM-40484",
      "name": "BRD-K58808184",
      "pubchemCid": 44503987,
      "chebiId": 128932,
      "inchiParent": "InChI=1S/C25H33Cl2N3O5S/c1-16-12-30(17(2)15-31)25(32)11-19-10-20(28-36(4,33)34)6-8-23(19)35-24(16)14-29(3)13-18-5-7-21(26)22(27)9-18/h5-10,16-17,24,28,31H,11-15H2,1-4H3/t16-,17-,24+/m1/s1",
      "inchiKeyParent": "VHEBRLFBVVIGEB-OJLQRUNKSA-N",
      "smilesParent": "C[C@H](CO)N1C[C@@H](C)[C@H](CN(C)Cc2ccc(Cl)c(Cl)c2)Oc3ccc(NS(=O)(=O)C)cc3CC1=O"
    },
    "unichem": {
      "chebi": "128932",
      "lincs": "LSM-40484",
      "pubchem": "44503987"
    },
    "pubchem": [
      {
        "cid": 44503987,
        "inchi": "InChI=1S/C25H33Cl2N3O5S/c1-16-12-30(17(2)15-31)25(32)11-19-10-20(28-36(4,33)34)6-8-23(19)35-24(16)14-29(3)13-18-5-7-21(26)22(27)9-18/h5-10,16-17,24,28,31H,11-15H2,1-4H3/t16-,17-,24+/m1/s1",
        "inchikey": "VHEBRLFBVVIGEB-OJLQRUNKSA-N",
        "iupac": {
          "systematic": "N-[(2R,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]methanesulfonamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)CC2=C(C=CC(=C2)NS(=O)(=O)C)OC1CN(C)CC3=CC(=C(C=C3)Cl)Cl)C(C)CO"
        },
        "molecularFormula": "C25H33Cl2N3O5S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:39:54Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c863e"
    },
    "name": "BRD-K62200616",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c863e.png",
    "lincs": {
      "id": "LSM-36573",
      "name": "BRD-K62200616",
      "pubchemCid": 60184983,
      "chebiId": 125111,
      "inchiParent": "InChI=1S/C22H20FN5O/c23-17-2-1-3-18(8-17)26-22(29)28-11-19-21(20(12-28)27-19)15-6-4-14(5-7-15)16-9-24-13-25-10-16/h1-10,13,19-21,27H,11-12H2,(H,26,29)/t19-,20+,21?",
      "inchiKeyParent": "LDBAZNWOVYQXEL-WCRBZPEASA-N",
      "smilesParent": "Fc1cccc(NC(=O)N2C[C@@H]3N[C@H](C2)[C@@H]3c4ccc(cc4)c5cncnc5)c1"
    },
    "unichem": {
      "chebi": "125111",
      "lincs": "LSM-36573",
      "pubchem": "60184983"
    },
    "pubchem": [
      {
        "cid": 60184983,
        "inchi": "InChI=1S/C22H20FN5O/c23-17-2-1-3-18(8-17)26-22(29)28-11-19-21(20(12-28)27-19)15-6-4-14(5-7-15)16-9-24-13-25-10-16/h1-10,13,19-21,27H,11-12H2,(H,26,29)/t19-,20+,21?",
        "inchikey": "LDBAZNWOVYQXEL-WCRBZPEASA-N",
        "iupac": {
          "systematic": "(1R,5S)-N-(3-fluorophenyl)-7-(4-pyrimidin-5-ylphenyl)-3,6-diazabicyclo[3.1.1]heptane-3-carboxamide"
        },
        "smiles": {
          "canonical": "C1C2C(C(N2)CN1C(=O)NC3=CC(=CC=C3)F)C4=CC=C(C=C4)C5=CN=CN=C5"
        },
        "molecularFormula": "C22H20FN5O"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:39:56Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8640"
    },
    "name": "BRD-K71169857",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8640.png",
    "lincs": {
      "id": "LSM-41147",
      "name": "BRD-K71169857",
      "pubchemCid": 54651333,
      "chebiId": 129596,
      "inchiParent": "InChI=1S/C19H26N2O3/c1-2-17(23)20-11-15-18(13-7-4-3-5-8-13)16(12-22)21(15)19(24)14-9-6-10-14/h3-5,7-8,14-16,18,22H,2,6,9-12H2,1H3,(H,20,23)/t15-,16-,18-/m1/s1",
      "inchiKeyParent": "USKATFAIQYPQIB-JFIYKMOQSA-N",
      "smilesParent": "CCC(=O)NC[C@@H]1[C@H]([C@@H](CO)N1C(=O)C2CCC2)c3ccccc3"
    },
    "unichem": {
      "chebi": "129596",
      "lincs": "LSM-41147",
      "pubchem": "54651333"
    },
    "pubchem": [
      {
        "cid": 54651333,
        "inchi": "InChI=1S/C19H26N2O3/c1-2-17(23)20-11-15-18(13-7-4-3-5-8-13)16(12-22)21(15)19(24)14-9-6-10-14/h3-5,7-8,14-16,18,22H,2,6,9-12H2,1H3,(H,20,23)/t15-,16-,18-/m1/s1",
        "inchikey": "USKATFAIQYPQIB-JFIYKMOQSA-N",
        "iupac": {
          "systematic": "N-[[(2S,3R,4S)-1-(cyclobutanecarbonyl)-4-(hydroxymethyl)-3-phenylazetidin-2-yl]methyl]propanamide"
        },
        "smiles": {
          "canonical": "CCC(=O)NCC1C(C(N1C(=O)C2CCC2)CO)C3=CC=CC=C3"
        },
        "molecularFormula": "C19H26N2O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:39:58Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83a0"
    },
    "name": "BRD-K40750649",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83a0.png",
    "lincs": {
      "id": "LSM-8230",
      "name": "BRD-K40750649",
      "pubchemCid": 44488168,
      "chebiId": 96851,
      "inchiParent": "InChI=1S/C26H40N6O4/c1-19-13-32(20(2)17-33)26(34)6-5-9-31-15-22(27-28-31)18-36-25(19)16-29(3)14-21-7-8-23-24(12-21)35-11-10-30(23)4/h7-8,12,15,19-20,25,33H,5-6,9-11,13-14,16-18H2,1-4H3/t19-,20+,25+/m1/s1",
      "inchiKeyParent": "VRVGAAPGNIASDT-RNHFSVANSA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@@H](C)[C@H](CN(C)Cc2ccc3N(C)CCOc3c2)OCc4cn(CCCC1=O)nn4"
    },
    "unichem": {
      "chebi": "96851",
      "lincs": "LSM-8230",
      "pubchem": "44488168"
    },
    "pubchem": [
      {
        "cid": 44488168,
        "inchi": "InChI=1S/C26H40N6O4/c1-19-13-32(20(2)17-33)26(34)6-5-9-31-15-22(27-28-31)18-36-25(19)16-29(3)14-21-7-8-23-24(12-21)35-11-10-30(23)4/h7-8,12,15,19-20,25,33H,5-6,9-11,13-14,16-18H2,1-4H3/t19-,20+,25+/m1/s1",
        "inchikey": "VRVGAAPGNIASDT-RNHFSVANSA-N",
        "iupac": {
          "systematic": "(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(4-methyl-2,3-dihydro-1,4-benzoxazin-7-yl)methyl]amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)CCCN2C=C(COC1CN(C)CC3=CC4=C(C=C3)N(CCO4)C)N=N2)C(C)CO"
        },
        "molecularFormula": "C26H40N6O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:40:00Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83b5"
    },
    "name": "BRD-K45092764",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83b5.png",
    "lincs": {
      "id": "LSM-39767",
      "name": "BRD-K45092764",
      "pubchemCid": 44502612,
      "chebiId": 128212,
      "inchiParent": "InChI=1S/C27H35F3N4O4/c1-18-14-34(19(2)17-35)26(37)13-21-12-22(32-25(36)6-9-27(28,29)30)4-5-23(21)38-24(18)16-33(3)15-20-7-10-31-11-8-20/h4-5,7-8,10-12,18-19,24,35H,6,9,13-17H2,1-3H3,(H,32,36)/t18-,19-,24-/m0/s1",
      "inchiKeyParent": "SGONDPMGILSHIM-JXQFQVJHSA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@H](C)[C@H](CN(C)Cc2ccncc2)Oc3ccc(NC(=O)CCC(F)(F)F)cc3CC1=O"
    },
    "unichem": {
      "chebi": "128212",
      "lincs": "LSM-39767",
      "pubchem": "44502612"
    },
    "pubchem": [
      {
        "cid": 44502612,
        "inchi": "InChI=1S/C27H35F3N4O4/c1-18-14-34(19(2)17-35)26(37)13-21-12-22(32-25(36)6-9-27(28,29)30)4-5-23(21)38-24(18)16-33(3)15-20-7-10-31-11-8-20/h4-5,7-8,10-12,18-19,24,35H,6,9,13-17H2,1-3H3,(H,32,36)/t18-,19-,24-/m0/s1",
        "inchikey": "SGONDPMGILSHIM-JXQFQVJHSA-N",
        "iupac": {
          "systematic": "4,4,4-trifluoro-N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]butanamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)CC2=C(C=CC(=C2)NC(=O)CCC(F)(F)F)OC1CN(C)CC3=CC=NC=C3)C(C)CO"
        },
        "molecularFormula": "C27H35F3N4O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:40:03Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83c2"
    },
    "name": "BRD-K61825138",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83c2.png",
    "lincs": {
      "id": "LSM-12177",
      "name": "BRD-K61825138",
      "pubchemCid": 54646018,
      "chebiId": 100803,
      "inchiParent": "InChI=1S/C29H35N3O7/c33-16-26-28-22(14-20(38-26)15-27(34)30-8-11-32-9-2-1-3-10-32)21-13-19(5-7-23(21)39-28)31-29(35)18-4-6-24-25(12-18)37-17-36-24/h4-7,12-13,20,22,26,28,33H,1-3,8-11,14-17H2,(H,30,34)(H,31,35)/t20-,22+,26-,28-/m1/s1",
      "inchiKeyParent": "WXIRIDSMDJYJEU-UKTDVOJESA-N",
      "smilesParent": "OC[C@H]1O[C@@H](CC(=O)NCCN2CCCCC2)C[C@@H]3[C@H]1Oc4ccc(NC(=O)c5ccc6OCOc6c5)cc34"
    },
    "unichem": {
      "chebi": "100803",
      "lincs": "LSM-12177",
      "pubchem": "54646018"
    },
    "pubchem": [
      {
        "cid": 54646018,
        "inchi": "InChI=1S/C29H35N3O7/c33-16-26-28-22(14-20(38-26)15-27(34)30-8-11-32-9-2-1-3-10-32)21-13-19(5-7-23(21)39-28)31-29(35)18-4-6-24-25(12-18)37-17-36-24/h4-7,12-13,20,22,26,28,33H,1-3,8-11,14-17H2,(H,30,34)(H,31,35)/t20-,22+,26-,28-/m1/s1",
        "inchikey": "WXIRIDSMDJYJEU-UKTDVOJESA-N",
        "iupac": {
          "systematic": "N-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(2-piperidin-1-ylethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide"
        },
        "smiles": {
          "canonical": "C1CCN(CC1)CCNC(=O)CC2CC3C(C(O2)CO)OC4=C3C=C(C=C4)NC(=O)C5=CC6=C(C=C5)OCO6"
        },
        "molecularFormula": "C29H35N3O7"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:40:05Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83de"
    },
    "name": "BRD-K58698092",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83de.png",
    "lincs": {
      "id": "LSM-40480",
      "name": "BRD-K58698092",
      "pubchemCid": 44489216,
      "chebiId": 128928,
      "inchiParent": "InChI=1S/C23H31N3O5S/c1-16-14-26(17(2)15-27)23(28)12-18-11-19(9-10-21(18)31-22(16)13-24-3)25-32(29,30)20-7-5-4-6-8-20/h4-11,16-17,22,24-25,27H,12-15H2,1-3H3/t16-,17+,22-/m1/s1",
      "inchiKeyParent": "QTKSJTZHLLMPJE-HYFFOGBASA-N",
      "smilesParent": "CNC[C@H]1Oc2ccc(NS(=O)(=O)c3ccccc3)cc2CC(=O)N(C[C@H]1C)[C@@H](C)CO"
    },
    "unichem": {
      "chebi": "128928",
      "lincs": "LSM-40480",
      "pubchem": "44489216"
    },
    "pubchem": [
      {
        "cid": 44489216,
        "inchi": "InChI=1S/C23H31N3O5S/c1-16-14-26(17(2)15-27)23(28)12-18-11-19(9-10-21(18)31-22(16)13-24-3)25-32(29,30)20-7-5-4-6-8-20/h4-11,16-17,22,24-25,27H,12-15H2,1-3H3/t16-,17+,22-/m1/s1",
        "inchikey": "QTKSJTZHLLMPJE-HYFFOGBASA-N",
        "iupac": {
          "systematic": "N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]benzenesulfonamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)CC2=C(C=CC(=C2)NS(=O)(=O)C3=CC=CC=C3)OC1CNC)C(C)CO"
        },
        "molecularFormula": "C23H31N3O5S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:40:07Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83f9"
    },
    "name": "BRD-K24638771",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83f9.png",
    "lincs": {
      "id": "LSM-7164",
      "name": "BRD-K24638771",
      "pubchemCid": 54618384,
      "chebiId": 95785,
      "inchiParent": "InChI=1S/C29H40N4O6S/c1-19-16-33(20(2)18-34)40(36,37)27-14-13-24(12-8-11-23-9-6-7-10-23)15-25(27)38-26(19)17-32(5)29(35)30-28-21(3)31-39-22(28)4/h13-15,19-20,23,26,34H,6-7,9-11,16-18H2,1-5H3,(H,30,35)/t19-,20+,26+/m1/s1",
      "inchiKeyParent": "DYHTZISNAWRTSH-GOHWNWGWSA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@@H](C)[C@H](CN(C)C(=O)Nc2c(C)onc2C)Oc3cc(ccc3S1(=O)=O)C#CCC4CCCC4"
    },
    "unichem": {
      "chebi": "95785",
      "lincs": "LSM-7164",
      "pubchem": "54618384"
    },
    "pubchem": [
      {
        "cid": 54618384,
        "inchi": "InChI=1S/C29H40N4O6S/c1-19-16-33(20(2)18-34)40(36,37)27-14-13-24(12-8-11-23-9-6-7-10-23)15-25(27)38-26(19)17-32(5)29(35)30-28-21(3)31-39-22(28)4/h13-15,19-20,23,26,34H,6-7,9-11,16-18H2,1-5H3,(H,30,35)/t19-,20+,26+/m1/s1",
        "inchikey": "DYHTZISNAWRTSH-GOHWNWGWSA-N",
        "iupac": {
          "systematic": "1-[[(4R,5R)-8-(3-cyclopentylprop-1-ynyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-3-(3,5-dimethyl-1,2-oxazol-4-yl)-1-methylurea"
        },
        "smiles": {
          "canonical": "CC1CN(S(=O)(=O)C2=C(C=C(C=C2)C#CCC3CCCC3)OC1CN(C)C(=O)NC4=C(ON=C4C)C)C(C)CO"
        },
        "molecularFormula": "C29H40N4O6S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:40:10Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8412"
    },
    "name": "BRD-K68246261",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8412.png",
    "lincs": {
      "id": "LSM-7759",
      "name": "BRD-K68246261",
      "pubchemCid": 44504958,
      "chebiId": 96380,
      "inchiParent": "InChI=1S/C22H32FN5O5S/c1-16-11-28(17(2)14-29)22(30)9-6-10-27-12-18(24-25-27)15-33-20(16)13-26(3)34(31,32)21-8-5-4-7-19(21)23/h4-5,7-8,12,16-17,20,29H,6,9-11,13-15H2,1-3H3/t16-,17+,20-/m1/s1",
      "inchiKeyParent": "JYOVEVCXPRGJRX-FUHIMQAGSA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@@H](C)[C@@H](CN(C)S(=O)(=O)c2ccccc2F)OCc3cn(CCCC1=O)nn3"
    },
    "unichem": {
      "chebi": "96380",
      "lincs": "LSM-7759",
      "pubchem": "44504958"
    },
    "pubchem": [
      {
        "cid": 44504958,
        "inchi": "InChI=1S/C22H32FN5O5S/c1-16-11-28(17(2)14-29)22(30)9-6-10-27-12-18(24-25-27)15-33-20(16)13-26(3)34(31,32)21-8-5-4-7-19(21)23/h4-5,7-8,12,16-17,20,29H,6,9-11,13-15H2,1-3H3/t16-,17+,20-/m1/s1",
        "inchikey": "JYOVEVCXPRGJRX-FUHIMQAGSA-N",
        "iupac": {
          "systematic": "2-fluoro-N-[[(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylbenzenesulfonamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)CCCN2C=C(COC1CN(C)S(=O)(=O)C3=CC=CC=C3F)N=N2)C(C)CO"
        },
        "molecularFormula": "C22H32FN5O5S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:40:12Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8416"
    },
    "name": "BRD-K12882397",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8416.png",
    "lincs": {
      "id": "LSM-9193",
      "name": "BRD-K12882397",
      "pubchemCid": 54631627,
      "chebiId": 97814,
      "inchiParent": "InChI=1S/C26H40F3N3O5S/c1-18-13-32(14-20-8-6-5-7-9-20)19(2)16-37-23-11-10-21(30-38(34,35)17-26(27,28)29)12-22(23)25(33)31(3)15-24(18)36-4/h10-12,18-20,24,30H,5-9,13-17H2,1-4H3/t18-,19+,24+/m1/s1",
      "inchiKeyParent": "IQLGILJFFYEPBE-IMWIBFENSA-N",
      "smilesParent": "CO[C@H]1CN(C)C(=O)c2cc(NS(=O)(=O)CC(F)(F)F)ccc2OC[C@H](C)N(CC3CCCCC3)C[C@H]1C"
    },
    "unichem": {
      "chebi": "97814",
      "lincs": "LSM-9193",
      "pubchem": "54631627"
    },
    "pubchem": [
      {
        "cid": 54631627,
        "inchi": "InChI=1S/C26H40F3N3O5S/c1-18-13-32(14-20-8-6-5-7-9-20)19(2)16-37-23-11-10-21(30-38(34,35)17-26(27,28)29)12-22(23)25(33)31(3)15-24(18)36-4/h10-12,18-20,24,30H,5-9,13-17H2,1-4H3/t18-,19+,24+/m1/s1",
        "inchikey": "IQLGILJFFYEPBE-IMWIBFENSA-N",
        "iupac": {
          "systematic": "N-[(4S,7R,8R)-5-(cyclohexylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2,2,2-trifluoroethanesulfonamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(COC2=C(C=C(C=C2)NS(=O)(=O)CC(F)(F)F)C(=O)N(CC1OC)C)C)CC3CCCCC3"
        },
        "molecularFormula": "C26H40F3N3O5S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:40:14Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8377"
    },
    "name": "BRD-K25097708",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8377.png",
    "lincs": {
      "id": "LSM-9956",
      "name": "BRD-K25097708",
      "pubchemCid": 54631855,
      "chebiId": 98577,
      "inchiParent": "InChI=1S/C25H36N4O4S/c1-6-7-23(30)27-19-8-9-21-20(12-19)25(31)28(4)14-22(32-5)17(2)13-29(18(3)16-33-21)15-24-26-10-11-34-24/h8-12,17-18,22H,6-7,13-16H2,1-5H3,(H,27,30)/t17-,18+,22-/m1/s1",
      "inchiKeyParent": "LLNFNSHBDLACGS-KGVIQGDOSA-N",
      "smilesParent": "CCCC(=O)Nc1ccc2OC[C@H](C)N(Cc3nccs3)C[C@@H](C)[C@@H](CN(C)C(=O)c2c1)OC"
    },
    "unichem": {
      "chebi": "98577",
      "lincs": "LSM-9956",
      "pubchem": "54631855"
    },
    "pubchem": [
      {
        "cid": 54631855,
        "inchi": "InChI=1S/C25H36N4O4S/c1-6-7-23(30)27-19-8-9-21-20(12-19)25(31)28(4)14-22(32-5)17(2)13-29(18(3)16-33-21)15-24-26-10-11-34-24/h8-12,17-18,22H,6-7,13-16H2,1-5H3,(H,27,30)/t17-,18+,22-/m1/s1",
        "inchikey": "LLNFNSHBDLACGS-KGVIQGDOSA-N",
        "iupac": {
          "systematic": "N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(1,3-thiazol-2-ylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide"
        },
        "smiles": {
          "canonical": "CCCC(=O)NC1=CC2=C(C=C1)OCC(N(CC(C(CN(C2=O)C)OC)C)CC3=NC=CS3)C"
        },
        "molecularFormula": "C25H36N4O4S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:40:16Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83f6"
    },
    "name": "MLS003129189",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83f6.png",
    "lincs": {
      "id": "LSM-7086",
      "name": "MLS003129189",
      "alternativeNames": [
        "BRD-K18273607"
      ],
      "pubchemCid": 44496391,
      "chebiId": 95707,
      "inchiParent": "InChI=1S/C23H35N5O6S/c1-17-13-27(18(2)15-29)23(30)10-7-11-28-19(12-24-25-28)16-34-21(17)14-26(3)35(31,32)22-9-6-5-8-20(22)33-4/h5-6,8-9,12,17-18,21,29H,7,10-11,13-16H2,1-4H3/t17-,18-,21+/m1/s1",
      "inchiKeyParent": "QLGFDRXFQQZFKX-OPYAIIAOSA-N",
      "smilesParent": "COc1ccccc1S(=O)(=O)N(C)C[C@@H]2OCc3cnnn3CCCC(=O)N(C[C@H]2C)[C@H](C)CO"
    },
    "unichem": {
      "chebi": "95707",
      "lincs": "LSM-7086",
      "pubchem": "44496391"
    },
    "pubchem": [
      {
        "cid": 44496391,
        "inchi": "InChI=1S/C23H35N5O6S/c1-17-13-27(18(2)15-29)23(30)10-7-11-28-19(12-24-25-28)16-34-21(17)14-26(3)35(31,32)22-9-6-5-8-20(22)33-4/h5-6,8-9,12,17-18,21,29H,7,10-11,13-16H2,1-4H3/t17-,18-,21+/m1/s1",
        "inchikey": "QLGFDRXFQQZFKX-OPYAIIAOSA-N",
        "iupac": {
          "systematic": "N-[[(8R,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-2-methoxy-N-methylbenzenesulfonamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)CCCN2C(=CN=N2)COC1CN(C)S(=O)(=O)C3=CC=CC=C3OC)C(C)CO"
        },
        "molecularFormula": "C23H35N5O6S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:40:19Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83a3"
    },
    "name": "CHEMBL2131897",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83a3.png",
    "lincs": {
      "id": "LSM-7928",
      "name": "CHEMBL2131897",
      "alternativeNames": [
        "BRD-K83879237"
      ],
      "pubchemCid": 44505087,
      "chebiId": 96549,
      "inchiParent": "InChI=1S/C30H31F3N4O6/c1-17-13-37(18(2)15-38)28(39)23-10-20(19-5-4-6-21(9-19)30(31,32)33)12-34-27(23)43-26(17)14-36(3)29(40)35-22-7-8-24-25(11-22)42-16-41-24/h4-12,17-18,26,38H,13-16H2,1-3H3,(H,35,40)/t17-,18+,26-/m0/s1",
      "inchiKeyParent": "CDAZLJBZDLYAFI-DFXHWTJYSA-N",
      "smilesParent": "C[C@H](CO)N1C[C@H](C)[C@H](CN(C)C(=O)Nc2ccc3OCOc3c2)Oc4ncc(cc4C1=O)c5cccc(c5)C(F)(F)F"
    },
    "unichem": {
      "chebi": "96549",
      "chembl": "CHEMBL2131897",
      "lincs": "LSM-7928",
      "pubchem": "44505087"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL2131897",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 600.59,
        "hba": 7,
        "hbd": 2,
        "qedWeighted": 0.41
      }
    },
    "pubchem": [
      {
        "cid": 44505087,
        "inchi": "InChI=1S/C30H31F3N4O6/c1-17-13-37(18(2)15-38)28(39)23-10-20(19-5-4-6-21(9-19)30(31,32)33)12-34-27(23)43-26(17)14-36(3)29(40)35-22-7-8-24-25(11-22)42-16-41-24/h4-12,17-18,26,38H,13-16H2,1-3H3,(H,35,40)/t17-,18+,26-/m0/s1",
        "inchikey": "CDAZLJBZDLYAFI-DFXHWTJYSA-N",
        "iupac": {
          "systematic": "3-(1,3-benzodioxol-5-yl)-1-[[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[3-(trifluoromethyl)phenyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methylurea"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(N=CC(=C2)C3=CC(=CC=C3)C(F)(F)F)OC1CN(C)C(=O)NC4=CC5=C(C=C4)OCO5)C(C)CO"
        },
        "molecularFormula": "C30H31F3N4O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:40:30Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84a5"
    },
    "name": "BRD-K53407305",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84a5.png",
    "lincs": {
      "id": "LSM-11686",
      "name": "BRD-K53407305",
      "pubchemCid": 54657769,
      "chebiId": 100311,
      "inchiParent": "InChI=1S/C21H28F2N2O5/c1-2-21(28)25-10-16(26)11-29-12-19-18(25)4-3-17(30-19)8-20(27)24-9-13-5-14(22)7-15(23)6-13/h5-7,16-19,26H,2-4,8-12H2,1H3,(H,24,27)/t16-,17-,18-,19+/m0/s1",
      "inchiKeyParent": "LJZGTTWSAOWWCB-CADBVGFASA-N",
      "smilesParent": "CCC(=O)N1C[C@H](O)COC[C@H]2O[C@H](CC(=O)NCc3cc(F)cc(F)c3)CC[C@H]12"
    },
    "unichem": {
      "chebi": "100311",
      "lincs": "LSM-11686",
      "pubchem": "54657769"
    },
    "pubchem": [
      {
        "cid": 54657769,
        "inchi": "InChI=1S/C21H28F2N2O5/c1-2-21(28)25-10-16(26)11-29-12-19-18(25)4-3-17(30-19)8-20(27)24-9-13-5-14(22)7-15(23)6-13/h5-7,16-19,26H,2-4,8-12H2,1H3,(H,24,27)/t16-,17-,18-,19+/m0/s1",
        "inchikey": "LJZGTTWSAOWWCB-CADBVGFASA-N",
        "iupac": {
          "systematic": "2-[(3S,6aS,8S,10aS)-3-hydroxy-1-propanoyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(3,5-difluorophenyl)methyl]acetamide"
        },
        "smiles": {
          "canonical": "CCC(=O)N1CC(COCC2C1CCC(O2)CC(=O)NCC3=CC(=CC(=C3)F)F)O"
        },
        "molecularFormula": "C21H28F2N2O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:40:32Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84ee"
    },
    "name": "BRD-K37562700",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84ee.png",
    "lincs": {
      "id": "LSM-39340",
      "name": "BRD-K37562700",
      "pubchemCid": 54652551,
      "chebiId": 127784,
      "inchiParent": "InChI=1S/C19H19FN2O4S/c1-12(24)22-17-10-21(27(25,26)14-8-6-13(20)7-9-14)16-5-3-2-4-15(16)19(17)18(22)11-23/h2-9,17-19,23H,10-11H2,1H3/t17-,18-,19+/m0/s1",
      "inchiKeyParent": "KXLUOHYQIRXECE-GBESFXJTSA-N",
      "smilesParent": "CC(=O)N1[C@@H](CO)[C@H]2[C@@H]1CN(c3ccccc23)S(=O)(=O)c4ccc(F)cc4"
    },
    "unichem": {
      "chebi": "127784",
      "lincs": "LSM-39340",
      "pubchem": "54652551"
    },
    "pubchem": [
      {
        "cid": 54652551,
        "inchi": "InChI=1S/C19H19FN2O4S/c1-12(24)22-17-10-21(27(25,26)14-8-6-13(20)7-9-14)16-5-3-2-4-15(16)19(17)18(22)11-23/h2-9,17-19,23H,10-11H2,1H3/t17-,18-,19+/m0/s1",
        "inchikey": "KXLUOHYQIRXECE-GBESFXJTSA-N",
        "iupac": {
          "systematic": "1-[(1R,2aR,8bR)-4-(4-fluorophenyl)sulfonyl-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]ethanone"
        },
        "smiles": {
          "canonical": "CC(=O)N1C2CN(C3=CC=CC=C3C2C1CO)S(=O)(=O)C4=CC=C(C=C4)F"
        },
        "molecularFormula": "C19H19FN2O4S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:40:34Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8490"
    },
    "name": "BRD-K00889002",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8490.png",
    "lincs": {
      "id": "LSM-47323",
      "name": "BRD-K00889002",
      "pubchemCid": 54667819,
      "inchiParent": "InChI=1S/C29H32FN3O3/c1-36-27-10-3-2-9-24(27)31-29(35)32-15-4-5-16-33-25(18-32)28(26(33)19-34)21-13-11-20(12-14-21)22-7-6-8-23(30)17-22/h2-3,6-14,17,25-26,28,34H,4-5,15-16,18-19H2,1H3,(H,31,35)/t25-,26-,28-/m1/s1",
      "inchiKeyParent": "YTDDESHVJSQIPW-STROYTFGSA-N",
      "smilesParent": "COc1ccccc1NC(=O)N2CCCCN3[C@H](CO)[C@@H]([C@H]3C2)c4ccc(cc4)c5cccc(F)c5"
    },
    "unichem": {
      "pubchem": "54667819"
    },
    "pubchem": [
      {
        "cid": 54667819,
        "inchi": "InChI=1S/C29H32FN3O3/c1-36-27-10-3-2-9-24(27)31-29(35)32-15-4-5-16-33-25(18-32)28(26(33)19-34)21-13-11-20(12-14-21)22-7-6-8-23(30)17-22/h2-3,6-14,17,25-26,28,34H,4-5,15-16,18-19H2,1H3,(H,31,35)/t25-,26-,28-/m1/s1",
        "inchikey": "YTDDESHVJSQIPW-STROYTFGSA-N",
        "iupac": {
          "systematic": "(8S,9R,10S)-9-[4-(3-fluorophenyl)phenyl]-10-(hydroxymethyl)-N-(2-methoxyphenyl)-1,6-diazabicyclo[6.2.0]decane-6-carboxamide"
        },
        "smiles": {
          "canonical": "COC1=CC=CC=C1NC(=O)N2CCCCN3C(C2)C(C3CO)C4=CC=C(C=C4)C5=CC(=CC=C5)F"
        },
        "molecularFormula": "C29H32FN3O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:40:37Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84ae"
    },
    "name": "BRD-K66577472",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84ae.png",
    "lincs": {
      "id": "LSM-12482",
      "name": "BRD-K66577472",
      "pubchemCid": 54657718,
      "chebiId": 101113,
      "inchiParent": "InChI=1S/C25H27Cl2FN2O5/c26-19-7-5-15(9-20(19)27)11-29-24(32)10-17-6-8-22-23(35-17)14-34-13-16(31)12-30(22)25(33)18-3-1-2-4-21(18)28/h1-5,7,9,16-17,22-23,31H,6,8,10-14H2,(H,29,32)/t16-,17-,22+,23-/m1/s1",
      "inchiKeyParent": "NLZWENHPOORBAO-ROEJJBDBSA-N",
      "smilesParent": "O[C@H]1COC[C@H]2O[C@@H](CC(=O)NCc3ccc(Cl)c(Cl)c3)CC[C@@H]2N(C1)C(=O)c4ccccc4F"
    },
    "unichem": {
      "chebi": "101113",
      "lincs": "LSM-12482",
      "pubchem": "54657718"
    },
    "pubchem": [
      {
        "cid": 54657718,
        "inchi": "InChI=1S/C25H27Cl2FN2O5/c26-19-7-5-15(9-20(19)27)11-29-24(32)10-17-6-8-22-23(35-17)14-34-13-16(31)12-30(22)25(33)18-3-1-2-4-21(18)28/h1-5,7,9,16-17,22-23,31H,6,8,10-14H2,(H,29,32)/t16-,17-,22+,23-/m1/s1",
        "inchikey": "NLZWENHPOORBAO-ROEJJBDBSA-N",
        "iupac": {
          "systematic": "2-[(3R,6aS,8R,10aS)-1-(2-fluorobenzoyl)-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(3,4-dichlorophenyl)methyl]acetamide"
        },
        "smiles": {
          "canonical": "C1CC2C(COCC(CN2C(=O)C3=CC=CC=C3F)O)OC1CC(=O)NCC4=CC(=C(C=C4)Cl)Cl"
        },
        "molecularFormula": "C25H27Cl2FN2O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:40:39Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84b9"
    },
    "name": "BRD-K28035139",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84b9.png",
    "lincs": {
      "id": "LSM-10128",
      "name": "BRD-K28035139",
      "pubchemCid": 54650159,
      "chebiId": 98749,
      "inchiParent": "InChI=1S/C19H22N2O/c20-12-17-19(18(13-22)21-17)16-10-8-15(9-11-16)7-6-14-4-2-1-3-5-14/h8-11,14,17-19,21-22H,1-5,13H2/t17-,18-,19-/m0/s1",
      "inchiKeyParent": "ANDSQWRABKLSGR-FHWLQOOXSA-N",
      "smilesParent": "OC[C@@H]1N[C@@H](C#N)[C@@H]1c2ccc(cc2)C#CC3CCCCC3"
    },
    "unichem": {
      "chebi": "98749",
      "lincs": "LSM-10128",
      "pubchem": "54650159"
    },
    "pubchem": [
      {
        "cid": 54650159,
        "inchi": "InChI=1S/C19H22N2O/c20-12-17-19(18(13-22)21-17)16-10-8-15(9-11-16)7-6-14-4-2-1-3-5-14/h8-11,14,17-19,21-22H,1-5,13H2/t17-,18-,19-/m0/s1",
        "inchikey": "ANDSQWRABKLSGR-FHWLQOOXSA-N",
        "iupac": {
          "systematic": "(2R,3S,4R)-3-[4-(2-cyclohexylethynyl)phenyl]-4-(hydroxymethyl)azetidine-2-carbonitrile"
        },
        "smiles": {
          "canonical": "C1CCC(CC1)C#CC2=CC=C(C=C2)C3C(NC3C#N)CO"
        },
        "molecularFormula": "C19H22N2O"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:40:41Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8421"
    },
    "name": "BRD-K87217296",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8421.png",
    "lincs": {
      "id": "LSM-7967",
      "name": "BRD-K87217296",
      "pubchemCid": 54618468,
      "chebiId": 96588,
      "inchiParent": "InChI=1S/C32H35N3O5/c1-22-18-35(23(2)21-36)31(37)28-16-26(11-7-10-24-8-5-4-6-9-24)17-33-30(28)40-29(22)20-34(3)19-25-12-14-27(15-13-25)32(38)39/h4-6,8-9,12-17,22-23,29,36H,10,18-21H2,1-3H3,(H,38,39)/t22-,23-,29-/m1/s1",
      "inchiKeyParent": "FGMBKJAJBFHUEJ-VDWGHMIBSA-N",
      "smilesParent": "C[C@H](CO)N1C[C@@H](C)[C@@H](CN(C)Cc2ccc(cc2)C(=O)O)Oc3ncc(cc3C1=O)C#CCc4ccccc4"
    },
    "unichem": {
      "chebi": "96588",
      "lincs": "LSM-7967",
      "pubchem": "54618468"
    },
    "pubchem": [
      {
        "cid": 54618468,
        "inchi": "InChI=1S/C32H35N3O5/c1-22-18-35(23(2)21-36)31(37)28-16-26(11-7-10-24-8-5-4-6-9-24)17-33-30(28)40-29(22)20-34(3)19-25-12-14-27(15-13-25)32(38)39/h4-6,8-9,12-17,22-23,29,36H,10,18-21H2,1-3H3,(H,38,39)/t22-,23-,29-/m1/s1",
        "inchikey": "FGMBKJAJBFHUEJ-VDWGHMIBSA-N",
        "iupac": {
          "systematic": "4-[[[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-(3-phenylprop-1-ynyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl-methylamino]methyl]benzoic acid"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(N=CC(=C2)C#CCC3=CC=CC=C3)OC1CN(C)CC4=CC=C(C=C4)C(=O)O)C(C)CO"
        },
        "molecularFormula": "C32H35N3O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:40:43Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c847c"
    },
    "name": "BRD-K98945308",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c847c.png",
    "lincs": {
      "id": "LSM-14501",
      "name": "BRD-K98945308",
      "pubchemCid": 54657652,
      "chebiId": 103156,
      "inchiParent": "InChI=1S/C22H27FN4O6S/c23-15-2-1-3-19(8-15)34(30,31)27-11-17(28)12-32-13-21-20(27)5-4-18(33-21)9-22(29)25-10-16-6-7-24-14-26-16/h1-3,6-8,14,17-18,20-21,28H,4-5,9-13H2,(H,25,29)/t17-,18-,20-,21+/m0/s1",
      "inchiKeyParent": "FPMJOPUHYZGMQU-JYAXBFRTSA-N",
      "smilesParent": "O[C@@H]1COC[C@H]2O[C@H](CC(=O)NCc3ccncn3)CC[C@@H]2N(C1)S(=O)(=O)c4cccc(F)c4"
    },
    "unichem": {
      "chebi": "103156",
      "lincs": "LSM-14501",
      "pubchem": "54657652"
    },
    "pubchem": [
      {
        "cid": 54657652,
        "inchi": "InChI=1S/C22H27FN4O6S/c23-15-2-1-3-19(8-15)34(30,31)27-11-17(28)12-32-13-21-20(27)5-4-18(33-21)9-22(29)25-10-16-6-7-24-14-26-16/h1-3,6-8,14,17-18,20-21,28H,4-5,9-13H2,(H,25,29)/t17-,18-,20-,21+/m0/s1",
        "inchikey": "FPMJOPUHYZGMQU-JYAXBFRTSA-N",
        "iupac": {
          "systematic": "2-[(3S,6aS,8S,10aS)-1-(3-fluorophenyl)sulfonyl-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(pyrimidin-4-ylmethyl)acetamide"
        },
        "smiles": {
          "canonical": "C1CC2C(COCC(CN2S(=O)(=O)C3=CC=CC(=C3)F)O)OC1CC(=O)NCC4=NC=NC=C4"
        },
        "molecularFormula": "C22H27FN4O6S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:40:46Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84c8"
    },
    "name": "BRD-K10388622",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84c8.png",
    "lincs": {
      "id": "LSM-9057",
      "name": "BRD-K10388622",
      "pubchemCid": 54654029,
      "chebiId": 97678,
      "inchiParent": "InChI=1S/C26H32N4O5/c1-29(2)24(31)14-19-10-11-21-23(35-19)16-34-22-12-9-18(13-20(22)25(32)30(21)3)28-26(33)27-15-17-7-5-4-6-8-17/h4-9,12-13,19,21,23H,10-11,14-16H2,1-3H3,(H2,27,28,33)/t19-,21+,23+/m0/s1",
      "inchiKeyParent": "IOGMTQBPALZMTJ-XKCSPQBFSA-N",
      "smilesParent": "CN(C)C(=O)C[C@@H]1CC[C@@H]2[C@@H](COc3ccc(NC(=O)NCc4ccccc4)cc3C(=O)N2C)O1"
    },
    "unichem": {
      "chebi": "97678",
      "lincs": "LSM-9057",
      "pubchem": "54654029"
    },
    "pubchem": [
      {
        "cid": 54654029,
        "inchi": "InChI=1S/C26H32N4O5/c1-29(2)24(31)14-19-10-11-21-23(35-19)16-34-22-12-9-18(13-20(22)25(32)30(21)3)28-26(33)27-15-17-7-5-4-6-8-17/h4-9,12-13,19,21,23H,10-11,14-16H2,1-3H3,(H2,27,28,33)/t19-,21+,23+/m0/s1",
        "inchikey": "IOGMTQBPALZMTJ-XKCSPQBFSA-N",
        "iupac": {
          "systematic": "2-[(2S,4aR,12aS)-8-(benzylcarbamoylamino)-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N,N-dimethylacetamide"
        },
        "smiles": {
          "canonical": "CN1C2CCC(OC2COC3=C(C1=O)C=C(C=C3)NC(=O)NCC4=CC=CC=C4)CC(=O)N(C)C"
        },
        "molecularFormula": "C26H32N4O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:40:48Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84f0"
    },
    "name": "BRD-K42245756",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84f0.png",
    "lincs": {
      "id": "LSM-39601",
      "name": "BRD-K42245756",
      "pubchemCid": 60191408,
      "chebiId": 128045,
      "inchiParent": "InChI=1S/C22H28N2O4S/c1-29(27,28)23-13-19-22(20(15-25)24(19)21(26)14-23)18-11-9-17(10-12-18)8-4-7-16-5-2-3-6-16/h9-12,16,19-20,22,25H,2-3,5-7,13-15H2,1H3/t19-,20-,22+/m0/s1",
      "inchiKeyParent": "ZSUKBHXIWPHONU-JAXLGGSGSA-N",
      "smilesParent": "CS(=O)(=O)N1C[C@H]2[C@H]([C@H](CO)N2C(=O)C1)c3ccc(cc3)C#CCC4CCCC4"
    },
    "unichem": {
      "chebi": "128045",
      "lincs": "LSM-39601",
      "pubchem": "60191408"
    },
    "pubchem": [
      {
        "cid": 60191408,
        "inchi": "InChI=1S/C22H28N2O4S/c1-29(27,28)23-13-19-22(20(15-25)24(19)21(26)14-23)18-11-9-17(10-12-18)8-4-7-16-5-2-3-6-16/h9-12,16,19-20,22,25H,2-3,5-7,13-15H2,1H3/t19-,20-,22+/m0/s1",
        "inchikey": "ZSUKBHXIWPHONU-JAXLGGSGSA-N",
        "iupac": {
          "systematic": "(6R,7R,8R)-7-[4-(3-cyclopentylprop-1-ynyl)phenyl]-8-(hydroxymethyl)-4-methylsulfonyl-1,4-diazabicyclo[4.2.0]octan-2-one"
        },
        "smiles": {
          "canonical": "CS(=O)(=O)N1CC2C(C(N2C(=O)C1)CO)C3=CC=C(C=C3)C#CCC4CCCC4"
        },
        "molecularFormula": "C22H28N2O4S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:40:50Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c845e"
    },
    "name": "BRD-K67269534",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c845e.png",
    "lincs": {
      "id": "LSM-7746",
      "name": "BRD-K67269534",
      "pubchemCid": 44485769,
      "chebiId": 96367,
      "inchiParent": "InChI=1S/C16H29N5O3/c1-12-8-21(13(2)10-22)16(23)5-4-6-20-9-14(18-19-20)11-24-15(12)7-17-3/h9,12-13,15,17,22H,4-8,10-11H2,1-3H3/t12-,13-,15+/m1/s1",
      "inchiKeyParent": "DOGJCEWMCMFHOH-NFAWXSAZSA-N",
      "smilesParent": "CNC[C@@H]1OCc2cn(CCCC(=O)N(C[C@H]1C)[C@H](C)CO)nn2"
    },
    "unichem": {
      "chebi": "96367",
      "lincs": "LSM-7746",
      "pubchem": "44485769"
    },
    "pubchem": [
      {
        "cid": 44485769,
        "inchi": "InChI=1S/C16H29N5O3/c1-12-8-21(13(2)10-22)16(23)5-4-6-20-9-14(18-19-20)11-24-15(12)7-17-3/h9,12-13,15,17,22H,4-8,10-11H2,1-3H3/t12-,13-,15+/m1/s1",
        "inchikey": "DOGJCEWMCMFHOH-NFAWXSAZSA-N",
        "iupac": {
          "systematic": "(8R,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-(methylaminomethyl)-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)CCCN2C=C(COC1CNC)N=N2)C(C)CO"
        },
        "molecularFormula": "C16H29N5O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:40:52Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8473"
    },
    "name": "BRD-K88903268",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8473.png",
    "lincs": {
      "id": "LSM-13894",
      "name": "BRD-K88903268",
      "pubchemCid": 54660834,
      "chebiId": 102547,
      "inchiParent": "InChI=1S/C27H28FN5O3/c28-18-5-3-17(4-6-18)20-7-8-23-24-21(13-32(23)27(20)36)22(14-34)25(33(24)12-16-1-2-16)26(35)30-11-19-9-10-29-15-31-19/h3-10,15-16,21-22,24-25,34H,1-2,11-14H2,(H,30,35)/t21-,22-,24+,25-/m0/s1",
      "inchiKeyParent": "URDKMROJZUNSLX-HFOXQMJASA-N",
      "smilesParent": "OC[C@H]1[C@@H]2CN3C(=CC=C(C3=O)c4ccc(F)cc4)[C@@H]2N(CC5CC5)[C@@H]1C(=O)NCc6ccncn6"
    },
    "unichem": {
      "chebi": "102547",
      "lincs": "LSM-13894",
      "pubchem": "54660834"
    },
    "pubchem": [
      {
        "cid": 54660834,
        "inchi": "InChI=1S/C27H28FN5O3/c28-18-5-3-17(4-6-18)20-7-8-23-24-21(13-32(23)27(20)36)22(14-34)25(33(24)12-16-1-2-16)26(35)30-11-19-9-10-29-15-31-19/h3-10,15-16,21-22,24-25,34H,1-2,11-14H2,(H,30,35)/t21-,22-,24+,25-/m0/s1",
        "inchikey": "URDKMROJZUNSLX-HFOXQMJASA-N",
        "iupac": {
          "systematic": "(2S,3S,3aR,9bR)-1-(cyclopropylmethyl)-7-(4-fluorophenyl)-3-(hydroxymethyl)-6-oxo-N-(pyrimidin-4-ylmethyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide"
        },
        "smiles": {
          "canonical": "C1CC1CN2C3C(CN4C3=CC=C(C4=O)C5=CC=C(C=C5)F)C(C2C(=O)NCC6=NC=NC=C6)CO"
        },
        "molecularFormula": "C27H28FN5O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:40:55Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84b5"
    },
    "name": "BRD-K94177318",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84b5.png",
    "lincs": {
      "id": "LSM-14199",
      "name": "BRD-K94177318",
      "pubchemCid": 54638800,
      "chebiId": 102853,
      "inchiParent": "InChI=1S/C20H30N2O5S/c1-14-2-7-17(8-3-14)28(25,26)21-11-10-16-6-9-18(19(13-23)27-16)22-20(24)12-15-4-5-15/h2-3,7-8,15-16,18-19,21,23H,4-6,9-13H2,1H3,(H,22,24)/t16-,18-,19+/m0/s1",
      "inchiKeyParent": "VPHPWASIVZFRRJ-YTQUADARSA-N",
      "smilesParent": "Cc1ccc(cc1)S(=O)(=O)NCC[C@@H]2CC[C@H](NC(=O)CC3CC3)[C@@H](CO)O2"
    },
    "unichem": {
      "chebi": "102853",
      "lincs": "LSM-14199",
      "pubchem": "54638800"
    },
    "pubchem": [
      {
        "cid": 54638800,
        "inchi": "InChI=1S/C20H30N2O5S/c1-14-2-7-17(8-3-14)28(25,26)21-11-10-16-6-9-18(19(13-23)27-16)22-20(24)12-15-4-5-15/h2-3,7-8,15-16,18-19,21,23H,4-6,9-13H2,1H3,(H,22,24)/t16-,18-,19+/m0/s1",
        "inchikey": "VPHPWASIVZFRRJ-YTQUADARSA-N",
        "iupac": {
          "systematic": "2-cyclopropyl-N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-[(4-methylphenyl)sulfonylamino]ethyl]oxan-3-yl]acetamide"
        },
        "smiles": {
          "canonical": "CC1=CC=C(C=C1)S(=O)(=O)NCCC2CCC(C(O2)CO)NC(=O)CC3CC3"
        },
        "molecularFormula": "C20H30N2O5S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:40:57Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8466"
    },
    "name": "BRD-K94067270",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8466.png",
    "lincs": {
      "id": "LSM-43501",
      "name": "BRD-K94067270",
      "pubchemCid": 54650172,
      "inchiParent": "InChI=1S/C20H19N3O2/c1-2-4-14-6-8-15(9-7-14)19-17(11-21)23(18(19)13-24)20(25)16-5-3-10-22-12-16/h2-10,12,17-19,24H,13H2,1H3/b4-2+/t17-,18+,19+/m1/s1",
      "inchiKeyParent": "SONVGTXFTWWDQR-HHXYLULKSA-N",
      "smilesParent": "C\\C=C\\c1ccc(cc1)[C@@H]2[C@H](CO)N([C@@H]2C#N)C(=O)c3cccnc3"
    },
    "unichem": {
      "lincs": "LSM-43501",
      "pubchem": "54650172"
    },
    "pubchem": [
      {
        "cid": 54650172,
        "inchi": "InChI=1S/C20H19N3O2/c1-2-4-14-6-8-15(9-7-14)19-17(11-21)23(18(19)13-24)20(25)16-5-3-10-22-12-16/h2-10,12,17-19,24H,13H2,1H3/b4-2+/t17-,18+,19+/m1/s1",
        "inchikey": "SONVGTXFTWWDQR-HHXYLULKSA-N",
        "iupac": {
          "systematic": "(2S,3S,4R)-4-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]-1-(pyridine-3-carbonyl)azetidine-2-carbonitrile"
        },
        "smiles": {
          "canonical": "CC=CC1=CC=C(C=C1)C2C(N(C2C#N)C(=O)C3=CN=CC=C3)CO"
        },
        "molecularFormula": "C20H19N3O2"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:40:59Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84ea"
    },
    "name": "BRD-K43263266",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84ea.png",
    "lincs": {
      "id": "LSM-39648",
      "name": "BRD-K43263266",
      "pubchemCid": 60189726,
      "chebiId": 128092,
      "inchiParent": "InChI=1S/C28H35N3O4/c1-19(33)31-18-28(11-13-30(14-12-28)16-20-7-5-6-8-25(20)35-4)26-22-10-9-21(34-3)15-23(22)29(2)27(26)24(31)17-32/h5-10,15,24,32H,11-14,16-18H2,1-4H3/t24-/m0/s1",
      "inchiKeyParent": "NQEZVMQIEYGDLX-DEOSSOPVSA-N",
      "smilesParent": "COc1ccc2c3c([C@H](CO)N(CC34CCN(Cc5ccccc5OC)CC4)C(=O)C)n(C)c2c1"
    },
    "unichem": {
      "chebi": "128092",
      "lincs": "LSM-39648",
      "pubchem": "60189726"
    },
    "pubchem": [
      {
        "cid": 60189726,
        "inchi": "InChI=1S/C28H35N3O4/c1-19(33)31-18-28(11-13-30(14-12-28)16-20-7-5-6-8-25(20)35-4)26-22-10-9-21(34-3)15-23(22)29(2)27(26)24(31)17-32/h5-10,15,24,32H,11-14,16-18H2,1-4H3/t24-/m0/s1",
        "inchikey": "NQEZVMQIEYGDLX-DEOSSOPVSA-N",
        "iupac": {
          "systematic": "1-[(1R)-1-(hydroxymethyl)-7-methoxy-1'-[(2-methoxyphenyl)methyl]-9-methylspiro[1,3-dihydropyrido[3,4-b]indole-4,4'-piperidine]-2-yl]ethanone"
        },
        "smiles": {
          "canonical": "CC(=O)N1CC2(CCN(CC2)CC3=CC=CC=C3OC)C4=C(C1CO)N(C5=C4C=CC(=C5)OC)C"
        },
        "molecularFormula": "C28H35N3O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:41:01Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84f4"
    },
    "name": "BRD-K00484200",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84f4.png",
    "lincs": {
      "id": "LSM-8461",
      "name": "BRD-K00484200",
      "pubchemCid": 54660821,
      "chebiId": 97082,
      "inchiParent": "InChI=1S/C27H30N4O4/c1-35-23-7-3-2-5-19(23)15-31-25-20(16-30-22(25)6-4-8-24(30)33)21(17-32)26(31)27(34)29-14-11-18-9-12-28-13-10-18/h2-10,12-13,20-21,25-26,32H,11,14-17H2,1H3,(H,29,34)/t20-,21-,25+,26-/m0/s1",
      "inchiKeyParent": "SNUVNVMLNYTLKH-MSNAGZIKSA-N",
      "smilesParent": "COc1ccccc1CN2[C@@H]([C@@H](CO)[C@@H]3CN4C(=O)C=CC=C4[C@H]23)C(=O)NCCc5ccncc5"
    },
    "unichem": {
      "chebi": "97082",
      "lincs": "LSM-8461",
      "pubchem": "54660821"
    },
    "pubchem": [
      {
        "cid": 54660821,
        "inchi": "InChI=1S/C27H30N4O4/c1-35-23-7-3-2-5-19(23)15-31-25-20(16-30-22(25)6-4-8-24(30)33)21(17-32)26(31)27(34)29-14-11-18-9-12-28-13-10-18/h2-10,12-13,20-21,25-26,32H,11,14-17H2,1H3,(H,29,34)/t20-,21-,25+,26-/m0/s1",
        "inchikey": "SNUVNVMLNYTLKH-MSNAGZIKSA-N",
        "iupac": {
          "systematic": "(2S,3S,3aR,9bR)-3-(hydroxymethyl)-1-[(2-methoxyphenyl)methyl]-6-oxo-N-(2-pyridin-4-ylethyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide"
        },
        "smiles": {
          "canonical": "COC1=CC=CC=C1CN2C3C(CN4C3=CC=CC4=O)C(C2C(=O)NCCC5=CC=NC=C5)CO"
        },
        "molecularFormula": "C27H30N4O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:41:04Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8447"
    },
    "name": "BRD-K95549765",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8447.png",
    "lincs": {
      "id": "LSM-14287",
      "name": "BRD-K95549765",
      "pubchemCid": 54631309,
      "chebiId": 102941,
      "inchiParent": "InChI=1S/C22H36N4O4/c1-14(2)23-22(28)24-17-8-9-18-19(10-17)30-13-16(4)25(5)11-15(3)20(29-7)12-26(6)21(18)27/h8-10,14-16,20H,11-13H2,1-7H3,(H2,23,24,28)/t15-,16+,20+/m1/s1",
      "inchiKeyParent": "AADVJQLQUVDEBP-GUXCAODWSA-N",
      "smilesParent": "CO[C@H]1CN(C)C(=O)c2ccc(NC(=O)NC(C)C)cc2OC[C@H](C)N(C)C[C@H]1C"
    },
    "unichem": {
      "chebi": "102941",
      "lincs": "LSM-14287",
      "pubchem": "54631309"
    },
    "pubchem": [
      {
        "cid": 54631309,
        "inchi": "InChI=1S/C22H36N4O4/c1-14(2)23-22(28)24-17-8-9-18-19(10-17)30-13-16(4)25(5)11-15(3)20(29-7)12-26(6)21(18)27/h8-10,14-16,20H,11-13H2,1-7H3,(H2,23,24,28)/t15-,16+,20+/m1/s1",
        "inchikey": "AADVJQLQUVDEBP-GUXCAODWSA-N",
        "iupac": {
          "systematic": "1-[(4S,7R,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-15-yl]-3-propan-2-ylurea"
        },
        "smiles": {
          "canonical": "CC1CN(C(COC2=C(C=CC(=C2)NC(=O)NC(C)C)C(=O)N(CC1OC)C)C)C"
        },
        "molecularFormula": "C22H36N4O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:41:06Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8472"
    },
    "name": "BRD-K66199755",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8472.png",
    "lincs": {
      "id": "LSM-47007",
      "name": "BRD-K66199755",
      "pubchemCid": 44491543,
      "inchiParent": "InChI=1S/C29H38N4O6/c1-18-13-33(19(2)16-34)28(35)11-21-10-22(6-8-24(21)39-27(18)15-32(3)14-20-4-5-20)30-29(36)31-23-7-9-25-26(12-23)38-17-37-25/h6-10,12,18-20,27,34H,4-5,11,13-17H2,1-3H3,(H2,30,31,36)/t18-,19+,27+/m0/s1",
      "inchiKeyParent": "BQSXXCPQQGYVBA-DSNGTPCMSA-N",
      "smilesParent": "C[C@H](CO)N1C[C@H](C)[C@@H](CN(C)CC2CC2)Oc3ccc(NC(=O)Nc4ccc5OCOc5c4)cc3CC1=O"
    },
    "unichem": {
      "pubchem": "44491543"
    },
    "pubchem": [
      {
        "cid": 44491543,
        "inchi": "InChI=1S/C29H38N4O6/c1-18-13-33(19(2)16-34)28(35)11-21-10-22(6-8-24(21)39-27(18)15-32(3)14-20-4-5-20)30-29(36)31-23-7-9-25-26(12-23)38-17-37-25/h6-10,12,18-20,27,34H,4-5,11,13-17H2,1-3H3,(H2,30,31,36)/t18-,19+,27+/m0/s1",
        "inchikey": "BQSXXCPQQGYVBA-DSNGTPCMSA-N",
        "iupac": {
          "systematic": "1-(1,3-benzodioxol-5-yl)-3-[(2S,3S)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]urea"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)CC2=C(C=CC(=C2)NC(=O)NC3=CC4=C(C=C3)OCO4)OC1CN(C)CC5CC5)C(C)CO"
        },
        "molecularFormula": "C29H38N4O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:41:08Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8495"
    },
    "name": "MLS003129589",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8495.png",
    "lincs": {
      "id": "LSM-8378",
      "name": "MLS003129589",
      "alternativeNames": [
        "BRD-K82494568"
      ],
      "pubchemCid": 44489806,
      "chebiId": 96999,
      "inchiParent": "InChI=1S/C24H35N5O5/c1-17-7-9-21(10-8-17)34-24(32)27(4)14-22-18(2)13-28(19(3)15-30)23(31)6-5-11-29-20(16-33-22)12-25-26-29/h7-10,12,18-19,22,30H,5-6,11,13-16H2,1-4H3/t18-,19+,22+/m0/s1",
      "inchiKeyParent": "YRBTUIBMTXMQGX-NNMXDRDESA-N",
      "smilesParent": "C[C@H](CO)N1C[C@H](C)[C@@H](CN(C)C(=O)Oc2ccc(C)cc2)OCc3cnnn3CCCC1=O"
    },
    "unichem": {
      "chebi": "96999",
      "chembl": "CHEMBL1885391",
      "lincs": "LSM-8378",
      "pubchem": "44489806"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL1885391",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 473.57,
        "hba": 8,
        "hbd": 1,
        "qedWeighted": 0.71
      }
    },
    "pubchem": [
      {
        "cid": 44489806,
        "inchi": "InChI=1S/C24H35N5O5/c1-17-7-9-21(10-8-17)34-24(32)27(4)14-22-18(2)13-28(19(3)15-30)23(31)6-5-11-29-20(16-33-22)12-25-26-29/h7-10,12,18-19,22,30H,5-6,11,13-16H2,1-4H3/t18-,19+,22+/m0/s1",
        "inchikey": "YRBTUIBMTXMQGX-NNMXDRDESA-N",
        "iupac": {
          "systematic": "(4-methylphenyl) N-[[(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methylcarbamate"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)CCCN2C(=CN=N2)COC1CN(C)C(=O)OC3=CC=C(C=C3)C)C(C)CO"
        },
        "molecularFormula": "C24H35N5O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:41:19Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84a2"
    },
    "name": "BRD-K19362120",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84a2.png",
    "lincs": {
      "id": "LSM-9595",
      "name": "BRD-K19362120",
      "pubchemCid": 54650185,
      "chebiId": 98216,
      "inchiParent": "InChI=1S/C21H27N3O2/c1-2-12-23-21(26)24-18(13-22)20(19(24)14-25)17-10-8-16(9-11-17)15-6-4-3-5-7-15/h6,8-11,18-20,25H,2-5,7,12,14H2,1H3,(H,23,26)/t18-,19+,20-/m1/s1",
      "inchiKeyParent": "BSUDBHASFVKNIG-HSALFYBXSA-N",
      "smilesParent": "CCCNC(=O)N1[C@@H](CO)[C@@H]([C@H]1C#N)c2ccc(cc2)C3=CCCCC3"
    },
    "unichem": {
      "chebi": "98216",
      "lincs": "LSM-9595",
      "pubchem": "54650185"
    },
    "pubchem": [
      {
        "cid": 54650185,
        "inchi": "InChI=1S/C21H27N3O2/c1-2-12-23-21(26)24-18(13-22)20(19(24)14-25)17-10-8-16(9-11-17)15-6-4-3-5-7-15/h6,8-11,18-20,25H,2-5,7,12,14H2,1H3,(H,23,26)/t18-,19+,20-/m1/s1",
        "inchikey": "BSUDBHASFVKNIG-HSALFYBXSA-N",
        "iupac": {
          "systematic": "(2S,3R,4R)-2-cyano-3-[4-(cyclohexen-1-yl)phenyl]-4-(hydroxymethyl)-N-propylazetidine-1-carboxamide"
        },
        "smiles": {
          "canonical": "CCCNC(=O)N1C(C(C1C#N)C2=CC=C(C=C2)C3=CCCCC3)CO"
        },
        "molecularFormula": "C21H27N3O2"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:41:21Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8463"
    },
    "name": "BRD-K90281509",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8463.png",
    "lincs": {
      "id": "LSM-42198",
      "name": "BRD-K90281509",
      "pubchemCid": 44501519,
      "chebiId": 130649,
      "inchiParent": "InChI=1S/C35H44N4O6/c1-24-21-39(25(2)23-40)35(43)30-20-29(37-33(41)27-11-6-5-7-12-27)13-14-31(30)45-26(3)10-8-9-19-44-32(24)22-38(4)34(42)28-15-17-36-18-16-28/h5-7,11-18,20,24-26,32,40H,8-10,19,21-23H2,1-4H3,(H,37,41)/t24-,25+,26+,32+/m0/s1",
      "inchiKeyParent": "LFSFSXVVLAKPPY-MQBJWECPSA-N",
      "smilesParent": "C[C@H](CO)N1C[C@H](C)[C@@H](CN(C)C(=O)c2ccncc2)OCCCC[C@@H](C)Oc3ccc(NC(=O)c4ccccc4)cc3C1=O"
    },
    "unichem": {
      "chebi": "130649",
      "lincs": "LSM-42198",
      "pubchem": "44501519"
    },
    "pubchem": [
      {
        "cid": 44501519,
        "inchi": "InChI=1S/C35H44N4O6/c1-24-21-39(25(2)23-40)35(43)30-20-29(37-33(41)27-11-6-5-7-12-27)13-14-31(30)45-26(3)10-8-9-19-44-32(24)22-38(4)34(42)28-15-17-36-18-16-28/h5-7,11-18,20,24-26,32,40H,8-10,19,21-23H2,1-4H3,(H,37,41)/t24-,25+,26+,32+/m0/s1",
        "inchikey": "LFSFSXVVLAKPPY-MQBJWECPSA-N",
        "iupac": {
          "systematic": "N-[[(3R,9S,10S)-16-benzamido-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methylpyridine-4-carboxamide"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NC(=O)C3=CC=CC=C3)C(C)CO)C)CN(C)C(=O)C4=CC=NC=C4"
        },
        "molecularFormula": "C35H44N4O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:41:24Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8499"
    },
    "name": "BRD-K96977520",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8499.png",
    "lincs": {
      "id": "LSM-30841",
      "name": "BRD-K96977520",
      "pubchemCid": 54638184,
      "chebiId": 119392,
      "inchiParent": "InChI=1S/C30H34N2O5/c1-21-17-32(22(2)19-33)29(34)27-16-10-9-15-26(27)25-14-8-7-11-23(25)20-36-28(21)18-31(3)30(35)37-24-12-5-4-6-13-24/h4-16,21-22,28,33H,17-20H2,1-3H3/t21-,22+,28-/m0/s1",
      "inchiKeyParent": "FCGPHHIJUXAVKG-TYPXCFOJSA-N",
      "smilesParent": "C[C@H](CO)N1C[C@H](C)[C@H](CN(C)C(=O)Oc2ccccc2)OCc3ccccc3c4ccccc4C1=O"
    },
    "unichem": {
      "chebi": "119392",
      "lincs": "LSM-30841",
      "pubchem": "54638184"
    },
    "pubchem": [
      {
        "cid": 54638184,
        "inchi": "InChI=1S/C30H34N2O5/c1-21-17-32(22(2)19-33)29(34)27-16-10-9-15-26(27)25-14-8-7-11-23(25)20-36-28(21)18-31(3)30(35)37-24-12-5-4-6-13-24/h4-16,21-22,28,33H,17-20H2,1-3H3/t21-,22+,28-/m0/s1",
        "inchikey": "FCGPHHIJUXAVKG-TYPXCFOJSA-N",
        "iupac": {
          "systematic": "phenyl N-[[(10R,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=CC=CC=C2C3=CC=CC=C3COC1CN(C)C(=O)OC4=CC=CC=C4)C(C)CO"
        },
        "molecularFormula": "C30H34N2O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:41:26Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84ac"
    },
    "name": "BRD-K68340318",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84ac.png",
    "lincs": {
      "id": "LSM-12597",
      "name": "BRD-K68340318",
      "pubchemCid": 54638276,
      "chebiId": 101229,
      "inchiParent": "InChI=1S/C19H32N4O5S/c1-23-11-19(21-13-23)29(26,27)22-16-8-7-15(28-17(16)12-24)9-18(25)20-10-14-5-3-2-4-6-14/h11,13-17,22,24H,2-10,12H2,1H3,(H,20,25)/t15-,16-,17-/m0/s1",
      "inchiKeyParent": "VHNINRJVEBHVBF-ULQDDVLXSA-N",
      "smilesParent": "Cn1cnc(c1)S(=O)(=O)N[C@H]2CC[C@@H](CC(=O)NCC3CCCCC3)O[C@H]2CO"
    },
    "unichem": {
      "chebi": "101229",
      "lincs": "LSM-12597",
      "pubchem": "54638276"
    },
    "pubchem": [
      {
        "cid": 54638276,
        "inchi": "InChI=1S/C19H32N4O5S/c1-23-11-19(21-13-23)29(26,27)22-16-8-7-15(28-17(16)12-24)9-18(25)20-10-14-5-3-2-4-6-14/h11,13-17,22,24H,2-10,12H2,1H3,(H,20,25)/t15-,16-,17-/m0/s1",
        "inchikey": "VHNINRJVEBHVBF-ULQDDVLXSA-N",
        "iupac": {
          "systematic": "N-(cyclohexylmethyl)-2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[(1-methylimidazol-4-yl)sulfonylamino]oxan-2-yl]acetamide"
        },
        "smiles": {
          "canonical": "CN1C=C(N=C1)S(=O)(=O)NC2CCC(OC2CO)CC(=O)NCC3CCCCC3"
        },
        "molecularFormula": "C19H32N4O5S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:41:28Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84d1"
    },
    "name": "BRD-K30436233",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84d1.png",
    "lincs": {
      "id": "LSM-10262",
      "name": "BRD-K30436233",
      "pubchemCid": 54645937,
      "chebiId": 98883,
      "inchiParent": "InChI=1S/C28H29FN2O6S/c1-17(18-5-3-2-4-6-18)30-27(33)15-21-14-24-23-13-20(9-12-25(23)37-28(24)26(16-32)36-21)31-38(34,35)22-10-7-19(29)8-11-22/h2-13,17,21,24,26,28,31-32H,14-16H2,1H3,(H,30,33)/t17-,21-,24-,26-,28+/m0/s1",
      "inchiKeyParent": "SUQCIPRCFCPKOO-NEYRPFOQSA-N",
      "smilesParent": "C[C@H](NC(=O)C[C@@H]1C[C@@H]2[C@@H](Oc3ccc(NS(=O)(=O)c4ccc(F)cc4)cc23)[C@H](CO)O1)c5ccccc5"
    },
    "unichem": {
      "chebi": "98883",
      "lincs": "LSM-10262",
      "pubchem": "54645937"
    },
    "pubchem": [
      {
        "cid": 54645937,
        "inchi": "InChI=1S/C28H29FN2O6S/c1-17(18-5-3-2-4-6-18)30-27(33)15-21-14-24-23-13-20(9-12-25(23)37-28(24)26(16-32)36-21)31-38(34,35)22-10-7-19(29)8-11-22/h2-13,17,21,24,26,28,31-32H,14-16H2,1H3,(H,30,33)/t17-,21-,24-,26-,28+/m0/s1",
        "inchikey": "SUQCIPRCFCPKOO-NEYRPFOQSA-N",
        "iupac": {
          "systematic": "2-[(1S,3S,4aS,9aR)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-[(1S)-1-phenylethyl]acetamide"
        },
        "smiles": {
          "canonical": "CC(C1=CC=CC=C1)NC(=O)CC2CC3C(C(O2)CO)OC4=C3C=C(C=C4)NS(=O)(=O)C5=CC=C(C=C5)F"
        },
        "molecularFormula": "C28H29FN2O6S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:41:31Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84b0"
    },
    "name": "BRD-K61855818",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84b0.png",
    "lincs": {
      "id": "LSM-14883",
      "name": "BRD-K61855818",
      "pubchemCid": 44491506,
      "chebiId": 103539,
      "inchiParent": "InChI=1S/C34H50N4O6/c1-23(2)35-34(42)36-28-15-16-30-29(19-28)33(41)38(25(4)22-39)20-24(3)31(43-17-11-10-12-26(5)44-30)21-37(6)32(40)18-27-13-8-7-9-14-27/h7-9,13-16,19,23-26,31,39H,10-12,17-18,20-22H2,1-6H3,(H2,35,36,42)/t24-,25+,26-,31+/m0/s1",
      "inchiKeyParent": "IEZOTXDZAGKSTL-GURVGDRESA-N",
      "smilesParent": "CC(C)NC(=O)Nc1ccc2O[C@@H](C)CCCCO[C@H](CN(C)C(=O)Cc3ccccc3)[C@@H](C)CN([C@H](C)CO)C(=O)c2c1"
    },
    "unichem": {
      "chebi": "103539",
      "lincs": "LSM-14883",
      "pubchem": "44491506"
    },
    "pubchem": [
      {
        "cid": 44491506,
        "inchi": "InChI=1S/C34H50N4O6/c1-23(2)35-34(42)36-28-15-16-30-29(19-28)33(41)38(25(4)22-39)20-24(3)31(43-17-11-10-12-26(5)44-30)21-37(6)32(40)18-27-13-8-7-9-14-27/h7-9,13-16,19,23-26,31,39H,10-12,17-18,20-22H2,1-6H3,(H2,35,36,42)/t24-,25+,26-,31+/m0/s1",
        "inchikey": "IEZOTXDZAGKSTL-GURVGDRESA-N",
        "iupac": {
          "systematic": "N-[[(3S,9S,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-(propan-2-ylcarbamoylamino)-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methyl-2-phenylacetamide"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NC(=O)NC(C)C)C(C)CO)C)CN(C)C(=O)CC3=CC=CC=C3"
        },
        "molecularFormula": "C34H50N4O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:41:33Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84ed"
    },
    "name": "BRD-K47812430",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84ed.png",
    "lincs": {
      "id": "LSM-11339",
      "name": "BRD-K47812430",
      "pubchemCid": 54654440,
      "chebiId": 99960,
      "inchiParent": "InChI=1S/C33H38N4O5S/c1-36-28-11-10-25(17-31(38)35-24-13-14-37(20-24)19-22-6-3-2-4-7-22)42-30(28)21-41-29-12-9-23(16-27(29)33(36)40)34-32(39)18-26-8-5-15-43-26/h2-9,12,15-16,24-25,28,30H,10-11,13-14,17-21H2,1H3,(H,34,39)(H,35,38)/t24-,25+,28+,30+/m1/s1",
      "inchiKeyParent": "YIAMBQQGWRAZTQ-WVWXGCDFSA-N",
      "smilesParent": "CN1[C@H]2CC[C@@H](CC(=O)N[C@@H]3CCN(Cc4ccccc4)C3)O[C@H]2COc5ccc(NC(=O)Cc6cccs6)cc5C1=O"
    },
    "unichem": {
      "chebi": "99960",
      "lincs": "LSM-11339",
      "pubchem": "54654440"
    },
    "pubchem": [
      {
        "cid": 54654440,
        "inchi": "InChI=1S/C33H38N4O5S/c1-36-28-11-10-25(17-31(38)35-24-13-14-37(20-24)19-22-6-3-2-4-7-22)42-30(28)21-41-29-12-9-23(16-27(29)33(36)40)34-32(39)18-26-8-5-15-43-26/h2-9,12,15-16,24-25,28,30H,10-11,13-14,17-21H2,1H3,(H,34,39)(H,35,38)/t24-,25+,28+,30+/m1/s1",
        "inchikey": "YIAMBQQGWRAZTQ-WVWXGCDFSA-N",
        "iupac": {
          "systematic": "2-[(2S,4aS,12aR)-5-methyl-6-oxo-8-[(2-thiophen-2-ylacetyl)amino]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-[(3R)-1-benzylpyrrolidin-3-yl]acetamide"
        },
        "smiles": {
          "canonical": "CN1C2CCC(OC2COC3=C(C1=O)C=C(C=C3)NC(=O)CC4=CC=CS4)CC(=O)NC5CCN(C5)CC6=CC=CC=C6"
        },
        "molecularFormula": "C33H38N4O5S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:41:35Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c843e"
    },
    "name": "CHEMBL2355441",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c843e.png",
    "lincs": {
      "id": "LSM-40243",
      "name": "CHEMBL2355441",
      "alternativeNames": [
        "BRD-K54263226"
      ],
      "pubchemCid": 54615110,
      "chebiId": 128689,
      "inchiParent": "InChI=1S/C35H47F3N4O7S/c1-22-18-42(23(2)21-43)34(44)30-17-29(40-50(45,46)33-25(4)39-49-26(33)5)14-15-31(30)48-24(3)9-7-8-16-47-32(22)20-41(6)19-27-10-12-28(13-11-27)35(36,37)38/h10-15,17,22-24,32,40,43H,7-9,16,18-21H2,1-6H3/t22-,23+,24-,32+/m1/s1",
      "inchiKeyParent": "CBAAPWVHONFTKW-KSUBRIHNSA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@@H](C)[C@H](CN(C)Cc2ccc(cc2)C(F)(F)F)OCCCC[C@@H](C)Oc3ccc(NS(=O)(=O)c4c(C)onc4C)cc3C1=O"
    },
    "unichem": {
      "chebi": "128689",
      "chembl": "CHEMBL2355441",
      "lincs": "LSM-40243",
      "pubchem": "54615110"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL2355441",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 724.84,
        "hba": 9,
        "hbd": 2,
        "qedWeighted": 0.27
      }
    },
    "pubchem": [
      {
        "cid": 54615110,
        "inchi": "InChI=1S/C35H47F3N4O7S/c1-22-18-42(23(2)21-43)34(44)30-17-29(40-50(45,46)33-25(4)39-49-26(33)5)14-15-31(30)48-24(3)9-7-8-16-47-32(22)20-41(6)19-27-10-12-28(13-11-27)35(36,37)38/h10-15,17,22-24,32,40,43H,7-9,16,18-21H2,1-6H3/t22-,23+,24-,32+/m1/s1",
        "inchikey": "CBAAPWVHONFTKW-KSUBRIHNSA-N",
        "iupac": {
          "systematic": "N-[(3R,9R,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3,5-dimethyl-1,2-oxazole-4-sulfonamide"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NS(=O)(=O)C3=C(ON=C3C)C)C(C)CO)C)CN(C)CC4=CC=C(C=C4)C(F)(F)F"
        },
        "molecularFormula": "C35H47F3N4O7S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:41:46Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8460"
    },
    "name": "BRD-K32233845",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8460.png",
    "lincs": {
      "id": "LSM-10382",
      "name": "BRD-K32233845",
      "pubchemCid": 54638392,
      "chebiId": 99003,
      "inchiParent": "InChI=1S/C21H32N2O7S/c1-28-18-4-2-3-5-20(18)31(26,27)23-17-7-6-16(30-19(17)14-24)8-11-22-21(25)15-9-12-29-13-10-15/h2-5,15-17,19,23-24H,6-14H2,1H3,(H,22,25)/t16-,17-,19+/m0/s1",
      "inchiKeyParent": "BDFFQCHCBQOAPA-JENIJYKNSA-N",
      "smilesParent": "COc1ccccc1S(=O)(=O)N[C@H]2CC[C@@H](CCNC(=O)C3CCOCC3)O[C@@H]2CO"
    },
    "unichem": {
      "chebi": "99003",
      "lincs": "LSM-10382",
      "pubchem": "54638392"
    },
    "pubchem": [
      {
        "cid": 54638392,
        "inchi": "InChI=1S/C21H32N2O7S/c1-28-18-4-2-3-5-20(18)31(26,27)23-17-7-6-16(30-19(17)14-24)8-11-22-21(25)15-9-12-29-13-10-15/h2-5,15-17,19,23-24H,6-14H2,1H3,(H,22,25)/t16-,17-,19+/m0/s1",
        "inchikey": "BDFFQCHCBQOAPA-JENIJYKNSA-N",
        "iupac": {
          "systematic": "N-[2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[(2-methoxyphenyl)sulfonylamino]oxan-2-yl]ethyl]oxane-4-carboxamide"
        },
        "smiles": {
          "canonical": "COC1=CC=CC=C1S(=O)(=O)NC2CCC(OC2CO)CCNC(=O)C3CCOCC3"
        },
        "molecularFormula": "C21H32N2O7S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:41:48Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84c9"
    },
    "name": "BRD-K33054146",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84c9.png",
    "lincs": {
      "id": "LSM-10439",
      "name": "BRD-K33054146",
      "pubchemCid": 54637732,
      "chebiId": 99060,
      "inchiParent": "InChI=1S/C34H38N4O6/c1-21-16-38(22(2)18-39)33(40)32-31(26-11-7-8-12-27(26)37(32)4)25-10-6-5-9-23(25)19-42-30(21)17-36(3)34(41)35-24-13-14-28-29(15-24)44-20-43-28/h5-15,21-22,30,39H,16-20H2,1-4H3,(H,35,41)/t21-,22+,30-/m0/s1",
      "inchiKeyParent": "KFLLAZWDLYDTFJ-ZQLNOWDWSA-N",
      "smilesParent": "C[C@H](CO)N1C[C@H](C)[C@H](CN(C)C(=O)Nc2ccc3OCOc3c2)OCc4ccccc4c5c(C1=O)n(C)c6ccccc56"
    },
    "unichem": {
      "chebi": "99060",
      "lincs": "LSM-10439",
      "pubchem": "54637732"
    },
    "pubchem": [
      {
        "cid": 54637732,
        "inchi": "InChI=1S/C34H38N4O6/c1-21-16-38(22(2)18-39)33(40)32-31(26-11-7-8-12-27(26)37(32)4)25-10-6-5-9-23(25)19-42-30(21)17-36(3)34(41)35-24-13-14-28-29(15-24)44-20-43-28/h5-15,21-22,30,39H,16-20H2,1-4H3,(H,35,41)/t21-,22+,30-/m0/s1",
        "inchikey": "KFLLAZWDLYDTFJ-ZQLNOWDWSA-N",
        "iupac": {
          "systematic": "3-(1,3-benzodioxol-5-yl)-1-[[(10R,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-1-methylurea"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(C3=CC=CC=C3COC1CN(C)C(=O)NC4=CC5=C(C=C4)OCO5)C6=CC=CC=C6N2C)C(C)CO"
        },
        "molecularFormula": "C34H38N4O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:41:51Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c843b"
    },
    "name": "CHEMBL2359413",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c843b.png",
    "lincs": {
      "id": "LSM-38527",
      "name": "CHEMBL2359413",
      "alternativeNames": [
        "BRD-K23117210"
      ],
      "pubchemCid": 44501994,
      "chebiId": 126964,
      "inchiParent": "InChI=1S/C35H47F3N4O7S/c1-22-18-42(23(2)21-43)34(44)30-17-29(40-50(45,46)33-25(4)39-49-26(33)5)14-15-31(30)48-24(3)9-7-8-16-47-32(22)20-41(6)19-27-10-12-28(13-11-27)35(36,37)38/h10-15,17,22-24,32,40,43H,7-9,16,18-21H2,1-6H3/t22-,23+,24+,32-/m0/s1",
      "inchiKeyParent": "CBAAPWVHONFTKW-UDWIDTORSA-N",
      "smilesParent": "C[C@H](CO)N1C[C@H](C)[C@H](CN(C)Cc2ccc(cc2)C(F)(F)F)OCCCC[C@@H](C)Oc3ccc(NS(=O)(=O)c4c(C)onc4C)cc3C1=O"
    },
    "unichem": {
      "chebi": "126964",
      "chembl": "CHEMBL2359413",
      "lincs": "LSM-38527",
      "pubchem": "44501994"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL2359413",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 724.84,
        "hba": 9,
        "hbd": 2,
        "qedWeighted": 0.27
      }
    },
    "pubchem": [
      {
        "cid": 44501994,
        "inchi": "InChI=1S/C35H47F3N4O7S/c1-22-18-42(23(2)21-43)34(44)30-17-29(40-50(45,46)33-25(4)39-49-26(33)5)14-15-31(30)48-24(3)9-7-8-16-47-32(22)20-41(6)19-27-10-12-28(13-11-27)35(36,37)38/h10-15,17,22-24,32,40,43H,7-9,16,18-21H2,1-6H3/t22-,23+,24+,32-/m0/s1",
        "inchikey": "CBAAPWVHONFTKW-UDWIDTORSA-N",
        "iupac": {
          "systematic": "N-[(3R,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3,5-dimethyl-1,2-oxazole-4-sulfonamide"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NS(=O)(=O)C3=C(ON=C3C)C)C(C)CO)C)CN(C)CC4=CC=C(C=C4)C(F)(F)F"
        },
        "molecularFormula": "C35H47F3N4O7S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:42:02Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8456"
    },
    "name": "CHEMBL2360848",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8456.png",
    "lincs": {
      "id": "LSM-14958",
      "name": "CHEMBL2360848",
      "alternativeNames": [
        "BRD-K84653575"
      ],
      "pubchemCid": 44495045,
      "chebiId": 103614,
      "inchiParent": "InChI=1S/C26H44N4O5/c1-17(2)28-26(33)29-21-10-11-23-22(13-21)25(32)30(19(4)16-31)15-18(3)24(14-27-6)34-12-8-7-9-20(5)35-23/h10-11,13,17-20,24,27,31H,7-9,12,14-16H2,1-6H3,(H2,28,29,33)/t18-,19+,20-,24+/m1/s1",
      "inchiKeyParent": "DGSOXKKLHVIDDH-ZSTWQFLISA-N",
      "smilesParent": "CNC[C@@H]1OCCCC[C@@H](C)Oc2ccc(NC(=O)NC(C)C)cc2C(=O)N(C[C@H]1C)[C@@H](C)CO"
    },
    "unichem": {
      "chebi": "103614",
      "chembl": "CHEMBL2360848",
      "lincs": "LSM-14958",
      "pubchem": "44495045"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL2360848",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 492.66,
        "hba": 6,
        "hbd": 4,
        "qedWeighted": 0.49
      }
    },
    "pubchem": [
      {
        "cid": 44495045,
        "inchi": "InChI=1S/C26H44N4O5/c1-17(2)28-26(33)29-21-10-11-23-22(13-21)25(32)30(19(4)16-31)15-18(3)24(14-27-6)34-12-8-7-9-20(5)35-23/h10-11,13,17-20,24,27,31H,7-9,12,14-16H2,1-6H3,(H2,28,29,33)/t18-,19+,20-,24+/m1/s1",
        "inchikey": "DGSOXKKLHVIDDH-ZSTWQFLISA-N",
        "iupac": {
          "systematic": "1-[(3R,9R,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-propan-2-ylurea"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NC(=O)NC(C)C)C(C)CO)C)CNC"
        },
        "molecularFormula": "C26H44N4O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:42:13Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8484"
    },
    "name": "BRD-K47551852",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8484.png",
    "lincs": {
      "id": "LSM-11325",
      "name": "BRD-K47551852",
      "pubchemCid": 54657605,
      "chebiId": 99946,
      "inchiParent": "InChI=1S/C31H34N2O6/c34-25-17-33(16-21-6-13-28-29(14-21)38-20-37-28)27-12-11-26(39-30(27)19-36-18-25)15-31(35)32-24-9-7-23(8-10-24)22-4-2-1-3-5-22/h1-10,13-14,25-27,30,34H,11-12,15-20H2,(H,32,35)/t25-,26-,27-,30+/m1/s1",
      "inchiKeyParent": "OJBHRHOQEWVARJ-LCQQBMRFSA-N",
      "smilesParent": "O[C@H]1COC[C@@H]2O[C@@H](CC(=O)Nc3ccc(cc3)c4ccccc4)CC[C@H]2N(Cc5ccc6OCOc6c5)C1"
    },
    "unichem": {
      "chebi": "99946",
      "lincs": "LSM-11325",
      "pubchem": "54657605"
    },
    "pubchem": [
      {
        "cid": 54657605,
        "inchi": "InChI=1S/C31H34N2O6/c34-25-17-33(16-21-6-13-28-29(14-21)38-20-37-28)27-12-11-26(39-30(27)19-36-18-25)15-31(35)32-24-9-7-23(8-10-24)22-4-2-1-3-5-22/h1-10,13-14,25-27,30,34H,11-12,15-20H2,(H,32,35)/t25-,26-,27-,30+/m1/s1",
        "inchikey": "OJBHRHOQEWVARJ-LCQQBMRFSA-N",
        "iupac": {
          "systematic": "2-[(3R,6aR,8R,10aR)-1-(1,3-benzodioxol-5-ylmethyl)-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(4-phenylphenyl)acetamide"
        },
        "smiles": {
          "canonical": "C1CC2C(COCC(CN2CC3=CC4=C(C=C3)OCO4)O)OC1CC(=O)NC5=CC=C(C=C5)C6=CC=CC=C6"
        },
        "molecularFormula": "C31H34N2O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:42:15Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84bb"
    },
    "name": "BRD-K79564569",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84bb.png",
    "lincs": {
      "id": "LSM-13288",
      "name": "BRD-K79564569",
      "pubchemCid": 54657714,
      "chebiId": 101927,
      "inchiParent": "InChI=1S/C25H27Cl2FN2O5/c26-19-7-5-15(9-20(19)27)11-29-24(32)10-17-6-8-22-23(35-17)14-34-13-16(31)12-30(22)25(33)18-3-1-2-4-21(18)28/h1-5,7,9,16-17,22-23,31H,6,8,10-14H2,(H,29,32)/t16-,17-,22-,23+/m0/s1",
      "inchiKeyParent": "NLZWENHPOORBAO-BSWISCRUSA-N",
      "smilesParent": "O[C@@H]1COC[C@H]2O[C@H](CC(=O)NCc3ccc(Cl)c(Cl)c3)CC[C@@H]2N(C1)C(=O)c4ccccc4F"
    },
    "unichem": {
      "chebi": "101927",
      "lincs": "LSM-13288",
      "pubchem": "54657714"
    },
    "pubchem": [
      {
        "cid": 54657714,
        "inchi": "InChI=1S/C25H27Cl2FN2O5/c26-19-7-5-15(9-20(19)27)11-29-24(32)10-17-6-8-22-23(35-17)14-34-13-16(31)12-30(22)25(33)18-3-1-2-4-21(18)28/h1-5,7,9,16-17,22-23,31H,6,8,10-14H2,(H,29,32)/t16-,17-,22-,23+/m0/s1",
        "inchikey": "NLZWENHPOORBAO-BSWISCRUSA-N",
        "iupac": {
          "systematic": "2-[(3S,6aS,8S,10aS)-1-(2-fluorobenzoyl)-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(3,4-dichlorophenyl)methyl]acetamide"
        },
        "smiles": {
          "canonical": "C1CC2C(COCC(CN2C(=O)C3=CC=CC=C3F)O)OC1CC(=O)NCC4=CC(=C(C=C4)Cl)Cl"
        },
        "molecularFormula": "C25H27Cl2FN2O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:42:18Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84c7"
    },
    "name": "BRD-K00636532",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84c7.png",
    "lincs": {
      "id": "LSM-8475",
      "name": "BRD-K00636532",
      "pubchemCid": 54649240,
      "chebiId": 97096,
      "inchiParent": "InChI=1S/C24H33Cl2N3O3/c1-17(13-29(18(2)16-30)14-19-7-5-6-8-22(19)26)23(32-4)15-28(3)24(31)27-21-11-9-20(25)10-12-21/h5-12,17-18,23,30H,13-16H2,1-4H3,(H,27,31)/t17-,18-,23-/m1/s1",
      "inchiKeyParent": "REZGKQRSIIUNQT-PMAPCBKXSA-N",
      "smilesParent": "CO[C@H](CN(C)C(=O)Nc1ccc(Cl)cc1)[C@H](C)CN(Cc2ccccc2Cl)[C@H](C)CO"
    },
    "unichem": {
      "chebi": "97096",
      "lincs": "LSM-8475",
      "pubchem": "54649240"
    },
    "pubchem": [
      {
        "cid": 54649240,
        "inchi": "InChI=1S/C24H33Cl2N3O3/c1-17(13-29(18(2)16-30)14-19-7-5-6-8-22(19)26)23(32-4)15-28(3)24(31)27-21-11-9-20(25)10-12-21/h5-12,17-18,23,30H,13-16H2,1-4H3,(H,27,31)/t17-,18-,23-/m1/s1",
        "inchikey": "REZGKQRSIIUNQT-PMAPCBKXSA-N",
        "iupac": {
          "systematic": "3-(4-chlorophenyl)-1-[(2S,3R)-4-[(2-chlorophenyl)methyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-1-methylurea"
        },
        "smiles": {
          "canonical": "CC(CN(CC1=CC=CC=C1Cl)C(C)CO)C(CN(C)C(=O)NC2=CC=C(C=C2)Cl)OC"
        },
        "molecularFormula": "C24H33Cl2N3O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:42:20Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c844b"
    },
    "name": "BRD-K22932079",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c844b.png",
    "lincs": {
      "id": "LSM-43457",
      "name": "BRD-K22932079",
      "pubchemCid": 54660917,
      "inchiParent": "InChI=1S/C29H36N4O3/c1-30-13-15-31(16-14-30)29(36)27-24(19-34)23-18-32-25(26(23)33(27)17-21-7-8-21)12-11-22(28(32)35)10-9-20-5-3-2-4-6-20/h2-6,9-12,21,23-24,26-27,34H,7-8,13-19H2,1H3/b10-9+/t23-,24-,26+,27-/m0/s1",
      "inchiKeyParent": "BARBWXSVHSAMRQ-MXZZZELRSA-N",
      "smilesParent": "CN1CCN(CC1)C(=O)[C@@H]2[C@@H](CO)[C@@H]3CN4C(=O)C(=CC=C4[C@@H]3N2CC5CC5)\\C=C\\c6ccccc6"
    },
    "unichem": {
      "lincs": "LSM-43457",
      "pubchem": "54660917"
    },
    "pubchem": [
      {
        "cid": 54660917,
        "inchi": "InChI=1S/C29H36N4O3/c1-30-13-15-31(16-14-30)29(36)27-24(19-34)23-18-32-25(26(23)33(27)17-21-7-8-21)12-11-22(28(32)35)10-9-20-5-3-2-4-6-20/h2-6,9-12,21,23-24,26-27,34H,7-8,13-19H2,1H3/b10-9+/t23-,24-,26+,27-/m0/s1",
        "inchikey": "BARBWXSVHSAMRQ-MXZZZELRSA-N",
        "iupac": {
          "systematic": "(2S,3S,3aR,9bR)-1-(cyclopropylmethyl)-3-(hydroxymethyl)-2-(4-methylpiperazine-1-carbonyl)-7-[(E)-2-phenylethenyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizin-6-one"
        },
        "smiles": {
          "canonical": "CN1CCN(CC1)C(=O)C2C(C3CN4C(=CC=C(C4=O)C=CC5=CC=CC=C5)C3N2CC6CC6)CO"
        },
        "molecularFormula": "C29H36N4O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:42:22Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c846a"
    },
    "name": "BRD-K72318460",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c846a.png",
    "lincs": {
      "id": "LSM-7800",
      "name": "BRD-K72318460",
      "pubchemCid": 54618296,
      "chebiId": 96421,
      "inchiParent": "InChI=1S/C29H36FN3O5S/c1-20-17-33(21(2)19-34)29(35)26-14-23(13-12-22-8-5-4-6-9-22)16-31-28(26)38-27(20)18-32(3)39(36,37)25-11-7-10-24(30)15-25/h7,10-11,14-16,20-22,27,34H,4-6,8-9,17-19H2,1-3H3/t20-,21-,27+/m0/s1",
      "inchiKeyParent": "FWJMPRMSYCMNDB-NOMHHCBYSA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@H](C)[C@@H](CN(C)S(=O)(=O)c2cccc(F)c2)Oc3ncc(cc3C1=O)C#CC4CCCCC4"
    },
    "unichem": {
      "chebi": "96421",
      "lincs": "LSM-7800",
      "pubchem": "54618296"
    },
    "pubchem": [
      {
        "cid": 54618296,
        "inchi": "InChI=1S/C29H36FN3O5S/c1-20-17-33(21(2)19-34)29(35)26-14-23(13-12-22-8-5-4-6-9-22)16-31-28(26)38-27(20)18-32(3)39(36,37)25-11-7-10-24(30)15-25/h7,10-11,14-16,20-22,27,34H,4-6,8-9,17-19H2,1-3H3/t20-,21-,27+/m0/s1",
        "inchikey": "FWJMPRMSYCMNDB-NOMHHCBYSA-N",
        "iupac": {
          "systematic": "N-[[(2S,3S)-8-(2-cyclohexylethynyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-3-fluoro-N-methylbenzenesulfonamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(N=CC(=C2)C#CC3CCCCC3)OC1CN(C)S(=O)(=O)C4=CC=CC(=C4)F)C(C)CO"
        },
        "molecularFormula": "C29H36FN3O5S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:42:25Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8479"
    },
    "name": "BRD-K29423519",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8479.png",
    "lincs": {
      "id": "LSM-38871",
      "name": "BRD-K29423519",
      "pubchemCid": 44487297,
      "chebiId": 127312,
      "inchiParent": "InChI=1S/C27H43N5O5/c1-17(2)28-26(35)29-21-11-12-23-22(13-21)25(34)32(19(4)16-33)14-18(3)24(37-23)15-31(5)27(36)30-20-9-7-6-8-10-20/h11-13,17-20,24,33H,6-10,14-16H2,1-5H3,(H,30,36)(H2,28,29,35)/t18-,19-,24-/m0/s1",
      "inchiKeyParent": "ZJSYKXMVEOUFIY-JXQFQVJHSA-N",
      "smilesParent": "CC(C)NC(=O)Nc1ccc2O[C@@H](CN(C)C(=O)NC3CCCCC3)[C@@H](C)CN([C@@H](C)CO)C(=O)c2c1"
    },
    "unichem": {
      "chebi": "127312",
      "lincs": "LSM-38871",
      "pubchem": "44487297"
    },
    "pubchem": [
      {
        "cid": 44487297,
        "inchi": "InChI=1S/C27H43N5O5/c1-17(2)28-26(35)29-21-11-12-23-22(13-21)25(34)32(19(4)16-33)14-18(3)24(37-23)15-31(5)27(36)30-20-9-7-6-8-10-20/h11-13,17-20,24,33H,6-10,14-16H2,1-5H3,(H,30,36)(H2,28,29,35)/t18-,19-,24-/m0/s1",
        "inchikey": "ZJSYKXMVEOUFIY-JXQFQVJHSA-N",
        "iupac": {
          "systematic": "3-cyclohexyl-1-[[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-(propan-2-ylcarbamoylamino)-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(C=CC(=C2)NC(=O)NC(C)C)OC1CN(C)C(=O)NC3CCCCC3)C(C)CO"
        },
        "molecularFormula": "C27H43N5O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:42:27Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c849d"
    },
    "name": "BRD-K73575094",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c849d.png",
    "lincs": {
      "id": "LSM-12938",
      "name": "BRD-K73575094",
      "pubchemCid": 54649340,
      "chebiId": 101575,
      "inchiParent": "InChI=1S/C32H37N5O3S/c1-32(2,3)41(40)37-21-26-19-27(31(39)36-15-13-35(4)14-16-36)34-30(29(26)28(37)12-17-38)25-7-5-6-24(18-25)23-10-8-22(20-33)9-11-23/h5-11,18-19,28,38H,12-17,21H2,1-4H3/t28-,41-/m1/s1",
      "inchiKeyParent": "QBIQCDDCSMFVTJ-GIEABIOQSA-N",
      "smilesParent": "CN1CCN(CC1)C(=O)c2cc3CN([C@H](CCO)c3c(n2)c4cccc(c4)c5ccc(cc5)C#N)[S@](=O)C(C)(C)C"
    },
    "unichem": {
      "chebi": "101575",
      "lincs": "LSM-12938",
      "pubchem": "54649340"
    },
    "pubchem": [
      {
        "cid": 54649340,
        "inchi": "InChI=1S/C32H37N5O3S/c1-32(2,3)41(40)37-21-26-19-27(31(39)36-15-13-35(4)14-16-36)34-30(29(26)28(37)12-17-38)25-7-5-6-24(18-25)23-10-8-22(20-33)9-11-23/h5-11,18-19,28,38H,12-17,21H2,1-4H3/t28-,41-/m1/s1",
        "inchikey": "QBIQCDDCSMFVTJ-GIEABIOQSA-N",
        "iupac": {
          "systematic": "4-[3-[(3R)-2-[(R)-tert-butylsulfinyl]-3-(2-hydroxyethyl)-6-(4-methylpiperazine-1-carbonyl)-1,3-dihydropyrrolo[3,4-c]pyridin-4-yl]phenyl]benzonitrile"
        },
        "smiles": {
          "canonical": "CC(C)(C)S(=O)N1CC2=CC(=NC(=C2C1CCO)C3=CC=CC(=C3)C4=CC=C(C=C4)C#N)C(=O)N5CCN(CC5)C"
        },
        "molecularFormula": "C32H37N5O3S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:42:29Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84c0"
    },
    "name": "BRD-K66480544",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84c0.png",
    "lincs": {
      "id": "LSM-12477",
      "name": "BRD-K66480544",
      "pubchemCid": 54661013,
      "chebiId": 101108,
      "inchiParent": "InChI=1S/C28H32N4O4/c33-16-23-22-15-31-24(7-4-8-25(31)34)26(22)32(14-21-17-36-18-29-21)27(23)28(35)30-11-9-20(10-12-30)13-19-5-2-1-3-6-19/h1-8,17-18,20,22-23,26-27,33H,9-16H2/t22-,23-,26+,27-/m1/s1",
      "inchiKeyParent": "YCNDEIYRXZASMY-JUIYCPNDSA-N",
      "smilesParent": "OC[C@@H]1[C@H]2CN3C(=O)C=CC=C3[C@H]2N(Cc4cocn4)[C@H]1C(=O)N5CCC(Cc6ccccc6)CC5"
    },
    "unichem": {
      "chebi": "101108",
      "lincs": "LSM-12477",
      "pubchem": "54661013"
    },
    "pubchem": [
      {
        "cid": 54661013,
        "inchi": "InChI=1S/C28H32N4O4/c33-16-23-22-15-31-24(7-4-8-25(31)34)26(22)32(14-21-17-36-18-29-21)27(23)28(35)30-11-9-20(10-12-30)13-19-5-2-1-3-6-19/h1-8,17-18,20,22-23,26-27,33H,9-16H2/t22-,23-,26+,27-/m1/s1",
        "inchikey": "YCNDEIYRXZASMY-JUIYCPNDSA-N",
        "iupac": {
          "systematic": "(2R,3R,3aS,9bS)-2-(4-benzylpiperidine-1-carbonyl)-3-(hydroxymethyl)-1-(1,3-oxazol-4-ylmethyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizin-6-one"
        },
        "smiles": {
          "canonical": "C1CN(CCC1CC2=CC=CC=C2)C(=O)C3C(C4CN5C(=O)C=CC=C5C4N3CC6=COC=N6)CO"
        },
        "molecularFormula": "C28H32N4O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:42:31Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84ec"
    },
    "name": "BRD-K91686310",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84ec.png",
    "lincs": {
      "id": "LSM-14059",
      "name": "BRD-K91686310",
      "pubchemCid": 54657653,
      "chebiId": 102712,
      "inchiParent": "InChI=1S/C22H27FN4O6S/c23-15-2-1-3-19(8-15)34(30,31)27-11-17(28)12-32-13-21-20(27)5-4-18(33-21)9-22(29)25-10-16-6-7-24-14-26-16/h1-3,6-8,14,17-18,20-21,28H,4-5,9-13H2,(H,25,29)/t17-,18-,20-,21+/m1/s1",
      "inchiKeyParent": "FPMJOPUHYZGMQU-UKAVVXHISA-N",
      "smilesParent": "O[C@H]1COC[C@@H]2O[C@@H](CC(=O)NCc3ccncn3)CC[C@H]2N(C1)S(=O)(=O)c4cccc(F)c4"
    },
    "unichem": {
      "chebi": "102712",
      "lincs": "LSM-14059",
      "pubchem": "54657653"
    },
    "pubchem": [
      {
        "cid": 54657653,
        "inchi": "InChI=1S/C22H27FN4O6S/c23-15-2-1-3-19(8-15)34(30,31)27-11-17(28)12-32-13-21-20(27)5-4-18(33-21)9-22(29)25-10-16-6-7-24-14-26-16/h1-3,6-8,14,17-18,20-21,28H,4-5,9-13H2,(H,25,29)/t17-,18-,20-,21+/m1/s1",
        "inchikey": "FPMJOPUHYZGMQU-UKAVVXHISA-N",
        "iupac": {
          "systematic": "2-[(3R,6aR,8R,10aR)-1-(3-fluorophenyl)sulfonyl-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(pyrimidin-4-ylmethyl)acetamide"
        },
        "smiles": {
          "canonical": "C1CC2C(COCC(CN2S(=O)(=O)C3=CC=CC(=C3)F)O)OC1CC(=O)NCC4=NC=NC=C4"
        },
        "molecularFormula": "C22H27FN4O6S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:42:33Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84e3"
    },
    "name": "BRD-K01800462",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84e3.png",
    "lincs": {
      "id": "LSM-8547",
      "name": "BRD-K01800462",
      "pubchemCid": 54654122,
      "chebiId": 97168,
      "inchiParent": "InChI=1S/C25H28FN3O6/c1-29-20-9-8-18(12-23(30)27-16-5-3-15(26)4-6-16)35-22(20)13-34-21-10-7-17(11-19(21)25(29)32)28-24(31)14-33-2/h3-7,10-11,18,20,22H,8-9,12-14H2,1-2H3,(H,27,30)(H,28,31)/t18-,20+,22-/m1/s1",
      "inchiKeyParent": "SISNYLBWEAESFQ-KAGYGMCKSA-N",
      "smilesParent": "COCC(=O)Nc1ccc2OC[C@H]3O[C@@H](CC(=O)Nc4ccc(F)cc4)CC[C@@H]3N(C)C(=O)c2c1"
    },
    "unichem": {
      "chebi": "97168",
      "lincs": "LSM-8547",
      "pubchem": "54654122"
    },
    "pubchem": [
      {
        "cid": 54654122,
        "inchi": "InChI=1S/C25H28FN3O6/c1-29-20-9-8-18(12-23(30)27-16-5-3-15(26)4-6-16)35-22(20)13-34-21-10-7-17(11-19(21)25(29)32)28-24(31)14-33-2/h3-7,10-11,18,20,22H,8-9,12-14H2,1-2H3,(H,27,30)(H,28,31)/t18-,20+,22-/m1/s1",
        "inchikey": "SISNYLBWEAESFQ-KAGYGMCKSA-N",
        "iupac": {
          "systematic": "2-[(2R,4aS,12aS)-8-[(2-methoxyacetyl)amino]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(4-fluorophenyl)acetamide"
        },
        "smiles": {
          "canonical": "CN1C2CCC(OC2COC3=C(C1=O)C=C(C=C3)NC(=O)COC)CC(=O)NC4=CC=C(C=C4)F"
        },
        "molecularFormula": "C25H28FN3O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:42:36Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c851e"
    },
    "name": "BRD-K41069217",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c851e.png",
    "lincs": {
      "id": "LSM-39540",
      "name": "BRD-K41069217",
      "pubchemCid": 54615103,
      "chebiId": 127984,
      "inchiParent": "InChI=1S/C35H44N4O6/c1-24-21-39(25(2)23-40)35(43)30-20-29(37-33(41)27-11-6-5-7-12-27)13-14-31(30)45-26(3)10-8-9-19-44-32(24)22-38(4)34(42)28-15-17-36-18-16-28/h5-7,11-18,20,24-26,32,40H,8-10,19,21-23H2,1-4H3,(H,37,41)/t24-,25-,26-,32+/m0/s1",
      "inchiKeyParent": "LFSFSXVVLAKPPY-PXSDZQOHSA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@H](C)[C@@H](CN(C)C(=O)c2ccncc2)OCCCC[C@H](C)Oc3ccc(NC(=O)c4ccccc4)cc3C1=O"
    },
    "unichem": {
      "chebi": "127984",
      "lincs": "LSM-39540",
      "pubchem": "54615103"
    },
    "pubchem": [
      {
        "cid": 54615103,
        "inchi": "InChI=1S/C35H44N4O6/c1-24-21-39(25(2)23-40)35(43)30-20-29(37-33(41)27-11-6-5-7-12-27)13-14-31(30)45-26(3)10-8-9-19-44-32(24)22-38(4)34(42)28-15-17-36-18-16-28/h5-7,11-18,20,24-26,32,40H,8-10,19,21-23H2,1-4H3,(H,37,41)/t24-,25-,26-,32+/m0/s1",
        "inchikey": "LFSFSXVVLAKPPY-PXSDZQOHSA-N",
        "iupac": {
          "systematic": "N-[[(3S,9S,10S)-16-benzamido-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methylpyridine-4-carboxamide"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NC(=O)C3=CC=CC=C3)C(C)CO)C)CN(C)C(=O)C4=CC=NC=C4"
        },
        "molecularFormula": "C35H44N4O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:42:38Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c855c"
    },
    "name": "BRD-K95411194",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c855c.png",
    "lincs": {
      "id": "LSM-42441",
      "name": "BRD-K95411194",
      "pubchemCid": 44620550,
      "chebiId": 130892,
      "inchiParent": "InChI=1S/C32H47N3O6S/c1-23-19-35(24(2)22-36)32(37)29-18-27(33-42(38,39)28-11-6-5-7-12-28)15-16-30(29)41-25(3)10-8-9-17-40-31(23)21-34(4)20-26-13-14-26/h5-7,11-12,15-16,18,23-26,31,33,36H,8-10,13-14,17,19-22H2,1-4H3/t23-,24+,25-,31-/m1/s1",
      "inchiKeyParent": "BVXYTNIWYSYKAL-XDAUYTPDSA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@@H](C)[C@@H](CN(C)CC2CC2)OCCCC[C@@H](C)Oc3ccc(NS(=O)(=O)c4ccccc4)cc3C1=O"
    },
    "unichem": {
      "chebi": "130892",
      "lincs": "LSM-42441",
      "pubchem": "44620550"
    },
    "pubchem": [
      {
        "cid": 44620550,
        "inchi": "InChI=1S/C32H47N3O6S/c1-23-19-35(24(2)22-36)32(37)29-18-27(33-42(38,39)28-11-6-5-7-12-28)15-16-30(29)41-25(3)10-8-9-17-40-31(23)21-34(4)20-26-13-14-26/h5-7,11-12,15-16,18,23-26,31,33,36H,8-10,13-14,17,19-22H2,1-4H3/t23-,24+,25-,31-/m1/s1",
        "inchikey": "BVXYTNIWYSYKAL-XDAUYTPDSA-N",
        "iupac": {
          "systematic": "N-[(3R,9S,10R)-9-[[cyclopropylmethyl(methyl)amino]methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]benzenesulfonamide"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NS(=O)(=O)C3=CC=CC=C3)C(C)CO)C)CN(C)CC4CC4"
        },
        "molecularFormula": "C32H47N3O6S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:42:40Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8599"
    },
    "name": "BRD-K84449870",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8599.png",
    "lincs": {
      "id": "LSM-41882",
      "name": "BRD-K84449870",
      "pubchemCid": 54652464,
      "chebiId": 130333,
      "inchiParent": "InChI=1S/C24H24N2O5/c27-12-19-23-16-3-1-2-4-17(16)25(11-18(23)26(19)22(28)9-14-5-6-14)24(29)15-7-8-20-21(10-15)31-13-30-20/h1-4,7-8,10,14,18-19,23,27H,5-6,9,11-13H2/t18-,19+,23+/m0/s1",
      "inchiKeyParent": "JXUIDYBNAPLZHZ-YCRNBWNJSA-N",
      "smilesParent": "OC[C@@H]1[C@H]2[C@H](CN(C(=O)c3ccc4OCOc4c3)c5ccccc25)N1C(=O)CC6CC6"
    },
    "unichem": {
      "chebi": "130333",
      "lincs": "LSM-41882",
      "pubchem": "54652464"
    },
    "pubchem": [
      {
        "cid": 54652464,
        "inchi": "InChI=1S/C24H24N2O5/c27-12-19-23-16-3-1-2-4-17(16)25(11-18(23)26(19)22(28)9-14-5-6-14)24(29)15-7-8-20-21(10-15)31-13-30-20/h1-4,7-8,10,14,18-19,23,27H,5-6,9,11-13H2/t18-,19+,23+/m0/s1",
        "inchikey": "JXUIDYBNAPLZHZ-YCRNBWNJSA-N",
        "iupac": {
          "systematic": "1-[(1S,2aR,8bR)-4-(1,3-benzodioxole-5-carbonyl)-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]-2-cyclopropylethanone"
        },
        "smiles": {
          "canonical": "C1CC1CC(=O)N2C3CN(C4=CC=CC=C4C3C2CO)C(=O)C5=CC6=C(C=C5)OCO6"
        },
        "molecularFormula": "C24H24N2O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:42:43Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85af"
    },
    "name": "MLS004342539",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85af.png",
    "lincs": {
      "id": "LSM-11202",
      "name": "MLS004342539",
      "alternativeNames": [
        "BRD-K45480436"
      ],
      "pubchemCid": 54653981,
      "chebiId": 99823,
      "inchiParent": "InChI=1S/C29H38N4O6S/c1-32-24-7-6-21(17-27(34)30-9-3-10-33-11-13-37-14-12-33)39-26(24)19-38-25-8-5-20(16-23(25)29(32)36)31-28(35)18-22-4-2-15-40-22/h2,4-5,8,15-16,21,24,26H,3,6-7,9-14,17-19H2,1H3,(H,30,34)(H,31,35)/t21-,24+,26-/m1/s1",
      "inchiKeyParent": "CJRLOTNMWBMMLN-LJGDZFJRSA-N",
      "smilesParent": "CN1[C@H]2CC[C@H](CC(=O)NCCCN3CCOCC3)O[C@@H]2COc4ccc(NC(=O)Cc5cccs5)cc4C1=O"
    },
    "unichem": {
      "chebi": "99823",
      "lincs": "LSM-11202",
      "pubchem": "54653981"
    },
    "pubchem": [
      {
        "cid": 54653981,
        "inchi": "InChI=1S/C29H38N4O6S/c1-32-24-7-6-21(17-27(34)30-9-3-10-33-11-13-37-14-12-33)39-26(24)19-38-25-8-5-20(16-23(25)29(32)36)31-28(35)18-22-4-2-15-40-22/h2,4-5,8,15-16,21,24,26H,3,6-7,9-14,17-19H2,1H3,(H,30,34)(H,31,35)/t21-,24+,26-/m1/s1",
        "inchikey": "CJRLOTNMWBMMLN-LJGDZFJRSA-N",
        "iupac": {
          "systematic": "2-[(2R,4aS,12aS)-5-methyl-6-oxo-8-[(2-thiophen-2-ylacetyl)amino]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(3-morpholin-4-ylpropyl)acetamide"
        },
        "smiles": {
          "canonical": "CN1C2CCC(OC2COC3=C(C1=O)C=C(C=C3)NC(=O)CC4=CC=CS4)CC(=O)NCCCN5CCOCC5"
        },
        "molecularFormula": "C29H38N4O6S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:42:45Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85c4"
    },
    "name": "SA-1973507",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85c4.png",
    "lincs": {
      "id": "LSM-6829",
      "name": "SA-1973507",
      "alternativeNames": [
        "BRD-K35468722"
      ],
      "pubchemCid": 54657689,
      "chebiId": 95450,
      "inchiParent": "InChI=1S/C33H38N2O5/c36-27-21-35(19-24-10-12-29(13-11-24)39-28-8-2-1-3-9-28)31-15-14-30(40-32(31)23-38-22-27)18-33(37)34-17-16-25-6-4-5-7-26(25)20-34/h1-13,27,30-32,36H,14-23H2/t27-,30-,31-,32+/m0/s1",
      "inchiKeyParent": "HJQSQTAMFLANGO-AIGPYBJDSA-N",
      "smilesParent": "O[C@@H]1COC[C@H]2O[C@H](CC(=O)N3CCc4ccccc4C3)CC[C@@H]2N(Cc5ccc(Oc6ccccc6)cc5)C1"
    },
    "unichem": {
      "chebi": "95450",
      "lincs": "LSM-6829",
      "pubchem": "54657689"
    },
    "pubchem": [
      {
        "cid": 54657689,
        "inchi": "InChI=1S/C33H38N2O5/c36-27-21-35(19-24-10-12-29(13-11-24)39-28-8-2-1-3-9-28)31-15-14-30(40-32(31)23-38-22-27)18-33(37)34-17-16-25-6-4-5-7-26(25)20-34/h1-13,27,30-32,36H,14-23H2/t27-,30-,31-,32+/m0/s1",
        "inchikey": "HJQSQTAMFLANGO-AIGPYBJDSA-N",
        "iupac": {
          "systematic": "2-[(3S,6aS,8S,10aS)-3-hydroxy-1-[(4-phenoxyphenyl)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(3,4-dihydro-1H-isoquinolin-2-yl)ethanone"
        },
        "smiles": {
          "canonical": "C1CC2C(COCC(CN2CC3=CC=C(C=C3)OC4=CC=CC=C4)O)OC1CC(=O)N5CCC6=CC=CC=C6C5"
        },
        "molecularFormula": "C33H38N2O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:42:47Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c863d"
    },
    "name": "BRD-K30007764",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c863d.png",
    "lincs": {
      "id": "LSM-38904",
      "name": "BRD-K30007764",
      "pubchemCid": 60190084,
      "chebiId": 127346,
      "inchiParent": "InChI=1S/C23H31N3O4/c1-29-16-2-3-17-18(12-16)25-21-19(13-27)24-14-23(20(17)21)6-8-26(9-7-23)22(28)15-4-10-30-11-5-15/h2-3,12,15,19,24-25,27H,4-11,13-14H2,1H3/t19-/m0/s1",
      "inchiKeyParent": "QCPCXFRNGVFKGK-IBGZPJMESA-N",
      "smilesParent": "COc1ccc2c3c([nH]c2c1)[C@H](CO)NCC34CCN(CC4)C(=O)C5CCOCC5"
    },
    "unichem": {
      "chebi": "127346",
      "lincs": "LSM-38904",
      "pubchem": "60190084"
    },
    "pubchem": [
      {
        "cid": 60190084,
        "inchi": "InChI=1S/C23H31N3O4/c1-29-16-2-3-17-18(12-16)25-21-19(13-27)24-14-23(20(17)21)6-8-26(9-7-23)22(28)15-4-10-30-11-5-15/h2-3,12,15,19,24-25,27H,4-11,13-14H2,1H3/t19-/m0/s1",
        "inchikey": "QCPCXFRNGVFKGK-IBGZPJMESA-N",
        "iupac": {
          "systematic": "[(1R)-1-(hydroxymethyl)-7-methoxyspiro[1,2,3,9-tetrahydropyrido[3,4-b]indole-4,4'-piperidine]-1'-yl]-(oxan-4-yl)methanone"
        },
        "smiles": {
          "canonical": "COC1=CC2=C(C=C1)C3=C(N2)C(NCC34CCN(CC4)C(=O)C5CCOCC5)CO"
        },
        "molecularFormula": "C23H31N3O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:42:50Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8646"
    },
    "name": "BRD-K31290842",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8646.png",
    "lincs": {
      "id": "LSM-10321",
      "name": "BRD-K31290842",
      "pubchemCid": 54660761,
      "chebiId": 98942,
      "inchiParent": "InChI=1S/C25H25FN4O3/c26-17-3-1-16(2-4-17)18-5-6-21-23-22(19(14-31)20(29-23)13-30(21)25(18)33)24(32)28-12-9-15-7-10-27-11-8-15/h1-8,10-11,19-20,22-23,29,31H,9,12-14H2,(H,28,32)/t19-,20-,22+,23+/m0/s1",
      "inchiKeyParent": "FVDKOQJIZWFRLQ-JFJDKTSWSA-N",
      "smilesParent": "OC[C@H]1[C@@H]2CN3C(=CC=C(C3=O)c4ccc(F)cc4)[C@@H](N2)[C@@H]1C(=O)NCCc5ccncc5"
    },
    "unichem": {
      "chebi": "98942",
      "lincs": "LSM-10321",
      "pubchem": "54660761"
    },
    "pubchem": [
      {
        "cid": 54660761,
        "inchi": "InChI=1S/C25H25FN4O3/c26-17-3-1-16(2-4-17)18-5-6-21-23-22(19(14-31)20(29-23)13-30(21)25(18)33)24(32)28-12-9-15-7-10-27-11-8-15/h1-8,10-11,19-20,22-23,29,31H,9,12-14H2,(H,28,32)/t19-,20-,22+,23+/m0/s1",
        "inchikey": "FVDKOQJIZWFRLQ-JFJDKTSWSA-N",
        "iupac": {
          "systematic": "(1S,9R,10R,11R)-5-(4-fluorophenyl)-10-(hydroxymethyl)-6-oxo-N-(2-pyridin-4-ylethyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide"
        },
        "smiles": {
          "canonical": "C1C2C(C(C(N2)C3=CC=C(C(=O)N31)C4=CC=C(C=C4)F)C(=O)NCCC5=CC=NC=C5)CO"
        },
        "molecularFormula": "C25H25FN4O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:42:52Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84fd"
    },
    "name": "BRD-K31183432",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84fd.png",
    "lincs": {
      "id": "LSM-10313",
      "name": "BRD-K31183432",
      "pubchemCid": 54660719,
      "chebiId": 98934,
      "inchiParent": "InChI=1S/C25H29N3O3/c1-15(16-7-3-2-4-8-16)26-24(30)23-20(14-29)19-13-28-21(22(19)27-23)12-11-18(25(28)31)17-9-5-6-10-17/h2-4,7-9,11-12,15,19-20,22-23,27,29H,5-6,10,13-14H2,1H3,(H,26,30)/t15-,19+,20+,22-,23+/m1/s1",
      "inchiKeyParent": "DEERBQNZFWMEPS-GKOPTACNSA-N",
      "smilesParent": "C[C@@H](NC(=O)[C@H]1N[C@@H]2[C@@H](CN3C(=O)C(=CC=C23)C4=CCCC4)[C@@H]1CO)c5ccccc5"
    },
    "unichem": {
      "chebi": "98934",
      "lincs": "LSM-10313",
      "pubchem": "54660719"
    },
    "pubchem": [
      {
        "cid": 54660719,
        "inchi": "InChI=1S/C25H29N3O3/c1-15(16-7-3-2-4-8-16)26-24(30)23-20(14-29)19-13-28-21(22(19)27-23)12-11-18(25(28)31)17-9-5-6-10-17/h2-4,7-9,11-12,15,19-20,22-23,27,29H,5-6,10,13-14H2,1H3,(H,26,30)/t15-,19+,20+,22-,23+/m1/s1",
        "inchikey": "DEERBQNZFWMEPS-GKOPTACNSA-N",
        "iupac": {
          "systematic": "(2S,3S,3aR,9bR)-7-(cyclopenten-1-yl)-3-(hydroxymethyl)-6-oxo-N-[(1R)-1-phenylethyl]-1,2,3,3a,4,9b-hexahydropyrrolo[2,3-a]indolizine-2-carboxamide"
        },
        "smiles": {
          "canonical": "CC(C1=CC=CC=C1)NC(=O)C2C(C3CN4C(=CC=C(C4=O)C5=CCCC5)C3N2)CO"
        },
        "molecularFormula": "C25H29N3O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:42:54Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8506"
    },
    "name": "BRD-K18152229",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8506.png",
    "lincs": {
      "id": "LSM-9516",
      "name": "BRD-K18152229",
      "pubchemCid": 54654546,
      "chebiId": 98137,
      "inchiParent": "InChI=1S/C30H38ClN5O6/c1-35-25-9-8-21(18-28(37)32-11-4-12-36-13-15-40-16-14-36)42-27(25)19-41-26-10-7-20(17-22(26)29(35)38)33-30(39)34-24-6-3-2-5-23(24)31/h2-3,5-7,10,17,21,25,27H,4,8-9,11-16,18-19H2,1H3,(H,32,37)(H2,33,34,39)/t21-,25+,27+/m0/s1",
      "inchiKeyParent": "MRBZRZGKCPBOJB-MAFNXUKGSA-N",
      "smilesParent": "CN1[C@@H]2CC[C@@H](CC(=O)NCCCN3CCOCC3)O[C@@H]2COc4ccc(NC(=O)Nc5ccccc5Cl)cc4C1=O"
    },
    "unichem": {
      "chebi": "98137",
      "lincs": "LSM-9516",
      "pubchem": "54654546"
    },
    "pubchem": [
      {
        "cid": 54654546,
        "inchi": "InChI=1S/C30H38ClN5O6/c1-35-25-9-8-21(18-28(37)32-11-4-12-36-13-15-40-16-14-36)42-27(25)19-41-26-10-7-20(17-22(26)29(35)38)33-30(39)34-24-6-3-2-5-23(24)31/h2-3,5-7,10,17,21,25,27H,4,8-9,11-16,18-19H2,1H3,(H,32,37)(H2,33,34,39)/t21-,25+,27+/m0/s1",
        "inchikey": "MRBZRZGKCPBOJB-MAFNXUKGSA-N",
        "iupac": {
          "systematic": "2-[(2S,4aR,12aS)-8-[(2-chlorophenyl)carbamoylamino]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(3-morpholin-4-ylpropyl)acetamide"
        },
        "smiles": {
          "canonical": "CN1C2CCC(OC2COC3=C(C1=O)C=C(C=C3)NC(=O)NC4=CC=CC=C4Cl)CC(=O)NCCCN5CCOCC5"
        },
        "molecularFormula": "C30H38ClN5O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:42:57Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8538"
    },
    "name": "BRD-K62102996",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8538.png",
    "lincs": {
      "id": "LSM-14885",
      "name": "BRD-K62102996",
      "pubchemCid": 44489298,
      "chebiId": 103541,
      "inchiParent": "InChI=1S/C32H55N5O6/c1-22(2)33-32(41)34-26-14-15-28-27(18-26)31(40)37(24(4)21-38)19-23(3)29(42-17-10-9-12-25(5)43-28)20-36(8)30(39)13-11-16-35(6)7/h14-15,18,22-25,29,38H,9-13,16-17,19-21H2,1-8H3,(H2,33,34,41)/t23-,24-,25-,29-/m0/s1",
      "inchiKeyParent": "AIBBTECRVWULHH-MGQBIDJDSA-N",
      "smilesParent": "CC(C)NC(=O)Nc1ccc2O[C@@H](C)CCCCO[C@@H](CN(C)C(=O)CCCN(C)C)[C@@H](C)CN([C@@H](C)CO)C(=O)c2c1"
    },
    "unichem": {
      "chebi": "103541",
      "lincs": "LSM-14885",
      "pubchem": "44489298"
    },
    "pubchem": [
      {
        "cid": 44489298,
        "inchi": "InChI=1S/C32H55N5O6/c1-22(2)33-32(41)34-26-14-15-28-27(18-26)31(40)37(24(4)21-38)19-23(3)29(42-17-10-9-12-25(5)43-28)20-36(8)30(39)13-11-16-35(6)7/h14-15,18,22-25,29,38H,9-13,16-17,19-21H2,1-8H3,(H2,33,34,41)/t23-,24-,25-,29-/m0/s1",
        "inchikey": "AIBBTECRVWULHH-MGQBIDJDSA-N",
        "iupac": {
          "systematic": "4-(dimethylamino)-N-[[(3S,9R,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-(propan-2-ylcarbamoylamino)-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methylbutanamide"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NC(=O)NC(C)C)C(C)CO)C)CN(C)C(=O)CCCN(C)C"
        },
        "molecularFormula": "C32H55N5O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:42:59Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c853c"
    },
    "name": "BRD-K23154136",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c853c.png",
    "lincs": {
      "id": "LSM-9831",
      "name": "BRD-K23154136",
      "pubchemCid": 54657919,
      "chebiId": 98452,
      "inchiParent": "InChI=1S/C19H32N2O6/c1-2-20-18(23)9-15-3-4-16-17(27-15)12-26-11-14(22)10-21(16)19(24)13-5-7-25-8-6-13/h13-17,22H,2-12H2,1H3,(H,20,23)/t14-,15-,16+,17-/m0/s1",
      "inchiKeyParent": "MWTQFHHONBVRQP-NXOAAHMSSA-N",
      "smilesParent": "CCNC(=O)C[C@@H]1CC[C@@H]2[C@H](COC[C@@H](O)CN2C(=O)C3CCOCC3)O1"
    },
    "unichem": {
      "chebi": "98452",
      "lincs": "LSM-9831",
      "pubchem": "54657919"
    },
    "pubchem": [
      {
        "cid": 54657919,
        "inchi": "InChI=1S/C19H32N2O6/c1-2-20-18(23)9-15-3-4-16-17(27-15)12-26-11-14(22)10-21(16)19(24)13-5-7-25-8-6-13/h13-17,22H,2-12H2,1H3,(H,20,23)/t14-,15-,16+,17-/m0/s1",
        "inchikey": "MWTQFHHONBVRQP-NXOAAHMSSA-N",
        "iupac": {
          "systematic": "2-[(3S,6aR,8S,10aR)-3-hydroxy-1-(oxane-4-carbonyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-ethylacetamide"
        },
        "smiles": {
          "canonical": "CCNC(=O)CC1CCC2C(O1)COCC(CN2C(=O)C3CCOCC3)O"
        },
        "molecularFormula": "C19H32N2O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:43:01Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8587"
    },
    "name": "BRD-K41908552",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8587.png",
    "lincs": {
      "id": "LSM-39586",
      "name": "BRD-K41908552",
      "pubchemCid": 60184951,
      "chebiId": 128030,
      "inchiParent": "InChI=1S/C26H32N6O4/c1-16(2)29-25(35)32-15-26(6-10-31(11-7-26)24(34)20-13-27-8-9-28-20)22-18-5-4-17(36-3)12-19(18)30-23(22)21(32)14-33/h4-5,8-9,12-13,16,21,30,33H,6-7,10-11,14-15H2,1-3H3,(H,29,35)/t21-/m0/s1",
      "inchiKeyParent": "FKOSOIDZXAWLFY-NRFANRHFSA-N",
      "smilesParent": "COc1ccc2c3c([nH]c2c1)[C@H](CO)N(CC34CCN(CC4)C(=O)c5cnccn5)C(=O)NC(C)C"
    },
    "unichem": {
      "chebi": "128030",
      "lincs": "LSM-39586",
      "pubchem": "60184951"
    },
    "pubchem": [
      {
        "cid": 60184951,
        "inchi": "InChI=1S/C26H32N6O4/c1-16(2)29-25(35)32-15-26(6-10-31(11-7-26)24(34)20-13-27-8-9-28-20)22-18-5-4-17(36-3)12-19(18)30-23(22)21(32)14-33/h4-5,8-9,12-13,16,21,30,33H,6-7,10-11,14-15H2,1-3H3,(H,29,35)/t21-/m0/s1",
        "inchikey": "FKOSOIDZXAWLFY-NRFANRHFSA-N",
        "iupac": {
          "systematic": "(1R)-1-(hydroxymethyl)-7-methoxy-N-propan-2-yl-1'-(pyrazine-2-carbonyl)spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4'-piperidine]-2-carboxamide"
        },
        "smiles": {
          "canonical": "CC(C)NC(=O)N1CC2(CCN(CC2)C(=O)C3=NC=CN=C3)C4=C(C1CO)NC5=C4C=CC(=C5)OC"
        },
        "molecularFormula": "C26H32N6O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:43:03Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85c0"
    },
    "name": "BRD-K31883841",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85c0.png",
    "lincs": {
      "id": "LSM-14794",
      "name": "BRD-K31883841",
      "pubchemCid": 44495973,
      "chebiId": 103450,
      "inchiParent": "InChI=1S/C27H46N4O5/c1-18(2)28-27(34)29-22-11-12-24-23(14-22)26(33)31(20(4)17-32)15-19(3)25(16-30(6)7)35-13-9-8-10-21(5)36-24/h11-12,14,18-21,25,32H,8-10,13,15-17H2,1-7H3,(H2,28,29,34)/t19-,20+,21-,25-/m0/s1",
      "inchiKeyParent": "YWYDVFGOYOJBGO-PDFGSZSQSA-N",
      "smilesParent": "CC(C)NC(=O)Nc1ccc2O[C@@H](C)CCCCO[C@@H](CN(C)C)[C@@H](C)CN([C@H](C)CO)C(=O)c2c1"
    },
    "unichem": {
      "chebi": "103450",
      "lincs": "LSM-14794",
      "pubchem": "44495973"
    },
    "pubchem": [
      {
        "cid": 44495973,
        "inchi": "InChI=1S/C27H46N4O5/c1-18(2)28-27(34)29-22-11-12-24-23(14-22)26(33)31(20(4)17-32)15-19(3)25(16-30(6)7)35-13-9-8-10-21(5)36-24/h11-12,14,18-21,25,32H,8-10,13,15-17H2,1-7H3,(H2,28,29,34)/t19-,20+,21-,25-/m0/s1",
        "inchikey": "YWYDVFGOYOJBGO-PDFGSZSQSA-N",
        "iupac": {
          "systematic": "1-[(3S,9R,10S)-9-[(dimethylamino)methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-propan-2-ylurea"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NC(=O)NC(C)C)C(C)CO)C)CN(C)C"
        },
        "molecularFormula": "C27H46N4O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:43:05Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85d0"
    },
    "name": "CHEMBL2360112",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85d0.png",
    "lincs": {
      "id": "LSM-39416",
      "name": "CHEMBL2360112",
      "alternativeNames": [
        "BRD-K38934024"
      ],
      "pubchemCid": 44617816,
      "chebiId": 127860,
      "inchiParent": "InChI=1S/C35H47F3N4O7S/c1-22-18-42(23(2)21-43)34(44)30-17-29(40-50(45,46)33-25(4)39-49-26(33)5)14-15-31(30)48-24(3)9-7-8-16-47-32(22)20-41(6)19-27-10-12-28(13-11-27)35(36,37)38/h10-15,17,22-24,32,40,43H,7-9,16,18-21H2,1-6H3/t22-,23-,24+,32+/m1/s1",
      "inchiKeyParent": "CBAAPWVHONFTKW-OGIDDNHMSA-N",
      "smilesParent": "C[C@H](CO)N1C[C@@H](C)[C@H](CN(C)Cc2ccc(cc2)C(F)(F)F)OCCCC[C@H](C)Oc3ccc(NS(=O)(=O)c4c(C)onc4C)cc3C1=O"
    },
    "unichem": {
      "chebi": "127860",
      "chembl": "CHEMBL2360112",
      "lincs": "LSM-39416",
      "pubchem": "44617816"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL2360112",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 724.84,
        "hba": 9,
        "hbd": 2,
        "qedWeighted": 0.27
      }
    },
    "pubchem": [
      {
        "cid": 44617816,
        "inchi": "InChI=1S/C35H47F3N4O7S/c1-22-18-42(23(2)21-43)34(44)30-17-29(40-50(45,46)33-25(4)39-49-26(33)5)14-15-31(30)48-24(3)9-7-8-16-47-32(22)20-41(6)19-27-10-12-28(13-11-27)35(36,37)38/h10-15,17,22-24,32,40,43H,7-9,16,18-21H2,1-6H3/t22-,23-,24+,32+/m1/s1",
        "inchikey": "CBAAPWVHONFTKW-OGIDDNHMSA-N",
        "iupac": {
          "systematic": "N-[(3S,9R,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3,5-dimethyl-1,2-oxazole-4-sulfonamide"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NS(=O)(=O)C3=C(ON=C3C)C)C(C)CO)C)CN(C)CC4=CC=C(C=C4)C(F)(F)F"
        },
        "molecularFormula": "C35H47F3N4O7S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:43:17Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84ff"
    },
    "name": "BRD-K81476029",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84ff.png",
    "lincs": {
      "id": "LSM-13403",
      "name": "BRD-K81476029",
      "pubchemCid": 54660836,
      "chebiId": 102043,
      "inchiParent": "InChI=1S/C25H25F2N5O3/c1-30(2)25(35)23-19(12-33)18-11-31-21(6-4-17(24(31)34)15-8-28-13-29-9-15)22(18)32(23)10-14-7-16(26)3-5-20(14)27/h3-9,13,18-19,22-23,33H,10-12H2,1-2H3/t18-,19-,22+,23-/m1/s1",
      "inchiKeyParent": "GNOSXJXTVJBPTF-PJIZGREPSA-N",
      "smilesParent": "CN(C)C(=O)[C@H]1[C@H](CO)[C@H]2CN3C(=CC=C(C3=O)c4cncnc4)[C@H]2N1Cc5cc(F)ccc5F"
    },
    "unichem": {
      "chebi": "102043",
      "lincs": "LSM-13403",
      "pubchem": "54660836"
    },
    "pubchem": [
      {
        "cid": 54660836,
        "inchi": "InChI=1S/C25H25F2N5O3/c1-30(2)25(35)23-19(12-33)18-11-31-21(6-4-17(24(31)34)15-8-28-13-29-9-15)22(18)32(23)10-14-7-16(26)3-5-20(14)27/h3-9,13,18-19,22-23,33H,10-12H2,1-2H3/t18-,19-,22+,23-/m1/s1",
        "inchikey": "GNOSXJXTVJBPTF-PJIZGREPSA-N",
        "iupac": {
          "systematic": "(2R,3R,3aS,9bS)-1-[(2,5-difluorophenyl)methyl]-3-(hydroxymethyl)-N,N-dimethyl-6-oxo-7-pyrimidin-5-yl-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide"
        },
        "smiles": {
          "canonical": "CN(C)C(=O)C1C(C2CN3C(=CC=C(C3=O)C4=CN=CN=C4)C2N1CC5=C(C=CC(=C5)F)F)CO"
        },
        "molecularFormula": "C25H25F2N5O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:43:19Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8577"
    },
    "name": "BRD-K34545522",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8577.png",
    "lincs": {
      "id": "LSM-39158",
      "name": "BRD-K34545522",
      "pubchemCid": 60190949,
      "chebiId": 127601,
      "inchiParent": "InChI=1S/C24H25FN2O4S/c25-19-6-3-7-20(12-19)32(30,31)26-13-21-24(22(15-28)27(21)23(29)14-26)18-10-8-17(9-11-18)16-4-1-2-5-16/h3-4,6-12,21-22,24,28H,1-2,5,13-15H2/t21-,22+,24-/m0/s1",
      "inchiKeyParent": "DKXZRNXCWOKGFW-ZDXQCDESSA-N",
      "smilesParent": "OC[C@@H]1[C@H]([C@@H]2CN(CC(=O)N12)S(=O)(=O)c3cccc(F)c3)c4ccc(cc4)C5=CCCC5"
    },
    "unichem": {
      "chebi": "127601",
      "lincs": "LSM-39158",
      "pubchem": "60190949"
    },
    "pubchem": [
      {
        "cid": 60190949,
        "inchi": "InChI=1S/C24H25FN2O4S/c25-19-6-3-7-20(12-19)32(30,31)26-13-21-24(22(15-28)27(21)23(29)14-26)18-10-8-17(9-11-18)16-4-1-2-5-16/h3-4,6-12,21-22,24,28H,1-2,5,13-15H2/t21-,22+,24-/m0/s1",
        "inchikey": "DKXZRNXCWOKGFW-ZDXQCDESSA-N",
        "iupac": {
          "systematic": "(6R,7S,8S)-7-[4-(cyclopenten-1-yl)phenyl]-4-(3-fluorophenyl)sulfonyl-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one"
        },
        "smiles": {
          "canonical": "C1CC=C(C1)C2=CC=C(C=C2)C3C4CN(CC(=O)N4C3CO)S(=O)(=O)C5=CC=CC(=C5)F"
        },
        "molecularFormula": "C24H25FN2O4S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:43:21Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c857c"
    },
    "name": "BRD-K88281008",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c857c.png",
    "lincs": {
      "id": "LSM-13852",
      "name": "BRD-K88281008",
      "pubchemCid": 54654272,
      "chebiId": 102503,
      "inchiParent": "InChI=1S/C30H32ClN3O6S/c1-19(20-6-4-3-5-7-20)32-29(35)17-23-11-14-26-28(40-23)18-39-27-15-10-22(16-25(27)30(36)34(26)2)33-41(37,38)24-12-8-21(31)9-13-24/h3-10,12-13,15-16,19,23,26,28,33H,11,14,17-18H2,1-2H3,(H,32,35)/t19-,23-,26+,28-/m0/s1",
      "inchiKeyParent": "UIBIEJVTTJAUBZ-PWQSGXPHSA-N",
      "smilesParent": "C[C@H](NC(=O)C[C@@H]1CC[C@@H]2[C@H](COc3ccc(NS(=O)(=O)c4ccc(Cl)cc4)cc3C(=O)N2C)O1)c5ccccc5"
    },
    "unichem": {
      "chebi": "102503",
      "lincs": "LSM-13852",
      "pubchem": "54654272"
    },
    "pubchem": [
      {
        "cid": 54654272,
        "inchi": "InChI=1S/C30H32ClN3O6S/c1-19(20-6-4-3-5-7-20)32-29(35)17-23-11-14-26-28(40-23)18-39-27-15-10-22(16-25(27)30(36)34(26)2)33-41(37,38)24-12-8-21(31)9-13-24/h3-10,12-13,15-16,19,23,26,28,33H,11,14,17-18H2,1-2H3,(H,32,35)/t19-,23-,26+,28-/m0/s1",
        "inchikey": "UIBIEJVTTJAUBZ-PWQSGXPHSA-N",
        "iupac": {
          "systematic": "2-[(2S,4aR,12aR)-8-[(4-chlorophenyl)sulfonylamino]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-[(1S)-1-phenylethyl]acetamide"
        },
        "smiles": {
          "canonical": "CC(C1=CC=CC=C1)NC(=O)CC2CCC3C(O2)COC4=C(C=C(C=C4)NS(=O)(=O)C5=CC=C(C=C5)Cl)C(=O)N3C"
        },
        "molecularFormula": "C30H32ClN3O6S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:43:24Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c858f"
    },
    "name": "BRD-K20170530",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c858f.png",
    "lincs": {
      "id": "LSM-38359",
      "name": "BRD-K20170530",
      "pubchemCid": 60189761,
      "chebiId": 126796,
      "inchiParent": "InChI=1S/C28H34N4O3/c1-30-23-15-21(35-2)5-6-22(23)25-26(30)24(17-33)32(27(34)20-7-11-29-12-8-20)18-28(25)9-13-31(14-10-28)16-19-3-4-19/h5-8,11-12,15,19,24,33H,3-4,9-10,13-14,16-18H2,1-2H3/t24-/m0/s1",
      "inchiKeyParent": "MGDQFVBQSWCYMZ-DEOSSOPVSA-N",
      "smilesParent": "COc1ccc2c3c([C@H](CO)N(CC34CCN(CC5CC5)CC4)C(=O)c6ccncc6)n(C)c2c1"
    },
    "unichem": {
      "chebi": "126796",
      "lincs": "LSM-38359",
      "pubchem": "60189761"
    },
    "pubchem": [
      {
        "cid": 60189761,
        "inchi": "InChI=1S/C28H34N4O3/c1-30-23-15-21(35-2)5-6-22(23)25-26(30)24(17-33)32(27(34)20-7-11-29-12-8-20)18-28(25)9-13-31(14-10-28)16-19-3-4-19/h5-8,11-12,15,19,24,33H,3-4,9-10,13-14,16-18H2,1-2H3/t24-/m0/s1",
        "inchikey": "MGDQFVBQSWCYMZ-DEOSSOPVSA-N",
        "iupac": {
          "systematic": "[(1R)-1'-(cyclopropylmethyl)-1-(hydroxymethyl)-7-methoxy-9-methylspiro[1,3-dihydropyrido[3,4-b]indole-4,4'-piperidine]-2-yl]-pyridin-4-ylmethanone"
        },
        "smiles": {
          "canonical": "CN1C2=C(C=CC(=C2)OC)C3=C1C(N(CC34CCN(CC4)CC5CC5)C(=O)C6=CC=NC=C6)CO"
        },
        "molecularFormula": "C28H34N4O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:43:26Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84f8"
    },
    "name": "BRD-K21690323",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84f8.png",
    "lincs": {
      "id": "LSM-38450",
      "name": "BRD-K21690323",
      "pubchemCid": 60185258,
      "chebiId": 126887,
      "inchiParent": "InChI=1S/C23H34N4O3/c1-15(2)24-22(29)27-10-8-23(9-11-27)14-25(3)19(13-28)21-20(23)17-7-6-16(30-5)12-18(17)26(21)4/h6-7,12,15,19,28H,8-11,13-14H2,1-5H3,(H,24,29)/t19-/m1/s1",
      "inchiKeyParent": "GPILBLPXWOLSJY-LJQANCHMSA-N",
      "smilesParent": "COc1ccc2c3c([C@@H](CO)N(C)CC34CCN(CC4)C(=O)NC(C)C)n(C)c2c1"
    },
    "unichem": {
      "chebi": "126887",
      "lincs": "LSM-38450",
      "pubchem": "60185258"
    },
    "pubchem": [
      {
        "cid": 60185258,
        "inchi": "InChI=1S/C23H34N4O3/c1-15(2)24-22(29)27-10-8-23(9-11-27)14-25(3)19(13-28)21-20(23)17-7-6-16(30-5)12-18(17)26(21)4/h6-7,12,15,19,28H,8-11,13-14H2,1-5H3,(H,24,29)/t19-/m1/s1",
        "inchikey": "GPILBLPXWOLSJY-LJQANCHMSA-N",
        "iupac": {
          "systematic": "(1S)-1-(hydroxymethyl)-7-methoxy-2,9-dimethyl-N-propan-2-ylspiro[1,3-dihydropyrido[3,4-b]indole-4,4'-piperidine]-1'-carboxamide"
        },
        "smiles": {
          "canonical": "CC(C)NC(=O)N1CCC2(CC1)CN(C(C3=C2C4=C(N3C)C=C(C=C4)OC)CO)C"
        },
        "molecularFormula": "C23H34N4O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:43:28Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c851b"
    },
    "name": "BRD-K30794866",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c851b.png",
    "lincs": {
      "id": "LSM-10284",
      "name": "BRD-K30794866",
      "pubchemCid": 54654597,
      "chebiId": 98905,
      "inchiParent": "InChI=1S/C30H35N3O8/c1-33-23-5-4-21(14-28(34)31-15-18-2-6-25-26(12-18)40-17-39-25)41-27(23)16-38-24-7-3-20(13-22(24)30(33)36)32-29(35)19-8-10-37-11-9-19/h2-3,6-7,12-13,19,21,23,27H,4-5,8-11,14-17H2,1H3,(H,31,34)(H,32,35)/t21-,23+,27-/m0/s1",
      "inchiKeyParent": "JZWHDUCFLDKMHA-AIUHUKMKSA-N",
      "smilesParent": "CN1[C@@H]2CC[C@@H](CC(=O)NCc3ccc4OCOc4c3)O[C@H]2COc5ccc(NC(=O)C6CCOCC6)cc5C1=O"
    },
    "unichem": {
      "chebi": "98905",
      "lincs": "LSM-10284",
      "pubchem": "54654597"
    },
    "pubchem": [
      {
        "cid": 54654597,
        "inchi": "InChI=1S/C30H35N3O8/c1-33-23-5-4-21(14-28(34)31-15-18-2-6-25-26(12-18)40-17-39-25)41-27(23)16-38-24-7-3-20(13-22(24)30(33)36)32-29(35)19-8-10-37-11-9-19/h2-3,6-7,12-13,19,21,23,27H,4-5,8-11,14-17H2,1H3,(H,31,34)(H,32,35)/t21-,23+,27-/m0/s1",
        "inchikey": "JZWHDUCFLDKMHA-AIUHUKMKSA-N",
        "iupac": {
          "systematic": "N-[(2S,4aR,12aR)-2-[2-(1,3-benzodioxol-5-ylmethylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]oxane-4-carboxamide"
        },
        "smiles": {
          "canonical": "CN1C2CCC(OC2COC3=C(C1=O)C=C(C=C3)NC(=O)C4CCOCC4)CC(=O)NCC5=CC6=C(C=C5)OCO6"
        },
        "molecularFormula": "C30H35N3O8"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:43:30Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8546"
    },
    "name": "BRD-K75179331",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8546.png",
    "lincs": {
      "id": "LSM-13031",
      "name": "BRD-K75179331",
      "pubchemCid": 54649493,
      "chebiId": 101668,
      "inchiParent": "InChI=1S/C25H35N3O6/c1-16-21(32-5)14-28(3)25(30)19-8-6-7-17(13-26)23(19)33-15-22-20(31-4)10-9-18(34-22)11-12-27(2)24(16)29/h6-8,16,18,20-22H,9-12,14-15H2,1-5H3/t16-,18+,20+,21-,22+/m1/s1",
      "inchiKeyParent": "XYLRKRISJMFHFX-FEHPBONCSA-N",
      "smilesParent": "CO[C@H]1CC[C@H]2CCN(C)C(=O)[C@H](C)[C@@H](CN(C)C(=O)c3cccc(C#N)c3OC[C@@H]1O2)OC"
    },
    "unichem": {
      "chebi": "101668",
      "lincs": "LSM-13031",
      "pubchem": "54649493"
    },
    "pubchem": [
      {
        "cid": 54649493,
        "inchi": "InChI=1S/C25H35N3O6/c1-16-21(32-5)14-28(3)25(30)19-8-6-7-17(13-26)23(19)33-15-22-20(31-4)10-9-18(34-22)11-12-27(2)24(16)29/h6-8,16,18,20-22H,9-12,14-15H2,1-5H3/t16-,18+,20+,21-,22+/m1/s1",
        "inchikey": "XYLRKRISJMFHFX-FEHPBONCSA-N",
        "iupac": {
          "systematic": "(1S,13S,14R,19S,22S)-13,22-dimethoxy-11,14,16-trimethyl-10,15-dioxo-3,23-dioxa-11,16-diazatricyclo[17.3.1.04,9]tricosa-4,6,8-triene-5-carbonitrile"
        },
        "smiles": {
          "canonical": "CC1C(CN(C(=O)C2=CC=CC(=C2OCC3C(CCC(O3)CCN(C1=O)C)OC)C#N)C)OC"
        },
        "molecularFormula": "C25H35N3O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:43:33Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c858b"
    },
    "name": "BRD-K13667629",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c858b.png",
    "lincs": {
      "id": "LSM-9252",
      "name": "BRD-K13667629",
      "pubchemCid": 54654143,
      "chebiId": 97873,
      "inchiParent": "InChI=1S/C29H37FN4O6S/c1-33-25-10-9-22(18-28(35)31-12-15-34-13-3-2-4-14-34)40-27(25)19-39-26-11-8-21(17-24(26)29(33)36)32-41(37,38)23-7-5-6-20(30)16-23/h5-8,11,16-17,22,25,27,32H,2-4,9-10,12-15,18-19H2,1H3,(H,31,35)/t22-,25+,27+/m0/s1",
      "inchiKeyParent": "TUUZOQPHVDGSNW-GEWUYGHSSA-N",
      "smilesParent": "CN1[C@@H]2CC[C@@H](CC(=O)NCCN3CCCCC3)O[C@@H]2COc4ccc(NS(=O)(=O)c5cccc(F)c5)cc4C1=O"
    },
    "unichem": {
      "chebi": "97873",
      "lincs": "LSM-9252",
      "pubchem": "54654143"
    },
    "pubchem": [
      {
        "cid": 54654143,
        "inchi": "InChI=1S/C29H37FN4O6S/c1-33-25-10-9-22(18-28(35)31-12-15-34-13-3-2-4-14-34)40-27(25)19-39-26-11-8-21(17-24(26)29(33)36)32-41(37,38)23-7-5-6-20(30)16-23/h5-8,11,16-17,22,25,27,32H,2-4,9-10,12-15,18-19H2,1H3,(H,31,35)/t22-,25+,27+/m0/s1",
        "inchikey": "TUUZOQPHVDGSNW-GEWUYGHSSA-N",
        "iupac": {
          "systematic": "2-[(2S,4aR,12aS)-8-[(3-fluorophenyl)sulfonylamino]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(2-piperidin-1-ylethyl)acetamide"
        },
        "smiles": {
          "canonical": "CN1C2CCC(OC2COC3=C(C1=O)C=C(C=C3)NS(=O)(=O)C4=CC=CC(=C4)F)CC(=O)NCCN5CCCCC5"
        },
        "molecularFormula": "C29H37FN4O6S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:43:35Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8592"
    },
    "name": "BRD-K79962460",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8592.png",
    "lincs": {
      "id": "LSM-41633",
      "name": "BRD-K79962460",
      "pubchemCid": 60184930,
      "chebiId": 130083,
      "inchiParent": "InChI=1S/C31H38FN3O4/c1-33-26-17-23(38-2)7-8-24(26)28-29(33)27(19-36)35(18-22-5-3-4-6-25(22)32)20-31(28)11-13-34(14-12-31)30(37)21-9-15-39-16-10-21/h3-8,17,21,27,36H,9-16,18-20H2,1-2H3/t27-/m1/s1",
      "inchiKeyParent": "GGVQAARRTIEONC-HHHXNRCGSA-N",
      "smilesParent": "COc1ccc2c3c([C@@H](CO)N(Cc4ccccc4F)CC35CCN(CC5)C(=O)C6CCOCC6)n(C)c2c1"
    },
    "unichem": {
      "chebi": "130083",
      "lincs": "LSM-41633",
      "pubchem": "60184930"
    },
    "pubchem": [
      {
        "cid": 60184930,
        "inchi": "InChI=1S/C31H38FN3O4/c1-33-26-17-23(38-2)7-8-24(26)28-29(33)27(19-36)35(18-22-5-3-4-6-25(22)32)20-31(28)11-13-34(14-12-31)30(37)21-9-15-39-16-10-21/h3-8,17,21,27,36H,9-16,18-20H2,1-2H3/t27-/m1/s1",
        "inchikey": "GGVQAARRTIEONC-HHHXNRCGSA-N",
        "iupac": {
          "systematic": "[(1S)-2-[(2-fluorophenyl)methyl]-1-(hydroxymethyl)-7-methoxy-9-methylspiro[1,3-dihydropyrido[3,4-b]indole-4,4'-piperidine]-1'-yl]-(oxan-4-yl)methanone"
        },
        "smiles": {
          "canonical": "CN1C2=C(C=CC(=C2)OC)C3=C1C(N(CC34CCN(CC4)C(=O)C5CCOCC5)CC6=CC=CC=C6F)CO"
        },
        "molecularFormula": "C31H38FN3O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:43:37Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c861a"
    },
    "name": "BRD-K66740714",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c861a.png",
    "lincs": {
      "id": "LSM-12494",
      "name": "BRD-K66740714",
      "pubchemCid": 54654569,
      "chebiId": 101125,
      "inchiParent": "InChI=1S/C21H29N3O7S/c1-23-17-5-4-15(12-20(25)24-7-9-29-10-8-24)31-19(17)13-30-18-6-3-14(22-32(2,27)28)11-16(18)21(23)26/h3,6,11,15,17,19,22H,4-5,7-10,12-13H2,1-2H3/t15-,17+,19-/m0/s1",
      "inchiKeyParent": "VPEDYPFQYJVQKE-WDYCEAGBSA-N",
      "smilesParent": "CN1[C@@H]2CC[C@@H](CC(=O)N3CCOCC3)O[C@H]2COc4ccc(NS(=O)(=O)C)cc4C1=O"
    },
    "unichem": {
      "chebi": "101125",
      "lincs": "LSM-12494",
      "pubchem": "54654569"
    },
    "pubchem": [
      {
        "cid": 54654569,
        "inchi": "InChI=1S/C21H29N3O7S/c1-23-17-5-4-15(12-20(25)24-7-9-29-10-8-24)31-19(17)13-30-18-6-3-14(22-32(2,27)28)11-16(18)21(23)26/h3,6,11,15,17,19,22H,4-5,7-10,12-13H2,1-2H3/t15-,17+,19-/m0/s1",
        "inchikey": "VPEDYPFQYJVQKE-WDYCEAGBSA-N",
        "iupac": {
          "systematic": "N-[(2S,4aR,12aR)-5-methyl-2-(2-morpholin-4-yl-2-oxoethyl)-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]methanesulfonamide"
        },
        "smiles": {
          "canonical": "CN1C2CCC(OC2COC3=C(C1=O)C=C(C=C3)NS(=O)(=O)C)CC(=O)N4CCOCC4"
        },
        "molecularFormula": "C21H29N3O7S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:43:39Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8505"
    },
    "name": "BRD-K46183911",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8505.png",
    "lincs": {
      "id": "LSM-39828",
      "name": "BRD-K46183911",
      "pubchemCid": 54666638,
      "chebiId": 128273,
      "inchiParent": "InChI=1S/C26H29FN4O/c27-23-6-2-1-5-22(23)20-7-9-21(10-8-20)26-24-16-30(15-19-13-28-18-29-14-19)11-3-4-12-31(24)25(26)17-32/h1-2,5-10,13-14,18,24-26,32H,3-4,11-12,15-17H2/t24-,25-,26-/m1/s1",
      "inchiKeyParent": "XNSBVUHLLQGYEX-TWJOJJKGSA-N",
      "smilesParent": "OC[C@@H]1[C@@H]([C@H]2CN(Cc3cncnc3)CCCCN12)c4ccc(cc4)c5ccccc5F"
    },
    "unichem": {
      "chebi": "128273",
      "lincs": "LSM-39828",
      "pubchem": "54666638"
    },
    "pubchem": [
      {
        "cid": 54666638,
        "inchi": "InChI=1S/C26H29FN4O/c27-23-6-2-1-5-22(23)20-7-9-21(10-8-20)26-24-16-30(15-19-13-28-18-29-14-19)11-3-4-12-31(24)25(26)17-32/h1-2,5-10,13-14,18,24-26,32H,3-4,11-12,15-17H2/t24-,25-,26-/m1/s1",
        "inchikey": "XNSBVUHLLQGYEX-TWJOJJKGSA-N",
        "iupac": {
          "systematic": "[(8S,9R,10S)-9-[4-(2-fluorophenyl)phenyl]-6-(pyrimidin-5-ylmethyl)-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol"
        },
        "smiles": {
          "canonical": "C1CCN2C(CN(C1)CC3=CN=CN=C3)C(C2CO)C4=CC=C(C=C4)C5=CC=CC=C5F"
        },
        "molecularFormula": "C26H29FN4O"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:43:41Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8537"
    },
    "name": "BRD-K02279849",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8537.png",
    "lincs": {
      "id": "LSM-37403",
      "name": "BRD-K02279849",
      "pubchemCid": 44501153,
      "chebiId": 125836,
      "inchiParent": "InChI=1S/C29H40N4O6/c1-18(2)30-29(36)31-23-7-9-24-22(11-23)12-28(35)33(20(4)16-34)13-19(3)27(39-24)15-32(5)14-21-6-8-25-26(10-21)38-17-37-25/h6-11,18-20,27,34H,12-17H2,1-5H3,(H2,30,31,36)/t19-,20+,27-/m0/s1",
      "inchiKeyParent": "LBSHWJURJCXAHO-VKIDHGPPSA-N",
      "smilesParent": "CC(C)NC(=O)Nc1ccc2O[C@@H](CN(C)Cc3ccc4OCOc4c3)[C@@H](C)CN([C@H](C)CO)C(=O)Cc2c1"
    },
    "unichem": {
      "chebi": "125836",
      "lincs": "LSM-37403",
      "pubchem": "44501153"
    },
    "pubchem": [
      {
        "cid": 44501153,
        "inchi": "InChI=1S/C29H40N4O6/c1-18(2)30-29(36)31-23-7-9-24-22(11-23)12-28(35)33(20(4)16-34)13-19(3)27(39-24)15-32(5)14-21-6-8-25-26(10-21)38-17-37-25/h6-11,18-20,27,34H,12-17H2,1-5H3,(H2,30,31,36)/t19-,20+,27-/m0/s1",
        "inchikey": "LBSHWJURJCXAHO-VKIDHGPPSA-N",
        "iupac": {
          "systematic": "1-[(2R,3S)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-propan-2-ylurea"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)CC2=C(C=CC(=C2)NC(=O)NC(C)C)OC1CN(C)CC3=CC4=C(C=C3)OCO4)C(C)CO"
        },
        "molecularFormula": "C29H40N4O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:43:44Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8586"
    },
    "name": "BRD-K49066776",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8586.png",
    "lincs": {
      "id": "LSM-36555",
      "name": "BRD-K49066776",
      "pubchemCid": 60185253,
      "chebiId": 125093,
      "inchiParent": "InChI=1S/C24H24N4O2/c1-30-20-8-6-19(7-9-20)26-24(29)28-14-21-23(22(15-28)27-21)18-4-2-16(3-5-18)17-10-12-25-13-11-17/h2-13,21-23,27H,14-15H2,1H3,(H,26,29)/t21-,22+,23?",
      "inchiKeyParent": "COQDKCRLRIUNRV-AIZNXBIQSA-N",
      "smilesParent": "COc1ccc(NC(=O)N2C[C@@H]3N[C@H](C2)[C@H]3c4ccc(cc4)c5ccncc5)cc1"
    },
    "unichem": {
      "chebi": "125093",
      "lincs": "LSM-36555",
      "pubchem": "60185253"
    },
    "pubchem": [
      {
        "cid": 60185253,
        "inchi": "InChI=1S/C24H24N4O2/c1-30-20-8-6-19(7-9-20)26-24(29)28-14-21-23(22(15-28)27-21)18-4-2-16(3-5-18)17-10-12-25-13-11-17/h2-13,21-23,27H,14-15H2,1H3,(H,26,29)/t21-,22+,23?",
        "inchikey": "COQDKCRLRIUNRV-AIZNXBIQSA-N",
        "iupac": {
          "systematic": "(1R,5S)-N-(4-methoxyphenyl)-7-(4-pyridin-4-ylphenyl)-3,6-diazabicyclo[3.1.1]heptane-3-carboxamide"
        },
        "smiles": {
          "canonical": "COC1=CC=C(C=C1)NC(=O)N2CC3C(C(C2)N3)C4=CC=C(C=C4)C5=CC=NC=C5"
        },
        "molecularFormula": "C24H24N4O2"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:43:46Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85a7"
    },
    "name": "BRD-K88279116",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85a7.png",
    "lincs": {
      "id": "LSM-13851",
      "name": "BRD-K88279116",
      "pubchemCid": 54654165,
      "chebiId": 102502,
      "inchiParent": "InChI=1S/C24H25F2N3O5/c1-27-22(30)11-17-4-5-19-21(34-17)12-33-20-6-3-16(10-18(20)24(32)29(19)2)28-23(31)13-7-14(25)9-15(26)8-13/h3,6-10,17,19,21H,4-5,11-12H2,1-2H3,(H,27,30)(H,28,31)/t17-,19+,21+/m1/s1",
      "inchiKeyParent": "RQAOUBOGQGVTCU-LMNJBCLMSA-N",
      "smilesParent": "CNC(=O)C[C@H]1CC[C@H]2[C@H](COc3ccc(NC(=O)c4cc(F)cc(F)c4)cc3C(=O)N2C)O1"
    },
    "unichem": {
      "chebi": "102502",
      "lincs": "LSM-13851",
      "pubchem": "54654165"
    },
    "pubchem": [
      {
        "cid": 54654165,
        "inchi": "InChI=1S/C24H25F2N3O5/c1-27-22(30)11-17-4-5-19-21(34-17)12-33-20-6-3-16(10-18(20)24(32)29(19)2)28-23(31)13-7-14(25)9-15(26)8-13/h3,6-10,17,19,21H,4-5,11-12H2,1-2H3,(H,27,30)(H,28,31)/t17-,19+,21+/m1/s1",
        "inchikey": "RQAOUBOGQGVTCU-LMNJBCLMSA-N",
        "iupac": {
          "systematic": "N-[(2R,4aS,12aR)-5-methyl-2-[2-(methylamino)-2-oxoethyl]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-3,5-difluorobenzamide"
        },
        "smiles": {
          "canonical": "CNC(=O)CC1CCC2C(O1)COC3=C(C=C(C=C3)NC(=O)C4=CC(=CC(=C4)F)F)C(=O)N2C"
        },
        "molecularFormula": "C24H25F2N3O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:43:48Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85ce"
    },
    "name": "BRD-K00458136",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85ce.png",
    "lincs": {
      "id": "LSM-37307",
      "name": "BRD-K00458136",
      "pubchemCid": 44618831,
      "chebiId": 125738,
      "inchiParent": "InChI=1S/C34H43N5O6/c1-23-20-39(24(2)22-40)34(43)29-19-28(37-32(41)26-10-14-35-15-11-26)8-9-30(29)45-25(3)7-5-6-18-44-31(23)21-38(4)33(42)27-12-16-36-17-13-27/h8-17,19,23-25,31,40H,5-7,18,20-22H2,1-4H3,(H,37,41)/t23-,24-,25+,31+/m1/s1",
      "inchiKeyParent": "INBITKGVNBCCNN-CYOUBLJMSA-N",
      "smilesParent": "C[C@H](CO)N1C[C@@H](C)[C@H](CN(C)C(=O)c2ccncc2)OCCCC[C@H](C)Oc3ccc(NC(=O)c4ccncc4)cc3C1=O"
    },
    "unichem": {
      "chebi": "125738",
      "lincs": "LSM-37307",
      "pubchem": "44618831"
    },
    "pubchem": [
      {
        "cid": 44618831,
        "inchi": "InChI=1S/C34H43N5O6/c1-23-20-39(24(2)22-40)34(43)29-19-28(37-32(41)26-10-14-35-15-11-26)8-9-30(29)45-25(3)7-5-6-18-44-31(23)21-38(4)33(42)27-12-16-36-17-13-27/h8-17,19,23-25,31,40H,5-7,18,20-22H2,1-4H3,(H,37,41)/t23-,24-,25+,31+/m1/s1",
        "inchikey": "INBITKGVNBCCNN-CYOUBLJMSA-N",
        "iupac": {
          "systematic": "N-[(3S,9R,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(pyridine-4-carbonyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]pyridine-4-carboxamide"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NC(=O)C3=CC=NC=C3)C(C)CO)C)CN(C)C(=O)C4=CC=NC=C4"
        },
        "molecularFormula": "C34H43N5O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:43:50Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85df"
    },
    "name": "BRD-K79339982",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85df.png",
    "lincs": {
      "id": "LSM-13278",
      "name": "BRD-K79339982",
      "pubchemCid": 54646632,
      "chebiId": 101917,
      "inchiParent": "InChI=1S/C22H22F3N3O5/c23-22(24,25)11-27-19(30)8-14-7-16-15-6-13(28-21(31)12-2-1-5-26-9-12)3-4-17(15)33-20(16)18(10-29)32-14/h1-6,9,14,16,18,20,29H,7-8,10-11H2,(H,27,30)(H,28,31)/t14-,16+,18-,20-/m1/s1",
      "inchiKeyParent": "ILIPRRONQGJVHL-IHMNZUQTSA-N",
      "smilesParent": "OC[C@H]1O[C@@H](CC(=O)NCC(F)(F)F)C[C@@H]2[C@H]1Oc3ccc(NC(=O)c4cccnc4)cc23"
    },
    "unichem": {
      "chebi": "101917",
      "lincs": "LSM-13278",
      "pubchem": "54646632"
    },
    "pubchem": [
      {
        "cid": 54646632,
        "inchi": "InChI=1S/C22H22F3N3O5/c23-22(24,25)11-27-19(30)8-14-7-16-15-6-13(28-21(31)12-2-1-5-26-9-12)3-4-17(15)33-20(16)18(10-29)32-14/h1-6,9,14,16,18,20,29H,7-8,10-11H2,(H,27,30)(H,28,31)/t14-,16+,18-,20-/m1/s1",
        "inchikey": "ILIPRRONQGJVHL-IHMNZUQTSA-N",
        "iupac": {
          "systematic": "N-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]pyridine-3-carboxamide"
        },
        "smiles": {
          "canonical": "C1C(OC(C2C1C3=C(O2)C=CC(=C3)NC(=O)C4=CN=CC=C4)CO)CC(=O)NCC(F)(F)F"
        },
        "molecularFormula": "C22H22F3N3O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:43:53Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85fb"
    },
    "name": "BRD-K71197999",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85fb.png",
    "lincs": {
      "id": "LSM-12776",
      "name": "BRD-K71197999",
      "pubchemCid": 54649028,
      "chebiId": 101413,
      "inchiParent": "InChI=1S/C23H31ClFN3O5S/c1-16(13-28(17(2)15-29)23(30)26-21-11-6-5-10-20(21)25)22(33-4)14-27(3)34(31,32)19-9-7-8-18(24)12-19/h5-12,16-17,22,29H,13-15H2,1-4H3,(H,26,30)/t16-,17+,22+/m1/s1",
      "inchiKeyParent": "QUGGTUJVTWBVOW-JLHGSKIFSA-N",
      "smilesParent": "CO[C@@H](CN(C)S(=O)(=O)c1cccc(Cl)c1)[C@H](C)CN([C@@H](C)CO)C(=O)Nc2ccccc2F"
    },
    "unichem": {
      "chebi": "101413",
      "lincs": "LSM-12776",
      "pubchem": "54649028"
    },
    "pubchem": [
      {
        "cid": 54649028,
        "inchi": "InChI=1S/C23H31ClFN3O5S/c1-16(13-28(17(2)15-29)23(30)26-21-11-6-5-10-20(21)25)22(33-4)14-27(3)34(31,32)19-9-7-8-18(24)12-19/h5-12,16-17,22,29H,13-15H2,1-4H3,(H,26,30)/t16-,17+,22+/m1/s1",
        "inchikey": "QUGGTUJVTWBVOW-JLHGSKIFSA-N",
        "iupac": {
          "systematic": "1-[(2R,3R)-4-[(3-chlorophenyl)sulfonyl-methylamino]-3-methoxy-2-methylbutyl]-3-(2-fluorophenyl)-1-[(2S)-1-hydroxypropan-2-yl]urea"
        },
        "smiles": {
          "canonical": "CC(CN(C(C)CO)C(=O)NC1=CC=CC=C1F)C(CN(C)S(=O)(=O)C2=CC(=CC=C2)Cl)OC"
        },
        "molecularFormula": "C23H31ClFN3O5S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:43:55Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8618"
    },
    "name": "BRD-K09014535",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8618.png",
    "lincs": {
      "id": "LSM-37752",
      "name": "BRD-K09014535",
      "pubchemCid": 60189874,
      "chebiId": 126185,
      "inchiParent": "InChI=1S/C25H34N4O3/c1-32-18-8-9-19-20(10-18)27-23-21(12-30)28(11-16-6-7-16)13-25(22(19)23)14-29(15-25)24(31)26-17-4-2-3-5-17/h8-10,16-17,21,27,30H,2-7,11-15H2,1H3,(H,26,31)/t21-/m1/s1",
      "inchiKeyParent": "YOMIOEXLRSAPBQ-OAQYLSRUSA-N",
      "smilesParent": "COc1ccc2c3c([nH]c2c1)[C@@H](CO)N(CC4CC4)CC35CN(C5)C(=O)NC6CCCC6"
    },
    "unichem": {
      "chebi": "126185",
      "lincs": "LSM-37752",
      "pubchem": "60189874"
    },
    "pubchem": [
      {
        "cid": 60189874,
        "inchi": "InChI=1S/C25H34N4O3/c1-32-18-8-9-19-20(10-18)27-23-21(12-30)28(11-16-6-7-16)13-25(22(19)23)14-29(15-25)24(31)26-17-4-2-3-5-17/h8-10,16-17,21,27,30H,2-7,11-15H2,1H3,(H,26,31)/t21-/m1/s1",
        "inchikey": "YOMIOEXLRSAPBQ-OAQYLSRUSA-N",
        "iupac": {
          "systematic": "(1S)-N-cyclopentyl-2-(cyclopropylmethyl)-1-(hydroxymethyl)-7-methoxyspiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3'-azetidine]-1'-carboxamide"
        },
        "smiles": {
          "canonical": "COC1=CC2=C(C=C1)C3=C(N2)C(N(CC34CN(C4)C(=O)NC5CCCC5)CC6CC6)CO"
        },
        "molecularFormula": "C25H34N4O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:43:57Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8629"
    },
    "name": "CHEMBL3183896",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8629.png",
    "lincs": {
      "id": "LSM-44923",
      "name": "CHEMBL3183896",
      "alternativeNames": [
        "BRD-K97516320"
      ],
      "pubchemCid": 54651324,
      "inchiParent": "InChI=1S/C24H31N3O2/c1-4-7-18-9-11-19(12-10-18)23-21(26-22(23)16-28)15-27(14-17(2)3)24(29)20-8-5-6-13-25-20/h4-13,17,21-23,26,28H,14-16H2,1-3H3/b7-4+/t21-,22-,23-/m0/s1",
      "inchiKeyParent": "OBKJPIVUKOQMKX-OKLUWZQDSA-N",
      "smilesParent": "C\\C=C\\c1ccc(cc1)[C@@H]2[C@H](CO)N[C@H]2CN(CC(C)C)C(=O)c3ccccn3"
    },
    "unichem": {
      "chembl": "CHEMBL3183896",
      "lincs": "LSM-44923",
      "pubchem": "54651324"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL3183896",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 393.53,
        "hba": 4,
        "hbd": 2,
        "qedWeighted": 0.72
      }
    },
    "pubchem": [
      {
        "cid": 54651324,
        "inchi": "InChI=1S/C24H31N3O2/c1-4-7-18-9-11-19(12-10-18)23-21(26-22(23)16-28)15-27(14-17(2)3)24(29)20-8-5-6-13-25-20/h4-13,17,21-23,26,28H,14-16H2,1-3H3/b7-4+/t21-,22-,23-/m0/s1",
        "inchikey": "OBKJPIVUKOQMKX-OKLUWZQDSA-N",
        "iupac": {
          "systematic": "N-[[(2R,3S,4R)-4-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]azetidin-2-yl]methyl]-N-(2-methylpropyl)pyridine-2-carboxamide"
        },
        "smiles": {
          "canonical": "CC=CC1=CC=C(C=C1)C2C(NC2CO)CN(CC(C)C)C(=O)C3=CC=CC=N3"
        },
        "molecularFormula": "C24H31N3O2"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:44:08Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8644"
    },
    "name": "BRD-K01245760",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8644.png",
    "lincs": {
      "id": "LSM-8509",
      "name": "BRD-K01245760",
      "pubchemCid": 54654450,
      "chebiId": 97130,
      "inchiParent": "InChI=1S/C25H25ClF3N3O5/c1-32-19-8-7-15(11-22(33)30-13-25(27,28)29)37-21(19)12-36-20-9-6-14(10-17(20)24(32)35)31-23(34)16-4-2-3-5-18(16)26/h2-6,9-10,15,19,21H,7-8,11-13H2,1H3,(H,30,33)(H,31,34)/t15-,19-,21-/m1/s1",
      "inchiKeyParent": "KEGRQPVLAXHQPZ-QFIXIFRTSA-N",
      "smilesParent": "CN1[C@@H]2CC[C@H](CC(=O)NCC(F)(F)F)O[C@@H]2COc3ccc(NC(=O)c4ccccc4Cl)cc3C1=O"
    },
    "unichem": {
      "chebi": "97130",
      "lincs": "LSM-8509",
      "pubchem": "54654450"
    },
    "pubchem": [
      {
        "cid": 54654450,
        "inchi": "InChI=1S/C25H25ClF3N3O5/c1-32-19-8-7-15(11-22(33)30-13-25(27,28)29)37-21(19)12-36-20-9-6-14(10-17(20)24(32)35)31-23(34)16-4-2-3-5-18(16)26/h2-6,9-10,15,19,21H,7-8,11-13H2,1H3,(H,30,33)(H,31,34)/t15-,19-,21-/m1/s1",
        "inchikey": "KEGRQPVLAXHQPZ-QFIXIFRTSA-N",
        "iupac": {
          "systematic": "N-[(2R,4aR,12aS)-5-methyl-6-oxo-2-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-2-chlorobenzamide"
        },
        "smiles": {
          "canonical": "CN1C2CCC(OC2COC3=C(C1=O)C=C(C=C3)NC(=O)C4=CC=CC=C4Cl)CC(=O)NCC(F)(F)F"
        },
        "molecularFormula": "C25H25ClF3N3O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:44:11Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8529"
    },
    "name": "BRD-K17630163",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8529.png",
    "lincs": {
      "id": "LSM-14741",
      "name": "BRD-K17630163",
      "pubchemCid": 44617305,
      "chebiId": 103397,
      "inchiParent": "InChI=1S/C30H51N5O6/c1-19(2)31-29(38)33-24-12-13-26-25(15-24)28(37)35(22(6)18-36)16-21(5)27(17-34(8)30(39)32-20(3)4)40-14-10-9-11-23(7)41-26/h12-13,15,19-23,27,36H,9-11,14,16-18H2,1-8H3,(H,32,39)(H2,31,33,38)/t21-,22+,23-,27+/m1/s1",
      "inchiKeyParent": "HPPNONYMLIWSNI-IDIXZGLXSA-N",
      "smilesParent": "CC(C)NC(=O)Nc1ccc2O[C@H](C)CCCCO[C@@H](CN(C)C(=O)NC(C)C)[C@H](C)CN([C@@H](C)CO)C(=O)c2c1"
    },
    "unichem": {
      "chebi": "103397",
      "lincs": "LSM-14741",
      "pubchem": "44617305"
    },
    "pubchem": [
      {
        "cid": 44617305,
        "inchi": "InChI=1S/C30H51N5O6/c1-19(2)31-29(38)33-24-12-13-26-25(15-24)28(37)35(22(6)18-36)16-21(5)27(17-34(8)30(39)32-20(3)4)40-14-10-9-11-23(7)41-26/h12-13,15,19-23,27,36H,9-11,14,16-18H2,1-8H3,(H,32,39)(H2,31,33,38)/t21-,22+,23-,27+/m1/s1",
        "inchikey": "HPPNONYMLIWSNI-IDIXZGLXSA-N",
        "iupac": {
          "systematic": "1-[[(3R,9R,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-(propan-2-ylcarbamoylamino)-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-propan-2-ylurea"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NC(=O)NC(C)C)C(C)CO)C)CN(C)C(=O)NC(C)C"
        },
        "molecularFormula": "C30H51N5O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:44:13Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c852c"
    },
    "name": "BRD-K66888355",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c852c.png",
    "lincs": {
      "id": "LSM-40922",
      "name": "BRD-K66888355",
      "pubchemCid": 44501791,
      "chebiId": 129371,
      "inchiParent": "InChI=1S/C33H56N4O5/c1-23(2)34-33(40)35-28-15-16-30-29(18-28)32(39)37(25(4)22-38)19-24(3)31(41-17-11-10-12-26(5)42-30)21-36(6)20-27-13-8-7-9-14-27/h15-16,18,23-27,31,38H,7-14,17,19-22H2,1-6H3,(H2,34,35,40)/t24-,25+,26+,31-/m0/s1",
      "inchiKeyParent": "LVWPDIFFHCBIRV-PXFJVXAFSA-N",
      "smilesParent": "CC(C)NC(=O)Nc1ccc2O[C@H](C)CCCCO[C@@H](CN(C)CC3CCCCC3)[C@@H](C)CN([C@H](C)CO)C(=O)c2c1"
    },
    "unichem": {
      "chebi": "129371",
      "lincs": "LSM-40922",
      "pubchem": "44501791"
    },
    "pubchem": [
      {
        "cid": 44501791,
        "inchi": "InChI=1S/C33H56N4O5/c1-23(2)34-33(40)35-28-15-16-30-29(18-28)32(39)37(25(4)22-38)19-24(3)31(41-17-11-10-12-26(5)42-30)21-36(6)20-27-13-8-7-9-14-27/h15-16,18,23-27,31,38H,7-14,17,19-22H2,1-6H3,(H2,34,35,40)/t24-,25+,26+,31-/m0/s1",
        "inchikey": "LVWPDIFFHCBIRV-PXFJVXAFSA-N",
        "iupac": {
          "systematic": "1-[(3R,9R,10S)-9-[[cyclohexylmethyl(methyl)amino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-propan-2-ylurea"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NC(=O)NC(C)C)C(C)CO)C)CN(C)CC3CCCCC3"
        },
        "molecularFormula": "C33H56N4O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:44:15Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8555"
    },
    "name": "BRD-K23414424",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8555.png",
    "lincs": {
      "id": "LSM-9840",
      "name": "BRD-K23414424",
      "pubchemCid": 54654186,
      "chebiId": 98461,
      "inchiParent": "InChI=1S/C28H33N3O6/c1-30-23-9-8-21(14-27(33)31-12-11-18-5-3-4-6-19(18)15-31)37-25(23)16-36-24-10-7-20(13-22(24)28(30)34)29-26(32)17-35-2/h3-7,10,13,21,23,25H,8-9,11-12,14-17H2,1-2H3,(H,29,32)/t21-,23+,25-/m1/s1",
      "inchiKeyParent": "HUCZTLCWVGQLCW-NMVJMZGASA-N",
      "smilesParent": "COCC(=O)Nc1ccc2OC[C@H]3O[C@@H](CC(=O)N4CCc5ccccc5C4)CC[C@@H]3N(C)C(=O)c2c1"
    },
    "unichem": {
      "chebi": "98461",
      "lincs": "LSM-9840",
      "pubchem": "54654186"
    },
    "pubchem": [
      {
        "cid": 54654186,
        "inchi": "InChI=1S/C28H33N3O6/c1-30-23-9-8-21(14-27(33)31-12-11-18-5-3-4-6-19(18)15-31)37-25(23)16-36-24-10-7-20(13-22(24)28(30)34)29-26(32)17-35-2/h3-7,10,13,21,23,25H,8-9,11-12,14-17H2,1-2H3,(H,29,32)/t21-,23+,25-/m1/s1",
        "inchikey": "HUCZTLCWVGQLCW-NMVJMZGASA-N",
        "iupac": {
          "systematic": "N-[(2R,4aS,12aS)-2-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-2-methoxyacetamide"
        },
        "smiles": {
          "canonical": "CN1C2CCC(OC2COC3=C(C1=O)C=C(C=C3)NC(=O)COC)CC(=O)N4CCC5=CC=CC=C5C4"
        },
        "molecularFormula": "C28H33N3O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:44:17Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8597"
    },
    "name": "BRD-K87458009",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8597.png",
    "lincs": {
      "id": "LSM-42038",
      "name": "BRD-K87458009",
      "pubchemCid": 60190036,
      "chebiId": 130489,
      "inchiParent": "InChI=1S/C23H29N5O6S/c1-5-35(31,32)27-10-23(11-27)12-28(22(30)25-20-13(2)26-34-14(20)3)18(9-29)21-19(23)16-7-6-15(33-4)8-17(16)24-21/h6-8,18,24,29H,5,9-12H2,1-4H3,(H,25,30)/t18-/m1/s1",
      "inchiKeyParent": "DXDVJROCPRKFRC-GOSISDBHSA-N",
      "smilesParent": "CCS(=O)(=O)N1CC2(C1)CN([C@H](CO)c3[nH]c4cc(OC)ccc4c23)C(=O)Nc5c(C)onc5C"
    },
    "unichem": {
      "chebi": "130489",
      "lincs": "LSM-42038",
      "pubchem": "60190036"
    },
    "pubchem": [
      {
        "cid": 60190036,
        "inchi": "InChI=1S/C23H29N5O6S/c1-5-35(31,32)27-10-23(11-27)12-28(22(30)25-20-13(2)26-34-14(20)3)18(9-29)21-19(23)16-7-6-15(33-4)8-17(16)24-21/h6-8,18,24,29H,5,9-12H2,1-4H3,(H,25,30)/t18-/m1/s1",
        "inchikey": "DXDVJROCPRKFRC-GOSISDBHSA-N",
        "iupac": {
          "systematic": "(1S)-N-(3,5-dimethyl-1,2-oxazol-4-yl)-1'-ethylsulfonyl-1-(hydroxymethyl)-7-methoxyspiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3'-azetidine]-2-carboxamide"
        },
        "smiles": {
          "canonical": "CCS(=O)(=O)N1CC2(C1)CN(C(C3=C2C4=C(N3)C=C(C=C4)OC)CO)C(=O)NC5=C(ON=C5C)C"
        },
        "molecularFormula": "C23H29N5O6S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:44:19Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85e5"
    },
    "name": "BRD-K86323620",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85e5.png",
    "lincs": {
      "id": "LSM-13714",
      "name": "BRD-K86323620",
      "pubchemCid": 54646670,
      "chebiId": 102362,
      "inchiParent": "InChI=1S/C26H31FN2O6S/c27-16-6-9-20(10-7-16)36(32,33)29-18-8-11-23-21(12-18)22-13-19(34-24(15-30)26(22)35-23)14-25(31)28-17-4-2-1-3-5-17/h6-12,17,19,22,24,26,29-30H,1-5,13-15H2,(H,28,31)/t19-,22-,24+,26+/m0/s1",
      "inchiKeyParent": "SGAJFFANPLXWDT-TUTLFNSSSA-N",
      "smilesParent": "OC[C@H]1O[C@H](CC(=O)NC2CCCCC2)C[C@@H]3[C@H]1Oc4ccc(NS(=O)(=O)c5ccc(F)cc5)cc34"
    },
    "unichem": {
      "chebi": "102362",
      "lincs": "LSM-13714",
      "pubchem": "54646670"
    },
    "pubchem": [
      {
        "cid": 54646670,
        "inchi": "InChI=1S/C26H31FN2O6S/c27-16-6-9-20(10-7-16)36(32,33)29-18-8-11-23-21(12-18)22-13-19(34-24(15-30)26(22)35-23)14-25(31)28-17-4-2-1-3-5-17/h6-12,17,19,22,24,26,29-30H,1-5,13-15H2,(H,28,31)/t19-,22-,24+,26+/m0/s1",
        "inchikey": "SGAJFFANPLXWDT-TUTLFNSSSA-N",
        "iupac": {
          "systematic": "2-[(1R,3S,4aS,9aR)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-cyclohexylacetamide"
        },
        "smiles": {
          "canonical": "C1CCC(CC1)NC(=O)CC2CC3C(C(O2)CO)OC4=C3C=C(C=C4)NS(=O)(=O)C5=CC=C(C=C5)F"
        },
        "molecularFormula": "C26H31FN2O6S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:44:22Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85f9"
    },
    "name": "BRD-K20159808",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85f9.png",
    "lincs": {
      "id": "LSM-9656",
      "name": "BRD-K20159808",
      "pubchemCid": 54657477,
      "chebiId": 98277,
      "inchiParent": "InChI=1S/C19H28N2O6S/c1-28(24,25)21-11-15(22)12-26-13-18-17(21)8-7-16(27-18)9-19(23)20-10-14-5-3-2-4-6-14/h2-6,15-18,22H,7-13H2,1H3,(H,20,23)/t15-,16-,17+,18-/m1/s1",
      "inchiKeyParent": "CRYMYAPOZVNFQJ-ZJPYXAASSA-N",
      "smilesParent": "CS(=O)(=O)N1C[C@@H](O)COC[C@H]2O[C@@H](CC(=O)NCc3ccccc3)CC[C@H]12"
    },
    "unichem": {
      "chebi": "98277",
      "lincs": "LSM-9656",
      "pubchem": "54657477"
    },
    "pubchem": [
      {
        "cid": 54657477,
        "inchi": "InChI=1S/C19H28N2O6S/c1-28(24,25)21-11-15(22)12-26-13-18-17(21)8-7-16(27-18)9-19(23)20-10-14-5-3-2-4-6-14/h2-6,15-18,22H,7-13H2,1H3,(H,20,23)/t15-,16-,17+,18-/m1/s1",
        "inchikey": "CRYMYAPOZVNFQJ-ZJPYXAASSA-N",
        "iupac": {
          "systematic": "2-[(3R,6aS,8R,10aS)-3-hydroxy-1-methylsulfonyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-benzylacetamide"
        },
        "smiles": {
          "canonical": "CS(=O)(=O)N1CC(COCC2C1CCC(O2)CC(=O)NCC3=CC=CC=C3)O"
        },
        "molecularFormula": "C19H28N2O6S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:44:24Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84fa"
    },
    "name": "BRD-K95270854",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84fa.png",
    "lincs": {
      "id": "LSM-42433",
      "name": "BRD-K95270854",
      "pubchemCid": 60190964,
      "chebiId": 130884,
      "inchiParent": "InChI=1S/C24H21FN4O3/c25-18-3-1-2-17(10-18)15-4-6-16(7-5-15)23-20-12-28(13-22(31)29(20)21(23)14-30)24(32)19-11-26-8-9-27-19/h1-11,20-21,23,30H,12-14H2/t20-,21+,23-/m1/s1",
      "inchiKeyParent": "RBGWWDWZZPGPAM-FUPPJEDESA-N",
      "smilesParent": "OC[C@H]1[C@@H]([C@H]2CN(CC(=O)N12)C(=O)c3cnccn3)c4ccc(cc4)c5cccc(F)c5"
    },
    "unichem": {
      "chebi": "130884",
      "lincs": "LSM-42433",
      "pubchem": "60190964"
    },
    "pubchem": [
      {
        "cid": 60190964,
        "inchi": "InChI=1S/C24H21FN4O3/c25-18-3-1-2-17(10-18)15-4-6-16(7-5-15)23-20-12-28(13-22(31)29(20)21(23)14-30)24(32)19-11-26-8-9-27-19/h1-11,20-21,23,30H,12-14H2/t20-,21+,23-/m1/s1",
        "inchikey": "RBGWWDWZZPGPAM-FUPPJEDESA-N",
        "iupac": {
          "systematic": "(6S,7R,8R)-7-[4-(3-fluorophenyl)phenyl]-8-(hydroxymethyl)-4-(pyrazine-2-carbonyl)-1,4-diazabicyclo[4.2.0]octan-2-one"
        },
        "smiles": {
          "canonical": "C1C2C(C(N2C(=O)CN1C(=O)C3=NC=CN=C3)CO)C4=CC=C(C=C4)C5=CC(=CC=C5)F"
        },
        "molecularFormula": "C24H21FN4O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:44:26Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c853b"
    },
    "name": "BRD-K20148542",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c853b.png",
    "lincs": {
      "id": "LSM-9655",
      "name": "BRD-K20148542",
      "pubchemCid": 54646271,
      "chebiId": 98276,
      "inchiParent": "InChI=1S/C30H33N3O6/c1-37-22-10-7-20(8-11-22)32-30(36)33-21-9-12-26-24(15-21)25-16-23(38-27(18-34)29(25)39-26)17-28(35)31-14-13-19-5-3-2-4-6-19/h2-12,15,23,25,27,29,34H,13-14,16-18H2,1H3,(H,31,35)(H2,32,33,36)/t23-,25+,27+,29-/m1/s1",
      "inchiKeyParent": "FOSRSIPYUZSGIW-KYYACDKCSA-N",
      "smilesParent": "COc1ccc(NC(=O)Nc2ccc3O[C@H]4[C@H](CO)O[C@@H](CC(=O)NCCc5ccccc5)C[C@H]4c3c2)cc1"
    },
    "unichem": {
      "chebi": "98276",
      "lincs": "LSM-9655",
      "pubchem": "54646271"
    },
    "pubchem": [
      {
        "cid": 54646271,
        "inchi": "InChI=1S/C30H33N3O6/c1-37-22-10-7-20(8-11-22)32-30(36)33-21-9-12-26-24(15-21)25-16-23(38-27(18-34)29(25)39-26)17-28(35)31-14-13-19-5-3-2-4-6-19/h2-12,15,23,25,27,29,34H,13-14,16-18H2,1H3,(H,31,35)(H2,32,33,36)/t23-,25+,27+,29-/m1/s1",
        "inchikey": "FOSRSIPYUZSGIW-KYYACDKCSA-N",
        "iupac": {
          "systematic": "2-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-6-[(4-methoxyphenyl)carbamoylamino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-(2-phenylethyl)acetamide"
        },
        "smiles": {
          "canonical": "COC1=CC=C(C=C1)NC(=O)NC2=CC3=C(C=C2)OC4C3CC(OC4CO)CC(=O)NCCC5=CC=CC=C5"
        },
        "molecularFormula": "C30H33N3O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:44:28Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83c4"
    },
    "name": "Tamatinib",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83c4.png",
    "lincs": {
      "id": "LSM-1040",
      "name": "Tamatinib",
      "alternativeNames": [
        "R406",
        "R-406",
        "R406 (FREE BASE)"
      ],
      "pubchemCid": 11213558,
      "chebiId": 91348,
      "inchiParent": "InChI=1S/C22H23FN6O5/c1-22(2)20(30)28-19-13(34-22)6-7-16(27-19)26-18-12(23)10-24-21(29-18)25-11-8-14(31-3)17(33-5)15(9-11)32-4/h6-10H,1-5H3,(H3,24,25,26,27,28,29,30)",
      "inchiKeyParent": "NHHQJBCNYHBUSI-UHFFFAOYSA-N",
      "smilesParent": "COc1cc(Nc2ncc(F)c(Nc3ccc4OC(C)(C)C(=O)Nc4n3)n2)cc(OC)c1OC"
    },
    "unichem": {
      "chebi": "91348",
      "chembl": "CHEMBL475251",
      "lincs": "LSM-1040",
      "pubchem": "11213558",
      "drugbank": "DB07159"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL475251",
      "prefName": "R-406",
      "maxPhase": 2.0,
      "maxPhaseCurated": "Phase 2 Clinical Trials",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 470.46,
        "hba": 10,
        "hbd": 3,
        "qedWeighted": 0.47
      },
      "moleculeSynonyms": [
        {
          "moleculeSynonym": "R-406",
          "synType": "OTHER",
          "synonyms": "R-406"
        },
        {
          "moleculeSynonym": "R-406",
          "synType": "RESEARCH_CODE",
          "synonyms": "R-406"
        },
        {
          "moleculeSynonym": "R940406",
          "synType": "OTHER",
          "synonyms": "R940406"
        },
        {
          "moleculeSynonym": "Tamatinib",
          "synType": "OTHER",
          "synonyms": "TAMATINIB"
        }
      ],
      "drugMechanisms": [
        {
          "mechanismOfAction": "Tyrosine-protein kinase SYK inhibitor",
          "actionType": "INHIBITOR",
          "targetName": "Tyrosine-protein kinase SYK",
          "targetOrganism": "Homo sapiens",
          "targetType": "SINGLE PROTEIN",
          "targetComponents": [
            {
              "uniprot": [
                "P43405"
              ]
            }
          ]
        }
      ]
    },
    "pubchem": [
      {
        "cid": 11213558,
        "inchi": "InChI=1S/C22H23FN6O5/c1-22(2)20(30)28-19-13(34-22)6-7-16(27-19)26-18-12(23)10-24-21(29-18)25-11-8-14(31-3)17(33-5)15(9-11)32-4/h6-10H,1-5H3,(H3,24,25,26,27,28,29,30)",
        "inchikey": "NHHQJBCNYHBUSI-UHFFFAOYSA-N",
        "iupac": {
          "systematic": "6-[[5-fluoro-2-(3,4,5-trimethoxyanilino)pyrimidin-4-yl]amino]-2,2-dimethyl-4H-pyrido[3,2-b][1,4]oxazin-3-one"
        },
        "smiles": {
          "canonical": "CC1(C(=O)NC2=C(O1)C=CC(=N2)NC3=NC(=NC=C3F)NC4=CC(=C(C(=C4)OC)OC)OC)C"
        },
        "molecularFormula": "C22H23FN6O5"
      }
    ],
    "clinicaltrials": [
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT03246074",
            "briefTitle": "Clinical Trial of Combined Fostamatinib and Paclitaxel in Ovarian Cancer",
            "officialTitle": "Phase I Clinical Trial of Combined Fostamatinib and Paclitaxel in Ovarian Cancer"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2017-06-15",
            "resultsFirstSubmitDate": "2024-03-11"
          },
          "conditionsModule": {
            "conditions": [
              "Ovarian Cancer"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Safety and Tolerability of Fostamatinib",
                "timeFrame": "First cycle (28 days) of treatment"
              },
              {
                "measure": "Maximum Tolerated Dose (MTD) of Fostamatinib",
                "timeFrame": "28 days"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Objective Response Rate in the Study Population Treated With the Combination of Fostamatinib and Paclitaxel"
              },
              {
                "measure": "Progression-free Survival in the Study Population Treated With the Combination of Fostamatinib and Paclitaxel"
              },
              {
                "measure": "Pharmacokinetic (PK) Profile of Fostamatinib When Combined With Weekly Paclitaxel - Tmax"
              },
              {
                "measure": "Pharmacokinetic (PK) Profile of Fostamatinib When Combined With Weekly Paclitaxel - Cmax"
              },
              {
                "measure": "Pharmacokinetic (PK) Profile of Fostamatinib When Combined With Weekly Paclitaxel - Area Under the Curve (AUC) 0-6hours"
              }
            ]
          }
        }
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:44:40Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83f7"
    },
    "name": "BRD-K13660244",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83f7.png",
    "lincs": {
      "id": "LSM-37973",
      "name": "BRD-K13660244",
      "pubchemCid": 44492755,
      "chebiId": 126408,
      "inchiParent": "InChI=1S/C32H35F3N4O5/c1-20-17-39(21(2)19-40)30(42)26-16-25(36-29(41)15-22-7-5-4-6-8-22)13-14-27(26)44-28(20)18-38(3)31(43)37-24-11-9-23(10-12-24)32(33,34)35/h4-14,16,20-21,28,40H,15,17-19H2,1-3H3,(H,36,41)(H,37,43)/t20-,21+,28-/m0/s1",
      "inchiKeyParent": "PRDAOTFPZPBVJB-GTNJKRJXSA-N",
      "smilesParent": "C[C@H](CO)N1C[C@H](C)[C@H](CN(C)C(=O)Nc2ccc(cc2)C(F)(F)F)Oc3ccc(NC(=O)Cc4ccccc4)cc3C1=O"
    },
    "unichem": {
      "chebi": "126408",
      "lincs": "LSM-37973",
      "pubchem": "44492755"
    },
    "pubchem": [
      {
        "cid": 44492755,
        "inchi": "InChI=1S/C32H35F3N4O5/c1-20-17-39(21(2)19-40)30(42)26-16-25(36-29(41)15-22-7-5-4-6-8-22)13-14-27(26)44-28(20)18-38(3)31(43)37-24-11-9-23(10-12-24)32(33,34)35/h4-14,16,20-21,28,40H,15,17-19H2,1-3H3,(H,36,41)(H,37,43)/t20-,21+,28-/m0/s1",
        "inchikey": "PRDAOTFPZPBVJB-GTNJKRJXSA-N",
        "iupac": {
          "systematic": "N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]carbamoyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-2-phenylacetamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(C=CC(=C2)NC(=O)CC3=CC=CC=C3)OC1CN(C)C(=O)NC4=CC=C(C=C4)C(F)(F)F)C(C)CO"
        },
        "molecularFormula": "C32H35F3N4O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:44:42Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c840a"
    },
    "name": "BRD-K53198520",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c840a.png",
    "lincs": {
      "id": "LSM-40193",
      "name": "BRD-K53198520",
      "pubchemCid": 44494878,
      "chebiId": 128639,
      "inchiParent": "InChI=1S/C28H34N4O6S/c1-18-15-32(19(2)17-33)27(34)22-12-8-14-24(30-39(4,36)37)26(22)38-25(18)16-31(3)28(35)29-23-13-7-10-20-9-5-6-11-21(20)23/h5-14,18-19,25,30,33H,15-17H2,1-4H3,(H,29,35)/t18-,19-,25-/m0/s1",
      "inchiKeyParent": "ZCTHAUMPHRHCFX-MHPIHPPYSA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@H](C)[C@H](CN(C)C(=O)Nc2cccc3ccccc23)Oc4c(NS(=O)(=O)C)cccc4C1=O"
    },
    "unichem": {
      "chebi": "128639",
      "lincs": "LSM-40193",
      "pubchem": "44494878"
    },
    "pubchem": [
      {
        "cid": 44494878,
        "inchi": "InChI=1S/C28H34N4O6S/c1-18-15-32(19(2)17-33)27(34)22-12-8-14-24(30-39(4,36)37)26(22)38-25(18)16-31(3)28(35)29-23-13-7-10-20-9-5-6-11-21(20)23/h5-14,18-19,25,30,33H,15-17H2,1-4H3,(H,29,35)/t18-,19-,25-/m0/s1",
        "inchikey": "ZCTHAUMPHRHCFX-MHPIHPPYSA-N",
        "iupac": {
          "systematic": "1-[[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-10-(methanesulfonamido)-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-naphthalen-1-ylurea"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(C(=CC=C2)NS(=O)(=O)C)OC1CN(C)C(=O)NC3=CC=CC4=CC=CC=C43)C(C)CO"
        },
        "molecularFormula": "C28H34N4O6S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:44:45Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8372"
    },
    "name": "BRD-K25743534",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8372.png",
    "lincs": {
      "id": "LSM-38674",
      "name": "BRD-K25743534",
      "pubchemCid": 44487692,
      "chebiId": 127112,
      "inchiParent": "InChI=1S/C31H39N5O5/c1-19(2)32-30(39)33-23-13-14-27-25(15-23)29(38)36(21(4)18-37)16-20(3)28(41-27)17-35(5)31(40)34-26-12-8-10-22-9-6-7-11-24(22)26/h6-15,19-21,28,37H,16-18H2,1-5H3,(H,34,40)(H2,32,33,39)/t20-,21-,28+/m1/s1",
      "inchiKeyParent": "KYHZFTDIMWCHFE-CJYOKPGZSA-N",
      "smilesParent": "CC(C)NC(=O)Nc1ccc2O[C@@H](CN(C)C(=O)Nc3cccc4ccccc34)[C@H](C)CN([C@H](C)CO)C(=O)c2c1"
    },
    "unichem": {
      "chebi": "127112",
      "lincs": "LSM-38674",
      "pubchem": "44487692"
    },
    "pubchem": [
      {
        "cid": 44487692,
        "inchi": "InChI=1S/C31H39N5O5/c1-19(2)32-30(39)33-23-13-14-27-25(15-23)29(38)36(21(4)18-37)16-20(3)28(41-27)17-35(5)31(40)34-26-12-8-10-22-9-6-7-11-24(22)26/h6-15,19-21,28,37H,16-18H2,1-5H3,(H,34,40)(H2,32,33,39)/t20-,21-,28+/m1/s1",
        "inchikey": "KYHZFTDIMWCHFE-CJYOKPGZSA-N",
        "iupac": {
          "systematic": "1-[[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-(propan-2-ylcarbamoylamino)-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-naphthalen-1-ylurea"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(C=CC(=C2)NC(=O)NC(C)C)OC1CN(C)C(=O)NC3=CC=CC4=CC=CC=C43)C(C)CO"
        },
        "molecularFormula": "C31H39N5O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:44:47Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83e8"
    },
    "name": "BRD-K47492310",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83e8.png",
    "lincs": {
      "id": "LSM-39900",
      "name": "BRD-K47492310",
      "pubchemCid": 54649700,
      "chebiId": 128345,
      "inchiParent": "InChI=1S/C22H29N3O5/c1-14-21(26)24(2)11-10-16-8-9-18(28-4)19(30-16)13-29-20-15(12-23)6-5-7-17(20)22(27)25(14)3/h5-7,14,16,18-19H,8-11,13H2,1-4H3/t14-,16+,18-,19-/m0/s1",
      "inchiKeyParent": "HLSMAPUQSFTYPM-FXECBMLZSA-N",
      "smilesParent": "CO[C@H]1CC[C@@H]2CCN(C)C(=O)[C@H](C)N(C)C(=O)c3cccc(C#N)c3OC[C@@H]1O2"
    },
    "unichem": {
      "chebi": "128345",
      "lincs": "LSM-39900",
      "pubchem": "54649700"
    },
    "pubchem": [
      {
        "cid": 54649700,
        "inchi": "InChI=1S/C22H29N3O5/c1-14-21(26)24(2)11-10-16-8-9-18(28-4)19(30-16)13-29-20-15(12-23)6-5-7-17(20)22(27)25(14)3/h5-7,14,16,18-19H,8-11,13H2,1-4H3/t14-,16+,18-,19-/m0/s1",
        "inchikey": "HLSMAPUQSFTYPM-FXECBMLZSA-N",
        "iupac": {
          "systematic": "(1S,12S,17R,20S)-20-methoxy-11,12,14-trimethyl-10,13-dioxo-3,21-dioxa-11,14-diazatricyclo[15.3.1.04,9]henicosa-4,6,8-triene-5-carbonitrile"
        },
        "smiles": {
          "canonical": "CC1C(=O)N(CCC2CCC(C(O2)COC3=C(C=CC=C3C(=O)N1C)C#N)OC)C"
        },
        "molecularFormula": "C22H29N3O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:44:49Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8418"
    },
    "name": "BRD-K86762131",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8418.png",
    "lincs": {
      "id": "LSM-7959",
      "name": "BRD-K86762131",
      "pubchemCid": 54618396,
      "chebiId": 96580,
      "inchiParent": "InChI=1S/C26H32N4O5/c1-17-14-30(18(2)16-31)26(34)22-11-21(6-5-19(3)32)13-28-25(22)35-23(17)15-29(4)24(33)12-20-7-9-27-10-8-20/h7-11,13,17-19,23,31-32H,12,14-16H2,1-4H3/t17-,18+,19-,23-/m0/s1",
      "inchiKeyParent": "XXZIILLLBOPLBY-YWNPBTLJSA-N",
      "smilesParent": "C[C@H](O)C#Cc1cnc2O[C@@H](CN(C)C(=O)Cc3ccncc3)[C@@H](C)CN([C@H](C)CO)C(=O)c2c1"
    },
    "unichem": {
      "chebi": "96580",
      "lincs": "LSM-7959",
      "pubchem": "54618396"
    },
    "pubchem": [
      {
        "cid": 54618396,
        "inchi": "InChI=1S/C26H32N4O5/c1-17-14-30(18(2)16-31)26(34)22-11-21(6-5-19(3)32)13-28-25(22)35-23(17)15-29(4)24(33)12-20-7-9-27-10-8-20/h7-11,13,17-19,23,31-32H,12,14-16H2,1-4H3/t17-,18+,19-,23-/m0/s1",
        "inchikey": "XXZIILLLBOPLBY-YWNPBTLJSA-N",
        "iupac": {
          "systematic": "N-[[(2R,3S)-8-[(3S)-3-hydroxybut-1-ynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-pyridin-4-ylacetamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(N=CC(=C2)C#CC(C)O)OC1CN(C)C(=O)CC3=CC=NC=C3)C(C)CO"
        },
        "molecularFormula": "C26H32N4O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:44:52Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83c1"
    },
    "name": "BRD-K43249401",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83c1.png",
    "lincs": {
      "id": "LSM-11058",
      "name": "BRD-K43249401",
      "pubchemCid": 54639014,
      "chebiId": 99679,
      "inchiParent": "InChI=1S/C17H28N2O4/c20-10-15-14(19-17(22)12-2-1-3-12)7-6-13(23-15)8-16(21)18-9-11-4-5-11/h11-15,20H,1-10H2,(H,18,21)(H,19,22)/t13-,14-,15+/m0/s1",
      "inchiKeyParent": "MSNHHRRUCLPTHC-SOUVJXGZSA-N",
      "smilesParent": "OC[C@H]1O[C@H](CC(=O)NCC2CC2)CC[C@@H]1NC(=O)C3CCC3"
    },
    "unichem": {
      "chebi": "99679",
      "lincs": "LSM-11058",
      "pubchem": "54639014"
    },
    "pubchem": [
      {
        "cid": 54639014,
        "inchi": "InChI=1S/C17H28N2O4/c20-10-15-14(19-17(22)12-2-1-3-12)7-6-13(23-15)8-16(21)18-9-11-4-5-11/h11-15,20H,1-10H2,(H,18,21)(H,19,22)/t13-,14-,15+/m0/s1",
        "inchikey": "MSNHHRRUCLPTHC-SOUVJXGZSA-N",
        "iupac": {
          "systematic": "N-[(2S,3S,6S)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)oxan-3-yl]cyclobutanecarboxamide"
        },
        "smiles": {
          "canonical": "C1CC(C1)C(=O)NC2CCC(OC2CO)CC(=O)NCC3CC3"
        },
        "molecularFormula": "C17H28N2O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:44:54Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83da"
    },
    "name": "BRD-K64641861",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83da.png",
    "lincs": {
      "id": "LSM-12378",
      "name": "BRD-K64641861",
      "pubchemCid": 54650109,
      "chebiId": 101005,
      "inchiParent": "InChI=1S/C19H19N3O3/c1-25-17-10-6-5-9-14(17)21-19(24)22-15(11-20)18(16(22)12-23)13-7-3-2-4-8-13/h2-10,15-16,18,23H,12H2,1H3,(H,21,24)/t15-,16+,18-/m1/s1",
      "inchiKeyParent": "MOIIHOSYSQGYMW-SOLBZPMBSA-N",
      "smilesParent": "COc1ccccc1NC(=O)N2[C@@H](CO)[C@@H]([C@H]2C#N)c3ccccc3"
    },
    "unichem": {
      "chebi": "101005",
      "lincs": "LSM-12378",
      "pubchem": "54650109"
    },
    "pubchem": [
      {
        "cid": 54650109,
        "inchi": "InChI=1S/C19H19N3O3/c1-25-17-10-6-5-9-14(17)21-19(24)22-15(11-20)18(16(22)12-23)13-7-3-2-4-8-13/h2-10,15-16,18,23H,12H2,1H3,(H,21,24)/t15-,16+,18-/m1/s1",
        "inchikey": "MOIIHOSYSQGYMW-SOLBZPMBSA-N",
        "iupac": {
          "systematic": "(2S,3R,4R)-2-cyano-4-(hydroxymethyl)-N-(2-methoxyphenyl)-3-phenylazetidine-1-carboxamide"
        },
        "smiles": {
          "canonical": "COC1=CC=CC=C1NC(=O)N2C(C(C2C#N)C3=CC=CC=C3)CO"
        },
        "molecularFormula": "C19H19N3O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:44:56Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83f5"
    },
    "name": "BRD-K47272214",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83f5.png",
    "lincs": {
      "id": "LSM-7451",
      "name": "BRD-K47272214",
      "pubchemCid": 54618245,
      "chebiId": 96072,
      "inchiParent": "InChI=1S/C26H34N2O8S2/c1-19-16-28(20(2)18-29)38(32,33)26-13-8-21(7-6-14-34-4)15-24(26)36-25(19)17-27(3)37(30,31)23-11-9-22(35-5)10-12-23/h8-13,15,19-20,25,29H,14,16-18H2,1-5H3/t19-,20+,25-/m1/s1",
      "inchiKeyParent": "NHORSMPXTAJMFN-OHUGHZGNSA-N",
      "smilesParent": "COCC#Cc1ccc2c(O[C@H](CN(C)S(=O)(=O)c3ccc(OC)cc3)[C@H](C)CN([C@@H](C)CO)S2(=O)=O)c1"
    },
    "unichem": {
      "chebi": "96072",
      "lincs": "LSM-7451",
      "pubchem": "54618245"
    },
    "pubchem": [
      {
        "cid": 54618245,
        "inchi": "InChI=1S/C26H34N2O8S2/c1-19-16-28(20(2)18-29)38(32,33)26-13-8-21(7-6-14-34-4)15-24(26)36-25(19)17-27(3)37(30,31)23-11-9-22(35-5)10-12-23/h8-13,15,19-20,25,29H,14,16-18H2,1-5H3/t19-,20+,25-/m1/s1",
        "inchikey": "NHORSMPXTAJMFN-OHUGHZGNSA-N",
        "iupac": {
          "systematic": "N-[[(4R,5S)-2-[(2S)-1-hydroxypropan-2-yl]-8-(3-methoxyprop-1-ynyl)-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-4-methoxy-N-methylbenzenesulfonamide"
        },
        "smiles": {
          "canonical": "CC1CN(S(=O)(=O)C2=C(C=C(C=C2)C#CCOC)OC1CN(C)S(=O)(=O)C3=CC=C(C=C3)OC)C(C)CO"
        },
        "molecularFormula": "C26H34N2O8S2"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:44:58Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8369"
    },
    "name": "BRD-K85237791",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8369.png",
    "lincs": {
      "id": "LSM-13640",
      "name": "BRD-K85237791",
      "pubchemCid": 54654387,
      "chebiId": 102287,
      "inchiParent": "InChI=1S/C26H29F3N4O5/c1-15-3-5-16(6-4-15)31-25(36)32-17-7-10-21-19(11-17)24(35)33(2)20-9-8-18(38-22(20)13-37-21)12-23(34)30-14-26(27,28)29/h3-7,10-11,18,20,22H,8-9,12-14H2,1-2H3,(H,30,34)(H2,31,32,36)/t18-,20+,22+/m0/s1",
      "inchiKeyParent": "PPTVZYJXLGYDRY-CZTZKLFOSA-N",
      "smilesParent": "CN1[C@@H]2CC[C@@H](CC(=O)NCC(F)(F)F)O[C@@H]2COc3ccc(NC(=O)Nc4ccc(C)cc4)cc3C1=O"
    },
    "unichem": {
      "chebi": "102287",
      "lincs": "LSM-13640",
      "pubchem": "54654387"
    },
    "pubchem": [
      {
        "cid": 54654387,
        "inchi": "InChI=1S/C26H29F3N4O5/c1-15-3-5-16(6-4-15)31-25(36)32-17-7-10-21-19(11-17)24(35)33(2)20-9-8-18(38-22(20)13-37-21)12-23(34)30-14-26(27,28)29/h3-7,10-11,18,20,22H,8-9,12-14H2,1-2H3,(H,30,34)(H2,31,32,36)/t18-,20+,22+/m0/s1",
        "inchikey": "PPTVZYJXLGYDRY-CZTZKLFOSA-N",
        "iupac": {
          "systematic": "2-[(2S,4aR,12aS)-5-methyl-8-[(4-methylphenyl)carbamoylamino]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(2,2,2-trifluoroethyl)acetamide"
        },
        "smiles": {
          "canonical": "CC1=CC=C(C=C1)NC(=O)NC2=CC3=C(C=C2)OCC4C(CCC(O4)CC(=O)NCC(F)(F)F)N(C3=O)C"
        },
        "molecularFormula": "C26H29F3N4O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:45:01Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83d1"
    },
    "name": "CHEMBL2361224",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83d1.png",
    "lincs": {
      "id": "LSM-6834",
      "name": "CHEMBL2361224",
      "alternativeNames": [
        "BRD-K46123637"
      ],
      "pubchemCid": 54618962,
      "chebiId": 95455,
      "inchiParent": "InChI=1S/C32H38N2O5S/c1-23-19-34(24(2)22-35)40(37,38)32-17-14-26(11-10-25(3)36)18-30(32)39-31(23)21-33(4)20-27-12-15-29(16-13-27)28-8-6-5-7-9-28/h5-9,12-18,23-25,31,35-36H,19-22H2,1-4H3/t23-,24-,25+,31+/m0/s1",
      "inchiKeyParent": "AXBJPSYRCLUHNL-CNFUJFEGSA-N",
      "smilesParent": "C[C@@H](O)C#Cc1ccc2c(O[C@H](CN(C)Cc3ccc(cc3)c4ccccc4)[C@@H](C)CN([C@@H](C)CO)S2(=O)=O)c1"
    },
    "unichem": {
      "chebi": "95455",
      "chembl": "CHEMBL2361224",
      "lincs": "LSM-6834",
      "pubchem": "54618962"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL2361224",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 562.73,
        "hba": 6,
        "hbd": 2,
        "qedWeighted": 0.42
      }
    },
    "pubchem": [
      {
        "cid": 54618962,
        "inchi": "InChI=1S/C32H38N2O5S/c1-23-19-34(24(2)22-35)40(37,38)32-17-14-26(11-10-25(3)36)18-30(32)39-31(23)21-33(4)20-27-12-15-29(16-13-27)28-8-6-5-7-9-28/h5-9,12-18,23-25,31,35-36H,19-22H2,1-4H3/t23-,24-,25+,31+/m0/s1",
        "inchikey": "AXBJPSYRCLUHNL-CNFUJFEGSA-N",
        "iupac": {
          "systematic": "(2R)-4-[(4S,5S)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-5-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-8-yl]but-3-yn-2-ol"
        },
        "smiles": {
          "canonical": "CC1CN(S(=O)(=O)C2=C(C=C(C=C2)C#CC(C)O)OC1CN(C)CC3=CC=C(C=C3)C4=CC=CC=C4)C(C)CO"
        },
        "molecularFormula": "C32H38N2O5S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:45:12Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83d3"
    },
    "name": "CHEMBL3183224",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83d3.png",
    "lincs": {
      "id": "LSM-12312",
      "name": "CHEMBL3183224",
      "alternativeNames": [
        "BRD-K63809549"
      ],
      "pubchemCid": 54649427,
      "chebiId": 100939,
      "inchiParent": "InChI=1S/C33H34N4O5S/c1-33(2,3)43(40)37-19-25-17-26(32(39)35-18-21-7-8-28-29(15-21)42-20-41-28)36-31(30(25)27(37)11-14-38)24-6-4-5-23(16-24)22-9-12-34-13-10-22/h4-10,12-13,15-17,27,38H,11,14,18-20H2,1-3H3,(H,35,39)/t27-,43-/m1/s1",
      "inchiKeyParent": "OLAATLBQFXJPIK-ACXULAKISA-N",
      "smilesParent": "CC(C)(C)[S@@](=O)N1Cc2cc(nc(c3cccc(c3)c4ccncc4)c2[C@H]1CCO)C(=O)NCc5ccc6OCOc6c5"
    },
    "unichem": {
      "chebi": "100939",
      "chembl": "CHEMBL3183224",
      "lincs": "LSM-12312",
      "pubchem": "54649427"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL3183224",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 598.73,
        "hba": 8,
        "hbd": 2,
        "qedWeighted": 0.27
      }
    },
    "pubchem": [
      {
        "cid": 54649427,
        "inchi": "InChI=1S/C33H34N4O5S/c1-33(2,3)43(40)37-19-25-17-26(32(39)35-18-21-7-8-28-29(15-21)42-20-41-28)36-31(30(25)27(37)11-14-38)24-6-4-5-23(16-24)22-9-12-34-13-10-22/h4-10,12-13,15-17,27,38H,11,14,18-20H2,1-3H3,(H,35,39)/t27-,43-/m1/s1",
        "inchikey": "OLAATLBQFXJPIK-ACXULAKISA-N",
        "iupac": {
          "systematic": "(3R)-N-(1,3-benzodioxol-5-ylmethyl)-2-[(R)-tert-butylsulfinyl]-3-(2-hydroxyethyl)-4-(3-pyridin-4-ylphenyl)-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide"
        },
        "smiles": {
          "canonical": "CC(C)(C)S(=O)N1CC2=CC(=NC(=C2C1CCO)C3=CC=CC(=C3)C4=CC=NC=C4)C(=O)NCC5=CC6=C(C=C5)OCO6"
        },
        "molecularFormula": "C33H34N4O5S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:45:23Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8405"
    },
    "name": "BRD-K19147816",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8405.png",
    "lincs": {
      "id": "LSM-7095",
      "name": "BRD-K19147816",
      "pubchemCid": 54618477,
      "chebiId": 95716,
      "inchiParent": "InChI=1S/C32H33N3O7/c1-20-16-35(21(2)18-36)32(38)25-13-22(9-10-23-7-5-6-8-26(23)39-4)15-33-30(25)42-29(20)17-34(3)31(37)24-11-12-27-28(14-24)41-19-40-27/h5-8,11-15,20-21,29,36H,16-19H2,1-4H3/t20-,21-,29-/m0/s1",
      "inchiKeyParent": "MIOBFWIJYZOKSQ-WURXVLGASA-N",
      "smilesParent": "COc1ccccc1C#Cc2cnc3O[C@@H](CN(C)C(=O)c4ccc5OCOc5c4)[C@@H](C)CN([C@@H](C)CO)C(=O)c3c2"
    },
    "unichem": {
      "chebi": "95716",
      "lincs": "LSM-7095",
      "pubchem": "54618477"
    },
    "pubchem": [
      {
        "cid": 54618477,
        "inchi": "InChI=1S/C32H33N3O7/c1-20-16-35(21(2)18-36)32(38)25-13-22(9-10-23-7-5-6-8-26(23)39-4)15-33-30(25)42-29(20)17-34(3)31(37)24-11-12-27-28(14-24)41-19-40-27/h5-8,11-15,20-21,29,36H,16-19H2,1-4H3/t20-,21-,29-/m0/s1",
        "inchikey": "MIOBFWIJYZOKSQ-WURXVLGASA-N",
        "iupac": {
          "systematic": "N-[[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-8-[2-(2-methoxyphenyl)ethynyl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-1,3-benzodioxole-5-carboxamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(N=CC(=C2)C#CC3=CC=CC=C3OC)OC1CN(C)C(=O)C4=CC5=C(C=C4)OCO5)C(C)CO"
        },
        "molecularFormula": "C32H33N3O7"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:45:25Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c842b"
    },
    "name": "BRD-M80240720",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c842b.png",
    "lincs": {
      "id": "LSM-45070",
      "name": "BRD-M80240720",
      "pubchemCid": 54661211,
      "chebiId": 103307,
      "inchiParent": "InChI=1S/C25H37N5O4/c1-4-7-17-8-9-20-21-18(14-29(20)24(17)33)19(15-31)22(30(21)25(34)27-16(2)3)23(32)26-10-13-28-11-5-6-12-28/h4,7-9,16,18-19,21-22,31H,5-6,10-15H2,1-3H3,(H,26,32)(H,27,34)/t18-,19-,21+,22-/m0/s1",
      "inchiKeyParent": "PNJNHSHUQBINAQ-MPJJRAAHSA-N",
      "smilesParent": "CC=CC1=CC=C2[C@H]3[C@@H](CN2C1=O)[C@H](CO)[C@H](N3C(=O)NC(C)C)C(=O)NCCN4CCCC4"
    },
    "unichem": {
      "chebi": "103307",
      "lincs": "LSM-45070",
      "pubchem": "139032154"
    },
    "pubchem": [
      {
        "cid": 139032154,
        "inchi": "InChI=1S/C25H37N5O4/c1-4-7-17-8-9-20-21-18(14-29(20)24(17)33)19(15-31)22(30(21)25(34)27-16(2)3)23(32)26-10-13-28-11-5-6-12-28/h4,7-9,16,18-19,21-22,31H,5-6,10-15H2,1-3H3,(H,26,32)(H,27,34)/t18-,19-,21+,22-/m0/s1",
        "inchikey": "PNJNHSHUQBINAQ-MPJJRAAHSA-N",
        "iupac": {
          "systematic": "(2S,3S,3aR,9bR)-3-(hydroxymethyl)-6-oxo-1-N-propan-2-yl-7-prop-1-enyl-2-N-(2-pyrrolidin-1-ylethyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-1,2-dicarboxamide"
        },
        "smiles": {
          "canonical": "CC=CC1=CC=C2C3C(CN2C1=O)C(C(N3C(=O)NC(C)C)C(=O)NCCN4CCCC4)CO"
        },
        "molecularFormula": "C25H37N5O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:45:28Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8452"
    },
    "name": "BRD-K38797319",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8452.png",
    "lincs": {
      "id": "LSM-10780",
      "name": "BRD-K38797319",
      "pubchemCid": 54657611,
      "chebiId": 99401,
      "inchiParent": "InChI=1S/C25H29ClF2N2O4/c26-18-3-1-16(2-4-18)11-29-25(32)10-21-6-8-23-24(34-21)15-33-14-20(31)13-30(23)12-17-9-19(27)5-7-22(17)28/h1-5,7,9,20-21,23-24,31H,6,8,10-15H2,(H,29,32)/t20-,21+,23-,24+/m1/s1",
      "inchiKeyParent": "VYCGBAYEGCCJIH-JSRBNTPPSA-N",
      "smilesParent": "O[C@H]1COC[C@@H]2O[C@H](CC(=O)NCc3ccc(Cl)cc3)CC[C@H]2N(Cc4cc(F)ccc4F)C1"
    },
    "unichem": {
      "chebi": "99401",
      "lincs": "LSM-10780",
      "pubchem": "54657611"
    },
    "pubchem": [
      {
        "cid": 54657611,
        "inchi": "InChI=1S/C25H29ClF2N2O4/c26-18-3-1-16(2-4-18)11-29-25(32)10-21-6-8-23-24(34-21)15-33-14-20(31)13-30(23)12-17-9-19(27)5-7-22(17)28/h1-5,7,9,20-21,23-24,31H,6,8,10-15H2,(H,29,32)/t20-,21+,23-,24+/m1/s1",
        "inchikey": "VYCGBAYEGCCJIH-JSRBNTPPSA-N",
        "iupac": {
          "systematic": "2-[(3R,6aR,8S,10aR)-1-[(2,5-difluorophenyl)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(4-chlorophenyl)methyl]acetamide"
        },
        "smiles": {
          "canonical": "C1CC2C(COCC(CN2CC3=C(C=CC(=C3)F)F)O)OC1CC(=O)NCC4=CC=C(C=C4)Cl"
        },
        "molecularFormula": "C25H29ClF2N2O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:45:30Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8467"
    },
    "name": "(+)-Niguldipine",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8467.png",
    "lincs": {
      "id": "LSM-15284",
      "name": "(+)-Niguldipine",
      "alternativeNames": [
        "Niguldipine",
        "(+)-Niguldipine",
        "(S)-(+)-Niguldipine hydrochloride"
      ],
      "pubchemCid": 60602,
      "chebiId": 103931,
      "inchiParent": "InChI=1S/C36H39N3O6/c1-25-31(34(40)44-3)33(27-12-10-17-30(24-27)39(42)43)32(26(2)37-25)35(41)45-23-11-20-38-21-18-36(19-22-38,28-13-6-4-7-14-28)29-15-8-5-9-16-29/h4-10,12-17,24,33,37H,11,18-23H2,1-3H3/t33-/m0/s1",
      "inchiKeyParent": "SVJMLYUFVDMUHP-XIFFEERXSA-N",
      "smilesParent": "COC(=O)C1=C(C)NC(=C([C@H]1c2cccc(c2)[N+](=O)[O-])C(=O)OCCCN3CCC(CC3)(c4ccccc4)c5ccccc5)C"
    },
    "unichem": {
      "chebi": "103931",
      "chembl": "CHEMBL405355",
      "lincs": "LSM-15284",
      "pubchem": "60602",
      "drugbank": "DB09239"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL405355",
      "prefName": "NIGULDIPINE",
      "maxPhase": 2.0,
      "maxPhaseCurated": "Phase 2 Clinical Trials",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 609.72,
        "hba": 8,
        "hbd": 1,
        "qedWeighted": 0.13
      },
      "moleculeSynonyms": [
        {
          "moleculeSynonym": "(+)-niguldipine",
          "synType": "OTHER",
          "synonyms": "(+)-niguldipine"
        },
        {
          "moleculeSynonym": "Niguldipine",
          "synType": "OTHER",
          "synonyms": "Niguldipine"
        },
        {
          "moleculeSynonym": "Niguldipine",
          "synType": "INN",
          "synonyms": "NIGULDIPINE"
        },
        {
          "moleculeSynonym": "Niguldipino",
          "synType": "INN_SPANISH",
          "synonyms": "NIGULDIPINO"
        }
      ]
    },
    "pubchem": [
      {
        "cid": 60602,
        "inchi": "InChI=1S/C36H39N3O6/c1-25-31(34(40)44-3)33(27-12-10-17-30(24-27)39(42)43)32(26(2)37-25)35(41)45-23-11-20-38-21-18-36(19-22-38,28-13-6-4-7-14-28)29-15-8-5-9-16-29/h4-10,12-17,24,33,37H,11,18-23H2,1-3H3/t33-/m0/s1",
        "inchikey": "SVJMLYUFVDMUHP-XIFFEERXSA-N",
        "iupac": {
          "systematic": "5-O-[3-(4,4-diphenylpiperidin-1-yl)propyl] 3-O-methyl (4S)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate"
        },
        "smiles": {
          "canonical": "CC1=C(C(C(=C(N1)C)C(=O)OCCCN2CCC(CC2)(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC(=CC=C5)[N+](=O)[O-])C(=O)OC"
        },
        "molecularFormula": "C36H39N3O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:45:42Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8477"
    },
    "name": "BRD-K93577185",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8477.png",
    "lincs": {
      "id": "LSM-14991",
      "name": "BRD-K93577185",
      "pubchemCid": 44485822,
      "chebiId": 103647,
      "inchiParent": "InChI=1S/C32H55N5O6/c1-22(2)33-32(41)36(8)20-29-23(3)19-37(24(4)21-38)31(40)27-18-26(34-30(39)13-11-16-35(6)7)14-15-28(27)43-25(5)12-9-10-17-42-29/h14-15,18,22-25,29,38H,9-13,16-17,19-21H2,1-8H3,(H,33,41)(H,34,39)/t23-,24-,25+,29+/m0/s1",
      "inchiKeyParent": "SUHZFPHQAJGSMY-RGYUWNBKSA-N",
      "smilesParent": "CC(C)NC(=O)N(C)C[C@H]1OCCCC[C@@H](C)Oc2ccc(NC(=O)CCCN(C)C)cc2C(=O)N(C[C@@H]1C)[C@@H](C)CO"
    },
    "unichem": {
      "chebi": "103647",
      "lincs": "LSM-14991",
      "pubchem": "44485822"
    },
    "pubchem": [
      {
        "cid": 44485822,
        "inchi": "InChI=1S/C32H55N5O6/c1-22(2)33-32(41)36(8)20-29-23(3)19-37(24(4)21-38)31(40)27-18-26(34-30(39)13-11-16-35(6)7)14-15-28(27)43-25(5)12-9-10-17-42-29/h14-15,18,22-25,29,38H,9-13,16-17,19-21H2,1-8H3,(H,33,41)(H,34,39)/t23-,24-,25+,29+/m0/s1",
        "inchikey": "SUHZFPHQAJGSMY-RGYUWNBKSA-N",
        "iupac": {
          "systematic": "4-(dimethylamino)-N-[(3R,9S,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(propan-2-ylcarbamoyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]butanamide"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NC(=O)CCCN(C)C)C(C)CO)C)CN(C)C(=O)NC(C)C"
        },
        "molecularFormula": "C32H55N5O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:45:44Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84b2"
    },
    "name": "4-Cyclohexyl-5-(pyridin-3-yl)-4H-1,2,4-triazole-3-thiol",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84b2.png",
    "lincs": {
      "id": "LSM-36758",
      "name": "4-Cyclohexyl-5-(pyridin-3-yl)-4H-1,2,4-triazole-3-thiol",
      "alternativeNames": [
        "BRD-K94818765"
      ],
      "pubchemCid": 695345,
      "chebiId": 125287,
      "inchiParent": "InChI=1S/C13H16N4S/c18-13-16-15-12(10-5-4-8-14-9-10)17(13)11-6-2-1-3-7-11/h4-5,8-9,11H,1-3,6-7H2,(H,16,18)",
      "inchiKeyParent": "DLXNXOFBPGMUJI-UHFFFAOYSA-N",
      "smilesParent": "S=C1NN=C(N1C2CCCCC2)c3cccnc3"
    },
    "unichem": {
      "chebi": "125287",
      "chembl": "CHEMBL1334716",
      "lincs": "LSM-36758",
      "pubchem": "695345"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL1334716",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 260.37,
        "hba": 5,
        "hbd": 1,
        "qedWeighted": 0.84
      }
    },
    "pubchem": [
      {
        "cid": 695345,
        "inchi": "InChI=1S/C13H16N4S/c18-13-16-15-12(10-5-4-8-14-9-10)17(13)11-6-2-1-3-7-11/h4-5,8-9,11H,1-3,6-7H2,(H,16,18)",
        "inchikey": "DLXNXOFBPGMUJI-UHFFFAOYSA-N",
        "iupac": {
          "systematic": "4-cyclohexyl-3-pyridin-3-yl-1H-1,2,4-triazole-5-thione"
        },
        "smiles": {
          "canonical": "C1CCC(CC1)N2C(=NNC2=S)C3=CN=CC=C3"
        },
        "molecularFormula": "C13H16N4S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:45:55Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84b4"
    },
    "name": "BRD-K35930698",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84b4.png",
    "lincs": {
      "id": "LSM-10587",
      "name": "BRD-K35930698",
      "pubchemCid": 54649261,
      "chebiId": 99208,
      "inchiParent": "InChI=1S/C29H37FN4O3/c1-21(17-34(22(2)20-35)29(36)32-26-14-12-25(30)13-15-26)28(37-4)19-33(3)18-23-8-10-24(11-9-23)27-7-5-6-16-31-27/h5-16,21-22,28,35H,17-20H2,1-4H3,(H,32,36)/t21-,22+,28-/m0/s1",
      "inchiKeyParent": "XSSRKRLNCLGOQF-TYPXCFOJSA-N",
      "smilesParent": "CO[C@@H](CN(C)Cc1ccc(cc1)c2ccccn2)[C@@H](C)CN([C@H](C)CO)C(=O)Nc3ccc(F)cc3"
    },
    "unichem": {
      "chebi": "99208",
      "lincs": "LSM-10587",
      "pubchem": "54649261"
    },
    "pubchem": [
      {
        "cid": 54649261,
        "inchi": "InChI=1S/C29H37FN4O3/c1-21(17-34(22(2)20-35)29(36)32-26-14-12-25(30)13-15-26)28(37-4)19-33(3)18-23-8-10-24(11-9-23)27-7-5-6-16-31-27/h5-16,21-22,28,35H,17-20H2,1-4H3,(H,32,36)/t21-,22+,28-/m0/s1",
        "inchikey": "XSSRKRLNCLGOQF-TYPXCFOJSA-N",
        "iupac": {
          "systematic": "3-(4-fluorophenyl)-1-[(2R)-1-hydroxypropan-2-yl]-1-[(2S,3R)-3-methoxy-2-methyl-4-[methyl-[(4-pyridin-2-ylphenyl)methyl]amino]butyl]urea"
        },
        "smiles": {
          "canonical": "CC(CN(C(C)CO)C(=O)NC1=CC=C(C=C1)F)C(CN(C)CC2=CC=C(C=C2)C3=CC=CC=N3)OC"
        },
        "molecularFormula": "C29H37FN4O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:45:57Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84d4"
    },
    "name": "BRD-K32162437",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84d4.png",
    "lincs": {
      "id": "LSM-10377",
      "name": "BRD-K32162437",
      "pubchemCid": 54649078,
      "chebiId": 98998,
      "inchiParent": "InChI=1S/C21H33N3O4S2/c1-16-6-8-19(9-7-16)30(26,27)24(18(3)15-25)12-17(2)20(28-5)13-23(4)14-21-22-10-11-29-21/h6-11,17-18,20,25H,12-15H2,1-5H3/t17-,18-,20-/m1/s1",
      "inchiKeyParent": "APKXKRHWPGHKNH-QWFCFKBJSA-N",
      "smilesParent": "CO[C@H](CN(C)Cc1nccs1)[C@H](C)CN([C@H](C)CO)S(=O)(=O)c2ccc(C)cc2"
    },
    "unichem": {
      "chebi": "98998",
      "lincs": "LSM-10377",
      "pubchem": "54649078"
    },
    "pubchem": [
      {
        "cid": 54649078,
        "inchi": "InChI=1S/C21H33N3O4S2/c1-16-6-8-19(9-7-16)30(26,27)24(18(3)15-25)12-17(2)20(28-5)13-23(4)14-21-22-10-11-29-21/h6-11,17-18,20,25H,12-15H2,1-5H3/t17-,18-,20-/m1/s1",
        "inchikey": "APKXKRHWPGHKNH-QWFCFKBJSA-N",
        "iupac": {
          "systematic": "N-[(2R)-1-hydroxypropan-2-yl]-N-[(2R,3S)-3-methoxy-2-methyl-4-[methyl(1,3-thiazol-2-ylmethyl)amino]butyl]-4-methylbenzenesulfonamide"
        },
        "smiles": {
          "canonical": "CC1=CC=C(C=C1)S(=O)(=O)N(CC(C)C(CN(C)CC2=NC=CS2)OC)C(C)CO"
        },
        "molecularFormula": "C21H33N3O4S2"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:45:59Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84ad"
    },
    "name": "BRD-K99567611",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84ad.png",
    "lincs": {
      "id": "LSM-14545",
      "name": "BRD-K99567611",
      "pubchemCid": 54638523,
      "chebiId": 103200,
      "inchiParent": "InChI=1S/C20H33N3O5S/c1-15-5-8-17(9-6-15)29(26,27)22-18-10-7-16(28-19(18)14-24)13-20(25)21-11-4-12-23(2)3/h5-6,8-9,16,18-19,22,24H,4,7,10-14H2,1-3H3,(H,21,25)/t16-,18+,19-/m0/s1",
      "inchiKeyParent": "ZAZOOTZCNDNOOW-UHOSZYNNSA-N",
      "smilesParent": "CN(C)CCCNC(=O)C[C@@H]1CC[C@@H](NS(=O)(=O)c2ccc(C)cc2)[C@H](CO)O1"
    },
    "unichem": {
      "chebi": "103200",
      "lincs": "LSM-14545",
      "pubchem": "54638523"
    },
    "pubchem": [
      {
        "cid": 54638523,
        "inchi": "InChI=1S/C20H33N3O5S/c1-15-5-8-17(9-6-15)29(26,27)22-18-10-7-16(28-19(18)14-24)13-20(25)21-11-4-12-23(2)3/h5-6,8-9,16,18-19,22,24H,4,7,10-14H2,1-3H3,(H,21,25)/t16-,18+,19-/m0/s1",
        "inchikey": "ZAZOOTZCNDNOOW-UHOSZYNNSA-N",
        "iupac": {
          "systematic": "N-[3-(dimethylamino)propyl]-2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[(4-methylphenyl)sulfonylamino]oxan-2-yl]acetamide"
        },
        "smiles": {
          "canonical": "CC1=CC=C(C=C1)S(=O)(=O)NC2CCC(OC2CO)CC(=O)NCCCN(C)C"
        },
        "molecularFormula": "C20H33N3O5S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:46:02Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c842f"
    },
    "name": "BRD-K59404663",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c842f.png",
    "lincs": {
      "id": "LSM-12020",
      "name": "BRD-K59404663",
      "pubchemCid": 54638640,
      "chebiId": 100646,
      "inchiParent": "InChI=1S/C21H22Cl2N2O5S/c22-17-8-6-14(10-18(17)23)12-24-21(27)11-15-7-9-19(20(13-26)30-15)25-31(28,29)16-4-2-1-3-5-16/h1-10,15,19-20,25-26H,11-13H2,(H,24,27)/t15-,19-,20-/m0/s1",
      "inchiKeyParent": "LRDWIZFOJOHHOT-YSSFQJQWSA-N",
      "smilesParent": "OC[C@@H]1O[C@H](CC(=O)NCc2ccc(Cl)c(Cl)c2)C=C[C@@H]1NS(=O)(=O)c3ccccc3"
    },
    "unichem": {
      "chebi": "100646",
      "lincs": "LSM-12020",
      "pubchem": "54638640"
    },
    "pubchem": [
      {
        "cid": 54638640,
        "inchi": "InChI=1S/C21H22Cl2N2O5S/c22-17-8-6-14(10-18(17)23)12-24-21(27)11-15-7-9-19(20(13-26)30-15)25-31(28,29)16-4-2-1-3-5-16/h1-10,15,19-20,25-26H,11-13H2,(H,24,27)/t15-,19-,20-/m0/s1",
        "inchikey": "LRDWIZFOJOHHOT-YSSFQJQWSA-N",
        "iupac": {
          "systematic": "2-[(2R,3S,6R)-3-(benzenesulfonamido)-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[(3,4-dichlorophenyl)methyl]acetamide"
        },
        "smiles": {
          "canonical": "C1=CC=C(C=C1)S(=O)(=O)NC2C=CC(OC2CO)CC(=O)NCC3=CC(=C(C=C3)Cl)Cl"
        },
        "molecularFormula": "C21H22Cl2N2O5S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:46:04Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84a9"
    },
    "name": "BRD-K67480908",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84a9.png",
    "lincs": {
      "id": "LSM-12535",
      "name": "BRD-K67480908",
      "pubchemCid": 54649203,
      "chebiId": 101166,
      "inchiParent": "InChI=1S/C23H32Cl2N2O4S/c1-17(13-27(18(2)16-28)14-19-7-5-6-8-22(19)25)23(31-4)15-26(3)32(29,30)21-11-9-20(24)10-12-21/h5-12,17-18,23,28H,13-16H2,1-4H3/t17-,18+,23+/m0/s1",
      "inchiKeyParent": "JYNGQINEBKOLSY-YZZKKUAISA-N",
      "smilesParent": "CO[C@H](CN(C)S(=O)(=O)c1ccc(Cl)cc1)[C@@H](C)CN(Cc2ccccc2Cl)[C@H](C)CO"
    },
    "unichem": {
      "chebi": "101166",
      "lincs": "LSM-12535",
      "pubchem": "54649203"
    },
    "pubchem": [
      {
        "cid": 54649203,
        "inchi": "InChI=1S/C23H32Cl2N2O4S/c1-17(13-27(18(2)16-28)14-19-7-5-6-8-22(19)25)23(31-4)15-26(3)32(29,30)21-11-9-20(24)10-12-21/h5-12,17-18,23,28H,13-16H2,1-4H3/t17-,18+,23+/m0/s1",
        "inchikey": "JYNGQINEBKOLSY-YZZKKUAISA-N",
        "iupac": {
          "systematic": "4-chloro-N-[(2S,3S)-4-[(2-chlorophenyl)methyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methylbenzenesulfonamide"
        },
        "smiles": {
          "canonical": "CC(CN(CC1=CC=CC=C1Cl)C(C)CO)C(CN(C)S(=O)(=O)C2=CC=C(C=C2)Cl)OC"
        },
        "molecularFormula": "C23H32Cl2N2O4S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:46:06Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84e1"
    },
    "name": "BRD-K43421680",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84e1.png",
    "lincs": {
      "id": "LSM-11070",
      "name": "BRD-K43421680",
      "pubchemCid": 54657545,
      "chebiId": 99691,
      "inchiParent": "InChI=1S/C26H32ClN3O5/c1-17(18-6-3-2-4-7-18)28-25(32)13-22-10-11-23-24(35-22)16-34-15-21(31)14-30(23)26(33)29-20-9-5-8-19(27)12-20/h2-9,12,17,21-24,31H,10-11,13-16H2,1H3,(H,28,32)(H,29,33)/t17-,21-,22+,23-,24+/m1/s1",
      "inchiKeyParent": "QYSMODXJNCJWNA-JCTDHXFVSA-N",
      "smilesParent": "C[C@@H](NC(=O)C[C@@H]1CC[C@@H]2[C@H](COC[C@H](O)CN2C(=O)Nc3cccc(Cl)c3)O1)c4ccccc4"
    },
    "unichem": {
      "chebi": "99691",
      "lincs": "LSM-11070",
      "pubchem": "54657545"
    },
    "pubchem": [
      {
        "cid": 54657545,
        "inchi": "InChI=1S/C26H32ClN3O5/c1-17(18-6-3-2-4-7-18)28-25(32)13-22-10-11-23-24(35-22)16-34-15-21(31)14-30(23)26(33)29-20-9-5-8-19(27)12-20/h2-9,12,17,21-24,31H,10-11,13-16H2,1H3,(H,28,32)(H,29,33)/t17-,21-,22+,23-,24+/m1/s1",
        "inchikey": "QYSMODXJNCJWNA-JCTDHXFVSA-N",
        "iupac": {
          "systematic": "(3R,6aR,8S,10aR)-N-(3-chlorophenyl)-3-hydroxy-8-[2-oxo-2-[[(1R)-1-phenylethyl]amino]ethyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide"
        },
        "smiles": {
          "canonical": "CC(C1=CC=CC=C1)NC(=O)CC2CCC3C(O2)COCC(CN3C(=O)NC4=CC(=CC=C4)Cl)O"
        },
        "molecularFormula": "C26H32ClN3O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:46:08Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8432"
    },
    "name": "BRD-K73658839",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8432.png",
    "lincs": {
      "id": "LSM-12942",
      "name": "BRD-K73658839",
      "pubchemCid": 54638008,
      "chebiId": 101579,
      "inchiParent": "InChI=1S/C29H35N3O3/c1-21-16-32(22(2)19-33)29(34)27-11-7-6-10-26(27)25-9-5-4-8-24(25)20-35-28(21)18-31(3)17-23-12-14-30-15-13-23/h4-15,21-22,28,33H,16-20H2,1-3H3/t21-,22+,28+/m0/s1",
      "inchiKeyParent": "KEOFNYFHDQHRAV-PFPZSTESSA-N",
      "smilesParent": "C[C@H](CO)N1C[C@H](C)[C@@H](CN(C)Cc2ccncc2)OCc3ccccc3c4ccccc4C1=O"
    },
    "unichem": {
      "chebi": "101579",
      "lincs": "LSM-12942",
      "pubchem": "54638008"
    },
    "pubchem": [
      {
        "cid": 54638008,
        "inchi": "InChI=1S/C29H35N3O3/c1-21-16-32(22(2)19-33)29(34)27-11-7-6-10-26(27)25-9-5-4-8-24(25)20-35-28(21)18-31(3)17-23-12-14-30-15-13-23/h4-15,21-22,28,33H,16-20H2,1-3H3/t21-,22+,28+/m0/s1",
        "inchikey": "KEOFNYFHDQHRAV-PFPZSTESSA-N",
        "iupac": {
          "systematic": "(10S,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-10-[[methyl(pyridin-4-ylmethyl)amino]methyl]-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-14-one"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=CC=CC=C2C3=CC=CC=C3COC1CN(C)CC4=CC=NC=C4)C(C)CO"
        },
        "molecularFormula": "C29H35N3O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:46:11Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8488"
    },
    "name": "BRD-K98240084",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8488.png",
    "lincs": {
      "id": "LSM-14465",
      "name": "BRD-K98240084",
      "pubchemCid": 54645989,
      "chebiId": 103120,
      "inchiParent": "InChI=1S/C29H29FN2O6S/c30-20-5-8-23(9-6-20)39(35,36)31-21-7-10-26-24(13-21)25-14-22(37-27(17-33)29(25)38-26)15-28(34)32-12-11-18-3-1-2-4-19(18)16-32/h1-10,13,22,25,27,29,31,33H,11-12,14-17H2/t22-,25+,27+,29-/m0/s1",
      "inchiKeyParent": "RHYJRBPAXZYDBS-VWGZZBOQSA-N",
      "smilesParent": "OC[C@H]1O[C@H](CC(=O)N2CCc3ccccc3C2)C[C@H]4[C@@H]1Oc5ccc(NS(=O)(=O)c6ccc(F)cc6)cc45"
    },
    "unichem": {
      "chebi": "103120",
      "lincs": "LSM-14465",
      "pubchem": "54645989"
    },
    "pubchem": [
      {
        "cid": 54645989,
        "inchi": "InChI=1S/C29H29FN2O6S/c30-20-5-8-23(9-6-20)39(35,36)31-21-7-10-26-24(13-21)25-14-22(37-27(17-33)29(25)38-26)15-28(34)32-12-11-18-3-1-2-4-19(18)16-32/h1-10,13,22,25,27,29,31,33H,11-12,14-17H2/t22-,25+,27+,29-/m0/s1",
        "inchikey": "RHYJRBPAXZYDBS-VWGZZBOQSA-N",
        "iupac": {
          "systematic": "N-[(1R,3S,4aR,9aS)-3-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]-4-fluorobenzenesulfonamide"
        },
        "smiles": {
          "canonical": "C1CN(CC2=CC=CC=C21)C(=O)CC3CC4C(C(O3)CO)OC5=C4C=C(C=C5)NS(=O)(=O)C6=CC=C(C=C6)F"
        },
        "molecularFormula": "C29H29FN2O6S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:46:13Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84c6"
    },
    "name": "BRD-K06891569",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84c6.png",
    "lincs": {
      "id": "LSM-8837",
      "name": "BRD-K06891569",
      "pubchemCid": 54657762,
      "chebiId": 97458,
      "inchiParent": "InChI=1S/C25H36ClN3O5/c26-18-6-8-19(9-7-18)28-25(32)29-14-20(30)15-33-16-23-22(29)11-10-21(34-23)12-24(31)27-13-17-4-2-1-3-5-17/h6-9,17,20-23,30H,1-5,10-16H2,(H,27,31)(H,28,32)/t20-,21+,22+,23-/m0/s1",
      "inchiKeyParent": "SYCYKHHPUCXRJT-AFXVXQJMSA-N",
      "smilesParent": "O[C@@H]1COC[C@@H]2O[C@@H](CC(=O)NCC3CCCCC3)CC[C@H]2N(C1)C(=O)Nc4ccc(Cl)cc4"
    },
    "unichem": {
      "chebi": "97458",
      "lincs": "LSM-8837",
      "pubchem": "54657762"
    },
    "pubchem": [
      {
        "cid": 54657762,
        "inchi": "InChI=1S/C25H36ClN3O5/c26-18-6-8-19(9-7-18)28-25(32)29-14-20(30)15-33-16-23-22(29)11-10-21(34-23)12-24(31)27-13-17-4-2-1-3-5-17/h6-9,17,20-23,30H,1-5,10-16H2,(H,27,31)(H,28,32)/t20-,21+,22+,23-/m0/s1",
        "inchikey": "SYCYKHHPUCXRJT-AFXVXQJMSA-N",
        "iupac": {
          "systematic": "(3S,6aR,8R,10aR)-N-(4-chlorophenyl)-8-[2-(cyclohexylmethylamino)-2-oxoethyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide"
        },
        "smiles": {
          "canonical": "C1CCC(CC1)CNC(=O)CC2CCC3C(O2)COCC(CN3C(=O)NC4=CC=C(C=C4)Cl)O"
        },
        "molecularFormula": "C25H36ClN3O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:46:15Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8464"
    },
    "name": "BRD-K07008972",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8464.png",
    "lincs": {
      "id": "LSM-14702",
      "name": "BRD-K07008972",
      "pubchemCid": 44489847,
      "chebiId": 103358,
      "inchiParent": "InChI=1S/C30H47F3N4O6/c1-19(2)34-29(41)36(6)17-26-20(3)16-37(21(4)18-38)28(40)24-15-23(35-27(39)12-13-30(31,32)33)10-11-25(24)43-22(5)9-7-8-14-42-26/h10-11,15,19-22,26,38H,7-9,12-14,16-18H2,1-6H3,(H,34,41)(H,35,39)/t20-,21-,22-,26-/m0/s1",
      "inchiKeyParent": "WCMOVSVGEGOMDB-YGWSKSRPSA-N",
      "smilesParent": "CC(C)NC(=O)N(C)C[C@@H]1OCCCC[C@H](C)Oc2ccc(NC(=O)CCC(F)(F)F)cc2C(=O)N(C[C@@H]1C)[C@@H](C)CO"
    },
    "unichem": {
      "chebi": "103358",
      "lincs": "LSM-14702",
      "pubchem": "44489847"
    },
    "pubchem": [
      {
        "cid": 44489847,
        "inchi": "InChI=1S/C30H47F3N4O6/c1-19(2)34-29(41)36(6)17-26-20(3)16-37(21(4)18-38)28(40)24-15-23(35-27(39)12-13-30(31,32)33)10-11-25(24)43-22(5)9-7-8-14-42-26/h10-11,15,19-22,26,38H,7-9,12-14,16-18H2,1-6H3,(H,34,41)(H,35,39)/t20-,21-,22-,26-/m0/s1",
        "inchikey": "WCMOVSVGEGOMDB-YGWSKSRPSA-N",
        "iupac": {
          "systematic": "4,4,4-trifluoro-N-[(3S,9R,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(propan-2-ylcarbamoyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]butanamide"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NC(=O)CCC(F)(F)F)C(C)CO)C)CN(C)C(=O)NC(C)C"
        },
        "molecularFormula": "C30H47F3N4O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:46:17Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c847a"
    },
    "name": "BRD-K68774060",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c847a.png",
    "lincs": {
      "id": "LSM-12624",
      "name": "BRD-K68774060",
      "pubchemCid": 54649298,
      "chebiId": 131210,
      "inchiParent": "InChI=1S/C23H31F2N3O5S/c1-16(13-28(17(2)15-29)23(30)26-21-8-6-5-7-20(21)25)22(33-4)14-27(3)34(31,32)19-11-9-18(24)10-12-19/h5-12,16-17,22,29H,13-15H2,1-4H3,(H,26,30)/t16-,17-,22+/m0/s1",
      "inchiKeyParent": "DYSXQKGXYVAXRN-PNLZDCPESA-N",
      "smilesParent": "CO[C@H](CN(C)S(=O)(=O)c1ccc(F)cc1)[C@@H](C)CN([C@@H](C)CO)C(=O)Nc2ccccc2F"
    },
    "unichem": {
      "chebi": "131210",
      "lincs": "LSM-12624",
      "pubchem": "54649298"
    },
    "pubchem": [
      {
        "cid": 54649298,
        "inchi": "InChI=1S/C23H31F2N3O5S/c1-16(13-28(17(2)15-29)23(30)26-21-8-6-5-7-20(21)25)22(33-4)14-27(3)34(31,32)19-11-9-18(24)10-12-19/h5-12,16-17,22,29H,13-15H2,1-4H3,(H,26,30)/t16-,17-,22+/m0/s1",
        "inchikey": "DYSXQKGXYVAXRN-PNLZDCPESA-N",
        "iupac": {
          "systematic": "3-(2-fluorophenyl)-1-[(2S,3S)-4-[(4-fluorophenyl)sulfonyl-methylamino]-3-methoxy-2-methylbutyl]-1-[(2S)-1-hydroxypropan-2-yl]urea"
        },
        "smiles": {
          "canonical": "CC(CN(C(C)CO)C(=O)NC1=CC=CC=C1F)C(CN(C)S(=O)(=O)C2=CC=C(C=C2)F)OC"
        },
        "molecularFormula": "C23H31F2N3O5S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:46:20Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84a7"
    },
    "name": "BRD-K32710535",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84a7.png",
    "lincs": {
      "id": "LSM-30425",
      "name": "BRD-K32710535",
      "pubchemCid": 54640940,
      "chebiId": 118976,
      "inchiParent": "InChI=1S/C19H26F3N3O4/c1-2-17(27)25-15-8-7-14(29-16(15)11-26)9-10-23-18(28)24-13-5-3-12(4-6-13)19(20,21)22/h3-6,14-16,26H,2,7-11H2,1H3,(H,25,27)(H2,23,24,28)/t14-,15-,16+/m1/s1",
      "inchiKeyParent": "IVJDFQRYYIVNGV-OAGGEKHMSA-N",
      "smilesParent": "CCC(=O)N[C@@H]1CC[C@H](CCNC(=O)Nc2ccc(cc2)C(F)(F)F)O[C@H]1CO"
    },
    "unichem": {
      "chebi": "118976",
      "lincs": "LSM-30425",
      "pubchem": "54640940"
    },
    "pubchem": [
      {
        "cid": 54640940,
        "inchi": "InChI=1S/C19H26F3N3O4/c1-2-17(27)25-15-8-7-14(29-16(15)11-26)9-10-23-18(28)24-13-5-3-12(4-6-13)19(20,21)22/h3-6,14-16,26H,2,7-11H2,1H3,(H,25,27)(H2,23,24,28)/t14-,15-,16+/m1/s1",
        "inchikey": "IVJDFQRYYIVNGV-OAGGEKHMSA-N",
        "iupac": {
          "systematic": "N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-[[4-(trifluoromethyl)phenyl]carbamoylamino]ethyl]oxan-3-yl]propanamide"
        },
        "smiles": {
          "canonical": "CCC(=O)NC1CCC(OC1CO)CCNC(=O)NC2=CC=C(C=C2)C(F)(F)F"
        },
        "molecularFormula": "C19H26F3N3O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:46:22Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84cd"
    },
    "name": "BRD-K13131627",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84cd.png",
    "lincs": {
      "id": "LSM-9216",
      "name": "BRD-K13131627",
      "pubchemCid": 54646355,
      "chebiId": 97837,
      "inchiParent": "InChI=1S/C28H27F3N4O5/c29-28(30,31)17-3-5-18(6-4-17)34-27(38)35-19-7-8-23-21(10-19)22-11-20(39-24(15-36)26(22)40-23)12-25(37)33-14-16-2-1-9-32-13-16/h1-10,13,20,22,24,26,36H,11-12,14-15H2,(H,33,37)(H2,34,35,38)/t20-,22+,24+,26-/m1/s1",
      "inchiKeyParent": "IMICHJYMUCZKDW-GRTAZNFBSA-N",
      "smilesParent": "OC[C@@H]1O[C@@H](CC(=O)NCc2cccnc2)C[C@@H]3[C@H]1Oc4ccc(NC(=O)Nc5ccc(cc5)C(F)(F)F)cc34"
    },
    "unichem": {
      "chebi": "97837",
      "lincs": "LSM-9216",
      "pubchem": "54646355"
    },
    "pubchem": [
      {
        "cid": 54646355,
        "inchi": "InChI=1S/C28H27F3N4O5/c29-28(30,31)17-3-5-18(6-4-17)34-27(38)35-19-7-8-23-21(10-19)22-11-20(39-24(15-36)26(22)40-23)12-25(37)33-14-16-2-1-9-32-13-16/h1-10,13,20,22,24,26,36H,11-12,14-15H2,(H,33,37)(H2,34,35,38)/t20-,22+,24+,26-/m1/s1",
        "inchikey": "IMICHJYMUCZKDW-GRTAZNFBSA-N",
        "iupac": {
          "systematic": "2-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-6-[[4-(trifluoromethyl)phenyl]carbamoylamino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-(pyridin-3-ylmethyl)acetamide"
        },
        "smiles": {
          "canonical": "C1C(OC(C2C1C3=C(O2)C=CC(=C3)NC(=O)NC4=CC=C(C=C4)C(F)(F)F)CO)CC(=O)NCC5=CN=CC=C5"
        },
        "molecularFormula": "C28H27F3N4O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:46:24Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c842c"
    },
    "name": "BRD-K45221651",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c842c.png",
    "lincs": {
      "id": "LSM-11180",
      "name": "BRD-K45221651",
      "pubchemCid": 54639008,
      "chebiId": 99801,
      "inchiParent": "InChI=1S/C20H30FN3O6S/c21-15-1-4-17(5-2-15)31(27,28)23-18-6-3-16(30-19(18)14-25)7-8-22-20(26)13-24-9-11-29-12-10-24/h1-2,4-5,16,18-19,23,25H,3,6-14H2,(H,22,26)/t16-,18-,19-/m0/s1",
      "inchiKeyParent": "JNXYUDJSGYXBCY-WDSOQIARSA-N",
      "smilesParent": "OC[C@@H]1O[C@H](CCNC(=O)CN2CCOCC2)CC[C@@H]1NS(=O)(=O)c3ccc(F)cc3"
    },
    "unichem": {
      "chebi": "99801",
      "lincs": "LSM-11180",
      "pubchem": "54639008"
    },
    "pubchem": [
      {
        "cid": 54639008,
        "inchi": "InChI=1S/C20H30FN3O6S/c21-15-1-4-17(5-2-15)31(27,28)23-18-6-3-16(30-19(18)14-25)7-8-22-20(26)13-24-9-11-29-12-10-24/h1-2,4-5,16,18-19,23,25H,3,6-14H2,(H,22,26)/t16-,18-,19-/m0/s1",
        "inchikey": "JNXYUDJSGYXBCY-WDSOQIARSA-N",
        "iupac": {
          "systematic": "N-[2-[(2S,5S,6R)-5-[(4-fluorophenyl)sulfonylamino]-6-(hydroxymethyl)oxan-2-yl]ethyl]-2-morpholin-4-ylacetamide"
        },
        "smiles": {
          "canonical": "C1CC(C(OC1CCNC(=O)CN2CCOCC2)CO)NS(=O)(=O)C3=CC=C(C=C3)F"
        },
        "molecularFormula": "C20H30FN3O6S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:46:27Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c842e"
    },
    "name": "BRD-K00575273",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c842e.png",
    "lincs": {
      "id": "LSM-8470",
      "name": "BRD-K00575273",
      "pubchemCid": 54638588,
      "chebiId": 97091,
      "inchiParent": "InChI=1S/C20H27FN2O5S/c21-14-6-9-17(10-7-14)29(26,27)23-18-11-8-16(28-19(18)13-24)12-20(25)22-15-4-2-1-3-5-15/h6-11,15-16,18-19,23-24H,1-5,12-13H2,(H,22,25)/t16-,18+,19+/m1/s1",
      "inchiKeyParent": "VZTWMEPVNSFWIB-NEWSRXKRSA-N",
      "smilesParent": "OC[C@@H]1O[C@@H](CC(=O)NC2CCCCC2)C=C[C@@H]1NS(=O)(=O)c3ccc(F)cc3"
    },
    "unichem": {
      "chebi": "97091",
      "lincs": "LSM-8470",
      "pubchem": "54638588"
    },
    "pubchem": [
      {
        "cid": 54638588,
        "inchi": "InChI=1S/C20H27FN2O5S/c21-14-6-9-17(10-7-14)29(26,27)23-18-11-8-16(28-19(18)13-24)12-20(25)22-15-4-2-1-3-5-15/h6-11,15-16,18-19,23-24H,1-5,12-13H2,(H,22,25)/t16-,18+,19+/m1/s1",
        "inchikey": "VZTWMEPVNSFWIB-NEWSRXKRSA-N",
        "iupac": {
          "systematic": "N-cyclohexyl-2-[(2R,3S,6S)-3-[(4-fluorophenyl)sulfonylamino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetamide"
        },
        "smiles": {
          "canonical": "C1CCC(CC1)NC(=O)CC2C=CC(C(O2)CO)NS(=O)(=O)C3=CC=C(C=C3)F"
        },
        "molecularFormula": "C20H27FN2O5S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:46:29Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8442"
    },
    "name": "BRD-K11624501",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8442.png",
    "lincs": {
      "id": "LSM-37863",
      "name": "BRD-K11624501",
      "pubchemCid": 44618473,
      "chebiId": 126297,
      "inchiParent": "InChI=1S/C40H56N4O5/c1-28-24-44(29(2)27-45)39(46)35-23-33(41-40(47)42-36-19-12-17-32-16-8-9-18-34(32)36)20-21-37(35)49-30(3)13-10-11-22-48-38(28)26-43(4)25-31-14-6-5-7-15-31/h8-9,12,16-21,23,28-31,38,45H,5-7,10-11,13-15,22,24-27H2,1-4H3,(H2,41,42,47)/t28-,29-,30-,38-/m1/s1",
      "inchiKeyParent": "DTGXRBNGNVLSQA-VZHNYULCSA-N",
      "smilesParent": "C[C@H](CO)N1C[C@@H](C)[C@@H](CN(C)CC2CCCCC2)OCCCC[C@@H](C)Oc3ccc(NC(=O)Nc4cccc5ccccc45)cc3C1=O"
    },
    "unichem": {
      "chebi": "126297",
      "lincs": "LSM-37863",
      "pubchem": "44618473"
    },
    "pubchem": [
      {
        "cid": 44618473,
        "inchi": "InChI=1S/C40H56N4O5/c1-28-24-44(29(2)27-45)39(46)35-23-33(41-40(47)42-36-19-12-17-32-16-8-9-18-34(32)36)20-21-37(35)49-30(3)13-10-11-22-48-38(28)26-43(4)25-31-14-6-5-7-15-31/h8-9,12,16-21,23,28-31,38,45H,5-7,10-11,13-15,22,24-27H2,1-4H3,(H2,41,42,47)/t28-,29-,30-,38-/m1/s1",
        "inchikey": "DTGXRBNGNVLSQA-VZHNYULCSA-N",
        "iupac": {
          "systematic": "1-[(3R,9S,10R)-9-[[cyclohexylmethyl(methyl)amino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-naphthalen-1-ylurea"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NC(=O)NC3=CC=CC4=CC=CC=C43)C(C)CO)C)CN(C)CC5CCCCC5"
        },
        "molecularFormula": "C40H56N4O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:46:31Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8454"
    },
    "name": "BRD-K44699604",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8454.png",
    "lincs": {
      "id": "LSM-11146",
      "name": "BRD-K44699604",
      "pubchemCid": 54657782,
      "chebiId": 99767,
      "inchiParent": "InChI=1S/C20H28N2O4/c23-16-10-21-18-6-5-17(26-19(18)13-25-12-16)9-20(24)22-8-7-14-3-1-2-4-15(14)11-22/h1-4,16-19,21,23H,5-13H2/t16-,17-,18+,19-/m1/s1",
      "inchiKeyParent": "MNYFKSZVIZZWBR-AKHDSKFASA-N",
      "smilesParent": "O[C@@H]1CN[C@H]2CC[C@H](CC(=O)N3CCc4ccccc4C3)O[C@@H]2COC1"
    },
    "unichem": {
      "chebi": "99767",
      "lincs": "LSM-11146",
      "pubchem": "54657782"
    },
    "pubchem": [
      {
        "cid": 54657782,
        "inchi": "InChI=1S/C20H28N2O4/c23-16-10-21-18-6-5-17(26-19(18)13-25-12-16)9-20(24)22-8-7-14-3-1-2-4-15(14)11-22/h1-4,16-19,21,23H,5-13H2/t16-,17-,18+,19-/m1/s1",
        "inchikey": "MNYFKSZVIZZWBR-AKHDSKFASA-N",
        "iupac": {
          "systematic": "2-[(3R,6aS,8R,10aS)-3-hydroxy-1,2,3,4,6,6a,8,9,10,10a-decahydropyrano[2,3-c][1,5]oxazocin-8-yl]-1-(3,4-dihydro-1H-isoquinolin-2-yl)ethanone"
        },
        "smiles": {
          "canonical": "C1CC2C(COCC(CN2)O)OC1CC(=O)N3CCC4=CC=CC=C4C3"
        },
        "molecularFormula": "C20H28N2O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:46:33Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8480"
    },
    "name": "BRD-K79370508",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8480.png",
    "lincs": {
      "id": "LSM-20189",
      "name": "BRD-K79370508",
      "pubchemCid": 44497230,
      "chebiId": 108790,
      "inchiParent": "InChI=1S/C29H41FN4O6S/c1-20-17-34(21(2)19-35)29(37)16-22-15-24(31-28(36)7-6-14-32(3)4)10-13-26(22)40-27(20)18-33(5)41(38,39)25-11-8-23(30)9-12-25/h8-13,15,20-21,27,35H,6-7,14,16-19H2,1-5H3,(H,31,36)/t20-,21-,27-/m0/s1",
      "inchiKeyParent": "QROKXOKLOVAMIJ-IZVMNLJQSA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@H](C)[C@H](CN(C)S(=O)(=O)c2ccc(F)cc2)Oc3ccc(NC(=O)CCCN(C)C)cc3CC1=O"
    },
    "unichem": {
      "chebi": "108790",
      "lincs": "LSM-20189",
      "pubchem": "44497230"
    },
    "pubchem": [
      {
        "cid": 44497230,
        "inchi": "InChI=1S/C29H41FN4O6S/c1-20-17-34(21(2)19-35)29(37)16-22-15-24(31-28(36)7-6-14-32(3)4)10-13-26(22)40-27(20)18-33(5)41(38,39)25-11-8-23(30)9-12-25/h8-13,15,20-21,27,35H,6-7,14,16-19H2,1-5H3,(H,31,36)/t20-,21-,27-/m0/s1",
        "inchikey": "QROKXOKLOVAMIJ-IZVMNLJQSA-N",
        "iupac": {
          "systematic": "4-(dimethylamino)-N-[(2R,3S)-2-[[(4-fluorophenyl)sulfonyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]butanamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)CC2=C(C=CC(=C2)NC(=O)CCCN(C)C)OC1CN(C)S(=O)(=O)C3=CC=C(C=C3)F)C(C)CO"
        },
        "molecularFormula": "C29H41FN4O6S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:46:35Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84da"
    },
    "name": "BRD-K86156277",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84da.png",
    "lincs": {
      "id": "LSM-13706",
      "name": "BRD-K86156277",
      "pubchemCid": 54654381,
      "chebiId": 102354,
      "inchiParent": "InChI=1S/C27H33FN4O5/c1-16(2)30-27(35)31-19-8-11-23-21(12-19)26(34)32(3)22-10-9-20(37-24(22)15-36-23)13-25(33)29-14-17-4-6-18(28)7-5-17/h4-8,11-12,16,20,22,24H,9-10,13-15H2,1-3H3,(H,29,33)(H2,30,31,35)/t20-,22+,24-/m0/s1",
      "inchiKeyParent": "CMDXATVLXHEPLP-FJIJXJHWSA-N",
      "smilesParent": "CC(C)NC(=O)Nc1ccc2OC[C@@H]3O[C@H](CC(=O)NCc4ccc(F)cc4)CC[C@H]3N(C)C(=O)c2c1"
    },
    "unichem": {
      "chebi": "102354",
      "lincs": "LSM-13706",
      "pubchem": "54654381"
    },
    "pubchem": [
      {
        "cid": 54654381,
        "inchi": "InChI=1S/C27H33FN4O5/c1-16(2)30-27(35)31-19-8-11-23-21(12-19)26(34)32(3)22-10-9-20(37-24(22)15-36-23)13-25(33)29-14-17-4-6-18(28)7-5-17/h4-8,11-12,16,20,22,24H,9-10,13-15H2,1-3H3,(H,29,33)(H2,30,31,35)/t20-,22+,24-/m0/s1",
        "inchikey": "CMDXATVLXHEPLP-FJIJXJHWSA-N",
        "iupac": {
          "systematic": "2-[(2S,4aR,12aR)-5-methyl-6-oxo-8-(propan-2-ylcarbamoylamino)-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-[(4-fluorophenyl)methyl]acetamide"
        },
        "smiles": {
          "canonical": "CC(C)NC(=O)NC1=CC2=C(C=C1)OCC3C(CCC(O3)CC(=O)NCC4=CC=C(C=C4)F)N(C2=O)C"
        },
        "molecularFormula": "C27H33FN4O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:46:38Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8457"
    },
    "name": "CHEMBL2362220",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8457.png",
    "lincs": {
      "id": "LSM-39025",
      "name": "CHEMBL2362220",
      "alternativeNames": [
        "BRD-K31999759"
      ],
      "pubchemCid": 54615111,
      "chebiId": 127467,
      "inchiParent": "InChI=1S/C35H47F3N4O7S/c1-22-18-42(23(2)21-43)34(44)30-17-29(40-50(45,46)33-25(4)39-49-26(33)5)14-15-31(30)48-24(3)9-7-8-16-47-32(22)20-41(6)19-27-10-12-28(13-11-27)35(36,37)38/h10-15,17,22-24,32,40,43H,7-9,16,18-21H2,1-6H3/t22-,23-,24-,32+/m1/s1",
      "inchiKeyParent": "CBAAPWVHONFTKW-RICRHEPGSA-N",
      "smilesParent": "C[C@H](CO)N1C[C@@H](C)[C@H](CN(C)Cc2ccc(cc2)C(F)(F)F)OCCCC[C@@H](C)Oc3ccc(NS(=O)(=O)c4c(C)onc4C)cc3C1=O"
    },
    "unichem": {
      "chebi": "127467",
      "chembl": "CHEMBL2362220",
      "lincs": "LSM-39025",
      "pubchem": "54615111"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL2362220",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 724.84,
        "hba": 9,
        "hbd": 2,
        "qedWeighted": 0.27
      }
    },
    "pubchem": [
      {
        "cid": 54615111,
        "inchi": "InChI=1S/C35H47F3N4O7S/c1-22-18-42(23(2)21-43)34(44)30-17-29(40-50(45,46)33-25(4)39-49-26(33)5)14-15-31(30)48-24(3)9-7-8-16-47-32(22)20-41(6)19-27-10-12-28(13-11-27)35(36,37)38/h10-15,17,22-24,32,40,43H,7-9,16,18-21H2,1-6H3/t22-,23-,24-,32+/m1/s1",
        "inchikey": "CBAAPWVHONFTKW-RICRHEPGSA-N",
        "iupac": {
          "systematic": "N-[(3R,9R,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3,5-dimethyl-1,2-oxazole-4-sulfonamide"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NS(=O)(=O)C3=C(ON=C3C)C)C(C)CO)C)CN(C)CC4=CC=C(C=C4)C(F)(F)F"
        },
        "molecularFormula": "C35H47F3N4O7S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:46:49Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84e5"
    },
    "name": "BRD-K58493574",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84e5.png",
    "lincs": {
      "id": "LSM-11958",
      "name": "BRD-K58493574",
      "pubchemCid": 54660866,
      "chebiId": 100584,
      "inchiParent": "InChI=1S/C26H33FN4O3/c1-3-10-30-23-19(20(16-32)24(30)26(34)29-13-11-28(2)12-14-29)15-31-22(23)9-8-18(25(31)33)17-6-4-5-7-21(17)27/h4-9,19-20,23-24,32H,3,10-16H2,1-2H3/t19-,20-,23+,24-/m0/s1",
      "inchiKeyParent": "USYUKGCDRIQXPK-JVODISISSA-N",
      "smilesParent": "CCCN1[C@@H]([C@@H](CO)[C@@H]2CN3C(=CC=C(C3=O)c4ccccc4F)[C@H]12)C(=O)N5CCN(C)CC5"
    },
    "unichem": {
      "chebi": "100584",
      "lincs": "LSM-11958",
      "pubchem": "54660866"
    },
    "pubchem": [
      {
        "cid": 54660866,
        "inchi": "InChI=1S/C26H33FN4O3/c1-3-10-30-23-19(20(16-32)24(30)26(34)29-13-11-28(2)12-14-29)15-31-22(23)9-8-18(25(31)33)17-6-4-5-7-21(17)27/h4-9,19-20,23-24,32H,3,10-16H2,1-2H3/t19-,20-,23+,24-/m0/s1",
        "inchikey": "USYUKGCDRIQXPK-JVODISISSA-N",
        "iupac": {
          "systematic": "(2S,3S,3aR,9bR)-7-(2-fluorophenyl)-3-(hydroxymethyl)-2-(4-methylpiperazine-1-carbonyl)-1-propyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizin-6-one"
        },
        "smiles": {
          "canonical": "CCCN1C2C(CN3C2=CC=C(C3=O)C4=CC=CC=C4F)C(C1C(=O)N5CCN(CC5)C)CO"
        },
        "molecularFormula": "C26H33FN4O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:46:51Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c841c"
    },
    "name": "BRD-K40439253",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c841c.png",
    "lincs": {
      "id": "LSM-39498",
      "name": "BRD-K40439253",
      "pubchemCid": 44484220,
      "chebiId": 127942,
      "inchiParent": "InChI=1S/C31H39N5O5/c1-19(2)32-30(39)33-23-13-14-27-25(15-23)29(38)36(21(4)18-37)16-20(3)28(41-27)17-35(5)31(40)34-26-12-8-10-22-9-6-7-11-24(22)26/h6-15,19-21,28,37H,16-18H2,1-5H3,(H,34,40)(H2,32,33,39)/t20-,21-,28-/m0/s1",
      "inchiKeyParent": "KYHZFTDIMWCHFE-CZBREUMFSA-N",
      "smilesParent": "CC(C)NC(=O)Nc1ccc2O[C@@H](CN(C)C(=O)Nc3cccc4ccccc34)[C@@H](C)CN([C@@H](C)CO)C(=O)c2c1"
    },
    "unichem": {
      "chebi": "127942",
      "lincs": "LSM-39498",
      "pubchem": "44484220"
    },
    "pubchem": [
      {
        "cid": 44484220,
        "inchi": "InChI=1S/C31H39N5O5/c1-19(2)32-30(39)33-23-13-14-27-25(15-23)29(38)36(21(4)18-37)16-20(3)28(41-27)17-35(5)31(40)34-26-12-8-10-22-9-6-7-11-24(22)26/h6-15,19-21,28,37H,16-18H2,1-5H3,(H,34,40)(H2,32,33,39)/t20-,21-,28-/m0/s1",
        "inchikey": "KYHZFTDIMWCHFE-CZBREUMFSA-N",
        "iupac": {
          "systematic": "1-[[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-(propan-2-ylcarbamoylamino)-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-naphthalen-1-ylurea"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(C=CC(=C2)NC(=O)NC(C)C)OC1CN(C)C(=O)NC3=CC=CC4=CC=CC=C43)C(C)CO"
        },
        "molecularFormula": "C31H39N5O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:46:53Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8445"
    },
    "name": "BRD-K60069399",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8445.png",
    "lincs": {
      "id": "LSM-30898",
      "name": "BRD-K60069399",
      "pubchemCid": 56835413,
      "chebiId": 119449,
      "inchiParent": "InChI=1S/C29H37N3O5/c1-6-36-29(35)30(4)16-25-19(2)15-32(20(3)17-33)28(34)27-26(22-12-8-7-11-21(22)18-37-25)23-13-9-10-14-24(23)31(27)5/h7-14,19-20,25,33H,6,15-18H2,1-5H3/t19-,20+,25+/m0/s1",
      "inchiKeyParent": "KJOWQTUXPGZSAG-WZOHSFFVSA-N",
      "smilesParent": "CCOC(=O)N(C)C[C@H]1OCc2ccccc2c3c(C(=O)N(C[C@@H]1C)[C@H](C)CO)n(C)c4ccccc34"
    },
    "unichem": {
      "chebi": "119449",
      "lincs": "LSM-30898",
      "pubchem": "56835413"
    },
    "pubchem": [
      {
        "cid": 56835413,
        "inchi": "InChI=1S/C29H37N3O5/c1-6-36-29(35)30(4)16-25-19(2)15-32(20(3)17-33)28(34)27-26(22-12-8-7-11-21(22)18-37-25)23-13-9-10-14-24(23)31(27)5/h7-14,19-20,25,33H,6,15-18H2,1-5H3/t19-,20+,25+/m0/s1",
        "inchikey": "KJOWQTUXPGZSAG-WZOHSFFVSA-N",
        "iupac": {
          "systematic": "ethyl N-[[(10S,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylcarbamate"
        },
        "smiles": {
          "canonical": "CCOC(=O)N(C)CC1C(CN(C(=O)C2=C(C3=CC=CC=C3CO1)C4=CC=CC=C4N2C)C(C)CO)C"
        },
        "molecularFormula": "C29H37N3O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:46:56Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8449"
    },
    "name": "BRD-K46769156",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8449.png",
    "lincs": {
      "id": "LSM-39870",
      "name": "BRD-K46769156",
      "pubchemCid": 44502996,
      "chebiId": 128315,
      "inchiParent": "InChI=1S/C32H46N4O5/c1-22-18-36(23(2)21-37)31(38)17-25-16-27(34-32(39)33-26-8-6-5-7-9-26)12-15-29(25)41-30(22)20-35(3)19-24-10-13-28(40-4)14-11-24/h10-16,22-23,26,30,37H,5-9,17-21H2,1-4H3,(H2,33,34,39)/t22-,23-,30-/m1/s1",
      "inchiKeyParent": "VLYSFBPSHIXFSY-IQLGONJTSA-N",
      "smilesParent": "COc1ccc(CN(C)C[C@H]2Oc3ccc(NC(=O)NC4CCCCC4)cc3CC(=O)N(C[C@H]2C)[C@H](C)CO)cc1"
    },
    "unichem": {
      "chebi": "128315",
      "lincs": "LSM-39870",
      "pubchem": "44502996"
    },
    "pubchem": [
      {
        "cid": 44502996,
        "inchi": "InChI=1S/C32H46N4O5/c1-22-18-36(23(2)21-37)31(38)17-25-16-27(34-32(39)33-26-8-6-5-7-9-26)12-15-29(25)41-30(22)20-35(3)19-24-10-13-28(40-4)14-11-24/h10-16,22-23,26,30,37H,5-9,17-21H2,1-4H3,(H2,33,34,39)/t22-,23-,30-/m1/s1",
        "inchikey": "VLYSFBPSHIXFSY-IQLGONJTSA-N",
        "iupac": {
          "systematic": "1-cyclohexyl-3-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)methyl-methylamino]methyl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]urea"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)CC2=C(C=CC(=C2)NC(=O)NC3CCCCC3)OC1CN(C)CC4=CC=C(C=C4)OC)C(C)CO"
        },
        "molecularFormula": "C32H46N4O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:46:58Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c846b"
    },
    "name": "BRD-K86107831",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c846b.png",
    "lincs": {
      "id": "LSM-13702",
      "name": "BRD-K86107831",
      "pubchemCid": 54631535,
      "chebiId": 102350,
      "inchiParent": "InChI=1S/C25H35N5O4/c1-6-11-30-14-17(2)23(33-5)15-29(4)25(32)20-12-19(7-8-22(20)34-16-18(30)3)28-24(31)21-13-26-9-10-27-21/h7-10,12-13,17-18,23H,6,11,14-16H2,1-5H3,(H,28,31)/t17-,18+,23-/m1/s1",
      "inchiKeyParent": "ZGJMWZDWXNCIBA-IEGUWTFLSA-N",
      "smilesParent": "CCCN1C[C@@H](C)[C@@H](CN(C)C(=O)c2cc(NC(=O)c3cnccn3)ccc2OC[C@@H]1C)OC"
    },
    "unichem": {
      "chebi": "102350",
      "lincs": "LSM-13702",
      "pubchem": "54631535"
    },
    "pubchem": [
      {
        "cid": 54631535,
        "inchi": "InChI=1S/C25H35N5O4/c1-6-11-30-14-17(2)23(33-5)15-29(4)25(32)20-12-19(7-8-22(20)34-16-18(30)3)28-24(31)21-13-26-9-10-27-21/h7-10,12-13,17-18,23H,6,11,14-16H2,1-5H3,(H,28,31)/t17-,18+,23-/m1/s1",
        "inchikey": "ZGJMWZDWXNCIBA-IEGUWTFLSA-N",
        "iupac": {
          "systematic": "N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]pyrazine-2-carboxamide"
        },
        "smiles": {
          "canonical": "CCCN1CC(C(CN(C(=O)C2=C(C=CC(=C2)NC(=O)C3=NC=CN=C3)OCC1C)C)OC)C"
        },
        "molecularFormula": "C25H35N5O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:47:00Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8487"
    },
    "name": "BRD-K99115033",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8487.png",
    "lincs": {
      "id": "LSM-14515",
      "name": "BRD-K99115033",
      "pubchemCid": 54638467,
      "chebiId": 103170,
      "inchiParent": "InChI=1S/C18H25N3O5/c22-12-16-14(20-18(24)15-3-1-2-6-19-15)5-4-13(26-16)11-17(23)21-7-9-25-10-8-21/h1-3,6,13-14,16,22H,4-5,7-12H2,(H,20,24)/t13-,14+,16-/m1/s1",
      "inchiKeyParent": "QWCXAENNPFGWBU-IJEWVQPXSA-N",
      "smilesParent": "OC[C@H]1O[C@@H](CC(=O)N2CCOCC2)CC[C@@H]1NC(=O)c3ccccn3"
    },
    "unichem": {
      "chebi": "103170",
      "lincs": "LSM-14515",
      "pubchem": "54638467"
    },
    "pubchem": [
      {
        "cid": 54638467,
        "inchi": "InChI=1S/C18H25N3O5/c22-12-16-14(20-18(24)15-3-1-2-6-19-15)5-4-13(26-16)11-17(23)21-7-9-25-10-8-21/h1-3,6,13-14,16,22H,4-5,7-12H2,(H,20,24)/t13-,14+,16-/m1/s1",
        "inchikey": "QWCXAENNPFGWBU-IJEWVQPXSA-N",
        "iupac": {
          "systematic": "N-[(2S,3S,6R)-2-(hydroxymethyl)-6-(2-morpholin-4-yl-2-oxoethyl)oxan-3-yl]pyridine-2-carboxamide"
        },
        "smiles": {
          "canonical": "C1CC(C(OC1CC(=O)N2CCOCC2)CO)NC(=O)C3=CC=CC=N3"
        },
        "molecularFormula": "C18H25N3O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:47:02Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84df"
    },
    "name": "BRD-K77070775",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84df.png",
    "lincs": {
      "id": "LSM-13142",
      "name": "BRD-K77070775",
      "pubchemCid": 54638243,
      "chebiId": 101780,
      "inchiParent": "InChI=1S/C22H25ClN2O7S/c23-15-2-5-17(6-3-15)33(28,29)25-18-7-4-16(32-21(18)12-26)9-10-24-22(27)14-1-8-19-20(11-14)31-13-30-19/h1-3,5-6,8,11,16,18,21,25-26H,4,7,9-10,12-13H2,(H,24,27)/t16-,18+,21-/m1/s1",
      "inchiKeyParent": "WVRHSCPXBJSNMQ-PLMTUMEDSA-N",
      "smilesParent": "OC[C@H]1O[C@@H](CCNC(=O)c2ccc3OCOc3c2)CC[C@@H]1NS(=O)(=O)c4ccc(Cl)cc4"
    },
    "unichem": {
      "chebi": "101780",
      "lincs": "LSM-13142",
      "pubchem": "54638243"
    },
    "pubchem": [
      {
        "cid": 54638243,
        "inchi": "InChI=1S/C22H25ClN2O7S/c23-15-2-5-17(6-3-15)33(28,29)25-18-7-4-16(32-21(18)12-26)9-10-24-22(27)14-1-8-19-20(11-14)31-13-30-19/h1-3,5-6,8,11,16,18,21,25-26H,4,7,9-10,12-13H2,(H,24,27)/t16-,18+,21-/m1/s1",
        "inchikey": "WVRHSCPXBJSNMQ-PLMTUMEDSA-N",
        "iupac": {
          "systematic": "N-[2-[(2R,5S,6S)-5-[(4-chlorophenyl)sulfonylamino]-6-(hydroxymethyl)oxan-2-yl]ethyl]-1,3-benzodioxole-5-carboxamide"
        },
        "smiles": {
          "canonical": "C1CC(C(OC1CCNC(=O)C2=CC3=C(C=C2)OCO3)CO)NS(=O)(=O)C4=CC=C(C=C4)Cl"
        },
        "molecularFormula": "C22H25ClN2O7S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:47:04Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8476"
    },
    "name": "BRD-K60084530",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8476.png",
    "lincs": {
      "id": "LSM-34319",
      "name": "BRD-K60084530",
      "pubchemCid": 54647294,
      "chebiId": 122876,
      "inchiParent": "InChI=1S/C21H28N2O6/c24-11-18-20-16(9-14(28-18)10-19(25)26)15-8-13(6-7-17(15)29-20)23-21(27)22-12-4-2-1-3-5-12/h6-8,12,14,16,18,20,24H,1-5,9-11H2,(H,25,26)(H2,22,23,27)/t14-,16-,18+,20+/m0/s1",
      "inchiKeyParent": "BVUMLAQBIXIYMI-LBLLVPRASA-N",
      "smilesParent": "OC[C@H]1O[C@H](CC(=O)O)C[C@@H]2[C@H]1Oc3ccc(NC(=O)NC4CCCCC4)cc23"
    },
    "unichem": {
      "chebi": "122876",
      "lincs": "LSM-34319",
      "pubchem": "54647294"
    },
    "pubchem": [
      {
        "cid": 54647294,
        "inchi": "InChI=1S/C21H28N2O6/c24-11-18-20-16(9-14(28-18)10-19(25)26)15-8-13(6-7-17(15)29-20)23-21(27)22-12-4-2-1-3-5-12/h6-8,12,14,16,18,20,24H,1-5,9-11H2,(H,25,26)(H2,22,23,27)/t14-,16-,18+,20+/m0/s1",
        "inchikey": "BVUMLAQBIXIYMI-LBLLVPRASA-N",
        "iupac": {
          "systematic": "2-[(1R,3S,4aS,9aR)-6-(cyclohexylcarbamoylamino)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]acetic acid"
        },
        "smiles": {
          "canonical": "C1CCC(CC1)NC(=O)NC2=CC3=C(C=C2)OC4C3CC(OC4CO)CC(=O)O"
        },
        "molecularFormula": "C21H28N2O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:47:07Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84ce"
    },
    "name": "BRD-K65506786",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84ce.png",
    "lincs": {
      "id": "LSM-6757",
      "name": "BRD-K65506786",
      "pubchemCid": 54650194,
      "chebiId": 95378,
      "inchiParent": "InChI=1S/C23H29N3O2/c1-16(2)25-23(28)26-20(14-24)22(21(26)15-27)19-12-10-18(11-13-19)9-8-17-6-4-3-5-7-17/h10-13,16-17,20-22,27H,3-7,15H2,1-2H3,(H,25,28)/t20-,21-,22-/m1/s1",
      "inchiKeyParent": "FHQNTJUBGIRGFL-YPAWHYETSA-N",
      "smilesParent": "CC(C)NC(=O)N1[C@H](CO)[C@@H]([C@H]1C#N)c2ccc(cc2)C#CC3CCCCC3"
    },
    "unichem": {
      "chebi": "95378",
      "lincs": "LSM-6757",
      "pubchem": "54650194"
    },
    "pubchem": [
      {
        "cid": 54650194,
        "inchi": "InChI=1S/C23H29N3O2/c1-16(2)25-23(28)26-20(14-24)22(21(26)15-27)19-12-10-18(11-13-19)9-8-17-6-4-3-5-7-17/h10-13,16-17,20-22,27H,3-7,15H2,1-2H3,(H,25,28)/t20-,21-,22-/m1/s1",
        "inchikey": "FHQNTJUBGIRGFL-YPAWHYETSA-N",
        "iupac": {
          "systematic": "(2S,3R,4S)-2-cyano-3-[4-(2-cyclohexylethynyl)phenyl]-4-(hydroxymethyl)-N-propan-2-ylazetidine-1-carboxamide"
        },
        "smiles": {
          "canonical": "CC(C)NC(=O)N1C(C(C1C#N)C2=CC=C(C=C2)C#CC3CCCCC3)CO"
        },
        "molecularFormula": "C23H29N3O2"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:47:09Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84d8"
    },
    "name": "BRD-K31122916",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84d8.png",
    "lincs": {
      "id": "LSM-10308",
      "name": "BRD-K31122916",
      "pubchemCid": 54661272,
      "chebiId": 98929,
      "inchiParent": "InChI=1S/C25H30N4O6/c1-13(2)26-25(35)29-19-11-28-18(21(29)20(24(33)34)17(19)12-30)9-8-16(23(28)32)14-6-5-7-15(10-14)22(31)27(3)4/h5-10,13,17,19-21,30H,11-12H2,1-4H3,(H,26,35)(H,33,34)/t17-,19-,20+,21+/m0/s1",
      "inchiKeyParent": "HBVVCYLQQFLTLW-MJUUVYJYSA-N",
      "smilesParent": "CC(C)NC(=O)N1[C@H]2CN3C(=CC=C(C3=O)c4cccc(c4)C(=O)N(C)C)[C@@H]1[C@@H]([C@H]2CO)C(=O)O"
    },
    "unichem": {
      "chebi": "98929",
      "lincs": "LSM-10308",
      "pubchem": "54661272"
    },
    "pubchem": [
      {
        "cid": 54661272,
        "inchi": "InChI=1S/C25H30N4O6/c1-13(2)26-25(35)29-19-11-28-18(21(29)20(24(33)34)17(19)12-30)9-8-16(23(28)32)14-6-5-7-15(10-14)22(31)27(3)4/h5-10,13,17,19-21,30H,11-12H2,1-4H3,(H,26,35)(H,33,34)/t17-,19-,20+,21+/m0/s1",
        "inchikey": "HBVVCYLQQFLTLW-MJUUVYJYSA-N",
        "iupac": {
          "systematic": "(1S,9R,10R,11R)-5-[3-(dimethylcarbamoyl)phenyl]-10-(hydroxymethyl)-6-oxo-12-(propan-2-ylcarbamoyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxylic acid"
        },
        "smiles": {
          "canonical": "CC(C)NC(=O)N1C2CN3C(=CC=C(C3=O)C4=CC(=CC=C4)C(=O)N(C)C)C1C(C2CO)C(=O)O"
        },
        "molecularFormula": "C25H30N4O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:47:12Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8429"
    },
    "name": "BRD-K38787519",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8429.png",
    "lincs": {
      "id": "LSM-39404",
      "name": "BRD-K38787519",
      "pubchemCid": 54649710,
      "chebiId": 127848,
      "inchiParent": "InChI=1S/C23H31N3O5/c1-15-13-26(3)23(28)18-11-16(12-24)5-7-19(18)30-14-21-20(29-4)8-6-17(31-21)9-10-25(2)22(15)27/h5,7,11,15,17,20-21H,6,8-10,13-14H2,1-4H3/t15-,17+,20-,21-/m1/s1",
      "inchiKeyParent": "WOVPJXMLSNBLNW-ZHFAOOELSA-N",
      "smilesParent": "CO[C@@H]1CC[C@H]2CCN(C)C(=O)[C@H](C)CN(C)C(=O)c3cc(ccc3OC[C@H]1O2)C#N"
    },
    "unichem": {
      "chebi": "127848",
      "lincs": "LSM-39404",
      "pubchem": "54649710"
    },
    "pubchem": [
      {
        "cid": 54649710,
        "inchi": "InChI=1S/C23H31N3O5/c1-15-13-26(3)23(28)18-11-16(12-24)5-7-19(18)30-14-21-20(29-4)8-6-17(31-21)9-10-25(2)22(15)27/h5,7,11,15,17,20-21H,6,8-10,13-14H2,1-4H3/t15-,17+,20-,21-/m1/s1",
        "inchikey": "WOVPJXMLSNBLNW-ZHFAOOELSA-N",
        "iupac": {
          "systematic": "(1R,13R,18S,21R)-21-methoxy-11,13,15-trimethyl-10,14-dioxo-3,22-dioxa-11,15-diazatricyclo[16.3.1.04,9]docosa-4(9),5,7-triene-7-carbonitrile"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(C=CC(=C2)C#N)OCC3C(CCC(O3)CCN(C1=O)C)OC)C"
        },
        "molecularFormula": "C23H31N3O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:47:14Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84cb"
    },
    "name": "BRD-K27239120-001-01-1",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84cb.png",
    "lincs": {
      "id": "LSM-6802",
      "name": "BRD-K27239120-001-01-1",
      "alternativeNames": [
        "BRD9120",
        "SD-6-035-A11"
      ],
      "pubchemCid": 49843318,
      "chebiId": 95423,
      "inchiParent": "InChI=1S/C32H47N3O6/c1-22-17-35(23(2)20-36)32(37)27-16-26(33(4)5)11-13-28(27)41-24(3)9-7-8-14-38-31(22)19-34(6)18-25-10-12-29-30(15-25)40-21-39-29/h10-13,15-16,22-24,31,36H,7-9,14,17-21H2,1-6H3/t22-,23+,24-,31-/m0/s1",
      "inchiKeyParent": "WIYHORLWMFSPCL-PKWXPSSRSA-N",
      "smilesParent": "C[C@H](CO)N1C[C@H](C)[C@H](CN(C)Cc2ccc3OCOc3c2)OCCCC[C@H](C)Oc4ccc(cc4C1=O)N(C)C"
    },
    "unichem": {
      "chebi": "95423",
      "lincs": "LSM-6802",
      "pubchem": "49843318"
    },
    "pubchem": [
      {
        "cid": 49843318,
        "inchi": "InChI=1S/C32H47N3O6/c1-22-17-35(23(2)20-36)32(37)27-16-26(33(4)5)11-13-28(27)41-24(3)9-7-8-14-38-31(22)19-34(6)18-25-10-12-29-30(15-25)40-21-39-29/h10-13,15-16,22-24,31,36H,7-9,14,17-21H2,1-6H3/t22-,23+,24-,31-/m0/s1",
        "inchikey": "WIYHORLWMFSPCL-PKWXPSSRSA-N",
        "iupac": {
          "systematic": "(3S,9R,10S)-9-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-13-one"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)N(C)C)C(C)CO)C)CN(C)CC3=CC4=C(C=C3)OCO4"
        },
        "molecularFormula": "C32H47N3O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:47:16Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84d7"
    },
    "name": "BRD-K07458582",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84d7.png",
    "lincs": {
      "id": "LSM-8869",
      "name": "BRD-K07458582",
      "pubchemCid": 54650080,
      "chebiId": 97490,
      "inchiParent": "InChI=1S/C24H22N2O3/c1-29-22-5-3-2-4-17(22)9-6-16-7-10-18(11-8-16)23-20(14-25)26(21(23)15-27)24(28)19-12-13-19/h2-5,7-8,10-11,19-21,23,27H,12-13,15H2,1H3/t20-,21+,23+/m1/s1",
      "inchiKeyParent": "VFHDDKSZNLSDOB-GIWBLDEGSA-N",
      "smilesParent": "COc1ccccc1C#Cc2ccc(cc2)[C@@H]3[C@H](CO)N([C@@H]3C#N)C(=O)C4CC4"
    },
    "unichem": {
      "chebi": "97490",
      "chembl": "CHEMBL3560667",
      "lincs": "LSM-8869",
      "pubchem": "54650080"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL3560667",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 386.45,
        "hba": 4,
        "hbd": 1,
        "qedWeighted": 0.82
      }
    },
    "pubchem": [
      {
        "cid": 54650080,
        "inchi": "InChI=1S/C24H22N2O3/c1-29-22-5-3-2-4-17(22)9-6-16-7-10-18(11-8-16)23-20(14-25)26(21(23)15-27)24(28)19-12-13-19/h2-5,7-8,10-11,19-21,23,27H,12-13,15H2,1H3/t20-,21+,23+/m1/s1",
        "inchikey": "VFHDDKSZNLSDOB-GIWBLDEGSA-N",
        "iupac": {
          "systematic": "(2S,3S,4R)-1-(cyclopropanecarbonyl)-4-(hydroxymethyl)-3-[4-[2-(2-methoxyphenyl)ethynyl]phenyl]azetidine-2-carbonitrile"
        },
        "smiles": {
          "canonical": "COC1=CC=CC=C1C#CC2=CC=C(C=C2)C3C(N(C3C#N)C(=O)C4CC4)CO"
        },
        "molecularFormula": "C24H22N2O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:47:27Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8439"
    },
    "name": "BRD-K93411257",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8439.png",
    "lincs": {
      "id": "LSM-42350",
      "name": "BRD-K93411257",
      "pubchemCid": 60185163,
      "chebiId": 130801,
      "inchiParent": "InChI=1S/C23H28N4O3S/c1-3-4-20(29)27-14-23(12-26(13-23)10-19-24-7-8-31-19)21-16-6-5-15(30-2)9-17(16)25-22(21)18(27)11-28/h5-9,18,25,28H,3-4,10-14H2,1-2H3/t18-/m0/s1",
      "inchiKeyParent": "RHAHIDRIPBSPCL-SFHVURJKSA-N",
      "smilesParent": "CCCC(=O)N1CC2(CN(Cc3nccs3)C2)c4c([nH]c5cc(OC)ccc45)[C@@H]1CO"
    },
    "unichem": {
      "chebi": "130801",
      "lincs": "LSM-42350",
      "pubchem": "60185163"
    },
    "pubchem": [
      {
        "cid": 60185163,
        "inchi": "InChI=1S/C23H28N4O3S/c1-3-4-20(29)27-14-23(12-26(13-23)10-19-24-7-8-31-19)21-16-6-5-15(30-2)9-17(16)25-22(21)18(27)11-28/h5-9,18,25,28H,3-4,10-14H2,1-2H3/t18-/m0/s1",
        "inchikey": "RHAHIDRIPBSPCL-SFHVURJKSA-N",
        "iupac": {
          "systematic": "1-[(1R)-1-(hydroxymethyl)-7-methoxy-1'-(1,3-thiazol-2-ylmethyl)spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3'-azetidine]-2-yl]butan-1-one"
        },
        "smiles": {
          "canonical": "CCCC(=O)N1CC2(CN(C2)CC3=NC=CS3)C4=C(C1CO)NC5=C4C=CC(=C5)OC"
        },
        "molecularFormula": "C23H28N4O3S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:47:29Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8494"
    },
    "name": "BRD-K97101742",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8494.png",
    "lincs": {
      "id": "LSM-14393",
      "name": "BRD-K97101742",
      "pubchemCid": 54645950,
      "chebiId": 103047,
      "inchiParent": "InChI=1S/C24H32N2O5/c27-13-21-23-19(11-17(30-21)12-22(28)25-15-6-1-2-7-15)18-10-16(8-9-20(18)31-23)26-24(29)14-4-3-5-14/h8-10,14-15,17,19,21,23,27H,1-7,11-13H2,(H,25,28)(H,26,29)/t17-,19-,21-,23+/m0/s1",
      "inchiKeyParent": "MOMUNQNAFOIKEQ-RAKJYXHLSA-N",
      "smilesParent": "OC[C@@H]1O[C@H](CC(=O)NC2CCCC2)C[C@@H]3[C@H]1Oc4ccc(NC(=O)C5CCC5)cc34"
    },
    "unichem": {
      "chebi": "103047",
      "lincs": "LSM-14393",
      "pubchem": "54645950"
    },
    "pubchem": [
      {
        "cid": 54645950,
        "inchi": "InChI=1S/C24H32N2O5/c27-13-21-23-19(11-17(30-21)12-22(28)25-15-6-1-2-7-15)18-10-16(8-9-20(18)31-23)26-24(29)14-4-3-5-14/h8-10,14-15,17,19,21,23,27H,1-7,11-13H2,(H,25,28)(H,26,29)/t17-,19-,21-,23+/m0/s1",
        "inchikey": "MOMUNQNAFOIKEQ-RAKJYXHLSA-N",
        "iupac": {
          "systematic": "N-[(1S,3S,4aS,9aR)-3-[2-(cyclopentylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]cyclobutanecarboxamide"
        },
        "smiles": {
          "canonical": "C1CCC(C1)NC(=O)CC2CC3C(C(O2)CO)OC4=C3C=C(C=C4)NC(=O)C5CCC5"
        },
        "molecularFormula": "C24H32N2O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:47:32Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8496"
    },
    "name": "BRD-K77423370",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8496.png",
    "lincs": {
      "id": "LSM-7856",
      "name": "BRD-K77423370",
      "pubchemCid": 54618212,
      "chebiId": 96477,
      "inchiParent": "InChI=1S/C24H32N4O4/c1-15-13-28(16(2)14-29)24(31)20-10-19(11-26-22(20)32-21(15)12-25-3)17-7-6-8-18(9-17)23(30)27(4)5/h6-11,15-16,21,25,29H,12-14H2,1-5H3/t15-,16+,21+/m0/s1",
      "inchiKeyParent": "JOFZJSROTWODFL-GCKMJXCFSA-N",
      "smilesParent": "CNC[C@H]1Oc2ncc(cc2C(=O)N(C[C@@H]1C)[C@H](C)CO)c3cccc(c3)C(=O)N(C)C"
    },
    "unichem": {
      "chebi": "96477",
      "lincs": "LSM-7856",
      "pubchem": "54618212"
    },
    "pubchem": [
      {
        "cid": 54618212,
        "inchi": "InChI=1S/C24H32N4O4/c1-15-13-28(16(2)14-29)24(31)20-10-19(11-26-22(20)32-21(15)12-25-3)17-7-6-8-18(9-17)23(30)27(4)5/h6-11,15-16,21,25,29H,12-14H2,1-5H3/t15-,16+,21+/m0/s1",
        "inchikey": "JOFZJSROTWODFL-GCKMJXCFSA-N",
        "iupac": {
          "systematic": "3-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-8-yl]-N,N-dimethylbenzamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(N=CC(=C2)C3=CC(=CC=C3)C(=O)N(C)C)OC1CNC)C(C)CO"
        },
        "molecularFormula": "C24H32N4O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:47:34Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8497"
    },
    "name": "BRD-K99026889",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8497.png",
    "lincs": {
      "id": "LSM-14509",
      "name": "BRD-K99026889",
      "pubchemCid": 56835429,
      "chebiId": 103164,
      "inchiParent": "InChI=1S/C31H42N4O4/c1-21-17-35(22(2)19-36)31(38)30-29(25-13-9-10-14-26(25)34(30)6)24-12-8-7-11-23(24)20-39-27(21)18-33(5)28(37)15-16-32(3)4/h7-14,21-22,27,36H,15-20H2,1-6H3/t21-,22-,27+/m0/s1",
      "inchiKeyParent": "UPHSEAQPRHOHRJ-BCQCSXDESA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@H](C)[C@@H](CN(C)C(=O)CCN(C)C)OCc2ccccc2c3c(C1=O)n(C)c4ccccc34"
    },
    "unichem": {
      "chebi": "103164",
      "lincs": "LSM-14509",
      "pubchem": "56835429"
    },
    "pubchem": [
      {
        "cid": 56835429,
        "inchi": "InChI=1S/C31H42N4O4/c1-21-17-35(22(2)19-36)31(38)30-29(25-13-9-10-14-26(25)34(30)6)24-12-8-7-11-23(24)20-39-27(21)18-33(5)28(37)15-16-32(3)4/h7-14,21-22,27,36H,15-20H2,1-6H3/t21-,22-,27+/m0/s1",
        "inchikey": "UPHSEAQPRHOHRJ-BCQCSXDESA-N",
        "iupac": {
          "systematic": "3-(dimethylamino)-N-[[(10S,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylpropanamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(C3=CC=CC=C3COC1CN(C)C(=O)CCN(C)C)C4=CC=CC=C4N2C)C(C)CO"
        },
        "molecularFormula": "C31H42N4O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:47:36Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c849a"
    },
    "name": "BRD-K81954574",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c849a.png",
    "lincs": {
      "id": "LSM-13431",
      "name": "BRD-K81954574",
      "pubchemCid": 54638559,
      "chebiId": 102071,
      "inchiParent": "InChI=1S/C21H30FN3O5/c22-16-3-1-2-15(10-16)12-23-20(27)11-17-4-5-18(19(14-26)30-17)24-21(28)13-25-6-8-29-9-7-25/h1-3,10,17-19,26H,4-9,11-14H2,(H,23,27)(H,24,28)/t17-,18-,19+/m1/s1",
      "inchiKeyParent": "ZEQYNXCYKJRRAG-QRVBRYPASA-N",
      "smilesParent": "OC[C@@H]1O[C@@H](CC(=O)NCc2cccc(F)c2)CC[C@H]1NC(=O)CN3CCOCC3"
    },
    "unichem": {
      "chebi": "102071",
      "lincs": "LSM-13431",
      "pubchem": "54638559"
    },
    "pubchem": [
      {
        "cid": 54638559,
        "inchi": "InChI=1S/C21H30FN3O5/c22-16-3-1-2-15(10-16)12-23-20(27)11-17-4-5-18(19(14-26)30-17)24-21(28)13-25-6-8-29-9-7-25/h1-3,10,17-19,26H,4-9,11-14H2,(H,23,27)(H,24,28)/t17-,18-,19+/m1/s1",
        "inchikey": "ZEQYNXCYKJRRAG-QRVBRYPASA-N",
        "iupac": {
          "systematic": "N-[(3-fluorophenyl)methyl]-2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[(2-morpholin-4-ylacetyl)amino]oxan-2-yl]acetamide"
        },
        "smiles": {
          "canonical": "C1CC(C(OC1CC(=O)NCC2=CC(=CC=C2)F)CO)NC(=O)CN3CCOCC3"
        },
        "molecularFormula": "C21H30FN3O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:47:38Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84bd"
    },
    "name": "BRD-K87758256",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84bd.png",
    "lincs": {
      "id": "LSM-13811",
      "name": "BRD-K87758256",
      "pubchemCid": 54661321,
      "chebiId": 102460,
      "inchiParent": "InChI=1S/C26H32N2O5/c1-32-22-10-6-5-9-17(22)18-11-12-21-23-19(14-27(21)25(18)30)20(15-29)24(26(31)33-2)28(23)13-16-7-3-4-8-16/h5-6,9-12,16,19-20,23-24,29H,3-4,7-8,13-15H2,1-2H3/t19-,20-,23+,24-/m0/s1",
      "inchiKeyParent": "FQNLDYTYHLYOSL-JVODISISSA-N",
      "smilesParent": "COC(=O)[C@@H]1[C@@H](CO)[C@@H]2CN3C(=CC=C(C3=O)c4ccccc4OC)[C@@H]2N1CC5CCCC5"
    },
    "unichem": {
      "chebi": "102460",
      "lincs": "LSM-13811",
      "pubchem": "54661321"
    },
    "pubchem": [
      {
        "cid": 54661321,
        "inchi": "InChI=1S/C26H32N2O5/c1-32-22-10-6-5-9-17(22)18-11-12-21-23-19(14-27(21)25(18)30)20(15-29)24(26(31)33-2)28(23)13-16-7-3-4-8-16/h5-6,9-12,16,19-20,23-24,29H,3-4,7-8,13-15H2,1-2H3/t19-,20-,23+,24-/m0/s1",
        "inchikey": "FQNLDYTYHLYOSL-JVODISISSA-N",
        "iupac": {
          "systematic": "methyl (2S,3S,3aR,9bR)-1-(cyclopentylmethyl)-3-(hydroxymethyl)-7-(2-methoxyphenyl)-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxylate"
        },
        "smiles": {
          "canonical": "COC1=CC=CC=C1C2=CC=C3C4C(CN3C2=O)C(C(N4CC5CCCC5)C(=O)OC)CO"
        },
        "molecularFormula": "C26H32N2O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:47:40Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84c1"
    },
    "name": "BRD-K88328468",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84c1.png",
    "lincs": {
      "id": "LSM-13857",
      "name": "BRD-K88328468",
      "pubchemCid": 54638940,
      "chebiId": 102508,
      "inchiParent": "InChI=1S/C16H24N2O4/c19-9-14-13(18-16(21)10-4-5-10)7-6-12(22-14)8-15(20)17-11-2-1-3-11/h6-7,10-14,19H,1-5,8-9H2,(H,17,20)(H,18,21)/t12-,13-,14-/m1/s1",
      "inchiKeyParent": "RGLUKSSVDYQFDC-MGPQQGTHSA-N",
      "smilesParent": "OC[C@H]1O[C@@H](CC(=O)NC2CCC2)C=C[C@H]1NC(=O)C3CC3"
    },
    "unichem": {
      "chebi": "102508",
      "lincs": "LSM-13857",
      "pubchem": "54638940"
    },
    "pubchem": [
      {
        "cid": 54638940,
        "inchi": "InChI=1S/C16H24N2O4/c19-9-14-13(18-16(21)10-4-5-10)7-6-12(22-14)8-15(20)17-11-2-1-3-11/h6-7,10-14,19H,1-5,8-9H2,(H,17,20)(H,18,21)/t12-,13-,14-/m1/s1",
        "inchikey": "RGLUKSSVDYQFDC-MGPQQGTHSA-N",
        "iupac": {
          "systematic": "N-[(2S,3R,6S)-6-[2-(cyclobutylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]cyclopropanecarboxamide"
        },
        "smiles": {
          "canonical": "C1CC(C1)NC(=O)CC2C=CC(C(O2)CO)NC(=O)C3CC3"
        },
        "molecularFormula": "C16H24N2O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:47:43Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84d6"
    },
    "name": "BRD-K90074540",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84d6.png",
    "lincs": {
      "id": "LSM-13986",
      "name": "BRD-K90074540",
      "pubchemCid": 54637819,
      "chebiId": 102639,
      "inchiParent": "InChI=1S/C32H39N5O5/c1-19-15-37(20(2)17-38)31(39)30-28(25-13-9-10-14-26(25)36(30)6)24-12-8-7-11-23(24)18-41-27(19)16-35(5)32(40)33-29-21(3)34-42-22(29)4/h7-14,19-20,27,38H,15-18H2,1-6H3,(H,33,40)/t19-,20+,27-/m0/s1",
      "inchiKeyParent": "WBCPGODJHKXDGU-VKIDHGPPSA-N",
      "smilesParent": "C[C@H](CO)N1C[C@H](C)[C@H](CN(C)C(=O)Nc2c(C)onc2C)OCc3ccccc3c4c(C1=O)n(C)c5ccccc45"
    },
    "unichem": {
      "chebi": "102639",
      "lincs": "LSM-13986",
      "pubchem": "54637819"
    },
    "pubchem": [
      {
        "cid": 54637819,
        "inchi": "InChI=1S/C32H39N5O5/c1-19-15-37(20(2)17-38)31(39)30-28(25-13-9-10-14-26(25)36(30)6)24-12-8-7-11-23(24)18-41-27(19)16-35(5)32(40)33-29-21(3)34-42-22(29)4/h7-14,19-20,27,38H,15-18H2,1-6H3,(H,33,40)/t19-,20+,27-/m0/s1",
        "inchikey": "WBCPGODJHKXDGU-VKIDHGPPSA-N",
        "iupac": {
          "systematic": "3-(3,5-dimethyl-1,2-oxazol-4-yl)-1-[[(10R,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-1-methylurea"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(C3=CC=CC=C3COC1CN(C)C(=O)NC4=C(ON=C4C)C)C5=CC=CC=C5N2C)C(C)CO"
        },
        "molecularFormula": "C32H39N5O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:47:45Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c842a"
    },
    "name": "BRD-K29824954",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c842a.png",
    "lincs": {
      "id": "LSM-7231",
      "name": "BRD-K29824954",
      "pubchemCid": 54618447,
      "chebiId": 95852,
      "inchiParent": "InChI=1S/C31H40N2O6S/c1-22-18-33(23(2)21-34)40(37,38)30-15-14-25(11-6-10-24-8-4-5-9-24)17-28(30)39-29(22)20-32(3)19-26-12-7-13-27(16-26)31(35)36/h7,12-17,22-24,29,34H,4-5,8-10,18-21H2,1-3H3,(H,35,36)/t22-,23+,29+/m0/s1",
      "inchiKeyParent": "DKZVPIDPIJUHTD-QFWOEDSFSA-N",
      "smilesParent": "C[C@H](CO)N1C[C@H](C)[C@@H](CN(C)Cc2cccc(c2)C(=O)O)Oc3cc(ccc3S1(=O)=O)C#CCC4CCCC4"
    },
    "unichem": {
      "chebi": "95852",
      "lincs": "LSM-7231",
      "pubchem": "54618447"
    },
    "pubchem": [
      {
        "cid": 54618447,
        "inchi": "InChI=1S/C31H40N2O6S/c1-22-18-33(23(2)21-34)40(37,38)30-15-14-25(11-6-10-24-8-4-5-9-24)17-28(30)39-29(22)20-32(3)19-26-12-7-13-27(16-26)31(35)36/h7,12-17,22-24,29,34H,4-5,8-10,18-21H2,1-3H3,(H,35,36)/t22-,23+,29+/m0/s1",
        "inchikey": "DKZVPIDPIJUHTD-QFWOEDSFSA-N",
        "iupac": {
          "systematic": "3-[[[(4S,5S)-8-(3-cyclopentylprop-1-ynyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl-methylamino]methyl]benzoic acid"
        },
        "smiles": {
          "canonical": "CC1CN(S(=O)(=O)C2=C(C=C(C=C2)C#CCC3CCCC3)OC1CN(C)CC4=CC(=CC=C4)C(=O)O)C(C)CO"
        },
        "molecularFormula": "C31H40N2O6S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:47:47Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8430"
    },
    "name": "BRD-K51583960",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8430.png",
    "lincs": {
      "id": "LSM-11583",
      "name": "BRD-K51583960",
      "pubchemCid": 54657678,
      "chebiId": 100206,
      "inchiParent": "InChI=1S/C23H28N2O4/c26-19-13-24-21-11-10-20(29-22(21)15-28-14-19)12-23(27)25-18-8-6-17(7-9-18)16-4-2-1-3-5-16/h1-9,19-22,24,26H,10-15H2,(H,25,27)/t19-,20+,21-,22+/m1/s1",
      "inchiKeyParent": "UTTUQCGEIXLGEI-MBDNFAEBSA-N",
      "smilesParent": "O[C@@H]1CN[C@@H]2CC[C@@H](CC(=O)Nc3ccc(cc3)c4ccccc4)O[C@H]2COC1"
    },
    "unichem": {
      "chebi": "100206",
      "lincs": "LSM-11583",
      "pubchem": "54657678"
    },
    "pubchem": [
      {
        "cid": 54657678,
        "inchi": "InChI=1S/C23H28N2O4/c26-19-13-24-21-11-10-20(29-22(21)15-28-14-19)12-23(27)25-18-8-6-17(7-9-18)16-4-2-1-3-5-16/h1-9,19-22,24,26H,10-15H2,(H,25,27)/t19-,20+,21-,22+/m1/s1",
        "inchikey": "UTTUQCGEIXLGEI-MBDNFAEBSA-N",
        "iupac": {
          "systematic": "2-[(3R,6aR,8S,10aR)-3-hydroxy-1,2,3,4,6,6a,8,9,10,10a-decahydropyrano[2,3-c][1,5]oxazocin-8-yl]-N-(4-phenylphenyl)acetamide"
        },
        "smiles": {
          "canonical": "C1CC2C(COCC(CN2)O)OC1CC(=O)NC3=CC=C(C=C3)C4=CC=CC=C4"
        },
        "molecularFormula": "C23H28N2O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:47:49Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c843c"
    },
    "name": "BRD-K73008154",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c843c.png",
    "lincs": {
      "id": "LSM-41235",
      "name": "BRD-K73008154",
      "pubchemCid": 54666534,
      "chebiId": 129684,
      "inchiParent": "InChI=1S/C28H31FN2O3S/c1-20-7-6-8-23(17-20)21-11-13-22(14-12-21)28-25-18-30(15-4-5-16-31(25)26(28)19-32)35(33,34)27-10-3-2-9-24(27)29/h2-3,6-14,17,25-26,28,32H,4-5,15-16,18-19H2,1H3/t25-,26-,28+/m1/s1",
      "inchiKeyParent": "AYZWBNSPUGXEJF-GTNKKZTPSA-N",
      "smilesParent": "Cc1cccc(c1)c2ccc(cc2)[C@@H]3[C@@H](CO)N4CCCCN(C[C@H]34)S(=O)(=O)c5ccccc5F"
    },
    "unichem": {
      "chebi": "129684",
      "lincs": "LSM-41235",
      "pubchem": "54666534"
    },
    "pubchem": [
      {
        "cid": 54666534,
        "inchi": "InChI=1S/C28H31FN2O3S/c1-20-7-6-8-23(17-20)21-11-13-22(14-12-21)28-25-18-30(15-4-5-16-31(25)26(28)19-32)35(33,34)27-10-3-2-9-24(27)29/h2-3,6-14,17,25-26,28,32H,4-5,15-16,18-19H2,1H3/t25-,26-,28+/m1/s1",
        "inchikey": "AYZWBNSPUGXEJF-GTNKKZTPSA-N",
        "iupac": {
          "systematic": "[(8S,9S,10S)-6-(2-fluorophenyl)sulfonyl-9-[4-(3-methylphenyl)phenyl]-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol"
        },
        "smiles": {
          "canonical": "CC1=CC(=CC=C1)C2=CC=C(C=C2)C3C4CN(CCCCN4C3CO)S(=O)(=O)C5=CC=CC=C5F"
        },
        "molecularFormula": "C28H31FN2O3S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:47:51Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8462"
    },
    "name": "Alisertib",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8462.png",
    "lincs": {
      "id": "LSM-37184",
      "name": "Alisertib",
      "alternativeNames": [
        "Alisertib",
        "ALISERTIB (MLN8237)",
        "Alisertib Sodium",
        "MLN8237",
        "MLN 8237",
        "MLN-8237",
        "MLN-8237-004"
      ],
      "pubchemCid": 24771867,
      "chebiId": 125628,
      "inchiParent": "InChI=1S/C27H20ClFN4O4/c1-36-21-5-3-4-20(29)23(21)25-19-10-15(28)6-8-17(19)24-14(12-30-25)13-31-27(33-24)32-16-7-9-18(26(34)35)22(11-16)37-2/h3-11,13H,12H2,1-2H3,(H,34,35)(H,31,32,33)",
      "inchiKeyParent": "ZLHFILGSQDJULK-UHFFFAOYSA-N",
      "smilesParent": "COc1cccc(F)c1C2=NCc3cnc(Nc4ccc(C(=O)O)c(OC)c4)nc3c5ccc(Cl)cc25"
    },
    "unichem": {
      "chebi": "125628",
      "chembl": "CHEMBL483158",
      "lincs": "LSM-37184",
      "pubchem": "24771867",
      "drugbank": "DB05220"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL483158",
      "prefName": "ALISERTIB",
      "maxPhase": 3.0,
      "maxPhaseCurated": "Phase 3 Clinical Trials",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 518.93,
        "hba": 7,
        "hbd": 2,
        "qedWeighted": 0.33
      },
      "moleculeSynonyms": [
        {
          "moleculeSynonym": "Alisertib",
          "synType": "USAN",
          "synonyms": "Alisertib"
        },
        {
          "moleculeSynonym": "Alisertib",
          "synType": "INN",
          "synonyms": "ALISERTIB"
        },
        {
          "moleculeSynonym": "Alisertib",
          "synType": "OTHER",
          "synonyms": "ALISERTIB"
        },
        {
          "moleculeSynonym": "MLN 8237",
          "synType": "RESEARCH_CODE",
          "synonyms": "MLN 8237"
        },
        {
          "moleculeSynonym": "Mln-8237",
          "synType": "OTHER",
          "synonyms": "MLN-8237"
        },
        {
          "moleculeSynonym": "MLN-8237",
          "synType": "RESEARCH_CODE",
          "synonyms": "MLN-8237"
        },
        {
          "moleculeSynonym": "MLN8237",
          "synType": "RESEARCH_CODE",
          "synonyms": "MLN8237"
        }
      ],
      "drugIndications": [
        {
          "efoId": "EFO:0000574",
          "efoTerm": "lymphoma",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT01512758,NCT01714947,NCT01844583,NCT01898078,NCT02214147,NCT02259010"
            ]
          },
          "maxPhaseForInd": 1.0,
          "meshHeading": "Lymphoma"
        },
        {
          "efoId": "EFO:0000673",
          "efoTerm": "prostate adenocarcinoma",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT01094288,NCT01799278,NCT01848067"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Prostatic Neoplasms"
        },
        {
          "efoId": "EFO:0000616",
          "efoTerm": "neoplasm",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT00962091"
            ]
          },
          "maxPhaseForInd": 1.0,
          "meshHeading": "Neoplasms"
        },
        {
          "efoId": "EFO:0000621",
          "efoTerm": "neuroblastoma",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT01601535,NCT02444884"
            ]
          },
          "maxPhaseForInd": 1.0,
          "meshHeading": "Neuroblastoma"
        },
        {
          "efoId": "EFO:0001075",
          "efoTerm": "ovarian carcinoma",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT00853307,NCT01091428"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Ovarian Neoplasms"
        },
        {
          "efoId": "EFO:0000305",
          "efoTerm": "breast carcinoma",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT01091428,NCT02187991,NCT02219789,NCT02860000"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Breast Neoplasms"
        },
        {
          "efoId": "EFO:0000198",
          "efoTerm": "myelodysplastic syndrome",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT00830518"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Myelodysplastic Syndromes"
        },
        {
          "efoId": "EFO:0000211",
          "efoTerm": "unspecified peripheral T-cell lymphoma",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT01482962"
            ]
          },
          "maxPhaseForInd": 3.0,
          "meshHeading": "Lymphoma, T-Cell, Peripheral"
        },
        {
          "efoId": "EFO:0000222",
          "efoTerm": "acute myeloid leukemia",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT00830518,NCT01779843,NCT02560025"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Leukemia, Myeloid, Acute"
        },
        {
          "efoId": "EFO:0000309",
          "efoTerm": "Burkitts lymphoma",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT01397825,NCT02700022"
            ]
          },
          "maxPhaseForInd": 1.0,
          "meshHeading": "Burkitt Lymphoma"
        },
        {
          "efoId": "EFO:0000403",
          "efoTerm": "diffuse large B-cell lymphoma",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT01397825,NCT02700022"
            ]
          },
          "maxPhaseForInd": 1.0,
          "meshHeading": "Lymphoma, Large B-Cell, Diffuse"
        },
        {
          "efoId": "EFO:0000702",
          "efoTerm": "small cell lung carcinoma",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT02038647"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Small Cell Lung Carcinoma"
        },
        {
          "efoId": "EFO:0001378",
          "efoTerm": "multiple myeloma",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT01034553"
            ]
          },
          "maxPhaseForInd": 1.0,
          "meshHeading": "Multiple Myeloma"
        },
        {
          "efoId": "EFO:0006859",
          "efoTerm": "head and neck malignant neoplasia",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT01540682"
            ]
          },
          "maxPhaseForInd": 1.0,
          "meshHeading": "Head and Neck Neoplasms"
        },
        {
          "efoId": "EFO:1001469",
          "efoTerm": "Mantle cell lymphoma",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT01397825"
            ]
          },
          "maxPhaseForInd": 1.0,
          "meshHeading": "Lymphoma, Mantle-Cell"
        },
        {
          "efoId": "MONDO:0002087",
          "efoTerm": "peritoneum cancer",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT01091428"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Peritoneal Neoplasms"
        },
        {
          "efoId": "MONDO:0002158",
          "efoTerm": "fallopian tube cancer",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT01091428"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Fallopian Tube Neoplasms"
        },
        {
          "efoId": "MONDO:0002516",
          "efoTerm": "digestive system cancer",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT02319018"
            ]
          },
          "maxPhaseForInd": 1.0,
          "meshHeading": "Digestive System Neoplasms"
        },
        {
          "efoId": "MONDO:0007254",
          "efoTerm": "breast cancer",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT02719691"
            ]
          },
          "maxPhaseForInd": 2.0,
          "meshHeading": "Breast Neoplasms"
        },
        {
          "efoId": "MONDO:0008903",
          "efoTerm": "lung cancer",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT04085315"
            ]
          },
          "maxPhaseForInd": 1.0,
          "meshHeading": "Lung Neoplasms"
        },
        {
          "efoId": "MONDO:0018906",
          "efoTerm": "follicular lymphoma",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT01397825,NCT02700022"
            ]
          },
          "maxPhaseForInd": 1.0,
          "meshHeading": "Lymphoma, Follicular"
        },
        {
          "efoId": "EFO:0000181",
          "efoTerm": "head and neck squamous cell carcinoma",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT04555837"
            ]
          },
          "maxPhaseForInd": 1.0,
          "meshHeading": "Carcinoma, Squamous Cell"
        },
        {
          "efoId": "EFO:0003060",
          "efoTerm": "non-small cell lung carcinoma",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT04479306"
            ]
          },
          "maxPhaseForInd": 1.0,
          "meshHeading": "Carcinoma, Non-Small-Cell Lung"
        },
        {
          "efoId": "MONDO:0004992",
          "efoTerm": "cancer",
          "indicationRefs": {
            "clinicalTrials": [
              "NCT00500903,NCT00651664,NCT01613261,NCT02327169"
            ]
          },
          "maxPhaseForInd": 1.0,
          "meshHeading": "Neoplasms"
        }
      ],
      "drugMechanisms": [
        {
          "mechanismOfAction": "Serine/threonine-protein kinase Aurora-A inhibitor",
          "actionType": "INHIBITOR",
          "targetName": "Serine/threonine-protein kinase Aurora-A",
          "targetOrganism": "Homo sapiens",
          "targetType": "SINGLE PROTEIN",
          "targetComponents": [
            {
              "uniprot": [
                "O14965"
              ]
            }
          ]
        }
      ]
    },
    "pubchem": [
      {
        "cid": 24771867,
        "inchi": "InChI=1S/C27H20ClFN4O4/c1-36-21-5-3-4-20(29)23(21)25-19-10-15(28)6-8-17(19)24-14(12-30-25)13-31-27(33-24)32-16-7-9-18(26(34)35)22(11-16)37-2/h3-11,13H,12H2,1-2H3,(H,34,35)(H,31,32,33)",
        "inchikey": "ZLHFILGSQDJULK-UHFFFAOYSA-N",
        "iupac": {
          "systematic": "4-[[9-chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino]-2-methoxybenzoic acid"
        },
        "smiles": {
          "canonical": "COC1=C(C(=CC=C1)F)C2=NCC3=CN=C(N=C3C4=C2C=C(C=C4)Cl)NC5=CC(=C(C=C5)C(=O)O)OC"
        },
        "molecularFormula": "C27H20ClFN4O4"
      }
    ],
    "clinicaltrials": [
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02187991",
            "briefTitle": "Study to Compare Alisertib With Paclitaxel vs. Paclitaxel Alone in Metastatic or Locally Recurrent Breast Cancer",
            "officialTitle": "A Phase II, Multicenter, Randomized, Parallel Group Study to Compare Alisertib in Combination With Paclitaxel vs. Paclitaxel Alone in Patients With Metastatic or Locally Recurrent Breast Cancer"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2014-07-06",
            "resultsFirstSubmitDate": "2024-08-21"
          },
          "conditionsModule": {
            "conditions": [
              "Breast Cancer",
              "Breast Carcinoma",
              "Breast Tumors",
              "Malignant Neoplasm of Breast"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Time to Disease Progression - Tumor Response Based on RECIST 1.1 Criteria",
                "timeFrame": "until disease progression (assessed by RECIST 1.1), unacceptable toxicity, death, or discontinuation from study for any other reason, up to 3 years from date of patient registration"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Overall Survival"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01540682",
            "briefTitle": "MLN8237 in Head and Neck Cancer",
            "officialTitle": "Phase I Study of MLN8237 in Combination With Cetuximab and Definitive Radiation in Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2012-02-09"
          },
          "conditionsModule": {
            "conditions": [
              "Head and Neck Cancer"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Number of Adverse Events"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01924260",
            "briefTitle": "Alisertib and Gemcitabine Hydrochloride in Treating Patients With Solid Tumors or Pancreatic Cancer",
            "officialTitle": "Phase I Study of the Combination of MLN8237 and Gemcitabine in Advanced Solid Tumors With Emphasis on Pancreatic Cancer"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2013-08-13"
          },
          "conditionsModule": {
            "conditions": [
              "Acinar Cell Adenocarcinoma of the Pancreas",
              "Duct Cell Adenocarcinoma of the Pancreas",
              "Recurrent Pancreatic Cancer",
              "Stage III Pancreatic Cancer",
              "Stage IV Pancreatic Cancer",
              "Unspecified Adult Solid Tumor, Protocol Specific"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Dose-limiting toxicity (DLT) defined as any related (possibly, probably, or definitely) grade 3 non-hematological toxicity or any attributable grade 4 toxicity graded according to the National Cancer Institute (NCI) CTCAE version 4.0",
                "timeFrame": "Up to 21 days"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Incidence of adverse events graded according to NCI CTCAE version 4.0"
              },
              {
                "measure": "Response rate according to Response Evaluation Criteria In Solid Tumors (RECIST) 1.1"
              },
              {
                "measure": "Progression Free Survival"
              },
              {
                "measure": "Maximum-tolerated dose (MTD) defined as the maximum dose level at which less than 2 patients experience DLT graded according to NCI CTCAE version 4.0"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00962091",
            "briefTitle": "Study of MLN8237 in Participants With Advanced Solid Tumors",
            "officialTitle": "An Open-label, Phase 1 Study of the Relative Bioavailability, Food Effect, Safety and Tolerability of MLN8237 in Patients With Advanced Solid Tumors"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2009-08-18",
            "resultsFirstSubmitDate": "2018-06-12"
          },
          "conditionsModule": {
            "conditions": [
              "Advanced Solid Tumors"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Part A: Dose-normalized Cmax (Maximum Observed Concentration) for Estimation of Relative Bioavailability for Alisertib Oral Solution (OS) Versus Powder in Capsule Formulations (PIC)",
                "timeFrame": "Cycles 1 and 2 Day 1 predose and at multiple time points (up to 48 hours) postdose, and, if clinically feasible, at the time of a serious or unusual adverse event (AE) that was judged by the investigator to be treatment related."
              },
              {
                "measure": "Part A: Dose-normalized AUClast (Area Under the Concentration-Time Curve From Time 0 to Time of the Last Quantifiable Concentration) for Estimation of Relative Bioavailability for Alisertib Oral Solution (OS) Versus Powder in Capsule Formulations (PIC)",
                "timeFrame": "Cycles 1 and 2 Day 1 predose and at multiple time points (up to 48 hours) postdose, and, if clinically feasible, at the time of a serious or unusual AE that was judged by the investigator to be treatment related."
              },
              {
                "measure": "Part B: Cmax: Maximum Observed Concentration for Alisertib Administered as an Oral Solution With Food Versus Without Food",
                "timeFrame": "Cycles 1 and 2 Day 1 predose and at multiple time points (up to 48 hours) postdose, and, if clinically feasible, at the time of a serious or unusual AE that was judged by the investigator to be treatment related."
              },
              {
                "measure": "Part B: AUClast: Area Under the Concentration-Time Curve From Time 0 to Time of the Last Quantifiable Concentration for Alisertib Administered as an Oral Solution With Food Versus Without Food",
                "timeFrame": "Cycles 1 and 2 Day 1 predose and at multiple time points (up to 48 hours) postdose, and, if clinically feasible, at the time of a serious or unusual AE that was judged by the investigator to be treatment related."
              },
              {
                "measure": "Part B: Cmax: Maximum Plasma Concentration for Alisertib Oral Solution Following Multiple-Dose Administration",
                "timeFrame": "Cycle 1 Day 9 predose and at multiple time points (up to 12 hours) postdose, and, if clinically feasible, at the time of a serious or unusual AE that was judged by the investigator to be treatment related."
              },
              {
                "measure": "Part B: Tmax: Time of First Occurrence of Cmax Over the Dosing Interval for Alisertib Oral Solution Following Multiple-Dose Administration",
                "timeFrame": "Cycle 1 Day 9 predose and at multiple time points (up to 12 hours) postdose, and, if clinically feasible, at the time of a serious or unusual AE that was judged by the investigator to be treatment related."
              },
              {
                "measure": "Part B: AUC\u03c4: Area Under the Concentration-Time Curve From Time 0 to End of Dosing Interval for Alisertib Oral Solution Following Multiple-Dose Administration",
                "timeFrame": "Cycle 1 Day 9 predose and at multiple time points (up to 12 hours) postdose, and, if clinically feasible, at the time of a serious or unusual AE that was judged by the investigator to be treatment related."
              },
              {
                "measure": "Part C: Cmax: Maximum Observed Concentration for Alisertib Administered as an Enteric-Coated Capsule (ECT) With Food Versus Without Food",
                "timeFrame": "Cycles 1 and 2 Day 1 predose and at multiple time points (up to 48 hours) postdose, and, if clinically feasible, at the time of a serious or unusual AE that was judged by the investigator to be treatment related."
              },
              {
                "measure": "Part C: AUClast: Area Under the Concentration-Time Curve From Time 0 to Time of the Last Quantifiable Concentration for Alisertib Administered as an Enteric-Coated Capsule (ECT) With Food Versus Without Food",
                "timeFrame": "Cycles 1 and 2 on Day 1 predose and at multiple time points (up to 48 hours) postdose, and, if clinically feasible, at the time of a serious or unusual AE that was judged by the investigator to be treatment related."
              },
              {
                "measure": "Part C: AUC\u221e: Area Under the Concentration-Time Curve From Time 0 to Infinity, Calculated Using the Observed Value of the Last Quantifiable Concentration for Alisertib Administered as an Enteric-Coated Capsule (ECT) With Food Versus Without Food",
                "timeFrame": "Cycles 1 and 2 on Day 1 predose and at multiple time points (up to 48 hours) postdose, and, if clinically feasible, at the time of a serious or unusual AE that was judged by the investigator to be treatment related."
              },
              {
                "measure": "Number of Participants With Adverse Events (AEs) and Serious Adverse Events (SAEs)",
                "timeFrame": "Up to 30 days after the last dose of study drug (up to 27.4 months)"
              },
              {
                "measure": "Number of Participants With Abnormal Laboratory Values Reported as Adverse Events at an Incidence of at Least 5%",
                "timeFrame": "Up to 30 days after the last dose of study drug (up to 27.4 months)"
              },
              {
                "measure": "Number of Participants With Abnormal Vital Signs Reported as Adverse Events",
                "timeFrame": "Up to 30 days after the last dose of study drug (up to 24 months approximately)"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Best Overall Response (CR+PR) Based on Investigator's Assessment According to the Response Evaluation Criteria in Solid Tumors (RECIST) Version 1.1"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02114229",
            "briefTitle": "Phase 2 Study of Alisertib Therapy for Rhabdoid Tumors",
            "officialTitle": "Phase 2 Study of Alisertib as a Single Agent in Recurrent or Progressive Central Nervous System (CNS) Atypical Teratoid Rhabdoid Tumors (AT/RT) and Extra-CNS Malignant Rhabdoid Tumors (MRT) and in Combination Therapy in Newly Diagnosed AT/RT"
          },
          "statusModule": {
            "overallStatus": "ACTIVE_NOT_RECRUITING",
            "studyFirstSubmitDate": "2014-04-11"
          },
          "conditionsModule": {
            "conditions": [
              "Malignant Rhabdoid Tumor",
              "Atypical Teratoid Rhabdoid Tumor"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Sustained response rate of pediatric participants with recurrent or refractory AT/RT treated with alisertib (stratum A1)",
                "timeFrame": "Within 30 weeks after start of alisertib therapy"
              },
              {
                "measure": "Sustained response rate of pediatric participants with recurrent or refractory MRT treated with alisertib (stratum A2)",
                "timeFrame": "Within 30 weeks after start of alisertib therapy"
              },
              {
                "measure": "3-year progression free survival rate (stratum B1)",
                "timeFrame": "Up to 3 years after the last enrolled patient starts therapy"
              },
              {
                "measure": "1-year progression free survival rate (stratum B2)",
                "timeFrame": "Up to 1 year after the last enrolled patient starts therapy"
              },
              {
                "measure": "3-year progression free survival rate (stratum C1)",
                "timeFrame": "Up to 3 years after the last enrolled patient starts therapy"
              },
              {
                "measure": "1-year progression free survival rate (stratum C2)",
                "timeFrame": "Up to 1-year after the last enrolled patient starts therapy"
              },
              {
                "measure": "Single dose and steady state pharmacokinetics and pharmacodynamics of alisertib",
                "timeFrame": "Treatment Cycle 1 on days 1 and 7"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Duration of objective response by stratum A1 and A2"
              },
              {
                "measure": "1-year progression-free survival (PFS) by stratum A1 and A2"
              },
              {
                "measure": "5-year Progression-free survival (PFS) rate in patients with newly diagnosed AT/RT (strata B1, B2, B3, C1, C2)"
              },
              {
                "measure": "5-year Overall survival (OS) rate in patients with newly diagnosed AT/RT (strata B1, B2, B3, C1, C2)"
              },
              {
                "measure": "Proportion of local and distant failure in strata B1, B2, B3, C1 and C2"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02719691",
            "briefTitle": "Phase I Study of MLN0128 and MLN8237 in Patients With Advanced Solid Tumors and Metastatic Triple-negative Breast Cancer",
            "officialTitle": "A Phase Ib Study of the Combination of MLN0128 (Dual TORC1/2 Inhibitor) and MLN8237 (Aurora A Inhibitor, Alisertib) in Patients With Advanced Solid Tumors With an Expansion Cohort in Metastatic Triple-negative Breast Cancer (TNBC)"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2016-03-21",
            "resultsFirstSubmitDate": "2021-10-27"
          },
          "conditionsModule": {
            "conditions": [
              "Metastatic Breast Cancer",
              "Solid Tumors"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "The Maximum Tolerated Dose (MTD) in the Combination of MLN0128 and Alisertib in Patients With Advanced Solid Tumors Measured by Treatment Adverse Events as Assessed by the CTCAE v4.03",
                "timeFrame": "Up to 28 days"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "The Safety Profile and Tolerability of the Combination of MLN0128 and Alisertib in Adult Patients With Advanced Solid Tumors."
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT03005262",
            "briefTitle": "MLN8237 for a Subject With Adenocarcinoma of the Prostate",
            "officialTitle": "Expanded Access To MLN8237, For An Individual Patient With Adenocarcinoma Of The Prostate (CTMS# 16-0122)"
          },
          "statusModule": {
            "overallStatus": "NO_LONGER_AVAILABLE",
            "studyFirstSubmitDate": "2016-12-22"
          },
          "conditionsModule": {
            "conditions": [
              "Prostate Cancer"
            ]
          },
          "designModule": {
            "studyType": "EXPANDED_ACCESS"
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01397825",
            "briefTitle": "MLN8237 in Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma Treated With Rituximab +/- Vincristine",
            "officialTitle": "A Multicenter, Phase 1-2 Study of MLN8237, an Oral Aurora A Kinase Inhibitor, in Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma Treated With Rituximab and Vincristine"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2011-07-17",
            "resultsFirstSubmitDate": "2018-01-04"
          },
          "conditionsModule": {
            "conditions": [
              "Diffuse Large B-Cell Lymphoma",
              "Transformed Follicular Lymphoma",
              "Mantle Cell Lymphoma",
              "Burkitt's Lymphoma"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Number of Participants With Clinically Significant Vital Signs Findings (Treatment Related and Unrelated) [Phase 1]",
                "timeFrame": "First dose of alisertib through 30 days after the last dose of alisertib (Up to 5.2 Years)"
              },
              {
                "measure": "Number of Participants With Clinically Significant Changes in Electrocardiograms (ECGs) [Phase 1]",
                "timeFrame": "First dose of alisertib through 30 days after the last dose of alisertib (Up to 5.2 Years)"
              },
              {
                "measure": "Number of Participants With Clinically Significant Changes in Multigated Acquisition (MUGA)/ Echocardiogram (ECHO) [Phase 1]",
                "timeFrame": "First dose of alisertib through 30 days after the last dose of alisertib (Up to 5.2 Years)"
              },
              {
                "measure": "Number of Participants With Clinically Significant Changes in Physical Examination Findings [Phase 1]",
                "timeFrame": "First dose of alisertib through 30 days after the last dose of alisertib (Up to 5.2 Years)"
              },
              {
                "measure": "Number of Participants With Clinically Significant Laboratory Tests Reported as Adverse Events [Phase 1]",
                "timeFrame": "First dose of alisertib through 30 days after the last dose of alisertib (Up to 5.2 Years)"
              },
              {
                "measure": "Number of Participants With Treatment-Emergent Adverse Events [Phase 1]",
                "timeFrame": "First dose of alisertib through 30 days after the last dose of alisertib (Up to 5.2 Years)"
              },
              {
                "measure": "Overall Response Rate [Phase 2]",
                "timeFrame": "At the end of Cycle 2, at the end of every second treatment cycle until 6 months, then every 12 weeks thereafter, approximately 2 years"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Overall Response Rate as Assessed by the Investigator [Phase 1]"
              },
              {
                "measure": "Complete Response Rate [Phase 2]"
              },
              {
                "measure": "Duration of Response (DOR) [Phase 2]"
              },
              {
                "measure": "Progression Free Survival (PFS) [Phase 2]"
              },
              {
                "measure": "Number of Participants With Treatment-Emergent Adverse Events [Phase 2]"
              },
              {
                "measure": "Number of Participants With Clinically Significant Vital Signs Findings [Phase 2]"
              },
              {
                "measure": "Number of Participants With Clinically Significant Changes in Electrocardiograms (ECGs) [Phase 2]"
              },
              {
                "measure": "Number of Participants With Clinically Significant Changes in Multigated Acquisition (MUGA)/ Echocardiogram (ECHO) [Phase 2]"
              },
              {
                "measure": "Number of Participants With Clinically Significant Laboratory Tests Reported as Adverse Events [Phase 2]"
              },
              {
                "measure": "Cmax: Maximum Plasma Concentration for Alisertib"
              },
              {
                "measure": "Tmax: Time to First Occurrence of Cmax fo Alisertib"
              },
              {
                "measure": "AUCt: Area Under the Concentration Time Curve Over the Dosing Interval From Time 0 to Time t for Alisertib"
              },
              {
                "measure": "Cmax: Maximum Plasma Concentration for Vincristine"
              },
              {
                "measure": "AUCt: Area Under the Concentration-time Time Curve Over the Dosing Interval From Time 0 to Time t for Vincristine"
              },
              {
                "measure": "AUC\u221e: Area Under the Concentration-time Curve From Time 0 to Infinity for Vincristine"
              },
              {
                "measure": "T1/2: Terminal Disposition Phase Half-life for Vincristine"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01512758",
            "briefTitle": "A Study of Alisertib (MLN8237) in Adult East Asian Participants With Advanced Solid Tumors or Lymphomas",
            "officialTitle": "A Phase 1 Dose Escalation and Pharmacokinetic Study of Alisertib (MLN8237), an Aurora A Kinase Inhibitor, in Adult East Asian Patients With Advanced Solid Tumors or Lymphomas"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2012-01-13",
            "resultsFirstSubmitDate": "2018-04-09"
          },
          "conditionsModule": {
            "conditions": [
              "Advanced Solid Tumors",
              "Lymphomas"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D)",
                "timeFrame": "Treatment Cycle 1"
              },
              {
                "measure": "Number of Participants With Adverse Events and Serious Adverse Events",
                "timeFrame": "First dose to 30 days past last dose (Up to 12.1 Months)"
              },
              {
                "measure": "Number of Participants With Abnormal Clinical Laboratory Values Reported as Adverse Events",
                "timeFrame": "First dose to 30 days past last dose (Up to 12.1 Months)"
              },
              {
                "measure": "Number of Participants With Clinically Significant Changes in Vital Signs Reported as Adverse Events",
                "timeFrame": "First dose to 30 days past last dose (Up to 12.1 Months)"
              },
              {
                "measure": "Cmax: Maximum Observed Concentration for Alisertib",
                "timeFrame": "Cycle 1 Days 1 and 7 predose and at multiple time points (up to 12 hours) postdose"
              },
              {
                "measure": "Tmax: Time to First Occurrence of Cmax for Alisertib",
                "timeFrame": "Cycle 1 Days 1 and 7 predose and at multiple time points (up to 12 hours) postdose"
              },
              {
                "measure": "AUC\u03c4: Area Under the Concentration-Time Curve From Time 0 to End of Dosing Interval (\u03c4) for Alisertib",
                "timeFrame": "Cycle 1 Days 1 and 7 predose and at multiple time points (up to 12 hours) postdose"
              },
              {
                "measure": "Dose Normalized AUC\u03c4: Area Under the Concentration-Time Curve From Time 0 to Time t for Alisertib",
                "timeFrame": "Cycle 1 Day 7 predose and at multiple time points (up to 12 hours) postdose"
              },
              {
                "measure": "T1/2: Terminal Half-Life for Alisertib",
                "timeFrame": "Cycle 1 Day 7 predose and at multiple time points (up to 12 hours) postdose"
              },
              {
                "measure": "Rac: Accumulation Ratio for Alisertib",
                "timeFrame": "Cycle 1 Day 7 predose and at multiple time points (up to 12 hours) postdose"
              },
              {
                "measure": "PTR: Peak Trough Ratio During a Dosing Interval, at Steady State for Alisertib",
                "timeFrame": "Cycle 1 Day 7 predose and at multiple time points (up to 12 hours) postdose"
              },
              {
                "measure": "CLss/F: Apparent Clearance After Extravascular Administration, at Steady State, Calculated Using AUC\u03c4 for Alisertib",
                "timeFrame": "Cycle 1 Day 7 predose and at multiple time points (up to 12 hours) postdose"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Best Overall Response Rate Based on Investigator Assessment"
              },
              {
                "measure": "Duration of Response"
              },
              {
                "measure": "Concentrations of Relevant Tumor Markers"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02219789",
            "briefTitle": "Alisertib and Fulvestrant in Treating Patients With Hormone Receptor Positive Breast Cancer That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery",
            "officialTitle": "A Phase I Trial to Evaluate the Safety of the Addition of Alisertib to Fulvestrant in Women With Advanced Hormone Receptor Positive (HR+) Breast Cancer"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2014-08-15"
          },
          "conditionsModule": {
            "conditions": [
              "Estrogen Receptor Positive",
              "Progesterone Receptor Positive",
              "Recurrent Breast Carcinoma",
              "Stage IIIB Breast Cancer",
              "Stage IIIC Breast Cancer",
              "Stage IV Breast Cancer"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Maximum tolerated dose (MTD) of alisertib in combination with fulvestrant graded according to National Cancer Institute Common Terminology Criteria for Adverse Events version 4.0",
                "timeFrame": "28 days"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Tumor response (complete or partial response) using Response Evaluation Criteria in Solid Tumors version 1.1"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01482962",
            "briefTitle": "Alisertib (MLN8237) or Investigator's Choice in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma",
            "officialTitle": "A Phase 3, Randomized, Two-Arm, Open-Label, Multicenter, International Trial of Alisertib (MLN8237) or Investigator's Choice (Selected Single Agent) in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2011-11-28",
            "resultsFirstSubmitDate": "2018-05-09"
          },
          "conditionsModule": {
            "conditions": [
              "Relapsed Peripheral T-Cell Lymphoma",
              "Refractory Peripheral T-Cell Lymphoma"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Overall Response Rate (ORR) Based on Independent Review Committee (IRC) Assessment",
                "timeFrame": "Every 8 weeks from date of first dose treatment; every 12 weeks after 40 week assessment; at end of treatment visit until progressive disease. Duration is approximately 3 years"
              },
              {
                "measure": "Progression-Free Survival (PFS) Based on IRC Assessment",
                "timeFrame": "Every 8 weeks from date of first dose treatment; every 12 weeks after 40 week assessment; at end of treatment visit until progressive disease. Duration is approximately 3 years"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Overall Survival (OS)"
              },
              {
                "measure": "Number of Participants With Treatment-Emergent Adverse Events (TEAEs) and Serious Adverse Events (SAEs)"
              },
              {
                "measure": "Number of Participants With Clinically Important Abnormal Laboratory Values Reported as AEs"
              },
              {
                "measure": "Number of Participants With Clinically Important Vital Sign Measurements Reported as AEs"
              },
              {
                "measure": "Complete Response (CR) Rate"
              },
              {
                "measure": "Time to Disease Progression (TTP)"
              },
              {
                "measure": "Duration of Response (DOR)"
              },
              {
                "measure": "Time to Response"
              },
              {
                "measure": "Time to Subsequent Antineoplastic Therapy"
              },
              {
                "measure": "Plasma Concentration-time Data to Contribute to Future Population Pharmacokinetics (PK) Analysis"
              },
              {
                "measure": "Change Form Baseline in Reported Symptoms and Quality of Life (QoL) Assessment Per Functional Assessment of Cancer Therapy-Lymphoma (FACT-LYM) for Functioning and Symptoms"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02700022",
            "briefTitle": "A Phase I Study of Alisertib + R-EPOCH for Treatment of Myc-Positive Aggressive B-cell Lymphomas",
            "officialTitle": "A Phase I/Ib Study of Alisertib Plus R-EPOCH for Treatment of Myc-Positive Aggressive B-Cell Lymphomas"
          },
          "statusModule": {
            "overallStatus": "TERMINATED",
            "whyStopped": "Lack of funding",
            "studyFirstSubmitDate": "2016-02-17"
          },
          "conditionsModule": {
            "conditions": [
              "Diffuse Large B-cell Lymphoma",
              "Follicular Lymphoma",
              "Burkitt Lymphoma"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Maximum tolerated dose (MTD)",
                "timeFrame": "2 years"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Toxicity"
              },
              {
                "measure": "Rate of Response"
              },
              {
                "measure": "Progression free survival"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01316692",
            "briefTitle": "Aurora A Kinase Inhibitor MLN8237 in Treating Patients With Unresectable Stage III-IV Melanoma",
            "officialTitle": "A Phase II Correlative Clinical Trial of MLN8237, a Selective Aurora Kinase A (AURKA) Inhibitor, in Patients With Unresectable Stage III or Stage IV Melanoma Disease"
          },
          "statusModule": {
            "overallStatus": "TERMINATED",
            "whyStopped": "low accrual",
            "studyFirstSubmitDate": "2011-03-15",
            "resultsFirstSubmitDate": "2016-04-21"
          },
          "conditionsModule": {
            "conditions": [
              "Recurrent Melanoma",
              "Stage IIIc Melanoma",
              "Stage IV Melanoma"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Overall Response Rate",
                "timeFrame": "At 18 weeks"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Progression-free Survival"
              },
              {
                "measure": "Overall Survival"
              },
              {
                "measure": "Number of Grade 3 and 4 Study-related Toxicities"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02259010",
            "briefTitle": "A Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of Alisertib in Participants With Advanced Solid Tumors or Relapsed/Refractory Lymphoma",
            "officialTitle": "A Phase 1 Study to Evaluate the Effect of Itraconazole, a Strong CYP3A Inhibitor, on the Pharmacokinetics of Alisertib (MLN8237) in Adult Patients With Advanced Solid Tumors or Relapsed/Refractory Lymphoma"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2014-10-03",
            "resultsFirstSubmitDate": "2018-04-09"
          },
          "conditionsModule": {
            "conditions": [
              "Advanced Solid Tumors",
              "Relapsed/Refractory Lymphoma"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Cmax: Maximum Observed Concentration of Alisertib in Presence and Absence of Itraconazole in Part A",
                "timeFrame": "Day 1 pre-dose and at multiple time points (up to 96 hours) post-dose in Cycle 1 for alisertib without itraconazole arm; Day 10 pre-dose and at multiple time points (up to 96 hours) post-dose in Cycle 1 for alisertib with itraconazole arm"
              },
              {
                "measure": "AUC(Last): Area Under the Plasma Concentration Curve From Time 0 to the Time of the Last Quantifiable Concentration of Alisertib in Presence and Absence of Itraconazole in Part A",
                "timeFrame": "Day 1 pre-dose and at multiple time points (up to 96 hours) post-dose in Cycle 1 for alisertib without itraconazole arm; Day 10 pre-dose and at multiple time points (up to 96 hours) post-dose in Cycle 1 for alisertib with itraconazole arm"
              },
              {
                "measure": "AUC\u221e: Area Under the Plasma Concentration Curve From Time 0 to Infinity of Alisertib in Presence and Absence of Itraconazole in Part A",
                "timeFrame": "Day 1 pre-dose and at multiple time points (up to 96 hours) post-dose in Cycle 1 for alisertib without itraconazole arm; Day 10 pre-dose and at multiple time points (up to 96 hours) post-dose in Cycle 1 for alisertib with itraconazole arm"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "CL/F: Oral Clearance of Alisertib in Presence and Absence of Itraconazole in Part A"
              },
              {
                "measure": "Tmax: Time to Reach Maximum Plasma Concentration of Alisertib in Presence and Absence of Itraconazole in Part A"
              },
              {
                "measure": "Terminal Phase Elimination Half-Life of Alisertib in Presence and Absence of Itraconazole in Part A"
              },
              {
                "measure": "Cmax: Maximum Observed Plasma Concentration for Alisertib Metabolites M1 and M2 in Presence and Absence of Itraconazole in Part A"
              },
              {
                "measure": "Tmax: Time to Reach the Maximum Plasma Concentration (Cmax) for Alisertib Metabolites M1 and M2 in Presence and Absence of Itraconazole in Part A"
              },
              {
                "measure": "AUClast: Area Under the Plasma Concentration-Time Curve From Time 0 to the Time of the Last Quantifiable Concentration for Alisertib Metabolites M1 and M2 in Presence and Absence of Itraconazole in Part A"
              },
              {
                "measure": "Number of Participants With Treatment Emergent Adverse Events (TEAEs) and Serious Adverse Events (SAEs)"
              },
              {
                "measure": "Number of Participants With Abnormal Laboratory Values Reported as AEs"
              },
              {
                "measure": "Number of Participants With Clinically Significant Change in Weight Reported as AEs"
              },
              {
                "measure": "Number of Participants With Clinically Significant Change in Vital Sign Reported as AEs"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01897012",
            "briefTitle": "Alisertib and Romidepsin in Treating Patients With Relapsed or Refractory B-Cell or T-Cell Lymphomas",
            "officialTitle": "A Phase 1 Trial of MLN8237 Plus Romidepsin for Relapsed/Refractory Aggressive B-Cell and T-Cell Lymphomas"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2013-07-08"
          },
          "conditionsModule": {
            "conditions": [
              "MYC Positive",
              "Recurrent B-Cell Non-Hodgkin Lymphoma",
              "Recurrent Burkitt Lymphoma",
              "Recurrent Diffuse Large B-Cell Lymphoma",
              "Recurrent Follicular Lymphoma",
              "Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements",
              "Recurrent Hodgkin Lymphoma",
              "Recurrent Mantle Cell Lymphoma",
              "Recurrent Mature T- and NK-Cell Non-Hodgkin Lymphoma",
              "Refractory B-Cell Non-Hodgkin Lymphoma",
              "Refractory Burkitt Lymphoma",
              "Refractory Diffuse Large B-Cell Lymphoma",
              "Refractory Follicular Lymphoma",
              "Refractory High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements",
              "Refractory Hodgkin Lymphoma",
              "Refractory Mantle Cell Lymphoma",
              "Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Incidence of adverse events as graded by the National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE) version 5.0 (utilized for adverse event reporting beginning April 1, 2018)",
                "timeFrame": "Up to 4 weeks post-treatment"
              },
              {
                "measure": "Maximum tolerated dose graded according to NCI CTCAE version 5.0",
                "timeFrame": "Up to 28 days"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Overall response rate"
              },
              {
                "measure": "Complete response"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01848067",
            "briefTitle": "Alisertib, Abiraterone Acetate and Prednisone in Treating Patients With Hormone-Resistant Prostate Cancer",
            "officialTitle": "A Phase I/II Study of Alisertib in Combination With Abiraterone and Prednisone for Patients With Castration-Resistant Prostate Cancer After Progression on Abiraterone"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2013-05-03",
            "resultsFirstSubmitDate": "2017-11-08"
          },
          "conditionsModule": {
            "conditions": [
              "Adenocarcinoma of the Prostate",
              "Hormone-resistant Prostate Cancer",
              "Recurrent Prostate Cancer",
              "Stage IV Prostate Cancer"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Phase I: Frequency of Dose Limiting Toxicities of Alisertib, Graded According to the National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) v4.1",
                "timeFrame": "Up to 21 days"
              },
              {
                "measure": "Phase II: Duration of Progression Free Survival According to the PCWG2 Criteria",
                "timeFrame": "12 weeks"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Number of Participants With a PSA Value Equal to or Greater Than 25%"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02560025",
            "briefTitle": "Phase II Trial of Alisertib With Induction Chemotherapy in High-risk AML",
            "officialTitle": "A Phase II Study of the Aurora A Kinase Inhibitor Alisertib in Combination With 7+3 Induction Chemotherapy in Patients With High-risk Acute Myeloid Leukemia"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2015-09-23",
            "resultsFirstSubmitDate": "2018-09-07"
          },
          "conditionsModule": {
            "conditions": [
              "Acute Myeloid Leukemia"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Number of Participants That Achieved Complete Remission",
                "timeFrame": "From the start of treatment until the end of study treatment, up to approximately 10 months"
              },
              {
                "measure": "Number of Participants That Achieved Complete Remission With Incomplete Blood Count Recovery (CRi)",
                "timeFrame": "From the start of treatment until the end of study treatment, up to approximately 10 months"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "1 Year Overall Survival Rate"
              },
              {
                "measure": "Median Relapse Free Survival"
              },
              {
                "measure": "Median Duration of Remission"
              },
              {
                "measure": "Number of Participants With Serious Adverse Events"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02327169",
            "briefTitle": "A Study MLN2480 in Combination With MLN0128 or Alisertib, or Paclitaxel, or Cetuximab, or Irinotecan in Adult Participants With Advanced Nonhematologic Malignancies",
            "officialTitle": "A Multiarm, Open-label, Phase 1b Study of MLN2480 (an Oral A-, B-, and CRAF Inhibitor) in Combination With MLN0128 (an Oral mTORC 1/2 Inhibitor), or Alisertib (an Oral Aurora A Kinase Inhibitor), or Paclitaxel, or Cetuximab, or Irinotecan, in Adult Patients With Advanced Nonhematologic Malignancies"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2014-12-23",
            "resultsFirstSubmitDate": "2019-06-26"
          },
          "conditionsModule": {
            "conditions": [
              "Advanced Nonhematologic Malignancies"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Number of Participants With Adverse Events (AEs) and Serious Adverse Events (SAEs)",
                "timeFrame": "From Day 1, Cycle 1 through 30 days after the last dose of study drug (up to 13 months)"
              },
              {
                "measure": "Number of Participants With Dose-Limiting Toxicities (DLTs)",
                "timeFrame": "From Day 1, Cycle 1 through 30 days after the last dose in Cycle 1 (up to 8 weeks)"
              },
              {
                "measure": "Maximum Tolerated Dose (MTD) for MLN2480",
                "timeFrame": "Day 1, Cycle 1 up to 28 days"
              },
              {
                "measure": "Recommended Phase 2 Dose (RP2D) of MLN2480",
                "timeFrame": "Day 1, Cycle 1 up to 28 days"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Cmax : Maximum Observed Plasma Concentration for MLN2480"
              },
              {
                "measure": "Cmax: Maximum Observed Plasma Concentration for MLN0128"
              },
              {
                "measure": "Cmax: Maximum Observed Plasma Concentration for Alisertib"
              },
              {
                "measure": "Tmax: Time to Reach the Maximum Plasma Concentration (Cmax) for MLN2480"
              },
              {
                "measure": "Tmax: Time to Reach the Maximum Plasma Concentration (Cmax) for MLN0128"
              },
              {
                "measure": "Tmax: Time to Reach the Maximum Plasma Concentration (Cmax) for Alisertib"
              },
              {
                "measure": "AUC(0-tau): Area Under the Plasma Concentration-time Curve From Time 0 to Time Tau Over the Dosing Interval for MLN2480"
              },
              {
                "measure": "AUC(0-tau): Area Under the Plasma Concentration-time Curve From Time 0 to Time Tau Over the Dosing Interval for MLN0128"
              },
              {
                "measure": "AUC(0-tau): Area Under the Plasma Concentration-time Curve From Time 0 to Time Tau Over the Dosing Interval for Alisertib"
              },
              {
                "measure": "Cmax: Maximum Observed Plasma Concentration for Paclitaxel"
              },
              {
                "measure": "AUC(0-last): Area Under the Plasma Concentration-Time Curve From Time 0 to the Time of the Last Quantifiable Concentration for Paclitaxel"
              },
              {
                "measure": "AUC(0-inf): Area Under the Plasma Concentration-time Curve From Time 0 to Infinity, Calculated Using the Observed Value of the Last Quantifiable Concentration for Paclitaxel"
              },
              {
                "measure": "Terminal Elimination Half-life (T1/2) for Paclitaxel"
              },
              {
                "measure": "Objective Response Rate (ORR) Based on Response Evaluation Criteria in Solid Tumors (RECIST)"
              },
              {
                "measure": "Duration of Response"
              },
              {
                "measure": "Time to Response"
              },
              {
                "measure": "Progression Free Survival (PFS)"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00697346",
            "briefTitle": "Study of MLN8237 in Participants With Advanced Hematological Malignancies",
            "officialTitle": "An Open-label, Phase 1 Study of MLN8237, a Novel Aurora A Kinase Inhibitor, in Patients With Advanced Hematological Malignancies"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2008-06-11",
            "resultsFirstSubmitDate": "2018-01-04"
          },
          "conditionsModule": {
            "conditions": [
              "B-cell Follicular Lymphoma",
              "B-cell Marginal Zone Lymphoma",
              "Diffuse Large B-cell Lymphoma",
              "B-cell Mantle Cell Lymphoma",
              "B-cell Small Lymphocytic Lymphoma",
              "B-Cell Chronic Lymphocytic Leukemia",
              "Multiple Myeloma",
              "Waldenstrom's Macroglobulinemia",
              "Noncutaneous Peripheral T-cell Lymphoma Not Otherwise Specified",
              "Angioimmunoblastic T-cell Lymphoma",
              "Anaplastic Large Cell Lymphoma",
              "Enteropathy Associated T-cell Lymphoma",
              "NK Lymphoma"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Number of Participants With Dose-Limiting Toxicity (DLT)",
                "timeFrame": "From first dose of study drug to 30 days after the last dose (up to 422 days)"
              },
              {
                "measure": "Maximum Tolerated Dose (MTD) of Alisertib",
                "timeFrame": "From first dose of study drug to 30 days after the last dose (up to 422 days)"
              },
              {
                "measure": "Cmax: Maximum Observed Concentration for Alisertib as Pill in Capsule (PIC) With Once Daily for 21 Days (QD21D) Dosing at Day 1",
                "timeFrame": "Cycle 1 Day 1 predose and at multiple timepoints (up to 24 hours) postdose"
              },
              {
                "measure": "Cmax: Maximum Observed Concentration for Alisertib as Pill in Capsule (PIC) With Once Daily for 21 Days (QD21D) Dosing at Day 21",
                "timeFrame": "Cycle 1 Day 21 predose and at multiple timepoints (up to 6 hours) postdose"
              },
              {
                "measure": "Tmax: Time of First Occurrence of Cmax for Alisertib as Pill in Capsule (PIC) With Once Daily for 21 Days (QD21D) Dosing at Day 1",
                "timeFrame": "Cycle 1 Day 1 predose and at multiple timepoints (up to 24 hours) postdose"
              },
              {
                "measure": "Tmax: Time of First Occurrence of Cmax for Alisertib as Pill in Capsule (PIC) With Once Daily for 21 Days (QD21D) Dosing at Day 21",
                "timeFrame": "Cycle 1 Day 21 predose and at multiple timepoints (up to 6 hours) postdose"
              },
              {
                "measure": "AUCt: Area Under the Concentration Time Curve From Time 0 to Time t for Alisertib as Pill in Capsule (PIC) With Once Daily for 21 Days (QD21D) Dosing at Day 21",
                "timeFrame": "Cycle 1 Day 21 predose and at multiple time points (up to 6 hours) postdose"
              },
              {
                "measure": "Terminal Half-Life (t1/2) for Alisertib as Pill in Capsule (PIC) With Once Daily for 21 Days (QD21D) Dosing at Day 21",
                "timeFrame": "Cycle 1 Day 21 predose and at multiple time points (up to 6 hours) postdose"
              },
              {
                "measure": "Accumulation Ratio (Rac) for Alisertib as Pill in Capsule (PIC) With Once Daily for 21 Days (QD21D) Dosing at Day 21",
                "timeFrame": "Cycle 1 Day 21 predose and at multiple time points (up to 6 hours) postdose"
              },
              {
                "measure": "Peak/Trough Ratio for Alisertib as Pill in Capsule (PIC) With Once Daily for 21 Days (QD21D) Dosing at Day 21",
                "timeFrame": "Cycle 1 Day 21 predose and at multiple timepoints (up to 6 hours) postdose"
              },
              {
                "measure": "CLss/F: Apparent Oral Clearance at Steady State for Alisertib as Pill in Capsule (PIC) With Once Daily for 21 Days (QD21D) Dosing at Day 21",
                "timeFrame": "Cycle 1 Day 21 predose and at multiple timepoints (up to 6 hours) postdose"
              },
              {
                "measure": "Cmax: Maximum Observed Concentration for Alisertib as Pill in Capsule (PIC) With Once Daily for 14 Days (QD14D) Dosing at Day 1",
                "timeFrame": "Cycle 1 Day 1 predose and at multiple timepoints (up to 24 hours) postdose"
              },
              {
                "measure": "Cmax: Maximum Observed Concentration for Alisertib as Pill in Capsule (PIC) With Once Daily for 14 Days (QD14D) Dosing at Day 14",
                "timeFrame": "Cycle 1 Day 14 predose and at multiple timepoints (up to 8 hours) postdose"
              },
              {
                "measure": "Tmax: Time of First Occurrence of Cmax for Alisertib as Pill in Capsule (PIC) With Once Daily for 14 Days (QD14D) Dosing at Day 1",
                "timeFrame": "Cycle 1 Day 1 predose and at multiple timepoints (up to 24 hours) postdose"
              },
              {
                "measure": "Tmax: Time of First Occurrence of Cmax for Alisertib as Pill in Capsule (PIC) With Once Daily for 14 Days (QD14D) Dosing at Day 14",
                "timeFrame": "Cycle 1 Day 14 predose and at multiple timepoints (up to 8 hours) postdose"
              },
              {
                "measure": "AUCt: Area Under the Concentration Time Curve From Time 0 to Time t for Alisertib as Pill in Capsule (PIC) With Once Daily for 14 Days (QD14D) Dosing at Day 14",
                "timeFrame": "Cycle 1 Day 14 predose and at multiple timepoints (up to 8 hours) postdose"
              },
              {
                "measure": "Accumulation Ratio (Rac) for Alisertib as Pill in Capsule (PIC) With Once Daily for 14 Days (QD14D) Dosing at Day 14",
                "timeFrame": "Cycle 1 Day 14 predose and at multiple timepoints (up to 8 hours) postdose"
              },
              {
                "measure": "Peak/Trough Ratio for Alisertib as Pill in Capsule (PIC) With Once Daily for 14 Days (QD14D) Dosing at Day 14",
                "timeFrame": "Cycle 1 Day 14 predose and at multiple timepoints (up to 8 hours) postdose"
              },
              {
                "measure": "CLss/F: Apparent Oral Clearance at Steady State for Alisertib as Pill in Capsule (PIC) With Once Daily for 14 Days (QD14D) Dosing at Day 14",
                "timeFrame": "Cycle 1 Day 14 predose and at multiple timepoints (up to 8 hours) postdose"
              },
              {
                "measure": "Cmax: Maximum Observed Concentration for Alisertib as Enteric Coated Tablet (ECT) With Once Daily for 14 Days (QD14D) Dosing at Day 1",
                "timeFrame": "Cycle 1 Day 1 predose and at multiple timepoints (up to 24 hours) postdose"
              },
              {
                "measure": "Cmax: Maximum Observed Concentration for Alisertib as Enteric Coated Tablet (ECT) With Once Daily for 14 Days (QD14D) Dosing at Day 14",
                "timeFrame": "Cycle 1 Day 14 predose and at multiple timepoints (up to 8 hours) postdose"
              },
              {
                "measure": "Tmax: Time of First Occurrence of Cmax for Alisertib as Enteric Coated Tablet (ECT) With Once Daily for 14 Days (QD14D) Dosing at Day 1",
                "timeFrame": "Cycle 1 Day 1 predose and at multiple timepoints (up to 24 hours) postdose"
              },
              {
                "measure": "Tmax: Time of First Occurrence of Cmax for Alisertib as Enteric Coated Tablet (ECT) With Once Daily for 14 Days (QD14D) Dosing at Day 14",
                "timeFrame": "Cycle 1 Day 14 predose and at multiple timepoints (up to 8 hours) postdose"
              },
              {
                "measure": "AUCt: Area Under the Concentration Time Curve From Time 0 to Time t for Alisertib as Enteric Coated Tablet (ECT) With Once Daily for 14 Days (QD14D) Dosing at Day 14",
                "timeFrame": "Cycle 1 Day 14 predose and at multiple timepoints (up to 8 hours) postdose"
              },
              {
                "measure": "Terminal Half Life for Alisertib as Enteric Coated Tablet (ECT) With Once Daily for 14 Days (QD14D) Dosing at Day 14",
                "timeFrame": "Cycle 1 Day 14 predose and at multiple timepoints (up to 8 hours) postdose"
              },
              {
                "measure": "Peak/Trough Ratio for Alisertib as Enteric Coated Tablet (ECT) With Once Daily for 14 Days (QD14D) Dosing at Day 14",
                "timeFrame": "Cycle 1 Day 14 predose and at multiple timepoints (up to 8 hours) postdose"
              },
              {
                "measure": "CLss/F: Apparent Oral Clearance at Steady State for Alisertib as Enteric Coated Tablet (ECT) With Once Daily for 14 Days (QD14D) Dosing at Day 14",
                "timeFrame": "Cycle 1 Day 14 predose and at multiple timepoints (up to 8 hours) postdose"
              },
              {
                "measure": "Cmax: Maximum Observed Concentration for Alisertib as Enteric Coated Tablet (ECT) With Twice Daily for 7 Days (BID7D) Dosing at Day 1",
                "timeFrame": "Cycle 1 Day 1 predose and at multiple timepoints (up to 12 hours) postdose"
              },
              {
                "measure": "Cmax: Maximum Observed Concentration for Alisertib as Enteric Coated Tablet (ECT) With Twice Daily for 7 Days (BID7D) Dosing at Day 7",
                "timeFrame": "Cycle 1 Day 7 predose and at multiple timepoints (up to 12 hours) postdose"
              },
              {
                "measure": "Tmax: Time of First Occurrence of Cmax for Alisertib as Enteric Coated Tablet (ECT) With Twice Daily for 7 Days (BID7D) Dosing at Day 1",
                "timeFrame": "Cycle 1 Day 1 predose and at multiple timepoints (up to 12 hours) postdose"
              },
              {
                "measure": "Tmax: Time of First Occurrence of Cmax for Alisertib as Enteric Coated Tablet (ECT) With Twice Daily for 7 Days (BID7D) Dosing at Day 7",
                "timeFrame": "Cycle 1 Day 7 predose and at multiple timepoints (up to 12 hours) postdose"
              },
              {
                "measure": "AUCt: Area Under the Concentration Time Curve From Time 0 to Time t for Alisertib as Enteric Coated Tablet (ECT) With Twice Daily for 7 Days (BID7D) Dosing at Day 1",
                "timeFrame": "Cycle 1 Days 1 predose and at multiple timepoints (up to 12 hours) postdose"
              },
              {
                "measure": "AUCt: Area Under the Concentration Time Curve From Time 0 to Time t for Alisertib as Enteric Coated Tablet (ECT) With Twice Daily for 7 Days (BID7D) Dosing at Day 7",
                "timeFrame": "Cycle 1 Day 7 predose and at multiple timepoints (up to 12 hours) postdose"
              },
              {
                "measure": "Terminal Half-Life (t1/2) for Alisertib as Enteric Coated Tablet (ECT) With Twice Daily for 7 Days (BID7D) Dosing at Day 7",
                "timeFrame": "Cycle 1 Day 7 predose and at multiple timepoints (up to 12 hours) postdose"
              },
              {
                "measure": "Accumulation Ratio (Rac) for Alisertib as Enteric Coated Tablet (ECT) With Twice Daily for 7 Days (BID7D) Dosing at Day 7",
                "timeFrame": "Cycle 1 Day 7 predose and at multiple timepoints (up to 12 hours) postdose"
              },
              {
                "measure": "Peak/Trough Ratio for Alisertib as Enteric Coated Tablet (ECT) With Twice Daily for 7 Days (BID7D) Dosing at Day 7",
                "timeFrame": "Cycle 1 Day 7 predose and at multiple timepoints (up to 12 hours) postdose"
              },
              {
                "measure": "CLss/F: Apparent Oral Clearance at Steady State for Alisertib as Enteric Coated Tablet (ECT) With Twice Daily for 7 Days (BID7D) Dosing at Day 7",
                "timeFrame": "Cycle 1 Day 7 predose and at multiple timepoints (up to 12 hours) postdose"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Best Overall Response Rate Based on Investigator's Assessment"
              },
              {
                "measure": "Duration of Response (DOR)"
              },
              {
                "measure": "Number of Participants With Polymorphisms in Gene Encoding Enzyme UGT1A1"
              },
              {
                "measure": "Number of Participants With Polymorphisms in Aurora A Kinase"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01466881",
            "briefTitle": "Alisertib in Treating Patients With Relapsed or Refractory Peripheral T-Cell Non-Hodgkin Lymphoma",
            "officialTitle": "Phase II Trial of the Aurora Kinase A Inhibitor MLN8237, in Relapsed or Refractory Peripheral T-Cell Non-Hodgkin Lymphoma"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2011-11-03",
            "resultsFirstSubmitDate": "2016-02-09"
          },
          "conditionsModule": {
            "conditions": [
              "Adult Nasal Type Extranodal NK/T-Cell Lymphoma",
              "Anaplastic Large Cell Lymphoma",
              "Angioimmunoblastic T-Cell Lymphoma",
              "Hepatosplenic T-Cell Lymphoma",
              "Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma",
              "Recurrent Adult Non-Hodgkin Lymphoma",
              "Recurrent Adult T-Cell Leukemia/Lymphoma"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Objective Response Rate (Complete Responses (CR) + Partial Responses (PR))",
                "timeFrame": "Up to 1 year after registration"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Overall Survival (OS)"
              },
              {
                "measure": "Progression Free Survival (PFS)"
              },
              {
                "measure": "To Evaluate the Safety and Tolerability of MLN8237 (Number of With Grade 3 Through Grade 5 Adverse Events That Are Related to MLN8237)"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00807495",
            "briefTitle": "Study of Alisertib (MLN8237) in Adults With Aggressive Non-Hodgkin's Lymphoma",
            "officialTitle": "A Phase 2 Trial of MLN8237, an Oral Aurora A Kinase Inhibitor, in Adult Patients With Aggressive Non-Hodgkin's Lymphoma"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2008-12-11",
            "resultsFirstSubmitDate": "2018-01-04"
          },
          "conditionsModule": {
            "conditions": [
              "Diffuse Large B-cell Lymphoma",
              "Mantle Cell Lymphoma",
              "Burkitt's Lymphoma",
              "T-cell Lymphoma, Excluding Primary Cutaneous T-cell Lymphoma",
              "Transformed Follicular Lymphoma With \u2265 50% Diffuse Large Cell Component"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Best Overall Response Rate Based on Investigator's Assessment (Applying the IWG 2007 Response Criteria)",
                "timeFrame": "Baseline and every 2 cycles up to Month 12 (approximately 16 cycles), from Cycle 16 every 4 cycles until disease progression, after end of treatment every 12 weeks for up to 12 Months from last dose (Up to 4 years)"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Time to Progression (TTP)"
              },
              {
                "measure": "Progression Free Survival (PFS)"
              },
              {
                "measure": "Duration of Response (DOR)"
              },
              {
                "measure": "Number of Participants With Treatment-Emergent Adverse Events"
              },
              {
                "measure": "Number of Participants With Abnormal Vital Signs Reported as Treatment-Emergent Adverse Events"
              },
              {
                "measure": "Number of Participants With Abnormal Laboratory Values Reported as Treatment-Emergent Adverse Events"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01601535",
            "briefTitle": "Study of MLN8237 in Combination With Irinotecan and Temozolomide",
            "officialTitle": "Phase I/II Study of MLN8237 in Combination With Irinotecan and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2012-05-11",
            "resultsFirstSubmitDate": "2019-05-30"
          },
          "conditionsModule": {
            "conditions": [
              "Neuroblastoma"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Maximum Tolerated Dose (MTD) When Given Together With Fixed Doses of Irinotecan and Temozolomide in Children and Young Adults With Relapsed or Refractory Neuroblastoma",
                "timeFrame": "21 days, from study day 1"
              },
              {
                "measure": "Dose Limiting Toxicity (DLT) Data Associated With the Determination of the Recommended Phase 2 Dose",
                "timeFrame": "21 days, from study day 1"
              },
              {
                "measure": "Pharmacokinetics When Given Together With Fixed Doses of Irinotecan and Temozolomide in Children and Young Adults With Relapsed or Refractory Neuroblastoma: Alisertib Day 4 Trough, Day 5 Trough and Cmax",
                "timeFrame": "1st week of cycle 1"
              },
              {
                "measure": "Pharmacokinetics When Given Together With Fixed Doses of Irinotecan and Temozolomide in Children and Young Adults With Relapsed or Refractory Neuroblastoma: Alisertib Tmax and Half-life",
                "timeFrame": "1st week of cycle 1"
              },
              {
                "measure": "Pharmacokinetics When Given Together With Fixed Doses of Irinotecan and Temozolomide in Children and Young Adults With Relapsed or Refractory Neuroblastoma: Alisertib AUC",
                "timeFrame": "1st week of cycle 1"
              },
              {
                "measure": "Pharmacokinetics When Given Together With Fixed Doses of Irinotecan and Temozolomide in Children and Young Adults With Relapsed or Refractory Neuroblastoma: Irinotecan Cmax, APC Cmax, SN-38 Cmax, and SN-38G Cmax",
                "timeFrame": "1st week of cycle 1"
              },
              {
                "measure": "Pharmacokinetics When Given Together With Fixed Doses of Irinotecan and Temozolomide in Children and Young Adults With Relapsed or Refractory Neuroblastoma: Irinotecan AUC, APC AUC, SN-38 AUC, and SN-38G AUC",
                "timeFrame": "1st week of cycle 1"
              },
              {
                "measure": "Pharmacokinetics When Given Together With Fixed Doses of Irinotecan and Temozolomide in Children and Young Adults With Relapsed or Refractory Neuroblastoma: Irinotecan Clearance",
                "timeFrame": "1st week of cycle 1"
              },
              {
                "measure": "Response Rate for Patients With Relapsed or Refractory Neuroblastoma Treated With MLN8237, Irinotecan, and Temozolomide at the Identified MTD",
                "timeFrame": "Cycles repeated every 21 days for up to 34 cycles."
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Aurora A Expression"
              },
              {
                "measure": "UGT1A1 Genotype"
              },
              {
                "measure": "AURKA Genotype"
              },
              {
                "measure": "One Year Progression Free Survival Rate"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01154816",
            "briefTitle": "Alisertib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia",
            "officialTitle": "A Phase II Study of MLN8237, a Selective Aurora A Kinase Inhibitor in Children With Recurrent/Refractory Solid Tumors and Leukemias"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2010-06-30",
            "resultsFirstSubmitDate": "2016-07-28"
          },
          "conditionsModule": {
            "conditions": [
              "Hepatoblastoma",
              "Previously Treated Childhood Rhabdomyosarcoma",
              "Recurrent Childhood Acute Lymphoblastic Leukemia",
              "Recurrent Childhood Acute Myeloid Leukemia",
              "Recurrent Childhood Kidney Neoplasm",
              "Recurrent Childhood Malignant Germ Cell Tumor",
              "Recurrent Childhood Rhabdomyosarcoma",
              "Recurrent Childhood Soft Tissue Sarcoma",
              "Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor",
              "Recurrent Neuroblastoma",
              "Recurrent Osteosarcoma"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Number of Participants With Overall Response",
                "timeFrame": "From first dose of alisertib through 6 cycles of protocol therapy or until removal from protocol therapy whichever occurred first."
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Number of Patients Cycles With Grade 3 or Higher Adverse Event"
              },
              {
                "measure": "Serum Concentration of Alisertib Prior to the First Day of Administration"
              },
              {
                "measure": "Serum Concentration of Alisertib on the First Day of Administration One Hour After Administration"
              },
              {
                "measure": "Serum Concentration of Alisertib on the First Day of Administration Three Hours After Administration"
              },
              {
                "measure": "Serum Concentration of Alisertib on the First Day of Administration Six Hours After Administration"
              },
              {
                "measure": "Serum Concentration of Alisertib on the Fourth Day of Administration Prior to the Administration of the Day 4 Dose"
              },
              {
                "measure": "Serum Concentration of Alisertib on the Seventh Day of Administration Prior to the Administration of the Day 7 Dose."
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02530619",
            "briefTitle": "Alisertib in Treating Patients With Myelofibrosis or Relapsed or Refractory Acute Megakaryoblastic Leukemia",
            "officialTitle": "A Multicenter, Open-Label, Pilot Study of Alisertib (MLN8237), a Novel Inhibitor of Aurora Kinase A, in Adult Patients With Relapsed/Refractory Acute Megakaryoblastic Leukemia or Myelofibrosis (Including Primary and Post-Essential/Post-Polycythemic Myelofibrosis)"
          },
          "statusModule": {
            "overallStatus": "UNKNOWN",
            "studyFirstSubmitDate": "2015-08-18",
            "resultsFirstSubmitDate": "2020-11-19"
          },
          "conditionsModule": {
            "conditions": [
              "Acute Megakaryoblastic Leukemia",
              "Myelofibrosis",
              "Primary Myelofibrosis"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Safety Profile of Alisertib Per NCI's Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0.",
                "timeFrame": "From time of treatment to 6 months post discontinuation (range of cycles attempted 1 to 29, median 7.5 cycles, 1 Cycle = 21 days)"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Response to Treatment"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01695941",
            "briefTitle": "Alisertib, Bortezomib, and Rituximab in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma or B-cell Low Grade Non-Hodgkin Lymphoma",
            "officialTitle": "A Phase I Study of MLN8237 in Combination With Bortezomib and Rituximab in Relapsed and Refractory Mantle Cell and Low Grade Non-Hodgkin Lymphoma"
          },
          "statusModule": {
            "overallStatus": "ACTIVE_NOT_RECRUITING",
            "studyFirstSubmitDate": "2012-09-26"
          },
          "conditionsModule": {
            "conditions": [
              "Recurrent B-Cell Non-Hodgkin Lymphoma",
              "Recurrent Mantle Cell Lymphoma",
              "Refractory B-Cell Non-Hodgkin Lymphoma",
              "Refractory Mantle Cell Lymphoma"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Recommended phase II dose of alisertib when combined with bortezomib and rituximab, defined as the highest dose level at which < 33% of the dose cohort experience a dose limiting toxicity (DLT)",
                "timeFrame": "21 days"
              },
              {
                "measure": "Recommended phase II dose of bortezomib when combined with alisertib and rituximab, defined as the highest dose level at which < 33% of the dose cohort experience a dose limiting toxicity (DLT)",
                "timeFrame": "21 days"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Overall response rate (ORR) (complete response and partial response)"
              },
              {
                "measure": "Progression free survival (PFS)"
              },
              {
                "measure": "Duration of response (DOR)"
              },
              {
                "measure": "Overall survival"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT04479306",
            "briefTitle": "Osimertinib in Combination With Alisertib or Sapanisertib for the Treatment of Osimertinib-Resistant EGFR Mutant Stage IIIB or IV Non-Small Cell Lung Cancer",
            "officialTitle": "A Ph1b Study of Osimertinib + Alisertib or Sapanisertib for Osimertinib-Resistant EGFR Mutant Non-Small Cell Lung Cancer (NSCLC) (Crossover Study)"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2020-07-16"
          },
          "conditionsModule": {
            "conditions": [
              "Recurrent Lung Non-Small Cell Carcinoma",
              "Stage IIIB Lung Cancer AJCC v8",
              "Stage IV Lung Cancer AJCC v8",
              "Stage IVA Lung Cancer AJCC v8",
              "Stage IVB Lung Cancer AJCC v8"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Recommended phase 2 dose (RP2D) of osimertinib and alisertib combination (Arm A)",
                "timeFrame": "Up to 30 days after the last dose"
              },
              {
                "measure": "RP2D of osimertinib and sapanisertib combination (Arm B)",
                "timeFrame": "Up to 30 days"
              },
              {
                "measure": "Dose-limiting toxicity (DLT)",
                "timeFrame": "During cycle 1 (28 days)"
              },
              {
                "measure": "Incidence of adverse events",
                "timeFrame": "Up to 30 days after the last dose"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Objective response rate"
              },
              {
                "measure": "Progression-free survival"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02319018",
            "briefTitle": "Alisertib and Combination Chemotherapy in Treating Patients With Gastrointestinal Tumors",
            "officialTitle": "A Phase 1 Study of Alisertib (MLN8237) in Combination With mFOLFOX in Gastrointestinal Tumors"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2014-12-17"
          },
          "conditionsModule": {
            "conditions": [
              "Malignant Digestive System Neoplasm"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Maximum tolerated dose and the recommended phase II doses of mFOLFOX given in combination with alisertib, defined as the dose level at which the probability of dose limiting toxicities is 30%",
                "timeFrame": "28 days"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Anti-tumor activity associated with this treatment, evaluated using the new international criteria proposed by the revised Response Evaluation Criteria in Solid Tumors version 1.1"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02444884",
            "briefTitle": "MLN8237 to Treat Children With Relapsed/Refractory Solid Tumors",
            "officialTitle": "A Phase I/II Study of MLN8237, an Oral Selective Small Molecule Inhibitor of Aurora A Kinase, in Children With Relapsed/Refractory Solid Tumors"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2015-05-07"
          },
          "conditionsModule": {
            "conditions": [
              "Unspecified Childhood Solid Tumor, Excluding CNS",
              "Neuroblastoma"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Determine maximum tolerated dose and RP2D administered once daily on Days 1-7",
                "timeFrame": "Up to 21 days (1st cycle) of protocol therapy"
              },
              {
                "measure": "Determine maximum tolerated dose and RP2D administered po BID on Days 1-7",
                "timeFrame": "Up to 21 days (1st cycle) of protocol therapy"
              },
              {
                "measure": "Adverse events as assessed by (CTCAE) version 4.0",
                "timeFrame": "Every 21 days (each cycle) of protocol therapy for up to 35 cycles [up to 105 weeks]"
              },
              {
                "measure": "PK Profile: MLN8237 concentrations in plasma samples",
                "timeFrame": "30 min after the first dose, and at 1,2, 3, 4, 6-8, 24 hours, Day 4 and 7 in Cycle 1"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00500903",
            "briefTitle": "A Study of MLN8237, a Novel Aurora A Kinase Inhibitor, in Participants With Advanced Solid Tumors",
            "officialTitle": "An Open-Label, Dose Escalation Phase 1 Study of MLN8237, a Novel Aurora A Kinase Inhibitor, in Patients With Advanced Solid Tumors"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2007-07-12",
            "resultsFirstSubmitDate": "2018-01-04"
          },
          "conditionsModule": {
            "conditions": [
              "Advanced Malignancies"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Number of Participants With Dose-Limiting Toxicity (DLT)",
                "timeFrame": "Cycle 1 Day 1 up to Day 35 (alisertib daily for 7 to 21 days followed by a 14-day recovery period)"
              },
              {
                "measure": "Maximum Tolerated Dose (MTD) of Alisertib",
                "timeFrame": "From first dose of study drug to 30 days after the last dose (up to 1011 days)"
              },
              {
                "measure": "Number of Participants With Adverse Events (AEs) and Serious Adverse Events (SAEs)",
                "timeFrame": "From first dose of study drug to 30 days after the last dose (up to 1011 days)"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Cmax: Maximum Observed Concentration for Alisertib as Powder-in-Capsule (PIC) With Once Daily for 7 Days (QD7D) Dosing"
              },
              {
                "measure": "Tmax: Time of First Occurrence of Cmax for Alisertib as Powder-in-Capsule (PIC) With Once Daily for 7 Days (QD7D) Dosing"
              },
              {
                "measure": "AUCt: Area Under the Concentration-Time Curve From Time 0 to Time t for Alisertib as Powder-in-Capsule (PIC) With Once Daily for 7 Days (QD7D) Dosing"
              },
              {
                "measure": "Terminal Half-Life (t1/2) for Alisertib as Powder-in-Capsule (PIC) With Once Daily for 7 Days (QD7D) Dosing"
              },
              {
                "measure": "Accumulation Ratio (Rac) for Alisertib as Powder-in-Capsule (PIC) With Once Daily for 7 Days (QD7D) Dosing"
              },
              {
                "measure": "Peak/Trough Ratio for Alisertib as Powder-in-Capsule (PIC) With Once Daily for 7 Days (QD7D) Dosing"
              },
              {
                "measure": "CLss/F: Apparent Oral Clearance at Steady State for Alisertib as Powder-in-Capsule (PIC) With Once Daily for 7 Days (QD7D) Dosing"
              },
              {
                "measure": "Ae: Amount of Alisertib Excreted in Urine Over the Collection Period for Alisertib as Powder-in-Capsule (PIC) With Once Daily for 7 Days (QD7D) Dosing"
              },
              {
                "measure": "CLr: Renal Clearance of Alisertib as Powder-in-Capsule (PIC) With Once Daily for 7 Days (QD7D) Dosing"
              },
              {
                "measure": "Cmax: Maximum Observed Concentration for Alisertib as Powder-in-Capsule (PIC) With Once Daily for 14 Days (QD14D) Dosing"
              },
              {
                "measure": "Tmax: Time of First Occurrence of Cmax for Alisertib as Powder-in-Capsule (PIC) With Once Daily for 14 Days (QD14D) Dosing"
              },
              {
                "measure": "AUCt: Area Under the Concentration--Time Curve From Time 0 to Time t for Alisertib as Powder-in-Capsule (PIC) With Once Daily for 14 Days (QD14D) Dosing"
              },
              {
                "measure": "Terminal Half-Life for Alisertib as Powder-in-Capsule (PIC) With Once Daily for 14 Days (QD14D) Dosing"
              },
              {
                "measure": "Accumulation Ratio (Rac) for Alisertib as Powder-in-Capsule (PIC) With Once Daily for 14 Days (QD14D) Dosing"
              },
              {
                "measure": "Peak/Trough Ratio for Alisertib as Powder-in-Capsule (PIC) With Once Daily for 14 Days (QD14D) Dosing"
              },
              {
                "measure": "CLss/F: Apparent Oral Clearance at Steady State for Alisertib as Powder-in-Capsule (PIC) With Once Daily for 14 Days (QD14D) Dosing"
              },
              {
                "measure": "Ae: Amount of Alisertib Excreted in Urine Over the Collection Period for Alisertib as Powder-in-Capsule (PIC) With Once Daily for 14 Days (QD14D) Dosing"
              },
              {
                "measure": "CLr: Renal Clearance of Alisertib as Powder-in-Capsule (PIC) With Once Daily for 14 Days (QD14D) Dosing"
              },
              {
                "measure": "Cmax: Maximum Observed Concentration for Alisertib as Powder-in-Capsule (PIC) With Once Daily for 21 Days (QD21D) Dosing"
              },
              {
                "measure": "Tmax: Time of First Occurrence of Cmax for Alisertib as Powder-in-Capsule (PIC) With Once Daily for 21 Days (QD21D) Dosing"
              },
              {
                "measure": "AUCt: Area Under the Concentration-time Curve From Time 0 to Time t for Alisertib as Powder-in-Capsule (PIC) With Once Daily for 21 Days (QD21D) Dosing"
              },
              {
                "measure": "Terminal Half-Life (t1/2) for Alisertib as Powder-in-Capsule (PIC) With Once Daily for 21 Days (QD21D) Dosing"
              },
              {
                "measure": "Accumulation Ratio (Rac) for Alisertib as Powder-in-Capsule (PIC) With Once Daily for 21 Days (QD21D) Dosing"
              },
              {
                "measure": "Peak/Trough Ratio for Alisertib as Powder-in-Capsule (PIC) With Once Daily for 21 Days (QD21D) Dosing"
              },
              {
                "measure": "CLss/F: Apparent Oral Clearance at Steady State for Alisertib as Powder-in-Capsule (PIC) With Once Daily for 21 Days (QD21D) Dosing"
              },
              {
                "measure": "Ae: Amount of Alisertib Excreted in Urine Over the Collection Period for Alisertib as Powder-in-Capsule (PIC) With Once Daily for 21 Days (QD21D) Dosing"
              },
              {
                "measure": "CLr: Renal Clearance of Alisertib as Powder-in-Capsule (PIC) With Once Daily for 21 Days (QD21D) Dosing"
              },
              {
                "measure": "Cmax: Maximum Observed Concentration for Alisertib as Powder-in-Capsule (PIC) With Twice Daily for 7 Days (BID7D) Dosing"
              },
              {
                "measure": "Tmax: Time of First Occurrence of Cmax for Alisertib as Powder-in-Capsule (PIC) With Twice Daily for 7 Days (BID7D) Dosing"
              },
              {
                "measure": "AUCt: Area Under the Concentration-time Curve From Time 0 to Time t for Alisertib as Powder-in-Capsule (PIC) With Twice Daily for 7 Days (BID7D) Dosing"
              },
              {
                "measure": "Terminal Half-Life (t1/2) for Alisertib as Powder-in-Capsule (PIC) With Twice Daily for 7 Days (BID7D) Dosing"
              },
              {
                "measure": "Accumulation Ratio (Rac) for Alisertib as Powder-in-Capsule (PIC) With Twice Daily for 7 Days (BID7D) Dosing"
              },
              {
                "measure": "Peak/Trough Ratio for Alisertib as Powder-in-Capsule (PIC) With Twice Daily for 7 Days (BID7D) Dosing"
              },
              {
                "measure": "CLss/F: Apparent Oral Clearance at Steady State for Alisertib as Powder-in-Capsule (PIC) With Twice Daily for 7 Days (BID7D) Dosing"
              },
              {
                "measure": "Ae: Amount of Alisertib Excreted in Urine Over the Collection Period for Alisertib as Powder-in-Capsule (PIC) With Twice Daily for 7 Days (BID7D) Dosing"
              },
              {
                "measure": "CLr: Renal Clearance of Alisertib as Powder-in-Capsule (PIC) With Twice Daily for 7 Days (BID7D) Dosing"
              },
              {
                "measure": "Cmax: Maximum Observed Concentration for Alisertib as Powder-in-Capsule (PIC) With Twice Daily for 14 Days (BID14D) Dosing"
              },
              {
                "measure": "Tmax: Time of First Occurrence of Cmax for Alisertib as Powder-in-Capsule (PIC) With Twice Daily for 14 Days (BID14D) Dosing"
              },
              {
                "measure": "AUCt: Area Under the Concentration-time Curve From Time 0 to Time t for Alisertib as Powder-in-Capsule (PIC) With Twice Daily for 14 Days (BID14D) Dosing"
              },
              {
                "measure": "AUCt: Area Under the Concentration-time Curve From Time 0 to Time t as Assessment of Relative Bioavailability for Alisertib as Enteric-coated Tablet (ECT) Versus PIC at Day 7"
              },
              {
                "measure": "Cmax: Maximum Observed Concentration as Assessment of Relative Bioavailability for Alisertib as Enteric-coated Tablet (ECT) Versus PIC at Day 7"
              },
              {
                "measure": "Change From Baseline in Alisertib Skin Punch Biopsy as Measured by Mitotic Index With PIC Once Daily for 7 Days (QD7D) Dosing"
              },
              {
                "measure": "Change From Baseline in Alisertib Skin Punch Biopsy as Measured by Apoptotic Index With PIC Once Daily for 7 Days (QD7D) Dosing"
              },
              {
                "measure": "Change From Baseline in Alisertib Skin Punch Biopsy as Measured by Mitotic Index With PIC Once Daily for 14 Days (QD14D) Dosing"
              },
              {
                "measure": "Change From Baseline in Alisertib Skin Punch Biopsy as Measured by Apoptotic Index With PIC Once Daily for 14 Days (QD14D) Dosing"
              },
              {
                "measure": "Change From Baseline in Alisertib Skin Punch Biopsy as Measured by Mitotic Index With PIC Once Daily for 21 Days (QD21D) Dosing"
              },
              {
                "measure": "Change From Baseline in Alisertib Skin Punch Biopsy as Measured by Apoptotic Index With PIC Once Daily for 21 Days (QD21D) Dosing"
              },
              {
                "measure": "Change From Baseline in Alisertib Skin Punch Biopsy as Measured by Mitotic Index With PIC Twice Daily for 7 Days (BID7D) Dosing"
              },
              {
                "measure": "Change From Baseline in Alisertib Skin Punch Biopsy as Measured by Apoptotic Index With PIC Twice Daily for 7 Days (BID7D) Dosing"
              },
              {
                "measure": "Change From Baseline in Alisertib Skin Punch Biopsy as Measured by Mitotic Index With PIC Twice Daily for 14 Days (BID14D) Dosing"
              },
              {
                "measure": "Change From Baseline in Alisertib Skin Punch Biopsy as Measured by Apoptotic Index With PIC Twice Daily for 14 Days (BID14D) Dosing"
              },
              {
                "measure": "Number of Participants With Polymorphisms in Gene Encoding Enzyme UGT1A1"
              },
              {
                "measure": "Best Overall Response Based on Investigator Assessment"
              },
              {
                "measure": "Duration Of Response (DOR)"
              },
              {
                "measure": "Effect of Food on the Pharmacokinetics (PK) of Alisertib"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02551055",
            "briefTitle": "MLN1117 in Combination With Docetaxel, Paclitaxel, and Other Investigational Anticancer Agents to Treat Participants With Gastric and Gastroesophageal Adenocarcinoma",
            "officialTitle": "An Umbrella Study to Evaluate MLN1117 in Combination With Taxanes (Docetaxel or Paclitaxel) and Other Investigational Anticancer Agents for the Treatment of Patients With Previously Treated Advanced and Metastatic Gastric and Gastroesophageal Adenocarcinoma"
          },
          "statusModule": {
            "overallStatus": "TERMINATED",
            "whyStopped": "Business Decision; No Safety Or Efficacy Concerns.",
            "studyFirstSubmitDate": "2015-09-02",
            "resultsFirstSubmitDate": "2018-02-16"
          },
          "conditionsModule": {
            "conditions": [
              "Advanced and Metastatic Gastric or Gastroesophageal Adenocarcinoma"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Number of Participants Who Experienced Cycle 1 Dose Limiting Toxicity (DLT) in Part 1",
                "timeFrame": "Up to Cycle 1 (28 days for MLN1117+TAK-659, MLN1117+Alisertib, MLN1117+Paclitaxel or 21 days for MLN1117+Docetaxel)"
              },
              {
                "measure": "Number of Participants With at Least 1 Treatment-Emergent Adverse Event (TEAE) in Part 1",
                "timeFrame": "From first dose of study drug through 30 days after the last dose of study drug (approximately up to 366 days)"
              },
              {
                "measure": "Number of Participants With at Least 1 \u2265 Grade 3 TEAE in Part 1",
                "timeFrame": "From first dose of study drug through 30 days after the last dose of study drug (approximately up to 366 days)"
              },
              {
                "measure": "Number of Participants With at Least 1 Treatment-Emergent Serious Adverse Event (SAE) in Part 1",
                "timeFrame": "From first dose of study drug through 30 days after the last dose of study drug (approximately up to 366 days)"
              },
              {
                "measure": "Number of Participants With at Least 1 Dose Modification Due to AE in Part 1",
                "timeFrame": "From first dose of study drug through 30 days after the last dose of study drug (approximately up to 366 days)"
              },
              {
                "measure": "Overall Response Rate in Part 2",
                "timeFrame": "Days 25-28 for MLN1117+TAK-659, MLN1117+Alisertib, and MLN1117+Paclitaxel and Days 18-21 for MLN1117+Docetaxel of Cycles 2, 4, 6; every other cycle until study discontinuation due to disease progression, unacceptable toxicity, or death (up to 336 days)"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Number of Participants With at Least 1 TEAE and Serious TEAE in Part 1 and 2"
              },
              {
                "measure": "Number of Participants With Dose Delays, Dose Reductions, and Dose Interruptions Due To AE in Part 1 and 2"
              },
              {
                "measure": "Progression-Free Survival (PFS) Based on RECIST Criteria V 1.1 Assessment in Part 2"
              },
              {
                "measure": "Percentage of Participants With Disease Control Based on RECIST Criteria V 1.1 Assessment in Part 2"
              },
              {
                "measure": "Duration of Response (DOR) Based on RECIST Criteria V 1.1 Assessment in Part 2"
              },
              {
                "measure": "Time to Disease Progression (TTP) Based on RECIST Criteria V 1.1 Assessment in Part 2"
              },
              {
                "measure": "Overall Survival (OS) Based on RECIST Criteria V 1.1 Assessment"
              },
              {
                "measure": "Plasma Concentration of MLN1117-1003"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02367352",
            "briefTitle": "Alisertib (MLN8237) in Combination With Weekly Paclitaxel in East Asian Patients With Advanced Solid Tumors",
            "officialTitle": "A Phase 1b Study of Alisertib (MLN8237) in Combination With Weekly Paclitaxel in East Asian Patients With Advanced Solid Tumors"
          },
          "statusModule": {
            "overallStatus": "TERMINATED",
            "whyStopped": "Sponsor's decision",
            "studyFirstSubmitDate": "2015-02-11",
            "resultsFirstSubmitDate": "2018-04-30"
          },
          "conditionsModule": {
            "conditions": [
              "Advanced Solid Tumors",
              "Ovarian Cancer",
              "Small Cell Lung Cancer"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Dose Escalation Phase: Number of Participants With Adverse Events (AEs) and Serious Adverse Events (SAEs)",
                "timeFrame": "From Day 1 to 30 days after the last dose of study drug (approximately 21 months)"
              },
              {
                "measure": "Dose Escalation Phase: Number of Participants With Clinically Significant Laboratory Findings",
                "timeFrame": "From Day 1 to 30 days after the last dose of study drug (approximately 21 months)"
              },
              {
                "measure": "Dose Escalation Phase: Number of Participants With Clinically Significant Vital Sign Findings",
                "timeFrame": "From Day 1 to 30 days after the last dose of study drug (approximately 21 months)"
              },
              {
                "measure": "Dose Escalation Phase: Cmax: Maximum Observed Plasma Concentration of Alisertib",
                "timeFrame": "Day 1 and Day 3 predose and at multiple time points (up to 12 hours) post-dose"
              },
              {
                "measure": "Dose Escalation Phase: Tmax: Time to Reach the Maximum Plasma Concentration of Alisertib",
                "timeFrame": "Day 1 and Day 3 predose and at multiple time points (up to 12 hours) post-dose"
              },
              {
                "measure": "Dose Escalation Phase: AUC(0-tau): Area Under the Plasma Concentration-time Curve From Time 0 to Time Tau Over the Dosing Interval for Alisertib",
                "timeFrame": "Day 1 and Day 3 predose and at multiple time points (up to 12 hours) post-dose"
              },
              {
                "measure": "Dose Escalation Phase: Cmax: Maximum Observed Plasma Concentration of Paclitaxel",
                "timeFrame": "Day 1 predose and Day 1, 2 and 3 at multiple time points (up to 12 hours) post-dose"
              },
              {
                "measure": "Dose Escalation Phase: Tmax: Time to Reach the Maximum Plasma Concentration of Paclitaxel",
                "timeFrame": "Day 1 predose and Day 1, 2, and 3 at multiple time points (up to 12 hours) post-dose"
              },
              {
                "measure": "Dose Escalation Phase: AUC(0-tlast): Area Under the Plasma Concentration Curve From Time Zero to the Time of the Last Quantifiable Concentration of Paclitaxel",
                "timeFrame": "Day 1 predose and Day 1, 2, and 3 at multiple time points (up to 12 hours) post-dose"
              },
              {
                "measure": "Dose Escalation Phase: AUC(0-inf): Area Under the Plasma Concentration-Time Curve From Tme 0 to Infinity",
                "timeFrame": "Day 1 predose and Day 1, 2, and 3 at multiple time points (up to 12 hours) post-dose"
              },
              {
                "measure": "Dose Escalation Phase: T\u00bd: Terminal Phase Elimination Half-Life of Paclitaxel",
                "timeFrame": "Day 1 predose and Day 1, 2, and 3 at multiple time points (up to 12 hours) post-dose"
              },
              {
                "measure": "Dose Expansion Phase: Number of Participants With Adverse Events (AEs) and Serious Adverse Events (SAEs)",
                "timeFrame": "From Day 1 to 30 days after the last dose of study drug"
              },
              {
                "measure": "Dose Expansion Phase: Number of Participants With Clinically Significant Laboratory Findings",
                "timeFrame": "From Day 1 to 30 days after the last dose of study drug"
              },
              {
                "measure": "Dose Expansion Phase: Number of Participants With Clinically Significant Vital Sign Findings",
                "timeFrame": "From Day 1 to 30 days after the last dose of study drug"
              },
              {
                "measure": "Dose Expansion Phase: Cmax: Maximum Observed Plasma Concentration of Alisertib",
                "timeFrame": "Day 1 and Day 3 predose and at multiple time points (up to 12 hours) post-dose"
              },
              {
                "measure": "Dose Expansion Phase: Tmax: Time to Reach the Maximum Plasma Concentration of Alisertib",
                "timeFrame": "Day 1 and Day 3 predose and at multiple time points (up to 12 hours) post-dose"
              },
              {
                "measure": "Dose Expansion Phase: AUC(0-tau): Area Under the Plasma Concentration-time Curve From Time 0 to Time Tau Over the Dosing Interval for Alisertib",
                "timeFrame": "Day 1 and Day 3 predose and at multiple time points (up to 12 hours) post-dose"
              },
              {
                "measure": "Dose Expansion Phase: Cmax: Maximum Observed Plasma Concentration of Paclitaxel",
                "timeFrame": "Day 1 predose and Day 1, 2, and 3 at multiple time points (up to 12 hours) post-dose"
              },
              {
                "measure": "Dose Expansion Phase: Tmax: Time to Reach the Maximum Plasma Concentration of Paclitaxel",
                "timeFrame": "Day 1 predose and Day 1, 2, and 3 at multiple time points (up to 12 hours) post-dose"
              },
              {
                "measure": "Dose Expansion Phase: AUC(0-tlast): Area Under the Plasma Concentration Curve From Time Zero to the Time of the Last Quantifiable Concentration of Paclitaxel",
                "timeFrame": "Day 1 predose and Day 1, 2, and 3 at multiple time points (up to 12 hours) post-dose"
              },
              {
                "measure": "Dose Expansion Phase: AUC(0-inf): Area Under the Plasma Concentration-Time Curve From Time 0 to Infinity of Paclitaxel",
                "timeFrame": "Day 1 predose and Day 1, 2, and 3 at multiple time points (up to 12 hours) post-dose"
              },
              {
                "measure": "Dose Expansion Phase: T\u00bd: Terminal Phase Elimination Half-Life of Paclitaxel",
                "timeFrame": "Day 1 predose and Day 1, 2, and 3 at multiple time points (up to 12 hours) post-dose"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Dose Expansion Phase: Overall Response Rate (ORR)"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01045421",
            "briefTitle": "Alisertib in Adults With Nonhematological Malignancies, Followed by Alisertib in Lung, Breast, Head and Neck or Gastroesophageal Malignancies",
            "officialTitle": "A Phase 1 Dose Escalation Study of MLN8237, an Aurora A Kinase Inhibitor, in Adult Patients With Nonhematological Malignancies, Followed by a Phase 2 of MLN8237 in Lung, Breast, Head and Neck, or Gastroesophageal Malignancies"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2010-01-08",
            "resultsFirstSubmitDate": "2015-07-22"
          },
          "conditionsModule": {
            "conditions": [
              "Advanced Nonhematological Malignancies",
              "Non-Small Cell Lung Cancer",
              "Small Cell Lung Cancer",
              "Metastatic Breast Cancer",
              "Head and Neck Squamous Cell Carcinoma",
              "Gastroesophageal Adenocarcinoma"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Phase 1: Number of Participants With Dose-Limiting Toxicities (DLTs)",
                "timeFrame": "Phase 1: Cycle 1 Day 1 to Cycle 2 Day 21"
              },
              {
                "measure": "Phase 2: Percentage of Participants With Objective Response",
                "timeFrame": "Baseline until complete response or partial response, assessed every 2 cycles up to end of study (up to 50 cycles)"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Phase 2: Progression-free Survival (PFS)"
              },
              {
                "measure": "Phase 2: Time to Disease Progression (TTP)"
              },
              {
                "measure": "Phase 2: Duration of Response (DOR)"
              },
              {
                "measure": "Phase 2: Number of Participants Reporting One or More Treatment-emergent Adverse Events and Serious Adverse Events"
              },
              {
                "measure": "Phase 1: Cmax- Maximum Observed Plasma Concentration for Alisertib"
              },
              {
                "measure": "Phase 1: Tmax- Time to Reach the Maximum Plasma Concentration (Cmax) for Alisertib"
              },
              {
                "measure": "Phase 1: AUC(0-tau): Area Under the Plasma Concentration-time Curve From Time 0 to Time Tau Over the Dosing Interval for Alisertib"
              },
              {
                "measure": "Phase 1: Terminal Phase Elimination Half-life (T1/2) for Alisertib"
              },
              {
                "measure": "Phase 1: Rac- Accumulation Ratio for Alisertib"
              },
              {
                "measure": "Phase 1: Peak to Trough Ratio for Alisertib"
              },
              {
                "measure": "Phase 1: Steady State Oral Clearance (CLss/F) for Alisertib"
              },
              {
                "measure": "Phase 2: Relationship Between Clinical Response and Molecular Markers of Response"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01779843",
            "briefTitle": "Alisertib for Acute Myeloid Leukemia",
            "officialTitle": "A Phase I Study of the Aurora A Kinase Inhibitor Alisertib in Combination With 7+3 Induction Chemotherapy in Patients With Acute Myeloid Leukemia"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2013-01-25"
          },
          "conditionsModule": {
            "conditions": [
              "Acute Myelogenous Leukemia"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Maximum Tolerated Dose of Alisertib in combination with 7+3 induction chemotherapy",
                "timeFrame": "2 years"
              },
              {
                "measure": "Evaluate safety and tolerability of alisertib, including number of adverse events and severity.",
                "timeFrame": "2 years"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Severity and number of all trial-related toxicities"
              },
              {
                "measure": "Rates of response"
              },
              {
                "measure": "One-year relapse-free and overall survival"
              },
              {
                "measure": "Measurement of tumor mitotic index, Ki67 and cPARP statining, Pharmacodynamic parameters for aurora kinase A inhibition, during treatment"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00651664",
            "briefTitle": "A Phase I Clinical and Pharmacodynamic Study of MLN8237, A Novel Aurora A Kinase Inhibitor, in Participants With Advanced Malignancies",
            "officialTitle": "A Phase I Clinical and Pharmacodynamic Study of MLN8237, A Novel Aurora A Kinase Inhibitor, in Patients With Advanced Malignancies"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2008-03-31",
            "resultsFirstSubmitDate": "2018-01-04"
          },
          "conditionsModule": {
            "conditions": [
              "Advanced Malignancies"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Number of Participants With Dose-Limiting Toxicity (DLT)",
                "timeFrame": "First dose through 30 days following the last dose of study drug (up to 730 days)"
              },
              {
                "measure": "Maximum Tolerated Dose (MTD) of Alisertib",
                "timeFrame": "Signing of the Informed Consent through 30 days following the last dose of study drug (up to 730 days)"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Cmax: Maximum Observed Concentration for Alisertib 7 Day Dosing"
              },
              {
                "measure": "Tmax: Time of First Occurrence of Cmax for Alisertib 7 Day Dosing"
              },
              {
                "measure": "AUCt: Area Under the Concentration-time Curve From Time 0 to Time t for Alisertib 7 Day Dosing"
              },
              {
                "measure": "Terminal Half-Life (t1/2) for Alisertib 7 Day Dosing"
              },
              {
                "measure": "Accumulation Ratio (Rac) for Alisertib 7 Day Dosing"
              },
              {
                "measure": "Peak/Trough Ratio for Aliserib 7 Day Dosing"
              },
              {
                "measure": "CLss/F: Apparent Oral Clearance at Steady State 7 Day Dosing"
              },
              {
                "measure": "Cmax: Maximum Observed Concentration for Alisertib 14 Day Dosing"
              },
              {
                "measure": "Tmax: Time of First Occurrence of Cmax for Alisertib 14 Day Dosing"
              },
              {
                "measure": "AUCt: Area Under the Concentration-time Curve From Time 0 to Time t for Alisertib 14 Day Dosing"
              },
              {
                "measure": "Terminal Half-Life (t1/2) for Alisertib 14 Day Dosing"
              },
              {
                "measure": "Accumulation Ratio (Rac) for Alisertib 14 Day Dosing"
              },
              {
                "measure": "Peak/Trough Ratio for Aliserib 14 Day Dosing"
              },
              {
                "measure": "CLss/F: Apparent Oral Clearance at Steady State 14 Day Dosing"
              },
              {
                "measure": "Cmax: Maximum Observed Concentration for Alisertib 21 Day Dosing"
              },
              {
                "measure": "Tmax: Time of First Occurrence of Cmax for Alisertib 21 Day Dosing"
              },
              {
                "measure": "AUCt: Area Under the Concentration-time Curve From Time 0 to Time t for Alisertib 21 Day Dosing"
              },
              {
                "measure": "Terminal Half-Life (t1/2) for Alisertib 21 Day Dosing"
              },
              {
                "measure": "Accumulation Ratio (Rac) for Alisertib 21 Day Dosing"
              },
              {
                "measure": "Peak/Trough Ratio for Aliserib 21 Day Dosing"
              },
              {
                "measure": "CLss/F: Apparent Oral Clearance at Steady State 21 Day Dosing"
              },
              {
                "measure": "Change From Baseline in Alisertib Skin Punch Biopsy Mitotic Index 7 Day Dosing"
              },
              {
                "measure": "Change From Baseline in Alisertib Skin Punch Biopsy Mitotic Index 14 Day Dosing"
              },
              {
                "measure": "Change From Baseline in Alisertib Skin Punch Biopsy Mitotic Index 21 Day Dosing"
              },
              {
                "measure": "Change From Baseline in Alisertib Skin Punch Biopsy Apoptotic Index 7 Day Dosing"
              },
              {
                "measure": "Change From Baseline in Alisertib Skin Punch Biopsy Apoptotic Index 14 Day Dosing"
              },
              {
                "measure": "Change From Baseline in Alisertib Skin Punch Biopsy Apoptotic Index 21 Day Dosing"
              },
              {
                "measure": "Change From Baseline in Alisertib Tumor Biopsy Mitotic Index 7 Day Dosing"
              },
              {
                "measure": "Change From Baseline in Alisertib Tumor Biopsy Mitotic Index 14 Day Dosing"
              },
              {
                "measure": "Change From Baseline in Alisertib Tumor Biopsy Mitotic Index 21 Day Dosing"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01471964",
            "briefTitle": "Study to Assess Safety and Tolerability of MLN8237, In Combination With Erlotinib to Treat Non-Small Cell Lung Cancer",
            "officialTitle": "A Phase I/II Trial to Assess Safety and Tolerability of an Oral Aurora Kinase A Inhibitor, MLN8237, In Combination With Erlotinib In Patients With Recurrent or Metastatic Non-Small Cell Lung Cancer"
          },
          "statusModule": {
            "overallStatus": "TERMINATED",
            "whyStopped": "Phase I portion completed. Phase II will open pending amendment approval.",
            "studyFirstSubmitDate": "2011-11-04"
          },
          "conditionsModule": {
            "conditions": [
              "Non-small Cell Lung Cancer Metastatic",
              "Non-small Cell Lung Cancer Recurrent"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Safety and tolerability of the combination treatment (Phase I)",
                "timeFrame": "Participants will be followed for the duration of treatment (up to 2 years) through 30 days of completion of treatment"
              },
              {
                "measure": "MTD of alisertib when given in combination with standard dose erlotinib hydrochloride (Phase I)",
                "timeFrame": "Participants will be followed for the duration of treatment (up to 2 years)"
              },
              {
                "measure": "PFS (Phase II)",
                "timeFrame": "Participants will be followed for the duration of treatment (up to 2 years) until the date of first documented progression or date of death for any cause, whichever came first"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "PK parameters of erlotinib hydrochloride and alisertib, including, but not limited to Cmax, Tmax, and AUC 0-tlast"
              },
              {
                "measure": "ORR (Phase II)"
              },
              {
                "measure": "DOR (Phase II)"
              },
              {
                "measure": "TTP (Phase II)"
              },
              {
                "measure": "OS (Phase II)"
              },
              {
                "measure": "AEs, SAEs, and assessments of clinical laboratory values (Phase II)"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02860000",
            "briefTitle": "Alisertib With or Without Fulvestrant in Treating Patients With Locally Advanced or Metastatic, Endocrine-Resistant Breast Cancer",
            "officialTitle": "Randomized Phase II Trial to Evaluate Alisertib Alone or Combined With Fulvestrant for Women With Advanced, Endocrine-Resistant Breast Cancer"
          },
          "statusModule": {
            "overallStatus": "ACTIVE_NOT_RECRUITING",
            "studyFirstSubmitDate": "2016-08-04",
            "resultsFirstSubmitDate": "2024-06-13"
          },
          "conditionsModule": {
            "conditions": [
              "Estrogen Receptor Status",
              "HER2/Neu Negative",
              "Invasive Breast Carcinoma",
              "Postmenopausal",
              "Stage III Breast Cancer",
              "Stage IIIA Breast Cancer",
              "Stage IIIB Breast Cancer",
              "Stage IIIC Breast Cancer",
              "Stage IV Breast Cancer"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Tumor Response Rate Defined as 100% Times the Number of Patients Who Meet the Criteria for Complete Response (CR) or Partial Response (PR) Using RECIST Criteria Version 1.1",
                "timeFrame": "Up to 4.5 years"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Biomarkers and ER Alpha Expression Assessed Using Tumor Tissue"
              },
              {
                "measure": "Change in Blood Biomarker Levels"
              },
              {
                "measure": "Change in Tumor Biomarker Levels"
              },
              {
                "measure": "Clinical Benefit Rate (CBR) During Initial Treatment Defined as Percentage of Patients Who Completed 6 Courses of Treatment Without Documentation of Disease Progression"
              },
              {
                "measure": "Duration of Response Defined as Time From Randomization to Disease Progression Among Those Patients Whose Disease Meets the RECIST Criteria for CR or PR on 2 Consecutive Evaluations Approximately 8 Weeks Apart During Initial Treatment"
              },
              {
                "measure": "Incidence of Adverse Events Graded by Common Terminology Criteria-Criteria for Adverse Events (CTCAE) Version 4.0"
              },
              {
                "measure": "Overall Survival"
              },
              {
                "measure": "Progression-free Survival"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00830518",
            "briefTitle": "A Phase 2 Trial of MLN8237 in Adult Participants With Acute Myelogenous Leukemia and High-Grade Myelodysplastic Syndrome",
            "officialTitle": "A Phase 2 Trial of MLN8237, an Oral Aurora A Kinase Inhibitor, in Adult Patients With Acute Myelogenous Leukemia and High-Grade Myelodysplastic Syndrome"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2009-01-27",
            "resultsFirstSubmitDate": "2018-01-04"
          },
          "conditionsModule": {
            "conditions": [
              "Acute Myelogenous Leukemia",
              "High-Grade Myelodysplastic Syndrome"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Best Overall Response Rate (ORR) Based on Investigator's Assessment",
                "timeFrame": "Baseline and every 2 cycles up to Cycle 16 (up to Month 12), from Cycle 17 every 4 cycles until disease progression, after end of treatment every 12 weeks for up to 12 Months (Approximately 2.4 years)"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Progression Free Survival (PFS)"
              },
              {
                "measure": "Duration of Response (DOR)"
              },
              {
                "measure": "Best Overall Hematologic Improvement (HI) Response for Myelodysplastic Syndrome Based on Investigator Assessment"
              },
              {
                "measure": "Number of Participants With Adverse Events (AEs), Serious Adverse Events (SAEs) and Deaths"
              },
              {
                "measure": "Number of Participants With Abnormal Vital Signs Reported as Treatment-Emergent Adverse Events"
              },
              {
                "measure": "Number of Participants With Abnormal Laboratory Values Reported as Treatment-Emergent Adverse Events"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01677559",
            "briefTitle": "Combining MLN8237 With Nab-Paclitaxel in Patients With Advanced Solid Malignancies",
            "officialTitle": "Phase I Study Combining MLN8237 With Nab-Paclitaxel in Patients With Advanced Solid Malignancies"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2012-08-27"
          },
          "conditionsModule": {
            "conditions": [
              "Adenocarcinoma",
              "Pancreatic Neoplasms"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Maximum tolerated dose (MTD)",
                "timeFrame": "Completion of cycle 1"
              },
              {
                "measure": "Dose-limiting toxicities (DLTs)",
                "timeFrame": "Completion of cycle 1"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Antitumor activity of MLN8237 and nab-paclitaxel combination therapy"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT04555837",
            "briefTitle": "Alisertib and Pembrolizumab for the Treatment of Patients With Rb-deficient Head and Neck Squamous Cell Cancer",
            "officialTitle": "A Phase I-II, Open Label Study Evaluating the Safety and Efficacy of Alisertib and Pembrolizumab in Patients With Rb-Deficient Head and Neck Squamous Cell Carcinomas"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2020-09-14",
            "resultsFirstSubmitDate": "2024-08-07"
          },
          "conditionsModule": {
            "conditions": [
              "Head and Neck Squamous Cell Carcinoma",
              "Malignant Solid Neoplasm"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Phase I: The Recommended Phase II Dose Determenation. Phase II: Overall Response Rate (ORR) and Progression Free Survival (PFS)",
                "timeFrame": "Approximately 33 months"
              },
              {
                "measure": "Phase II: Overall Response Rate (ORR)",
                "timeFrame": "Approximately 33 months"
              },
              {
                "measure": "Phase II: Progression Free Survival (PFS)",
                "timeFrame": "Approximately 33 months"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "The Safety of the Combination of Pembrolizumab and Alisertib"
              },
              {
                "measure": "The Overall Survival in HNSCC Patients"
              },
              {
                "measure": "The Relationship Between Pharmacokinetics, Pharmacodynamics, Baseline Immune and Tumor Biomarkers and Clinical Responses"
              },
              {
                "measure": "Correlations Between Clinical Responses and the Effect of the Treatment on Human Papilloma Virus (HPV)-Reactive T Cells in HPV+ Cancers."
              },
              {
                "measure": "Correlations Between Clinical Responses and Tumor Infiltrating Lymphocyte Function and T Cell Repertoire."
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01923337",
            "briefTitle": "Irinotecan and Alisertib in Treating Patients With Advanced Solid Tumors or Colorectal Cancer",
            "officialTitle": "Phase I Study of the Combination of Irinotecan and MLN8237 in Advanced Solid Tumors With Emphasis on Colorectal Cancer"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2013-08-13"
          },
          "conditionsModule": {
            "conditions": [
              "Mucinous Adenocarcinoma of the Colon",
              "Mucinous Adenocarcinoma of the Rectum",
              "Recurrent Colon Cancer",
              "Recurrent Rectal Cancer",
              "Signet Ring Adenocarcinoma of the Colon",
              "Signet Ring Adenocarcinoma of the Rectum",
              "Stage IIIA Colon Cancer",
              "Unspecified Adult Solid Tumor, Protocol Specific"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "MTD, defined as the highest dose tested in which fewer than 33% of patients experience dose-limiting toxicity (DLT) attributable to the study drugs, graded using the National Cancer Institute (NCI) CTCAE version 4.0",
                "timeFrame": "Up to day 21"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Incidence of toxicities observed at each dose level graded according to NCI CTCAE version 4.0"
              },
              {
                "measure": "Response rates, as determined by the Response Evaluation Criteria in Solid Tumors (RECIST) v1.1"
              },
              {
                "measure": "Survival"
              },
              {
                "measure": "Time to failure"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01094288",
            "briefTitle": "A Phase 1 Study of Alisertib Participants With Advanced Solid Tumors Including Castration-Resistant Prostate Cancer Receiving a Standard Docetaxel Regimen",
            "officialTitle": "A Phase 1 Study of MLN8237, an Aurora A Kinase Inhibitor, in Patients With Advanced Solid Tumors Including Castration-Resistant Prostate Cancer Receiving a Standard Docetaxel Regimen"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2010-03-17",
            "resultsFirstSubmitDate": "2018-01-04"
          },
          "conditionsModule": {
            "conditions": [
              "Advanced Solid Tumors",
              "Adenocarcinoma of the Prostate"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Number of Participants With Adverse Events (AEs) and Serious Adverse Events (SAEs)",
                "timeFrame": "From enrollment through 30 days after the last dose of study drug (approximately up to 77 months)"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Cmax: Maximum Observed Plasma Concentration for Docetaxel"
              },
              {
                "measure": "AUC(Last): Area Under the Plasma Concentration Curve From Time 0 to the Time of the Last Quantifiable Concentration for Docetaxel"
              },
              {
                "measure": "AUC\u221e: Area Under the Plasma Concentration Curve From Time 0 to Infinity for Docetaxel"
              },
              {
                "measure": "Terminal Phase Elimination Half-life (T1/2) for Docetaxel"
              },
              {
                "measure": "Cmax: Maximum Observed Plasma Concentration for Alisertib"
              },
              {
                "measure": "Tmax: Time to Reach the Maximum Plasma Concentration (Cmax) for Alisertib"
              },
              {
                "measure": "AUC\u03c4: Area Under the Plasma Concentration-time Curve From Time 0 to Day 7 Over the Dosing Interval for Alisertib"
              },
              {
                "measure": "Overall Response Rate (ORR) Assessed for Overall Participant Population"
              },
              {
                "measure": "Overall Response Rate for Prostate Cancer Participants"
              },
              {
                "measure": "Best Overall Response Rate Assessed by RECIST Criteria"
              },
              {
                "measure": "Best Overall Response Rate Assessed by PSA Response by Prostate Cancer Working Group 2 (PCWG2) Criteria"
              },
              {
                "measure": "Duration of Response"
              },
              {
                "measure": "Duration of Stable Disease (SD)"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT06369285",
            "briefTitle": "A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer",
            "officialTitle": "A Phase 2 Study of Alisertib in Combination With Endocrine Therapy in Patients With HR+, HER2-negative Recurrent or Metastatic Breast Cancer"
          },
          "statusModule": {
            "overallStatus": "RECRUITING",
            "studyFirstSubmitDate": "2024-04-12"
          },
          "conditionsModule": {
            "conditions": [
              "Hormone Receptor Positive HER-2 Negative Breast Cancer",
              "Metastatic Breast Cancer",
              "Recurrent Breast Cancer"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Objective Response Rate (ORR) Within Dose Subgroup",
                "timeFrame": "From date of randomization to first confirmed Complete or Partial Response, whichever came earlier, assessed up to 48 months"
              },
              {
                "measure": "Duration of Response (DOR) Within Dose Subgroup",
                "timeFrame": "From start date of response (after date of randomization) to first PD, assessed up to 48 months"
              },
              {
                "measure": "Disease Control Rate (DCR) Within Dose Subgroup",
                "timeFrame": "From date of randomization to first confirmed Complete or Partial Response, whichever came earlier, assessed up to 48 months"
              },
              {
                "measure": "Progression Free Survival (PFS) Within Dose Subgroup",
                "timeFrame": "From date of randomization to date of recurrence, progression or death, assessed up to 48 months"
              },
              {
                "measure": "Overall Survival (OS) Within Dose Subgroup",
                "timeFrame": "From date of randomization to death, assessed up to 48 months"
              },
              {
                "measure": "Percentage of Participants With Treatment-Emergent Adverse Events (Adverse Events and Serious Adverse Events) in the Enrolled Population",
                "timeFrame": "From date of first dose through last dose plus 28 days, assessed up to 48 months"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Objective Response Rate (ORR) Within Biomarker-Defined Subgroup"
              },
              {
                "measure": "Duration of Response (DOR) Within Biomarker-Defined Subgroup"
              },
              {
                "measure": "Disease Control Rate (DCR) Within Biomarker-Defined Subgroup"
              },
              {
                "measure": "Progression Free Survival (PFS) Within Biomarker-Defined Subgroup"
              },
              {
                "measure": "Overall Survival (OS) Within Biomarker-Defined Subgroup"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02812056",
            "briefTitle": "Alisertib and TAK-228 in Participants With Human Papilloma Virus (HPV) Associated Malignancies",
            "officialTitle": "A Phase I Study of Alisertib and TAK-228 in Participants With Human Papilloma Virus (HPV) Associated Malignancies"
          },
          "statusModule": {
            "overallStatus": "WITHDRAWN",
            "studyFirstSubmitDate": "2016-06-16"
          },
          "conditionsModule": {
            "conditions": [
              "Malignant Neoplasms of Digestive Organs",
              "Malignant Neoplasms of Female Genital Organs",
              "Malignant Neoplasms of Lip Oral Cavity and Pharynx",
              "Malignant Neoplasms of Male Genital Organs"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Maximum Tolerated Dose (MTD) of Alisertib and TAK-228 in Participants with Human Papilloma Virus (HPV) Associated Malignancies",
                "timeFrame": "21 days"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Clinical Benefit of Alisertib and TAK-228 in Participants with Human Papilloma Virus (HPV) Associated Malignancies"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT04085315",
            "briefTitle": "Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer",
            "officialTitle": "A Phase I/Ib Study of Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer"
          },
          "statusModule": {
            "overallStatus": "RECRUITING",
            "studyFirstSubmitDate": "2019-09-06"
          },
          "conditionsModule": {
            "conditions": [
              "Lung Cancer Metastatic",
              "EGFR Gene Mutation"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Determination of Maximum Tolerated Dose (MTD) (Cohort A)",
                "timeFrame": "First 28 days of study treatment (1 cycle is 28 days)"
              },
              {
                "measure": "Proportion of patients experiencing dose limiting toxicity (DLT) (Cohort A)",
                "timeFrame": "First 28 days of study treatment (1 cycle is 28 days)"
              },
              {
                "measure": "Proportion of patients experiencing serious adverse event (SAE)",
                "timeFrame": "Up to 2 years"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Overall Response Rate (ORR)"
              },
              {
                "measure": "Median Duration of Response (DR)"
              },
              {
                "measure": "Percentage of tumor shrinkage"
              },
              {
                "measure": "Disease Control Rate (DCR)"
              },
              {
                "measure": "Median Progression Free Survival (PFS)"
              },
              {
                "measure": "Median Overall Survival (OS)"
              },
              {
                "measure": "Intratumoral TPX2 expression by Immunohistochemistry (IHC)"
              },
              {
                "measure": "Area Under Curve (AUC)"
              },
              {
                "measure": "Maximum (or peak) serum concentration (Cmax)"
              },
              {
                "measure": "Amount of time (maximum) drug concentration in serum (Tmax)"
              },
              {
                "measure": "Central Nervous System (CNS) disease control rate"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01567709",
            "briefTitle": "Alisertib in Combination With Vorinostat in Treating Patients With Relapsed or Recurrent Hodgkin Lymphoma, B-Cell Non-Hodgkin Lymphoma, or Peripheral T-Cell Lymphoma",
            "officialTitle": "Phase I Study of the Aurora Kinase a Inhibitor MLN8237 in Combination With the Histone Deacetylase Inhibitor Vorinostat in Lymphoid Malignancies"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2012-03-29"
          },
          "conditionsModule": {
            "conditions": [
              "Adult B Acute Lymphoblastic Leukemia",
              "Adult T Acute Lymphoblastic Leukemia",
              "Anaplastic Large Cell Lymphoma",
              "Angioimmunoblastic T-Cell Lymphoma",
              "Chronic Lymphocytic Leukemia",
              "Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue",
              "Hepatosplenic T-Cell Lymphoma",
              "Intraocular Lymphoma",
              "Lymphomatous Involvement of Non-Cutaneous Extranodal Site",
              "Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma",
              "Nodal Marginal Zone Lymphoma",
              "Primary Cutaneous B-Cell Non-Hodgkin Lymphoma",
              "Recurrent Adult Acute Lymphoblastic Leukemia",
              "Recurrent Adult Burkitt Lymphoma",
              "Recurrent Adult Grade III Lymphomatoid Granulomatosis",
              "Recurrent Adult Hodgkin Lymphoma",
              "Recurrent Adult Immunoblastic Lymphoma",
              "Recurrent Adult Lymphoblastic Lymphoma",
              "Recurrent Adult T-Cell Leukemia/Lymphoma",
              "Recurrent Grade 1 Follicular Lymphoma",
              "Recurrent Grade 2 Follicular Lymphoma",
              "Recurrent Grade 3 Follicular Lymphoma",
              "Recurrent Mantle Cell Lymphoma",
              "Recurrent Marginal Zone Lymphoma",
              "Recurrent Mycosis Fungoides and Sezary Syndrome",
              "Recurrent Non-Hodgkin Lymphoma",
              "Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma",
              "Recurrent Small Lymphocytic Lymphoma",
              "Refractory Chronic Lymphocytic Leukemia",
              "Refractory Hairy Cell Leukemia",
              "Small Intestinal Lymphoma",
              "Splenic Marginal Zone Lymphoma",
              "T-Cell Large Granular Lymphocyte Leukemia",
              "Testicular Lymphoma",
              "Waldenstrom Macroglobulinemia"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "MTD of alisertib defined as the highest dose tested in which less than 33% of patients experienced dose-limiting toxicity (DLT) graded according to the National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE) version (v.)4.0",
                "timeFrame": "21 days"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Incidence of toxicities produced by alisertib in combination with vorinostat assessed by the NCI CTCAE version 4.0"
              },
              {
                "measure": "Clinical response rate"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT02186509",
            "briefTitle": "Alisertib and Fractionated Stereotactic Radiosurgery in Treating Patients With Recurrent High Grade Gliomas",
            "officialTitle": "Phase I Study of Alisertib With Concurrent Fractionated Stereotactic Radiation Treatment for Recurrent High Grade Gliomas"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2014-07-07",
            "resultsFirstSubmitDate": "2019-05-16"
          },
          "conditionsModule": {
            "conditions": [
              "Adult Anaplastic Astrocytoma",
              "Adult Anaplastic Ependymoma",
              "Adult Anaplastic Oligodendroglioma",
              "Adult Brain Stem Glioma",
              "Adult Diffuse Astrocytoma",
              "Adult Giant Cell Glioblastoma",
              "Adult Glioblastoma",
              "Adult Gliosarcoma",
              "Adult Mixed Glioma",
              "Adult Oligodendroglioma",
              "Adult Pilocytic Astrocytoma",
              "Adult Pineal Gland Astrocytoma",
              "Adult Subependymal Giant Cell Astrocytoma",
              "Recurrent Adult Brain Tumor"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Maximum Tolerated Dose (MTD) of Alisertib",
                "timeFrame": "Up to 30 days after completion of radiation therapy"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Number of Participants With Complete or Partial Response"
              },
              {
                "measure": "Number of Participants With Progression Free Survival at 6 Months"
              },
              {
                "measure": "Number of Participants With Overall Survival at 6 Months"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT00853307",
            "briefTitle": "MLN8237 for Treatment of Participants With Ovarian, Fallopian Tube, or Peritoneal Carcinoma",
            "officialTitle": "A Phase 2 Study of MLN8237, a Novel Aurora A Kinase Inhibitor, in the Treatment of Patients With Platinum-Refractory or Platinum-Resistant Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2009-02-26",
            "resultsFirstSubmitDate": "2018-01-04"
          },
          "conditionsModule": {
            "conditions": [
              "Ovarian Carcinoma"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Combined Best Overall Response Rate Based on Investigator Assessment",
                "timeFrame": "Every 2 cycles up to 12 months until progressive disease (PD); Participants who discontinue study drug before PD: Follow-Up (FU)-every 12 weeks up to 12 months until PD/other cancer therapy; CA 125 Day 1 of cycle, End of Treatment and FU (Up to 22 Months)"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Progression Free Survival (PFS)"
              },
              {
                "measure": "Duration Of Response (DOR)"
              },
              {
                "measure": "Time To Progression (TTP)"
              },
              {
                "measure": "Clinical Benefit Rate"
              },
              {
                "measure": "Number of Participants With Treatment-Emergent Adverse Events and Serious Adverse Events"
              },
              {
                "measure": "Number of Participants With Abnormal Vital Signs Reported as Treatment-Emergent Adverse Events"
              },
              {
                "measure": "Number of Participants With Abnormal Laboratory Values Reported as Treatment-Emergent Adverse Events"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01799278",
            "briefTitle": "A Phase II Trial of MLN8237 in Patients With Metastatic Castrate Resistant and Neuroendocrine Prostate Cancer",
            "officialTitle": "A Phase II Trial of the Aurora Kinase A Inhibitor MLN8237 in Patients With Metastatic Castrate Resistant and Neuroendocrine Prostate Cancer"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2013-02-22",
            "resultsFirstSubmitDate": "2017-10-30"
          },
          "conditionsModule": {
            "conditions": [
              "Small Cell Prostate Cancer",
              "Neuroendocrine Prostate Cancer",
              "Prostate Adenocarcinoma Plus > 50% Immunohistochemical Staining for Neuroendocrine Markers"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Response Rate, as Assessed by CT/MRI and Bone Scan, of Treatment With MLN8237 for Patients With Neuroendocrine Prostate Cancer",
                "timeFrame": "one year"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Progression-free Survival in Response to Therapy"
              },
              {
                "measure": "Overall Survival in Response to Therapy"
              },
              {
                "measure": "Prostate-Specific Antigen (PSA) Test Response Rate"
              },
              {
                "measure": "Circulating Tumor Cell (CTC) Response"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01639911",
            "briefTitle": "Phase I Study of MLN8237 and Pazopanib in Patients With Solid Tumors",
            "officialTitle": "STM-01: Phase I EffTox Study of Aurora A Kinase Inhibitor Alisertib (MLN8237) Given in Combination With Selective VEGFR Inhibitor Pazopanib (Votrient) for Therapy of Solid Tumors"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2012-03-26"
          },
          "conditionsModule": {
            "conditions": [
              "Malignant Neoplasm of Breast",
              "CNS Malignancy",
              "Malignant Neoplasm of Gastrointestinal Tract",
              "Genitourinary Neoplasms Malignancy and Gender Unspecified",
              "Head and Neck Neoplasms",
              "Melanoma",
              "Malignant Neoplasm of Thorax"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Optimally Tolerated Dose",
                "timeFrame": "At end of Cycle 1 (approximately Day 21)"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Toxicity Profile"
              }
            ]
          }
        }
      },
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT01898078",
            "briefTitle": "Food Effect Study of Alisertib (MLN8237) in Participants With Advanced Solid Tumors or Lymphomas",
            "officialTitle": "An Open-Label, Phase 1, Two-Way, Cross-Over Study of the Effect of the Food on the Pharmacokinetics of MLN8237 (Alisertib) in Patients With Advanced Solid Tumors or Lymphomas"
          },
          "statusModule": {
            "overallStatus": "COMPLETED",
            "studyFirstSubmitDate": "2013-07-01",
            "resultsFirstSubmitDate": "2018-02-21"
          },
          "conditionsModule": {
            "conditions": [
              "Advanced Solid Tumors",
              "Lymphoma"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Cmax: Maximum Observed Plasma Concentration of Alisertib",
                "timeFrame": "Cycles 1 and 2, Day 1 pre-dose and at multiple time points (up to 72 hours) post-dose"
              },
              {
                "measure": "AUC(Last): Area Under the Plasma Concentration Curve From Time 0 to the Time of the Last Quantifiable Concentration of Alisertib",
                "timeFrame": "Cycles 1 and 2, Day 1 pre-dose and at multiple time points (up to 72 hours) post-dose"
              },
              {
                "measure": "AUC\u221e: Area Under the Plasma Concentration Curve From Time 0 to Infinity of Alisertib",
                "timeFrame": "Cycles 1 and 2, Day 1 pre-dose and at multiple time points (up to 72 hours) post-dose"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Number of Participants With Adverse Events (AEs) and Serious Adverse Events (SAEs)"
              },
              {
                "measure": "Number of Participants With Clinically Significant Change in Laboratory Parameters Reported as AEs"
              },
              {
                "measure": "Number of Participants With Clinically Significant Change in Vital Sign Reported as AEs"
              }
            ]
          }
        }
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:48:03Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c846e"
    },
    "name": "BRD-K92061784",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c846e.png",
    "lincs": {
      "id": "LSM-14085",
      "name": "BRD-K92061784",
      "pubchemCid": 54638263,
      "chebiId": 102739,
      "inchiParent": "InChI=1S/C23H23F2N3O6/c24-14-2-4-16(25)18(8-14)28-23(31)27-17-5-3-15(34-21(17)11-29)9-22(30)26-10-13-1-6-19-20(7-13)33-12-32-19/h1-8,15,17,21,29H,9-12H2,(H,26,30)(H2,27,28,31)/t15-,17+,21-/m1/s1",
      "inchiKeyParent": "VZUMNNKKGVSTKF-LDBYXDLTSA-N",
      "smilesParent": "OC[C@H]1O[C@@H](CC(=O)NCc2ccc3OCOc3c2)C=C[C@@H]1NC(=O)Nc4cc(F)ccc4F"
    },
    "unichem": {
      "chebi": "102739",
      "lincs": "LSM-14085",
      "pubchem": "54638263"
    },
    "pubchem": [
      {
        "cid": 54638263,
        "inchi": "InChI=1S/C23H23F2N3O6/c24-14-2-4-16(25)18(8-14)28-23(31)27-17-5-3-15(34-21(17)11-29)9-22(30)26-10-13-1-6-19-20(7-13)33-12-32-19/h1-8,15,17,21,29H,9-12H2,(H,26,30)(H2,27,28,31)/t15-,17+,21-/m1/s1",
        "inchikey": "VZUMNNKKGVSTKF-LDBYXDLTSA-N",
        "iupac": {
          "systematic": "N-(1,3-benzodioxol-5-ylmethyl)-2-[(2S,3S,6S)-3-[(2,5-difluorophenyl)carbamoylamino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetamide"
        },
        "smiles": {
          "canonical": "C1OC2=C(O1)C=C(C=C2)CNC(=O)CC3C=CC(C(O3)CO)NC(=O)NC4=C(C=CC(=C4)F)F"
        },
        "molecularFormula": "C23H23F2N3O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:48:05Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85e9"
    },
    "name": "BRD-K02952507",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85e9.png",
    "lincs": {
      "id": "LSM-6740",
      "name": "BRD-K02952507",
      "pubchemCid": 54650144,
      "chebiId": 95361,
      "inchiParent": "InChI=1S/C23H21FN2O2/c1-15(2)6-7-16-8-10-17(11-9-16)22-20(13-25)26(21(22)14-27)23(28)18-4-3-5-19(24)12-18/h3-5,8-12,15,20-22,27H,14H2,1-2H3/t20-,21-,22-/m1/s1",
      "inchiKeyParent": "DGEMMPDKDCWCNC-YPAWHYETSA-N",
      "smilesParent": "CC(C)C#Cc1ccc(cc1)[C@H]2[C@@H](CO)N([C@@H]2C#N)C(=O)c3cccc(F)c3"
    },
    "unichem": {
      "chebi": "95361",
      "lincs": "LSM-6740",
      "pubchem": "54650144"
    },
    "pubchem": [
      {
        "cid": 54650144,
        "inchi": "InChI=1S/C23H21FN2O2/c1-15(2)6-7-16-8-10-17(11-9-16)22-20(13-25)26(21(22)14-27)23(28)18-4-3-5-19(24)12-18/h3-5,8-12,15,20-22,27H,14H2,1-2H3/t20-,21-,22-/m1/s1",
        "inchikey": "DGEMMPDKDCWCNC-YPAWHYETSA-N",
        "iupac": {
          "systematic": "(2S,3R,4S)-1-(3-fluorobenzoyl)-4-(hydroxymethyl)-3-[4-(3-methylbut-1-ynyl)phenyl]azetidine-2-carbonitrile"
        },
        "smiles": {
          "canonical": "CC(C)C#CC1=CC=C(C=C1)C2C(N(C2C#N)C(=O)C3=CC(=CC=C3)F)CO"
        },
        "molecularFormula": "C23H21FN2O2"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:48:08Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8622"
    },
    "name": "BRD-K25298922",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8622.png",
    "lincs": {
      "id": "LSM-38652",
      "name": "BRD-K25298922",
      "pubchemCid": 60190217,
      "chebiId": 127089,
      "inchiParent": "InChI=1S/C22H32N4O3/c1-24(2)12-19(28)26-9-7-22(8-10-26)14-25(3)18(13-27)21-20(22)16-6-5-15(29-4)11-17(16)23-21/h5-6,11,18,23,27H,7-10,12-14H2,1-4H3/t18-/m1/s1",
      "inchiKeyParent": "JDLNVBUVHOBJMI-GOSISDBHSA-N",
      "smilesParent": "COc1ccc2c3c([nH]c2c1)[C@@H](CO)N(C)CC34CCN(CC4)C(=O)CN(C)C"
    },
    "unichem": {
      "chebi": "127089",
      "lincs": "LSM-38652",
      "pubchem": "60190217"
    },
    "pubchem": [
      {
        "cid": 60190217,
        "inchi": "InChI=1S/C22H32N4O3/c1-24(2)12-19(28)26-9-7-22(8-10-26)14-25(3)18(13-27)21-20(22)16-6-5-15(29-4)11-17(16)23-21/h5-6,11,18,23,27H,7-10,12-14H2,1-4H3/t18-/m1/s1",
        "inchikey": "JDLNVBUVHOBJMI-GOSISDBHSA-N",
        "iupac": {
          "systematic": "2-(dimethylamino)-1-[(1S)-1-(hydroxymethyl)-7-methoxy-2-methylspiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4'-piperidine]-1'-yl]ethanone"
        },
        "smiles": {
          "canonical": "CN1CC2(CCN(CC2)C(=O)CN(C)C)C3=C(C1CO)NC4=C3C=CC(=C4)OC"
        },
        "molecularFormula": "C22H32N4O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:48:10Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8516"
    },
    "name": "BRD-K07269289",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8516.png",
    "lincs": {
      "id": "LSM-8856",
      "name": "BRD-K07269289",
      "pubchemCid": 54657595,
      "chebiId": 97477,
      "inchiParent": "InChI=1S/C31H41N3O6/c1-38-28-10-6-5-9-26(28)32-31(37)34-19-24(35)20-39-21-29-27(34)12-11-25(40-29)18-30(36)33-15-13-23(14-16-33)17-22-7-3-2-4-8-22/h2-10,23-25,27,29,35H,11-21H2,1H3,(H,32,37)/t24-,25+,27-,29+/m0/s1",
      "inchiKeyParent": "PLPDORRRKBPITR-IKQRCTNISA-N",
      "smilesParent": "COc1ccccc1NC(=O)N2C[C@H](O)COC[C@H]3O[C@@H](CC(=O)N4CCC(Cc5ccccc5)CC4)CC[C@H]23"
    },
    "unichem": {
      "chebi": "97477",
      "lincs": "LSM-8856",
      "pubchem": "54657595"
    },
    "pubchem": [
      {
        "cid": 54657595,
        "inchi": "InChI=1S/C31H41N3O6/c1-38-28-10-6-5-9-26(28)32-31(37)34-19-24(35)20-39-21-29-27(34)12-11-25(40-29)18-30(36)33-15-13-23(14-16-33)17-22-7-3-2-4-8-22/h2-10,23-25,27,29,35H,11-21H2,1H3,(H,32,37)/t24-,25+,27-,29+/m0/s1",
        "inchikey": "PLPDORRRKBPITR-IKQRCTNISA-N",
        "iupac": {
          "systematic": "(3S,6aS,8R,10aS)-8-[2-(4-benzylpiperidin-1-yl)-2-oxoethyl]-3-hydroxy-N-(2-methoxyphenyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide"
        },
        "smiles": {
          "canonical": "COC1=CC=CC=C1NC(=O)N2CC(COCC3C2CCC(O3)CC(=O)N4CCC(CC4)CC5=CC=CC=C5)O"
        },
        "molecularFormula": "C31H41N3O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:48:12Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8547"
    },
    "name": "BRD-K27161555",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8547.png",
    "lincs": {
      "id": "LSM-10070",
      "name": "BRD-K27161555",
      "pubchemCid": 54657542,
      "chebiId": 98691,
      "inchiParent": "InChI=1S/C26H32ClN3O5/c1-17(18-6-3-2-4-7-18)28-25(32)13-22-10-11-23-24(35-22)16-34-15-21(31)14-30(23)26(33)29-20-9-5-8-19(27)12-20/h2-9,12,17,21-24,31H,10-11,13-16H2,1H3,(H,28,32)(H,29,33)/t17-,21+,22+,23+,24-/m1/s1",
      "inchiKeyParent": "QYSMODXJNCJWNA-ADWPFFDDSA-N",
      "smilesParent": "C[C@@H](NC(=O)C[C@@H]1CC[C@H]2[C@@H](COC[C@@H](O)CN2C(=O)Nc3cccc(Cl)c3)O1)c4ccccc4"
    },
    "unichem": {
      "chebi": "98691",
      "lincs": "LSM-10070",
      "pubchem": "54657542"
    },
    "pubchem": [
      {
        "cid": 54657542,
        "inchi": "InChI=1S/C26H32ClN3O5/c1-17(18-6-3-2-4-7-18)28-25(32)13-22-10-11-23-24(35-22)16-34-15-21(31)14-30(23)26(33)29-20-9-5-8-19(27)12-20/h2-9,12,17,21-24,31H,10-11,13-16H2,1H3,(H,28,32)(H,29,33)/t17-,21+,22+,23+,24-/m1/s1",
        "inchikey": "QYSMODXJNCJWNA-ADWPFFDDSA-N",
        "iupac": {
          "systematic": "(3S,6aS,8S,10aS)-N-(3-chlorophenyl)-3-hydroxy-8-[2-oxo-2-[[(1R)-1-phenylethyl]amino]ethyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide"
        },
        "smiles": {
          "canonical": "CC(C1=CC=CC=C1)NC(=O)CC2CCC3C(O2)COCC(CN3C(=O)NC4=CC(=CC=C4)Cl)O"
        },
        "molecularFormula": "C26H32ClN3O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:48:14Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c857a"
    },
    "name": "BRD-K25827371",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c857a.png",
    "lincs": {
      "id": "LSM-46052",
      "name": "BRD-K25827371",
      "inchiParent": "InChI=1S/C21H21FN4O2S/c1-25-12-20(23-13-25)29(27,28)26-10-18-21(19(11-26)24-18)15-8-6-14(7-9-15)16-4-2-3-5-17(16)22/h2-9,12-13,18-19,21,24H,10-11H2,1H3/t18-,19+,21-",
      "inchiKeyParent": "GMNZGGJWOJJWDN-CEQLMSFQSA-N",
      "smilesParent": "Cn1cnc(c1)S(=O)(=O)N2C[C@@H]3N[C@H](C2)[C@H]3c4ccc(cc4)c5ccccc5F"
    },
    "unichem": {
      "lincs": "LSM-46052"
    },
    "createdAt": {
      "$date": "2025-05-24T08:48:16Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8581"
    },
    "name": "BRD-K16897811",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8581.png",
    "lincs": {
      "id": "LSM-38161",
      "name": "BRD-K16897811",
      "pubchemCid": 60184954,
      "chebiId": 126597,
      "inchiParent": "InChI=1S/C26H28FN3O3/c1-33-19-8-9-20-21(10-19)28-24-22(12-31)29(11-16-2-3-16)13-26(23(20)24)14-30(15-26)25(32)17-4-6-18(27)7-5-17/h4-10,16,22,28,31H,2-3,11-15H2,1H3/t22-/m0/s1",
      "inchiKeyParent": "MXMKKVOZZZVICE-QFIPXVFZSA-N",
      "smilesParent": "COc1ccc2c3c([nH]c2c1)[C@H](CO)N(CC4CC4)CC35CN(C5)C(=O)c6ccc(F)cc6"
    },
    "unichem": {
      "chebi": "126597",
      "lincs": "LSM-38161",
      "pubchem": "60184954"
    },
    "pubchem": [
      {
        "cid": 60184954,
        "inchi": "InChI=1S/C26H28FN3O3/c1-33-19-8-9-20-21(10-19)28-24-22(12-31)29(11-16-2-3-16)13-26(23(20)24)14-30(15-26)25(32)17-4-6-18(27)7-5-17/h4-10,16,22,28,31H,2-3,11-15H2,1H3/t22-/m0/s1",
        "inchikey": "MXMKKVOZZZVICE-QFIPXVFZSA-N",
        "iupac": {
          "systematic": "[(1R)-2-(cyclopropylmethyl)-1-(hydroxymethyl)-7-methoxyspiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3'-azetidine]-1'-yl]-(4-fluorophenyl)methanone"
        },
        "smiles": {
          "canonical": "COC1=CC2=C(C=C1)C3=C(N2)C(N(CC34CN(C4)C(=O)C5=CC=C(C=C5)F)CC6CC6)CO"
        },
        "molecularFormula": "C26H28FN3O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:48:18Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85c8"
    },
    "name": "BRD-K83859302",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85c8.png",
    "lincs": {
      "id": "LSM-13554",
      "name": "BRD-K83859302",
      "pubchemCid": 54657491,
      "chebiId": 102196,
      "inchiParent": "InChI=1S/C26H34N4O6/c1-16-25(17(2)36-28-16)27-26(33)30-13-20(31)14-34-15-23-22(30)8-7-21(35-23)11-24(32)29-10-9-18-5-3-4-6-19(18)12-29/h3-6,20-23,31H,7-15H2,1-2H3,(H,27,33)/t20-,21-,22-,23+/m0/s1",
      "inchiKeyParent": "SVQJPVUULHSFBY-CWBXHPNXSA-N",
      "smilesParent": "Cc1onc(C)c1NC(=O)N2C[C@H](O)COC[C@H]3O[C@H](CC(=O)N4CCc5ccccc5C4)CC[C@H]23"
    },
    "unichem": {
      "chebi": "102196",
      "lincs": "LSM-13554",
      "pubchem": "54657491"
    },
    "pubchem": [
      {
        "cid": 54657491,
        "inchi": "InChI=1S/C26H34N4O6/c1-16-25(17(2)36-28-16)27-26(33)30-13-20(31)14-34-15-23-22(30)8-7-21(35-23)11-24(32)29-10-9-18-5-3-4-6-19(18)12-29/h3-6,20-23,31H,7-15H2,1-2H3,(H,27,33)/t20-,21-,22-,23+/m0/s1",
        "inchikey": "SVQJPVUULHSFBY-CWBXHPNXSA-N",
        "iupac": {
          "systematic": "(3S,6aS,8S,10aS)-8-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-N-(3,5-dimethyl-1,2-oxazol-4-yl)-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide"
        },
        "smiles": {
          "canonical": "CC1=C(C(=NO1)C)NC(=O)N2CC(COCC3C2CCC(O3)CC(=O)N4CCC5=CC=CC=C5C4)O"
        },
        "molecularFormula": "C26H34N4O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:48:21Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8612"
    },
    "name": "BRD-K90365097",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8612.png",
    "lincs": {
      "id": "LSM-42202",
      "name": "BRD-K90365097",
      "pubchemCid": 60189746,
      "chebiId": 130653,
      "inchiParent": "InChI=1S/C19H27N3O3/c1-4-16(24)21-11-19(12-21)17(14-8-6-5-7-9-14)15(10-23)22(19)18(25)20-13(2)3/h5-9,13,15,17,23H,4,10-12H2,1-3H3,(H,20,25)/t15-,17-/m1/s1",
      "inchiKeyParent": "VTNWJIKWMRYGDU-NVXWUHKLSA-N",
      "smilesParent": "CCC(=O)N1CC2(C1)[C@@H]([C@@H](CO)N2C(=O)NC(C)C)c3ccccc3"
    },
    "unichem": {
      "chebi": "130653",
      "lincs": "LSM-42202",
      "pubchem": "60189746"
    },
    "pubchem": [
      {
        "cid": 60189746,
        "inchi": "InChI=1S/C19H27N3O3/c1-4-16(24)21-11-19(12-21)17(14-8-6-5-7-9-14)15(10-23)22(19)18(25)20-13(2)3/h5-9,13,15,17,23H,4,10-12H2,1-3H3,(H,20,25)/t15-,17-/m1/s1",
        "inchikey": "VTNWJIKWMRYGDU-NVXWUHKLSA-N",
        "iupac": {
          "systematic": "(2S,3R)-2-(hydroxymethyl)-3-phenyl-6-propanoyl-N-propan-2-yl-1,6-diazaspiro[3.3]heptane-1-carboxamide"
        },
        "smiles": {
          "canonical": "CCC(=O)N1CC2(C1)C(C(N2C(=O)NC(C)C)CO)C3=CC=CC=C3"
        },
        "molecularFormula": "C19H27N3O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:48:23Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c851a"
    },
    "name": "BRD-K13982317",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c851a.png",
    "lincs": {
      "id": "LSM-37983",
      "name": "BRD-K13982317",
      "pubchemCid": 60190153,
      "chebiId": 126418,
      "inchiParent": "InChI=1S/C24H33N3O4/c1-5-6-21(30)26-11-9-24(10-12-26)15-27(16(2)29)20(14-28)23-22(24)18-8-7-17(31-4)13-19(18)25(23)3/h7-8,13,20,28H,5-6,9-12,14-15H2,1-4H3/t20-/m0/s1",
      "inchiKeyParent": "LQHPTFMCEXWYJV-FQEVSTJZSA-N",
      "smilesParent": "CCCC(=O)N1CCC2(CC1)CN([C@@H](CO)c3c2c4ccc(OC)cc4n3C)C(=O)C"
    },
    "unichem": {
      "chebi": "126418",
      "lincs": "LSM-37983",
      "pubchem": "60190153"
    },
    "pubchem": [
      {
        "cid": 60190153,
        "inchi": "InChI=1S/C24H33N3O4/c1-5-6-21(30)26-11-9-24(10-12-26)15-27(16(2)29)20(14-28)23-22(24)18-8-7-17(31-4)13-19(18)25(23)3/h7-8,13,20,28H,5-6,9-12,14-15H2,1-4H3/t20-/m0/s1",
        "inchikey": "LQHPTFMCEXWYJV-FQEVSTJZSA-N",
        "iupac": {
          "systematic": "1-[(1R)-2-acetyl-1-(hydroxymethyl)-7-methoxy-9-methylspiro[1,3-dihydropyrido[3,4-b]indole-4,4'-piperidine]-1'-yl]butan-1-one"
        },
        "smiles": {
          "canonical": "CCCC(=O)N1CCC2(CC1)CN(C(C3=C2C4=C(N3C)C=C(C=C4)OC)CO)C(=O)C"
        },
        "molecularFormula": "C24H33N3O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:48:25Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8525"
    },
    "name": "BRD-K41871066",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8525.png",
    "lincs": {
      "id": "LSM-39582",
      "name": "BRD-K41871066",
      "pubchemCid": 54615025,
      "chebiId": 128026,
      "inchiParent": "InChI=1S/C34H46ClN5O8S/c1-21-18-40(22(2)20-41)33(42)29-17-27(36-34(43)37-32-24(4)38-48-25(32)5)12-15-30(29)47-23(3)9-7-8-16-46-31(21)19-39(6)49(44,45)28-13-10-26(35)11-14-28/h10-15,17,21-23,31,41H,7-9,16,18-20H2,1-6H3,(H2,36,37,43)/t21-,22+,23-,31+/m1/s1",
      "inchiKeyParent": "XQVZVPLVZQHPJK-KWBCDCJNSA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@@H](C)[C@H](CN(C)S(=O)(=O)c2ccc(Cl)cc2)OCCCC[C@@H](C)Oc3ccc(NC(=O)Nc4c(C)onc4C)cc3C1=O"
    },
    "unichem": {
      "chebi": "128026",
      "lincs": "LSM-39582",
      "pubchem": "54615025"
    },
    "pubchem": [
      {
        "cid": 54615025,
        "inchi": "InChI=1S/C34H46ClN5O8S/c1-21-18-40(22(2)20-41)33(42)29-17-27(36-34(43)37-32-24(4)38-48-25(32)5)12-15-30(29)47-23(3)9-7-8-16-46-31(21)19-39(6)49(44,45)28-13-10-26(35)11-14-28/h10-15,17,21-23,31,41H,7-9,16,18-20H2,1-6H3,(H2,36,37,43)/t21-,22+,23-,31+/m1/s1",
        "inchikey": "XQVZVPLVZQHPJK-KWBCDCJNSA-N",
        "iupac": {
          "systematic": "1-[(3R,9R,10R)-9-[[(4-chlorophenyl)sulfonyl-methylamino]methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-(3,5-dimethyl-1,2-oxazol-4-yl)urea"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NC(=O)NC3=C(ON=C3C)C)C(C)CO)C)CN(C)S(=O)(=O)C4=CC=C(C=C4)Cl"
        },
        "molecularFormula": "C34H46ClN5O8S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:48:27Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c854a"
    },
    "name": "CHEMBL2359567",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c854a.png",
    "lincs": {
      "id": "LSM-11855",
      "name": "CHEMBL2359567",
      "alternativeNames": [
        "BRD-K56712828"
      ],
      "pubchemCid": 54637807,
      "chebiId": 100481,
      "inchiParent": "InChI=1S/C31H35N3O6/c1-20-15-34(21(2)17-35)30(36)26-11-7-6-10-25(26)24-9-5-4-8-22(24)18-38-29(20)16-33(3)31(37)32-23-12-13-27-28(14-23)40-19-39-27/h4-14,20-21,29,35H,15-19H2,1-3H3,(H,32,37)/t20-,21+,29-/m1/s1",
      "inchiKeyParent": "APWUXYFXBMGRIO-HNMNOHOESA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@@H](C)[C@@H](CN(C)C(=O)Nc2ccc3OCOc3c2)OCc4ccccc4c5ccccc5C1=O"
    },
    "unichem": {
      "chebi": "100481",
      "chembl": "CHEMBL2359567",
      "lincs": "LSM-11855",
      "pubchem": "54637807"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL2359567",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 545.64,
        "hba": 6,
        "hbd": 2,
        "qedWeighted": 0.49
      }
    },
    "pubchem": [
      {
        "cid": 54637807,
        "inchi": "InChI=1S/C31H35N3O6/c1-20-15-34(21(2)17-35)30(36)26-11-7-6-10-25(26)24-9-5-4-8-22(24)18-38-29(20)16-33(3)31(37)32-23-12-13-27-28(14-23)40-19-39-27/h4-14,20-21,29,35H,15-19H2,1-3H3,(H,32,37)/t20-,21+,29-/m1/s1",
        "inchikey": "APWUXYFXBMGRIO-HNMNOHOESA-N",
        "iupac": {
          "systematic": "3-(1,3-benzodioxol-5-yl)-1-[[(10S,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methylurea"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=CC=CC=C2C3=CC=CC=C3COC1CN(C)C(=O)NC4=CC5=C(C=C4)OCO5)C(C)CO"
        },
        "molecularFormula": "C31H35N3O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:48:38Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8572"
    },
    "name": "BRD-K60151092",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8572.png",
    "lincs": {
      "id": "LSM-12067",
      "name": "BRD-K60151092",
      "pubchemCid": 54638360,
      "chebiId": 100693,
      "inchiParent": "InChI=1S/C21H30N4O4/c26-15-19-18(24-21(28)16-5-4-8-22-14-16)7-6-17(29-19)13-20(27)23-9-12-25-10-2-1-3-11-25/h4-8,14,17-19,26H,1-3,9-13,15H2,(H,23,27)(H,24,28)/t17-,18+,19+/m1/s1",
      "inchiKeyParent": "VGDFEWNPUKUXSQ-QYZOEREBSA-N",
      "smilesParent": "OC[C@@H]1O[C@@H](CC(=O)NCCN2CCCCC2)C=C[C@@H]1NC(=O)c3cccnc3"
    },
    "unichem": {
      "chebi": "100693",
      "lincs": "LSM-12067",
      "pubchem": "54638360"
    },
    "pubchem": [
      {
        "cid": 54638360,
        "inchi": "InChI=1S/C21H30N4O4/c26-15-19-18(24-21(28)16-5-4-8-22-14-16)7-6-17(29-19)13-20(27)23-9-12-25-10-2-1-3-11-25/h4-8,14,17-19,26H,1-3,9-13,15H2,(H,23,27)(H,24,28)/t17-,18+,19+/m1/s1",
        "inchikey": "VGDFEWNPUKUXSQ-QYZOEREBSA-N",
        "iupac": {
          "systematic": "N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(2-piperidin-1-ylethylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]pyridine-3-carboxamide"
        },
        "smiles": {
          "canonical": "C1CCN(CC1)CCNC(=O)CC2C=CC(C(O2)CO)NC(=O)C3=CN=CC=C3"
        },
        "molecularFormula": "C21H30N4O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:48:40Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85a4"
    },
    "name": "BRD-M95429326",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85a4.png",
    "lincs": {
      "id": "LSM-45088",
      "name": "BRD-M95429326",
      "pubchemCid": 54660736,
      "chebiId": 103325,
      "inchiParent": "InChI=1S/C24H26FN3O4/c1-4-5-14-8-11-18-21-20(24(32)26(2)3)17(13-29)19(12-27(18)22(14)30)28(21)23(31)15-6-9-16(25)10-7-15/h4-11,17,19-21,29H,12-13H2,1-3H3/t17-,19-,20+,21+/m1/s1",
      "inchiKeyParent": "QHTBDTJLVQLHTQ-PBASOCQRSA-N",
      "smilesParent": "CC=CC1=CC=C2[C@H]3[C@H]([C@H](CO)[C@@H](CN2C1=O)N3C(=O)c4ccc(F)cc4)C(=O)N(C)C"
    },
    "unichem": {
      "chebi": "103325",
      "lincs": "LSM-45088",
      "pubchem": "139032172"
    },
    "pubchem": [
      {
        "cid": 139032172,
        "inchi": "InChI=1S/C24H26FN3O4/c1-4-5-14-8-11-18-21-20(24(32)26(2)3)17(13-29)19(12-27(18)22(14)30)28(21)23(31)15-6-9-16(25)10-7-15/h4-11,17,19-21,29H,12-13H2,1-3H3/t17-,19-,20+,21+/m1/s1",
        "inchikey": "QHTBDTJLVQLHTQ-PBASOCQRSA-N",
        "iupac": {
          "systematic": "(1R,9S,10S,11S)-12-(4-fluorobenzoyl)-10-(hydroxymethyl)-N,N-dimethyl-6-oxo-5-prop-1-enyl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide"
        },
        "smiles": {
          "canonical": "CC=CC1=CC=C2C3C(C(C(N3C(=O)C4=CC=C(C=C4)F)CN2C1=O)CO)C(=O)N(C)C"
        },
        "molecularFormula": "C24H26FN3O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:48:43Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85e7"
    },
    "name": "BRD-K49076793",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85e7.png",
    "lincs": {
      "id": "LSM-11412",
      "name": "BRD-K49076793",
      "pubchemCid": 54646749,
      "chebiId": 100033,
      "inchiParent": "InChI=1S/C27H34N4O5/c32-17-24-26-22(14-20(35-24)15-25(33)29-9-12-31-10-2-1-3-11-31)21-13-19(6-7-23(21)36-26)30-27(34)18-5-4-8-28-16-18/h4-8,13,16,20,22,24,26,32H,1-3,9-12,14-15,17H2,(H,29,33)(H,30,34)/t20-,22+,24-,26-/m1/s1",
      "inchiKeyParent": "SWOCEPZEXMNKQZ-FWSIMYTDSA-N",
      "smilesParent": "OC[C@H]1O[C@@H](CC(=O)NCCN2CCCCC2)C[C@@H]3[C@H]1Oc4ccc(NC(=O)c5cccnc5)cc34"
    },
    "unichem": {
      "chebi": "100033",
      "lincs": "LSM-11412",
      "pubchem": "54646749"
    },
    "pubchem": [
      {
        "cid": 54646749,
        "inchi": "InChI=1S/C27H34N4O5/c32-17-24-26-22(14-20(35-24)15-25(33)29-9-12-31-10-2-1-3-11-31)21-13-19(6-7-23(21)36-26)30-27(34)18-5-4-8-28-16-18/h4-8,13,16,20,22,24,26,32H,1-3,9-12,14-15,17H2,(H,29,33)(H,30,34)/t20-,22+,24-,26-/m1/s1",
        "inchikey": "SWOCEPZEXMNKQZ-FWSIMYTDSA-N",
        "iupac": {
          "systematic": "N-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(2-piperidin-1-ylethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]pyridine-3-carboxamide"
        },
        "smiles": {
          "canonical": "C1CCN(CC1)CCNC(=O)CC2CC3C(C(O2)CO)OC4=C3C=C(C=C4)NC(=O)C5=CN=CC=C5"
        },
        "molecularFormula": "C27H34N4O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:48:45Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85f7"
    },
    "name": "BRD-K91423746",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85f7.png",
    "lincs": {
      "id": "LSM-14046",
      "name": "BRD-K91423746",
      "pubchemCid": 54646499,
      "chebiId": 102699,
      "inchiParent": "InChI=1S/C24H35N3O5/c1-27(2)13-23(30)26-16-8-9-20-18(10-16)19-11-17(31-21(14-28)24(19)32-20)12-22(29)25-15-6-4-3-5-7-15/h8-10,15,17,19,21,24,28H,3-7,11-14H2,1-2H3,(H,25,29)(H,26,30)/t17-,19-,21+,24+/m1/s1",
      "inchiKeyParent": "KRQAAGOFZVBHDO-GOSIJUEPSA-N",
      "smilesParent": "CN(C)CC(=O)Nc1ccc2O[C@@H]3[C@H](CO)O[C@@H](CC(=O)NC4CCCCC4)C[C@@H]3c2c1"
    },
    "unichem": {
      "chebi": "102699",
      "lincs": "LSM-14046",
      "pubchem": "54646499"
    },
    "pubchem": [
      {
        "cid": 54646499,
        "inchi": "InChI=1S/C24H35N3O5/c1-27(2)13-23(30)26-16-8-9-20-18(10-16)19-11-17(31-21(14-28)24(19)32-20)12-22(29)25-15-6-4-3-5-7-15/h8-10,15,17,19,21,24,28H,3-7,11-14H2,1-2H3,(H,25,29)(H,26,30)/t17-,19-,21+,24+/m1/s1",
        "inchikey": "KRQAAGOFZVBHDO-GOSIJUEPSA-N",
        "iupac": {
          "systematic": "2-[(1S,3R,4aR,9aS)-6-[[2-(dimethylamino)acetyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-cyclohexylacetamide"
        },
        "smiles": {
          "canonical": "CN(C)CC(=O)NC1=CC2=C(C=C1)OC3C2CC(OC3CO)CC(=O)NC4CCCCC4"
        },
        "molecularFormula": "C24H35N3O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:48:47Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c851f"
    },
    "name": "BRD-K97860318",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c851f.png",
    "lincs": {
      "id": "LSM-15006",
      "name": "BRD-K97860318",
      "pubchemCid": 44485828,
      "chebiId": 103662,
      "inchiParent": "InChI=1S/C32H55N5O6/c1-22(2)33-32(41)36(8)20-29-23(3)19-37(24(4)21-38)31(40)27-18-26(34-30(39)13-11-16-35(6)7)14-15-28(27)43-25(5)12-9-10-17-42-29/h14-15,18,22-25,29,38H,9-13,16-17,19-21H2,1-8H3,(H,33,41)(H,34,39)/t23-,24+,25-,29+/m0/s1",
      "inchiKeyParent": "SUHZFPHQAJGSMY-APSVEGKFSA-N",
      "smilesParent": "CC(C)NC(=O)N(C)C[C@H]1OCCCC[C@H](C)Oc2ccc(NC(=O)CCCN(C)C)cc2C(=O)N(C[C@@H]1C)[C@H](C)CO"
    },
    "unichem": {
      "chebi": "103662",
      "lincs": "LSM-15006",
      "pubchem": "44485828"
    },
    "pubchem": [
      {
        "cid": 44485828,
        "inchi": "InChI=1S/C32H55N5O6/c1-22(2)33-32(41)36(8)20-29-23(3)19-37(24(4)21-38)31(40)27-18-26(34-30(39)13-11-16-35(6)7)14-15-28(27)43-25(5)12-9-10-17-42-29/h14-15,18,22-25,29,38H,9-13,16-17,19-21H2,1-8H3,(H,33,41)(H,34,39)/t23-,24+,25-,29+/m0/s1",
        "inchikey": "SUHZFPHQAJGSMY-APSVEGKFSA-N",
        "iupac": {
          "systematic": "4-(dimethylamino)-N-[(3S,9S,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(propan-2-ylcarbamoyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]butanamide"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NC(=O)CCCN(C)C)C(C)CO)C)CN(C)C(=O)NC(C)C"
        },
        "molecularFormula": "C32H55N5O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:48:50Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8570"
    },
    "name": "BRD-K36109933",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8570.png",
    "lincs": {
      "id": "LSM-10605",
      "name": "BRD-K36109933",
      "pubchemCid": 56835475,
      "chebiId": 99226,
      "inchiParent": "InChI=1S/C31H36N2O6/c1-21-17-33(22(2)19-34)30(35)28-12-8-7-11-27(28)26-10-6-5-9-23(26)20-38-29(21)18-32(3)31(36)39-25-15-13-24(37-4)14-16-25/h5-16,21-22,29,34H,17-20H2,1-4H3/t21-,22+,29+/m1/s1",
      "inchiKeyParent": "FTPUTVYFFNSJIR-BXOOBUKZSA-N",
      "smilesParent": "COc1ccc(OC(=O)N(C)C[C@@H]2OCc3ccccc3c4ccccc4C(=O)N(C[C@H]2C)[C@@H](C)CO)cc1"
    },
    "unichem": {
      "chebi": "99226",
      "lincs": "LSM-10605",
      "pubchem": "56835475"
    },
    "pubchem": [
      {
        "cid": 56835475,
        "inchi": "InChI=1S/C31H36N2O6/c1-21-17-33(22(2)19-34)30(35)28-12-8-7-11-27(28)26-10-6-5-9-23(26)20-38-29(21)18-32(3)31(36)39-25-15-13-24(37-4)14-16-25/h5-16,21-22,29,34H,17-20H2,1-4H3/t21-,22+,29+/m1/s1",
        "inchikey": "FTPUTVYFFNSJIR-BXOOBUKZSA-N",
        "iupac": {
          "systematic": "(4-methoxyphenyl) N-[[(10R,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=CC=CC=C2C3=CC=CC=C3COC1CN(C)C(=O)OC4=CC=C(C=C4)OC)C(C)CO"
        },
        "molecularFormula": "C31H36N2O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:48:52Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c857f"
    },
    "name": "BRD-K82927587",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c857f.png",
    "lincs": {
      "id": "LSM-41804",
      "name": "BRD-K82927587",
      "pubchemCid": 54652720,
      "chebiId": 130255,
      "inchiParent": "InChI=1S/C15H21N3O2/c1-9(2)17-15(20)18-12-7-16-11-6-4-3-5-10(11)14(12)13(18)8-19/h3-6,9,12-14,16,19H,7-8H2,1-2H3,(H,17,20)/t12-,13+,14+/m0/s1",
      "inchiKeyParent": "MTJHDTCXBQPDGK-BFHYXJOUSA-N",
      "smilesParent": "CC(C)NC(=O)N1[C@H](CO)[C@H]2[C@@H]1CNc3ccccc23"
    },
    "unichem": {
      "chebi": "130255",
      "lincs": "LSM-41804",
      "pubchem": "54652720"
    },
    "pubchem": [
      {
        "cid": 54652720,
        "inchi": "InChI=1S/C15H21N3O2/c1-9(2)17-15(20)18-12-7-16-11-6-4-3-5-10(11)14(12)13(18)8-19/h3-6,9,12-14,16,19H,7-8H2,1-2H3,(H,17,20)/t12-,13+,14+/m0/s1",
        "inchikey": "MTJHDTCXBQPDGK-BFHYXJOUSA-N",
        "iupac": {
          "systematic": "(1S,2aR,8bR)-1-(hydroxymethyl)-N-propan-2-yl-2a,3,4,8b-tetrahydro-1H-azeto[2,3-c]quinoline-2-carboxamide"
        },
        "smiles": {
          "canonical": "CC(C)NC(=O)N1C2CNC3=CC=CC=C3C2C1CO"
        },
        "molecularFormula": "C15H21N3O2"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:48:54Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85a9"
    },
    "name": "BRD-K62689646",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85a9.png",
    "lincs": {
      "id": "LSM-12234",
      "name": "BRD-K62689646",
      "pubchemCid": 54654158,
      "chebiId": 100860,
      "inchiParent": "InChI=1S/C25H31N5O5S/c1-28-7-9-30(10-8-28)23(31)12-17-4-5-20-22(35-17)13-34-21-6-3-16(11-18(21)25(33)29(20)2)27-24(32)19-14-36-15-26-19/h3,6,11,14-15,17,20,22H,4-5,7-10,12-13H2,1-2H3,(H,27,32)/t17-,20+,22+/m1/s1",
      "inchiKeyParent": "MBWHXZFHLNKYMT-AGHHOFFYSA-N",
      "smilesParent": "CN1CCN(CC1)C(=O)C[C@H]2CC[C@H]3[C@H](COc4ccc(NC(=O)c5cscn5)cc4C(=O)N3C)O2"
    },
    "unichem": {
      "chebi": "100860",
      "lincs": "LSM-12234",
      "pubchem": "54654158"
    },
    "pubchem": [
      {
        "cid": 54654158,
        "inchi": "InChI=1S/C25H31N5O5S/c1-28-7-9-30(10-8-28)23(31)12-17-4-5-20-22(35-17)13-34-21-6-3-16(11-18(21)25(33)29(20)2)27-24(32)19-14-36-15-26-19/h3,6,11,14-15,17,20,22H,4-5,7-10,12-13H2,1-2H3,(H,27,32)/t17-,20+,22+/m1/s1",
        "inchikey": "MBWHXZFHLNKYMT-AGHHOFFYSA-N",
        "iupac": {
          "systematic": "N-[(2R,4aS,12aR)-5-methyl-2-[2-(4-methylpiperazin-1-yl)-2-oxoethyl]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-1,3-thiazole-4-carboxamide"
        },
        "smiles": {
          "canonical": "CN1CCN(CC1)C(=O)CC2CCC3C(O2)COC4=C(C=C(C=C4)NC(=O)C5=CSC=N5)C(=O)N3C"
        },
        "molecularFormula": "C25H31N5O5S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:48:57Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85c7"
    },
    "name": "BRD-K14533651",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85c7.png",
    "lincs": {
      "id": "LSM-38025",
      "name": "BRD-K14533651",
      "pubchemCid": 44486156,
      "chebiId": 126461,
      "inchiParent": "InChI=1S/C23H31N3O5S/c1-16-13-26(17(2)15-27)23(28)20-12-18(10-11-21(20)31-22(16)14-25(3)4)24-32(29,30)19-8-6-5-7-9-19/h5-12,16-17,22,24,27H,13-15H2,1-4H3/t16-,17+,22-/m0/s1",
      "inchiKeyParent": "WIJHLCNCWFONNF-JKSBSHDWSA-N",
      "smilesParent": "C[C@H](CO)N1C[C@H](C)[C@H](CN(C)C)Oc2ccc(NS(=O)(=O)c3ccccc3)cc2C1=O"
    },
    "unichem": {
      "chebi": "126461",
      "lincs": "LSM-38025",
      "pubchem": "44486156"
    },
    "pubchem": [
      {
        "cid": 44486156,
        "inchi": "InChI=1S/C23H31N3O5S/c1-16-13-26(17(2)15-27)23(28)20-12-18(10-11-21(20)31-22(16)14-25(3)4)24-32(29,30)19-8-6-5-7-9-19/h5-12,16-17,22,24,27H,13-15H2,1-4H3/t16-,17+,22-/m0/s1",
        "inchikey": "WIJHLCNCWFONNF-JKSBSHDWSA-N",
        "iupac": {
          "systematic": "N-[(2R,3S)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]benzenesulfonamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(C=CC(=C2)NS(=O)(=O)C3=CC=CC=C3)OC1CN(C)C)C(C)CO"
        },
        "molecularFormula": "C23H31N3O5S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:48:59Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85db"
    },
    "name": "BRD-K93339435",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85db.png",
    "lincs": {
      "id": "LSM-14153",
      "name": "BRD-K93339435",
      "pubchemCid": 54654274,
      "chebiId": 102807,
      "inchiParent": "InChI=1S/C30H32ClN3O6S/c1-19(20-6-4-3-5-7-20)32-29(35)17-23-11-14-26-28(40-23)18-39-27-15-10-22(16-25(27)30(36)34(26)2)33-41(37,38)24-12-8-21(31)9-13-24/h3-10,12-13,15-16,19,23,26,28,33H,11,14,17-18H2,1-2H3,(H,32,35)/t19-,23+,26-,28+/m0/s1",
      "inchiKeyParent": "UIBIEJVTTJAUBZ-RGBPKTGBSA-N",
      "smilesParent": "C[C@H](NC(=O)C[C@H]1CC[C@H]2[C@@H](COc3ccc(NS(=O)(=O)c4ccc(Cl)cc4)cc3C(=O)N2C)O1)c5ccccc5"
    },
    "unichem": {
      "chebi": "102807",
      "lincs": "LSM-14153",
      "pubchem": "54654274"
    },
    "pubchem": [
      {
        "cid": 54654274,
        "inchi": "InChI=1S/C30H32ClN3O6S/c1-19(20-6-4-3-5-7-20)32-29(35)17-23-11-14-26-28(40-23)18-39-27-15-10-22(16-25(27)30(36)34(26)2)33-41(37,38)24-12-8-21(31)9-13-24/h3-10,12-13,15-16,19,23,26,28,33H,11,14,17-18H2,1-2H3,(H,32,35)/t19-,23+,26-,28+/m0/s1",
        "inchikey": "UIBIEJVTTJAUBZ-RGBPKTGBSA-N",
        "iupac": {
          "systematic": "2-[(2R,4aS,12aS)-8-[(4-chlorophenyl)sulfonylamino]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-[(1S)-1-phenylethyl]acetamide"
        },
        "smiles": {
          "canonical": "CC(C1=CC=CC=C1)NC(=O)CC2CCC3C(O2)COC4=C(C=C(C=C4)NS(=O)(=O)C5=CC=C(C=C5)Cl)C(=O)N3C"
        },
        "molecularFormula": "C30H32ClN3O6S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:49:01Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8517"
    },
    "name": "BRD-K22608272",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8517.png",
    "lincs": {
      "id": "LSM-9799",
      "name": "BRD-K22608272",
      "pubchemCid": 54654076,
      "chebiId": 98420,
      "inchiParent": "InChI=1S/C26H28F3N3O6/c1-32-20-8-7-18(12-23(33)30-14-26(27,28)29)38-22(20)13-37-21-9-6-16(11-19(21)25(32)35)31-24(34)15-4-3-5-17(10-15)36-2/h3-6,9-11,18,20,22H,7-8,12-14H2,1-2H3,(H,30,33)(H,31,34)/t18-,20+,22-/m0/s1",
      "inchiKeyParent": "RKECGHSSKXUWCJ-DWLFOUALSA-N",
      "smilesParent": "COc1cccc(c1)C(=O)Nc2ccc3OC[C@@H]4O[C@H](CC(=O)NCC(F)(F)F)CC[C@H]4N(C)C(=O)c3c2"
    },
    "unichem": {
      "chebi": "98420",
      "lincs": "LSM-9799",
      "pubchem": "54654076"
    },
    "pubchem": [
      {
        "cid": 54654076,
        "inchi": "InChI=1S/C26H28F3N3O6/c1-32-20-8-7-18(12-23(33)30-14-26(27,28)29)38-22(20)13-37-21-9-6-16(11-19(21)25(32)35)31-24(34)15-4-3-5-17(10-15)36-2/h3-6,9-11,18,20,22H,7-8,12-14H2,1-2H3,(H,30,33)(H,31,34)/t18-,20+,22-/m0/s1",
        "inchikey": "RKECGHSSKXUWCJ-DWLFOUALSA-N",
        "iupac": {
          "systematic": "N-[(2S,4aR,12aR)-5-methyl-6-oxo-2-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-3-methoxybenzamide"
        },
        "smiles": {
          "canonical": "CN1C2CCC(OC2COC3=C(C1=O)C=C(C=C3)NC(=O)C4=CC(=CC=C4)OC)CC(=O)NCC(F)(F)F"
        },
        "molecularFormula": "C26H28F3N3O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:49:03Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c853d"
    },
    "name": "BRD-K80777319",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c853d.png",
    "lincs": {
      "id": "LSM-13368",
      "name": "BRD-K80777319",
      "pubchemCid": 54645847,
      "chebiId": 102007,
      "inchiParent": "InChI=1S/C26H26FN3O6S/c27-17-3-6-20(7-4-17)37(33,34)30-18-5-8-23-21(10-18)22-11-19(35-24(15-31)26(22)36-23)12-25(32)29-14-16-2-1-9-28-13-16/h1-10,13,19,22,24,26,30-31H,11-12,14-15H2,(H,29,32)/t19-,22-,24-,26+/m0/s1",
      "inchiKeyParent": "MZNDQAVBBCTOIA-CLKGCZJISA-N",
      "smilesParent": "OC[C@@H]1O[C@H](CC(=O)NCc2cccnc2)C[C@@H]3[C@H]1Oc4ccc(NS(=O)(=O)c5ccc(F)cc5)cc34"
    },
    "unichem": {
      "chebi": "102007",
      "lincs": "LSM-13368",
      "pubchem": "54645847"
    },
    "pubchem": [
      {
        "cid": 54645847,
        "inchi": "InChI=1S/C26H26FN3O6S/c27-17-3-6-20(7-4-17)37(33,34)30-18-5-8-23-21(10-18)22-11-19(35-24(15-31)26(22)36-23)12-25(32)29-14-16-2-1-9-28-13-16/h1-10,13,19,22,24,26,30-31H,11-12,14-15H2,(H,29,32)/t19-,22-,24-,26+/m0/s1",
        "inchikey": "MZNDQAVBBCTOIA-CLKGCZJISA-N",
        "iupac": {
          "systematic": "2-[(1S,3S,4aS,9aR)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-(pyridin-3-ylmethyl)acetamide"
        },
        "smiles": {
          "canonical": "C1C(OC(C2C1C3=C(O2)C=CC(=C3)NS(=O)(=O)C4=CC=C(C=C4)F)CO)CC(=O)NCC5=CN=CC=C5"
        },
        "molecularFormula": "C26H26FN3O6S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:49:06Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c854d"
    },
    "name": "BRD-K50058777",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c854d.png",
    "lincs": {
      "id": "LSM-40046",
      "name": "BRD-K50058777",
      "pubchemCid": 54615037,
      "chebiId": 128492,
      "inchiParent": "InChI=1S/C34H43N5O6/c1-23-20-39(24(2)22-40)34(43)29-19-28(37-32(41)26-10-14-35-15-11-26)8-9-30(29)45-25(3)7-5-6-18-44-31(23)21-38(4)33(42)27-12-16-36-17-13-27/h8-17,19,23-25,31,40H,5-7,18,20-22H2,1-4H3,(H,37,41)/t23-,24+,25-,31+/m0/s1",
      "inchiKeyParent": "INBITKGVNBCCNN-TXHDDHBJSA-N",
      "smilesParent": "C[C@H](CO)N1C[C@H](C)[C@@H](CN(C)C(=O)c2ccncc2)OCCCC[C@H](C)Oc3ccc(NC(=O)c4ccncc4)cc3C1=O"
    },
    "unichem": {
      "chebi": "128492",
      "lincs": "LSM-40046",
      "pubchem": "54615037"
    },
    "pubchem": [
      {
        "cid": 54615037,
        "inchi": "InChI=1S/C34H43N5O6/c1-23-20-39(24(2)22-40)34(43)29-19-28(37-32(41)26-10-14-35-15-11-26)8-9-30(29)45-25(3)7-5-6-18-44-31(23)21-38(4)33(42)27-12-16-36-17-13-27/h8-17,19,23-25,31,40H,5-7,18,20-22H2,1-4H3,(H,37,41)/t23-,24+,25-,31+/m0/s1",
        "inchikey": "INBITKGVNBCCNN-TXHDDHBJSA-N",
        "iupac": {
          "systematic": "N-[(3S,9S,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(pyridine-4-carbonyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]pyridine-4-carboxamide"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NC(=O)C3=CC=NC=C3)C(C)CO)C)CN(C)C(=O)C4=CC=NC=C4"
        },
        "molecularFormula": "C34H43N5O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:49:08Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8595"
    },
    "name": "BRD-K45907733",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8595.png",
    "lincs": {
      "id": "LSM-39814",
      "name": "BRD-K45907733",
      "pubchemCid": 60191231,
      "chebiId": 128259,
      "inchiParent": "InChI=1S/C13H15BrN2O2/c14-9-3-1-8(2-4-9)13-10-5-15-6-12(18)16(10)11(13)7-17/h1-4,10-11,13,15,17H,5-7H2/t10-,11+,13-/m0/s1",
      "inchiKeyParent": "CPZPDKPINUWRBY-LOWVWBTDSA-N",
      "smilesParent": "OC[C@@H]1[C@H]([C@@H]2CNCC(=O)N12)c3ccc(Br)cc3"
    },
    "unichem": {
      "chebi": "128259",
      "lincs": "LSM-39814",
      "pubchem": "60191231"
    },
    "pubchem": [
      {
        "cid": 60191231,
        "inchi": "InChI=1S/C13H15BrN2O2/c14-9-3-1-8(2-4-9)13-10-5-15-6-12(18)16(10)11(13)7-17/h1-4,10-11,13,15,17H,5-7H2/t10-,11+,13-/m0/s1",
        "inchikey": "CPZPDKPINUWRBY-LOWVWBTDSA-N",
        "iupac": {
          "systematic": "(6R,7S,8S)-7-(4-bromophenyl)-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one"
        },
        "smiles": {
          "canonical": "C1C2C(C(N2C(=O)CN1)CO)C3=CC=C(C=C3)Br"
        },
        "molecularFormula": "C13H15BrN2O2"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:49:10Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8624"
    },
    "name": "BRD-K96552587",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8624.png",
    "lincs": {
      "id": "LSM-42512",
      "name": "BRD-K96552587",
      "pubchemCid": 60191355,
      "chebiId": 130964,
      "inchiParent": "InChI=1S/C20H19N3O2/c21-9-13-1-3-14(4-2-13)15-5-7-16(8-6-15)20-17-10-22-11-19(25)23(17)18(20)12-24/h1-8,17-18,20,22,24H,10-12H2/t17-,18-,20+/m0/s1",
      "inchiKeyParent": "OUKAGPBTRJAGIF-CMKODMSKSA-N",
      "smilesParent": "OC[C@H]1[C@@H]([C@@H]2CNCC(=O)N12)c3ccc(cc3)c4ccc(cc4)C#N"
    },
    "unichem": {
      "chebi": "130964",
      "lincs": "LSM-42512",
      "pubchem": "60191355"
    },
    "pubchem": [
      {
        "cid": 60191355,
        "inchi": "InChI=1S/C20H19N3O2/c21-9-13-1-3-14(4-2-13)15-5-7-16(8-6-15)20-17-10-22-11-19(25)23(17)18(20)12-24/h1-8,17-18,20,22,24H,10-12H2/t17-,18-,20+/m0/s1",
        "inchikey": "OUKAGPBTRJAGIF-CMKODMSKSA-N",
        "iupac": {
          "systematic": "4-[4-[(6R,7R,8R)-8-(hydroxymethyl)-2-oxo-1,4-diazabicyclo[4.2.0]octan-7-yl]phenyl]benzonitrile"
        },
        "smiles": {
          "canonical": "C1C2C(C(N2C(=O)CN1)CO)C3=CC=C(C=C3)C4=CC=C(C=C4)C#N"
        },
        "molecularFormula": "C20H19N3O2"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:49:12Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8559"
    },
    "name": "BRD-K05032830",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8559.png",
    "lincs": {
      "id": "LSM-8733",
      "name": "BRD-K05032830",
      "pubchemCid": 54637955,
      "chebiId": 97354,
      "inchiParent": "InChI=1S/C32H38N4O5/c1-19-15-36(20(2)17-37)32(39)30-29(25-13-9-10-14-26(25)35(30)6)24-12-8-7-11-23(24)18-40-27(19)16-34(5)31(38)28-21(3)33-41-22(28)4/h7-14,19-20,27,37H,15-18H2,1-6H3/t19-,20+,27-/m0/s1",
      "inchiKeyParent": "LBGXIXNVJUEMSO-VKIDHGPPSA-N",
      "smilesParent": "C[C@H](CO)N1C[C@H](C)[C@H](CN(C)C(=O)c2c(C)onc2C)OCc3ccccc3c4c(C1=O)n(C)c5ccccc45"
    },
    "unichem": {
      "chebi": "97354",
      "lincs": "LSM-8733",
      "pubchem": "54637955"
    },
    "pubchem": [
      {
        "cid": 54637955,
        "inchi": "InChI=1S/C32H38N4O5/c1-19-15-36(20(2)17-37)32(39)30-29(25-13-9-10-14-26(25)35(30)6)24-12-8-7-11-23(24)18-40-27(19)16-34(5)31(38)28-21(3)33-41-22(28)4/h7-14,19-20,27,37H,15-18H2,1-6H3/t19-,20+,27-/m0/s1",
        "inchikey": "LBGXIXNVJUEMSO-VKIDHGPPSA-N",
        "iupac": {
          "systematic": "N-[[(10R,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N,3,5-trimethyl-1,2-oxazole-4-carboxamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(C3=CC=CC=C3COC1CN(C)C(=O)C4=C(ON=C4C)C)C5=CC=CC=C5N2C)C(C)CO"
        },
        "molecularFormula": "C32H38N4O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:49:15Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c847e"
    },
    "name": "BRD-K58421169",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c847e.png",
    "lincs": {
      "id": "LSM-40465",
      "name": "BRD-K58421169",
      "pubchemCid": 44485423,
      "chebiId": 128913,
      "inchiParent": "InChI=1S/C33H39N5O4/c1-22-17-38(23(2)21-39)33(41)28-16-26(35-32(40)15-25-19-37(4)29-8-6-5-7-27(25)29)9-10-30(28)42-31(22)20-36(3)18-24-11-13-34-14-12-24/h5-14,16,19,22-23,31,39H,15,17-18,20-21H2,1-4H3,(H,35,40)/t22-,23+,31-/m1/s1",
      "inchiKeyParent": "NHCHRXXZNQAEEO-IKBQMQIHSA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@@H](C)[C@@H](CN(C)Cc2ccncc2)Oc3ccc(NC(=O)Cc4cn(C)c5ccccc45)cc3C1=O"
    },
    "unichem": {
      "chebi": "128913",
      "lincs": "LSM-40465",
      "pubchem": "44485423"
    },
    "pubchem": [
      {
        "cid": 44485423,
        "inchi": "InChI=1S/C33H39N5O4/c1-22-17-38(23(2)21-39)33(41)28-16-26(35-32(40)15-25-19-37(4)29-8-6-5-7-27(25)29)9-10-30(28)42-31(22)20-36(3)18-24-11-13-34-14-12-24/h5-14,16,19,22-23,31,39H,15,17-18,20-21H2,1-4H3,(H,35,40)/t22-,23+,31-/m1/s1",
        "inchikey": "NHCHRXXZNQAEEO-IKBQMQIHSA-N",
        "iupac": {
          "systematic": "N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-2-(1-methylindol-3-yl)acetamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(C=CC(=C2)NC(=O)CC3=CN(C4=CC=CC=C43)C)OC1CN(C)CC5=CC=NC=C5)C(C)CO"
        },
        "molecularFormula": "C33H39N5O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:49:17Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c849f"
    },
    "name": "BRD-K76522065",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c849f.png",
    "lincs": {
      "id": "LSM-23492",
      "name": "BRD-K76522065",
      "pubchemCid": 54632415,
      "chebiId": 112079,
      "inchiParent": "InChI=1S/C26H35N3O4/c1-18-15-28(3)19(2)17-33-23-14-21(27-25(30)13-20-9-7-6-8-10-20)11-12-22(23)26(31)29(4)16-24(18)32-5/h6-12,14,18-19,24H,13,15-17H2,1-5H3,(H,27,30)/t18-,19+,24-/m0/s1",
      "inchiKeyParent": "GLJKQBVQGMWNRJ-GLDPYIMESA-N",
      "smilesParent": "CO[C@H]1CN(C)C(=O)c2ccc(NC(=O)Cc3ccccc3)cc2OC[C@@H](C)N(C)C[C@@H]1C"
    },
    "unichem": {
      "chebi": "112079",
      "lincs": "LSM-23492",
      "pubchem": "54632415"
    },
    "pubchem": [
      {
        "cid": 54632415,
        "inchi": "InChI=1S/C26H35N3O4/c1-18-15-28(3)19(2)17-33-23-14-21(27-25(30)13-20-9-7-6-8-10-20)11-12-22(23)26(31)29(4)16-24(18)32-5/h6-12,14,18-19,24H,13,15-17H2,1-5H3,(H,27,30)/t18-,19+,24-/m0/s1",
        "inchikey": "GLJKQBVQGMWNRJ-GLDPYIMESA-N",
        "iupac": {
          "systematic": "N-[(4R,7S,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-15-yl]-2-phenylacetamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(COC2=C(C=CC(=C2)NC(=O)CC3=CC=CC=C3)C(=O)N(CC1OC)C)C)C"
        },
        "molecularFormula": "C26H35N3O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:49:19Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84ba"
    },
    "name": "BRD-K04922291",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84ba.png",
    "lincs": {
      "id": "LSM-8729",
      "name": "BRD-K04922291",
      "pubchemCid": 54649206,
      "chebiId": 97350,
      "inchiParent": "InChI=1S/C23H32Cl2N2O4S/c1-17(13-27(18(2)16-28)14-19-7-5-6-8-22(19)25)23(31-4)15-26(3)32(29,30)21-11-9-20(24)10-12-21/h5-12,17-18,23,28H,13-16H2,1-4H3/t17-,18-,23+/m0/s1",
      "inchiKeyParent": "JYNGQINEBKOLSY-IUKKYPGJSA-N",
      "smilesParent": "CO[C@H](CN(C)S(=O)(=O)c1ccc(Cl)cc1)[C@@H](C)CN(Cc2ccccc2Cl)[C@@H](C)CO"
    },
    "unichem": {
      "chebi": "97350",
      "lincs": "LSM-8729",
      "pubchem": "54649206"
    },
    "pubchem": [
      {
        "cid": 54649206,
        "inchi": "InChI=1S/C23H32Cl2N2O4S/c1-17(13-27(18(2)16-28)14-19-7-5-6-8-22(19)25)23(31-4)15-26(3)32(29,30)21-11-9-20(24)10-12-21/h5-12,17-18,23,28H,13-16H2,1-4H3/t17-,18-,23+/m0/s1",
        "inchikey": "JYNGQINEBKOLSY-IUKKYPGJSA-N",
        "iupac": {
          "systematic": "4-chloro-N-[(2S,3S)-4-[(2-chlorophenyl)methyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methylbenzenesulfonamide"
        },
        "smiles": {
          "canonical": "CC(CN(CC1=CC=CC=C1Cl)C(C)CO)C(CN(C)S(=O)(=O)C2=CC=C(C=C2)Cl)OC"
        },
        "molecularFormula": "C23H32Cl2N2O4S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:49:21Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84c5"
    },
    "name": "BRD-K77741497",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84c5.png",
    "lincs": {
      "id": "LSM-41509",
      "name": "BRD-K77741497",
      "pubchemCid": 54615101,
      "chebiId": 129958,
      "inchiParent": "InChI=1S/C35H44N4O6/c1-24-21-39(25(2)23-40)35(43)30-20-29(37-33(41)27-11-6-5-7-12-27)13-14-31(30)45-26(3)10-8-9-19-44-32(24)22-38(4)34(42)28-15-17-36-18-16-28/h5-7,11-18,20,24-26,32,40H,8-10,19,21-23H2,1-4H3,(H,37,41)/t24-,25-,26+,32-/m1/s1",
      "inchiKeyParent": "LFSFSXVVLAKPPY-UOJGMACNSA-N",
      "smilesParent": "C[C@H](CO)N1C[C@@H](C)[C@@H](CN(C)C(=O)c2ccncc2)OCCCC[C@H](C)Oc3ccc(NC(=O)c4ccccc4)cc3C1=O"
    },
    "unichem": {
      "chebi": "129958",
      "lincs": "LSM-41509",
      "pubchem": "54615101"
    },
    "pubchem": [
      {
        "cid": 54615101,
        "inchi": "InChI=1S/C35H44N4O6/c1-24-21-39(25(2)23-40)35(43)30-20-29(37-33(41)27-11-6-5-7-12-27)13-14-31(30)45-26(3)10-8-9-19-44-32(24)22-38(4)34(42)28-15-17-36-18-16-28/h5-7,11-18,20,24-26,32,40H,8-10,19,21-23H2,1-4H3,(H,37,41)/t24-,25-,26+,32-/m1/s1",
        "inchikey": "LFSFSXVVLAKPPY-UOJGMACNSA-N",
        "iupac": {
          "systematic": "N-[[(3S,9S,10R)-16-benzamido-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methylpyridine-4-carboxamide"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NC(=O)C3=CC=CC=C3)C(C)CO)C)CN(C)C(=O)C4=CC=NC=C4"
        },
        "molecularFormula": "C35H44N4O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:49:24Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84cc"
    },
    "name": "BRD-K77709215",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84cc.png",
    "lincs": {
      "id": "LSM-13178",
      "name": "BRD-K77709215",
      "pubchemCid": 54639023,
      "chebiId": 101816,
      "inchiParent": "InChI=1S/C21H29N3O6/c1-23-6-8-24(9-7-23)20(26)11-15-3-4-16(19(12-25)30-15)22-21(27)14-2-5-17-18(10-14)29-13-28-17/h2,5,10,15-16,19,25H,3-4,6-9,11-13H2,1H3,(H,22,27)/t15-,16-,19+/m1/s1",
      "inchiKeyParent": "OCHDOPTVTSINTO-MDZRGWNJSA-N",
      "smilesParent": "CN1CCN(CC1)C(=O)C[C@H]2CC[C@@H](NC(=O)c3ccc4OCOc4c3)[C@H](CO)O2"
    },
    "unichem": {
      "chebi": "101816",
      "lincs": "LSM-13178",
      "pubchem": "54639023"
    },
    "pubchem": [
      {
        "cid": 54639023,
        "inchi": "InChI=1S/C21H29N3O6/c1-23-6-8-24(9-7-23)20(26)11-15-3-4-16(19(12-25)30-15)22-21(27)14-2-5-17-18(10-14)29-13-28-17/h2,5,10,15-16,19,25H,3-4,6-9,11-13H2,1H3,(H,22,27)/t15-,16-,19+/m1/s1",
        "inchikey": "OCHDOPTVTSINTO-MDZRGWNJSA-N",
        "iupac": {
          "systematic": "N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-(4-methylpiperazin-1-yl)-2-oxoethyl]oxan-3-yl]-1,3-benzodioxole-5-carboxamide"
        },
        "smiles": {
          "canonical": "CN1CCN(CC1)C(=O)CC2CCC(C(O2)CO)NC(=O)C3=CC4=C(C=C3)OCO4"
        },
        "molecularFormula": "C21H29N3O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:49:26Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84d2"
    },
    "name": "BRD-K98303739",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84d2.png",
    "lincs": {
      "id": "LSM-14468",
      "name": "BRD-K98303739",
      "pubchemCid": 54649234,
      "chebiId": 103123,
      "inchiParent": "InChI=1S/C25H34N2O5/c1-18(13-27(19(2)16-28)25(29)21-8-6-5-7-9-21)24(30-4)15-26(3)14-20-10-11-22-23(12-20)32-17-31-22/h5-12,18-19,24,28H,13-17H2,1-4H3/t18-,19+,24+/m1/s1",
      "inchiKeyParent": "RDQYWFNTQPCNSM-IMWIBFENSA-N",
      "smilesParent": "CO[C@@H](CN(C)Cc1ccc2OCOc2c1)[C@H](C)CN([C@@H](C)CO)C(=O)c3ccccc3"
    },
    "unichem": {
      "chebi": "103123",
      "lincs": "LSM-14468",
      "pubchem": "54649234"
    },
    "pubchem": [
      {
        "cid": 54649234,
        "inchi": "InChI=1S/C25H34N2O5/c1-18(13-27(19(2)16-28)25(29)21-8-6-5-7-9-21)24(30-4)15-26(3)14-20-10-11-22-23(12-20)32-17-31-22/h5-12,18-19,24,28H,13-17H2,1-4H3/t18-,19+,24+/m1/s1",
        "inchikey": "RDQYWFNTQPCNSM-IMWIBFENSA-N",
        "iupac": {
          "systematic": "N-[(2R,3R)-4-[1,3-benzodioxol-5-ylmethyl(methyl)amino]-3-methoxy-2-methylbutyl]-N-[(2S)-1-hydroxypropan-2-yl]benzamide"
        },
        "smiles": {
          "canonical": "CC(CN(C(C)CO)C(=O)C1=CC=CC=C1)C(CN(C)CC2=CC3=C(C=C2)OCO3)OC"
        },
        "molecularFormula": "C25H34N2O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:49:28Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84f1"
    },
    "name": "BRD-K34665338",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84f1.png",
    "lincs": {
      "id": "LSM-39166",
      "name": "BRD-K34665338",
      "pubchemCid": 60187512,
      "chebiId": 127609,
      "inchiParent": "InChI=1S/C26H33N5O5/c1-5-21(33)31-14-26(8-10-30(11-9-26)25(34)28-23-15(2)29-36-16(23)3)22-18-7-6-17(35-4)12-19(18)27-24(22)20(31)13-32/h6-7,12,20,27,32H,5,8-11,13-14H2,1-4H3,(H,28,34)/t20-/m0/s1",
      "inchiKeyParent": "VMAIHIRLRJTNCQ-FQEVSTJZSA-N",
      "smilesParent": "CCC(=O)N1CC2(CCN(CC2)C(=O)Nc3c(C)onc3C)c4c([nH]c5cc(OC)ccc45)[C@@H]1CO"
    },
    "unichem": {
      "chebi": "127609",
      "lincs": "LSM-39166",
      "pubchem": "60187512"
    },
    "pubchem": [
      {
        "cid": 60187512,
        "inchi": "InChI=1S/C26H33N5O5/c1-5-21(33)31-14-26(8-10-30(11-9-26)25(34)28-23-15(2)29-36-16(23)3)22-18-7-6-17(35-4)12-19(18)27-24(22)20(31)13-32/h6-7,12,20,27,32H,5,8-11,13-14H2,1-4H3,(H,28,34)/t20-/m0/s1",
        "inchikey": "VMAIHIRLRJTNCQ-FQEVSTJZSA-N",
        "iupac": {
          "systematic": "(1R)-N-(3,5-dimethyl-1,2-oxazol-4-yl)-1-(hydroxymethyl)-7-methoxy-2-propanoylspiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4'-piperidine]-1'-carboxamide"
        },
        "smiles": {
          "canonical": "CCC(=O)N1CC2(CCN(CC2)C(=O)NC3=C(ON=C3C)C)C4=C(C1CO)NC5=C4C=CC(=C5)OC"
        },
        "molecularFormula": "C26H33N5O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:49:30Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8435"
    },
    "name": "BRD-K78032863",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8435.png",
    "lincs": {
      "id": "LSM-41531",
      "name": "BRD-K78032863",
      "pubchemCid": 60184902,
      "chebiId": 129980,
      "inchiParent": "InChI=1S/C26H35N5O3S/c1-17(2)28-25(33)31-16-26(7-10-30(11-8-26)14-22-27-9-12-35-22)23-19-6-5-18(34-4)13-20(19)29(3)24(23)21(31)15-32/h5-6,9,12-13,17,21,32H,7-8,10-11,14-16H2,1-4H3,(H,28,33)/t21-/m0/s1",
      "inchiKeyParent": "PPRTXVLQEFGUPH-NRFANRHFSA-N",
      "smilesParent": "COc1ccc2c3c([C@H](CO)N(CC34CCN(Cc5nccs5)CC4)C(=O)NC(C)C)n(C)c2c1"
    },
    "unichem": {
      "chebi": "129980",
      "lincs": "LSM-41531",
      "pubchem": "60184902"
    },
    "pubchem": [
      {
        "cid": 60184902,
        "inchi": "InChI=1S/C26H35N5O3S/c1-17(2)28-25(33)31-16-26(7-10-30(11-8-26)14-22-27-9-12-35-22)23-19-6-5-18(34-4)13-20(19)29(3)24(23)21(31)15-32/h5-6,9,12-13,17,21,32H,7-8,10-11,14-16H2,1-4H3,(H,28,33)/t21-/m0/s1",
        "inchikey": "PPRTXVLQEFGUPH-NRFANRHFSA-N",
        "iupac": {
          "systematic": "(1R)-1-(hydroxymethyl)-7-methoxy-9-methyl-N-propan-2-yl-1'-(1,3-thiazol-2-ylmethyl)spiro[1,3-dihydropyrido[3,4-b]indole-4,4'-piperidine]-2-carboxamide"
        },
        "smiles": {
          "canonical": "CC(C)NC(=O)N1CC2(CCN(CC2)CC3=NC=CS3)C4=C(C1CO)N(C5=C4C=CC(=C5)OC)C"
        },
        "molecularFormula": "C26H35N5O3S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:49:33Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c847f"
    },
    "name": "BRD-K01070670",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c847f.png",
    "lincs": {
      "id": "LSM-8502",
      "name": "BRD-K01070670",
      "pubchemCid": 54638322,
      "chebiId": 97123,
      "inchiParent": "InChI=1S/C23H28F2N4O5/c1-33-16-5-3-15(4-6-16)27-23(32)28-19-9-7-17(34-21(19)13-30)10-11-26-22(31)29-20-12-14(24)2-8-18(20)25/h2-6,8,12,17,19,21,30H,7,9-11,13H2,1H3,(H2,26,29,31)(H2,27,28,32)/t17-,19-,21-/m1/s1",
      "inchiKeyParent": "CXRYDROHJOKZNG-YFVAEKQCSA-N",
      "smilesParent": "COc1ccc(NC(=O)N[C@@H]2CC[C@H](CCNC(=O)Nc3cc(F)ccc3F)O[C@@H]2CO)cc1"
    },
    "unichem": {
      "chebi": "97123",
      "lincs": "LSM-8502",
      "pubchem": "54638322"
    },
    "pubchem": [
      {
        "cid": 54638322,
        "inchi": "InChI=1S/C23H28F2N4O5/c1-33-16-5-3-15(4-6-16)27-23(32)28-19-9-7-17(34-21(19)13-30)10-11-26-22(31)29-20-12-14(24)2-8-18(20)25/h2-6,8,12,17,19,21,30H,7,9-11,13H2,1H3,(H2,26,29,31)(H2,27,28,32)/t17-,19-,21-/m1/s1",
        "inchikey": "CXRYDROHJOKZNG-YFVAEKQCSA-N",
        "iupac": {
          "systematic": "1-(2,5-difluorophenyl)-3-[2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[(4-methoxyphenyl)carbamoylamino]oxan-2-yl]ethyl]urea"
        },
        "smiles": {
          "canonical": "COC1=CC=C(C=C1)NC(=O)NC2CCC(OC2CO)CCNC(=O)NC3=C(C=CC(=C3)F)F"
        },
        "molecularFormula": "C23H28F2N4O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:49:35Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c849e"
    },
    "name": "BRD-K38752276",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c849e.png",
    "lincs": {
      "id": "LSM-30176",
      "name": "BRD-K38752276",
      "pubchemCid": 54639658,
      "chebiId": 118727,
      "inchiParent": "InChI=1S/C22H24F2N2O6S/c1-31-19-4-2-3-5-21(19)33(29,30)26-18-7-6-17(32-20(18)13-27)11-22(28)25-12-14-8-15(23)10-16(24)9-14/h2-10,17-18,20,26-27H,11-13H2,1H3,(H,25,28)/t17-,18-,20+/m0/s1",
      "inchiKeyParent": "VAIOXDFGBLKFCW-CMKODMSKSA-N",
      "smilesParent": "COc1ccccc1S(=O)(=O)N[C@H]2C=C[C@@H](CC(=O)NCc3cc(F)cc(F)c3)O[C@@H]2CO"
    },
    "unichem": {
      "chebi": "118727",
      "lincs": "LSM-30176",
      "pubchem": "54639658"
    },
    "pubchem": [
      {
        "cid": 54639658,
        "inchi": "InChI=1S/C22H24F2N2O6S/c1-31-19-4-2-3-5-21(19)33(29,30)26-18-7-6-17(32-20(18)13-27)11-22(28)25-12-14-8-15(23)10-16(24)9-14/h2-10,17-18,20,26-27H,11-13H2,1H3,(H,25,28)/t17-,18-,20+/m0/s1",
        "inchikey": "VAIOXDFGBLKFCW-CMKODMSKSA-N",
        "iupac": {
          "systematic": "N-[(3,5-difluorophenyl)methyl]-2-[(2S,3S,6R)-2-(hydroxymethyl)-3-[(2-methoxyphenyl)sulfonylamino]-3,6-dihydro-2H-pyran-6-yl]acetamide"
        },
        "smiles": {
          "canonical": "COC1=CC=CC=C1S(=O)(=O)NC2C=CC(OC2CO)CC(=O)NCC3=CC(=CC(=C3)F)F"
        },
        "molecularFormula": "C22H24F2N2O6S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:49:37Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84c4"
    },
    "name": "BRD-K82494420",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84c4.png",
    "lincs": {
      "id": "LSM-13469",
      "name": "BRD-K82494420",
      "pubchemCid": 54661054,
      "chebiId": 102109,
      "inchiParent": "InChI=1S/C17H25N3O3/c1-4-8-19-13-9-20-12(6-5-7-14(20)22)16(19)15(11(13)10-21)17(23)18(2)3/h5-7,11,13,15-16,21H,4,8-10H2,1-3H3/t11-,13-,15+,16+/m1/s1",
      "inchiKeyParent": "OCXQXADZMXZZGR-OYNZBZHQSA-N",
      "smilesParent": "CCCN1[C@@H]2CN3C(=O)C=CC=C3[C@H]1[C@H]([C@@H]2CO)C(=O)N(C)C"
    },
    "unichem": {
      "chebi": "102109",
      "lincs": "LSM-13469",
      "pubchem": "54661054"
    },
    "pubchem": [
      {
        "cid": 54661054,
        "inchi": "InChI=1S/C17H25N3O3/c1-4-8-19-13-9-20-12(6-5-7-14(20)22)16(19)15(11(13)10-21)17(23)18(2)3/h5-7,11,13,15-16,21H,4,8-10H2,1-3H3/t11-,13-,15+,16+/m1/s1",
        "inchikey": "OCXQXADZMXZZGR-OYNZBZHQSA-N",
        "iupac": {
          "systematic": "(1R,9S,10S,11S)-10-(hydroxymethyl)-N,N-dimethyl-6-oxo-12-propyl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide"
        },
        "smiles": {
          "canonical": "CCCN1C2CN3C(=O)C=CC=C3C1C(C2CO)C(=O)N(C)C"
        },
        "molecularFormula": "C17H25N3O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:49:39Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84e4"
    },
    "name": "BRD-K60737413",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84e4.png",
    "lincs": {
      "id": "LSM-40588",
      "name": "BRD-K60737413",
      "pubchemCid": 54652626,
      "chebiId": 129036,
      "inchiParent": "InChI=1S/C21H30N4O4/c1-2-7-22-21(28)24-12-17-20(15-5-3-4-6-16(15)24)18(14-26)25(17)19(27)13-23-8-10-29-11-9-23/h3-6,17-18,20,26H,2,7-14H2,1H3,(H,22,28)/t17-,18+,20+/m0/s1",
      "inchiKeyParent": "BIVWTSHLSFNMQV-NLWGTHIKSA-N",
      "smilesParent": "CCCNC(=O)N1C[C@H]2[C@H]([C@@H](CO)N2C(=O)CN3CCOCC3)c4ccccc14"
    },
    "unichem": {
      "chebi": "129036",
      "lincs": "LSM-40588",
      "pubchem": "54652626"
    },
    "pubchem": [
      {
        "cid": 54652626,
        "inchi": "InChI=1S/C21H30N4O4/c1-2-7-22-21(28)24-12-17-20(15-5-3-4-6-16(15)24)18(14-26)25(17)19(27)13-23-8-10-29-11-9-23/h3-6,17-18,20,26H,2,7-14H2,1H3,(H,22,28)/t17-,18+,20+/m0/s1",
        "inchikey": "BIVWTSHLSFNMQV-NLWGTHIKSA-N",
        "iupac": {
          "systematic": "(1S,2aR,8bR)-1-(hydroxymethyl)-2-(2-morpholin-4-ylacetyl)-N-propyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide"
        },
        "smiles": {
          "canonical": "CCCNC(=O)N1CC2C(C(N2C(=O)CN3CCOCC3)CO)C4=CC=CC=C41"
        },
        "molecularFormula": "C21H30N4O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:49:42Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8448"
    },
    "name": "BRD-K77908171",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8448.png",
    "lincs": {
      "id": "LSM-13193",
      "name": "BRD-K77908171",
      "pubchemCid": 54660907,
      "chebiId": 101831,
      "inchiParent": "InChI=1S/C19H19FN2O6S/c1-29(27,28)22-16-13(14(9-23)17(22)19(25)26)8-21-15(16)7-6-12(18(21)24)10-2-4-11(20)5-3-10/h2-7,13-14,16-17,23H,8-9H2,1H3,(H,25,26)/t13-,14-,16+,17-/m1/s1",
      "inchiKeyParent": "PCISDUIZPJCQMU-TXCZRRACSA-N",
      "smilesParent": "CS(=O)(=O)N1[C@H]([C@H](CO)[C@H]2CN3C(=CC=C(C3=O)c4ccc(F)cc4)[C@@H]12)C(=O)O"
    },
    "unichem": {
      "chebi": "101831",
      "lincs": "LSM-13193",
      "pubchem": "54660907"
    },
    "pubchem": [
      {
        "cid": 54660907,
        "inchi": "InChI=1S/C19H19FN2O6S/c1-29(27,28)22-16-13(14(9-23)17(22)19(25)26)8-21-15(16)7-6-12(18(21)24)10-2-4-11(20)5-3-10/h2-7,13-14,16-17,23H,8-9H2,1H3,(H,25,26)/t13-,14-,16+,17-/m1/s1",
        "inchikey": "PCISDUIZPJCQMU-TXCZRRACSA-N",
        "iupac": {
          "systematic": "(2R,3R,3aS,9bS)-7-(4-fluorophenyl)-3-(hydroxymethyl)-1-methylsulfonyl-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxylic acid"
        },
        "smiles": {
          "canonical": "CS(=O)(=O)N1C2C(CN3C2=CC=C(C3=O)C4=CC=C(C=C4)F)C(C1C(=O)O)CO"
        },
        "molecularFormula": "C19H19FN2O6S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:49:44Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c844c"
    },
    "name": "BRD-K38643780",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c844c.png",
    "lincs": {
      "id": "LSM-10771",
      "name": "BRD-K38643780",
      "pubchemCid": 54657787,
      "chebiId": 99392,
      "inchiParent": "InChI=1S/C21H28Cl2N2O6/c1-29-5-4-24-20(27)9-17-2-3-18-19(31-17)12-30-11-16(26)10-25(18)21(28)13-6-14(22)8-15(23)7-13/h6-8,16-19,26H,2-5,9-12H2,1H3,(H,24,27)/t16-,17-,18+,19-/m0/s1",
      "inchiKeyParent": "GXFSXISHSMAVNQ-OKYOBFRVSA-N",
      "smilesParent": "COCCNC(=O)C[C@@H]1CC[C@@H]2[C@H](COC[C@@H](O)CN2C(=O)c3cc(Cl)cc(Cl)c3)O1"
    },
    "unichem": {
      "chebi": "99392",
      "lincs": "LSM-10771",
      "pubchem": "54657787"
    },
    "pubchem": [
      {
        "cid": 54657787,
        "inchi": "InChI=1S/C21H28Cl2N2O6/c1-29-5-4-24-20(27)9-17-2-3-18-19(31-17)12-30-11-16(26)10-25(18)21(28)13-6-14(22)8-15(23)7-13/h6-8,16-19,26H,2-5,9-12H2,1H3,(H,24,27)/t16-,17-,18+,19-/m0/s1",
        "inchikey": "GXFSXISHSMAVNQ-OKYOBFRVSA-N",
        "iupac": {
          "systematic": "2-[(3S,6aR,8S,10aR)-1-(3,5-dichlorobenzoyl)-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-methoxyethyl)acetamide"
        },
        "smiles": {
          "canonical": "COCCNC(=O)CC1CCC2C(O1)COCC(CN2C(=O)C3=CC(=CC(=C3)Cl)Cl)O"
        },
        "molecularFormula": "C21H28Cl2N2O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:49:47Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8492"
    },
    "name": "BRD-K99259037",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8492.png",
    "lincs": {
      "id": "LSM-15173",
      "name": "BRD-K99259037",
      "pubchemCid": 54619273,
      "chebiId": 103829,
      "inchiParent": "InChI=1S/C29H35F2N3O5S/c1-19-16-34(20(2)18-35)40(37,38)28-13-10-22(9-8-21-6-4-5-7-21)14-26(28)39-27(19)17-33(3)29(36)32-25-15-23(30)11-12-24(25)31/h10-15,19-21,27,35H,4-7,16-18H2,1-3H3,(H,32,36)/t19-,20+,27+/m1/s1",
      "inchiKeyParent": "CROBQSVNIOLQSN-JVAFGIKQSA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@@H](C)[C@H](CN(C)C(=O)Nc2cc(F)ccc2F)Oc3cc(ccc3S1(=O)=O)C#CC4CCCC4"
    },
    "unichem": {
      "chebi": "103829",
      "lincs": "LSM-15173",
      "pubchem": "54619273"
    },
    "pubchem": [
      {
        "cid": 54619273,
        "inchi": "InChI=1S/C29H35F2N3O5S/c1-19-16-34(20(2)18-35)40(37,38)28-13-10-22(9-8-21-6-4-5-7-21)14-26(28)39-27(19)17-33(3)29(36)32-25-15-23(30)11-12-24(25)31/h10-15,19-21,27,35H,4-7,16-18H2,1-3H3,(H,32,36)/t19-,20+,27+/m1/s1",
        "inchikey": "CROBQSVNIOLQSN-JVAFGIKQSA-N",
        "iupac": {
          "systematic": "1-[[(4R,5R)-8-(2-cyclopentylethynyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-3-(2,5-difluorophenyl)-1-methylurea"
        },
        "smiles": {
          "canonical": "CC1CN(S(=O)(=O)C2=C(C=C(C=C2)C#CC3CCCC3)OC1CN(C)C(=O)NC4=C(C=CC(=C4)F)F)C(C)CO"
        },
        "molecularFormula": "C29H35F2N3O5S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:49:49Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84a1"
    },
    "name": "CHEMBL2130605",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84a1.png",
    "lincs": {
      "id": "LSM-22206",
      "name": "CHEMBL2130605",
      "alternativeNames": [
        "2141-024",
        "BRD-K98645985"
      ],
      "pubchemCid": 54633693,
      "chebiId": 110762,
      "inchiParent": "InChI=1S/C33H43N5O4/c1-22(2)35-33(40)36-27-14-15-30-28(17-27)32(39)37(5)20-31(41-6)23(3)18-38(24(4)21-42-30)19-25-10-12-26(13-11-25)29-9-7-8-16-34-29/h7-17,22-24,31H,18-21H2,1-6H3,(H2,35,36,40)/t23-,24-,31-/m0/s1",
      "inchiKeyParent": "DZGZFXRKNSZUSK-MKGJDZFWSA-N",
      "smilesParent": "CO[C@H]1CN(C)C(=O)c2cc(NC(=O)NC(C)C)ccc2OC[C@H](C)N(Cc3ccc(cc3)c4ccccn4)C[C@@H]1C"
    },
    "unichem": {
      "chebi": "110762",
      "chembl": "CHEMBL2130605",
      "lincs": "LSM-22206",
      "pubchem": "54633693"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL2130605",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 573.74,
        "hba": 6,
        "hbd": 2,
        "qedWeighted": 0.42
      }
    },
    "pubchem": [
      {
        "cid": 54633693,
        "inchi": "InChI=1S/C33H43N5O4/c1-22(2)35-33(40)36-27-14-15-30-28(17-27)32(39)37(5)20-31(41-6)23(3)18-38(24(4)21-42-30)19-25-10-12-26(13-11-25)29-9-7-8-16-34-29/h7-17,22-24,31H,18-21H2,1-6H3,(H2,35,36,40)/t23-,24-,31-/m0/s1",
        "inchikey": "DZGZFXRKNSZUSK-MKGJDZFWSA-N",
        "iupac": {
          "systematic": "1-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[(4-pyridin-2-ylphenyl)methyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propan-2-ylurea"
        },
        "smiles": {
          "canonical": "CC1CN(C(COC2=C(C=C(C=C2)NC(=O)NC(C)C)C(=O)N(CC1OC)C)C)CC3=CC=C(C=C3)C4=CC=CC=N4"
        },
        "molecularFormula": "C33H43N5O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:50:00Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8450"
    },
    "name": "SA-246522",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8450.png",
    "lincs": {
      "id": "LSM-38089",
      "name": "SA-246522",
      "pubchemCid": 44503093,
      "chebiId": 126525,
      "inchiParent": "InChI=1S/C25H40N4O4/c1-16(2)26-25(32)27-21-8-9-22-20(10-21)11-24(31)29(18(4)15-30)12-17(3)23(33-22)14-28(5)13-19-6-7-19/h8-10,16-19,23,30H,6-7,11-15H2,1-5H3,(H2,26,27,32)/t17-,18-,23+/m0/s1",
      "inchiKeyParent": "UCKREMIJSDYNRS-IUKKYPGJSA-N",
      "smilesParent": "CC(C)NC(=O)Nc1ccc2O[C@H](CN(C)CC3CC3)[C@@H](C)CN([C@@H](C)CO)C(=O)Cc2c1"
    },
    "unichem": {
      "chebi": "126525",
      "lincs": "LSM-38089",
      "pubchem": "44503093"
    },
    "pubchem": [
      {
        "cid": 44503093,
        "inchi": "InChI=1S/C25H40N4O4/c1-16(2)26-25(32)27-21-8-9-22-20(10-21)11-24(31)29(18(4)15-30)12-17(3)23(33-22)14-28(5)13-19-6-7-19/h8-10,16-19,23,30H,6-7,11-15H2,1-5H3,(H2,26,27,32)/t17-,18-,23+/m0/s1",
        "inchikey": "UCKREMIJSDYNRS-IUKKYPGJSA-N",
        "iupac": {
          "systematic": "1-[(2S,3S)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-propan-2-ylurea"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)CC2=C(C=CC(=C2)NC(=O)NC(C)C)OC1CN(C)CC3CC3)C(C)CO"
        },
        "molecularFormula": "C25H40N4O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:50:03Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8458"
    },
    "name": "BRD-K73276569",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8458.png",
    "lincs": {
      "id": "LSM-41250",
      "name": "BRD-K73276569",
      "pubchemCid": 54651426,
      "chebiId": 129699,
      "inchiParent": "InChI=1S/C20H23FN2O3/c1-26-12-19(25)22-10-17-20(18(11-24)23-17)14-8-6-13(7-9-14)15-4-2-3-5-16(15)21/h2-9,17-18,20,23-24H,10-12H2,1H3,(H,22,25)/t17-,18-,20-/m1/s1",
      "inchiKeyParent": "FIZOSTDDVVNHMP-QWFCFKBJSA-N",
      "smilesParent": "COCC(=O)NC[C@H]1N[C@H](CO)[C@@H]1c2ccc(cc2)c3ccccc3F"
    },
    "unichem": {
      "chebi": "129699",
      "lincs": "LSM-41250",
      "pubchem": "54651426"
    },
    "pubchem": [
      {
        "cid": 54651426,
        "inchi": "InChI=1S/C20H23FN2O3/c1-26-12-19(25)22-10-17-20(18(11-24)23-17)14-8-6-13(7-9-14)15-4-2-3-5-16(15)21/h2-9,17-18,20,23-24H,10-12H2,1H3,(H,22,25)/t17-,18-,20-/m1/s1",
        "inchikey": "FIZOSTDDVVNHMP-QWFCFKBJSA-N",
        "iupac": {
          "systematic": "N-[[(2S,3R,4S)-3-[4-(2-fluorophenyl)phenyl]-4-(hydroxymethyl)azetidin-2-yl]methyl]-2-methoxyacetamide"
        },
        "smiles": {
          "canonical": "COCC(=O)NCC1C(C(N1)CO)C2=CC=C(C=C2)C3=CC=CC=C3F"
        },
        "molecularFormula": "C20H23FN2O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:50:05Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c847d"
    },
    "name": "BRD-K81752795",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c847d.png",
    "lincs": {
      "id": "LSM-13422",
      "name": "BRD-K81752795",
      "pubchemCid": 54660835,
      "chebiId": 102062,
      "inchiParent": "InChI=1S/C27H28FN5O3/c28-18-5-3-17(4-6-18)20-7-8-23-24-21(13-32(23)27(20)36)22(14-34)25(33(24)12-16-1-2-16)26(35)30-11-19-9-10-29-15-31-19/h3-10,15-16,21-22,24-25,34H,1-2,11-14H2,(H,30,35)/t21-,22-,24+,25-/m1/s1",
      "inchiKeyParent": "URDKMROJZUNSLX-YQIMAOPZSA-N",
      "smilesParent": "OC[C@@H]1[C@H]2CN3C(=CC=C(C3=O)c4ccc(F)cc4)[C@H]2N(CC5CC5)[C@H]1C(=O)NCc6ccncn6"
    },
    "unichem": {
      "chebi": "102062",
      "lincs": "LSM-13422",
      "pubchem": "54660835"
    },
    "pubchem": [
      {
        "cid": 54660835,
        "inchi": "InChI=1S/C27H28FN5O3/c28-18-5-3-17(4-6-18)20-7-8-23-24-21(13-32(23)27(20)36)22(14-34)25(33(24)12-16-1-2-16)26(35)30-11-19-9-10-29-15-31-19/h3-10,15-16,21-22,24-25,34H,1-2,11-14H2,(H,30,35)/t21-,22-,24+,25-/m1/s1",
        "inchikey": "URDKMROJZUNSLX-YQIMAOPZSA-N",
        "iupac": {
          "systematic": "(2R,3R,3aS,9bS)-1-(cyclopropylmethyl)-7-(4-fluorophenyl)-3-(hydroxymethyl)-6-oxo-N-(pyrimidin-4-ylmethyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide"
        },
        "smiles": {
          "canonical": "C1CC1CN2C3C(CN4C3=CC=C(C4=O)C5=CC=C(C=C5)F)C(C2C(=O)NCC6=NC=NC=C6)CO"
        },
        "molecularFormula": "C27H28FN5O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:50:07Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8483"
    },
    "name": "BRD-K87126403",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8483.png",
    "lincs": {
      "id": "LSM-7966",
      "name": "BRD-K87126403",
      "pubchemCid": 54618378,
      "chebiId": 96587,
      "inchiParent": "InChI=1S/C23H33N5O5S/c1-5-8-26-23(30)27(4)13-21-16(2)12-28(17(3)14-29)34(31,32)22-7-6-18(9-20(22)33-21)19-10-24-15-25-11-19/h6-7,9-11,15-17,21,29H,5,8,12-14H2,1-4H3,(H,26,30)/t16-,17-,21+/m1/s1",
      "inchiKeyParent": "NMUQMAVVZJKKCB-LZJOCLMNSA-N",
      "smilesParent": "CCCNC(=O)N(C)C[C@@H]1Oc2cc(ccc2S(=O)(=O)N(C[C@H]1C)[C@H](C)CO)c3cncnc3"
    },
    "unichem": {
      "chebi": "96587",
      "lincs": "LSM-7966",
      "pubchem": "54618378"
    },
    "pubchem": [
      {
        "cid": 54618378,
        "inchi": "InChI=1S/C23H33N5O5S/c1-5-8-26-23(30)27(4)13-21-16(2)12-28(17(3)14-29)34(31,32)22-7-6-18(9-20(22)33-21)19-10-24-15-25-11-19/h6-7,9-11,15-17,21,29H,5,8,12-14H2,1-4H3,(H,26,30)/t16-,17-,21+/m1/s1",
        "inchikey": "NMUQMAVVZJKKCB-LZJOCLMNSA-N",
        "iupac": {
          "systematic": "1-[[(4R,5R)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-pyrimidin-5-yl-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-1-methyl-3-propylurea"
        },
        "smiles": {
          "canonical": "CCCNC(=O)N(C)CC1C(CN(S(=O)(=O)C2=C(O1)C=C(C=C2)C3=CN=CN=C3)C(C)CO)C"
        },
        "molecularFormula": "C23H33N5O5S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:50:09Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c848e"
    },
    "name": "CHEMBL2359502",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c848e.png",
    "lincs": {
      "id": "LSM-42618",
      "name": "CHEMBL2359502",
      "alternativeNames": [
        "BRD-K98731749"
      ],
      "pubchemCid": 44618522,
      "chebiId": 131070,
      "inchiParent": "InChI=1S/C38H49F3N4O6/c1-25-21-45(26(2)24-46)36(47)33-20-31(43-37(48)42-30-13-11-29(12-14-30)38(39,40)41)15-18-34(33)51-27(3)8-6-7-19-50-35(25)23-44(4)22-28-9-16-32(49-5)17-10-28/h9-18,20,25-27,35,46H,6-8,19,21-24H2,1-5H3,(H2,42,43,48)/t25-,26-,27+,35-/m1/s1",
      "inchiKeyParent": "XGMQKVJTWVADHD-MCYUDXQTSA-N",
      "smilesParent": "COc1ccc(CN(C)C[C@H]2OCCCC[C@H](C)Oc3ccc(NC(=O)Nc4ccc(cc4)C(F)(F)F)cc3C(=O)N(C[C@H]2C)[C@H](C)CO)cc1"
    },
    "unichem": {
      "chebi": "131070",
      "chembl": "CHEMBL2359502",
      "lincs": "LSM-42618",
      "pubchem": "44618522"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL2359502",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 714.83,
        "hba": 7,
        "hbd": 3,
        "qedWeighted": 0.21
      }
    },
    "pubchem": [
      {
        "cid": 44618522,
        "inchi": "InChI=1S/C38H49F3N4O6/c1-25-21-45(26(2)24-46)36(47)33-20-31(43-37(48)42-30-13-11-29(12-14-30)38(39,40)41)15-18-34(33)51-27(3)8-6-7-19-50-35(25)23-44(4)22-28-9-16-32(49-5)17-10-28/h9-18,20,25-27,35,46H,6-8,19,21-24H2,1-5H3,(H2,42,43,48)/t25-,26-,27+,35-/m1/s1",
        "inchikey": "XGMQKVJTWVADHD-MCYUDXQTSA-N",
        "iupac": {
          "systematic": "1-[(3S,9S,10R)-12-[(2R)-1-hydroxypropan-2-yl]-9-[[(4-methoxyphenyl)methyl-methylamino]methyl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-[4-(trifluoromethyl)phenyl]urea"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NC(=O)NC3=CC=C(C=C3)C(F)(F)F)C(C)CO)C)CN(C)CC4=CC=C(C=C4)OC"
        },
        "molecularFormula": "C38H49F3N4O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:50:20Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84db"
    },
    "name": "BRD-K94761446",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84db.png",
    "lincs": {
      "id": "LSM-14237",
      "name": "BRD-K94761446",
      "pubchemCid": 54646482,
      "chebiId": 102891,
      "inchiParent": "InChI=1S/C28H34N2O6/c1-17(18-5-3-2-4-6-18)29-26(32)15-21-14-23-22-13-20(30-28(33)19-9-11-34-12-10-19)7-8-24(22)36-27(23)25(16-31)35-21/h2-8,13,17,19,21,23,25,27,31H,9-12,14-16H2,1H3,(H,29,32)(H,30,33)/t17-,21+,23+,25-,27-/m0/s1",
      "inchiKeyParent": "ISBRQPNQXSURAN-LLAXMMLTSA-N",
      "smilesParent": "C[C@H](NC(=O)C[C@H]1C[C@H]2[C@H](Oc3ccc(NC(=O)C4CCOCC4)cc23)[C@H](CO)O1)c5ccccc5"
    },
    "unichem": {
      "chebi": "102891",
      "lincs": "LSM-14237",
      "pubchem": "54646482"
    },
    "pubchem": [
      {
        "cid": 54646482,
        "inchi": "InChI=1S/C28H34N2O6/c1-17(18-5-3-2-4-6-18)29-26(32)15-21-14-23-22-13-20(30-28(33)19-9-11-34-12-10-19)7-8-24(22)36-27(23)25(16-31)35-21/h2-8,13,17,19,21,23,25,27,31H,9-12,14-16H2,1H3,(H,29,32)(H,30,33)/t17-,21+,23+,25-,27-/m0/s1",
        "inchikey": "ISBRQPNQXSURAN-LLAXMMLTSA-N",
        "iupac": {
          "systematic": "N-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-[[(1S)-1-phenylethyl]amino]ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]oxane-4-carboxamide"
        },
        "smiles": {
          "canonical": "CC(C1=CC=CC=C1)NC(=O)CC2CC3C(C(O2)CO)OC4=C3C=C(C=C4)NC(=O)C5CCOCC5"
        },
        "molecularFormula": "C28H34N2O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:50:23Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8423"
    },
    "name": "BRD-K78467731",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8423.png",
    "lincs": {
      "id": "LSM-13226",
      "name": "BRD-K78467731",
      "pubchemCid": 54638793,
      "chebiId": 101865,
      "inchiParent": "InChI=1S/C21H26N2O6/c24-12-19-16(22-21(26)14-4-7-17-18(10-14)28-13-27-17)6-5-15(29-19)11-20(25)23-8-2-1-3-9-23/h4-7,10,15-16,19,24H,1-3,8-9,11-13H2,(H,22,26)/t15-,16+,19-/m0/s1",
      "inchiKeyParent": "ZKMZGYJTUFHVCC-FCEWJHQRSA-N",
      "smilesParent": "OC[C@@H]1O[C@H](CC(=O)N2CCCCC2)C=C[C@H]1NC(=O)c3ccc4OCOc4c3"
    },
    "unichem": {
      "chebi": "101865",
      "lincs": "LSM-13226",
      "pubchem": "54638793"
    },
    "pubchem": [
      {
        "cid": 54638793,
        "inchi": "InChI=1S/C21H26N2O6/c24-12-19-16(22-21(26)14-4-7-17-18(10-14)28-13-27-17)6-5-15(29-19)11-20(25)23-8-2-1-3-9-23/h4-7,10,15-16,19,24H,1-3,8-9,11-13H2,(H,22,26)/t15-,16+,19-/m0/s1",
        "inchikey": "ZKMZGYJTUFHVCC-FCEWJHQRSA-N",
        "iupac": {
          "systematic": "N-[(2R,3R,6R)-2-(hydroxymethyl)-6-(2-oxo-2-piperidin-1-ylethyl)-3,6-dihydro-2H-pyran-3-yl]-1,3-benzodioxole-5-carboxamide"
        },
        "smiles": {
          "canonical": "C1CCN(CC1)C(=O)CC2C=CC(C(O2)CO)NC(=O)C3=CC4=C(C=C3)OCO4"
        },
        "molecularFormula": "C21H26N2O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:50:25Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8428"
    },
    "name": "BRD-K58631614",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8428.png",
    "lincs": {
      "id": "LSM-11968",
      "name": "BRD-K58631614",
      "pubchemCid": 54646511,
      "chebiId": 100594,
      "inchiParent": "InChI=1S/C29H26F2N2O7/c30-17-2-4-22(31)16(7-17)12-32-27(35)11-19-10-21-20-9-18(3-6-23(20)40-28(21)26(13-34)39-19)33-29(36)15-1-5-24-25(8-15)38-14-37-24/h1-9,19,21,26,28,34H,10-14H2,(H,32,35)(H,33,36)/t19-,21+,26+,28-/m1/s1",
      "inchiKeyParent": "JRAPIMFHFBSUKE-GGUBSOLTSA-N",
      "smilesParent": "OC[C@@H]1O[C@@H](CC(=O)NCc2cc(F)ccc2F)C[C@@H]3[C@H]1Oc4ccc(NC(=O)c5ccc6OCOc6c5)cc34"
    },
    "unichem": {
      "chebi": "100594",
      "lincs": "LSM-11968",
      "pubchem": "54646511"
    },
    "pubchem": [
      {
        "cid": 54646511,
        "inchi": "InChI=1S/C29H26F2N2O7/c30-17-2-4-22(31)16(7-17)12-32-27(35)11-19-10-21-20-9-18(3-6-23(20)40-28(21)26(13-34)39-19)33-29(36)15-1-5-24-25(8-15)38-14-37-24/h1-9,19,21,26,28,34H,10-14H2,(H,32,35)(H,33,36)/t19-,21+,26+,28-/m1/s1",
        "inchikey": "JRAPIMFHFBSUKE-GGUBSOLTSA-N",
        "iupac": {
          "systematic": "N-[(1S,3R,4aS,9aR)-3-[2-[(2,5-difluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide"
        },
        "smiles": {
          "canonical": "C1C(OC(C2C1C3=C(O2)C=CC(=C3)NC(=O)C4=CC5=C(C=C4)OCO5)CO)CC(=O)NCC6=C(C=CC(=C6)F)F"
        },
        "molecularFormula": "C29H26F2N2O7"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:50:27Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c844a"
    },
    "name": "BRD-K99999497",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c844a.png",
    "lincs": {
      "id": "LSM-14576",
      "name": "BRD-K99999497",
      "pubchemCid": 54650199,
      "chebiId": 103232,
      "inchiParent": "InChI=1S/C23H29N3O2/c1-16(2)25-23(28)26-20(14-24)22(21(26)15-27)19-12-10-18(11-13-19)9-8-17-6-4-3-5-7-17/h10-13,16-17,20-22,27H,3-7,15H2,1-2H3,(H,25,28)/t20-,21+,22-/m0/s1",
      "inchiKeyParent": "FHQNTJUBGIRGFL-BDTNDASRSA-N",
      "smilesParent": "CC(C)NC(=O)N1[C@H](CO)[C@H]([C@@H]1C#N)c2ccc(cc2)C#CC3CCCCC3"
    },
    "unichem": {
      "chebi": "103232",
      "lincs": "LSM-14576",
      "pubchem": "54650199"
    },
    "pubchem": [
      {
        "cid": 54650199,
        "inchi": "InChI=1S/C23H29N3O2/c1-16(2)25-23(28)26-20(14-24)22(21(26)15-27)19-12-10-18(11-13-19)9-8-17-6-4-3-5-7-17/h10-13,16-17,20-22,27H,3-7,15H2,1-2H3,(H,25,28)/t20-,21+,22-/m0/s1",
        "inchikey": "FHQNTJUBGIRGFL-BDTNDASRSA-N",
        "iupac": {
          "systematic": "(2R,3S,4S)-2-cyano-3-[4-(2-cyclohexylethynyl)phenyl]-4-(hydroxymethyl)-N-propan-2-ylazetidine-1-carboxamide"
        },
        "smiles": {
          "canonical": "CC(C)NC(=O)N1C(C(C1C#N)C2=CC=C(C=C2)C#CC3CCCCC3)CO"
        },
        "molecularFormula": "C23H29N3O2"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:50:29Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84eb"
    },
    "name": "BRD-K04262969",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84eb.png",
    "lincs": {
      "id": "LSM-8690",
      "name": "BRD-K04262969",
      "pubchemCid": 54660857,
      "chebiId": 97311,
      "inchiParent": "InChI=1S/C25H29N3O3/c29-15-19-21-14-27-20(6-3-7-22(27)30)24(28(21)12-16-8-9-16)23(19)25(31)26-11-10-17-4-1-2-5-18(17)13-26/h1-7,16,19,21,23-24,29H,8-15H2/t19-,21-,23+,24+/m1/s1",
      "inchiKeyParent": "MQRDGSKRUJYVOI-ZXMXYHOLSA-N",
      "smilesParent": "OC[C@@H]1[C@H]2CN3C(=O)C=CC=C3[C@@H]([C@H]1C(=O)N4CCc5ccccc5C4)N2CC6CC6"
    },
    "unichem": {
      "chebi": "97311",
      "lincs": "LSM-8690",
      "pubchem": "54660857"
    },
    "pubchem": [
      {
        "cid": 54660857,
        "inchi": "InChI=1S/C25H29N3O3/c29-15-19-21-14-27-20(6-3-7-22(27)30)24(28(21)12-16-8-9-16)23(19)25(31)26-11-10-17-4-1-2-5-18(17)13-26/h1-7,16,19,21,23-24,29H,8-15H2/t19-,21-,23+,24+/m1/s1",
        "inchikey": "MQRDGSKRUJYVOI-ZXMXYHOLSA-N",
        "iupac": {
          "systematic": "(1R,9S,10S,11S)-12-(cyclopropylmethyl)-11-(3,4-dihydro-1H-isoquinoline-2-carbonyl)-10-(hydroxymethyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-dien-6-one"
        },
        "smiles": {
          "canonical": "C1CC1CN2C3CN4C(=O)C=CC=C4C2C(C3CO)C(=O)N5CCC6=CC=CC=C6C5"
        },
        "molecularFormula": "C25H29N3O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:50:32Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8508"
    },
    "name": "BRD-K70512038",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8508.png",
    "lincs": {
      "id": "LSM-12730",
      "name": "BRD-K70512038",
      "pubchemCid": 54660838,
      "chebiId": 101366,
      "inchiParent": "InChI=1S/C25H31FN4O5/c1-14(2)28-25(34)30-20-12-29-19(8-7-17(24(29)33)15-5-4-6-16(26)11-15)22(30)21(18(20)13-31)23(32)27-9-10-35-3/h4-8,11,14,18,20-22,31H,9-10,12-13H2,1-3H3,(H,27,32)(H,28,34)/t18-,20-,21+,22+/m1/s1",
      "inchiKeyParent": "RKZCTJVPZQLRIW-YJMBLLCNSA-N",
      "smilesParent": "COCCNC(=O)[C@H]1[C@H](CO)[C@H]2CN3C(=CC=C(C3=O)c4cccc(F)c4)[C@@H]1N2C(=O)NC(C)C"
    },
    "unichem": {
      "chebi": "101366",
      "lincs": "LSM-12730",
      "pubchem": "54660838"
    },
    "pubchem": [
      {
        "cid": 54660838,
        "inchi": "InChI=1S/C25H31FN4O5/c1-14(2)28-25(34)30-20-12-29-19(8-7-17(24(29)33)15-5-4-6-16(26)11-15)22(30)21(18(20)13-31)23(32)27-9-10-35-3/h4-8,11,14,18,20-22,31H,9-10,12-13H2,1-3H3,(H,27,32)(H,28,34)/t18-,20-,21+,22+/m1/s1",
        "inchikey": "RKZCTJVPZQLRIW-YJMBLLCNSA-N",
        "iupac": {
          "systematic": "(1R,9S,10S,11S)-5-(3-fluorophenyl)-10-(hydroxymethyl)-11-N-(2-methoxyethyl)-6-oxo-12-N-propan-2-yl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11,12-dicarboxamide"
        },
        "smiles": {
          "canonical": "CC(C)NC(=O)N1C2CN3C(=CC=C(C3=O)C4=CC(=CC=C4)F)C1C(C2CO)C(=O)NCCOC"
        },
        "molecularFormula": "C25H31FN4O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:50:34Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8578"
    },
    "name": "BRD-K04288183",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8578.png",
    "lincs": {
      "id": "LSM-37504",
      "name": "BRD-K04288183",
      "pubchemCid": 54652639,
      "chebiId": 125937,
      "inchiParent": "InChI=1S/C24H25FN2O4/c25-17-5-3-4-16(12-17)23(29)26-13-20-22(18-6-1-2-7-19(18)26)21(14-28)27(20)24(30)15-8-10-31-11-9-15/h1-7,12,15,20-22,28H,8-11,13-14H2/t20-,21+,22+/m0/s1",
      "inchiKeyParent": "RAIYMEHSZRPCGC-BHDDXSALSA-N",
      "smilesParent": "OC[C@@H]1[C@H]2[C@H](CN(C(=O)c3cccc(F)c3)c4ccccc24)N1C(=O)C5CCOCC5"
    },
    "unichem": {
      "chebi": "125937",
      "lincs": "LSM-37504",
      "pubchem": "54652639"
    },
    "pubchem": [
      {
        "cid": 54652639,
        "inchi": "InChI=1S/C24H25FN2O4/c25-17-5-3-4-16(12-17)23(29)26-13-20-22(18-6-1-2-7-19(18)26)21(14-28)27(20)24(30)15-8-10-31-11-9-15/h1-7,12,15,20-22,28H,8-11,13-14H2/t20-,21+,22+/m0/s1",
        "inchikey": "RAIYMEHSZRPCGC-BHDDXSALSA-N",
        "iupac": {
          "systematic": "[(1S,2aR,8bR)-4-(3-fluorobenzoyl)-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]-(oxan-4-yl)methanone"
        },
        "smiles": {
          "canonical": "C1COCCC1C(=O)N2C3CN(C4=CC=CC=C4C3C2CO)C(=O)C5=CC(=CC=C5)F"
        },
        "molecularFormula": "C24H25FN2O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:50:36Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8590"
    },
    "name": "BRD-K04574057",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8590.png",
    "lincs": {
      "id": "LSM-8706",
      "name": "BRD-K04574057",
      "pubchemCid": 54657509,
      "chebiId": 97327,
      "inchiParent": "InChI=1S/C25H32F3N5O5/c1-32-11-18(30-15-32)8-9-29-23(35)10-20-6-7-21-22(38-20)14-37-13-19(34)12-33(21)24(36)31-17-4-2-16(3-5-17)25(26,27)28/h2-5,11,15,19-22,34H,6-10,12-14H2,1H3,(H,29,35)(H,31,36)/t19-,20-,21-,22+/m0/s1",
      "inchiKeyParent": "TWGHTEGHSVIJBR-MYGLTJDJSA-N",
      "smilesParent": "Cn1cnc(CCNC(=O)C[C@@H]2CC[C@H]3[C@@H](COC[C@@H](O)CN3C(=O)Nc4ccc(cc4)C(F)(F)F)O2)c1"
    },
    "unichem": {
      "chebi": "97327",
      "lincs": "LSM-8706",
      "pubchem": "54657509"
    },
    "pubchem": [
      {
        "cid": 54657509,
        "inchi": "InChI=1S/C25H32F3N5O5/c1-32-11-18(30-15-32)8-9-29-23(35)10-20-6-7-21-22(38-20)14-37-13-19(34)12-33(21)24(36)31-17-4-2-16(3-5-17)25(26,27)28/h2-5,11,15,19-22,34H,6-10,12-14H2,1H3,(H,29,35)(H,31,36)/t19-,20-,21-,22+/m0/s1",
        "inchikey": "TWGHTEGHSVIJBR-MYGLTJDJSA-N",
        "iupac": {
          "systematic": "(3S,6aS,8S,10aS)-3-hydroxy-8-[2-[2-(1-methylimidazol-4-yl)ethylamino]-2-oxoethyl]-N-[4-(trifluoromethyl)phenyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide"
        },
        "smiles": {
          "canonical": "CN1C=C(N=C1)CCNC(=O)CC2CCC3C(O2)COCC(CN3C(=O)NC4=CC=C(C=C4)C(F)(F)F)O"
        },
        "molecularFormula": "C25H32F3N5O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:50:39Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85c2"
    },
    "name": "BRD-K38468651",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85c2.png",
    "lincs": {
      "id": "LSM-39387",
      "name": "BRD-K38468651",
      "pubchemCid": 44492490,
      "chebiId": 127831,
      "inchiParent": "InChI=1S/C35H38N4O6/c1-22-17-39(23(2)20-40)34(41)27-11-7-13-29(37-35(42)36-28-12-6-9-25-8-4-5-10-26(25)28)33(27)45-32(22)19-38(3)18-24-14-15-30-31(16-24)44-21-43-30/h4-16,22-23,32,40H,17-21H2,1-3H3,(H2,36,37,42)/t22-,23+,32-/m0/s1",
      "inchiKeyParent": "LDFNDVLWJVMLLU-YBBGPBPVSA-N",
      "smilesParent": "C[C@H](CO)N1C[C@H](C)[C@H](CN(C)Cc2ccc3OCOc3c2)Oc4c(NC(=O)Nc5cccc6ccccc56)cccc4C1=O"
    },
    "unichem": {
      "chebi": "127831",
      "lincs": "LSM-39387",
      "pubchem": "44492490"
    },
    "pubchem": [
      {
        "cid": 44492490,
        "inchi": "InChI=1S/C35H38N4O6/c1-22-17-39(23(2)20-40)34(41)27-11-7-13-29(37-35(42)36-28-12-6-9-25-8-4-5-10-26(25)28)33(27)45-32(22)19-38(3)18-24-14-15-30-31(16-24)44-21-43-30/h4-16,22-23,32,40H,17-21H2,1-3H3,(H2,36,37,42)/t22-,23+,32-/m0/s1",
        "inchikey": "LDFNDVLWJVMLLU-YBBGPBPVSA-N",
        "iupac": {
          "systematic": "1-[(2R,3S)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-naphthalen-1-ylurea"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(C(=CC=C2)NC(=O)NC3=CC=CC4=CC=CC=C43)OC1CN(C)CC5=CC6=C(C=C5)OCO6)C(C)CO"
        },
        "molecularFormula": "C35H38N4O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:50:41Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c864f"
    },
    "name": "BRD-K89840812",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c864f.png",
    "lincs": {
      "id": "LSM-42169",
      "name": "BRD-K89840812",
      "pubchemCid": 60189688,
      "chebiId": 130620,
      "inchiParent": "InChI=1S/C29H28FN5O4/c1-33-23-12-21(39-2)9-10-22(23)25-26(33)24(14-36)35(28(38)32-20-7-5-19(30)6-8-20)17-29(25)15-34(16-29)27(37)18-4-3-11-31-13-18/h3-13,24,36H,14-17H2,1-2H3,(H,32,38)/t24-/m1/s1",
      "inchiKeyParent": "MITHLIFONVYSRL-XMMPIXPASA-N",
      "smilesParent": "COc1ccc2c3c([C@@H](CO)N(CC34CN(C4)C(=O)c5cccnc5)C(=O)Nc6ccc(F)cc6)n(C)c2c1"
    },
    "unichem": {
      "chebi": "130620",
      "lincs": "LSM-42169",
      "pubchem": "60189688"
    },
    "pubchem": [
      {
        "cid": 60189688,
        "inchi": "InChI=1S/C29H28FN5O4/c1-33-23-12-21(39-2)9-10-22(23)25-26(33)24(14-36)35(28(38)32-20-7-5-19(30)6-8-20)17-29(25)15-34(16-29)27(37)18-4-3-11-31-13-18/h3-13,24,36H,14-17H2,1-2H3,(H,32,38)/t24-/m1/s1",
        "inchikey": "MITHLIFONVYSRL-XMMPIXPASA-N",
        "iupac": {
          "systematic": "(1S)-N-(4-fluorophenyl)-1-(hydroxymethyl)-7-methoxy-9-methyl-1'-(pyridine-3-carbonyl)spiro[1,3-dihydropyrido[3,4-b]indole-4,3'-azetidine]-2-carboxamide"
        },
        "smiles": {
          "canonical": "CN1C2=C(C=CC(=C2)OC)C3=C1C(N(CC34CN(C4)C(=O)C5=CN=CC=C5)C(=O)NC6=CC=C(C=C6)F)CO"
        },
        "molecularFormula": "C29H28FN5O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:50:43Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8531"
    },
    "name": "BRD-K76850979",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8531.png",
    "lincs": {
      "id": "LSM-41469",
      "name": "BRD-K76850979",
      "pubchemCid": 54615079,
      "chebiId": 129918,
      "inchiParent": "InChI=1S/C34H50N4O6/c1-23-19-38(24(2)22-39)33(40)30-18-28(36-34(41)35-27-11-14-29(42-5)15-12-27)13-16-31(30)44-25(3)8-6-7-17-43-32(23)21-37(4)20-26-9-10-26/h11-16,18,23-26,32,39H,6-10,17,19-22H2,1-5H3,(H2,35,36,41)/t23-,24+,25-,32+/m1/s1",
      "inchiKeyParent": "NRXGVPPIKRTMIX-DXJUBFBHSA-N",
      "smilesParent": "COc1ccc(NC(=O)Nc2ccc3O[C@H](C)CCCCO[C@@H](CN(C)CC4CC4)[C@H](C)CN([C@@H](C)CO)C(=O)c3c2)cc1"
    },
    "unichem": {
      "chebi": "129918",
      "lincs": "LSM-41469",
      "pubchem": "54615079"
    },
    "pubchem": [
      {
        "cid": 54615079,
        "inchi": "InChI=1S/C34H50N4O6/c1-23-19-38(24(2)22-39)33(40)30-18-28(36-34(41)35-27-11-14-29(42-5)15-12-27)13-16-31(30)44-25(3)8-6-7-17-43-32(23)21-37(4)20-26-9-10-26/h11-16,18,23-26,32,39H,6-10,17,19-22H2,1-5H3,(H2,35,36,41)/t23-,24+,25-,32+/m1/s1",
        "inchikey": "NRXGVPPIKRTMIX-DXJUBFBHSA-N",
        "iupac": {
          "systematic": "1-[(3R,9R,10R)-9-[[cyclopropylmethyl(methyl)amino]methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-(4-methoxyphenyl)urea"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NC(=O)NC3=CC=C(C=C3)OC)C(C)CO)C)CN(C)CC4CC4"
        },
        "molecularFormula": "C34H50N4O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:50:45Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8533"
    },
    "name": "BRD-K70647219",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8533.png",
    "lincs": {
      "id": "LSM-41113",
      "name": "BRD-K70647219",
      "pubchemCid": 44502244,
      "chebiId": 129562,
      "inchiParent": "InChI=1S/C33H47N5O9S2/c1-23-18-38(24(2)21-39)33(40)29-17-26(35-48(41,42)32-20-36(4)22-34-32)10-15-30(29)47-25(3)9-7-8-16-46-31(23)19-37(5)49(43,44)28-13-11-27(45-6)12-14-28/h10-15,17,20,22-25,31,35,39H,7-9,16,18-19,21H2,1-6H3/t23-,24+,25+,31+/m0/s1",
      "inchiKeyParent": "SFUGSXPFEQWGAS-DTTPJGKXSA-N",
      "smilesParent": "COc1ccc(cc1)S(=O)(=O)N(C)C[C@H]2OCCCC[C@@H](C)Oc3ccc(NS(=O)(=O)c4cn(C)cn4)cc3C(=O)N(C[C@@H]2C)[C@H](C)CO"
    },
    "unichem": {
      "chebi": "129562",
      "lincs": "LSM-41113",
      "pubchem": "44502244"
    },
    "pubchem": [
      {
        "cid": 44502244,
        "inchi": "InChI=1S/C33H47N5O9S2/c1-23-18-38(24(2)21-39)33(40)29-17-26(35-48(41,42)32-20-36(4)22-34-32)10-15-30(29)47-25(3)9-7-8-16-46-31(23)19-37(5)49(43,44)28-13-11-27(45-6)12-14-28/h10-15,17,20,22-25,31,35,39H,7-9,16,18-19,21H2,1-6H3/t23-,24+,25+,31+/m0/s1",
        "inchikey": "SFUGSXPFEQWGAS-DTTPJGKXSA-N",
        "iupac": {
          "systematic": "N-[(3R,9S,10S)-12-[(2R)-1-hydroxypropan-2-yl]-9-[[(4-methoxyphenyl)sulfonyl-methylamino]methyl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-1-methylimidazole-4-sulfonamide"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NS(=O)(=O)C3=CN(C=N3)C)C(C)CO)C)CN(C)S(=O)(=O)C4=CC=C(C=C4)OC"
        },
        "molecularFormula": "C33H47N5O9S2"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:50:48Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8569"
    },
    "name": "BRD-K73400194",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8569.png",
    "lincs": {
      "id": "LSM-12924",
      "name": "BRD-K73400194",
      "pubchemCid": 54638783,
      "chebiId": 101561,
      "inchiParent": "InChI=1S/C21H23N3O4/c25-14-19-18(24-20(26)11-15-5-4-10-22-13-15)9-8-17(28-19)12-21(27)23-16-6-2-1-3-7-16/h1-10,13,17-19,25H,11-12,14H2,(H,23,27)(H,24,26)/t17-,18-,19+/m1/s1",
      "inchiKeyParent": "XLYDKAUYLYXOHP-QRVBRYPASA-N",
      "smilesParent": "OC[C@@H]1O[C@@H](CC(=O)Nc2ccccc2)C=C[C@H]1NC(=O)Cc3cccnc3"
    },
    "unichem": {
      "chebi": "101561",
      "lincs": "LSM-12924",
      "pubchem": "54638783"
    },
    "pubchem": [
      {
        "cid": 54638783,
        "inchi": "InChI=1S/C21H23N3O4/c25-14-19-18(24-20(26)11-15-5-4-10-22-13-15)9-8-17(28-19)12-21(27)23-16-6-2-1-3-7-16/h1-10,13,17-19,25H,11-12,14H2,(H,23,27)(H,24,26)/t17-,18-,19+/m1/s1",
        "inchikey": "XLYDKAUYLYXOHP-QRVBRYPASA-N",
        "iupac": {
          "systematic": "2-[(2R,3R,6S)-2-(hydroxymethyl)-3-[(2-pyridin-3-ylacetyl)amino]-3,6-dihydro-2H-pyran-6-yl]-N-phenylacetamide"
        },
        "smiles": {
          "canonical": "C1=CC=C(C=C1)NC(=O)CC2C=CC(C(O2)CO)NC(=O)CC3=CN=CC=C3"
        },
        "molecularFormula": "C21H23N3O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:50:50Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c856f"
    },
    "name": "BRD-K52662613",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c856f.png",
    "lincs": {
      "id": "LSM-11645",
      "name": "BRD-K52662613",
      "pubchemCid": 54657569,
      "chebiId": 100270,
      "inchiParent": "InChI=1S/C25H39N3O5/c1-31-21-6-4-19(5-7-21)15-28-16-20(29)17-32-18-24-23(28)9-8-22(33-24)14-25(30)26-10-13-27-11-2-3-12-27/h4-7,20,22-24,29H,2-3,8-18H2,1H3,(H,26,30)/t20-,22+,23+,24-/m1/s1",
      "inchiKeyParent": "JSQZMBUYZHIIMM-AYVPJYCDSA-N",
      "smilesParent": "COc1ccc(CN2C[C@@H](O)COC[C@H]3O[C@H](CC(=O)NCCN4CCCC4)CC[C@H]23)cc1"
    },
    "unichem": {
      "chebi": "100270",
      "lincs": "LSM-11645",
      "pubchem": "54657569"
    },
    "pubchem": [
      {
        "cid": 54657569,
        "inchi": "InChI=1S/C25H39N3O5/c1-31-21-6-4-19(5-7-21)15-28-16-20(29)17-32-18-24-23(28)9-8-22(33-24)14-25(30)26-10-13-27-11-2-3-12-27/h4-7,20,22-24,29H,2-3,8-18H2,1H3,(H,26,30)/t20-,22+,23+,24-/m1/s1",
        "inchikey": "JSQZMBUYZHIIMM-AYVPJYCDSA-N",
        "iupac": {
          "systematic": "2-[(3R,6aS,8S,10aS)-3-hydroxy-1-[(4-methoxyphenyl)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-pyrrolidin-1-ylethyl)acetamide"
        },
        "smiles": {
          "canonical": "COC1=CC=C(C=C1)CN2CC(COCC3C2CCC(O3)CC(=O)NCCN4CCCC4)O"
        },
        "molecularFormula": "C25H39N3O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:50:52Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c857b"
    },
    "name": "BRD-K17750548",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c857b.png",
    "lincs": {
      "id": "LSM-9497",
      "name": "BRD-K17750548",
      "pubchemCid": 54657523,
      "chebiId": 98118,
      "inchiParent": "InChI=1S/C15H26N2O6/c1-2-5-16-15(21)17-7-10(18)8-22-9-13-12(17)4-3-11(23-13)6-14(19)20/h10-13,18H,2-9H2,1H3,(H,16,21)(H,19,20)/t10-,11+,12-,13+/m0/s1",
      "inchiKeyParent": "DUBDZBJJIAHCBK-QNWHQSFQSA-N",
      "smilesParent": "CCCNC(=O)N1C[C@H](O)COC[C@H]2O[C@@H](CC(=O)O)CC[C@H]12"
    },
    "unichem": {
      "chebi": "98118",
      "lincs": "LSM-9497",
      "pubchem": "54657523"
    },
    "pubchem": [
      {
        "cid": 54657523,
        "inchi": "InChI=1S/C15H26N2O6/c1-2-5-16-15(21)17-7-10(18)8-22-9-13-12(17)4-3-11(23-13)6-14(19)20/h10-13,18H,2-9H2,1H3,(H,16,21)(H,19,20)/t10-,11+,12-,13+/m0/s1",
        "inchikey": "DUBDZBJJIAHCBK-QNWHQSFQSA-N",
        "iupac": {
          "systematic": "2-[(3S,6aS,8R,10aS)-3-hydroxy-1-(propylcarbamoyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]acetic acid"
        },
        "smiles": {
          "canonical": "CCCNC(=O)N1CC(COCC2C1CCC(O2)CC(=O)O)O"
        },
        "molecularFormula": "C15H26N2O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:50:54Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c858a"
    },
    "name": "BRD-K05896800",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c858a.png",
    "lincs": {
      "id": "LSM-37593",
      "name": "BRD-K05896800",
      "pubchemCid": 54651374,
      "chebiId": 126026,
      "inchiParent": "InChI=1S/C22H28N2O2/c1-15(2)24(16(3)26)13-20-22(21(14-25)23-20)19-11-9-18(10-12-19)17-7-5-4-6-8-17/h4-12,15,20-23,25H,13-14H2,1-3H3/t20-,21-,22-/m0/s1",
      "inchiKeyParent": "HKQKKWWMRZRAPL-FKBYEOEOSA-N",
      "smilesParent": "CC(C)N(C[C@@H]1N[C@@H](CO)[C@H]1c2ccc(cc2)c3ccccc3)C(=O)C"
    },
    "unichem": {
      "chebi": "126026",
      "lincs": "LSM-37593",
      "pubchem": "54651374"
    },
    "pubchem": [
      {
        "cid": 54651374,
        "inchi": "InChI=1S/C22H28N2O2/c1-15(2)24(16(3)26)13-20-22(21(14-25)23-20)19-11-9-18(10-12-19)17-7-5-4-6-8-17/h4-12,15,20-23,25H,13-14H2,1-3H3/t20-,21-,22-/m0/s1",
        "inchikey": "HKQKKWWMRZRAPL-FKBYEOEOSA-N",
        "iupac": {
          "systematic": "N-[[(2R,3S,4R)-4-(hydroxymethyl)-3-(4-phenylphenyl)azetidin-2-yl]methyl]-N-propan-2-ylacetamide"
        },
        "smiles": {
          "canonical": "CC(C)N(CC1C(C(N1)CO)C2=CC=C(C=C2)C3=CC=CC=C3)C(=O)C"
        },
        "molecularFormula": "C22H28N2O2"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:50:57Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85f3"
    },
    "name": "BRD-K33761091",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85f3.png",
    "lincs": {
      "id": "LSM-10475",
      "name": "BRD-K33761091",
      "pubchemCid": 54638802,
      "chebiId": 99096,
      "inchiParent": "InChI=1S/C20H30N6O3/c1-25(2)12-16-13-26(24-23-16)9-7-17-5-6-18(19(14-27)29-17)22-20(28)10-15-4-3-8-21-11-15/h3-4,8,11,13,17-19,27H,5-7,9-10,12,14H2,1-2H3,(H,22,28)/t17-,18+,19+/m0/s1",
      "inchiKeyParent": "NKPFHNDONDWVBL-IPMKNSEASA-N",
      "smilesParent": "CN(C)Cc1cn(CC[C@@H]2CC[C@@H](NC(=O)Cc3cccnc3)[C@@H](CO)O2)nn1"
    },
    "unichem": {
      "chebi": "99096",
      "lincs": "LSM-10475",
      "pubchem": "54638802"
    },
    "pubchem": [
      {
        "cid": 54638802,
        "inchi": "InChI=1S/C20H30N6O3/c1-25(2)12-16-13-26(24-23-16)9-7-17-5-6-18(19(14-27)29-17)22-20(28)10-15-4-3-8-21-11-15/h3-4,8,11,13,17-19,27H,5-7,9-10,12,14H2,1-2H3,(H,22,28)/t17-,18+,19+/m0/s1",
        "inchikey": "NKPFHNDONDWVBL-IPMKNSEASA-N",
        "iupac": {
          "systematic": "N-[(2S,3R,6S)-6-[2-[4-[(dimethylamino)methyl]triazol-1-yl]ethyl]-2-(hydroxymethyl)oxan-3-yl]-2-pyridin-3-ylacetamide"
        },
        "smiles": {
          "canonical": "CN(C)CC1=CN(N=N1)CCC2CCC(C(O2)CO)NC(=O)CC3=CN=CC=C3"
        },
        "molecularFormula": "C20H30N6O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:50:59Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8608"
    },
    "name": "BRD-K14649905",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8608.png",
    "lincs": {
      "id": "LSM-9315",
      "name": "BRD-K14649905",
      "pubchemCid": 54646155,
      "chebiId": 97936,
      "inchiParent": "InChI=1S/C28H36N4O5/c33-18-25-28-23(16-21(36-25)17-26(34)30-10-13-32-11-2-1-3-12-32)22-15-20(4-5-24(22)37-28)31-27(35)14-19-6-8-29-9-7-19/h4-9,15,21,23,25,28,33H,1-3,10-14,16-18H2,(H,30,34)(H,31,35)/t21-,23-,25-,28+/m0/s1",
      "inchiKeyParent": "FBZDSUDTYUQYGJ-CRZMAGMNSA-N",
      "smilesParent": "OC[C@@H]1O[C@H](CC(=O)NCCN2CCCCC2)C[C@@H]3[C@H]1Oc4ccc(NC(=O)Cc5ccncc5)cc34"
    },
    "unichem": {
      "chebi": "97936",
      "lincs": "LSM-9315",
      "pubchem": "54646155"
    },
    "pubchem": [
      {
        "cid": 54646155,
        "inchi": "InChI=1S/C28H36N4O5/c33-18-25-28-23(16-21(36-25)17-26(34)30-10-13-32-11-2-1-3-12-32)22-15-20(4-5-24(22)37-28)31-27(35)14-19-6-8-29-9-7-19/h4-9,15,21,23,25,28,33H,1-3,10-14,16-18H2,(H,30,34)(H,31,35)/t21-,23-,25-,28+/m0/s1",
        "inchikey": "FBZDSUDTYUQYGJ-CRZMAGMNSA-N",
        "iupac": {
          "systematic": "2-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-6-[(2-pyridin-4-ylacetyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-(2-piperidin-1-ylethyl)acetamide"
        },
        "smiles": {
          "canonical": "C1CCN(CC1)CCNC(=O)CC2CC3C(C(O2)CO)OC4=C3C=C(C=C4)NC(=O)CC5=CC=NC=C5"
        },
        "molecularFormula": "C28H36N4O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:51:01Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8635"
    },
    "name": "CHEMBL2136711",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8635.png",
    "lincs": {
      "id": "LSM-37843",
      "name": "CHEMBL2136711",
      "alternativeNames": [
        "BRD-K11095531"
      ],
      "pubchemCid": 54651237,
      "chebiId": 126277,
      "inchiParent": "InChI=1S/C23H27FN2O3/c1-4-22(29)25(3)13-20-23(21(14-27)26(20)15(2)28)17-11-9-16(10-12-17)18-7-5-6-8-19(18)24/h5-12,20-21,23,27H,4,13-14H2,1-3H3/t20-,21+,23+/m1/s1",
      "inchiKeyParent": "LFVZONGIIWXQAC-GIWBLDEGSA-N",
      "smilesParent": "CCC(=O)N(C)C[C@@H]1[C@@H]([C@H](CO)N1C(=O)C)c2ccc(cc2)c3ccccc3F"
    },
    "unichem": {
      "chebi": "126277",
      "chembl": "CHEMBL2136711",
      "lincs": "LSM-37843",
      "pubchem": "54651237"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL2136711",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 398.48,
        "hba": 3,
        "hbd": 1,
        "qedWeighted": 0.81
      }
    },
    "pubchem": [
      {
        "cid": 54651237,
        "inchi": "InChI=1S/C23H27FN2O3/c1-4-22(29)25(3)13-20-23(21(14-27)26(20)15(2)28)17-11-9-16(10-12-17)18-7-5-6-8-19(18)24/h5-12,20-21,23,27H,4,13-14H2,1-3H3/t20-,21+,23+/m1/s1",
        "inchikey": "LFVZONGIIWXQAC-GIWBLDEGSA-N",
        "iupac": {
          "systematic": "N-[[(2S,3S,4R)-1-acetyl-3-[4-(2-fluorophenyl)phenyl]-4-(hydroxymethyl)azetidin-2-yl]methyl]-N-methylpropanamide"
        },
        "smiles": {
          "canonical": "CCC(=O)N(C)CC1C(C(N1C(=O)C)CO)C2=CC=C(C=C2)C3=CC=CC=C3F"
        },
        "molecularFormula": "C23H27FN2O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:51:12Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8507"
    },
    "name": "BRD-K96450063",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8507.png",
    "lincs": {
      "id": "LSM-46125",
      "name": "BRD-K96450063",
      "inchiParent": "InChI=1S/C26H24F3N3O2/c1-34-21-4-2-3-18(13-21)16-5-7-17(8-6-16)24-22-14-30-15-23(24)32(22)25(33)31-20-11-9-19(10-12-20)26(27,28)29/h2-13,22-24,30H,14-15H2,1H3,(H,31,33)/t22-,23+,24+",
      "inchiKeyParent": "UFQDQBMWIIWRHQ-UBRQYEGLSA-N",
      "smilesParent": "COc1cccc(c1)c2ccc(cc2)[C@H]3[C@H]4CNC[C@@H]3N4C(=O)Nc5ccc(cc5)C(F)(F)F"
    },
    "unichem": {
      "lincs": "LSM-46125"
    },
    "createdAt": {
      "$date": "2025-05-24T08:51:14Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c856b"
    },
    "name": "BRD-K31830150",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c856b.png",
    "lincs": {
      "id": "LSM-10360",
      "name": "BRD-K31830150",
      "pubchemCid": 54657736,
      "chebiId": 98981,
      "inchiParent": "InChI=1S/C29H31N3O5/c33-24-17-32(29(35)22-7-4-14-30-16-22)26-13-12-25(37-27(26)19-36-18-24)15-28(34)31-23-10-8-21(9-11-23)20-5-2-1-3-6-20/h1-11,14,16,24-27,33H,12-13,15,17-19H2,(H,31,34)/t24-,25+,26-,27+/m1/s1",
      "inchiKeyParent": "WTHWQCPYZWPYSX-RAVGUYNFSA-N",
      "smilesParent": "O[C@H]1COC[C@@H]2O[C@H](CC(=O)Nc3ccc(cc3)c4ccccc4)CC[C@H]2N(C1)C(=O)c5cccnc5"
    },
    "unichem": {
      "chebi": "98981",
      "lincs": "LSM-10360",
      "pubchem": "54657736"
    },
    "pubchem": [
      {
        "cid": 54657736,
        "inchi": "InChI=1S/C29H31N3O5/c33-24-17-32(29(35)22-7-4-14-30-16-22)26-13-12-25(37-27(26)19-36-18-24)15-28(34)31-23-10-8-21(9-11-23)20-5-2-1-3-6-20/h1-11,14,16,24-27,33H,12-13,15,17-19H2,(H,31,34)/t24-,25+,26-,27+/m1/s1",
        "inchikey": "WTHWQCPYZWPYSX-RAVGUYNFSA-N",
        "iupac": {
          "systematic": "2-[(3R,6aR,8S,10aR)-3-hydroxy-1-(pyridine-3-carbonyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(4-phenylphenyl)acetamide"
        },
        "smiles": {
          "canonical": "C1CC2C(COCC(CN2C(=O)C3=CN=CC=C3)O)OC1CC(=O)NC4=CC=C(C=C4)C5=CC=CC=C5"
        },
        "molecularFormula": "C29H31N3O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:51:16Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85bb"
    },
    "name": "BRD-K82769855",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85bb.png",
    "lincs": {
      "id": "LSM-41794",
      "name": "BRD-K82769855",
      "pubchemCid": 44490823,
      "chebiId": 130245,
      "inchiParent": "InChI=1S/C25H33N3O7S/c1-16-11-28(17(2)14-29)25(30)19-6-5-7-20(26-36(4,31)32)24(19)35-23(16)13-27(3)12-18-8-9-21-22(10-18)34-15-33-21/h5-10,16-17,23,26,29H,11-15H2,1-4H3/t16-,17-,23-/m0/s1",
      "inchiKeyParent": "LOSHTFMJKXKCOQ-QQMNAOGKSA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@H](C)[C@H](CN(C)Cc2ccc3OCOc3c2)Oc4c(NS(=O)(=O)C)cccc4C1=O"
    },
    "unichem": {
      "chebi": "130245",
      "lincs": "LSM-41794",
      "pubchem": "44490823"
    },
    "pubchem": [
      {
        "cid": 44490823,
        "inchi": "InChI=1S/C25H33N3O7S/c1-16-11-28(17(2)14-29)25(30)19-6-5-7-20(26-36(4,31)32)24(19)35-23(16)13-27(3)12-18-8-9-21-22(10-18)34-15-33-21/h5-10,16-17,23,26,29H,11-15H2,1-4H3/t16-,17-,23-/m0/s1",
        "inchikey": "LOSHTFMJKXKCOQ-QQMNAOGKSA-N",
        "iupac": {
          "systematic": "N-[(2R,3S)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]methanesulfonamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(C(=CC=C2)NS(=O)(=O)C)OC1CN(C)CC3=CC4=C(C=C3)OCO4)C(C)CO"
        },
        "molecularFormula": "C25H33N3O7S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:51:18Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85cb"
    },
    "name": "BRD-K11480730",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85cb.png",
    "lincs": {
      "id": "LSM-37857",
      "name": "BRD-K11480730",
      "pubchemCid": 44485360,
      "chebiId": 126291,
      "inchiParent": "InChI=1S/C36H46N4O5/c1-26-22-40(27(2)25-41)36(43)32-21-31(37-35(42)15-16-39-17-19-44-20-18-39)13-14-33(32)45-34(26)24-38(3)23-28-9-11-30(12-10-28)29-7-5-4-6-8-29/h4-14,21,26-27,34,41H,15-20,22-25H2,1-3H3,(H,37,42)/t26-,27+,34-/m0/s1",
      "inchiKeyParent": "BPRBOEBHCISTIC-MZXMJASYSA-N",
      "smilesParent": "C[C@H](CO)N1C[C@H](C)[C@H](CN(C)Cc2ccc(cc2)c3ccccc3)Oc4ccc(NC(=O)CCN5CCOCC5)cc4C1=O"
    },
    "unichem": {
      "chebi": "126291",
      "lincs": "LSM-37857",
      "pubchem": "44485360"
    },
    "pubchem": [
      {
        "cid": 44485360,
        "inchi": "InChI=1S/C36H46N4O5/c1-26-22-40(27(2)25-41)36(43)32-21-31(37-35(42)15-16-39-17-19-44-20-18-39)13-14-33(32)45-34(26)24-38(3)23-28-9-11-30(12-10-28)29-7-5-4-6-8-29/h4-14,21,26-27,34,41H,15-20,22-25H2,1-3H3,(H,37,42)/t26-,27+,34-/m0/s1",
        "inchikey": "BPRBOEBHCISTIC-MZXMJASYSA-N",
        "iupac": {
          "systematic": "N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-morpholin-4-ylpropanamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(C=CC(=C2)NC(=O)CCN3CCOCC3)OC1CN(C)CC4=CC=C(C=C4)C5=CC=CC=C5)C(C)CO"
        },
        "molecularFormula": "C36H46N4O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:51:20Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c860e"
    },
    "name": "BRD-K08502366",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c860e.png",
    "lincs": {
      "id": "LSM-37735",
      "name": "BRD-K08502366",
      "pubchemCid": 60185098,
      "chebiId": 126168,
      "inchiParent": "InChI=1S/C28H36N4O3S/c1-35-20-7-8-21-22(15-20)30-26-23(17-33)32(16-24-29-11-14-36-24)18-28(25(21)26)9-12-31(13-10-28)27(34)19-5-3-2-4-6-19/h7-8,11,14-15,19,23,30,33H,2-6,9-10,12-13,16-18H2,1H3/t23-/m0/s1",
      "inchiKeyParent": "GXKALLIITMFLID-QHCPKHFHSA-N",
      "smilesParent": "COc1ccc2c3c([nH]c2c1)[C@H](CO)N(Cc4nccs4)CC35CCN(CC5)C(=O)C6CCCCC6"
    },
    "unichem": {
      "chebi": "126168",
      "lincs": "LSM-37735",
      "pubchem": "60185098"
    },
    "pubchem": [
      {
        "cid": 60185098,
        "inchi": "InChI=1S/C28H36N4O3S/c1-35-20-7-8-21-22(15-20)30-26-23(17-33)32(16-24-29-11-14-36-24)18-28(25(21)26)9-12-31(13-10-28)27(34)19-5-3-2-4-6-19/h7-8,11,14-15,19,23,30,33H,2-6,9-10,12-13,16-18H2,1H3/t23-/m0/s1",
        "inchikey": "GXKALLIITMFLID-QHCPKHFHSA-N",
        "iupac": {
          "systematic": "cyclohexyl-[(1R)-1-(hydroxymethyl)-7-methoxy-2-(1,3-thiazol-2-ylmethyl)spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4'-piperidine]-1'-yl]methanone"
        },
        "smiles": {
          "canonical": "COC1=CC2=C(C=C1)C3=C(N2)C(N(CC34CCN(CC4)C(=O)C5CCCCC5)CC6=NC=CS6)CO"
        },
        "molecularFormula": "C28H36N4O3S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:51:22Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c850e"
    },
    "name": "BRD-K86124549",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c850e.png",
    "lincs": {
      "id": "LSM-13703",
      "name": "BRD-K86124549",
      "pubchemCid": 54660840,
      "chebiId": 102351,
      "inchiParent": "InChI=1S/C27H33N3O5/c1-34-23-5-3-2-4-18(23)19-8-9-21-25-24(27(33)28-10-12-35-13-11-28)20(16-31)22(15-30(21)26(19)32)29(25)14-17-6-7-17/h2-5,8-9,17,20,22,24-25,31H,6-7,10-16H2,1H3/t20-,22-,24+,25+/m0/s1",
      "inchiKeyParent": "ZZGFZYXZJHIJMZ-MMTHZHQFSA-N",
      "smilesParent": "COc1ccccc1C2=CC=C3[C@@H]4[C@@H]([C@@H](CO)[C@H](CN3C2=O)N4CC5CC5)C(=O)N6CCOCC6"
    },
    "unichem": {
      "chebi": "102351",
      "lincs": "LSM-13703",
      "pubchem": "54660840"
    },
    "pubchem": [
      {
        "cid": 54660840,
        "inchi": "InChI=1S/C27H33N3O5/c1-34-23-5-3-2-4-18(23)19-8-9-21-25-24(27(33)28-10-12-35-13-11-28)20(16-31)22(15-30(21)26(19)32)29(25)14-17-6-7-17/h2-5,8-9,17,20,22,24-25,31H,6-7,10-16H2,1H3/t20-,22-,24+,25+/m0/s1",
        "inchikey": "ZZGFZYXZJHIJMZ-MMTHZHQFSA-N",
        "iupac": {
          "systematic": "(1S,9R,10R,11R)-12-(cyclopropylmethyl)-10-(hydroxymethyl)-5-(2-methoxyphenyl)-11-(morpholine-4-carbonyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-dien-6-one"
        },
        "smiles": {
          "canonical": "COC1=CC=CC=C1C2=CC=C3C4C(C(C(N4CC5CC5)CN3C2=O)CO)C(=O)N6CCOCC6"
        },
        "molecularFormula": "C27H33N3O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:51:25Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8561"
    },
    "name": "BRD-K15690570",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8561.png",
    "lincs": {
      "id": "LSM-9368",
      "name": "BRD-K15690570",
      "pubchemCid": 54654167,
      "chebiId": 97989,
      "inchiParent": "InChI=1S/C24H25F2N3O5/c1-27-22(30)11-17-4-5-19-21(34-17)12-33-20-6-3-16(10-18(20)24(32)29(19)2)28-23(31)13-7-14(25)9-15(26)8-13/h3,6-10,17,19,21H,4-5,11-12H2,1-2H3,(H,27,30)(H,28,31)/t17-,19-,21+/m0/s1",
      "inchiKeyParent": "RQAOUBOGQGVTCU-HFSMHLIXSA-N",
      "smilesParent": "CNC(=O)C[C@@H]1CC[C@H]2[C@@H](COc3ccc(NC(=O)c4cc(F)cc(F)c4)cc3C(=O)N2C)O1"
    },
    "unichem": {
      "chebi": "97989",
      "lincs": "LSM-9368",
      "pubchem": "54654167"
    },
    "pubchem": [
      {
        "cid": 54654167,
        "inchi": "InChI=1S/C24H25F2N3O5/c1-27-22(30)11-17-4-5-19-21(34-17)12-33-20-6-3-16(10-18(20)24(32)29(19)2)28-23(31)13-7-14(25)9-15(26)8-13/h3,6-10,17,19,21H,4-5,11-12H2,1-2H3,(H,27,30)(H,28,31)/t17-,19-,21+/m0/s1",
        "inchikey": "RQAOUBOGQGVTCU-HFSMHLIXSA-N",
        "iupac": {
          "systematic": "N-[(2S,4aS,12aS)-5-methyl-2-[2-(methylamino)-2-oxoethyl]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-3,5-difluorobenzamide"
        },
        "smiles": {
          "canonical": "CNC(=O)CC1CCC2C(O1)COC3=C(C=C(C=C3)NC(=O)C4=CC(=CC(=C4)F)F)C(=O)N2C"
        },
        "molecularFormula": "C24H25F2N3O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:51:27Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85d9"
    },
    "name": "ST004815",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85d9.png",
    "lincs": {
      "id": "LSM-36681",
      "name": "ST004815",
      "alternativeNames": [
        "BRD-K41172353"
      ],
      "pubchemCid": 673329,
      "chebiId": 125213,
      "inchiParent": "InChI=1S/C16H11NOS/c18-16(12-6-2-1-3-7-12)19-15-10-4-9-14-13(15)8-5-11-17-14/h1-11H",
      "inchiKeyParent": "KYHBLDMJXVGVKJ-UHFFFAOYSA-N",
      "smilesParent": "O=C(Sc1cccc2ncccc12)c3ccccc3"
    },
    "unichem": {
      "chebi": "125213",
      "lincs": "LSM-36681",
      "pubchem": "673329"
    },
    "pubchem": [
      {
        "cid": 673329,
        "inchi": "InChI=1S/C16H11NOS/c18-16(12-6-2-1-3-7-12)19-15-10-4-9-14-13(15)8-5-11-17-14/h1-11H",
        "inchikey": "KYHBLDMJXVGVKJ-UHFFFAOYSA-N",
        "iupac": {
          "systematic": "S-quinolin-5-yl benzenecarbothioate"
        },
        "smiles": {
          "canonical": "C1=CC=C(C=C1)C(=O)SC2=CC=CC3=C2C=CC=N3"
        },
        "molecularFormula": "C16H11NOS"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:51:29Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8611"
    },
    "name": "BRD-K52136013-019-01-9",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8611.png",
    "lincs": {
      "id": "LSM-44556",
      "name": "BRD-K52136013-019-01-9",
      "alternativeNames": [
        "BRD-K52136013",
        "BRD-K56231599"
      ],
      "pubchemCid": 60185205,
      "inchiParent": "InChI=1S/C23H27N3O/c1-25(2)16-22(27)26-14-20-23(21(15-26)24-20)19-12-10-18(11-13-19)9-8-17-6-4-3-5-7-17/h3-13,20-21,23-24H,14-16H2,1-2H3/b9-8+/t20-,21+,23?",
      "inchiKeyParent": "JRBCRMRMHKTKPI-VVQALIPLSA-N",
      "smilesParent": "CN(C)CC(=O)N1C[C@@H]2N[C@H](C1)[C@@H]2c3ccc(\\C=C\\c4ccccc4)cc3"
    },
    "unichem": {
      "lincs": "LSM-44556",
      "pubchem": "60185205"
    },
    "pubchem": [
      {
        "cid": 60185205,
        "inchi": "InChI=1S/C23H27N3O/c1-25(2)16-22(27)26-14-20-23(21(15-26)24-20)19-12-10-18(11-13-19)9-8-17-6-4-3-5-7-17/h3-13,20-21,23-24H,14-16H2,1-2H3/b9-8+/t20-,21+,23?",
        "inchikey": "JRBCRMRMHKTKPI-VVQALIPLSA-N",
        "iupac": {
          "systematic": "2-(dimethylamino)-1-[(1S,5R)-7-[4-[(E)-2-phenylethenyl]phenyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]ethanone"
        },
        "smiles": {
          "canonical": "CN(C)CC(=O)N1CC2C(C(C1)N2)C3=CC=C(C=C3)C=CC4=CC=CC=C4"
        },
        "molecularFormula": "C23H27N3O"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:51:32Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8628"
    },
    "name": "BRD-K80204885",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8628.png",
    "lincs": {
      "id": "LSM-41647",
      "name": "BRD-K80204885",
      "pubchemCid": 54652637,
      "chebiId": 130097,
      "inchiParent": "InChI=1S/C21H21FN2O4/c1-28-12-19(26)23-10-17-20(14-7-3-5-9-16(14)23)18(11-25)24(17)21(27)13-6-2-4-8-15(13)22/h2-9,17-18,20,25H,10-12H2,1H3/t17-,18+,20+/m0/s1",
      "inchiKeyParent": "FNVQGPHQAOFVNP-NLWGTHIKSA-N",
      "smilesParent": "COCC(=O)N1C[C@H]2[C@H]([C@@H](CO)N2C(=O)c3ccccc3F)c4ccccc14"
    },
    "unichem": {
      "chebi": "130097",
      "lincs": "LSM-41647",
      "pubchem": "54652637"
    },
    "pubchem": [
      {
        "cid": 54652637,
        "inchi": "InChI=1S/C21H21FN2O4/c1-28-12-19(26)23-10-17-20(14-7-3-5-9-16(14)23)18(11-25)24(17)21(27)13-6-2-4-8-15(13)22/h2-9,17-18,20,25H,10-12H2,1H3/t17-,18+,20+/m0/s1",
        "inchikey": "FNVQGPHQAOFVNP-NLWGTHIKSA-N",
        "iupac": {
          "systematic": "1-[(1S,2aR,8bR)-2-(2-fluorobenzoyl)-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-2-methoxyethanone"
        },
        "smiles": {
          "canonical": "COCC(=O)N1CC2C(C(N2C(=O)C3=CC=CC=C3F)CO)C4=CC=CC=C41"
        },
        "molecularFormula": "C21H21FN2O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:51:34Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8509"
    },
    "name": "BRD-K97599743",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8509.png",
    "lincs": {
      "id": "LSM-42557",
      "name": "BRD-K97599743",
      "pubchemCid": 54652438,
      "chebiId": 131009,
      "inchiParent": "InChI=1S/C22H26N4O2/c27-14-20-21-16-7-3-4-8-18(16)26(22(28)17-11-23-9-10-24-17)13-19(21)25(20)12-15-5-1-2-6-15/h3-4,7-11,15,19-21,27H,1-2,5-6,12-14H2/t19-,20+,21+/m0/s1",
      "inchiKeyParent": "JGYATIWRVBGIJM-PWRODBHTSA-N",
      "smilesParent": "OC[C@@H]1[C@H]2[C@H](CN(C(=O)c3cnccn3)c4ccccc24)N1CC5CCCC5"
    },
    "unichem": {
      "chebi": "131009",
      "lincs": "LSM-42557",
      "pubchem": "54652438"
    },
    "pubchem": [
      {
        "cid": 54652438,
        "inchi": "InChI=1S/C22H26N4O2/c27-14-20-21-16-7-3-4-8-18(16)26(22(28)17-11-23-9-10-24-17)13-19(21)25(20)12-15-5-1-2-6-15/h3-4,7-11,15,19-21,27H,1-2,5-6,12-14H2/t19-,20+,21+/m0/s1",
        "inchikey": "JGYATIWRVBGIJM-PWRODBHTSA-N",
        "iupac": {
          "systematic": "[(1S,2aR,8bR)-2-(cyclopentylmethyl)-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-pyrazin-2-ylmethanone"
        },
        "smiles": {
          "canonical": "C1CCC(C1)CN2C3CN(C4=CC=CC=C4C3C2CO)C(=O)C5=NC=CN=C5"
        },
        "molecularFormula": "C22H26N4O2"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:51:36Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8524"
    },
    "name": "BRD-K31175437",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8524.png",
    "lincs": {
      "id": "LSM-38970",
      "name": "BRD-K31175437",
      "pubchemCid": 54615102,
      "chebiId": 127412,
      "inchiParent": "InChI=1S/C35H44N4O6/c1-24-21-39(25(2)23-40)35(43)30-20-29(37-33(41)27-11-6-5-7-12-27)13-14-31(30)45-26(3)10-8-9-19-44-32(24)22-38(4)34(42)28-15-17-36-18-16-28/h5-7,11-18,20,24-26,32,40H,8-10,19,21-23H2,1-4H3,(H,37,41)/t24-,25-,26-,32-/m1/s1",
      "inchiKeyParent": "LFSFSXVVLAKPPY-WRZBRUQPSA-N",
      "smilesParent": "C[C@H](CO)N1C[C@@H](C)[C@@H](CN(C)C(=O)c2ccncc2)OCCCC[C@@H](C)Oc3ccc(NC(=O)c4ccccc4)cc3C1=O"
    },
    "unichem": {
      "chebi": "127412",
      "lincs": "LSM-38970",
      "pubchem": "54615102"
    },
    "pubchem": [
      {
        "cid": 54615102,
        "inchi": "InChI=1S/C35H44N4O6/c1-24-21-39(25(2)23-40)35(43)30-20-29(37-33(41)27-11-6-5-7-12-27)13-14-31(30)45-26(3)10-8-9-19-44-32(24)22-38(4)34(42)28-15-17-36-18-16-28/h5-7,11-18,20,24-26,32,40H,8-10,19,21-23H2,1-4H3,(H,37,41)/t24-,25-,26-,32-/m1/s1",
        "inchikey": "LFSFSXVVLAKPPY-WRZBRUQPSA-N",
        "iupac": {
          "systematic": "N-[[(3R,9S,10R)-16-benzamido-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methylpyridine-4-carboxamide"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NC(=O)C3=CC=CC=C3)C(C)CO)C)CN(C)C(=O)C4=CC=NC=C4"
        },
        "molecularFormula": "C35H44N4O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:51:38Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85a5"
    },
    "name": "BRD-K80579043",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85a5.png",
    "lincs": {
      "id": "LSM-41659",
      "name": "BRD-K80579043",
      "pubchemCid": 60185094,
      "chebiId": 130109,
      "inchiParent": "InChI=1S/C27H32N4O5/c1-29-21-14-18(36-3)7-8-19(21)24-25(29)22(15-32)31(23(33)16-35-2)17-27(24)9-12-30(13-10-27)26(34)20-6-4-5-11-28-20/h4-8,11,14,22,32H,9-10,12-13,15-17H2,1-3H3/t22-/m0/s1",
      "inchiKeyParent": "OWXHTGNPONOMFJ-QFIPXVFZSA-N",
      "smilesParent": "COCC(=O)N1CC2(CCN(CC2)C(=O)c3ccccn3)c4c([C@@H]1CO)n(C)c5cc(OC)ccc45"
    },
    "unichem": {
      "chebi": "130109",
      "lincs": "LSM-41659",
      "pubchem": "60185094"
    },
    "pubchem": [
      {
        "cid": 60185094,
        "inchi": "InChI=1S/C27H32N4O5/c1-29-21-14-18(36-3)7-8-19(21)24-25(29)22(15-32)31(23(33)16-35-2)17-27(24)9-12-30(13-10-27)26(34)20-6-4-5-11-28-20/h4-8,11,14,22,32H,9-10,12-13,15-17H2,1-3H3/t22-/m0/s1",
        "inchikey": "OWXHTGNPONOMFJ-QFIPXVFZSA-N",
        "iupac": {
          "systematic": "1-[(1R)-1-(hydroxymethyl)-7-methoxy-9-methyl-1'-(pyridine-2-carbonyl)spiro[1,3-dihydropyrido[3,4-b]indole-4,4'-piperidine]-2-yl]-2-methoxyethanone"
        },
        "smiles": {
          "canonical": "CN1C2=C(C=CC(=C2)OC)C3=C1C(N(CC34CCN(CC4)C(=O)C5=CC=CC=N5)C(=O)COC)CO"
        },
        "molecularFormula": "C27H32N4O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:51:40Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85e2"
    },
    "name": "BRD-K02159117",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85e2.png",
    "lincs": {
      "id": "LSM-8566",
      "name": "BRD-K02159117",
      "pubchemCid": 54649416,
      "chebiId": 97187,
      "inchiParent": "InChI=1S/C34H42N4O4S/c1-34(2,3)43(42)38-22-27-21-28(33(41)37-16-7-6-8-17-37)35-31(30(27)29(38)15-18-39)25-13-9-11-23(19-25)24-12-10-14-26(20-24)32(40)36(4)5/h9-14,19-21,29,39H,6-8,15-18,22H2,1-5H3/t29-,43-/m1/s1",
      "inchiKeyParent": "KPHKCBNGEDAQEL-WXTZLZKPSA-N",
      "smilesParent": "CN(C)C(=O)c1cccc(c1)c2cccc(c2)c3nc(cc4CN([C@H](CCO)c34)[S@](=O)C(C)(C)C)C(=O)N5CCCCC5"
    },
    "unichem": {
      "chebi": "97187",
      "lincs": "LSM-8566",
      "pubchem": "54649416"
    },
    "pubchem": [
      {
        "cid": 54649416,
        "inchi": "InChI=1S/C34H42N4O4S/c1-34(2,3)43(42)38-22-27-21-28(33(41)37-16-7-6-8-17-37)35-31(30(27)29(38)15-18-39)25-13-9-11-23(19-25)24-12-10-14-26(20-24)32(40)36(4)5/h9-14,19-21,29,39H,6-8,15-18,22H2,1-5H3/t29-,43-/m1/s1",
        "inchikey": "KPHKCBNGEDAQEL-WXTZLZKPSA-N",
        "iupac": {
          "systematic": "3-[3-[(3R)-2-[(R)-tert-butylsulfinyl]-3-(2-hydroxyethyl)-6-(piperidine-1-carbonyl)-1,3-dihydropyrrolo[3,4-c]pyridin-4-yl]phenyl]-N,N-dimethylbenzamide"
        },
        "smiles": {
          "canonical": "CC(C)(C)S(=O)N1CC2=CC(=NC(=C2C1CCO)C3=CC=CC(=C3)C4=CC(=CC=C4)C(=O)N(C)C)C(=O)N5CCCCC5"
        },
        "molecularFormula": "C34H42N4O4S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:51:43Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8648"
    },
    "name": "BRD-K92912836",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8648.png",
    "lincs": {
      "id": "LSM-42316",
      "name": "BRD-K92912836",
      "pubchemCid": 54652516,
      "chebiId": 130767,
      "inchiParent": "InChI=1S/C24H27ClN2O3/c25-18-7-5-16(6-8-18)13-26-21-14-27(24(29)17-9-11-30-12-10-17)20-4-2-1-3-19(20)23(21)22(26)15-28/h1-8,17,21-23,28H,9-15H2/t21-,22+,23+/m1/s1",
      "inchiKeyParent": "KGAZZJOVSJKWCZ-VJBWXMMDSA-N",
      "smilesParent": "OC[C@H]1[C@@H]2[C@@H](CN(C(=O)C3CCOCC3)c4ccccc24)N1Cc5ccc(Cl)cc5"
    },
    "unichem": {
      "chebi": "130767",
      "lincs": "LSM-42316",
      "pubchem": "54652516"
    },
    "pubchem": [
      {
        "cid": 54652516,
        "inchi": "InChI=1S/C24H27ClN2O3/c25-18-7-5-16(6-8-18)13-26-21-14-27(24(29)17-9-11-30-12-10-17)20-4-2-1-3-19(20)23(21)22(26)15-28/h1-8,17,21-23,28H,9-15H2/t21-,22+,23+/m1/s1",
        "inchikey": "KGAZZJOVSJKWCZ-VJBWXMMDSA-N",
        "iupac": {
          "systematic": "[(1R,2aS,8bS)-2-[(4-chlorophenyl)methyl]-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-(oxan-4-yl)methanone"
        },
        "smiles": {
          "canonical": "C1COCCC1C(=O)N2CC3C(C(N3CC4=CC=C(C=C4)Cl)CO)C5=CC=CC=C52"
        },
        "molecularFormula": "C24H27ClN2O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:51:45Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85c3"
    },
    "name": "BRD-K42841961",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85c3.png",
    "lincs": {
      "id": "LSM-39625",
      "name": "BRD-K42841961",
      "pubchemCid": 54615029,
      "chebiId": 128069,
      "inchiParent": "InChI=1S/C37H55N3O6/c1-26-22-40(27(2)25-41)37(43)33-21-31(38-36(42)30-12-7-6-8-13-30)16-19-34(33)46-28(3)11-9-10-20-45-35(26)24-39(4)23-29-14-17-32(44-5)18-15-29/h14-19,21,26-28,30,35,41H,6-13,20,22-25H2,1-5H3,(H,38,42)/t26-,27+,28-,35+/m1/s1",
      "inchiKeyParent": "UVSCGJDGVAXROK-GTZOPPDQSA-N",
      "smilesParent": "COc1ccc(CN(C)C[C@@H]2OCCCC[C@@H](C)Oc3ccc(NC(=O)C4CCCCC4)cc3C(=O)N(C[C@H]2C)[C@@H](C)CO)cc1"
    },
    "unichem": {
      "chebi": "128069",
      "lincs": "LSM-39625",
      "pubchem": "54615029"
    },
    "pubchem": [
      {
        "cid": 54615029,
        "inchi": "InChI=1S/C37H55N3O6/c1-26-22-40(27(2)25-41)37(43)33-21-31(38-36(42)30-12-7-6-8-13-30)16-19-34(33)46-28(3)11-9-10-20-45-35(26)24-39(4)23-29-14-17-32(44-5)18-15-29/h14-19,21,26-28,30,35,41H,6-13,20,22-25H2,1-5H3,(H,38,42)/t26-,27+,28-,35+/m1/s1",
        "inchikey": "UVSCGJDGVAXROK-GTZOPPDQSA-N",
        "iupac": {
          "systematic": "N-[(3R,9R,10R)-12-[(2S)-1-hydroxypropan-2-yl]-9-[[(4-methoxyphenyl)methyl-methylamino]methyl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]cyclohexanecarboxamide"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NC(=O)C3CCCCC3)C(C)CO)C)CN(C)CC4=CC=C(C=C4)OC"
        },
        "molecularFormula": "C37H55N3O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:51:47Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85f8"
    },
    "name": "MLS003650109",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85f8.png",
    "lincs": {
      "id": "LSM-11256",
      "name": "MLS003650109",
      "alternativeNames": [
        "BRD-K46352899"
      ],
      "pubchemCid": 53382758,
      "chebiId": 99877,
      "inchiParent": "InChI=1S/C12H21NO5/c1-16-12(15)4-9-2-3-10-11(18-9)7-17-6-8(14)5-13-10/h8-11,13-14H,2-7H2,1H3/t8-,9-,10-,11+/m1/s1",
      "inchiKeyParent": "FKMAUGDURCCEJG-DBIOUOCHSA-N",
      "smilesParent": "COC(=O)C[C@H]1CC[C@H]2NC[C@@H](O)COC[C@@H]2O1"
    },
    "unichem": {
      "chebi": "99877",
      "lincs": "LSM-11256",
      "pubchem": "53382758"
    },
    "pubchem": [
      {
        "cid": 53382758,
        "inchi": "InChI=1S/C12H21NO5/c1-16-12(15)4-9-2-3-10-11(18-9)7-17-6-8(14)5-13-10/h8-11,13-14H,2-7H2,1H3/t8-,9-,10-,11+/m1/s1",
        "inchikey": "FKMAUGDURCCEJG-DBIOUOCHSA-N",
        "iupac": {
          "systematic": "methyl 2-[(3R,6aR,8R,10aR)-3-hydroxy-1,2,3,4,6,6a,8,9,10,10a-decahydropyrano[2,3-c][1,5]oxazocin-8-yl]acetate"
        },
        "smiles": {
          "canonical": "COC(=O)CC1CCC2C(O1)COCC(CN2)O"
        },
        "molecularFormula": "C12H21NO5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:51:50Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8510"
    },
    "name": "BRD-K84617556",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8510.png",
    "lincs": {
      "id": "LSM-41890",
      "name": "BRD-K84617556",
      "pubchemCid": 71759654,
      "chebiId": 130341,
      "inchiParent": "InChI=1S/C25H28ClN3O3/c1-16(31)29-15-25(13-28(14-25)11-17-4-6-18(26)7-5-17)23-20-9-8-19(32-3)10-21(20)27(2)24(23)22(29)12-30/h4-10,22,30H,11-15H2,1-3H3/t22-/m0/s1",
      "inchiKeyParent": "KRDDKDDFMRKMHZ-QFIPXVFZSA-N",
      "smilesParent": "COc1ccc2c3c([C@H](CO)N(CC34CN(Cc5ccc(Cl)cc5)C4)C(=O)C)n(C)c2c1"
    },
    "unichem": {
      "chebi": "130341",
      "lincs": "LSM-41890",
      "pubchem": "71759654"
    },
    "pubchem": [
      {
        "cid": 71759654,
        "inchi": "InChI=1S/C25H28ClN3O3/c1-16(31)29-15-25(13-28(14-25)11-17-4-6-18(26)7-5-17)23-20-9-8-19(32-3)10-21(20)27(2)24(23)22(29)12-30/h4-10,22,30H,11-15H2,1-3H3/t22-/m0/s1",
        "inchikey": "KRDDKDDFMRKMHZ-QFIPXVFZSA-N",
        "iupac": {
          "systematic": "1-[(1R)-1'-[(4-chlorophenyl)methyl]-1-(hydroxymethyl)-7-methoxy-9-methylspiro[1,3-dihydropyrido[3,4-b]indole-4,3'-azetidine]-2-yl]ethanone"
        },
        "smiles": {
          "canonical": "CC(=O)N1CC2(CN(C2)CC3=CC=C(C=C3)Cl)C4=C(C1CO)N(C5=C4C=CC(=C5)OC)C"
        },
        "molecularFormula": "C25H28ClN3O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:51:52Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8522"
    },
    "name": "BRD-K19198293",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8522.png",
    "lincs": {
      "id": "LSM-38301",
      "name": "BRD-K19198293",
      "pubchemCid": 44502376,
      "chebiId": 126738,
      "inchiParent": "InChI=1S/C22H36N4O4/c1-14(2)23-22(29)24-18-7-8-19-17(9-18)10-21(28)26(16(4)13-27)11-15(3)20(30-19)12-25(5)6/h7-9,14-16,20,27H,10-13H2,1-6H3,(H2,23,24,29)/t15-,16-,20-/m1/s1",
      "inchiKeyParent": "VNWGQZGENSFMNJ-JXXFODFXSA-N",
      "smilesParent": "CC(C)NC(=O)Nc1ccc2O[C@H](CN(C)C)[C@H](C)CN([C@H](C)CO)C(=O)Cc2c1"
    },
    "unichem": {
      "chebi": "126738",
      "lincs": "LSM-38301",
      "pubchem": "44502376"
    },
    "pubchem": [
      {
        "cid": 44502376,
        "inchi": "InChI=1S/C22H36N4O4/c1-14(2)23-22(29)24-18-7-8-19-17(9-18)10-21(28)26(16(4)13-27)11-15(3)20(30-19)12-25(5)6/h7-9,14-16,20,27H,10-13H2,1-6H3,(H2,23,24,29)/t15-,16-,20-/m1/s1",
        "inchikey": "VNWGQZGENSFMNJ-JXXFODFXSA-N",
        "iupac": {
          "systematic": "1-[(2S,3R)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-propan-2-ylurea"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)CC2=C(C=CC(=C2)NC(=O)NC(C)C)OC1CN(C)C)C(C)CO"
        },
        "molecularFormula": "C22H36N4O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:51:54Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8565"
    },
    "name": "CHEMBL2362381",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8565.png",
    "lincs": {
      "id": "LSM-8599",
      "name": "CHEMBL2362381",
      "alternativeNames": [
        "BRD-K02581961"
      ],
      "pubchemCid": 56835484,
      "chebiId": 97220,
      "inchiParent": "InChI=1S/C34H39N3O4/c1-23-19-37(24(2)21-38)34(40)33-32(28-16-10-11-17-29(28)36(33)4)27-15-9-8-14-26(27)22-41-30(23)20-35(3)31(39)18-25-12-6-5-7-13-25/h5-17,23-24,30,38H,18-22H2,1-4H3/t23-,24-,30+/m0/s1",
      "inchiKeyParent": "BENJSVFNXVDSQO-FOUYOVOOSA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@H](C)[C@@H](CN(C)C(=O)Cc2ccccc2)OCc3ccccc3c4c(C1=O)n(C)c5ccccc45"
    },
    "unichem": {
      "chebi": "97220",
      "chembl": "CHEMBL2362381",
      "lincs": "LSM-8599",
      "pubchem": "56835484"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL2362381",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 553.7,
        "hba": 5,
        "hbd": 1,
        "qedWeighted": 0.37
      }
    },
    "pubchem": [
      {
        "cid": 56835484,
        "inchi": "InChI=1S/C34H39N3O4/c1-23-19-37(24(2)21-38)34(40)33-32(28-16-10-11-17-29(28)36(33)4)27-15-9-8-14-26(27)22-41-30(23)20-35(3)31(39)18-25-12-6-5-7-13-25/h5-17,23-24,30,38H,18-22H2,1-4H3/t23-,24-,30+/m0/s1",
        "inchikey": "BENJSVFNXVDSQO-FOUYOVOOSA-N",
        "iupac": {
          "systematic": "N-[[(10S,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methyl-2-phenylacetamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(C3=CC=CC=C3COC1CN(C)C(=O)CC4=CC=CC=C4)C5=CC=CC=C5N2C)C(C)CO"
        },
        "molecularFormula": "C34H39N3O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:52:05Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83bc"
    },
    "name": "BRD-K96198015",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83bc.png",
    "lincs": {
      "id": "LSM-8076",
      "name": "BRD-K96198015",
      "pubchemCid": 54618165,
      "chebiId": 96697,
      "inchiParent": "InChI=1S/C26H34N4O5S/c1-18(2)7-6-8-21-9-10-25-23(13-21)35-24(16-29(5)26(32)22-14-27-11-12-28-22)19(3)15-30(20(4)17-31)36(25,33)34/h9-14,18-20,24,31H,7,15-17H2,1-5H3/t19-,20-,24-/m0/s1",
      "inchiKeyParent": "ALBVOUUIQWHTKA-SKPFHBQLSA-N",
      "smilesParent": "CC(C)CC#Cc1ccc2c(O[C@@H](CN(C)C(=O)c3cnccn3)[C@@H](C)CN([C@@H](C)CO)S2(=O)=O)c1"
    },
    "unichem": {
      "chebi": "96697",
      "lincs": "LSM-8076",
      "pubchem": "54618165"
    },
    "pubchem": [
      {
        "cid": 54618165,
        "inchi": "InChI=1S/C26H34N4O5S/c1-18(2)7-6-8-21-9-10-25-23(13-21)35-24(16-29(5)26(32)22-14-27-11-12-28-22)19(3)15-30(20(4)17-31)36(25,33)34/h9-14,18-20,24,31H,7,15-17H2,1-5H3/t19-,20-,24-/m0/s1",
        "inchikey": "ALBVOUUIQWHTKA-SKPFHBQLSA-N",
        "iupac": {
          "systematic": "N-[[(4S,5R)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-8-(4-methylpent-1-ynyl)-1,1-dioxo-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-N-methylpyrazine-2-carboxamide"
        },
        "smiles": {
          "canonical": "CC1CN(S(=O)(=O)C2=C(C=C(C=C2)C#CCC(C)C)OC1CN(C)C(=O)C3=NC=CN=C3)C(C)CO"
        },
        "molecularFormula": "C26H34N4O5S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:52:09Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8407"
    },
    "name": "BRD-K86516784",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8407.png",
    "lincs": {
      "id": "LSM-13725",
      "name": "BRD-K86516784",
      "pubchemCid": 54646166,
      "chebiId": 102374,
      "inchiParent": "InChI=1S/C24H33N3O5/c1-26-7-9-27(10-8-26)22(29)13-17-12-19-18-11-16(25-24(30)15-3-2-4-15)5-6-20(18)32-23(19)21(14-28)31-17/h5-6,11,15,17,19,21,23,28H,2-4,7-10,12-14H2,1H3,(H,25,30)/t17-,19+,21-,23-/m1/s1",
      "inchiKeyParent": "SOARVSRWKWCBLL-GUBFDYSESA-N",
      "smilesParent": "CN1CCN(CC1)C(=O)C[C@H]2C[C@@H]3[C@@H](Oc4ccc(NC(=O)C5CCC5)cc34)[C@@H](CO)O2"
    },
    "unichem": {
      "chebi": "102374",
      "lincs": "LSM-13725",
      "pubchem": "54646166"
    },
    "pubchem": [
      {
        "cid": 54646166,
        "inchi": "InChI=1S/C24H33N3O5/c1-26-7-9-27(10-8-26)22(29)13-17-12-19-18-11-16(25-24(30)15-3-2-4-15)5-6-20(18)32-23(19)21(14-28)31-17/h5-6,11,15,17,19,21,23,28H,2-4,7-10,12-14H2,1H3,(H,25,30)/t17-,19+,21-,23-/m1/s1",
        "inchikey": "SOARVSRWKWCBLL-GUBFDYSESA-N",
        "iupac": {
          "systematic": "N-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-(4-methylpiperazin-1-yl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]cyclobutanecarboxamide"
        },
        "smiles": {
          "canonical": "CN1CCN(CC1)C(=O)CC2CC3C(C(O2)CO)OC4=C3C=C(C=C4)NC(=O)C5CCC5"
        },
        "molecularFormula": "C24H33N3O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:52:11Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8366"
    },
    "name": "BRD-K45494661",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8366.png",
    "lincs": {
      "id": "LSM-11204",
      "name": "BRD-K45494661",
      "pubchemCid": 54648977,
      "chebiId": 99825,
      "inchiParent": "InChI=1S/C24H34F2N2O4S/c1-17-6-9-22(10-7-17)33(30,31)28(19(3)16-29)13-18(2)24(32-5)15-27(4)14-20-12-21(25)8-11-23(20)26/h6-12,18-19,24,29H,13-16H2,1-5H3/t18-,19-,24+/m0/s1",
      "inchiKeyParent": "VKCFDPYGFDYBIC-AXHZCLLHSA-N",
      "smilesParent": "CO[C@H](CN(C)Cc1cc(F)ccc1F)[C@@H](C)CN([C@@H](C)CO)S(=O)(=O)c2ccc(C)cc2"
    },
    "unichem": {
      "chebi": "99825",
      "lincs": "LSM-11204",
      "pubchem": "54648977"
    },
    "pubchem": [
      {
        "cid": 54648977,
        "inchi": "InChI=1S/C24H34F2N2O4S/c1-17-6-9-22(10-7-17)33(30,31)28(19(3)16-29)13-18(2)24(32-5)15-27(4)14-20-12-21(25)8-11-23(20)26/h6-12,18-19,24,29H,13-16H2,1-5H3/t18-,19-,24+/m0/s1",
        "inchikey": "VKCFDPYGFDYBIC-AXHZCLLHSA-N",
        "iupac": {
          "systematic": "N-[(2S,3S)-4-[(2,5-difluorophenyl)methyl-methylamino]-3-methoxy-2-methylbutyl]-N-[(2S)-1-hydroxypropan-2-yl]-4-methylbenzenesulfonamide"
        },
        "smiles": {
          "canonical": "CC1=CC=C(C=C1)S(=O)(=O)N(CC(C)C(CN(C)CC2=C(C=CC(=C2)F)F)OC)C(C)CO"
        },
        "molecularFormula": "C24H34F2N2O4S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:52:13Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83ad"
    },
    "name": "BRD-K67689741",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83ad.png",
    "lincs": {
      "id": "LSM-12550",
      "name": "BRD-K67689741",
      "pubchemCid": 54649142,
      "chebiId": 101181,
      "inchiParent": "InChI=1S/C25H34N2O7S/c1-17-6-9-21(10-7-17)35(30,31)27(19(3)15-28)13-18(2)24(32-5)14-26(4)25(29)20-8-11-22-23(12-20)34-16-33-22/h6-12,18-19,24,28H,13-16H2,1-5H3/t18-,19+,24-/m0/s1",
      "inchiKeyParent": "XFQUVXMASIHRAZ-GLDPYIMESA-N",
      "smilesParent": "CO[C@@H](CN(C)C(=O)c1ccc2OCOc2c1)[C@@H](C)CN([C@H](C)CO)S(=O)(=O)c3ccc(C)cc3"
    },
    "unichem": {
      "chebi": "101181",
      "lincs": "LSM-12550",
      "pubchem": "54649142"
    },
    "pubchem": [
      {
        "cid": 54649142,
        "inchi": "InChI=1S/C25H34N2O7S/c1-17-6-9-21(10-7-17)35(30,31)27(19(3)15-28)13-18(2)24(32-5)14-26(4)25(29)20-8-11-22-23(12-20)34-16-33-22/h6-12,18-19,24,28H,13-16H2,1-5H3/t18-,19+,24-/m0/s1",
        "inchikey": "XFQUVXMASIHRAZ-GLDPYIMESA-N",
        "iupac": {
          "systematic": "N-[(2R,3S)-4-[[(2R)-1-hydroxypropan-2-yl]-(4-methylphenyl)sulfonylamino]-2-methoxy-3-methylbutyl]-N-methyl-1,3-benzodioxole-5-carboxamide"
        },
        "smiles": {
          "canonical": "CC1=CC=C(C=C1)S(=O)(=O)N(CC(C)C(CN(C)C(=O)C2=CC3=C(C=C2)OCO3)OC)C(C)CO"
        },
        "molecularFormula": "C25H34N2O7S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:52:16Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83e0"
    },
    "name": "BRD-K64882872",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83e0.png",
    "lincs": {
      "id": "LSM-7712",
      "name": "BRD-K64882872",
      "pubchemCid": 54618794,
      "chebiId": 96333,
      "inchiParent": "InChI=1S/C28H36N4O3/c1-20-16-32(21(2)19-33)28(34)25-14-23(11-12-24-10-6-7-13-29-24)15-30-27(25)35-26(20)18-31(3)17-22-8-4-5-9-22/h6-7,10,13-15,20-22,26,33H,4-5,8-9,16-19H2,1-3H3/t20-,21-,26-/m0/s1",
      "inchiKeyParent": "CLQLHKYRPGBFMB-WOVHNISZSA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@H](C)[C@H](CN(C)CC2CCCC2)Oc3ncc(cc3C1=O)C#Cc4ccccn4"
    },
    "unichem": {
      "chebi": "96333",
      "lincs": "LSM-7712",
      "pubchem": "54618794"
    },
    "pubchem": [
      {
        "cid": 54618794,
        "inchi": "InChI=1S/C28H36N4O3/c1-20-16-32(21(2)19-33)28(34)25-14-23(11-12-24-10-6-7-13-29-24)15-30-27(25)35-26(20)18-31(3)17-22-8-4-5-9-22/h6-7,10,13-15,20-22,26,33H,4-5,8-9,16-19H2,1-3H3/t20-,21-,26-/m0/s1",
        "inchikey": "CLQLHKYRPGBFMB-WOVHNISZSA-N",
        "iupac": {
          "systematic": "(2R,3S)-2-[[cyclopentylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-8-(2-pyridin-2-ylethynyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(N=CC(=C2)C#CC3=CC=CC=N3)OC1CN(C)CC4CCCC4)C(C)CO"
        },
        "molecularFormula": "C28H36N4O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:52:18Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83e6"
    },
    "name": "BRD-K72529818",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83e6.png",
    "lincs": {
      "id": "LSM-12878",
      "name": "BRD-K72529818",
      "pubchemCid": 54637935,
      "chebiId": 101515,
      "inchiParent": "InChI=1S/C33H36N4O5S/c1-22-18-37(23(2)20-38)33(39)32-31(28-14-7-8-15-29(28)36(32)4)27-13-6-5-11-25(27)21-42-30(22)19-35(3)43(40,41)26-12-9-10-24(16-26)17-34/h5-16,22-23,30,38H,18-21H2,1-4H3/t22-,23+,30-/m1/s1",
      "inchiKeyParent": "DEQYHGFYIZKXEQ-DUELTEGESA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@@H](C)[C@@H](CN(C)S(=O)(=O)c2cccc(c2)C#N)OCc3ccccc3c4c(C1=O)n(C)c5ccccc45"
    },
    "unichem": {
      "chebi": "101515",
      "lincs": "LSM-12878",
      "pubchem": "54637935"
    },
    "pubchem": [
      {
        "cid": 54637935,
        "inchi": "InChI=1S/C33H36N4O5S/c1-22-18-37(23(2)20-38)33(39)32-31(28-14-7-8-15-29(28)36(32)4)27-13-6-5-11-25(27)21-42-30(22)19-35(3)43(40,41)26-12-9-10-24(16-26)17-34/h5-16,22-23,30,38H,18-21H2,1-4H3/t22-,23+,30-/m1/s1",
        "inchikey": "DEQYHGFYIZKXEQ-DUELTEGESA-N",
        "iupac": {
          "systematic": "3-cyano-N-[[(10S,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylbenzenesulfonamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(C3=CC=CC=C3COC1CN(C)S(=O)(=O)C4=CC=CC(=C4)C#N)C5=CC=CC=C5N2C)C(C)CO"
        },
        "molecularFormula": "C33H36N4O5S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:52:20Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8417"
    },
    "name": "BRD-K56581148",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8417.png",
    "lincs": {
      "id": "LSM-11848",
      "name": "BRD-K56581148",
      "pubchemCid": 54638685,
      "chebiId": 100474,
      "inchiParent": "InChI=1S/C16H25N3O5S/c1-2-25(22,23)19-14-7-6-13(24-15(14)11-20)9-16(21)18-10-12-5-3-4-8-17-12/h3-5,8,13-15,19-20H,2,6-7,9-11H2,1H3,(H,18,21)/t13-,14-,15-/m0/s1",
      "inchiKeyParent": "MEPVQKQIDHVRNZ-KKUMJFAQSA-N",
      "smilesParent": "CCS(=O)(=O)N[C@H]1CC[C@@H](CC(=O)NCc2ccccn2)O[C@H]1CO"
    },
    "unichem": {
      "chebi": "100474",
      "lincs": "LSM-11848",
      "pubchem": "54638685"
    },
    "pubchem": [
      {
        "cid": 54638685,
        "inchi": "InChI=1S/C16H25N3O5S/c1-2-25(22,23)19-14-7-6-13(24-15(14)11-20)9-16(21)18-10-12-5-3-4-8-17-12/h3-5,8,13-15,19-20H,2,6-7,9-11H2,1H3,(H,18,21)/t13-,14-,15-/m0/s1",
        "inchikey": "MEPVQKQIDHVRNZ-KKUMJFAQSA-N",
        "iupac": {
          "systematic": "2-[(2S,5S,6R)-5-(ethylsulfonylamino)-6-(hydroxymethyl)oxan-2-yl]-N-(pyridin-2-ylmethyl)acetamide"
        },
        "smiles": {
          "canonical": "CCS(=O)(=O)NC1CCC(OC1CO)CC(=O)NCC2=CC=CC=N2"
        },
        "molecularFormula": "C16H25N3O5S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:52:22Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8397"
    },
    "name": "MLS003129743",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8397.png",
    "lincs": {
      "id": "LSM-7388",
      "name": "MLS003129743",
      "alternativeNames": [
        "BRD-K42420111"
      ],
      "pubchemCid": 44486956,
      "chebiId": 96009,
      "inchiParent": "InChI=1S/C26H36N6O4/c1-18-13-32(19(2)16-33)25(34)6-5-10-31-14-22(27-28-31)17-36-24(18)15-30(4)26(35)21-8-7-20-9-11-29(3)23(20)12-21/h7-9,11-12,14,18-19,24,33H,5-6,10,13,15-17H2,1-4H3/t18-,19+,24+/m0/s1",
      "inchiKeyParent": "BWTMYHAPSQQINJ-XLNZFTOWSA-N",
      "smilesParent": "C[C@H](CO)N1C[C@H](C)[C@@H](CN(C)C(=O)c2ccc3ccn(C)c3c2)OCc4cn(CCCC1=O)nn4"
    },
    "unichem": {
      "chebi": "96009",
      "chembl": "CHEMBL2000538",
      "lincs": "LSM-7388",
      "pubchem": "44486956"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL2000538",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 496.61,
        "hba": 8,
        "hbd": 1,
        "qedWeighted": 0.58
      }
    },
    "pubchem": [
      {
        "cid": 44486956,
        "inchi": "InChI=1S/C26H36N6O4/c1-18-13-32(19(2)16-33)25(34)6-5-10-31-14-22(27-28-31)17-36-24(18)15-30(4)26(35)21-8-7-20-9-11-29(3)23(20)12-21/h7-9,11-12,14,18-19,24,33H,5-6,10,13,15-17H2,1-4H3/t18-,19+,24+/m0/s1",
        "inchikey": "BWTMYHAPSQQINJ-XLNZFTOWSA-N",
        "iupac": {
          "systematic": "N-[[(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N,1-dimethylindole-6-carboxamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)CCCN2C=C(COC1CN(C)C(=O)C3=CC4=C(C=C3)C=CN4C)N=N2)C(C)CO"
        },
        "molecularFormula": "C26H36N6O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:52:33Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83cc"
    },
    "name": "BRD-K27006579",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83cc.png",
    "lincs": {
      "id": "LSM-10066",
      "name": "BRD-K27006579",
      "pubchemCid": 54654368,
      "chebiId": 98687,
      "inchiParent": "InChI=1S/C27H38N4O6/c1-29-9-11-31(12-10-29)25(32)16-20-4-5-22-24(37-20)17-36-23-6-3-19(15-21(23)27(34)30(22)2)28-26(33)18-7-13-35-14-8-18/h3,6,15,18,20,22,24H,4-5,7-14,16-17H2,1-2H3,(H,28,33)/t20-,22-,24-/m1/s1",
      "inchiKeyParent": "HKYXYLDUIXPRSO-KIFXHHALSA-N",
      "smilesParent": "CN1CCN(CC1)C(=O)C[C@H]2CC[C@@H]3[C@@H](COc4ccc(NC(=O)C5CCOCC5)cc4C(=O)N3C)O2"
    },
    "unichem": {
      "chebi": "98687",
      "lincs": "LSM-10066",
      "pubchem": "54654368"
    },
    "pubchem": [
      {
        "cid": 54654368,
        "inchi": "InChI=1S/C27H38N4O6/c1-29-9-11-31(12-10-29)25(32)16-20-4-5-22-24(37-20)17-36-23-6-3-19(15-21(23)27(34)30(22)2)28-26(33)18-7-13-35-14-8-18/h3,6,15,18,20,22,24H,4-5,7-14,16-17H2,1-2H3,(H,28,33)/t20-,22-,24-/m1/s1",
        "inchikey": "HKYXYLDUIXPRSO-KIFXHHALSA-N",
        "iupac": {
          "systematic": "N-[(2R,4aR,12aS)-5-methyl-2-[2-(4-methylpiperazin-1-yl)-2-oxoethyl]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]oxane-4-carboxamide"
        },
        "smiles": {
          "canonical": "CN1CCN(CC1)C(=O)CC2CCC3C(O2)COC4=C(C=C(C=C4)NC(=O)C5CCOCC5)C(=O)N3C"
        },
        "molecularFormula": "C27H38N4O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:52:35Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83e7"
    },
    "name": "BRD-K42383812",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83e7.png",
    "lincs": {
      "id": "LSM-10998",
      "name": "BRD-K42383812",
      "pubchemCid": 54645810,
      "chebiId": 99619,
      "inchiParent": "InChI=1S/C23H27FN2O4/c1-26(2)16-6-7-20-18(9-16)19-10-17(29-21(13-27)23(19)30-20)11-22(28)25-12-14-4-3-5-15(24)8-14/h3-9,17,19,21,23,27H,10-13H2,1-2H3,(H,25,28)/t17-,19+,21-,23-/m0/s1",
      "inchiKeyParent": "WXYXTVXIMWIJFY-FTJYFCJYSA-N",
      "smilesParent": "CN(C)c1ccc2O[C@@H]3[C@H](CO)O[C@H](CC(=O)NCc4cccc(F)c4)C[C@@H]3c2c1"
    },
    "unichem": {
      "chebi": "99619",
      "lincs": "LSM-10998",
      "pubchem": "54645810"
    },
    "pubchem": [
      {
        "cid": 54645810,
        "inchi": "InChI=1S/C23H27FN2O4/c1-26(2)16-6-7-20-18(9-16)19-10-17(29-21(13-27)23(19)30-20)11-22(28)25-12-14-4-3-5-15(24)8-14/h3-9,17,19,21,23,27H,10-13H2,1-2H3,(H,25,28)/t17-,19+,21-,23-/m0/s1",
        "inchikey": "WXYXTVXIMWIJFY-FTJYFCJYSA-N",
        "iupac": {
          "systematic": "2-[(1S,3S,4aR,9aS)-6-(dimethylamino)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-[(3-fluorophenyl)methyl]acetamide"
        },
        "smiles": {
          "canonical": "CN(C)C1=CC2=C(C=C1)OC3C2CC(OC3CO)CC(=O)NCC4=CC(=CC=C4)F"
        },
        "molecularFormula": "C23H27FN2O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:52:38Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c83fd"
    },
    "name": "BRD-K83241810",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c83fd.png",
    "lincs": {
      "id": "LSM-7919",
      "name": "BRD-K83241810",
      "pubchemCid": 54618429,
      "chebiId": 96540,
      "inchiParent": "InChI=1S/C31H40N2O6S/c1-22-18-33(23(2)21-34)40(37,38)30-15-14-25(11-6-10-24-8-4-5-9-24)17-28(30)39-29(22)20-32(3)19-26-12-7-13-27(16-26)31(35)36/h7,12-17,22-24,29,34H,4-5,8-10,18-21H2,1-3H3,(H,35,36)/t22-,23+,29+/m1/s1",
      "inchiKeyParent": "DKZVPIDPIJUHTD-AFKLWXAFSA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@@H](C)[C@H](CN(C)Cc2cccc(c2)C(=O)O)Oc3cc(ccc3S1(=O)=O)C#CCC4CCCC4"
    },
    "unichem": {
      "chebi": "96540",
      "lincs": "LSM-7919",
      "pubchem": "54618429"
    },
    "pubchem": [
      {
        "cid": 54618429,
        "inchi": "InChI=1S/C31H40N2O6S/c1-22-18-33(23(2)21-34)40(37,38)30-15-14-25(11-6-10-24-8-4-5-9-24)17-28(30)39-29(22)20-32(3)19-26-12-7-13-27(16-26)31(35)36/h7,12-17,22-24,29,34H,4-5,8-10,18-21H2,1-3H3,(H,35,36)/t22-,23+,29+/m1/s1",
        "inchikey": "DKZVPIDPIJUHTD-AFKLWXAFSA-N",
        "iupac": {
          "systematic": "3-[[[(4R,5R)-8-(3-cyclopentylprop-1-ynyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl-methylamino]methyl]benzoic acid"
        },
        "smiles": {
          "canonical": "CC1CN(S(=O)(=O)C2=C(C=C(C=C2)C#CCC3CCCC3)OC1CN(C)CC4=CC(=CC=C4)C(=O)O)C(C)CO"
        },
        "molecularFormula": "C31H40N2O6S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:52:40Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c843d"
    },
    "name": "BRD-K88524550",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c843d.png",
    "lincs": {
      "id": "LSM-47617",
      "name": "BRD-K88524550",
      "pubchemCid": 134828872,
      "inchiParent": "InChI=1S/C25H26N2O3S/c1-30-22-13-11-20(12-14-22)19-7-9-21(10-8-19)25-23-15-27(16-24(25)26-23)31(28,29)17-18-5-3-2-4-6-18/h2-14,23-26H,15-17H2,1H3/t23-,24+,25+",
      "inchiKeyParent": "NZCXNPOUNFQRSY-LNWKWYTESA-N",
      "smilesParent": "COc1ccc(cc1)c2ccc(cc2)[C@@H]3[C@@H]4CN(C[C@H]3N4)S(=O)(=O)Cc5ccccc5"
    },
    "pubchem": [
      {
        "cid": 134828872,
        "inchi": "InChI=1S/C25H26N2O3S/c1-30-22-13-11-20(12-14-22)19-7-9-21(10-8-19)25-23-15-27(16-24(25)26-23)31(28,29)17-18-5-3-2-4-6-18/h2-14,23-26H,15-17H2,1H3/t23-,24+,25?",
        "inchikey": "NZCXNPOUNFQRSY-XMGLRAKGSA-N",
        "iupac": {
          "systematic": "(1S,5R)-3-benzylsulfonyl-7-[4-(4-methoxyphenyl)phenyl]-3,6-diazabicyclo[3.1.1]heptane"
        },
        "smiles": {
          "canonical": "COC1=CC=C(C=C1)C2=CC=C(C=C2)C3C4CN(CC3N4)S(=O)(=O)CC5=CC=CC=C5"
        },
        "molecularFormula": "C25H26N2O3S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:52:42Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c844f"
    },
    "name": "BRD-K44649335",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c844f.png",
    "lincs": {
      "id": "LSM-26787",
      "name": "BRD-K44649335",
      "pubchemCid": 54633209,
      "chebiId": 115330,
      "inchiParent": "InChI=1S/C25H33FN4O4/c1-16-13-29(3)17(2)15-34-22-10-9-20(12-21(22)24(31)30(4)14-23(16)33-5)28-25(32)27-19-8-6-7-18(26)11-19/h6-12,16-17,23H,13-15H2,1-5H3,(H2,27,28,32)/t16-,17+,23+/m1/s1",
      "inchiKeyParent": "BCUUTPUMPAWJAT-DGGJZMOXSA-N",
      "smilesParent": "CO[C@H]1CN(C)C(=O)c2cc(NC(=O)Nc3cccc(F)c3)ccc2OC[C@H](C)N(C)C[C@H]1C"
    },
    "unichem": {
      "chebi": "115330",
      "lincs": "LSM-26787",
      "pubchem": "54633209"
    },
    "pubchem": [
      {
        "cid": 54633209,
        "inchi": "InChI=1S/C25H33FN4O4/c1-16-13-29(3)17(2)15-34-22-10-9-20(12-21(22)24(31)30(4)14-23(16)33-5)28-25(32)27-19-8-6-7-18(26)11-19/h6-12,16-17,23H,13-15H2,1-5H3,(H2,27,28,32)/t16-,17+,23+/m1/s1",
        "inchikey": "BCUUTPUMPAWJAT-DGGJZMOXSA-N",
        "iupac": {
          "systematic": "1-(3-fluorophenyl)-3-[(4S,7R,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea"
        },
        "smiles": {
          "canonical": "CC1CN(C(COC2=C(C=C(C=C2)NC(=O)NC3=CC(=CC=C3)F)C(=O)N(CC1OC)C)C)C"
        },
        "molecularFormula": "C25H33FN4O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:52:45Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8474"
    },
    "name": "BRD-K29054201",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8474.png",
    "lincs": {
      "id": "LSM-10190",
      "name": "BRD-K29054201",
      "pubchemCid": 54649492,
      "chebiId": 98811,
      "inchiParent": "InChI=1S/C25H35N3O6/c1-16-21(32-5)14-28(3)25(30)19-8-6-7-17(13-26)23(19)33-15-22-20(31-4)10-9-18(34-22)11-12-27(2)24(16)29/h6-8,16,18,20-22H,9-12,14-15H2,1-5H3/t16-,18-,20+,21-,22+/m1/s1",
      "inchiKeyParent": "XYLRKRISJMFHFX-GBKCLDHKSA-N",
      "smilesParent": "CO[C@H]1CC[C@@H]2CCN(C)C(=O)[C@H](C)[C@@H](CN(C)C(=O)c3cccc(C#N)c3OC[C@@H]1O2)OC"
    },
    "unichem": {
      "chebi": "98811",
      "lincs": "LSM-10190",
      "pubchem": "54649492"
    },
    "pubchem": [
      {
        "cid": 54649492,
        "inchi": "InChI=1S/C25H35N3O6/c1-16-21(32-5)14-28(3)25(30)19-8-6-7-17(13-26)23(19)33-15-22-20(31-4)10-9-18(34-22)11-12-27(2)24(16)29/h6-8,16,18,20-22H,9-12,14-15H2,1-5H3/t16-,18-,20+,21-,22+/m1/s1",
        "inchikey": "XYLRKRISJMFHFX-GBKCLDHKSA-N",
        "iupac": {
          "systematic": "(1S,13S,14R,19R,22S)-13,22-dimethoxy-11,14,16-trimethyl-10,15-dioxo-3,23-dioxa-11,16-diazatricyclo[17.3.1.04,9]tricosa-4,6,8-triene-5-carbonitrile"
        },
        "smiles": {
          "canonical": "CC1C(CN(C(=O)C2=CC=CC(=C2OCC3C(CCC(O3)CCN(C1=O)C)OC)C#N)C)OC"
        },
        "molecularFormula": "C25H35N3O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:52:47Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84b3"
    },
    "name": "BRD-K73261664",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84b3.png",
    "lincs": {
      "id": "LSM-12914",
      "name": "BRD-K73261664",
      "pubchemCid": 54639140,
      "chebiId": 101551,
      "inchiParent": "InChI=1S/C27H29N3O4/c31-18-25-24(30-26(32)15-19-5-4-14-28-17-19)13-12-23(34-25)16-27(33)29-22-10-8-21(9-11-22)20-6-2-1-3-7-20/h1-11,14,17,23-25,31H,12-13,15-16,18H2,(H,29,33)(H,30,32)/t23-,24-,25+/m0/s1",
      "inchiKeyParent": "JZSLTRUJUOZFGD-CCDWMCETSA-N",
      "smilesParent": "OC[C@H]1O[C@H](CC(=O)Nc2ccc(cc2)c3ccccc3)CC[C@@H]1NC(=O)Cc4cccnc4"
    },
    "unichem": {
      "chebi": "101551",
      "lincs": "LSM-12914",
      "pubchem": "54639140"
    },
    "pubchem": [
      {
        "cid": 54639140,
        "inchi": "InChI=1S/C27H29N3O4/c31-18-25-24(30-26(32)15-19-5-4-14-28-17-19)13-12-23(34-25)16-27(33)29-22-10-8-21(9-11-22)20-6-2-1-3-7-20/h1-11,14,17,23-25,31H,12-13,15-16,18H2,(H,29,33)(H,30,32)/t23-,24-,25+/m0/s1",
        "inchikey": "JZSLTRUJUOZFGD-CCDWMCETSA-N",
        "iupac": {
          "systematic": "2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[(2-pyridin-3-ylacetyl)amino]oxan-2-yl]-N-(4-phenylphenyl)acetamide"
        },
        "smiles": {
          "canonical": "C1CC(C(OC1CC(=O)NC2=CC=C(C=C2)C3=CC=CC=C3)CO)NC(=O)CC4=CN=CC=C4"
        },
        "molecularFormula": "C27H29N3O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:52:49Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84e0"
    },
    "name": "BRD-K04326190",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84e0.png",
    "lincs": {
      "id": "LSM-8693",
      "name": "BRD-K04326190",
      "pubchemCid": 54657649,
      "chebiId": 97314,
      "inchiParent": "InChI=1S/C22H27FN4O6S/c23-15-2-1-3-19(8-15)34(30,31)27-11-17(28)12-32-13-21-20(27)5-4-18(33-21)9-22(29)25-10-16-6-7-24-14-26-16/h1-3,6-8,14,17-18,20-21,28H,4-5,9-13H2,(H,25,29)/t17-,18+,20-,21+/m1/s1",
      "inchiKeyParent": "FPMJOPUHYZGMQU-JYRKZWEQSA-N",
      "smilesParent": "O[C@H]1COC[C@@H]2O[C@H](CC(=O)NCc3ccncn3)CC[C@H]2N(C1)S(=O)(=O)c4cccc(F)c4"
    },
    "unichem": {
      "chebi": "97314",
      "lincs": "LSM-8693",
      "pubchem": "54657649"
    },
    "pubchem": [
      {
        "cid": 54657649,
        "inchi": "InChI=1S/C22H27FN4O6S/c23-15-2-1-3-19(8-15)34(30,31)27-11-17(28)12-32-13-21-20(27)5-4-18(33-21)9-22(29)25-10-16-6-7-24-14-26-16/h1-3,6-8,14,17-18,20-21,28H,4-5,9-13H2,(H,25,29)/t17-,18+,20-,21+/m1/s1",
        "inchikey": "FPMJOPUHYZGMQU-JYRKZWEQSA-N",
        "iupac": {
          "systematic": "2-[(3R,6aR,8S,10aR)-1-(3-fluorophenyl)sulfonyl-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(pyrimidin-4-ylmethyl)acetamide"
        },
        "smiles": {
          "canonical": "C1CC2C(COCC(CN2S(=O)(=O)C3=CC=CC(=C3)F)O)OC1CC(=O)NCC4=NC=NC=C4"
        },
        "molecularFormula": "C22H27FN4O6S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:52:51Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84e9"
    },
    "name": "BRD-K26441788",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84e9.png",
    "lincs": {
      "id": "LSM-38710",
      "name": "BRD-K26441788",
      "pubchemCid": 60189790,
      "chebiId": 127148,
      "inchiParent": "InChI=1S/C28H32FN5O4S/c1-32-15-25(30-18-32)39(36,37)34-17-28(9-11-33(12-10-28)14-19-5-3-4-6-22(19)29)26-21-8-7-20(38-2)13-23(21)31-27(26)24(34)16-35/h3-8,13,15,18,24,31,35H,9-12,14,16-17H2,1-2H3/t24-/m0/s1",
      "inchiKeyParent": "INKSFZDGSMIVLV-DEOSSOPVSA-N",
      "smilesParent": "COc1ccc2c3c([nH]c2c1)[C@H](CO)N(CC34CCN(Cc5ccccc5F)CC4)S(=O)(=O)c6cn(C)cn6"
    },
    "unichem": {
      "chebi": "127148",
      "lincs": "LSM-38710",
      "pubchem": "60189790"
    },
    "pubchem": [
      {
        "cid": 60189790,
        "inchi": "InChI=1S/C28H32FN5O4S/c1-32-15-25(30-18-32)39(36,37)34-17-28(9-11-33(12-10-28)14-19-5-3-4-6-22(19)29)26-21-8-7-20(38-2)13-23(21)31-27(26)24(34)16-35/h3-8,13,15,18,24,31,35H,9-12,14,16-17H2,1-2H3/t24-/m0/s1",
        "inchikey": "INKSFZDGSMIVLV-DEOSSOPVSA-N",
        "iupac": {
          "systematic": "[(1R)-1'-[(2-fluorophenyl)methyl]-7-methoxy-2-(1-methylimidazol-4-yl)sulfonylspiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4'-piperidine]-1-yl]methanol"
        },
        "smiles": {
          "canonical": "CN1C=C(N=C1)S(=O)(=O)N2CC3(CCN(CC3)CC4=CC=CC=C4F)C5=C(C2CO)NC6=C5C=CC(=C6)OC"
        },
        "molecularFormula": "C28H32FN5O4S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:52:53Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c841f"
    },
    "name": "BRD-K19770227",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c841f.png",
    "lincs": {
      "id": "LSM-9624",
      "name": "BRD-K19770227",
      "pubchemCid": 54638517,
      "chebiId": 98245,
      "inchiParent": "InChI=1S/C20H33N3O5S/c1-15-5-8-17(9-6-15)29(26,27)22-18-10-7-16(28-19(18)14-24)13-20(25)21-11-4-12-23(2)3/h5-6,8-9,16,18-19,22,24H,4,7,10-14H2,1-3H3,(H,21,25)/t16-,18+,19+/m1/s1",
      "inchiKeyParent": "ZAZOOTZCNDNOOW-NEWSRXKRSA-N",
      "smilesParent": "CN(C)CCCNC(=O)C[C@H]1CC[C@H](NS(=O)(=O)c2ccc(C)cc2)[C@H](CO)O1"
    },
    "unichem": {
      "chebi": "98245",
      "lincs": "LSM-9624",
      "pubchem": "54638517"
    },
    "pubchem": [
      {
        "cid": 54638517,
        "inchi": "InChI=1S/C20H33N3O5S/c1-15-5-8-17(9-6-15)29(26,27)22-18-10-7-16(28-19(18)14-24)13-20(25)21-11-4-12-23(2)3/h5-6,8-9,16,18-19,22,24H,4,7,10-14H2,1-3H3,(H,21,25)/t16-,18+,19+/m1/s1",
        "inchikey": "ZAZOOTZCNDNOOW-NEWSRXKRSA-N",
        "iupac": {
          "systematic": "N-[3-(dimethylamino)propyl]-2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[(4-methylphenyl)sulfonylamino]oxan-2-yl]acetamide"
        },
        "smiles": {
          "canonical": "CC1=CC=C(C=C1)S(=O)(=O)NC2CCC(OC2CO)CC(=O)NCCCN(C)C"
        },
        "molecularFormula": "C20H33N3O5S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:52:56Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8424"
    },
    "name": "BRD-K82935485",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8424.png",
    "lincs": {
      "id": "LSM-13494",
      "name": "BRD-K82935485",
      "pubchemCid": 54646543,
      "chebiId": 102135,
      "inchiParent": "InChI=1S/C26H32N4O5/c1-29-8-10-30(11-9-29)25(33)15-19-14-21-20-13-18(28-24(32)12-17-4-6-27-7-5-17)2-3-22(20)35-26(21)23(16-31)34-19/h2-7,13,19,21,23,26,31H,8-12,14-16H2,1H3,(H,28,32)/t19-,21-,23-,26+/m1/s1",
      "inchiKeyParent": "LVKYMQHIUYSGLY-INZVZTLUSA-N",
      "smilesParent": "CN1CCN(CC1)C(=O)C[C@H]2C[C@H]3[C@H](Oc4ccc(NC(=O)Cc5ccncc5)cc34)[C@@H](CO)O2"
    },
    "unichem": {
      "chebi": "102135",
      "lincs": "LSM-13494",
      "pubchem": "54646543"
    },
    "pubchem": [
      {
        "cid": 54646543,
        "inchi": "InChI=1S/C26H32N4O5/c1-29-8-10-30(11-9-29)25(33)15-19-14-21-20-13-18(28-24(32)12-17-4-6-27-7-5-17)2-3-22(20)35-26(21)23(16-31)34-19/h2-7,13,19,21,23,26,31H,8-12,14-16H2,1H3,(H,28,32)/t19-,21-,23-,26+/m1/s1",
        "inchikey": "LVKYMQHIUYSGLY-INZVZTLUSA-N",
        "iupac": {
          "systematic": "N-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-(4-methylpiperazin-1-yl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]-2-pyridin-4-ylacetamide"
        },
        "smiles": {
          "canonical": "CN1CCN(CC1)C(=O)CC2CC3C(C(O2)CO)OC4=C3C=C(C=C4)NC(=O)CC5=CC=NC=C5"
        },
        "molecularFormula": "C26H32N4O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:52:58Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8431"
    },
    "name": "BRD-K03013810",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8431.png",
    "lincs": {
      "id": "LSM-8620",
      "name": "BRD-K03013810",
      "pubchemCid": 54638216,
      "chebiId": 97241,
      "inchiParent": "InChI=1S/C18H24N2O4/c21-11-16-15(20-18(23)12-6-7-12)9-8-14(24-16)10-17(22)19-13-4-2-1-3-5-13/h1-5,12,14-16,21H,6-11H2,(H,19,22)(H,20,23)/t14-,15-,16-/m1/s1",
      "inchiKeyParent": "SOYBDXBXTZOLGY-BZUAXINKSA-N",
      "smilesParent": "OC[C@H]1O[C@@H](CC(=O)Nc2ccccc2)CC[C@H]1NC(=O)C3CC3"
    },
    "unichem": {
      "chebi": "97241",
      "lincs": "LSM-8620",
      "pubchem": "54638216"
    },
    "pubchem": [
      {
        "cid": 54638216,
        "inchi": "InChI=1S/C18H24N2O4/c21-11-16-15(20-18(23)12-6-7-12)9-8-14(24-16)10-17(22)19-13-4-2-1-3-5-13/h1-5,12,14-16,21H,6-11H2,(H,19,22)(H,20,23)/t14-,15-,16-/m1/s1",
        "inchikey": "SOYBDXBXTZOLGY-BZUAXINKSA-N",
        "iupac": {
          "systematic": "N-[(2S,3R,6R)-6-(2-anilino-2-oxoethyl)-2-(hydroxymethyl)oxan-3-yl]cyclopropanecarboxamide"
        },
        "smiles": {
          "canonical": "C1CC1C(=O)NC2CCC(OC2CO)CC(=O)NC3=CC=CC=C3"
        },
        "molecularFormula": "C18H24N2O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:53:00Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c844d"
    },
    "name": "BRD-K66814954",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c844d.png",
    "lincs": {
      "id": "LSM-12499",
      "name": "BRD-K66814954",
      "pubchemCid": 54650131,
      "chebiId": 101130,
      "inchiParent": "InChI=1S/C17H15FN2O3S/c18-13-6-8-14(9-7-13)24(22,23)20-15(10-19)17(16(20)11-21)12-4-2-1-3-5-12/h1-9,15-17,21H,11H2/t15-,16-,17+/m1/s1",
      "inchiKeyParent": "LIAUQGYQVCFFMZ-ZACQAIPSSA-N",
      "smilesParent": "OC[C@@H]1[C@H]([C@@H](C#N)N1S(=O)(=O)c2ccc(F)cc2)c3ccccc3"
    },
    "unichem": {
      "chebi": "101130",
      "lincs": "LSM-12499",
      "pubchem": "54650131"
    },
    "pubchem": [
      {
        "cid": 54650131,
        "inchi": "InChI=1S/C17H15FN2O3S/c18-13-6-8-14(9-7-13)24(22,23)20-15(10-19)17(16(20)11-21)12-4-2-1-3-5-12/h1-9,15-17,21H,11H2/t15-,16-,17+/m1/s1",
        "inchikey": "LIAUQGYQVCFFMZ-ZACQAIPSSA-N",
        "iupac": {
          "systematic": "(2S,3S,4S)-1-(4-fluorophenyl)sulfonyl-4-(hydroxymethyl)-3-phenylazetidine-2-carbonitrile"
        },
        "smiles": {
          "canonical": "C1=CC=C(C=C1)C2C(N(C2C#N)S(=O)(=O)C3=CC=C(C=C3)F)CO"
        },
        "molecularFormula": "C17H15FN2O3S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:53:02Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84ab"
    },
    "name": "BRD-K82328933",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84ab.png",
    "lincs": {
      "id": "LSM-13459",
      "name": "BRD-K82328933",
      "pubchemCid": 54649325,
      "chebiId": 102099,
      "inchiParent": "InChI=1S/C22H30Cl2N2O6S2/c1-16(13-26(17(2)15-27)34(30,31)21-7-5-6-19(24)12-21)22(32-4)14-25(3)33(28,29)20-10-8-18(23)9-11-20/h5-12,16-17,22,27H,13-15H2,1-4H3/t16-,17+,22+/m0/s1",
      "inchiKeyParent": "JTCZGLOUSBJUER-GSHUGGBRSA-N",
      "smilesParent": "CO[C@H](CN(C)S(=O)(=O)c1ccc(Cl)cc1)[C@@H](C)CN([C@H](C)CO)S(=O)(=O)c2cccc(Cl)c2"
    },
    "unichem": {
      "chebi": "102099",
      "lincs": "LSM-13459",
      "pubchem": "54649325"
    },
    "pubchem": [
      {
        "cid": 54649325,
        "inchi": "InChI=1S/C22H30Cl2N2O6S2/c1-16(13-26(17(2)15-27)34(30,31)21-7-5-6-19(24)12-21)22(32-4)14-25(3)33(28,29)20-10-8-18(23)9-11-20/h5-12,16-17,22,27H,13-15H2,1-4H3/t16-,17+,22+/m0/s1",
        "inchikey": "JTCZGLOUSBJUER-GSHUGGBRSA-N",
        "iupac": {
          "systematic": "3-chloro-N-[(2S,3S)-4-[(4-chlorophenyl)sulfonyl-methylamino]-3-methoxy-2-methylbutyl]-N-[(2R)-1-hydroxypropan-2-yl]benzenesulfonamide"
        },
        "smiles": {
          "canonical": "CC(CN(C(C)CO)S(=O)(=O)C1=CC(=CC=C1)Cl)C(CN(C)S(=O)(=O)C2=CC=C(C=C2)Cl)OC"
        },
        "molecularFormula": "C22H30Cl2N2O6S2"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:53:05Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84dc"
    },
    "name": "BRD-K63216438",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84dc.png",
    "lincs": {
      "id": "LSM-12274",
      "name": "BRD-K63216438",
      "pubchemCid": 54649100,
      "chebiId": 100900,
      "inchiParent": "InChI=1S/C23H31ClF2N2O4S/c1-16(23(32-4)14-27(3)13-18-11-20(25)7-10-22(18)26)12-28(17(2)15-29)33(30,31)21-8-5-19(24)6-9-21/h5-11,16-17,23,29H,12-15H2,1-4H3/t16-,17-,23-/m1/s1",
      "inchiKeyParent": "UIWWHFNWICLZIF-SEPYTNNBSA-N",
      "smilesParent": "CO[C@H](CN(C)Cc1cc(F)ccc1F)[C@H](C)CN([C@H](C)CO)S(=O)(=O)c2ccc(Cl)cc2"
    },
    "unichem": {
      "chebi": "100900",
      "lincs": "LSM-12274",
      "pubchem": "54649100"
    },
    "pubchem": [
      {
        "cid": 54649100,
        "inchi": "InChI=1S/C23H31ClF2N2O4S/c1-16(23(32-4)14-27(3)13-18-11-20(25)7-10-22(18)26)12-28(17(2)15-29)33(30,31)21-8-5-19(24)6-9-21/h5-11,16-17,23,29H,12-15H2,1-4H3/t16-,17-,23-/m1/s1",
        "inchikey": "UIWWHFNWICLZIF-SEPYTNNBSA-N",
        "iupac": {
          "systematic": "4-chloro-N-[(2R,3S)-4-[(2,5-difluorophenyl)methyl-methylamino]-3-methoxy-2-methylbutyl]-N-[(2R)-1-hydroxypropan-2-yl]benzenesulfonamide"
        },
        "smiles": {
          "canonical": "CC(CN(C(C)CO)S(=O)(=O)C1=CC=C(C=C1)Cl)C(CN(C)CC2=C(C=CC(=C2)F)F)OC"
        },
        "molecularFormula": "C23H31ClF2N2O4S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:53:07Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8469"
    },
    "name": "MLS003129251",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8469.png",
    "lincs": {
      "id": "LSM-7671",
      "name": "MLS003129251",
      "alternativeNames": [
        "BRD-K61953981"
      ],
      "pubchemCid": 44505407,
      "chebiId": 96292,
      "inchiParent": "InChI=1S/C27H35N5O5/c1-19-15-31(20(2)17-33)26(34)9-6-12-32-23(14-28-29-32)18-36-25(19)16-30(3)27(35)37-24-11-10-21-7-4-5-8-22(21)13-24/h4-5,7-8,10-11,13-14,19-20,25,33H,6,9,12,15-18H2,1-3H3/t19-,20+,25+/m0/s1",
      "inchiKeyParent": "PZGTZQIYRXDXGV-WZOHSFFVSA-N",
      "smilesParent": "C[C@H](CO)N1C[C@H](C)[C@@H](CN(C)C(=O)Oc2ccc3ccccc3c2)OCc4cnnn4CCCC1=O"
    },
    "unichem": {
      "chebi": "96292",
      "chembl": "CHEMBL1903857",
      "lincs": "LSM-7671",
      "pubchem": "44505407"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL1903857",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 509.61,
        "hba": 8,
        "hbd": 1,
        "qedWeighted": 0.56
      }
    },
    "pubchem": [
      {
        "cid": 44505407,
        "inchi": "InChI=1S/C27H35N5O5/c1-19-15-31(20(2)17-33)26(34)9-6-12-32-23(14-28-29-32)18-36-25(19)16-30(3)27(35)37-24-11-10-21-7-4-5-8-22(21)13-24/h4-5,7-8,10-11,13-14,19-20,25,33H,6,9,12,15-18H2,1-3H3/t19-,20+,25+/m0/s1",
        "inchikey": "PZGTZQIYRXDXGV-WZOHSFFVSA-N",
        "iupac": {
          "systematic": "naphthalen-2-yl N-[[(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methylcarbamate"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)CCCN2C(=CN=N2)COC1CN(C)C(=O)OC3=CC4=CC=CC=C4C=C3)C(C)CO"
        },
        "molecularFormula": "C27H35N5O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:53:18Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84aa"
    },
    "name": "BRD-K62242359",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84aa.png",
    "lincs": {
      "id": "LSM-40671",
      "name": "BRD-K62242359",
      "pubchemCid": 44485233,
      "chebiId": 129120,
      "inchiParent": "InChI=1S/C33H42N4O4/c1-22(2)34-33(40)35-28-15-16-30-29(17-28)32(39)37(24(4)21-38)18-23(3)31(41-30)20-36(5)19-25-11-13-27(14-12-25)26-9-7-6-8-10-26/h6-17,22-24,31,38H,18-21H2,1-5H3,(H2,34,35,40)/t23-,24+,31+/m1/s1",
      "inchiKeyParent": "KRCYYDXJFSFYMC-OXYPMYLPSA-N",
      "smilesParent": "CC(C)NC(=O)Nc1ccc2O[C@@H](CN(C)Cc3ccc(cc3)c4ccccc4)[C@H](C)CN([C@@H](C)CO)C(=O)c2c1"
    },
    "unichem": {
      "chebi": "129120",
      "lincs": "LSM-40671",
      "pubchem": "44485233"
    },
    "pubchem": [
      {
        "cid": 44485233,
        "inchi": "InChI=1S/C33H42N4O4/c1-22(2)34-33(40)35-28-15-16-30-29(17-28)32(39)37(24(4)21-38)18-23(3)31(41-30)20-36(5)19-25-11-13-27(14-12-25)26-9-7-6-8-10-26/h6-17,22-24,31,38H,18-21H2,1-5H3,(H2,34,35,40)/t23-,24+,31+/m1/s1",
        "inchikey": "KRCYYDXJFSFYMC-OXYPMYLPSA-N",
        "iupac": {
          "systematic": "1-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-propan-2-ylurea"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(C=CC(=C2)NC(=O)NC(C)C)OC1CN(C)CC3=CC=C(C=C3)C4=CC=CC=C4)C(C)CO"
        },
        "molecularFormula": "C33H42N4O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:53:20Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8489"
    },
    "name": "BRD-K34319349",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8489.png",
    "lincs": {
      "id": "LSM-47605",
      "name": "BRD-K34319349",
      "pubchemCid": 60185401,
      "inchiParent": "InChI=1S/C25H23N3O2S/c26-14-19-7-4-8-22(13-19)20-9-11-21(12-10-20)25-23-15-28(16-24(25)27-23)31(29,30)17-18-5-2-1-3-6-18/h1-13,23-25,27H,15-17H2/t23-,24+,25+",
      "inchiKeyParent": "LVLIWGGYVPRADT-LNWKWYTESA-N",
      "smilesParent": "O=S(=O)(Cc1ccccc1)N2C[C@@H]3N[C@H](C2)[C@@H]3c4ccc(cc4)c5cccc(c5)C#N"
    },
    "pubchem": [
      {
        "cid": 60185401,
        "inchi": "InChI=1S/C25H23N3O2S/c26-14-19-7-4-8-22(13-19)20-9-11-21(12-10-20)25-23-15-28(16-24(25)27-23)31(29,30)17-18-5-2-1-3-6-18/h1-13,23-25,27H,15-17H2/t23-,24+,25?",
        "inchikey": "LVLIWGGYVPRADT-XMGLRAKGSA-N",
        "iupac": {
          "systematic": "3-[4-[(1S,5R)-3-benzylsulfonyl-3,6-diazabicyclo[3.1.1]heptan-7-yl]phenyl]benzonitrile"
        },
        "smiles": {
          "canonical": "C1C2C(C(N2)CN1S(=O)(=O)CC3=CC=CC=C3)C4=CC=C(C=C4)C5=CC=CC(=C5)C#N"
        },
        "molecularFormula": "C25H23N3O2S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:53:22Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84bf"
    },
    "name": "BRD-K77793090",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84bf.png",
    "lincs": {
      "id": "LSM-13185",
      "name": "BRD-K77793090",
      "pubchemCid": 54631447,
      "chebiId": 101823,
      "inchiParent": "InChI=1S/C28H40N4O5/c1-7-13-32-16-19(2)26(36-6)17-31(4)27(33)24-12-11-22(15-25(24)37-18-20(32)3)30-28(34)29-21-9-8-10-23(14-21)35-5/h8-12,14-15,19-20,26H,7,13,16-18H2,1-6H3,(H2,29,30,34)/t19-,20+,26+/m1/s1",
      "inchiKeyParent": "NWXQZACELVQCTR-GOHWNWGWSA-N",
      "smilesParent": "CCCN1C[C@@H](C)[C@H](CN(C)C(=O)c2ccc(NC(=O)Nc3cccc(OC)c3)cc2OC[C@@H]1C)OC"
    },
    "unichem": {
      "chebi": "101823",
      "lincs": "LSM-13185",
      "pubchem": "54631447"
    },
    "pubchem": [
      {
        "cid": 54631447,
        "inchi": "InChI=1S/C28H40N4O5/c1-7-13-32-16-19(2)26(36-6)17-31(4)27(33)24-12-11-22(15-25(24)37-18-20(32)3)30-28(34)29-21-9-8-10-23(14-21)35-5/h8-12,14-15,19-20,26H,7,13,16-18H2,1-6H3,(H2,29,30,34)/t19-,20+,26+/m1/s1",
        "inchikey": "NWXQZACELVQCTR-GOHWNWGWSA-N",
        "iupac": {
          "systematic": "1-(3-methoxyphenyl)-3-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-15-yl]urea"
        },
        "smiles": {
          "canonical": "CCCN1CC(C(CN(C(=O)C2=C(C=C(C=C2)NC(=O)NC3=CC(=CC=C3)OC)OCC1C)C)OC)C"
        },
        "molecularFormula": "C28H40N4O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:53:25Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84dd"
    },
    "name": "BRD-K52045590",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84dd.png",
    "lincs": {
      "id": "LSM-11613",
      "name": "BRD-K52045590",
      "pubchemCid": 54646441,
      "chebiId": 100236,
      "inchiParent": "InChI=1S/C33H36N2O7/c36-20-30-32-28(27-16-23(8-11-29(27)42-32)35-33(38)22-12-14-39-15-13-22)17-26(41-30)18-31(37)34-19-21-6-9-25(10-7-21)40-24-4-2-1-3-5-24/h1-11,16,22,26,28,30,32,36H,12-15,17-20H2,(H,34,37)(H,35,38)/t26-,28+,30+,32-/m1/s1",
      "inchiKeyParent": "MARYDHBQWVLAFX-XXKKVQIQSA-N",
      "smilesParent": "OC[C@@H]1O[C@@H](CC(=O)NCc2ccc(Oc3ccccc3)cc2)C[C@@H]4[C@H]1Oc5ccc(NC(=O)C6CCOCC6)cc45"
    },
    "unichem": {
      "chebi": "100236",
      "lincs": "LSM-11613",
      "pubchem": "54646441"
    },
    "pubchem": [
      {
        "cid": 54646441,
        "inchi": "InChI=1S/C33H36N2O7/c36-20-30-32-28(27-16-23(8-11-29(27)42-32)35-33(38)22-12-14-39-15-13-22)17-26(41-30)18-31(37)34-19-21-6-9-25(10-7-21)40-24-4-2-1-3-5-24/h1-11,16,22,26,28,30,32,36H,12-15,17-20H2,(H,34,37)(H,35,38)/t26-,28+,30+,32-/m1/s1",
        "inchikey": "MARYDHBQWVLAFX-XXKKVQIQSA-N",
        "iupac": {
          "systematic": "N-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-[(4-phenoxyphenyl)methylamino]ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]oxane-4-carboxamide"
        },
        "smiles": {
          "canonical": "C1COCCC1C(=O)NC2=CC3=C(C=C2)OC4C3CC(OC4CO)CC(=O)NCC5=CC=C(C=C5)OC6=CC=CC=C6"
        },
        "molecularFormula": "C33H36N2O7"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:53:27Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84e6"
    },
    "name": "SA-1939936",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84e6.png",
    "lincs": {
      "id": "LSM-41620",
      "name": "SA-1939936",
      "pubchemCid": 60189878,
      "chebiId": 130069,
      "inchiParent": "InChI=1S/C24H27N3O3/c1-30-17-7-8-18-19(13-17)26-22-20(14-28)25-15-24(21(18)22)9-11-27(12-10-24)23(29)16-5-3-2-4-6-16/h2-8,13,20,25-26,28H,9-12,14-15H2,1H3/t20-/m0/s1",
      "inchiKeyParent": "AUWZQCQMTQQGSM-FQEVSTJZSA-N",
      "smilesParent": "COc1ccc2c3c([nH]c2c1)[C@H](CO)NCC34CCN(CC4)C(=O)c5ccccc5"
    },
    "unichem": {
      "chebi": "130069",
      "lincs": "LSM-41620",
      "pubchem": "60189878"
    },
    "pubchem": [
      {
        "cid": 60189878,
        "inchi": "InChI=1S/C24H27N3O3/c1-30-17-7-8-18-19(13-17)26-22-20(14-28)25-15-24(21(18)22)9-11-27(12-10-24)23(29)16-5-3-2-4-6-16/h2-8,13,20,25-26,28H,9-12,14-15H2,1H3/t20-/m0/s1",
        "inchikey": "AUWZQCQMTQQGSM-FQEVSTJZSA-N",
        "iupac": {
          "systematic": "[(1R)-1-(hydroxymethyl)-7-methoxyspiro[1,2,3,9-tetrahydropyrido[3,4-b]indole-4,4'-piperidine]-1'-yl]-phenylmethanone"
        },
        "smiles": {
          "canonical": "COC1=CC2=C(C=C1)C3=C(N2)C(NCC34CCN(CC4)C(=O)C5=CC=CC=C5)CO"
        },
        "molecularFormula": "C24H27N3O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:53:29Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84e8"
    },
    "name": "BRD-K61683215",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84e8.png",
    "lincs": {
      "id": "LSM-12168",
      "name": "BRD-K61683215",
      "pubchemCid": 54654276,
      "chebiId": 100794,
      "inchiParent": "InChI=1S/C27H29F2N3O6/c1-31-22-6-4-18(14-25(33)32-8-10-36-11-9-32)38-24(22)15-37-23-7-3-17(13-19(23)27(31)35)30-26(34)16-2-5-20(28)21(29)12-16/h2-3,5,7,12-13,18,22,24H,4,6,8-11,14-15H2,1H3,(H,30,34)/t18-,22-,24-/m1/s1",
      "inchiKeyParent": "RISZPRWRWDPXQV-IHLLOCCUSA-N",
      "smilesParent": "CN1[C@@H]2CC[C@H](CC(=O)N3CCOCC3)O[C@@H]2COc4ccc(NC(=O)c5ccc(F)c(F)c5)cc4C1=O"
    },
    "unichem": {
      "chebi": "100794",
      "lincs": "LSM-12168",
      "pubchem": "54654276"
    },
    "pubchem": [
      {
        "cid": 54654276,
        "inchi": "InChI=1S/C27H29F2N3O6/c1-31-22-6-4-18(14-25(33)32-8-10-36-11-9-32)38-24(22)15-37-23-7-3-17(13-19(23)27(31)35)30-26(34)16-2-5-20(28)21(29)12-16/h2-3,5,7,12-13,18,22,24H,4,6,8-11,14-15H2,1H3,(H,30,34)/t18-,22-,24-/m1/s1",
        "inchikey": "RISZPRWRWDPXQV-IHLLOCCUSA-N",
        "iupac": {
          "systematic": "N-[(2R,4aR,12aS)-5-methyl-2-(2-morpholin-4-yl-2-oxoethyl)-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-3,4-difluorobenzamide"
        },
        "smiles": {
          "canonical": "CN1C2CCC(OC2COC3=C(C1=O)C=C(C=C3)NC(=O)C4=CC(=C(C=C4)F)F)CC(=O)N5CCOCC5"
        },
        "molecularFormula": "C27H29F2N3O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:53:31Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c844e"
    },
    "name": "BRD-K95208083",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c844e.png",
    "lincs": {
      "id": "LSM-14263",
      "name": "BRD-K95208083",
      "pubchemCid": 54657716,
      "chebiId": 102917,
      "inchiParent": "InChI=1S/C25H27Cl2FN2O5/c26-19-7-5-15(9-20(19)27)11-29-24(32)10-17-6-8-22-23(35-17)14-34-13-16(31)12-30(22)25(33)18-3-1-2-4-21(18)28/h1-5,7,9,16-17,22-23,31H,6,8,10-14H2,(H,29,32)/t16-,17-,22-,23+/m1/s1",
      "inchiKeyParent": "NLZWENHPOORBAO-UOGRCSNTSA-N",
      "smilesParent": "O[C@H]1COC[C@@H]2O[C@@H](CC(=O)NCc3ccc(Cl)c(Cl)c3)CC[C@H]2N(C1)C(=O)c4ccccc4F"
    },
    "unichem": {
      "chebi": "102917",
      "lincs": "LSM-14263",
      "pubchem": "54657716"
    },
    "pubchem": [
      {
        "cid": 54657716,
        "inchi": "InChI=1S/C25H27Cl2FN2O5/c26-19-7-5-15(9-20(19)27)11-29-24(32)10-17-6-8-22-23(35-17)14-34-13-16(31)12-30(22)25(33)18-3-1-2-4-21(18)28/h1-5,7,9,16-17,22-23,31H,6,8,10-14H2,(H,29,32)/t16-,17-,22-,23+/m1/s1",
        "inchikey": "NLZWENHPOORBAO-UOGRCSNTSA-N",
        "iupac": {
          "systematic": "2-[(3R,6aR,8R,10aR)-1-(2-fluorobenzoyl)-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(3,4-dichlorophenyl)methyl]acetamide"
        },
        "smiles": {
          "canonical": "C1CC2C(COCC(CN2C(=O)C3=CC=CC=C3F)O)OC1CC(=O)NCC4=CC(=C(C=C4)Cl)Cl"
        },
        "molecularFormula": "C25H27Cl2FN2O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:53:33Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8481"
    },
    "name": "BRD-K28513938",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8481.png",
    "lincs": {
      "id": "LSM-10155",
      "name": "BRD-K28513938",
      "pubchemCid": 54649522,
      "chebiId": 98776,
      "inchiParent": "InChI=1S/C25H35N3O6/c1-16-22(32-5)14-28(3)25(30)19-12-17(13-26)6-8-20(19)33-15-23-21(31-4)9-7-18(34-23)10-11-27(2)24(16)29/h6,8,12,16,18,21-23H,7,9-11,14-15H2,1-5H3/t16-,18-,21-,22+,23-/m1/s1",
      "inchiKeyParent": "YDHXSWOLXDIZHC-MYCSGDSKSA-N",
      "smilesParent": "CO[C@@H]1CC[C@@H]2CCN(C)C(=O)[C@H](C)[C@H](CN(C)C(=O)c3cc(ccc3OC[C@H]1O2)C#N)OC"
    },
    "unichem": {
      "chebi": "98776",
      "lincs": "LSM-10155",
      "pubchem": "54649522"
    },
    "pubchem": [
      {
        "cid": 54649522,
        "inchi": "InChI=1S/C25H35N3O6/c1-16-22(32-5)14-28(3)25(30)19-12-17(13-26)6-8-20(19)33-15-23-21(31-4)9-7-18(34-23)10-11-27(2)24(16)29/h6,8,12,16,18,21-23H,7,9-11,14-15H2,1-5H3/t16-,18-,21-,22+,23-/m1/s1",
        "inchikey": "YDHXSWOLXDIZHC-MYCSGDSKSA-N",
        "iupac": {
          "systematic": "(1R,13R,14R,19R,22R)-13,22-dimethoxy-11,14,16-trimethyl-10,15-dioxo-3,23-dioxa-11,16-diazatricyclo[17.3.1.04,9]tricosa-4(9),5,7-triene-7-carbonitrile"
        },
        "smiles": {
          "canonical": "CC1C(CN(C(=O)C2=C(C=CC(=C2)C#N)OCC3C(CCC(O3)CCN(C1=O)C)OC)C)OC"
        },
        "molecularFormula": "C25H35N3O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:53:36Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84de"
    },
    "name": "BRD-K18306851",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84de.png",
    "lincs": {
      "id": "LSM-9525",
      "name": "BRD-K18306851",
      "pubchemCid": 54637962,
      "chebiId": 98146,
      "inchiParent": "InChI=1S/C30H33FN2O4/c1-20-16-33(21(2)18-34)30(36)27-11-7-6-10-26(27)25-9-5-4-8-23(25)19-37-28(20)17-32(3)29(35)22-12-14-24(31)15-13-22/h4-15,20-21,28,34H,16-19H2,1-3H3/t20-,21+,28-/m1/s1",
      "inchiKeyParent": "HTGRXZBGTMWDTQ-PHVLTXCSSA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@@H](C)[C@@H](CN(C)C(=O)c2ccc(F)cc2)OCc3ccccc3c4ccccc4C1=O"
    },
    "unichem": {
      "chebi": "98146",
      "lincs": "LSM-9525",
      "pubchem": "54637962"
    },
    "pubchem": [
      {
        "cid": 54637962,
        "inchi": "InChI=1S/C30H33FN2O4/c1-20-16-33(21(2)18-34)30(36)27-11-7-6-10-26(27)25-9-5-4-8-23(25)19-37-28(20)17-32(3)29(35)22-12-14-24(31)15-13-22/h4-15,20-21,28,34H,16-19H2,1-3H3/t20-,21+,28-/m1/s1",
        "inchikey": "HTGRXZBGTMWDTQ-PHVLTXCSSA-N",
        "iupac": {
          "systematic": "4-fluoro-N-[[(10S,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylbenzamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=CC=CC=C2C3=CC=CC=C3COC1CN(C)C(=O)C4=CC=C(C=C4)F)C(C)CO"
        },
        "molecularFormula": "C30H33FN2O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:53:38Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8427"
    },
    "name": "BRD-K95852551",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8427.png",
    "lincs": {
      "id": "LSM-8075",
      "name": "BRD-K95852551",
      "pubchemCid": 54618945,
      "chebiId": 96696,
      "inchiParent": "InChI=1S/C25H33N5O3/c1-17(2)6-7-20-8-22-24(28-11-20)33-23(14-29(5)13-21-9-26-16-27-10-21)18(3)12-30(25(22)32)19(4)15-31/h8-11,16-19,23,31H,12-15H2,1-5H3/t18-,19-,23-/m0/s1",
      "inchiKeyParent": "KVTAKNNJYPDOHV-YDHSSHFGSA-N",
      "smilesParent": "CC(C)C#Cc1cnc2O[C@@H](CN(C)Cc3cncnc3)[C@@H](C)CN([C@@H](C)CO)C(=O)c2c1"
    },
    "unichem": {
      "chebi": "96696",
      "lincs": "LSM-8075",
      "pubchem": "54618945"
    },
    "pubchem": [
      {
        "cid": 54618945,
        "inchi": "InChI=1S/C25H33N5O3/c1-17(2)6-7-20-8-22-24(28-11-20)33-23(14-29(5)13-21-9-26-16-27-10-21)18(3)12-30(25(22)32)19(4)15-31/h8-11,16-19,23,31H,12-15H2,1-5H3/t18-,19-,23-/m0/s1",
        "inchikey": "KVTAKNNJYPDOHV-YDHSSHFGSA-N",
        "iupac": {
          "systematic": "(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-8-(3-methylbut-1-ynyl)-2-[[methyl(pyrimidin-5-ylmethyl)amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(N=CC(=C2)C#CC(C)C)OC1CN(C)CC3=CN=CN=C3)C(C)CO"
        },
        "molecularFormula": "C25H33N5O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:53:40Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8443"
    },
    "name": "CHEMBL2356381",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8443.png",
    "lincs": {
      "id": "LSM-39052",
      "name": "CHEMBL2356381",
      "alternativeNames": [
        "BRD-K32389477"
      ],
      "pubchemCid": 44619439,
      "chebiId": 127494,
      "inchiParent": "InChI=1S/C35H47F3N4O7S/c1-22-18-42(23(2)21-43)34(44)30-17-29(40-50(45,46)33-25(4)39-49-26(33)5)14-15-31(30)48-24(3)9-7-8-16-47-32(22)20-41(6)19-27-10-12-28(13-11-27)35(36,37)38/h10-15,17,22-24,32,40,43H,7-9,16,18-21H2,1-6H3/t22-,23+,24+,32+/m1/s1",
      "inchiKeyParent": "CBAAPWVHONFTKW-LJUIALDASA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@@H](C)[C@H](CN(C)Cc2ccc(cc2)C(F)(F)F)OCCCC[C@H](C)Oc3ccc(NS(=O)(=O)c4c(C)onc4C)cc3C1=O"
    },
    "unichem": {
      "chebi": "127494",
      "chembl": "CHEMBL2356381",
      "lincs": "LSM-39052",
      "pubchem": "44619439"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL2356381",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 724.84,
        "hba": 9,
        "hbd": 2,
        "qedWeighted": 0.27
      }
    },
    "pubchem": [
      {
        "cid": 44619439,
        "inchi": "InChI=1S/C35H47F3N4O7S/c1-22-18-42(23(2)21-43)34(44)30-17-29(40-50(45,46)33-25(4)39-49-26(33)5)14-15-31(30)48-24(3)9-7-8-16-47-32(22)20-41(6)19-27-10-12-28(13-11-27)35(36,37)38/h10-15,17,22-24,32,40,43H,7-9,16,18-21H2,1-6H3/t22-,23+,24+,32+/m1/s1",
        "inchikey": "CBAAPWVHONFTKW-LJUIALDASA-N",
        "iupac": {
          "systematic": "N-[(3S,9R,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3,5-dimethyl-1,2-oxazole-4-sulfonamide"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NS(=O)(=O)C3=C(ON=C3C)C)C(C)CO)C)CN(C)CC4=CC=C(C=C4)C(F)(F)F"
        },
        "molecularFormula": "C35H47F3N4O7S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:53:51Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c845b"
    },
    "name": "BRD-K80357394",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c845b.png",
    "lincs": {
      "id": "LSM-26833",
      "name": "BRD-K80357394",
      "pubchemCid": 54633485,
      "chebiId": 115376,
      "inchiParent": "InChI=1S/C27H38N4O4/c1-6-7-26(32)29-22-8-9-23-24(14-22)35-18-20(3)31(16-21-10-12-28-13-11-21)15-19(2)25(34-5)17-30(4)27(23)33/h8-14,19-20,25H,6-7,15-18H2,1-5H3,(H,29,32)/t19-,20+,25+/m0/s1",
      "inchiKeyParent": "JAZMVIWKDLKWHZ-WZOHSFFVSA-N",
      "smilesParent": "CCCC(=O)Nc1ccc2C(=O)N(C)C[C@@H](OC)[C@@H](C)CN(Cc3ccncc3)[C@H](C)COc2c1"
    },
    "unichem": {
      "chebi": "115376",
      "lincs": "LSM-26833",
      "pubchem": "54633485"
    },
    "pubchem": [
      {
        "cid": 54633485,
        "inchi": "InChI=1S/C27H38N4O4/c1-6-7-26(32)29-22-8-9-23-24(14-22)35-18-20(3)31(16-21-10-12-28-13-11-21)15-19(2)25(34-5)17-30(4)27(23)33/h8-14,19-20,25H,6-7,15-18H2,1-5H3,(H,29,32)/t19-,20+,25+/m0/s1",
        "inchikey": "JAZMVIWKDLKWHZ-WZOHSFFVSA-N",
        "iupac": {
          "systematic": "N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(pyridin-4-ylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-15-yl]butanamide"
        },
        "smiles": {
          "canonical": "CCCC(=O)NC1=CC2=C(C=C1)C(=O)N(CC(C(CN(C(CO2)C)CC3=CC=NC=C3)C)OC)C"
        },
        "molecularFormula": "C27H38N4O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:53:54Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8470"
    },
    "name": "CHEMBL2355513",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8470.png",
    "lincs": {
      "id": "LSM-39806",
      "name": "CHEMBL2355513",
      "alternativeNames": [
        "SA-425500"
      ],
      "pubchemCid": 44498587,
      "chebiId": 128251,
      "inchiParent": "InChI=1S/C37H53F3N4O5/c1-25-21-44(26(2)24-45)35(46)32-20-31(42-36(47)41-30-15-13-29(14-16-30)37(38,39)40)17-18-33(32)49-27(3)10-8-9-19-48-34(25)23-43(4)22-28-11-6-5-7-12-28/h13-18,20,25-28,34,45H,5-12,19,21-24H2,1-4H3,(H2,41,42,47)/t25-,26+,27+,34-/m1/s1",
      "inchiKeyParent": "PEUKOTPXCYQHOA-ZIZQKJAQSA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@@H](C)[C@@H](CN(C)CC2CCCCC2)OCCCC[C@H](C)Oc3ccc(NC(=O)Nc4ccc(cc4)C(F)(F)F)cc3C1=O"
    },
    "unichem": {
      "chebi": "128251",
      "chembl": "CHEMBL2355513",
      "lincs": "LSM-39806",
      "pubchem": "44498587"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL2355513",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 690.85,
        "hba": 6,
        "hbd": 3,
        "qedWeighted": 0.26
      }
    },
    "pubchem": [
      {
        "cid": 44498587,
        "inchi": "InChI=1S/C37H53F3N4O5/c1-25-21-44(26(2)24-45)35(46)32-20-31(42-36(47)41-30-15-13-29(14-16-30)37(38,39)40)17-18-33(32)49-27(3)10-8-9-19-48-34(25)23-43(4)22-28-11-6-5-7-12-28/h13-18,20,25-28,34,45H,5-12,19,21-24H2,1-4H3,(H2,41,42,47)/t25-,26+,27+,34-/m1/s1",
        "inchikey": "PEUKOTPXCYQHOA-ZIZQKJAQSA-N",
        "iupac": {
          "systematic": "1-[(3S,9S,10R)-9-[[cyclohexylmethyl(methyl)amino]methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-[4-(trifluoromethyl)phenyl]urea"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NC(=O)NC3=CC=C(C=C3)C(F)(F)F)C(C)CO)C)CN(C)CC4CCCCC4"
        },
        "molecularFormula": "C37H53F3N4O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:54:05Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8438"
    },
    "name": "BRD-K93419974",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8438.png",
    "lincs": {
      "id": "LSM-42352",
      "name": "BRD-K93419974",
      "pubchemCid": 71759741,
      "chebiId": 130803,
      "inchiParent": "InChI=1S/C30H33N3O4S/c1-21-9-12-24(13-10-21)38(35,36)33-19-30(20-33)18-32(16-22-7-5-4-6-8-22)27(17-34)29-28(30)25-14-11-23(37-3)15-26(25)31(29)2/h4-15,27,34H,16-20H2,1-3H3/t27-/m0/s1",
      "inchiKeyParent": "OKCULXHRHVLDMD-MHZLTWQESA-N",
      "smilesParent": "COc1ccc2c3c([C@H](CO)N(Cc4ccccc4)CC35CN(C5)S(=O)(=O)c6ccc(C)cc6)n(C)c2c1"
    },
    "unichem": {
      "chebi": "130803",
      "lincs": "LSM-42352",
      "pubchem": "71759741"
    },
    "pubchem": [
      {
        "cid": 71759741,
        "inchi": "InChI=1S/C30H33N3O4S/c1-21-9-12-24(13-10-21)38(35,36)33-19-30(20-33)18-32(16-22-7-5-4-6-8-22)27(17-34)29-28(30)25-14-11-23(37-3)15-26(25)31(29)2/h4-15,27,34H,16-20H2,1-3H3/t27-/m0/s1",
        "inchikey": "OKCULXHRHVLDMD-MHZLTWQESA-N",
        "iupac": {
          "systematic": "[(1R)-2-benzyl-7-methoxy-9-methyl-1'-(4-methylphenyl)sulfonylspiro[1,3-dihydropyrido[3,4-b]indole-4,3'-azetidine]-1-yl]methanol"
        },
        "smiles": {
          "canonical": "CC1=CC=C(C=C1)S(=O)(=O)N2CC3(C2)CN(C(C4=C3C5=C(N4C)C=C(C=C5)OC)CO)CC6=CC=CC=C6"
        },
        "molecularFormula": "C30H33N3O4S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:54:07Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8444"
    },
    "name": "BRD-K41335306",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8444.png",
    "lincs": {
      "id": "LSM-44762",
      "name": "BRD-K41335306",
      "pubchemCid": 54666693,
      "inchiParent": "InChI=1S/C29H33N3O/c33-22-28-29(26-14-12-24(13-15-26)11-10-23-7-2-1-3-8-23)27-21-31(17-4-5-18-32(27)28)20-25-9-6-16-30-19-25/h1-3,6-16,19,27-29,33H,4-5,17-18,20-22H2/b11-10+/t27-,28+,29-/m1/s1",
      "inchiKeyParent": "ORVIWTYNJHNTDZ-OBGOALODSA-N",
      "smilesParent": "OC[C@H]1[C@@H]([C@H]2CN(Cc3cccnc3)CCCCN12)c4ccc(\\C=C\\c5ccccc5)cc4"
    },
    "unichem": {
      "lincs": "LSM-44762",
      "pubchem": "54666693"
    },
    "pubchem": [
      {
        "cid": 54666693,
        "inchi": "InChI=1S/C29H33N3O/c33-22-28-29(26-14-12-24(13-15-26)11-10-23-7-2-1-3-8-23)27-21-31(17-4-5-18-32(27)28)20-25-9-6-16-30-19-25/h1-3,6-16,19,27-29,33H,4-5,17-18,20-22H2/b11-10+/t27-,28+,29-/m1/s1",
        "inchikey": "ORVIWTYNJHNTDZ-OBGOALODSA-N",
        "iupac": {
          "systematic": "[(8S,9R,10R)-9-[4-[(E)-2-phenylethenyl]phenyl]-6-(pyridin-3-ylmethyl)-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol"
        },
        "smiles": {
          "canonical": "C1CCN2C(CN(C1)CC3=CN=CC=C3)C(C2CO)C4=CC=C(C=C4)C=CC5=CC=CC=C5"
        },
        "molecularFormula": "C29H33N3O"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:54:09Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c845f"
    },
    "name": "BRD-K14396276",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c845f.png",
    "lincs": {
      "id": "LSM-7045",
      "name": "BRD-K14396276",
      "pubchemCid": 54618105,
      "chebiId": 95666,
      "inchiParent": "InChI=1S/C26H30F2N4O5/c1-16-13-32(17(2)15-33)25(34)20-10-18(6-5-9-36-4)12-29-24(20)37-23(16)14-31(3)26(35)30-22-11-19(27)7-8-21(22)28/h7-8,10-12,16-17,23,33H,9,13-15H2,1-4H3,(H,30,35)/t16-,17-,23-/m1/s1",
      "inchiKeyParent": "SYMAGNSCDPNOSH-SEPYTNNBSA-N",
      "smilesParent": "COCC#Cc1cnc2O[C@H](CN(C)C(=O)Nc3cc(F)ccc3F)[C@H](C)CN([C@H](C)CO)C(=O)c2c1"
    },
    "unichem": {
      "chebi": "95666",
      "lincs": "LSM-7045",
      "pubchem": "54618105"
    },
    "pubchem": [
      {
        "cid": 54618105,
        "inchi": "InChI=1S/C26H30F2N4O5/c1-16-13-32(17(2)15-33)25(34)20-10-18(6-5-9-36-4)12-29-24(20)37-23(16)14-31(3)26(35)30-22-11-19(27)7-8-21(22)28/h7-8,10-12,16-17,23,33H,9,13-15H2,1-4H3,(H,30,35)/t16-,17-,23-/m1/s1",
        "inchikey": "SYMAGNSCDPNOSH-SEPYTNNBSA-N",
        "iupac": {
          "systematic": "3-(2,5-difluorophenyl)-1-[[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-8-(3-methoxyprop-1-ynyl)-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methylurea"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(N=CC(=C2)C#CCOC)OC1CN(C)C(=O)NC3=C(C=CC(=C3)F)F)C(C)CO"
        },
        "molecularFormula": "C26H30F2N4O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:54:12Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c846d"
    },
    "name": "BRD-K79944151",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c846d.png",
    "lincs": {
      "id": "LSM-13307",
      "name": "BRD-K79944151",
      "pubchemCid": 54638393,
      "chebiId": 101946,
      "inchiParent": "InChI=1S/C21H32N2O7S/c1-28-18-4-2-3-5-20(18)31(26,27)23-17-7-6-16(30-19(17)14-24)8-11-22-21(25)15-9-12-29-13-10-15/h2-5,15-17,19,23-24H,6-14H2,1H3,(H,22,25)/t16-,17-,19+/m1/s1",
      "inchiKeyParent": "BDFFQCHCBQOAPA-LMMKCTJWSA-N",
      "smilesParent": "COc1ccccc1S(=O)(=O)N[C@@H]2CC[C@H](CCNC(=O)C3CCOCC3)O[C@H]2CO"
    },
    "unichem": {
      "chebi": "101946",
      "lincs": "LSM-13307",
      "pubchem": "54638393"
    },
    "pubchem": [
      {
        "cid": 54638393,
        "inchi": "InChI=1S/C21H32N2O7S/c1-28-18-4-2-3-5-20(18)31(26,27)23-17-7-6-16(30-19(17)14-24)8-11-22-21(25)15-9-12-29-13-10-15/h2-5,15-17,19,23-24H,6-14H2,1H3,(H,22,25)/t16-,17-,19+/m1/s1",
        "inchikey": "BDFFQCHCBQOAPA-LMMKCTJWSA-N",
        "iupac": {
          "systematic": "N-[2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[(2-methoxyphenyl)sulfonylamino]oxan-2-yl]ethyl]oxane-4-carboxamide"
        },
        "smiles": {
          "canonical": "COC1=CC=CC=C1S(=O)(=O)NC2CCC(OC2CO)CCNC(=O)C3CCOCC3"
        },
        "molecularFormula": "C21H32N2O7S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:54:14Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84b7"
    },
    "name": "BRD-K36671795",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84b7.png",
    "lincs": {
      "id": "LSM-10646",
      "name": "BRD-K36671795",
      "pubchemCid": 54646301,
      "chebiId": 99267,
      "inchiParent": "InChI=1S/C30H31N3O5/c34-18-27-30-25(15-23(37-27)16-29(36)33-12-9-20-3-1-2-4-21(20)17-33)24-14-22(5-6-26(24)38-30)32-28(35)13-19-7-10-31-11-8-19/h1-8,10-11,14,23,25,27,30,34H,9,12-13,15-18H2,(H,32,35)/t23-,25+,27+,30-/m1/s1",
      "inchiKeyParent": "ZUSAVEKAEPAMKG-LWQGNWNJSA-N",
      "smilesParent": "OC[C@@H]1O[C@@H](CC(=O)N2CCc3ccccc3C2)C[C@@H]4[C@H]1Oc5ccc(NC(=O)Cc6ccncc6)cc45"
    },
    "unichem": {
      "chebi": "99267",
      "lincs": "LSM-10646",
      "pubchem": "54646301"
    },
    "pubchem": [
      {
        "cid": 54646301,
        "inchi": "InChI=1S/C30H31N3O5/c34-18-27-30-25(15-23(37-27)16-29(36)33-12-9-20-3-1-2-4-21(20)17-33)24-14-22(5-6-26(24)38-30)32-28(35)13-19-7-10-31-11-8-19/h1-8,10-11,14,23,25,27,30,34H,9,12-13,15-18H2,(H,32,35)/t23-,25+,27+,30-/m1/s1",
        "inchikey": "ZUSAVEKAEPAMKG-LWQGNWNJSA-N",
        "iupac": {
          "systematic": "N-[(1S,3R,4aS,9aR)-3-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]-2-pyridin-4-ylacetamide"
        },
        "smiles": {
          "canonical": "C1CN(CC2=CC=CC=C21)C(=O)CC3CC4C(C(O3)CO)OC5=C4C=C(C=C5)NC(=O)CC6=CC=NC=C6"
        },
        "molecularFormula": "C30H31N3O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:54:16Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c843a"
    },
    "name": "BRD-K21626096",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c843a.png",
    "lincs": {
      "id": "LSM-38442",
      "name": "BRD-K21626096",
      "pubchemCid": 60190234,
      "chebiId": 126879,
      "inchiParent": "InChI=1S/C25H31N3O4S/c1-17-5-4-6-19(13-17)33(30,31)28-11-9-25(10-12-28)16-26-21(15-29)24-23(25)20-8-7-18(32-3)14-22(20)27(24)2/h4-8,13-14,21,26,29H,9-12,15-16H2,1-3H3/t21-/m0/s1",
      "inchiKeyParent": "BIBACOGHJXNCPI-NRFANRHFSA-N",
      "smilesParent": "COc1ccc2c3c([C@H](CO)NCC34CCN(CC4)S(=O)(=O)c5cccc(C)c5)n(C)c2c1"
    },
    "unichem": {
      "chebi": "126879",
      "lincs": "LSM-38442",
      "pubchem": "60190234"
    },
    "pubchem": [
      {
        "cid": 60190234,
        "inchi": "InChI=1S/C25H31N3O4S/c1-17-5-4-6-19(13-17)33(30,31)28-11-9-25(10-12-28)16-26-21(15-29)24-23(25)20-8-7-18(32-3)14-22(20)27(24)2/h4-8,13-14,21,26,29H,9-12,15-16H2,1-3H3/t21-/m0/s1",
        "inchikey": "BIBACOGHJXNCPI-NRFANRHFSA-N",
        "iupac": {
          "systematic": "[(1R)-7-methoxy-9-methyl-1'-(3-methylphenyl)sulfonylspiro[2,3-dihydro-1H-pyrido[3,4-b]indole-4,4'-piperidine]-1-yl]methanol"
        },
        "smiles": {
          "canonical": "CC1=CC(=CC=C1)S(=O)(=O)N2CCC3(CC2)CNC(C4=C3C5=C(N4C)C=C(C=C5)OC)CO"
        },
        "molecularFormula": "C25H31N3O4S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:54:19Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c845d"
    },
    "name": "BRD-K50799972",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c845d.png",
    "lincs": {
      "id": "LSM-11526",
      "name": "BRD-K50799972",
      "pubchemCid": 54649381,
      "chebiId": 100149,
      "inchiParent": "InChI=1S/C33H36N4O4S/c1-33(2,3)42(40)37-21-25-19-27(32(39)35-20-22-12-15-34-16-13-22)36-31(30(25)28(37)14-17-38)24-9-7-8-23(18-24)26-10-5-6-11-29(26)41-4/h5-13,15-16,18-19,28,38H,14,17,20-21H2,1-4H3,(H,35,39)/t28-,42-/m0/s1",
      "inchiKeyParent": "VTKOTAQLGFRVGB-PJVIOAIDSA-N",
      "smilesParent": "COc1ccccc1c2cccc(c2)c3nc(cc4CN([C@@H](CCO)c34)[S@@](=O)C(C)(C)C)C(=O)NCc5ccncc5"
    },
    "unichem": {
      "chebi": "100149",
      "lincs": "LSM-11526",
      "pubchem": "54649381"
    },
    "pubchem": [
      {
        "cid": 54649381,
        "inchi": "InChI=1S/C33H36N4O4S/c1-33(2,3)42(40)37-21-25-19-27(32(39)35-20-22-12-15-34-16-13-22)36-31(30(25)28(37)14-17-38)24-9-7-8-23(18-24)26-10-5-6-11-29(26)41-4/h5-13,15-16,18-19,28,38H,14,17,20-21H2,1-4H3,(H,35,39)/t28-,42-/m0/s1",
        "inchikey": "VTKOTAQLGFRVGB-PJVIOAIDSA-N",
        "iupac": {
          "systematic": "(3S)-2-[(S)-tert-butylsulfinyl]-3-(2-hydroxyethyl)-4-[3-(2-methoxyphenyl)phenyl]-N-(pyridin-4-ylmethyl)-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide"
        },
        "smiles": {
          "canonical": "CC(C)(C)S(=O)N1CC2=CC(=NC(=C2C1CCO)C3=CC=CC(=C3)C4=CC=CC=C4OC)C(=O)NCC5=CC=NC=C5"
        },
        "molecularFormula": "C33H36N4O4S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:54:21Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8468"
    },
    "name": "BRD-K46746774",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8468.png",
    "lincs": {
      "id": "LSM-30003",
      "name": "BRD-K46746774",
      "pubchemCid": 54639484,
      "chebiId": 118554,
      "inchiParent": "InChI=1S/C16H28N2O5/c1-22-11-15(20)17-13-6-5-12(23-14(13)10-19)9-16(21)18-7-3-2-4-8-18/h12-14,19H,2-11H2,1H3,(H,17,20)/t12-,13-,14+/m0/s1",
      "inchiKeyParent": "DVRCOHXMQROJRA-MELADBBJSA-N",
      "smilesParent": "COCC(=O)N[C@H]1CC[C@@H](CC(=O)N2CCCCC2)O[C@@H]1CO"
    },
    "unichem": {
      "chebi": "118554",
      "lincs": "LSM-30003",
      "pubchem": "54639484"
    },
    "pubchem": [
      {
        "cid": 54639484,
        "inchi": "InChI=1S/C16H28N2O5/c1-22-11-15(20)17-13-6-5-12(23-14(13)10-19)9-16(21)18-7-3-2-4-8-18/h12-14,19H,2-11H2,1H3,(H,17,20)/t12-,13-,14+/m0/s1",
        "inchikey": "DVRCOHXMQROJRA-MELADBBJSA-N",
        "iupac": {
          "systematic": "N-[(2S,3S,6S)-2-(hydroxymethyl)-6-(2-oxo-2-piperidin-1-ylethyl)oxan-3-yl]-2-methoxyacetamide"
        },
        "smiles": {
          "canonical": "COCC(=O)NC1CCC(OC1CO)CC(=O)N2CCCCC2"
        },
        "molecularFormula": "C16H28N2O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:54:23Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8482"
    },
    "name": "BRD-K70852733",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8482.png",
    "lincs": {
      "id": "LSM-12751",
      "name": "BRD-K70852733",
      "pubchemCid": 54657531,
      "chebiId": 101388,
      "inchiParent": "InChI=1S/C26H33N5O5/c32-20-16-31(26(34)22-15-27-8-9-28-22)23-7-6-21(36-24(23)18-35-17-20)14-25(33)30-12-10-29(11-13-30)19-4-2-1-3-5-19/h1-5,8-9,15,20-21,23-24,32H,6-7,10-14,16-18H2/t20-,21-,23-,24+/m1/s1",
      "inchiKeyParent": "LCHNJAZNAXXEPD-KOVSNXQUSA-N",
      "smilesParent": "O[C@H]1COC[C@@H]2O[C@@H](CC(=O)N3CCN(CC3)c4ccccc4)CC[C@H]2N(C1)C(=O)c5cnccn5"
    },
    "unichem": {
      "chebi": "101388",
      "lincs": "LSM-12751",
      "pubchem": "54657531"
    },
    "pubchem": [
      {
        "cid": 54657531,
        "inchi": "InChI=1S/C26H33N5O5/c32-20-16-31(26(34)22-15-27-8-9-28-22)23-7-6-21(36-24(23)18-35-17-20)14-25(33)30-12-10-29(11-13-30)19-4-2-1-3-5-19/h1-5,8-9,15,20-21,23-24,32H,6-7,10-14,16-18H2/t20-,21-,23-,24+/m1/s1",
        "inchikey": "LCHNJAZNAXXEPD-KOVSNXQUSA-N",
        "iupac": {
          "systematic": "2-[(3R,6aR,8R,10aR)-3-hydroxy-1-(pyrazine-2-carbonyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(4-phenylpiperazin-1-yl)ethanone"
        },
        "smiles": {
          "canonical": "C1CC2C(COCC(CN2C(=O)C3=NC=CN=C3)O)OC1CC(=O)N4CCN(CC4)C5=CC=CC=C5"
        },
        "molecularFormula": "C26H33N5O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:54:26Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c848f"
    },
    "name": "CHEMBL2362080",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c848f.png",
    "lincs": {
      "id": "LSM-42120",
      "name": "CHEMBL2362080",
      "alternativeNames": [
        "BRD-K89000102"
      ],
      "pubchemCid": 49843444,
      "chebiId": 130571,
      "inchiParent": "InChI=1S/C37H47F3N4O5/c1-25-21-44(26(2)24-45)35(46)32-20-31(42-36(47)41-30-11-6-5-7-12-30)17-18-33(32)49-27(3)10-8-9-19-48-34(25)23-43(4)22-28-13-15-29(16-14-28)37(38,39)40/h5-7,11-18,20,25-27,34,45H,8-10,19,21-24H2,1-4H3,(H2,41,42,47)/t25-,26-,27+,34+/m1/s1",
      "inchiKeyParent": "VEYXNSARLJIJRR-GHVZQYPWSA-N",
      "smilesParent": "C[C@H](CO)N1C[C@@H](C)[C@H](CN(C)Cc2ccc(cc2)C(F)(F)F)OCCCC[C@H](C)Oc3ccc(NC(=O)Nc4ccccc4)cc3C1=O"
    },
    "unichem": {
      "chebi": "130571",
      "chembl": "CHEMBL2362080",
      "lincs": "LSM-42120",
      "pubchem": "49843444"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL2362080",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 684.8,
        "hba": 6,
        "hbd": 3,
        "qedWeighted": 0.23
      }
    },
    "pubchem": [
      {
        "cid": 49843444,
        "inchi": "InChI=1S/C37H47F3N4O5/c1-25-21-44(26(2)24-45)35(46)32-20-31(42-36(47)41-30-11-6-5-7-12-30)17-18-33(32)49-27(3)10-8-9-19-48-34(25)23-43(4)22-28-13-15-29(16-14-28)37(38,39)40/h5-7,11-18,20,25-27,34,45H,8-10,19,21-24H2,1-4H3,(H2,41,42,47)/t25-,26-,27+,34+/m1/s1",
        "inchikey": "VEYXNSARLJIJRR-GHVZQYPWSA-N",
        "iupac": {
          "systematic": "1-[(3S,9R,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-phenylurea"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NC(=O)NC3=CC=CC=C3)C(C)CO)C)CN(C)CC4=CC=C(C=C4)C(F)(F)F"
        },
        "molecularFormula": "C37H47F3N4O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:54:37Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84f3"
    },
    "name": "BRD-K67188562",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84f3.png",
    "lincs": {
      "id": "LSM-40933",
      "name": "BRD-K67188562",
      "pubchemCid": 54651349,
      "chebiId": 129382,
      "inchiParent": "InChI=1S/C20H23N3O4/c1-27-13-18(25)23-16(11-22-20(26)15-9-5-6-10-21-15)19(17(23)12-24)14-7-3-2-4-8-14/h2-10,16-17,19,24H,11-13H2,1H3,(H,22,26)/t16-,17+,19+/m0/s1",
      "inchiKeyParent": "GTTXVUOBMUATPQ-YQVWRLOYSA-N",
      "smilesParent": "COCC(=O)N1[C@H](CO)[C@@H]([C@@H]1CNC(=O)c2ccccn2)c3ccccc3"
    },
    "unichem": {
      "chebi": "129382",
      "lincs": "LSM-40933",
      "pubchem": "54651349"
    },
    "pubchem": [
      {
        "cid": 54651349,
        "inchi": "InChI=1S/C20H23N3O4/c1-27-13-18(25)23-16(11-22-20(26)15-9-5-6-10-21-15)19(17(23)12-24)14-7-3-2-4-8-14/h2-10,16-17,19,24H,11-13H2,1H3,(H,22,26)/t16-,17+,19+/m0/s1",
        "inchikey": "GTTXVUOBMUATPQ-YQVWRLOYSA-N",
        "iupac": {
          "systematic": "N-[[(2R,3R,4S)-4-(hydroxymethyl)-1-(2-methoxyacetyl)-3-phenylazetidin-2-yl]methyl]pyridine-2-carboxamide"
        },
        "smiles": {
          "canonical": "COCC(=O)N1C(C(C1CO)C2=CC=CC=C2)CNC(=O)C3=CC=CC=N3"
        },
        "molecularFormula": "C20H23N3O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:54:39Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c849b"
    },
    "name": "BRD-K86265745",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c849b.png",
    "lincs": {
      "id": "LSM-15168",
      "name": "BRD-K86265745",
      "pubchemCid": 54619271,
      "chebiId": 103824,
      "inchiParent": "InChI=1S/C29H35F2N3O5S/c1-19-16-34(20(2)18-35)40(37,38)28-13-10-22(9-8-21-6-4-5-7-21)14-26(28)39-27(19)17-33(3)29(36)32-25-15-23(30)11-12-24(25)31/h10-15,19-21,27,35H,4-7,16-18H2,1-3H3,(H,32,36)/t19-,20+,27-/m1/s1",
      "inchiKeyParent": "CROBQSVNIOLQSN-IOKPGSKQSA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@@H](C)[C@@H](CN(C)C(=O)Nc2cc(F)ccc2F)Oc3cc(ccc3S1(=O)=O)C#CC4CCCC4"
    },
    "unichem": {
      "chebi": "103824",
      "lincs": "LSM-15168",
      "pubchem": "54619271"
    },
    "pubchem": [
      {
        "cid": 54619271,
        "inchi": "InChI=1S/C29H35F2N3O5S/c1-19-16-34(20(2)18-35)40(37,38)28-13-10-22(9-8-21-6-4-5-7-21)14-26(28)39-27(19)17-33(3)29(36)32-25-15-23(30)11-12-24(25)31/h10-15,19-21,27,35H,4-7,16-18H2,1-3H3,(H,32,36)/t19-,20+,27-/m1/s1",
        "inchikey": "CROBQSVNIOLQSN-IOKPGSKQSA-N",
        "iupac": {
          "systematic": "1-[[(4R,5S)-8-(2-cyclopentylethynyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-3-(2,5-difluorophenyl)-1-methylurea"
        },
        "smiles": {
          "canonical": "CC1CN(S(=O)(=O)C2=C(C=C(C=C2)C#CC3CCCC3)OC1CN(C)C(=O)NC4=C(C=CC(=C4)F)F)C(C)CO"
        },
        "molecularFormula": "C29H35F2N3O5S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:54:42Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84a8"
    },
    "name": "BRD-K71752918",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84a8.png",
    "lincs": {
      "id": "LSM-12820",
      "name": "BRD-K71752918",
      "pubchemCid": 54638486,
      "chebiId": 101457,
      "inchiParent": "InChI=1S/C22H27FN2O5S/c1-15(16-6-3-2-4-7-16)24-22(27)13-18-10-11-20(21(14-26)30-18)25-31(28,29)19-9-5-8-17(23)12-19/h2-9,12,15,18,20-21,25-26H,10-11,13-14H2,1H3,(H,24,27)/t15-,18+,20+,21-/m1/s1",
      "inchiKeyParent": "YLLZUOSUTCBCJJ-WUHBCXKYSA-N",
      "smilesParent": "C[C@@H](NC(=O)C[C@@H]1CC[C@H](NS(=O)(=O)c2cccc(F)c2)[C@@H](CO)O1)c3ccccc3"
    },
    "unichem": {
      "chebi": "101457",
      "lincs": "LSM-12820",
      "pubchem": "54638486"
    },
    "pubchem": [
      {
        "cid": 54638486,
        "inchi": "InChI=1S/C22H27FN2O5S/c1-15(16-6-3-2-4-7-16)24-22(27)13-18-10-11-20(21(14-26)30-18)25-31(28,29)19-9-5-8-17(23)12-19/h2-9,12,15,18,20-21,25-26H,10-11,13-14H2,1H3,(H,24,27)/t15-,18+,20+,21-/m1/s1",
        "inchikey": "YLLZUOSUTCBCJJ-WUHBCXKYSA-N",
        "iupac": {
          "systematic": "2-[(2S,5S,6S)-5-[(3-fluorophenyl)sulfonylamino]-6-(hydroxymethyl)oxan-2-yl]-N-[(1R)-1-phenylethyl]acetamide"
        },
        "smiles": {
          "canonical": "CC(C1=CC=CC=C1)NC(=O)CC2CCC(C(O2)CO)NS(=O)(=O)C3=CC=CC(=C3)F"
        },
        "molecularFormula": "C22H27FN2O5S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:54:44Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84d3"
    },
    "name": "BRD-K05351800",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84d3.png",
    "lincs": {
      "id": "LSM-37555",
      "name": "BRD-K05351800",
      "pubchemCid": 54615094,
      "chebiId": 125988,
      "inchiParent": "InChI=1S/C33H53N3O5/c1-23-19-36(24(2)22-37)33(39)29-18-28(34-32(38)27-11-6-5-7-12-27)15-16-30(29)41-25(3)10-8-9-17-40-31(23)21-35(4)20-26-13-14-26/h15-16,18,23-27,31,37H,5-14,17,19-22H2,1-4H3,(H,34,38)/t23-,24-,25-,31-/m1/s1",
      "inchiKeyParent": "USUNOONMJLZZRB-GTEDWBNGSA-N",
      "smilesParent": "C[C@H](CO)N1C[C@@H](C)[C@@H](CN(C)CC2CC2)OCCCC[C@@H](C)Oc3ccc(NC(=O)C4CCCCC4)cc3C1=O"
    },
    "unichem": {
      "chebi": "125988",
      "lincs": "LSM-37555",
      "pubchem": "54615094"
    },
    "pubchem": [
      {
        "cid": 54615094,
        "inchi": "InChI=1S/C33H53N3O5/c1-23-19-36(24(2)22-37)33(39)29-18-28(34-32(38)27-11-6-5-7-12-27)15-16-30(29)41-25(3)10-8-9-17-40-31(23)21-35(4)20-26-13-14-26/h15-16,18,23-27,31,37H,5-14,17,19-22H2,1-4H3,(H,34,38)/t23-,24-,25-,31-/m1/s1",
        "inchikey": "USUNOONMJLZZRB-GTEDWBNGSA-N",
        "iupac": {
          "systematic": "N-[(3R,9S,10R)-9-[[cyclopropylmethyl(methyl)amino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]cyclohexanecarboxamide"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NC(=O)C3CCCCC3)C(C)CO)C)CN(C)CC4CC4"
        },
        "molecularFormula": "C33H53N3O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:54:46Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84d5"
    },
    "name": "BRD-K14974894",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84d5.png",
    "lincs": {
      "id": "LSM-9328",
      "name": "BRD-K14974894",
      "pubchemCid": 54649938,
      "chebiId": 97949,
      "inchiParent": "InChI=1S/C17H20N2O/c18-10-15-17(16(11-20)19-15)14-8-6-13(7-9-14)12-4-2-1-3-5-12/h4,6-9,15-17,19-20H,1-3,5,11H2/t15-,16-,17+/m0/s1",
      "inchiKeyParent": "SIGXZWYEWAPHMA-YESZJQIVSA-N",
      "smilesParent": "OC[C@@H]1N[C@@H](C#N)[C@H]1c2ccc(cc2)C3=CCCCC3"
    },
    "unichem": {
      "chebi": "97949",
      "lincs": "LSM-9328",
      "pubchem": "54649938"
    },
    "pubchem": [
      {
        "cid": 54649938,
        "inchi": "InChI=1S/C17H20N2O/c18-10-15-17(16(11-20)19-15)14-8-6-13(7-9-14)12-4-2-1-3-5-12/h4,6-9,15-17,19-20H,1-3,5,11H2/t15-,16-,17+/m0/s1",
        "inchikey": "SIGXZWYEWAPHMA-YESZJQIVSA-N",
        "iupac": {
          "systematic": "(2R,3R,4R)-3-[4-(cyclohexen-1-yl)phenyl]-4-(hydroxymethyl)azetidine-2-carbonitrile"
        },
        "smiles": {
          "canonical": "C1CCC(=CC1)C2=CC=C(C=C2)C3C(NC3C#N)CO"
        },
        "molecularFormula": "C17H20N2O"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:54:49Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c846f"
    },
    "name": "BRD-K97194822",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c846f.png",
    "lincs": {
      "id": "LSM-44922",
      "name": "BRD-K97194822",
      "pubchemCid": 54666675,
      "inchiParent": "InChI=1S/C27H35N3O2/c1-28(2)19-26(32)29-16-6-7-17-30-24(18-29)27(25(30)20-31)23-14-12-22(13-15-23)11-10-21-8-4-3-5-9-21/h3-5,8-15,24-25,27,31H,6-7,16-20H2,1-2H3/b11-10+/t24-,25+,27+/m0/s1",
      "inchiKeyParent": "ZAHXKZOKOUSJMC-WUBBLUHPSA-N",
      "smilesParent": "CN(C)CC(=O)N1CCCCN2[C@H](CO)[C@@H]([C@@H]2C1)c3ccc(\\C=C\\c4ccccc4)cc3"
    },
    "unichem": {
      "lincs": "LSM-44922",
      "pubchem": "54666675"
    },
    "pubchem": [
      {
        "cid": 54666675,
        "inchi": "InChI=1S/C27H35N3O2/c1-28(2)19-26(32)29-16-6-7-17-30-24(18-29)27(25(30)20-31)23-14-12-22(13-15-23)11-10-21-8-4-3-5-9-21/h3-5,8-15,24-25,27,31H,6-7,16-20H2,1-2H3/b11-10+/t24-,25+,27+/m0/s1",
        "inchikey": "ZAHXKZOKOUSJMC-WUBBLUHPSA-N",
        "iupac": {
          "systematic": "2-(dimethylamino)-1-[(8R,9R,10S)-10-(hydroxymethyl)-9-[4-[(E)-2-phenylethenyl]phenyl]-1,6-diazabicyclo[6.2.0]decan-6-yl]ethanone"
        },
        "smiles": {
          "canonical": "CN(C)CC(=O)N1CCCCN2C(C1)C(C2CO)C3=CC=C(C=C3)C=CC4=CC=CC=C4"
        },
        "molecularFormula": "C27H35N3O2"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:54:51Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84be"
    },
    "name": "BRD-K39255658",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84be.png",
    "lincs": {
      "id": "LSM-10812",
      "name": "BRD-K39255658",
      "pubchemCid": 54638507,
      "chebiId": 99433,
      "inchiParent": "InChI=1S/C29H30N2O7/c32-17-27-24(31-29(34)20-8-13-25-26(14-20)36-18-35-25)12-11-23(38-27)15-28(33)30-16-19-6-9-22(10-7-19)37-21-4-2-1-3-5-21/h1-10,13-14,23-24,27,32H,11-12,15-18H2,(H,30,33)(H,31,34)/t23-,24+,27-/m0/s1",
      "inchiKeyParent": "IKYPBPDRSBKALY-XFAFFCHDSA-N",
      "smilesParent": "OC[C@@H]1O[C@H](CC(=O)NCc2ccc(Oc3ccccc3)cc2)CC[C@H]1NC(=O)c4ccc5OCOc5c4"
    },
    "unichem": {
      "chebi": "99433",
      "lincs": "LSM-10812",
      "pubchem": "54638507"
    },
    "pubchem": [
      {
        "cid": 54638507,
        "inchi": "InChI=1S/C29H30N2O7/c32-17-27-24(31-29(34)20-8-13-25-26(14-20)36-18-35-25)12-11-23(38-27)15-28(33)30-16-19-6-9-22(10-7-19)37-21-4-2-1-3-5-21/h1-10,13-14,23-24,27,32H,11-12,15-18H2,(H,30,33)(H,31,34)/t23-,24+,27-/m0/s1",
        "inchikey": "IKYPBPDRSBKALY-XFAFFCHDSA-N",
        "iupac": {
          "systematic": "N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-[(4-phenoxyphenyl)methylamino]ethyl]oxan-3-yl]-1,3-benzodioxole-5-carboxamide"
        },
        "smiles": {
          "canonical": "C1CC(C(OC1CC(=O)NCC2=CC=C(C=C2)OC3=CC=CC=C3)CO)NC(=O)C4=CC5=C(C=C4)OCO5"
        },
        "molecularFormula": "C29H30N2O7"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:54:53Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84d9"
    },
    "name": "BRD-K68494763",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84d9.png",
    "lincs": {
      "id": "LSM-12606",
      "name": "BRD-K68494763",
      "pubchemCid": 54645837,
      "chebiId": 101238,
      "inchiParent": "InChI=1S/C27H32N2O6/c1-33-19-8-5-16(6-9-19)14-28-25(31)13-20-12-22-21-11-18(29-27(32)17-3-2-4-17)7-10-23(21)35-26(22)24(15-30)34-20/h5-11,17,20,22,24,26,30H,2-4,12-15H2,1H3,(H,28,31)(H,29,32)/t20-,22-,24-,26+/m0/s1",
      "inchiKeyParent": "QQFSWHWRRZLIPD-IFPZXYOKSA-N",
      "smilesParent": "COc1ccc(CNC(=O)C[C@@H]2C[C@@H]3[C@@H](Oc4ccc(NC(=O)C5CCC5)cc34)[C@H](CO)O2)cc1"
    },
    "unichem": {
      "chebi": "101238",
      "lincs": "LSM-12606",
      "pubchem": "54645837"
    },
    "pubchem": [
      {
        "cid": 54645837,
        "inchi": "InChI=1S/C27H32N2O6/c1-33-19-8-5-16(6-9-19)14-28-25(31)13-20-12-22-21-11-18(29-27(32)17-3-2-4-17)7-10-23(21)35-26(22)24(15-30)34-20/h5-11,17,20,22,24,26,30H,2-4,12-15H2,1H3,(H,28,31)(H,29,32)/t20-,22-,24-,26+/m0/s1",
        "inchikey": "QQFSWHWRRZLIPD-IFPZXYOKSA-N",
        "iupac": {
          "systematic": "N-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-[(4-methoxyphenyl)methylamino]-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]cyclobutanecarboxamide"
        },
        "smiles": {
          "canonical": "COC1=CC=C(C=C1)CNC(=O)CC2CC3C(C(O2)CO)OC4=C3C=C(C=C4)NC(=O)C5CCC5"
        },
        "molecularFormula": "C27H32N2O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:54:55Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84e2"
    },
    "name": "BRD-K25828886",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84e2.png",
    "lincs": {
      "id": "LSM-38680",
      "name": "BRD-K25828886",
      "pubchemCid": 60190041,
      "chebiId": 127118,
      "inchiParent": "InChI=1S/C27H29N3O4/c1-34-19-9-10-20-21(12-19)28-25-22(13-31)30(23(32)11-17-7-8-17)16-27(24(20)25)14-29(15-27)26(33)18-5-3-2-4-6-18/h2-6,9-10,12,17,22,28,31H,7-8,11,13-16H2,1H3/t22-/m1/s1",
      "inchiKeyParent": "ZGXNZUXYZONEJW-JOCHJYFZSA-N",
      "smilesParent": "COc1ccc2c3c([nH]c2c1)[C@@H](CO)N(CC34CN(C4)C(=O)c5ccccc5)C(=O)CC6CC6"
    },
    "unichem": {
      "chebi": "127118",
      "lincs": "LSM-38680",
      "pubchem": "60190041"
    },
    "pubchem": [
      {
        "cid": 60190041,
        "inchi": "InChI=1S/C27H29N3O4/c1-34-19-9-10-20-21(12-19)28-25-22(13-31)30(23(32)11-17-7-8-17)16-27(24(20)25)14-29(15-27)26(33)18-5-3-2-4-6-18/h2-6,9-10,12,17,22,28,31H,7-8,11,13-16H2,1H3/t22-/m1/s1",
        "inchikey": "ZGXNZUXYZONEJW-JOCHJYFZSA-N",
        "iupac": {
          "systematic": "1-[(1S)-1'-benzoyl-1-(hydroxymethyl)-7-methoxyspiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3'-azetidine]-2-yl]-2-cyclopropylethanone"
        },
        "smiles": {
          "canonical": "COC1=CC2=C(C=C1)C3=C(N2)C(N(CC34CN(C4)C(=O)C5=CC=CC=C5)C(=O)CC6CC6)CO"
        },
        "molecularFormula": "C27H29N3O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:54:57Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84ef"
    },
    "name": "BRD-K59261663",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84ef.png",
    "lincs": {
      "id": "LSM-44805",
      "name": "BRD-K59261663",
      "pubchemCid": 54651243,
      "inchiParent": "InChI=1S/C24H29FN2O2/c1-4-7-17-10-12-18(13-11-17)23-21(26-22(23)15-28)14-27(16(2)3)24(29)19-8-5-6-9-20(19)25/h4-13,16,21-23,26,28H,14-15H2,1-3H3/b7-4+/t21-,22-,23-/m0/s1",
      "inchiKeyParent": "RQDKADBGHPDYAV-OKLUWZQDSA-N",
      "smilesParent": "C\\C=C\\c1ccc(cc1)[C@@H]2[C@H](CO)N[C@H]2CN(C(C)C)C(=O)c3ccccc3F"
    },
    "unichem": {
      "lincs": "LSM-44805",
      "pubchem": "54651243"
    },
    "pubchem": [
      {
        "cid": 54651243,
        "inchi": "InChI=1S/C24H29FN2O2/c1-4-7-17-10-12-18(13-11-17)23-21(26-22(23)15-28)14-27(16(2)3)24(29)19-8-5-6-9-20(19)25/h4-13,16,21-23,26,28H,14-15H2,1-3H3/b7-4+/t21-,22-,23-/m0/s1",
        "inchikey": "RQDKADBGHPDYAV-OKLUWZQDSA-N",
        "iupac": {
          "systematic": "2-fluoro-N-[[(2R,3S,4R)-4-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]azetidin-2-yl]methyl]-N-propan-2-ylbenzamide"
        },
        "smiles": {
          "canonical": "CC=CC1=CC=C(C=C1)C2C(NC2CO)CN(C(C)C)C(=O)C3=CC=CC=C3F"
        },
        "molecularFormula": "C24H29FN2O2"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:55:00Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8459"
    },
    "name": "BRD-K16121755",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8459.png",
    "lincs": {
      "id": "LSM-9400",
      "name": "BRD-K16121755",
      "pubchemCid": 54646052,
      "chebiId": 98021,
      "inchiParent": "InChI=1S/C24H30N2O5/c1-26(2)16-8-9-21-18(10-16)19-11-17(30-22(14-27)24(19)31-21)12-23(28)25-13-15-6-4-5-7-20(15)29-3/h4-10,17,19,22,24,27H,11-14H2,1-3H3,(H,25,28)/t17-,19-,22+,24+/m1/s1",
      "inchiKeyParent": "YXRWVZTUBKEEPU-ZNMLIKKZSA-N",
      "smilesParent": "COc1ccccc1CNC(=O)C[C@H]2C[C@H]3[C@H](Oc4ccc(cc34)N(C)C)[C@H](CO)O2"
    },
    "unichem": {
      "chebi": "98021",
      "lincs": "LSM-9400",
      "pubchem": "54646052"
    },
    "pubchem": [
      {
        "cid": 54646052,
        "inchi": "InChI=1S/C24H30N2O5/c1-26(2)16-8-9-21-18(10-16)19-11-17(30-22(14-27)24(19)31-21)12-23(28)25-13-15-6-4-5-7-20(15)29-3/h4-10,17,19,22,24,27H,11-14H2,1-3H3,(H,25,28)/t17-,19-,22+,24+/m1/s1",
        "inchikey": "YXRWVZTUBKEEPU-ZNMLIKKZSA-N",
        "iupac": {
          "systematic": "2-[(1S,3R,4aR,9aS)-6-(dimethylamino)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-[(2-methoxyphenyl)methyl]acetamide"
        },
        "smiles": {
          "canonical": "CN(C)C1=CC2=C(C=C1)OC3C2CC(OC3CO)CC(=O)NCC4=CC=CC=C4OC"
        },
        "molecularFormula": "C24H30N2O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:55:02Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8493"
    },
    "name": "BRD-K20231471",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8493.png",
    "lincs": {
      "id": "LSM-31822",
      "name": "BRD-K20231471",
      "pubchemCid": 54640429,
      "chebiId": 120379,
      "inchiParent": "InChI=1S/C20H28N2O5/c23-14-18-17(21-19(24)12-15-4-2-1-3-5-15)7-6-16(27-18)13-20(25)22-8-10-26-11-9-22/h1-5,16-18,23H,6-14H2,(H,21,24)/t16-,17-,18-/m1/s1",
      "inchiKeyParent": "CLBFLRMDTNZFIM-KZNAEPCWSA-N",
      "smilesParent": "OC[C@H]1O[C@@H](CC(=O)N2CCOCC2)CC[C@H]1NC(=O)Cc3ccccc3"
    },
    "unichem": {
      "chebi": "120379",
      "lincs": "LSM-31822",
      "pubchem": "54640429"
    },
    "pubchem": [
      {
        "cid": 54640429,
        "inchi": "InChI=1S/C20H28N2O5/c23-14-18-17(21-19(24)12-15-4-2-1-3-5-15)7-6-16(27-18)13-20(25)22-8-10-26-11-9-22/h1-5,16-18,23H,6-14H2,(H,21,24)/t16-,17-,18-/m1/s1",
        "inchikey": "CLBFLRMDTNZFIM-KZNAEPCWSA-N",
        "iupac": {
          "systematic": "N-[(2S,3R,6R)-2-(hydroxymethyl)-6-(2-morpholin-4-yl-2-oxoethyl)oxan-3-yl]-2-phenylacetamide"
        },
        "smiles": {
          "canonical": "C1CC(C(OC1CC(=O)N2CCOCC2)CO)NC(=O)CC3=CC=CC=C3"
        },
        "molecularFormula": "C20H28N2O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:55:04Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84ca"
    },
    "name": "BRD-K88995397",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84ca.png",
    "lincs": {
      "id": "LSM-13904",
      "name": "BRD-K88995397",
      "pubchemCid": 54661232,
      "chebiId": 102557,
      "inchiParent": "InChI=1S/C28H29FN4O3/c29-22-6-2-1-5-19(22)20-9-10-23-26-25(27(35)31-13-17-7-8-17)21(16-34)24(15-33(23)28(20)36)32(26)14-18-4-3-11-30-12-18/h1-6,9-12,17,21,24-26,34H,7-8,13-16H2,(H,31,35)/t21-,24-,25+,26+/m0/s1",
      "inchiKeyParent": "PGXATXJTQODNDY-DTGGKOQTSA-N",
      "smilesParent": "OC[C@H]1[C@@H]2CN3C(=CC=C(C3=O)c4ccccc4F)[C@H]([C@@H]1C(=O)NCC5CC5)N2Cc6cccnc6"
    },
    "unichem": {
      "chebi": "102557",
      "lincs": "LSM-13904",
      "pubchem": "54661232"
    },
    "pubchem": [
      {
        "cid": 54661232,
        "inchi": "InChI=1S/C28H29FN4O3/c29-22-6-2-1-5-19(22)20-9-10-23-26-25(27(35)31-13-17-7-8-17)21(16-34)24(15-33(23)28(20)36)32(26)14-18-4-3-11-30-12-18/h1-6,9-12,17,21,24-26,34H,7-8,13-16H2,(H,31,35)/t21-,24-,25+,26+/m0/s1",
        "inchikey": "PGXATXJTQODNDY-DTGGKOQTSA-N",
        "iupac": {
          "systematic": "(1S,9R,10R,11R)-N-(cyclopropylmethyl)-5-(2-fluorophenyl)-10-(hydroxymethyl)-6-oxo-12-(pyridin-3-ylmethyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide"
        },
        "smiles": {
          "canonical": "C1CC1CNC(=O)C2C(C3CN4C(=CC=C(C4=O)C5=CC=CC=C5F)C2N3CC6=CN=CC=C6)CO"
        },
        "molecularFormula": "C28H29FN4O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:55:06Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84f2"
    },
    "name": "BRD-K69464603",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84f2.png",
    "lincs": {
      "id": "LSM-12665",
      "name": "BRD-K69464603",
      "pubchemCid": 54660833,
      "chebiId": 101299,
      "inchiParent": "InChI=1S/C26H29N5O4/c32-14-21-20-13-30-22(5-4-19(25(30)33)17-6-8-27-9-7-17)23(20)31(12-18-15-35-16-28-18)24(21)26(34)29-10-2-1-3-11-29/h4-9,15-16,20-21,23-24,32H,1-3,10-14H2/t20-,21-,23+,24-/m0/s1",
      "inchiKeyParent": "KRPKJWJGWXBFEA-ZQRMPTRQSA-N",
      "smilesParent": "OC[C@H]1[C@@H]2CN3C(=CC=C(C3=O)c4ccncc4)[C@@H]2N(Cc5cocn5)[C@@H]1C(=O)N6CCCCC6"
    },
    "unichem": {
      "chebi": "101299",
      "lincs": "LSM-12665",
      "pubchem": "54660833"
    },
    "pubchem": [
      {
        "cid": 54660833,
        "inchi": "InChI=1S/C26H29N5O4/c32-14-21-20-13-30-22(5-4-19(25(30)33)17-6-8-27-9-7-17)23(20)31(12-18-15-35-16-28-18)24(21)26(34)29-10-2-1-3-11-29/h4-9,15-16,20-21,23-24,32H,1-3,10-14H2/t20-,21-,23+,24-/m0/s1",
        "inchikey": "KRPKJWJGWXBFEA-ZQRMPTRQSA-N",
        "iupac": {
          "systematic": "(2S,3S,3aR,9bR)-3-(hydroxymethyl)-1-(1,3-oxazol-4-ylmethyl)-2-(piperidine-1-carbonyl)-7-pyridin-4-yl-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizin-6-one"
        },
        "smiles": {
          "canonical": "C1CCN(CC1)C(=O)C2C(C3CN4C(=CC=C(C4=O)C5=CC=NC=C5)C3N2CC6=COC=N6)CO"
        },
        "molecularFormula": "C26H29N5O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:55:08Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8515"
    },
    "name": "BRD-K07040635",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8515.png",
    "lincs": {
      "id": "LSM-37652",
      "name": "BRD-K07040635",
      "pubchemCid": 60190039,
      "chebiId": 126085,
      "inchiParent": "InChI=1S/C27H29N3O4/c1-34-19-9-10-20-21(12-19)28-25-22(13-31)30(23(32)11-17-7-8-17)16-27(24(20)25)14-29(15-27)26(33)18-5-3-2-4-6-18/h2-6,9-10,12,17,22,28,31H,7-8,11,13-16H2,1H3/t22-/m0/s1",
      "inchiKeyParent": "ZGXNZUXYZONEJW-QFIPXVFZSA-N",
      "smilesParent": "COc1ccc2c3c([nH]c2c1)[C@H](CO)N(CC34CN(C4)C(=O)c5ccccc5)C(=O)CC6CC6"
    },
    "unichem": {
      "chebi": "126085",
      "lincs": "LSM-37652",
      "pubchem": "60190039"
    },
    "pubchem": [
      {
        "cid": 60190039,
        "inchi": "InChI=1S/C27H29N3O4/c1-34-19-9-10-20-21(12-19)28-25-22(13-31)30(23(32)11-17-7-8-17)16-27(24(20)25)14-29(15-27)26(33)18-5-3-2-4-6-18/h2-6,9-10,12,17,22,28,31H,7-8,11,13-16H2,1H3/t22-/m0/s1",
        "inchikey": "ZGXNZUXYZONEJW-QFIPXVFZSA-N",
        "iupac": {
          "systematic": "1-[(1R)-1'-benzoyl-1-(hydroxymethyl)-7-methoxyspiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3'-azetidine]-2-yl]-2-cyclopropylethanone"
        },
        "smiles": {
          "canonical": "COC1=CC2=C(C=C1)C3=C(N2)C(N(CC34CN(C4)C(=O)C5=CC=CC=C5)C(=O)CC6CC6)CO"
        },
        "molecularFormula": "C27H29N3O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:55:11Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85a6"
    },
    "name": "BRD-K90640851",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85a6.png",
    "lincs": {
      "id": "LSM-14012",
      "name": "BRD-K90640851",
      "pubchemCid": 54660746,
      "chebiId": 102665,
      "inchiParent": "InChI=1S/C24H28ClN3O3/c25-19-8-3-2-7-16(19)13-28-22-17(14-27-20(22)9-6-10-21(27)30)18(15-29)23(28)24(31)26-11-4-1-5-12-26/h2-3,6-10,17-18,22-23,29H,1,4-5,11-15H2/t17-,18-,22+,23-/m1/s1",
      "inchiKeyParent": "VQCZTXNNKFBGGK-FJDVCKPCSA-N",
      "smilesParent": "OC[C@@H]1[C@H]2CN3C(=O)C=CC=C3[C@H]2N(Cc4ccccc4Cl)[C@H]1C(=O)N5CCCCC5"
    },
    "unichem": {
      "chebi": "102665",
      "lincs": "LSM-14012",
      "pubchem": "54660746"
    },
    "pubchem": [
      {
        "cid": 54660746,
        "inchi": "InChI=1S/C24H28ClN3O3/c25-19-8-3-2-7-16(19)13-28-22-17(14-27-20(22)9-6-10-21(27)30)18(15-29)23(28)24(31)26-11-4-1-5-12-26/h2-3,6-10,17-18,22-23,29H,1,4-5,11-15H2/t17-,18-,22+,23-/m1/s1",
        "inchikey": "VQCZTXNNKFBGGK-FJDVCKPCSA-N",
        "iupac": {
          "systematic": "(2R,3R,3aS,9bS)-1-[(2-chlorophenyl)methyl]-3-(hydroxymethyl)-2-(piperidine-1-carbonyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizin-6-one"
        },
        "smiles": {
          "canonical": "C1CCN(CC1)C(=O)C2C(C3CN4C(=O)C=CC=C4C3N2CC5=CC=CC=C5Cl)CO"
        },
        "molecularFormula": "C24H28ClN3O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:55:13Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85d4"
    },
    "name": "BRD-K46512834",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85d4.png",
    "lincs": {
      "id": "LSM-14838",
      "name": "BRD-K46512834",
      "pubchemCid": 44485803,
      "chebiId": 103494,
      "inchiParent": "InChI=1S/C33H49N5O6/c1-22(2)34-32(41)35-27-15-16-29-28(18-27)31(40)38(24(4)21-39)19-23(3)30(43-17-11-10-12-25(5)44-29)20-37(6)33(42)36-26-13-8-7-9-14-26/h7-9,13-16,18,22-25,30,39H,10-12,17,19-21H2,1-6H3,(H,36,42)(H2,34,35,41)/t23-,24-,25-,30-/m1/s1",
      "inchiKeyParent": "GBDHSNMZLIRBLK-SFOWLQBLSA-N",
      "smilesParent": "CC(C)NC(=O)Nc1ccc2O[C@H](C)CCCCO[C@H](CN(C)C(=O)Nc3ccccc3)[C@H](C)CN([C@H](C)CO)C(=O)c2c1"
    },
    "unichem": {
      "chebi": "103494",
      "lincs": "LSM-14838",
      "pubchem": "44485803"
    },
    "pubchem": [
      {
        "cid": 44485803,
        "inchi": "InChI=1S/C33H49N5O6/c1-22(2)34-32(41)35-27-15-16-29-28(18-27)31(40)38(24(4)21-39)19-23(3)30(43-17-11-10-12-25(5)44-29)20-37(6)33(42)36-26-13-8-7-9-14-26/h7-9,13-16,18,22-25,30,39H,10-12,17,19-21H2,1-6H3,(H,36,42)(H2,34,35,41)/t23-,24-,25-,30-/m1/s1",
        "inchikey": "GBDHSNMZLIRBLK-SFOWLQBLSA-N",
        "iupac": {
          "systematic": "1-[[(3R,9S,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-(propan-2-ylcarbamoylamino)-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-phenylurea"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NC(=O)NC(C)C)C(C)CO)C)CN(C)C(=O)NC3=CC=CC=C3"
        },
        "molecularFormula": "C33H49N5O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:55:15Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8633"
    },
    "name": "BRD-K78246556",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8633.png",
    "lincs": {
      "id": "LSM-41542",
      "name": "BRD-K78246556",
      "pubchemCid": 54652502,
      "chebiId": 129991,
      "inchiParent": "InChI=1S/C18H18FN3O2/c19-11-5-7-12(8-6-11)21-18(24)22-15-9-20-14-4-2-1-3-13(14)17(15)16(22)10-23/h1-8,15-17,20,23H,9-10H2,(H,21,24)/t15-,16+,17+/m1/s1",
      "inchiKeyParent": "ZANRKKPBGNDREH-IKGGRYGDSA-N",
      "smilesParent": "OC[C@H]1[C@@H]2[C@@H](CNc3ccccc23)N1C(=O)Nc4ccc(F)cc4"
    },
    "unichem": {
      "chebi": "129991",
      "lincs": "LSM-41542",
      "pubchem": "54652502"
    },
    "pubchem": [
      {
        "cid": 54652502,
        "inchi": "InChI=1S/C18H18FN3O2/c19-11-5-7-12(8-6-11)21-18(24)22-15-9-20-14-4-2-1-3-13(14)17(15)16(22)10-23/h1-8,15-17,20,23H,9-10H2,(H,21,24)/t15-,16+,17+/m1/s1",
        "inchikey": "ZANRKKPBGNDREH-IKGGRYGDSA-N",
        "iupac": {
          "systematic": "(1R,2aS,8bS)-N-(4-fluorophenyl)-1-(hydroxymethyl)-2a,3,4,8b-tetrahydro-1H-azeto[2,3-c]quinoline-2-carboxamide"
        },
        "smiles": {
          "canonical": "C1C2C(C(N2C(=O)NC3=CC=C(C=C3)F)CO)C4=CC=CC=C4N1"
        },
        "molecularFormula": "C18H18FN3O2"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:55:17Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c850d"
    },
    "name": "BRD-K18639483",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c850d.png",
    "lincs": {
      "id": "LSM-9550",
      "name": "BRD-K18639483",
      "pubchemCid": 54657568,
      "chebiId": 98171,
      "inchiParent": "InChI=1S/C25H39N3O5/c1-31-21-6-4-19(5-7-21)15-28-16-20(29)17-32-18-24-23(28)9-8-22(33-24)14-25(30)26-10-13-27-11-2-3-12-27/h4-7,20,22-24,29H,2-3,8-18H2,1H3,(H,26,30)/t20-,22-,23+,24-/m1/s1",
      "inchiKeyParent": "JSQZMBUYZHIIMM-CAUSLRQDSA-N",
      "smilesParent": "COc1ccc(CN2C[C@@H](O)COC[C@H]3O[C@@H](CC(=O)NCCN4CCCC4)CC[C@H]23)cc1"
    },
    "unichem": {
      "chebi": "98171",
      "lincs": "LSM-9550",
      "pubchem": "54657568"
    },
    "pubchem": [
      {
        "cid": 54657568,
        "inchi": "InChI=1S/C25H39N3O5/c1-31-21-6-4-19(5-7-21)15-28-16-20(29)17-32-18-24-23(28)9-8-22(33-24)14-25(30)26-10-13-27-11-2-3-12-27/h4-7,20,22-24,29H,2-3,8-18H2,1H3,(H,26,30)/t20-,22-,23+,24-/m1/s1",
        "inchikey": "JSQZMBUYZHIIMM-CAUSLRQDSA-N",
        "iupac": {
          "systematic": "2-[(3R,6aS,8R,10aS)-3-hydroxy-1-[(4-methoxyphenyl)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-pyrrolidin-1-ylethyl)acetamide"
        },
        "smiles": {
          "canonical": "COC1=CC=C(C=C1)CN2CC(COCC3C2CCC(O3)CC(=O)NCCN4CCCC4)O"
        },
        "molecularFormula": "C25H39N3O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:55:19Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8562"
    },
    "name": "BRD-K65300017",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8562.png",
    "lincs": {
      "id": "LSM-12408",
      "name": "BRD-K65300017",
      "pubchemCid": 54637878,
      "chebiId": 101035,
      "inchiParent": "InChI=1S/C33H39N3O5S/c1-23-18-36(24(2)20-37)33(38)32-31(28-16-10-11-17-29(28)35(32)4)27-15-9-8-14-26(27)21-41-30(23)19-34(3)42(39,40)22-25-12-6-5-7-13-25/h5-17,23-24,30,37H,18-22H2,1-4H3/t23-,24+,30-/m1/s1",
      "inchiKeyParent": "LJWHPXFZVGGEPZ-FSGGQHMVSA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@@H](C)[C@@H](CN(C)S(=O)(=O)Cc2ccccc2)OCc3ccccc3c4c(C1=O)n(C)c5ccccc45"
    },
    "unichem": {
      "chebi": "101035",
      "lincs": "LSM-12408",
      "pubchem": "54637878"
    },
    "pubchem": [
      {
        "cid": 54637878,
        "inchi": "InChI=1S/C33H39N3O5S/c1-23-18-36(24(2)20-37)33(38)32-31(28-16-10-11-17-29(28)35(32)4)27-15-9-8-14-26(27)21-41-30(23)19-34(3)42(39,40)22-25-12-6-5-7-13-25/h5-17,23-24,30,37H,18-22H2,1-4H3/t23-,24+,30-/m1/s1",
        "inchikey": "LJWHPXFZVGGEPZ-FSGGQHMVSA-N",
        "iupac": {
          "systematic": "N-[[(10S,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methyl-1-phenylmethanesulfonamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(C3=CC=CC=C3COC1CN(C)S(=O)(=O)CC4=CC=CC=C4)C5=CC=CC=C5N2C)C(C)CO"
        },
        "molecularFormula": "C33H39N3O5S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:55:22Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85a1"
    },
    "name": "BRD-K00348196",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85a1.png",
    "lincs": {
      "id": "LSM-37299",
      "name": "BRD-K00348196",
      "pubchemCid": 60189639,
      "chebiId": 125730,
      "inchiParent": "InChI=1S/C26H31N3O4/c1-27-21-11-19(33-3)9-10-20(21)24-25(27)22(13-30)29(23(31)14-32-2)17-26(24)15-28(16-26)12-18-7-5-4-6-8-18/h4-11,22,30H,12-17H2,1-3H3/t22-/m1/s1",
      "inchiKeyParent": "DNCWFJGHBTUPKD-JOCHJYFZSA-N",
      "smilesParent": "COCC(=O)N1CC2(CN(Cc3ccccc3)C2)c4c([C@H]1CO)n(C)c5cc(OC)ccc45"
    },
    "unichem": {
      "chebi": "125730",
      "lincs": "LSM-37299",
      "pubchem": "60189639"
    },
    "pubchem": [
      {
        "cid": 60189639,
        "inchi": "InChI=1S/C26H31N3O4/c1-27-21-11-19(33-3)9-10-20(21)24-25(27)22(13-30)29(23(31)14-32-2)17-26(24)15-28(16-26)12-18-7-5-4-6-8-18/h4-11,22,30H,12-17H2,1-3H3/t22-/m1/s1",
        "inchikey": "DNCWFJGHBTUPKD-JOCHJYFZSA-N",
        "iupac": {
          "systematic": "1-[(1S)-1'-benzyl-1-(hydroxymethyl)-7-methoxy-9-methylspiro[1,3-dihydropyrido[3,4-b]indole-4,3'-azetidine]-2-yl]-2-methoxyethanone"
        },
        "smiles": {
          "canonical": "CN1C2=C(C=CC(=C2)OC)C3=C1C(N(CC34CN(C4)CC5=CC=CC=C5)C(=O)COC)CO"
        },
        "molecularFormula": "C26H31N3O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:55:24Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8642"
    },
    "name": "BRD-K85790491",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8642.png",
    "lincs": {
      "id": "LSM-13684",
      "name": "BRD-K85790491",
      "pubchemCid": 54660658,
      "chebiId": 102332,
      "inchiParent": "InChI=1S/C27H33N3O4/c1-28(2)27(33)24-20(16-31)22-15-30-21(13-12-19(26(30)32)17-8-4-5-9-17)25(24)29(22)14-18-10-6-7-11-23(18)34-3/h6-8,10-13,20,22,24-25,31H,4-5,9,14-16H2,1-3H3/t20-,22-,24+,25+/m0/s1",
      "inchiKeyParent": "CAYQEZITEZQLOQ-MMTHZHQFSA-N",
      "smilesParent": "COc1ccccc1CN2[C@H]3CN4C(=CC=C(C5=CCCC5)C4=O)[C@@H]2[C@@H]([C@H]3CO)C(=O)N(C)C"
    },
    "unichem": {
      "chebi": "102332",
      "lincs": "LSM-13684",
      "pubchem": "54660658"
    },
    "pubchem": [
      {
        "cid": 54660658,
        "inchi": "InChI=1S/C27H33N3O4/c1-28(2)27(33)24-20(16-31)22-15-30-21(13-12-19(26(30)32)17-8-4-5-9-17)25(24)29(22)14-18-10-6-7-11-23(18)34-3/h6-8,10-13,20,22,24-25,31H,4-5,9,14-16H2,1-3H3/t20-,22-,24+,25+/m0/s1",
        "inchikey": "CAYQEZITEZQLOQ-MMTHZHQFSA-N",
        "iupac": {
          "systematic": "(1S,9R,10R,11R)-5-(cyclopenten-1-yl)-10-(hydroxymethyl)-12-[(2-methoxyphenyl)methyl]-N,N-dimethyl-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide"
        },
        "smiles": {
          "canonical": "CN(C)C(=O)C1C(C2CN3C(=CC=C(C3=O)C4=CCCC4)C1N2CC5=CC=CC=C5OC)CO"
        },
        "molecularFormula": "C27H33N3O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:55:26Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8541"
    },
    "name": "BRD-K28739456",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8541.png",
    "lincs": {
      "id": "LSM-10172",
      "name": "BRD-K28739456",
      "pubchemCid": 54646706,
      "chebiId": 98793,
      "inchiParent": "InChI=1S/C19H26N2O6S/c1-28(24,25)21-12-4-5-16-14(6-12)15-7-13(26-17(10-22)19(15)27-16)8-18(23)20-9-11-2-3-11/h4-6,11,13,15,17,19,21-22H,2-3,7-10H2,1H3,(H,20,23)/t13-,15+,17+,19-/m0/s1",
      "inchiKeyParent": "YSCGDHRCRJHNHR-KOJWFEOWSA-N",
      "smilesParent": "CS(=O)(=O)Nc1ccc2O[C@@H]3[C@@H](CO)O[C@H](CC(=O)NCC4CC4)C[C@@H]3c2c1"
    },
    "unichem": {
      "chebi": "98793",
      "lincs": "LSM-10172",
      "pubchem": "54646706"
    },
    "pubchem": [
      {
        "cid": 54646706,
        "inchi": "InChI=1S/C19H26N2O6S/c1-28(24,25)21-12-4-5-16-14(6-12)15-7-13(26-17(10-22)19(15)27-16)8-18(23)20-9-11-2-3-11/h4-6,11,13,15,17,19,21-22H,2-3,7-10H2,1H3,(H,20,23)/t13-,15+,17+,19-/m0/s1",
        "inchikey": "YSCGDHRCRJHNHR-KOJWFEOWSA-N",
        "iupac": {
          "systematic": "2-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-(cyclopropylmethyl)acetamide"
        },
        "smiles": {
          "canonical": "CS(=O)(=O)NC1=CC2=C(C=C1)OC3C2CC(OC3CO)CC(=O)NCC4CC4"
        },
        "molecularFormula": "C19H26N2O6S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:55:28Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8567"
    },
    "name": "BRD-K49911380",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8567.png",
    "lincs": {
      "id": "LSM-11462",
      "name": "BRD-K49911380",
      "pubchemCid": 54645972,
      "chebiId": 100083,
      "inchiParent": "InChI=1S/C24H28N2O7S/c27-15-22-24-20(13-17(32-22)14-23(28)26-8-10-31-11-9-26)19-12-16(6-7-21(19)33-24)25-34(29,30)18-4-2-1-3-5-18/h1-7,12,17,20,22,24-25,27H,8-11,13-15H2/t17-,20-,22-,24+/m1/s1",
      "inchiKeyParent": "CJNJMLGGDUQPOS-QSOCRCLWSA-N",
      "smilesParent": "OC[C@H]1O[C@@H](CC(=O)N2CCOCC2)C[C@H]3[C@@H]1Oc4ccc(NS(=O)(=O)c5ccccc5)cc34"
    },
    "unichem": {
      "chebi": "100083",
      "lincs": "LSM-11462",
      "pubchem": "54645972"
    },
    "pubchem": [
      {
        "cid": 54645972,
        "inchi": "InChI=1S/C24H28N2O7S/c27-15-22-24-20(13-17(32-22)14-23(28)26-8-10-31-11-9-26)19-12-16(6-7-21(19)33-24)25-34(29,30)18-4-2-1-3-5-18/h1-7,12,17,20,22,24-25,27H,8-11,13-15H2/t17-,20-,22-,24+/m1/s1",
        "inchikey": "CJNJMLGGDUQPOS-QSOCRCLWSA-N",
        "iupac": {
          "systematic": "N-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-3-(2-morpholin-4-yl-2-oxoethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]benzenesulfonamide"
        },
        "smiles": {
          "canonical": "C1COCCN1C(=O)CC2CC3C(C(O2)CO)OC4=C3C=C(C=C4)NS(=O)(=O)C5=CC=CC=C5"
        },
        "molecularFormula": "C24H28N2O7S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:55:30Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8583"
    },
    "name": "BRD-K73423175",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8583.png",
    "lincs": {
      "id": "LSM-41256",
      "name": "BRD-K73423175",
      "pubchemCid": 54666682,
      "chebiId": 129705,
      "inchiParent": "InChI=1S/C29H31FN2O3/c1-35-25-6-4-5-23(17-25)20-7-9-21(10-8-20)28-26-18-31(15-2-3-16-32(26)27(28)19-33)29(34)22-11-13-24(30)14-12-22/h4-14,17,26-28,33H,2-3,15-16,18-19H2,1H3/t26-,27-,28+/m1/s1",
      "inchiKeyParent": "CREOWEDUZDMJSE-FCEKVYKBSA-N",
      "smilesParent": "COc1cccc(c1)c2ccc(cc2)[C@@H]3[C@@H](CO)N4CCCCN(C[C@H]34)C(=O)c5ccc(F)cc5"
    },
    "unichem": {
      "chebi": "129705",
      "lincs": "LSM-41256",
      "pubchem": "54666682"
    },
    "pubchem": [
      {
        "cid": 54666682,
        "inchi": "InChI=1S/C29H31FN2O3/c1-35-25-6-4-5-23(17-25)20-7-9-21(10-8-20)28-26-18-31(15-2-3-16-32(26)27(28)19-33)29(34)22-11-13-24(30)14-12-22/h4-14,17,26-28,33H,2-3,15-16,18-19H2,1H3/t26-,27-,28+/m1/s1",
        "inchikey": "CREOWEDUZDMJSE-FCEKVYKBSA-N",
        "iupac": {
          "systematic": "(4-fluorophenyl)-[(8S,9S,10S)-10-(hydroxymethyl)-9-[4-(3-methoxyphenyl)phenyl]-1,6-diazabicyclo[6.2.0]decan-6-yl]methanone"
        },
        "smiles": {
          "canonical": "COC1=CC=CC(=C1)C2=CC=C(C=C2)C3C4CN(CCCCN4C3CO)C(=O)C5=CC=C(C=C5)F"
        },
        "molecularFormula": "C29H31FN2O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:55:33Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c858d"
    },
    "name": "CHEMBL2360806",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c858d.png",
    "lincs": {
      "id": "LSM-8653",
      "name": "CHEMBL2360806",
      "alternativeNames": [
        "BRD-K03568952"
      ],
      "pubchemCid": 54657494,
      "chebiId": 97274,
      "inchiParent": "InChI=1S/C21H25F2N3O4S/c22-14-5-13(6-15(23)7-14)9-26-10-16(27)11-29-12-19-18(26)2-1-17(30-19)8-20(28)25-21-24-3-4-31-21/h3-7,16-19,27H,1-2,8-12H2,(H,24,25,28)/t16-,17-,18+,19-/m1/s1",
      "inchiKeyParent": "HLMLEGKKEQKEEG-AKHDSKFASA-N",
      "smilesParent": "O[C@H]1COC[C@H]2O[C@@H](CC(=O)Nc3nccs3)CC[C@@H]2N(Cc4cc(F)cc(F)c4)C1"
    },
    "unichem": {
      "chebi": "97274",
      "chembl": "CHEMBL2360806",
      "lincs": "LSM-8653",
      "pubchem": "54657494"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL2360806",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 453.51,
        "hba": 7,
        "hbd": 2,
        "qedWeighted": 0.72
      }
    },
    "pubchem": [
      {
        "cid": 54657494,
        "inchi": "InChI=1S/C21H25F2N3O4S/c22-14-5-13(6-15(23)7-14)9-26-10-16(27)11-29-12-19-18(26)2-1-17(30-19)8-20(28)25-21-24-3-4-31-21/h3-7,16-19,27H,1-2,8-12H2,(H,24,25,28)/t16-,17-,18+,19-/m1/s1",
        "inchikey": "HLMLEGKKEQKEEG-AKHDSKFASA-N",
        "iupac": {
          "systematic": "2-[(3R,6aS,8R,10aS)-1-[(3,5-difluorophenyl)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(1,3-thiazol-2-yl)acetamide"
        },
        "smiles": {
          "canonical": "C1CC2C(COCC(CN2CC3=CC(=CC(=C3)F)F)O)OC1CC(=O)NC4=NC=CS4"
        },
        "molecularFormula": "C21H25F2N3O4S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:55:44Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85aa"
    },
    "name": "BRD-K97306770",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85aa.png",
    "lincs": {
      "id": "LSM-42544",
      "name": "BRD-K97306770",
      "pubchemCid": 60191397,
      "chebiId": 130996,
      "inchiParent": "InChI=1S/C28H26N2O5/c1-17-3-2-4-20(11-17)18-5-7-19(8-6-18)27-22-13-29(14-26(32)30(22)23(27)15-31)28(33)21-9-10-24-25(12-21)35-16-34-24/h2-12,22-23,27,31H,13-16H2,1H3/t22-,23-,27+/m1/s1",
      "inchiKeyParent": "NFYAYVQEBGGXMC-NOTUOJBMSA-N",
      "smilesParent": "Cc1cccc(c1)c2ccc(cc2)[C@@H]3[C@@H](CO)N4[C@@H]3CN(CC4=O)C(=O)c5ccc6OCOc6c5"
    },
    "unichem": {
      "chebi": "130996",
      "lincs": "LSM-42544",
      "pubchem": "60191397"
    },
    "pubchem": [
      {
        "cid": 60191397,
        "inchi": "InChI=1S/C28H26N2O5/c1-17-3-2-4-20(11-17)18-5-7-19(8-6-18)27-22-13-29(14-26(32)30(22)23(27)15-31)28(33)21-9-10-24-25(12-21)35-16-34-24/h2-12,22-23,27,31H,13-16H2,1H3/t22-,23-,27+/m1/s1",
        "inchikey": "NFYAYVQEBGGXMC-NOTUOJBMSA-N",
        "iupac": {
          "systematic": "(6S,7S,8S)-4-(1,3-benzodioxole-5-carbonyl)-8-(hydroxymethyl)-7-[4-(3-methylphenyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one"
        },
        "smiles": {
          "canonical": "CC1=CC(=CC=C1)C2=CC=C(C=C2)C3C4CN(CC(=O)N4C3CO)C(=O)C5=CC6=C(C=C5)OCO6"
        },
        "molecularFormula": "C28H26N2O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:55:46Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85b0"
    },
    "name": "BRD-K38373714",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85b0.png",
    "lincs": {
      "id": "LSM-39377",
      "name": "BRD-K38373714",
      "pubchemCid": 54652587,
      "chebiId": 127821,
      "inchiParent": "InChI=1S/C22H24FN3O3/c1-2-5-20(28)25-12-18-21(16-6-3-4-7-17(16)25)19(13-27)26(18)22(29)24-15-10-8-14(23)9-11-15/h3-4,6-11,18-19,21,27H,2,5,12-13H2,1H3,(H,24,29)/t18-,19-,21+/m1/s1",
      "inchiKeyParent": "CSSMSPNQBLKMRG-SBHAEUEKSA-N",
      "smilesParent": "CCCC(=O)N1C[C@@H]2[C@@H]([C@@H](CO)N2C(=O)Nc3ccc(F)cc3)c4ccccc14"
    },
    "unichem": {
      "chebi": "127821",
      "lincs": "LSM-39377",
      "pubchem": "54652587"
    },
    "pubchem": [
      {
        "cid": 54652587,
        "inchi": "InChI=1S/C22H24FN3O3/c1-2-5-20(28)25-12-18-21(16-6-3-4-7-17(16)25)19(13-27)26(18)22(29)24-15-10-8-14(23)9-11-15/h3-4,6-11,18-19,21,27H,2,5,12-13H2,1H3,(H,24,29)/t18-,19-,21+/m1/s1",
        "inchikey": "CSSMSPNQBLKMRG-SBHAEUEKSA-N",
        "iupac": {
          "systematic": "(1S,2aS,8bS)-4-butanoyl-N-(4-fluorophenyl)-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-2-carboxamide"
        },
        "smiles": {
          "canonical": "CCCC(=O)N1CC2C(C(N2C(=O)NC3=CC=C(C=C3)F)CO)C4=CC=CC=C41"
        },
        "molecularFormula": "C22H24FN3O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:55:48Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85b9"
    },
    "name": "BRD-K38891183",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85b9.png",
    "lincs": {
      "id": "LSM-39413",
      "name": "BRD-K38891183",
      "pubchemCid": 44484911,
      "chebiId": 127857,
      "inchiParent": "InChI=1S/C28H35N3O6/c1-17-13-31(18(2)16-32)27(34)23-12-22(29-26(33)20-8-9-20)10-11-24(23)37-25(17)15-30(3)14-19-4-6-21(7-5-19)28(35)36/h4-7,10-12,17-18,20,25,32H,8-9,13-16H2,1-3H3,(H,29,33)(H,35,36)/t17-,18+,25-/m0/s1",
      "inchiKeyParent": "KUULAZFVSMPUFO-ATLLOTDBSA-N",
      "smilesParent": "C[C@H](CO)N1C[C@H](C)[C@H](CN(C)Cc2ccc(cc2)C(=O)O)Oc3ccc(NC(=O)C4CC4)cc3C1=O"
    },
    "unichem": {
      "chebi": "127857",
      "lincs": "LSM-39413",
      "pubchem": "44484911"
    },
    "pubchem": [
      {
        "cid": 44484911,
        "inchi": "InChI=1S/C28H35N3O6/c1-17-13-31(18(2)16-32)27(34)23-12-22(29-26(33)20-8-9-20)10-11-24(23)37-25(17)15-30(3)14-19-4-6-21(7-5-19)28(35)36/h4-7,10-12,17-18,20,25,32H,8-9,13-16H2,1-3H3,(H,29,33)(H,35,36)/t17-,18+,25-/m0/s1",
        "inchikey": "KUULAZFVSMPUFO-ATLLOTDBSA-N",
        "iupac": {
          "systematic": "4-[[[(2R,3S)-8-(cyclopropanecarbonylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl-methylamino]methyl]benzoic acid"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(C=CC(=C2)NC(=O)C3CC3)OC1CN(C)CC4=CC=C(C=C4)C(=O)O)C(C)CO"
        },
        "molecularFormula": "C28H35N3O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:55:50Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8615"
    },
    "name": "BRD-K77433548",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8615.png",
    "lincs": {
      "id": "LSM-41495",
      "name": "BRD-K77433548",
      "pubchemCid": 60187467,
      "chebiId": 129944,
      "inchiParent": "InChI=1S/C25H27N5O2S/c1-32-18-2-3-19-20(10-18)28-24-21(13-31)30(12-22-27-8-9-33-22)16-25(23(19)24)14-29(15-25)11-17-4-6-26-7-5-17/h2-10,21,28,31H,11-16H2,1H3/t21-/m0/s1",
      "inchiKeyParent": "MOEADTRWTJDHBC-NRFANRHFSA-N",
      "smilesParent": "COc1ccc2c3c([nH]c2c1)[C@H](CO)N(Cc4nccs4)CC35CN(Cc6ccncc6)C5"
    },
    "unichem": {
      "chebi": "129944",
      "lincs": "LSM-41495",
      "pubchem": "60187467"
    },
    "pubchem": [
      {
        "cid": 60187467,
        "inchi": "InChI=1S/C25H27N5O2S/c1-32-18-2-3-19-20(10-18)28-24-21(13-31)30(12-22-27-8-9-33-22)16-25(23(19)24)14-29(15-25)11-17-4-6-26-7-5-17/h2-10,21,28,31H,11-16H2,1H3/t21-/m0/s1",
        "inchikey": "MOEADTRWTJDHBC-NRFANRHFSA-N",
        "iupac": {
          "systematic": "[(1R)-7-methoxy-1'-(pyridin-4-ylmethyl)-2-(1,3-thiazol-2-ylmethyl)spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3'-azetidine]-1-yl]methanol"
        },
        "smiles": {
          "canonical": "COC1=CC2=C(C=C1)C3=C(N2)C(N(CC34CN(C4)CC5=CC=NC=C5)CC6=NC=CS6)CO"
        },
        "molecularFormula": "C25H27N5O2S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:55:53Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85b7"
    },
    "name": "BRD-K85955502",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85b7.png",
    "lincs": {
      "id": "LSM-13695",
      "name": "BRD-K85955502",
      "pubchemCid": 54657645,
      "chebiId": 102343,
      "inchiParent": "InChI=1S/C24H34N4O7/c1-26-6-8-27(9-7-26)23(30)11-18-3-4-19-22(35-18)14-32-13-17(29)12-28(19)24(31)25-16-2-5-20-21(10-16)34-15-33-20/h2,5,10,17-19,22,29H,3-4,6-9,11-15H2,1H3,(H,25,31)/t17-,18-,19-,22+/m0/s1",
      "inchiKeyParent": "QICYWJCDSALLPT-ZVVDCOBXSA-N",
      "smilesParent": "CN1CCN(CC1)C(=O)C[C@@H]2CC[C@H]3[C@@H](COC[C@@H](O)CN3C(=O)Nc4ccc5OCOc5c4)O2"
    },
    "unichem": {
      "chebi": "102343",
      "lincs": "LSM-13695",
      "pubchem": "54657645"
    },
    "pubchem": [
      {
        "cid": 54657645,
        "inchi": "InChI=1S/C24H34N4O7/c1-26-6-8-27(9-7-26)23(30)11-18-3-4-19-22(35-18)14-32-13-17(29)12-28(19)24(31)25-16-2-5-20-21(10-16)34-15-33-20/h2,5,10,17-19,22,29H,3-4,6-9,11-15H2,1H3,(H,25,31)/t17-,18-,19-,22+/m0/s1",
        "inchikey": "QICYWJCDSALLPT-ZVVDCOBXSA-N",
        "iupac": {
          "systematic": "(3S,6aS,8S,10aS)-N-(1,3-benzodioxol-5-yl)-3-hydroxy-8-[2-(4-methylpiperazin-1-yl)-2-oxoethyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide"
        },
        "smiles": {
          "canonical": "CN1CCN(CC1)C(=O)CC2CCC3C(O2)COCC(CN3C(=O)NC4=CC5=C(C=C4)OCO5)O"
        },
        "molecularFormula": "C24H34N4O7"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:55:55Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85c1"
    },
    "name": "BRD-K84770507",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85c1.png",
    "lincs": {
      "id": "LSM-41898",
      "name": "BRD-K84770507",
      "pubchemCid": 44616576,
      "chebiId": 130349,
      "inchiParent": "InChI=1S/C34H48N4O7/c1-22-17-38(23(2)20-39)33(40)28-15-26(35-34(41)36-27-11-13-30-31(16-27)44-21-43-30)10-12-29(28)45-24(3)7-5-6-14-42-32(22)19-37(4)18-25-8-9-25/h10-13,15-16,22-25,32,39H,5-9,14,17-21H2,1-4H3,(H2,35,36,41)/t22-,23+,24-,32-/m1/s1",
      "inchiKeyParent": "HYEFXMLKRFQNEN-KOVGSKFNSA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@@H](C)[C@@H](CN(C)CC2CC2)OCCCC[C@@H](C)Oc3ccc(NC(=O)Nc4ccc5OCOc5c4)cc3C1=O"
    },
    "unichem": {
      "chebi": "130349",
      "lincs": "LSM-41898",
      "pubchem": "44616576"
    },
    "pubchem": [
      {
        "cid": 44616576,
        "inchi": "InChI=1S/C34H48N4O7/c1-22-17-38(23(2)20-39)33(40)28-15-26(35-34(41)36-27-11-13-30-31(16-27)44-21-43-30)10-12-29(28)45-24(3)7-5-6-14-42-32(22)19-37(4)18-25-8-9-25/h10-13,15-16,22-25,32,39H,5-9,14,17-21H2,1-4H3,(H2,35,36,41)/t22-,23+,24-,32-/m1/s1",
        "inchikey": "HYEFXMLKRFQNEN-KOVGSKFNSA-N",
        "iupac": {
          "systematic": "1-(1,3-benzodioxol-5-yl)-3-[(3R,9S,10R)-9-[[cyclopropylmethyl(methyl)amino]methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]urea"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NC(=O)NC3=CC4=C(C=C3)OCO4)C(C)CO)C)CN(C)CC5CC5"
        },
        "molecularFormula": "C34H48N4O7"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:55:57Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8639"
    },
    "name": "BRD-K71761811",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8639.png",
    "lincs": {
      "id": "LSM-12822",
      "name": "BRD-K71761811",
      "pubchemCid": 54654504,
      "chebiId": 101459,
      "inchiParent": "InChI=1S/C23H33N3O6S/c1-26-19-10-9-17(13-22(27)24-15-6-4-3-5-7-15)32-21(19)14-31-20-11-8-16(25-33(2,29)30)12-18(20)23(26)28/h8,11-12,15,17,19,21,25H,3-7,9-10,13-14H2,1-2H3,(H,24,27)/t17-,19-,21-/m0/s1",
      "inchiKeyParent": "VOOHCFNIWPJMMM-CUWPLCDZSA-N",
      "smilesParent": "CN1[C@H]2CC[C@@H](CC(=O)NC3CCCCC3)O[C@H]2COc4ccc(NS(=O)(=O)C)cc4C1=O"
    },
    "unichem": {
      "chebi": "101459",
      "lincs": "LSM-12822",
      "pubchem": "54654504"
    },
    "pubchem": [
      {
        "cid": 54654504,
        "inchi": "InChI=1S/C23H33N3O6S/c1-26-19-10-9-17(13-22(27)24-15-6-4-3-5-7-15)32-21(19)14-31-20-11-8-16(25-33(2,29)30)12-18(20)23(26)28/h8,11-12,15,17,19,21,25H,3-7,9-10,13-14H2,1-2H3,(H,24,27)/t17-,19-,21-/m0/s1",
        "inchikey": "VOOHCFNIWPJMMM-CUWPLCDZSA-N",
        "iupac": {
          "systematic": "2-[(2S,4aS,12aR)-8-(methanesulfonamido)-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-cyclohexylacetamide"
        },
        "smiles": {
          "canonical": "CN1C2CCC(OC2COC3=C(C1=O)C=C(C=C3)NS(=O)(=O)C)CC(=O)NC4CCCCC4"
        },
        "molecularFormula": "C23H33N3O6S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:55:59Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c857e"
    },
    "name": "BRD-K03228956",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c857e.png",
    "lincs": {
      "id": "LSM-37451",
      "name": "BRD-K03228956",
      "pubchemCid": 71759937,
      "chebiId": 125884,
      "inchiParent": "InChI=1S/C24H35N5O4/c1-6-9-25-23(32)29-15-24(13-28(14-24)20(31)11-26(2)3)21-17-8-7-16(33-5)10-18(17)27(4)22(21)19(29)12-30/h7-8,10,19,30H,6,9,11-15H2,1-5H3,(H,25,32)/t19-/m1/s1",
      "inchiKeyParent": "WSPIMEQWJCZEBF-LJQANCHMSA-N",
      "smilesParent": "CCCNC(=O)N1CC2(CN(C2)C(=O)CN(C)C)c3c([C@H]1CO)n(C)c4cc(OC)ccc34"
    },
    "unichem": {
      "chebi": "125884",
      "lincs": "LSM-37451",
      "pubchem": "71759937"
    },
    "pubchem": [
      {
        "cid": 71759937,
        "inchi": "InChI=1S/C24H35N5O4/c1-6-9-25-23(32)29-15-24(13-28(14-24)20(31)11-26(2)3)21-17-8-7-16(33-5)10-18(17)27(4)22(21)19(29)12-30/h7-8,10,19,30H,6,9,11-15H2,1-5H3,(H,25,32)/t19-/m1/s1",
        "inchikey": "WSPIMEQWJCZEBF-LJQANCHMSA-N",
        "iupac": {
          "systematic": "(1S)-1'-[2-(dimethylamino)acetyl]-1-(hydroxymethyl)-7-methoxy-9-methyl-N-propylspiro[1,3-dihydropyrido[3,4-b]indole-4,3'-azetidine]-2-carboxamide"
        },
        "smiles": {
          "canonical": "CCCNC(=O)N1CC2(CN(C2)C(=O)CN(C)C)C3=C(C1CO)N(C4=C3C=CC(=C4)OC)C"
        },
        "molecularFormula": "C24H35N5O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:56:01Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85d1"
    },
    "name": "BRD-K02418197",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85d1.png",
    "lincs": {
      "id": "LSM-37409",
      "name": "BRD-K02418197",
      "pubchemCid": 54615100,
      "chebiId": 125842,
      "inchiParent": "InChI=1S/C35H44N4O6/c1-24-21-39(25(2)23-40)35(43)30-20-29(37-33(41)27-11-6-5-7-12-27)13-14-31(30)45-26(3)10-8-9-19-44-32(24)22-38(4)34(42)28-15-17-36-18-16-28/h5-7,11-18,20,24-26,32,40H,8-10,19,21-23H2,1-4H3,(H,37,41)/t24-,25+,26+,32-/m1/s1",
      "inchiKeyParent": "LFSFSXVVLAKPPY-XDMKPEOCSA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@@H](C)[C@@H](CN(C)C(=O)c2ccncc2)OCCCC[C@H](C)Oc3ccc(NC(=O)c4ccccc4)cc3C1=O"
    },
    "unichem": {
      "chebi": "125842",
      "lincs": "LSM-37409",
      "pubchem": "54615100"
    },
    "pubchem": [
      {
        "cid": 54615100,
        "inchi": "InChI=1S/C35H44N4O6/c1-24-21-39(25(2)23-40)35(43)30-20-29(37-33(41)27-11-6-5-7-12-27)13-14-31(30)45-26(3)10-8-9-19-44-32(24)22-38(4)34(42)28-15-17-36-18-16-28/h5-7,11-18,20,24-26,32,40H,8-10,19,21-23H2,1-4H3,(H,37,41)/t24-,25+,26+,32-/m1/s1",
        "inchikey": "LFSFSXVVLAKPPY-XDMKPEOCSA-N",
        "iupac": {
          "systematic": "N-[[(3S,9S,10R)-16-benzamido-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methylpyridine-4-carboxamide"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NC(=O)C3=CC=CC=C3)C(C)CO)C)CN(C)C(=O)C4=CC=NC=C4"
        },
        "molecularFormula": "C35H44N4O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:56:04Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c857d"
    },
    "name": "BRD-K39398102",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c857d.png",
    "lincs": {
      "id": "LSM-10819",
      "name": "BRD-K39398102",
      "pubchemCid": 54654082,
      "chebiId": 99440,
      "inchiParent": "InChI=1S/C26H31N3O5S/c1-28-20-9-8-18(15-24(30)29-11-3-2-4-12-29)34-22(20)16-33-21-10-7-17(14-19(21)26(28)32)27-25(31)23-6-5-13-35-23/h5-7,10,13-14,18,20,22H,2-4,8-9,11-12,15-16H2,1H3,(H,27,31)/t18-,20-,22-/m0/s1",
      "inchiKeyParent": "IFOOEWPAOUEVPY-VCOUNFBDSA-N",
      "smilesParent": "CN1[C@H]2CC[C@@H](CC(=O)N3CCCCC3)O[C@H]2COc4ccc(NC(=O)c5cccs5)cc4C1=O"
    },
    "unichem": {
      "chebi": "99440",
      "lincs": "LSM-10819",
      "pubchem": "54654082"
    },
    "pubchem": [
      {
        "cid": 54654082,
        "inchi": "InChI=1S/C26H31N3O5S/c1-28-20-9-8-18(15-24(30)29-11-3-2-4-12-29)34-22(20)16-33-21-10-7-17(14-19(21)26(28)32)27-25(31)23-6-5-13-35-23/h5-7,10,13-14,18,20,22H,2-4,8-9,11-12,15-16H2,1H3,(H,27,31)/t18-,20-,22-/m0/s1",
        "inchikey": "IFOOEWPAOUEVPY-VCOUNFBDSA-N",
        "iupac": {
          "systematic": "N-[(2S,4aS,12aR)-5-methyl-6-oxo-2-(2-oxo-2-piperidin-1-ylethyl)-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]thiophene-2-carboxamide"
        },
        "smiles": {
          "canonical": "CN1C2CCC(OC2COC3=C(C1=O)C=C(C=C3)NC(=O)C4=CC=CS4)CC(=O)N5CCCCC5"
        },
        "molecularFormula": "C26H31N3O5S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:56:06Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85a3"
    },
    "name": "BRD-K65920478",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85a3.png",
    "lincs": {
      "id": "LSM-40872",
      "name": "BRD-K65920478",
      "pubchemCid": 60190188,
      "chebiId": 129321,
      "inchiParent": "InChI=1S/C29H37N3O4/c1-34-22-5-3-4-21(12-22)15-32-19-29(17-31(18-29)14-20-8-10-36-11-9-20)27-24-7-6-23(35-2)13-25(24)30-28(27)26(32)16-33/h3-7,12-13,20,26,30,33H,8-11,14-19H2,1-2H3/t26-/m1/s1",
      "inchiKeyParent": "BOYAXGSYXWVDBH-AREMUKBSSA-N",
      "smilesParent": "COc1cccc(CN2CC3(CN(CC4CCOCC4)C3)c5c([nH]c6cc(OC)ccc56)[C@H]2CO)c1"
    },
    "unichem": {
      "chebi": "129321",
      "lincs": "LSM-40872",
      "pubchem": "60190188"
    },
    "pubchem": [
      {
        "cid": 60190188,
        "inchi": "InChI=1S/C29H37N3O4/c1-34-22-5-3-4-21(12-22)15-32-19-29(17-31(18-29)14-20-8-10-36-11-9-20)27-24-7-6-23(35-2)13-25(24)30-28(27)26(32)16-33/h3-7,12-13,20,26,30,33H,8-11,14-19H2,1-2H3/t26-/m1/s1",
        "inchikey": "BOYAXGSYXWVDBH-AREMUKBSSA-N",
        "iupac": {
          "systematic": "[(1S)-7-methoxy-2-[(3-methoxyphenyl)methyl]-1'-(oxan-4-ylmethyl)spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3'-azetidine]-1-yl]methanol"
        },
        "smiles": {
          "canonical": "COC1=CC2=C(C=C1)C3=C(N2)C(N(CC34CN(C4)CC5CCOCC5)CC6=CC(=CC=C6)OC)CO"
        },
        "molecularFormula": "C29H37N3O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:56:08Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85ba"
    },
    "name": "BRD-K95419055",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85ba.png",
    "lincs": {
      "id": "LSM-42443",
      "name": "BRD-K95419055",
      "pubchemCid": 44616403,
      "chebiId": 130894,
      "inchiParent": "InChI=1S/C35H46N4O5/c1-25-21-39(26(2)24-40)35(42)31-20-30(37-34(41)29-15-17-36-18-16-29)13-14-32(31)44-27(3)10-8-9-19-43-33(25)23-38(4)22-28-11-6-5-7-12-28/h5-7,11-18,20,25-27,33,40H,8-10,19,21-24H2,1-4H3,(H,37,41)/t25-,26-,27+,33+/m1/s1",
      "inchiKeyParent": "OANCONKVZGQSHB-ZLFFOLKFSA-N",
      "smilesParent": "C[C@H](CO)N1C[C@@H](C)[C@H](CN(C)Cc2ccccc2)OCCCC[C@H](C)Oc3ccc(NC(=O)c4ccncc4)cc3C1=O"
    },
    "unichem": {
      "chebi": "130894",
      "lincs": "LSM-42443",
      "pubchem": "44616403"
    },
    "pubchem": [
      {
        "cid": 44616403,
        "inchi": "InChI=1S/C35H46N4O5/c1-25-21-39(26(2)24-40)35(42)31-20-30(37-34(41)29-15-17-36-18-16-29)13-14-32(31)44-27(3)10-8-9-19-43-33(25)23-38(4)22-28-11-6-5-7-12-28/h5-7,11-18,20,25-27,33,40H,8-10,19,21-24H2,1-4H3,(H,37,41)/t25-,26-,27+,33+/m1/s1",
        "inchikey": "OANCONKVZGQSHB-ZLFFOLKFSA-N",
        "iupac": {
          "systematic": "N-[(3S,9R,10R)-9-[[benzyl(methyl)amino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]pyridine-4-carboxamide"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NC(=O)C3=CC=NC=C3)C(C)CO)C)CN(C)CC4=CC=CC=C4"
        },
        "molecularFormula": "C35H46N4O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:56:10Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85bf"
    },
    "name": "BRD-K24523081",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85bf.png",
    "lincs": {
      "id": "LSM-38608",
      "name": "BRD-K24523081",
      "pubchemCid": 44504331,
      "chebiId": 127045,
      "inchiParent": "InChI=1S/C27H35F3N4O4/c1-18-14-34(19(2)17-35)26(37)13-21-12-22(32-25(36)6-9-27(28,29)30)4-5-23(21)38-24(18)16-33(3)15-20-7-10-31-11-8-20/h4-5,7-8,10-12,18-19,24,35H,6,9,13-17H2,1-3H3,(H,32,36)/t18-,19+,24-/m0/s1",
      "inchiKeyParent": "SGONDPMGILSHIM-GLDPYIMESA-N",
      "smilesParent": "C[C@H](CO)N1C[C@H](C)[C@H](CN(C)Cc2ccncc2)Oc3ccc(NC(=O)CCC(F)(F)F)cc3CC1=O"
    },
    "unichem": {
      "chebi": "127045",
      "lincs": "LSM-38608",
      "pubchem": "44504331"
    },
    "pubchem": [
      {
        "cid": 44504331,
        "inchi": "InChI=1S/C27H35F3N4O4/c1-18-14-34(19(2)17-35)26(37)13-21-12-22(32-25(36)6-9-27(28,29)30)4-5-23(21)38-24(18)16-33(3)15-20-7-10-31-11-8-20/h4-5,7-8,10-12,18-19,24,35H,6,9,13-17H2,1-3H3,(H,32,36)/t18-,19+,24-/m0/s1",
        "inchikey": "SGONDPMGILSHIM-GLDPYIMESA-N",
        "iupac": {
          "systematic": "4,4,4-trifluoro-N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]butanamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)CC2=C(C=CC(=C2)NC(=O)CCC(F)(F)F)OC1CN(C)CC3=CC=NC=C3)C(C)CO"
        },
        "molecularFormula": "C27H35F3N4O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:56:13Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85cf"
    },
    "name": "BRD-K30393343",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85cf.png",
    "lincs": {
      "id": "LSM-14786",
      "name": "BRD-K30393343",
      "pubchemCid": 44616397,
      "chebiId": 103442,
      "inchiParent": "InChI=1S/C33H54N4O6/c1-22(2)34-33(41)36(6)20-30-23(3)19-37(24(4)21-38)32(40)28-18-27(35-31(39)26-13-8-7-9-14-26)15-16-29(28)43-25(5)12-10-11-17-42-30/h15-16,18,22-26,30,38H,7-14,17,19-21H2,1-6H3,(H,34,41)(H,35,39)/t23-,24+,25-,30+/m1/s1",
      "inchiKeyParent": "PLFJTCJSGHSPAZ-ZXPXOXBPSA-N",
      "smilesParent": "CC(C)NC(=O)N(C)C[C@@H]1OCCCC[C@@H](C)Oc2ccc(NC(=O)C3CCCCC3)cc2C(=O)N(C[C@H]1C)[C@@H](C)CO"
    },
    "unichem": {
      "chebi": "103442",
      "lincs": "LSM-14786",
      "pubchem": "44616397"
    },
    "pubchem": [
      {
        "cid": 44616397,
        "inchi": "InChI=1S/C33H54N4O6/c1-22(2)34-33(41)36(6)20-30-23(3)19-37(24(4)21-38)32(40)28-18-27(35-31(39)26-13-8-7-9-14-26)15-16-29(28)43-25(5)12-10-11-17-42-30/h15-16,18,22-26,30,38H,7-14,17,19-21H2,1-6H3,(H,34,41)(H,35,39)/t23-,24+,25-,30+/m1/s1",
        "inchikey": "PLFJTCJSGHSPAZ-ZXPXOXBPSA-N",
        "iupac": {
          "systematic": "N-[(3R,9R,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(propan-2-ylcarbamoyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]cyclohexanecarboxamide"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NC(=O)C3CCCCC3)C(C)CO)C)CN(C)C(=O)NC(C)C"
        },
        "molecularFormula": "C33H54N4O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:56:15Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8632"
    },
    "name": "BRD-K65049758",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8632.png",
    "lincs": {
      "id": "LSM-12400",
      "name": "BRD-K65049758",
      "pubchemCid": 54661000,
      "chebiId": 101027,
      "inchiParent": "InChI=1S/C28H32FN3O4/c29-21-10-3-2-9-18(21)19-11-12-22-25-24(28(36)30-13-4-1-5-14-30)20(16-33)23(15-31(22)27(19)35)32(25)26(34)17-7-6-8-17/h2-3,9-12,17,20,23-25,33H,1,4-8,13-16H2/t20-,23-,24+,25+/m1/s1",
      "inchiKeyParent": "FMCRALLOZMCEMF-GATIMQMVSA-N",
      "smilesParent": "OC[C@@H]1[C@H]2CN3C(=CC=C(C3=O)c4ccccc4F)[C@@H]([C@H]1C(=O)N5CCCCC5)N2C(=O)C6CCC6"
    },
    "unichem": {
      "chebi": "101027",
      "lincs": "LSM-12400",
      "pubchem": "54661000"
    },
    "pubchem": [
      {
        "cid": 54661000,
        "inchi": "InChI=1S/C28H32FN3O4/c29-21-10-3-2-9-18(21)19-11-12-22-25-24(28(36)30-13-4-1-5-14-30)20(16-33)23(15-31(22)27(19)35)32(25)26(34)17-7-6-8-17/h2-3,9-12,17,20,23-25,33H,1,4-8,13-16H2/t20-,23-,24+,25+/m1/s1",
        "inchikey": "FMCRALLOZMCEMF-GATIMQMVSA-N",
        "iupac": {
          "systematic": "(1R,9S,10S,11S)-12-(cyclobutanecarbonyl)-5-(2-fluorophenyl)-10-(hydroxymethyl)-11-(piperidine-1-carbonyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-dien-6-one"
        },
        "smiles": {
          "canonical": "C1CCN(CC1)C(=O)C2C(C3CN4C(=CC=C(C4=O)C5=CC=CC=C5F)C2N3C(=O)C6CCC6)CO"
        },
        "molecularFormula": "C28H32FN3O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:56:17Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c852b"
    },
    "name": "BRD-K16970289",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c852b.png",
    "lincs": {
      "id": "LSM-14737",
      "name": "BRD-K16970289",
      "pubchemCid": 49843341,
      "chebiId": 103393,
      "inchiParent": "InChI=1S/C30H45N3O7S/c1-21-18-33(22(2)20-34)30(35)27-17-24(31-41(36,37)26-13-11-25(38-6)12-14-26)10-15-28(27)40-23(3)9-7-8-16-39-29(21)19-32(4)5/h10-15,17,21-23,29,31,34H,7-9,16,18-20H2,1-6H3/t21-,22-,23+,29+/m1/s1",
      "inchiKeyParent": "IVNRRFOIDKKMKL-NBOGMJGSSA-N",
      "smilesParent": "COc1ccc(cc1)S(=O)(=O)Nc2ccc3O[C@@H](C)CCCCO[C@@H](CN(C)C)[C@H](C)CN([C@H](C)CO)C(=O)c3c2"
    },
    "unichem": {
      "chebi": "103393",
      "lincs": "LSM-14737",
      "pubchem": "49843341"
    },
    "pubchem": [
      {
        "cid": 49843341,
        "inchi": "InChI=1S/C30H45N3O7S/c1-21-18-33(22(2)20-34)30(35)27-17-24(31-41(36,37)26-13-11-25(38-6)12-14-26)10-15-28(27)40-23(3)9-7-8-16-39-29(21)19-32(4)5/h10-15,17,21-23,29,31,34H,7-9,16,18-20H2,1-6H3/t21-,22-,23+,29+/m1/s1",
        "inchikey": "IVNRRFOIDKKMKL-NBOGMJGSSA-N",
        "iupac": {
          "systematic": "N-[(3S,9R,10R)-9-[(dimethylamino)methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-methoxybenzenesulfonamide"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NS(=O)(=O)C3=CC=C(C=C3)OC)C(C)CO)C)CN(C)C"
        },
        "molecularFormula": "C30H45N3O7S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:56:20Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8539"
    },
    "name": "BRD-K68319707",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8539.png",
    "lincs": {
      "id": "LSM-40988",
      "name": "BRD-K68319707",
      "pubchemCid": 44618781,
      "chebiId": 129437,
      "inchiParent": "InChI=1S/C32H43ClF3N3O7S/c1-21-18-39(22(2)20-40)31(42)27-17-25(37-47(43,44)26-11-8-24(33)9-12-26)10-13-28(27)46-23(3)7-5-6-16-45-29(21)19-38(4)30(41)14-15-32(34,35)36/h8-13,17,21-23,29,37,40H,5-7,14-16,18-20H2,1-4H3/t21-,22-,23-,29-/m1/s1",
      "inchiKeyParent": "HICHWNNNCJDVID-PZNASWHRSA-N",
      "smilesParent": "C[C@H](CO)N1C[C@@H](C)[C@@H](CN(C)C(=O)CCC(F)(F)F)OCCCC[C@@H](C)Oc2ccc(NS(=O)(=O)c3ccc(Cl)cc3)cc2C1=O"
    },
    "unichem": {
      "chebi": "129437",
      "lincs": "LSM-40988",
      "pubchem": "44618781"
    },
    "pubchem": [
      {
        "cid": 44618781,
        "inchi": "InChI=1S/C32H43ClF3N3O7S/c1-21-18-39(22(2)20-40)31(42)27-17-25(37-47(43,44)26-11-8-24(33)9-12-26)10-13-28(27)46-23(3)7-5-6-16-45-29(21)19-38(4)30(41)14-15-32(34,35)36/h8-13,17,21-23,29,37,40H,5-7,14-16,18-20H2,1-4H3/t21-,22-,23-,29-/m1/s1",
        "inchikey": "HICHWNNNCJDVID-PZNASWHRSA-N",
        "iupac": {
          "systematic": "N-[[(3R,9S,10R)-16-[(4-chlorophenyl)sulfonylamino]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-4,4,4-trifluoro-N-methylbutanamide"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NS(=O)(=O)C3=CC=C(C=C3)Cl)C(C)CO)C)CN(C)C(=O)CCC(F)(F)F"
        },
        "molecularFormula": "C32H43ClF3N3O7S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:56:22Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c859a"
    },
    "name": "SCHEMBL16984306",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c859a.png",
    "lincs": {
      "id": "LSM-6820",
      "name": "SCHEMBL16984306",
      "alternativeNames": [
        "BRD-K09701578"
      ],
      "pubchemCid": 54654332,
      "chebiId": 95441,
      "inchiParent": "InChI=1S/C34H36F2N4O5/c1-39-29-11-9-25(17-32(41)37-24-13-14-40(19-24)18-21-5-3-2-4-6-21)45-31(29)20-44-30-12-8-23(16-26(30)34(39)43)38-33(42)22-7-10-27(35)28(36)15-22/h2-8,10,12,15-16,24-25,29,31H,9,11,13-14,17-20H2,1H3,(H,37,41)(H,38,42)/t24-,25+,29+,31+/m1/s1",
      "inchiKeyParent": "UWMJOJNRDSZDAZ-ZREQJXQJSA-N",
      "smilesParent": "CN1[C@H]2CC[C@@H](CC(=O)N[C@@H]3CCN(Cc4ccccc4)C3)O[C@H]2COc5ccc(NC(=O)c6ccc(F)c(F)c6)cc5C1=O"
    },
    "unichem": {
      "chebi": "95441",
      "lincs": "LSM-6820",
      "pubchem": "54654332"
    },
    "pubchem": [
      {
        "cid": 54654332,
        "inchi": "InChI=1S/C34H36F2N4O5/c1-39-29-11-9-25(17-32(41)37-24-13-14-40(19-24)18-21-5-3-2-4-6-21)45-31(29)20-44-30-12-8-23(16-26(30)34(39)43)38-33(42)22-7-10-27(35)28(36)15-22/h2-8,10,12,15-16,24-25,29,31H,9,11,13-14,17-20H2,1H3,(H,37,41)(H,38,42)/t24-,25+,29+,31+/m1/s1",
        "inchikey": "UWMJOJNRDSZDAZ-ZREQJXQJSA-N",
        "iupac": {
          "systematic": "N-[(2S,4aS,12aR)-2-[2-[[(3R)-1-benzylpyrrolidin-3-yl]amino]-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-3,4-difluorobenzamide"
        },
        "smiles": {
          "canonical": "CN1C2CCC(OC2COC3=C(C1=O)C=C(C=C3)NC(=O)C4=CC(=C(C=C4)F)F)CC(=O)NC5CCN(C5)CC6=CC=CC=C6"
        },
        "molecularFormula": "C34H36F2N4O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:56:24Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c859d"
    },
    "name": "BRD-K45333259",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c859d.png",
    "lincs": {
      "id": "LSM-39783",
      "name": "BRD-K45333259",
      "pubchemCid": 60185066,
      "chebiId": 128228,
      "inchiParent": "InChI=1S/C24H35N5O4/c1-6-9-25-23(32)29-15-24(13-28(14-24)20(31)11-26(2)3)21-17-8-7-16(33-5)10-18(17)27(4)22(21)19(29)12-30/h7-8,10,19,30H,6,9,11-15H2,1-5H3,(H,25,32)/t19-/m0/s1",
      "inchiKeyParent": "WSPIMEQWJCZEBF-IBGZPJMESA-N",
      "smilesParent": "CCCNC(=O)N1CC2(CN(C2)C(=O)CN(C)C)c3c([C@@H]1CO)n(C)c4cc(OC)ccc34"
    },
    "unichem": {
      "chebi": "128228",
      "lincs": "LSM-39783",
      "pubchem": "60185066"
    },
    "pubchem": [
      {
        "cid": 60185066,
        "inchi": "InChI=1S/C24H35N5O4/c1-6-9-25-23(32)29-15-24(13-28(14-24)20(31)11-26(2)3)21-17-8-7-16(33-5)10-18(17)27(4)22(21)19(29)12-30/h7-8,10,19,30H,6,9,11-15H2,1-5H3,(H,25,32)/t19-/m0/s1",
        "inchikey": "WSPIMEQWJCZEBF-IBGZPJMESA-N",
        "iupac": {
          "systematic": "(1R)-1'-[2-(dimethylamino)acetyl]-1-(hydroxymethyl)-7-methoxy-9-methyl-N-propylspiro[1,3-dihydropyrido[3,4-b]indole-4,3'-azetidine]-2-carboxamide"
        },
        "smiles": {
          "canonical": "CCCNC(=O)N1CC2(CN(C2)C(=O)CN(C)C)C3=C(C1CO)N(C4=C3C=CC(=C4)OC)C"
        },
        "molecularFormula": "C24H35N5O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:56:27Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85f2"
    },
    "name": "BRD-K19917828",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85f2.png",
    "lincs": {
      "id": "LSM-9635",
      "name": "BRD-K19917828",
      "pubchemCid": 54661017,
      "chebiId": 98256,
      "inchiParent": "InChI=1S/C25H28N6O3S/c32-13-19-18-12-30-20(6-5-17(24(30)34)16-9-26-14-27-10-16)21(18)31(11-15-3-1-2-4-15)22(19)23(33)29-25-28-7-8-35-25/h5-10,14-15,18-19,21-22,32H,1-4,11-13H2,(H,28,29,33)/t18-,19-,21+,22-/m1/s1",
      "inchiKeyParent": "HGHULLBDNZJMJU-KRXUUXHPSA-N",
      "smilesParent": "OC[C@@H]1[C@H]2CN3C(=CC=C(C3=O)c4cncnc4)[C@H]2N(CC5CCCC5)[C@H]1C(=O)Nc6nccs6"
    },
    "unichem": {
      "chebi": "98256",
      "lincs": "LSM-9635",
      "pubchem": "54661017"
    },
    "pubchem": [
      {
        "cid": 54661017,
        "inchi": "InChI=1S/C25H28N6O3S/c32-13-19-18-12-30-20(6-5-17(24(30)34)16-9-26-14-27-10-16)21(18)31(11-15-3-1-2-4-15)22(19)23(33)29-25-28-7-8-35-25/h5-10,14-15,18-19,21-22,32H,1-4,11-13H2,(H,28,29,33)/t18-,19-,21+,22-/m1/s1",
        "inchikey": "HGHULLBDNZJMJU-KRXUUXHPSA-N",
        "iupac": {
          "systematic": "(2R,3R,3aS,9bS)-1-(cyclopentylmethyl)-3-(hydroxymethyl)-6-oxo-7-pyrimidin-5-yl-N-(1,3-thiazol-2-yl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide"
        },
        "smiles": {
          "canonical": "C1CCC(C1)CN2C3C(CN4C3=CC=C(C4=O)C5=CN=CN=C5)C(C2C(=O)NC6=NC=CS6)CO"
        },
        "molecularFormula": "C25H28N6O3S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:56:29Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c863b"
    },
    "name": "BRD-K41444660",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c863b.png",
    "lincs": {
      "id": "LSM-44763",
      "name": "BRD-K41444660",
      "pubchemCid": 54651313,
      "inchiParent": "InChI=1S/C24H30N2O2/c1-4-8-18-11-13-19(14-12-18)23-21(15-25-17(2)3)26(22(23)16-27)24(28)20-9-6-5-7-10-20/h4-14,17,21-23,25,27H,15-16H2,1-3H3/b8-4+/t21-,22-,23+/m1/s1",
      "inchiKeyParent": "QVBYNBOGWXOSKF-VPPDGZEESA-N",
      "smilesParent": "C\\C=C\\c1ccc(cc1)[C@@H]2[C@@H](CO)N([C@@H]2CNC(C)C)C(=O)c3ccccc3"
    },
    "unichem": {
      "lincs": "LSM-44763",
      "pubchem": "54651313"
    },
    "pubchem": [
      {
        "cid": 54651313,
        "inchi": "InChI=1S/C24H30N2O2/c1-4-8-18-11-13-19(14-12-18)23-21(15-25-17(2)3)26(22(23)16-27)24(28)20-9-6-5-7-10-20/h4-14,17,21-23,25,27H,15-16H2,1-3H3/b8-4+/t21-,22-,23+/m1/s1",
        "inchikey": "QVBYNBOGWXOSKF-VPPDGZEESA-N",
        "iupac": {
          "systematic": "[(2S,3S,4S)-2-(hydroxymethyl)-4-[(propan-2-ylamino)methyl]-3-[4-[(E)-prop-1-enyl]phenyl]azetidin-1-yl]-phenylmethanone"
        },
        "smiles": {
          "canonical": "CC=CC1=CC=C(C=C1)C2C(N(C2CO)C(=O)C3=CC=CC=C3)CNC(C)C"
        },
        "molecularFormula": "C24H30N2O2"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:56:31Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c852d"
    },
    "name": "BRD-K43253317",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c852d.png",
    "lincs": {
      "id": "LSM-39647",
      "name": "BRD-K43253317",
      "pubchemCid": 54615077,
      "chebiId": 128091,
      "inchiParent": "InChI=1S/C34H50N4O6/c1-23-19-38(24(2)22-39)33(40)30-18-28(36-34(41)35-27-11-14-29(42-5)15-12-27)13-16-31(30)44-25(3)8-6-7-17-43-32(23)21-37(4)20-26-9-10-26/h11-16,18,23-26,32,39H,6-10,17,19-22H2,1-5H3,(H2,35,36,41)/t23-,24-,25-,32+/m0/s1",
      "inchiKeyParent": "NRXGVPPIKRTMIX-RVMAYGNISA-N",
      "smilesParent": "COc1ccc(NC(=O)Nc2ccc3O[C@@H](C)CCCCO[C@H](CN(C)CC4CC4)[C@@H](C)CN([C@@H](C)CO)C(=O)c3c2)cc1"
    },
    "unichem": {
      "chebi": "128091",
      "lincs": "LSM-39647",
      "pubchem": "54615077"
    },
    "pubchem": [
      {
        "cid": 54615077,
        "inchi": "InChI=1S/C34H50N4O6/c1-23-19-38(24(2)22-39)33(40)30-18-28(36-34(41)35-27-11-14-29(42-5)15-12-27)13-16-31(30)44-25(3)8-6-7-17-43-32(23)21-37(4)20-26-9-10-26/h11-16,18,23-26,32,39H,6-10,17,19-22H2,1-5H3,(H2,35,36,41)/t23-,24-,25-,32+/m0/s1",
        "inchikey": "NRXGVPPIKRTMIX-RVMAYGNISA-N",
        "iupac": {
          "systematic": "1-[(3S,9S,10S)-9-[[cyclopropylmethyl(methyl)amino]methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-(4-methoxyphenyl)urea"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NC(=O)NC3=CC=C(C=C3)OC)C(C)CO)C)CN(C)CC4CC4"
        },
        "molecularFormula": "C34H50N4O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:56:34Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c856c"
    },
    "name": "BRD-K51266459",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c856c.png",
    "lincs": {
      "id": "LSM-11565",
      "name": "BRD-K51266459",
      "pubchemCid": 54646190,
      "chebiId": 100188,
      "inchiParent": "InChI=1S/C28H29FN2O7S/c1-36-24-5-3-2-4-17(24)15-30-27(33)14-20-13-23-22-12-19(8-11-25(22)38-28(23)26(16-32)37-20)31-39(34,35)21-9-6-18(29)7-10-21/h2-12,20,23,26,28,31-32H,13-16H2,1H3,(H,30,33)/t20-,23+,26-,28-/m1/s1",
      "inchiKeyParent": "CRNISVWSFUFTQR-SJPQFPLUSA-N",
      "smilesParent": "COc1ccccc1CNC(=O)C[C@H]2C[C@@H]3[C@@H](Oc4ccc(NS(=O)(=O)c5ccc(F)cc5)cc34)[C@@H](CO)O2"
    },
    "unichem": {
      "chebi": "100188",
      "lincs": "LSM-11565",
      "pubchem": "54646190"
    },
    "pubchem": [
      {
        "cid": 54646190,
        "inchi": "InChI=1S/C28H29FN2O7S/c1-36-24-5-3-2-4-17(24)15-30-27(33)14-20-13-23-22-12-19(8-11-25(22)38-28(23)26(16-32)37-20)31-39(34,35)21-9-6-18(29)7-10-21/h2-12,20,23,26,28,31-32H,13-16H2,1H3,(H,30,33)/t20-,23+,26-,28-/m1/s1",
        "inchikey": "CRNISVWSFUFTQR-SJPQFPLUSA-N",
        "iupac": {
          "systematic": "2-[(1R,3R,4aS,9aR)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-[(2-methoxyphenyl)methyl]acetamide"
        },
        "smiles": {
          "canonical": "COC1=CC=CC=C1CNC(=O)CC2CC3C(C(O2)CO)OC4=C3C=C(C=C4)NS(=O)(=O)C5=CC=C(C=C5)F"
        },
        "molecularFormula": "C28H29FN2O7S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:56:36Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8606"
    },
    "name": "BRD-K83546471",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8606.png",
    "lincs": {
      "id": "LSM-13537",
      "name": "BRD-K83546471",
      "pubchemCid": 54639146,
      "chebiId": 102179,
      "inchiParent": "InChI=1S/C24H28N4O4/c29-17-22-21(26-24(31)18-8-10-25-11-9-18)7-6-20(32-22)16-23(30)28-14-12-27(13-15-28)19-4-2-1-3-5-19/h1-11,20-22,29H,12-17H2,(H,26,31)/t20-,21-,22-/m0/s1",
      "inchiKeyParent": "BQXPJFPCKYJDQK-FKBYEOEOSA-N",
      "smilesParent": "OC[C@@H]1O[C@H](CC(=O)N2CCN(CC2)c3ccccc3)C=C[C@@H]1NC(=O)c4ccncc4"
    },
    "unichem": {
      "chebi": "102179",
      "lincs": "LSM-13537",
      "pubchem": "54639146"
    },
    "pubchem": [
      {
        "cid": 54639146,
        "inchi": "InChI=1S/C24H28N4O4/c29-17-22-21(26-24(31)18-8-10-25-11-9-18)7-6-20(32-22)16-23(30)28-14-12-27(13-15-28)19-4-2-1-3-5-19/h1-11,20-22,29H,12-17H2,(H,26,31)/t20-,21-,22-/m0/s1",
        "inchikey": "BQXPJFPCKYJDQK-FKBYEOEOSA-N",
        "iupac": {
          "systematic": "N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(4-phenylpiperazin-1-yl)ethyl]-3,6-dihydro-2H-pyran-3-yl]pyridine-4-carboxamide"
        },
        "smiles": {
          "canonical": "C1CN(CCN1C2=CC=CC=C2)C(=O)CC3C=CC(C(O3)CO)NC(=O)C4=CC=NC=C4"
        },
        "molecularFormula": "C24H28N4O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:56:38Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84fe"
    },
    "name": "BRD-K06303559",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84fe.png",
    "lincs": {
      "id": "LSM-37610",
      "name": "BRD-K06303559",
      "pubchemCid": 60191347,
      "chebiId": 126043,
      "inchiParent": "InChI=1S/C21H24N2O4/c1-27-13-20(26)22-10-17-21(18(12-24)23(17)19(25)11-22)16-8-6-15(7-9-16)5-4-14-2-3-14/h6-9,14,17-18,21,24H,2-3,10-13H2,1H3/t17-,18+,21-/m1/s1",
      "inchiKeyParent": "KVDPTJOHHVUPNF-LVCYWYKZSA-N",
      "smilesParent": "COCC(=O)N1C[C@@H]2[C@H]([C@H](CO)N2C(=O)C1)c3ccc(cc3)C#CC4CC4"
    },
    "unichem": {
      "chebi": "126043",
      "lincs": "LSM-37610",
      "pubchem": "60191347"
    },
    "pubchem": [
      {
        "cid": 60191347,
        "inchi": "InChI=1S/C21H24N2O4/c1-27-13-20(26)22-10-17-21(18(12-24)23(17)19(25)11-22)16-8-6-15(7-9-16)5-4-14-2-3-14/h6-9,14,17-18,21,24H,2-3,10-13H2,1H3/t17-,18+,21-/m1/s1",
        "inchikey": "KVDPTJOHHVUPNF-LVCYWYKZSA-N",
        "iupac": {
          "systematic": "(6S,7R,8R)-7-[4-(2-cyclopropylethynyl)phenyl]-8-(hydroxymethyl)-4-(2-methoxyacetyl)-1,4-diazabicyclo[4.2.0]octan-2-one"
        },
        "smiles": {
          "canonical": "COCC(=O)N1CC2C(C(N2C(=O)C1)CO)C3=CC=C(C=C3)C#CC4CC4"
        },
        "molecularFormula": "C21H24N2O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:56:40Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c851d"
    },
    "name": "BRD-K61465460",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c851d.png",
    "lincs": {
      "id": "LSM-14881",
      "name": "BRD-K61465460",
      "pubchemCid": 44485108,
      "chebiId": 103537,
      "inchiParent": "InChI=1S/C32H47N5O6/c1-21(2)34-32(41)35-26-10-11-28-27(17-26)31(40)37(23(4)20-38)18-22(3)29(42-16-8-7-9-24(5)43-28)19-36(6)30(39)25-12-14-33-15-13-25/h10-15,17,21-24,29,38H,7-9,16,18-20H2,1-6H3,(H2,34,35,41)/t22-,23-,24-,29+/m0/s1",
      "inchiKeyParent": "TYGOPRMPKRHVEQ-HGPRPZRGSA-N",
      "smilesParent": "CC(C)NC(=O)Nc1ccc2O[C@@H](C)CCCCO[C@H](CN(C)C(=O)c3ccncc3)[C@@H](C)CN([C@@H](C)CO)C(=O)c2c1"
    },
    "unichem": {
      "chebi": "103537",
      "lincs": "LSM-14881",
      "pubchem": "44485108"
    },
    "pubchem": [
      {
        "cid": 44485108,
        "inchi": "InChI=1S/C32H47N5O6/c1-21(2)34-32(41)35-26-10-11-28-27(17-26)31(40)37(23(4)20-38)18-22(3)29(42-16-8-7-9-24(5)43-28)19-36(6)30(39)25-12-14-33-15-13-25/h10-15,17,21-24,29,38H,7-9,16,18-20H2,1-6H3,(H2,34,35,41)/t22-,23-,24-,29+/m0/s1",
        "inchikey": "TYGOPRMPKRHVEQ-HGPRPZRGSA-N",
        "iupac": {
          "systematic": "N-[[(3S,9S,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-(propan-2-ylcarbamoylamino)-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methylpyridine-4-carboxamide"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NC(=O)NC(C)C)C(C)CO)C)CN(C)C(=O)C3=CC=NC=C3"
        },
        "molecularFormula": "C32H47N5O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:56:42Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8549"
    },
    "name": "BRD-K35188965",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8549.png",
    "lincs": {
      "id": "LSM-10543",
      "name": "BRD-K35188965",
      "pubchemCid": 54645957,
      "chebiId": 99164,
      "inchiParent": "InChI=1S/C21H28N2O7/c1-27-12-19(25)22-13-2-3-17-15(8-13)16-9-14(29-18(11-24)21(16)30-17)10-20(26)23-4-6-28-7-5-23/h2-3,8,14,16,18,21,24H,4-7,9-12H2,1H3,(H,22,25)/t14-,16-,18-,21+/m1/s1",
      "inchiKeyParent": "YLZXNIXKCHRFQK-OQBJRAFVSA-N",
      "smilesParent": "COCC(=O)Nc1ccc2O[C@@H]3[C@@H](CO)O[C@@H](CC(=O)N4CCOCC4)C[C@@H]3c2c1"
    },
    "unichem": {
      "chebi": "99164",
      "lincs": "LSM-10543",
      "pubchem": "54645957"
    },
    "pubchem": [
      {
        "cid": 54645957,
        "inchi": "InChI=1S/C21H28N2O7/c1-27-12-19(25)22-13-2-3-17-15(8-13)16-9-14(29-18(11-24)21(16)30-17)10-20(26)23-4-6-28-7-5-23/h2-3,8,14,16,18,21,24H,4-7,9-12H2,1H3,(H,22,25)/t14-,16-,18-,21+/m1/s1",
        "inchikey": "YLZXNIXKCHRFQK-OQBJRAFVSA-N",
        "iupac": {
          "systematic": "N-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-3-(2-morpholin-4-yl-2-oxoethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]-2-methoxyacetamide"
        },
        "smiles": {
          "canonical": "COCC(=O)NC1=CC2=C(C=C1)OC3C2CC(OC3CO)CC(=O)N4CCOCC4"
        },
        "molecularFormula": "C21H28N2O7"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:56:45Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c855a"
    },
    "name": "BRD-M72906282",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c855a.png",
    "lincs": {
      "id": "LSM-45061",
      "name": "BRD-M72906282",
      "pubchemCid": 54660639,
      "chebiId": 103298,
      "inchiParent": "InChI=1S/C23H29N5O5S/c1-3-5-14-8-9-17-21-20(22(30)25-15-6-4-7-15)16(12-29)18(10-27(17)23(14)31)28(21)34(32,33)19-11-26(2)13-24-19/h3,5,8-9,11,13,15-16,18,20-21,29H,4,6-7,10,12H2,1-2H3,(H,25,30)/t16-,18-,20+,21+/m0/s1",
      "inchiKeyParent": "FBXKHEMXYYDERF-XIGKFDRGSA-N",
      "smilesParent": "CC=CC1=CC=C2[C@@H]3[C@@H]([C@@H](CO)[C@H](CN2C1=O)N3S(=O)(=O)c4cn(C)cn4)C(=O)NC5CCC5"
    },
    "unichem": {
      "chebi": "103298",
      "lincs": "LSM-45061",
      "pubchem": "139032145"
    },
    "pubchem": [
      {
        "cid": 139032145,
        "inchi": "InChI=1S/C23H29N5O5S/c1-3-5-14-8-9-17-21-20(22(30)25-15-6-4-7-15)16(12-29)18(10-27(17)23(14)31)28(21)34(32,33)19-11-26(2)13-24-19/h3,5,8-9,11,13,15-16,18,20-21,29H,4,6-7,10,12H2,1-2H3,(H,25,30)/t16-,18-,20+,21+/m0/s1",
        "inchikey": "FBXKHEMXYYDERF-XIGKFDRGSA-N",
        "iupac": {
          "systematic": "(1S,9R,10R,11R)-N-cyclobutyl-10-(hydroxymethyl)-12-(1-methylimidazol-4-yl)sulfonyl-6-oxo-5-prop-1-enyl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide"
        },
        "smiles": {
          "canonical": "CC=CC1=CC=C2C3C(C(C(N3S(=O)(=O)C4=CN(C=N4)C)CN2C1=O)CO)C(=O)NC5CCC5"
        },
        "molecularFormula": "C23H29N5O5S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:56:47Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8596"
    },
    "name": "BRD-K53808186",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8596.png",
    "lincs": {
      "id": "LSM-11698",
      "name": "BRD-K53808186",
      "pubchemCid": 54654194,
      "chebiId": 100323,
      "inchiParent": "InChI=1S/C30H38ClN5O5/c1-35-25-11-10-23(18-28(37)32-13-16-36-14-3-2-4-15-36)41-27(25)19-40-26-12-9-22(17-24(26)29(35)38)34-30(39)33-21-7-5-20(31)6-8-21/h5-9,12,17,23,25,27H,2-4,10-11,13-16,18-19H2,1H3,(H,32,37)(H2,33,34,39)/t23-,25-,27-/m1/s1",
      "inchiKeyParent": "XIGYLWQKLZSYNZ-DFZDUAMZSA-N",
      "smilesParent": "CN1[C@@H]2CC[C@H](CC(=O)NCCN3CCCCC3)O[C@@H]2COc4ccc(NC(=O)Nc5ccc(Cl)cc5)cc4C1=O"
    },
    "unichem": {
      "chebi": "100323",
      "lincs": "LSM-11698",
      "pubchem": "54654194"
    },
    "pubchem": [
      {
        "cid": 54654194,
        "inchi": "InChI=1S/C30H38ClN5O5/c1-35-25-11-10-23(18-28(37)32-13-16-36-14-3-2-4-15-36)41-27(25)19-40-26-12-9-22(17-24(26)29(35)38)34-30(39)33-21-7-5-20(31)6-8-21/h5-9,12,17,23,25,27H,2-4,10-11,13-16,18-19H2,1H3,(H,32,37)(H2,33,34,39)/t23-,25-,27-/m1/s1",
        "inchikey": "XIGYLWQKLZSYNZ-DFZDUAMZSA-N",
        "iupac": {
          "systematic": "2-[(2R,4aR,12aS)-8-[(4-chlorophenyl)carbamoylamino]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(2-piperidin-1-ylethyl)acetamide"
        },
        "smiles": {
          "canonical": "CN1C2CCC(OC2COC3=C(C1=O)C=C(C=C3)NC(=O)NC4=CC=C(C=C4)Cl)CC(=O)NCCN5CCCCC5"
        },
        "molecularFormula": "C30H38ClN5O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:56:49Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85b1"
    },
    "name": "BRD-K18400716",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85b1.png",
    "lincs": {
      "id": "LSM-9536",
      "name": "BRD-K18400716",
      "pubchemCid": 54657634,
      "chebiId": 98157,
      "inchiParent": "InChI=1S/C21H29F3N2O4/c1-25(2)20(28)9-17-7-8-18-19(30-17)13-29-12-16(27)11-26(18)10-14-3-5-15(6-4-14)21(22,23)24/h3-6,16-19,27H,7-13H2,1-2H3/t16-,17+,18+,19-/m0/s1",
      "inchiKeyParent": "OUTWOBHUWTVFCP-MANSERQUSA-N",
      "smilesParent": "CN(C)C(=O)C[C@H]1CC[C@@H]2[C@H](COC[C@@H](O)CN2Cc3ccc(cc3)C(F)(F)F)O1"
    },
    "unichem": {
      "chebi": "98157",
      "lincs": "LSM-9536",
      "pubchem": "54657634"
    },
    "pubchem": [
      {
        "cid": 54657634,
        "inchi": "InChI=1S/C21H29F3N2O4/c1-25(2)20(28)9-17-7-8-18-19(30-17)13-29-12-16(27)11-26(18)10-14-3-5-15(6-4-14)21(22,23)24/h3-6,16-19,27H,7-13H2,1-2H3/t16-,17+,18+,19-/m0/s1",
        "inchikey": "OUTWOBHUWTVFCP-MANSERQUSA-N",
        "iupac": {
          "systematic": "2-[(3S,6aR,8R,10aR)-3-hydroxy-1-[[4-(trifluoromethyl)phenyl]methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N,N-dimethylacetamide"
        },
        "smiles": {
          "canonical": "CN(C)C(=O)CC1CCC2C(O1)COCC(CN2CC3=CC=C(C=C3)C(F)(F)F)O"
        },
        "molecularFormula": "C21H29F3N2O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:56:51Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85d3"
    },
    "name": "BRD-K49148689",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85d3.png",
    "lincs": {
      "id": "LSM-14847",
      "name": "BRD-K49148689",
      "pubchemCid": 44618182,
      "chebiId": 103503,
      "inchiParent": "InChI=1S/C33H54N4O6/c1-22(2)34-33(41)36(6)20-30-23(3)19-37(24(4)21-38)32(40)28-18-27(35-31(39)26-13-8-7-9-14-26)15-16-29(28)43-25(5)12-10-11-17-42-30/h15-16,18,22-26,30,38H,7-14,17,19-21H2,1-6H3,(H,34,41)(H,35,39)/t23-,24+,25+,30+/m1/s1",
      "inchiKeyParent": "PLFJTCJSGHSPAZ-DUXAABNJSA-N",
      "smilesParent": "CC(C)NC(=O)N(C)C[C@@H]1OCCCC[C@H](C)Oc2ccc(NC(=O)C3CCCCC3)cc2C(=O)N(C[C@H]1C)[C@@H](C)CO"
    },
    "unichem": {
      "chebi": "103503",
      "lincs": "LSM-14847",
      "pubchem": "44618182"
    },
    "pubchem": [
      {
        "cid": 44618182,
        "inchi": "InChI=1S/C33H54N4O6/c1-22(2)34-33(41)36(6)20-30-23(3)19-37(24(4)21-38)32(40)28-18-27(35-31(39)26-13-8-7-9-14-26)15-16-29(28)43-25(5)12-10-11-17-42-30/h15-16,18,22-26,30,38H,7-14,17,19-21H2,1-6H3,(H,34,41)(H,35,39)/t23-,24+,25+,30+/m1/s1",
        "inchikey": "PLFJTCJSGHSPAZ-DUXAABNJSA-N",
        "iupac": {
          "systematic": "N-[(3S,9R,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(propan-2-ylcarbamoyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]cyclohexanecarboxamide"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NC(=O)C3CCCCC3)C(C)CO)C)CN(C)C(=O)NC(C)C"
        },
        "molecularFormula": "C33H54N4O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:56:54Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84f6"
    },
    "name": "BRD-K75872636",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84f6.png",
    "lincs": {
      "id": "LSM-41402",
      "name": "BRD-K75872636",
      "pubchemCid": 60189822,
      "chebiId": 129851,
      "inchiParent": "InChI=1S/C20H27N3O5S/c1-4-5-17(25)23-12-20(10-22(11-20)29(3,26)27)18-14-7-6-13(28-2)8-15(14)21-19(18)16(23)9-24/h6-8,16,21,24H,4-5,9-12H2,1-3H3/t16-/m0/s1",
      "inchiKeyParent": "XMVIRUQNBREFSZ-INIZCTEOSA-N",
      "smilesParent": "CCCC(=O)N1CC2(CN(C2)S(=O)(=O)C)c3c([nH]c4cc(OC)ccc34)[C@@H]1CO"
    },
    "unichem": {
      "chebi": "129851",
      "lincs": "LSM-41402",
      "pubchem": "60189822"
    },
    "pubchem": [
      {
        "cid": 60189822,
        "inchi": "InChI=1S/C20H27N3O5S/c1-4-5-17(25)23-12-20(10-22(11-20)29(3,26)27)18-14-7-6-13(28-2)8-15(14)21-19(18)16(23)9-24/h6-8,16,21,24H,4-5,9-12H2,1-3H3/t16-/m0/s1",
        "inchikey": "XMVIRUQNBREFSZ-INIZCTEOSA-N",
        "iupac": {
          "systematic": "1-[(1R)-1-(hydroxymethyl)-7-methoxy-1'-methylsulfonylspiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3'-azetidine]-2-yl]butan-1-one"
        },
        "smiles": {
          "canonical": "CCCC(=O)N1CC2(CN(C2)S(=O)(=O)C)C3=C(C1CO)NC4=C3C=CC(=C4)OC"
        },
        "molecularFormula": "C20H27N3O5S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:56:56Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8514"
    },
    "name": "BRD-K12743465",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8514.png",
    "lincs": {
      "id": "LSM-37927",
      "name": "BRD-K12743465",
      "pubchemCid": 60189713,
      "chebiId": 126362,
      "inchiParent": "InChI=1S/C20H25N3O3/c1-22-9-20(10-23(11-20)19(25)12-3-4-12)17-14-6-5-13(26-2)7-15(14)21-18(17)16(22)8-24/h5-7,12,16,21,24H,3-4,8-11H2,1-2H3/t16-/m1/s1",
      "inchiKeyParent": "IBTXVFHWOBHAIT-MRXNPFEDSA-N",
      "smilesParent": "COc1ccc2c3c([nH]c2c1)[C@@H](CO)N(C)CC34CN(C4)C(=O)C5CC5"
    },
    "unichem": {
      "chebi": "126362",
      "lincs": "LSM-37927",
      "pubchem": "60189713"
    },
    "pubchem": [
      {
        "cid": 60189713,
        "inchi": "InChI=1S/C20H25N3O3/c1-22-9-20(10-23(11-20)19(25)12-3-4-12)17-14-6-5-13(26-2)7-15(14)21-18(17)16(22)8-24/h5-7,12,16,21,24H,3-4,8-11H2,1-2H3/t16-/m1/s1",
        "inchikey": "IBTXVFHWOBHAIT-MRXNPFEDSA-N",
        "iupac": {
          "systematic": "cyclopropyl-[(1S)-1-(hydroxymethyl)-7-methoxy-2-methylspiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3'-azetidine]-1'-yl]methanone"
        },
        "smiles": {
          "canonical": "CN1CC2(CN(C2)C(=O)C3CC3)C4=C(C1CO)NC5=C4C=CC(=C5)OC"
        },
        "molecularFormula": "C20H25N3O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:56:58Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8550"
    },
    "name": "BRD-K46359800",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8550.png",
    "lincs": {
      "id": "LSM-11257",
      "name": "BRD-K46359800",
      "pubchemCid": 54631334,
      "chebiId": 99878,
      "inchiParent": "InChI=1S/C25H30N4O4S/c1-15-12-26-16(2)14-33-20-11-17(9-10-18(20)25(31)29(3)13-21(15)32-4)27-23(30)24-28-19-7-5-6-8-22(19)34-24/h5-11,15-16,21,26H,12-14H2,1-4H3,(H,27,30)/t15-,16+,21+/m1/s1",
      "inchiKeyParent": "HNVRJEXAKGMODG-XFQAVAEZSA-N",
      "smilesParent": "CO[C@H]1CN(C)C(=O)c2ccc(NC(=O)c3nc4ccccc4s3)cc2OC[C@H](C)NC[C@H]1C"
    },
    "unichem": {
      "chebi": "99878",
      "lincs": "LSM-11257",
      "pubchem": "54631334"
    },
    "pubchem": [
      {
        "cid": 54631334,
        "inchi": "InChI=1S/C25H30N4O4S/c1-15-12-26-16(2)14-33-20-11-17(9-10-18(20)25(31)29(3)13-21(15)32-4)27-23(30)24-28-19-7-5-6-8-22(19)34-24/h5-11,15-16,21,26H,12-14H2,1-4H3,(H,27,30)/t15-,16+,21+/m1/s1",
        "inchikey": "HNVRJEXAKGMODG-XFQAVAEZSA-N",
        "iupac": {
          "systematic": "N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-15-yl]-1,3-benzothiazole-2-carboxamide"
        },
        "smiles": {
          "canonical": "CC1CNC(COC2=C(C=CC(=C2)NC(=O)C3=NC4=CC=CC=C4S3)C(=O)N(CC1OC)C)C"
        },
        "molecularFormula": "C25H30N4O4S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:57:00Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85d7"
    },
    "name": "BRD-K47539505",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85d7.png",
    "lincs": {
      "id": "LSM-14842",
      "name": "BRD-K47539505",
      "pubchemCid": 44489845,
      "chebiId": 103498,
      "inchiParent": "InChI=1S/C27H43N5O6S/c1-19-14-32(20(2)17-33)27(34)23-13-22(29-39(35,36)26-16-31(6)18-28-26)10-11-24(23)38-21(3)9-7-8-12-37-25(19)15-30(4)5/h10-11,13,16,18-21,25,29,33H,7-9,12,14-15,17H2,1-6H3/t19-,20-,21-,25-/m0/s1",
      "inchiKeyParent": "ULMVXXWMSACXHE-UKDJSQQHSA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@H](C)[C@H](CN(C)C)OCCCC[C@H](C)Oc2ccc(NS(=O)(=O)c3cn(C)cn3)cc2C1=O"
    },
    "unichem": {
      "chebi": "103498",
      "lincs": "LSM-14842",
      "pubchem": "44489845"
    },
    "pubchem": [
      {
        "cid": 44489845,
        "inchi": "InChI=1S/C27H43N5O6S/c1-19-14-32(20(2)17-33)27(34)23-13-22(29-39(35,36)26-16-31(6)18-28-26)10-11-24(23)38-21(3)9-7-8-12-37-25(19)15-30(4)5/h10-11,13,16,18-21,25,29,33H,7-9,12,14-15,17H2,1-6H3/t19-,20-,21-,25-/m0/s1",
        "inchikey": "ULMVXXWMSACXHE-UKDJSQQHSA-N",
        "iupac": {
          "systematic": "N-[(3S,9R,10S)-9-[(dimethylamino)methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-1-methylimidazole-4-sulfonamide"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NS(=O)(=O)C3=CN(C=N3)C)C(C)CO)C)CN(C)C"
        },
        "molecularFormula": "C27H43N5O6S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:57:03Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85f6"
    },
    "name": "BRD-K58590337",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85f6.png",
    "lincs": {
      "id": "LSM-11964",
      "name": "BRD-K58590337",
      "pubchemCid": 54631584,
      "chebiId": 100590,
      "inchiParent": "InChI=1S/C28H35F2N3O4/c1-17-13-33(14-20-11-21(29)7-10-24(20)30)18(2)16-37-25-12-22(31-27(34)19-5-6-19)8-9-23(25)28(35)32(3)15-26(17)36-4/h7-12,17-19,26H,5-6,13-16H2,1-4H3,(H,31,34)/t17-,18-,26+/m1/s1",
      "inchiKeyParent": "MHGGQJRIOQBKBK-KABRZNFWSA-N",
      "smilesParent": "CO[C@H]1CN(C)C(=O)c2ccc(NC(=O)C3CC3)cc2OC[C@@H](C)N(Cc4cc(F)ccc4F)C[C@H]1C"
    },
    "unichem": {
      "chebi": "100590",
      "lincs": "LSM-11964",
      "pubchem": "54631584"
    },
    "pubchem": [
      {
        "cid": 54631584,
        "inchi": "InChI=1S/C28H35F2N3O4/c1-17-13-33(14-20-11-21(29)7-10-24(20)30)18(2)16-37-25-12-22(31-27(34)19-5-6-19)8-9-23(25)28(35)32(3)15-26(17)36-4/h7-12,17-19,26H,5-6,13-16H2,1-4H3,(H,31,34)/t17-,18-,26+/m1/s1",
        "inchikey": "MHGGQJRIOQBKBK-KABRZNFWSA-N",
        "iupac": {
          "systematic": "N-[(4R,7R,8R)-5-[(2,5-difluorophenyl)methyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-15-yl]cyclopropanecarboxamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(COC2=C(C=CC(=C2)NC(=O)C3CC3)C(=O)N(CC1OC)C)C)CC4=C(C=CC(=C4)F)F"
        },
        "molecularFormula": "C28H35F2N3O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:57:05Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c850f"
    },
    "name": "BRD-M02207845",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c850f.png",
    "lincs": {
      "id": "LSM-44997",
      "name": "BRD-M02207845",
      "pubchemCid": 54660739,
      "chebiId": 103234,
      "inchiParent": "InChI=1S/C24H26FN3O4/c1-4-5-14-8-11-18-21-20(24(32)26(2)3)17(13-29)19(12-27(18)22(14)30)28(21)23(31)15-6-9-16(25)10-7-15/h4-11,17,19-21,29H,12-13H2,1-3H3/t17-,19-,20+,21+/m0/s1",
      "inchiKeyParent": "QHTBDTJLVQLHTQ-MJUUVYJYSA-N",
      "smilesParent": "CC=CC1=CC=C2[C@@H]3[C@@H]([C@@H](CO)[C@H](CN2C1=O)N3C(=O)c4ccc(F)cc4)C(=O)N(C)C"
    },
    "unichem": {
      "chebi": "103234",
      "lincs": "LSM-44997",
      "pubchem": "139032078"
    },
    "pubchem": [
      {
        "cid": 139032078,
        "inchi": "InChI=1S/C24H26FN3O4/c1-4-5-14-8-11-18-21-20(24(32)26(2)3)17(13-29)19(12-27(18)22(14)30)28(21)23(31)15-6-9-16(25)10-7-15/h4-11,17,19-21,29H,12-13H2,1-3H3/t17-,19-,20+,21+/m0/s1",
        "inchikey": "QHTBDTJLVQLHTQ-MJUUVYJYSA-N",
        "iupac": {
          "systematic": "(1S,9R,10R,11R)-12-(4-fluorobenzoyl)-10-(hydroxymethyl)-N,N-dimethyl-6-oxo-5-prop-1-enyl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide"
        },
        "smiles": {
          "canonical": "CC=CC1=CC=C2C3C(C(C(N3C(=O)C4=CC=C(C=C4)F)CN2C1=O)CO)C(=O)N(C)C"
        },
        "molecularFormula": "C24H26FN3O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:57:07Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85ed"
    },
    "name": "BRD-K24465933",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85ed.png",
    "lincs": {
      "id": "LSM-9910",
      "name": "BRD-K24465933",
      "pubchemCid": 56835326,
      "chebiId": 98531,
      "inchiParent": "InChI=1S/C35H41N3O5/c1-23-19-38(24(2)21-39)34(40)32-31(28-17-11-12-18-29(28)37(32)4)27-16-10-9-15-26(27)22-43-30(23)20-36(3)35(41)33(42-5)25-13-7-6-8-14-25/h6-18,23-24,30,33,39H,19-22H2,1-5H3/t23-,24-,30+,33+/m0/s1",
      "inchiKeyParent": "ZXKFKEACMTVYCV-BAMXSYKFSA-N",
      "smilesParent": "CO[C@@H](C(=O)N(C)C[C@H]1OCc2ccccc2c3c(C(=O)N(C[C@@H]1C)[C@@H](C)CO)n(C)c4ccccc34)c5ccccc5"
    },
    "unichem": {
      "chebi": "98531",
      "lincs": "LSM-9910",
      "pubchem": "56835326"
    },
    "pubchem": [
      {
        "cid": 56835326,
        "inchi": "InChI=1S/C35H41N3O5/c1-23-19-38(24(2)21-39)34(40)32-31(28-17-11-12-18-29(28)37(32)4)27-16-10-9-15-26(27)22-43-30(23)20-36(3)35(41)33(42-5)25-13-7-6-8-14-25/h6-18,23-24,30,33,39H,19-22H2,1-5H3/t23-,24-,30+,33+/m0/s1",
        "inchikey": "ZXKFKEACMTVYCV-BAMXSYKFSA-N",
        "iupac": {
          "systematic": "(2R)-N-[[(10S,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-2-methoxy-N-methyl-2-phenylacetamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(C3=CC=CC=C3COC1CN(C)C(=O)C(C4=CC=CC=C4)OC)C5=CC=CC=C5N2C)C(C)CO"
        },
        "molecularFormula": "C35H41N3O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:57:09Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8604"
    },
    "name": "BRD-K13060097",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8604.png",
    "lincs": {
      "id": "LSM-9210",
      "name": "BRD-K13060097",
      "pubchemCid": 54637808,
      "chebiId": 97831,
      "inchiParent": "InChI=1S/C31H35N3O6/c1-20-15-34(21(2)17-35)30(36)26-11-7-6-10-25(26)24-9-5-4-8-22(24)18-38-29(20)16-33(3)31(37)32-23-12-13-27-28(14-23)40-19-39-27/h4-14,20-21,29,35H,15-19H2,1-3H3,(H,32,37)/t20-,21-,29-/m1/s1",
      "inchiKeyParent": "APWUXYFXBMGRIO-GVNDJSPXSA-N",
      "smilesParent": "C[C@H](CO)N1C[C@@H](C)[C@@H](CN(C)C(=O)Nc2ccc3OCOc3c2)OCc4ccccc4c5ccccc5C1=O"
    },
    "unichem": {
      "chebi": "97831",
      "lincs": "LSM-9210",
      "pubchem": "54637808"
    },
    "pubchem": [
      {
        "cid": 54637808,
        "inchi": "InChI=1S/C31H35N3O6/c1-20-15-34(21(2)17-35)30(36)26-11-7-6-10-25(26)24-9-5-4-8-22(24)18-38-29(20)16-33(3)31(37)32-23-12-13-27-28(14-23)40-19-39-27/h4-14,20-21,29,35H,15-19H2,1-3H3,(H,32,37)/t20-,21-,29-/m1/s1",
        "inchikey": "APWUXYFXBMGRIO-GVNDJSPXSA-N",
        "iupac": {
          "systematic": "3-(1,3-benzodioxol-5-yl)-1-[[(10S,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methylurea"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=CC=CC=C2C3=CC=CC=C3COC1CN(C)C(=O)NC4=CC5=C(C=C4)OCO5)C(C)CO"
        },
        "molecularFormula": "C31H35N3O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:57:11Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8637"
    },
    "name": "BRD-K16009699",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8637.png",
    "lincs": {
      "id": "LSM-9390",
      "name": "BRD-K16009699",
      "pubchemCid": 54660865,
      "chebiId": 98011,
      "inchiParent": "InChI=1S/C24H29N3O6S/c1-33-20-6-4-3-5-15(20)16-9-10-19-21-17(12-26(19)24(16)30)18(13-28)22(27(21)34(2,31)32)23(29)25-11-14-7-8-14/h3-6,9-10,14,17-18,21-22,28H,7-8,11-13H2,1-2H3,(H,25,29)/t17-,18-,21+,22-/m0/s1",
      "inchiKeyParent": "WJZKQLYLFQXOJV-HXHBTQRASA-N",
      "smilesParent": "COc1ccccc1C2=CC=C3[C@H]4[C@@H](CN3C2=O)[C@H](CO)[C@H](N4S(=O)(=O)C)C(=O)NCC5CC5"
    },
    "unichem": {
      "chebi": "98011",
      "lincs": "LSM-9390",
      "pubchem": "54660865"
    },
    "pubchem": [
      {
        "cid": 54660865,
        "inchi": "InChI=1S/C24H29N3O6S/c1-33-20-6-4-3-5-15(20)16-9-10-19-21-17(12-26(19)24(16)30)18(13-28)22(27(21)34(2,31)32)23(29)25-11-14-7-8-14/h3-6,9-10,14,17-18,21-22,28H,7-8,11-13H2,1-2H3,(H,25,29)/t17-,18-,21+,22-/m0/s1",
        "inchikey": "WJZKQLYLFQXOJV-HXHBTQRASA-N",
        "iupac": {
          "systematic": "(2S,3S,3aR,9bR)-N-(cyclopropylmethyl)-3-(hydroxymethyl)-7-(2-methoxyphenyl)-1-methylsulfonyl-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide"
        },
        "smiles": {
          "canonical": "COC1=CC=CC=C1C2=CC=C3C4C(CN3C2=O)C(C(N4S(=O)(=O)C)C(=O)NCC5CC5)CO"
        },
        "molecularFormula": "C24H29N3O6S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:57:13Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85b8"
    },
    "name": "BRD-K96157570",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85b8.png",
    "lincs": {
      "id": "LSM-15002",
      "name": "BRD-K96157570",
      "pubchemCid": 44493596,
      "chebiId": 103658,
      "inchiParent": "InChI=1S/C33H49N5O6/c1-22(2)34-33(42)37(6)20-30-23(3)19-38(24(4)21-39)31(40)28-18-27(36-32(41)35-26-13-8-7-9-14-26)15-16-29(28)44-25(5)12-10-11-17-43-30/h7-9,13-16,18,22-25,30,39H,10-12,17,19-21H2,1-6H3,(H,34,42)(H2,35,36,41)/t23-,24+,25+,30-/m1/s1",
      "inchiKeyParent": "YYAGCQUXHYGTOT-UBRKHCEVSA-N",
      "smilesParent": "CC(C)NC(=O)N(C)C[C@H]1OCCCC[C@H](C)Oc2ccc(NC(=O)Nc3ccccc3)cc2C(=O)N(C[C@H]1C)[C@@H](C)CO"
    },
    "unichem": {
      "chebi": "103658",
      "lincs": "LSM-15002",
      "pubchem": "44493596"
    },
    "pubchem": [
      {
        "cid": 44493596,
        "inchi": "InChI=1S/C33H49N5O6/c1-22(2)34-33(42)37(6)20-30-23(3)19-38(24(4)21-39)31(40)28-18-27(36-32(41)35-26-13-8-7-9-14-26)15-16-29(28)44-25(5)12-10-11-17-43-30/h7-9,13-16,18,22-25,30,39H,10-12,17,19-21H2,1-6H3,(H,34,42)(H2,35,36,41)/t23-,24+,25+,30-/m1/s1",
        "inchikey": "YYAGCQUXHYGTOT-UBRKHCEVSA-N",
        "iupac": {
          "systematic": "1-[[(3S,9S,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-(phenylcarbamoylamino)-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-propan-2-ylurea"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NC(=O)NC3=CC=CC=C3)C(C)CO)C)CN(C)C(=O)NC(C)C"
        },
        "molecularFormula": "C33H49N5O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:57:16Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85d5"
    },
    "name": "BRD-K67829818",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85d5.png",
    "lincs": {
      "id": "LSM-14902",
      "name": "BRD-K67829818",
      "pubchemCid": 44503657,
      "chebiId": 103558,
      "inchiParent": "InChI=1S/C33H54N4O6/c1-22(2)34-33(41)36(6)20-30-23(3)19-37(24(4)21-38)32(40)28-18-27(35-31(39)26-13-8-7-9-14-26)15-16-29(28)43-25(5)12-10-11-17-42-30/h15-16,18,22-26,30,38H,7-14,17,19-21H2,1-6H3,(H,34,41)(H,35,39)/t23-,24+,25+,30-/m0/s1",
      "inchiKeyParent": "PLFJTCJSGHSPAZ-RPQPUBLWSA-N",
      "smilesParent": "CC(C)NC(=O)N(C)C[C@@H]1OCCCC[C@@H](C)Oc2ccc(NC(=O)C3CCCCC3)cc2C(=O)N(C[C@@H]1C)[C@H](C)CO"
    },
    "unichem": {
      "chebi": "103558",
      "lincs": "LSM-14902",
      "pubchem": "44503657"
    },
    "pubchem": [
      {
        "cid": 44503657,
        "inchi": "InChI=1S/C33H54N4O6/c1-22(2)34-33(41)36(6)20-30-23(3)19-37(24(4)21-38)32(40)28-18-27(35-31(39)26-13-8-7-9-14-26)15-16-29(28)43-25(5)12-10-11-17-42-30/h15-16,18,22-26,30,38H,7-14,17,19-21H2,1-6H3,(H,34,41)(H,35,39)/t23-,24+,25+,30-/m0/s1",
        "inchikey": "PLFJTCJSGHSPAZ-RPQPUBLWSA-N",
        "iupac": {
          "systematic": "N-[(3R,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(propan-2-ylcarbamoyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]cyclohexanecarboxamide"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NC(=O)C3CCCCC3)C(C)CO)C)CN(C)C(=O)NC(C)C"
        },
        "molecularFormula": "C33H54N4O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:57:18Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85ec"
    },
    "name": "BRD-K13137954",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85ec.png",
    "lincs": {
      "id": "LSM-9217",
      "name": "BRD-K13137954",
      "pubchemCid": 54646522,
      "chebiId": 97838,
      "inchiParent": "InChI=1S/C27H31N3O7/c1-29-6-8-30(9-7-29)25(32)13-18-12-20-19-11-17(3-5-21(19)37-26(20)24(14-31)36-18)28-27(33)16-2-4-22-23(10-16)35-15-34-22/h2-5,10-11,18,20,24,26,31H,6-9,12-15H2,1H3,(H,28,33)/t18-,20-,24-,26+/m1/s1",
      "inchiKeyParent": "WXTNJIBEBHTDAA-FNVZBELISA-N",
      "smilesParent": "CN1CCN(CC1)C(=O)C[C@H]2C[C@H]3[C@H](Oc4ccc(NC(=O)c5ccc6OCOc6c5)cc34)[C@@H](CO)O2"
    },
    "unichem": {
      "chebi": "97838",
      "lincs": "LSM-9217",
      "pubchem": "54646522"
    },
    "pubchem": [
      {
        "cid": 54646522,
        "inchi": "InChI=1S/C27H31N3O7/c1-29-6-8-30(9-7-29)25(32)13-18-12-20-19-11-17(3-5-21(19)37-26(20)24(14-31)36-18)28-27(33)16-2-4-22-23(10-16)35-15-34-22/h2-5,10-11,18,20,24,26,31H,6-9,12-15H2,1H3,(H,28,33)/t18-,20-,24-,26+/m1/s1",
        "inchikey": "WXTNJIBEBHTDAA-FNVZBELISA-N",
        "iupac": {
          "systematic": "N-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-(4-methylpiperazin-1-yl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide"
        },
        "smiles": {
          "canonical": "CN1CCN(CC1)C(=O)CC2CC3C(C(O2)CO)OC4=C3C=C(C=C4)NC(=O)C5=CC6=C(C=C5)OCO6"
        },
        "molecularFormula": "C27H31N3O7"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:57:20Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8623"
    },
    "name": "BRD-K30684242",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8623.png",
    "lincs": {
      "id": "LSM-10273",
      "name": "BRD-K30684242",
      "pubchemCid": 54657646,
      "chebiId": 98894,
      "inchiParent": "InChI=1S/C24H34N4O7/c1-26-6-8-27(9-7-26)23(30)11-18-3-4-19-22(35-18)14-32-13-17(29)12-28(19)24(31)25-16-2-5-20-21(10-16)34-15-33-20/h2,5,10,17-19,22,29H,3-4,6-9,11-15H2,1H3,(H,25,31)/t17-,18+,19+,22-/m0/s1",
      "inchiKeyParent": "QICYWJCDSALLPT-JYLXEMOASA-N",
      "smilesParent": "CN1CCN(CC1)C(=O)C[C@H]2CC[C@@H]3[C@H](COC[C@@H](O)CN3C(=O)Nc4ccc5OCOc5c4)O2"
    },
    "unichem": {
      "chebi": "98894",
      "lincs": "LSM-10273",
      "pubchem": "54657646"
    },
    "pubchem": [
      {
        "cid": 54657646,
        "inchi": "InChI=1S/C24H34N4O7/c1-26-6-8-27(9-7-26)23(30)11-18-3-4-19-22(35-18)14-32-13-17(29)12-28(19)24(31)25-16-2-5-20-21(10-16)34-15-33-20/h2,5,10,17-19,22,29H,3-4,6-9,11-15H2,1H3,(H,25,31)/t17-,18+,19+,22-/m0/s1",
        "inchikey": "QICYWJCDSALLPT-JYLXEMOASA-N",
        "iupac": {
          "systematic": "(3S,6aR,8R,10aR)-N-(1,3-benzodioxol-5-yl)-3-hydroxy-8-[2-(4-methylpiperazin-1-yl)-2-oxoethyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide"
        },
        "smiles": {
          "canonical": "CN1CCN(CC1)C(=O)CC2CCC3C(O2)COCC(CN3C(=O)NC4=CC5=C(C=C4)OCO5)O"
        },
        "molecularFormula": "C24H34N4O7"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:57:22Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c864d"
    },
    "name": "BRD-K19882533",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c864d.png",
    "lincs": {
      "id": "LSM-9632",
      "name": "BRD-K19882533",
      "pubchemCid": 54660841,
      "chebiId": 98253,
      "inchiParent": "InChI=1S/C27H33N3O5/c1-34-23-5-3-2-4-18(23)19-8-9-21-25-24(27(33)28-10-12-35-13-11-28)20(16-31)22(15-30(21)26(19)32)29(25)14-17-6-7-17/h2-5,8-9,17,20,22,24-25,31H,6-7,10-16H2,1H3/t20-,22-,24+,25+/m1/s1",
      "inchiKeyParent": "ZZGFZYXZJHIJMZ-KAKDDGLXSA-N",
      "smilesParent": "COc1ccccc1C2=CC=C3[C@H]4[C@H]([C@H](CO)[C@@H](CN3C2=O)N4CC5CC5)C(=O)N6CCOCC6"
    },
    "unichem": {
      "chebi": "98253",
      "lincs": "LSM-9632",
      "pubchem": "54660841"
    },
    "pubchem": [
      {
        "cid": 54660841,
        "inchi": "InChI=1S/C27H33N3O5/c1-34-23-5-3-2-4-18(23)19-8-9-21-25-24(27(33)28-10-12-35-13-11-28)20(16-31)22(15-30(21)26(19)32)29(25)14-17-6-7-17/h2-5,8-9,17,20,22,24-25,31H,6-7,10-16H2,1H3/t20-,22-,24+,25+/m1/s1",
        "inchikey": "ZZGFZYXZJHIJMZ-KAKDDGLXSA-N",
        "iupac": {
          "systematic": "(1R,9S,10S,11S)-12-(cyclopropylmethyl)-10-(hydroxymethyl)-5-(2-methoxyphenyl)-11-(morpholine-4-carbonyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-dien-6-one"
        },
        "smiles": {
          "canonical": "COC1=CC=CC=C1C2=CC=C3C4C(C(C(N4CC5CC5)CN3C2=O)CO)C(=O)N6CCOCC6"
        },
        "molecularFormula": "C27H33N3O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:57:25Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84f7"
    },
    "name": "BRD-K74341727",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84f7.png",
    "lincs": {
      "id": "LSM-12980",
      "name": "BRD-K74341727",
      "pubchemCid": 54657655,
      "chebiId": 101617,
      "inchiParent": "InChI=1S/C26H32FN3O6/c1-34-23-5-3-2-4-17(23)13-28-25(32)12-21-10-11-22-24(36-21)16-35-15-20(31)14-30(22)26(33)29-19-8-6-18(27)7-9-19/h2-9,20-22,24,31H,10-16H2,1H3,(H,28,32)(H,29,33)/t20-,21-,22+,24-/m0/s1",
      "inchiKeyParent": "ADXBMBRYFBFALA-YCSHWKNNSA-N",
      "smilesParent": "COc1ccccc1CNC(=O)C[C@@H]2CC[C@@H]3[C@H](COC[C@@H](O)CN3C(=O)Nc4ccc(F)cc4)O2"
    },
    "unichem": {
      "chebi": "101617",
      "lincs": "LSM-12980",
      "pubchem": "54657655"
    },
    "pubchem": [
      {
        "cid": 54657655,
        "inchi": "InChI=1S/C26H32FN3O6/c1-34-23-5-3-2-4-17(23)13-28-25(32)12-21-10-11-22-24(36-21)16-35-15-20(31)14-30(22)26(33)29-19-8-6-18(27)7-9-19/h2-9,20-22,24,31H,10-16H2,1H3,(H,28,32)(H,29,33)/t20-,21-,22+,24-/m0/s1",
        "inchikey": "ADXBMBRYFBFALA-YCSHWKNNSA-N",
        "iupac": {
          "systematic": "(3S,6aR,8S,10aR)-N-(4-fluorophenyl)-3-hydroxy-8-[2-[(2-methoxyphenyl)methylamino]-2-oxoethyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide"
        },
        "smiles": {
          "canonical": "COC1=CC=CC=C1CNC(=O)CC2CCC3C(O2)COCC(CN3C(=O)NC4=CC=C(C=C4)F)O"
        },
        "molecularFormula": "C26H32FN3O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:57:27Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84f9"
    },
    "name": "BRD-K31633278",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84f9.png",
    "lincs": {
      "id": "LSM-38995",
      "name": "BRD-K31633278",
      "pubchemCid": 60189773,
      "chebiId": 127437,
      "inchiParent": "InChI=1S/C27H31N5O2S/c1-34-20-4-5-21-22(13-20)30-26-23(17-33)32(16-24-29-9-12-35-24)18-27(25(21)26)6-10-31(11-7-27)15-19-3-2-8-28-14-19/h2-5,8-9,12-14,23,30,33H,6-7,10-11,15-18H2,1H3/t23-/m0/s1",
      "inchiKeyParent": "DHJIUPKAKMQMKH-QHCPKHFHSA-N",
      "smilesParent": "COc1ccc2c3c([nH]c2c1)[C@H](CO)N(Cc4nccs4)CC35CCN(Cc6cccnc6)CC5"
    },
    "unichem": {
      "chebi": "127437",
      "lincs": "LSM-38995",
      "pubchem": "60189773"
    },
    "pubchem": [
      {
        "cid": 60189773,
        "inchi": "InChI=1S/C27H31N5O2S/c1-34-20-4-5-21-22(13-20)30-26-23(17-33)32(16-24-29-9-12-35-24)18-27(25(21)26)6-10-31(11-7-27)15-19-3-2-8-28-14-19/h2-5,8-9,12-14,23,30,33H,6-7,10-11,15-18H2,1H3/t23-/m0/s1",
        "inchikey": "DHJIUPKAKMQMKH-QHCPKHFHSA-N",
        "iupac": {
          "systematic": "[(1R)-7-methoxy-1'-(pyridin-3-ylmethyl)-2-(1,3-thiazol-2-ylmethyl)spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4'-piperidine]-1-yl]methanol"
        },
        "smiles": {
          "canonical": "COC1=CC2=C(C=C1)C3=C(N2)C(N(CC34CCN(CC4)CC5=CN=CC=C5)CC6=NC=CS6)CO"
        },
        "molecularFormula": "C27H31N5O2S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:57:29Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c850b"
    },
    "name": "BRD-K09388341",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c850b.png",
    "lincs": {
      "id": "LSM-8994",
      "name": "BRD-K09388341",
      "pubchemCid": 54657610,
      "chebiId": 97615,
      "inchiParent": "InChI=1S/C25H29ClF2N2O4/c26-18-3-1-16(2-4-18)11-29-25(32)10-21-6-8-23-24(34-21)15-33-14-20(31)13-30(23)12-17-9-19(27)5-7-22(17)28/h1-5,7,9,20-21,23-24,31H,6,8,10-15H2,(H,29,32)/t20-,21+,23+,24-/m0/s1",
      "inchiKeyParent": "VYCGBAYEGCCJIH-SCDRESIJSA-N",
      "smilesParent": "O[C@@H]1COC[C@@H]2O[C@@H](CC(=O)NCc3ccc(Cl)cc3)CC[C@H]2N(Cc4cc(F)ccc4F)C1"
    },
    "unichem": {
      "chebi": "97615",
      "lincs": "LSM-8994",
      "pubchem": "54657610"
    },
    "pubchem": [
      {
        "cid": 54657610,
        "inchi": "InChI=1S/C25H29ClF2N2O4/c26-18-3-1-16(2-4-18)11-29-25(32)10-21-6-8-23-24(34-21)15-33-14-20(31)13-30(23)12-17-9-19(27)5-7-22(17)28/h1-5,7,9,20-21,23-24,31H,6,8,10-15H2,(H,29,32)/t20-,21+,23+,24-/m0/s1",
        "inchikey": "VYCGBAYEGCCJIH-SCDRESIJSA-N",
        "iupac": {
          "systematic": "2-[(3S,6aR,8R,10aR)-1-[(2,5-difluorophenyl)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(4-chlorophenyl)methyl]acetamide"
        },
        "smiles": {
          "canonical": "C1CC2C(COCC(CN2CC3=C(C=CC(=C3)F)F)O)OC1CC(=O)NCC4=CC=C(C=C4)Cl"
        },
        "molecularFormula": "C25H29ClF2N2O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:57:31Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8527"
    },
    "name": "BRD-K62431786",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8527.png",
    "lincs": {
      "id": "LSM-14886",
      "name": "BRD-K62431786",
      "pubchemCid": 54615009,
      "chebiId": 103542,
      "inchiParent": "InChI=1S/C32H49N5O5/c1-22(2)34-32(40)35-27-10-11-29-28(17-27)31(39)37(24(4)21-38)18-23(3)30(41-16-8-7-9-25(5)42-29)20-36(6)19-26-12-14-33-15-13-26/h10-15,17,22-25,30,38H,7-9,16,18-21H2,1-6H3,(H2,34,35,40)/t23-,24+,25-,30-/m1/s1",
      "inchiKeyParent": "YBLKRDGTGIUFGT-FJRSXGRASA-N",
      "smilesParent": "CC(C)NC(=O)Nc1ccc2O[C@H](C)CCCCO[C@H](CN(C)Cc3ccncc3)[C@H](C)CN([C@@H](C)CO)C(=O)c2c1"
    },
    "unichem": {
      "chebi": "103542",
      "lincs": "LSM-14886",
      "pubchem": "54615009"
    },
    "pubchem": [
      {
        "cid": 54615009,
        "inchi": "InChI=1S/C32H49N5O5/c1-22(2)34-32(40)35-27-10-11-29-28(17-27)31(39)37(24(4)21-38)18-23(3)30(41-16-8-7-9-25(5)42-29)20-36(6)19-26-12-14-33-15-13-26/h10-15,17,22-25,30,38H,7-9,16,18-21H2,1-6H3,(H2,34,35,40)/t23-,24+,25-,30-/m1/s1",
        "inchikey": "YBLKRDGTGIUFGT-FJRSXGRASA-N",
        "iupac": {
          "systematic": "1-[(3R,9S,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-propan-2-ylurea"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NC(=O)NC(C)C)C(C)CO)C)CN(C)CC3=CC=NC=C3"
        },
        "molecularFormula": "C32H49N5O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:57:33Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8585"
    },
    "name": "SCHEMBL17783969",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8585.png",
    "lincs": {
      "id": "LSM-41670",
      "name": "SCHEMBL17783969",
      "alternativeNames": [
        "BRD-K80749795"
      ],
      "pubchemCid": 60189883,
      "chebiId": 130120,
      "inchiParent": "InChI=1S/C29H36ClN3O2/c1-31-25-15-23(35-2)9-10-24(25)27-28(31)26(18-34)33(17-21-5-7-22(30)8-6-21)19-29(27)11-13-32(14-12-29)16-20-3-4-20/h5-10,15,20,26,34H,3-4,11-14,16-19H2,1-2H3/t26-/m1/s1",
      "inchiKeyParent": "ZDPJGKQIQRRUQL-AREMUKBSSA-N",
      "smilesParent": "COc1ccc2c3c([C@@H](CO)N(Cc4ccc(Cl)cc4)CC35CCN(CC6CC6)CC5)n(C)c2c1"
    },
    "unichem": {
      "chebi": "130120",
      "chembl": "CHEMBL3561461",
      "lincs": "LSM-41670",
      "pubchem": "60189883"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL3561461",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 494.08,
        "hba": 5,
        "hbd": 1,
        "qedWeighted": 0.52
      }
    },
    "pubchem": [
      {
        "cid": 60189883,
        "inchi": "InChI=1S/C29H36ClN3O2/c1-31-25-15-23(35-2)9-10-24(25)27-28(31)26(18-34)33(17-21-5-7-22(30)8-6-21)19-29(27)11-13-32(14-12-29)16-20-3-4-20/h5-10,15,20,26,34H,3-4,11-14,16-19H2,1-2H3/t26-/m1/s1",
        "inchikey": "ZDPJGKQIQRRUQL-AREMUKBSSA-N",
        "iupac": {
          "systematic": "[(1S)-2-[(4-chlorophenyl)methyl]-1'-(cyclopropylmethyl)-7-methoxy-9-methylspiro[1,3-dihydropyrido[3,4-b]indole-4,4'-piperidine]-1-yl]methanol"
        },
        "smiles": {
          "canonical": "CN1C2=C(C=CC(=C2)OC)C3=C1C(N(CC34CCN(CC4)CC5CC5)CC6=CC=C(C=C6)Cl)CO"
        },
        "molecularFormula": "C29H36ClN3O2"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:57:45Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85ab"
    },
    "name": "BRD-K44413293",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85ab.png",
    "lincs": {
      "id": "LSM-39723",
      "name": "BRD-K44413293",
      "pubchemCid": 54652508,
      "chebiId": 128168,
      "inchiParent": "InChI=1S/C22H22ClN3O3/c23-14-7-9-15(10-8-14)24-22(29)25-11-18-20(16-3-1-2-4-17(16)25)19(12-27)26(18)21(28)13-5-6-13/h1-4,7-10,13,18-20,27H,5-6,11-12H2,(H,24,29)/t18-,19+,20+/m0/s1",
      "inchiKeyParent": "GOAOGPBEIKPTBG-XUVXKRRUSA-N",
      "smilesParent": "OC[C@@H]1[C@H]2[C@H](CN(C(=O)Nc3ccc(Cl)cc3)c4ccccc24)N1C(=O)C5CC5"
    },
    "unichem": {
      "chebi": "128168",
      "lincs": "LSM-39723",
      "pubchem": "54652508"
    },
    "pubchem": [
      {
        "cid": 54652508,
        "inchi": "InChI=1S/C22H22ClN3O3/c23-14-7-9-15(10-8-14)24-22(29)25-11-18-20(16-3-1-2-4-17(16)25)19(12-27)26(18)21(28)13-5-6-13/h1-4,7-10,13,18-20,27H,5-6,11-12H2,(H,24,29)/t18-,19+,20+/m0/s1",
        "inchikey": "GOAOGPBEIKPTBG-XUVXKRRUSA-N",
        "iupac": {
          "systematic": "(1S,2aR,8bR)-N-(4-chlorophenyl)-2-(cyclopropanecarbonyl)-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide"
        },
        "smiles": {
          "canonical": "C1CC1C(=O)N2C3CN(C4=CC=CC=C4C3C2CO)C(=O)NC5=CC=C(C=C5)Cl"
        },
        "molecularFormula": "C22H22ClN3O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:57:47Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8601"
    },
    "name": "BRD-K68630394",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8601.png",
    "lincs": {
      "id": "LSM-40997",
      "name": "BRD-K68630394",
      "pubchemCid": 44616955,
      "chebiId": 129446,
      "inchiParent": "InChI=1S/C33H48N4O5/c1-23-19-37(24(2)22-38)32(39)29-18-28(35-33(40)34-27-11-6-5-7-12-27)15-16-30(29)42-25(3)10-8-9-17-41-31(23)21-36(4)20-26-13-14-26/h5-7,11-12,15-16,18,23-26,31,38H,8-10,13-14,17,19-22H2,1-4H3,(H2,34,35,40)/t23-,24+,25+,31+/m0/s1",
      "inchiKeyParent": "WSGOBIVUANXEAU-DTTPJGKXSA-N",
      "smilesParent": "C[C@H](CO)N1C[C@H](C)[C@@H](CN(C)CC2CC2)OCCCC[C@@H](C)Oc3ccc(NC(=O)Nc4ccccc4)cc3C1=O"
    },
    "unichem": {
      "chebi": "129446",
      "lincs": "LSM-40997",
      "pubchem": "44616955"
    },
    "pubchem": [
      {
        "cid": 44616955,
        "inchi": "InChI=1S/C33H48N4O5/c1-23-19-37(24(2)22-38)32(39)29-18-28(35-33(40)34-27-11-6-5-7-12-27)15-16-30(29)42-25(3)10-8-9-17-41-31(23)21-36(4)20-26-13-14-26/h5-7,11-12,15-16,18,23-26,31,38H,8-10,13-14,17,19-22H2,1-4H3,(H2,34,35,40)/t23-,24+,25+,31+/m0/s1",
        "inchikey": "WSGOBIVUANXEAU-DTTPJGKXSA-N",
        "iupac": {
          "systematic": "1-[(3R,9S,10S)-9-[[cyclopropylmethyl(methyl)amino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-phenylurea"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NC(=O)NC3=CC=CC=C3)C(C)CO)C)CN(C)CC4CC4"
        },
        "molecularFormula": "C33H48N4O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:57:49Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8649"
    },
    "name": "BRD-K88899793",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8649.png",
    "lincs": {
      "id": "LSM-42115",
      "name": "BRD-K88899793",
      "pubchemCid": 60189730,
      "chebiId": 130566,
      "inchiParent": "InChI=1S/C27H32ClN3O3/c1-3-24(33)31-17-27(10-12-30(13-11-27)15-18-6-4-5-7-21(18)28)25-20-9-8-19(34-2)14-22(20)29-26(25)23(31)16-32/h4-9,14,23,29,32H,3,10-13,15-17H2,1-2H3/t23-/m1/s1",
      "inchiKeyParent": "OHNLIOCTEKXPSN-HSZRJFAPSA-N",
      "smilesParent": "CCC(=O)N1CC2(CCN(Cc3ccccc3Cl)CC2)c4c([nH]c5cc(OC)ccc45)[C@H]1CO"
    },
    "unichem": {
      "chebi": "130566",
      "lincs": "LSM-42115",
      "pubchem": "60189730"
    },
    "pubchem": [
      {
        "cid": 60189730,
        "inchi": "InChI=1S/C27H32ClN3O3/c1-3-24(33)31-17-27(10-12-30(13-11-27)15-18-6-4-5-7-21(18)28)25-20-9-8-19(34-2)14-22(20)29-26(25)23(31)16-32/h4-9,14,23,29,32H,3,10-13,15-17H2,1-2H3/t23-/m1/s1",
        "inchikey": "OHNLIOCTEKXPSN-HSZRJFAPSA-N",
        "iupac": {
          "systematic": "1-[(1S)-1'-[(2-chlorophenyl)methyl]-1-(hydroxymethyl)-7-methoxyspiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4'-piperidine]-2-yl]propan-1-one"
        },
        "smiles": {
          "canonical": "CCC(=O)N1CC2(CCN(CC2)CC3=CC=CC=C3Cl)C4=C(C1CO)NC5=C4C=CC(=C5)OC"
        },
        "molecularFormula": "C27H32ClN3O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:57:51Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8534"
    },
    "name": "BRD-K38986089",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8534.png",
    "lincs": {
      "id": "LSM-14809",
      "name": "BRD-K38986089",
      "pubchemCid": 44487442,
      "chebiId": 103465,
      "inchiParent": "InChI=1S/C35H47N5O5/c1-25-21-40(26(2)24-41)34(42)31-20-30(38-35(43)37-29-11-6-5-7-12-29)13-14-32(31)45-27(3)10-8-9-19-44-33(25)23-39(4)22-28-15-17-36-18-16-28/h5-7,11-18,20,25-27,33,41H,8-10,19,21-24H2,1-4H3,(H2,37,38,43)/t25-,26-,27+,33+/m0/s1",
      "inchiKeyParent": "LMYACBAJSFEPOG-SQQWPVGBSA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@H](C)[C@@H](CN(C)Cc2ccncc2)OCCCC[C@@H](C)Oc3ccc(NC(=O)Nc4ccccc4)cc3C1=O"
    },
    "unichem": {
      "chebi": "103465",
      "lincs": "LSM-14809",
      "pubchem": "44487442"
    },
    "pubchem": [
      {
        "cid": 44487442,
        "inchi": "InChI=1S/C35H47N5O5/c1-25-21-40(26(2)24-41)34(42)31-20-30(38-35(43)37-29-11-6-5-7-12-29)13-14-32(31)45-27(3)10-8-9-19-44-33(25)23-39(4)22-28-15-17-36-18-16-28/h5-7,11-18,20,25-27,33,41H,8-10,19,21-24H2,1-4H3,(H2,37,38,43)/t25-,26-,27+,33+/m0/s1",
        "inchikey": "LMYACBAJSFEPOG-SQQWPVGBSA-N",
        "iupac": {
          "systematic": "1-[(3R,9S,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-phenylurea"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NC(=O)NC3=CC=CC=C3)C(C)CO)C)CN(C)CC4=CC=NC=C4"
        },
        "molecularFormula": "C35H47N5O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:57:54Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85c6"
    },
    "name": "BRD-K01739339",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85c6.png",
    "lincs": {
      "id": "LSM-14679",
      "name": "BRD-K01739339",
      "pubchemCid": 54614998,
      "chebiId": 103335,
      "inchiParent": "InChI=1S/C30H47F3N4O6/c1-19(2)34-29(41)35-23-10-11-25-24(15-23)28(40)37(21(4)18-38)16-20(3)26(42-14-8-7-9-22(5)43-25)17-36(6)27(39)12-13-30(31,32)33/h10-11,15,19-22,26,38H,7-9,12-14,16-18H2,1-6H3,(H2,34,35,41)/t20-,21+,22+,26-/m1/s1",
      "inchiKeyParent": "NPRRWKGRZALGNG-FYBXHKAZSA-N",
      "smilesParent": "CC(C)NC(=O)Nc1ccc2O[C@@H](C)CCCCO[C@H](CN(C)C(=O)CCC(F)(F)F)[C@H](C)CN([C@@H](C)CO)C(=O)c2c1"
    },
    "unichem": {
      "chebi": "103335",
      "lincs": "LSM-14679",
      "pubchem": "54614998"
    },
    "pubchem": [
      {
        "cid": 54614998,
        "inchi": "InChI=1S/C30H47F3N4O6/c1-19(2)34-29(41)35-23-10-11-25-24(15-23)28(40)37(21(4)18-38)16-20(3)26(42-14-8-7-9-22(5)43-25)17-36(6)27(39)12-13-30(31,32)33/h10-11,15,19-22,26,38H,7-9,12-14,16-18H2,1-6H3,(H2,34,35,41)/t20-,21+,22+,26-/m1/s1",
        "inchikey": "NPRRWKGRZALGNG-FYBXHKAZSA-N",
        "iupac": {
          "systematic": "4,4,4-trifluoro-N-[[(3S,9S,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-(propan-2-ylcarbamoylamino)-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methylbutanamide"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NC(=O)NC(C)C)C(C)CO)C)CN(C)C(=O)CCC(F)(F)F"
        },
        "molecularFormula": "C30H47F3N4O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:57:56Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85cd"
    },
    "name": "BRD-K88821227",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85cd.png",
    "lincs": {
      "id": "LSM-13887",
      "name": "BRD-K88821227",
      "pubchemCid": 54657510,
      "chebiId": 102540,
      "inchiParent": "InChI=1S/C25H32F3N5O5/c1-32-11-18(30-15-32)8-9-29-23(35)10-20-6-7-21-22(38-20)14-37-13-19(34)12-33(21)24(36)31-17-4-2-16(3-5-17)25(26,27)28/h2-5,11,15,19-22,34H,6-10,12-14H2,1H3,(H,29,35)(H,31,36)/t19-,20+,21+,22-/m1/s1",
      "inchiKeyParent": "TWGHTEGHSVIJBR-CLAROIROSA-N",
      "smilesParent": "Cn1cnc(CCNC(=O)C[C@@H]2CC[C@H]3[C@@H](COC[C@H](O)CN3C(=O)Nc4ccc(cc4)C(F)(F)F)O2)c1"
    },
    "unichem": {
      "chebi": "102540",
      "lincs": "LSM-13887",
      "pubchem": "54657510"
    },
    "pubchem": [
      {
        "cid": 54657510,
        "inchi": "InChI=1S/C25H32F3N5O5/c1-32-11-18(30-15-32)8-9-29-23(35)10-20-6-7-21-22(38-20)14-37-13-19(34)12-33(21)24(36)31-17-4-2-16(3-5-17)25(26,27)28/h2-5,11,15,19-22,34H,6-10,12-14H2,1H3,(H,29,35)(H,31,36)/t19-,20+,21+,22-/m1/s1",
        "inchikey": "TWGHTEGHSVIJBR-CLAROIROSA-N",
        "iupac": {
          "systematic": "(3R,6aS,8S,10aS)-3-hydroxy-8-[2-[2-(1-methylimidazol-4-yl)ethylamino]-2-oxoethyl]-N-[4-(trifluoromethyl)phenyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide"
        },
        "smiles": {
          "canonical": "CN1C=C(N=C1)CCNC(=O)CC2CCC3C(O2)COCC(CN3C(=O)NC4=CC=C(C=C4)C(F)(F)F)O"
        },
        "molecularFormula": "C25H32F3N5O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:57:58Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84fb"
    },
    "name": "BRD-K56731825",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84fb.png",
    "lincs": {
      "id": "LSM-11857",
      "name": "BRD-K56731825",
      "pubchemCid": 54654552,
      "chebiId": 100483,
      "inchiParent": "InChI=1S/C25H28FN3O5/c1-28(2)23(30)13-18-9-10-20-22(34-18)14-33-21-11-8-17(12-19(21)25(32)29(20)3)27-24(31)15-4-6-16(26)7-5-15/h4-8,11-12,18,20,22H,9-10,13-14H2,1-3H3,(H,27,31)/t18-,20-,22+/m0/s1",
      "inchiKeyParent": "VIDGDBZXEWMIQL-RCZSKKKRSA-N",
      "smilesParent": "CN(C)C(=O)C[C@@H]1CC[C@H]2[C@@H](COc3ccc(NC(=O)c4ccc(F)cc4)cc3C(=O)N2C)O1"
    },
    "unichem": {
      "chebi": "100483",
      "lincs": "LSM-11857",
      "pubchem": "54654552"
    },
    "pubchem": [
      {
        "cid": 54654552,
        "inchi": "InChI=1S/C25H28FN3O5/c1-28(2)23(30)13-18-9-10-20-22(34-18)14-33-21-11-8-17(12-19(21)25(32)29(20)3)27-24(31)15-4-6-16(26)7-5-15/h4-8,11-12,18,20,22H,9-10,13-14H2,1-3H3,(H,27,31)/t18-,20-,22+/m0/s1",
        "inchikey": "VIDGDBZXEWMIQL-RCZSKKKRSA-N",
        "iupac": {
          "systematic": "N-[(2S,4aS,12aS)-2-[2-(dimethylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-fluorobenzamide"
        },
        "smiles": {
          "canonical": "CN1C2CCC(OC2COC3=C(C1=O)C=C(C=C3)NC(=O)C4=CC=C(C=C4)F)CC(=O)N(C)C"
        },
        "molecularFormula": "C25H28FN3O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:58:01Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8504"
    },
    "name": "BRD-K85411199",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8504.png",
    "lincs": {
      "id": "LSM-41931",
      "name": "BRD-K85411199",
      "pubchemCid": 60185211,
      "chebiId": 130382,
      "inchiParent": "InChI=1S/C27H28FN5O3S/c1-31-21-11-19(36-2)6-7-20(21)24-25(31)22(13-34)33(26(35)30-18-5-3-4-17(28)10-18)16-27(24)14-32(15-27)12-23-29-8-9-37-23/h3-11,22,34H,12-16H2,1-2H3,(H,30,35)/t22-/m0/s1",
      "inchiKeyParent": "HAMKAMUMLNLHFC-QFIPXVFZSA-N",
      "smilesParent": "COc1ccc2c3c([C@H](CO)N(CC34CN(Cc5nccs5)C4)C(=O)Nc6cccc(F)c6)n(C)c2c1"
    },
    "unichem": {
      "chebi": "130382",
      "lincs": "LSM-41931",
      "pubchem": "60185211"
    },
    "pubchem": [
      {
        "cid": 60185211,
        "inchi": "InChI=1S/C27H28FN5O3S/c1-31-21-11-19(36-2)6-7-20(21)24-25(31)22(13-34)33(26(35)30-18-5-3-4-17(28)10-18)16-27(24)14-32(15-27)12-23-29-8-9-37-23/h3-11,22,34H,12-16H2,1-2H3,(H,30,35)/t22-/m0/s1",
        "inchikey": "HAMKAMUMLNLHFC-QFIPXVFZSA-N",
        "iupac": {
          "systematic": "(1R)-N-(3-fluorophenyl)-1-(hydroxymethyl)-7-methoxy-9-methyl-1'-(1,3-thiazol-2-ylmethyl)spiro[1,3-dihydropyrido[3,4-b]indole-4,3'-azetidine]-2-carboxamide"
        },
        "smiles": {
          "canonical": "CN1C2=C(C=CC(=C2)OC)C3=C1C(N(CC34CN(C4)CC5=NC=CS5)C(=O)NC6=CC(=CC=C6)F)CO"
        },
        "molecularFormula": "C27H28FN5O3S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:58:03Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8556"
    },
    "name": "BRD-K13275849",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8556.png",
    "lincs": {
      "id": "LSM-9225",
      "name": "BRD-K13275849",
      "pubchemCid": 54638872,
      "chebiId": 97846,
      "inchiParent": "InChI=1S/C19H33N3O5/c23-13-17-16(21-18(24)12-22-8-10-26-11-9-22)5-4-15(27-17)6-7-20-19(25)14-2-1-3-14/h14-17,23H,1-13H2,(H,20,25)(H,21,24)/t15-,16+,17-/m1/s1",
      "inchiKeyParent": "CARWJPWJJJMDHW-IXDOHACOSA-N",
      "smilesParent": "OC[C@H]1O[C@@H](CCNC(=O)C2CCC2)CC[C@@H]1NC(=O)CN3CCOCC3"
    },
    "unichem": {
      "chebi": "97846",
      "lincs": "LSM-9225",
      "pubchem": "54638872"
    },
    "pubchem": [
      {
        "cid": 54638872,
        "inchi": "InChI=1S/C19H33N3O5/c23-13-17-16(21-18(24)12-22-8-10-26-11-9-22)5-4-15(27-17)6-7-20-19(25)14-2-1-3-14/h14-17,23H,1-13H2,(H,20,25)(H,21,24)/t15-,16+,17-/m1/s1",
        "inchikey": "CARWJPWJJJMDHW-IXDOHACOSA-N",
        "iupac": {
          "systematic": "N-[2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[(2-morpholin-4-ylacetyl)amino]oxan-2-yl]ethyl]cyclobutanecarboxamide"
        },
        "smiles": {
          "canonical": "C1CC(C1)C(=O)NCCC2CCC(C(O2)CO)NC(=O)CN3CCOCC3"
        },
        "molecularFormula": "C19H33N3O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:58:05Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8566"
    },
    "name": "BRD-K78948132",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8566.png",
    "lincs": {
      "id": "LSM-13250",
      "name": "BRD-K78948132",
      "pubchemCid": 54646011,
      "chebiId": 101889,
      "inchiParent": "InChI=1S/C21H27NO7/c1-26-19(24)10-14-9-16-15-8-13(22-21(25)12-4-6-27-7-5-12)2-3-17(15)29-20(16)18(11-23)28-14/h2-3,8,12,14,16,18,20,23H,4-7,9-11H2,1H3,(H,22,25)/t14-,16+,18-,20-/m0/s1",
      "inchiKeyParent": "CYYYAXPAVULRAL-HUOQQOJOSA-N",
      "smilesParent": "COC(=O)C[C@@H]1C[C@H]2[C@H](Oc3ccc(NC(=O)C4CCOCC4)cc23)[C@H](CO)O1"
    },
    "unichem": {
      "chebi": "101889",
      "lincs": "LSM-13250",
      "pubchem": "54646011"
    },
    "pubchem": [
      {
        "cid": 54646011,
        "inchi": "InChI=1S/C21H27NO7/c1-26-19(24)10-14-9-16-15-8-13(22-21(25)12-4-6-27-7-5-12)2-3-17(15)29-20(16)18(11-23)28-14/h2-3,8,12,14,16,18,20,23H,4-7,9-11H2,1H3,(H,22,25)/t14-,16+,18-,20-/m0/s1",
        "inchikey": "CYYYAXPAVULRAL-HUOQQOJOSA-N",
        "iupac": {
          "systematic": "methyl 2-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-6-(oxane-4-carbonylamino)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]acetate"
        },
        "smiles": {
          "canonical": "COC(=O)CC1CC2C(C(O1)CO)OC3=C2C=C(C=C3)NC(=O)C4CCOCC4"
        },
        "molecularFormula": "C21H27NO7"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:58:08Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8568"
    },
    "name": "BRD-K84994827",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8568.png",
    "lincs": {
      "id": "LSM-13620",
      "name": "BRD-K84994827",
      "pubchemCid": 54646225,
      "chebiId": 102267,
      "inchiParent": "InChI=1S/C26H32N4O5/c31-15-23-25-21(12-19(34-23)13-24(32)28-14-16-7-9-27-10-8-16)20-11-18(5-6-22(20)35-25)30-26(33)29-17-3-1-2-4-17/h5-11,17,19,21,23,25,31H,1-4,12-15H2,(H,28,32)(H2,29,30,33)/t19-,21-,23-,25+/m1/s1",
      "inchiKeyParent": "CSQKNNUUWCECGY-YTAKYCMFSA-N",
      "smilesParent": "OC[C@H]1O[C@@H](CC(=O)NCc2ccncc2)C[C@H]3[C@@H]1Oc4ccc(NC(=O)NC5CCCC5)cc34"
    },
    "unichem": {
      "chebi": "102267",
      "lincs": "LSM-13620",
      "pubchem": "54646225"
    },
    "pubchem": [
      {
        "cid": 54646225,
        "inchi": "InChI=1S/C26H32N4O5/c31-15-23-25-21(12-19(34-23)13-24(32)28-14-16-7-9-27-10-8-16)20-11-18(5-6-22(20)35-25)30-26(33)29-17-3-1-2-4-17/h5-11,17,19,21,23,25,31H,1-4,12-15H2,(H,28,32)(H2,29,30,33)/t19-,21-,23-,25+/m1/s1",
        "inchikey": "CSQKNNUUWCECGY-YTAKYCMFSA-N",
        "iupac": {
          "systematic": "2-[(1R,3R,4aR,9aS)-6-(cyclopentylcarbamoylamino)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide"
        },
        "smiles": {
          "canonical": "C1CCC(C1)NC(=O)NC2=CC3=C(C=C2)OC4C3CC(OC4CO)CC(=O)NCC5=CC=NC=C5"
        },
        "molecularFormula": "C26H32N4O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:58:10Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8573"
    },
    "name": "BRD-K03601317",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8573.png",
    "lincs": {
      "id": "LSM-8654",
      "name": "BRD-K03601317",
      "pubchemCid": 54657980,
      "chebiId": 97275,
      "inchiParent": "InChI=1S/C31H37N3O5/c1-37-29-8-3-2-6-25(29)17-33-31(36)16-27-9-10-28-30(39-27)21-38-20-26(35)19-34(28)18-22-5-4-7-24(15-22)23-11-13-32-14-12-23/h2-8,11-15,26-28,30,35H,9-10,16-21H2,1H3,(H,33,36)/t26-,27+,28-,30+/m1/s1",
      "inchiKeyParent": "IQZRHVPMCXNVFS-UONLKORASA-N",
      "smilesParent": "COc1ccccc1CNC(=O)C[C@@H]2CC[C@@H]3[C@H](COC[C@H](O)CN3Cc4cccc(c4)c5ccncc5)O2"
    },
    "unichem": {
      "chebi": "97275",
      "lincs": "LSM-8654",
      "pubchem": "54657980"
    },
    "pubchem": [
      {
        "cid": 54657980,
        "inchi": "InChI=1S/C31H37N3O5/c1-37-29-8-3-2-6-25(29)17-33-31(36)16-27-9-10-28-30(39-27)21-38-20-26(35)19-34(28)18-22-5-4-7-24(15-22)23-11-13-32-14-12-23/h2-8,11-15,26-28,30,35H,9-10,16-21H2,1H3,(H,33,36)/t26-,27+,28-,30+/m1/s1",
        "inchikey": "IQZRHVPMCXNVFS-UONLKORASA-N",
        "iupac": {
          "systematic": "2-[(3R,6aR,8S,10aR)-3-hydroxy-1-[(3-pyridin-4-ylphenyl)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(2-methoxyphenyl)methyl]acetamide"
        },
        "smiles": {
          "canonical": "COC1=CC=CC=C1CNC(=O)CC2CCC3C(O2)COCC(CN3CC4=CC(=CC=C4)C5=CC=NC=C5)O"
        },
        "molecularFormula": "C31H37N3O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:58:12Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8598"
    },
    "name": "BRD-K79199685",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8598.png",
    "lincs": {
      "id": "LSM-13268",
      "name": "BRD-K79199685",
      "pubchemCid": 54657483,
      "chebiId": 101907,
      "inchiParent": "InChI=1S/C12H21NO5/c1-16-12(15)4-9-2-3-10-11(18-9)7-17-6-8(14)5-13-10/h8-11,13-14H,2-7H2,1H3/t8-,9-,10+,11-/m0/s1",
      "inchiKeyParent": "FKMAUGDURCCEJG-MMWGEVLESA-N",
      "smilesParent": "COC(=O)C[C@@H]1CC[C@H]2NC[C@H](O)COC[C@@H]2O1"
    },
    "unichem": {
      "chebi": "101907",
      "lincs": "LSM-13268",
      "pubchem": "54657483"
    },
    "pubchem": [
      {
        "cid": 54657483,
        "inchi": "InChI=1S/C12H21NO5/c1-16-12(15)4-9-2-3-10-11(18-9)7-17-6-8(14)5-13-10/h8-11,13-14H,2-7H2,1H3/t8-,9-,10+,11-/m0/s1",
        "inchikey": "FKMAUGDURCCEJG-MMWGEVLESA-N",
        "iupac": {
          "systematic": "methyl 2-[(3S,6aR,8S,10aR)-3-hydroxy-1,2,3,4,6,6a,8,9,10,10a-decahydropyrano[2,3-c][1,5]oxazocin-8-yl]acetate"
        },
        "smiles": {
          "canonical": "COC(=O)CC1CCC2C(O1)COCC(CN2)O"
        },
        "molecularFormula": "C12H21NO5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:58:15Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8600"
    },
    "name": "BRD-K74732057",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8600.png",
    "lincs": {
      "id": "LSM-13009",
      "name": "BRD-K74732057",
      "pubchemCid": 54661089,
      "chebiId": 101646,
      "inchiParent": "InChI=1S/C27H28FN3O3/c1-29(2)27(34)24-21(16-32)23-15-31-22(25(24)30(23)14-17-7-4-3-5-8-17)12-11-20(26(31)33)18-9-6-10-19(28)13-18/h3-13,21,23-25,32H,14-16H2,1-2H3/t21-,23-,24+,25+/m1/s1",
      "inchiKeyParent": "DPECORRGLVHITO-VGCGRUFVSA-N",
      "smilesParent": "CN(C)C(=O)[C@H]1[C@H](CO)[C@H]2CN3C(=CC=C(C3=O)c4cccc(F)c4)[C@@H]1N2Cc5ccccc5"
    },
    "unichem": {
      "chebi": "101646",
      "lincs": "LSM-13009",
      "pubchem": "54661089"
    },
    "pubchem": [
      {
        "cid": 54661089,
        "inchi": "InChI=1S/C27H28FN3O3/c1-29(2)27(34)24-21(16-32)23-15-31-22(25(24)30(23)14-17-7-4-3-5-8-17)12-11-20(26(31)33)18-9-6-10-19(28)13-18/h3-13,21,23-25,32H,14-16H2,1-2H3/t21-,23-,24+,25+/m1/s1",
        "inchikey": "DPECORRGLVHITO-VGCGRUFVSA-N",
        "iupac": {
          "systematic": "(1R,9S,10S,11S)-12-benzyl-5-(3-fluorophenyl)-10-(hydroxymethyl)-N,N-dimethyl-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide"
        },
        "smiles": {
          "canonical": "CN(C)C(=O)C1C(C2CN3C(=CC=C(C3=O)C4=CC(=CC=C4)F)C1N2CC5=CC=CC=C5)CO"
        },
        "molecularFormula": "C27H28FN3O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:58:17Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8620"
    },
    "name": "BRD-K95434676",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8620.png",
    "lincs": {
      "id": "LSM-42446",
      "name": "BRD-K95434676",
      "pubchemCid": 54651418,
      "chebiId": 130897,
      "inchiParent": "InChI=1S/C23H32N2O2/c1-16(27)25(13-17-5-4-6-17)14-21-23(22(15-26)24-21)20-11-9-19(10-12-20)18-7-2-3-8-18/h7,9-12,17,21-24,26H,2-6,8,13-15H2,1H3/t21-,22-,23-/m1/s1",
      "inchiKeyParent": "ROUZYGJQEJQROM-DNVJHFABSA-N",
      "smilesParent": "CC(=O)N(CC1CCC1)C[C@H]2N[C@H](CO)[C@@H]2c3ccc(cc3)C4=CCCC4"
    },
    "unichem": {
      "chebi": "130897",
      "lincs": "LSM-42446",
      "pubchem": "54651418"
    },
    "pubchem": [
      {
        "cid": 54651418,
        "inchi": "InChI=1S/C23H32N2O2/c1-16(27)25(13-17-5-4-6-17)14-21-23(22(15-26)24-21)20-11-9-19(10-12-20)18-7-2-3-8-18/h7,9-12,17,21-24,26H,2-6,8,13-15H2,1H3/t21-,22-,23-/m1/s1",
        "inchikey": "ROUZYGJQEJQROM-DNVJHFABSA-N",
        "iupac": {
          "systematic": "N-(cyclobutylmethyl)-N-[[(2S,3R,4S)-3-[4-(cyclopenten-1-yl)phenyl]-4-(hydroxymethyl)azetidin-2-yl]methyl]acetamide"
        },
        "smiles": {
          "canonical": "CC(=O)N(CC1CCC1)CC2C(C(N2)CO)C3=CC=C(C=C3)C4=CCCC4"
        },
        "molecularFormula": "C23H32N2O2"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:58:19Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c864c"
    },
    "name": "BRD-K80223377",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c864c.png",
    "lincs": {
      "id": "LSM-13330",
      "name": "BRD-K80223377",
      "pubchemCid": 54657530,
      "chebiId": 101969,
      "inchiParent": "InChI=1S/C26H33N5O5/c32-20-16-31(26(34)22-15-27-8-9-28-22)23-7-6-21(36-24(23)18-35-17-20)14-25(33)30-12-10-29(11-13-30)19-4-2-1-3-5-19/h1-5,8-9,15,20-21,23-24,32H,6-7,10-14,16-18H2/t20-,21-,23+,24-/m0/s1",
      "inchiKeyParent": "LCHNJAZNAXXEPD-ZQRMPTRQSA-N",
      "smilesParent": "O[C@@H]1COC[C@@H]2O[C@H](CC(=O)N3CCN(CC3)c4ccccc4)CC[C@H]2N(C1)C(=O)c5cnccn5"
    },
    "unichem": {
      "chebi": "101969",
      "lincs": "LSM-13330",
      "pubchem": "54657530"
    },
    "pubchem": [
      {
        "cid": 54657530,
        "inchi": "InChI=1S/C26H33N5O5/c32-20-16-31(26(34)22-15-27-8-9-28-22)23-7-6-21(36-24(23)18-35-17-20)14-25(33)30-12-10-29(11-13-30)19-4-2-1-3-5-19/h1-5,8-9,15,20-21,23-24,32H,6-7,10-14,16-18H2/t20-,21-,23+,24-/m0/s1",
        "inchikey": "LCHNJAZNAXXEPD-ZQRMPTRQSA-N",
        "iupac": {
          "systematic": "2-[(3S,6aR,8S,10aR)-3-hydroxy-1-(pyrazine-2-carbonyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(4-phenylpiperazin-1-yl)ethanone"
        },
        "smiles": {
          "canonical": "C1CC2C(COCC(CN2C(=O)C3=NC=CN=C3)O)OC1CC(=O)N4CCN(CC4)C5=CC=CC=C5"
        },
        "molecularFormula": "C26H33N5O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:58:21Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c864e"
    },
    "name": "BRD-K54168930",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c864e.png",
    "lincs": {
      "id": "LSM-40239",
      "name": "BRD-K54168930",
      "pubchemCid": 60191436,
      "chebiId": 128685,
      "inchiParent": "InChI=1S/C24H26N2O4/c1-30-19-10-8-16(9-11-19)15-2-4-17(5-3-15)23-20-12-25(24(29)18-6-7-18)13-22(28)26(20)21(23)14-27/h2-5,8-11,18,20-21,23,27H,6-7,12-14H2,1H3/t20-,21+,23+/m1/s1",
      "inchiKeyParent": "WAHANFXMDDRLLD-GIWBLDEGSA-N",
      "smilesParent": "COc1ccc(cc1)c2ccc(cc2)[C@@H]3[C@H](CO)N4[C@@H]3CN(CC4=O)C(=O)C5CC5"
    },
    "unichem": {
      "chebi": "128685",
      "lincs": "LSM-40239",
      "pubchem": "60191436"
    },
    "pubchem": [
      {
        "cid": 60191436,
        "inchi": "InChI=1S/C24H26N2O4/c1-30-19-10-8-16(9-11-19)15-2-4-17(5-3-15)23-20-12-25(24(29)18-6-7-18)13-22(28)26(20)21(23)14-27/h2-5,8-11,18,20-21,23,27H,6-7,12-14H2,1H3/t20-,21+,23+/m1/s1",
        "inchikey": "WAHANFXMDDRLLD-GIWBLDEGSA-N",
        "iupac": {
          "systematic": "(6S,7S,8R)-4-(cyclopropanecarbonyl)-8-(hydroxymethyl)-7-[4-(4-methoxyphenyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one"
        },
        "smiles": {
          "canonical": "COC1=CC=C(C=C1)C2=CC=C(C=C2)C3C4CN(CC(=O)N4C3CO)C(=O)C5CC5"
        },
        "molecularFormula": "C24H26N2O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:58:23Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8526"
    },
    "name": "BRD-K87838816",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8526.png",
    "lincs": {
      "id": "LSM-13815",
      "name": "BRD-K87838816",
      "pubchemCid": 54657639,
      "chebiId": 102464,
      "inchiParent": "InChI=1S/C21H29F3N2O4/c1-25(2)20(28)9-17-7-8-18-19(30-17)13-29-12-16(27)11-26(18)10-14-3-5-15(6-4-14)21(22,23)24/h3-6,16-19,27H,7-13H2,1-2H3/t16-,17-,18-,19+/m1/s1",
      "inchiKeyParent": "OUTWOBHUWTVFCP-MKXGPGLRSA-N",
      "smilesParent": "CN(C)C(=O)C[C@H]1CC[C@@H]2[C@H](COC[C@H](O)CN2Cc3ccc(cc3)C(F)(F)F)O1"
    },
    "unichem": {
      "chebi": "102464",
      "lincs": "LSM-13815",
      "pubchem": "54657639"
    },
    "pubchem": [
      {
        "cid": 54657639,
        "inchi": "InChI=1S/C21H29F3N2O4/c1-25(2)20(28)9-17-7-8-18-19(30-17)13-29-12-16(27)11-26(18)10-14-3-5-15(6-4-14)21(22,23)24/h3-6,16-19,27H,7-13H2,1-2H3/t16-,17-,18-,19+/m1/s1",
        "inchikey": "OUTWOBHUWTVFCP-MKXGPGLRSA-N",
        "iupac": {
          "systematic": "2-[(3R,6aR,8R,10aR)-3-hydroxy-1-[[4-(trifluoromethyl)phenyl]methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N,N-dimethylacetamide"
        },
        "smiles": {
          "canonical": "CN(C)C(=O)CC1CCC2C(O1)COCC(CN2CC3=CC=C(C=C3)C(F)(F)F)O"
        },
        "molecularFormula": "C21H29F3N2O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:58:26Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c855f"
    },
    "name": "BRD-K63376220",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c855f.png",
    "lincs": {
      "id": "LSM-12286",
      "name": "BRD-K63376220",
      "pubchemCid": 54638431,
      "chebiId": 100912,
      "inchiParent": "InChI=1S/C20H29N3O5/c1-23(2)12-20(26)22-16-9-8-15(28-18(16)13-24)10-19(25)21-11-14-6-4-5-7-17(14)27-3/h4-9,15-16,18,24H,10-13H2,1-3H3,(H,21,25)(H,22,26)/t15-,16+,18+/m0/s1",
      "inchiKeyParent": "YJKUDHPPBXQQCK-LZLYRXPVSA-N",
      "smilesParent": "COc1ccccc1CNC(=O)C[C@H]2O[C@H](CO)[C@H](NC(=O)CN(C)C)C=C2"
    },
    "unichem": {
      "chebi": "100912",
      "lincs": "LSM-12286",
      "pubchem": "54638431"
    },
    "pubchem": [
      {
        "cid": 54638431,
        "inchi": "InChI=1S/C20H29N3O5/c1-23(2)12-20(26)22-16-9-8-15(28-18(16)13-24)10-19(25)21-11-14-6-4-5-7-17(14)27-3/h4-9,15-16,18,24H,10-13H2,1-3H3,(H,21,25)(H,22,26)/t15-,16+,18+/m0/s1",
        "inchikey": "YJKUDHPPBXQQCK-LZLYRXPVSA-N",
        "iupac": {
          "systematic": "2-[(2S,3R,6R)-3-[[2-(dimethylamino)acetyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[(2-methoxyphenyl)methyl]acetamide"
        },
        "smiles": {
          "canonical": "CN(C)CC(=O)NC1C=CC(OC1CO)CC(=O)NCC2=CC=CC=C2OC"
        },
        "molecularFormula": "C20H29N3O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:58:28Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8563"
    },
    "name": "BRD-K86631008",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8563.png",
    "lincs": {
      "id": "LSM-13734",
      "name": "BRD-K86631008",
      "pubchemCid": 54645998,
      "chebiId": 102383,
      "inchiParent": "InChI=1S/C27H34N2O7S/c1-34-19-8-5-9-21(13-19)37(32,33)29-18-10-11-24-22(12-18)23-14-20(35-25(16-30)27(23)36-24)15-26(31)28-17-6-3-2-4-7-17/h5,8-13,17,20,23,25,27,29-30H,2-4,6-7,14-16H2,1H3,(H,28,31)/t20-,23+,25-,27-/m1/s1",
      "inchiKeyParent": "MPXYHEQTTLDTMZ-MBHFTIIHSA-N",
      "smilesParent": "COc1cccc(c1)S(=O)(=O)Nc2ccc3O[C@H]4[C@@H](CO)O[C@@H](CC(=O)NC5CCCCC5)C[C@H]4c3c2"
    },
    "unichem": {
      "chebi": "102383",
      "lincs": "LSM-13734",
      "pubchem": "54645998"
    },
    "pubchem": [
      {
        "cid": 54645998,
        "inchi": "InChI=1S/C27H34N2O7S/c1-34-19-8-5-9-21(13-19)37(32,33)29-18-10-11-24-22(12-18)23-14-20(35-25(16-30)27(23)36-24)15-26(31)28-17-6-3-2-4-7-17/h5,8-13,17,20,23,25,27,29-30H,2-4,6-7,14-16H2,1H3,(H,28,31)/t20-,23+,25-,27-/m1/s1",
        "inchikey": "MPXYHEQTTLDTMZ-MBHFTIIHSA-N",
        "iupac": {
          "systematic": "2-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-6-[(3-methoxyphenyl)sulfonylamino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-cyclohexylacetamide"
        },
        "smiles": {
          "canonical": "COC1=CC(=CC=C1)S(=O)(=O)NC2=CC3=C(C=C2)OC4C3CC(OC4CO)CC(=O)NC5CCCCC5"
        },
        "molecularFormula": "C27H34N2O7S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:58:30Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85a2"
    },
    "name": "BRD-K80563095",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85a2.png",
    "lincs": {
      "id": "LSM-13355",
      "name": "BRD-K80563095",
      "pubchemCid": 54654219,
      "chebiId": 101994,
      "inchiParent": "InChI=1S/C20H27N3O5/c1-4-21-19(25)10-14-6-7-16-18(28-14)11-27-17-8-5-13(22-12(2)24)9-15(17)20(26)23(16)3/h5,8-9,14,16,18H,4,6-7,10-11H2,1-3H3,(H,21,25)(H,22,24)/t14-,16+,18-/m0/s1",
      "inchiKeyParent": "WVVDCAKHEAPTNY-LESCRADOSA-N",
      "smilesParent": "CCNC(=O)C[C@@H]1CC[C@@H]2[C@H](COc3ccc(NC(=O)C)cc3C(=O)N2C)O1"
    },
    "unichem": {
      "chebi": "101994",
      "lincs": "LSM-13355",
      "pubchem": "54654219"
    },
    "pubchem": [
      {
        "cid": 54654219,
        "inchi": "InChI=1S/C20H27N3O5/c1-4-21-19(25)10-14-6-7-16-18(28-14)11-27-17-8-5-13(22-12(2)24)9-15(17)20(26)23(16)3/h5,8-9,14,16,18H,4,6-7,10-11H2,1-3H3,(H,21,25)(H,22,24)/t14-,16+,18-/m0/s1",
        "inchikey": "WVVDCAKHEAPTNY-LESCRADOSA-N",
        "iupac": {
          "systematic": "2-[(2S,4aR,12aR)-8-acetamido-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-ethylacetamide"
        },
        "smiles": {
          "canonical": "CCNC(=O)CC1CCC2C(O1)COC3=C(C=C(C=C3)NC(=O)C)C(=O)N2C"
        },
        "molecularFormula": "C20H27N3O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:58:32Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85e8"
    },
    "name": "BRD-K87850000",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85e8.png",
    "lincs": {
      "id": "LSM-13818",
      "name": "BRD-K87850000",
      "pubchemCid": 54646269,
      "chebiId": 102468,
      "inchiParent": "InChI=1S/C30H33N3O6/c1-37-22-10-7-20(8-11-22)32-30(36)33-21-9-12-26-24(15-21)25-16-23(38-27(18-34)29(25)39-26)17-28(35)31-14-13-19-5-3-2-4-6-19/h2-12,15,23,25,27,29,34H,13-14,16-18H2,1H3,(H,31,35)(H2,32,33,36)/t23-,25-,27-,29+/m1/s1",
      "inchiKeyParent": "FOSRSIPYUZSGIW-ACEYUQJJSA-N",
      "smilesParent": "COc1ccc(NC(=O)Nc2ccc3O[C@@H]4[C@@H](CO)O[C@@H](CC(=O)NCCc5ccccc5)C[C@@H]4c3c2)cc1"
    },
    "unichem": {
      "chebi": "102468",
      "lincs": "LSM-13818",
      "pubchem": "54646269"
    },
    "pubchem": [
      {
        "cid": 54646269,
        "inchi": "InChI=1S/C30H33N3O6/c1-37-22-10-7-20(8-11-22)32-30(36)33-21-9-12-26-24(15-21)25-16-23(38-27(18-34)29(25)39-26)17-28(35)31-14-13-19-5-3-2-4-6-19/h2-12,15,23,25,27,29,34H,13-14,16-18H2,1H3,(H,31,35)(H2,32,33,36)/t23-,25-,27-,29+/m1/s1",
        "inchikey": "FOSRSIPYUZSGIW-ACEYUQJJSA-N",
        "iupac": {
          "systematic": "2-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-6-[(4-methoxyphenyl)carbamoylamino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-(2-phenylethyl)acetamide"
        },
        "smiles": {
          "canonical": "COC1=CC=C(C=C1)NC(=O)NC2=CC3=C(C=C2)OC4C3CC(OC4CO)CC(=O)NCCC5=CC=CC=C5"
        },
        "molecularFormula": "C30H33N3O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:58:34Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c860c"
    },
    "name": "BRD-K22668950",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c860c.png",
    "lincs": {
      "id": "LSM-9805",
      "name": "BRD-K22668950",
      "pubchemCid": 54639016,
      "chebiId": 98426,
      "inchiParent": "InChI=1S/C17H28N2O4/c20-10-15-14(19-17(22)12-2-1-3-12)7-6-13(23-15)8-16(21)18-9-11-4-5-11/h11-15,20H,1-10H2,(H,18,21)(H,19,22)/t13-,14+,15-/m1/s1",
      "inchiKeyParent": "MSNHHRRUCLPTHC-QLFBSQMISA-N",
      "smilesParent": "OC[C@H]1O[C@@H](CC(=O)NCC2CC2)CC[C@@H]1NC(=O)C3CCC3"
    },
    "unichem": {
      "chebi": "98426",
      "lincs": "LSM-9805",
      "pubchem": "54639016"
    },
    "pubchem": [
      {
        "cid": 54639016,
        "inchi": "InChI=1S/C17H28N2O4/c20-10-15-14(19-17(22)12-2-1-3-12)7-6-13(23-15)8-16(21)18-9-11-4-5-11/h11-15,20H,1-10H2,(H,18,21)(H,19,22)/t13-,14+,15-/m1/s1",
        "inchikey": "MSNHHRRUCLPTHC-QLFBSQMISA-N",
        "iupac": {
          "systematic": "N-[(2S,3S,6R)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)oxan-3-yl]cyclobutanecarboxamide"
        },
        "smiles": {
          "canonical": "C1CC(C1)C(=O)NC2CCC(OC2CO)CC(=O)NCC3CC3"
        },
        "molecularFormula": "C17H28N2O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:58:37Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c856a"
    },
    "name": "BRD-K42361507",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c856a.png",
    "lincs": {
      "id": "LSM-10994",
      "name": "BRD-K42361507",
      "pubchemCid": 54638302,
      "chebiId": 99615,
      "inchiParent": "InChI=1S/C19H31N5O5/c1-12-18(13(2)29-22-12)21-19(27)20-15-5-4-14(28-16(15)11-25)10-17(26)24-8-6-23(3)7-9-24/h14-16,25H,4-11H2,1-3H3,(H2,20,21,27)/t14-,15-,16+/m1/s1",
      "inchiKeyParent": "ZKSUBHWMVQQNNI-OAGGEKHMSA-N",
      "smilesParent": "CN1CCN(CC1)C(=O)C[C@H]2CC[C@@H](NC(=O)Nc3c(C)onc3C)[C@H](CO)O2"
    },
    "unichem": {
      "chebi": "99615",
      "lincs": "LSM-10994",
      "pubchem": "54638302"
    },
    "pubchem": [
      {
        "cid": 54638302,
        "inchi": "InChI=1S/C19H31N5O5/c1-12-18(13(2)29-22-12)21-19(27)20-15-5-4-14(28-16(15)11-25)10-17(26)24-8-6-23(3)7-9-24/h14-16,25H,4-11H2,1-3H3,(H2,20,21,27)/t14-,15-,16+/m1/s1",
        "inchikey": "ZKSUBHWMVQQNNI-OAGGEKHMSA-N",
        "iupac": {
          "systematic": "1-(3,5-dimethyl-1,2-oxazol-4-yl)-3-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-(4-methylpiperazin-1-yl)-2-oxoethyl]oxan-3-yl]urea"
        },
        "smiles": {
          "canonical": "CC1=C(C(=NO1)C)NC(=O)NC2CCC(OC2CO)CC(=O)N3CCN(CC3)C"
        },
        "molecularFormula": "C19H31N5O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:58:39Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8625"
    },
    "name": "BRD-K34106732",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8625.png",
    "lincs": {
      "id": "LSM-10490",
      "name": "BRD-K34106732",
      "pubchemCid": 54654427,
      "chebiId": 99111,
      "inchiParent": "InChI=1S/C29H38N4O6S/c1-3-40(36,37)31-21-9-12-26-24(15-21)29(35)32(2)25-11-10-23(39-27(25)19-38-26)16-28(34)30-22-13-14-33(18-22)17-20-7-5-4-6-8-20/h4-9,12,15,22-23,25,27,31H,3,10-11,13-14,16-19H2,1-2H3,(H,30,34)/t22-,23-,25+,27-/m1/s1",
      "inchiKeyParent": "IJWLFSVDDGQQHF-MRWFPNEWSA-N",
      "smilesParent": "CCS(=O)(=O)Nc1ccc2OC[C@H]3O[C@@H](CC(=O)N[C@@H]4CCN(Cc5ccccc5)C4)CC[C@@H]3N(C)C(=O)c2c1"
    },
    "unichem": {
      "chebi": "99111",
      "lincs": "LSM-10490",
      "pubchem": "54654427"
    },
    "pubchem": [
      {
        "cid": 54654427,
        "inchi": "InChI=1S/C29H38N4O6S/c1-3-40(36,37)31-21-9-12-26-24(15-21)29(35)32(2)25-11-10-23(39-27(25)19-38-26)16-28(34)30-22-13-14-33(18-22)17-20-7-5-4-6-8-20/h4-9,12,15,22-23,25,27,31H,3,10-11,13-14,16-19H2,1-2H3,(H,30,34)/t22-,23-,25+,27-/m1/s1",
        "inchikey": "IJWLFSVDDGQQHF-MRWFPNEWSA-N",
        "iupac": {
          "systematic": "2-[(2R,4aS,12aS)-8-(ethylsulfonylamino)-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-[(3R)-1-benzylpyrrolidin-3-yl]acetamide"
        },
        "smiles": {
          "canonical": "CCS(=O)(=O)NC1=CC2=C(C=C1)OCC3C(CCC(O3)CC(=O)NC4CCN(C4)CC5=CC=CC=C5)N(C2=O)C"
        },
        "molecularFormula": "C29H38N4O6S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:58:41Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8641"
    },
    "name": "BRD-K21751020",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8641.png",
    "lincs": {
      "id": "LSM-38455",
      "name": "BRD-K21751020",
      "pubchemCid": 60191104,
      "chebiId": 126892,
      "inchiParent": "InChI=1S/C26H29N3O4/c1-3-13-27-26(32)28-15-22-25(23(17-30)29(22)24(31)16-28)20-11-9-18(10-12-20)7-8-19-5-4-6-21(14-19)33-2/h4-6,9-12,14,22-23,25,30H,3,13,15-17H2,1-2H3,(H,27,32)/t22-,23-,25+/m0/s1",
      "inchiKeyParent": "HWTLLAZAXGMWGF-SONWIMMPSA-N",
      "smilesParent": "CCCNC(=O)N1C[C@H]2[C@H]([C@H](CO)N2C(=O)C1)c3ccc(cc3)C#Cc4cccc(OC)c4"
    },
    "unichem": {
      "chebi": "126892",
      "lincs": "LSM-38455",
      "pubchem": "60191104"
    },
    "pubchem": [
      {
        "cid": 60191104,
        "inchi": "InChI=1S/C26H29N3O4/c1-3-13-27-26(32)28-15-22-25(23(17-30)29(22)24(31)16-28)20-11-9-18(10-12-20)7-8-19-5-4-6-21(14-19)33-2/h4-6,9-12,14,22-23,25,30H,3,13,15-17H2,1-2H3,(H,27,32)/t22-,23-,25+/m0/s1",
        "inchikey": "HWTLLAZAXGMWGF-SONWIMMPSA-N",
        "iupac": {
          "systematic": "(6R,7R,8R)-8-(hydroxymethyl)-7-[4-[2-(3-methoxyphenyl)ethynyl]phenyl]-2-oxo-N-propyl-1,4-diazabicyclo[4.2.0]octane-4-carboxamide"
        },
        "smiles": {
          "canonical": "CCCNC(=O)N1CC2C(C(N2C(=O)C1)CO)C3=CC=C(C=C3)C#CC4=CC(=CC=C4)OC"
        },
        "molecularFormula": "C26H29N3O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:58:43Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8502"
    },
    "name": "BRD-K76915833",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8502.png",
    "lincs": {
      "id": "LSM-41472",
      "name": "BRD-K76915833",
      "pubchemCid": 60190999,
      "chebiId": 129921,
      "inchiParent": "InChI=1S/C26H29N3O4/c1-3-13-27-26(32)28-15-22-25(23(17-30)29(22)24(31)16-28)20-11-9-18(10-12-20)7-8-19-5-4-6-21(14-19)33-2/h4-6,9-12,14,22-23,25,30H,3,13,15-17H2,1-2H3,(H,27,32)/t22-,23+,25+/m1/s1",
      "inchiKeyParent": "HWTLLAZAXGMWGF-CUYJMHBOSA-N",
      "smilesParent": "CCCNC(=O)N1C[C@@H]2[C@@H]([C@H](CO)N2C(=O)C1)c3ccc(cc3)C#Cc4cccc(OC)c4"
    },
    "unichem": {
      "chebi": "129921",
      "lincs": "LSM-41472",
      "pubchem": "60190999"
    },
    "pubchem": [
      {
        "cid": 60190999,
        "inchi": "InChI=1S/C26H29N3O4/c1-3-13-27-26(32)28-15-22-25(23(17-30)29(22)24(31)16-28)20-11-9-18(10-12-20)7-8-19-5-4-6-21(14-19)33-2/h4-6,9-12,14,22-23,25,30H,3,13,15-17H2,1-2H3,(H,27,32)/t22-,23+,25+/m1/s1",
        "inchikey": "HWTLLAZAXGMWGF-CUYJMHBOSA-N",
        "iupac": {
          "systematic": "(6S,7S,8R)-8-(hydroxymethyl)-7-[4-[2-(3-methoxyphenyl)ethynyl]phenyl]-2-oxo-N-propyl-1,4-diazabicyclo[4.2.0]octane-4-carboxamide"
        },
        "smiles": {
          "canonical": "CCCNC(=O)N1CC2C(C(N2C(=O)C1)CO)C3=CC=C(C=C3)C#CC4=CC(=CC=C4)OC"
        },
        "molecularFormula": "C26H29N3O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:58:46Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8512"
    },
    "name": "BRD-K10422753",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8512.png",
    "lincs": {
      "id": "LSM-37811",
      "name": "BRD-K10422753",
      "pubchemCid": 54666469,
      "chebiId": 126245,
      "inchiParent": "InChI=1S/C27H30N2O5/c1-18(31)4-5-19-6-8-20(9-7-19)26-22-15-28(12-2-3-13-29(22)23(26)16-30)27(32)21-10-11-24-25(14-21)34-17-33-24/h6-11,14,18,22-23,26,30-31H,2-3,12-13,15-17H2,1H3/t18-,22-,23-,26-/m0/s1",
      "inchiKeyParent": "UELXIDKHDZHDNE-NPZLAWLJSA-N",
      "smilesParent": "C[C@H](O)C#Cc1ccc(cc1)[C@@H]2[C@H](CO)N3CCCCN(C[C@@H]23)C(=O)c4ccc5OCOc5c4"
    },
    "unichem": {
      "chebi": "126245",
      "lincs": "LSM-37811",
      "pubchem": "54666469"
    },
    "pubchem": [
      {
        "cid": 54666469,
        "inchi": "InChI=1S/C27H30N2O5/c1-18(31)4-5-19-6-8-20(9-7-19)26-22-15-28(12-2-3-13-29(22)23(26)16-30)27(32)21-10-11-24-25(14-21)34-17-33-24/h6-11,14,18,22-23,26,30-31H,2-3,12-13,15-17H2,1H3/t18-,22-,23-,26-/m0/s1",
        "inchikey": "UELXIDKHDZHDNE-NPZLAWLJSA-N",
        "iupac": {
          "systematic": "1,3-benzodioxol-5-yl-[(8R,9S,10R)-9-[4-[(3S)-3-hydroxybut-1-ynyl]phenyl]-10-(hydroxymethyl)-1,6-diazabicyclo[6.2.0]decan-6-yl]methanone"
        },
        "smiles": {
          "canonical": "CC(C#CC1=CC=C(C=C1)C2C3CN(CCCCN3C2CO)C(=O)C4=CC5=C(C=C4)OCO5)O"
        },
        "molecularFormula": "C27H30N2O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:58:48Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8530"
    },
    "name": "BRD-K06905668",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8530.png",
    "lincs": {
      "id": "LSM-37643",
      "name": "BRD-K06905668",
      "pubchemCid": 44494694,
      "chebiId": 126076,
      "inchiParent": "InChI=1S/C31H43N5O6/c1-20-17-36(21(2)19-37)29(38)25-11-8-12-26(34-30(39)32-22-9-6-5-7-10-22)28(25)42-27(20)18-35(3)31(40)33-23-13-15-24(41-4)16-14-23/h8,11-16,20-22,27,37H,5-7,9-10,17-19H2,1-4H3,(H,33,40)(H2,32,34,39)/t20-,21-,27+/m1/s1",
      "inchiKeyParent": "SWAMQWMVKYBBNH-GNMOFYLKSA-N",
      "smilesParent": "COc1ccc(NC(=O)N(C)C[C@@H]2Oc3c(NC(=O)NC4CCCCC4)cccc3C(=O)N(C[C@H]2C)[C@H](C)CO)cc1"
    },
    "unichem": {
      "chebi": "126076",
      "lincs": "LSM-37643",
      "pubchem": "44494694"
    },
    "pubchem": [
      {
        "cid": 44494694,
        "inchi": "InChI=1S/C31H43N5O6/c1-20-17-36(21(2)19-37)29(38)25-11-8-12-26(34-30(39)32-22-9-6-5-7-10-22)28(25)42-27(20)18-35(3)31(40)33-23-13-15-24(41-4)16-14-23/h8,11-16,20-22,27,37H,5-7,9-10,17-19H2,1-4H3,(H,33,40)(H2,32,34,39)/t20-,21-,27+/m1/s1",
        "inchikey": "SWAMQWMVKYBBNH-GNMOFYLKSA-N",
        "iupac": {
          "systematic": "1-[[(2R,3R)-10-(cyclohexylcarbamoylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-3-(4-methoxyphenyl)-1-methylurea"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(C(=CC=C2)NC(=O)NC3CCCCC3)OC1CN(C)C(=O)NC4=CC=C(C=C4)OC)C(C)CO"
        },
        "molecularFormula": "C31H43N5O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:58:50Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8535"
    },
    "name": "BRD-K45690206",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8535.png",
    "lincs": {
      "id": "LSM-39797",
      "name": "BRD-K45690206",
      "pubchemCid": 44616995,
      "chebiId": 128242,
      "inchiParent": "InChI=1S/C37H55N3O6/c1-26-22-40(27(2)25-41)37(43)33-21-31(38-36(42)30-12-7-6-8-13-30)16-19-34(33)46-28(3)11-9-10-20-45-35(26)24-39(4)23-29-14-17-32(44-5)18-15-29/h14-19,21,26-28,30,35,41H,6-13,20,22-25H2,1-5H3,(H,38,42)/t26-,27-,28+,35-/m1/s1",
      "inchiKeyParent": "UVSCGJDGVAXROK-RIKJNLPISA-N",
      "smilesParent": "COc1ccc(CN(C)C[C@H]2OCCCC[C@H](C)Oc3ccc(NC(=O)C4CCCCC4)cc3C(=O)N(C[C@H]2C)[C@H](C)CO)cc1"
    },
    "unichem": {
      "chebi": "128242",
      "lincs": "LSM-39797",
      "pubchem": "44616995"
    },
    "pubchem": [
      {
        "cid": 44616995,
        "inchi": "InChI=1S/C37H55N3O6/c1-26-22-40(27(2)25-41)37(43)33-21-31(38-36(42)30-12-7-6-8-13-30)16-19-34(33)46-28(3)11-9-10-20-45-35(26)24-39(4)23-29-14-17-32(44-5)18-15-29/h14-19,21,26-28,30,35,41H,6-13,20,22-25H2,1-5H3,(H,38,42)/t26-,27-,28+,35-/m1/s1",
        "inchikey": "UVSCGJDGVAXROK-RIKJNLPISA-N",
        "iupac": {
          "systematic": "N-[(3S,9S,10R)-12-[(2R)-1-hydroxypropan-2-yl]-9-[[(4-methoxyphenyl)methyl-methylamino]methyl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]cyclohexanecarboxamide"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NC(=O)C3CCCCC3)C(C)CO)C)CN(C)CC4=CC=C(C=C4)OC"
        },
        "molecularFormula": "C37H55N3O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:58:53Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85b5"
    },
    "name": "BRD-K17492515",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85b5.png",
    "lincs": {
      "id": "LSM-38195",
      "name": "BRD-K17492515",
      "pubchemCid": 44617069,
      "chebiId": 126632,
      "inchiParent": "InChI=1S/C34H39N5O4/c1-23-19-39(24(2)22-40)33(41)18-27-17-28(36-34(42)37-30-10-6-8-26-7-4-5-9-29(26)30)11-12-31(27)43-32(23)21-38(3)20-25-13-15-35-16-14-25/h4-17,23-24,32,40H,18-22H2,1-3H3,(H2,36,37,42)/t23-,24+,32+/m0/s1",
      "inchiKeyParent": "QYOWCAGNJDGPGP-JOUUIMRQSA-N",
      "smilesParent": "C[C@H](CO)N1C[C@H](C)[C@@H](CN(C)Cc2ccncc2)Oc3ccc(NC(=O)Nc4cccc5ccccc45)cc3CC1=O"
    },
    "unichem": {
      "chebi": "126632",
      "lincs": "LSM-38195",
      "pubchem": "44617069"
    },
    "pubchem": [
      {
        "cid": 44617069,
        "inchi": "InChI=1S/C34H39N5O4/c1-23-19-39(24(2)22-40)33(41)18-27-17-28(36-34(42)37-30-10-6-8-26-7-4-5-9-29(26)30)11-12-31(27)43-32(23)21-38(3)20-25-13-15-35-16-14-25/h4-17,23-24,32,40H,18-22H2,1-3H3,(H2,36,37,42)/t23-,24+,32+/m0/s1",
        "inchikey": "QYOWCAGNJDGPGP-JOUUIMRQSA-N",
        "iupac": {
          "systematic": "1-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-naphthalen-1-ylurea"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)CC2=C(C=CC(=C2)NC(=O)NC3=CC=CC4=CC=CC=C43)OC1CN(C)CC5=CC=NC=C5)C(C)CO"
        },
        "molecularFormula": "C34H39N5O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:58:55Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85c5"
    },
    "name": "BRD-K50277523",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85c5.png",
    "lincs": {
      "id": "LSM-40056",
      "name": "BRD-K50277523",
      "pubchemCid": 44487589,
      "chebiId": 128502,
      "inchiParent": "InChI=1S/C26H39N3O6S2/c1-18-16-29(19(2)17-30)26(31)22-14-21(28-37(32,33)25-9-7-13-36-25)10-11-23(22)35-20(3)8-5-6-12-34-24(18)15-27-4/h7,9-11,13-14,18-20,24,27-28,30H,5-6,8,12,15-17H2,1-4H3/t18-,19-,20-,24+/m1/s1",
      "inchiKeyParent": "HTMJKWITGYZJOG-FIXDAVPBSA-N",
      "smilesParent": "CNC[C@@H]1OCCCC[C@@H](C)Oc2ccc(NS(=O)(=O)c3cccs3)cc2C(=O)N(C[C@H]1C)[C@H](C)CO"
    },
    "unichem": {
      "chebi": "128502",
      "lincs": "LSM-40056",
      "pubchem": "44487589"
    },
    "pubchem": [
      {
        "cid": 44487589,
        "inchi": "InChI=1S/C26H39N3O6S2/c1-18-16-29(19(2)17-30)26(31)22-14-21(28-37(32,33)25-9-7-13-36-25)10-11-23(22)35-20(3)8-5-6-12-34-24(18)15-27-4/h7,9-11,13-14,18-20,24,27-28,30H,5-6,8,12,15-17H2,1-4H3/t18-,19-,20-,24+/m1/s1",
        "inchikey": "HTMJKWITGYZJOG-FIXDAVPBSA-N",
        "iupac": {
          "systematic": "N-[(3R,9R,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]thiophene-2-sulfonamide"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NS(=O)(=O)C3=CC=CS3)C(C)CO)C)CNC"
        },
        "molecularFormula": "C26H39N3O6S2"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:58:57Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85da"
    },
    "name": "BRD-K23396987",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85da.png",
    "lincs": {
      "id": "LSM-9837",
      "name": "BRD-K23396987",
      "pubchemCid": 54646027,
      "chebiId": 98458,
      "inchiParent": "InChI=1S/C25H35N3O5/c29-15-22-24-20(13-18(32-22)14-23(30)28-10-4-1-5-11-28)19-12-17(8-9-21(19)33-24)27-25(31)26-16-6-2-3-7-16/h8-9,12,16,18,20,22,24,29H,1-7,10-11,13-15H2,(H2,26,27,31)/t18-,20+,22-,24-/m0/s1",
      "inchiKeyParent": "GFIPGJIGSRXJBU-FVSDWULHSA-N",
      "smilesParent": "OC[C@@H]1O[C@H](CC(=O)N2CCCCC2)C[C@H]3[C@@H]1Oc4ccc(NC(=O)NC5CCCC5)cc34"
    },
    "unichem": {
      "chebi": "98458",
      "lincs": "LSM-9837",
      "pubchem": "54646027"
    },
    "pubchem": [
      {
        "cid": 54646027,
        "inchi": "InChI=1S/C25H35N3O5/c29-15-22-24-20(13-18(32-22)14-23(30)28-10-4-1-5-11-28)19-12-17(8-9-21(19)33-24)27-25(31)26-16-6-2-3-7-16/h8-9,12,16,18,20,22,24,29H,1-7,10-11,13-15H2,(H2,26,27,31)/t18-,20+,22-,24-/m0/s1",
        "inchikey": "GFIPGJIGSRXJBU-FVSDWULHSA-N",
        "iupac": {
          "systematic": "1-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-3-(2-oxo-2-piperidin-1-ylethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]-3-cyclopentylurea"
        },
        "smiles": {
          "canonical": "C1CCN(CC1)C(=O)CC2CC3C(C(O2)CO)OC4=C3C=C(C=C4)NC(=O)NC5CCCC5"
        },
        "molecularFormula": "C25H35N3O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:58:59Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85e6"
    },
    "name": "BRD-K96640402",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85e6.png",
    "lincs": {
      "id": "LSM-14362",
      "name": "BRD-K96640402",
      "pubchemCid": 54657507,
      "chebiId": 103016,
      "inchiParent": "InChI=1S/C25H32F3N5O5/c1-32-11-18(30-15-32)8-9-29-23(35)10-20-6-7-21-22(38-20)14-37-13-19(34)12-33(21)24(36)31-17-4-2-16(3-5-17)25(26,27)28/h2-5,11,15,19-22,34H,6-10,12-14H2,1H3,(H,29,35)(H,31,36)/t19-,20-,21+,22-/m0/s1",
      "inchiKeyParent": "TWGHTEGHSVIJBR-KJJMTIBFSA-N",
      "smilesParent": "Cn1cnc(CCNC(=O)C[C@@H]2CC[C@@H]3[C@H](COC[C@@H](O)CN3C(=O)Nc4ccc(cc4)C(F)(F)F)O2)c1"
    },
    "unichem": {
      "chebi": "103016",
      "lincs": "LSM-14362",
      "pubchem": "54657507"
    },
    "pubchem": [
      {
        "cid": 54657507,
        "inchi": "InChI=1S/C25H32F3N5O5/c1-32-11-18(30-15-32)8-9-29-23(35)10-20-6-7-21-22(38-20)14-37-13-19(34)12-33(21)24(36)31-17-4-2-16(3-5-17)25(26,27)28/h2-5,11,15,19-22,34H,6-10,12-14H2,1H3,(H,29,35)(H,31,36)/t19-,20-,21+,22-/m0/s1",
        "inchikey": "TWGHTEGHSVIJBR-KJJMTIBFSA-N",
        "iupac": {
          "systematic": "(3S,6aR,8S,10aR)-3-hydroxy-8-[2-[2-(1-methylimidazol-4-yl)ethylamino]-2-oxoethyl]-N-[4-(trifluoromethyl)phenyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide"
        },
        "smiles": {
          "canonical": "CN1C=C(N=C1)CCNC(=O)CC2CCC3C(O2)COCC(CN3C(=O)NC4=CC=C(C=C4)C(F)(F)F)O"
        },
        "molecularFormula": "C25H32F3N5O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:59:01Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85f1"
    },
    "name": "BRD-K09170549",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85f1.png",
    "lincs": {
      "id": "LSM-8984",
      "name": "BRD-K09170549",
      "pubchemCid": 54646103,
      "chebiId": 97605,
      "inchiParent": "InChI=1S/C23H28N2O7S/c1-25(2)22(27)12-16-11-19-18-10-14(4-9-20(18)32-23(19)21(13-26)31-16)24-33(28,29)17-7-5-15(30-3)6-8-17/h4-10,16,19,21,23-24,26H,11-13H2,1-3H3/t16-,19-,21+,23+/m0/s1",
      "inchiKeyParent": "GJVLYDQXVFQAHZ-PZMSFCMUSA-N",
      "smilesParent": "COc1ccc(cc1)S(=O)(=O)Nc2ccc3O[C@H]4[C@@H](CO)O[C@H](CC(=O)N(C)C)C[C@H]4c3c2"
    },
    "unichem": {
      "chebi": "97605",
      "lincs": "LSM-8984",
      "pubchem": "54646103"
    },
    "pubchem": [
      {
        "cid": 54646103,
        "inchi": "InChI=1S/C23H28N2O7S/c1-25(2)22(27)12-16-11-19-18-10-14(4-9-20(18)32-23(19)21(13-26)31-16)24-33(28,29)17-7-5-15(30-3)6-8-17/h4-10,16,19,21,23-24,26H,11-13H2,1-3H3/t16-,19-,21+,23+/m0/s1",
        "inchikey": "GJVLYDQXVFQAHZ-PZMSFCMUSA-N",
        "iupac": {
          "systematic": "2-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-6-[(4-methoxyphenyl)sulfonylamino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N,N-dimethylacetamide"
        },
        "smiles": {
          "canonical": "CN(C)C(=O)CC1CC2C(C(O1)CO)OC3=C2C=C(C=C3)NS(=O)(=O)C4=CC=C(C=C4)OC"
        },
        "molecularFormula": "C23H28N2O7S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:59:04Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8519"
    },
    "name": "BRD-K48254300",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8519.png",
    "lincs": {
      "id": "LSM-39948",
      "name": "BRD-K48254300",
      "pubchemCid": 60185116,
      "chebiId": 128393,
      "inchiParent": "InChI=1S/C25H34N4O5/c1-15(2)26-24(32)28-12-25(13-28)14-29(23(31)16-6-8-34-9-7-16)20(11-30)22-21(25)18-5-4-17(33-3)10-19(18)27-22/h4-5,10,15-16,20,27,30H,6-9,11-14H2,1-3H3,(H,26,32)/t20-/m0/s1",
      "inchiKeyParent": "ITKAHHPFNIBSCR-FQEVSTJZSA-N",
      "smilesParent": "COc1ccc2c3c([nH]c2c1)[C@H](CO)N(CC34CN(C4)C(=O)NC(C)C)C(=O)C5CCOCC5"
    },
    "unichem": {
      "chebi": "128393",
      "lincs": "LSM-39948",
      "pubchem": "60185116"
    },
    "pubchem": [
      {
        "cid": 60185116,
        "inchi": "InChI=1S/C25H34N4O5/c1-15(2)26-24(32)28-12-25(13-28)14-29(23(31)16-6-8-34-9-7-16)20(11-30)22-21(25)18-5-4-17(33-3)10-19(18)27-22/h4-5,10,15-16,20,27,30H,6-9,11-14H2,1-3H3,(H,26,32)/t20-/m0/s1",
        "inchikey": "ITKAHHPFNIBSCR-FQEVSTJZSA-N",
        "iupac": {
          "systematic": "(1R)-1-(hydroxymethyl)-7-methoxy-2-(oxane-4-carbonyl)-N-propan-2-ylspiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3'-azetidine]-1'-carboxamide"
        },
        "smiles": {
          "canonical": "CC(C)NC(=O)N1CC2(C1)CN(C(C3=C2C4=C(N3)C=C(C=C4)OC)CO)C(=O)C5CCOCC5"
        },
        "molecularFormula": "C25H34N4O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:59:06Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85ca"
    },
    "name": "BRD-K33215066",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85ca.png",
    "lincs": {
      "id": "LSM-14796",
      "name": "BRD-K33215066",
      "pubchemCid": 44486406,
      "chebiId": 103452,
      "inchiParent": "InChI=1S/C32H55N5O6/c1-22(2)33-32(41)36(8)20-29-23(3)19-37(24(4)21-38)31(40)27-18-26(34-30(39)13-11-16-35(6)7)14-15-28(27)43-25(5)12-9-10-17-42-29/h14-15,18,22-25,29,38H,9-13,16-17,19-21H2,1-8H3,(H,33,41)(H,34,39)/t23-,24+,25-,29-/m1/s1",
      "inchiKeyParent": "SUHZFPHQAJGSMY-MNGFJMBLSA-N",
      "smilesParent": "CC(C)NC(=O)N(C)C[C@H]1OCCCC[C@@H](C)Oc2ccc(NC(=O)CCCN(C)C)cc2C(=O)N(C[C@H]1C)[C@@H](C)CO"
    },
    "unichem": {
      "chebi": "103452",
      "lincs": "LSM-14796",
      "pubchem": "44486406"
    },
    "pubchem": [
      {
        "cid": 44486406,
        "inchi": "InChI=1S/C32H55N5O6/c1-22(2)33-32(41)36(8)20-29-23(3)19-37(24(4)21-38)31(40)27-18-26(34-30(39)13-11-16-35(6)7)14-15-28(27)43-25(5)12-9-10-17-42-29/h14-15,18,22-25,29,38H,9-13,16-17,19-21H2,1-8H3,(H,33,41)(H,34,39)/t23-,24+,25-,29-/m1/s1",
        "inchikey": "SUHZFPHQAJGSMY-MNGFJMBLSA-N",
        "iupac": {
          "systematic": "4-(dimethylamino)-N-[(3R,9S,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(propan-2-ylcarbamoyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]butanamide"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NC(=O)CCCN(C)C)C(C)CO)C)CN(C)C(=O)NC(C)C"
        },
        "molecularFormula": "C32H55N5O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:59:08Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85ee"
    },
    "name": "BRD-K15230829",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85ee.png",
    "lincs": {
      "id": "LSM-9342",
      "name": "BRD-K15230829",
      "pubchemCid": 54657936,
      "chebiId": 97963,
      "inchiParent": "InChI=1S/C23H32FN3O5/c1-25-8-10-26(11-9-25)22(29)12-17-6-7-20-21(32-17)15-31-14-16(28)13-27(20)23(30)18-4-2-3-5-19(18)24/h2-5,16-17,20-21,28H,6-15H2,1H3/t16-,17+,20-,21+/m0/s1",
      "inchiKeyParent": "JLPSQBARJGYMKN-KJNZLNQQSA-N",
      "smilesParent": "CN1CCN(CC1)C(=O)C[C@H]2CC[C@H]3[C@@H](COC[C@@H](O)CN3C(=O)c4ccccc4F)O2"
    },
    "unichem": {
      "chebi": "97963",
      "lincs": "LSM-9342",
      "pubchem": "54657936"
    },
    "pubchem": [
      {
        "cid": 54657936,
        "inchi": "InChI=1S/C23H32FN3O5/c1-25-8-10-26(11-9-25)22(29)12-17-6-7-20-21(32-17)15-31-14-16(28)13-27(20)23(30)18-4-2-3-5-19(18)24/h2-5,16-17,20-21,28H,6-15H2,1H3/t16-,17+,20-,21+/m0/s1",
        "inchikey": "JLPSQBARJGYMKN-KJNZLNQQSA-N",
        "iupac": {
          "systematic": "2-[(3S,6aS,8R,10aS)-1-(2-fluorobenzoyl)-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(4-methylpiperazin-1-yl)ethanone"
        },
        "smiles": {
          "canonical": "CN1CCN(CC1)C(=O)CC2CCC3C(O2)COCC(CN3C(=O)C4=CC=CC=C4F)O"
        },
        "molecularFormula": "C23H32FN3O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:59:10Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c855e"
    },
    "name": "BRD-K78914942",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c855e.png",
    "lincs": {
      "id": "LSM-13247",
      "name": "BRD-K78914942",
      "pubchemCid": 54657663,
      "chebiId": 101886,
      "inchiParent": "InChI=1S/C23H27NO8S/c25-16-13-24(21-11-8-19(12-23(26)27)32-22(21)15-30-14-16)33(28,29)20-9-6-18(7-10-20)31-17-4-2-1-3-5-17/h1-7,9-10,16,19,21-22,25H,8,11-15H2,(H,26,27)/t16-,19-,21+,22-/m0/s1",
      "inchiKeyParent": "WUYMKGAOXGWOLL-VHHKXPHXSA-N",
      "smilesParent": "O[C@@H]1COC[C@@H]2O[C@H](CC(=O)O)CC[C@H]2N(C1)S(=O)(=O)c3ccc(Oc4ccccc4)cc3"
    },
    "unichem": {
      "chebi": "101886",
      "lincs": "LSM-13247",
      "pubchem": "54657663"
    },
    "pubchem": [
      {
        "cid": 54657663,
        "inchi": "InChI=1S/C23H27NO8S/c25-16-13-24(21-11-8-19(12-23(26)27)32-22(21)15-30-14-16)33(28,29)20-9-6-18(7-10-20)31-17-4-2-1-3-5-17/h1-7,9-10,16,19,21-22,25H,8,11-15H2,(H,26,27)/t16-,19-,21+,22-/m0/s1",
        "inchikey": "WUYMKGAOXGWOLL-VHHKXPHXSA-N",
        "iupac": {
          "systematic": "2-[(3S,6aR,8S,10aR)-3-hydroxy-1-(4-phenoxyphenyl)sulfonyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]acetic acid"
        },
        "smiles": {
          "canonical": "C1CC2C(COCC(CN2S(=O)(=O)C3=CC=C(C=C3)OC4=CC=CC=C4)O)OC1CC(=O)O"
        },
        "molecularFormula": "C23H27NO8S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:59:13Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85de"
    },
    "name": "BRD-K54161818",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85de.png",
    "lincs": {
      "id": "LSM-11722",
      "name": "BRD-K54161818",
      "pubchemCid": 54646427,
      "chebiId": 100347,
      "inchiParent": "InChI=1S/C23H33N3O5/c1-25(2)13-21(28)24-15-6-7-19-17(10-15)18-11-16(30-20(14-27)23(18)31-19)12-22(29)26-8-4-3-5-9-26/h6-7,10,16,18,20,23,27H,3-5,8-9,11-14H2,1-2H3,(H,24,28)/t16-,18-,20+,23+/m0/s1",
      "inchiKeyParent": "MRLAOALNSBFOMY-VSCJKUSUSA-N",
      "smilesParent": "CN(C)CC(=O)Nc1ccc2O[C@H]3[C@@H](CO)O[C@H](CC(=O)N4CCCCC4)C[C@H]3c2c1"
    },
    "unichem": {
      "chebi": "100347",
      "lincs": "LSM-11722",
      "pubchem": "54646427"
    },
    "pubchem": [
      {
        "cid": 54646427,
        "inchi": "InChI=1S/C23H33N3O5/c1-25(2)13-21(28)24-15-6-7-19-17(10-15)18-11-16(30-20(14-27)23(18)31-19)12-22(29)26-8-4-3-5-9-26/h6-7,10,16,18,20,23,27H,3-5,8-9,11-14H2,1-2H3,(H,24,28)/t16-,18-,20+,23+/m0/s1",
        "inchikey": "MRLAOALNSBFOMY-VSCJKUSUSA-N",
        "iupac": {
          "systematic": "N-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-3-(2-oxo-2-piperidin-1-ylethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]-2-(dimethylamino)acetamide"
        },
        "smiles": {
          "canonical": "CN(C)CC(=O)NC1=CC2=C(C=C1)OC3C2CC(OC3CO)CC(=O)N4CCCCC4"
        },
        "molecularFormula": "C23H33N3O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:59:15Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8607"
    },
    "name": "CHEMBL3185285",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8607.png",
    "lincs": {
      "id": "LSM-13896",
      "name": "CHEMBL3185285",
      "alternativeNames": [
        "BRD-K88937432"
      ],
      "pubchemCid": 54649428,
      "chebiId": 102549,
      "inchiParent": "InChI=1S/C33H34N4O5S/c1-33(2,3)43(40)37-19-25-17-26(32(39)35-18-21-7-8-28-29(15-21)42-20-41-28)36-31(30(25)27(37)11-14-38)24-6-4-5-23(16-24)22-9-12-34-13-10-22/h4-10,12-13,15-17,27,38H,11,14,18-20H2,1-3H3,(H,35,39)/t27-,43-/m0/s1",
      "inchiKeyParent": "OLAATLBQFXJPIK-AMDSOUHQSA-N",
      "smilesParent": "CC(C)(C)[S@](=O)N1Cc2cc(nc(c3cccc(c3)c4ccncc4)c2[C@@H]1CCO)C(=O)NCc5ccc6OCOc6c5"
    },
    "unichem": {
      "chebi": "102549",
      "chembl": "CHEMBL3185285",
      "lincs": "LSM-13896",
      "pubchem": "54649428"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL3185285",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 598.73,
        "hba": 8,
        "hbd": 2,
        "qedWeighted": 0.27
      }
    },
    "pubchem": [
      {
        "cid": 54649428,
        "inchi": "InChI=1S/C33H34N4O5S/c1-33(2,3)43(40)37-19-25-17-26(32(39)35-18-21-7-8-28-29(15-21)42-20-41-28)36-31(30(25)27(37)11-14-38)24-6-4-5-23(16-24)22-9-12-34-13-10-22/h4-10,12-13,15-17,27,38H,11,14,18-20H2,1-3H3,(H,35,39)/t27-,43-/m0/s1",
        "inchikey": "OLAATLBQFXJPIK-AMDSOUHQSA-N",
        "iupac": {
          "systematic": "(3S)-N-(1,3-benzodioxol-5-ylmethyl)-2-[(S)-tert-butylsulfinyl]-3-(2-hydroxyethyl)-4-(3-pyridin-4-ylphenyl)-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide"
        },
        "smiles": {
          "canonical": "CC(C)(C)S(=O)N1CC2=CC(=NC(=C2C1CCO)C3=CC=CC(=C3)C4=CC=NC=C4)C(=O)NCC5=CC6=C(C=C5)OCO6"
        },
        "molecularFormula": "C33H34N4O5S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:59:26Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c861f"
    },
    "name": "BRD-K00317040",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c861f.png",
    "lincs": {
      "id": "LSM-37297",
      "name": "BRD-K00317040",
      "pubchemCid": 71758993,
      "chebiId": 125728,
      "inchiParent": "InChI=1S/C25H37N3O2/c1-27-22-14-19(30-2)8-9-20(22)23-24(27)21(16-29)26-17-25(23)10-12-28(13-11-25)15-18-6-4-3-5-7-18/h8-9,14,18,21,26,29H,3-7,10-13,15-17H2,1-2H3/t21-/m1/s1",
      "inchiKeyParent": "NUSRPSJLLQZCNL-OAQYLSRUSA-N",
      "smilesParent": "COc1ccc2c3c([C@@H](CO)NCC34CCN(CC5CCCCC5)CC4)n(C)c2c1"
    },
    "unichem": {
      "chebi": "125728",
      "lincs": "LSM-37297",
      "pubchem": "71758993"
    },
    "pubchem": [
      {
        "cid": 71758993,
        "inchi": "InChI=1S/C25H37N3O2/c1-27-22-14-19(30-2)8-9-20(22)23-24(27)21(16-29)26-17-25(23)10-12-28(13-11-25)15-18-6-4-3-5-7-18/h8-9,14,18,21,26,29H,3-7,10-13,15-17H2,1-2H3/t21-/m1/s1",
        "inchikey": "NUSRPSJLLQZCNL-OAQYLSRUSA-N",
        "iupac": {
          "systematic": "[(1S)-1'-(cyclohexylmethyl)-7-methoxy-9-methylspiro[2,3-dihydro-1H-pyrido[3,4-b]indole-4,4'-piperidine]-1-yl]methanol"
        },
        "smiles": {
          "canonical": "CN1C2=C(C=CC(=C2)OC)C3=C1C(NCC34CCN(CC4)CC5CCCCC5)CO"
        },
        "molecularFormula": "C25H37N3O2"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:59:29Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c862d"
    },
    "name": "BRD-K51372689",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c862d.png",
    "lincs": {
      "id": "LSM-40105",
      "name": "BRD-K51372689",
      "pubchemCid": 54651305,
      "chebiId": 128551,
      "inchiParent": "InChI=1S/C23H27N3O3/c27-15-20-22(17-5-2-1-3-6-17)19(14-25-23(29)18-7-4-8-18)26(20)21(28)13-16-9-11-24-12-10-16/h1-3,5-6,9-12,18-20,22,27H,4,7-8,13-15H2,(H,25,29)/t19-,20-,22-/m1/s1",
      "inchiKeyParent": "SVJDTLZTQFBDFC-KCZVDYSFSA-N",
      "smilesParent": "OC[C@@H]1[C@@H]([C@@H](CNC(=O)C2CCC2)N1C(=O)Cc3ccncc3)c4ccccc4"
    },
    "unichem": {
      "chebi": "128551",
      "lincs": "LSM-40105",
      "pubchem": "54651305"
    },
    "pubchem": [
      {
        "cid": 54651305,
        "inchi": "InChI=1S/C23H27N3O3/c27-15-20-22(17-5-2-1-3-6-17)19(14-25-23(29)18-7-4-8-18)26(20)21(28)13-16-9-11-24-12-10-16/h1-3,5-6,9-12,18-20,22,27H,4,7-8,13-15H2,(H,25,29)/t19-,20-,22-/m1/s1",
        "inchikey": "SVJDTLZTQFBDFC-KCZVDYSFSA-N",
        "iupac": {
          "systematic": "N-[[(2S,3R,4S)-4-(hydroxymethyl)-3-phenyl-1-(2-pyridin-4-ylacetyl)azetidin-2-yl]methyl]cyclobutanecarboxamide"
        },
        "smiles": {
          "canonical": "C1CC(C1)C(=O)NCC2C(C(N2C(=O)CC3=CC=NC=C3)CO)C4=CC=CC=C4"
        },
        "molecularFormula": "C23H27N3O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:59:31Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c862e"
    },
    "name": "BRD-K85981997",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c862e.png",
    "lincs": {
      "id": "LSM-41966",
      "name": "BRD-K85981997",
      "pubchemCid": 60189756,
      "chebiId": 130417,
      "inchiParent": "InChI=1S/C27H29F2N3O3/c1-35-19-6-7-20-22(10-19)30-25-23(12-33)31(11-17-9-18(28)5-8-21(17)29)13-27(24(20)25)14-32(15-27)26(34)16-3-2-4-16/h5-10,16,23,30,33H,2-4,11-15H2,1H3/t23-/m0/s1",
      "inchiKeyParent": "KWQYOPXXHRJLFX-QHCPKHFHSA-N",
      "smilesParent": "COc1ccc2c3c([nH]c2c1)[C@H](CO)N(Cc4cc(F)ccc4F)CC35CN(C5)C(=O)C6CCC6"
    },
    "unichem": {
      "chebi": "130417",
      "chembl": "CHEMBL3561657",
      "lincs": "LSM-41966",
      "pubchem": "60189756"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL3561657",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 481.54,
        "hba": 4,
        "hbd": 2,
        "qedWeighted": 0.58
      }
    },
    "pubchem": [
      {
        "cid": 60189756,
        "inchi": "InChI=1S/C27H29F2N3O3/c1-35-19-6-7-20-22(10-19)30-25-23(12-33)31(11-17-9-18(28)5-8-21(17)29)13-27(24(20)25)14-32(15-27)26(34)16-3-2-4-16/h5-10,16,23,30,33H,2-4,11-15H2,1H3/t23-/m0/s1",
        "inchikey": "KWQYOPXXHRJLFX-QHCPKHFHSA-N",
        "iupac": {
          "systematic": "cyclobutyl-[(1R)-2-[(2,5-difluorophenyl)methyl]-1-(hydroxymethyl)-7-methoxyspiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3'-azetidine]-1'-yl]methanone"
        },
        "smiles": {
          "canonical": "COC1=CC2=C(C=C1)C3=C(N2)C(N(CC34CN(C4)C(=O)C5CCC5)CC6=C(C=CC(=C6)F)F)CO"
        },
        "molecularFormula": "C27H29F2N3O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:59:42Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8634"
    },
    "name": "BRD-K70539465",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8634.png",
    "lincs": {
      "id": "LSM-41105",
      "name": "BRD-K70539465",
      "pubchemCid": 60185078,
      "chebiId": 129554,
      "inchiParent": "InChI=1S/C25H28FN3O3/c1-28-15-25(9-11-29(12-10-25)24(31)17-5-3-4-6-19(17)26)22-18-8-7-16(32-2)13-20(18)27-23(22)21(28)14-30/h3-8,13,21,27,30H,9-12,14-15H2,1-2H3/t21-/m0/s1",
      "inchiKeyParent": "KJWDLSLNDXZUDM-NRFANRHFSA-N",
      "smilesParent": "COc1ccc2c3c([nH]c2c1)[C@H](CO)N(C)CC34CCN(CC4)C(=O)c5ccccc5F"
    },
    "unichem": {
      "chebi": "129554",
      "lincs": "LSM-41105",
      "pubchem": "60185078"
    },
    "pubchem": [
      {
        "cid": 60185078,
        "inchi": "InChI=1S/C25H28FN3O3/c1-28-15-25(9-11-29(12-10-25)24(31)17-5-3-4-6-19(17)26)22-18-8-7-16(32-2)13-20(18)27-23(22)21(28)14-30/h3-8,13,21,27,30H,9-12,14-15H2,1-2H3/t21-/m0/s1",
        "inchikey": "KJWDLSLNDXZUDM-NRFANRHFSA-N",
        "iupac": {
          "systematic": "(2-fluorophenyl)-[(1R)-1-(hydroxymethyl)-7-methoxy-2-methylspiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4'-piperidine]-1'-yl]methanone"
        },
        "smiles": {
          "canonical": "CN1CC2(CCN(CC2)C(=O)C3=CC=CC=C3F)C4=C(C1CO)NC5=C4C=CC(=C5)OC"
        },
        "molecularFormula": "C25H28FN3O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:59:44Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c863a"
    },
    "name": "BRD-K32014638",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c863a.png",
    "lincs": {
      "id": "LSM-39026",
      "name": "BRD-K32014638",
      "pubchemCid": 60190029,
      "chebiId": 127468,
      "inchiParent": "InChI=1S/C24H33N3O6S/c1-32-17-3-4-18-19(13-17)25-22-20(14-28)27(23(29)16-5-11-33-12-6-16)15-24(21(18)22)7-9-26(10-8-24)34(2,30)31/h3-4,13,16,20,25,28H,5-12,14-15H2,1-2H3/t20-/m0/s1",
      "inchiKeyParent": "OSCUPXLIQKAFLS-FQEVSTJZSA-N",
      "smilesParent": "COc1ccc2c3c([nH]c2c1)[C@H](CO)N(CC34CCN(CC4)S(=O)(=O)C)C(=O)C5CCOCC5"
    },
    "unichem": {
      "chebi": "127468",
      "lincs": "LSM-39026",
      "pubchem": "60190029"
    },
    "pubchem": [
      {
        "cid": 60190029,
        "inchi": "InChI=1S/C24H33N3O6S/c1-32-17-3-4-18-19(13-17)25-22-20(14-28)27(23(29)16-5-11-33-12-6-16)15-24(21(18)22)7-9-26(10-8-24)34(2,30)31/h3-4,13,16,20,25,28H,5-12,14-15H2,1-2H3/t20-/m0/s1",
        "inchikey": "OSCUPXLIQKAFLS-FQEVSTJZSA-N",
        "iupac": {
          "systematic": "[(1R)-1-(hydroxymethyl)-7-methoxy-1'-methylsulfonylspiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4'-piperidine]-2-yl]-(oxan-4-yl)methanone"
        },
        "smiles": {
          "canonical": "COC1=CC2=C(C=C1)C3=C(N2)C(N(CC34CCN(CC4)S(=O)(=O)C)C(=O)C5CCOCC5)CO"
        },
        "molecularFormula": "C24H33N3O6S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:59:46Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8564"
    },
    "name": "BRD-K29827452",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8564.png",
    "lincs": {
      "id": "LSM-10238",
      "name": "BRD-K29827452",
      "pubchemCid": 54660892,
      "chebiId": 98859,
      "inchiParent": "InChI=1S/C25H32N2O5/c1-32-25(31)21-18(14-28)20-13-26-19(12-11-17(24(26)30)15-7-5-6-8-15)22(21)27(20)23(29)16-9-3-2-4-10-16/h7,11-12,16,18,20-22,28H,2-6,8-10,13-14H2,1H3/t18-,20-,21+,22+/m1/s1",
      "inchiKeyParent": "FAIHTTLOGWXJOT-YJMBLLCNSA-N",
      "smilesParent": "COC(=O)[C@H]1[C@H](CO)[C@H]2CN3C(=O)C(=CC=C3[C@@H]1N2C(=O)C4CCCCC4)C5=CCCC5"
    },
    "unichem": {
      "chebi": "98859",
      "lincs": "LSM-10238",
      "pubchem": "54660892"
    },
    "pubchem": [
      {
        "cid": 54660892,
        "inchi": "InChI=1S/C25H32N2O5/c1-32-25(31)21-18(14-28)20-13-26-19(12-11-17(24(26)30)15-7-5-6-8-15)22(21)27(20)23(29)16-9-3-2-4-10-16/h7,11-12,16,18,20-22,28H,2-6,8-10,13-14H2,1H3/t18-,20-,21+,22+/m1/s1",
        "inchikey": "FAIHTTLOGWXJOT-YJMBLLCNSA-N",
        "iupac": {
          "systematic": "methyl (1R,9S,10S,11S)-12-(cyclohexanecarbonyl)-5-(cyclopenten-1-yl)-10-(hydroxymethyl)-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxylate"
        },
        "smiles": {
          "canonical": "COC(=O)C1C(C2CN3C(=CC=C(C3=O)C4=CCCC4)C1N2C(=O)C5CCCCC5)CO"
        },
        "molecularFormula": "C25H32N2O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:59:49Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8518"
    },
    "name": "BRD-K21095834",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8518.png",
    "lincs": {
      "id": "LSM-38409",
      "name": "BRD-K21095834",
      "pubchemCid": 60185051,
      "chebiId": 126846,
      "inchiParent": "InChI=1S/C28H33N3O4/c1-29-22-12-20(34-2)10-11-21(22)25-26(29)23(14-32)31(27(33)18-8-9-18)17-28(25)15-30(16-28)13-19-6-4-5-7-24(19)35-3/h4-7,10-12,18,23,32H,8-9,13-17H2,1-3H3/t23-/m0/s1",
      "inchiKeyParent": "GPKISOQNMJYSOP-QHCPKHFHSA-N",
      "smilesParent": "COc1ccc2c3c([C@H](CO)N(CC34CN(Cc5ccccc5OC)C4)C(=O)C6CC6)n(C)c2c1"
    },
    "unichem": {
      "chebi": "126846",
      "lincs": "LSM-38409",
      "pubchem": "60185051"
    },
    "pubchem": [
      {
        "cid": 60185051,
        "inchi": "InChI=1S/C28H33N3O4/c1-29-22-12-20(34-2)10-11-21(22)25-26(29)23(14-32)31(27(33)18-8-9-18)17-28(25)15-30(16-28)13-19-6-4-5-7-24(19)35-3/h4-7,10-12,18,23,32H,8-9,13-17H2,1-3H3/t23-/m0/s1",
        "inchikey": "GPKISOQNMJYSOP-QHCPKHFHSA-N",
        "iupac": {
          "systematic": "cyclopropyl-[(1R)-1-(hydroxymethyl)-7-methoxy-1'-[(2-methoxyphenyl)methyl]-9-methylspiro[1,3-dihydropyrido[3,4-b]indole-4,3'-azetidine]-2-yl]methanone"
        },
        "smiles": {
          "canonical": "CN1C2=C(C=CC(=C2)OC)C3=C1C(N(CC34CN(C4)CC5=CC=CC=C5OC)C(=O)C6CC6)CO"
        },
        "molecularFormula": "C28H33N3O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:59:51Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c853a"
    },
    "name": "BRD-K27198330",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c853a.png",
    "lincs": {
      "id": "LSM-38747",
      "name": "BRD-K27198330",
      "pubchemCid": 44485796,
      "chebiId": 127187,
      "inchiParent": "InChI=1S/C26H39N3O6S2/c1-18-16-29(19(2)17-30)26(31)22-14-21(28-37(32,33)25-9-7-13-36-25)10-11-23(22)35-20(3)8-5-6-12-34-24(18)15-27-4/h7,9-11,13-14,18-20,24,27-28,30H,5-6,8,12,15-17H2,1-4H3/t18-,19-,20-,24-/m1/s1",
      "inchiKeyParent": "HTMJKWITGYZJOG-DBYOASNMSA-N",
      "smilesParent": "CNC[C@H]1OCCCC[C@@H](C)Oc2ccc(NS(=O)(=O)c3cccs3)cc2C(=O)N(C[C@H]1C)[C@H](C)CO"
    },
    "unichem": {
      "chebi": "127187",
      "lincs": "LSM-38747",
      "pubchem": "44485796"
    },
    "pubchem": [
      {
        "cid": 44485796,
        "inchi": "InChI=1S/C26H39N3O6S2/c1-18-16-29(19(2)17-30)26(31)22-14-21(28-37(32,33)25-9-7-13-36-25)10-11-23(22)35-20(3)8-5-6-12-34-24(18)15-27-4/h7,9-11,13-14,18-20,24,27-28,30H,5-6,8,12,15-17H2,1-4H3/t18-,19-,20-,24-/m1/s1",
        "inchikey": "HTMJKWITGYZJOG-DBYOASNMSA-N",
        "iupac": {
          "systematic": "N-[(3R,9S,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]thiophene-2-sulfonamide"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NS(=O)(=O)C3=CC=CS3)C(C)CO)C)CNC"
        },
        "molecularFormula": "C26H39N3O6S2"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:59:53Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c853f"
    },
    "name": "BRD-K56899980",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c853f.png",
    "lincs": {
      "id": "LSM-40391",
      "name": "BRD-K56899980",
      "pubchemCid": 54615091,
      "chebiId": 128839,
      "inchiParent": "InChI=1S/C32H49N5O6/c1-20-16-37(21(2)19-38)31(39)27-15-26(33-32(40)34-30-23(4)35-43-24(30)5)12-13-28(27)42-22(3)9-7-8-14-41-29(20)18-36(6)17-25-10-11-25/h12-13,15,20-22,25,29,38H,7-11,14,16-19H2,1-6H3,(H2,33,34,40)/t20-,21+,22-,29+/m0/s1",
      "inchiKeyParent": "JVILTGOVTWEXFK-CROAMNIPSA-N",
      "smilesParent": "C[C@H](CO)N1C[C@H](C)[C@@H](CN(C)CC2CC2)OCCCC[C@H](C)Oc3ccc(NC(=O)Nc4c(C)onc4C)cc3C1=O"
    },
    "unichem": {
      "chebi": "128839",
      "lincs": "LSM-40391",
      "pubchem": "54615091"
    },
    "pubchem": [
      {
        "cid": 54615091,
        "inchi": "InChI=1S/C32H49N5O6/c1-20-16-37(21(2)19-38)31(39)27-15-26(33-32(40)34-30-23(4)35-43-24(30)5)12-13-28(27)42-22(3)9-7-8-14-41-29(20)18-36(6)17-25-10-11-25/h12-13,15,20-22,25,29,38H,7-11,14,16-19H2,1-6H3,(H2,33,34,40)/t20-,21+,22-,29+/m0/s1",
        "inchikey": "JVILTGOVTWEXFK-CROAMNIPSA-N",
        "iupac": {
          "systematic": "1-[(3S,9S,10S)-9-[[cyclopropylmethyl(methyl)amino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-(3,5-dimethyl-1,2-oxazol-4-yl)urea"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NC(=O)NC3=C(ON=C3C)C)C(C)CO)C)CN(C)CC4CC4"
        },
        "molecularFormula": "C32H49N5O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:59:55Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8551"
    },
    "name": "BRD-K29326878",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8551.png",
    "lincs": {
      "id": "LSM-10207",
      "name": "BRD-K29326878",
      "pubchemCid": 54646053,
      "chebiId": 98828,
      "inchiParent": "InChI=1S/C25H30N2O6/c1-15(16-6-4-3-5-7-16)26-23(29)12-18-11-20-19-10-17(27-24(30)14-31-2)8-9-21(19)33-25(20)22(13-28)32-18/h3-10,15,18,20,22,25,28H,11-14H2,1-2H3,(H,26,29)(H,27,30)/t15-,18+,20+,22+,25-/m0/s1",
      "inchiKeyParent": "ALLGXHRZPBERLG-SPKYLNSMSA-N",
      "smilesParent": "COCC(=O)Nc1ccc2O[C@@H]3[C@@H](CO)O[C@@H](CC(=O)N[C@@H](C)c4ccccc4)C[C@@H]3c2c1"
    },
    "unichem": {
      "chebi": "98828",
      "lincs": "LSM-10207",
      "pubchem": "54646053"
    },
    "pubchem": [
      {
        "cid": 54646053,
        "inchi": "InChI=1S/C25H30N2O6/c1-15(16-6-4-3-5-7-16)26-23(29)12-18-11-20-19-10-17(27-24(30)14-31-2)8-9-21(19)33-25(20)22(13-28)32-18/h3-10,15,18,20,22,25,28H,11-14H2,1-2H3,(H,26,29)(H,27,30)/t15-,18+,20+,22+,25-/m0/s1",
        "inchikey": "ALLGXHRZPBERLG-SPKYLNSMSA-N",
        "iupac": {
          "systematic": "2-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-6-[(2-methoxyacetyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-[(1S)-1-phenylethyl]acetamide"
        },
        "smiles": {
          "canonical": "CC(C1=CC=CC=C1)NC(=O)CC2CC3C(C(O2)CO)OC4=C3C=C(C=C4)NC(=O)COC"
        },
        "molecularFormula": "C25H30N2O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T08:59:57Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c855b"
    },
    "name": "BRD-K38545029",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c855b.png",
    "lincs": {
      "id": "LSM-10765",
      "name": "BRD-K38545029",
      "pubchemCid": 54646741,
      "chebiId": 99386,
      "inchiParent": "InChI=1S/C30H30N2O7/c33-16-27-29-23(14-21(38-27)15-28(34)31-11-10-18-4-2-1-3-5-18)22-13-20(7-9-24(22)39-29)32-30(35)19-6-8-25-26(12-19)37-17-36-25/h1-9,12-13,21,23,27,29,33H,10-11,14-17H2,(H,31,34)(H,32,35)/t21-,23+,27+,29-/m1/s1",
      "inchiKeyParent": "WERZBRNJFLNQTM-ZDOYKXOFSA-N",
      "smilesParent": "OC[C@@H]1O[C@@H](CC(=O)NCCc2ccccc2)C[C@@H]3[C@H]1Oc4ccc(NC(=O)c5ccc6OCOc6c5)cc34"
    },
    "unichem": {
      "chebi": "99386",
      "lincs": "LSM-10765",
      "pubchem": "54646741"
    },
    "pubchem": [
      {
        "cid": 54646741,
        "inchi": "InChI=1S/C30H30N2O7/c33-16-27-29-23(14-21(38-27)15-28(34)31-11-10-18-4-2-1-3-5-18)22-13-20(7-9-24(22)39-29)32-30(35)19-6-8-25-26(12-19)37-17-36-25/h1-9,12-13,21,23,27,29,33H,10-11,14-17H2,(H,31,34)(H,32,35)/t21-,23+,27+,29-/m1/s1",
        "inchikey": "WERZBRNJFLNQTM-ZDOYKXOFSA-N",
        "iupac": {
          "systematic": "N-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(2-phenylethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide"
        },
        "smiles": {
          "canonical": "C1C(OC(C2C1C3=C(O2)C=CC(=C3)NC(=O)C4=CC5=C(C=C4)OCO5)CO)CC(=O)NCCC6=CC=CC=C6"
        },
        "molecularFormula": "C30H30N2O7"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:00:00Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8589"
    },
    "name": "BRD-K32460251",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8589.png",
    "lincs": {
      "id": "LSM-39057",
      "name": "BRD-K32460251",
      "pubchemCid": 54651442,
      "chebiId": 127499,
      "inchiParent": "InChI=1S/C22H27FN2O3/c1-3-25(21(27)14-28-2)12-19-22(20(13-26)24-19)17-6-4-15(5-7-17)16-8-10-18(23)11-9-16/h4-11,19-20,22,24,26H,3,12-14H2,1-2H3/t19-,20+,22-/m0/s1",
      "inchiKeyParent": "JTUOZIKDJHIQCB-VWPQPMDRSA-N",
      "smilesParent": "CCN(C[C@@H]1N[C@H](CO)[C@H]1c2ccc(cc2)c3ccc(F)cc3)C(=O)COC"
    },
    "unichem": {
      "chebi": "127499",
      "lincs": "LSM-39057",
      "pubchem": "54651442"
    },
    "pubchem": [
      {
        "cid": 54651442,
        "inchi": "InChI=1S/C22H27FN2O3/c1-3-25(21(27)14-28-2)12-19-22(20(13-26)24-19)17-6-4-15(5-7-17)16-8-10-18(23)11-9-16/h4-11,19-20,22,24,26H,3,12-14H2,1-2H3/t19-,20+,22-/m0/s1",
        "inchikey": "JTUOZIKDJHIQCB-VWPQPMDRSA-N",
        "iupac": {
          "systematic": "N-ethyl-N-[[(2R,3S,4S)-3-[4-(4-fluorophenyl)phenyl]-4-(hydroxymethyl)azetidin-2-yl]methyl]-2-methoxyacetamide"
        },
        "smiles": {
          "canonical": "CCN(CC1C(C(N1)CO)C2=CC=C(C=C2)C3=CC=C(C=C3)F)C(=O)COC"
        },
        "molecularFormula": "C22H27FN2O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:00:02Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c859f"
    },
    "name": "BRD-K13757679",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c859f.png",
    "lincs": {
      "id": "LSM-9260",
      "name": "BRD-K13757679",
      "pubchemCid": 54657629,
      "chebiId": 97881,
      "inchiParent": "InChI=1S/C28H34N2O5/c31-23-16-30(28(33)12-19-6-2-1-3-7-19)25-11-10-24(35-26(25)18-34-17-23)15-27(32)29-22-13-20-8-4-5-9-21(20)14-22/h1-9,22-26,31H,10-18H2,(H,29,32)/t23-,24-,25+,26-/m0/s1",
      "inchiKeyParent": "JKLIXGQQXOXZKK-SSUZURRFSA-N",
      "smilesParent": "O[C@@H]1COC[C@@H]2O[C@H](CC(=O)NC3Cc4ccccc4C3)CC[C@H]2N(C1)C(=O)Cc5ccccc5"
    },
    "unichem": {
      "chebi": "97881",
      "lincs": "LSM-9260",
      "pubchem": "54657629"
    },
    "pubchem": [
      {
        "cid": 54657629,
        "inchi": "InChI=1S/C28H34N2O5/c31-23-16-30(28(33)12-19-6-2-1-3-7-19)25-11-10-24(35-26(25)18-34-17-23)15-27(32)29-22-13-20-8-4-5-9-21(20)14-22/h1-9,22-26,31H,10-18H2,(H,29,32)/t23-,24-,25+,26-/m0/s1",
        "inchikey": "JKLIXGQQXOXZKK-SSUZURRFSA-N",
        "iupac": {
          "systematic": "2-[(3S,6aR,8S,10aR)-3-hydroxy-1-(2-phenylacetyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2,3-dihydro-1H-inden-2-yl)acetamide"
        },
        "smiles": {
          "canonical": "C1CC2C(COCC(CN2C(=O)CC3=CC=CC=C3)O)OC1CC(=O)NC4CC5=CC=CC=C5C4"
        },
        "molecularFormula": "C28H34N2O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:00:05Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c860a"
    },
    "name": "BRD-K21317335",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c860a.png",
    "lincs": {
      "id": "LSM-9724",
      "name": "BRD-K21317335",
      "pubchemCid": 54637714,
      "chebiId": 98345,
      "inchiParent": "InChI=1S/C31H36N2O5/c1-21-16-33(22(2)19-34)30(35)28-14-7-6-13-27(28)26-12-5-4-10-25(26)20-38-29(21)18-32(3)17-23-9-8-11-24(15-23)31(36)37/h4-15,21-22,29,34H,16-20H2,1-3H3,(H,36,37)/t21-,22-,29+/m0/s1",
      "inchiKeyParent": "QELHGDMSGADVOM-IHMCZWCLSA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@H](C)[C@@H](CN(C)Cc2cccc(c2)C(=O)O)OCc3ccccc3c4ccccc4C1=O"
    },
    "unichem": {
      "chebi": "98345",
      "lincs": "LSM-9724",
      "pubchem": "54637714"
    },
    "pubchem": [
      {
        "cid": 54637714,
        "inchi": "InChI=1S/C31H36N2O5/c1-21-16-33(22(2)19-34)30(35)28-14-7-6-13-27(28)26-12-5-4-10-25(26)20-38-29(21)18-32(3)17-23-9-8-11-24(15-23)31(36)37/h4-15,21-22,29,34H,16-20H2,1-3H3,(H,36,37)/t21-,22-,29+/m0/s1",
        "inchikey": "QELHGDMSGADVOM-IHMCZWCLSA-N",
        "iupac": {
          "systematic": "3-[[[(10S,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl-methylamino]methyl]benzoic acid"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=CC=CC=C2C3=CC=CC=C3COC1CN(C)CC4=CC(=CC=C4)C(=O)O)C(C)CO"
        },
        "molecularFormula": "C31H36N2O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:00:07Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8614"
    },
    "name": "BRD-K56704970",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8614.png",
    "lincs": {
      "id": "LSM-40383",
      "name": "BRD-K56704970",
      "pubchemCid": 60189718,
      "chebiId": 128831,
      "inchiParent": "InChI=1S/C31H38FN5O4/c1-35-25-17-23(41-2)11-12-24(25)27-28(35)26(18-38)37(30(40)34-22-9-7-20(32)8-10-22)19-31(27)13-15-36(16-14-31)29(39)33-21-5-3-4-6-21/h7-12,17,21,26,38H,3-6,13-16,18-19H2,1-2H3,(H,33,39)(H,34,40)/t26-/m0/s1",
      "inchiKeyParent": "KWGXIONTUQXQSV-SANMLTNESA-N",
      "smilesParent": "COc1ccc2c3c([C@H](CO)N(CC34CCN(CC4)C(=O)NC5CCCC5)C(=O)Nc6ccc(F)cc6)n(C)c2c1"
    },
    "unichem": {
      "chebi": "128831",
      "lincs": "LSM-40383",
      "pubchem": "60189718"
    },
    "pubchem": [
      {
        "cid": 60189718,
        "inchi": "InChI=1S/C31H38FN5O4/c1-35-25-17-23(41-2)11-12-24(25)27-28(35)26(18-38)37(30(40)34-22-9-7-20(32)8-10-22)19-31(27)13-15-36(16-14-31)29(39)33-21-5-3-4-6-21/h7-12,17,21,26,38H,3-6,13-16,18-19H2,1-2H3,(H,33,39)(H,34,40)/t26-/m0/s1",
        "inchikey": "KWGXIONTUQXQSV-SANMLTNESA-N",
        "iupac": {
          "systematic": "(1R)-1-N'-cyclopentyl-2-N-(4-fluorophenyl)-1-(hydroxymethyl)-7-methoxy-9-methylspiro[1,3-dihydropyrido[3,4-b]indole-4,4'-piperidine]-1',2-dicarboxamide"
        },
        "smiles": {
          "canonical": "CN1C2=C(C=CC(=C2)OC)C3=C1C(N(CC34CCN(CC4)C(=O)NC5CCCC5)C(=O)NC6=CC=C(C=C6)F)CO"
        },
        "molecularFormula": "C31H38FN5O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:00:09Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c852a"
    },
    "name": "BRD-K10232869",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c852a.png",
    "lincs": {
      "id": "LSM-37804",
      "name": "BRD-K10232869",
      "pubchemCid": 44483562,
      "chebiId": 131307,
      "inchiParent": "InChI=1S/C21H34N4O4/c1-13(2)22-21(28)23-16-7-8-18-17(9-16)20(27)25(15(4)12-26)10-14(3)19(29-18)11-24(5)6/h7-9,13-15,19,26H,10-12H2,1-6H3,(H2,22,23,28)/t14-,15+,19-/m1/s1",
      "inchiKeyParent": "KULYSGMCKHFPFK-ZRGWGRIASA-N",
      "smilesParent": "CC(C)NC(=O)Nc1ccc2O[C@H](CN(C)C)[C@H](C)CN([C@@H](C)CO)C(=O)c2c1"
    },
    "unichem": {
      "chebi": "131307",
      "lincs": "LSM-37804",
      "pubchem": "44483562"
    },
    "pubchem": [
      {
        "cid": 44483562,
        "inchi": "InChI=1S/C21H34N4O4/c1-13(2)22-21(28)23-16-7-8-18-17(9-16)20(27)25(15(4)12-26)10-14(3)19(29-18)11-24(5)6/h7-9,13-15,19,26H,10-12H2,1-6H3,(H2,22,23,28)/t14-,15+,19-/m1/s1",
        "inchikey": "KULYSGMCKHFPFK-ZRGWGRIASA-N",
        "iupac": {
          "systematic": "1-[(2S,3R)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-propan-2-ylurea"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(C=CC(=C2)NC(=O)NC(C)C)OC1CN(C)C)C(C)CO"
        },
        "molecularFormula": "C21H34N4O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:00:12Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85be"
    },
    "name": "BRD-K29360016",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85be.png",
    "lincs": {
      "id": "LSM-14783",
      "name": "BRD-K29360016",
      "pubchemCid": 44494441,
      "chebiId": 103439,
      "inchiParent": "InChI=1S/C26H44N4O5/c1-17(2)28-26(33)29-21-10-11-23-22(13-21)25(32)30(19(4)16-31)15-18(3)24(14-27-6)34-12-8-7-9-20(5)35-23/h10-11,13,17-20,24,27,31H,7-9,12,14-16H2,1-6H3,(H2,28,29,33)/t18-,19+,20+,24+/m0/s1",
      "inchiKeyParent": "DGSOXKKLHVIDDH-UECWXEIQSA-N",
      "smilesParent": "CNC[C@H]1OCCCC[C@@H](C)Oc2ccc(NC(=O)NC(C)C)cc2C(=O)N(C[C@@H]1C)[C@H](C)CO"
    },
    "unichem": {
      "chebi": "103439",
      "lincs": "LSM-14783",
      "pubchem": "44494441"
    },
    "pubchem": [
      {
        "cid": 44494441,
        "inchi": "InChI=1S/C26H44N4O5/c1-17(2)28-26(33)29-21-10-11-23-22(13-21)25(32)30(19(4)16-31)15-18(3)24(14-27-6)34-12-8-7-9-20(5)35-23/h10-11,13,17-20,24,27,31H,7-9,12,14-16H2,1-6H3,(H2,28,29,33)/t18-,19+,20+,24+/m0/s1",
        "inchikey": "DGSOXKKLHVIDDH-UECWXEIQSA-N",
        "iupac": {
          "systematic": "1-[(3R,9S,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-propan-2-ylurea"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NC(=O)NC(C)C)C(C)CO)C)CNC"
        },
        "molecularFormula": "C26H44N4O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:00:14Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8643"
    },
    "name": "BRD-K90417358",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8643.png",
    "lincs": {
      "id": "LSM-42204",
      "name": "BRD-K90417358",
      "pubchemCid": 60189953,
      "chebiId": 130655,
      "inchiParent": "InChI=1S/C26H30FN3O3/c1-4-23(32)30-16-26(14-29(15-26)12-17-5-7-18(27)8-6-17)24-20-10-9-19(33-3)11-21(20)28(2)25(24)22(30)13-31/h5-11,22,31H,4,12-16H2,1-3H3/t22-/m0/s1",
      "inchiKeyParent": "FTACQXCIEUQBTI-QFIPXVFZSA-N",
      "smilesParent": "CCC(=O)N1CC2(CN(Cc3ccc(F)cc3)C2)c4c([C@@H]1CO)n(C)c5cc(OC)ccc45"
    },
    "unichem": {
      "chebi": "130655",
      "lincs": "LSM-42204",
      "pubchem": "60189953"
    },
    "pubchem": [
      {
        "cid": 60189953,
        "inchi": "InChI=1S/C26H30FN3O3/c1-4-23(32)30-16-26(14-29(15-26)12-17-5-7-18(27)8-6-17)24-20-10-9-19(33-3)11-21(20)28(2)25(24)22(30)13-31/h5-11,22,31H,4,12-16H2,1-3H3/t22-/m0/s1",
        "inchikey": "FTACQXCIEUQBTI-QFIPXVFZSA-N",
        "iupac": {
          "systematic": "1-[(1R)-1'-[(4-fluorophenyl)methyl]-1-(hydroxymethyl)-7-methoxy-9-methylspiro[1,3-dihydropyrido[3,4-b]indole-4,3'-azetidine]-2-yl]propan-1-one"
        },
        "smiles": {
          "canonical": "CCC(=O)N1CC2(CN(C2)CC3=CC=C(C=C3)F)C4=C(C1CO)N(C5=C4C=CC(=C5)OC)C"
        },
        "molecularFormula": "C26H30FN3O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:00:16Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8584"
    },
    "name": "BRD-K22127625",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8584.png",
    "lincs": {
      "id": "LSM-38464",
      "name": "BRD-K22127625",
      "pubchemCid": 54651236,
      "chebiId": 126901,
      "inchiParent": "InChI=1S/C23H27FN2O3/c1-4-22(29)25(3)13-20-23(21(14-27)26(20)15(2)28)17-11-9-16(10-12-17)18-7-5-6-8-19(18)24/h5-12,20-21,23,27H,4,13-14H2,1-3H3/t20-,21+,23-/m1/s1",
      "inchiKeyParent": "LFVZONGIIWXQAC-FUPPJEDESA-N",
      "smilesParent": "CCC(=O)N(C)C[C@@H]1[C@H]([C@H](CO)N1C(=O)C)c2ccc(cc2)c3ccccc3F"
    },
    "unichem": {
      "chebi": "126901",
      "lincs": "LSM-38464",
      "pubchem": "54651236"
    },
    "pubchem": [
      {
        "cid": 54651236,
        "inchi": "InChI=1S/C23H27FN2O3/c1-4-22(29)25(3)13-20-23(21(14-27)26(20)15(2)28)17-11-9-16(10-12-17)18-7-5-6-8-19(18)24/h5-12,20-21,23,27H,4,13-14H2,1-3H3/t20-,21+,23-/m1/s1",
        "inchikey": "LFVZONGIIWXQAC-FUPPJEDESA-N",
        "iupac": {
          "systematic": "N-[[(2S,3R,4R)-1-acetyl-3-[4-(2-fluorophenyl)phenyl]-4-(hydroxymethyl)azetidin-2-yl]methyl]-N-methylpropanamide"
        },
        "smiles": {
          "canonical": "CCC(=O)N(C)CC1C(C(N1C(=O)C)CO)C2=CC=C(C=C2)C3=CC=CC=C3F"
        },
        "molecularFormula": "C23H27FN2O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:00:19Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c859b"
    },
    "name": "BRD-K24896023",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c859b.png",
    "lincs": {
      "id": "LSM-38632",
      "name": "BRD-K24896023",
      "pubchemCid": 54652608,
      "chebiId": 127069,
      "inchiParent": "InChI=1S/C25H23FN4O3/c26-18-8-2-3-9-19(18)28-25(33)29-14-21-24(17-7-1-4-10-20(17)29)22(15-31)30(21)23(32)12-16-6-5-11-27-13-16/h1-11,13,21-22,24,31H,12,14-15H2,(H,28,33)/t21-,22+,24+/m1/s1",
      "inchiKeyParent": "DCPQWCYFROYRQR-GPXNEJASSA-N",
      "smilesParent": "OC[C@H]1[C@@H]2[C@@H](CN(C(=O)Nc3ccccc3F)c4ccccc24)N1C(=O)Cc5cccnc5"
    },
    "unichem": {
      "chebi": "127069",
      "lincs": "LSM-38632",
      "pubchem": "54652608"
    },
    "pubchem": [
      {
        "cid": 54652608,
        "inchi": "InChI=1S/C25H23FN4O3/c26-18-8-2-3-9-19(18)28-25(33)29-14-21-24(17-7-1-4-10-20(17)29)22(15-31)30(21)23(32)12-16-6-5-11-27-13-16/h1-11,13,21-22,24,31H,12,14-15H2,(H,28,33)/t21-,22+,24+/m1/s1",
        "inchikey": "DCPQWCYFROYRQR-GPXNEJASSA-N",
        "iupac": {
          "systematic": "(1R,2aS,8bS)-N-(2-fluorophenyl)-1-(hydroxymethyl)-2-(2-pyridin-3-ylacetyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide"
        },
        "smiles": {
          "canonical": "C1C2C(C(N2C(=O)CC3=CN=CC=C3)CO)C4=CC=CC=C4N1C(=O)NC5=CC=CC=C5F"
        },
        "molecularFormula": "C25H23FN4O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:00:21Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85a0"
    },
    "name": "BRD-K06328518",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85a0.png",
    "lincs": {
      "id": "LSM-37611",
      "name": "BRD-K06328518",
      "pubchemCid": 54652474,
      "chebiId": 126044,
      "inchiParent": "InChI=1S/C23H20N4O3/c28-14-20-21-16-5-1-2-7-18(16)26(22(29)15-8-11-24-12-9-15)13-19(21)27(20)23(30)17-6-3-4-10-25-17/h1-12,19-21,28H,13-14H2/t19-,20-,21+/m0/s1",
      "inchiKeyParent": "IBDAQUBWSFJDHC-PCCBWWKXSA-N",
      "smilesParent": "OC[C@H]1[C@H]2[C@H](CN(C(=O)c3ccncc3)c4ccccc24)N1C(=O)c5ccccn5"
    },
    "unichem": {
      "chebi": "126044",
      "lincs": "LSM-37611",
      "pubchem": "54652474"
    },
    "pubchem": [
      {
        "cid": 54652474,
        "inchi": "InChI=1S/C23H20N4O3/c28-14-20-21-16-5-1-2-7-18(16)26(22(29)15-8-11-24-12-9-15)13-19(21)27(20)23(30)17-6-3-4-10-25-17/h1-12,19-21,28H,13-14H2/t19-,20-,21+/m0/s1",
        "inchikey": "IBDAQUBWSFJDHC-PCCBWWKXSA-N",
        "iupac": {
          "systematic": "[(1R,2aR,8bR)-1-(hydroxymethyl)-2-(pyridine-2-carbonyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-pyridin-4-ylmethanone"
        },
        "smiles": {
          "canonical": "C1C2C(C(N2C(=O)C3=CC=CC=N3)CO)C4=CC=CC=C4N1C(=O)C5=CC=NC=C5"
        },
        "molecularFormula": "C23H20N4O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:00:23Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8503"
    },
    "name": "BRD-K00668050",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8503.png",
    "lincs": {
      "id": "LSM-37320",
      "name": "BRD-K00668050",
      "pubchemCid": 71760147,
      "chebiId": 125751,
      "inchiParent": "InChI=1S/C23H27N3O4S/c1-15-4-7-17(8-5-15)31(28,29)26-13-23(14-26)12-24-19(11-27)22-21(23)18-9-6-16(30-3)10-20(18)25(22)2/h4-10,19,24,27H,11-14H2,1-3H3/t19-/m0/s1",
      "inchiKeyParent": "WHTCQRCGQGHDMI-IBGZPJMESA-N",
      "smilesParent": "COc1ccc2c3c([C@H](CO)NCC34CN(C4)S(=O)(=O)c5ccc(C)cc5)n(C)c2c1"
    },
    "unichem": {
      "chebi": "125751",
      "lincs": "LSM-37320",
      "pubchem": "71760147"
    },
    "pubchem": [
      {
        "cid": 71760147,
        "inchi": "InChI=1S/C23H27N3O4S/c1-15-4-7-17(8-5-15)31(28,29)26-13-23(14-26)12-24-19(11-27)22-21(23)18-9-6-16(30-3)10-20(18)25(22)2/h4-10,19,24,27H,11-14H2,1-3H3/t19-/m0/s1",
        "inchikey": "WHTCQRCGQGHDMI-IBGZPJMESA-N",
        "iupac": {
          "systematic": "[(1R)-7-methoxy-9-methyl-1'-(4-methylphenyl)sulfonylspiro[2,3-dihydro-1H-pyrido[3,4-b]indole-4,3'-azetidine]-1-yl]methanol"
        },
        "smiles": {
          "canonical": "CC1=CC=C(C=C1)S(=O)(=O)N2CC3(C2)CNC(C4=C3C5=C(N4C)C=C(C=C5)OC)CO"
        },
        "molecularFormula": "C23H27N3O4S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:00:25Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8558"
    },
    "name": "BRD-K40121369",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8558.png",
    "lincs": {
      "id": "LSM-10876",
      "name": "BRD-K40121369",
      "pubchemCid": 54654257,
      "chebiId": 99497,
      "inchiParent": "InChI=1S/C28H30FN5O5/c1-16-22(14-33(2)32-16)31-26(35)13-20-8-9-23-25(39-20)15-38-24-10-7-19(12-21(24)28(37)34(23)3)30-27(36)17-5-4-6-18(29)11-17/h4-7,10-12,14,20,23,25H,8-9,13,15H2,1-3H3,(H,30,36)(H,31,35)/t20-,23+,25+/m1/s1",
      "inchiKeyParent": "LLFGMIFPADLUOD-PBXXJUDPSA-N",
      "smilesParent": "CN1[C@H]2CC[C@H](CC(=O)Nc3cn(C)nc3C)O[C@H]2COc4ccc(NC(=O)c5cccc(F)c5)cc4C1=O"
    },
    "unichem": {
      "chebi": "99497",
      "lincs": "LSM-10876",
      "pubchem": "54654257"
    },
    "pubchem": [
      {
        "cid": 54654257,
        "inchi": "InChI=1S/C28H30FN5O5/c1-16-22(14-33(2)32-16)31-26(35)13-20-8-9-23-25(39-20)15-38-24-10-7-19(12-21(24)28(37)34(23)3)30-27(36)17-5-4-6-18(29)11-17/h4-7,10-12,14,20,23,25H,8-9,13,15H2,1-3H3,(H,30,36)(H,31,35)/t20-,23+,25+/m1/s1",
        "inchikey": "LLFGMIFPADLUOD-PBXXJUDPSA-N",
        "iupac": {
          "systematic": "N-[(2R,4aS,12aR)-2-[2-[(1,3-dimethylpyrazol-4-yl)amino]-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-3-fluorobenzamide"
        },
        "smiles": {
          "canonical": "CC1=NN(C=C1NC(=O)CC2CCC3C(O2)COC4=C(C=C(C=C4)NC(=O)C5=CC(=CC=C5)F)C(=O)N3C)C"
        },
        "molecularFormula": "C28H30FN5O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:00:27Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85dc"
    },
    "name": "BRD-K33909884",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85dc.png",
    "lincs": {
      "id": "LSM-10482",
      "name": "BRD-K33909884",
      "pubchemCid": 54657912,
      "chebiId": 99103,
      "inchiParent": "InChI=1S/C14H21N3O4S/c18-9-6-16-11-2-1-10(21-12(11)8-20-7-9)5-13(19)17-14-15-3-4-22-14/h3-4,9-12,16,18H,1-2,5-8H2,(H,15,17,19)/t9-,10-,11-,12+/m0/s1",
      "inchiKeyParent": "LPUMVFGYOYFXDR-FIQHERPVSA-N",
      "smilesParent": "O[C@H]1CN[C@H]2CC[C@@H](CC(=O)Nc3nccs3)O[C@@H]2COC1"
    },
    "unichem": {
      "chebi": "99103",
      "lincs": "LSM-10482",
      "pubchem": "54657912"
    },
    "pubchem": [
      {
        "cid": 54657912,
        "inchi": "InChI=1S/C14H21N3O4S/c18-9-6-16-11-2-1-10(21-12(11)8-20-7-9)5-13(19)17-14-15-3-4-22-14/h3-4,9-12,16,18H,1-2,5-8H2,(H,15,17,19)/t9-,10-,11-,12+/m0/s1",
        "inchikey": "LPUMVFGYOYFXDR-FIQHERPVSA-N",
        "iupac": {
          "systematic": "2-[(3S,6aS,8S,10aS)-3-hydroxy-1,2,3,4,6,6a,8,9,10,10a-decahydropyrano[2,3-c][1,5]oxazocin-8-yl]-N-(1,3-thiazol-2-yl)acetamide"
        },
        "smiles": {
          "canonical": "C1CC2C(COCC(CN2)O)OC1CC(=O)NC3=NC=CS3"
        },
        "molecularFormula": "C14H21N3O4S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:00:30Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85e1"
    },
    "name": "BRD-K34692511",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85e1.png",
    "lincs": {
      "id": "LSM-10517",
      "name": "BRD-K34692511",
      "pubchemCid": 54631293,
      "chebiId": 99138,
      "inchiParent": "InChI=1S/C25H31F3N4O4/c1-15-12-29-16(2)14-36-21-10-9-19(11-20(21)23(33)32(3)13-22(15)35-4)31-24(34)30-18-7-5-17(6-8-18)25(26,27)28/h5-11,15-16,22,29H,12-14H2,1-4H3,(H2,30,31,34)/t15-,16+,22+/m0/s1",
      "inchiKeyParent": "GXRZKRPKTHFHBM-WJONJSRFSA-N",
      "smilesParent": "CO[C@@H]1CN(C)C(=O)c2cc(NC(=O)Nc3ccc(cc3)C(F)(F)F)ccc2OC[C@@H](C)NC[C@@H]1C"
    },
    "unichem": {
      "chebi": "99138",
      "chembl": "CHEMBL3560159",
      "lincs": "LSM-10517",
      "pubchem": "54631293"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL3560159",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 508.54,
        "hba": 5,
        "hbd": 3,
        "qedWeighted": 0.57
      }
    },
    "pubchem": [
      {
        "cid": 54631293,
        "inchi": "InChI=1S/C25H31F3N4O4/c1-15-12-29-16(2)14-36-21-10-9-19(11-20(21)23(33)32(3)13-22(15)35-4)31-24(34)30-18-7-5-17(6-8-18)25(26,27)28/h5-11,15-16,22,29H,12-14H2,1-4H3,(H2,30,31,34)/t15-,16+,22+/m0/s1",
        "inchikey": "GXRZKRPKTHFHBM-WJONJSRFSA-N",
        "iupac": {
          "systematic": "1-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-[4-(trifluoromethyl)phenyl]urea"
        },
        "smiles": {
          "canonical": "CC1CNC(COC2=C(C=C(C=C2)NC(=O)NC3=CC=C(C=C3)C(F)(F)F)C(=O)N(CC1OC)C)C"
        },
        "molecularFormula": "C25H31F3N4O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:00:41Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c864b"
    },
    "name": "BRD-K47681666",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c864b.png",
    "lincs": {
      "id": "LSM-11333",
      "name": "BRD-K47681666",
      "pubchemCid": 54660718,
      "chebiId": 99954,
      "inchiParent": "InChI=1S/C25H29N3O3/c1-15(16-7-3-2-4-8-16)26-24(30)23-20(14-29)19-13-28-21(22(19)27-23)12-11-18(25(28)31)17-9-5-6-10-17/h2-4,7-9,11-12,15,19-20,22-23,27,29H,5-6,10,13-14H2,1H3,(H,26,30)/t15-,19+,20+,22-,23+/m0/s1",
      "inchiKeyParent": "DEERBQNZFWMEPS-OLHFQXMRSA-N",
      "smilesParent": "C[C@H](NC(=O)[C@@H]1N[C@H]2[C@H](CN3C(=O)C(=CC=C23)C4=CCCC4)[C@H]1CO)c5ccccc5"
    },
    "unichem": {
      "chebi": "99954",
      "lincs": "LSM-11333",
      "pubchem": "54660718"
    },
    "pubchem": [
      {
        "cid": 54660718,
        "inchi": "InChI=1S/C25H29N3O3/c1-15(16-7-3-2-4-8-16)26-24(30)23-20(14-29)19-13-28-21(22(19)27-23)12-11-18(25(28)31)17-9-5-6-10-17/h2-4,7-9,11-12,15,19-20,22-23,27,29H,5-6,10,13-14H2,1H3,(H,26,30)/t15-,19+,20+,22-,23+/m0/s1",
        "inchikey": "DEERBQNZFWMEPS-OLHFQXMRSA-N",
        "iupac": {
          "systematic": "(2R,3R,3aS,9bS)-7-(cyclopenten-1-yl)-3-(hydroxymethyl)-6-oxo-N-[(1S)-1-phenylethyl]-1,2,3,3a,4,9b-hexahydropyrrolo[2,3-a]indolizine-2-carboxamide"
        },
        "smiles": {
          "canonical": "CC(C1=CC=CC=C1)NC(=O)C2C(C3CN4C(=CC=C(C4=O)C5=CCCC5)C3N2)CO"
        },
        "molecularFormula": "C25H29N3O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:00:43Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8500"
    },
    "name": "MLS005000104",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8500.png",
    "lincs": {
      "id": "LSM-39529",
      "name": "MLS005000104",
      "alternativeNames": [
        "BRD-K40951733"
      ],
      "pubchemCid": 60189739,
      "chebiId": 127973,
      "inchiParent": "InChI=1S/C24H29N3O7S2/c1-4-35(29,30)26-13-24(14-26)15-27(36(31,32)18-7-5-6-16(10-18)33-2)21(12-28)23-22(24)19-9-8-17(34-3)11-20(19)25-23/h5-11,21,25,28H,4,12-15H2,1-3H3/t21-/m0/s1",
      "inchiKeyParent": "SLWSIWLTTNIUPG-NRFANRHFSA-N",
      "smilesParent": "CCS(=O)(=O)N1CC2(C1)CN([C@@H](CO)c3[nH]c4cc(OC)ccc4c23)S(=O)(=O)c5cccc(OC)c5"
    },
    "unichem": {
      "chebi": "127973",
      "lincs": "LSM-39529",
      "pubchem": "60189739"
    },
    "pubchem": [
      {
        "cid": 60189739,
        "inchi": "InChI=1S/C24H29N3O7S2/c1-4-35(29,30)26-13-24(14-26)15-27(36(31,32)18-7-5-6-16(10-18)33-2)21(12-28)23-22(24)19-9-8-17(34-3)11-20(19)25-23/h5-11,21,25,28H,4,12-15H2,1-3H3/t21-/m0/s1",
        "inchikey": "SLWSIWLTTNIUPG-NRFANRHFSA-N",
        "iupac": {
          "systematic": "[(1R)-1'-ethylsulfonyl-7-methoxy-2-(3-methoxyphenyl)sulfonylspiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3'-azetidine]-1-yl]methanol"
        },
        "smiles": {
          "canonical": "CCS(=O)(=O)N1CC2(C1)CN(C(C3=C2C4=C(N3)C=C(C=C4)OC)CO)S(=O)(=O)C5=CC=CC(=C5)OC"
        },
        "molecularFormula": "C24H29N3O7S2"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:00:45Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c851c"
    },
    "name": "BRD-K93971021",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c851c.png",
    "lincs": {
      "id": "LSM-14994",
      "name": "BRD-K93971021",
      "pubchemCid": 54615018,
      "chebiId": 103650,
      "inchiParent": "InChI=1S/C36H45N3O6/c1-25-22-39(26(2)24-40)36(43)31-21-30(37-34(41)28-14-7-5-8-15-28)18-19-32(31)45-27(3)13-11-12-20-44-33(25)23-38(4)35(42)29-16-9-6-10-17-29/h5-10,14-19,21,25-27,33,40H,11-13,20,22-24H2,1-4H3,(H,37,41)/t25-,26+,27-,33+/m0/s1",
      "inchiKeyParent": "ZQNJSJYLLBSSCW-LIHQSLCGSA-N",
      "smilesParent": "C[C@H](CO)N1C[C@H](C)[C@@H](CN(C)C(=O)c2ccccc2)OCCCC[C@H](C)Oc3ccc(NC(=O)c4ccccc4)cc3C1=O"
    },
    "unichem": {
      "chebi": "103650",
      "lincs": "LSM-14994",
      "pubchem": "54615018"
    },
    "pubchem": [
      {
        "cid": 54615018,
        "inchi": "InChI=1S/C36H45N3O6/c1-25-22-39(26(2)24-40)36(43)31-21-30(37-34(41)28-14-7-5-8-15-28)18-19-32(31)45-27(3)13-11-12-20-44-33(25)23-38(4)35(42)29-16-9-6-10-17-29/h5-10,14-19,21,25-27,33,40H,11-13,20,22-24H2,1-4H3,(H,37,41)/t25-,26+,27-,33+/m0/s1",
        "inchikey": "ZQNJSJYLLBSSCW-LIHQSLCGSA-N",
        "iupac": {
          "systematic": "N-[(3S,9S,10S)-9-[[benzoyl(methyl)amino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]benzamide"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NC(=O)C3=CC=CC=C3)C(C)CO)C)CN(C)C(=O)C4=CC=CC=C4"
        },
        "molecularFormula": "C36H45N3O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:00:48Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8591"
    },
    "name": "BRD-K25706980",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8591.png",
    "lincs": {
      "id": "LSM-9988",
      "name": "BRD-K25706980",
      "pubchemCid": 54660670,
      "chebiId": 98609,
      "inchiParent": "InChI=1S/C25H27N5O3S/c31-14-18-20-12-30-19(4-3-17(25(30)33)16-5-7-26-8-6-16)23(29(20)13-21-27-9-10-34-21)22(18)24(32)28-11-15-1-2-15/h3-10,15,18,20,22-23,31H,1-2,11-14H2,(H,28,32)/t18-,20-,22+,23+/m1/s1",
      "inchiKeyParent": "HSQWCVQVATZDQW-SQMBMXPBSA-N",
      "smilesParent": "OC[C@@H]1[C@H]2CN3C(=CC=C(C3=O)c4ccncc4)[C@@H]([C@H]1C(=O)NCC5CC5)N2Cc6nccs6"
    },
    "unichem": {
      "chebi": "98609",
      "lincs": "LSM-9988",
      "pubchem": "54660670"
    },
    "pubchem": [
      {
        "cid": 54660670,
        "inchi": "InChI=1S/C25H27N5O3S/c31-14-18-20-12-30-19(4-3-17(25(30)33)16-5-7-26-8-6-16)23(29(20)13-21-27-9-10-34-21)22(18)24(32)28-11-15-1-2-15/h3-10,15,18,20,22-23,31H,1-2,11-14H2,(H,28,32)/t18-,20-,22+,23+/m1/s1",
        "inchikey": "HSQWCVQVATZDQW-SQMBMXPBSA-N",
        "iupac": {
          "systematic": "(1R,9S,10S,11S)-N-(cyclopropylmethyl)-10-(hydroxymethyl)-6-oxo-5-pyridin-4-yl-12-(1,3-thiazol-2-ylmethyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide"
        },
        "smiles": {
          "canonical": "C1CC1CNC(=O)C2C(C3CN4C(=CC=C(C4=O)C5=CC=NC=C5)C2N3CC6=NC=CS6)CO"
        },
        "molecularFormula": "C25H27N5O3S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:00:50Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c863c"
    },
    "name": "BRD-K48332988",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c863c.png",
    "lincs": {
      "id": "LSM-39951",
      "name": "BRD-K48332988",
      "pubchemCid": 60189954,
      "chebiId": 128396,
      "inchiParent": "InChI=1S/C26H30FN3O3/c1-4-23(32)30-16-26(14-29(15-26)12-17-5-7-18(27)8-6-17)24-20-10-9-19(33-3)11-21(20)28(2)25(24)22(30)13-31/h5-11,22,31H,4,12-16H2,1-3H3/t22-/m1/s1",
      "inchiKeyParent": "FTACQXCIEUQBTI-JOCHJYFZSA-N",
      "smilesParent": "CCC(=O)N1CC2(CN(Cc3ccc(F)cc3)C2)c4c([C@H]1CO)n(C)c5cc(OC)ccc45"
    },
    "unichem": {
      "chebi": "128396",
      "lincs": "LSM-39951",
      "pubchem": "60189954"
    },
    "pubchem": [
      {
        "cid": 60189954,
        "inchi": "InChI=1S/C26H30FN3O3/c1-4-23(32)30-16-26(14-29(15-26)12-17-5-7-18(27)8-6-17)24-20-10-9-19(33-3)11-21(20)28(2)25(24)22(30)13-31/h5-11,22,31H,4,12-16H2,1-3H3/t22-/m1/s1",
        "inchikey": "FTACQXCIEUQBTI-JOCHJYFZSA-N",
        "iupac": {
          "systematic": "1-[(1S)-1'-[(4-fluorophenyl)methyl]-1-(hydroxymethyl)-7-methoxy-9-methylspiro[1,3-dihydropyrido[3,4-b]indole-4,3'-azetidine]-2-yl]propan-1-one"
        },
        "smiles": {
          "canonical": "CCC(=O)N1CC2(CN(C2)CC3=CC=C(C=C3)F)C4=C(C1CO)N(C5=C4C=CC(=C5)OC)C"
        },
        "molecularFormula": "C26H30FN3O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:00:52Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8579"
    },
    "name": "BRD-K02593152",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8579.png",
    "lincs": {
      "id": "LSM-37419",
      "name": "BRD-K02593152",
      "pubchemCid": 60191226,
      "chebiId": 125852,
      "inchiParent": "InChI=1S/C13H15BrN2O2/c14-9-3-1-8(2-4-9)13-10-5-15-6-12(18)16(10)11(13)7-17/h1-4,10-11,13,15,17H,5-7H2/t10-,11+,13-/m1/s1",
      "inchiKeyParent": "CPZPDKPINUWRBY-NTZNESFSSA-N",
      "smilesParent": "OC[C@H]1[C@@H]([C@H]2CNCC(=O)N12)c3ccc(Br)cc3"
    },
    "unichem": {
      "chebi": "125852",
      "lincs": "LSM-37419",
      "pubchem": "60191226"
    },
    "pubchem": [
      {
        "cid": 60191226,
        "inchi": "InChI=1S/C13H15BrN2O2/c14-9-3-1-8(2-4-9)13-10-5-15-6-12(18)16(10)11(13)7-17/h1-4,10-11,13,15,17H,5-7H2/t10-,11+,13-/m1/s1",
        "inchikey": "CPZPDKPINUWRBY-NTZNESFSSA-N",
        "iupac": {
          "systematic": "(6S,7R,8R)-7-(4-bromophenyl)-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one"
        },
        "smiles": {
          "canonical": "C1C2C(C(N2C(=O)CN1)CO)C3=CC=C(C=C3)Br"
        },
        "molecularFormula": "C13H15BrN2O2"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:00:54Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8613"
    },
    "name": "BRD-K87341885",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8613.png",
    "lincs": {
      "id": "LSM-42029",
      "name": "BRD-K87341885",
      "pubchemCid": 54652620,
      "chebiId": 130480,
      "inchiParent": "InChI=1S/C18H19F3N2O3/c19-18(20,21)7-15(25)22-8-13-16(11-3-1-2-4-12(11)22)14(9-24)23(13)17(26)10-5-6-10/h1-4,10,13-14,16,24H,5-9H2/t13-,14-,16+/m0/s1",
      "inchiKeyParent": "FZJHIVUYMAQMIZ-OFQRWUPVSA-N",
      "smilesParent": "OC[C@H]1[C@H]2[C@H](CN(C(=O)CC(F)(F)F)c3ccccc23)N1C(=O)C4CC4"
    },
    "unichem": {
      "chebi": "130480",
      "lincs": "LSM-42029",
      "pubchem": "54652620"
    },
    "pubchem": [
      {
        "cid": 54652620,
        "inchi": "InChI=1S/C18H19F3N2O3/c19-18(20,21)7-15(25)22-8-13-16(11-3-1-2-4-12(11)22)14(9-24)23(13)17(26)10-5-6-10/h1-4,10,13-14,16,24H,5-9H2/t13-,14-,16+/m0/s1",
        "inchikey": "FZJHIVUYMAQMIZ-OFQRWUPVSA-N",
        "iupac": {
          "systematic": "1-[(1R,2aR,8bR)-2-(cyclopropanecarbonyl)-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-3,3,3-trifluoropropan-1-one"
        },
        "smiles": {
          "canonical": "C1CC1C(=O)N2C3CN(C4=CC=CC=C4C3C2CO)C(=O)CC(F)(F)F"
        },
        "molecularFormula": "C18H19F3N2O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:00:56Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c863f"
    },
    "name": "BRD-K36194373",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c863f.png",
    "lincs": {
      "id": "LSM-39250",
      "name": "BRD-K36194373",
      "pubchemCid": 60189672,
      "chebiId": 127693,
      "inchiParent": "InChI=1S/C25H30ClN3O4S/c1-4-34(31,32)29-15-25(16-29)14-28(12-17-6-5-7-18(26)10-17)22(13-30)24-23(25)20-9-8-19(33-3)11-21(20)27(24)2/h5-11,22,30H,4,12-16H2,1-3H3/t22-/m1/s1",
      "inchiKeyParent": "GOQJZKLLZQSRHQ-JOCHJYFZSA-N",
      "smilesParent": "CCS(=O)(=O)N1CC2(CN(Cc3cccc(Cl)c3)[C@H](CO)c4c2c5ccc(OC)cc5n4C)C1"
    },
    "unichem": {
      "chebi": "127693",
      "lincs": "LSM-39250",
      "pubchem": "60189672"
    },
    "pubchem": [
      {
        "cid": 60189672,
        "inchi": "InChI=1S/C25H30ClN3O4S/c1-4-34(31,32)29-15-25(16-29)14-28(12-17-6-5-7-18(26)10-17)22(13-30)24-23(25)20-9-8-19(33-3)11-21(20)27(24)2/h5-11,22,30H,4,12-16H2,1-3H3/t22-/m1/s1",
        "inchikey": "GOQJZKLLZQSRHQ-JOCHJYFZSA-N",
        "iupac": {
          "systematic": "[(1S)-2-[(3-chlorophenyl)methyl]-1'-ethylsulfonyl-7-methoxy-9-methylspiro[1,3-dihydropyrido[3,4-b]indole-4,3'-azetidine]-1-yl]methanol"
        },
        "smiles": {
          "canonical": "CCS(=O)(=O)N1CC2(C1)CN(C(C3=C2C4=C(N3C)C=C(C=C4)OC)CO)CC5=CC(=CC=C5)Cl"
        },
        "molecularFormula": "C25H30ClN3O4S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:00:59Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8582"
    },
    "name": "BRD-K54743934",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8582.png",
    "lincs": {
      "id": "LSM-11751",
      "name": "BRD-K54743934",
      "pubchemCid": 54654002,
      "chebiId": 100376,
      "inchiParent": "InChI=1S/C21H23N3O6S/c1-24-15-5-4-13(8-19(25)28-2)30-17(15)10-29-16-6-3-12(7-14(16)21(24)27)23-20(26)18-9-22-11-31-18/h3,6-7,9,11,13,15,17H,4-5,8,10H2,1-2H3,(H,23,26)/t13-,15+,17-/m1/s1",
      "inchiKeyParent": "UYHAGXSFPLQSEJ-UKPHBRMFSA-N",
      "smilesParent": "COC(=O)C[C@H]1CC[C@H]2[C@@H](COc3ccc(NC(=O)c4cncs4)cc3C(=O)N2C)O1"
    },
    "unichem": {
      "chebi": "100376",
      "lincs": "LSM-11751",
      "pubchem": "54654002"
    },
    "pubchem": [
      {
        "cid": 54654002,
        "inchi": "InChI=1S/C21H23N3O6S/c1-24-15-5-4-13(8-19(25)28-2)30-17(15)10-29-16-6-3-12(7-14(16)21(24)27)23-20(26)18-9-22-11-31-18/h3,6-7,9,11,13,15,17H,4-5,8,10H2,1-2H3,(H,23,26)/t13-,15+,17-/m1/s1",
        "inchikey": "UYHAGXSFPLQSEJ-UKPHBRMFSA-N",
        "iupac": {
          "systematic": "methyl 2-[(2R,4aS,12aS)-5-methyl-6-oxo-8-(1,3-thiazole-5-carbonylamino)-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]acetate"
        },
        "smiles": {
          "canonical": "CN1C2CCC(OC2COC3=C(C1=O)C=C(C=C3)NC(=O)C4=CN=CS4)CC(=O)OC"
        },
        "molecularFormula": "C21H23N3O6S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:01:01Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85d6"
    },
    "name": "BRD-K13559922",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85d6.png",
    "lincs": {
      "id": "LSM-37967",
      "name": "BRD-K13559922",
      "pubchemCid": 44617006,
      "chebiId": 126402,
      "inchiParent": "InChI=1S/C37H55N3O6/c1-26-22-40(27(2)25-41)37(43)33-21-31(38-36(42)30-12-7-6-8-13-30)16-19-34(33)46-28(3)11-9-10-20-45-35(26)24-39(4)23-29-14-17-32(44-5)18-15-29/h14-19,21,26-28,30,35,41H,6-13,20,22-25H2,1-5H3,(H,38,42)/t26-,27-,28-,35-/m1/s1",
      "inchiKeyParent": "UVSCGJDGVAXROK-FCSDHKMCSA-N",
      "smilesParent": "COc1ccc(CN(C)C[C@H]2OCCCC[C@@H](C)Oc3ccc(NC(=O)C4CCCCC4)cc3C(=O)N(C[C@H]2C)[C@H](C)CO)cc1"
    },
    "unichem": {
      "chebi": "126402",
      "lincs": "LSM-37967",
      "pubchem": "44617006"
    },
    "pubchem": [
      {
        "cid": 44617006,
        "inchi": "InChI=1S/C37H55N3O6/c1-26-22-40(27(2)25-41)37(43)33-21-31(38-36(42)30-12-7-6-8-13-30)16-19-34(33)46-28(3)11-9-10-20-45-35(26)24-39(4)23-29-14-17-32(44-5)18-15-29/h14-19,21,26-28,30,35,41H,6-13,20,22-25H2,1-5H3,(H,38,42)/t26-,27-,28-,35-/m1/s1",
        "inchikey": "UVSCGJDGVAXROK-FCSDHKMCSA-N",
        "iupac": {
          "systematic": "N-[(3R,9S,10R)-12-[(2R)-1-hydroxypropan-2-yl]-9-[[(4-methoxyphenyl)methyl-methylamino]methyl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]cyclohexanecarboxamide"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NC(=O)C3CCCCC3)C(C)CO)C)CN(C)CC4=CC=C(C=C4)OC"
        },
        "molecularFormula": "C37H55N3O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:01:03Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85fd"
    },
    "name": "BRD-K06127304",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85fd.png",
    "lincs": {
      "id": "LSM-8783",
      "name": "BRD-K06127304",
      "pubchemCid": 54646684,
      "chebiId": 97404,
      "inchiParent": "InChI=1S/C27H33N3O5/c1-29(2)15-25(32)28-19-7-8-23-21(11-19)22-12-20(34-24(16-31)27(22)35-23)13-26(33)30-10-9-17-5-3-4-6-18(17)14-30/h3-8,11,20,22,24,27,31H,9-10,12-16H2,1-2H3,(H,28,32)/t20-,22+,24-,27-/m1/s1",
      "inchiKeyParent": "AJOHYGOUUFRWKL-YIPBLFEHSA-N",
      "smilesParent": "CN(C)CC(=O)Nc1ccc2O[C@H]3[C@@H](CO)O[C@@H](CC(=O)N4CCc5ccccc5C4)C[C@H]3c2c1"
    },
    "unichem": {
      "chebi": "97404",
      "lincs": "LSM-8783",
      "pubchem": "54646684"
    },
    "pubchem": [
      {
        "cid": 54646684,
        "inchi": "InChI=1S/C27H33N3O5/c1-29(2)15-25(32)28-19-7-8-23-21(11-19)22-12-20(34-24(16-31)27(22)35-23)13-26(33)30-10-9-17-5-3-4-6-18(17)14-30/h3-8,11,20,22,24,27,31H,9-10,12-16H2,1-2H3,(H,28,32)/t20-,22+,24-,27-/m1/s1",
        "inchikey": "AJOHYGOUUFRWKL-YIPBLFEHSA-N",
        "iupac": {
          "systematic": "N-[(1R,3R,4aS,9aR)-3-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]-2-(dimethylamino)acetamide"
        },
        "smiles": {
          "canonical": "CN(C)CC(=O)NC1=CC2=C(C=C1)OC3C2CC(OC3CO)CC(=O)N4CCC5=CC=CC=C5C4"
        },
        "molecularFormula": "C27H33N3O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:01:06Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8544"
    },
    "name": "CHEMBL2359872",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8544.png",
    "lincs": {
      "id": "LSM-13378",
      "name": "CHEMBL2359872",
      "alternativeNames": [
        "BRD-K80881992"
      ],
      "pubchemCid": 54649448,
      "chebiId": 102017,
      "inchiParent": "InChI=1S/C29H34FN3O3S/c1-5-13-31-28(35)24-17-22-18-33(37(36)29(2,3)4)25(12-14-34)26(22)27(32-24)21-10-6-8-19(15-21)20-9-7-11-23(30)16-20/h6-11,15-17,25,34H,5,12-14,18H2,1-4H3,(H,31,35)/t25-,37-/m0/s1",
      "inchiKeyParent": "FSCHPCZBUZXFPL-RSUXDYMJSA-N",
      "smilesParent": "CCCNC(=O)c1cc2CN([C@@H](CCO)c2c(n1)c3cccc(c3)c4cccc(F)c4)[S@@](=O)C(C)(C)C"
    },
    "unichem": {
      "chebi": "102017",
      "chembl": "CHEMBL2359872",
      "lincs": "LSM-13378",
      "pubchem": "54649448"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL2359872",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 523.67,
        "hba": 5,
        "hbd": 2,
        "qedWeighted": 0.39
      }
    },
    "pubchem": [
      {
        "cid": 54649448,
        "inchi": "InChI=1S/C29H34FN3O3S/c1-5-13-31-28(35)24-17-22-18-33(37(36)29(2,3)4)25(12-14-34)26(22)27(32-24)21-10-6-8-19(15-21)20-9-7-11-23(30)16-20/h6-11,15-17,25,34H,5,12-14,18H2,1-4H3,(H,31,35)/t25-,37-/m0/s1",
        "inchikey": "FSCHPCZBUZXFPL-RSUXDYMJSA-N",
        "iupac": {
          "systematic": "(3S)-2-[(S)-tert-butylsulfinyl]-4-[3-(3-fluorophenyl)phenyl]-3-(2-hydroxyethyl)-N-propyl-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide"
        },
        "smiles": {
          "canonical": "CCCNC(=O)C1=NC(=C2C(N(CC2=C1)S(=O)C(C)(C)C)CCO)C3=CC=CC(=C3)C4=CC(=CC=C4)F"
        },
        "molecularFormula": "C29H34FN3O3S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:01:17Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8548"
    },
    "name": "BRD-K02917242",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8548.png",
    "lincs": {
      "id": "LSM-37430",
      "name": "BRD-K02917242",
      "pubchemCid": 54615092,
      "chebiId": 125863,
      "inchiParent": "InChI=1S/C32H49N5O6/c1-20-16-37(21(2)19-38)31(39)27-15-26(33-32(40)34-30-23(4)35-43-24(30)5)12-13-28(27)42-22(3)9-7-8-14-41-29(20)18-36(6)17-25-10-11-25/h12-13,15,20-22,25,29,38H,7-11,14,16-19H2,1-6H3,(H2,33,34,40)/t20-,21+,22-,29+/m1/s1",
      "inchiKeyParent": "JVILTGOVTWEXFK-FGUSOFTRSA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@@H](C)[C@H](CN(C)CC2CC2)OCCCC[C@@H](C)Oc3ccc(NC(=O)Nc4c(C)onc4C)cc3C1=O"
    },
    "unichem": {
      "chebi": "125863",
      "lincs": "LSM-37430",
      "pubchem": "54615092"
    },
    "pubchem": [
      {
        "cid": 54615092,
        "inchi": "InChI=1S/C32H49N5O6/c1-20-16-37(21(2)19-38)31(39)27-15-26(33-32(40)34-30-23(4)35-43-24(30)5)12-13-28(27)42-22(3)9-7-8-14-41-29(20)18-36(6)17-25-10-11-25/h12-13,15,20-22,25,29,38H,7-11,14,16-19H2,1-6H3,(H2,33,34,40)/t20-,21+,22-,29+/m1/s1",
        "inchikey": "JVILTGOVTWEXFK-FGUSOFTRSA-N",
        "iupac": {
          "systematic": "1-[(3R,9R,10R)-9-[[cyclopropylmethyl(methyl)amino]methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-(3,5-dimethyl-1,2-oxazol-4-yl)urea"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NC(=O)NC3=C(ON=C3C)C)C(C)CO)C)CN(C)CC4CC4"
        },
        "molecularFormula": "C32H49N5O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:01:19Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8554"
    },
    "name": "BRD-K82370171",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8554.png",
    "lincs": {
      "id": "LSM-13462",
      "name": "BRD-K82370171",
      "pubchemCid": 54646184,
      "chebiId": 102102,
      "inchiParent": "InChI=1S/C28H34N2O7/c1-34-23-5-3-2-4-18(23)15-29-26(32)14-20-13-22-21-12-19(30-28(33)17-8-10-35-11-9-17)6-7-24(21)37-27(22)25(16-31)36-20/h2-7,12,17,20,22,25,27,31H,8-11,13-16H2,1H3,(H,29,32)(H,30,33)/t20-,22-,25+,27+/m0/s1",
      "inchiKeyParent": "FSAONXZLMNAVLZ-ZTQIFVIOSA-N",
      "smilesParent": "COc1ccccc1CNC(=O)C[C@@H]2C[C@@H]3[C@@H](Oc4ccc(NC(=O)C5CCOCC5)cc34)[C@@H](CO)O2"
    },
    "unichem": {
      "chebi": "102102",
      "lincs": "LSM-13462",
      "pubchem": "54646184"
    },
    "pubchem": [
      {
        "cid": 54646184,
        "inchi": "InChI=1S/C28H34N2O7/c1-34-23-5-3-2-4-18(23)15-29-26(32)14-20-13-22-21-12-19(30-28(33)17-8-10-35-11-9-17)6-7-24(21)37-27(22)25(16-31)36-20/h2-7,12,17,20,22,25,27,31H,8-11,13-16H2,1H3,(H,29,32)(H,30,33)/t20-,22-,25+,27+/m0/s1",
        "inchikey": "FSAONXZLMNAVLZ-ZTQIFVIOSA-N",
        "iupac": {
          "systematic": "N-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-[(2-methoxyphenyl)methylamino]-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]oxane-4-carboxamide"
        },
        "smiles": {
          "canonical": "COC1=CC=CC=C1CNC(=O)CC2CC3C(C(O2)CO)OC4=C3C=C(C=C4)NC(=O)C5CCOCC5"
        },
        "molecularFormula": "C28H34N2O7"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:01:21Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8580"
    },
    "name": "BRD-K19004531",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8580.png",
    "lincs": {
      "id": "LSM-38289",
      "name": "BRD-K19004531",
      "pubchemCid": 60185071,
      "chebiId": 126726,
      "inchiParent": "InChI=1S/C24H28N4O3/c1-31-17-4-5-18-19(12-17)27-23-20(14-29)26-15-24(22(18)23)6-9-28(10-7-24)21(30)11-16-3-2-8-25-13-16/h2-5,8,12-13,20,26-27,29H,6-7,9-11,14-15H2,1H3/t20-/m0/s1",
      "inchiKeyParent": "NZUADFBIDGBVNA-FQEVSTJZSA-N",
      "smilesParent": "COc1ccc2c3c([nH]c2c1)[C@H](CO)NCC34CCN(CC4)C(=O)Cc5cccnc5"
    },
    "unichem": {
      "chebi": "126726",
      "lincs": "LSM-38289",
      "pubchem": "60185071"
    },
    "pubchem": [
      {
        "cid": 60185071,
        "inchi": "InChI=1S/C24H28N4O3/c1-31-17-4-5-18-19(12-17)27-23-20(14-29)26-15-24(22(18)23)6-9-28(10-7-24)21(30)11-16-3-2-8-25-13-16/h2-5,8,12-13,20,26-27,29H,6-7,9-11,14-15H2,1H3/t20-/m0/s1",
        "inchikey": "NZUADFBIDGBVNA-FQEVSTJZSA-N",
        "iupac": {
          "systematic": "1-[(1R)-1-(hydroxymethyl)-7-methoxyspiro[1,2,3,9-tetrahydropyrido[3,4-b]indole-4,4'-piperidine]-1'-yl]-2-pyridin-3-ylethanone"
        },
        "smiles": {
          "canonical": "COC1=CC2=C(C=C1)C3=C(N2)C(NCC34CCN(CC4)C(=O)CC5=CN=CC=C5)CO"
        },
        "molecularFormula": "C24H28N4O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:01:24Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85ac"
    },
    "name": "BRD-K62744999",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85ac.png",
    "lincs": {
      "id": "LSM-40703",
      "name": "BRD-K62744999",
      "pubchemCid": 54652689,
      "chebiId": 129152,
      "inchiParent": "InChI=1S/C16H23N3O2/c1-10(2)17-16(21)19-13-8-18(3)12-7-5-4-6-11(12)15(13)14(19)9-20/h4-7,10,13-15,20H,8-9H2,1-3H3,(H,17,21)/t13-,14-,15+/m1/s1",
      "inchiKeyParent": "QBCXEZHQPAEOAK-KFWWJZLASA-N",
      "smilesParent": "CC(C)NC(=O)N1[C@H](CO)[C@@H]2[C@H]1CN(C)c3ccccc23"
    },
    "unichem": {
      "chebi": "129152",
      "lincs": "LSM-40703",
      "pubchem": "54652689"
    },
    "pubchem": [
      {
        "cid": 54652689,
        "inchi": "InChI=1S/C16H23N3O2/c1-10(2)17-16(21)19-13-8-18(3)12-7-5-4-6-11(12)15(13)14(19)9-20/h4-7,10,13-15,20H,8-9H2,1-3H3,(H,17,21)/t13-,14-,15+/m1/s1",
        "inchikey": "QBCXEZHQPAEOAK-KFWWJZLASA-N",
        "iupac": {
          "systematic": "(1S,2aS,8bS)-1-(hydroxymethyl)-4-methyl-N-propan-2-yl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-2-carboxamide"
        },
        "smiles": {
          "canonical": "CC(C)NC(=O)N1C2CN(C3=CC=CC=C3C2C1CO)C"
        },
        "molecularFormula": "C16H23N3O2"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:01:26Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85ae"
    },
    "name": "BRD-K43931839",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85ae.png",
    "lincs": {
      "id": "LSM-11109",
      "name": "BRD-K43931839",
      "pubchemCid": 54654137,
      "chebiId": 99730,
      "inchiParent": "InChI=1S/C32H37N5O6/c1-18-30(19(2)43-36-18)35-32(40)34-23-10-13-27-25(15-23)31(39)37(3)26-12-11-24(42-28(26)17-41-27)16-29(38)33-22-9-8-20-6-4-5-7-21(20)14-22/h8-10,13-15,24,26,28H,4-7,11-12,16-17H2,1-3H3,(H,33,38)(H2,34,35,40)/t24-,26+,28-/m1/s1",
      "inchiKeyParent": "PMBFMNXVRNVJKX-MAARLIENSA-N",
      "smilesParent": "CN1[C@H]2CC[C@H](CC(=O)Nc3ccc4CCCCc4c3)O[C@@H]2COc5ccc(NC(=O)Nc6c(C)onc6C)cc5C1=O"
    },
    "unichem": {
      "chebi": "99730",
      "lincs": "LSM-11109",
      "pubchem": "54654137"
    },
    "pubchem": [
      {
        "cid": 54654137,
        "inchi": "InChI=1S/C32H37N5O6/c1-18-30(19(2)43-36-18)35-32(40)34-23-10-13-27-25(15-23)31(39)37(3)26-12-11-24(42-28(26)17-41-27)16-29(38)33-22-9-8-20-6-4-5-7-21(20)14-22/h8-10,13-15,24,26,28H,4-7,11-12,16-17H2,1-3H3,(H,33,38)(H2,34,35,40)/t24-,26+,28-/m1/s1",
        "inchikey": "PMBFMNXVRNVJKX-MAARLIENSA-N",
        "iupac": {
          "systematic": "2-[(2R,4aS,12aS)-8-[(3,5-dimethyl-1,2-oxazol-4-yl)carbamoylamino]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(5,6,7,8-tetrahydronaphthalen-2-yl)acetamide"
        },
        "smiles": {
          "canonical": "CC1=C(C(=NO1)C)NC(=O)NC2=CC3=C(C=C2)OCC4C(CCC(O4)CC(=O)NC5=CC6=C(CCCC6)C=C5)N(C3=O)C"
        },
        "molecularFormula": "C32H37N5O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:01:28Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85b6"
    },
    "name": "BRD-K67787765",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85b6.png",
    "lincs": {
      "id": "LSM-14901",
      "name": "BRD-K67787765",
      "pubchemCid": 44619149,
      "chebiId": 103557,
      "inchiParent": "InChI=1S/C33H54N4O6/c1-22(2)34-33(41)36(6)20-30-23(3)19-37(24(4)21-38)32(40)28-18-27(35-31(39)26-13-8-7-9-14-26)15-16-29(28)43-25(5)12-10-11-17-42-30/h15-16,18,22-26,30,38H,7-14,17,19-21H2,1-6H3,(H,34,41)(H,35,39)/t23-,24+,25-,30-/m1/s1",
      "inchiKeyParent": "PLFJTCJSGHSPAZ-FJRSXGRASA-N",
      "smilesParent": "CC(C)NC(=O)N(C)C[C@H]1OCCCC[C@@H](C)Oc2ccc(NC(=O)C3CCCCC3)cc2C(=O)N(C[C@H]1C)[C@@H](C)CO"
    },
    "unichem": {
      "chebi": "103557",
      "lincs": "LSM-14901",
      "pubchem": "44619149"
    },
    "pubchem": [
      {
        "cid": 44619149,
        "inchi": "InChI=1S/C33H54N4O6/c1-22(2)34-33(41)36(6)20-30-23(3)19-37(24(4)21-38)32(40)28-18-27(35-31(39)26-13-8-7-9-14-26)15-16-29(28)43-25(5)12-10-11-17-42-30/h15-16,18,22-26,30,38H,7-14,17,19-21H2,1-6H3,(H,34,41)(H,35,39)/t23-,24+,25-,30-/m1/s1",
        "inchikey": "PLFJTCJSGHSPAZ-FJRSXGRASA-N",
        "iupac": {
          "systematic": "N-[(3R,9S,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(propan-2-ylcarbamoyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]cyclohexanecarboxamide"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NC(=O)C3CCCCC3)C(C)CO)C)CN(C)C(=O)NC(C)C"
        },
        "molecularFormula": "C33H54N4O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:01:31Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8609"
    },
    "name": "BRD-K09817289",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8609.png",
    "lincs": {
      "id": "LSM-9028",
      "name": "BRD-K09817289",
      "pubchemCid": 54661328,
      "chebiId": 97649,
      "inchiParent": "InChI=1S/C21H31N3O3/c1-2-22-21(27)20-16(13-25)15-12-23-17(9-6-10-18(23)26)19(15)24(20)11-14-7-4-3-5-8-14/h6,9-10,14-16,19-20,25H,2-5,7-8,11-13H2,1H3,(H,22,27)/t15-,16-,19+,20-/m0/s1",
      "inchiKeyParent": "ZLPHSXDBJGBVPE-FEHORTKBSA-N",
      "smilesParent": "CCNC(=O)[C@@H]1[C@@H](CO)[C@@H]2CN3C(=O)C=CC=C3[C@@H]2N1CC4CCCCC4"
    },
    "unichem": {
      "chebi": "97649",
      "lincs": "LSM-9028",
      "pubchem": "54661328"
    },
    "pubchem": [
      {
        "cid": 54661328,
        "inchi": "InChI=1S/C21H31N3O3/c1-2-22-21(27)20-16(13-25)15-12-23-17(9-6-10-18(23)26)19(15)24(20)11-14-7-4-3-5-8-14/h6,9-10,14-16,19-20,25H,2-5,7-8,11-13H2,1H3,(H,22,27)/t15-,16-,19+,20-/m0/s1",
        "inchikey": "ZLPHSXDBJGBVPE-FEHORTKBSA-N",
        "iupac": {
          "systematic": "(2S,3S,3aR,9bR)-1-(cyclohexylmethyl)-N-ethyl-3-(hydroxymethyl)-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide"
        },
        "smiles": {
          "canonical": "CCNC(=O)C1C(C2CN3C(=O)C=CC=C3C2N1CC4CCCCC4)CO"
        },
        "molecularFormula": "C21H31N3O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:01:33Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c860f"
    },
    "name": "BRD-K75034919",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c860f.png",
    "lincs": {
      "id": "LSM-41358",
      "name": "BRD-K75034919",
      "pubchemCid": 54652600,
      "chebiId": 129807,
      "inchiParent": "InChI=1S/C21H23N3O4/c1-13(26)24-17-11-23(21(27)22-15-8-4-6-10-19(15)28-2)16-9-5-3-7-14(16)20(17)18(24)12-25/h3-10,17-18,20,25H,11-12H2,1-2H3,(H,22,27)/t17-,18+,20+/m1/s1",
      "inchiKeyParent": "QJDNWBNBGNMAFV-HBFSDRIKSA-N",
      "smilesParent": "COc1ccccc1NC(=O)N2C[C@@H]3[C@@H]([C@H](CO)N3C(=O)C)c4ccccc24"
    },
    "unichem": {
      "chebi": "129807",
      "lincs": "LSM-41358",
      "pubchem": "54652600"
    },
    "pubchem": [
      {
        "cid": 54652600,
        "inchi": "InChI=1S/C21H23N3O4/c1-13(26)24-17-11-23(21(27)22-15-8-4-6-10-19(15)28-2)16-9-5-3-7-14(16)20(17)18(24)12-25/h3-10,17-18,20,25H,11-12H2,1-2H3,(H,22,27)/t17-,18+,20+/m1/s1",
        "inchikey": "QJDNWBNBGNMAFV-HBFSDRIKSA-N",
        "iupac": {
          "systematic": "(1R,2aS,8bS)-2-acetyl-1-(hydroxymethyl)-N-(2-methoxyphenyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide"
        },
        "smiles": {
          "canonical": "CC(=O)N1C2CN(C3=CC=CC=C3C2C1CO)C(=O)NC4=CC=CC=C4OC"
        },
        "molecularFormula": "C21H23N3O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:01:35Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c861d"
    },
    "name": "BRD-K35046689",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c861d.png",
    "lincs": {
      "id": "LSM-39189",
      "name": "BRD-K35046689",
      "pubchemCid": 60189950,
      "chebiId": 127632,
      "inchiParent": "InChI=1S/C24H35N3O5S/c1-5-7-21(29)27-16-24(10-12-26(13-11-24)33(30,31)6-2)22-18-9-8-17(32-4)14-19(18)25(3)23(22)20(27)15-28/h8-9,14,20,28H,5-7,10-13,15-16H2,1-4H3/t20-/m0/s1",
      "inchiKeyParent": "MJMXLJSDDFUPOG-FQEVSTJZSA-N",
      "smilesParent": "CCCC(=O)N1CC2(CCN(CC2)S(=O)(=O)CC)c3c([C@@H]1CO)n(C)c4cc(OC)ccc34"
    },
    "unichem": {
      "chebi": "127632",
      "lincs": "LSM-39189",
      "pubchem": "60189950"
    },
    "pubchem": [
      {
        "cid": 60189950,
        "inchi": "InChI=1S/C24H35N3O5S/c1-5-7-21(29)27-16-24(10-12-26(13-11-24)33(30,31)6-2)22-18-9-8-17(32-4)14-19(18)25(3)23(22)20(27)15-28/h8-9,14,20,28H,5-7,10-13,15-16H2,1-4H3/t20-/m0/s1",
        "inchikey": "MJMXLJSDDFUPOG-FQEVSTJZSA-N",
        "iupac": {
          "systematic": "1-[(1R)-1'-ethylsulfonyl-1-(hydroxymethyl)-7-methoxy-9-methylspiro[1,3-dihydropyrido[3,4-b]indole-4,4'-piperidine]-2-yl]butan-1-one"
        },
        "smiles": {
          "canonical": "CCCC(=O)N1CC2(CCN(CC2)S(=O)(=O)CC)C3=C(C1CO)N(C4=C3C=CC(=C4)OC)C"
        },
        "molecularFormula": "C24H35N3O5S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:01:37Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8511"
    },
    "name": "CHEMBL3181937",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8511.png",
    "lincs": {
      "id": "LSM-44548",
      "name": "CHEMBL3181937",
      "alternativeNames": [
        "BRD-K30958256",
        "BRD-K72098339"
      ],
      "pubchemCid": 60185096,
      "inchiParent": "InChI=1S/C28H30N2O2/c1-31-24-14-22(15-25(16-24)32-2)17-30-18-26-28(27(19-30)29-26)23-12-10-21(11-13-23)9-8-20-6-4-3-5-7-20/h3-16,26-29H,17-19H2,1-2H3/b9-8+/t26-,27+,28?",
      "inchiKeyParent": "IDJJNZCYLDKCGS-INFKGONOSA-N",
      "smilesParent": "COc1cc(CN2C[C@@H]3N[C@H](C2)[C@@H]3c4ccc(\\C=C\\c5ccccc5)cc4)cc(OC)c1"
    },
    "unichem": {
      "lincs": "LSM-44548",
      "pubchem": "60185096"
    },
    "pubchem": [
      {
        "cid": 60185096,
        "inchi": "InChI=1S/C28H30N2O2/c1-31-24-14-22(15-25(16-24)32-2)17-30-18-26-28(27(19-30)29-26)23-12-10-21(11-13-23)9-8-20-6-4-3-5-7-20/h3-16,26-29H,17-19H2,1-2H3/b9-8+/t26-,27+,28?",
        "inchikey": "IDJJNZCYLDKCGS-INFKGONOSA-N",
        "iupac": {
          "systematic": "(1R,5S)-3-[(3,5-dimethoxyphenyl)methyl]-7-[4-[(E)-2-phenylethenyl]phenyl]-3,6-diazabicyclo[3.1.1]heptane"
        },
        "smiles": {
          "canonical": "COC1=CC(=CC(=C1)CN2CC3C(C(C2)N3)C4=CC=C(C=C4)C=CC5=CC=CC=C5)OC"
        },
        "molecularFormula": "C28H30N2O2"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:01:40Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c854f"
    },
    "name": "BRD-K99395085",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c854f.png",
    "lincs": {
      "id": "LSM-42650",
      "name": "BRD-K99395085",
      "pubchemCid": 44498248,
      "chebiId": 131102,
      "inchiParent": "InChI=1S/C31H45Cl2N3O4/c1-21-17-36(22(2)20-37)31(38)26-16-25(34(4)5)11-13-29(26)40-23(3)9-7-8-14-39-30(21)19-35(6)18-24-10-12-27(32)28(33)15-24/h10-13,15-16,21-23,30,37H,7-9,14,17-20H2,1-6H3/t21-,22-,23-,30+/m1/s1",
      "inchiKeyParent": "HDXBPNDJZFTSGZ-BCSOFFBWSA-N",
      "smilesParent": "C[C@H](CO)N1C[C@@H](C)[C@H](CN(C)Cc2ccc(Cl)c(Cl)c2)OCCCC[C@@H](C)Oc3ccc(cc3C1=O)N(C)C"
    },
    "unichem": {
      "chebi": "131102",
      "lincs": "LSM-42650",
      "pubchem": "44498248"
    },
    "pubchem": [
      {
        "cid": 44498248,
        "inchi": "InChI=1S/C31H45Cl2N3O4/c1-21-17-36(22(2)20-37)31(38)26-16-25(34(4)5)11-13-29(26)40-23(3)9-7-8-14-39-30(21)19-35(6)18-24-10-12-27(32)28(33)15-24/h10-13,15-16,21-23,30,37H,7-9,14,17-20H2,1-6H3/t21-,22-,23-,30+/m1/s1",
        "inchikey": "HDXBPNDJZFTSGZ-BCSOFFBWSA-N",
        "iupac": {
          "systematic": "(3R,9R,10R)-9-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-13-one"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)N(C)C)C(C)CO)C)CN(C)CC3=CC(=C(C=C3)Cl)Cl"
        },
        "molecularFormula": "C31H45Cl2N3O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:01:43Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85bd"
    },
    "name": "BRD-K55875111",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85bd.png",
    "lincs": {
      "id": "LSM-11813",
      "name": "BRD-K55875111",
      "pubchemCid": 54657699,
      "chebiId": 100438,
      "inchiParent": "InChI=1S/C19H27N3O5/c1-2-20-18(24)9-14-6-7-16-17(27-14)12-26-11-13(23)10-22(16)19(25)15-5-3-4-8-21-15/h3-5,8,13-14,16-17,23H,2,6-7,9-12H2,1H3,(H,20,24)/t13-,14-,16-,17+/m0/s1",
      "inchiKeyParent": "XTMFCURZJJHNFP-NXNVCVFFSA-N",
      "smilesParent": "CCNC(=O)C[C@@H]1CC[C@H]2[C@@H](COC[C@@H](O)CN2C(=O)c3ccccn3)O1"
    },
    "unichem": {
      "chebi": "100438",
      "lincs": "LSM-11813",
      "pubchem": "54657699"
    },
    "pubchem": [
      {
        "cid": 54657699,
        "inchi": "InChI=1S/C19H27N3O5/c1-2-20-18(24)9-14-6-7-16-17(27-14)12-26-11-13(23)10-22(16)19(25)15-5-3-4-8-21-15/h3-5,8,13-14,16-17,23H,2,6-7,9-12H2,1H3,(H,20,24)/t13-,14-,16-,17+/m0/s1",
        "inchikey": "XTMFCURZJJHNFP-NXNVCVFFSA-N",
        "iupac": {
          "systematic": "2-[(3S,6aS,8S,10aS)-3-hydroxy-1-(pyridine-2-carbonyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-ethylacetamide"
        },
        "smiles": {
          "canonical": "CCNC(=O)CC1CCC2C(O1)COCC(CN2C(=O)C3=CC=CC=N3)O"
        },
        "molecularFormula": "C19H27N3O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:01:45Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c862f"
    },
    "name": "BRD-K33841609",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c862f.png",
    "lincs": {
      "id": "LSM-39119",
      "name": "BRD-K33841609",
      "pubchemCid": 60190000,
      "chebiId": 127562,
      "inchiParent": "InChI=1S/C27H30F2N4O3/c1-31-22-10-18(36-2)6-7-19(22)24-25(31)23(12-34)32(11-16-3-4-16)13-27(24)14-33(15-27)26(35)30-21-8-5-17(28)9-20(21)29/h5-10,16,23,34H,3-4,11-15H2,1-2H3,(H,30,35)/t23-/m0/s1",
      "inchiKeyParent": "ANGGGRIYABJACC-QHCPKHFHSA-N",
      "smilesParent": "COc1ccc2c3c([C@H](CO)N(CC4CC4)CC35CN(C5)C(=O)Nc6ccc(F)cc6F)n(C)c2c1"
    },
    "unichem": {
      "chebi": "127562",
      "lincs": "LSM-39119",
      "pubchem": "60190000"
    },
    "pubchem": [
      {
        "cid": 60190000,
        "inchi": "InChI=1S/C27H30F2N4O3/c1-31-22-10-18(36-2)6-7-19(22)24-25(31)23(12-34)32(11-16-3-4-16)13-27(24)14-33(15-27)26(35)30-21-8-5-17(28)9-20(21)29/h5-10,16,23,34H,3-4,11-15H2,1-2H3,(H,30,35)/t23-/m0/s1",
        "inchikey": "ANGGGRIYABJACC-QHCPKHFHSA-N",
        "iupac": {
          "systematic": "(1R)-2-(cyclopropylmethyl)-N-(2,4-difluorophenyl)-1-(hydroxymethyl)-7-methoxy-9-methylspiro[1,3-dihydropyrido[3,4-b]indole-4,3'-azetidine]-1'-carboxamide"
        },
        "smiles": {
          "canonical": "CN1C2=C(C=CC(=C2)OC)C3=C1C(N(CC34CN(C4)C(=O)NC5=C(C=C(C=C5)F)F)CC6CC6)CO"
        },
        "molecularFormula": "C27H30F2N4O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:01:47Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8523"
    },
    "name": "BRD-K53220080",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8523.png",
    "lincs": {
      "id": "LSM-14859",
      "name": "BRD-K53220080",
      "pubchemCid": 54614990,
      "chebiId": 103515,
      "inchiParent": "InChI=1S/C32H49N5O5/c1-22(2)34-32(40)35-27-10-11-29-28(17-27)31(39)37(24(4)21-38)18-23(3)30(41-16-8-7-9-25(5)42-29)20-36(6)19-26-12-14-33-15-13-26/h10-15,17,22-25,30,38H,7-9,16,18-21H2,1-6H3,(H2,34,35,40)/t23-,24+,25-,30+/m1/s1",
      "inchiKeyParent": "YBLKRDGTGIUFGT-ZXPXOXBPSA-N",
      "smilesParent": "CC(C)NC(=O)Nc1ccc2O[C@H](C)CCCCO[C@@H](CN(C)Cc3ccncc3)[C@H](C)CN([C@@H](C)CO)C(=O)c2c1"
    },
    "unichem": {
      "chebi": "103515",
      "lincs": "LSM-14859",
      "pubchem": "54614990"
    },
    "pubchem": [
      {
        "cid": 54614990,
        "inchi": "InChI=1S/C32H49N5O5/c1-22(2)34-32(40)35-27-10-11-29-28(17-27)31(39)37(24(4)21-38)18-23(3)30(41-16-8-7-9-25(5)42-29)20-36(6)19-26-12-14-33-15-13-26/h10-15,17,22-25,30,38H,7-9,16,18-21H2,1-6H3,(H2,34,35,40)/t23-,24+,25-,30+/m1/s1",
        "inchikey": "YBLKRDGTGIUFGT-ZXPXOXBPSA-N",
        "iupac": {
          "systematic": "1-[(3R,9R,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-propan-2-ylurea"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NC(=O)NC(C)C)C(C)CO)C)CN(C)CC3=CC=NC=C3"
        },
        "molecularFormula": "C32H49N5O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:01:49Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8545"
    },
    "name": "BRD-K68148111",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8545.png",
    "lincs": {
      "id": "LSM-12581",
      "name": "BRD-K68148111",
      "pubchemCid": 54657620,
      "chebiId": 101212,
      "inchiParent": "InChI=1S/C19H32N2O5/c1-20(2)18(23)9-15-7-8-16-17(26-15)12-25-11-14(22)10-21(16)19(24)13-5-3-4-6-13/h13-17,22H,3-12H2,1-2H3/t14-,15-,16+,17-/m0/s1",
      "inchiKeyParent": "XUIBJKJBLJUMMA-NXOAAHMSSA-N",
      "smilesParent": "CN(C)C(=O)C[C@@H]1CC[C@@H]2[C@H](COC[C@@H](O)CN2C(=O)C3CCCC3)O1"
    },
    "unichem": {
      "chebi": "101212",
      "lincs": "LSM-12581",
      "pubchem": "54657620"
    },
    "pubchem": [
      {
        "cid": 54657620,
        "inchi": "InChI=1S/C19H32N2O5/c1-20(2)18(23)9-15-7-8-16-17(26-15)12-25-11-14(22)10-21(16)19(24)13-5-3-4-6-13/h13-17,22H,3-12H2,1-2H3/t14-,15-,16+,17-/m0/s1",
        "inchikey": "XUIBJKJBLJUMMA-NXOAAHMSSA-N",
        "iupac": {
          "systematic": "2-[(3S,6aR,8S,10aR)-1-(cyclopentanecarbonyl)-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N,N-dimethylacetamide"
        },
        "smiles": {
          "canonical": "CN(C)C(=O)CC1CCC2C(O1)COCC(CN2C(=O)C3CCCC3)O"
        },
        "molecularFormula": "C19H32N2O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:01:51Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c854b"
    },
    "name": "BRD-K19084671",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c854b.png",
    "lincs": {
      "id": "LSM-9576",
      "name": "BRD-K19084671",
      "pubchemCid": 54646342,
      "chebiId": 98197,
      "inchiParent": "InChI=1S/C27H30F2N2O6/c28-17-1-3-22(29)16(9-17)13-30-25(33)12-19-11-21-20-10-18(31-27(34)15-5-7-35-8-6-15)2-4-23(20)37-26(21)24(14-32)36-19/h1-4,9-10,15,19,21,24,26,32H,5-8,11-14H2,(H,30,33)(H,31,34)/t19-,21-,24+,26+/m0/s1",
      "inchiKeyParent": "UVPONYOZSFJNDG-FBNDAJROSA-N",
      "smilesParent": "OC[C@H]1O[C@H](CC(=O)NCc2cc(F)ccc2F)C[C@@H]3[C@H]1Oc4ccc(NC(=O)C5CCOCC5)cc34"
    },
    "unichem": {
      "chebi": "98197",
      "lincs": "LSM-9576",
      "pubchem": "54646342"
    },
    "pubchem": [
      {
        "cid": 54646342,
        "inchi": "InChI=1S/C27H30F2N2O6/c28-17-1-3-22(29)16(9-17)13-30-25(33)12-19-11-21-20-10-18(31-27(34)15-5-7-35-8-6-15)2-4-23(20)37-26(21)24(14-32)36-19/h1-4,9-10,15,19,21,24,26,32H,5-8,11-14H2,(H,30,33)(H,31,34)/t19-,21-,24+,26+/m0/s1",
        "inchikey": "UVPONYOZSFJNDG-FBNDAJROSA-N",
        "iupac": {
          "systematic": "N-[(1R,3S,4aS,9aR)-3-[2-[(2,5-difluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]oxane-4-carboxamide"
        },
        "smiles": {
          "canonical": "C1COCCC1C(=O)NC2=CC3=C(C=C2)OC4C3CC(OC4CO)CC(=O)NCC5=C(C=CC(=C5)F)F"
        },
        "molecularFormula": "C27H30F2N2O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:01:53Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8557"
    },
    "name": "BRD-K40123546",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8557.png",
    "lincs": {
      "id": "LSM-10877",
      "name": "BRD-K40123546",
      "pubchemCid": 54650032,
      "chebiId": 99498,
      "inchiParent": "InChI=1S/C18H18N2O2/c1-22-17-5-3-2-4-14(17)12-6-8-13(9-7-12)18-15(10-19)20-16(18)11-21/h2-9,15-16,18,20-21H,11H2,1H3/t15-,16-,18+/m0/s1",
      "inchiKeyParent": "BGJLKNVJWQWPQD-XYJFISCASA-N",
      "smilesParent": "COc1ccccc1c2ccc(cc2)[C@H]3[C@H](CO)N[C@H]3C#N"
    },
    "unichem": {
      "chebi": "99498",
      "lincs": "LSM-10877",
      "pubchem": "54650032"
    },
    "pubchem": [
      {
        "cid": 54650032,
        "inchi": "InChI=1S/C18H18N2O2/c1-22-17-5-3-2-4-14(17)12-6-8-13(9-7-12)18-15(10-19)20-16(18)11-21/h2-9,15-16,18,20-21H,11H2,1H3/t15-,16-,18+/m0/s1",
        "inchikey": "BGJLKNVJWQWPQD-XYJFISCASA-N",
        "iupac": {
          "systematic": "(2R,3R,4R)-4-(hydroxymethyl)-3-[4-(2-methoxyphenyl)phenyl]azetidine-2-carbonitrile"
        },
        "smiles": {
          "canonical": "COC1=CC=CC=C1C2=CC=C(C=C2)C3C(NC3C#N)CO"
        },
        "molecularFormula": "C18H18N2O2"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:01:56Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8571"
    },
    "name": "BRD-K88045846",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8571.png",
    "lincs": {
      "id": "LSM-13834",
      "name": "BRD-K88045846",
      "pubchemCid": 54639154,
      "chebiId": 131227,
      "inchiParent": "InChI=1S/C20H26N4O5S/c25-13-19-17(24-20(26)18-12-21-10-11-22-18)7-6-16(29-19)8-9-23-30(27,28)14-15-4-2-1-3-5-15/h1-5,10-12,16-17,19,23,25H,6-9,13-14H2,(H,24,26)/t16-,17-,19+/m1/s1",
      "inchiKeyParent": "JKKDNXFJBMMQFP-LMMKCTJWSA-N",
      "smilesParent": "OC[C@@H]1O[C@@H](CCNS(=O)(=O)Cc2ccccc2)CC[C@H]1NC(=O)c3cnccn3"
    },
    "unichem": {
      "chebi": "131227",
      "lincs": "LSM-13834",
      "pubchem": "54639154"
    },
    "pubchem": [
      {
        "cid": 54639154,
        "inchi": "InChI=1S/C20H26N4O5S/c25-13-19-17(24-20(26)18-12-21-10-11-22-18)7-6-16(29-19)8-9-23-30(27,28)14-15-4-2-1-3-5-15/h1-5,10-12,16-17,19,23,25H,6-9,13-14H2,(H,24,26)/t16-,17-,19+/m1/s1",
        "inchikey": "JKKDNXFJBMMQFP-LMMKCTJWSA-N",
        "iupac": {
          "systematic": "N-[(2R,3R,6R)-6-[2-(benzylsulfonylamino)ethyl]-2-(hydroxymethyl)oxan-3-yl]pyrazine-2-carboxamide"
        },
        "smiles": {
          "canonical": "C1CC(C(OC1CCNS(=O)(=O)CC2=CC=CC=C2)CO)NC(=O)C3=NC=CN=C3"
        },
        "molecularFormula": "C20H26N4O5S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:01:58Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c861b"
    },
    "name": "BRD-K62058497",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c861b.png",
    "lincs": {
      "id": "LSM-40662",
      "name": "BRD-K62058497",
      "pubchemCid": 60184848,
      "chebiId": 129111,
      "inchiParent": "InChI=1S/C33H33FN4O6/c1-36-25-16-23(42-2)8-9-24(25)29-30(36)26(17-39)38(32(41)35-22-6-4-21(34)5-7-22)18-33(29)11-13-37(14-12-33)31(40)20-3-10-27-28(15-20)44-19-43-27/h3-10,15-16,26,39H,11-14,17-19H2,1-2H3,(H,35,41)/t26-/m1/s1",
      "inchiKeyParent": "PDBYEHSJKGAMJS-AREMUKBSSA-N",
      "smilesParent": "COc1ccc2c3c([C@@H](CO)N(CC34CCN(CC4)C(=O)c5ccc6OCOc6c5)C(=O)Nc7ccc(F)cc7)n(C)c2c1"
    },
    "unichem": {
      "chebi": "129111",
      "lincs": "LSM-40662",
      "pubchem": "60184848"
    },
    "pubchem": [
      {
        "cid": 60184848,
        "inchi": "InChI=1S/C33H33FN4O6/c1-36-25-16-23(42-2)8-9-24(25)29-30(36)26(17-39)38(32(41)35-22-6-4-21(34)5-7-22)18-33(29)11-13-37(14-12-33)31(40)20-3-10-27-28(15-20)44-19-43-27/h3-10,15-16,26,39H,11-14,17-19H2,1-2H3,(H,35,41)/t26-/m1/s1",
        "inchikey": "PDBYEHSJKGAMJS-AREMUKBSSA-N",
        "iupac": {
          "systematic": "(1S)-1'-(1,3-benzodioxole-5-carbonyl)-N-(4-fluorophenyl)-1-(hydroxymethyl)-7-methoxy-9-methylspiro[1,3-dihydropyrido[3,4-b]indole-4,4'-piperidine]-2-carboxamide"
        },
        "smiles": {
          "canonical": "CN1C2=C(C=CC(=C2)OC)C3=C1C(N(CC34CCN(CC4)C(=O)C5=CC6=C(C=C5)OCO6)C(=O)NC7=CC=C(C=C7)F)CO"
        },
        "molecularFormula": "C33H33FN4O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:02:00Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8638"
    },
    "name": "BRD-K43168251",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8638.png",
    "lincs": {
      "id": "LSM-39642",
      "name": "BRD-K43168251",
      "pubchemCid": 54666526,
      "chebiId": 128086,
      "inchiParent": "InChI=1S/C29H34N2O3/c1-34-27-10-3-2-7-22(27)14-11-21-12-15-23(16-13-21)28-25-19-30(29(33)24-8-6-9-24)17-4-5-18-31(25)26(28)20-32/h2-3,7,10,12-13,15-16,24-26,28,32H,4-6,8-9,17-20H2,1H3/t25-,26+,28+/m0/s1",
      "inchiKeyParent": "NRAVNVUUWRMRFK-ZRRKCSAHSA-N",
      "smilesParent": "COc1ccccc1C#Cc2ccc(cc2)[C@H]3[C@@H](CO)N4CCCCN(C[C@@H]34)C(=O)C5CCC5"
    },
    "unichem": {
      "chebi": "128086",
      "lincs": "LSM-39642",
      "pubchem": "54666526"
    },
    "pubchem": [
      {
        "cid": 54666526,
        "inchi": "InChI=1S/C29H34N2O3/c1-34-27-10-3-2-7-22(27)14-11-21-12-15-23(16-13-21)28-25-19-30(29(33)24-8-6-9-24)17-4-5-18-31(25)26(28)20-32/h2-3,7,10,12-13,15-16,24-26,28,32H,4-6,8-9,17-20H2,1H3/t25-,26+,28+/m0/s1",
        "inchikey": "NRAVNVUUWRMRFK-ZRRKCSAHSA-N",
        "iupac": {
          "systematic": "cyclobutyl-[(8R,9R,10S)-10-(hydroxymethyl)-9-[4-[2-(2-methoxyphenyl)ethynyl]phenyl]-1,6-diazabicyclo[6.2.0]decan-6-yl]methanone"
        },
        "smiles": {
          "canonical": "COC1=CC=CC=C1C#CC2=CC=C(C=C2)C3C4CN(CCCCN4C3CO)C(=O)C5CCC5"
        },
        "molecularFormula": "C29H34N2O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:02:02Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8647"
    },
    "name": "BRD-K53923750",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8647.png",
    "lincs": {
      "id": "LSM-11706",
      "name": "BRD-K53923750",
      "pubchemCid": 54654490,
      "chebiId": 100331,
      "inchiParent": "InChI=1S/C29H32ClN5O6/c1-16-27(17(2)41-34-16)33-29(38)32-20-8-11-24-22(12-20)28(37)35(3)23-10-9-21(40-25(23)15-39-24)13-26(36)31-14-18-4-6-19(30)7-5-18/h4-8,11-12,21,23,25H,9-10,13-15H2,1-3H3,(H,31,36)(H2,32,33,38)/t21-,23-,25+/m1/s1",
      "inchiKeyParent": "VDMGESCZGFUZFC-PFATUAPWSA-N",
      "smilesParent": "CN1[C@@H]2CC[C@H](CC(=O)NCc3ccc(Cl)cc3)O[C@H]2COc4ccc(NC(=O)Nc5c(C)onc5C)cc4C1=O"
    },
    "unichem": {
      "chebi": "100331",
      "lincs": "LSM-11706",
      "pubchem": "54654490"
    },
    "pubchem": [
      {
        "cid": 54654490,
        "inchi": "InChI=1S/C29H32ClN5O6/c1-16-27(17(2)41-34-16)33-29(38)32-20-8-11-24-22(12-20)28(37)35(3)23-10-9-21(40-25(23)15-39-24)13-26(36)31-14-18-4-6-19(30)7-5-18/h4-8,11-12,21,23,25H,9-10,13-15H2,1-3H3,(H,31,36)(H2,32,33,38)/t21-,23-,25+/m1/s1",
        "inchikey": "VDMGESCZGFUZFC-PFATUAPWSA-N",
        "iupac": {
          "systematic": "2-[(2R,4aR,12aR)-8-[(3,5-dimethyl-1,2-oxazol-4-yl)carbamoylamino]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-[(4-chlorophenyl)methyl]acetamide"
        },
        "smiles": {
          "canonical": "CC1=C(C(=NO1)C)NC(=O)NC2=CC3=C(C=C2)OCC4C(CCC(O4)CC(=O)NCC5=CC=C(C=C5)Cl)N(C3=O)C"
        },
        "molecularFormula": "C29H32ClN5O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:02:04Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85c9"
    },
    "name": "BRD-K78025571",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85c9.png",
    "lincs": {
      "id": "LSM-41530",
      "name": "BRD-K78025571",
      "pubchemCid": 44488942,
      "chebiId": 129979,
      "inchiParent": "InChI=1S/C29H33FN4O6S/c1-19-16-34(20(2)18-35)28(36)25-15-23(32-41(38,39)24-7-5-4-6-8-24)13-14-26(25)40-27(19)17-33(3)29(37)31-22-11-9-21(30)10-12-22/h4-15,19-20,27,32,35H,16-18H2,1-3H3,(H,31,37)/t19-,20-,27+/m1/s1",
      "inchiKeyParent": "JVHWMDYUDFIPKY-DVHCVUMVSA-N",
      "smilesParent": "C[C@H](CO)N1C[C@@H](C)[C@H](CN(C)C(=O)Nc2ccc(F)cc2)Oc3ccc(NS(=O)(=O)c4ccccc4)cc3C1=O"
    },
    "unichem": {
      "chebi": "129979",
      "lincs": "LSM-41530",
      "pubchem": "44488942"
    },
    "pubchem": [
      {
        "cid": 44488942,
        "inchi": "InChI=1S/C29H33FN4O6S/c1-19-16-34(20(2)18-35)28(36)25-15-23(32-41(38,39)24-7-5-4-6-8-24)13-14-26(25)40-27(19)17-33(3)29(37)31-22-11-9-21(30)10-12-22/h4-15,19-20,27,32,35H,16-18H2,1-3H3,(H,31,37)/t19-,20-,27+/m1/s1",
        "inchikey": "JVHWMDYUDFIPKY-DVHCVUMVSA-N",
        "iupac": {
          "systematic": "1-[[(2R,3R)-8-(benzenesulfonamido)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-3-(4-fluorophenyl)-1-methylurea"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(C=CC(=C2)NS(=O)(=O)C3=CC=CC=C3)OC1CN(C)C(=O)NC4=CC=C(C=C4)F)C(C)CO"
        },
        "molecularFormula": "C29H33FN4O6S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:02:07Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85ea"
    },
    "name": "BRD-K34332181",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85ea.png",
    "lincs": {
      "id": "LSM-10497",
      "name": "BRD-K34332181",
      "pubchemCid": 54660747,
      "chebiId": 99118,
      "inchiParent": "InChI=1S/C24H28ClN3O3/c25-19-8-3-2-7-16(19)13-28-22-17(14-27-20(22)9-6-10-21(27)30)18(15-29)23(28)24(31)26-11-4-1-5-12-26/h2-3,6-10,17-18,22-23,29H,1,4-5,11-15H2/t17-,18-,22+,23-/m0/s1",
      "inchiKeyParent": "VQCZTXNNKFBGGK-JRSMBCBASA-N",
      "smilesParent": "OC[C@H]1[C@@H]2CN3C(=O)C=CC=C3[C@@H]2N(Cc4ccccc4Cl)[C@@H]1C(=O)N5CCCCC5"
    },
    "unichem": {
      "chebi": "99118",
      "lincs": "LSM-10497",
      "pubchem": "54660747"
    },
    "pubchem": [
      {
        "cid": 54660747,
        "inchi": "InChI=1S/C24H28ClN3O3/c25-19-8-3-2-7-16(19)13-28-22-17(14-27-20(22)9-6-10-21(27)30)18(15-29)23(28)24(31)26-11-4-1-5-12-26/h2-3,6-10,17-18,22-23,29H,1,4-5,11-15H2/t17-,18-,22+,23-/m0/s1",
        "inchikey": "VQCZTXNNKFBGGK-JRSMBCBASA-N",
        "iupac": {
          "systematic": "(2S,3S,3aR,9bR)-1-[(2-chlorophenyl)methyl]-3-(hydroxymethyl)-2-(piperidine-1-carbonyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizin-6-one"
        },
        "smiles": {
          "canonical": "C1CCN(CC1)C(=O)C2C(C3CN4C(=O)C=CC=C4C3N2CC5=CC=CC=C5Cl)CO"
        },
        "molecularFormula": "C24H28ClN3O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:02:09Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c860d"
    },
    "name": "BRD-K72014243",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c860d.png",
    "lincs": {
      "id": "LSM-12840",
      "name": "BRD-K72014243",
      "pubchemCid": 56835577,
      "chebiId": 101477,
      "inchiParent": "InChI=1S/C31H37FN4O3S/c1-31(2,3)40(39)36-20-24-19-26(30(38)35-14-12-34(4)13-15-35)33-29(28(24)27(36)11-16-37)23-9-5-7-21(17-23)22-8-6-10-25(32)18-22/h5-10,17-19,27,37H,11-16,20H2,1-4H3/t27-,40?/m0/s1",
      "inchiKeyParent": "BKCTXULBENSKFX-OVCFAJSKSA-N",
      "smilesParent": "CN1CCN(CC1)C(=O)c2cc3CN([C@@H](CCO)c3c(n2)c4cccc(c4)c5cccc(F)c5)S(=O)C(C)(C)C"
    },
    "unichem": {
      "chebi": "101477",
      "lincs": "LSM-12840",
      "pubchem": "56835577"
    },
    "pubchem": [
      {
        "cid": 56835577,
        "inchi": "InChI=1S/C31H37FN4O3S/c1-31(2,3)40(39)36-20-24-19-26(30(38)35-14-12-34(4)13-15-35)33-29(28(24)27(36)11-16-37)23-9-5-7-21(17-23)22-8-6-10-25(32)18-22/h5-10,17-19,27,37H,11-16,20H2,1-4H3/t27-,40?/m0/s1",
        "inchikey": "BKCTXULBENSKFX-OVCFAJSKSA-N",
        "iupac": {
          "systematic": "[(3S)-2-tert-butylsulfinyl-4-[3-(3-fluorophenyl)phenyl]-3-(2-hydroxyethyl)-1,3-dihydropyrrolo[3,4-c]pyridin-6-yl]-(4-methylpiperazin-1-yl)methanone"
        },
        "smiles": {
          "canonical": "CC(C)(C)S(=O)N1CC2=CC(=NC(=C2C1CCO)C3=CC=CC(=C3)C4=CC(=CC=C4)F)C(=O)N5CCN(CC5)C"
        },
        "molecularFormula": "C31H37FN4O3S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:02:12Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c850c"
    },
    "name": "BRD-K55792644",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c850c.png",
    "lincs": {
      "id": "LSM-40336",
      "name": "BRD-K55792644",
      "pubchemCid": 71760419,
      "chebiId": 128784,
      "inchiParent": "InChI=1S/C27H29FN6O5S/c1-31-11-23(29-16-31)40(37,38)33-13-27(14-33)15-34(26(36)30-18-6-4-17(28)5-7-18)22(12-35)25-24(27)20-9-8-19(39-3)10-21(20)32(25)2/h4-11,16,22,35H,12-15H2,1-3H3,(H,30,36)/t22-/m1/s1",
      "inchiKeyParent": "GSFSHJGWCPBMNU-JOCHJYFZSA-N",
      "smilesParent": "COc1ccc2c3c([C@@H](CO)N(CC34CN(C4)S(=O)(=O)c5cn(C)cn5)C(=O)Nc6ccc(F)cc6)n(C)c2c1"
    },
    "unichem": {
      "chebi": "128784",
      "lincs": "LSM-40336",
      "pubchem": "71760419"
    },
    "pubchem": [
      {
        "cid": 71760419,
        "inchi": "InChI=1S/C27H29FN6O5S/c1-31-11-23(29-16-31)40(37,38)33-13-27(14-33)15-34(26(36)30-18-6-4-17(28)5-7-18)22(12-35)25-24(27)20-9-8-19(39-3)10-21(20)32(25)2/h4-11,16,22,35H,12-15H2,1-3H3,(H,30,36)/t22-/m1/s1",
        "inchikey": "GSFSHJGWCPBMNU-JOCHJYFZSA-N",
        "iupac": {
          "systematic": "(1S)-N-(4-fluorophenyl)-1-(hydroxymethyl)-7-methoxy-9-methyl-1'-(1-methylimidazol-4-yl)sulfonylspiro[1,3-dihydropyrido[3,4-b]indole-4,3'-azetidine]-2-carboxamide"
        },
        "smiles": {
          "canonical": "CN1C=C(N=C1)S(=O)(=O)N2CC3(C2)CN(C(C4=C3C5=C(N4C)C=C(C=C5)OC)CO)C(=O)NC6=CC=C(C=C6)F"
        },
        "molecularFormula": "C27H29FN6O5S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:02:14Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8520"
    },
    "name": "BRD-K70595737",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8520.png",
    "lincs": {
      "id": "LSM-41111",
      "name": "BRD-K70595737",
      "pubchemCid": 54615069,
      "chebiId": 129560,
      "inchiParent": "InChI=1S/C34H49N3O5/c1-24-20-37(25(2)23-38)34(40)30-19-29(35-33(39)18-27-11-6-5-7-12-27)15-16-31(30)42-26(3)10-8-9-17-41-32(24)22-36(4)21-28-13-14-28/h5-7,11-12,15-16,19,24-26,28,32,38H,8-10,13-14,17-18,20-23H2,1-4H3,(H,35,39)/t24-,25+,26-,32-/m1/s1",
      "inchiKeyParent": "UCKSTMSAUWGXTL-VUKRRIEASA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@@H](C)[C@@H](CN(C)CC2CC2)OCCCC[C@@H](C)Oc3ccc(NC(=O)Cc4ccccc4)cc3C1=O"
    },
    "unichem": {
      "chebi": "129560",
      "lincs": "LSM-41111",
      "pubchem": "54615069"
    },
    "pubchem": [
      {
        "cid": 54615069,
        "inchi": "InChI=1S/C34H49N3O5/c1-24-20-37(25(2)23-38)34(40)30-19-29(35-33(39)18-27-11-6-5-7-12-27)15-16-31(30)42-26(3)10-8-9-17-41-32(24)22-36(4)21-28-13-14-28/h5-7,11-12,15-16,19,24-26,28,32,38H,8-10,13-14,17-18,20-23H2,1-4H3,(H,35,39)/t24-,25+,26-,32-/m1/s1",
        "inchikey": "UCKSTMSAUWGXTL-VUKRRIEASA-N",
        "iupac": {
          "systematic": "N-[(3R,9S,10R)-9-[[cyclopropylmethyl(methyl)amino]methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-2-phenylacetamide"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NC(=O)CC3=CC=CC=C3)C(C)CO)C)CN(C)CC4CC4"
        },
        "molecularFormula": "C34H49N3O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:02:16Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c854e"
    },
    "name": "BRD-K57696989",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c854e.png",
    "lincs": {
      "id": "LSM-11921",
      "name": "BRD-K57696989",
      "pubchemCid": 54654570,
      "chebiId": 100547,
      "inchiParent": "InChI=1S/C21H29N3O7S/c1-23-17-5-4-15(12-20(25)24-7-9-29-10-8-24)31-19(17)13-30-18-6-3-14(22-32(2,27)28)11-16(18)21(23)26/h3,6,11,15,17,19,22H,4-5,7-10,12-13H2,1-2H3/t15-,17-,19-/m0/s1",
      "inchiKeyParent": "VPEDYPFQYJVQKE-IEZWGBDMSA-N",
      "smilesParent": "CN1[C@H]2CC[C@@H](CC(=O)N3CCOCC3)O[C@H]2COc4ccc(NS(=O)(=O)C)cc4C1=O"
    },
    "unichem": {
      "chebi": "100547",
      "lincs": "LSM-11921",
      "pubchem": "54654570"
    },
    "pubchem": [
      {
        "cid": 54654570,
        "inchi": "InChI=1S/C21H29N3O7S/c1-23-17-5-4-15(12-20(25)24-7-9-29-10-8-24)31-19(17)13-30-18-6-3-14(22-32(2,27)28)11-16(18)21(23)26/h3,6,11,15,17,19,22H,4-5,7-10,12-13H2,1-2H3/t15-,17-,19-/m0/s1",
        "inchikey": "VPEDYPFQYJVQKE-IEZWGBDMSA-N",
        "iupac": {
          "systematic": "N-[(2S,4aS,12aR)-5-methyl-2-(2-morpholin-4-yl-2-oxoethyl)-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]methanesulfonamide"
        },
        "smiles": {
          "canonical": "CN1C2CCC(OC2COC3=C(C1=O)C=C(C=C3)NS(=O)(=O)C)CC(=O)N4CCOCC4"
        },
        "molecularFormula": "C21H29N3O7S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:02:18Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c859c"
    },
    "name": "BRD-K12961950",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c859c.png",
    "lincs": {
      "id": "LSM-37937",
      "name": "BRD-K12961950",
      "pubchemCid": 60191272,
      "chebiId": 126372,
      "inchiParent": "InChI=1S/C25H26FN3O3/c1-2-3-4-6-17-9-11-18(12-10-17)24-21-14-28(15-23(31)29(21)22(24)16-30)25(32)27-20-8-5-7-19(26)13-20/h5,7-13,21-22,24,30H,2-3,14-16H2,1H3,(H,27,32)/t21-,22-,24-/m0/s1",
      "inchiKeyParent": "UCBYLLYLADIOJP-FIXSFTCYSA-N",
      "smilesParent": "CCCC#Cc1ccc(cc1)[C@@H]2[C@H](CO)N3[C@H]2CN(CC3=O)C(=O)Nc4cccc(F)c4"
    },
    "unichem": {
      "chebi": "126372",
      "lincs": "LSM-37937",
      "pubchem": "60191272"
    },
    "pubchem": [
      {
        "cid": 60191272,
        "inchi": "InChI=1S/C25H26FN3O3/c1-2-3-4-6-17-9-11-18(12-10-17)24-21-14-28(15-23(31)29(21)22(24)16-30)25(32)27-20-8-5-7-19(26)13-20/h5,7-13,21-22,24,30H,2-3,14-16H2,1H3,(H,27,32)/t21-,22-,24-/m0/s1",
        "inchikey": "UCBYLLYLADIOJP-FIXSFTCYSA-N",
        "iupac": {
          "systematic": "(6R,7S,8R)-N-(3-fluorophenyl)-8-(hydroxymethyl)-2-oxo-7-(4-pent-1-ynylphenyl)-1,4-diazabicyclo[4.2.0]octane-4-carboxamide"
        },
        "smiles": {
          "canonical": "CCCC#CC1=CC=C(C=C1)C2C3CN(CC(=O)N3C2CO)C(=O)NC4=CC(=CC=C4)F"
        },
        "molecularFormula": "C25H26FN3O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:02:20Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85bc"
    },
    "name": "BRD-K45222065",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85bc.png",
    "lincs": {
      "id": "LSM-39775",
      "name": "BRD-K45222065",
      "pubchemCid": 44616467,
      "chebiId": 128220,
      "inchiParent": "InChI=1S/C32H46FN3O6S/c1-22-18-36(23(2)21-37)32(38)29-17-27(34-43(39,40)28-13-10-26(33)11-14-28)12-15-30(29)42-24(3)7-5-6-16-41-31(22)20-35(4)19-25-8-9-25/h10-15,17,22-25,31,34,37H,5-9,16,18-21H2,1-4H3/t22-,23+,24-,31-/m0/s1",
      "inchiKeyParent": "RTHCXGNRZPZERE-PKWXPSSRSA-N",
      "smilesParent": "C[C@H](CO)N1C[C@H](C)[C@H](CN(C)CC2CC2)OCCCC[C@H](C)Oc3ccc(NS(=O)(=O)c4ccc(F)cc4)cc3C1=O"
    },
    "unichem": {
      "chebi": "128220",
      "lincs": "LSM-39775",
      "pubchem": "44616467"
    },
    "pubchem": [
      {
        "cid": 44616467,
        "inchi": "InChI=1S/C32H46FN3O6S/c1-22-18-36(23(2)21-37)32(38)29-17-27(34-43(39,40)28-13-10-26(33)11-14-28)12-15-30(29)42-24(3)7-5-6-16-41-31(22)20-35(4)19-25-8-9-25/h10-15,17,22-25,31,34,37H,5-9,16,18-21H2,1-4H3/t22-,23+,24-,31-/m0/s1",
        "inchikey": "RTHCXGNRZPZERE-PKWXPSSRSA-N",
        "iupac": {
          "systematic": "N-[(3S,9R,10S)-9-[[cyclopropylmethyl(methyl)amino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-fluorobenzenesulfonamide"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NS(=O)(=O)C3=CC=C(C=C3)F)C(C)CO)C)CN(C)CC4CC4"
        },
        "molecularFormula": "C32H46FN3O6S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:02:23Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85d2"
    },
    "name": "BRD-K76959261",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85d2.png",
    "lincs": {
      "id": "LSM-41476",
      "name": "BRD-K76959261",
      "pubchemCid": 44493785,
      "chebiId": 129925,
      "inchiParent": "InChI=1S/C32H37N3O6/c1-21-17-35(22(2)20-36)31(38)27-16-26(33-30(37)15-23-7-5-4-6-8-23)13-14-28(27)41-29(21)19-34(3)18-24-9-11-25(12-10-24)32(39)40/h4-14,16,21-22,29,36H,15,17-20H2,1-3H3,(H,33,37)(H,39,40)/t21-,22+,29-/m0/s1",
      "inchiKeyParent": "NFIXFXCEHGPRBV-KERYWQKISA-N",
      "smilesParent": "C[C@H](CO)N1C[C@H](C)[C@H](CN(C)Cc2ccc(cc2)C(=O)O)Oc3ccc(NC(=O)Cc4ccccc4)cc3C1=O"
    },
    "unichem": {
      "chebi": "129925",
      "lincs": "LSM-41476",
      "pubchem": "44493785"
    },
    "pubchem": [
      {
        "cid": 44493785,
        "inchi": "InChI=1S/C32H37N3O6/c1-21-17-35(22(2)20-36)31(38)27-16-26(33-30(37)15-23-7-5-4-6-8-23)13-14-28(27)41-29(21)19-34(3)18-24-9-11-25(12-10-24)32(39)40/h4-14,16,21-22,29,36H,15,17-20H2,1-3H3,(H,33,37)(H,39,40)/t21-,22+,29-/m0/s1",
        "inchikey": "NFIXFXCEHGPRBV-KERYWQKISA-N",
        "iupac": {
          "systematic": "4-[[[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(2-phenylacetyl)amino]-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl-methylamino]methyl]benzoic acid"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(C=CC(=C2)NC(=O)CC3=CC=CC=C3)OC1CN(C)CC4=CC=C(C=C4)C(=O)O)C(C)CO"
        },
        "molecularFormula": "C32H37N3O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:02:25Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85e3"
    },
    "name": "BRD-K57166447",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85e3.png",
    "lincs": {
      "id": "LSM-11891",
      "name": "BRD-K57166447",
      "pubchemCid": 54638219,
      "chebiId": 100517,
      "inchiParent": "InChI=1S/C18H24N2O4/c21-11-16-15(20-18(23)12-6-7-12)9-8-14(24-16)10-17(22)19-13-4-2-1-3-5-13/h1-5,12,14-16,21H,6-11H2,(H,19,22)(H,20,23)/t14-,15-,16+/m1/s1",
      "inchiKeyParent": "SOYBDXBXTZOLGY-OAGGEKHMSA-N",
      "smilesParent": "OC[C@@H]1O[C@@H](CC(=O)Nc2ccccc2)CC[C@H]1NC(=O)C3CC3"
    },
    "unichem": {
      "chebi": "100517",
      "lincs": "LSM-11891",
      "pubchem": "54638219"
    },
    "pubchem": [
      {
        "cid": 54638219,
        "inchi": "InChI=1S/C18H24N2O4/c21-11-16-15(20-18(23)12-6-7-12)9-8-14(24-16)10-17(22)19-13-4-2-1-3-5-13/h1-5,12,14-16,21H,6-11H2,(H,19,22)(H,20,23)/t14-,15-,16+/m1/s1",
        "inchikey": "SOYBDXBXTZOLGY-OAGGEKHMSA-N",
        "iupac": {
          "systematic": "N-[(2R,3R,6R)-6-(2-anilino-2-oxoethyl)-2-(hydroxymethyl)oxan-3-yl]cyclopropanecarboxamide"
        },
        "smiles": {
          "canonical": "C1CC1C(=O)NC2CCC(OC2CO)CC(=O)NC3=CC=CC=C3"
        },
        "molecularFormula": "C18H24N2O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:02:27Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85ef"
    },
    "name": "BRD-K97001739",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85ef.png",
    "lincs": {
      "id": "LSM-14385",
      "name": "BRD-K97001739",
      "pubchemCid": 54638411,
      "chebiId": 103039,
      "inchiParent": "InChI=1S/C23H27Cl2N3O5/c1-32-20-5-3-2-4-18(20)27-23(31)28-19-9-7-15(33-21(19)13-29)11-22(30)26-12-14-6-8-16(24)17(25)10-14/h2-6,8,10,15,19,21,29H,7,9,11-13H2,1H3,(H,26,30)(H2,27,28,31)/t15-,19-,21+/m1/s1",
      "inchiKeyParent": "XCDRDXJNPKYISK-VMRPVKRXSA-N",
      "smilesParent": "COc1ccccc1NC(=O)N[C@@H]2CC[C@H](CC(=O)NCc3ccc(Cl)c(Cl)c3)O[C@H]2CO"
    },
    "unichem": {
      "chebi": "103039",
      "lincs": "LSM-14385",
      "pubchem": "54638411"
    },
    "pubchem": [
      {
        "cid": 54638411,
        "inchi": "InChI=1S/C23H27Cl2N3O5/c1-32-20-5-3-2-4-18(20)27-23(31)28-19-9-7-15(33-21(19)13-29)11-22(30)26-12-14-6-8-16(24)17(25)10-14/h2-6,8,10,15,19,21,29H,7,9,11-13H2,1H3,(H,26,30)(H2,27,28,31)/t15-,19-,21+/m1/s1",
        "inchikey": "XCDRDXJNPKYISK-VMRPVKRXSA-N",
        "iupac": {
          "systematic": "N-[(3,4-dichlorophenyl)methyl]-2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[(2-methoxyphenyl)carbamoylamino]oxan-2-yl]acetamide"
        },
        "smiles": {
          "canonical": "COC1=CC=CC=C1NC(=O)NC2CCC(OC2CO)CC(=O)NCC3=CC(=C(C=C3)Cl)Cl"
        },
        "molecularFormula": "C23H27Cl2N3O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:02:29Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85fa"
    },
    "name": "BRD-K19995388",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85fa.png",
    "lincs": {
      "id": "LSM-9643",
      "name": "BRD-K19995388",
      "pubchemCid": 54657947,
      "chebiId": 98264,
      "inchiParent": "InChI=1S/C19H27N3O5/c1-21(2)18(24)9-15-3-4-16-17(27-15)12-26-11-14(23)10-22(16)19(25)13-5-7-20-8-6-13/h5-8,14-17,23H,3-4,9-12H2,1-2H3/t14-,15-,16+,17-/m1/s1",
      "inchiKeyParent": "JDHZCDHPHAWVKT-WCXIOVBPSA-N",
      "smilesParent": "CN(C)C(=O)C[C@H]1CC[C@H]2[C@@H](COC[C@H](O)CN2C(=O)c3ccncc3)O1"
    },
    "unichem": {
      "chebi": "98264",
      "lincs": "LSM-9643",
      "pubchem": "54657947"
    },
    "pubchem": [
      {
        "cid": 54657947,
        "inchi": "InChI=1S/C19H27N3O5/c1-21(2)18(24)9-15-3-4-16-17(27-15)12-26-11-14(23)10-22(16)19(25)13-5-7-20-8-6-13/h5-8,14-17,23H,3-4,9-12H2,1-2H3/t14-,15-,16+,17-/m1/s1",
        "inchikey": "JDHZCDHPHAWVKT-WCXIOVBPSA-N",
        "iupac": {
          "systematic": "2-[(3R,6aS,8R,10aS)-3-hydroxy-1-(pyridine-4-carbonyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N,N-dimethylacetamide"
        },
        "smiles": {
          "canonical": "CN(C)C(=O)CC1CCC2C(O1)COCC(CN2C(=O)C3=CC=NC=C3)O"
        },
        "molecularFormula": "C19H27N3O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:02:31Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85ff"
    },
    "name": "BRD-K62342148",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85ff.png",
    "lincs": {
      "id": "LSM-12216",
      "name": "BRD-K62342148",
      "pubchemCid": 54646392,
      "chebiId": 100842,
      "inchiParent": "InChI=1S/C16H21NO7S/c1-22-15(19)7-10-6-12-11-5-9(17-25(2,20)21)3-4-13(11)24-16(12)14(8-18)23-10/h3-5,10,12,14,16-18H,6-8H2,1-2H3/t10-,12-,14+,16+/m1/s1",
      "inchiKeyParent": "STSQWNRYWIJNCW-ILHHOCCXSA-N",
      "smilesParent": "COC(=O)C[C@H]1C[C@H]2[C@H](Oc3ccc(NS(=O)(=O)C)cc23)[C@H](CO)O1"
    },
    "unichem": {
      "chebi": "100842",
      "lincs": "LSM-12216",
      "pubchem": "54646392"
    },
    "pubchem": [
      {
        "cid": 54646392,
        "inchi": "InChI=1S/C16H21NO7S/c1-22-15(19)7-10-6-12-11-5-9(17-25(2,20)21)3-4-13(11)24-16(12)14(8-18)23-10/h3-5,10,12,14,16-18H,6-8H2,1-2H3/t10-,12-,14+,16+/m1/s1",
        "inchikey": "STSQWNRYWIJNCW-ILHHOCCXSA-N",
        "iupac": {
          "systematic": "methyl 2-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]acetate"
        },
        "smiles": {
          "canonical": "COC(=O)CC1CC2C(C(O1)CO)OC3=C2C=C(C=C3)NS(=O)(=O)C"
        },
        "molecularFormula": "C16H21NO7S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:02:34Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8645"
    },
    "name": "BRD-K93181983",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8645.png",
    "lincs": {
      "id": "LSM-42331",
      "name": "BRD-K93181983",
      "pubchemCid": 54652480,
      "chebiId": 130782,
      "inchiParent": "InChI=1S/C20H20F3N3O2/c21-20(22,23)8-18(28)26-11-16-19(14-5-1-2-6-15(14)26)17(12-27)25(16)10-13-4-3-7-24-9-13/h1-7,9,16-17,19,27H,8,10-12H2/t16-,17-,19+/m0/s1",
      "inchiKeyParent": "MLJFMAHJLRFJJA-JENIJYKNSA-N",
      "smilesParent": "OC[C@H]1[C@H]2[C@H](CN(C(=O)CC(F)(F)F)c3ccccc23)N1Cc4cccnc4"
    },
    "unichem": {
      "chebi": "130782",
      "lincs": "LSM-42331",
      "pubchem": "54652480"
    },
    "pubchem": [
      {
        "cid": 54652480,
        "inchi": "InChI=1S/C20H20F3N3O2/c21-20(22,23)8-18(28)26-11-16-19(14-5-1-2-6-15(14)26)17(12-27)25(16)10-13-4-3-7-24-9-13/h1-7,9,16-17,19,27H,8,10-12H2/t16-,17-,19+/m0/s1",
        "inchikey": "MLJFMAHJLRFJJA-JENIJYKNSA-N",
        "iupac": {
          "systematic": "1-[(1R,2aR,8bR)-1-(hydroxymethyl)-2-(pyridin-3-ylmethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-3,3,3-trifluoropropan-1-one"
        },
        "smiles": {
          "canonical": "C1C2C(C(N2CC3=CN=CC=C3)CO)C4=CC=CC=C4N1C(=O)CC(F)(F)F"
        },
        "molecularFormula": "C20H20F3N3O2"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:02:36Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c864a"
    },
    "name": "BRD-K82727027",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c864a.png",
    "lincs": {
      "id": "LSM-13479",
      "name": "BRD-K82727027",
      "pubchemCid": 54657683,
      "chebiId": 102119,
      "inchiParent": "InChI=1S/C22H28ClN3O4S/c23-18-4-2-1-3-15(18)10-25-21(28)9-17-5-6-19-20(30-17)14-29-13-16(27)11-26(19)12-22-24-7-8-31-22/h1-4,7-8,16-17,19-20,27H,5-6,9-14H2,(H,25,28)/t16-,17-,19-,20+/m0/s1",
      "inchiKeyParent": "VRNJYJIECLSBHX-QGZVKYPTSA-N",
      "smilesParent": "O[C@@H]1COC[C@H]2O[C@H](CC(=O)NCc3ccccc3Cl)CC[C@@H]2N(Cc4nccs4)C1"
    },
    "unichem": {
      "chebi": "102119",
      "lincs": "LSM-13479",
      "pubchem": "54657683"
    },
    "pubchem": [
      {
        "cid": 54657683,
        "inchi": "InChI=1S/C22H28ClN3O4S/c23-18-4-2-1-3-15(18)10-25-21(28)9-17-5-6-19-20(30-17)14-29-13-16(27)11-26(19)12-22-24-7-8-31-22/h1-4,7-8,16-17,19-20,27H,5-6,9-14H2,(H,25,28)/t16-,17-,19-,20+/m0/s1",
        "inchikey": "VRNJYJIECLSBHX-QGZVKYPTSA-N",
        "iupac": {
          "systematic": "2-[(3S,6aS,8S,10aS)-3-hydroxy-1-(1,3-thiazol-2-ylmethyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(2-chlorophenyl)methyl]acetamide"
        },
        "smiles": {
          "canonical": "C1CC2C(COCC(CN2CC3=NC=CS3)O)OC1CC(=O)NCC4=CC=CC=C4Cl"
        },
        "molecularFormula": "C22H28ClN3O4S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:02:38Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8536"
    },
    "name": "BRD-K46629170",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8536.png",
    "lincs": {
      "id": "LSM-39860",
      "name": "BRD-K46629170",
      "pubchemCid": 54615031,
      "chebiId": 128305,
      "inchiParent": "InChI=1S/C37H55N3O6/c1-26-22-40(27(2)25-41)37(43)33-21-31(38-36(42)30-12-7-6-8-13-30)16-19-34(33)46-28(3)11-9-10-20-45-35(26)24-39(4)23-29-14-17-32(44-5)18-15-29/h14-19,21,26-28,30,35,41H,6-13,20,22-25H2,1-5H3,(H,38,42)/t26-,27-,28-,35+/m1/s1",
      "inchiKeyParent": "UVSCGJDGVAXROK-GBJJYOARSA-N",
      "smilesParent": "COc1ccc(CN(C)C[C@@H]2OCCCC[C@@H](C)Oc3ccc(NC(=O)C4CCCCC4)cc3C(=O)N(C[C@H]2C)[C@H](C)CO)cc1"
    },
    "unichem": {
      "chebi": "128305",
      "lincs": "LSM-39860",
      "pubchem": "54615031"
    },
    "pubchem": [
      {
        "cid": 54615031,
        "inchi": "InChI=1S/C37H55N3O6/c1-26-22-40(27(2)25-41)37(43)33-21-31(38-36(42)30-12-7-6-8-13-30)16-19-34(33)46-28(3)11-9-10-20-45-35(26)24-39(4)23-29-14-17-32(44-5)18-15-29/h14-19,21,26-28,30,35,41H,6-13,20,22-25H2,1-5H3,(H,38,42)/t26-,27-,28-,35+/m1/s1",
        "inchikey": "UVSCGJDGVAXROK-GBJJYOARSA-N",
        "iupac": {
          "systematic": "N-[(3R,9R,10R)-12-[(2R)-1-hydroxypropan-2-yl]-9-[[(4-methoxyphenyl)methyl-methylamino]methyl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]cyclohexanecarboxamide"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NC(=O)C3CCCCC3)C(C)CO)C)CN(C)CC4=CC=C(C=C4)OC"
        },
        "molecularFormula": "C37H55N3O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:02:40Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8540"
    },
    "name": "BRD-K69792693-001-01-5",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8540.png",
    "lincs": {
      "id": "LSM-12689",
      "name": "BRD-K69792693-001-01-5",
      "alternativeNames": [
        "BRD-K69792693"
      ],
      "pubchemCid": 54645844,
      "chebiId": 101323,
      "inchiParent": "InChI=1S/C15H19NO5/c1-19-14(18)6-9-5-11-10-4-8(16)2-3-12(10)21-15(11)13(7-17)20-9/h2-4,9,11,13,15,17H,5-7,16H2,1H3/t9-,11-,13+,15+/m1/s1",
      "inchiKeyParent": "HQNYHUFQGPMYGV-RNKJKDHYSA-N",
      "smilesParent": "COC(=O)C[C@H]1C[C@H]2[C@H](Oc3ccc(N)cc23)[C@H](CO)O1"
    },
    "unichem": {
      "chebi": "101323",
      "lincs": "LSM-12689",
      "pubchem": "54645844"
    },
    "pubchem": [
      {
        "cid": 54645844,
        "inchi": "InChI=1S/C15H19NO5/c1-19-14(18)6-9-5-11-10-4-8(16)2-3-12(10)21-15(11)13(7-17)20-9/h2-4,9,11,13,15,17H,5-7,16H2,1H3/t9-,11-,13+,15+/m1/s1",
        "inchikey": "HQNYHUFQGPMYGV-RNKJKDHYSA-N",
        "iupac": {
          "systematic": "methyl 2-[(1S,3R,4aR,9aS)-6-amino-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]acetate"
        },
        "smiles": {
          "canonical": "COC(=O)CC1CC2C(C(O1)CO)OC3=C2C=C(C=C3)N"
        },
        "molecularFormula": "C15H19NO5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:02:43Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8560"
    },
    "name": "BRD-K62995317",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8560.png",
    "lincs": {
      "id": "LSM-12261",
      "name": "BRD-K62995317",
      "pubchemCid": 54657522,
      "chebiId": 100887,
      "inchiParent": "InChI=1S/C15H26N2O6/c1-2-5-16-15(21)17-7-10(18)8-22-9-13-12(17)4-3-11(23-13)6-14(19)20/h10-13,18H,2-9H2,1H3,(H,16,21)(H,19,20)/t10-,11-,12-,13+/m0/s1",
      "inchiKeyParent": "DUBDZBJJIAHCBK-ZDEQEGDKSA-N",
      "smilesParent": "CCCNC(=O)N1C[C@H](O)COC[C@H]2O[C@H](CC(=O)O)CC[C@H]12"
    },
    "unichem": {
      "chebi": "100887",
      "lincs": "LSM-12261",
      "pubchem": "54657522"
    },
    "pubchem": [
      {
        "cid": 54657522,
        "inchi": "InChI=1S/C15H26N2O6/c1-2-5-16-15(21)17-7-10(18)8-22-9-13-12(17)4-3-11(23-13)6-14(19)20/h10-13,18H,2-9H2,1H3,(H,16,21)(H,19,20)/t10-,11-,12-,13+/m0/s1",
        "inchikey": "DUBDZBJJIAHCBK-ZDEQEGDKSA-N",
        "iupac": {
          "systematic": "2-[(3S,6aS,8S,10aS)-3-hydroxy-1-(propylcarbamoyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]acetic acid"
        },
        "smiles": {
          "canonical": "CCCNC(=O)N1CC(COCC2C1CCC(O2)CC(=O)O)O"
        },
        "molecularFormula": "C15H26N2O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:02:45Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8576"
    },
    "name": "BRD-K58600416",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8576.png",
    "lincs": {
      "id": "LSM-11966",
      "name": "BRD-K58600416",
      "pubchemCid": 54660816,
      "chebiId": 100592,
      "inchiParent": "InChI=1S/C26H35N5O4/c1-29(2)11-5-10-27-25(33)23-20(14-32)22-13-31-21(24(23)30(22)12-18-15-35-16-28-18)9-8-19(26(31)34)17-6-3-4-7-17/h6,8-9,15-16,20,22-24,32H,3-5,7,10-14H2,1-2H3,(H,27,33)/t20-,22-,23+,24+/m0/s1",
      "inchiKeyParent": "GJSDPDSQBZFABN-IQFVJIFQSA-N",
      "smilesParent": "CN(C)CCCNC(=O)[C@@H]1[C@@H](CO)[C@@H]2CN3C(=CC=C(C4=CCCC4)C3=O)[C@H]1N2Cc5cocn5"
    },
    "unichem": {
      "chebi": "100592",
      "lincs": "LSM-11966",
      "pubchem": "54660816"
    },
    "pubchem": [
      {
        "cid": 54660816,
        "inchi": "InChI=1S/C26H35N5O4/c1-29(2)11-5-10-27-25(33)23-20(14-32)22-13-31-21(24(23)30(22)12-18-15-35-16-28-18)9-8-19(26(31)34)17-6-3-4-7-17/h6,8-9,15-16,20,22-24,32H,3-5,7,10-14H2,1-2H3,(H,27,33)/t20-,22-,23+,24+/m0/s1",
        "inchikey": "GJSDPDSQBZFABN-IQFVJIFQSA-N",
        "iupac": {
          "systematic": "(1S,9R,10R,11R)-5-(cyclopenten-1-yl)-N-[3-(dimethylamino)propyl]-10-(hydroxymethyl)-12-(1,3-oxazol-4-ylmethyl)-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide"
        },
        "smiles": {
          "canonical": "CN(C)CCCNC(=O)C1C(C2CN3C(=CC=C(C3=O)C4=CCCC4)C1N2CC5=COC=N5)CO"
        },
        "molecularFormula": "C26H35N5O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:02:47Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8594"
    },
    "name": "BRD-K35809598",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8594.png",
    "lincs": {
      "id": "LSM-10579",
      "name": "BRD-K35809598",
      "pubchemCid": 54660788,
      "chebiId": 99200,
      "inchiParent": "InChI=1S/C17H19N3O4S/c1-24-17(23)15-10(9-21)12-7-19-11(3-2-4-14(19)22)16(15)20(12)8-13-18-5-6-25-13/h2-6,10,12,15-16,21H,7-9H2,1H3/t10-,12-,15+,16+/m0/s1",
      "inchiKeyParent": "AQWQARACBBXMKO-GDJRKYJOSA-N",
      "smilesParent": "COC(=O)[C@@H]1[C@@H](CO)[C@@H]2CN3C(=O)C=CC=C3[C@H]1N2Cc4nccs4"
    },
    "unichem": {
      "chebi": "99200",
      "lincs": "LSM-10579",
      "pubchem": "54660788"
    },
    "pubchem": [
      {
        "cid": 54660788,
        "inchi": "InChI=1S/C17H19N3O4S/c1-24-17(23)15-10(9-21)12-7-19-11(3-2-4-14(19)22)16(15)20(12)8-13-18-5-6-25-13/h2-6,10,12,15-16,21H,7-9H2,1H3/t10-,12-,15+,16+/m0/s1",
        "inchikey": "AQWQARACBBXMKO-GDJRKYJOSA-N",
        "iupac": {
          "systematic": "methyl (1S,9R,10R,11R)-10-(hydroxymethyl)-6-oxo-12-(1,3-thiazol-2-ylmethyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxylate"
        },
        "smiles": {
          "canonical": "COC(=O)C1C(C2CN3C(=O)C=CC=C3C1N2CC4=NC=CS4)CO"
        },
        "molecularFormula": "C17H19N3O4S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:02:49Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85a8"
    },
    "name": "BRD-K83441480",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85a8.png",
    "lincs": {
      "id": "LSM-41824",
      "name": "BRD-K83441480",
      "pubchemCid": 54652647,
      "chebiId": 130275,
      "inchiParent": "InChI=1S/C21H24N2O4S/c1-3-20(25)23-17-12-22(28(26,27)19-11-7-4-8-14(19)2)16-10-6-5-9-15(16)21(17)18(23)13-24/h4-11,17-18,21,24H,3,12-13H2,1-2H3/t17-,18+,21+/m0/s1",
      "inchiKeyParent": "JZJDAFMFJLEAEU-WAOWUJCRSA-N",
      "smilesParent": "CCC(=O)N1[C@H](CO)[C@H]2[C@@H]1CN(c3ccccc23)S(=O)(=O)c4ccccc4C"
    },
    "unichem": {
      "chebi": "130275",
      "lincs": "LSM-41824",
      "pubchem": "54652647"
    },
    "pubchem": [
      {
        "cid": 54652647,
        "inchi": "InChI=1S/C21H24N2O4S/c1-3-20(25)23-17-12-22(28(26,27)19-11-7-4-8-14(19)2)16-10-6-5-9-15(16)21(17)18(23)13-24/h4-11,17-18,21,24H,3,12-13H2,1-2H3/t17-,18+,21+/m0/s1",
        "inchikey": "JZJDAFMFJLEAEU-WAOWUJCRSA-N",
        "iupac": {
          "systematic": "1-[(1S,2aR,8bR)-1-(hydroxymethyl)-4-(2-methylphenyl)sulfonyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]propan-1-one"
        },
        "smiles": {
          "canonical": "CCC(=O)N1C2CN(C3=CC=CC=C3C2C1CO)S(=O)(=O)C4=CC=CC=C4C"
        },
        "molecularFormula": "C21H24N2O4S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:02:51Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85fe"
    },
    "name": "BRD-K70243592",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85fe.png",
    "lincs": {
      "id": "LSM-12717",
      "name": "BRD-K70243592",
      "pubchemCid": 56835324,
      "chebiId": 101352,
      "inchiParent": "InChI=1S/C33H39N3O6S/c1-22-18-36(23(2)20-37)33(38)32-31(26-14-8-9-15-27(26)35(32)4)25-13-7-6-12-24(25)21-42-29(22)19-34(3)43(39,40)30-17-11-10-16-28(30)41-5/h6-17,22-23,29,37H,18-21H2,1-5H3/t22-,23-,29+/m0/s1",
      "inchiKeyParent": "VHDWJFVGOVHSLC-SBZVUBOMSA-N",
      "smilesParent": "COc1ccccc1S(=O)(=O)N(C)C[C@H]2OCc3ccccc3c4c(C(=O)N(C[C@@H]2C)[C@@H](C)CO)n(C)c5ccccc45"
    },
    "unichem": {
      "chebi": "101352",
      "chembl": "CHEMBL3559872",
      "lincs": "LSM-12717",
      "pubchem": "56835324"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL3559872",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 605.76,
        "hba": 7,
        "hbd": 1,
        "qedWeighted": 0.33
      }
    },
    "pubchem": [
      {
        "cid": 56835324,
        "inchi": "InChI=1S/C33H39N3O6S/c1-22-18-36(23(2)20-37)33(38)32-31(26-14-8-9-15-27(26)35(32)4)25-13-7-6-12-24(25)21-42-29(22)19-34(3)43(39,40)30-17-11-10-16-28(30)41-5/h6-17,22-23,29,37H,18-21H2,1-5H3/t22-,23-,29+/m0/s1",
        "inchikey": "VHDWJFVGOVHSLC-SBZVUBOMSA-N",
        "iupac": {
          "systematic": "N-[[(10S,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-2-methoxy-N-methylbenzenesulfonamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(C3=CC=CC=C3COC1CN(C)S(=O)(=O)C4=CC=CC=C4OC)C5=CC=CC=C5N2C)C(C)CO"
        },
        "molecularFormula": "C33H39N3O6S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:03:02Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8616"
    },
    "name": "BRD-K48923155",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8616.png",
    "lincs": {
      "id": "LSM-11406",
      "name": "BRD-K48923155",
      "pubchemCid": 54654323,
      "chebiId": 100027,
      "inchiParent": "InChI=1S/C26H31N3O6/c1-15-9-16(2)11-18(10-15)28-26(32)27-17-5-8-22-20(12-17)25(31)29(3)21-7-6-19(13-24(30)33-4)35-23(21)14-34-22/h5,8-12,19,21,23H,6-7,13-14H2,1-4H3,(H2,27,28,32)/t19-,21+,23-/m1/s1",
      "inchiKeyParent": "ANPNCKARMDTJMY-UNWVZKJWSA-N",
      "smilesParent": "COC(=O)C[C@H]1CC[C@H]2[C@@H](COc3ccc(NC(=O)Nc4cc(C)cc(C)c4)cc3C(=O)N2C)O1"
    },
    "unichem": {
      "chebi": "100027",
      "lincs": "LSM-11406",
      "pubchem": "54654323"
    },
    "pubchem": [
      {
        "cid": 54654323,
        "inchi": "InChI=1S/C26H31N3O6/c1-15-9-16(2)11-18(10-15)28-26(32)27-17-5-8-22-20(12-17)25(31)29(3)21-7-6-19(13-24(30)33-4)35-23(21)14-34-22/h5,8-12,19,21,23H,6-7,13-14H2,1-4H3,(H2,27,28,32)/t19-,21+,23-/m1/s1",
        "inchikey": "ANPNCKARMDTJMY-UNWVZKJWSA-N",
        "iupac": {
          "systematic": "methyl 2-[(2R,4aS,12aS)-8-[(3,5-dimethylphenyl)carbamoylamino]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]acetate"
        },
        "smiles": {
          "canonical": "CC1=CC(=CC(=C1)NC(=O)NC2=CC3=C(C=C2)OCC4C(CCC(O4)CC(=O)OC)N(C3=O)C)C"
        },
        "molecularFormula": "C26H31N3O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:03:04Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8636"
    },
    "name": "BRD-K47727686",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8636.png",
    "lincs": {
      "id": "LSM-39921",
      "name": "BRD-K47727686",
      "pubchemCid": 54652710,
      "chebiId": 128366,
      "inchiParent": "InChI=1S/C23H27N3O3/c1-24(2)14-22(29)26-19-13-25(21(28)12-16-8-4-3-5-9-16)18-11-7-6-10-17(18)23(19)20(26)15-27/h3-11,19-20,23,27H,12-15H2,1-2H3/t19-,20-,23+/m0/s1",
      "inchiKeyParent": "IKAOLLHWZROYFB-SXWKCWPCSA-N",
      "smilesParent": "CN(C)CC(=O)N1[C@@H](CO)[C@H]2[C@@H]1CN(C(=O)Cc3ccccc3)c4ccccc24"
    },
    "unichem": {
      "chebi": "128366",
      "lincs": "LSM-39921",
      "pubchem": "54652710"
    },
    "pubchem": [
      {
        "cid": 54652710,
        "inchi": "InChI=1S/C23H27N3O3/c1-24(2)14-22(29)26-19-13-25(21(28)12-16-8-4-3-5-9-16)18-11-7-6-10-17(18)23(19)20(26)15-27/h3-11,19-20,23,27H,12-15H2,1-2H3/t19-,20-,23+/m0/s1",
        "inchikey": "IKAOLLHWZROYFB-SXWKCWPCSA-N",
        "iupac": {
          "systematic": "1-[(1R,2aR,8bR)-2-[2-(dimethylamino)acetyl]-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-2-phenylethanone"
        },
        "smiles": {
          "canonical": "CN(C)CC(=O)N1C2CN(C3=CC=CC=C3C2C1CO)C(=O)CC4=CC=CC=C4"
        },
        "molecularFormula": "C23H27N3O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:03:07Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8650"
    },
    "name": "BRD-K62222886",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8650.png",
    "lincs": {
      "id": "LSM-40670",
      "name": "BRD-K62222886",
      "pubchemCid": 44501586,
      "chebiId": 129119,
      "inchiParent": "InChI=1S/C32H43N5O5/c1-20(2)33-32(41)36(6)18-29-21(3)16-37(22(4)19-38)31(40)15-23-13-25(11-12-28(23)42-29)34-30(39)14-24-17-35(5)27-10-8-7-9-26(24)27/h7-13,17,20-22,29,38H,14-16,18-19H2,1-6H3,(H,33,41)(H,34,39)/t21-,22+,29-/m1/s1",
      "inchiKeyParent": "PXCLLIDWELYOMM-UETOGOEVSA-N",
      "smilesParent": "CC(C)NC(=O)N(C)C[C@H]1Oc2ccc(NC(=O)Cc3cn(C)c4ccccc34)cc2CC(=O)N(C[C@H]1C)[C@@H](C)CO"
    },
    "unichem": {
      "chebi": "129119",
      "lincs": "LSM-40670",
      "pubchem": "44501586"
    },
    "pubchem": [
      {
        "cid": 44501586,
        "inchi": "InChI=1S/C32H43N5O5/c1-20(2)33-32(41)36(6)18-29-21(3)16-37(22(4)19-38)31(40)15-23-13-25(11-12-28(23)42-29)34-30(39)14-24-17-35(5)27-10-8-7-9-26(24)27/h7-13,17,20-22,29,38H,14-16,18-19H2,1-6H3,(H,33,41)(H,34,39)/t21-,22+,29-/m1/s1",
        "inchikey": "PXCLLIDWELYOMM-UETOGOEVSA-N",
        "iupac": {
          "systematic": "N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(propan-2-ylcarbamoyl)amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-(1-methylindol-3-yl)acetamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)CC2=C(C=CC(=C2)NC(=O)CC3=CN(C4=CC=CC=C43)C)OC1CN(C)C(=O)NC(C)C)C(C)CO"
        },
        "molecularFormula": "C32H43N5O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:03:09Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85b4"
    },
    "name": "BRD-K84536720",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85b4.png",
    "lincs": {
      "id": "LSM-41886",
      "name": "BRD-K84536720",
      "pubchemCid": 44619957,
      "chebiId": 130337,
      "inchiParent": "InChI=1S/C34H48N4O7/c1-22-17-38(23(2)20-39)33(40)28-15-26(35-34(41)36-27-11-13-30-31(16-27)44-21-43-30)10-12-29(28)45-24(3)7-5-6-14-42-32(22)19-37(4)18-25-8-9-25/h10-13,15-16,22-25,32,39H,5-9,14,17-21H2,1-4H3,(H2,35,36,41)/t22-,23+,24-,32+/m1/s1",
      "inchiKeyParent": "HYEFXMLKRFQNEN-KSUBRIHNSA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@@H](C)[C@H](CN(C)CC2CC2)OCCCC[C@@H](C)Oc3ccc(NC(=O)Nc4ccc5OCOc5c4)cc3C1=O"
    },
    "unichem": {
      "chebi": "130337",
      "lincs": "LSM-41886",
      "pubchem": "44619957"
    },
    "pubchem": [
      {
        "cid": 44619957,
        "inchi": "InChI=1S/C34H48N4O7/c1-22-17-38(23(2)20-39)33(40)28-15-26(35-34(41)36-27-11-13-30-31(16-27)44-21-43-30)10-12-29(28)45-24(3)7-5-6-14-42-32(22)19-37(4)18-25-8-9-25/h10-13,15-16,22-25,32,39H,5-9,14,17-21H2,1-4H3,(H2,35,36,41)/t22-,23+,24-,32+/m1/s1",
        "inchikey": "HYEFXMLKRFQNEN-KSUBRIHNSA-N",
        "iupac": {
          "systematic": "1-(1,3-benzodioxol-5-yl)-3-[(3R,9R,10R)-9-[[cyclopropylmethyl(methyl)amino]methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]urea"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NC(=O)NC3=CC4=C(C=C3)OCO4)C(C)CO)C)CN(C)CC5CC5"
        },
        "molecularFormula": "C34H48N4O7"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:03:11Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85f4"
    },
    "name": "BRD-K45924279",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85f4.png",
    "lincs": {
      "id": "LSM-11227",
      "name": "BRD-K45924279",
      "pubchemCid": 54654516,
      "chebiId": 99848,
      "inchiParent": "InChI=1S/C29H41N3O6/c1-32-24-9-8-22(16-27(33)30-17-19-5-3-2-4-6-19)38-26(24)18-37-25-10-7-21(15-23(25)29(32)35)31-28(34)20-11-13-36-14-12-20/h7,10,15,19-20,22,24,26H,2-6,8-9,11-14,16-18H2,1H3,(H,30,33)(H,31,34)/t22-,24+,26-/m0/s1",
      "inchiKeyParent": "JZXYXAGICCVVHG-FBILRYNDSA-N",
      "smilesParent": "CN1[C@@H]2CC[C@@H](CC(=O)NCC3CCCCC3)O[C@H]2COc4ccc(NC(=O)C5CCOCC5)cc4C1=O"
    },
    "unichem": {
      "chebi": "99848",
      "lincs": "LSM-11227",
      "pubchem": "54654516"
    },
    "pubchem": [
      {
        "cid": 54654516,
        "inchi": "InChI=1S/C29H41N3O6/c1-32-24-9-8-22(16-27(33)30-17-19-5-3-2-4-6-19)38-26(24)18-37-25-10-7-21(15-23(25)29(32)35)31-28(34)20-11-13-36-14-12-20/h7,10,15,19-20,22,24,26H,2-6,8-9,11-14,16-18H2,1H3,(H,30,33)(H,31,34)/t22-,24+,26-/m0/s1",
        "inchikey": "JZXYXAGICCVVHG-FBILRYNDSA-N",
        "iupac": {
          "systematic": "N-[(2S,4aR,12aR)-2-[2-(cyclohexylmethylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]oxane-4-carboxamide"
        },
        "smiles": {
          "canonical": "CN1C2CCC(OC2COC3=C(C1=O)C=C(C=C3)NC(=O)C4CCOCC4)CC(=O)NCC5CCCCC5"
        },
        "molecularFormula": "C29H41N3O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:03:14Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8605"
    },
    "name": "BRD-K14096157",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8605.png",
    "lincs": {
      "id": "LSM-9279",
      "name": "BRD-K14096157",
      "pubchemCid": 54596141,
      "chebiId": 97900,
      "inchiParent": "InChI=1S/C22H24FN3O6S/c23-15-4-1-2-6-18(15)33(30,31)26-17-12-25-16(5-3-7-19(25)28)21(26)20(14(17)13-27)22(29)24-8-10-32-11-9-24/h1-7,14,17,20-21,27H,8-13H2/t14-,17-,20+,21+/m1/s1",
      "inchiKeyParent": "YMYITTQDNPCSPN-LPNJYYIDSA-N",
      "smilesParent": "OC[C@@H]1[C@H]2CN3C(=O)C=CC=C3[C@@H]([C@H]1C(=O)N4CCOCC4)N2S(=O)(=O)c5ccccc5F"
    },
    "unichem": {
      "chebi": "97900",
      "lincs": "LSM-9279",
      "pubchem": "54596141"
    },
    "pubchem": [
      {
        "cid": 54596141,
        "inchi": "InChI=1S/C22H24FN3O6S/c23-15-4-1-2-6-18(15)33(30,31)26-17-12-25-16(5-3-7-19(25)28)21(26)20(14(17)13-27)22(29)24-8-10-32-11-9-24/h1-7,14,17,20-21,27H,8-13H2/t14-,17-,20+,21+/m1/s1",
        "inchikey": "YMYITTQDNPCSPN-LPNJYYIDSA-N",
        "iupac": {
          "systematic": "(1R,9S,10S,11S)-12-(2-fluorophenyl)sulfonyl-10-(hydroxymethyl)-11-(morpholine-4-carbonyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-dien-6-one"
        },
        "smiles": {
          "canonical": "C1COCCN1C(=O)C2C(C3CN4C(=O)C=CC=C4C2N3S(=O)(=O)C5=CC=CC=C5F)CO"
        },
        "molecularFormula": "C22H24FN3O6S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:03:16Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8521"
    },
    "name": "BRD-K71555338",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8521.png",
    "lincs": {
      "id": "LSM-41163",
      "name": "BRD-K71555338",
      "pubchemCid": 44486037,
      "chebiId": 129612,
      "inchiParent": "InChI=1S/C26H36N4O5/c1-17-14-30(18(2)16-31)25(32)22-13-20(28(3)4)9-12-23(22)35-24(17)15-29(5)26(33)27-19-7-10-21(34-6)11-8-19/h7-13,17-18,24,31H,14-16H2,1-6H3,(H,27,33)/t17-,18+,24-/m0/s1",
      "inchiKeyParent": "WPUIFJYVSOAUNQ-RHGYRFJNSA-N",
      "smilesParent": "COc1ccc(NC(=O)N(C)C[C@@H]2Oc3ccc(cc3C(=O)N(C[C@@H]2C)[C@H](C)CO)N(C)C)cc1"
    },
    "unichem": {
      "chebi": "129612",
      "lincs": "LSM-41163",
      "pubchem": "44486037"
    },
    "pubchem": [
      {
        "cid": 44486037,
        "inchi": "InChI=1S/C26H36N4O5/c1-17-14-30(18(2)16-31)25(32)22-13-20(28(3)4)9-12-23(22)35-24(17)15-29(5)26(33)27-19-7-10-21(34-6)11-8-19/h7-13,17-18,24,31H,14-16H2,1-6H3,(H,27,33)/t17-,18+,24-/m0/s1",
        "inchikey": "WPUIFJYVSOAUNQ-RHGYRFJNSA-N",
        "iupac": {
          "systematic": "1-[[(2R,3S)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-3-(4-methoxyphenyl)-1-methylurea"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(C=CC(=C2)N(C)C)OC1CN(C)C(=O)NC3=CC=C(C=C3)OC)C(C)CO"
        },
        "molecularFormula": "C26H36N4O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:03:18Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8532"
    },
    "name": "BRD-K47301880",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8532.png",
    "lincs": {
      "id": "LSM-14840",
      "name": "BRD-K47301880",
      "pubchemCid": 44496035,
      "chebiId": 103496,
      "inchiParent": "InChI=1S/C33H49N5O6/c1-22(2)34-33(42)37(6)20-30-23(3)19-38(24(4)21-39)31(40)28-18-27(36-32(41)35-26-13-8-7-9-14-26)15-16-29(28)44-25(5)12-10-11-17-43-30/h7-9,13-16,18,22-25,30,39H,10-12,17,19-21H2,1-6H3,(H,34,42)(H2,35,36,41)/t23-,24+,25+,30+/m1/s1",
      "inchiKeyParent": "YYAGCQUXHYGTOT-DUXAABNJSA-N",
      "smilesParent": "CC(C)NC(=O)N(C)C[C@@H]1OCCCC[C@H](C)Oc2ccc(NC(=O)Nc3ccccc3)cc2C(=O)N(C[C@H]1C)[C@@H](C)CO"
    },
    "unichem": {
      "chebi": "103496",
      "lincs": "LSM-14840",
      "pubchem": "44496035"
    },
    "pubchem": [
      {
        "cid": 44496035,
        "inchi": "InChI=1S/C33H49N5O6/c1-22(2)34-33(42)37(6)20-30-23(3)19-38(24(4)21-39)31(40)28-18-27(36-32(41)35-26-13-8-7-9-14-26)15-16-29(28)44-25(5)12-10-11-17-43-30/h7-9,13-16,18,22-25,30,39H,10-12,17,19-21H2,1-6H3,(H,34,42)(H2,35,36,41)/t23-,24+,25+,30+/m1/s1",
        "inchikey": "YYAGCQUXHYGTOT-DUXAABNJSA-N",
        "iupac": {
          "systematic": "1-[[(3S,9R,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-(phenylcarbamoylamino)-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-propan-2-ylurea"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NC(=O)NC3=CC=CC=C3)C(C)CO)C)CN(C)C(=O)NC(C)C"
        },
        "molecularFormula": "C33H49N5O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:03:20Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8575"
    },
    "name": "CHEMBL3182917",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8575.png",
    "lincs": {
      "id": "LSM-8934",
      "name": "CHEMBL3182917",
      "alternativeNames": [
        "BRD-K08377525"
      ],
      "pubchemCid": 54657904,
      "chebiId": 97555,
      "inchiParent": "InChI=1S/C27H30Cl2N2O5/c28-20-9-19(10-21(29)11-20)27(34)31-14-22(32)15-35-16-25-24(31)6-5-23(36-25)12-26(33)30-8-7-17-3-1-2-4-18(17)13-30/h1-4,9-11,22-25,32H,5-8,12-16H2/t22-,23+,24-,25+/m0/s1",
      "inchiKeyParent": "RFSVTUPSJXWLCE-FQUZAXHOSA-N",
      "smilesParent": "O[C@@H]1COC[C@H]2O[C@@H](CC(=O)N3CCc4ccccc4C3)CC[C@@H]2N(C1)C(=O)c5cc(Cl)cc(Cl)c5"
    },
    "unichem": {
      "chebi": "97555",
      "chembl": "CHEMBL3182917",
      "lincs": "LSM-8934",
      "pubchem": "54657904"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL3182917",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 533.45,
        "hba": 5,
        "hbd": 1,
        "qedWeighted": 0.65
      }
    },
    "pubchem": [
      {
        "cid": 54657904,
        "inchi": "InChI=1S/C27H30Cl2N2O5/c28-20-9-19(10-21(29)11-20)27(34)31-14-22(32)15-35-16-25-24(31)6-5-23(36-25)12-26(33)30-8-7-17-3-1-2-4-18(17)13-30/h1-4,9-11,22-25,32H,5-8,12-16H2/t22-,23+,24-,25+/m0/s1",
        "inchikey": "RFSVTUPSJXWLCE-FQUZAXHOSA-N",
        "iupac": {
          "systematic": "2-[(3S,6aS,8R,10aS)-1-(3,5-dichlorobenzoyl)-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(3,4-dihydro-1H-isoquinolin-2-yl)ethanone"
        },
        "smiles": {
          "canonical": "C1CC2C(COCC(CN2C(=O)C3=CC(=CC(=C3)Cl)Cl)O)OC1CC(=O)N4CCC5=CC=CC=C5C4"
        },
        "molecularFormula": "C27H30Cl2N2O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:03:31Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85b2"
    },
    "name": "BRD-K42454450",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85b2.png",
    "lincs": {
      "id": "LSM-14826",
      "name": "BRD-K42454450",
      "pubchemCid": 44617880,
      "chebiId": 103482,
      "inchiParent": "InChI=1S/C33H55N5O6/c1-22(2)34-32(41)35-27-15-16-29-28(18-27)31(40)38(24(4)21-39)19-23(3)30(43-17-11-10-12-25(5)44-29)20-37(6)33(42)36-26-13-8-7-9-14-26/h15-16,18,22-26,30,39H,7-14,17,19-21H2,1-6H3,(H,36,42)(H2,34,35,41)/t23-,24-,25+,30-/m1/s1",
      "inchiKeyParent": "STZYNHZFNFWBAK-ZASNTINBSA-N",
      "smilesParent": "CC(C)NC(=O)Nc1ccc2O[C@@H](C)CCCCO[C@H](CN(C)C(=O)NC3CCCCC3)[C@H](C)CN([C@H](C)CO)C(=O)c2c1"
    },
    "unichem": {
      "chebi": "103482",
      "lincs": "LSM-14826",
      "pubchem": "44617880"
    },
    "pubchem": [
      {
        "cid": 44617880,
        "inchi": "InChI=1S/C33H55N5O6/c1-22(2)34-32(41)35-27-15-16-29-28(18-27)31(40)38(24(4)21-39)19-23(3)30(43-17-11-10-12-25(5)44-29)20-37(6)33(42)36-26-13-8-7-9-14-26/h15-16,18,22-26,30,39H,7-14,17,19-21H2,1-6H3,(H,36,42)(H2,34,35,41)/t23-,24-,25+,30-/m1/s1",
        "inchikey": "STZYNHZFNFWBAK-ZASNTINBSA-N",
        "iupac": {
          "systematic": "3-cyclohexyl-1-[[(3S,9S,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-(propan-2-ylcarbamoylamino)-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methylurea"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NC(=O)NC(C)C)C(C)CO)C)CN(C)C(=O)NC3CCCCC3"
        },
        "molecularFormula": "C33H55N5O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:03:34Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8617"
    },
    "name": "BRD-K71590271",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8617.png",
    "lincs": {
      "id": "LSM-41166",
      "name": "BRD-K71590271",
      "pubchemCid": 60185284,
      "chebiId": 129615,
      "inchiParent": "InChI=1S/C28H34ClN3O3/c1-4-25(34)32-18-28(11-13-31(14-12-28)16-19-5-7-20(29)8-6-19)26-22-10-9-21(35-3)15-23(22)30(2)27(26)24(32)17-33/h5-10,15,24,33H,4,11-14,16-18H2,1-3H3/t24-/m0/s1",
      "inchiKeyParent": "XDANQGKQJDFUGD-DEOSSOPVSA-N",
      "smilesParent": "CCC(=O)N1CC2(CCN(Cc3ccc(Cl)cc3)CC2)c4c([C@@H]1CO)n(C)c5cc(OC)ccc45"
    },
    "unichem": {
      "chebi": "129615",
      "chembl": "CHEMBL3561203",
      "lincs": "LSM-41166",
      "pubchem": "60185284"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL3561203",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 496.05,
        "hba": 5,
        "hbd": 1,
        "qedWeighted": 0.56
      }
    },
    "pubchem": [
      {
        "cid": 60185284,
        "inchi": "InChI=1S/C28H34ClN3O3/c1-4-25(34)32-18-28(11-13-31(14-12-28)16-19-5-7-20(29)8-6-19)26-22-10-9-21(35-3)15-23(22)30(2)27(26)24(32)17-33/h5-10,15,24,33H,4,11-14,16-18H2,1-3H3/t24-/m0/s1",
        "inchikey": "XDANQGKQJDFUGD-DEOSSOPVSA-N",
        "iupac": {
          "systematic": "1-[(1R)-1'-[(4-chlorophenyl)methyl]-1-(hydroxymethyl)-7-methoxy-9-methylspiro[1,3-dihydropyrido[3,4-b]indole-4,4'-piperidine]-2-yl]propan-1-one"
        },
        "smiles": {
          "canonical": "CCC(=O)N1CC2(CCN(CC2)CC3=CC=C(C=C3)Cl)C4=C(C1CO)N(C5=C4C=CC(=C5)OC)C"
        },
        "molecularFormula": "C28H34ClN3O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:03:44Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8619"
    },
    "name": "BRD-K31415071",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8619.png",
    "lincs": {
      "id": "LSM-10330",
      "name": "BRD-K31415071",
      "pubchemCid": 54657575,
      "chebiId": 98951,
      "inchiParent": "InChI=1S/C25H37N3O6/c29-20-16-28(25(31)19-5-2-1-3-6-19)22-8-7-21(34-23(22)18-33-17-20)15-24(30)26-9-4-10-27-11-13-32-14-12-27/h1-3,5-6,20-23,29H,4,7-18H2,(H,26,30)/t20-,21-,22+,23-/m1/s1",
      "inchiKeyParent": "AMMWEOQELITDAS-BXXSPATCSA-N",
      "smilesParent": "O[C@H]1COC[C@H]2O[C@@H](CC(=O)NCCCN3CCOCC3)CC[C@@H]2N(C1)C(=O)c4ccccc4"
    },
    "unichem": {
      "chebi": "98951",
      "lincs": "LSM-10330",
      "pubchem": "54657575"
    },
    "pubchem": [
      {
        "cid": 54657575,
        "inchi": "InChI=1S/C25H37N3O6/c29-20-16-28(25(31)19-5-2-1-3-6-19)22-8-7-21(34-23(22)18-33-17-20)15-24(30)26-9-4-10-27-11-13-32-14-12-27/h1-3,5-6,20-23,29H,4,7-18H2,(H,26,30)/t20-,21-,22+,23-/m1/s1",
        "inchikey": "AMMWEOQELITDAS-BXXSPATCSA-N",
        "iupac": {
          "systematic": "2-[(3R,6aS,8R,10aS)-1-benzoyl-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(3-morpholin-4-ylpropyl)acetamide"
        },
        "smiles": {
          "canonical": "C1CC2C(COCC(CN2C(=O)C3=CC=CC=C3)O)OC1CC(=O)NCCCN4CCOCC4"
        },
        "molecularFormula": "C25H37N3O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:03:46Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8543"
    },
    "name": "MLS003128716",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8543.png",
    "lincs": {
      "id": "LSM-10614",
      "name": "MLS003128716",
      "alternativeNames": [
        "BRD-K36165258"
      ],
      "pubchemCid": 44504318,
      "chebiId": 99235,
      "inchiParent": "InChI=1S/C32H47N3O5/c1-23-20-35(24(2)22-36)32(38)28-19-27(33(4)5)15-16-29(28)40-25(3)12-10-11-17-39-30(23)21-34(6)31(37)18-26-13-8-7-9-14-26/h7-9,13-16,19,23-25,30,36H,10-12,17-18,20-22H2,1-6H3/t23-,24+,25+,30-/m0/s1",
      "inchiKeyParent": "ZGCRSIABJPRXFC-RPQPUBLWSA-N",
      "smilesParent": "C[C@H](CO)N1C[C@H](C)[C@H](CN(C)C(=O)Cc2ccccc2)OCCCC[C@@H](C)Oc3ccc(cc3C1=O)N(C)C"
    },
    "unichem": {
      "chebi": "99235",
      "chembl": "CHEMBL1887696",
      "lincs": "LSM-10614",
      "pubchem": "44504318"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL1887696",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 553.74,
        "hba": 6,
        "hbd": 1,
        "qedWeighted": 0.55
      }
    },
    "pubchem": [
      {
        "cid": 44504318,
        "inchi": "InChI=1S/C32H47N3O5/c1-23-20-35(24(2)22-36)32(38)28-19-27(33(4)5)15-16-29(28)40-25(3)12-10-11-17-39-30(23)21-34(6)31(37)18-26-13-8-7-9-14-26/h7-9,13-16,19,23-25,30,36H,10-12,17-18,20-22H2,1-6H3/t23-,24+,25+,30-/m0/s1",
        "inchikey": "ZGCRSIABJPRXFC-RPQPUBLWSA-N",
        "iupac": {
          "systematic": "N-[[(3R,9R,10S)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methyl-2-phenylacetamide"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)N(C)C)C(C)CO)C)CN(C)C(=O)CC3=CC=CC=C3"
        },
        "molecularFormula": "C32H47N3O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:03:58Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c854c"
    },
    "name": "BRD-K44777226",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c854c.png",
    "lincs": {
      "id": "LSM-11152",
      "name": "BRD-K44777226",
      "pubchemCid": 54646239,
      "chebiId": 99773,
      "inchiParent": "InChI=1S/C28H30N4O6/c1-36-20-8-5-17(6-9-20)31-28(35)32-18-7-10-24-22(12-18)23-13-21(37-25(16-33)27(23)38-24)14-26(34)30-15-19-4-2-3-11-29-19/h2-12,21,23,25,27,33H,13-16H2,1H3,(H,30,34)(H2,31,32,35)/t21-,23-,25-,27+/m1/s1",
      "inchiKeyParent": "FWDZHOQSJMEDFJ-UFUIAINPSA-N",
      "smilesParent": "COc1ccc(NC(=O)Nc2ccc3O[C@@H]4[C@@H](CO)O[C@@H](CC(=O)NCc5ccccn5)C[C@@H]4c3c2)cc1"
    },
    "unichem": {
      "chebi": "99773",
      "lincs": "LSM-11152",
      "pubchem": "54646239"
    },
    "pubchem": [
      {
        "cid": 54646239,
        "inchi": "InChI=1S/C28H30N4O6/c1-36-20-8-5-17(6-9-20)31-28(35)32-18-7-10-24-22(12-18)23-13-21(37-25(16-33)27(23)38-24)14-26(34)30-15-19-4-2-3-11-29-19/h2-12,21,23,25,27,33H,13-16H2,1H3,(H,30,34)(H2,31,32,35)/t21-,23-,25-,27+/m1/s1",
        "inchikey": "FWDZHOQSJMEDFJ-UFUIAINPSA-N",
        "iupac": {
          "systematic": "2-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-6-[(4-methoxyphenyl)carbamoylamino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-(pyridin-2-ylmethyl)acetamide"
        },
        "smiles": {
          "canonical": "COC1=CC=C(C=C1)NC(=O)NC2=CC3=C(C=C2)OC4C3CC(OC4CO)CC(=O)NCC5=CC=CC=N5"
        },
        "molecularFormula": "C28H30N4O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:04:00Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8552"
    },
    "name": "BRD-K33064169",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8552.png",
    "lincs": {
      "id": "LSM-10441",
      "name": "BRD-K33064169",
      "pubchemCid": 54661260,
      "chebiId": 99062,
      "inchiParent": "InChI=1S/C30H37N3O3/c34-19-25-24-18-33-26(12-11-23(29(33)35)22-9-5-2-6-10-22)27(24)31-28(25)30(36)32-15-13-21(14-16-32)17-20-7-3-1-4-8-20/h1,3-4,7-9,11-12,21,24-25,27-28,31,34H,2,5-6,10,13-19H2/t24-,25-,27+,28-/m1/s1",
      "inchiKeyParent": "FDPYZAHJFSZBPH-QKBZBAIHSA-N",
      "smilesParent": "OC[C@@H]1[C@H]2CN3C(=O)C(=CC=C3[C@H]2N[C@H]1C(=O)N4CCC(Cc5ccccc5)CC4)C6=CCCCC6"
    },
    "unichem": {
      "chebi": "99062",
      "lincs": "LSM-10441",
      "pubchem": "54661260"
    },
    "pubchem": [
      {
        "cid": 54661260,
        "inchi": "InChI=1S/C30H37N3O3/c34-19-25-24-18-33-26(12-11-23(29(33)35)22-9-5-2-6-10-22)27(24)31-28(25)30(36)32-15-13-21(14-16-32)17-20-7-3-1-4-8-20/h1,3-4,7-9,11-12,21,24-25,27-28,31,34H,2,5-6,10,13-19H2/t24-,25-,27+,28-/m1/s1",
        "inchikey": "FDPYZAHJFSZBPH-QKBZBAIHSA-N",
        "iupac": {
          "systematic": "(2R,3R,3aS,9bS)-2-(4-benzylpiperidine-1-carbonyl)-7-(cyclohexen-1-yl)-3-(hydroxymethyl)-1,2,3,3a,4,9b-hexahydropyrrolo[2,3-a]indolizin-6-one"
        },
        "smiles": {
          "canonical": "C1CCC(=CC1)C2=CC=C3C4C(CN3C2=O)C(C(N4)C(=O)N5CCC(CC5)CC6=CC=CC=C6)CO"
        },
        "molecularFormula": "C30H37N3O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:04:02Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8553"
    },
    "name": "BRD-K82096551",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8553.png",
    "lincs": {
      "id": "LSM-13444",
      "name": "BRD-K82096551",
      "pubchemCid": 54638823,
      "chebiId": 102084,
      "inchiParent": "InChI=1S/C20H27ClN2O4/c21-15-5-3-14(4-6-15)11-22-19(25)10-16-7-8-17(18(12-24)27-16)23-20(26)9-13-1-2-13/h3-6,13,16-18,24H,1-2,7-12H2,(H,22,25)(H,23,26)/t16-,17-,18+/m1/s1",
      "inchiKeyParent": "QFAVGRCFIOJHOR-KURKYZTESA-N",
      "smilesParent": "OC[C@@H]1O[C@@H](CC(=O)NCc2ccc(Cl)cc2)CC[C@H]1NC(=O)CC3CC3"
    },
    "unichem": {
      "chebi": "102084",
      "lincs": "LSM-13444",
      "pubchem": "54638823"
    },
    "pubchem": [
      {
        "cid": 54638823,
        "inchi": "InChI=1S/C20H27ClN2O4/c21-15-5-3-14(4-6-15)11-22-19(25)10-16-7-8-17(18(12-24)27-16)23-20(26)9-13-1-2-13/h3-6,13,16-18,24H,1-2,7-12H2,(H,22,25)(H,23,26)/t16-,17-,18+/m1/s1",
        "inchikey": "QFAVGRCFIOJHOR-KURKYZTESA-N",
        "iupac": {
          "systematic": "N-[(2R,3R,6R)-6-[2-[(4-chlorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)oxan-3-yl]-2-cyclopropylacetamide"
        },
        "smiles": {
          "canonical": "C1CC1CC(=O)NC2CCC(OC2CO)CC(=O)NCC3=CC=C(C=C3)Cl"
        },
        "molecularFormula": "C20H27ClN2O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:04:04Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85b3"
    },
    "name": "BRD-K56208365",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85b3.png",
    "lincs": {
      "id": "LSM-14865",
      "name": "BRD-K56208365",
      "pubchemCid": 44494129,
      "chebiId": 103521,
      "inchiParent": "InChI=1S/C34H50N4O6/c1-23(2)35-34(42)37(6)21-31-24(3)20-38(25(4)22-39)33(41)29-19-28(36-32(40)18-27-13-8-7-9-14-27)15-16-30(29)44-26(5)12-10-11-17-43-31/h7-9,13-16,19,23-26,31,39H,10-12,17-18,20-22H2,1-6H3,(H,35,42)(H,36,40)/t24-,25+,26+,31-/m1/s1",
      "inchiKeyParent": "JEEWDARUSPNTGW-SQRAXXTESA-N",
      "smilesParent": "CC(C)NC(=O)N(C)C[C@H]1OCCCC[C@H](C)Oc2ccc(NC(=O)Cc3ccccc3)cc2C(=O)N(C[C@H]1C)[C@@H](C)CO"
    },
    "unichem": {
      "chebi": "103521",
      "lincs": "LSM-14865",
      "pubchem": "44494129"
    },
    "pubchem": [
      {
        "cid": 44494129,
        "inchi": "InChI=1S/C34H50N4O6/c1-23(2)35-34(42)37(6)21-31-24(3)20-38(25(4)22-39)33(41)29-19-28(36-32(40)18-27-13-8-7-9-14-27)15-16-30(29)44-26(5)12-10-11-17-43-31/h7-9,13-16,19,23-26,31,39H,10-12,17-18,20-22H2,1-6H3,(H,35,42)(H,36,40)/t24-,25+,26+,31-/m1/s1",
        "inchikey": "JEEWDARUSPNTGW-SQRAXXTESA-N",
        "iupac": {
          "systematic": "N-[(3S,9S,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(propan-2-ylcarbamoyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-2-phenylacetamide"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NC(=O)CC3=CC=CC=C3)C(C)CO)C)CN(C)C(=O)NC(C)C"
        },
        "molecularFormula": "C34H50N4O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:04:06Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c861e"
    },
    "name": "BRD-K77786391",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c861e.png",
    "lincs": {
      "id": "LSM-13183",
      "name": "BRD-K77786391",
      "pubchemCid": 54657486,
      "chebiId": 101821,
      "inchiParent": "InChI=1S/C22H39N3O5/c1-23-6-8-24(9-7-23)22(27)12-19-2-3-20-21(30-19)16-29-15-18(26)14-25(20)13-17-4-10-28-11-5-17/h17-21,26H,2-16H2,1H3/t18-,19-,20+,21-/m1/s1",
      "inchiKeyParent": "MTMISLSQWFYTRE-MXEMCNAFSA-N",
      "smilesParent": "CN1CCN(CC1)C(=O)C[C@H]2CC[C@H]3[C@@H](COC[C@H](O)CN3CC4CCOCC4)O2"
    },
    "unichem": {
      "chebi": "101821",
      "lincs": "LSM-13183",
      "pubchem": "54657486"
    },
    "pubchem": [
      {
        "cid": 54657486,
        "inchi": "InChI=1S/C22H39N3O5/c1-23-6-8-24(9-7-23)22(27)12-19-2-3-20-21(30-19)16-29-15-18(26)14-25(20)13-17-4-10-28-11-5-17/h17-21,26H,2-16H2,1H3/t18-,19-,20+,21-/m1/s1",
        "inchikey": "MTMISLSQWFYTRE-MXEMCNAFSA-N",
        "iupac": {
          "systematic": "2-[(3R,6aS,8R,10aS)-3-hydroxy-1-(oxan-4-ylmethyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(4-methylpiperazin-1-yl)ethanone"
        },
        "smiles": {
          "canonical": "CN1CCN(CC1)C(=O)CC2CCC3C(O2)COCC(CN3CC4CCOCC4)O"
        },
        "molecularFormula": "C22H39N3O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:04:09Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c862a"
    },
    "name": "BRD-K27133763",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c862a.png",
    "lincs": {
      "id": "LSM-38743",
      "name": "BRD-K27133763",
      "pubchemCid": 60185181,
      "chebiId": 127183,
      "inchiParent": "InChI=1S/C29H32N4O4/c1-19(35)33-18-29(27-23-9-8-22(36-2)15-24(23)30-28(27)25(33)17-34)10-12-32(13-11-29)16-21-14-26(37-31-21)20-6-4-3-5-7-20/h3-9,14-15,25,30,34H,10-13,16-18H2,1-2H3/t25-/m0/s1",
      "inchiKeyParent": "AIQMCLHSJXWCQX-VWLOTQADSA-N",
      "smilesParent": "COc1ccc2c3c([nH]c2c1)[C@H](CO)N(CC34CCN(Cc5cc(on5)c6ccccc6)CC4)C(=O)C"
    },
    "unichem": {
      "chebi": "127183",
      "lincs": "LSM-38743",
      "pubchem": "60185181"
    },
    "pubchem": [
      {
        "cid": 60185181,
        "inchi": "InChI=1S/C29H32N4O4/c1-19(35)33-18-29(27-23-9-8-22(36-2)15-24(23)30-28(27)25(33)17-34)10-12-32(13-11-29)16-21-14-26(37-31-21)20-6-4-3-5-7-20/h3-9,14-15,25,30,34H,10-13,16-18H2,1-2H3/t25-/m0/s1",
        "inchikey": "AIQMCLHSJXWCQX-VWLOTQADSA-N",
        "iupac": {
          "systematic": "1-[(1R)-1-(hydroxymethyl)-7-methoxy-1'-[(5-phenyl-1,2-oxazol-3-yl)methyl]spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4'-piperidine]-2-yl]ethanone"
        },
        "smiles": {
          "canonical": "CC(=O)N1CC2(CCN(CC2)CC3=NOC(=C3)C4=CC=CC=C4)C5=C(C1CO)NC6=C5C=CC(=C6)OC"
        },
        "molecularFormula": "C29H32N4O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:04:11Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c84fc"
    },
    "name": "BRD-K33071234",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c84fc.png",
    "lincs": {
      "id": "LSM-10443",
      "name": "BRD-K33071234",
      "pubchemCid": 54654444,
      "chebiId": 99064,
      "inchiParent": "InChI=1S/C23H25ClN2O7S/c1-26-18-9-8-15(12-22(27)31-2)33-20(18)13-32-19-10-7-14(11-16(19)23(26)28)25-34(29,30)21-6-4-3-5-17(21)24/h3-7,10-11,15,18,20,25H,8-9,12-13H2,1-2H3/t15-,18+,20+/m1/s1",
      "inchiKeyParent": "QTFAPORQFWHYLC-BPAFIMBUSA-N",
      "smilesParent": "COC(=O)C[C@H]1CC[C@H]2[C@H](COc3ccc(NS(=O)(=O)c4ccccc4Cl)cc3C(=O)N2C)O1"
    },
    "unichem": {
      "chebi": "99064",
      "lincs": "LSM-10443",
      "pubchem": "54654444"
    },
    "pubchem": [
      {
        "cid": 54654444,
        "inchi": "InChI=1S/C23H25ClN2O7S/c1-26-18-9-8-15(12-22(27)31-2)33-20(18)13-32-19-10-7-14(11-16(19)23(26)28)25-34(29,30)21-6-4-3-5-17(21)24/h3-7,10-11,15,18,20,25H,8-9,12-13H2,1-2H3/t15-,18+,20+/m1/s1",
        "inchikey": "QTFAPORQFWHYLC-BPAFIMBUSA-N",
        "iupac": {
          "systematic": "methyl 2-[(2R,4aS,12aR)-8-[(2-chlorophenyl)sulfonylamino]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]acetate"
        },
        "smiles": {
          "canonical": "CN1C2CCC(OC2COC3=C(C1=O)C=C(C=C3)NS(=O)(=O)C4=CC=CC=C4Cl)CC(=O)OC"
        },
        "molecularFormula": "C23H25ClN2O7S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:04:13Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c852f"
    },
    "name": "BRD-K93880770",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c852f.png",
    "lincs": {
      "id": "LSM-14187",
      "name": "BRD-K93880770",
      "pubchemCid": 54657761,
      "chebiId": 102841,
      "inchiParent": "InChI=1S/C25H36ClN3O5/c26-18-6-8-19(9-7-18)28-25(32)29-14-20(30)15-33-16-23-22(29)11-10-21(34-23)12-24(31)27-13-17-4-2-1-3-5-17/h6-9,17,20-23,30H,1-5,10-16H2,(H,27,31)(H,28,32)/t20-,21-,22+,23-/m1/s1",
      "inchiKeyParent": "SYCYKHHPUCXRJT-BXXSPATCSA-N",
      "smilesParent": "O[C@H]1COC[C@H]2O[C@@H](CC(=O)NCC3CCCCC3)CC[C@@H]2N(C1)C(=O)Nc4ccc(Cl)cc4"
    },
    "unichem": {
      "chebi": "102841",
      "lincs": "LSM-14187",
      "pubchem": "54657761"
    },
    "pubchem": [
      {
        "cid": 54657761,
        "inchi": "InChI=1S/C25H36ClN3O5/c26-18-6-8-19(9-7-18)28-25(32)29-14-20(30)15-33-16-23-22(29)11-10-21(34-23)12-24(31)27-13-17-4-2-1-3-5-17/h6-9,17,20-23,30H,1-5,10-16H2,(H,27,31)(H,28,32)/t20-,21-,22+,23-/m1/s1",
        "inchikey": "SYCYKHHPUCXRJT-BXXSPATCSA-N",
        "iupac": {
          "systematic": "(3R,6aS,8R,10aS)-N-(4-chlorophenyl)-8-[2-(cyclohexylmethylamino)-2-oxoethyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide"
        },
        "smiles": {
          "canonical": "C1CCC(CC1)CNC(=O)CC2CCC3C(O2)COCC(CN3C(=O)NC4=CC=C(C=C4)Cl)O"
        },
        "molecularFormula": "C25H36ClN3O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:04:15Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c856d"
    },
    "name": "BRD-K31846842",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c856d.png",
    "lincs": {
      "id": "LSM-10362",
      "name": "BRD-K31846842",
      "pubchemCid": 54631520,
      "chebiId": 98983,
      "inchiParent": "InChI=1S/C30H37N5O7/c1-18-15-35(30(38)32-23-9-7-8-10-26(23)39-5)19(2)17-41-25-12-11-21(31-28(36)24-13-20(3)42-33-24)14-22(25)29(37)34(4)16-27(18)40-6/h7-14,18-19,27H,15-17H2,1-6H3,(H,31,36)(H,32,38)/t18-,19-,27-/m1/s1",
      "inchiKeyParent": "HEGRZDISCWUYOS-DRGJWEBESA-N",
      "smilesParent": "CO[C@@H]1CN(C)C(=O)c2cc(NC(=O)c3cc(C)on3)ccc2OC[C@@H](C)N(C[C@H]1C)C(=O)Nc4ccccc4OC"
    },
    "unichem": {
      "chebi": "98983",
      "lincs": "LSM-10362",
      "pubchem": "54631520"
    },
    "pubchem": [
      {
        "cid": 54631520,
        "inchi": "InChI=1S/C30H37N5O7/c1-18-15-35(30(38)32-23-9-7-8-10-26(23)39-5)19(2)17-41-25-12-11-21(31-28(36)24-13-20(3)42-33-24)14-22(25)29(37)34(4)16-27(18)40-6/h7-14,18-19,27H,15-17H2,1-6H3,(H,31,36)(H,32,38)/t18-,19-,27-/m1/s1",
        "inchikey": "HEGRZDISCWUYOS-DRGJWEBESA-N",
        "iupac": {
          "systematic": "(4R,7R,8S)-8-methoxy-N-(2-methoxyphenyl)-4,7,10-trimethyl-14-[(5-methyl-1,2-oxazole-3-carbonyl)amino]-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-5-carboxamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(COC2=C(C=C(C=C2)NC(=O)C3=NOC(=C3)C)C(=O)N(CC1OC)C)C)C(=O)NC4=CC=CC=C4OC"
        },
        "molecularFormula": "C30H37N5O7"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:04:17Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c858e"
    },
    "name": "BRD-K64402699",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c858e.png",
    "lincs": {
      "id": "LSM-40783",
      "name": "BRD-K64402699",
      "pubchemCid": 54652696,
      "chebiId": 129232,
      "inchiParent": "InChI=1S/C25H25N3O3/c1-31-23-11-5-2-7-18(23)14-27-21-15-28(25(30)17-8-6-12-26-13-17)20-10-4-3-9-19(20)24(21)22(27)16-29/h2-13,21-22,24,29H,14-16H2,1H3/t21-,22-,24+/m0/s1",
      "inchiKeyParent": "AVFJRCXGABTTSO-WPFOTENUSA-N",
      "smilesParent": "COc1ccccc1CN2[C@@H](CO)[C@H]3[C@@H]2CN(C(=O)c4cccnc4)c5ccccc35"
    },
    "unichem": {
      "chebi": "129232",
      "lincs": "LSM-40783",
      "pubchem": "54652696"
    },
    "pubchem": [
      {
        "cid": 54652696,
        "inchi": "InChI=1S/C25H25N3O3/c1-31-23-11-5-2-7-18(23)14-27-21-15-28(25(30)17-8-6-12-26-13-17)20-10-4-3-9-19(20)24(21)22(27)16-29/h2-13,21-22,24,29H,14-16H2,1H3/t21-,22-,24+/m0/s1",
        "inchikey": "AVFJRCXGABTTSO-WPFOTENUSA-N",
        "iupac": {
          "systematic": "[(1R,2aR,8bR)-1-(hydroxymethyl)-2-[(2-methoxyphenyl)methyl]-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-pyridin-3-ylmethanone"
        },
        "smiles": {
          "canonical": "COC1=CC=CC=C1CN2C3CN(C4=CC=CC=C4C3C2CO)C(=O)C5=CN=CC=C5"
        },
        "molecularFormula": "C25H25N3O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:04:20Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c859e"
    },
    "name": "BRD-K83443720",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c859e.png",
    "lincs": {
      "id": "LSM-41825",
      "name": "BRD-K83443720",
      "pubchemCid": 60189969,
      "chebiId": 130276,
      "inchiParent": "InChI=1S/C22H29N5O4S/c1-25-11-19(23-14-25)32(29,30)27-8-6-22(7-9-27)13-26(2)18(12-28)21-20(22)16-5-4-15(31-3)10-17(16)24-21/h4-5,10-11,14,18,24,28H,6-9,12-13H2,1-3H3/t18-/m1/s1",
      "inchiKeyParent": "RYBVUVRUGVCQGA-GOSISDBHSA-N",
      "smilesParent": "COc1ccc2c3c([nH]c2c1)[C@@H](CO)N(C)CC34CCN(CC4)S(=O)(=O)c5cn(C)cn5"
    },
    "unichem": {
      "chebi": "130276",
      "lincs": "LSM-41825",
      "pubchem": "60189969"
    },
    "pubchem": [
      {
        "cid": 60189969,
        "inchi": "InChI=1S/C22H29N5O4S/c1-25-11-19(23-14-25)32(29,30)27-8-6-22(7-9-27)13-26(2)18(12-28)21-20(22)16-5-4-15(31-3)10-17(16)24-21/h4-5,10-11,14,18,24,28H,6-9,12-13H2,1-3H3/t18-/m1/s1",
        "inchikey": "RYBVUVRUGVCQGA-GOSISDBHSA-N",
        "iupac": {
          "systematic": "[(1S)-7-methoxy-2-methyl-1'-(1-methylimidazol-4-yl)sulfonylspiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4'-piperidine]-1-yl]methanol"
        },
        "smiles": {
          "canonical": "CN1CC2(CCN(CC2)S(=O)(=O)C3=CN(C=N3)C)C4=C(C1CO)NC5=C4C=CC(=C5)OC"
        },
        "molecularFormula": "C22H29N5O4S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:04:22Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85fc"
    },
    "name": "BRD-K83837862",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85fc.png",
    "lincs": {
      "id": "LSM-13553",
      "name": "BRD-K83837862",
      "pubchemCid": 56835558,
      "chebiId": 102195,
      "inchiParent": "InChI=1S/C30H41N3O4/c1-21-17-33(22(2)19-34)29(35)27-16-10-9-15-26(27)25-14-8-7-11-23(25)20-37-28(21)18-32(3)30(36)31-24-12-5-4-6-13-24/h7-11,14-16,21-22,24,28,34H,4-6,12-13,17-20H2,1-3H3,(H,31,36)/t21-,22-,28-/m0/s1",
      "inchiKeyParent": "FOMDXHZXOKRLRD-VPYPWEPUSA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@H](C)[C@H](CN(C)C(=O)NC2CCCCC2)OCc3ccccc3c4ccccc4C1=O"
    },
    "unichem": {
      "chebi": "102195",
      "lincs": "LSM-13553",
      "pubchem": "56835558"
    },
    "pubchem": [
      {
        "cid": 56835558,
        "inchi": "InChI=1S/C30H41N3O4/c1-21-17-33(22(2)19-34)29(35)27-16-10-9-15-26(27)25-14-8-7-11-23(25)20-37-28(21)18-32(3)30(36)31-24-12-5-4-6-13-24/h7-11,14-16,21-22,24,28,34H,4-6,12-13,17-20H2,1-3H3,(H,31,36)/t21-,22-,28-/m0/s1",
        "inchikey": "FOMDXHZXOKRLRD-VPYPWEPUSA-N",
        "iupac": {
          "systematic": "3-cyclohexyl-1-[[(10R,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methylurea"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=CC=CC=C2C3=CC=CC=C3COC1CN(C)C(=O)NC4CCCCC4)C(C)CO"
        },
        "molecularFormula": "C30H41N3O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:04:24Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8610"
    },
    "name": "BRD-K16274875-019-01-0",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8610.png",
    "lincs": {
      "id": "LSM-36497",
      "name": "BRD-K16274875-019-01-0",
      "alternativeNames": [
        "BRD-K16274875",
        "BRD-K65138538"
      ],
      "pubchemCid": 60185283,
      "chebiId": 125035,
      "inchiParent": "InChI=1S/C19H20N4O/c24-19(14-5-6-14)23-9-16-18(17(10-23)22-16)13-3-1-12(2-4-13)15-7-20-11-21-8-15/h1-4,7-8,11,14,16-18,22H,5-6,9-10H2/t16-,17+,18?",
      "inchiKeyParent": "SURRSBGQMWTHJI-JWTNVVGKSA-N",
      "smilesParent": "O=C(C1CC1)N2C[C@@H]3N[C@H](C2)[C@H]3c4ccc(cc4)c5cncnc5"
    },
    "unichem": {
      "chebi": "125035",
      "lincs": "LSM-36497",
      "pubchem": "60185283"
    },
    "pubchem": [
      {
        "cid": 60185283,
        "inchi": "InChI=1S/C19H20N4O/c24-19(14-5-6-14)23-9-16-18(17(10-23)22-16)13-3-1-12(2-4-13)15-7-20-11-21-8-15/h1-4,7-8,11,14,16-18,22H,5-6,9-10H2/t16-,17+,18?",
        "inchikey": "SURRSBGQMWTHJI-JWTNVVGKSA-N",
        "iupac": {
          "systematic": "cyclopropyl-[(1R,5S)-7-(4-pyrimidin-5-ylphenyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl]methanone"
        },
        "smiles": {
          "canonical": "C1CC1C(=O)N2CC3C(C(C2)N3)C4=CC=C(C=C4)C5=CN=CN=C5"
        },
        "molecularFormula": "C19H20N4O"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:04:27Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8626"
    },
    "name": "BRD-K12562048",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8626.png",
    "lincs": {
      "id": "LSM-37918",
      "name": "BRD-K12562048",
      "pubchemCid": 60191323,
      "chebiId": 126353,
      "inchiParent": "InChI=1S/C20H19N3O2/c21-9-13-1-3-14(4-2-13)15-5-7-16(8-6-15)20-17-10-22-11-19(25)23(17)18(20)12-24/h1-8,17-18,20,22,24H,10-12H2/t17-,18+,20-/m0/s1",
      "inchiKeyParent": "OUKAGPBTRJAGIF-NSHGMRRFSA-N",
      "smilesParent": "OC[C@@H]1[C@H]([C@@H]2CNCC(=O)N12)c3ccc(cc3)c4ccc(cc4)C#N"
    },
    "unichem": {
      "chebi": "126353",
      "lincs": "LSM-37918",
      "pubchem": "60191323"
    },
    "pubchem": [
      {
        "cid": 60191323,
        "inchi": "InChI=1S/C20H19N3O2/c21-9-13-1-3-14(4-2-13)15-5-7-16(8-6-15)20-17-10-22-11-19(25)23(17)18(20)12-24/h1-8,17-18,20,22,24H,10-12H2/t17-,18+,20-/m0/s1",
        "inchikey": "OUKAGPBTRJAGIF-NSHGMRRFSA-N",
        "iupac": {
          "systematic": "4-[4-[(6R,7S,8S)-8-(hydroxymethyl)-2-oxo-1,4-diazabicyclo[4.2.0]octan-7-yl]phenyl]benzonitrile"
        },
        "smiles": {
          "canonical": "C1C2C(C(N2C(=O)CN1)CO)C3=CC=C(C=C3)C4=CC=C(C=C4)C#N"
        },
        "molecularFormula": "C20H19N3O2"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:04:29Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8631"
    },
    "name": "BRD-K99660708",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8631.png",
    "lincs": {
      "id": "LSM-42672",
      "name": "BRD-K99660708",
      "pubchemCid": 60189872,
      "chebiId": 131124,
      "inchiParent": "InChI=1S/C22H29N3O3/c1-23-11-22(12-25(13-22)21(27)14-5-4-6-14)19-16-8-7-15(28-3)9-17(16)24(2)20(19)18(23)10-26/h7-9,14,18,26H,4-6,10-13H2,1-3H3/t18-/m1/s1",
      "inchiKeyParent": "LCNVNGFFJPQQPW-GOSISDBHSA-N",
      "smilesParent": "COc1ccc2c3c([C@@H](CO)N(C)CC34CN(C4)C(=O)C5CCC5)n(C)c2c1"
    },
    "unichem": {
      "chebi": "131124",
      "lincs": "LSM-42672",
      "pubchem": "60189872"
    },
    "pubchem": [
      {
        "cid": 60189872,
        "inchi": "InChI=1S/C22H29N3O3/c1-23-11-22(12-25(13-22)21(27)14-5-4-6-14)19-16-8-7-15(28-3)9-17(16)24(2)20(19)18(23)10-26/h7-9,14,18,26H,4-6,10-13H2,1-3H3/t18-/m1/s1",
        "inchikey": "LCNVNGFFJPQQPW-GOSISDBHSA-N",
        "iupac": {
          "systematic": "cyclobutyl-[(1S)-1-(hydroxymethyl)-7-methoxy-2,9-dimethylspiro[1,3-dihydropyrido[3,4-b]indole-4,3'-azetidine]-1'-yl]methanone"
        },
        "smiles": {
          "canonical": "CN1CC2(CN(C2)C(=O)C3CCC3)C4=C(C1CO)N(C5=C4C=CC(=C5)OC)C"
        },
        "molecularFormula": "C22H29N3O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:04:32Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c855d"
    },
    "name": "BRD-K22630074",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c855d.png",
    "lincs": {
      "id": "LSM-9801",
      "name": "BRD-K22630074",
      "pubchemCid": 54654060,
      "chebiId": 98422,
      "inchiParent": "InChI=1S/C22H34N4O6S/c1-25(2)11-5-10-23-21(27)13-16-7-8-18-20(32-16)14-31-19-9-6-15(24-33(4,29)30)12-17(19)22(28)26(18)3/h6,9,12,16,18,20,24H,5,7-8,10-11,13-14H2,1-4H3,(H,23,27)/t16-,18+,20+/m0/s1",
      "inchiKeyParent": "CDAYNQARGBNMSE-ILZDJORESA-N",
      "smilesParent": "CN(C)CCCNC(=O)C[C@@H]1CC[C@@H]2[C@@H](COc3ccc(NS(=O)(=O)C)cc3C(=O)N2C)O1"
    },
    "unichem": {
      "chebi": "98422",
      "lincs": "LSM-9801",
      "pubchem": "54654060"
    },
    "pubchem": [
      {
        "cid": 54654060,
        "inchi": "InChI=1S/C22H34N4O6S/c1-25(2)11-5-10-23-21(27)13-16-7-8-18-20(32-16)14-31-19-9-6-15(24-33(4,29)30)12-17(19)22(28)26(18)3/h6,9,12,16,18,20,24H,5,7-8,10-11,13-14H2,1-4H3,(H,23,27)/t16-,18+,20+/m0/s1",
        "inchikey": "CDAYNQARGBNMSE-ILZDJORESA-N",
        "iupac": {
          "systematic": "2-[(2S,4aR,12aS)-8-(methanesulfonamido)-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-[3-(dimethylamino)propyl]acetamide"
        },
        "smiles": {
          "canonical": "CN1C2CCC(OC2COC3=C(C1=O)C=C(C=C3)NS(=O)(=O)C)CC(=O)NCCCN(C)C"
        },
        "molecularFormula": "C22H34N4O6S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:04:34Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c858c"
    },
    "name": "BRD-K83980681",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c858c.png",
    "lincs": {
      "id": "LSM-13560",
      "name": "BRD-K83980681",
      "pubchemCid": 54654011,
      "chebiId": 102202,
      "inchiParent": "InChI=1S/C28H30N4O7/c1-32-21-9-8-19(14-26(33)29-15-17-5-3-4-6-22(17)36-2)38-25(21)16-37-23-10-7-18(13-20(23)28(32)35)31-27(34)24-11-12-30-39-24/h3-7,10-13,19,21,25H,8-9,14-16H2,1-2H3,(H,29,33)(H,31,34)/t19-,21+,25-/m1/s1",
      "inchiKeyParent": "NHAXNTZRJLBPPG-FZOAFFARSA-N",
      "smilesParent": "COc1ccccc1CNC(=O)C[C@H]2CC[C@H]3[C@@H](COc4ccc(NC(=O)c5oncc5)cc4C(=O)N3C)O2"
    },
    "unichem": {
      "chebi": "102202",
      "lincs": "LSM-13560",
      "pubchem": "54654011"
    },
    "pubchem": [
      {
        "cid": 54654011,
        "inchi": "InChI=1S/C28H30N4O7/c1-32-21-9-8-19(14-26(33)29-15-17-5-3-4-6-22(17)36-2)38-25(21)16-37-23-10-7-18(13-20(23)28(32)35)31-27(34)24-11-12-30-39-24/h3-7,10-13,19,21,25H,8-9,14-16H2,1-2H3,(H,29,33)(H,31,34)/t19-,21+,25-/m1/s1",
        "inchikey": "NHAXNTZRJLBPPG-FZOAFFARSA-N",
        "iupac": {
          "systematic": "N-[(2R,4aS,12aS)-2-[2-[(2-methoxyphenyl)methylamino]-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-1,2-oxazole-5-carboxamide"
        },
        "smiles": {
          "canonical": "CN1C2CCC(OC2COC3=C(C1=O)C=C(C=C3)NC(=O)C4=CC=NO4)CC(=O)NCC5=CC=CC=C5OC"
        },
        "molecularFormula": "C28H30N4O7"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:04:36Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85ad"
    },
    "name": "BRD-K86291677",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85ad.png",
    "lincs": {
      "id": "LSM-13713",
      "name": "BRD-K86291677",
      "pubchemCid": 54660657,
      "chebiId": 102361,
      "inchiParent": "InChI=1S/C27H33N3O4/c1-28(2)27(33)24-20(16-31)22-15-30-21(13-12-19(26(30)32)17-8-4-5-9-17)25(24)29(22)14-18-10-6-7-11-23(18)34-3/h6-8,10-13,20,22,24-25,31H,4-5,9,14-16H2,1-3H3/t20-,22-,24+,25+/m1/s1",
      "inchiKeyParent": "CAYQEZITEZQLOQ-KAKDDGLXSA-N",
      "smilesParent": "COc1ccccc1CN2[C@@H]3CN4C(=CC=C(C5=CCCC5)C4=O)[C@H]2[C@H]([C@@H]3CO)C(=O)N(C)C"
    },
    "unichem": {
      "chebi": "102361",
      "lincs": "LSM-13713",
      "pubchem": "54660657"
    },
    "pubchem": [
      {
        "cid": 54660657,
        "inchi": "InChI=1S/C27H33N3O4/c1-28(2)27(33)24-20(16-31)22-15-30-21(13-12-19(26(30)32)17-8-4-5-9-17)25(24)29(22)14-18-10-6-7-11-23(18)34-3/h6-8,10-13,20,22,24-25,31H,4-5,9,14-16H2,1-3H3/t20-,22-,24+,25+/m1/s1",
        "inchikey": "CAYQEZITEZQLOQ-KAKDDGLXSA-N",
        "iupac": {
          "systematic": "(1R,9S,10S,11S)-5-(cyclopenten-1-yl)-10-(hydroxymethyl)-12-[(2-methoxyphenyl)methyl]-N,N-dimethyl-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide"
        },
        "smiles": {
          "canonical": "CN(C)C(=O)C1C(C2CN3C(=CC=C(C3=O)C4=CCCC4)C1N2CC5=CC=CC=C5OC)CO"
        },
        "molecularFormula": "C27H33N3O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:04:38Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c862b"
    },
    "name": "BRD-K44352336",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c862b.png",
    "lincs": {
      "id": "LSM-39716",
      "name": "BRD-K44352336",
      "pubchemCid": 60185073,
      "chebiId": 128161,
      "inchiParent": "InChI=1S/C26H33N5O3/c1-4-9-28-25(33)31-17-26(15-30(16-26)13-18-6-5-10-27-12-18)23-20-8-7-19(34-3)11-21(20)29(2)24(23)22(31)14-32/h5-8,10-12,22,32H,4,9,13-17H2,1-3H3,(H,28,33)/t22-/m0/s1",
      "inchiKeyParent": "KFUDZWZDFVVFQZ-QFIPXVFZSA-N",
      "smilesParent": "CCCNC(=O)N1CC2(CN(Cc3cccnc3)C2)c4c([C@@H]1CO)n(C)c5cc(OC)ccc45"
    },
    "unichem": {
      "chebi": "128161",
      "lincs": "LSM-39716",
      "pubchem": "60185073"
    },
    "pubchem": [
      {
        "cid": 60185073,
        "inchi": "InChI=1S/C26H33N5O3/c1-4-9-28-25(33)31-17-26(15-30(16-26)13-18-6-5-10-27-12-18)23-20-8-7-19(34-3)11-21(20)29(2)24(23)22(31)14-32/h5-8,10-12,22,32H,4,9,13-17H2,1-3H3,(H,28,33)/t22-/m0/s1",
        "inchikey": "KFUDZWZDFVVFQZ-QFIPXVFZSA-N",
        "iupac": {
          "systematic": "(1R)-1-(hydroxymethyl)-7-methoxy-9-methyl-N-propyl-1'-(pyridin-3-ylmethyl)spiro[1,3-dihydropyrido[3,4-b]indole-4,3'-azetidine]-2-carboxamide"
        },
        "smiles": {
          "canonical": "CCCNC(=O)N1CC2(CN(C2)CC3=CN=CC=C3)C4=C(C1CO)N(C5=C4C=CC(=C5)OC)C"
        },
        "molecularFormula": "C26H33N5O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:04:40Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8501"
    },
    "name": "BRD-K51703152",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8501.png",
    "lincs": {
      "id": "LSM-11590",
      "name": "BRD-K51703152",
      "pubchemCid": 54654266,
      "chebiId": 100213,
      "inchiParent": "InChI=1S/C30H32ClN3O6S/c1-19(20-6-4-3-5-7-20)32-29(35)17-23-11-14-26-28(40-23)18-39-27-15-10-22(16-25(27)30(36)34(26)2)33-41(37,38)24-12-8-21(31)9-13-24/h3-10,12-13,15-16,19,23,26,28,33H,11,14,17-18H2,1-2H3,(H,32,35)/t19-,23+,26-,28-/m0/s1",
      "inchiKeyParent": "UIBIEJVTTJAUBZ-OKWYHVSVSA-N",
      "smilesParent": "C[C@H](NC(=O)C[C@H]1CC[C@H]2[C@H](COc3ccc(NS(=O)(=O)c4ccc(Cl)cc4)cc3C(=O)N2C)O1)c5ccccc5"
    },
    "unichem": {
      "chebi": "100213",
      "lincs": "LSM-11590",
      "pubchem": "54654266"
    },
    "pubchem": [
      {
        "cid": 54654266,
        "inchi": "InChI=1S/C30H32ClN3O6S/c1-19(20-6-4-3-5-7-20)32-29(35)17-23-11-14-26-28(40-23)18-39-27-15-10-22(16-25(27)30(36)34(26)2)33-41(37,38)24-12-8-21(31)9-13-24/h3-10,12-13,15-16,19,23,26,28,33H,11,14,17-18H2,1-2H3,(H,32,35)/t19-,23+,26-,28-/m0/s1",
        "inchikey": "UIBIEJVTTJAUBZ-OKWYHVSVSA-N",
        "iupac": {
          "systematic": "2-[(2R,4aS,12aR)-8-[(4-chlorophenyl)sulfonylamino]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-[(1S)-1-phenylethyl]acetamide"
        },
        "smiles": {
          "canonical": "CC(C1=CC=CC=C1)NC(=O)CC2CCC3C(O2)COC4=C(C=C(C=C4)NS(=O)(=O)C5=CC=C(C=C5)Cl)C(=O)N3C"
        },
        "molecularFormula": "C30H32ClN3O6S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:04:42Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c850a"
    },
    "name": "BRD-K05001416",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c850a.png",
    "lincs": {
      "id": "LSM-37538",
      "name": "BRD-K05001416",
      "pubchemCid": 54652472,
      "chebiId": 125971,
      "inchiParent": "InChI=1S/C25H24N2O4S/c28-17-23-25-20-13-7-8-14-21(20)26(24(29)15-18-9-3-1-4-10-18)16-22(25)27(23)32(30,31)19-11-5-2-6-12-19/h1-14,22-23,25,28H,15-17H2/t22-,23-,25+/m1/s1",
      "inchiKeyParent": "JVDZBXYYJOYVHG-OYRHQHFDSA-N",
      "smilesParent": "OC[C@@H]1[C@@H]2[C@@H](CN(C(=O)Cc3ccccc3)c4ccccc24)N1S(=O)(=O)c5ccccc5"
    },
    "unichem": {
      "chebi": "125971",
      "lincs": "LSM-37538",
      "pubchem": "54652472"
    },
    "pubchem": [
      {
        "cid": 54652472,
        "inchi": "InChI=1S/C25H24N2O4S/c28-17-23-25-20-13-7-8-14-21(20)26(24(29)15-18-9-3-1-4-10-18)16-22(25)27(23)32(30,31)19-11-5-2-6-12-19/h1-14,22-23,25,28H,15-17H2/t22-,23-,25+/m1/s1",
        "inchikey": "JVDZBXYYJOYVHG-OYRHQHFDSA-N",
        "iupac": {
          "systematic": "1-[(1S,2aS,8bS)-2-(benzenesulfonyl)-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-2-phenylethanone"
        },
        "smiles": {
          "canonical": "C1C2C(C(N2S(=O)(=O)C3=CC=CC=C3)CO)C4=CC=CC=C4N1C(=O)CC5=CC=CC=C5"
        },
        "molecularFormula": "C25H24N2O4S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:04:45Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8528"
    },
    "name": "BRD-K05543055",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8528.png",
    "lincs": {
      "id": "LSM-8755",
      "name": "BRD-K05543055",
      "pubchemCid": 54657596,
      "chebiId": 97376,
      "inchiParent": "InChI=1S/C31H41N3O6/c1-38-28-10-6-5-9-26(28)32-31(37)34-19-24(35)20-39-21-29-27(34)12-11-25(40-29)18-30(36)33-15-13-23(14-16-33)17-22-7-3-2-4-8-22/h2-10,23-25,27,29,35H,11-21H2,1H3,(H,32,37)/t24-,25-,27+,29-/m1/s1",
      "inchiKeyParent": "PLPDORRRKBPITR-MCXWQWDOSA-N",
      "smilesParent": "COc1ccccc1NC(=O)N2C[C@@H](O)COC[C@H]3O[C@@H](CC(=O)N4CCC(Cc5ccccc5)CC4)CC[C@H]23"
    },
    "unichem": {
      "chebi": "97376",
      "lincs": "LSM-8755",
      "pubchem": "54657596"
    },
    "pubchem": [
      {
        "cid": 54657596,
        "inchi": "InChI=1S/C31H41N3O6/c1-38-28-10-6-5-9-26(28)32-31(37)34-19-24(35)20-39-21-29-27(34)12-11-25(40-29)18-30(36)33-15-13-23(14-16-33)17-22-7-3-2-4-8-22/h2-10,23-25,27,29,35H,11-21H2,1H3,(H,32,37)/t24-,25-,27+,29-/m1/s1",
        "inchikey": "PLPDORRRKBPITR-MCXWQWDOSA-N",
        "iupac": {
          "systematic": "(3R,6aS,8R,10aS)-8-[2-(4-benzylpiperidin-1-yl)-2-oxoethyl]-3-hydroxy-N-(2-methoxyphenyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide"
        },
        "smiles": {
          "canonical": "COC1=CC=CC=C1NC(=O)N2CC(COCC3C2CCC(O3)CC(=O)N4CCC(CC4)CC5=CC=CC=C5)O"
        },
        "molecularFormula": "C31H41N3O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:04:47Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c856e"
    },
    "name": "BRD-K08173649",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c856e.png",
    "lincs": {
      "id": "LSM-8922",
      "name": "BRD-K08173649",
      "pubchemCid": 54639072,
      "chebiId": 97543,
      "inchiParent": "InChI=1S/C16H26N2O5/c1-22-11-15(20)17-13-6-5-12(23-14(13)10-19)9-16(21)18-7-3-2-4-8-18/h5-6,12-14,19H,2-4,7-11H2,1H3,(H,17,20)/t12-,13-,14+/m1/s1",
      "inchiKeyParent": "BHRCWANBCSKYFS-MCIONIFRSA-N",
      "smilesParent": "COCC(=O)N[C@@H]1C=C[C@H](CC(=O)N2CCCCC2)O[C@H]1CO"
    },
    "unichem": {
      "chebi": "97543",
      "lincs": "LSM-8922",
      "pubchem": "54639072"
    },
    "pubchem": [
      {
        "cid": 54639072,
        "inchi": "InChI=1S/C16H26N2O5/c1-22-11-15(20)17-13-6-5-12(23-14(13)10-19)9-16(21)18-7-3-2-4-8-18/h5-6,12-14,19H,2-4,7-11H2,1H3,(H,17,20)/t12-,13-,14+/m1/s1",
        "inchikey": "BHRCWANBCSKYFS-MCIONIFRSA-N",
        "iupac": {
          "systematic": "N-[(2R,3R,6S)-2-(hydroxymethyl)-6-(2-oxo-2-piperidin-1-ylethyl)-3,6-dihydro-2H-pyran-3-yl]-2-methoxyacetamide"
        },
        "smiles": {
          "canonical": "COCC(=O)NC1C=CC(OC1CO)CC(=O)N2CCCCC2"
        },
        "molecularFormula": "C16H26N2O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:04:49Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8574"
    },
    "name": "BRD-K23871470",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8574.png",
    "lincs": {
      "id": "LSM-9868",
      "name": "BRD-K23871470",
      "pubchemCid": 54637782,
      "chebiId": 98489,
      "inchiParent": "InChI=1S/C34H43N3O4/c1-24-20-37(25(2)22-38)33(39)30-18-12-11-17-29(30)28-16-10-9-15-27(28)23-41-32(24)21-36(5)34(40)31(35(3)4)19-26-13-7-6-8-14-26/h6-18,24-25,31-32,38H,19-23H2,1-5H3/t24-,25+,31+,32-/m0/s1",
      "inchiKeyParent": "ZQFGNRPCSITOFH-NKBCUSNNSA-N",
      "smilesParent": "C[C@H](CO)N1C[C@H](C)[C@H](CN(C)C(=O)[C@@H](Cc2ccccc2)N(C)C)OCc3ccccc3c4ccccc4C1=O"
    },
    "unichem": {
      "chebi": "98489",
      "lincs": "LSM-9868",
      "pubchem": "54637782"
    },
    "pubchem": [
      {
        "cid": 54637782,
        "inchi": "InChI=1S/C34H43N3O4/c1-24-20-37(25(2)22-38)33(39)30-18-12-11-17-29(30)28-16-10-9-15-27(28)23-41-32(24)21-36(5)34(40)31(35(3)4)19-26-13-7-6-8-14-26/h6-18,24-25,31-32,38H,19-23H2,1-5H3/t24-,25+,31+,32-/m0/s1",
        "inchikey": "ZQFGNRPCSITOFH-NKBCUSNNSA-N",
        "iupac": {
          "systematic": "(2R)-2-(dimethylamino)-N-[[(10R,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methyl-3-phenylpropanamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=CC=CC=C2C3=CC=CC=C3COC1CN(C)C(=O)C(CC4=CC=CC=C4)N(C)C)C(C)CO"
        },
        "molecularFormula": "C34H43N3O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:04:51Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85e4"
    },
    "name": "BRD-K26127000",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85e4.png",
    "lincs": {
      "id": "LSM-10011",
      "name": "BRD-K26127000",
      "pubchemCid": 54639125,
      "chebiId": 98632,
      "inchiParent": "InChI=1S/C19H26FN3O5S/c1-22-7-9-23(10-8-22)19(25)12-15-5-6-17(18(13-24)28-15)21-29(26,27)16-4-2-3-14(20)11-16/h2-6,11,15,17-18,21,24H,7-10,12-13H2,1H3/t15-,17-,18+/m1/s1",
      "inchiKeyParent": "BAJOMULNWMTCGT-NXHRZFHOSA-N",
      "smilesParent": "CN1CCN(CC1)C(=O)C[C@@H]2O[C@@H](CO)[C@H](NS(=O)(=O)c3cccc(F)c3)C=C2"
    },
    "unichem": {
      "chebi": "98632",
      "lincs": "LSM-10011",
      "pubchem": "54639125"
    },
    "pubchem": [
      {
        "cid": 54639125,
        "inchi": "InChI=1S/C19H26FN3O5S/c1-22-7-9-23(10-8-22)19(25)12-15-5-6-17(18(13-24)28-15)21-29(26,27)16-4-2-3-14(20)11-16/h2-6,11,15,17-18,21,24H,7-10,12-13H2,1H3/t15-,17-,18+/m1/s1",
        "inchikey": "BAJOMULNWMTCGT-NXHRZFHOSA-N",
        "iupac": {
          "systematic": "3-fluoro-N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-(4-methylpiperazin-1-yl)-2-oxoethyl]-3,6-dihydro-2H-pyran-3-yl]benzenesulfonamide"
        },
        "smiles": {
          "canonical": "CN1CCN(CC1)C(=O)CC2C=CC(C(O2)CO)NS(=O)(=O)C3=CC=CC(=C3)F"
        },
        "molecularFormula": "C19H26FN3O5S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:04:53Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85f5"
    },
    "name": "BRD-K42207609",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85f5.png",
    "lincs": {
      "id": "LSM-10991",
      "name": "BRD-K42207609",
      "pubchemCid": 54657960,
      "chebiId": 99612,
      "inchiParent": "InChI=1S/C26H34N4O6/c1-34-23-5-3-2-4-21(23)29-26(33)30-15-19(31)16-35-17-24-22(30)7-6-20(36-24)14-25(32)28-13-10-18-8-11-27-12-9-18/h2-5,8-9,11-12,19-20,22,24,31H,6-7,10,13-17H2,1H3,(H,28,32)(H,29,33)/t19-,20+,22+,24-/m0/s1",
      "inchiKeyParent": "YKBSBMDVZJDWJN-IKJKNFHUSA-N",
      "smilesParent": "COc1ccccc1NC(=O)N2C[C@H](O)COC[C@@H]3O[C@@H](CC(=O)NCCc4ccncc4)CC[C@@H]23"
    },
    "unichem": {
      "chebi": "99612",
      "lincs": "LSM-10991",
      "pubchem": "54657960"
    },
    "pubchem": [
      {
        "cid": 54657960,
        "inchi": "InChI=1S/C26H34N4O6/c1-34-23-5-3-2-4-21(23)29-26(33)30-15-19(31)16-35-17-24-22(30)7-6-20(36-24)14-25(32)28-13-10-18-8-11-27-12-9-18/h2-5,8-9,11-12,19-20,22,24,31H,6-7,10,13-17H2,1H3,(H,28,32)(H,29,33)/t19-,20+,22+,24-/m0/s1",
        "inchikey": "YKBSBMDVZJDWJN-IKJKNFHUSA-N",
        "iupac": {
          "systematic": "(3S,6aR,8R,10aR)-3-hydroxy-N-(2-methoxyphenyl)-8-[2-oxo-2-(2-pyridin-4-ylethylamino)ethyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide"
        },
        "smiles": {
          "canonical": "COC1=CC=CC=C1NC(=O)N2CC(COCC3C2CCC(O3)CC(=O)NCCC4=CC=NC=C4)O"
        },
        "molecularFormula": "C26H34N4O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:04:56Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8602"
    },
    "name": "BRD-K74370838",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8602.png",
    "lincs": {
      "id": "LSM-12982",
      "name": "BRD-K74370838",
      "pubchemCid": 54638677,
      "chebiId": 101619,
      "inchiParent": "InChI=1S/C20H29N3O4/c1-2-11-22-20(26)23-17-9-8-16(27-18(17)14-24)13-19(25)21-12-10-15-6-4-3-5-7-15/h3-9,16-18,24H,2,10-14H2,1H3,(H,21,25)(H2,22,23,26)/t16-,17+,18+/m1/s1",
      "inchiKeyParent": "UYZCTKNUILRIOW-SQNIBIBYSA-N",
      "smilesParent": "CCCNC(=O)N[C@H]1C=C[C@H](CC(=O)NCCc2ccccc2)O[C@H]1CO"
    },
    "unichem": {
      "chebi": "101619",
      "lincs": "LSM-12982",
      "pubchem": "54638677"
    },
    "pubchem": [
      {
        "cid": 54638677,
        "inchi": "InChI=1S/C20H29N3O4/c1-2-11-22-20(26)23-17-9-8-16(27-18(17)14-24)13-19(25)21-12-10-15-6-4-3-5-7-15/h3-9,16-18,24H,2,10-14H2,1H3,(H,21,25)(H2,22,23,26)/t16-,17+,18+/m1/s1",
        "inchikey": "UYZCTKNUILRIOW-SQNIBIBYSA-N",
        "iupac": {
          "systematic": "2-[(2R,3S,6S)-2-(hydroxymethyl)-3-(propylcarbamoylamino)-3,6-dihydro-2H-pyran-6-yl]-N-(2-phenylethyl)acetamide"
        },
        "smiles": {
          "canonical": "CCCNC(=O)NC1C=CC(OC1CO)CC(=O)NCCC2=CC=CC=C2"
        },
        "molecularFormula": "C20H29N3O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:04:58Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8603"
    },
    "name": "BRD-K59893964",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8603.png",
    "lincs": {
      "id": "LSM-12047",
      "name": "BRD-K59893964",
      "pubchemCid": 56835505,
      "chebiId": 100673,
      "inchiParent": "InChI=1S/C30H36N2O6S/c1-21-17-32(22(2)19-33)30(34)28-15-8-7-14-27(28)26-13-6-5-10-23(26)20-38-29(21)18-31(3)39(35,36)25-12-9-11-24(16-25)37-4/h5-16,21-22,29,33H,17-20H2,1-4H3/t21-,22+,29+/m1/s1",
      "inchiKeyParent": "GTRXSASKUSVSHJ-BXOOBUKZSA-N",
      "smilesParent": "COc1cccc(c1)S(=O)(=O)N(C)C[C@@H]2OCc3ccccc3c4ccccc4C(=O)N(C[C@H]2C)[C@@H](C)CO"
    },
    "unichem": {
      "chebi": "100673",
      "lincs": "LSM-12047",
      "pubchem": "56835505"
    },
    "pubchem": [
      {
        "cid": 56835505,
        "inchi": "InChI=1S/C30H36N2O6S/c1-21-17-32(22(2)19-33)30(34)28-15-8-7-14-27(28)26-13-6-5-10-23(26)20-38-29(21)18-31(3)39(35,36)25-12-9-11-24(16-25)37-4/h5-16,21-22,29,33H,17-20H2,1-4H3/t21-,22+,29+/m1/s1",
        "inchikey": "GTRXSASKUSVSHJ-BXOOBUKZSA-N",
        "iupac": {
          "systematic": "N-[[(10R,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-3-methoxy-N-methylbenzenesulfonamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=CC=CC=C2C3=CC=CC=C3COC1CN(C)S(=O)(=O)C4=CC=CC(=C4)OC)C(C)CO"
        },
        "molecularFormula": "C30H36N2O6S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:05:00Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c853e"
    },
    "name": "BRD-K55313038",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c853e.png",
    "lincs": {
      "id": "LSM-11781",
      "name": "BRD-K55313038",
      "pubchemCid": 54657927,
      "chebiId": 100406,
      "inchiParent": "InChI=1S/C22H29Cl2N3O5/c23-17-6-4-14(8-18(17)24)26-22(30)27-10-15(28)11-31-12-20-19(27)7-5-16(32-20)9-21(29)25-13-2-1-3-13/h4,6,8,13,15-16,19-20,28H,1-3,5,7,9-12H2,(H,25,29)(H,26,30)/t15-,16-,19-,20+/m0/s1",
      "inchiKeyParent": "KPSAIAGNOOFEEI-CPLUKWAASA-N",
      "smilesParent": "O[C@@H]1COC[C@H]2O[C@H](CC(=O)NC3CCC3)CC[C@@H]2N(C1)C(=O)Nc4ccc(Cl)c(Cl)c4"
    },
    "unichem": {
      "chebi": "100406",
      "lincs": "LSM-11781",
      "pubchem": "54657927"
    },
    "pubchem": [
      {
        "cid": 54657927,
        "inchi": "InChI=1S/C22H29Cl2N3O5/c23-17-6-4-14(8-18(17)24)26-22(30)27-10-15(28)11-31-12-20-19(27)7-5-16(32-20)9-21(29)25-13-2-1-3-13/h4,6,8,13,15-16,19-20,28H,1-3,5,7,9-12H2,(H,25,29)(H,26,30)/t15-,16-,19-,20+/m0/s1",
        "inchikey": "KPSAIAGNOOFEEI-CPLUKWAASA-N",
        "iupac": {
          "systematic": "(3S,6aS,8S,10aS)-8-[2-(cyclobutylamino)-2-oxoethyl]-N-(3,4-dichlorophenyl)-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide"
        },
        "smiles": {
          "canonical": "C1CC(C1)NC(=O)CC2CCC3C(O2)COCC(CN3C(=O)NC4=CC(=C(C=C4)Cl)Cl)O"
        },
        "molecularFormula": "C22H29Cl2N3O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:05:02Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85f0"
    },
    "name": "BRD-K19426893",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85f0.png",
    "lincs": {
      "id": "LSM-9600",
      "name": "BRD-K19426893",
      "pubchemCid": 54638850,
      "chebiId": 98221,
      "inchiParent": "InChI=1S/C22H32FN3O4/c23-17-8-4-5-9-18(17)25-22(29)26-19-11-10-16(30-20(19)14-27)12-13-24-21(28)15-6-2-1-3-7-15/h4-5,8-9,15-16,19-20,27H,1-3,6-7,10-14H2,(H,24,28)(H2,25,26,29)/t16-,19-,20-/m0/s1",
      "inchiKeyParent": "ABKGFAHRWOKBSI-VDGAXYAQSA-N",
      "smilesParent": "OC[C@@H]1O[C@H](CCNC(=O)C2CCCCC2)CC[C@@H]1NC(=O)Nc3ccccc3F"
    },
    "unichem": {
      "chebi": "98221",
      "lincs": "LSM-9600",
      "pubchem": "54638850"
    },
    "pubchem": [
      {
        "cid": 54638850,
        "inchi": "InChI=1S/C22H32FN3O4/c23-17-8-4-5-9-18(17)25-22(29)26-19-11-10-16(30-20(19)14-27)12-13-24-21(28)15-6-2-1-3-7-15/h4-5,8-9,15-16,19-20,27H,1-3,6-7,10-14H2,(H,24,28)(H2,25,26,29)/t16-,19-,20-/m0/s1",
        "inchikey": "ABKGFAHRWOKBSI-VDGAXYAQSA-N",
        "iupac": {
          "systematic": "N-[2-[(2S,5S,6R)-5-[(2-fluorophenyl)carbamoylamino]-6-(hydroxymethyl)oxan-2-yl]ethyl]cyclohexanecarboxamide"
        },
        "smiles": {
          "canonical": "C1CCC(CC1)C(=O)NCCC2CCC(C(O2)CO)NC(=O)NC3=CC=CC=C3F"
        },
        "molecularFormula": "C22H32FN3O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:05:04Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8630"
    },
    "name": "BRD-K78088483",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8630.png",
    "lincs": {
      "id": "LSM-41532",
      "name": "BRD-K78088483",
      "pubchemCid": 60190951,
      "chebiId": 129981,
      "inchiParent": "InChI=1S/C26H29N3O4/c1-17(2)8-9-18-10-12-19(13-11-18)25-21-14-28(15-24(31)29(21)22(25)16-30)26(32)27-20-6-4-5-7-23(20)33-3/h4-7,10-13,17,21-22,25,30H,14-16H2,1-3H3,(H,27,32)/t21-,22+,25-/m0/s1",
      "inchiKeyParent": "HGEDECRDPWELMS-FBLLAGFSSA-N",
      "smilesParent": "COc1ccccc1NC(=O)N2C[C@H]3[C@@H]([C@@H](CO)N3C(=O)C2)c4ccc(cc4)C#CC(C)C"
    },
    "unichem": {
      "chebi": "129981",
      "lincs": "LSM-41532",
      "pubchem": "60190951"
    },
    "pubchem": [
      {
        "cid": 60190951,
        "inchi": "InChI=1S/C26H29N3O4/c1-17(2)8-9-18-10-12-19(13-11-18)25-21-14-28(15-24(31)29(21)22(25)16-30)26(32)27-20-6-4-5-7-23(20)33-3/h4-7,10-13,17,21-22,25,30H,14-16H2,1-3H3,(H,27,32)/t21-,22+,25-/m0/s1",
        "inchikey": "HGEDECRDPWELMS-FBLLAGFSSA-N",
        "iupac": {
          "systematic": "(6R,7S,8S)-8-(hydroxymethyl)-N-(2-methoxyphenyl)-7-[4-(3-methylbut-1-ynyl)phenyl]-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide"
        },
        "smiles": {
          "canonical": "CC(C)C#CC1=CC=C(C=C1)C2C3CN(CC(=O)N3C2CO)C(=O)NC4=CC=CC=C4OC"
        },
        "molecularFormula": "C26H29N3O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:05:28Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8513"
    },
    "name": "CHEMBL2137151",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8513.png",
    "lincs": {
      "id": "LSM-44753",
      "name": "CHEMBL2137151",
      "alternativeNames": [
        "BRD-K38172414"
      ],
      "pubchemCid": 54651315,
      "inchiParent": "InChI=1S/C23H29N3O2/c1-3-7-17-9-11-18(12-10-17)23-20(14-25-22(28)4-2)26(21(23)16-27)15-19-8-5-6-13-24-19/h3,5-13,20-21,23,27H,4,14-16H2,1-2H3,(H,25,28)/b7-3+/t20-,21+,23+/m0/s1",
      "inchiKeyParent": "JQIVQIXEWIJDCO-VXEHQLPOSA-N",
      "smilesParent": "CCC(=O)NC[C@H]1[C@H]([C@@H](CO)N1Cc2ccccn2)c3ccc(\\C=C\\C)cc3"
    },
    "unichem": {
      "chembl": "CHEMBL2137151",
      "lincs": "LSM-44753",
      "pubchem": "54651315"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL2137151",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 379.5,
        "hba": 4,
        "hbd": 2,
        "qedWeighted": 0.74
      }
    },
    "pubchem": [
      {
        "cid": 54651315,
        "inchi": "InChI=1S/C23H29N3O2/c1-3-7-17-9-11-18(12-10-17)23-20(14-25-22(28)4-2)26(21(23)16-27)15-19-8-5-6-13-24-19/h3,5-13,20-21,23,27H,4,14-16H2,1-2H3,(H,25,28)/b7-3+/t20-,21+,23+/m0/s1",
        "inchikey": "JQIVQIXEWIJDCO-VXEHQLPOSA-N",
        "iupac": {
          "systematic": "N-[[(2R,3R,4S)-4-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]-1-(pyridin-2-ylmethyl)azetidin-2-yl]methyl]propanamide"
        },
        "smiles": {
          "canonical": "CCC(=O)NCC1C(C(N1CC2=CC=CC=N2)CO)C3=CC=C(C=C3)C=CC"
        },
        "molecularFormula": "C23H29N3O2"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:05:39Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85cc"
    },
    "name": "BRD-K09019812",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85cc.png",
    "lincs": {
      "id": "LSM-37753",
      "name": "BRD-K09019812",
      "pubchemCid": 54615056,
      "chebiId": 126186,
      "inchiParent": "InChI=1S/C33H48N4O5/c1-23-19-37(24(2)22-38)32(39)29-18-28(35-33(40)34-27-11-6-5-7-12-27)15-16-30(29)42-25(3)10-8-9-17-41-31(23)21-36(4)20-26-13-14-26/h5-7,11-12,15-16,18,23-26,31,38H,8-10,13-14,17,19-22H2,1-4H3,(H2,34,35,40)/t23-,24+,25-,31+/m1/s1",
      "inchiKeyParent": "WSGOBIVUANXEAU-FXIKWKPTSA-N",
      "smilesParent": "C[C@@H](CO)N1C[C@@H](C)[C@H](CN(C)CC2CC2)OCCCC[C@@H](C)Oc3ccc(NC(=O)Nc4ccccc4)cc3C1=O"
    },
    "unichem": {
      "chebi": "126186",
      "lincs": "LSM-37753",
      "pubchem": "54615056"
    },
    "pubchem": [
      {
        "cid": 54615056,
        "inchi": "InChI=1S/C33H48N4O5/c1-23-19-37(24(2)22-38)32(39)29-18-28(35-33(40)34-27-11-6-5-7-12-27)15-16-30(29)42-25(3)10-8-9-17-41-31(23)21-36(4)20-26-13-14-26/h5-7,11-12,15-16,18,23-26,31,38H,8-10,13-14,17,19-22H2,1-4H3,(H2,34,35,40)/t23-,24+,25-,31+/m1/s1",
        "inchikey": "WSGOBIVUANXEAU-FXIKWKPTSA-N",
        "iupac": {
          "systematic": "1-[(3R,9R,10R)-9-[[cyclopropylmethyl(methyl)amino]methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-phenylurea"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NC(=O)NC3=CC=CC=C3)C(C)CO)C)CN(C)CC4CC4"
        },
        "molecularFormula": "C33H48N4O5"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:05:41Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85e0"
    },
    "name": "BRD-K03515977",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85e0.png",
    "lincs": {
      "id": "LSM-8651",
      "name": "BRD-K03515977",
      "pubchemCid": 54661384,
      "chebiId": 97272,
      "inchiParent": "InChI=1S/C25H29N3O4/c1-26(2)25(32)21-18(14-29)20-13-27-19(22(21)28(20)23(30)16-9-6-10-16)12-11-17(24(27)31)15-7-4-3-5-8-15/h3-5,7-8,11-12,16,18,20-22,29H,6,9-10,13-14H2,1-2H3/t18-,20-,21+,22+/m0/s1",
      "inchiKeyParent": "MBRBGBQUUNVPJA-VXSCBNMQSA-N",
      "smilesParent": "CN(C)C(=O)[C@@H]1[C@@H](CO)[C@@H]2CN3C(=CC=C(C3=O)c4ccccc4)[C@H]1N2C(=O)C5CCC5"
    },
    "unichem": {
      "chebi": "97272",
      "lincs": "LSM-8651",
      "pubchem": "54661384"
    },
    "pubchem": [
      {
        "cid": 54661384,
        "inchi": "InChI=1S/C25H29N3O4/c1-26(2)25(32)21-18(14-29)20-13-27-19(22(21)28(20)23(30)16-9-6-10-16)12-11-17(24(27)31)15-7-4-3-5-8-15/h3-5,7-8,11-12,16,18,20-22,29H,6,9-10,13-14H2,1-2H3/t18-,20-,21+,22+/m0/s1",
        "inchikey": "MBRBGBQUUNVPJA-VXSCBNMQSA-N",
        "iupac": {
          "systematic": "(1S,9R,10R,11R)-12-(cyclobutanecarbonyl)-10-(hydroxymethyl)-N,N-dimethyl-6-oxo-5-phenyl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide"
        },
        "smiles": {
          "canonical": "CN(C)C(=O)C1C(C2CN3C(=CC=C(C3=O)C4=CC=CC=C4)C1N2C(=O)C5CCC5)CO"
        },
        "molecularFormula": "C25H29N3O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:05:43Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85eb"
    },
    "name": "BRD-K36864553",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85eb.png",
    "lincs": {
      "id": "LSM-39288",
      "name": "BRD-K36864553",
      "pubchemCid": 44502476,
      "chebiId": 127731,
      "inchiParent": "InChI=1S/C37H55N3O6/c1-26-22-40(27(2)25-41)37(43)33-21-31(38-36(42)30-12-7-6-8-13-30)16-19-34(33)46-28(3)11-9-10-20-45-35(26)24-39(4)23-29-14-17-32(44-5)18-15-29/h14-19,21,26-28,30,35,41H,6-13,20,22-25H2,1-5H3,(H,38,42)/t26-,27+,28+,35+/m0/s1",
      "inchiKeyParent": "UVSCGJDGVAXROK-ITEXHPTBSA-N",
      "smilesParent": "COc1ccc(CN(C)C[C@H]2OCCCC[C@@H](C)Oc3ccc(NC(=O)C4CCCCC4)cc3C(=O)N(C[C@@H]2C)[C@H](C)CO)cc1"
    },
    "unichem": {
      "chebi": "127731",
      "lincs": "LSM-39288",
      "pubchem": "44502476"
    },
    "pubchem": [
      {
        "cid": 44502476,
        "inchi": "InChI=1S/C37H55N3O6/c1-26-22-40(27(2)25-41)37(43)33-21-31(38-36(42)30-12-7-6-8-13-30)16-19-34(33)46-28(3)11-9-10-20-45-35(26)24-39(4)23-29-14-17-32(44-5)18-15-29/h14-19,21,26-28,30,35,41H,6-13,20,22-25H2,1-5H3,(H,38,42)/t26-,27+,28+,35+/m0/s1",
        "inchikey": "UVSCGJDGVAXROK-ITEXHPTBSA-N",
        "iupac": {
          "systematic": "N-[(3R,9S,10S)-12-[(2R)-1-hydroxypropan-2-yl]-9-[[(4-methoxyphenyl)methyl-methylamino]methyl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]cyclohexanecarboxamide"
        },
        "smiles": {
          "canonical": "CC1CCCCOC(C(CN(C(=O)C2=C(O1)C=CC(=C2)NC(=O)C3CCCCC3)C(C)CO)C)CN(C)CC4=CC=C(C=C4)OC"
        },
        "molecularFormula": "C37H55N3O6"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:05:46Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c861c"
    },
    "name": "BRD-K43212439",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c861c.png",
    "lincs": {
      "id": "LSM-39643",
      "name": "BRD-K43212439",
      "pubchemCid": 60189947,
      "chebiId": 128087,
      "inchiParent": "InChI=1S/C23H31N3O3/c1-3-4-20(28)26-13-23(14-26)12-25(10-15-5-6-15)19(11-27)22-21(23)17-8-7-16(29-2)9-18(17)24-22/h7-9,15,19,24,27H,3-6,10-14H2,1-2H3/t19-/m0/s1",
      "inchiKeyParent": "WEHHXPNDTZVABV-IBGZPJMESA-N",
      "smilesParent": "CCCC(=O)N1CC2(CN(CC3CC3)[C@@H](CO)c4[nH]c5cc(OC)ccc5c24)C1"
    },
    "unichem": {
      "chebi": "128087",
      "lincs": "LSM-39643",
      "pubchem": "60189947"
    },
    "pubchem": [
      {
        "cid": 60189947,
        "inchi": "InChI=1S/C23H31N3O3/c1-3-4-20(28)26-13-23(14-26)12-25(10-15-5-6-15)19(11-27)22-21(23)17-8-7-16(29-2)9-18(17)24-22/h7-9,15,19,24,27H,3-6,10-14H2,1-2H3/t19-/m0/s1",
        "inchikey": "WEHHXPNDTZVABV-IBGZPJMESA-N",
        "iupac": {
          "systematic": "1-[(1R)-2-(cyclopropylmethyl)-1-(hydroxymethyl)-7-methoxyspiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3'-azetidine]-1'-yl]butan-1-one"
        },
        "smiles": {
          "canonical": "CCCC(=O)N1CC2(C1)CN(C(C3=C2C4=C(N3)C=C(C=C4)OC)CO)CC5CC5"
        },
        "molecularFormula": "C23H31N3O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:05:48Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8627"
    },
    "name": "BRD-K70053541",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8627.png",
    "lincs": {
      "id": "LSM-41077",
      "name": "BRD-K70053541",
      "pubchemCid": 60185074,
      "chebiId": 129526,
      "inchiParent": "InChI=1S/C26H33N5O3/c1-4-9-28-25(33)31-17-26(15-30(16-26)13-18-6-5-10-27-12-18)23-20-8-7-19(34-3)11-21(20)29(2)24(23)22(31)14-32/h5-8,10-12,22,32H,4,9,13-17H2,1-3H3,(H,28,33)/t22-/m1/s1",
      "inchiKeyParent": "KFUDZWZDFVVFQZ-JOCHJYFZSA-N",
      "smilesParent": "CCCNC(=O)N1CC2(CN(Cc3cccnc3)C2)c4c([C@H]1CO)n(C)c5cc(OC)ccc45"
    },
    "unichem": {
      "chebi": "129526",
      "lincs": "LSM-41077",
      "pubchem": "60185074"
    },
    "pubchem": [
      {
        "cid": 60185074,
        "inchi": "InChI=1S/C26H33N5O3/c1-4-9-28-25(33)31-17-26(15-30(16-26)13-18-6-5-10-27-12-18)23-20-8-7-19(34-3)11-21(20)29(2)24(23)22(31)14-32/h5-8,10-12,22,32H,4,9,13-17H2,1-3H3,(H,28,33)/t22-/m1/s1",
        "inchikey": "KFUDZWZDFVVFQZ-JOCHJYFZSA-N",
        "iupac": {
          "systematic": "(1S)-1-(hydroxymethyl)-7-methoxy-9-methyl-N-propyl-1'-(pyridin-3-ylmethyl)spiro[1,3-dihydropyrido[3,4-b]indole-4,3'-azetidine]-2-carboxamide"
        },
        "smiles": {
          "canonical": "CCCNC(=O)N1CC2(CN(C2)CC3=CN=CC=C3)C4=C(C1CO)N(C5=C4C=CC(=C5)OC)C"
        },
        "molecularFormula": "C26H33N5O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:05:50Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c862c"
    },
    "name": "BRD-K42100231",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c862c.png",
    "lincs": {
      "id": "LSM-39595",
      "name": "BRD-K42100231",
      "pubchemCid": 60191151,
      "chebiId": 128039,
      "inchiParent": "InChI=1S/C27H28N2O3/c1-32-23-13-11-21(12-14-23)20-7-9-22(10-8-20)27-24-16-28(15-19-5-3-2-4-6-19)17-26(31)29(24)25(27)18-30/h2-14,24-25,27,30H,15-18H2,1H3/t24-,25+,27+/m1/s1",
      "inchiKeyParent": "XSDFHOHDMKHWQT-OBDYRVMHSA-N",
      "smilesParent": "COc1ccc(cc1)c2ccc(cc2)[C@@H]3[C@H](CO)N4[C@@H]3CN(Cc5ccccc5)CC4=O"
    },
    "unichem": {
      "chebi": "128039",
      "lincs": "LSM-39595",
      "pubchem": "60191151"
    },
    "pubchem": [
      {
        "cid": 60191151,
        "inchi": "InChI=1S/C27H28N2O3/c1-32-23-13-11-21(12-14-23)20-7-9-22(10-8-20)27-24-16-28(15-19-5-3-2-4-6-19)17-26(31)29(24)25(27)18-30/h2-14,24-25,27,30H,15-18H2,1H3/t24-,25+,27+/m1/s1",
        "inchikey": "XSDFHOHDMKHWQT-OBDYRVMHSA-N",
        "iupac": {
          "systematic": "(6S,7S,8R)-4-benzyl-8-(hydroxymethyl)-7-[4-(4-methoxyphenyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one"
        },
        "smiles": {
          "canonical": "COC1=CC=C(C=C1)C2=CC=C(C=C2)C3C4CN(CC(=O)N4C3CO)CC5=CC=CC=C5"
        },
        "molecularFormula": "C27H28N2O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:05:52Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8542"
    },
    "name": "MLS003650132",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8542.png",
    "lincs": {
      "id": "LSM-9187",
      "name": "MLS003650132",
      "alternativeNames": [
        "BRD-K12805559"
      ],
      "pubchemCid": 53382781,
      "chebiId": 97808,
      "inchiParent": "InChI=1S/C26H33ClN2O4/c27-21-8-6-20(7-9-21)15-29-16-22(30)17-32-18-25-24(29)11-10-23(33-25)14-26(31)28-13-12-19-4-2-1-3-5-19/h1-9,22-25,30H,10-18H2,(H,28,31)/t22-,23+,24+,25-/m0/s1",
      "inchiKeyParent": "CXJRMLHIKXWLHJ-LIONHTAISA-N",
      "smilesParent": "O[C@@H]1COC[C@@H]2O[C@@H](CC(=O)NCCc3ccccc3)CC[C@H]2N(Cc4ccc(Cl)cc4)C1"
    },
    "unichem": {
      "chebi": "97808",
      "chembl": "CHEMBL2355581",
      "lincs": "LSM-9187",
      "pubchem": "53382781"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL2355581",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 473.01,
        "hba": 5,
        "hbd": 2,
        "qedWeighted": 0.65
      }
    },
    "pubchem": [
      {
        "cid": 53382781,
        "inchi": "InChI=1S/C26H33ClN2O4/c27-21-8-6-20(7-9-21)15-29-16-22(30)17-32-18-25-24(29)11-10-23(33-25)14-26(31)28-13-12-19-4-2-1-3-5-19/h1-9,22-25,30H,10-18H2,(H,28,31)/t22-,23+,24+,25-/m0/s1",
        "inchikey": "CXJRMLHIKXWLHJ-LIONHTAISA-N",
        "iupac": {
          "systematic": "2-[(3S,6aR,8R,10aR)-1-[(4-chlorophenyl)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-phenylethyl)acetamide"
        },
        "smiles": {
          "canonical": "C1CC2C(COCC(CN2CC3=CC=C(C=C3)Cl)O)OC1CC(=O)NCCC4=CC=CC=C4"
        },
        "molecularFormula": "C26H33ClN2O4"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:06:03Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85d8"
    },
    "name": "PD-98059",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85d8.png",
    "lincs": {
      "id": "LSM-3394",
      "name": "PD-98059",
      "alternativeNames": [
        "PD 98059",
        "PD-98059"
      ],
      "pubchemCid": 4713,
      "chebiId": 77954,
      "inchiParent": "InChI=1S/C16H13NO3/c1-19-14-8-4-6-11(16(14)17)15-9-12(18)10-5-2-3-7-13(10)20-15/h2-9H,17H2,1H3",
      "inchiKeyParent": "QFWCYNPOPKQOKV-UHFFFAOYSA-N",
      "smilesParent": "COc1cccc(C2=CC(=O)c3ccccc3O2)c1N"
    },
    "unichem": {
      "chebi": "77954",
      "chembl": "CHEMBL35482",
      "lincs": "LSM-3394",
      "pubchem": "4713",
      "drugbank": "DB17042"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL35482",
      "chebiParId": "77954",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 267.28,
        "hba": 4,
        "hbd": 1,
        "qedWeighted": 0.72
      },
      "moleculeSynonyms": [
        {
          "moleculeSynonym": "PD-98059",
          "synType": "RESEARCH_CODE",
          "synonyms": "PD-98059"
        }
      ]
    },
    "pubchem": [
      {
        "cid": 4713,
        "inchi": "InChI=1S/C16H13NO3/c1-19-14-8-4-6-11(16(14)17)15-9-12(18)10-5-2-3-7-13(10)20-15/h2-9H,17H2,1H3",
        "inchikey": "QFWCYNPOPKQOKV-UHFFFAOYSA-N",
        "iupac": {
          "systematic": "2-(2-amino-3-methoxyphenyl)chromen-4-one"
        },
        "smiles": {
          "canonical": "COC1=CC=CC(=C1N)C2=CC(=O)C3=CC=CC=C3O2"
        },
        "molecularFormula": "C16H13NO3"
      }
    ],
    "clinicaltrials": [
      {
        "protocolSection": {
          "identificationModule": {
            "nctId": "NCT03747484",
            "briefTitle": "Gene-Modified Immune Cells (FH-MCVA2TCR) in Treating Patients With Metastatic or Unresectable Merkel Cell Cancer",
            "officialTitle": "ATTAC-MCC: Phase I/II Study of Autologous CD8+ and CD4+ Transgenic T Cells Expressing High Affinity MCPyV-specific TCRs Combined With Avelumab and Class I MHC-upregulation in Patients With Metastatic MCC Refractory to PD-1 Axis Blockade"
          },
          "statusModule": {
            "overallStatus": "TERMINATED",
            "whyStopped": "Terminated due to insufficient funding",
            "studyFirstSubmitDate": "2018-11-16",
            "resultsFirstSubmitDate": "2024-12-26"
          },
          "conditionsModule": {
            "conditions": [
              "Other Skin"
            ]
          },
          "designModule": {
            "studyType": "INTERVENTIONAL"
          },
          "outcomesModule": {
            "primaryOutcomes": [
              {
                "measure": "Incidence of Adverse Events Grade 3 or Higher Determined to be Possibly, Probably or Definitely Secondary to Study Treatments.",
                "timeFrame": "Up to 1 year post infusion"
              },
              {
                "measure": "Best Overall Response",
                "timeFrame": "Up to 1 year post infusion"
              }
            ],
            "secondaryOutcomes": [
              {
                "measure": "Progression-free Survival"
              },
              {
                "measure": "Overall Survival"
              }
            ]
          }
        }
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:06:14Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8588"
    },
    "name": "BRD-K85950149",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8588.png",
    "lincs": {
      "id": "LSM-41965",
      "name": "BRD-K85950149",
      "pubchemCid": 54652642,
      "chebiId": 130416,
      "inchiParent": "InChI=1S/C14H18N2O3/c1-19-8-13(18)16-11-6-15-10-5-3-2-4-9(10)14(11)12(16)7-17/h2-5,11-12,14-15,17H,6-8H2,1H3/t11-,12-,14+/m1/s1",
      "inchiKeyParent": "XWXBNJNOOSAFDW-BZPMIXESSA-N",
      "smilesParent": "COCC(=O)N1[C@H](CO)[C@@H]2[C@H]1CNc3ccccc23"
    },
    "unichem": {
      "chebi": "130416",
      "lincs": "LSM-41965",
      "pubchem": "54652642"
    },
    "pubchem": [
      {
        "cid": 54652642,
        "inchi": "InChI=1S/C14H18N2O3/c1-19-8-13(18)16-11-6-15-10-5-3-2-4-9(10)14(11)12(16)7-17/h2-5,11-12,14-15,17H,6-8H2,1H3/t11-,12-,14+/m1/s1",
        "inchikey": "XWXBNJNOOSAFDW-BZPMIXESSA-N",
        "iupac": {
          "systematic": "1-[(1S,2aS,8bS)-1-(hydroxymethyl)-2a,3,4,8b-tetrahydro-1H-azeto[2,3-c]quinolin-2-yl]-2-methoxyethanone"
        },
        "smiles": {
          "canonical": "COCC(=O)N1C2CNC3=CC=CC=C3C2C1CO"
        },
        "molecularFormula": "C14H18N2O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:06:16Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8593"
    },
    "name": "MLS005000118",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8593.png",
    "lincs": {
      "id": "LSM-42647",
      "name": "MLS005000118",
      "alternativeNames": [
        "BRD-K99354840"
      ],
      "pubchemCid": 60189775,
      "chebiId": 131099,
      "inchiParent": "InChI=1S/C26H35N5O3S/c1-28(2)15-23(33)30-10-7-26(8-11-30)17-31(14-22-27-9-12-35-22)21(16-32)25-24(26)19-6-5-18(34-4)13-20(19)29(25)3/h5-6,9,12-13,21,32H,7-8,10-11,14-17H2,1-4H3/t21-/m0/s1",
      "inchiKeyParent": "YUHBREGIJPWXHQ-NRFANRHFSA-N",
      "smilesParent": "COc1ccc2c3c([C@H](CO)N(Cc4nccs4)CC35CCN(CC5)C(=O)CN(C)C)n(C)c2c1"
    },
    "unichem": {
      "chebi": "131099",
      "lincs": "LSM-42647",
      "pubchem": "60189775"
    },
    "pubchem": [
      {
        "cid": 60189775,
        "inchi": "InChI=1S/C26H35N5O3S/c1-28(2)15-23(33)30-10-7-26(8-11-30)17-31(14-22-27-9-12-35-22)21(16-32)25-24(26)19-6-5-18(34-4)13-20(19)29(25)3/h5-6,9,12-13,21,32H,7-8,10-11,14-17H2,1-4H3/t21-/m0/s1",
        "inchikey": "YUHBREGIJPWXHQ-NRFANRHFSA-N",
        "iupac": {
          "systematic": "2-(dimethylamino)-1-[(1R)-1-(hydroxymethyl)-7-methoxy-9-methyl-2-(1,3-thiazol-2-ylmethyl)spiro[1,3-dihydropyrido[3,4-b]indole-4,4'-piperidine]-1'-yl]ethanone"
        },
        "smiles": {
          "canonical": "CN1C2=C(C=CC(=C2)OC)C3=C1C(N(CC34CCN(CC4)C(=O)CN(C)C)CC5=NC=CS5)CO"
        },
        "molecularFormula": "C26H35N5O3S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:06:19Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c85dd"
    },
    "name": "BRD-K20793945",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c85dd.png",
    "lincs": {
      "id": "LSM-9694",
      "name": "BRD-K20793945",
      "pubchemCid": 54661323,
      "chebiId": 98315,
      "inchiParent": "InChI=1S/C23H29N5O3/c1-25-9-11-26(12-10-25)23(31)21-17(15-29)19-14-27-18(3-2-4-20(27)30)22(21)28(19)13-16-5-7-24-8-6-16/h2-8,17,19,21-22,29H,9-15H2,1H3/t17-,19-,21+,22+/m0/s1",
      "inchiKeyParent": "BSTTWZJBQFNDNI-HVJHZFLKSA-N",
      "smilesParent": "CN1CCN(CC1)C(=O)[C@@H]2[C@@H](CO)[C@@H]3CN4C(=O)C=CC=C4[C@H]2N3Cc5ccncc5"
    },
    "unichem": {
      "chebi": "98315",
      "lincs": "LSM-9694",
      "pubchem": "54661323"
    },
    "pubchem": [
      {
        "cid": 54661323,
        "inchi": "InChI=1S/C23H29N5O3/c1-25-9-11-26(12-10-25)23(31)21-17(15-29)19-14-27-18(3-2-4-20(27)30)22(21)28(19)13-16-5-7-24-8-6-16/h2-8,17,19,21-22,29H,9-15H2,1H3/t17-,19-,21+,22+/m0/s1",
        "inchikey": "BSTTWZJBQFNDNI-HVJHZFLKSA-N",
        "iupac": {
          "systematic": "(1S,9R,10R,11R)-10-(hydroxymethyl)-11-(4-methylpiperazine-1-carbonyl)-12-(pyridin-4-ylmethyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-dien-6-one"
        },
        "smiles": {
          "canonical": "CN1CCN(CC1)C(=O)C2C(C3CN4C(=O)C=CC=C4C2N3CC5=CC=NC=C5)CO"
        },
        "molecularFormula": "C23H29N5O3"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:06:21Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c860b"
    },
    "name": "CHEMBL2361075",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c860b.png",
    "lincs": {
      "id": "LSM-8460",
      "name": "CHEMBL2361075",
      "alternativeNames": [
        "BRD-K00478394"
      ],
      "pubchemCid": 54637934,
      "chebiId": 97081,
      "inchiParent": "InChI=1S/C33H36N4O5S/c1-22-18-37(23(2)20-38)33(39)32-31(28-14-7-8-15-29(28)36(32)4)27-13-6-5-11-25(27)21-42-30(22)19-35(3)43(40,41)26-12-9-10-24(16-26)17-34/h5-16,22-23,30,38H,18-21H2,1-4H3/t22-,23+,30-/m0/s1",
      "inchiKeyParent": "DEQYHGFYIZKXEQ-BURCIIJTSA-N",
      "smilesParent": "C[C@H](CO)N1C[C@H](C)[C@H](CN(C)S(=O)(=O)c2cccc(c2)C#N)OCc3ccccc3c4c(C1=O)n(C)c5ccccc45"
    },
    "unichem": {
      "chebi": "97081",
      "chembl": "CHEMBL2361075",
      "lincs": "LSM-8460",
      "pubchem": "54637934"
    },
    "chembl": {
      "moleculeChemblId": "CHEMBL2361075",
      "oral": false,
      "parenteral": false,
      "withdrawnFlag": false,
      "blackBoxWarning": false,
      "moleculeProperties": {
        "fullMwt": 600.74,
        "hba": 7,
        "hbd": 1,
        "qedWeighted": 0.35
      }
    },
    "pubchem": [
      {
        "cid": 54637934,
        "inchi": "InChI=1S/C33H36N4O5S/c1-22-18-37(23(2)20-38)33(39)32-31(28-14-7-8-15-29(28)36(32)4)27-13-6-5-11-25(27)21-42-30(22)19-35(3)43(40,41)26-12-9-10-24(16-26)17-34/h5-16,22-23,30,38H,18-21H2,1-4H3/t22-,23+,30-/m0/s1",
        "inchikey": "DEQYHGFYIZKXEQ-BURCIIJTSA-N",
        "iupac": {
          "systematic": "3-cyano-N-[[(10R,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylbenzenesulfonamide"
        },
        "smiles": {
          "canonical": "CC1CN(C(=O)C2=C(C3=CC=CC=C3COC1CN(C)S(=O)(=O)C4=CC=CC(=C4)C#N)C5=CC=CC=C5N2C)C(C)CO"
        },
        "molecularFormula": "C33H36N4O5S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:06:32Z"
    }
  },
  {
    "_id": {
      "$oid": "67bce554bd4a50a0578c8621"
    },
    "name": "BRD-K69237309",
    "scope": "public",
    "structureImage": "https://stmetaregdeveus.blob.core.windows.net/chemical-structures/67bce554bd4a50a0578c8621.png",
    "lincs": {
      "id": "LSM-41038",
      "name": "BRD-K69237309",
      "pubchemCid": 60189952,
      "chebiId": 129487,
      "inchiParent": "InChI=1S/C25H28FN3O5S/c1-4-35(32,33)28-13-25(14-28)15-29(24(31)16-5-7-17(26)8-6-16)21(12-30)23-22(25)19-10-9-18(34-3)11-20(19)27(23)2/h5-11,21,30H,4,12-15H2,1-3H3/t21-/m0/s1",
      "inchiKeyParent": "RVMALAFFYHTCFN-NRFANRHFSA-N",
      "smilesParent": "CCS(=O)(=O)N1CC2(C1)CN([C@@H](CO)c3c2c4ccc(OC)cc4n3C)C(=O)c5ccc(F)cc5"
    },
    "unichem": {
      "chebi": "129487",
      "lincs": "LSM-41038",
      "pubchem": "60189952"
    },
    "pubchem": [
      {
        "cid": 60189952,
        "inchi": "InChI=1S/C25H28FN3O5S/c1-4-35(32,33)28-13-25(14-28)15-29(24(31)16-5-7-17(26)8-6-16)21(12-30)23-22(25)19-10-9-18(34-3)11-20(19)27(23)2/h5-11,21,30H,4,12-15H2,1-3H3/t21-/m0/s1",
        "inchikey": "RVMALAFFYHTCFN-NRFANRHFSA-N",
        "iupac": {
          "systematic": "[(1R)-1'-ethylsulfonyl-1-(hydroxymethyl)-7-methoxy-9-methylspiro[1,3-dihydropyrido[3,4-b]indole-4,3'-azetidine]-2-yl]-(4-fluorophenyl)methanone"
        },
        "smiles": {
          "canonical": "CCS(=O)(=O)N1CC2(C1)CN(C(C3=C2C4=C(N3C)C=C(C=C4)OC)CO)C(=O)C5=CC=C(C=C5)F"
        },
        "molecularFormula": "C25H28FN3O5S"
      }
    ],
    "createdAt": {
      "$date": "2025-05-24T09:06:35Z"
    }
  }
]